Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 17q21.33-24.2(chr17:36449220-68170214)x3	LOC116276472|LOC116276473|LOC121587594|LOC121587595|LOC121587596|LOC121587597|LOC121852931|LOC121852932|LOC121852933|LOC121852944|LOC121852945|LOC125177472|LOC125177481|LOC125177482|LOC125177484|LOC125177493|LOC125177494|LOC125177495|LOC125177508|LOC125177509|LOC125177522|LOC125177523|LOC125316771|LOC125316772|LOC125316773|LOC125316774|LOC125316775|LOC126862544|LOC126862545|LOC126862557|LOC126862558|LOC126862568|LOC126862581|LOC126862582|LOC126862583|LOC126862595|LOC126862596|LOC126862597|LOC126862598|LOC126862609|LOC126862620|LOC126862621|LOC129390870|LOC129390871|LOC129390872|LOC129390873|LOC129390874|LOC129390888|LOC129390889|LOC129390901|LOC129390902|LOC129390903|LOC129390913|LOC129390914|LOC130060742|LOC130060743|LOC130060753|LOC130060754|LOC130060755|LOC130060756|LOC130060765|LOC130060766|LOC130060767|LOC130060777|LOC130060778|LOC130060790|LOC130060791|LOC130060792|LOC130060803|LOC130060804|LOC130060805|LOC130060811|LOC130060812|LOC130060820|LOC130060821|LOC130060822|LOC130060823|LOC130060833|LOC130060834|LOC130060843|LOC130060844|LOC130060850|LOC130060851|LOC130060852|LOC130060861|LOC130060862|LOC130060869|LOC130060870|LOC130060878|LOC130060879|LOC130060880|LOC130060890|LOC130060897|LOC130060898|LOC130060906|LOC130060914|LOC130060915|LOC130060916|LOC130060926|LOC130060927|LOC130060935|LOC130060936|LOC130060943|LOC130060944|LOC130060945|LOC130060946|LOC130060951|LOC130060952|LOC130060953|LOC130060960|LOC130060961|LOC130060962|LOC130060967|LOC130060968|LOC130060975|LOC130060976|LOC130060977|LOC130060978|LOC130060969|LOC130060970|LOC130060971|LOC130060972|LOC130060973|LOC130060974|LOC130060979|LOC130060980|LOC130060981|LOC130060982|LOC130060983|LOC130060984|LOC130060985|LOC130060986|LOC130060987|LOC130060988|LOC130060948|LOC130060949|LOC130060950|LOC130060947|LOC130060954|LOC130060955|LOC130060956|LOC130060957|LOC130060958|LOC130060959|LOC130060917|LOC130060918|LOC130060923|LOC130060924|LOC130060925|LOC130060919|LOC130060920|LOC130060921|LOC130060922|LOC130060963|LOC130060964|LOC130060928|LOC130060929|LOC130060930|LOC130060931|LOC130060932|LOC130060933|LOC130060934|LOC130060965|LOC130060937|LOC130060938|LOC130060891|LOC130060892|LOC130060893|LOC130060894|LOC130060895|LOC130060896|LOC130060939|LOC130060940|LOC130060899|LOC130060900|LOC130060903|LOC130060904|LOC130060905|LOC130060901|LOC130060902|LOC130060941|LOC130060942|LOC130060907|LOC130060908|LOC130060863|LOC130060864|LOC130060867|LOC130060868|LOC130060865|LOC130060866|LOC130060909|LOC130060910|LOC130060911|LOC130060871|LOC130060872|LOC130060873|LOC130060874|LOC130060875|LOC130060876|LOC130060877|LOC130060912|LOC130060913|LOC130060881|LOC130060882|LOC130060883|LOC130060835|LOC130060836|LOC130060884|LOC130060885|LOC130060886|LOC130060837|LOC130060838|LOC130060839|LOC130060840|LOC130060841|LOC130060842|LOC130060845|LOC130060846|LOC130060847|LOC130060830|LOC130060831|LOC130060832|LOC130060824|LOC130060825|LOC130060826|LOC130060827|LOC130060828|LOC130060829|LOC130060849|LOC130060848|LOC130060887|LOC130060888|LOC130060889|LOC130060853|LOC130060854|LOC130060855|LOC130060856|LOC130060857|LOC130060793|LOC130060794|LOC130060795|LOC130060798|LOC130060799|LOC130060800|LOC130060801|LOC130060802|LOC130060858|LOC130060859|LOC130060860|LOC130060806|LOC130060807|LOC130060809|LOC130060810|LOC130060808|LOC130060966|LOC130060757|LOC130060758|LOC130060813|LOC130060814|LOC130060768|LOC130060769|LOC130060770|LOC130060774|LOC130060775|LOC130060776|LOC130060818|LOC130060819|LOC130060779|LOC130060780|LOC130060781|LOC129390890|LOC129390891|LOC130060787|LOC130060788|LOC130060789|LOC129390875|LOC129390876|LOC129390877|LOC129390904|LOC129390905|LOC130060784|LOC130060785|LOC130060786|LOC126862599|LOC129390915|LOC129390916|LOC129390917|LOC129390918|LOC130060815|LOC130060816|LOC130060817|LOC130060744|LOC130060745|LOC126862610|LOC126862546|LOC126862547|LOC125177524|LOC125177525|LOC125177526|LOC130060749|LOC130060750|LOC130060751|LOC125316776|LOC126862559|LOC125177473|LOC126862622|LOC126862623|LOC125177485|LOC125177486|LOC125177487|LOC126862569|LOC126862570|LOC126862571|LOC116276474|LOC116276475|LOC116276476|LOC125177496|LOC121587598|LOC121587599|LOC121587600|LOC130060752|LOC121852934|LOC121852935|LOC121852936|LOC125177510|LOC121852946|LOC121852947|LOC126862584|LOC126862585|LOC116276477|LOC116276478|LOC121587601|LOC121587602|LOC121852937|LOC125177462|LOC125177463|LOC125177474|LOC125177488|LOC125177497|LOC125177498|LOC125177512|LOC125177513|LOC125177527|LOC125312415|LOC125312416|LOC125316777|LOC126862548|LOC126862549|LOC126862560|LOC126862561|LOC126862572|LOC126862573|LOC126862574|LOC126862586|LOC126862587|LOC126862588|LOC126862600|LOC126862601|LOC126862602|LOC126862611|LOC126862612|LOC126862613|LOC128669077|LOC128669078|LOC129390878|LOC129390879|LOC129390880|LOC129390892|LOC129390893|LOC129390906|LOC129390907|LOC129390908|LOC129390919|LOC129390920|LOC129390921|LOC130060746|LOC130060747|LOC130060748|LOC130060759|LOC130060760|LOC130060761|LOC130060771|LOC130060772|LOC130060773|LOC129390910|LOC129390911|LOC129390912|LOC130060762|LOC130060763|LOC130060764|LOC129390881|LOC129390882|LOC129390883|LOC130060782|LOC130060783|LOC129390884|LOC129390885|LOC129390886|LOC129390887|LOC129390894|LOC129390895|LOC129390922|LOC130060737|LOC130060738|LOC129390909|LOC126862614|LOC126862615|LOC129390866|LOC129390867|LOC129390865|LOC126862607|LOC126862608|LOC129390868|LOC129390869|LOC129390898|LOC129390899|LOC129390900|LOC129390896|LOC129390897|LOC126862593|LOC126862594|LOC130060739|LOC130060740|LOC130060741|LOC126862616|LOC126862617|LOC126862603|LOC126862604|LOC126862605|LOC126862576|LOC126862577|LOC126862578|LOC126862579|LOC126862580|LOC126862575|LOC126862618|LOC126862619|LOC130060796|LOC130060797|LOC126862606|LOC126862563|LOC126862564|LOC126862565|LOC126862566|LOC126862567|LOC125316778|LOC126862589|LOC126862550|LOC126862590|LOC126862591|LOC126862592|LOC125312420|LOC125316770|LOC125316779|LOC125316780|LOC125316781|LOC126862543|LOC126862562|LOC125177516|LOC125177517|LOC125177514|LOC125177515|LOC125177518|LOC125177519|LOC125177520|LOC125177521|LOC126862551|LOC126862552|LOC126862553|LOC126862554|LOC126862555|LOC126862556|LOC125177503|LOC125177504|LOC125177505|LOC125177507|LOC125177489|LOC125177476|LOC125177477|LOC125312417|LOC125177500|LOC125177501|LOC125177502|LOC125177492|LOC125177466|LOC125177464|LOC125177465|LOC125177467|LOC125177469|LOC125177470|LOC125177471|LOC125177490|LOC125177491|LOC125312418|LOC125312419|LOC121852939|LOC121852940|LOC121852941|LOC121852942|LOC121852943|LOC121587603|LOC121587604|LOC121587605|LOC125177475|LOC121587591|LOC121587592|LOC121587593|LOC121852938|LOC121603768|LOC121603769|LOC121603770|LOC121603771|LOC116276468|LOC116276469|LOC125177478|LOC125177479|LOC125177480|LOC120285839|LOC121587588|LOC116276470|LOC116276471|LOC121587589|LOC121587590|LOC130060989|LOC130060990|LOC130060991|LOC130060992|LOC130060993|LOC130060994|LOC130060995|LOC130060996|LOC130060997|LOC130060998|LOC130060999|LOC130061000|LOC130061001|LOC130061002|LOC130061003|LOC130061004|LOC130061005|LOC130061006|LOC130061007|LOC130061008|LOC130061009|LOC130061010|LOC130061011|LOC130061012|LOC130061013|LOC130061014|LOC130061015|LOC130061016|LOC130061017|LOC130061018|LOC130061019|LOC130061020|LOC130061021|LOC130061022|LOC130061023|LOC130061024|LOC130061025|LOC130061026|LOC130061027|LOC130061028|LOC130061029|LOC130061030|LOC130061031|LOC130061032|LOC130061033|LOC130061034|LOC130061035|LOC130061036|LOC130061037|LOC130061038|LOC130061039|LOC130061040|LOC130061041|LOC130061042|LOC130061043|LOC130061044|LOC130061045|LOC130061046|LOC130061047|LOC130061048|LOC130061049|LOC130061050|LOC130061051|LOC130061052|LOC130061053|LOC130061054|LOC130061055|LOC130061056|LOC130061057|LOC130061058|LOC130061059|LOC130061060|LOC130061061|LOC130061062|LOC130061063|LOC130061064|LOC130061065|LOC130061066|LOC130061067|LOC130061068|LOC130061069|LOC130061070|LOC130061071|LOC130061072|LOC130061073|LOC130061074|LOC130061075|LOC130061076|LOC130061077|LOC130061078|LOC130061079|LOC130061080|LOC130061081|LOC130061082|LOC130061083|LOC130061084|LOC130061085|LOC130061086|LOC130061087|LOC130061088|LOC130061089|LOC130061090|LOC130061091|LOC130061092|LOC130061093|LOC130061094|LOC130061095|LOC130061096|LOC130061097|LOC130061098|LOC130061099|LOC130061100|LOC130061101|LOC130061102|LOC130061103|LOC130061104|LOC130061105|LOC130061106|LOC130061107|LOC130061108|LOC130061109|LOC130061110|LOC130061111|LOC130061112|LOC130061113|LOC130061114|LOC130061115|LOC130061116|LOC130061117|LOC130061118|LOC130061119|LOC130061120|LOC130061121|LOC130061122|LOC130061123|LOC130061124|LOC130061125|LOC130061126|LOC130061127|LOC130061128|LOC130061129|LOC130061130|LOC130061131|LOC130061132|LOC130061133|LOC130061134|LOC130061135|LOC130061136|LOC130061137|LOC130061138|LOC130061139|LOC130061140|LOC130061141|LOC130061142|LOC130061143|LOC130061144|LOC130061145|LOC130061146|LOC130061147|LOC130061148|LOC130061149|LOC130061150|LOC130061151|LOC130061152|LOC130061153|LOC130061154|LOC130061155|LOC130061156|LOC130061157|LOC130061158|LOC130061159|LOC130061160|LOC130061161|LOC130061162|LOC130061163|LOC130061164|LOC130061165|LOC130061166|LOC130061167|LOC130061168|LOC130061169|LOC130061170|LOC130061171|LOC130061172|LOC130061173|LOC130061174|LOC130061175|LOC130061176|LOC130061177|LOC130061178|LOC130061179|LOC130061180|LOC130061181|LOC130061182|LOC130061183|LOC130061184|LOC130061185|LOC130061186|LOC130061187|LOC130061188|LOC130061189|LOC130061190|LOC130061191|LOC130061192|LOC130061193|LOC130061194|LOC130061195|LOC130061196|LOC130061197|LOC130061198|LOC130061199|LOC130061200|LOC130061201|LOC130061202|LOC130061203|LOC130061204|LOC130061205|LOC130061206|LOC130061207|LOC130061208|LOC130061209|LOC130061210|LOC130061211|LOC130061212|LOC130061213|LOC130061214|LOC130061215|LOC130061216|LOC130061217|LOC130061218|LOC130061219|LOC130061220|LOC130061221|LOC130061222|LOC130061223|LOC130061224|LOC130061225|LOC130061226|LOC130061227|LOC130061228|LOC130061229|LOC130061230|LOC130061231|LOC130061232|LOC130061233|LOC130061234|LOC130061235|LOC130061236|LOC130061237|LOC130061238|LOC130061239|LOC130061240|LOC130061241|LOC130061242|LOC130061243|LOC130061244|LOC130061245|LOC130061246|LOC130061247|LOC130061248|LOC130061249|LOC130061250|LOC130061251|LOC130061252|LOC130061253|LOC130061254|LOC130061255|LOC130061256|LOC130061257|LOC130061258|LOC130061259|LOC130061260|LOC130061261|LOC130061262|LOC130061263|LOC130061264|LOC130061265|LOC130061266|LOC130061267|LOC130061268|LOC130061269|LOC130061270|LOC130061271|LOC130061272|LOC130061273|LOC130061274|LOC130061275|LOC130061276|LOC130061277|LOC130061278|LOC130061279|LOC130061280|LOC130061281|LOC130061282|LOC130061283|LOC130061284|LOC130061285|LOC130061286|LOC130061287|LOC130061288|LOC130061289|LOC130061290|LOC130061291|LOC130061292|LOC130061293|LOC130061294|LOC130061295|LOC130061296|LOC130061297|LOC130061298|LOC130061299|LOC130061300|LOC130061301|LOC130061302|LOC130061303|LOC130061304|LOC130061305|LOC130061306|LOC130061307|LOC130061308|LOC130061309|LOC130061310|LOC130061311|LOC130061312|LOC130061313|LOC130061314|LOC130061315|LOC130061316|LOC130061317|LOC130061318|LOC130061319|LOC130061320|LOC130061321|LOC130061322|LOC130061323|LOC130061324|LOC130061325|LOC130061326|LOC130061327|LOC130061328|LOC130061329|LOC130061330|LOC130061331|LOC130061332|LOC130061333|LOC130061334|LOC130061335|LOC130061336|LOC130061337|LOC130061338|LOC130061339|LOC130061340|LOC130061341|LOC130061342|LOC130061343|LOC130061344|LOC130061345|LOC130061346|LOC130061347|LOC130061348|LOC130061349|LOC130061350|LOC130061351|LOC130061352|LOC130061353|LOC130061354|LOC130061355|LOC130061356|LOC130061357|LOC130061358|LOC130061359|LOC130061360|LOC130061361|LOC130061362|LOC130061363|LOC130061364|LOC130061365|LOC130061366|LOC130061367|LOC130061368|LOC130061369|LOC130061370|LOC130061371|LOC130061372|LOC130061373|LOC130061374|LOC130061375|LOC130061376|LOC130061377|LOC130061378|LOC130061379|LOC130061380|LOC130061381|LOC130061382|LOC130061383|LOC130061384|LOC130061385|LOC130061386|LOC130061387|LOC130061388|LOC130061389|LOC130061390|LOC130061391|LOC130061392|LOC130061393|LOC130061394|LOC130061395|LOC130061396|LOC130061397|LOC130061398|LOC130061399|LOC130061400|LOC130061401|LOC130061402|LOC130061403|LOC130061404|LOC130061405|LOC130061406|LOC130061407|LOC130061408|LOC130061409|LOC130061410|LOC130061411|LOC130061412|LOC130061413|LOC130061414|LOC130061415|LOC130061416|LOC130061417|LOC130061418|LOC130061419|LOC130061420|LOC130061421|LOC130061422|LOC130061423|LOC130061424|LOC130061425|LOC130061426|LOC130061427|LOC130061428|LOC130061429|LOC130061430|LOC130061431|LOC130061432|LOC130061433|LOC130061434|LOC130061435|LOC130061436|LOC130061437|LOC130061438|LOC130061439|LOC130061440|LOC130061441|LOC130061442|LOC130061443|LOC130061444|LOC130061445|LOC130061446|LOC130061447|LOC130061448|LOC130061449|LOC130061450|LOC130061451|LOC130061452|LOC130061453|LOC130061454|LOC130061455|LOC130061456|LOC130061457|LOC130061458|LOC130061459|LOC130061460|LOC130061461|LOC130061462|LOC130061463|LOC130061464|LOC130061465|LOC130061466|LOC130061467|LOC130061468|LOC130061469|LOC130061470|LOC130061471|LOC130061472|LOC130061473|LOC130061474|LOC130061475|LOC130061476|LOC130061477|LOC130061478|LOC130061479|LOC130061480|LOC130061481|LOC130061482|LOC130061483|LOC130061484|LOC130061485|LOC130061486|LOC130061487|LOC130061488|LOC130061489|LOC130061490|LOC130061491|LOC130061492|LOC130061493|LOC130061494|LOC130061495|LOC130061496|LOC130061497|LOC130061498|LOC130061499|LOC130061500|LOC130061501|LOC130061502|LOC130061503|LOC130061504|LOC729683|LPO|LRRC37A|LRRC37A2|LRRC37A3|LRRC3C|LRRC46|LRRC59|LRRC59-AS1|LSM12|LUC7L3|MAP3K14|MAP3K14-AS1|MAP3K3|MAPT|MAPT-AS1|MAPT-IT1|MARCHF10|MARCHF10-AS1|MARCHF10-DT|MBTD1|MED1|MED13|MED24|MEIOC|MEOX1|METTL2A|MIEN1|MILR1|MIR10226|MIR10A|MIR1203|MIR142|MIR142HG|MIR152|MIR196A1|MIR21|MIR2117|MIR2117HG|MIR2909|MIR301A|MIR3064|MIR3185|MIR3614|MIR378J|MIR4315-1|MIR4315-2|MIR454|MIR4726|MIR4727|MIR4728|MIR4729|MIR4734|MIR4736|MIR4737|MIR5010|MIR5047|MIR5089|MIR548AA2|MIR548AT|MIR548BC|MIR548D2|MIR6080|MIR6129|MIR6165|MIR633|MIR634|MIR6510|MIR6779|MIR6780A|MIR6781|MIR6782|MIR6783|MIR6784|MIR6866|MIR6867|MIR6884|MIR8059|MKS1|MLLT6|MLX|MMD|MPO|MPP2|MPP3|MRC2|MRM1|MRPL10|MRPL27|MRPL45|MRPS23|MSI2|MSI2-AS1|MSL1|MTMR4|MYCBPAP|MYL4|MYO19|NACA2|NAGLU|NAGS|NBR1|NBR2|NEUROD2|NFE2L1|NFE2L1-DT|NGFR|NGFR-AS1|NKIRAS2|NME1|NME1-NME2|NME2|NMT1|NOG|NOL11|NPEPPS|NR1D1|NSF|NT5C3B|NXPH3|ODAD4|OR4D1|OR4D2|ORMDL3|OSBPL7|P3H4|PCGF2|PCTP|PDK2|PECAM1|PGAP3|PHB1|PHOSPHO1|PICART1|PIGW|PIP4K2B|PITPNC1|PLCD3|PLEKHH3|PLEKHM1|PLXDC1|PNMT|PNPO|POLG2|PRAC2|PPM1D|PPM1E|PPP1R1B|PPP1R9B|PPY|PRAC1|PRKCA|PRKCA-AS1|PRR11|PRR15L|PRR29|PRR29-AS1|PSMB3|PSMC3IP|PSMC5|PSMD12|PSMD3|PSMD3-AS1|PSME3|PTGES3L|PTGES3L-AARSD1|PTRH2|PYY|RAB5C|RAB5C-AS1|RAD51C|RAMP2|RAMP2-AS1|RAPGEFL1|RARA|RARA-AS1|RETREG3|RGS9|RND2|RNF43|RNFT1|RNFT1-DT|RNU2-1|RPL19|RPL23|RPL27|RPRML|RPS6KB1|RSAD1|RUNDC1|RUNDC3A|RUNDC3A-AS1|SAMD14|SCARNA20|SCN4A|SCPEP1|SCRN2|SEPTIN4|SEPTIN4-AS1|SGCA|SKA2|SKAP1|SKAP1-AS2|SLC25A39|SLC35B1|SLC4A1|SMARCD2|SMARCE1|SMG8|SMIM36|SMURF2|SNF8|SNHG25|SNORA21|SNORA21B|SNORA38B|SNORA50C|SNORA90|SNORD104|SNORD124|SNX11|SOCS7|SOST|SP2|SP2-AS1|SP2-DT|SP6|SPAG9|SPATA20|SPATA32|SPMAP1|SPOP|SPPL2C|SRCIN1|SRSF1|STAC2|STARD3|STAT3|STAT5A|STAT5B|STH|STRADA|STXBP4|SUPT4H1|SYNRG|TAC4|TACO1|TADA2A|TANC2|TBC1D3|TBC1D3C|TBC1D3D|TBC1D3E|TBC1D3K|TBC1D3L|TBKBP1|TBX2|TBX2-AS1|TBX21|TBX4|TCAP|TEX14|TEX2|THRA|TILAM|TLK2|TMEM100|TMEM101|TMEM106A|TMEM92|TMEM92-AS1|TMUB2|TNS4|TOB1|TOB1-AS1|TOM1L1|TOP2A|TRC-GCA14-1|TRC-GCA2-2|TRC-GCA2-3|TRC-GCA2-4|TRC-GCA4-1|TRIM25|TRIM37|TRN-GTT2-5|TRQ-TTG1-1|TRR-CCG2-1|TRSUP-TTA1-1|TSPOAP1|TSPOAP1-AS1|TTLL6|TUBD1|TUBG1|TUBG2|UBE2Z|UBTF|USP32|UTP18|VAT1|VEZF1|VMP1|VPS25|WFIKKN2|WIPF2|WNK4|WNT3|WNT9B|XYLT2|YPEL2|ZNF385C|ZNF652|ZNF652-AS1|ZNHIT3|ZPBP2|AARSD1|AATF|ABCC3|ABI3|ACACA|ACBD4|ACE|ACLY|ACSF2|ADAM11|AKAP1|AKAP1-DT|ANKFN1|ANKRD40|ANKRD40CL|AOC2|AOC3|APOH|APPBP2|APPBP2-DT|ARHGAP23|ARHGAP27|ARL17A|ARL17B|ARL4D|ARL5C|ASB16|ASB16-AS1|ATP5MC1|ATP6V0A1|ATXN7L3|ATXN7L3-AS1|AXIN2|B4GALNT2|BCAS3|BCAS3-AS1|BECN1|BPTF|BRCA1|BRIP1|C17orf113|C17orf47|C17orf58|C17orf67|C17orf78|C1QL1|CA10|CA4|CACNA1G|CACNA1G-AS1|CACNB1|CACNG1|CACNG4|CACNG5|CALCOCO2|CASC3|CAVIN1|CBX1|CCDC182|CCDC200|CCDC43|CCDC47|CCR10|CCR7|CD300LG|CD79B|CDC27|CDC6|CDK12|CDK5RAP3|CEP112|CEP95|CFAP97D1|CHAD|CHCT1|CISD3|CLTC|CNP|CNTD1|CNTNAP1|COA3|COASY|COIL|COL1A1|COPZ2|COX11|CRHR1|CSF3|CSH1|CSH2|CSHL1|CUEDC1|CWC25|CYB561|DBF4B|DCAF7|DCAKD|DDX42|DDX5|DDX52|DGKE|DHRS11|DHX40|DHX58|DHX8|DLX3|DLX4|DNAAF19|DNAJC7|DUSP14|DUSP3|DYNLL2|DYNLL2-DT|EFCAB13|EFCAB13-DT|EFCAB3|EFTUD2|EIF1|EME1|EPN3|EPOP|EPX|ERBB2|ERN1|ETV4|EZH1|FAM117A|FAM171A2|FAM187A|FAM215A|FAM215B|FBXL20|FBXO47|FKBP10|FLJ40194|FLJ45513|FMNL1|FMNL1-AS1|FMNL1-DT|FTSJ3|FZD2|G6PC1|G6PC3|GAST|GDPD1|GFAP|GGNBP2|GH-LCR|GH1|GH2|GHDC|GIP|GJC1|GJD3|GJD3-AS1|GNA13|GNGT2|GOSR2|GOSR2-DT|GPATCH8|GPR179|GRB7|GRN|GSDMA|GSDMB|HAP1|HCRT|HDAC5|HEATR6|HEATR6-DT|HELZ|HELZ-AS1|HEXIM1|HEXIM2|HEXIM2-AS1|HEXIM2-AS2|HIGD1B|HLF|HNF1B|HOXB-AS1|HOXB-AS2|HOXB-AS3|HOXB-AS4|HOXB1|HOXB13|HOXB2|HOXB3|HOXB4|HOXB5|HOXB6|HOXB7|HOXB8|HOXB9|HOXBLINC|HROB|HSD17B1|HSD17B1-AS1|HSF5|HSPB9|ICAM2|IFI35|IGBP1C|IGF2BP1|IGFBP4|IKZF3|INTS2|ITGA2B|ITGA3|ITGB3|JUP|KANSL1|KANSL1-AS1|KAT2A|KAT7|KCNH4|KCNH6|KIF18B|KIF2B|KLHL10|KLHL11|KPNA2|KPNB1|KPNB1-DT|KRT10|KRT10-AS1|KRT12|KRT13|KRT14|KRT15|KRT16|KRT17|KRT19|KRT20|KRT222|KRT23|KRT24|KRT25|KRT26|KRT27|KRT28|KRT31|KRT32|KRT33A|KRT33B|KRT34|KRT35|KRT36|KRT37|KRT38|KRT39|KRT40|KRT9|KRTAP1-1|KRTAP1-3|KRTAP1-4|KRTAP1-5|KRTAP16-1|KRTAP17-1|KRTAP2-1|KRTAP2-2|KRTAP2-3|KRTAP2-4|KRTAP29-1|KRTAP3-1|KRTAP3-2|KRTAP3-3|KRTAP4-1|KRTAP4-11|KRTAP4-12|KRTAP4-16|KRTAP4-2|KRTAP4-3|KRTAP4-4|KRTAP4-5|KRTAP4-6|KRTAP4-7|KRTAP4-8|KRTAP4-9|KRTAP9-1|KRTAP9-2|KRTAP9-3|KRTAP9-4|KRTAP9-6|KRTAP9-7|KRTAP9-8|KRTAP9-9|LASP1|LASP1NB|LHX1|LHX1-DT|LIMD2|LINC00671|LINC00674|LINC00910|LINC00974|LINC01180|LINC01476|LINC01974|LINC01976|LINC01982|LINC01999|LINC02071|LINC02072|LINC02073|LINC02075|LINC02079|LINC02086|LINC02089|LINC02210|LINC02210-CRHR1|LINC02563|LINC02594|LINC02875|LINC02876|LINC03057|LOC100287808|LOC100505782|LOC100507002|LOC100996660|LOC101927166|LOC101927557|LOC101927855|LOC101928045|LOC101929767|LOC101929777|LOC102724183|LOC105371756|LOC105371763|LOC105371767|LOC105371773|LOC105371789|LOC105371814|LOC105371824|LOC105371856|LOC105371934|LOC105980078|LOC106677019|LOC106694315|LOC106694316|LOC108004529|LOC108004536|LOC108281137|LOC109280161|LOC109286563|LOC109609706|LOC110120862|LOC110120863|LOC110120913|LOC110120923|LOC110120932|LOC110121386|LOC110121446|LOC110121451|LOC110121475|LOC110121501|LOC110485084|LOC110485085|LOC111089947|LOC111240475|LOC111465016|LOC111589213|LOC111589215|LOC111589216|LOC111822952|LOC112529910|LOC112529911|LOC112529912|LOC112529913|LOC112529914|LOC112533637|LOC112533638|LOC112533639|LOC112533640|LOC112533641|LOC112533642|LOC112533643|LOC112533644|LOC112533645|LOC112533646|LOC112533647|LOC112533648|LOC112533649|LOC112533650|LOC112533651|LOC112533652|LOC112533653|LOC112533654|LOC112533655|LOC112533658|LOC112533659|LOC112533660|LOC112533661|LOC112533662|LOC113939962|LOC113939963|LOC114803472|LOC114827848|LOC116276460|LOC116276461|LOC116276462|LOC116276463|LOC116276464|LOC116276465|LOC116276466|LOC116276467		See cases	VCV000057282	17	48563237 - 65936105	17	36449220 - 68170214	57282	71877			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 17q12-21.31(chr17:39199873-45629579)x3	NT5C3B|ODAD4|ORMDL3|P3H4|PGAP3|PLCD3|PLEKHH3|PLEKHM1|PNMT|PPP1R1B|PPY|PSMC3IP|PSMD3|PSMD3-AS1|PSME3|PTGES3L|PTGES3L-AARSD1|PYY|RAB5C|RAB5C-AS1|RAMP2|RAMP2-AS1|RAPGEFL1|RARA|RARA-AS1|RETREG3|RND2|RNU2-1|RPL19|RPL27|RUNDC1|RUNDC3A|RUNDC3A-AS1|SLC25A39|SLC4A1|SMARCE1|SNORD124|SOST|SPATA32|STAC2|STARD3|STAT3|STAT5A|STAT5B|TCAP|THRA|TMEM101|TMEM106A|TMUB2|TNS4|TOP2A|TUBG1|TUBG2|UBTF|VAT1|VPS25|WIPF2|WNK4|ZNF385C|ZPBP2|ERBB2|ETV4|EZH1|FAM171A2|FAM187A|FAM215A|FBXL20|FKBP10|FMNL1|FMNL1-AS1|FMNL1-DT|FZD2|G6PC1|G6PC3|GAST|GFAP|GHDC|GJC1|GJD3|GJD3-AS1|GPATCH8|GRB7|GRN|GSDMA|GSDMB|HAP1|HCRT|HDAC5|HEXIM1|HEXIM2|HEXIM2-AS1|HEXIM2-AS2|HIGD1B|HROB|HSD17B1|HSD17B1-AS1|HSPB9|IFI35|IGFBP4|IKZF3|ITGA2B|JUP|KAT2A|KCNH4|KIF18B|KLHL10|KLHL11|KRT10|KRT10-AS1|KRT12|KRT13|KRT14|KRT15|KRT16|KRT17|KRT19|KRT20|KRT222|KRT23|KRT24|KRT25|KRT26|KRT27|KRT28|KRT31|KRT32|KRT33A|KRT33B|KRT34|KRT35|KRT36|KRT37|KRT38|KRT39|KRT40|KRT9|KRTAP1-1|KRTAP1-3|KRTAP1-4|KRTAP1-5|KRTAP16-1|KRTAP17-1|KRTAP2-1|KRTAP2-2|KRTAP2-3|KRTAP2-4|KRTAP29-1|KRTAP3-1|KRTAP3-2|KRTAP3-3|KRTAP4-1|KRTAP4-11|KRTAP4-12|KRTAP4-16|KRTAP4-2|KRTAP4-3|KRTAP4-4|KRTAP4-5|KRTAP4-6|KRTAP4-7|KRTAP4-8|KRTAP4-9|KRTAP9-1|KRTAP9-2|KRTAP9-3|KRTAP9-4|KRTAP9-6|KRTAP9-7|KRTAP9-8|KRTAP9-9|LINC00671|LINC00910|LINC00974|LINC01180|LINC01976|LINC02210|LINC02210-CRHR1|LINC02594|LOC100505782|LOC101929767|LOC102724183|LOC105371773|LOC105371789|LOC105371934|LOC110120913|LOC110121446|LOC110485084|LOC110485085|LOC111089947|LOC111240475|LOC111465016|LOC111589215|LOC111589216|LOC112529913|LOC112529914|LOC112533637|LOC112533638|LOC112533639|LOC112533640|LOC112533641|LOC112533642|LOC113939962|LOC116276461|LOC116276462|LOC116276463|LOC116276464|LOC116276465|LOC116276466|LOC116276467|LOC116276468|LOC121587590|LOC121587591|LOC121587592|LOC121587593|LOC121587594|LOC121587595|LOC121587596|LOC121587597|LOC121852931|LOC121852932|LOC121852933|LOC125177467|LOC125177469|LOC125177470|LOC125177471|LOC125177472|LOC125177473|LOC125177474|LOC125177475|LOC125177476|LOC125177477|LOC125177478|LOC125177479|LOC125177480|LOC125177481|LOC125177482|LOC125177484|LOC125177485|LOC125177486|LOC125177487|LOC125177488|LOC125177489|LOC125177490|LOC125177491|LOC126862553|LOC126862554|LOC126862555|LOC126862556|LOC126862557|LOC126862558|LOC126862559|LOC126862560|LOC126862561|LOC126862562|LOC126862563|LOC126862564|LOC126862565|LOC126862566|LOC126862567|LOC126862568|LOC126862569|LOC126862570|LOC126862571|LOC126862572|LOC126862573|LOC126862574|LOC126862575|LOC128669077|LOC128669078|LOC129390868|LOC129390869|LOC129390870|LOC129390871|LOC129390872|LOC129390873|LOC129390874|LOC129390875|LOC129390876|LOC129390877|LOC130060753|LOC130060754|LOC130060755|LOC130060756|LOC130060757|LOC130060758|LOC130060759|LOC130060760|LOC130060761|LOC130060762|LOC130060763|LOC130060764|LOC130060765|LOC130060766|LOC130060767|LOC130060768|LOC130060769|LOC130060770|LOC130060771|LOC130060772|LOC130060773|LOC130060774|LOC130060775|LOC130060776|LOC130060777|LOC130060778|LOC130060779|LOC130060780|LOC130060781|LOC130060782|LOC130060783|LOC130060784|LOC130060785|LOC130060786|LOC130060787|LOC130060788|LOC130060789|LOC130060790|LOC130060791|LOC130060792|LOC130060793|LOC130060794|LOC130060795|LOC130060796|LOC130060797|LOC130060798|LOC130060799|LOC130060800|LOC130060801|LOC130060802|LOC130060803|LOC130060804|LOC130060805|LOC130060806|LOC130060807|LOC130060808|LOC130060809|LOC130060810|LOC130060811|LOC130060812|LOC130060813|LOC130060814|LOC130060815|LOC130060816|LOC130060817|LOC130060818|LOC130060819|LOC130060820|LOC130060821|LOC130060822|LOC130060823|LOC130060824|LOC130060825|LOC130060826|LOC130060827|LOC130060828|LOC130060829|LOC130060830|LOC130060831|LOC130060832|LOC130060833|LOC130060834|LOC130060835|LOC130060836|LOC130060837|LOC130060838|LOC130060839|LOC130060840|LOC130060841|LOC130060842|LOC130060843|LOC130060844|LOC130060845|LOC130060846|LOC130060847|LOC130060848|LOC130060849|LOC130060850|LOC130060851|LOC130060852|LOC130060853|LOC130060854|LOC130060855|LOC130060856|LOC130060857|LOC130060858|LOC130060859|LOC130060860|LOC130060861|LOC130060862|LOC130060863|LOC130060864|LOC130060865|LOC130060866|LOC130060867|LOC130060868|LOC130060869|LOC130060870|LOC130060871|LOC130060872|LOC130060873|LOC130060874|LOC130060875|LOC130060876|LOC130060877|LOC130060878|LOC130060879|LOC130060880|LOC130060881|LOC130060882|LOC130060883|LOC130060884|LOC130060885|LOC130060886|LOC130060887|LOC130060888|LOC130060889|LOC130060890|LOC130060891|LOC130060892|LOC130060893|LOC130060894|LOC130060895|LOC130060896|LOC130060897|LOC130060898|LOC130060899|LOC130060900|LOC130060901|LOC130060902|LOC130060903|LOC130060904|LOC130060905|LOC130060906|LOC130060907|LOC130060908|LOC130060909|LOC130060910|LOC130060911|LOC130060912|LOC130060913|LOC130060914|LOC130060915|LOC130060916|LOC130060917|LOC130060918|LOC130060919|LOC130060920|LOC130060921|LOC130060922|LOC130060923|LOC130060924|LOC130060925|LOC130060926|LOC130060927|LOC130060928|LOC130060929|LOC130060930|LOC130060931|LOC130060932|LOC130060933|LOC130060934|LOC130060935|LOC130060936|LOC130060937|LOC130060938|LOC130060939|LOC130060940|LOC130060941|LOC130060942|LOC130060943|LOC130060944|LOC130060945|LOC130060946|LOC130060947|LOC130060948|LOC130060949|LOC130060950|LOC130060951|LOC130060952|LOC130060953|LOC130060954|LOC130060955|LOC130060956|LOC130060957|LOC130060958|LOC130060959|LOC130060960|LOC130060961|LOC130060962|LOC130060963|LOC130060964|LOC130060965|LOC130060966|LOC130060967|LOC130060968|LOC130060969|LOC130060970|LOC130060971|LOC130060972|LOC130060973|LOC130060974|LOC130060975|LOC130060976|LOC130060977|LOC130060978|LOC130060979|LOC130060980|LOC130060981|LOC130060982|LOC130060983|LOC130060984|LOC130060985|LOC130060986|LOC130060987|LOC130060988|LOC130060989|LOC130060990|LOC130060991|LOC130060992|LOC130060993|LOC130060994|LOC130060995|LOC130060996|LOC130060997|LOC130060998|LOC130060999|LOC130061000|LOC130061001|LOC130061002|LOC130061003|LOC130061004|LOC130061005|LOC130061006|LOC130061007|LOC130061008|LOC130061009|LOC130061010|LOC130061011|LOC130061012|LOC130061013|LOC130061014|LOC130061015|LOC130061016|LOC130061017|LOC130061018|LOC130061019|LOC130061020|LOC130061021|LOC130061022|LOC130061023|LOC130061024|LOC130061025|LOC130061026|LOC130061027|LOC130061028|LOC130061029|LOC130061030|LRRC3C|LSM12|MAP3K14|MAP3K14-AS1|MED1|MED24|MEIOC|MEOX1|MIEN1|MIR2117|MIR2117HG|MIR4315-1|MIR4728|MIR5010|MIR548AT|MIR548BC|MIR6510|MIR6780A|MIR6781|MIR6782|MIR6783|MIR6784|MIR6866|MIR6867|MIR6884|MLX|MPP2|MPP3|MSL1|NAGLU|NAGS|NBR1|NBR2|NEUROD2|NKIRAS2|NMT1|NR1D1|AARSD1|ACBD4|ACLY|ADAM11|AOC2|AOC3|ARHGAP27|ARL4D|ASB16|ASB16-AS1|ATP6V0A1|ATXN7L3|ATXN7L3-AS1|BECN1|BRCA1|C17orf113|C1QL1|CASC3|CAVIN1|CCDC200|CCDC43|CCR10|CCR7|CD300LG|CDC6|CDK12|CFAP97D1|CNP|CNTD1|CNTNAP1|COA3|COASY|CSF3|DBF4B|DCAKD|DHX58|DHX8|DNAAF19|DNAJC7|DUSP3|EFTUD2|EIF1		See cases	VCV000058696	17	37356126 - 43706945	17	39199873 - 45629579	58696	73291			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(135581_1441370)del(;)(147057_150288)_(160933_166866)del	RND2|LOC110485084|LOC111589215|LOC111589216|LOC125177482|LOC126862571|LOC130060934|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373888	17|17	41176312 - 41277500	17|17	43024295 - 43125483	373888	360749|360754			Haplotype		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(135581_1441370)del	RND2|BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC125177482|LOC126862571|LOC130060934		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373863	17	41176312 - 41277500	17	43024295 - 43125483	373863	360749			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
Single allele	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373845	17	41189422 - 41200474	17	43037405 - 43048457	373845	360720			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.43041662_43046087delinsTG	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373858	17	41193679 - 41198104	17	43041662 - 43046087	373858	360721			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5468_*1383del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000664769	17	41196311 - 41197818	17	43044294 - 43045801	664769	645916			Deletion		Pathogenic	Nov 5, 2018	criteria provided, single submitter							
NC_000017.11:g.(?_43044295)_(43124115_?)del	BRCA1|LOC110485084|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000417801			17	43044295 - 43124115	417801	401499			Deletion		Pathogenic	Nov 6, 2016	criteria provided, single submitter							
NC_000017.11:g.(?_43044295)_(43099880_?)del	LOC126862571|BRCA1		Hereditary breast ovarian cancer syndrome	VCV000417601	17	41196312 - 41251897	17	43044295 - 43099880	417601	401968			Deletion		Pathogenic	Oct 16, 2016	criteria provided, single submitter							
NC_000017.11:g.(?_43044295)_(43045802_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000417600	17	41196312 - 41197819	17	43044295 - 43045802	417600	401496			Deletion		Pathogenic	Sep 27, 2016	criteria provided, single submitter							
NC_000017.11:g.(?_43044295)_(43057135_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000417594	17	41196312 - 41209152	17	43044295 - 43057135	417594	402242			Deletion		Pathogenic	Jul 25, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5278-502_*756del	BRCA1		not provided	VCV001713201	17	41196939 - 41203636	17	43044922 - 43051619	1713201	1770713			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Feb 17, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5278-1970_*669del	BRCA1		not provided	VCV003337589	17	41197026 - 41205104	17	43045009 - 43053087	3337589	3496250			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Oct 6, 2022	criteria provided, single submitter							
NC_000017.11:g.43045086_43057213del	BRCA1		Familial cancer of breast	VCV001685578			17	43045086 - 43057213	1685578	1677594			Deletion		Pathogenic	May 4, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43045584)_(43045853_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001679087			17	43045584 - 43045853	1679087	1670881			Deletion		Pathogenic	Apr 19, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43045658)_(43047723_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000584078	17	41197675 - 41199740	17	43045658 - 43047723	584078	570789			Deletion		Pathogenic	Jun 14, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045658)_(43045822_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000583664	17	41197675 - 41197839	17	43045658 - 43045822	583664	570681			Deletion		Pathogenic	Jul 2, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045658)_(43125483_?)del	LOC111589216|LOC126862571|BRCA1|LOC110485084|LOC111589215		Hereditary breast ovarian cancer syndrome	VCV000583655	17	41197675 - 41277500	17	43045658 - 43125483	583655	568591			Deletion		Pathogenic	May 13, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045658)_(43051137_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000583614	17	41197675 - 41203154	17	43045658 - 43051137	583614	568590			Deletion		Pathogenic	May 29, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045672)_(43106539_?)del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000531557	17	41197689 - 41258556	17	43045672 - 43106539	531557	530835			Deletion		Pathogenic	Mar 21, 2018	criteria provided, single submitter							
NC_000017.11:g.(?_43045672)_(43115785_?)del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000462175	17	41197689 - 41267802	17	43045672 - 43115785	462175	466224			Deletion		Pathogenic	Feb 15, 2017	criteria provided, single submitter							
NC_000017.11:g.(?_43045672)_(43047709_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462173	17	41197689 - 41199726	17	43045672 - 43047709	462173	467091			Deletion		Pathogenic	Feb 27, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5468-1_*1del	BRCA1		Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003780829	17	41197694 - 41197820	17	43045677 - 43045803	3780829	3896789			Deletion	splice acceptor variant	Pathogenic	Apr 1, 2019	criteria provided, single submitter							
NG_005905.2:g.(113863_118103)_(172307_?)del	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373884	17	41197694 - 41256138	17	43045677 - 43104121	373884	360773			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(160933_166866)_(172307_?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373883	17	41197694 - 41209068	17	43045677 - 43057051	373883	360769			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(170342_172181)_(172307_?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373879	17	41197694 - 41199659	17	43045677 - 43047642	373879	360767			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(172307_?)del	LOC110485084|BRCA1|LOC111589215|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373875	17	41197694 - 41277500	17	43045677 - 43125483	373875	360776			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(168864_170280)_(172307_?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373869	17	41197694 - 41201137	17	43045677 - 43049120	373869	360768			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(154652_160848)_(172307_?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373868	17	41197694 - 41215349	17	43045677 - 43063332	373868	360770			Deletion		Pathogenic	Oct 2, 2015	criteria provided, multiple submitters, no conflicts							
NG_005905.2:g.(92714_93868)_(172307_?)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373867	17	41197694 - 41277287	17	43045677 - 43125270	373867	360775			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(147057_150288)_(172307_?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373866	17	41197694 - 41222944	17	43045677 - 43070927	373866	360772			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(150290_154032)_(172307_?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373862	17	41197694 - 41219711	17	43045677 - 43067694	373862	360771			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(102259_111450)_(172307_?)del	LOC126862571|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373860	17	41197694 - 41267742	17	43045677 - 43115725	373860	360774			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5407-?_*(1_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000219561	17	41197694 - 41199720	17	43045677 - 43047703	219561	222546			Deletion		Pathogenic	Jul 18, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5278_5592del315 (p.Ile1760_Ter1864del)	BRCA1	I1712fs, I1713fs, I1717fs, I1718fs, I1719fs, I1758fs, I1759fs, I1760fs, I655fs, I656fs	Hereditary breast ovarian cancer syndrome|Familial pancreatic carcinoma	VCV003780830	17	41197695 - 41203134	17	43045678 - 43051117	3780830	3896790			Deletion	stop lost|splice acceptor variant|splice donor variant|frameshift variant	Pathogenic	Jul 16, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045678)_(43051117_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000437839	17	41197695 - 41203134	17	43045678 - 43051117	437839	420997			Deletion		Pathogenic	Oct 14, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5503_5564del (p.Arg1835fs)	BRCA1	R1856fs, R1835fs, R731fs, R1788fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055602	17	41197723 - 41197784	17	43045706 - 43045767	55602	70269	rs80359883		Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5558_5561del (p.Thr1852_Tyr1853insTer)	BRCA1		Fanconi anemia, complementation group S	VCV003778922	17	41197726 - 41197729	17	43045709 - 43045712	3778922	3894909		NC_000017.11:43045708:AGGTAGGT:AGGT	Microsatellite	nonsense|3 prime UTR variant	Pathogenic	Oct 21, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5554_5560del (p.Asp1851_Thr1852insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573261	17	41197727 - 41197733	17	43045710 - 43045716	2573261	2738209	rs2545873293	NC_000017.11:43045709:GGTAGGTG:G	Deletion	nonsense|3 prime UTR variant|frameshift variant	Pathogenic	Feb 15, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5560del (p.Tyr1853_Leu1854insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266565	17	41197727	17	43045710	266565	261563	rs886040306	NC_000017.11:43045709:GG:G	Deletion	frameshift variant|nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5556_5560del (p.Tyr1853fs)	BRCA1	Y1853fs, Y1806fs, Y1874fs, Y749fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266564	17	41197727 - 41197731	17	43045710 - 43045714	266564	261562	rs886040305	NC_000017.11:43045709:GGTAGG:G	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5559C>G (p.Tyr1853Ter)	BRCA1	Y1853*, Y749*, Y1874*, Y1806*, Y1556*, Y1741*, Y1763*, Y1764*, Y1782*, Y1805*, Y1827*, Y1834*, Y1849*, Y1873*, Y441*, Y573*, Y640*, Y661*, Y680*, Y746*, Y748*, Y772*, Y1740*, Y1742*, Y1781*, Y1784*, Y1785*, Y1804*, Y1809*, Y1810*, Y1833*, Y1848*, Y623*, Y637*, Y641*, Y668*, Y679*, Y701*, Y708*, Y709*, Y1684*, Y1699*, Y1724*, Y1725*, Y1765*, Y1783*, Y1786*, Y1851*, Y1852*, Y660*, Y662*, Y670*, Y678*, Y702*, Y703*, Y707*, Y711*, Y723*, Y724*, Y747*, Y750*, Y771*, Y985*, Y1557*, Y1726*, Y1769*, Y1811*, Y1812*, Y1825*, Y1826*, Y1850*, Y1875*, Y582*, Y622*, Y636*, Y682*, Y683*, Y705*, Y710*, Y725*, Y984*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055630	17	41197728	17	43045711	55630	70297	rs80357336	NC_000017.11:43045710:G:C	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5559C>A (p.Tyr1853Ter)	BRCA1	Y1853*, Y1806*, Y1874*, Y749*, Y1556*, Y1557*, Y1742*, Y1781*, Y1784*, Y1805*, Y1809*, Y1810*, Y1826*, Y1850*, Y1852*, Y660*, Y678*, Y680*, Y682*, Y725*, Y771*, Y1726*, Y1741*, Y1769*, Y1782*, Y1812*, Y1825*, Y1833*, Y1849*, Y1875*, Y623*, Y640*, Y662*, Y670*, Y701*, Y705*, Y707*, Y709*, Y711*, Y746*, Y748*, Y750*, Y984*, Y1684*, Y1699*, Y1725*, Y1764*, Y1785*, Y1786*, Y1811*, Y1848*, Y1851*, Y441*, Y582*, Y636*, Y679*, Y702*, Y703*, Y724*, Y747*, Y1724*, Y1740*, Y1763*, Y1765*, Y1783*, Y1804*, Y1827*, Y1834*, Y1873*, Y573*, Y622*, Y637*, Y641*, Y661*, Y668*, Y683*, Y708*, Y710*, Y723*, Y772*, Y985*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055629	17	41197728	17	43045711	55629	70296	rs80357336	NC_000017.11:43045710:G:T	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5558dup (p.Tyr1853Ter)	BRCA1	Y1853*, Y1806*, Y1874*, Y749*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055628	17	41197728 - 41197729	17	43045711 - 43045712	55628	70295	rs80357629	NC_000017.11:43045711:T:TT	Duplication	frameshift variant|nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5554_5558del (p.Thr1852fs)	BRCA1	T1852fs, T1805fs, T1873fs, T748fs	Hereditary cancer-predisposing syndrome	VCV000825825	17	41197729 - 41197733	17	43045712 - 43045716	825825	813638	rs1597796682	NC_000017.11:43045711:TAGGT:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 30, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5558A>G (p.Tyr1853Cys)	BRCA1	Y1853C, Y1806C, Y749C, Y1874C, Y1556C, Y1557C, Y1699C, Y1740C, Y1741C, Y1742C, Y1784C, Y1765C, Y1783C, Y1811C, Y1825C, Y1827C, Y1849C, Y1852C, Y441C, Y636C, Y640C, Y668C, Y670C, Y679C, Y683C, Y709C, Y710C, Y724C, Y746C, Y771C, Y772C, Y1785C, Y1805C, Y1809C, Y1810C, Y1826C, Y1850C, Y573C, Y622C, Y661C, Y680C, Y682C, Y701C, Y703C, Y711C, Y725C, Y748C, Y750C, Y985C, Y1724C, Y1781C, Y1782C, Y1786C, Y1812C, Y1833C, Y1873C, Y1875C, Y582C, Y623C, Y641C, Y660C, Y702C, Y705C, Y747C, Y1684C, Y1725C, Y1726C, Y1763C, Y1764C, Y1769C, Y1804C, Y1834C, Y1848C, Y1851C, Y637C, Y662C, Y678C, Y707C, Y708C, Y723C, Y984C	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055627	17	41197729	17	43045712	55627	70294	rs80357258	NC_000017.11:43045711:T:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5537_5556del (p.Gln1846fs)	BRCA1	Q1799fs, Q1846fs, Q742fs, Q1867fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266561	17	41197731 - 41197750	17	43045714 - 43045733	266561	261564	rs886040302	NC_000017.11:43045713:GGTGTCCAGCTCCTGGCACTGGT:GGT	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5554_5555del (p.Thr1852fs)	BRCA1	T1852fs, T1805fs, T748fs, T1873fs	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000855160	17	41197732 - 41197733	17	43045715 - 43045716	855160	845358	rs2050861886	NC_000017.11:43045714:GTGT:GT	Microsatellite	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5553dup (p.Thr1852fs)	BRCA1	T748fs, T1852fs, T1805fs, T1873fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055625	17	41197733 - 41197734	17	43045716 - 43045717	55625	70292	rs397509297	NC_000017.11:43045716:G:GG	Duplication	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5551del (p.Asp1851fs)	BRCA1	D1851fs, D747fs, D1804fs, D1872fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266563	17	41197736	17	43045719	266563	261565	rs886040304	NC_000017.11:43045718:CC:C	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5549delinsCA (p.Leu1850fs)	BRCA1	L619fs, L620fs, L633fs, L634fs, L637fs, L638fs, L657fs, L658fs, L659fs, L665fs, L667fs, L675fs, L676fs, L677fs, L679fs, L680fs, L698fs, L699fs, L700fs, L702fs, L704fs, L705fs, L706fs, L707fs, L708fs, L720fs, L721fs, L722fs, L743fs, L744fs, L745fs, L746fs, L747fs, L768fs, L769fs, L981fs, L982fs, L1553fs, L1554fs, L1681fs, L1696fs, L1721fs, L1722fs, L1723fs, L1737fs, L1738fs, L1739fs, L1760fs, L1761fs, L1762fs, L1766fs, L1778fs, L1779fs, L1780fs, L1781fs, L1782fs, L1783fs, L1801fs, L1802fs, L1803fs, L1806fs, L1807fs, L1808fs, L1809fs, L1822fs, L1823fs, L1824fs, L1830fs, L1831fs, L1845fs, L1846fs, L1847fs, L1848fs, L1849fs, L1850fs, L1870fs, L1871fs, L1872fs, L438fs, L570fs, L579fs	Hereditary cancer-predisposing syndrome	VCV003226174	17	41197738	17	43045721	3226174	3387237	rs2545909115	NC_000017.11:43045720:A:TG	Indel	frameshift variant|3 prime UTR variant	Pathogenic	Dec 13, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5548del (p.Leu1850fs)	BRCA1	L1803fs, L1850fs, L1871fs, L746fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055623	17	41197739	17	43045722	55623	70290	rs397509296	NC_000017.11:43045721:G:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5542C>T (p.Gln1848Ter)	BRCA1	Q1848*, Q1801*, Q1869*, Q744*, Q1551*, Q1679*, Q1719*, Q1737*, Q1759*, Q1777*, Q1778*, Q1780*, Q1804*, Q1807*, Q1820*, Q1821*, Q1844*, Q1847*, Q1868*, Q577*, Q618*, Q636*, Q706*, Q719*, Q766*, Q767*, Q1694*, Q1721*, Q1735*, Q1736*, Q1758*, Q1764*, Q1776*, Q1799*, Q1828*, Q1843*, Q568*, Q631*, Q632*, Q665*, Q677*, Q678*, Q698*, Q704*, Q741*, Q745*, Q979*, Q1552*, Q1779*, Q1781*, Q1800*, Q1805*, Q1846*, Q635*, Q657*, Q663*, Q673*, Q696*, Q697*, Q700*, Q703*, Q720*, Q742*, Q980*, Q1720*, Q1760*, Q1806*, Q1822*, Q1829*, Q1845*, Q1870*, Q436*, Q617*, Q655*, Q656*, Q674*, Q675*, Q702*, Q705*, Q718*, Q743*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266562	17	41197745	17	43045728	266562	261566	rs886040303	NC_000017.11:43045727:G:A	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5541C>A (p.Cys1847Ter)	BRCA1	C1847*, C1800*, C1868*, C743*, C1678*, C1719*, C1720*, C1734*, C1735*, C1736*, C1758*, C1777*, C1780*, C1803*, C1804*, C1806*, C1820*, C1827*, C1828*, C1867*, C631*, C664*, C673*, C676*, C699*, C701*, C705*, C744*, C978*, C979*, C1551*, C1776*, C1778*, C1779*, C1819*, C1843*, C1844*, C616*, C695*, C717*, C740*, C741*, C1550*, C1718*, C1763*, C1805*, C567*, C617*, C634*, C655*, C662*, C674*, C677*, C696*, C704*, C719*, C742*, C766*, C630*, C635*, C654*, C656*, C672*, C697*, C702*, C703*, C718*, C765*, C1693*, C1757*, C1759*, C1775*, C1798*, C1799*, C1821*, C1842*, C1845*, C1846*, C1869*, C435*, C576*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055622	17	41197746	17	43045729	55622	70289	rs397509295	NC_000017.11:43045728:G:T	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5534_5539del (p.Tyr1845_Gln1846del)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV004082399	17	41197748 - 41197753	17	43045731 - 43045736	4082399	4195085		NC_000017.11:43045730:ACTGGTA:A	Deletion	3 prime UTR variant|inframe_deletion	Pathogenic	Jan 1, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5536del (p.Gln1846fs)	BRCA1	Q1867fs, Q742fs, Q1846fs, Q1799fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266560	17	41197751	17	43045734	266560	261567	rs886040301	NC_000017.11:43045733:GG:G	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5536C>T (p.Gln1846Ter)	BRCA1	Q1846*, Q1867*, Q1799*, Q742*, Q1719*, Q1733*, Q1734*, Q1775*, Q1797*, Q1805*, Q1819*, Q1826*, Q1827*, Q1842*, Q1868*, Q434*, Q566*, Q629*, Q630*, Q654*, Q671*, Q676*, Q700*, Q701*, Q703*, Q717*, Q718*, Q740*, Q978*, Q1717*, Q1718*, Q1756*, Q1757*, Q1758*, Q1779*, Q1798*, Q1803*, Q1820*, Q1843*, Q575*, Q615*, Q634*, Q653*, Q655*, Q672*, Q673*, Q696*, Q739*, Q764*, Q1549*, Q1677*, Q1762*, Q1774*, Q1776*, Q1802*, Q1804*, Q1818*, Q1841*, Q1844*, Q1845*, Q694*, Q695*, Q702*, Q704*, Q765*, Q977*, Q1550*, Q1692*, Q1735*, Q1777*, Q1778*, Q1866*, Q616*, Q633*, Q661*, Q663*, Q675*, Q698*, Q716*, Q741*, Q743*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055620	17	41197751	17	43045734	55620	70287	rs80356873	NC_000017.11:43045733:G:A	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5535C>G (p.Tyr1845Ter)	BRCA1	Y1845*, Y1798*, Y741*, Y1866*, Y1676*, Y1717*, Y1761*, Y1797*, Y1802*, Y1818*, Y1841*, Y433*, Y614*, Y632*, Y652*, Y671*, Y674*, Y693*, Y697*, Y699*, Y701*, Y702*, Y763*, Y977*, Y1549*, Y1733*, Y1734*, Y1755*, Y1757*, Y1775*, Y1776*, Y1801*, Y1817*, Y1826*, Y1843*, Y1844*, Y1865*, Y565*, Y629*, Y654*, Y660*, Y670*, Y672*, Y694*, Y695*, Y703*, Y717*, Y738*, Y764*, Y1718*, Y1756*, Y1774*, Y1796*, Y1804*, Y1825*, Y1842*, Y662*, Y715*, Y742*, Y976*, Y1803*, Y1819*, Y1840*, Y1867*, Y574*, Y615*, Y628*, Y633*, Y653*, Y675*, Y700*, Y716*, Y739*, Y740*, Y1548*, Y1691*, Y1716*, Y1732*, Y1773*, Y1777*, Y1778*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266559	17	41197752	17	43045735	266559	261568	rs80356977	NC_000017.11:43045734:G:C	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5535C>A (p.Tyr1845Ter)	BRCA1	Y1845*, Y1798*, Y1866*, Y741*, Y1676*, Y1717*, Y1755*, Y1801*, Y1802*, Y1804*, Y1825*, Y1826*, Y1842*, Y565*, Y629*, Y632*, Y662*, Y675*, Y694*, Y695*, Y701*, Y703*, Y716*, Y977*, Y1548*, Y1549*, Y1718*, Y1797*, Y1803*, Y1819*, Y1841*, Y1865*, Y1867*, Y433*, Y652*, Y660*, Y674*, Y738*, Y740*, Y763*, Y976*, Y1732*, Y1733*, Y1734*, Y1756*, Y1774*, Y1776*, Y1777*, Y1778*, Y1817*, Y1818*, Y1843*, Y1844*, Y614*, Y693*, Y697*, Y699*, Y700*, Y717*, Y742*, Y1691*, Y1716*, Y1757*, Y1761*, Y1773*, Y1775*, Y1796*, Y1840*, Y574*, Y615*, Y628*, Y633*, Y653*, Y654*, Y670*, Y671*, Y672*, Y702*, Y715*, Y739*, Y764*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055619	17	41197752	17	43045735	55619	70286	rs80356977	NC_000017.11:43045734:G:T	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5533_5534insG (p.Tyr1845Ter)	BRCA1	Y1798*, Y1845*, Y1866*, Y741*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548197	17	41197753 - 41197754	17	43045736 - 43045737	548197	538758	rs1555574384	NC_000017.11:43045736::C	Insertion	frameshift variant|nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5534del (p.Tyr1845fs)	BRCA1	Y1866fs, Y1798fs, Y741fs, Y1845fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417827	17	41197753	17	43045736	417827	404709	rs1060505048	NC_000017.11:43045735:T:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5533dup (p.Tyr1845fs)	BRCA1	Y1798fs, Y1845fs, Y1866fs, Y741fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055618	17	41197753 - 41197754	17	43045736 - 43045737	55618	70285	rs397509294	NC_000017.11:43045736:A:AA	Duplication	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5532_5533del (p.Tyr1845fs)	BRCA1	Y1845fs, Y741fs, Y1866fs, Y1798fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000418073	17	41197754 - 41197755	17	43045737 - 43045738	418073	409939	rs1064793059	NC_000017.11:43045736:AGAG:AG	Microsatellite	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5524_5531del (p.Val1842fs)	BRCA1	V1842fs, V1795fs, V738fs, V1863fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252389	17	41197756 - 41197763	17	43045739 - 43045746	252389	246808	rs879255287	NC_000017.11:43045738:AGTGCTACA:A	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5526dup (p.Ala1843fs)	BRCA1	A1546fs, A1547fs, A1674fs, A1689fs, A1714fs, A1715fs, A1716fs, A1730fs, A1731fs, A1732fs, A1753fs, A1754fs, A1755fs, A1759fs, A1771fs, A1772fs, A1773fs, A1774fs, A1775fs, A1776fs, A1794fs, A1795fs, A1796fs, A1799fs, A1800fs, A1801fs, A1802fs, A1815fs, A1816fs, A1817fs, A1823fs, A1824fs, A1838fs, A1839fs, A1840fs, A1841fs, A1842fs, A1843fs, A1863fs, A1864fs, A1865fs, A431fs, A563fs, A572fs, A612fs, A613fs, A626fs, A627fs, A630fs, A631fs, A650fs, A651fs, A652fs, A658fs, A660fs, A668fs, A669fs, A670fs, A672fs, A673fs, A691fs, A692fs, A693fs, A695fs, A697fs, A698fs, A699fs, A700fs, A701fs, A713fs, A714fs, A715fs, A736fs, A737fs, A738fs, A739fs, A740fs, A761fs, A762fs, A974fs, A975fs	Hereditary breast ovarian cancer syndrome	VCV003338418	17	41197760 - 41197761	17	43045743 - 43045744	3338418	3497079		NC_000017.11:43045743:T:TT	Duplication	frameshift variant|3 prime UTR variant	Pathogenic	Aug 13, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5500_5526delinsCACTGGTAGAGT (p.Thr1834_Val1842delinsHisTrpTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001450624	17	41197761 - 41197787	17	43045744 - 43045770	1450624	1351145	rs2152535126	NC_000017.11:43045743:TACACTGTCCAACACCCACTCTCGGGT:ACTCTACCAGTG	Indel	inframe_indel|nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5525del (p.Val1842fs)	BRCA1	V1863fs, V1795fs, V738fs, V1842fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000219716	17	41197762	17	43045745	219716	222645	rs864622220	NC_000017.11:43045744:A:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5518_5524del (p.Leu1839_Asp1840insTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV003893677	17	41197763 - 41197769	17	43045746 - 43045752	3893677	4009558		NC_000017.11:43045745:CACTGTCCA:CA	Deletion	nonsense|3 prime UTR variant	Pathogenic	Mar 24, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5523T>G (p.Ser1841Arg)	BRCA1	S1862R, S737R, S1794R, S1841R, S1672R, S1728R, S1753R, S1757R, S1769R, S1772R, S1792R, S1797R, S1813R, S1815R, S1821R, S1822R, S1863R, S429R, S625R, S629R, S697R, S699R, S711R, S734R, S760R, S1544R, S1545R, S1687R, S1729R, S1752R, S1770R, S1773R, S1774R, S1799R, S1837R, S650R, S666R, S667R, S668R, S689R, S690R, S691R, S1712R, S1714R, S1771R, S1798R, S1800R, S1836R, S1840R, S570R, S610R, S628R, S648R, S649R, S656R, S670R, S695R, S696R, S698R, S712R, S713R, S736R, S759R, S973R, S1713R, S1730R, S1751R, S1793R, S1814R, S1838R, S1839R, S1861R, S561R, S611R, S624R, S658R, S671R, S693R, S735R, S738R, S972R	Hereditary breast ovarian cancer syndrome	VCV000869006	17	41197764	17	43045747	869006	853157	rs878854960	NC_000017.11:43045746:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 11, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5522G>A (p.Ser1841Asn)	BRCA1	S1841N, S1862N, S737N, S1794N, S1714N, S1751N, S1757N, S1772N, S1773N, S1774N, S1792N, S1797N, S1798N, S1813N, S1821N, S1839N, S1861N, S611N, S625N, S628N, S629N, S650N, S668N, S689N, S759N, S1712N, S735N, S738N, S1799N, S1836N, S570N, S610N, S624N, S648N, S656N, S667N, S697N, S711N, S973N, S1544N, S1672N, S1730N, S1753N, S1769N, S1771N, S1800N, S1815N, S1822N, S1838N, S1863N, S429N, S561N, S658N, S671N, S690N, S691N, S698N, S734N, S736N, S760N, S972N, S1545N, S1687N, S1713N, S1728N, S1729N, S1752N, S1770N, S1793N, S1814N, S1837N, S1840N, S649N, S666N, S670N, S693N, S695N, S696N, S699N, S712N, S713N	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055613	17	41197765	17	43045748	55613	70280	rs80357368	NC_000017.11:43045747:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5468-11_5520dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267605	17	41197766 - 41197767	17	43045749 - 43045750	267605	262916	rs1555574411		Duplication	splice acceptor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5521del (p.Ser1841fs)	BRCA1	S1794fs, S1841fs, S737fs, S1862fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055612	17	41197766	17	43045749	55612	70279	rs80357721	NC_000017.11:43045748:T:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5518_5519del (p.Asp1840fs)	BRCA1	D1543fs, D1544fs, D1671fs, D1686fs, D1711fs, D1712fs, D1713fs, D1727fs, D1728fs, D1729fs, D1750fs, D1751fs, D1752fs, D1756fs, D1768fs, D1769fs, D1770fs, D1771fs, D1772fs, D1773fs, D1791fs, D1792fs, D1793fs, D1796fs, D1797fs, D1798fs, D1799fs, D1812fs, D1813fs, D1814fs, D1820fs, D1821fs, D1835fs, D1836fs, D1837fs, D1838fs, D1839fs, D1840fs, D1860fs, D1861fs, D1862fs, D428fs, D560fs, D569fs, D609fs, D610fs, D623fs, D624fs, D627fs, D628fs, D647fs, D648fs, D649fs, D655fs, D657fs, D665fs, D666fs, D667fs, D669fs, D670fs, D688fs, D689fs, D690fs, D692fs, D694fs, D695fs, D696fs, D697fs, D698fs, D710fs, D711fs, D712fs, D733fs, D734fs, D735fs, D736fs, D737fs, D758fs, D759fs, D971fs, D972fs	Hereditary cancer-predisposing syndrome	VCV003893764	17	41197768 - 41197769	17	43045751 - 43045752	3893764	4009645		NC_000017.11:43045750:TC:	Deletion	frameshift variant|3 prime UTR variant	Pathogenic	Apr 29, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5517_5518insC (p.Asp1840fs)	BRCA1	D1793fs, D1840fs, D1861fs, D736fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000660234	17	41197769 - 41197770	17	43045752 - 43045753	660234	645918	rs1597796956	NC_000017.11:43045752::G	Insertion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5518del (p.Asp1840fs)	BRCA1	D1840fs, D1793fs, D1861fs, D736fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548201	17	41197769	17	43045752	548201	538759	rs1555574414	NC_000017.11:43045751:CC:C	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5516del (p.Leu1839fs)	BRCA1	L1839fs, L1792fs, L1860fs, L735fs	Hereditary breast ovarian cancer syndrome	VCV001354632	17	41197771	17	43045754	1354632	1434217	rs2152543224	NC_000017.11:43045753:AA:A	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Mar 27, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5516T>C (p.Leu1839Ser)	BRCA1	L1839S, L1792S, L735S, L1860S, L1728S, L1751S, L1770S, L1837S, L427S, L609S, L626S, L627S, L656S, L669S, L688S, L695S, L733S, L757S, L758S, L970S, L1542S, L1749S, L1767S, L1771S, L1772S, L1795S, L1797S, L1813S, L1820S, L1834S, L646S, L664S, L689S, L710S, L734S, L736S, L1670S, L1710S, L1711S, L1726S, L1768S, L1791S, L1819S, L1543S, L1685S, L1712S, L1727S, L1750S, L1755S, L1769S, L1790S, L1796S, L1798S, L1811S, L1812S, L1836S, L1838S, L608S, L623S, L647S, L648S, L654S, L665S, L668S, L687S, L691S, L697S, L709S, L971S, L1835S, L1859S, L1861S, L559S, L568S, L622S, L666S, L693S, L694S, L696S, L711S, L732S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091656	17	41197771	17	43045754	91656	97133	rs398122702	NC_000017.11:43045753:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5514del (p.Leu1839fs)	BRCA1	L1792fs, L1860fs, L1839fs, L735fs	Hereditary breast ovarian cancer syndrome	VCV001389584	17	41197773	17	43045756	1389584	1377064	rs2152544961	NC_000017.11:43045755:C:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 1, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5513T>A (p.Val1838Glu)	BRCA1	V1838E, V1859E, V734E, V1791E, V1669E, V1684E, V1749E, V1750E, V1771E, V1789E, V1795E, V1797E, V1812E, V1858E, V426E, V607E, V625E, V645E, V646E, V668E, V687E, V695E, V756E, V969E, V1541E, V1725E, V1766E, V1770E, V1790E, V1794E, V1811E, V1819E, V1836E, V1837E, V558E, V621E, V626E, V647E, V653E, V655E, V688E, V709E, V731E, V733E, V735E, V1542E, V1711E, V1726E, V1727E, V1767E, V1768E, V1769E, V1796E, V1833E, V1834E, V1860E, V567E, V664E, V686E, V693E, V710E, V757E, V970E, V1709E, V1710E, V1748E, V1754E, V1810E, V1818E, V1835E, V608E, V622E, V663E, V665E, V667E, V690E, V692E, V694E, V696E, V708E, V732E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055611	17	41197774	17	43045757	55611	70278	rs80357107	NC_000017.11:43045756:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5512del (p.Val1838fs)	BRCA1	V1859fs, V1838fs, V1791fs, V734fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055610	17	41197775	17	43045758	55610	70277	rs80357839	NC_000017.11:43045757:CCC:CC	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5511G>C (p.Trp1837Cys)	BRCA1	W1837C, W1790C, W733C, W1858C, W1540C, W1709C, W1724C, W1753C, W1766C, W1788C, W1789C, W1796C, W1833C, W566C, W689C, W691C, W708C, W731C, W755C, W968C, W1541C, W1726C, W1748C, W1767C, W1795C, W1809C, W1817C, W1818C, W1857C, W1859C, W621C, W662C, W663C, W666C, W693C, W694C, W707C, W709C, W734C, W969C, W1668C, W1683C, W1725C, W1747C, W1770C, W1793C, W1810C, W1832C, W1835C, W645C, W646C, W664C, W695C, W732C, W756C, W1708C, W1710C, W1749C, W1765C, W1768C, W1769C, W1794C, W1811C, W1834C, W1836C, W425C, W557C, W606C, W607C, W620C, W624C, W625C, W644C, W652C, W654C, W667C, W685C, W686C, W687C, W692C, W730C	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|not provided|Hereditary breast ovarian cancer syndrome	VCV000421244	17	41197776	17	43045759	421244	409942	rs80356914	NC_000017.11:43045758:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5498_5511del (p.Val1833fs)	BRCA1	V1786fs, V1833fs, V729fs, V1854fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125867	17	41197776 - 41197789	17	43045759 - 43045772	125867	131405	rs80359873	NC_000017.11:43045758:CCACTCTCGGGTCACCAC:CCAC	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5511G>A (p.Trp1837Ter)	BRCA1	W1837*, W1790*, W1858*, W733*, W1668*, W1709*, W1710*, W1724*, W1747*, W1766*, W1767*, W1768*, W1796*, W1811*, W1833*, W566*, W606*, W624*, W646*, W663*, W687*, W695*, W707*, W709*, W730*, W734*, W969*, W1540*, W1725*, W1770*, W1788*, W1836*, W607*, W620*, W625*, W644*, W664*, W685*, W691*, W692*, W708*, W756*, W968*, W1749*, W1769*, W1795*, W1832*, W1857*, W1859*, W557*, W654*, W662*, W666*, W693*, W694*, W731*, W1541*, W1683*, W1708*, W1726*, W1748*, W1753*, W1765*, W1789*, W1793*, W1794*, W1809*, W1810*, W1817*, W1818*, W1834*, W1835*, W425*, W621*, W645*, W652*, W667*, W686*, W689*, W732*, W755*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055609	17	41197776	17	43045759	55609	70276	rs80356914	NC_000017.11:43045758:C:T	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5511G>T (p.Trp1837Cys)	BRCA1	W1837C, W1790C, W733C, W1858C, W1541C, W1708C, W1724C, W1725C, W1726C, W1768C, W1788C, W1793C, W1809C, W1811C, W1818C, W606C, W607C, W646C, W652C, W654C, W662C, W663C, W664C, W667C, W686C, W689C, W692C, W695C, W734C, W755C, W756C, W1709C, W1710C, W1748C, W1749C, W1789C, W1794C, W1795C, W1835C, W1857C, W566C, W624C, W694C, W968C, W1683C, W1747C, W1765C, W1766C, W1769C, W1833C, W1834C, W557C, W620C, W625C, W644C, W685C, W691C, W707C, W708C, W709C, W730C, W1540C, W1668C, W1753C, W1767C, W1770C, W1796C, W1810C, W1817C, W1832C, W1836C, W1859C, W425C, W621C, W645C, W666C, W687C, W693C, W731C, W732C, W969C	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000037680	17	41197776	17	43045759	37680	46236	rs80356914	NC_000017.11:43045758:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5509_5510del (p.Trp1837fs)	BRCA1	W1790fs, W1858fs, W733fs, W1837fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431281	17	41197777 - 41197778	17	43045760 - 43045761	431281	424782	rs1135401888	NC_000017.11:43045759:CAC:C	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5486_5510del (p.Glu1829fs)	BRCA1	E1782fs, E1829fs, E1850fs, E725fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266554	17	41197777 - 41197801	17	43045760 - 43045784	266554	261569	rs886040297	NC_000017.11:43045759:CACTCTCGGGTCACCACAGGTGCCTCAC:CAC	Deletion	frameshift variant|stop lost|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5510G>A (p.Trp1837Ter)	BRCA1	W1837*, W733*, W1858*, W1790*, W1708*, W1709*, W1725*, W1747*, W1768*, W1796*, W1811*, W1833*, W620*, W621*, W624*, W645*, W664*, W666*, W667*, W687*, W695*, W707*, W708*, W730*, W1668*, W1748*, W1749*, W1766*, W1769*, W1789*, W1817*, W1836*, W1857*, W425*, W606*, W663*, W731*, W756*, W968*, W969*, W1541*, W1710*, W1724*, W1726*, W1765*, W1770*, W1788*, W1793*, W1794*, W1809*, W1810*, W1834*, W1859*, W566*, W607*, W625*, W644*, W654*, W662*, W686*, W689*, W692*, W732*, W755*, W1540*, W1683*, W1753*, W1767*, W1795*, W1818*, W1832*, W1835*, W557*, W646*, W652*, W685*, W691*, W693*, W694*, W709*, W734*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055608	17	41197777	17	43045760	55608	70275	rs80357307	NC_000017.11:43045759:C:T	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5509T>A (p.Trp1837Arg)	BRCA1	W1790R, W733R, W1837R, W1858R, W1540R, W1708R, W1725R, W1747R, W1748R, W1793R, W1795R, W1796R, W1811R, W1835R, W557R, W566R, W646R, W662R, W666R, W685R, W687R, W730R, W734R, W755R, W756R, W1541R, W1710R, W1726R, W1765R, W1766R, W1769R, W1770R, W1809R, W1817R, W1818R, W1859R, W625R, W645R, W664R, W667R, W689R, W692R, W694R, W969R, W1668R, W1683R, W1709R, W1724R, W1749R, W1753R, W1768R, W1788R, W1789R, W1833R, W1834R, W1836R, W621R, W644R, W686R, W695R, W708R, W968R, W663R, W691R, W693R, W707R, W709R, W731R, W732R, W1767R, W1794R, W1810R, W1832R, W1857R, W425R, W606R, W607R, W620R, W624R, W652R, W654R	Hereditary breast ovarian cancer syndrome|not provided	VCV000853483	17	41197778	17	43045761	853483	845361	rs80356959	NC_000017.11:43045760:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5509T>G (p.Trp1837Gly)	BRCA1	W1837G, W1790G, W1858G, W733G, W1541G, W1710G, W1725G, W1749G, W1753G, W1765G, W1768G, W1770G, W1789G, W606G, W624G, W625G, W689G, W691G, W693G, W707G, W730G, W731G, W732G, W755G, W1540G, W1708G, W1726G, W1747G, W1769G, W1788G, W1810G, W1811G, W1817G, W1834G, W1835G, W620G, W621G, W644G, W652G, W666G, W667G, W694G, W708G, W734G, W756G, W969G, W1683G, W1724G, W1766G, W1794G, W1796G, W1836G, W1857G, W607G, W663G, W664G, W686G, W687G, W692G, W709G, W1668G, W1709G, W1748G, W1767G, W1793G, W1795G, W1809G, W1818G, W1832G, W1833G, W1859G, W425G, W557G, W566G, W645G, W646G, W654G, W662G, W685G, W695G, W968G	BRCA1-related cancer predisposition	VCV000055607	17	41197778	17	43045761	55607	70274	rs80356959	NC_000017.11:43045760:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.5509T>C (p.Trp1837Arg)	BRCA1	W1837R, W733R, W1858R, W1790R, W1540R, W1541R, W1725R, W1747R, W1766R, W1768R, W1794R, W1817R, W425R, W621R, W624R, W625R, W646R, W662R, W663R, W685R, W691R, W707R, W731R, W1668R, W1683R, W1724R, W1765R, W1770R, W1789R, W1795R, W1796R, W1809R, W1810R, W1832R, W1857R, W1859R, W557R, W606R, W666R, W667R, W687R, W692R, W730R, W734R, W1708R, W1709R, W1710R, W1726R, W1767R, W1788R, W1818R, W1833R, W566R, W607R, W644R, W652R, W664R, W686R, W693R, W694R, W695R, W708R, W732R, W1748R, W1749R, W1753R, W1769R, W1793R, W1811R, W1834R, W1835R, W1836R, W620R, W645R, W654R, W689R, W709R, W755R, W756R, W968R, W969R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037679	17	41197778	17	43045761	37679	46235	rs80356959	NC_000017.11:43045760:A:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5507_5508del (p.Glu1836fs)	BRCA1	E1789fs, E1836fs, E1857fs, E732fs	Hereditary cancer-predisposing syndrome	VCV004082356	17	41197779 - 41197780	17	43045762 - 43045763	4082356	1245882		NC_000017.11:43045761:CTCTC:CTC	Microsatellite	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 26, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5506del (p.Glu1836fs)	BRCA1	E1789fs, E1836fs, E1857fs, E732fs	Hereditary breast ovarian cancer syndrome	VCV003384162	17	41197781	17	43045764	3384162	1245881		NC_000017.11:43045763:C:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Nov 25, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5503_5506del (p.Arg1835fs)	BRCA1	R1835fs, R1856fs, R1788fs, R731fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266557	17	41197781 - 41197784	17	43045764 - 43045767	266557	261570	rs886040300	NC_000017.11:43045763:CTCG:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5506G>T (p.Glu1836Ter)	BRCA1	E1836*, E732*, E1857*, E1789*, E1539*, E1708*, E1709*, E1746*, E1747*, E1764*, E1787*, E1793*, E1832*, E424*, E565*, E619*, E645*, E651*, E663*, E690*, E708*, E733*, E1667*, E1724*, E1725*, E1752*, E1765*, E1767*, E1788*, E1816*, E1831*, E1834*, E1858*, E620*, E623*, E624*, E653*, E684*, E686*, E692*, E706*, E707*, E729*, E967*, E1540*, E1707*, E1766*, E1768*, E1792*, E1795*, E1809*, E1817*, E556*, E605*, E643*, E644*, E662*, E685*, E688*, E691*, E731*, E755*, E968*, E1682*, E1723*, E1748*, E1769*, E1794*, E1808*, E1810*, E1833*, E1835*, E1856*, E606*, E661*, E665*, E666*, E693*, E694*, E730*, E754*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055606	17	41197781	17	43045764	55606	70273	rs80356942	NC_000017.11:43045763:C:A	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5497_5506del (p.Val1833fs)	BRCA1	V729fs, V1786fs, V1833fs, V1854fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055599	17	41197781 - 41197790	17	43045764 - 43045773	55599	70266	rs273902775	NC_000017.11:43045763:CTCGGGTCACC:C	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5496_5506delinsA (p.Val1833fs)	BRCA1	V1786fs, V1833fs, V1854fs, V729fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055597	17	41197781 - 41197791	17	43045764 - 43045774	55597	70264	rs273902775	NC_000017.11:43045763:CTCGGGTCACC:T	Indel	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5503dup (p.Arg1835fs)	BRCA1	R1856fs, R1788fs, R1835fs, R731fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266558	17	41197783 - 41197784	17	43045766 - 43045767	266558	261572	rs397509291	NC_000017.11:43045766:GGG:GGGG	Duplication	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5502_5503dup (p.Arg1835fs)	BRCA1	R1788fs, R731fs, R1835fs, R1856fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266556	17	41197783 - 41197784	17	43045766 - 43045767	266556	261571	rs397509291	NC_000017.11:43045766:GGG:GGGGG	Duplication	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5503del (p.Arg1835fs)	BRCA1	R1835fs, R1856fs, R1788fs, R731fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055603	17	41197784	17	43045767	55603	70270	rs397509291	NC_000017.11:43045766:GGG:GG	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5503C>T (p.Arg1835Ter)	BRCA1	R1835*, R1856*, R1788*, R731*, R1539*, R1681*, R1706*, R1708*, R1764*, R1808*, R1809*, R1857*, R604*, R605*, R644*, R661*, R687*, R689*, R705*, R753*, R754*, R1666*, R1722*, R1723*, R1745*, R1747*, R1763*, R1766*, R1767*, R1807*, R1816*, R1831*, R1834*, R555*, R564*, R619*, R622*, R623*, R652*, R683*, R684*, R691*, R693*, R706*, R1538*, R1707*, R1724*, R1765*, R1787*, R1791*, R1793*, R1794*, R1815*, R1830*, R1855*, R618*, R642*, R643*, R660*, R662*, R664*, R685*, R729*, R966*, R1746*, R1751*, R1768*, R1786*, R1792*, R1832*, R1833*, R423*, R650*, R665*, R690*, R692*, R707*, R728*, R730*, R732*, R967*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055601	17	41197784	17	43045767	55601	70268	rs41293465	NC_000017.11:43045766:G:A	single nucleotide variant	nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5496_5499del (p.Val1833fs)	BRCA1	V1854fs, V729fs, V1833fs, V1786fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236274	17	41197788 - 41197791	17	43045771 - 43045774	236274	237827	rs878853296	NC_000017.11:43045770:CACC:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5497del (p.Val1832_Val1833insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001453808	17	41197790	17	43045773	1453808	1451334	rs2152561810	NC_000017.11:43045772:CC:C	Deletion	frameshift variant|nonsense|3 prime UTR variant|non-coding transcript variant	Pathogenic	Nov 27, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5497G>A (p.Val1833Met)	BRCA1	V1833M, V1854M, V729M, V1786M, V1536M, V1722M, V1745M, V1761M, V1763M, V1764M, V1765M, V1784M, V1790M, V1807M, V1828M, V1830M, V1831M, V1853M, V553M, V617M, V621M, V642M, V659M, V683M, V689M, V703M, V704M, V752M, V965M, V1537M, V1664M, V1679M, V1720M, V1721M, V1749M, V1813M, V1829M, V1855M, V603M, V640M, V660M, V726M, V964M, V1706M, V1743M, V1744M, V1785M, V1789M, V1806M, V1814M, V1832M, V421M, V602M, V616M, V650M, V663M, V682M, V727M, V751M, V1704M, V1705M, V1762M, V1766M, V1791M, V1792M, V1805M, V562M, V620M, V641M, V648M, V658M, V662M, V681M, V685M, V687M, V688M, V690M, V691M, V705M, V728M, V730M	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000055598	17	41197790	17	43045773	55598	70265	rs80357268	NC_000017.11:43045772:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5484_5496del (p.Cys1828fs)	BRCA1	C1531fs, C1532fs, C1659fs, C1674fs, C1699fs, C1700fs, C1701fs, C1715fs, C1716fs, C1717fs, C1738fs, C1739fs, C1740fs, C1744fs, C1756fs, C1757fs, C1758fs, C1759fs, C1760fs, C1761fs, C1779fs, C1780fs, C1781fs, C1784fs, C1785fs, C1786fs, C1787fs, C1800fs, C1801fs, C1802fs, C1808fs, C1809fs, C1823fs, C1824fs, C1825fs, C1826fs, C1827fs, C1828fs, C1848fs, C1849fs, C1850fs, C416fs, C548fs, C557fs, C597fs, C598fs, C611fs, C612fs, C615fs, C616fs, C635fs, C636fs, C637fs, C643fs, C645fs, C653fs, C654fs, C655fs, C657fs, C658fs, C676fs, C677fs, C678fs, C680fs, C682fs, C683fs, C684fs, C685fs, C686fs, C698fs, C699fs, C700fs, C721fs, C722fs, C723fs, C724fs, C725fs, C746fs, C747fs, C959fs, C960fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002674447	17	41197791 - 41197803	17	43045774 - 43045786	2674447	2841933	rs2546061147	NC_000017.11:43045773:CACAGGTGCCTCACACA:CACA	Deletion	frameshift variant|stop lost	Pathogenic	Jul 31, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5495_5496insTT (p.Val1833fs)	BRCA1	V1854fs, V1786fs, V729fs, V1833fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548175	17	41197791 - 41197792	17	43045774 - 43045775	548175	538760	rs1555574436	NC_000017.11:43045774:A:AAA	Insertion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5493_5494insTT (p.Val1832fs)	BRCA1	V1832fs, V1853fs, V1785fs, V728fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266555	17	41197793 - 41197794	17	43045776 - 43045777	266555	261573	rs886040298	NC_000017.11:43045776:A:AAA	Insertion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5492del (p.Pro1831fs)	BRCA1	P1852fs, P1784fs, P727fs, P1831fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055596	17	41197795	17	43045778	55596	70263	rs80357582	NC_000017.11:43045777:GG:G	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5478_5490del (p.Gln1826fs)	BRCA1	D698fs, Q1779fs, Q1826fs, Q1847fs, Q722fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002431321	17	41197797 - 41197809	17	43045780 - 43045792	2431321	2404825	rs2546076440	NC_000017.11:43045779:TGCCTCACACATCTGCC:TGCC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 17, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5490del (p.Pro1831fs)	BRCA1	P1831fs, P727fs, P1784fs, P1852fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125861	17	41197797	17	43045780	125861	131399	rs80357976	NC_000017.11:43045779:T:	Deletion	frameshift variant|3 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5485dup (p.Glu1829fs)	BRCA1	E1782fs, E725fs, E1850fs, E1829fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254471	17	41197801 - 41197802	17	43045784 - 43045785	254471	249073	rs768401297	NC_000017.11:43045784:C:CC	Duplication	frameshift variant|stop lost|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5484dup (p.Glu1829Ter)	BRCA1	E1716*, E1717*, E1718*, E1739*, E1740*, E1741*, E1745*, E1757*, E1758*, E1759*, E1760*, E1761*, E1762*, E1780*, E1781*, E1782*, E1785*, E1786*, E1787*, E1788*, E1801*, E1802*, E1803*, E1809*, E1810*, E1824*, E1825*, E1826*, E1827*, E1828*, E1829*, E1849*, E1850*, E1851*, E417*, E549*, E558*, E598*, E599*, E612*, E613*, E616*, E617*, E636*, E637*, E638*, E644*, E646*, E654*, E655*, E656*, E658*, E659*, E677*, E678*, E679*, E681*, E683*, E684*, E685*, E686*, E687*, E699*, E700*, E701*, E722*, E723*, E724*, E725*, E726*, E747*, E748*, E960*, E961*, E1532*, E1533*, E1660*, E1675*, E1700*, E1701*, E1702*	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002583814	17	41197802 - 41197803	17	43045785 - 43045786	2583814	2751384	rs2546095844	NC_000017.11:43045785:A:AA	Duplication	nonsense|frameshift variant|stop lost	Pathogenic	May 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5484_5485del (p.Cys1828_Glu1829delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254470	17	41197802 - 41197803	17	43045785 - 43045786	254470	249072	rs886038046	NC_000017.11:43045784:CACACA:CACA	Microsatellite	frameshift variant|nonsense|stop lost|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5484T>A (p.Cys1828Ter)	BRCA1	C1828*, C1781*, C1849*, C724*, C1531*, C1659*, C1716*, C1717*, C1740*, C1759*, C1826*, C1850*, C598*, C636*, C684*, C698*, C960*, C1757*, C1758*, C1785*, C1786*, C1800*, C1801*, C1825*, C1848*, C548*, C557*, C597*, C635*, C643*, C653*, C654*, C655*, C677*, C680*, C721*, C722*, C723*, C746*, C1674*, C1700*, C1715*, C1739*, C1744*, C1761*, C1780*, C1808*, C1824*, C416*, C611*, C637*, C658*, C682*, C683*, C700*, C725*, C959*, C1532*, C1699*, C1701*, C1738*, C1756*, C1760*, C1779*, C1784*, C1787*, C1802*, C1809*, C1823*, C1827*, C612*, C615*, C616*, C645*, C657*, C676*, C678*, C685*, C686*, C699*, C747*	Hereditary breast ovarian cancer syndrome	VCV000868580	17	41197803	17	43045786	868580	853231	rs2050885130	NC_000017.11:43045785:A:T	single nucleotide variant	nonsense|stop lost|non-coding transcript variant	Pathogenic	Aug 23, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5483del (p.Cys1828fs)	BRCA1	C1828fs, C724fs, C1849fs, C1781fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055593	17	41197804	17	43045787	55593	70260	rs397509288	NC_000017.11:43045786:C:	Deletion	frameshift variant|non-coding transcript variant|stop lost	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5474_5481del (p.Gly1825fs)	BRCA1	G1778fs, G1825fs, G1846fs, G721fs, W696fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182075	17	41197806 - 41197813	17	43045789 - 43045796	182075	180816	rs730881441	NC_000017.11:43045788:CATCTGCCCA:CA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5478_5479dup (p.Met1827fs)	BRCA1	M1848fs, M723fs, M1780fs, M1827fs, D698fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096952	17	41197807 - 41197808	17	43045790 - 43045791	96952	102855	rs80357757	NC_000017.11:43045790:TCT:TCTCT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5470_5477del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055591	17	41197810 - 41197817	17	43045793 - 43045800	55591	70258	rs80357973	NC_000017.11:43045792:TGCCCAATTGC:TGC	Deletion	splice acceptor variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5476del (p.Gln1826fs)	BRCA1	A697fs, Q1779fs, Q1826fs, Q1847fs, Q722fs	not provided|Hereditary cancer-predisposing syndrome	VCV001330093	17	41197811	17	43045794	1330093	1320776	rs2152575457	NC_000017.11:43045793:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5476C>T (p.Gln1826Ter)	BRCA1	A697V, Q722*, Q1826*, Q1779*, Q1847*, A1758V, A1759V, A1760V, Q1657*, Q1713*, Q1715*, Q1742*, Q1757*, Q1758*, Q1782*, Q1825*, Q555*, Q595*, Q613*, Q633*, Q651*, Q653*, Q680*, Q681*, Q698*, Q958*, A1799V, A1801V, A696V, Q1530*, Q1697*, Q1698*, Q1699*, Q1714*, Q1737*, Q1798*, Q1806*, Q1821*, Q1822*, Q1848*, Q546*, Q610*, Q635*, Q652*, Q656*, Q674*, Q675*, Q678*, Q684*, Q696*, Q697*, Q723*, Q744*, Q1846*, Q609*, Q683*, Q719*, Q957*, A1754V, A1800V, Q1529*, Q1754*, Q1777*, Q1778*, Q1783*, Q1799*, Q1800*, Q1807*, Q1823*, Q414*, Q596*, Q614*, Q634*, Q641*, Q643*, Q655*, Q676*, Q682*, Q720*, Q721*, Q745*, A1753V, Q1672*, Q1736*, Q1738*, Q1755*, Q1756*, Q1759*, Q1784*, Q1785*, Q1824*	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000868969	17	41197811	17	43045794	868969	853247	rs587782887	NC_000017.11:43045793:G:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5468-1_5469del	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001363523	17	41197818 - 41197820	17	43045801 - 43045803	1363523	1489383	rs2152598561	NC_000017.11:43045800:TGCTG:TG	Deletion	splice acceptor variant	Pathogenic/Likely pathogenic	Mar 17, 2025	criteria provided, multiple submitters, no conflicts							
NG_005905.2:g.(?_92501)_(170342_172181)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373871	17	41197820 - 41277500	17	43045803 - 43125483	373871	360750			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5468-1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125856	17	41197820	17	43045803	125856	131394	rs80358048	NC_000017.11:43045802:C:T	single nucleotide variant	splice acceptor variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5468-2A>T	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267606	17	41197821	17	43045804	267606	262917	rs398122699	NC_000017.11:43045803:T:A	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	May 6, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5468-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091653	17	41197821	17	43045804	91653	97130	rs398122699	NC_000017.11:43045803:T:C	single nucleotide variant	splice acceptor variant	Pathogenic	Mar 26, 2025	criteria provided, multiple submitters, no conflicts							
Single allele	LOC126862571|NBR2|LOC111589216|LOC111589215|BRCA1|LOC110485084		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000560136	17	41198799 - 41277749	17	43046782 - 43125732	560136	550852			Deletion		Pathogenic	Mar 30, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5277+2100_5467+344dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373834	17	41199315 - 41199316	17	43047298 - 43047299	373834	360722			Duplication	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(?_43047623)_(43125483_?)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000651258	17	41199640 - 41277500	17	43047623 - 43125483	651258	652814			Deletion		Pathogenic	Oct 24, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5467+1_5467+16del	BRCA1		Hereditary cancer-predisposing syndrome	VCV001172074	17	41199644 - 41199659	17	43047627 - 43047642	1172074	1161352	rs2152760370	NC_000017.11:43047626:CATGCAGGCACCTTACCATG:CATG	Deletion	splice donor variant	Pathogenic/Likely pathogenic	Sep 11, 2024	criteria provided, multiple submitters, no conflicts							
NC_000017.11:g.(?_43047637)_(43099886_?)del	LOC126862571|BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462172	17	41199654 - 41251903	17	43047637 - 43099886	462172	466234			Deletion		Pathogenic	Feb 26, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5467+2T>C	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000125851	17	41199658	17	43047641	125851	131389	rs80358009	NC_000017.11:43047640:A:G	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5407-75_5467+1del	BRCA1		Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003779412	17	41199659 - 41199795	17	43047642 - 43047778	3779412	3895396			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Apr 6, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5467+1del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267604	17	41199659	17	43047642	267604	262918	rs886040918	NC_000017.11:43047641:CC:C	Deletion	splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5467+1G>A	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037673	17	41199659	17	43047642	37673	46229	rs80358145	NC_000017.11:43047641:C:T	single nucleotide variant	splice donor variant	Pathogenic	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5467G>T (p.Ala1823Ser)	BRCA1	A1844S, A1823S, A719S, A1776S, C694F, A1669S, A1695S, A1774S, A1779S, A1782S, A1818S, A1819S, A1820S, A1845S, A543S, A638S, A652S, A675S, A677S, A679S, A717S, A742S, C1755F, C693F, A1526S, A1696S, A1710S, A1734S, A1735S, A1795S, A1822S, A592S, A610S, A611S, A630S, A632S, A648S, A653S, A671S, A693S, A716S, A954S, C1757F, C1797F, A1527S, A1654S, A1694S, A1739S, A1753S, A1755S, A1756S, A1775S, A1796S, A1797S, A1803S, A1843S, A593S, A606S, A607S, A640S, A649S, A680S, A694S, A720S, C1751F, A1711S, A1712S, A1733S, A1751S, A1752S, A1754S, A1780S, A1781S, A1804S, A1821S, A411S, A552S, A631S, A650S, A672S, A673S, A678S, A681S, A695S, A718S, A741S, A955S, C1750F, C1756F, C1796F, C1798F	Hereditary cancer-predisposing syndrome	VCV000868922	17	41199660	17	43047643	868922	853268	rs80357212	NC_000017.11:43047642:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5466dup (p.Ala1823fs)	BRCA1	C694fs, A1776fs, A1823fs, A1844fs, A719fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548237	17	41199660 - 41199661	17	43047643 - 43047644	548237	538761	rs1555574698	NC_000017.11:43047643:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NC_000017.11:g.(?_43047643)_(43124115_?)del	BRCA1|LOC110485084|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000417591	17	41199660 - 41276132	17	43047643 - 43124115	417591	401512			Deletion		Pathogenic	Nov 18, 2016	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5278-?_5467+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188228	17	41199660 - 41203134	17	43047643 - 43051117	188228	186238			Deletion		Pathogenic	Aug 19, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5467G>A (p.Ala1823Thr)	BRCA1	A1823T, A1844T, A719T, A1776T, C694Y, A1526T, A1654T, A1696T, A1774T, A1775T, A1779T, A1818T, A1843T, A1845T, A632T, A640T, A653T, A671T, A677T, A680T, A694T, A717T, A1712T, A1735T, A1739T, A1753T, A1756T, A1781T, A1796T, A1803T, A1804T, A1820T, A593T, A606T, A638T, A650T, A652T, A672T, A673T, A695T, A718T, A741T, C1750Y, C1797Y, A1669T, A1694T, A1711T, A1752T, A1755T, A1780T, A1795T, A1797T, A592T, A607T, A610T, A630T, A631T, A648T, A675T, A678T, A679T, A720T, C1756Y, C1757Y, C1796Y, C1798Y, C693Y, A1527T, A1695T, A1710T, A1733T, A1734T, A1751T, A1754T, A1782T, A1819T, A1821T, A1822T, A411T, A543T, A552T, A611T, A649T, A681T, A693T, A716T, A742T, A954T, A955T, C1751Y, C1755Y	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055588	17	41199660	17	43047643	55588	70255	rs80357212	NC_000017.11:43047642:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5464_5465insT (p.His1822fs)	BRCA1	H1822fs, H1843fs, C694fs, H718fs, H1775fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125850	17	41199662 - 41199663	17	43047645 - 43047646	125850	131388	rs273902769	NC_000017.11:43047645::A	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5463_5464insT (p.His1822fs)	BRCA1	H1775fs, P693fs, H718fs, H1843fs, H1822fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373823	17	41199663 - 41199664	17	43047646 - 43047647	373823	360716	rs1057518636	NC_000017.11:43047646::A	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5451_5455del (p.Asp1818fs)	BRCA1	G1746fs, D1522fs, D1691fs, D1705fs, D1734fs, D1777fs, D1790fs, D1799fs, D1816fs, D1818fs, D1838fs, D602fs, D605fs, D1706fs, D1746fs, D1750fs, D1769fs, D1771fs, D1775fs, D1814fs, D1815fs, D1817fs, D538fs, D601fs, D644fs, D673fs, D676fs, D689fs, D713fs, D950fs, G1750fs, G1791fs, G688fs, D1664fs, D1690fs, D1728fs, D1747fs, D1774fs, D1792fs, D1813fs, D406fs, D587fs, D606fs, D625fs, D666fs, D667fs, D668fs, D674fs, D675fs, D690fs, D712fs, D737fs, G1792fs, G1793fs, D1521fs, D1649fs, D1689fs, D1707fs, D1729fs, D1730fs, D1748fs, D1749fs, D1751fs, D1770fs, D1776fs, D1791fs, D1798fs, D1839fs, D1840fs, D547fs, D588fs, D643fs, D647fs, D688fs, D715fs, D736fs, D949fs, D626fs, D627fs, D633fs, D635fs, D645fs, D648fs, D670fs, D672fs, D711fs, D714fs, G1745fs, G1751fs, G1752fs, G689fs	Hereditary breast ovarian cancer syndrome	VCV002819809	17	41199672 - 41199676	17	43047655 - 43047659	2819809	2988164	rs2546619470	NC_000017.11:43047654:TGTCCT:T	Deletion	frameshift variant	Pathogenic	Dec 10, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5453A>G (p.Asp1818Gly)	BRCA1	D1818G, D1839G, D714G, D1771G, D1664G, D1706G, D1746G, D1770G, D1775G, D1798G, D538G, D643G, D713G, D1522G, D1689G, D1690G, D1748G, D1749G, D1777G, D1791G, D1816G, D1838G, D1840G, D587G, D605G, D635G, D645G, D666G, D668G, D670G, D688G, D736G, D950G, D1521G, D1649G, D1705G, D1707G, D1728G, D1734G, D1750G, D1751G, D1769G, D1774G, D1799G, D1813G, D1814G, D602G, D606G, D625G, D626G, D647G, D648G, D674G, D690G, D711G, D712G, D737G, D1691G, D1729G, D1730G, D1747G, D1776G, D1790G, D1792G, D1815G, D1817G, D406G, D547G, D588G, D601G, D627G, D633G, D644G, D667G, D672G, D673G, D675G, D676G, D689G, D715G, D949G	BRCA1-related cancer predisposition|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037672	17	41199674	17	43047657	37672	46228	rs80357477	NC_000017.11:43047656:T:C	single nucleotide variant	missense variant|synonymous variant	Pathogenic/Likely pathogenic	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5450_5451del (p.Glu1817fs)	BRCA1	E1770fs, E1817fs, G689fs, E1838fs, E713fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055584	17	41199676 - 41199677	17	43047659 - 43047660	55584	70251	rs397509286	NC_000017.11:43047658:CTCT:CT	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5434_5449del (p.Pro1812fs)	BRCA1	A683fs, P1765fs, P1833fs, P1812fs, P708fs	Hereditary breast ovarian cancer syndrome	VCV001375839	17	41199678 - 41199693	17	43047661 - 43047676	1375839	1470225	rs2152780514	NC_000017.11:43047660:CTGTCCAGGCATCTGGCTG:CTG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 12, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5449G>T (p.Glu1817Ter)	BRCA1	E1817*, R688I, E1770*, E713*, E1838*, E1704*, E1706*, E1745*, E1746*, E1769*, E1774*, E1775*, E1798*, E1815*, E1837*, E604*, E671*, E673*, E688*, E711*, E736*, E948*, R1749I, R1751I, R1791I, E1520*, E1690*, E1728*, E1729*, E1747*, E1773*, E1776*, E1789*, E1791*, E1797*, E1812*, E1816*, E586*, E587*, E601*, E625*, E634*, E642*, E647*, E666*, E689*, E712*, E714*, E735*, R1744I, R1792I, R687I, E1521*, E1663*, E1705*, E1727*, E1749*, E1813*, E600*, E632*, E643*, E644*, E646*, E665*, E672*, E675*, E949*, R1745I, E1648*, E1688*, E1689*, E1733*, E1748*, E1750*, E1768*, E1790*, E1814*, E1839*, E405*, E537*, E546*, E605*, E624*, E626*, E667*, E669*, E674*, E687*, E710*, R1750I, R1790I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055583	17	41199678	17	43047661	55583	70250	rs80356868	NC_000017.11:43047660:C:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5445G>A (p.Trp1815Ter)	BRCA1	W1815*, D687N, W1836*, W1768*, W711*, D1743N, D1750N, D1789N, W1518*, W1688*, W1726*, W1743*, W1744*, W1745*, W1771*, W1788*, W1812*, W1813*, W598*, W602*, W622*, W624*, W670*, W685*, W687*, W709*, D1744N, D1748N, W1703*, W1725*, W1766*, W1772*, W1789*, W1795*, W1810*, W1835*, W403*, W584*, W623*, W630*, W642*, W644*, W645*, W671*, W672*, W712*, W734*, D1791N, D686N, W1661*, W1727*, W1747*, W1767*, W1773*, W1796*, W1811*, W535*, W585*, W640*, W665*, W669*, W946*, D1749N, D1790N, W1519*, W1646*, W1686*, W1687*, W1702*, W1704*, W1731*, W1746*, W1748*, W1774*, W1787*, W1814*, W1837*, W544*, W599*, W603*, W632*, W641*, W663*, W664*, W667*, W673*, W686*, W708*, W710*, W733*, W947*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055581	17	41199682	17	43047665	55581	70248	rs397509284	NC_000017.11:43047664:C:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5444G>A (p.Trp1815Ter)	BRCA1	W1815*, W711*, W1836*, W1768*, W1518*, W1661*, W1744*, W1745*, W1746*, W1747*, W1796*, W1810*, W1811*, W1835*, W535*, W623*, W624*, W667*, W947*, W1703*, W1725*, W1727*, W1731*, W1767*, W1773*, W1789*, W1795*, W544*, W602*, W642*, W644*, W670*, W671*, W710*, W733*, W1813*, W1814*, W1837*, W403*, W584*, W585*, W599*, W603*, W622*, W630*, W640*, W641*, W645*, W664*, W665*, W672*, W685*, W687*, W709*, W712*, W734*, W946*, W1519*, W1646*, W1702*, W1704*, W1743*, W1748*, W1766*, W1772*, W1774*, W1787*, W1788*, W1812*, W1686*, W1687*, W1688*, W1726*, W1771*, W598*, W632*, W663*, W669*, W673*, W686*, W708*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055580	17	41199683	17	43047666	55580	70247	rs80356962	NC_000017.11:43047665:C:T	single nucleotide variant	nonsense|synonymous variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5440dup (p.Ala1814fs)	BRCA1	A1767fs, A1835fs, C685fs, A1814fs, A710fs	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000372068	17	41199686 - 41199687	17	43047669 - 43047670	372068	358927	rs1057517637	NC_000017.11:43047669:C:CC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jul 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5440del (p.Ala1814fs)	BRCA1	A1767fs, A1835fs, C685fs, A1814fs, A710fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055579	17	41199687	17	43047670	55579	70246	rs80357946	NC_000017.11:43047669:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5432_5439del (p.Gln1811fs)	BRCA1	A683fs, Q1764fs, Q1811fs, Q1832fs, Q707fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001747503	17	41199688 - 41199695	17	43047671 - 43047678	1747503	1799801	rs2546651447	NC_000017.11:43047670:ATCTGGCT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5434C>G (p.Pro1812Ala)	BRCA1	P1812A, A683G, P1833A, P1765A, P708A, A1744G, P1683A, P1685A, P1723A, P1724A, P1742A, P1743A, P1744A, P1786A, P1792A, P1808A, P1834A, P599A, P619A, P627A, P629A, P641A, P642A, P660A, P666A, P683A, P706A, P731A, P943A, P944A, A1739G, A1786G, A1787G, P1700A, P1701A, P1722A, P1728A, P1740A, P1768A, P1785A, P1807A, P1811A, P1832A, P532A, P582A, P595A, P596A, P620A, P637A, P662A, P669A, P670A, P682A, P705A, P707A, A1740G, A1745G, A682G, P1516A, P1643A, P1741A, P1764A, P1769A, P1771A, P1793A, P1810A, P581A, P621A, P638A, P639A, P664A, P684A, P709A, P730A, A1746G, A1785G, P1515A, P1658A, P1684A, P1699A, P1745A, P1763A, P1770A, P1784A, P1809A, P400A, P541A, P600A, P661A, P667A, P668A	Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037670	17	41199693	17	43047676	37670	46226	rs1800751	NC_000017.11:43047675:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5427_5433del (p.Val1810fs)	BRCA1	C1738fs, C1744fs, C1785fs, C680fs, V1697fs, V1721fs, V1722fs, V1738fs, V1743fs, V1762fs, V1763fs, V1768fs, V1807fs, V530fs, V580fs, V618fs, V619fs, V637fs, V658fs, V704fs, V729fs, C1783fs, C1784fs, V1513fs, V1514fs, V1682fs, V1699fs, V1740fs, V1761fs, V1782fs, V1783fs, V1809fs, V1810fs, V1832fs, V593fs, V594fs, V598fs, V635fs, V659fs, V666fs, V668fs, V680fs, V703fs, C1743fs, C681fs, V1641fs, V1656fs, V1681fs, V1739fs, V1741fs, V1767fs, V1769fs, V1805fs, V1831fs, V539fs, V579fs, V597fs, V617fs, V625fs, V627fs, V640fs, V664fs, V681fs, V705fs, V941fs, C1737fs, C1742fs, V1683fs, V1698fs, V1720fs, V1726fs, V1742fs, V1766fs, V1784fs, V1790fs, V1791fs, V1806fs, V1808fs, V1830fs, V398fs, V636fs, V639fs, V660fs, V662fs, V665fs, V667fs, V682fs, V706fs, V707fs, V728fs, V942fs	Hereditary breast ovarian cancer syndrome	VCV002820227	17	41199694 - 41199700	17	43047677 - 43047683	2820227	2985158	rs2546663270	NC_000017.11:43047676:CTGCACA:	Deletion	frameshift variant	Pathogenic	Dec 12, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5432del (p.Gln1811fs)	BRCA1	Q707fs, A683fs, Q1764fs, Q1811fs, Q1832fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001455990	17	41199695	17	43047678	1455990	1380250	rs2152796748	NC_000017.11:43047677:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5430_5431insGA (p.Gln1811fs)	BRCA1	Q1811fs, A682fs, Q1764fs, Q1832fs, Q707fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548179	17	41199696 - 41199697	17	43047679 - 43047680	548179	538762	rs1555574722	NC_000017.11:43047679::TC	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5431C>T (p.Gln1811Ter)	BRCA1	Q1811*, A682V, Q1764*, Q707*, Q1832*, A1738V, A1745V, A1784V, A681V, Q1515*, Q1642*, Q1657*, Q1684*, Q1700*, Q1727*, Q1740*, Q1742*, Q1768*, Q1785*, Q1791*, Q1809*, Q399*, A1785V, A1786V, Q1514*, Q1698*, Q1723*, Q1744*, Q1770*, Q1792*, Q1808*, Q1831*, Q540*, Q580*, Q595*, Q599*, Q618*, Q619*, Q637*, Q660*, Q683*, Q704*, Q729*, Q594*, Q626*, Q628*, Q659*, Q667*, Q668*, Q706*, Q942*, Q943*, A1743V, A1744V, Q1682*, Q1699*, Q1722*, Q1743*, Q1763*, Q1767*, Q1783*, Q1784*, Q1807*, Q1833*, Q581*, Q641*, Q665*, Q666*, Q669*, Q682*, Q705*, Q708*, A1739V, Q1683*, Q1721*, Q1739*, Q1741*, Q1762*, Q1769*, Q1806*, Q1810*, Q531*, Q598*, Q620*, Q636*, Q638*, Q640*, Q661*, Q663*, Q681*, Q730*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055577	17	41199696	17	43047679	55577	70244	rs397509283	NC_000017.11:43047678:G:A	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5427dup (p.Val1810fs)	BRCA1	V706fs, V1763fs, V1810fs, C681fs, V1831fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433737	17	41199699 - 41199700	17	43047682 - 43047683	433737	427519	rs1555574739	NC_000017.11:43047682:AA:AAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5419dup (p.Ile1807fs)	BRCA1	I1807fs, N678fs, I1760fs, I1828fs, I703fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266553	17	41199707 - 41199708	17	43047690 - 43047691	266553	261574	rs80357934	NC_000017.11:43047690:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5419del (p.Ile1807fs)	BRCA1	I1760fs, I1807fs, I1828fs, I703fs, N678fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055571	17	41199708	17	43047691	55571	70238	rs80357934	NC_000017.11:43047690:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5417del (p.Pro1806fs)	BRCA1	P1759fs, N678fs, P1806fs, P702fs, P1827fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037669	17	41199710	17	43047693	37669	46225	rs80357558	NC_000017.11:43047692:GGG:GG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5407_5414delGGTGTCCA (p.Gly1803fs)	BRCA1	G1803fs, G1824fs, G1756fs, G674fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267222	17	41199713 - 41199720	17	43047696 - 43047703	267222	262099	rs886040865	NC_000017.11:43047695:TGGACACC:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5408G>C (p.Gly1803Ala)	BRCA1	G1803A, G1824A, G699A, G1756A, G1506A, G1676A, G1714A, G1735A, G1761A, G1775A, G1776A, G1777A, G1799A, G1801A, G523A, G587A, G610A, G611A, G630A, G653A, G1507A, G1634A, G1691A, G1713A, G1715A, G1719A, G1731A, G1736A, G1760A, G1762A, G1784A, G1802A, G1825A, G532A, G612A, G632A, G651A, G652A, G660A, G935A, G657A, G661A, G673A, G674A, G698A, G700A, G721A, G722A, G1649A, G1675A, G1692A, G1732A, G1733A, G1800A, G586A, G591A, G633A, G655A, G658A, G659A, G697A, G934A, G1674A, G1690A, G1734A, G1754A, G1755A, G1759A, G1783A, G1798A, G1823A, G391A, G572A, G573A, G590A, G618A, G620A, G628A, G629A, G675A, G696A	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000037668	17	41199719	17	43047702	37668	46224	rs80357149	NC_000017.11:43047701:C:G	single nucleotide variant	missense variant|synonymous variant	Pathogenic/Likely pathogenic	Aug 25, 2025	criteria provided, multiple submitters, no conflicts							
NC_000017.11:g.(43047704_43049120)_(43049195_43051062)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000988773	17	41199721 - 41203079	17	43047704 - 43051062	988773	976701			Deletion		Pathogenic	Jul 1, 2015	criteria provided, single submitter							
NC_000017.11:g.(43047704_43049120)_(43049195_43051062)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000440438	17	41199721 - 41203079	17	43047704 - 43051062	440438	434068			Deletion		Pathogenic	Nov 19, 2019	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(168862_170280)dup	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373878	17	41199721 - 41277500	17	43047704 - 43125483	373878	360752			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(168862_170280)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373877	17	41199721 - 41277500	17	43047704 - 43125483	373877	360751			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5407-1G>C	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125846	17	41199721	17	43047704	125846	131384	rs80358029	NC_000017.11:43047703:C:G	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Aug 23, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5407-1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000125845	17	41199721	17	43047704	125845	131383	rs80358029	NC_000017.11:43047703:C:T	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 12, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5407-2A>G	BRCA1		not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055567	17	41199722	17	43047705	55567	70234	rs80358002	NC_000017.11:43047704:T:C	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Aug 22, 2023	criteria provided, multiple submitters, no conflicts							
Single allele	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373833	17	41200602 - 41211992	17	43048585 - 43059975	373833	360723			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5333-36_5406+400del	BRCA1		BRCA1-related cancer predisposition	VCV000267601	17	41200738 - 41201247	17	43048721 - 43049230	267601	262919	rs1555574977		Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NC_000017.11:g.(?_43048992)_(43049260_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001679086			17	43048992 - 43049260	1679086	1670880			Deletion		Pathogenic	Apr 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5406+4_5406+7del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000531285	17	41201131 - 41201134	17	43049114 - 43049117	531285	531540	rs1555575073	NC_000017.11:43049113:TACTTACT:TACT	Microsatellite	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5406+5G>C	BRCA1		not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055565	17	41201133	17	43049116	55565	70232	rs80358073	NC_000017.11:43049115:C:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Mar 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5406+5G>A	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055564	17	41201133	17	43049116	55564	70231	rs80358073	NC_000017.11:43049115:C:T	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Jan 30, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5406+5G>T	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037667	17	41201133	17	43049116	37667	46223	rs80358073	NC_000017.11:43049115:C:A	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5406+4del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773126	17	41201134	17	43049117	3773126	3889276		NC_000017.11:43049116:TT:T	Deletion	intron variant	Pathogenic	Oct 16, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5406+4A>G	BRCA1		not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055563	17	41201134	17	43049117	55563	70230	rs397509279	NC_000017.11:43049116:T:C	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Feb 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5406+3A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055562	17	41201135	17	43049118	55562	70229	rs397509278	NC_000017.11:43049117:T:A	single nucleotide variant	intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5406+1_5406+3del	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055560	17	41201135 - 41201137	17	43049118 - 43049120	55560	70227	rs397509277	NC_000017.11:43049117:TACT:T	Deletion	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5406+2T>A	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868429	17	41201136	17	43049119	868429	855267	rs2051071309	NC_000017.11:43049118:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5406+2del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125837	17	41201136	17	43049119	125837	131375	rs273901765	NC_000017.11:43049118:A:	Deletion	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5333-1_5406+1del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast	VCV003893009	17	41201137 - 41201212	17	43049120 - 43049195	3893009	4008893			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Mar 7, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5406+1G>T	BRCA1		not provided	VCV000868428	17	41201137	17	43049120	868428	855268	rs80358028	NC_000017.11:43049119:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5406+1G>C	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000868427	17	41201137	17	43049120	868427	855269	rs80358028	NC_000017.11:43049119:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Oct 10, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5406+1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037666	17	41201137	17	43049120	37666	46222	rs80358028	NC_000017.11:43049119:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5333_5406del (p.Asp1778fs)	BRCA1	D1731fs, D1778fs, D1799fs, D674fs	not provided	VCV000993167	17	41201138 - 41201211	17	43049121 - 43049194	993167	981157	rs2051071982		Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Mar 6, 2020	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5278-?_5406+?del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000417599	17	41201138 - 41203134	17	43049121 - 43051117	417599	401973			Deletion		Pathogenic	Nov 8, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5398del (p.Gly1801fs)	BRCA1	G1822fs, G697fs, G1801fs, G1754fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000420726	17	41201146	17	43049129	420726	409944	rs1064794662	NC_000017.11:43049128:GGG:GG	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5370_5397del (p.Val1791fs)	BRCA1	V1812fs, V1744fs, V1791fs, V687fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125833	17	41201147 - 41201174	17	43049130 - 43049157	125833	131371	rs80359878	NC_000017.11:43049129:GGTGAATGATGAAAGCTCCTTCACCACAG:G	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5391del (p.Phe1798fs)	BRCA1	F1798fs, F694fs, F1751fs, F1819fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254469	17	41201153	17	43049136	254469	249074	rs774988515	NC_000017.11:43049135:T:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5390C>A (p.Ser1797Ter)	BRCA1	S1797*, S1750*, S1818*, S693*, S1500*, S1501*, S1670*, S1709*, S1754*, S1770*, S1792*, S1817*, S517*, S526*, S566*, S581*, S585*, S604*, S652*, S654*, S669*, S690*, S691*, S1668*, S1684*, S1685*, S1708*, S1727*, S1729*, S1749*, S1753*, S1769*, S1795*, S385*, S584*, S605*, S614*, S649*, S651*, S667*, S668*, S928*, S1686*, S1707*, S1725*, S1726*, S1728*, S1748*, S1755*, S1756*, S1777*, S1778*, S1794*, S567*, S580*, S606*, S612*, S624*, S626*, S627*, S645*, S647*, S653*, S694*, S716*, S929*, S1628*, S1643*, S1669*, S1730*, S1771*, S1793*, S1796*, S1819*, S622*, S623*, S646*, S655*, S692*, S715*	Hereditary cancer-predisposing syndrome	VCV000491173	17	41201154	17	43049137	491173	484820	rs879255492	NC_000017.11:43049136:G:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Apr 12, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5390C>G (p.Ser1797Ter)	BRCA1	S1797*, S1750*, S1818*, S693*, S1500*, S1668*, S1669*, S1670*, S1685*, S1686*, S1726*, S1727*, S1729*, S1754*, S1756*, S1770*, S1792*, S1793*, S566*, S606*, S622*, S626*, S627*, S646*, S647*, S652*, S655*, S669*, S692*, S716*, S1501*, S1628*, S1708*, S1725*, S1730*, S1749*, S1755*, S1769*, S1777*, S517*, S1709*, S1753*, S1771*, S1796*, S1819*, S526*, S584*, S604*, S649*, S651*, S715*, S928*, S1643*, S1684*, S1707*, S1728*, S1748*, S1778*, S1794*, S1795*, S1817*, S385*, S580*, S581*, S605*, S612*, S623*, S645*, S653*, S667*, S668*, S694*, S567*, S585*, S614*, S624*, S654*, S690*, S691*, S929*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266552	17	41201154	17	43049137	266552	261575	rs879255492	NC_000017.11:43049136:G:C	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5389dup (p.Ser1797fs)	BRCA1	S1750fs, S1797fs, S1818fs, S693fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266551	17	41201154 - 41201155	17	43049137 - 43049138	266551	261576	rs886040295	NC_000017.11:43049137:A:AA	Duplication	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5387C>G (p.Ser1796Ter)	BRCA1	S1817*, S692*, S1796*, S1749*, S1668*, S1683*, S1753*, S1755*, S1769*, S1770*, S1794*, S1818*, S384*, S566*, S579*, S580*, S584*, S613*, S622*, S625*, S626*, S651*, S652*, S667*, S689*, S714*, S1642*, S1627*, S1669*, S1725*, S1727*, S1728*, S1776*, S1793*, S1816*, S603*, S623*, S644*, S645*, S653*, S691*, S928*, S1708*, S1724*, S1726*, S1747*, S1752*, S1768*, S1791*, S1795*, S516*, S611*, S646*, S648*, S650*, S668*, S690*, S715*, S927*, S1499*, S1500*, S1667*, S1684*, S1685*, S1706*, S1707*, S1729*, S1748*, S1754*, S1777*, S1792*, S525*, S565*, S583*, S604*, S605*, S621*, S654*, S666*, S693*	Hereditary cancer-predisposing syndrome	VCV000868408	17	41201157	17	43049140	868408	853442	rs80357055	NC_000017.11:43049139:G:C	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 9, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5333-198_5387del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267599	17	41201157 - 41201409	17	43049140 - 43049392	267599	262920	rs1555575109		Deletion	splice acceptor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5386dup (p.Ser1796fs)	BRCA1	S1749fs, S1796fs, S1817fs, S692fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055558	17	41201157 - 41201158	17	43049140 - 43049141	55558	70225	rs80357838	NC_000017.11:43049140:AAA:AAAA	Duplication	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5387C>A (p.Ser1796Ter)	BRCA1	S1796*, S692*, S1817*, S1749*, S584*, S604*, S626*, S650*, S652*, S691*, S693*, S715*, S1499*, S1669*, S1683*, S1708*, S1725*, S1726*, S1753*, S1768*, S1770*, S1777*, S1818*, S525*, S579*, S580*, S605*, S621*, S623*, S644*, S651*, S927*, S1667*, S1685*, S1747*, S1754*, S1791*, S1795*, S516*, S566*, S1500*, S1627*, S1642*, S1707*, S1724*, S1727*, S1728*, S1748*, S1752*, S1776*, S1793*, S1794*, S603*, S611*, S613*, S645*, S648*, S653*, S654*, S667*, S689*, S714*, S1668*, S1684*, S1706*, S1729*, S1755*, S1769*, S1792*, S1816*, S384*, S565*, S583*, S622*, S625*, S646*, S666*, S668*, S690*, S928*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037663	17	41201157	17	43049140	37663	46219	rs80357055	NC_000017.11:43049139:G:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5386del (p.Ser1796fs)	BRCA1	S1749fs, S1817fs, S1796fs, S692fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037662	17	41201158	17	43049141	37662	46218	rs80357838	NC_000017.11:43049140:AAA:AA	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5369_5385del (p.Ser1790fs)	BRCA1	S686fs, S1743fs, S1790fs, S1811fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055554	17	41201159 - 41201175	17	43049142 - 43049158	55554	70221	rs397509272	NC_000017.11:43049141:AAGCTCCTTCACCACAGAAGC:AAGC	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5380G>T (p.Glu1794Ter)	BRCA1	E1794*, E1815*, E1747*, E690*, E1625*, E1640*, E1705*, E1724*, E1725*, E1745*, E1746*, E1750*, E1752*, E1790*, E1791*, E582*, E602*, E644*, E649*, E665*, E712*, E713*, E578*, E623*, E624*, E648*, E650*, E652*, E664*, E687*, E1666*, E1681*, E1722*, E1723*, E1751*, E1753*, E1789*, E382*, E563*, E581*, E619*, E621*, E642*, E646*, E666*, E689*, E925*, E1498*, E1667*, E1682*, E1704*, E1726*, E1727*, E1766*, E1768*, E1775*, E1814*, E523*, E514*, E691*, E926*, E564*, E577*, E601*, E603*, E609*, E611*, E620*, E643*, E651*, E688*, E1497*, E1665*, E1683*, E1706*, E1767*, E1774*, E1792*, E1793*, E1816*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433733	17	41201164	17	43049147	433733	427523	rs776323117	NC_000017.11:43049146:C:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5377A>T (p.Lys1793Ter)	BRCA1	K1793*, K1814*, K689*, K1746*, K1680*, K1682*, K1703*, K1723*, K1724*, K1744*, K1750*, K1752*, K1767*, K1773*, K1790*, K513*, K562*, K563*, K600*, K601*, K619*, K623*, K641*, K664*, K665*, K686*, K687*, K688*, K1496*, K1665*, K1705*, K1722*, K1725*, K1745*, K1749*, K1751*, K1789*, K1813*, K1815*, K608*, K620*, K648*, K663*, K711*, K925*, K1497*, K1624*, K1664*, K1681*, K1766*, K1792*, K522*, K576*, K577*, K610*, K645*, K647*, K649*, K650*, K690*, K924*, K1639*, K1666*, K1704*, K1721*, K1726*, K1765*, K1774*, K1788*, K1791*, K381*, K580*, K581*, K602*, K618*, K622*, K642*, K643*, K651*, K712*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055556	17	41201167	17	43049150	55556	70223	rs397509274	NC_000017.11:43049149:T:A	single nucleotide variant	non-coding transcript variant|intron variant|nonsense	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5368dup (p.Ser1790fs)	BRCA1	S1493fs, S1661fs, S1677fs, S1678fs, S1719fs, S1741fs, S1743fs, S1786fs, S378fs, S1494fs, S1662fs, S1663fs, S1679fs, S1702fs, S1762fs, S1764fs, S1770fs, S1789fs, S577fs, S617fs, S638fs, S639fs, S640fs, S642fs, S683fs, S685fs, S1812fs, S510fs, S578fs, S598fs, S599fs, S605fs, S646fs, S648fs, S660fs, S709fs, S921fs, S1621fs, S1636fs, S1718fs, S1721fs, S1722fs, S1723fs, S1742fs, S1748fs, S1749fs, S1787fs, S1788fs, S1810fs, S1811fs, S519fs, S574fs, S597fs, S607fs, S645fs, S647fs, S661fs, S922fs, S1700fs, S1701fs, S1720fs, S1746fs, S1747fs, S1763fs, S1771fs, S1785fs, S1790fs, S559fs, S560fs, S573fs, S615fs, S616fs, S619fs, S620fs, S644fs, S662fs, S684fs, S686fs, S687fs, S708fs	Hereditary breast ovarian cancer syndrome	VCV003726829	17	41201175 - 41201176	17	43049158 - 43049159	3726829	3851450		NC_000017.11:43049158:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5368del (p.Ser1790fs)	BRCA1	S1743fs, S1790fs, S686fs, S1811fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000246134	17	41201176	17	43049159	246134	245018	rs879254116	NC_000017.11:43049158:AA:A	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5365_5366delinsA (p.Ala1789fs)	BRCA1	A1810fs, A1742fs, A1789fs, A685fs	Hereditary breast ovarian cancer syndrome	VCV000462672	17	41201178 - 41201179	17	43049161 - 43049162	462672	466821	rs1555575142	NC_000017.11:43049160:GC:T	Indel	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Aug 5, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5366del (p.Ala1789fs)	BRCA1	A1789fs, A1810fs, A685fs, A1742fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254468	17	41201178	17	43049161	254468	249075	rs760188581	NC_000017.11:43049160:G:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5359_5363delinsAGTGA (p.Cys1787_Gly1788delinsSerAsp)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187349	17	41201181 - 41201185	17	43049164 - 43049168	187349	184875	rs786203663	NC_000017.11:43049163:CCACA:TCACT	Indel	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 25, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5363G>T (p.Gly1788Val)	BRCA1	G1788V, G1741V, G1809V, G684V, G1619V, G1677V, G1717V, G1739V, G1491V, G1634V, G1660V, G1718V, G1746V, G1768V, G1783V, G1786V, G1808V, G376V, G517V, G558V, G576V, G617V, G618V, G643V, G658V, G683V, G706V, G1492V, G1659V, G1661V, G1700V, G1719V, G1720V, G1740V, G571V, G595V, G597V, G613V, G614V, G637V, G638V, G640V, G642V, G644V, G685V, G920V, G1675V, G1676V, G1698V, G1699V, G1716V, G1721V, G1744V, G1747V, G1762V, G1785V, G1787V, G557V, G572V, G575V, G596V, G615V, G645V, G646V, G660V, G682V, G919V, G1745V, G1760V, G1761V, G1769V, G1784V, G1810V, G508V, G603V, G605V, G636V, G659V, G681V, G707V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037660	17	41201181	17	43049164	37660	46216	rs80357069	NC_000017.11:43049163:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5361_5362del (p.Cys1787fs)	BRCA1	C1787fs, C1808fs, C683fs, C1740fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266550	17	41201182 - 41201183	17	43049165 - 43049166	266550	261577	rs886040294	NC_000017.11:43049164:CACACA:CACA	Microsatellite	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5360_5361delinsAG (p.Cys1787Ter)	BRCA1	C1740*, C1808*, C1787*, C683*, C1490*, C1491*, C1659*, C1660*, C1743*, C1744*, C1760*, C1761*, C1767*, C1785*, C1809*, C571*, C575*, C595*, C596*, C604*, C616*, C639*, C641*, C643*, C680*, C684*, C1658*, C1674*, C1698*, C1739*, C1768*, C1782*, C507*, C516*, C556*, C557*, C570*, C574*, C1618*, C1633*, C1675*, C1676*, C1697*, C1699*, C1715*, C1716*, C1718*, C1720*, C1738*, C1783*, C1807*, C375*, C594*, C614*, C636*, C659*, C705*, C706*, C1717*, C1719*, C1745*, C1746*, C1759*, C1784*, C1786*, C602*, C612*, C613*, C617*, C637*, C642*, C644*, C657*, C682*, C635*, C645*, C658*, C681*, C918*, C919*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055549	17	41201183 - 41201184	17	43049166 - 43049167	55549	70216	rs397509270	NC_000017.11:43049165:AC:CT	Indel	nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NC_000017.10:g.[41201181C>T;41201185A>T]	BRCA1	C1787S, C1740S, C1808S, C683S, C1698S, C1699S, C1717S, C1719S, C1739S, C1744S, C1745S, C1759S, C1767S, C1783S, C571S, C602S, C604S, C614S, C616S, C636S, C645S, C684S, C705S, C706S, C1491S, C1618S, C1633S, C1660S, C1674S, C1715S, C1716S, C1720S, C1761S, C1782S, C1785S, C1786S, C516S, C570S, C574S, C595S, C617S, C682S, C919S, C1658S, C1659S, C1676S, C1697S, C1738S, C1746S, C1760S, C1784S, C1807S, C375S, C556S, C596S, C612S, C613S, C635S, C637S, C639S, C641S, C642S, C644S, C658S, C680S, C1490S, C1675S, C1718S, C1743S, C1768S, C1809S, C507S, C557S, C575S, C594S, C643S, C657S, C659S, C681S, C918S, G1788D, G684D, G1809D, G1741D, G1491D, G1676D, G1698D, G1717D, G1718D, G1761D, G1769D, G1785D, G508D, G557D, G572D, G595D, G605D, G636D, G638D, G645D, G658D, G660D, G682D, G706D, G1492D, G1619D, G1634D, G1659D, G1740D, G1744D, G1747D, G1760D, G1762D, G1768D, G1787D, G376D, G596D, G603D, G614D, G618D, G637D, G642D, G644D, G646D, G659D, G681D, G683D, G1660D, G1661D, G1677D, G1700D, G1719D, G1720D, G1784D, G1786D, G1808D, G1810D, G571D, G597D, G613D, G617D, G640D, G707D, G919D, G920D, G1675D, G1699D, G1716D, G1721D, G1739D, G1745D, G1746D, G1783D, G517D, G558D, G575D, G576D, G615D, G643D, G685D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000624568	17|17	41201185	17|17	43049168	624568	70215|70218	rs80357065|rs80357069	NC_000017.11:43049167:A:T|NC_000017.11:43049163:C:T	Haplotype	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 25, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5353_5354dup (p.Gln1785fs)	BRCA1	Q1806fs, Q1738fs, Q1785fs, Q681fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266549	17	41201189 - 41201190	17	43049172 - 43049173	266549	261578	rs886040293	NC_000017.11:43049172:TGT:TGTGT	Duplication	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5352dup (p.Gln1785fs)	BRCA1	Q1738fs, Q1785fs, Q1806fs, Q681fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125832	17	41201191 - 41201192	17	43049174 - 43049175	125832	131370	rs80357744	NC_000017.11:43049174:T:TT	Duplication	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5353C>T (p.Gln1785Ter)	BRCA1	Q1785*, Q681*, Q1738*, Q1806*, Q1488*, Q1616*, Q1672*, Q1674*, Q1695*, Q1718*, Q1737*, Q1757*, Q1766*, Q568*, Q573*, Q612*, Q614*, Q634*, Q640*, Q655*, Q680*, Q1489*, Q1656*, Q1696*, Q1697*, Q1717*, Q1736*, Q1741*, Q1759*, Q1805*, Q505*, Q514*, Q555*, Q600*, Q642*, Q643*, Q916*, Q917*, Q1631*, Q1658*, Q1713*, Q1714*, Q1715*, Q1716*, Q1742*, Q1743*, Q1780*, Q1781*, Q1783*, Q554*, Q569*, Q592*, Q593*, Q602*, Q615*, Q635*, Q637*, Q641*, Q656*, Q657*, Q678*, Q704*, Q1657*, Q1673*, Q1744*, Q1758*, Q1765*, Q1782*, Q1784*, Q1807*, Q373*, Q572*, Q594*, Q610*, Q611*, Q633*, Q639*, Q679*, Q682*, Q703*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055546	17	41201191	17	43049174	55546	70213	rs80356969	NC_000017.11:43049173:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5350del (p.Val1784fs)	BRCA1	V1784fs, V1805fs, V680fs, V1737fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000918430	17	41201194	17	43049177	918430	913859	rs2051091746	NC_000017.11:43049176:CC:C	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5348del (p.Met1783fs)	BRCA1	M1736fs, M1783fs, M1804fs, M679fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266548	17	41201196	17	43049179	266548	261579	rs886040292	NC_000017.11:43049178:A:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5346G>A (p.Trp1782Ter)	BRCA1	W1782*, W678*, W1803*, W1735*, W1485*, W1671*, W1714*, W1733*, W1754*, W1763*, W589*, W608*, W612*, W632*, W637*, W639*, W652*, W653*, W675*, W676*, W679*, W913*, W1655*, W1711*, W1715*, W1734*, W1741*, W1762*, W1777*, W1778*, W1781*, W1804*, W370*, W511*, W566*, W570*, W591*, W597*, W611*, W630*, W631*, W700*, W1486*, W1670*, W1692*, W1693*, W1710*, W1712*, W1713*, W1740*, W551*, W552*, W569*, W590*, W599*, W607*, W609*, W634*, W636*, W638*, W654*, W701*, W914*, W1613*, W1628*, W1653*, W1654*, W1669*, W1694*, W1738*, W1739*, W1755*, W1756*, W1779*, W1780*, W1802*, W502*, W565*, W640*, W677*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037658	17	41201198	17	43049181	37658	46214	rs80357284	NC_000017.11:43049180:C:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5345G>A (p.Trp1782Ter)	BRCA1	W1782*, W1803*, W678*, W1735*, W1485*, W1628*, W1653*, W1671*, W1692*, W1733*, W1738*, W1741*, W1778*, W1780*, W1802*, W591*, W608*, W611*, W612*, W632*, W637*, W676*, W679*, W701*, W1670*, W1711*, W1714*, W1755*, W1756*, W1779*, W1781*, W1804*, W370*, W502*, W551*, W597*, W653*, W654*, W1486*, W1655*, W1693*, W1694*, W1734*, W1740*, W1777*, W565*, W566*, W631*, W638*, W639*, W640*, W677*, W700*, W914*, W1613*, W1654*, W1669*, W1710*, W1712*, W1713*, W1715*, W1739*, W1754*, W1762*, W1763*, W511*, W552*, W569*, W570*, W589*, W590*, W599*, W607*, W609*, W630*, W634*, W636*, W652*, W675*, W913*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055544	17	41201199	17	43049182	55544	70211	rs80357219	NC_000017.11:43049181:C:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NC_000017.11:g.(?_43049184)_(43057059_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000431360	17	41201201 - 41209076	17	43049184 - 43057059	431360	424880			Deletion		Pathogenic	Apr 20, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5341_5343delinsTG (p.Glu1781fs)	BRCA1	E1781fs, E1802fs, E1734fs, E677fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266547	17	41201201 - 41201203	17	43049184 - 43049186	266547	261580	rs886040291	NC_000017.11:43049183:TTC:CA	Indel	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5341del (p.Glu1781fs)	BRCA1	E1781fs, E677fs, E1734fs, E1802fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055543	17	41201203	17	43049186	55543	70210	rs80357694	NC_000017.11:43049185:CC:C	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5341G>T (p.Glu1781Ter)	BRCA1	E1781*, E1734*, E1802*, E677*, E1654*, E1692*, E1711*, E1738*, E1739*, E1777*, E1778*, E369*, E550*, E651*, E652*, E1652*, E1669*, E1670*, E1691*, E1709*, E1710*, E1714*, E1732*, E1754*, E1779*, E1803*, E501*, E565*, E569*, E588*, E589*, E607*, E610*, E630*, E631*, E636*, E637*, E638*, E639*, E674*, E678*, E1485*, E1612*, E1627*, E1653*, E1668*, E1693*, E1713*, E1733*, E1740*, E1776*, E1780*, E1801*, E551*, E568*, E590*, E596*, E598*, E606*, E629*, E633*, E675*, E699*, E913*, E1484*, E1712*, E1737*, E1753*, E1755*, E1761*, E1762*, E510*, E564*, E608*, E611*, E635*, E653*, E676*, E700*, E912*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055542	17	41201203	17	43049186	55542	70209	rs397509268	NC_000017.11:43049185:C:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5339T>C (p.Leu1780Pro)	BRCA1	L1780P, L676P, L1733P, L1801P, L1484P, L1653P, L1667P, L1668P, L1692P, L1711P, L1712P, L1713P, L1731P, L1732P, L500P, L509P, L589P, L605P, L606P, L607P, L609P, L628P, L634P, L650P, L698P, L699P, L911P, L1483P, L1611P, L1669P, L1691P, L1708P, L1738P, L1739P, L1761P, L1775P, L1779P, L1800P, L368P, L550P, L588P, L595P, L636P, L652P, L674P, L677P, L1709P, L1736P, L1752P, L1753P, L1754P, L1777P, L1778P, L564P, L567P, L587P, L610P, L637P, L638P, L651P, L675P, L912P, L1626P, L1651P, L1652P, L1690P, L1710P, L1737P, L1760P, L1776P, L1802P, L549P, L563P, L568P, L597P, L629P, L630P, L632P, L635P, L673P	Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055541	17	41201205	17	43049188	55541	70208	rs80357474	NC_000017.11:43049187:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5338del (p.Leu1780fs)	BRCA1	L1733fs, L1801fs, L1780fs, L676fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254467	17	41201206	17	43049189	254467	249076	rs886038045	NC_000017.11:43049188:G:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5335C>T (p.Gln1779Ter)	BRCA1	Q1779*, Q1732*, Q675*, Q1800*, Q1482*, Q1708*, Q1738*, Q1752*, Q1759*, Q1799*, Q1801*, Q508*, Q548*, Q549*, Q566*, Q586*, Q587*, Q606*, Q627*, Q631*, Q633*, Q698*, Q1483*, Q1666*, Q1668*, Q1707*, Q1775*, Q1776*, Q1777*, Q563*, Q567*, Q605*, Q609*, Q629*, Q635*, Q637*, Q649*, Q651*, Q672*, Q1610*, Q1625*, Q1652*, Q1690*, Q1710*, Q1711*, Q1712*, Q1731*, Q1736*, Q1737*, Q1751*, Q1760*, Q1774*, Q367*, Q499*, Q594*, Q604*, Q608*, Q628*, Q634*, Q674*, Q697*, Q911*, Q1650*, Q1651*, Q1667*, Q1689*, Q1691*, Q1709*, Q1730*, Q1735*, Q1753*, Q1778*, Q562*, Q588*, Q596*, Q636*, Q650*, Q673*, Q676*, Q910*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055540	17	41201209	17	43049192	55540	70207	rs397509267	NC_000017.11:43049191:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5335del (p.Gln1779fs)	BRCA1	Q1732fs, Q1800fs, Q675fs, Q1779fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037657	17	41201209	17	43049192	37657	46213	rs80357590	NC_000017.11:43049191:G:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NG_005905.2:g.(?_92501)_(166922_168789)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373859	17	41201212 - 41277500	17	43049195 - 43125483	373859	360753			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5333-1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267600	17	41201212	17	43049195	267600	262921	rs80358126	NC_000017.11:43049194:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5333-1G>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055534	17	41201212	17	43049195	55534	70201	rs80358126	NC_000017.11:43049194:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Nov 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5333-1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055533	17	41201212	17	43049195	55533	70200	rs80358126	NC_000017.11:43049194:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5333-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000449937	17	41201213	17	43049196	449937	445776	rs397509264	NC_000017.11:43049195:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5333-2A>T	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055536	17	41201213	17	43049196	55536	70203	rs397509264	NC_000017.11:43049195:T:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jan 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5333-2A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055535	17	41201213	17	43049196	55535	70202	rs397509264	NC_000017.11:43049195:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5333-3T>G	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055537	17	41201214	17	43049197	55537	70204	rs397509265	NC_000017.11:43049196:A:C	single nucleotide variant	intron variant	Pathogenic	Feb 13, 2025	criteria provided, multiple submitters, no conflicts							
NC_000017.11:g.(?_43051057)_(43051123_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000531566	17	41203074 - 41203140	17	43051057 - 43051123	531566	531023			Deletion		Pathogenic	Feb 28, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5331_5332+6delinsCAACAT	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267596	17	41203074 - 41203081	17	43051057 - 43051064	267596	262922	rs886040917	NC_000017.11:43051056:TCTTACCT:ATGTTG	Indel	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5332+3A>C	BRCA1		Hereditary cancer-predisposing syndrome	VCV000868308	17	41203077	17	43051060	868308	855343	rs766614917	NC_000017.11:43051059:T:G	single nucleotide variant	intron variant	Pathogenic	Sep 9, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5332+2T>C	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267598	17	41203078	17	43051061	267598	262923	rs80358182	NC_000017.11:43051060:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jan 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5332+2T>G	BRCA1		not provided	VCV000182168	17	41203078	17	43051061	182168	180821	rs80358182	NC_000017.11:43051060:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 20, 2014	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5332+2T>A	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000125825	17	41203078	17	43051061	125825	131363	rs80358182	NC_000017.11:43051060:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Sep 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5332+1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267597	17	41203079	17	43051062	267597	262924	rs80358041	NC_000017.11:43051061:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Feb 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5331_5332+1delinsCAACAT	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236263	17	41203079 - 41203081	17	43051062 - 43051064	236263	237828	rs878853286	NC_000017.11:43051061:CCT:ATGTTG	Indel	splice donor variant|intron variant	Pathogenic	Apr 3, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5311_5332+1del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125822	17	41203079 - 41203101	17	43051062 - 43051084	125822	131360	rs886040916	NC_000017.11:43051061:CCTGTGGGCATGTTGGTGAAGGGCC:CC	Deletion	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5332+1del	BRCA1		Hereditary cancer-predisposing syndrome	VCV000055529	17	41203079	17	43051062	55529	70196	rs397509263	NC_000017.11:43051061:CC:C	Deletion	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5332+1G>C	BRCA1		not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055528	17	41203079	17	43051062	55528	70195	rs80358041	NC_000017.11:43051061:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5332+1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055527	17	41203079	17	43051062	55527	70194	rs80358041	NC_000017.11:43051061:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Apr 3, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5332G>A (p.Asp1778Asn)	BRCA1	D1778N, D1731N, G674R, D1799N, D674N, D1609N, D1624N, D1651N, D1689N, D1690N, D1710N, D1736N, D1759N, D1773N, D1774N, D1800N, D498N, D547N, D562N, D593N, D604N, D608N, D627N, D628N, D634N, D673N, D696N, D697N, G1736R, G1776R, G673R, D1482N, D1665N, D1666N, D1709N, D1711N, D1734N, D1737N, D1752N, D1775N, D1777N, D366N, D548N, D561N, D585N, D587N, D595N, D607N, D632N, D636N, D675N, G1737R, D1481N, D1688N, D1707N, D1708N, D1758N, D1776N, D603N, D649N, D671N, D909N, G1731R, G1778R, D1649N, D1650N, D1667N, D1706N, D1729N, D1730N, D1735N, D1750N, D1751N, D1798N, D507N, D565N, D566N, D586N, D605N, D626N, D630N, D633N, D635N, D648N, D650N, D672N, D910N, G1730R, G1735R, G1777R	BRCA1-related cancer predisposition	VCV000055530	17	41203080	17	43051063	55530	70197	rs80357112	NC_000017.11:43051062:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 22, 2025	reviewed by expert panel							
NM_007294.4(BRCA1):c.5328dup (p.Thr1777fs)	BRCA1	T673fs, T1777fs, T1798fs, T1730fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055526	17	41203083 - 41203084	17	43051066 - 43051067	55526	70193	rs80357751	NC_000017.11:43051066:GGG:GGGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5328del (p.Thr1777fs)	BRCA1	T1798fs, T673fs, T1777fs, T1730fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232820	17	41203084	17	43051067	232820	235932	rs80357751	NC_000017.11:43051066:GGG:GG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5323_5324del (p.Met1775fs)	BRCA1	M1796fs, M671fs, M1775fs, M1728fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055525	17	41203088 - 41203089	17	43051071 - 43051072	55525	70192	rs397509262	NC_000017.11:43051070:AT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys)	BRCA1	M1775K, M1728K, M671K, M1796K, M1479K, M1647K, M1685K, M1704K, M1756K, M363K, M544K, M562K, M582K, M625K, M627K, M630K, M668K, M694K, M907K, M1664K, M1686K, M1726K, M1731K, M1732K, M1733K, M1771K, M1773K, M504K, M545K, M592K, M601K, M906K, M1606K, M1646K, M1648K, M1663K, M1687K, M1706K, M1708K, M1727K, M1734K, M1748K, M1755K, M1795K, M495K, M558K, M559K, M563K, M583K, M602K, M604K, M624K, M647K, M669K, M670K, M693K, M1478K, M1621K, M1662K, M1703K, M1705K, M1707K, M1747K, M1749K, M1770K, M1772K, M1774K, M1797K, M584K, M590K, M600K, M605K, M623K, M629K, M631K, M632K, M633K, M645K, M646K, M672K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017695	17	41203088	17	43051071	17695	32734	rs41293463	NC_000017.11:43051070:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5324T>G (p.Met1775Arg)	BRCA1	M1775R, M1728R, M1796R, M671R, M1478R, M1647R, M1663R, M1686R, M1703R, M1704R, M1727R, M1733R, M1771R, M1773R, M1795R, M363R, M504R, M562R, M583R, M584R, M600R, M602R, M625R, M631R, M632R, M633R, M645R, M670R, M693R, M906R, M907R, M1648R, M1664R, M1706R, M1734R, M1749R, M1770R, M1772R, M1774R, M1797R, M558R, M559R, M582R, M604R, M629R, M630R, M668R, M672R, M1479R, M1606R, M1662R, M1687R, M1705R, M1707R, M1708R, M1726R, M1731R, M1732R, M1755R, M495R, M592R, M627R, M647R, M669R, M694R, M1621R, M1646R, M1685R, M1747R, M1748R, M1756R, M544R, M545R, M563R, M590R, M601R, M605R, M623R, M624R, M646R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017694	17	41203088	17	43051071	17694	32733	rs41293463	NC_000017.11:43051070:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5320_5321del (p.Asn1774fs)	BRCA1	N1727fs, N670fs, N1774fs, N1795fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055524	17	41203091 - 41203092	17	43051074 - 43051075	55524	70191	rs80357818	NC_000017.11:43051073:TT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5319dup (p.Asn1774fs)	BRCA1	N1774fs, N670fs, N1727fs, N1795fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055523	17	41203092 - 41203093	17	43051075 - 43051076	55523	70190	rs80357823	NC_000017.11:43051075:GG:GGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5315del (p.Phe1772fs)	BRCA1	F1772fs, F1793fs, F1725fs, F668fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055520	17	41203097	17	43051080	55520	70187	rs397509261	NC_000017.11:43051079:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5309_5312dup (p.Phe1772fs)	BRCA1	F1475fs, F1476fs, F1603fs, F1618fs, F1643fs, F1644fs, F1645fs, F1659fs, F1660fs, F1661fs, F1682fs, F1683fs, F1684fs, F1700fs, F1701fs, F1702fs, F1703fs, F1704fs, F1705fs, F1723fs, F1724fs, F1725fs, F1728fs, F1729fs, F1730fs, F1731fs, F1744fs, F1745fs, F1746fs, F1752fs, F1753fs, F1767fs, F1768fs, F1769fs, F1770fs, F1771fs, F1772fs, F1792fs, F1793fs, F1794fs, F360fs, F492fs, F501fs, F541fs, F542fs, F555fs, F556fs, F559fs, F560fs, F579fs, F580fs, F581fs, F587fs, F589fs, F597fs, F598fs, F599fs, F601fs, F602fs, F620fs, F621fs, F622fs, F624fs, F626fs, F627fs, F628fs, F629fs, F630fs, F642fs, F643fs, F644fs, F665fs, F666fs, F667fs, F668fs, F669fs, F690fs, F691fs, F903fs, F904fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002583818	17	41203099 - 41203100	17	43051082 - 43051083	2583818	2751388	rs2547525655	NC_000017.11:43051082:GGCC:GGCCGGCC	Duplication	frameshift variant|intron variant	Pathogenic	May 8, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5310_5311del (p.Pro1771fs)	BRCA1	P1771fs, P667fs, P1724fs, P1792fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000141536	17	41203101 - 41203102	17	43051084 - 43051085	141536	151250	rs587781825	NC_000017.11:43051083:GC:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5310dup (p.Pro1771fs)	BRCA1	P667fs, P1724fs, P1792fs, P1771fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055517	17	41203101 - 41203102	17	43051084 - 43051085	55517	70184	rs80357581	NC_000017.11:43051084:CCC:CCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5310del (p.Phe1772fs)	BRCA1	F668fs, F1725fs, F1772fs, F1793fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055516	17	41203102	17	43051085	55516	70183	rs80357581	NC_000017.11:43051084:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	BRCA1	G1770V, G1791V, G1723V, G666V, G1474V, G1601V, G1616V, G1641V, G1658V, G1698V, G1727V, G1792V, G490V, G539V, G554V, G577V, G585V, G587V, G596V, G618V, G626V, G627V, G663V, G665V, G901V, G1657V, G1680V, G1681V, G1701V, G1722V, G1729V, G1742V, G1744V, G1766V, G1769V, G499V, G540V, G558V, G579V, G619V, G622V, G628V, G902V, G1659V, G1682V, G1700V, G1726V, G1728V, G1743V, G1750V, G1765V, G1768V, G1790V, G358V, G553V, G600V, G620V, G625V, G641V, G664V, G688V, G1473V, G1642V, G1643V, G1699V, G1702V, G1703V, G1721V, G1751V, G1767V, G557V, G578V, G595V, G597V, G599V, G624V, G640V, G642V, G667V, G689V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417832	17	41203103	17	43051086	417832	404710	rs863224765	NC_000017.11:43051085:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jul 18, 2018	reviewed by expert panel							
NM_007294.4(BRCA1):c.5307T>G (p.Tyr1769Ter)	BRCA1	Y1769*, Y1790*, Y1722*, Y665*, Y1656*, Y1699*, Y1700*, Y1721*, Y1743*, Y1749*, Y1765*, Y1767*, Y1791*, Y498*, Y539*, Y596*, Y640*, Y666*, Y900*, Y553*, Y556*, Y578*, Y584*, Y598*, Y617*, Y619*, Y624*, Y626*, Y627*, Y662*, Y663*, Y687*, Y901*, Y1473*, Y1640*, Y1642*, Y1681*, Y1697*, Y1701*, Y1726*, Y1727*, Y1728*, Y1742*, Y1766*, Y1789*, Y538*, Y557*, Y577*, Y586*, Y595*, Y599*, Y618*, Y621*, Y625*, Y639*, Y641*, Y688*, Y1615*, Y1641*, Y1657*, Y1679*, Y1680*, Y1702*, Y1725*, Y1741*, Y1750*, Y357*, Y489*, Y552*, Y576*, Y594*, Y623*, Y664*, Y1472*, Y1600*, Y1658*, Y1698*, Y1720*, Y1764*, Y1768*	Hereditary cancer-predisposing syndrome	VCV000371864	17	41203105	17	43051088	371864	358930	rs397509258	NC_000017.11:43051087:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Mar 23, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5307T>A (p.Tyr1769Ter)	BRCA1	Y1769*, Y1790*, Y1722*, Y665*, Y1679*, Y1681*, Y1700*, Y1725*, Y1750*, Y1766*, Y1767*, Y1768*, Y357*, Y489*, Y552*, Y556*, Y576*, Y586*, Y594*, Y596*, Y621*, Y626*, Y640*, Y663*, Y664*, Y688*, Y900*, Y1473*, Y1615*, Y1642*, Y1658*, Y1697*, Y1698*, Y1720*, Y1726*, Y1728*, Y1741*, Y1764*, Y1789*, Y498*, Y539*, Y577*, Y598*, Y619*, Y639*, Y662*, Y666*, Y1791*, Y538*, Y553*, Y557*, Y584*, Y618*, Y623*, Y625*, Y641*, Y1472*, Y1640*, Y1656*, Y1657*, Y1680*, Y1699*, Y1721*, Y1727*, Y1749*, Y1765*, Y1600*, Y1641*, Y1701*, Y1702*, Y1742*, Y1743*, Y578*, Y595*, Y599*, Y617*, Y624*, Y627*, Y687*, Y901*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055514	17	41203105	17	43051088	55514	70181	rs397509258	NC_000017.11:43051087:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5304del (p.Tyr1769fs)	BRCA1	Y665fs, Y1769fs, Y1722fs, Y1790fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125820	17	41203108	17	43051091	125820	131358	rs80357959	NC_000017.11:43051090:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5302del (p.Cys1768fs)	BRCA1	C1768fs, C1789fs, C1721fs, C664fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266545	17	41203110	17	43051093	266545	261581	rs886040289	NC_000017.11:43051092:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5301T>A (p.Cys1767Ter)	BRCA1	C1767*, C1788*, C1720*, C663*, C1613*, C1677*, C1698*, C1699*, C1719*, C1740*, C1762*, C355*, C496*, C536*, C550*, C554*, C576*, C615*, C617*, C619*, C664*, C1471*, C1470*, C1598*, C1638*, C1655*, C1678*, C1723*, C1725*, C1741*, C1763*, C551*, C593*, C597*, C622*, C623*, C637*, C662*, C1640*, C1654*, C1679*, C1697*, C1718*, C1726*, C1764*, C1766*, C487*, C537*, C574*, C575*, C582*, C584*, C616*, C621*, C638*, C660*, C685*, C686*, C1639*, C1656*, C1695*, C1696*, C1700*, C1724*, C1739*, C1747*, C1748*, C1765*, C1787*, C1789*, C555*, C592*, C594*, C596*, C624*, C625*, C639*, C661*, C898*, C899*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266544	17	41203111	17	43051094	266544	261582	rs886040288	NC_000017.11:43051093:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5300_5301del (p.Cys1767fs)	BRCA1	C663fs, C1767fs, C1720fs, C1788fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266543	17	41203111 - 41203112	17	43051094 - 43051095	266543	261583	rs886040287	NC_000017.11:43051093:ACA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5299del (p.Cys1767fs)	BRCA1	C1788fs, C663fs, C1720fs, C1767fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266542	17	41203113	17	43051096	266542	261584	rs886040286	NC_000017.11:43051095:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5296dup (p.Ile1766fs)	BRCA1	I662fs, I1719fs, I1766fs, I1787fs	Hereditary cancer-predisposing syndrome	VCV000481473	17	41203115 - 41203116	17	43051098 - 43051099	481473	479252	rs1555575732	NC_000017.11:43051098:TTT:TTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jan 20, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5297T>A (p.Ile1766Asn)	BRCA1	I1766N, I662N, I1787N, I1719N, I1470N, I1597N, I1637N, I1638N, I1639N, I1676N, I1678N, I1694N, I1696N, I1722N, I1725N, I1740N, I1764N, I1765N, I1788N, I354N, I495N, I549N, I573N, I581N, I583N, I592N, I595N, I596N, I616N, I660N, I685N, I1653N, I1698N, I1718N, I1724N, I1747N, I1761N, I1763N, I536N, I553N, I591N, I593N, I622N, I624N, I636N, I637N, I638N, I684N, I1612N, I1654N, I1655N, I1697N, I1699N, I1723N, I1746N, I1762N, I486N, I535N, I550N, I575N, I615N, I621N, I661N, I898N, I1469N, I1677N, I1695N, I1717N, I1738N, I1739N, I1786N, I554N, I574N, I614N, I618N, I620N, I623N, I659N, I663N, I897N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267594	17	41203115	17	43051098	267594	262926	rs80357463	NC_000017.11:43051097:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5297T>G (p.Ile1766Ser)	BRCA1	I1766S, I1719S, I662S, I1787S, I1637S, I1638S, I1678S, I1697S, I1699S, I1722S, I1747S, I1765S, I495S, I574S, I591S, I592S, I595S, I615S, I616S, I620S, I623S, I637S, I663S, I685S, I897S, I1597S, I1612S, I1653S, I1694S, I1723S, I1724S, I1725S, I1762S, I1786S, I536S, I553S, I554S, I573S, I581S, I614S, I659S, I661S, I684S, I1470S, I1639S, I1677S, I1698S, I1717S, I1738S, I1740S, I1761S, I1788S, I354S, I486S, I535S, I549S, I583S, I593S, I596S, I618S, I624S, I636S, I638S, I898S, I1469S, I1654S, I1655S, I1676S, I1695S, I1696S, I1718S, I1739S, I1746S, I1763S, I1764S, I550S, I575S, I621S, I622S, I660S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037656	17	41203115	17	43051098	37656	46212	rs80357463	NC_000017.11:43051097:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5292_5293insCT (p.Glu1765fs)	BRCA1	E1786fs, E661fs, E1765fs, E1718fs	Hereditary breast ovarian cancer syndrome	VCV002027167	17	41203119 - 41203120	17	43051102 - 43051103	2027167	2081240	rs2547564061	NC_000017.11:43051102::AG	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 26, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5293G>T (p.Glu1765Ter)	BRCA1	E1765*, E661*, E1718*, E1786*, E1469*, E1638*, E1676*, E1717*, E1738*, E485*, E535*, E549*, E552*, E580*, E582*, E614*, E615*, E619*, E621*, E623*, E636*, E658*, E660*, E683*, E1468*, E1596*, E1675*, E1677*, E1697*, E1721*, E1737*, E1760*, E1763*, E1787*, E548*, E553*, E572*, E573*, E590*, E592*, E594*, E620*, E635*, E662*, E897*, E1652*, E1654*, E1693*, E1695*, E1696*, E1716*, E1722*, E1724*, E1745*, E534*, E574*, E591*, E595*, E637*, E684*, E896*, E1611*, E1636*, E1637*, E1653*, E1694*, E1698*, E1723*, E1739*, E1746*, E1761*, E1762*, E1764*, E1785*, E353*, E494*, E613*, E617*, E622*, E659*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055511	17	41203119	17	43051102	55511	70178	rs397509256	NC_000017.11:43051101:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	BRCA1	L1764P, L1717P, L660P, L1785P, L1468P, L1610P, L1635P, L1651P, L1694P, L1736P, L1745P, L1760P, L1784P, L484P, L571P, L594P, L618P, L622P, L635P, L658P, L661P, L896P, L1467P, L1636P, L1637P, L1676P, L1693P, L1695P, L1697P, L1721P, L1723P, L1737P, L1744P, L1786P, L352P, L534P, L572P, L579P, L581P, L590P, L593P, L657P, L682P, L1595P, L1652P, L1653P, L1674P, L1692P, L1696P, L1715P, L1716P, L1759P, L1761P, L1763P, L552P, L589P, L612P, L613P, L619P, L621P, L634P, L636P, L895P, L1675P, L1720P, L1722P, L1738P, L1762P, L493P, L533P, L547P, L548P, L551P, L573P, L591P, L614P, L616P, L620P, L659P, L683P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055510	17	41203121	17	43051104	55510	70177	rs80357281	NC_000017.11:43051103:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5290del (p.Gly1763_Leu1764insTer)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000934498	17	41203122	17	43051105	934498	937939	rs2051210433	NC_000017.11:43051104:G:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5289dup (p.Leu1764fs)	BRCA1	L1717fs, L1785fs, L1764fs, L660fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037655	17	41203122 - 41203123	17	43051105 - 43051106	37655	46211	rs80357886	NC_000017.11:43051105:CCCCC:CCCCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5289del (p.Gly1763_Leu1764insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055508	17	41203123	17	43051106	55508	70175	rs80357886	NC_000017.11:43051105:CCCCC:CCCC	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5284del (p.Arg1762fs)	BRCA1	R1783fs, R1762fs, R1715fs, R658fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055506	17	41203128	17	43051111	55506	70173	rs80357684	NC_000017.11:43051110:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5282del (p.Phe1761fs)	BRCA1	F1714fs, F1761fs, F657fs, F1782fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266541	17	41203130	17	43051113	266541	261585	rs886040285	NC_000017.11:43051112:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NG_005905.2:g.(?_92501)_(160933_166866)del	LOC111589216|LOC126862571|LOC110485084|LOC111589215|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373873	17	41203135 - 41277500	17	43051118 - 43125483	373873	360755			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5278-1G>T	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055502	17	41203135	17	43051118	55502	70169	rs80358099	NC_000017.11:43051117:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5278-1G>C	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000055501	17	41203135	17	43051118	55501	70168	rs80358099	NC_000017.11:43051117:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5278-1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055500	17	41203135	17	43051118	55500	70167	rs80358099	NC_000017.11:43051117:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5278-2A>C	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000868283	17	41203136	17	43051119	868283	855344	rs397509253	NC_000017.11:43051118:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5278-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267593	17	41203136	17	43051119	267593	262927	rs397509253	NC_000017.11:43051118:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5278-2del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236262	17	41203136	17	43051119	236262	237829	rs878853285	NC_000017.11:43051118:T:	Deletion	splice acceptor variant|intron variant	Pathogenic	Apr 3, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-2A>T	BRCA1		Hereditary cancer-predisposing syndrome	VCV000055503	17	41203136	17	43051119	55503	70170	rs397509253	NC_000017.11:43051118:T:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	May 6, 2025	criteria provided, multiple submitters, no conflicts							
Single allele	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373847	17	41204256 - 41227656	17	43052239 - 43075639	373847	360724			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5194-452_5278-2297del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267586	17	41205431 - 41209604	17	43053414 - 43057587	267586	262928			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5213_5278-2753delinsT	BRCA1		Hereditary cancer-predisposing syndrome	VCV001713200	17	41205887 - 41209133	17	43053870 - 43057116	1713200	1770712			Indel	splice donor variant	Pathogenic	Mar 1, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5256_5278-2757del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373846	17	41205891 - 41209090	17	43053874 - 43057073	373846	360725			Deletion	splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.[5243_5277+2788del;5277+2916_5277+2946delinsGG]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267496	17|17	41206281 - 41209103	17|17	43054264 - 43057086	267496	262930|262929	rs886040897	NC_000017.11:43054105:ATGGAGGAAAAAATCCAAAGCACTAGAATTT:CC	Haplotype	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5193+340_5277+2206del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267587	17	41206863 - 41215010	17	43054846 - 43062993	267587	262931			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.152940_163021dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373837	17	41206980 - 41217061	17	43054963 - 43065044	373837	360726			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5194-1730_5277+1996delins268	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267583	17	41207073 - 41210882	17	43055056 - 43058865	267583	262933			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5194-1699_5277+1996delins236	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267582	17	41207073 - 41210851	17	43055056 - 43058834	267582	262932			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5277+833_5277+1671delins141	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267588	17	41207398 - 41208236	17	43055381 - 43056219	267588	262934			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5193+2628_5277+670del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373843	17	41208399 - 41212722	17	43056382 - 43060705	373843	360727			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(?_43057032)_(43057155_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000583620	17	41209049 - 41209172	17	43057032 - 43057155	583620	574260			Deletion		Pathogenic	Oct 27, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43057046)_(43074527_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000531567	17	41209063 - 41226544	17	43057046 - 43074527	531567	530629			Deletion		Pathogenic	Feb 25, 2018	criteria provided, single submitter							
NC_000017.11:g.(?_43057046)_(43057141_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462183	17	41209063 - 41209158	17	43057046 - 43057141	462183	467028			Deletion		Pathogenic	Mar 3, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5277+1_5277+6del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125810	17	41209063 - 41209068	17	43057046 - 43057051	125810	131348	rs1060502356	NC_000017.11:43057045:CTTTACCTTT:CTTT	Deletion	splice donor variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+2T>G	BRCA1		not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000865231	17	41209067	17	43057050	865231	855410	rs2051494815	NC_000017.11:43057049:A:C	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5194-1_5277+1del	BRCA1		Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003779414	17	41209068 - 41209153	17	43057051 - 43057136	3779414	3895398			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Apr 1, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5277+1G>T	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462668	17	41209068	17	43057051	462668	466827	rs80358150	NC_000017.11:43057050:C:A	single nucleotide variant	splice donor variant	Pathogenic	Apr 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5277+1del	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091644	17	41209068	17	43057051	91644	97121	rs273901754	NC_000017.11:43057050:CC:C	Deletion	splice donor variant	Pathogenic/Likely pathogenic	Feb 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5277+1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037654	17	41209068	17	43057051	37654	46210	rs80358150	NC_000017.11:43057050:C:T	single nucleotide variant	splice donor variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NC_000017.11:g.43057054_43057137del	BRCA1		Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003780831	17	41209069 - 41209152	17	43057052 - 43057135	3780831	3896791			Deletion		Pathogenic	Dec 19, 2017	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5075-?_5277+?dup203	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000254074	17	41209069 - 41215968	17	43057052 - 43063951	254074	248522			Duplication		Pathogenic/Likely pathogenic	Dec 13, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.4358-?_5277+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000089063	17	41209069 - 41228631	17	43057052 - 43076614	89063	94606			Deletion		Pathogenic	Apr 10, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5276del (p.Lys1759fs)	BRCA1	K655fs, K1712fs, K1759fs, K1780fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254466	17	41209070	17	43057053	254466	249077	rs80357732	NC_000017.11:43057052:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5270_5276del (p.Asp1757fs)	BRCA1	D1710fs, D653fs, D1757fs, D1778fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055492	17	41209070 - 41209076	17	43057053 - 43057059	55492	70159	rs397509248	NC_000017.11:43057052:TTTCTGT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5268_5274del (p.Asp1757fs)	BRCA1	D1757fs, D1778fs, D653fs, D1710fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254465	17	41209072 - 41209078	17	43057055 - 43057061	254465	249078	rs886038043	NC_000017.11:43057054:TCTGTCCT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5273del (p.Arg1758fs)	BRCA1	R1758fs, R1779fs, R1711fs, R654fs	Hereditary breast ovarian cancer syndrome	VCV001374693	17	41209073	17	43057056	1374693	1453662	rs2153357308	NC_000017.11:43057055:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Feb 11, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5269_5273del (p.Asp1757fs)	BRCA1	D653fs, D1710fs, D1757fs, D1778fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185261	17	41209073 - 41209077	17	43057056 - 43057060	185261	184880	rs786202040	NC_000017.11:43057055:CTGTCCTG:CTG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5271_5272del (p.Asp1757fs)	BRCA1	D1710fs, D1757fs, D1778fs, D653fs	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001315517	17	41209074 - 41209075	17	43057057 - 43057058	1315517	1305777	rs2153358441	NC_000017.11:43057056:TGT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5269_5270insC (p.Asp1757fs)	BRCA1	D1778fs, D653fs, D1710fs, D1757fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548205	17	41209076 - 41209077	17	43057059 - 43057060	548205	538763	rs1555576840	NC_000017.11:43057059::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5268_5269insC (p.Asp1757fs)	BRCA1	D1757fs, D653fs, D1710fs, D1778fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096946	17	41209077 - 41209078	17	43057060 - 43057061	96946	102849	rs431825414	NC_000017.11:43057060::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5266_5267dup (p.Gln1756fs)	BRCA1	Q1709fs, Q1756fs, Q1777fs, Q652fs	not provided	VCV000988271	17	41209078 - 41209079	17	43057061 - 43057062	988271	976421	rs2051500205	NC_000017.11:43057061:TG:TGTG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 25, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5267_5268insC (p.Gln1756fs)	BRCA1	Q1777fs, Q1709fs, Q652fs, Q1756fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266540	17	41209078 - 41209079	17	43057061 - 43057062	266540	261586	rs886040284	NC_000017.11:43057061::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5266dup (p.Gln1756fs)	BRCA1	Q1756fs, Q1777fs, Q652fs, Q1709fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017677	17	41209079 - 41209080	17	43057062 - 43057063	17677	32716	rs80357906	NC_000017.11:43057062:GGG:GGGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5266C>T (p.Gln1756Ter)	BRCA1	Q1756*, Q1709*, Q1777*, Q652*, Q1460*, Q1587*, Q1627*, Q1644*, Q1645*, Q1684*, Q1686*, Q1707*, Q1752*, Q1776*, Q476*, Q539*, Q540*, Q544*, Q573*, Q583*, Q604*, Q650*, Q674*, Q888*, Q1628*, Q1666*, Q1689*, Q1713*, Q1714*, Q1728*, Q1730*, Q1737*, Q1751*, Q344*, Q543*, Q582*, Q586*, Q611*, Q613*, Q626*, Q627*, Q649*, Q651*, Q675*, Q887*, Q1667*, Q1685*, Q1688*, Q1754*, Q525*, Q563*, Q608*, Q612*, Q628*, Q1459*, Q1602*, Q1629*, Q1643*, Q1668*, Q1687*, Q1708*, Q1712*, Q1715*, Q1729*, Q1736*, Q1753*, Q1755*, Q1778*, Q485*, Q526*, Q564*, Q565*, Q571*, Q581*, Q585*, Q605*, Q606*, Q610*, Q614*, Q653*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055490	17	41209080	17	43057063	55490	70157	rs397509247	NC_000017.11:43057062:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5260_5261del (p.Glu1754fs)	BRCA1	E1457fs, E1458fs, E1585fs, E1600fs, E1625fs, E1626fs, E1627fs, E1641fs, E1642fs, E1643fs, E1664fs, E1665fs, E1666fs, E1682fs, E1683fs, E1684fs, E1685fs, E1686fs, E1687fs, E1705fs, E1706fs, E1707fs, E1710fs, E1711fs, E1712fs, E1713fs, E1726fs, E1727fs, E1728fs, E1734fs, E1735fs, E1749fs, E1750fs, E1751fs, E1752fs, E1753fs, E1754fs, E1774fs, E1775fs, E1776fs, E342fs, E474fs, E483fs, E523fs, E524fs, E537fs, E538fs, E541fs, E542fs, E561fs, E562fs, E563fs, E569fs, E571fs, E579fs, E580fs, E581fs, E583fs, E584fs, E602fs, E603fs, E604fs, E606fs, E608fs, E609fs, E610fs, E611fs, E612fs, E624fs, E625fs, E626fs, E647fs, E648fs, E649fs, E650fs, E651fs, E672fs, E673fs, E885fs, E886fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573235	17	41209085 - 41209086	17	43057068 - 43057069	2573235	2738184	rs2548386452	NC_000017.11:43057067:TCTCT:TCT	Microsatellite	frameshift variant	Pathogenic	Mar 16, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5260G>T (p.Glu1754Ter)	BRCA1	E1754*, E1707*, E1775*, E650*, E1665*, E1682*, E1683*, E1684*, E1705*, E1712*, E1728*, E1734*, E1752*, E524*, E538*, E542*, E561*, E563*, E583*, E584*, E602*, E606*, E611*, E625*, E626*, E647*, E648*, E673*, E886*, E1457*, E1585*, E1643*, E1686*, E1711*, E1727*, E1749*, E1774*, E1776*, E537*, E624*, E649*, E651*, E1458*, E1625*, E1641*, E1664*, E1687*, E1713*, E1735*, E1750*, E474*, E523*, E562*, E569*, E604*, E608*, E610*, E612*, E672*, E1600*, E1626*, E1627*, E1642*, E1666*, E1685*, E1706*, E1710*, E1726*, E1751*, E1753*, E342*, E483*, E541*, E571*, E579*, E580*, E581*, E603*, E609*, E885*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055489	17	41209086	17	43057069	55489	70156	rs80357432	NC_000017.11:43057068:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5259A>C (p.Arg1753Ser)	BRCA1	R649S, R1774S, R1706S, R1753S, R1457S, R1640S, R1642S, R1665S, R1683S, R1686S, R1709S, R1726S, R1727S, R1749S, R1775S, R473S, R482S, R536S, R560S, R579S, R582S, R672S, R561S, R568S, R578S, R583S, R602S, R603S, R610S, R611S, R648S, R650S, R885S, R1584S, R1624S, R1626S, R1681S, R1682S, R1725S, R1748S, R1751S, R341S, R522S, R540S, R562S, R570S, R580S, R601S, R605S, R608S, R609S, R623S, R624S, R646S, R647S, R1733S, R1752S, R1773S, R537S, R541S, R1456S, R1641S, R1663S, R1685S, R1704S, R1705S, R1710S, R1599S, R1625S, R1664S, R1684S, R1711S, R1712S, R1734S, R1750S, R523S, R607S, R625S, R671S, R884S	Hereditary breast ovarian cancer syndrome	VCV000865211	17	41209087	17	43057070	865211	853687	rs771577266	NC_000017.11:43057069:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 29, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5259del (p.Glu1754fs)	BRCA1	E1707fs, E1754fs, E1775fs, E650fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037651	17	41209087	17	43057070	37651	46207	rs80357925	NC_000017.11:43057069:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5257dup (p.Arg1753fs)	BRCA1	R1753fs, R649fs, R1706fs, R1774fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055486	17	41209088 - 41209089	17	43057071 - 43057072	55486	70153	rs397509245	NC_000017.11:43057071:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5255C>A (p.Ala1752Glu)	BRCA1	A1705E, A1752E, A1773E, A648E, A1623E, A1625E, A1639E, A1641E, A1680E, A1682E, A1709E, A1711E, A1726E, A1733E, A340E, A472E, A560E, A561E, A567E, A582E, A601E, A624E, A646E, A647E, A1662E, A1663E, A1683E, A1684E, A1704E, A1708E, A1751E, A535E, A559E, A607E, A622E, A671E, A883E, A1456E, A1583E, A1624E, A1640E, A1664E, A1732E, A1747E, A1748E, A1749E, A481E, A522E, A536E, A540E, A569E, A578E, A579E, A602E, A604E, A606E, A623E, A670E, A884E, A1455E, A1598E, A1681E, A1685E, A1703E, A1710E, A1724E, A1725E, A1750E, A1772E, A1774E, A521E, A539E, A577E, A581E, A600E, A608E, A609E, A610E, A645E, A649E	Hereditary cancer-predisposing syndrome	VCV000868230	17	41209091	17	43057074	868230	853693	rs80357028	NC_000017.11:43057073:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 15, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5254G>C (p.Ala1752Pro)	BRCA1	A1752P, A648P, A1705P, A1773P, A1639P, A1640P, A1641P, A1683P, A1703P, A1708P, A1725P, A1732P, A1748P, A1750P, A481P, A522P, A535P, A560P, A601P, A608P, A610P, A670P, A884P, A1455P, A1624P, A1625P, A1662P, A1680P, A1682P, A1704P, A1710P, A472P, A539P, A540P, A569P, A577P, A578P, A582P, A604P, A609P, A622P, A646P, A883P, A1583P, A1598P, A1664P, A1684P, A1709P, A1724P, A1726P, A1747P, A1751P, A1772P, A581P, A600P, A602P, A607P, A623P, A649P, A671P, A1456P, A1623P, A1663P, A1681P, A1685P, A1711P, A1733P, A1749P, A1774P, A340P, A521P, A536P, A559P, A561P, A567P, A579P, A606P, A624P, A645P, A647P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|not provided|Hereditary breast ovarian cancer syndrome	VCV000055483	17	41209092	17	43057075	55483	70150	rs80357074	NC_000017.11:43057074:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5251del (p.Arg1751fs)	BRCA1	R1454fs, R1455fs, R1582fs, R1623fs, R1638fs, R1680fs, R1731fs, R1732fs, R1748fs, R1750fs, R535fs, R1622fs, R1640fs, R1681fs, R1682fs, R1708fs, R1709fs, R1725fs, R1746fs, R1751fs, R1771fs, R471fs, R521fs, R558fs, R568fs, R576fs, R581fs, R599fs, R608fs, R623fs, R645fs, R648fs, R882fs, R1597fs, R1624fs, R1639fs, R1661fs, R1662fs, R1663fs, R1679fs, R1684fs, R1702fs, R1707fs, R1723fs, R1747fs, R1772fs, R339fs, R480fs, R520fs, R534fs, R580fs, R607fs, R621fs, R622fs, R644fs, R646fs, R670fs, R538fs, R539fs, R559fs, R566fs, R577fs, R578fs, R603fs, R606fs, R669fs, R1683fs, R1703fs, R1704fs, R1710fs, R1724fs, R1749fs, R1773fs, R560fs, R600fs, R601fs, R605fs, R609fs, R647fs, R883fs	Hereditary cancer-predisposing syndrome	VCV003992584	17	41209095	17	43057078	3992584	4104835		NC_000017.11:43057077:G:	Deletion	frameshift variant	Pathogenic	Apr 2, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5236_5251del (p.His1746fs)	BRCA1	H1699fs, H1746fs, H1767fs, H642fs	Hereditary breast ovarian cancer syndrome	VCV000936431	17	41209095 - 41209110	17	43057078 - 43057093	936431	937940	rs2051505994	NC_000017.11:43057077:GCTTTGGACCTTGGTGG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Feb 9, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5251C>T (p.Arg1751Ter)	BRCA1	R1751*, R1772*, R647*, R1704*, R1454*, R1681*, R1682*, R1703*, R1771*, R1773*, R521*, R558*, R566*, R568*, R581*, R599*, R605*, R606*, R622*, R644*, R646*, R1455*, R1582*, R1624*, R1638*, R1639*, R1661*, R1683*, R1684*, R1708*, R1723*, R1725*, R1746*, R1747*, R471*, R480*, R535*, R577*, R601*, R607*, R608*, R621*, R623*, R882*, R1597*, R1662*, R1663*, R1679*, R1702*, R1732*, R1748*, R339*, R538*, R560*, R576*, R603*, R645*, R648*, R670*, R1622*, R1623*, R1640*, R1680*, R1707*, R1709*, R1710*, R1724*, R1731*, R1749*, R1750*, R520*, R534*, R539*, R559*, R578*, R580*, R600*, R609*, R669*, R883*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055480	17	41209095	17	43057078	55480	70147	rs80357123	NC_000017.11:43057077:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5249dup (p.Arg1751fs)	BRCA1	R1772fs, R647fs, R1704fs, R1751fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548260	17	41209096 - 41209097	17	43057079 - 43057080	548260	538765	rs879253993	NC_000017.11:43057079:TTT:TTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5250del (p.Lys1750fs)	BRCA1	K646fs, K1750fs, K1771fs, K1703fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479226	17	41209096	17	43057079	479226	478518	rs1555576868	NC_000017.11:43057078:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 8, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5248_5249insTC (p.Lys1750fs)	BRCA1	K1703fs, K1750fs, K1771fs, K646fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548214	17	41209097 - 41209098	17	43057080 - 43057081	548214	538764	rs1555576871	NC_000017.11:43057080::GA	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5249del (p.Lys1750fs)	BRCA1	K646fs, K1703fs, K1750fs, K1771fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000245901	17	41209097	17	43057080	245901	245020	rs879253993	NC_000017.11:43057079:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5248A>T (p.Lys1750Ter)	BRCA1	K1703*, K1750*, K646*, K1771*, K1621*, K1623*, K1661*, K1679*, K1701*, K1724*, K1731*, K1748*, K1770*, K519*, K533*, K537*, K604*, K605*, K606*, K620*, K622*, K669*, K881*, K882*, K1453*, K1581*, K1622*, K1639*, K1683*, K1706*, K1709*, K1723*, K1730*, K1749*, K470*, K534*, K565*, K567*, K575*, K580*, K598*, K600*, K608*, K645*, K647*, K1454*, K1638*, K1662*, K1680*, K1682*, K1702*, K1707*, K1722*, K1745*, K1772*, K338*, K479*, K538*, K559*, K576*, K599*, K607*, K644*, K668*, K1596*, K1637*, K1660*, K1678*, K1681*, K1708*, K1746*, K1747*, K520*, K557*, K558*, K577*, K579*, K602*, K621*, K643*	Hereditary breast ovarian cancer syndrome	VCV000865201	17	41209098	17	43057081	865201	853703	rs2051507325	NC_000017.11:43057080:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 23, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5247_5248insTC (p.Lys1750fs)	BRCA1	K1703fs, K1771fs, K646fs, K1750fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548278	17	41209098 - 41209099	17	43057081 - 43057082	548278	538766	rs1555576878	NC_000017.11:43057081::GA	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5209_5248delinsTC (p.Arg1737fs)	BRCA1	R1690fs, R1737fs, R633fs, R1758fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055459	17	41209098 - 41209137	17	43057081 - 43057120	55459	70126	rs273901753	NC_000017.11:43057080:TTGGACCTTGGTGGTTTCTTCCATTGACCACATCTCCTCT:GA	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5208_5247delinsTC (p.Arg1737fs)	BRCA1	R1690fs, R1758fs, R633fs, R1737fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266532	17	41209099 - 41209138	17	43057082 - 43057121	266532	261587	rs886040277	NC_000017.11:43057081:TGGACCTTGGTGGTTTCTTCCATTGACCACATCTCCTCTG:GA	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5246C>G (p.Pro1749Arg)	BRCA1	P1749R, P1702R, P1770R, P645R, P1636R, P1661R, P1700R, P1706R, P1723R, P533R, P574R, P606R, P607R, P644R, P646R, P880R, P881R, P1637R, P1638R, P1659R, P1677R, P1679R, P1705R, P1708R, P1721R, P1729R, P1746R, P1769R, P1771R, P518R, P519R, P537R, P557R, P575R, P578R, P597R, P598R, P604R, P619R, P643R, P1580R, P1595R, P1621R, P1678R, P1681R, P1701R, P1745R, P1748R, P532R, P556R, P558R, P579R, P601R, P603R, P620R, P642R, P1452R, P1453R, P1620R, P1622R, P1660R, P1680R, P1682R, P1707R, P1722R, P1730R, P1744R, P1747R, P337R, P469R, P478R, P536R, P564R, P566R, P576R, P599R, P605R, P621R, P667R, P668R	not provided	VCV000055479	17	41209100	17	43057083	55479	70146	rs80357462	NC_000017.11:43057082:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 2, 2014	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5244dup (p.Pro1749fs)	BRCA1	P1595fs, P1620fs, P1621fs, P1637fs, P1638fs, P1660fs, P1702fs, P1707fs, P1721fs, P1747fs, P1769fs, P337fs, P469fs, P557fs, P558fs, P564fs, P579fs, P599fs, P601fs, P607fs, P619fs, P621fs, P642fs, P667fs, P1452fs, P1580fs, P1636fs, P1659fs, P1677fs, P1700fs, P1729fs, P1730fs, P1748fs, P1749fs, P1770fs, P478fs, P519fs, P575fs, P597fs, P603fs, P605fs, P643fs, P644fs, P646fs, P668fs, P1622fs, P1681fs, P1705fs, P1708fs, P1744fs, P1745fs, P1771fs, P532fs, P533fs, P536fs, P556fs, P574fs, P604fs, P645fs, P880fs, P1453fs, P1661fs, P1678fs, P1679fs, P1680fs, P1682fs, P1701fs, P1706fs, P1722fs, P1723fs, P1746fs, P518fs, P537fs, P566fs, P576fs, P578fs, P598fs, P606fs, P620fs, P881fs	Hereditary breast ovarian cancer syndrome	VCV002693875	17	41209101 - 41209102	17	43057084 - 43057085	2693875	2854008	rs2548416943	NC_000017.11:43057084:A:AA	Duplication	frameshift variant	Pathogenic	Jun 6, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5243del (p.Gly1748fs)	BRCA1	G1769fs, G644fs, G1701fs, G1748fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055477	17	41209103	17	43057086	55477	70144	rs80357676	NC_000017.11:43057085:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5243G>A (p.Gly1748Asp)	BRCA1	G1748D, G644D, G1701D, G1769D, G1579D, G1636D, G1677D, G1707D, G1720D, G1721D, G1729D, G1743D, G1744D, G1746D, G468D, G532D, G575D, G577D, G603D, G619D, G620D, G642D, G666D, G1452D, G1619D, G1678D, G1681D, G1700D, G1704D, G1745D, G1768D, G336D, G518D, G535D, G563D, G565D, G573D, G600D, G605D, G606D, G643D, G645D, G667D, G1635D, G1660D, G1679D, G1722D, G1728D, G1747D, G1770D, G531D, G536D, G555D, G578D, G598D, G641D, G879D, G1451D, G1594D, G1620D, G1621D, G1637D, G1658D, G1659D, G1676D, G1680D, G1699D, G1705D, G1706D, G477D, G517D, G556D, G557D, G574D, G596D, G597D, G602D, G604D, G618D, G880D	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055476	17	41209103	17	43057086	55476	70143	rs397509243	NC_000017.11:43057085:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5241del (p.Gly1748fs)	BRCA1	G1769fs, G644fs, G1701fs, G1748fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125807	17	41209105	17	43057088	125807	131345	rs80357791	NC_000017.11:43057087:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5239dup (p.Gln1747fs)	BRCA1	Q1700fs, Q1747fs, Q643fs, Q1768fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266539	17	41209106 - 41209107	17	43057089 - 43057090	266539	261589	rs886040282	NC_000017.11:43057089:GG:GGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5239del (p.Gln1747fs)	BRCA1	Q1700fs, Q1747fs, Q643fs, Q1768fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266538	17	41209107	17	43057090	266538	261588	rs886040282	NC_000017.11:43057089:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5239C>T (p.Gln1747Ter)	BRCA1	Q1747*, Q1768*, Q1700*, Q643*, Q1578*, Q1657*, Q1659*, Q1677*, Q1706*, Q1719*, Q1721*, Q1728*, Q1744*, Q1746*, Q531*, Q534*, Q535*, Q554*, Q555*, Q564*, Q572*, Q576*, Q595*, Q597*, Q601*, Q604*, Q617*, Q619*, Q644*, Q879*, Q1450*, Q1593*, Q1658*, Q1703*, Q1705*, Q1727*, Q1742*, Q1743*, Q1745*, Q516*, Q562*, Q573*, Q577*, Q603*, Q618*, Q666*, Q1618*, Q1620*, Q1634*, Q1635*, Q1636*, Q1675*, Q1676*, Q1679*, Q1704*, Q1767*, Q1769*, Q476*, Q517*, Q530*, Q596*, Q599*, Q602*, Q641*, Q642*, Q665*, Q1451*, Q1619*, Q1678*, Q1680*, Q1698*, Q1699*, Q1720*, Q335*, Q467*, Q556*, Q574*, Q605*, Q640*, Q878*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055473	17	41209107	17	43057090	55473	70140	rs80357367	NC_000017.11:43057089:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5232_5238delinsGTCCAAAGCGAG (p.Asn1745fs)	BRCA1	N641fs, N1766fs, N1698fs, N1745fs	Hereditary breast ovarian cancer syndrome|not provided	VCV000449982	17	41209108 - 41209114	17	43057091 - 43057097	449982	445777	rs483353071	NC_000017.11:43057090:GTGGTTT:CTCGCTTTGGAC	Indel	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5237del (p.His1746fs)	BRCA1	H1767fs, H642fs, H1699fs, H1746fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548308	17	41209109	17	43057092	548308	538767	rs1555576907	NC_000017.11:43057091:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-10_5236dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV000495094	17	41209109 - 41209110	17	43057092 - 43057093	495094	486651	rs1555576921		Duplication	splice acceptor variant	Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5230_5237del (p.Arg1744fs)	BRCA1	R1697fs, R1744fs, R1765fs, R640fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266537	17	41209109 - 41209116	17	43057092 - 43057099	266537	261590	rs886040281	NC_000017.11:43057091:TGGTTTCTT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5236del (p.His1746fs)	BRCA1	H1767fs, H642fs, H1699fs, H1746fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231997	17	41209110	17	43057093	231997	235938	rs876659483	NC_000017.11:43057092:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5234dup (p.Asn1745fs)	BRCA1	N1698fs, N1745fs, N1766fs, N641fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254464	17	41209111 - 41209112	17	43057094 - 43057095	254464	249079	rs886038042	NC_000017.11:43057094:TTT:TTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5231del (p.Arg1744fs)	BRCA1	R1744fs, R640fs, R1697fs, R1765fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055471	17	41209115	17	43057098	55471	70138	rs397509241	NC_000017.11:43057097:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5230del (p.Arg1744fs)	BRCA1	R1765fs, R1744fs, R640fs, R1697fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055470	17	41209116	17	43057099	55470	70137	rs397509240	NC_000017.11:43057098:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5229_5230del (p.Arg1744fs)	BRCA1	R1765fs, R640fs, R1697fs, R1744fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055469	17	41209116 - 41209117	17	43057099 - 43057100	55469	70136	rs80357852	NC_000017.11:43057098:TT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5228del (p.Gly1743fs)	BRCA1	G1696fs, G1743fs, G1764fs, G639fs	not specified	VCV001330011	17	41209118	17	43057101	1330011	1320695	rs1567764473	NC_000017.11:43057100:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 9, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5227G>T (p.Gly1743Ter)	BRCA1	G1743*, G1696*, G1764*, G639*, G1446*, G1447*, G1655*, G1695*, G1700*, G1739*, G1741*, G512*, G527*, G530*, G568*, G591*, G592*, G599*, G613*, G661*, G875*, G1574*, G1589*, G1631*, G1672*, G1674*, G1694*, G1715*, G1738*, G1763*, G513*, G550*, G551*, G569*, G573*, G593*, G598*, G600*, G638*, G874*, G1632*, G1654*, G1673*, G1675*, G1676*, G1699*, G1701*, G1702*, G1716*, G1717*, G1723*, G331*, G472*, G526*, G531*, G572*, G615*, G637*, G640*, G1614*, G1615*, G1616*, G1630*, G1653*, G1671*, G1724*, G1740*, G1742*, G1765*, G463*, G552*, G558*, G560*, G570*, G595*, G597*, G601*, G614*, G636*, G662*	Hereditary breast ovarian cancer syndrome	VCV000848155	17	41209119	17	43057102	848155	845367	rs2051517323	NC_000017.11:43057101:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jan 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5225del (p.Asn1742fs)	BRCA1	N1445fs, N1446fs, N1573fs, N1588fs, N1613fs, N1614fs, N1615fs, N1629fs, N1630fs, N1631fs, N1652fs, N1653fs, N1654fs, N1670fs, N1671fs, N1672fs, N1673fs, N1674fs, N1675fs, N1693fs, N1694fs, N1695fs, N1698fs, N1699fs, N1700fs, N1701fs, N1714fs, N1715fs, N1716fs, N1722fs, N1723fs, N1737fs, N1738fs, N1739fs, N1740fs, N1741fs, N1742fs, N1762fs, N1763fs, N1764fs, N330fs, N462fs, N471fs, N511fs, N512fs, N525fs, N526fs, N529fs, N530fs, N549fs, N550fs, N551fs, N557fs, N559fs, N567fs, N568fs, N569fs, N571fs, N572fs, N590fs, N591fs, N592fs, N594fs, N596fs, N597fs, N598fs, N599fs, N600fs, N612fs, N613fs, N614fs, N635fs, N636fs, N637fs, N638fs, N639fs, N660fs, N661fs, N873fs, N874fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573285	17	41209121	17	43057104	2573285	2738233	rs2548462026	NC_000017.11:43057103:TT:T	Deletion	frameshift variant	Pathogenic	Feb 8, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5221_5224del (p.Val1741fs)	BRCA1	V1741fs, V1762fs, V1694fs, V637fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266536	17	41209122 - 41209125	17	43057105 - 43057108	266536	261591	rs886040280	NC_000017.11:43057104:TGAC:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5223del (p.Asn1742fs)	BRCA1	N1695fs, N638fs, N1763fs, N1742fs	Hereditary cancer-predisposing syndrome	VCV000825567	17	41209123	17	43057106	825567	813657	rs1597810843	NC_000017.11:43057105:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 16, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5216del (p.Asp1739fs)	BRCA1	D635fs, D1692fs, D1760fs, D1739fs	Hereditary breast ovarian cancer syndrome	VCV000838433	17	41209130	17	43057113	838433	845368	rs2051521489	NC_000017.11:43057112:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 4, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5215_5216del (p.Asp1739fs)	BRCA1	D635fs, D1692fs, D1739fs, D1760fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000420420	17	41209130 - 41209131	17	43057113 - 43057114	420420	409947	rs1064794467	NC_000017.11:43057112:TCTC:TC	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5216A>T (p.Asp1739Val)	BRCA1	D1739V, D1692V, D635V, D1760V, D1585V, D1611V, D1649V, D1650V, D1669V, D1671V, D1695V, D1697V, D1719V, D1734V, D1737V, D1761V, D327V, D459V, D468V, D509V, D526V, D547V, D556V, D564V, D594V, D596V, D610V, D658V, D1570V, D1612V, D1626V, D1667V, D1668V, D1672V, D1690V, D1691V, D1713V, D1736V, D527V, D565V, D566V, D568V, D589V, D593V, D597V, D609V, D634V, D871V, D1442V, D1610V, D1628V, D1670V, D1698V, D1720V, D508V, D523V, D546V, D548V, D569V, D587V, D632V, D636V, D595V, D611V, D633V, D657V, D870V, D1443V, D1627V, D1651V, D1696V, D1711V, D1712V, D1735V, D1738V, D1759V, D522V, D554V, D588V, D591V	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055466	17	41209130	17	43057113	55466	70133	rs80357227	NC_000017.11:43057112:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5216A>G (p.Asp1739Gly)	BRCA1	D1739G, D1760G, D1692G, D635G, D1442G, D1570G, D1610G, D1612G, D1691G, D1696G, D1711G, D1719G, D1735G, D1759G, D1761G, D547G, D566G, D568G, D588G, D610G, D633G, D634G, D657G, D658G, D870G, D871G, D1626G, D1651G, D1667G, D1671G, D1672G, D1713G, D1720G, D1734G, D1736G, D468G, D522G, D523G, D565G, D596G, D597G, D609G, D632G, D1443G, D1611G, D1628G, D1649G, D1650G, D1669G, D1670G, D1697G, D1737G, D509G, D526G, D546G, D554G, D556G, D564G, D589G, D591G, D594G, D1585G, D1627G, D1668G, D1690G, D1695G, D1698G, D1712G, D1738G, D327G, D459G, D508G, D527G, D548G, D569G, D587G, D593G, D595G, D611G, D636G	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055465	17	41209130	17	43057113	55465	70132	rs80357227	NC_000017.11:43057112:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5210GAG[1] (p.Gly1738del)	BRCA1	G1738del, G634del, G1691del, G1759del, G522del, G546del, G547del, G563del, G565del, G568del, G592del, G633del, G1627del, G1648del, G1695del, G1696del, G1697del, G1712del, G1718del, G1719del, G1733del, G1734del, G1737del, G326del, G467del, G1569del, G1584del, G1610del, G1666del, G1670del, G1671del, G1689del, G1736del, G458del, G507del, G525del, G545del, G567del, G586del, G587del, G870del, G1441del, G1442del, G1609del, G1611del, G1625del, G1650del, G1668del, G1669del, G1690del, G1694del, G1735del, G1758del, G508del, G526del, G555del, G564del, G590del, G594del, G596del, G608del, G609del, G635del, G657del, G1626del, G1649del, G1667del, G1710del, G1711del, G1760del, G521del, G553del, G588del, G593del, G595del, G610del, G631del, G632del, G656del, G869del	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055463	17	41209131 - 41209133	17	43057114 - 43057116	55463	70130	rs80358347	NC_000017.11:43057113:CTCCTC:CTC	Microsatellite	inframe_indel|inframe_deletion|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5213G>T (p.Gly1738Val)	BRCA1	G1691V, G1759V, G1738V, G634V, G1609V, G1648V, G1667V, G1670V, G1690V, G1710V, G1711V, G1719V, G1736V, G1760V, G507V, G522V, G546V, G568V, G592V, G595V, G635V, G657V, G870V, G1441V, G1442V, G1611V, G1627V, G1668V, G1669V, G1671V, G1689V, G1696V, G1697V, G1735V, G1737V, G467V, G508V, G526V, G553V, G588V, G594V, G596V, G608V, G609V, G610V, G633V, G656V, G1569V, G1610V, G1626V, G1712V, G1718V, G326V, G525V, G545V, G555V, G567V, G590V, G631V, G1584V, G1625V, G1649V, G1650V, G1666V, G1694V, G1695V, G1733V, G1734V, G1758V, G458V, G521V, G547V, G563V, G564V, G565V, G586V, G587V, G593V, G632V, G869V	Hereditary breast ovarian cancer syndrome	VCV000845528	17	41209133	17	43057116	845528	845369	rs80357450	NC_000017.11:43057115:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 30, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5213del (p.Gly1738fs)	BRCA1	G1759fs, G1738fs, G634fs, G1691fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266535	17	41209133	17	43057116	266535	261592	rs886040279	NC_000017.11:43057115:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5213G>A (p.Gly1738Glu)	BRCA1	G1738E, G1691E, G1759E, G634E, G1569E, G1610E, G1626E, G1627E, G1649E, G1710E, G1711E, G1733E, G1760E, G522E, G546E, G590E, G593E, G1609E, G1625E, G1666E, G1667E, G1670E, G1689E, G1690E, G1694E, G1735E, G1758E, G458E, G467E, G521E, G526E, G553E, G555E, G587E, G596E, G609E, G635E, G869E, G870E, G1442E, G1611E, G1650E, G1669E, G1696E, G1697E, G1712E, G1718E, G1734E, G1736E, G326E, G564E, G567E, G586E, G588E, G594E, G595E, G633E, G656E, G657E, G1441E, G1584E, G1648E, G1668E, G1671E, G1695E, G1719E, G1737E, G507E, G508E, G525E, G545E, G547E, G563E, G565E, G568E, G592E, G608E, G610E, G631E, G632E	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055462	17	41209133	17	43057116	55462	70129	rs80357450	NC_000017.11:43057115:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5212G>C (p.Gly1738Arg)	BRCA1	G1759R, G634R, G1738R, G1691R, G1442R, G1584R, G1626R, G1627R, G1670R, G1690R, G1694R, G1696R, G1719R, G1733R, G458R, G508R, G525R, G526R, G546R, G567R, G586R, G590R, G596R, G632R, G633R, G656R, G657R, G870R, G1441R, G1609R, G1610R, G1667R, G1669R, G1689R, G1695R, G1710R, G1711R, G1718R, G1734R, G1735R, G1758R, G326R, G553R, G555R, G564R, G588R, G608R, G610R, G631R, G1611R, G1625R, G1666R, G1671R, G1697R, G1712R, G1760R, G467R, G507R, G522R, G547R, G563R, G565R, G568R, G587R, G593R, G594R, G609R, G635R, G869R, G1569R, G1648R, G1649R, G1650R, G1668R, G1736R, G1737R, G521R, G545R, G592R, G595R	Hereditary cancer-predisposing syndrome	VCV000865165	17	41209134	17	43057117	865165	853771	rs80356937	NC_000017.11:43057116:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5211_5212del (p.Gly1738fs)	BRCA1	G1759fs, G634fs, G1691fs, G1738fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000531396	17	41209134 - 41209135	17	43057117 - 43057118	531396	531285	rs1555576959	NC_000017.11:43057116:CTCT:CT	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Dec 2, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5212G>T (p.Gly1738Ter)	BRCA1	G1738*, G634*, G1691*, G1759*, G1442*, G1649*, G1669*, G1689*, G1694*, G1710*, G1711*, G1712*, G1733*, G525*, G555*, G565*, G590*, G592*, G594*, G595*, G610*, G870*, G1569*, G1627*, G1667*, G1671*, G1695*, G1697*, G1718*, G1758*, G458*, G467*, G508*, G546*, G564*, G568*, G587*, G608*, G609*, G656*, G1441*, G1584*, G1609*, G1610*, G1611*, G1626*, G1650*, G1666*, G1696*, G1719*, G1735*, G1736*, G1737*, G1760*, G521*, G522*, G526*, G545*, G631*, G635*, G657*, G869*, G1625*, G1648*, G1668*, G1670*, G1690*, G1734*, G326*, G507*, G547*, G553*, G563*, G567*, G586*, G588*, G593*, G596*, G632*, G633*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266534	17	41209134	17	43057117	266534	261593	rs80356937	NC_000017.11:43057116:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5212G>A (p.Gly1738Arg)	BRCA1	G1738R, G1691R, G634R, G1759R, G1442R, G1609R, G1610R, G1611R, G1666R, G1670R, G1689R, G1696R, G1710R, G1719R, G1733R, G1734R, G326R, G522R, G525R, G526R, G553R, G555R, G563R, G592R, G608R, G609R, G610R, G635R, G869R, G1441R, G1584R, G1626R, G1648R, G1649R, G1669R, G1694R, G1695R, G1711R, G1712R, G1718R, G467R, G546R, G564R, G567R, G594R, G595R, G596R, G631R, G632R, G657R, G1667R, G1690R, G1697R, G1736R, G1737R, G521R, G565R, G586R, G587R, G593R, G1569R, G1625R, G1627R, G1650R, G1668R, G1671R, G1735R, G1758R, G1760R, G458R, G507R, G508R, G545R, G547R, G568R, G588R, G590R, G633R, G656R, G870R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055461	17	41209134	17	43057117	55461	70128	rs80356937	NC_000017.11:43057116:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5210_5211insC (p.Arg1737fs)	BRCA1	R633fs, R1690fs, R1737fs, R1758fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548204	17	41209135 - 41209136	17	43057118 - 43057119	548204	538768	rs1555576964	NC_000017.11:43057118::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5209dup (p.Arg1737fs)	BRCA1	R633fs, R1690fs, R1737fs, R1758fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266533	17	41209136 - 41209137	17	43057119 - 43057120	266533	261594	rs886040278	NC_000017.11:43057119:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5209A>T (p.Arg1737Ter)	BRCA1	R1737*, R633*, R1690*, R1758*, R1568*, R1583*, R1609*, R1610*, R1649*, R1669*, R1693*, R1695*, R1710*, R1717*, R1736*, R466*, R507*, R520*, R521*, R562*, R594*, R630*, R868*, R1625*, R1665*, R1667*, R1670*, R1711*, R1718*, R1732*, R1734*, R1735*, R1757*, R506*, R545*, R563*, R587*, R591*, R595*, R607*, R632*, R869*, R1441*, R1648*, R1666*, R1668*, R1689*, R1696*, R1709*, R457*, R524*, R552*, R554*, R567*, R586*, R589*, R593*, R608*, R634*, R656*, R1440*, R1608*, R1624*, R1626*, R1647*, R1688*, R1694*, R1733*, R1759*, R325*, R525*, R544*, R546*, R564*, R566*, R585*, R592*, R609*, R631*, R655*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055458	17	41209137	17	43057120	55458	70125	rs80357496	NC_000017.11:43057119:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5207del (p.Val1736fs)	BRCA1	V1689fs, V1757fs, V1736fs, V632fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055457	17	41209139	17	43057122	55457	70124	rs397509239	NC_000017.11:43057121:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5207T>G (p.Val1736Gly)	BRCA1	V1736G, V1757G, V1689G, V632G, V1439G, V1625G, V1647G, V1687G, V1688G, V1692G, V1708G, V1709G, V1710G, V1731G, V1734G, V1735G, V324G, V456G, V506G, V524G, V562G, V585G, V1567G, V1608G, V1624G, V1665G, V1666G, V1668G, V1716G, V1733G, V519G, V543G, V544G, V553G, V565G, V591G, V592G, V606G, V629G, V633G, V867G, V868G, V1609G, V1623G, V1648G, V1664G, V1667G, V1669G, V1693G, V1717G, V1758G, V465G, V523G, V545G, V551G, V566G, V584G, V586G, V593G, V607G, V631G, V654G, V1440G, V1582G, V1607G, V1646G, V1694G, V1695G, V1732G, V1756G, V505G, V520G, V561G, V563G, V588G, V590G, V594G, V608G, V630G, V655G	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000055456	17	41209139	17	43057122	55456	70123	rs45553935	NC_000017.11:43057121:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	BRCA1	V1736A, V1757A, V632A, V1689A, V1567A, V1582A, V1607A, V1624A, V1646A, V1664A, V1668A, V1692A, V1695A, V1716A, V1733A, V1735A, V1756A, V519A, V520A, V545A, V551A, V561A, V562A, V588A, V591A, V593A, V655A, V1439A, V1440A, V1609A, V1623A, V1647A, V1665A, V1669A, V1687A, V1688A, V1693A, V1708A, V324A, V506A, V524A, V543A, V565A, V594A, V606A, V608A, V630A, V631A, V654A, V868A, V1608A, V1666A, V1667A, V1694A, V1709A, V1717A, V1758A, V456A, V465A, V505A, V523A, V544A, V563A, V584A, V629A, V1625A, V1648A, V1710A, V1731A, V1732A, V1734A, V553A, V566A, V585A, V586A, V590A, V592A, V607A, V633A, V867A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037648	17	41209139	17	43057122	37648	46204	rs45553935	NC_000017.11:43057121:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 25, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5205del (p.Val1736fs)	BRCA1	V1757fs, V1736fs, V1689fs, V632fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000140168	17	41209141	17	43057124	140168	150134	rs587781258	NC_000017.11:43057123:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5203del (p.Glu1735fs)	BRCA1	E1581fs, E1622fs, E1663fs, E1665fs, E1667fs, E1688fs, E1733fs, E1755fs, E518fs, E519fs, E522fs, E583fs, E589fs, E593fs, E606fs, E631fs, E866fs, E592fs, E605fs, E607fs, E629fs, E632fs, E1566fs, E1606fs, E1646fs, E1664fs, E1687fs, E1715fs, E1732fs, E455fs, E504fs, E543fs, E560fs, E562fs, E590fs, E1439fs, E1607fs, E1623fs, E1645fs, E1666fs, E1693fs, E1707fs, E1709fs, E1730fs, E1756fs, E464fs, E505fs, E550fs, E564fs, E565fs, E584fs, E587fs, E591fs, E628fs, E630fs, E653fs, E654fs, E867fs, E1438fs, E1608fs, E1624fs, E1647fs, E1668fs, E1686fs, E1691fs, E1692fs, E1694fs, E1708fs, E1716fs, E1731fs, E1734fs, E1735fs, E1757fs, E323fs, E523fs, E542fs, E544fs, E552fs, E561fs, E585fs	Hereditary breast ovarian cancer syndrome	VCV002703638	17	41209143	17	43057126	2703638	2859929	rs2548502419	NC_000017.11:43057125:C:	Deletion	frameshift variant	Pathogenic	Feb 14, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5202dup (p.Glu1735Ter)	BRCA1	E1688*, E1735*, E1756*, E631*	Hereditary breast ovarian cancer syndrome|not provided	VCV001070907	17	41209143 - 41209144	17	43057126 - 43057127	1070907	1064181	rs876659867	NC_000017.11:43057126:AAAA:AAAAA	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5201_5202insC (p.Phe1734_Glu1735insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548284	17	41209144 - 41209145	17	43057127 - 43057128	548284	538769	rs1555576982	NC_000017.11:43057127::G	Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5202del (p.Phe1734fs)	BRCA1	F630fs, F1687fs, F1755fs, F1734fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232606	17	41209144	17	43057127	232606	235940	rs876659867	NC_000017.11:43057126:AAAA:AAA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5200_5201insC (p.Phe1734fs)	BRCA1	F1687fs, F630fs, F1734fs, F1755fs	Hereditary breast ovarian cancer syndrome	VCV000431359	17	41209145 - 41209146	17	43057128 - 43057129	431359	424882	rs1135401936	NC_000017.11:43057128::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 20, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5201T>C (p.Phe1734Ser)	BRCA1	F1734S, F1755S, F1687S, F630S, F1438S, F1607S, F1623S, F1644S, F1686S, F1692S, F1706S, F1714S, F1715S, F1731S, F517S, F560S, F564S, F629S, F865S, F1437S, F1580S, F1621S, F1646S, F1662S, F1666S, F1732S, F322S, F454S, F521S, F541S, F549S, F586S, F592S, F628S, F653S, F866S, F1606S, F1622S, F1645S, F1663S, F1664S, F1665S, F1685S, F1693S, F1733S, F503S, F504S, F518S, F522S, F542S, F543S, F551S, F561S, F563S, F582S, F584S, F588S, F589S, F591S, F604S, F606S, F631S, F1565S, F1605S, F1667S, F1690S, F1691S, F1707S, F1708S, F1729S, F1730S, F1754S, F1756S, F463S, F559S, F583S, F590S, F605S, F627S, F652S	Hereditary cancer-predisposing syndrome	VCV000055454	17	41209145	17	43057128	55454	70121	rs397509237	NC_000017.11:43057127:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5194-1_5197delinsTATT	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462665	17	41209149 - 41209153	17	43057132 - 43057136	462665	466829	rs1555576990	NC_000017.11:43057131:CATGC:AATA	Indel	splice acceptor variant	Pathogenic	Feb 6, 2017	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(154652_160848)del	LOC111589216|LOC126862571|BRCA1|LOC110485084|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373870	17	41209153 - 41277500	17	43057136 - 43125483	373870	360756			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5194-1G>T	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000267585	17	41209153	17	43057136	267585	262935	rs80358173	NC_000017.11:43057135:C:A	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5194-1G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267584	17	41209153	17	43057136	267584	262936	rs80358173	NC_000017.11:43057135:C:G	single nucleotide variant	splice acceptor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5194-1G>A	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000125804	17	41209153	17	43057136	125804	131342	rs80358173	NC_000017.11:43057135:C:T	single nucleotide variant	splice acceptor variant	Pathogenic	Jan 2, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5194-2A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865149	17	41209154	17	43057137	865149	855413	rs80358069	NC_000017.11:43057136:T:A	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5194-2A>G	BRCA1		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037647	17	41209154	17	43057137	37647	46203	rs80358069	NC_000017.11:43057136:T:C	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5194-12G>A	BRCA1		BRCA1-related cancer predisposition	VCV000055451	17	41209164	17	43057147	55451	70118	rs80358079	NC_000017.11:43057146:C:T	single nucleotide variant	intron variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NG_005905.2:g.152586_159830delins27	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373855	17	41210171 - 41217415	17	43058154 - 43065398	373855	360728			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5075-1461_5194-2072dup	BRCA1		not provided	VCV003337573	17	41211223 - 41211224	17	43059206 - 43059207	3337573	3496234			Duplication	splice acceptor variant|splice donor variant	Pathogenic	Mar 18, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5074+872_5193+2569dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001745173	17	41212780 - 41212781	17	43060763 - 43060764	1745173	1806019			Duplication	splice acceptor variant|splice donor variant	Pathogenic	Oct 5, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5152+149_5193+2200del	BRCA1		not provided	VCV003337576	17	41213150 - 41215742	17	43061133 - 43063725	3337576	3496237			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Aug 2, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5152+149_5193+2200delinsTTTTTTTTTTTT	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373854	17	41213150 - 41215742	17	43061133 - 43063725	373854	360729			Indel	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5074+991_5193+1541del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373840	17	41213809 - 41218634	17	43061792 - 43066617	373840	360730			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(?_43063313)_(43125483_?)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000583843	17	41215330 - 41277500	17	43063313 - 43125483	583843	568594			Deletion		Pathogenic	Oct 15, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41215988_?)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000583642	17	41215330 - 41215988	17	43063313 - 43063971	583642	568593			Duplication		Pathogenic	Oct 17, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43063327)_(43063379_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462187	17	41215344 - 41215396	17	43063327 - 43063379	462187	467354			Deletion		Pathogenic	Feb 6, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5193+2dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001745927	17	41215347 - 41215348	17	43063330 - 43063331	1745927	1245701	rs2549321348	NC_000017.11:43063330:A:AA	Duplication	splice donor variant	Pathogenic	Aug 21, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5193+2T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267579	17	41215348	17	43063331	267579	262937	rs886040915	NC_000017.11:43063330:A:C	single nucleotide variant	splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5193+2del	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055450	17	41215348	17	43063331	55450	70117	rs273901751	NC_000017.11:43063330:A:	Deletion	splice donor variant	Pathogenic	Sep 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5153-79_5193+1del	BRCA1		Fanconi anemia, complementation group S	VCV003779415	17	41215349 - 41215469	17	43063332 - 43063452	3779415	3895399			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Apr 1, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5193+1G>A	BRCA1		not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000096942	17	41215349	17	43063332	96942	102845	rs80358004	NC_000017.11:43063331:C:T	single nucleotide variant	splice donor variant	Pathogenic	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5193+1G>T	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091642	17	41215349	17	43063332	91642	97119	rs80358004	NC_000017.11:43063331:C:A	single nucleotide variant	splice donor variant	Pathogenic	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5193+1del	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary breast ovarian cancer syndrome	VCV000055449	17	41215349	17	43063332	55449	70116	rs397509236	NC_000017.11:43063331:CC:C	Deletion	splice donor variant	Pathogenic/Likely pathogenic	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5193+1G>C	BRCA1		Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000055448	17	41215349	17	43063332	55448	70115	rs80358004	NC_000017.11:43063331:C:G	single nucleotide variant	splice donor variant	Pathogenic	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5192_5193del (p.Glu1731fs)	BRCA1	E1562fs, E1602fs, E1618fs, E1619fs, E1620fs, E1643fs, E1659fs, E1661fs, E1662fs, E1683fs, E460fs, E515fs, E518fs, E557fs, E561fs, E583fs, E585fs, E586fs, E588fs, E589fs, E603fs, E624fs, E625fs, E627fs, E862fs, E863fs, E1435fs, E1434fs, E1577fs, E1660fs, E1682fs, E1684fs, E1689fs, E1703fs, E1727fs, E1728fs, E1729fs, E1730fs, E500fs, E501fs, E548fs, E580fs, E1603fs, E1641fs, E1642fs, E1663fs, E1688fs, E1704fs, E1705fs, E1711fs, E1726fs, E1731fs, E1751fs, E1752fs, E558fs, E560fs, E601fs, E628fs, E649fs, E1604fs, E1664fs, E1687fs, E1690fs, E1712fs, E1753fs, E319fs, E451fs, E514fs, E519fs, E538fs, E539fs, E540fs, E546fs, E556fs, E579fs, E581fs, E587fs, E602fs, E626fs, E650fs	Hereditary cancer-predisposing syndrome	VCV003992588	17	41215350 - 41215351	17	43063333 - 43063334	3992588	4104839		NC_000017.11:43063332:CTC:C	Deletion	frameshift variant	Pathogenic	Mar 26, 2025	criteria provided, single submitter							
NM_001408514.1(BRCA1):c.839-3744_957del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S	VCV003780832	17	41215350 - 41219712	17	43063333 - 43067695	3780832	3896792			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Nov 24, 2020	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5075-?_5193+?del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000417598	17	41215350 - 41215968	17	43063333 - 43063951	417598	401976			Deletion		Pathogenic	Nov 29, 2016	criteria provided, single submitter							
NC_000017.11:g.(?_43063333)_(43124115_?)del	BRCA1|LOC110485084|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000417595	17	41215350 - 41276132	17	43063333 - 43124115	417595	401508			Deletion		Pathogenic	Nov 6, 2016	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5075-?_5193+?dup119	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000417468	17	41215350 - 41215968	17	43063333 - 43063951	417468	401504			Duplication		Pathogenic	Nov 29, 2016	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4987-?_5193+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216004	17	41215350 - 41219712	17	43063333 - 43067695	216004	213234			Deletion		Pathogenic	Dec 13, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.548-?_5193+?del	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000089069	17	41215891 - 41249306	17	43063333 - 43097289	89069	94612			Deletion		Pathogenic	Oct 2, 2015	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5179_5192del (p.Lys1727fs)	BRCA1	K1680fs, K1748fs, K623fs, K1727fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055445	17	41215351 - 41215364	17	43063334 - 43063347	55445	70112	rs397509234	NC_000017.11:43063333:TCATTCAGCATTTTTC:TC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5191G>T (p.Glu1731Ter)	BRCA1	E1731*, E627*, E1752*, E1684*, E1435*, E1618*, E1662*, E1690*, E319*, E548*, E556*, E558*, E561*, E579*, E588*, E589*, E624*, E626*, E649*, E1434*, E1602*, E1603*, E1619*, E1641*, E1659*, E1664*, E1682*, E1683*, E1688*, E1703*, E1704*, E1705*, E1727*, E451*, E500*, E501*, E519*, E581*, E583*, E586*, E587*, E603*, E862*, E1604*, E1620*, E1642*, E1661*, E1728*, E1729*, E1730*, E514*, E518*, E538*, E546*, E557*, E585*, E601*, E602*, E625*, E628*, E1562*, E1577*, E1643*, E1660*, E1663*, E1687*, E1689*, E1711*, E1712*, E1726*, E1751*, E1753*, E460*, E515*, E539*, E540*, E560*, E580*, E650*, E863*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037646	17	41215352	17	43063335	37646	46202	rs397507244	NC_000017.11:43063334:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5186_5187insCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGAGGTCAGGAGATCGAGACCATCCNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAAAGAAAGAAAAATGCT (p.Asn1730fs)	BRCA1	N1751fs, N626fs, N1730fs, N1683fs	Hereditary breast ovarian cancer syndrome	VCV001452738	17	41215356 - 41215357	17	43063339 - 43063340	1452738	1431882	rs2153556225		Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Nov 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5186del (p.Leu1729fs)	BRCA1	L1682fs, L1750fs, L1729fs, L625fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091640	17	41215357	17	43063340	91640	97117	rs398122692	NC_000017.11:43063339:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5182dup (p.Met1728fs)	BRCA1	M624fs, M1681fs, M1749fs, M1728fs	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000571641	17	41215360 - 41215361	17	43063343 - 43063344	571641	569077	rs34570933	NC_000017.11:43063343:TTTTT:TTTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5181_5182del (p.Lys1727fs)	BRCA1	K1680fs, K1727fs, K1748fs, K623fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236273	17	41215361 - 41215362	17	43063344 - 43063345	236273	237830	rs34570933	NC_000017.11:43063343:TTTTT:TTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5182del (p.Met1728fs)	BRCA1	M1728fs, M624fs, M1681fs, M1749fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055446	17	41215361	17	43063344	55446	70113	rs34570933	NC_000017.11:43063343:TTTTT:TTTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5177_5180del (p.Arg1726fs)	BRCA1	R1747fs, R622fs, R1679fs, R1726fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037644	17	41215363 - 41215366	17	43063346 - 43063349	37644	46200	rs80357867	NC_000017.11:43063345:TTTCTTTCTTT:TTTCTTT	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5179A>T (p.Lys1727Ter)	BRCA1	K1727*, K1748*, K1680*, K623*, K1599*, K1679*, K1722*, K1747*, K1749*, K315*, K447*, K510*, K514*, K544*, K553*, K579*, K581*, K583*, K585*, K1600*, K1637*, K1638*, K1655*, K1656*, K1659*, K1683*, K1685*, K1700*, K1723*, K1724*, K496*, K511*, K535*, K552*, K575*, K582*, K599*, K620*, K622*, K1431*, K1558*, K1598*, K1614*, K1615*, K1616*, K1639*, K1660*, K1678*, K1684*, K1708*, K1726*, K456*, K497*, K515*, K554*, K557*, K576*, K598*, K624*, K645*, K534*, K536*, K542*, K556*, K577*, K584*, K597*, K621*, K646*, K858*, K859*, K1430*, K1573*, K1657*, K1658*, K1686*, K1699*, K1701*, K1707*, K1725*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037645	17	41215364	17	43063347	37645	46201	rs80357347	NC_000017.11:43063346:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5177_5178del (p.Arg1726fs)	BRCA1	R1679fs, R1747fs, R622fs, R1726fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055444	17	41215365 - 41215366	17	43063348 - 43063349	55444	70111	rs80357730	NC_000017.11:43063347:TCT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5176A>T (p.Arg1726Ter)	BRCA1	R1726*, R622*, R1679*, R1747*, R1429*, R1430*, R1557*, R1599*, R1654*, R1659*, R1677*, R1678*, R1684*, R1699*, R1725*, R455*, R514*, R533*, R534*, R535*, R555*, R575*, R576*, R582*, R620*, R857*, R858*, R1614*, R1638*, R1683*, R1721*, R1723*, R1724*, R1746*, R1748*, R496*, R513*, R551*, R556*, R574*, R578*, R583*, R621*, R644*, R645*, R1613*, R1572*, R1598*, R1615*, R1655*, R1657*, R1682*, R1700*, R1706*, R1707*, R446*, R495*, R543*, R552*, R581*, R597*, R619*, R623*, R1597*, R1636*, R1637*, R1656*, R1658*, R1685*, R1698*, R1722*, R314*, R509*, R510*, R541*, R553*, R580*, R584*, R596*, R598*	Hereditary breast ovarian cancer syndrome	VCV000570048	17	41215367	17	43063350	570048	569079	rs80357501	NC_000017.11:43063349:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	May 20, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5176del (p.Arg1726fs)	BRCA1	R1726fs, R622fs, R1679fs, R1747fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230276	17	41215367	17	43063350	230276	235943	rs876658478	NC_000017.11:43063349:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5172dup (p.Glu1725fs)	BRCA1	E1725fs, E1678fs, E621fs, E1746fs	Ovarian cancer	VCV000559969	17	41215370 - 41215371	17	43063353 - 43063354	559969	550688	rs1555578360	NC_000017.11:43063353:TTT:TTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Mar 10, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5173G>T (p.Glu1725Ter)	BRCA1	E1725*, E621*, E1678*, E1746*, E1429*, E1598*, E1614*, E1653*, E1676*, E1677*, E1681*, E1721*, E508*, E532*, E533*, E540*, E542*, E574*, E575*, E583*, E597*, E618*, E619*, E644*, E1596*, E1637*, E1655*, E1657*, E1684*, E1697*, E1705*, E1747*, E494*, E513*, E534*, E550*, E555*, E577*, E580*, E581*, E1612*, E1635*, E1656*, E1658*, E1682*, E1683*, E1706*, E1722*, E1724*, E1745*, E445*, E495*, E509*, E551*, E582*, E1428*, E1556*, E1571*, E1597*, E1613*, E1636*, E1654*, E1698*, E1699*, E1720*, E1723*, E313*, E454*, E512*, E552*, E554*, E573*, E579*, E595*, E596*, E620*, E622*, E643*, E856*, E857*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055442	17	41215370	17	43063353	55442	70109	rs80357291	NC_000017.11:43063352:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5167_5168del (p.Ser1722_Ile1723insTer)	BRCA1		not provided	VCV003337582	17	41215375 - 41215376	17	43063358 - 43063359	3337582	3496243		NC_000017.11:43063357:ATA:A	Deletion	nonsense	Pathogenic	Sep 14, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5167delinsTTT (p.Ile1723fs)	BRCA1	I619fs, I1676fs, I1744fs, I1723fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183180	17	41215376	17	43063359	183180	181313	rs730882167	NC_000017.11:43063358:T:AAA	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5165dup (p.Ile1723fs)	BRCA1	I1744fs, I1676fs, I1723fs, I619fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548279	17	41215377 - 41215378	17	43063360 - 43063361	548279	538770	rs1555578376	NC_000017.11:43063360:G:GG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5161_5165del (p.Gln1721fs)	BRCA1	Q1721fs, Q617fs, Q1674fs, Q1742fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266528	17	41215378 - 41215382	17	43063361 - 43063365	266528	261595	rs886040274	NC_000017.11:43063360:GACTGG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5163_5164insC (p.Ser1722fs)	BRCA1	S1675fs, S1722fs, S1743fs, S618fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266530	17	41215379 - 41215380	17	43063362 - 43063363	266530	261596	rs886040275	NC_000017.11:43063362::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5162del (p.Gln1721fs)	BRCA1	Q1674fs, Q1721fs, Q1742fs, Q617fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055440	17	41215381	17	43063364	55440	70107	rs397509233	NC_000017.11:43063363:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5161C>T (p.Gln1721Ter)	BRCA1	Q1721*, Q1674*, Q1742*, Q617*, Q1567*, Q1632*, Q1677*, Q1679*, Q1680*, Q1716*, Q1743*, Q441*, Q505*, Q529*, Q530*, Q551*, Q569*, Q615*, Q639*, Q852*, Q1424*, Q1425*, Q1552*, Q1631*, Q1633*, Q1649*, Q1672*, Q1678*, Q1717*, Q1718*, Q450*, Q491*, Q528*, Q547*, Q573*, Q592*, Q616*, Q640*, Q853*, Q1592*, Q1594*, Q1608*, Q1609*, Q1650*, Q1651*, Q1652*, Q1653*, Q1695*, Q1702*, Q1719*, Q309*, Q490*, Q550*, Q570*, Q576*, Q579*, Q591*, Q1593*, Q1610*, Q1654*, Q1673*, Q1693*, Q1694*, Q1701*, Q1720*, Q1741*, Q504*, Q508*, Q509*, Q536*, Q538*, Q546*, Q548*, Q571*, Q575*, Q577*, Q578*, Q593*, Q614*, Q618*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266529	17	41215382	17	43063365	266529	261597	rs878854957	NC_000017.11:43063364:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5153-19_5160del	BRCA1		Hereditary cancer-predisposing syndrome	VCV001745681	17	41215383 - 41215409	17	43063366 - 43063392	1745681	1799282	rs2549378092	NC_000017.11:43063365:GGTCACCCCTAAAGAGATCATAGAAAAG:G	Deletion	splice acceptor variant	Pathogenic	Jun 19, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5155_5159delinsAAA (p.Val1719fs)	BRCA1	V1672fs, V1740fs, V1719fs, V615fs	Hereditary breast ovarian cancer syndrome	VCV000531409	17	41215384 - 41215388	17	43063367 - 43063371	531409	531175	rs1555578398	NC_000017.11:43063366:GTCAC:TTT	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Sep 21, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5155_5158dup (p.Thr1720fs)	BRCA1	T1673fs, T1720fs, T616fs, T1741fs	Hereditary breast ovarian cancer syndrome	VCV000531299	17	41215384 - 41215385	17	43063367 - 43063368	531299	531050	rs1555578402	NC_000017.11:43063367:TCAC:TCACTCAC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 10, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5156_5157insAATA (p.Thr1720fs)	BRCA1	T1673fs, T1720fs, T1741fs, T616fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548309	17	41215386 - 41215387	17	43063369 - 43063370	548309	538771	rs1555578407	NC_000017.11:43063369::TATT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5156_5157del (p.Val1719fs)	BRCA1	V615fs, V1672fs, V1719fs, V1740fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055437	17	41215386 - 41215387	17	43063369 - 43063370	55437	70104	rs80357895	NC_000017.11:43063368:CAC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5156del (p.Val1719fs)	BRCA1	V1672fs, V1719fs, V1740fs, V615fs	Breast neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000371936	17	41215387	17	43063370	371936	358932	rs1057517590	NC_000017.11:43063369:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5155dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266527	17	41215387 - 41215388	17	43063370 - 43063371	266527	261598	rs80357743	NC_000017.11:43063370:CCCC:CCCCC	Duplication	splice acceptor variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
U14680.1(BRCA1):n.5274delG	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055436	17	41215388	17	43063371	55436	70103	rs80357743	NC_000017.11:43063370:CCCC:CCC	Deletion		Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5154G>C (p.Trp1718Cys)	BRCA1	W1718C, W1739C, W614C, W1671C, W1422C, W1549C, W1564C, W1605C, W1606C, W1648C, W1651C, W1669C, W1691C, W1699C, W1714C, W1716C, W438C, W533C, W535C, W547C, W568C, W573C, W575C, W611C, W1590C, W1591C, W1629C, W1646C, W1677C, W306C, W488C, W525C, W543C, W570C, W589C, W590C, W615C, W850C, W1421C, W1628C, W1630C, W1647C, W1649C, W1670C, W1674C, W1676C, W1698C, W1715C, W1717C, W1738C, W1740C, W487C, W505C, W506C, W526C, W548C, W566C, W567C, W576C, W588C, W612C, W613C, W636C, W1589C, W1607C, W1675C, W1690C, W1692C, W1713C, W447C, W501C, W502C, W527C, W544C, W545C, W572C, W574C, W637C, W849C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000865068	17	41215389	17	43063372	865068	853883	rs80357239	NC_000017.11:43063371:C:G	single nucleotide variant	missense variant|synonymous variant|non-coding transcript variant	Pathogenic		criteria provided, single submitter							
NM_007294.4(BRCA1):c.5154G>T (p.Trp1718Cys)	BRCA1	W1718C, W1671C, W1739C, W614C, W1422C, W1564C, W1628C, W1629C, W1647C, W1648C, W1670C, W1677C, W1699C, W1738C, W306C, W488C, W506C, W525C, W535C, W548C, W568C, W590C, W613C, W1549C, W1589C, W1607C, W1651C, W1669C, W1674C, W1691C, W1713C, W1740C, W501C, W533C, W544C, W547C, W567C, W573C, W576C, W615C, W849C, W1421C, W1590C, W1605C, W1606C, W1675C, W1690C, W1714C, W1715C, W1716C, W1717C, W487C, W505C, W526C, W527C, W545C, W570C, W572C, W588C, W612C, W636C, W1591C, W1630C, W1646C, W1649C, W1676C, W1692C, W1698C, W438C, W447C, W502C, W543C, W566C, W574C, W575C, W589C, W611C, W637C, W850C	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055435	17	41215389	17	43063372	55435	70102	rs80357239	NC_000017.11:43063371:C:A	single nucleotide variant	missense variant|synonymous variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5154G>A (p.Trp1718Ter)	BRCA1	W1718*, W614*, W1739*, W1671*, W1606*, W1607*, W1628*, W1647*, W1649*, W1674*, W1677*, W1699*, W1716*, W1738*, W488*, W502*, W547*, W548*, W574*, W575*, W611*, W613*, W849*, W1564*, W1591*, W1648*, W1690*, W1698*, W1714*, W1717*, W1740*, W438*, W506*, W526*, W527*, W533*, W543*, W572*, W615*, W637*, W1422*, W1549*, W1605*, W1629*, W1646*, W1651*, W1669*, W1675*, W1676*, W1691*, W1713*, W487*, W501*, W505*, W525*, W545*, W568*, W589*, W612*, W850*, W1421*, W1589*, W1590*, W1630*, W1670*, W1692*, W1715*, W306*, W447*, W535*, W544*, W566*, W567*, W570*, W573*, W576*, W588*, W590*, W636*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055434	17	41215389	17	43063372	55434	70101	rs80357239	NC_000017.11:43063371:C:T	single nucleotide variant	nonsense|synonymous variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5153G>A (p.Trp1718Ter)	BRCA1	W1718*, W1739*, W1671*, W614*, W1549*, W1590*, W1605*, W1647*, W1675*, W1677*, W1691*, W1699*, W1714*, W1717*, W447*, W501*, W502*, W505*, W535*, W548*, W570*, W572*, W573*, W589*, W612*, W637*, G1692E, W1421*, W1564*, W1589*, W1606*, W1646*, W1648*, W1670*, W1674*, W1690*, W1738*, W1740*, W306*, W438*, W506*, W525*, W543*, W547*, W566*, W588*, W613*, W615*, W849*, W1607*, W1628*, W1629*, W1630*, W1669*, W1676*, W1692*, W1698*, W1713*, W1715*, W1716*, W487*, W488*, W526*, W527*, W545*, W568*, W574*, W575*, W590*, W611*, W636*, W850*, G1650E, W1422*, W1591*, W1649*, W1651*, W533*, W544*, W567*, W576*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055432	17	41215390	17	43063373	55432	70099	rs41293461	NC_000017.11:43063372:C:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5153-1G>T	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000055430	17	41215391	17	43063374	55430	70097	rs80358137	NC_000017.11:43063373:C:A	single nucleotide variant	splice acceptor variant	Pathogenic	Mar 22, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5153-1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055429	17	41215391	17	43063374	55429	70096	rs80358137	NC_000017.11:43063373:C:T	single nucleotide variant	splice acceptor variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5153-1G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037643	17	41215391	17	43063374	37643	46199	rs80358137	NC_000017.11:43063373:C:G	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5153-2A>C	BRCA1		Hereditary breast ovarian cancer syndrome|Familial cancer of breast	VCV000868759	17	41215392	17	43063375	868759	855512	rs786202545	NC_000017.11:43063374:T:G	single nucleotide variant	splice acceptor variant	Pathogenic	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5153-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185900	17	41215392	17	43063375	185900	184885	rs786202545	NC_000017.11:43063374:T:C	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5153-2del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055431	17	41215392	17	43063375	55431	70098	rs273901746	NC_000017.11:43063374:T:	Deletion	splice acceptor variant	Pathogenic	Mar 23, 2025	criteria provided, multiple submitters, no conflicts							
NC_000017.11:g.(?_43063854)_(43125483_?)del	LOC111589215|LOC111589216|LOC126862571|BRCA1|LOC110485084		Hereditary breast ovarian cancer syndrome	VCV000583707	17	41215871 - 41277500	17	43063854 - 43125483	583707	570812			Deletion		Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NC_000017.11:g.(?_43063868)_(43124102_?)del	LOC111589216|LOC126862571|BRCA1|LOC110485084		Hereditary breast ovarian cancer syndrome	VCV000531553	17	41215885 - 41276119	17	43063868 - 43124102	531553	531024			Deletion		Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5152+6T>G	BRCA1		not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000125778	17	41215885	17	43063868	125778	131316	rs80358074	NC_000017.11:43063867:A:C	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5152+6T>C	BRCA1		BRCA1-related cancer predisposition	VCV000125777	17	41215885	17	43063868	125777	131315	rs80358074	NC_000017.11:43063867:A:G	single nucleotide variant	intron variant	Pathogenic	Aug 21, 2025	reviewed by expert panel							
NM_007294.4(BRCA1):c.5152+5G>C	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000220736	17	41215886	17	43063869	220736	222651	rs80358165	NC_000017.11:43063868:C:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Aug 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5152+5G>A	BRCA1		Ovarian cancer|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055427	17	41215886	17	43063869	55427	70094	rs80358165	NC_000017.11:43063868:C:T	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5152+2dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055424	17	41215888 - 41215889	17	43063871 - 43063872	55424	70091	rs397509231	NC_000017.11:43063871:A:AA	Duplication	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5152+2T>G	BRCA1		Ovarian neoplasm	VCV000617736	17	41215889	17	43063872	617736	609138	rs886040914	NC_000017.11:43063871:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Nov 12, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5152+2T>C	BRCA1		Hereditary cancer-predisposing syndrome	VCV000491096	17	41215889	17	43063872	491096	485062	rs886040914	NC_000017.11:43063871:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Jan 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5152+2T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267577	17	41215889	17	43063872	267577	262938	rs886040914	NC_000017.11:43063871:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5152+1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125768	17	41215890	17	43063873	125768	131306	rs80358094	NC_000017.11:43063872:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Mar 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5152+1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055423	17	41215890	17	43063873	55423	70090	rs80358094	NC_000017.11:43063872:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5152+1G>C	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037642	17	41215890	17	43063873	37642	46198	rs80358094	NC_000017.11:43063872:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Apr 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075_5152del (p.Asp1692_Trp1718delinsGly)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000433740	17	41215891 - 41215968	17	43063874 - 43063951	433740	427532	rs1555578539		Deletion	inframe_indel|non-coding transcript variant	Pathogenic		criteria provided, single submitter							
NM_007294.4(BRCA1):c.5150del (p.Phe1717fs)	BRCA1	F1717fs, F613fs, F1738fs, F1670fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055422	17	41215893	17	43063876	55422	70089	rs80357720	NC_000017.11:43063875:AAA:AA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5148_5149insC (p.Phe1717fs)	BRCA1	F1670fs, F613fs, F1717fs, F1738fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548266	17	41215894 - 41215895	17	43063877 - 43063878	548266	538772	rs1555578542	NC_000017.11:43063877::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5148T>A (p.Tyr1716Ter)	BRCA1	Y1716*, Y1669*, Y612*, Y1737*, Y1587*, Y1605*, Y1688*, Y1689*, Y1736*, Y485*, Y499*, Y531*, Y533*, Y541*, Y545*, Y568*, Y572*, Y610*, Y634*, Y847*, Y1420*, Y1603*, Y1626*, Y1628*, Y1644*, Y1647*, Y1674*, Y1675*, Y1690*, Y1696*, Y1697*, Y1712*, Y1738*, Y503*, Y504*, Y542*, Y565*, Y570*, Y571*, Y587*, Y613*, Y1419*, Y1589*, Y1604*, Y1646*, Y1649*, Y1673*, Y1711*, Y1714*, Y1715*, Y445*, Y486*, Y523*, Y525*, Y543*, Y546*, Y564*, Y573*, Y574*, Y586*, Y609*, Y611*, Y848*, Y1547*, Y1562*, Y1588*, Y1627*, Y1645*, Y1667*, Y1668*, Y1672*, Y1713*, Y304*, Y436*, Y500*, Y524*, Y566*, Y588*, Y635*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266526	17	41215895	17	43063878	266526	261599	rs397509230	NC_000017.11:43063877:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5148T>G (p.Tyr1716Ter)	BRCA1	Y1716*, Y1669*, Y1737*, Y612*, Y1419*, Y1603*, Y1645*, Y1667*, Y1673*, Y1711*, Y542*, Y543*, Y564*, Y571*, Y1644*, Y1646*, Y1672*, Y1674*, Y1713*, Y1736*, Y486*, Y500*, Y504*, Y531*, Y570*, Y572*, Y634*, Y635*, Y499*, Y523*, Y524*, Y533*, Y541*, Y545*, Y574*, Y586*, Y609*, Y613*, Y847*, Y1420*, Y1587*, Y1626*, Y1628*, Y1647*, Y1675*, Y1688*, Y1690*, Y1696*, Y1697*, Y1738*, Y304*, Y436*, Y485*, Y503*, Y1562*, Y1589*, Y1604*, Y1547*, Y1588*, Y1605*, Y1627*, Y1649*, Y1668*, Y1689*, Y1714*, Y1715*, Y1712*, Y445*, Y525*, Y546*, Y565*, Y566*, Y568*, Y587*, Y610*, Y848*, Y573*, Y588*, Y611*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055419	17	41215895	17	43063878	55419	70086	rs397509230	NC_000017.11:43063877:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5145del (p.Tyr1716fs)	BRCA1	Y1669fs, Y612fs, Y1716fs, Y1737fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125765	17	41215898	17	43063881	125765	131303	rs80357870	NC_000017.11:43063880:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg)	BRCA1	S1715R, S1736R, S611R, S1668R, S1546R, S1602R, S1604R, S1627R, S1666R, S1687R, S1689R, S303R, S435R, S484R, S502R, S523R, S532R, S571R, S573R, S634R, S1586R, S1625R, S1644R, S1648R, S1673R, S1695R, S1696R, S1710R, S1735R, S498R, S499R, S503R, S1418R, S1419R, S1561R, S1603R, S1646R, S1667R, S1672R, S1674R, S1688R, S1711R, S1713R, S1737R, S485R, S563R, S567R, S570R, S572R, S585R, S586R, S633R, S1587R, S1588R, S1626R, S1643R, S1645R, S1671R, S1712R, S1714R, S444R, S524R, S530R, S541R, S564R, S565R, S587R, S609R, S610R, S612R, S522R, S540R, S542R, S544R, S545R, S569R, S608R, S846R, S847R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055418	17	41215898	17	43063881	55418	70085	rs80357094	NC_000017.11:43063880:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5144G>A (p.Ser1715Asn)	BRCA1	S1715N, S1736N, S1668N, S611N, S1418N, S1604N, S1626N, S1648N, S1672N, S1687N, S1689N, S1695N, S1713N, S1735N, S1737N, S444N, S484N, S485N, S498N, S523N, S564N, S565N, S571N, S573N, S587N, S610N, S633N, S846N, S1419N, S1586N, S1587N, S1588N, S1603N, S1643N, S1644N, S1645N, S1666N, S1667N, S1673N, S1674N, S1688N, S1696N, S1710N, S303N, S503N, S532N, S540N, S542N, S563N, S585N, S586N, S609N, S847N, S1546N, S1561N, S1625N, S1627N, S1711N, S541N, S544N, S545N, S567N, S569N, S608N, S612N, S1602N, S1646N, S1671N, S1712N, S1714N, S435N, S499N, S502N, S522N, S524N, S530N, S570N, S572N, S634N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055416	17	41215899	17	43063882	55416	70083	rs45444999	NC_000017.11:43063881:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5143A>T (p.Ser1715Cys)	BRCA1	S1715C, S1736C, S611C, S1668C, S1546C, S1561C, S1666C, S1689C, S1710C, S1714C, S1737C, S444C, S498C, S502C, S503C, S530C, S545C, S565C, S572C, S573C, S587C, S610C, S612C, S634C, S846C, S1418C, S1588C, S1604C, S1625C, S1626C, S1644C, S1671C, S1688C, S1695C, S1712C, S1713C, S1735C, S484C, S499C, S523C, S544C, S569C, S570C, S586C, S608C, S609C, S1419C, S1586C, S1602C, S1603C, S1667C, S1672C, S1674C, S1687C, S1711C, S435C, S485C, S522C, S524C, S540C, S541C, S564C, S585C, S633C, S847C, S1587C, S1627C, S1643C, S1645C, S1646C, S1648C, S1673C, S1696C, S303C, S532C, S542C, S563C, S567C, S571C	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000055415	17	41215900	17	43063883	55415	70082	rs80357222	NC_000017.11:43063882:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5143A>C (p.Ser1715Arg)	BRCA1	S1715R, S1668R, S611R, S1736R, S1419R, S1561R, S1586R, S1587R, S1643R, S1644R, S1689R, S1696R, S1714R, S303R, S498R, S523R, S542R, S544R, S571R, S585R, S633R, S846R, S1602R, S1625R, S1626R, S1648R, S1666R, S1667R, S1671R, S1672R, S1687R, S1688R, S1713R, S1737R, S484R, S499R, S524R, S530R, S541R, S565R, S634R, S1418R, S1546R, S1588R, S1603R, S1627R, S1645R, S1673R, S1695R, S1711R, S1712R, S444R, S502R, S503R, S532R, S540R, S545R, S567R, S569R, S573R, S587R, S610R, S612R, S847R, S1604R, S1646R, S1674R, S1710R, S1735R, S435R, S485R, S522R, S563R, S564R, S570R, S572R, S586R, S608R, S609R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055414	17	41215900	17	43063883	55414	70081	rs80357222	NC_000017.11:43063882:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5141T>G (p.Val1714Gly)	BRCA1	V1714G, V610G, V1667G, V1735G, V1603G, V1643G, V1644G, V1647G, V1665G, V1713G, V1736G, V434G, V498G, V531G, V566G, V568G, V607G, V846G, V1417G, V1642G, V1673G, V1687G, V1709G, V1712G, V1734G, V302G, V483G, V484G, V501G, V523G, V529G, V543G, V544G, V562G, V564G, V569G, V571G, V584G, V608G, V611G, V1418G, V1585G, V1586G, V1602G, V1624G, V1626G, V1645G, V1666G, V1672G, V1686G, V1694G, V1710G, V1711G, V443G, V497G, V502G, V522G, V541G, V570G, V572G, V585G, V586G, V845G, V540G, V563G, V609G, V632G, V633G, V1545G, V1560G, V1587G, V1601G, V1625G, V1670G, V1671G, V1688G, V1695G, V521G, V539G	Breast neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055413	17	41215902	17	43063885	55413	70080	rs80357243	NC_000017.11:43063884:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5138_5139delinsGG (p.Val1713Gly)	BRCA1	V1417G, V1585G, V1623G, V1642G, V1644G, V1664G, V1672G, V1708G, V1734G, V433G, V442G, V483G, V538G, V543G, V561G, V562G, V609G, V631G, V632G, V845G, V1641G, V1646G, V1670G, V1686G, V1687G, V1710G, V1712G, V1735G, V482G, V497G, V540G, V542G, V565G, V567G, V568G, V569G, V571G, V585G, V608G, V844G, V1544G, V1584G, V1600G, V1624G, V1625G, V1665G, V1666G, V1671G, V1685G, V1709G, V1711G, V301G, V501G, V522G, V528G, V539G, V563G, V570G, V583G, V607G, V610G, V1416G, V1559G, V1586G, V1601G, V1602G, V1643G, V1669G, V1693G, V1694G, V1713G, V1733G, V496G, V500G, V520G, V521G, V530G, V584G, V606G	Hereditary cancer-predisposing syndrome	VCV001745580	17	41215904 - 41215905	17	43063887 - 43063888	1745580	1802632	rs2549494030	NC_000017.11:43063886:TA:CC	Indel	missense variant|non-coding transcript variant	Pathogenic	Oct 6, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5138T>G (p.Val1713Gly)	BRCA1	V1666G, V1713G, V1734G, V609G, V1417G, V1601G, V1602G, V1624G, V1625G, V1643G, V1670G, V1687G, V1693G, V301G, V501G, V521G, V530G, V538G, V542G, V570G, V583G, V608G, V632G, V1586G, V1623G, V1665G, V1671G, V1685G, V1694G, V1708G, V1710G, V1712G, V1735G, V483G, V496G, V500G, V522G, V528G, V539G, V540G, V561G, V569G, V571G, V584G, V606G, V845G, V1416G, V1544G, V1585G, V1600G, V1641G, V1642G, V1672G, V1686G, V497G, V565G, V567G, V568G, V610G, V1559G, V1584G, V1644G, V1646G, V1664G, V1669G, V1709G, V1711G, V1733G, V433G, V442G, V482G, V520G, V543G, V562G, V563G, V585G, V607G, V631G, V844G	Hereditary cancer-predisposing syndrome	VCV000868702	17	41215905	17	43063888	868702	853908	rs80357132	NC_000017.11:43063887:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5137dup (p.Val1713fs)	BRCA1	V1666fs, V1713fs, V609fs, V1734fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000531327	17	41215905 - 41215906	17	43063888 - 43063889	531327	531055	rs80357997	NC_000017.11:43063888:CCC:CCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5127_5137del (p.Gly1710fs)	BRCA1	G1710fs, G1731fs, G1663fs, G606fs	Hereditary breast ovarian cancer syndrome	VCV002105679	17	41215906 - 41215916	17	43063889 - 43063899	2105679	2166140	rs2549499057	NC_000017.11:43063888:CCCATTTTCCTCCC:CCC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Mar 2, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5137del (p.Trp1712_Val1713insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055411	17	41215906	17	43063889	55411	70078	rs80357997	NC_000017.11:43063888:CCC:CC	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5136G>A (p.Trp1712Ter)	BRCA1	W1712*, W1665*, W1733*, W608*, W1558*, W1583*, W1585*, W1624*, W1664*, W1669*, W1709*, W300*, W441*, W482*, W519*, W527*, W561*, W564*, W567*, W583*, W584*, W630*, W1599*, W1600*, W1601*, W1640*, W1663*, W1671*, W1684*, W1685*, W1707*, W1711*, W1732*, W496*, W521*, W537*, W539*, W566*, W569*, W605*, W609*, W844*, W1584*, W1622*, W1623*, W1645*, W1668*, W1670*, W1692*, W1693*, W1710*, W1734*, W481*, W520*, W529*, W541*, W542*, W560*, W568*, W582*, W631*, W1415*, W1416*, W1543*, W1641*, W1642*, W1643*, W1686*, W1708*, W432*, W495*, W499*, W500*, W538*, W562*, W570*, W606*, W607*, W843*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055410	17	41215907	17	43063890	55410	70077	rs80357418	NC_000017.11:43063889:C:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5135G>A (p.Trp1712Ter)	BRCA1	W1712*, W1733*, W608*, W1665*, W1558*, W1599*, W1624*, W1640*, W1643*, W1670*, W1686*, W1692*, W1707*, W1710*, W432*, W496*, W520*, W562*, W566*, W569*, W606*, W843*, W1585*, W1622*, W1645*, W1664*, W1669*, W1685*, W1732*, W441*, W481*, W495*, W519*, W538*, W539*, W560*, W564*, W582*, W584*, W605*, W630*, W844*, W1415*, W1416*, W1583*, W1601*, W1623*, W1642*, W1668*, W1693*, W1709*, W1734*, W521*, W527*, W529*, W537*, W542*, W561*, W570*, W583*, W631*, W1543*, W1584*, W1600*, W1641*, W1663*, W1671*, W1684*, W1708*, W1711*, W300*, W482*, W499*, W500*, W541*, W567*, W568*, W607*, W609*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230624	17	41215908	17	43063891	230624	235944	rs876658672	NC_000017.11:43063890:C:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5133dup (p.Trp1712fs)	BRCA1	W1665fs, W1733fs, W608fs, W1712fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254463	17	41215909 - 41215910	17	43063892 - 43063893	254463	249080	rs730880288	NC_000017.11:43063892:TTTT:TTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5133del (p.Lys1711fs)	BRCA1	K1664fs, K1711fs, K607fs, K1732fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000180698	17	41215910	17	43063893	180698	178861	rs730880288	NC_000017.11:43063892:TTTT:TTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5130_5131insG (p.Lys1711fs)	BRCA1	K1664fs, K1711fs, K1732fs, K607fs	Hereditary breast ovarian cancer syndrome	VCV002113186	17	41215912 - 41215913	17	43063895 - 43063896	2113186	2164474	rs2549506201	NC_000017.11:43063895::C	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Mar 17, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5131A>T (p.Lys1711Ter)	BRCA1	K1711*, K1732*, K1664*, K607*, K1557*, K1598*, K1600*, K1622*, K1640*, K1642*, K1644*, K1668*, K1691*, K1706*, K431*, K494*, K495*, K526*, K560*, K563*, K565*, K568*, K581*, K604*, K608*, K1599*, K1639*, K1641*, K1663*, K1667*, K1709*, K1710*, K519*, K528*, K536*, K538*, K569*, K606*, K1414*, K1415*, K1542*, K1621*, K1623*, K1669*, K1683*, K1707*, K1708*, K1731*, K1733*, K299*, K480*, K518*, K520*, K537*, K540*, K541*, K559*, K561*, K567*, K842*, K1582*, K1583*, K1584*, K1662*, K1670*, K1684*, K1685*, K1692*, K440*, K481*, K498*, K499*, K566*, K582*, K583*, K605*, K629*, K630*, K843*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266525	17	41215912	17	43063895	266525	261600	rs886040272	NC_000017.11:43063894:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5129del (p.Gly1710fs)	BRCA1	G1663fs, G1710fs, G1731fs, G606fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431187	17	41215914	17	43063897	431187	424711	rs1135401829	NC_000017.11:43063896:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5128G>T (p.Gly1710Ter)	BRCA1	G1710*, G1731*, G1663*, G606*, G1583*, G1620*, G1622*, G1638*, G1640*, G1683*, G1690*, G1707*, G1708*, G1732*, G439*, G479*, G498*, G518*, G519*, G527*, G536*, G566*, G567*, G605*, G629*, G1413*, G1597*, G1639*, G1641*, G1662*, G1682*, G1709*, G1730*, G430*, G493*, G539*, G560*, G607*, G628*, G842*, G1541*, G1556*, G1582*, G1661*, G1667*, G1669*, G1705*, G298*, G480*, G537*, G540*, G559*, G562*, G564*, G565*, G582*, G603*, G1414*, G1581*, G1598*, G1599*, G1621*, G1643*, G1666*, G1668*, G1684*, G1691*, G1706*, G494*, G497*, G517*, G525*, G535*, G558*, G568*, G580*, G581*, G604*, G841*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055409	17	41215915	17	43063898	55409	70076	rs397509229	NC_000017.11:43063897:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5126del (p.Gly1709fs)	BRCA1	G1730fs, G605fs, G1709fs, G1662fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055408	17	41215917	17	43063900	55408	70075	rs80357874	NC_000017.11:43063899:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5123del (p.Ala1708fs)	BRCA1	A1661fs, A1708fs, A1729fs, A604fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254462	17	41215920	17	43063903	254462	249081	rs886038040	NC_000017.11:43063902:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5123C>A (p.Ala1708Glu)	BRCA1	A1708E, A1661E, A1729E, A604E, A1580E, A1618E, A1619E, A1638E, A1659E, A1411E, A1539E, A1595E, A1641E, A1660E, A1666E, A1688E, A1730E, A437E, A478E, A495E, A535E, A538E, A562E, A564E, A566E, A578E, A627E, A1554E, A1579E, A1581E, A1596E, A1620E, A1636E, A1664E, A1681E, A428E, A496E, A517E, A525E, A533E, A563E, A579E, A601E, A605E, A839E, A1667E, A1704E, A1705E, A1706E, A477E, A515E, A516E, A557E, A560E, A580E, A603E, A626E, A1412E, A1597E, A1637E, A1639E, A1665E, A1680E, A1682E, A1689E, A1703E, A1707E, A1728E, A296E, A491E, A492E, A523E, A534E, A537E, A556E, A558E, A565E, A602E, A840E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055407	17	41215920	17	43063903	55407	70074	rs28897696	NC_000017.11:43063902:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5113_5121delinsA (p.Leu1705fs)	BRCA1	L1658fs, L1705fs, L1726fs, L601fs	Hereditary cancer-predisposing syndrome	VCV001745421	17	41215922 - 41215930	17	43063905 - 43063913	1745421	1802473	rs2549520266	NC_000017.11:43063904:AATTCCTAG:T	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Jan 18, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5114_5121del (p.Leu1705fs)	BRCA1	L1658fs, L1705fs, L1726fs, L601fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266524	17	41215922 - 41215929	17	43063905 - 43063912	266524	261601	rs886040271	NC_000017.11:43063904:AATTCCTA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5117del (p.Gly1706fs)	BRCA1	G1706fs, G602fs, G1659fs, G1727fs	Hereditary cancer-predisposing syndrome	VCV001745441	17	41215926	17	43063909	1745441	1802493	rs2549524360	NC_000017.11:43063908:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 31, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5117G>A (p.Gly1706Glu)	BRCA1	G1706E, G1727E, G1659E, G602E, G1577E, G1593E, G1595E, G1617E, G1636E, G1637E, G1657E, G1658E, G1663E, G1664E, G1665E, G1678E, G1679E, G1686E, G1703E, G435E, G475E, G476E, G490E, G514E, G515E, G523E, G532E, G536E, G554E, G563E, G578E, G599E, G601E, G1409E, G1634E, G1635E, G1701E, G1702E, G1726E, G493E, G531E, G533E, G555E, G561E, G562E, G576E, G1410E, G1537E, G1578E, G1616E, G1639E, G1662E, G1687E, G1705E, G426E, G489E, G521E, G558E, G560E, G564E, G600E, G624E, G625E, G1552E, G1579E, G1594E, G1618E, G1680E, G1704E, G1728E, G294E, G494E, G513E, G535E, G556E, G577E, G603E, G837E, G838E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037638	17	41215926	17	43063909	37638	46194	rs80356860	NC_000017.11:43063908:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5116G>T (p.Gly1706Ter)	BRCA1	G1706*, G1659*, G1727*, G602*, G1409*, G1410*, G1578*, G1595*, G1616*, G1634*, G1635*, G1637*, G1664*, G1665*, G1678*, G1701*, G1703*, G1726*, G294*, G513*, G514*, G521*, G533*, G536*, G603*, G624*, G1552*, G1579*, G1618*, G1657*, G1658*, G1662*, G1679*, G1687*, G1702*, G1705*, G1728*, G426*, G435*, G476*, G515*, G560*, G561*, G562*, G577*, G599*, G837*, G838*, G1593*, G1594*, G1617*, G1636*, G1639*, G1680*, G1704*, G489*, G490*, G532*, G535*, G555*, G558*, G563*, G578*, G625*, G1537*, G1577*, G1663*, G1686*, G475*, G493*, G494*, G523*, G531*, G554*, G556*, G564*, G576*, G600*, G601*	not provided|Hereditary cancer-predisposing syndrome	VCV000868672	17	41215927	17	43063910	868672	853953	rs886040864	NC_000017.11:43063909:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Mar 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5116G>A (p.Gly1706Arg)	BRCA1	G1706R, G1659R, G1727R, G602R, G1537R, G1579R, G1593R, G1634R, G1662R, G1678R, G1687R, G1728R, G476R, G513R, G514R, G523R, G531R, G532R, G558R, G578R, G600R, G601R, G837R, G1410R, G1577R, G1594R, G1616R, G1617R, G1636R, G1637R, G1658R, G1664R, G1665R, G1702R, G426R, G435R, G490R, G554R, G560R, G564R, G599R, G603R, G838R, G1552R, G1595R, G1618R, G1657R, G1663R, G1679R, G1703R, G294R, G493R, G535R, G555R, G556R, G563R, G577R, G1409R, G1578R, G1635R, G1639R, G1680R, G1686R, G1701R, G1704R, G1705R, G1726R, G475R, G489R, G494R, G515R, G521R, G533R, G536R, G561R, G562R, G576R, G624R, G625R	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267221	17	41215927	17	43063910	267221	262101	rs886040864	NC_000017.11:43063909:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5116G>C (p.Gly1706Arg)	BRCA1	G1706R, G1659R, G1727R, G602R, G1410R, G1578R, G1593R, G1595R, G1635R, G1657R, G1663R, G1687R, G1703R, G1704R, G1728R, G476R, G490R, G513R, G514R, G532R, G533R, G536R, G561R, G577R, G578R, G625R, G837R, G838R, G1537R, G1577R, G1594R, G1634R, G1636R, G1662R, G1664R, G1665R, G1678R, G1686R, G1701R, G1705R, G475R, G489R, G521R, G555R, G560R, G562R, G603R, G624R, G1552R, G1616R, G1639R, G1679R, G1702R, G294R, G426R, G435R, G494R, G535R, G554R, G556R, G558R, G563R, G564R, G1409R, G1579R, G1617R, G1618R, G1637R, G1658R, G1680R, G1726R, G493R, G515R, G523R, G531R, G576R, G599R, G600R, G601R	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267219	17	41215927	17	43063910	267219	262100	rs886040864	NC_000017.11:43063909:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5114T>C (p.Leu1705Pro)	BRCA1	L1705P, L1726P, L601P, L1658P, L1577P, L1578P, L1594P, L1635P, L1656P, L1661P, L1703P, L425P, L520P, L531P, L532P, L599P, L600P, L623P, L1592P, L1593P, L1615P, L1616P, L1634P, L1638P, L1664P, L1677P, L1686P, L1701P, L1704P, L475P, L488P, L493P, L513P, L534P, L557P, L559P, L560P, L562P, L576P, L602P, L1408P, L1409P, L1536P, L1617P, L1633P, L1657P, L1678P, L1679P, L1702P, L1725P, L1727P, L293P, L474P, L489P, L512P, L553P, L554P, L575P, L577P, L1551P, L1576P, L1636P, L1662P, L1663P, L1685P, L1700P, L434P, L492P, L514P, L522P, L530P, L535P, L555P, L561P, L563P, L598P, L624P, L836P, L837P	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000037637	17	41215929	17	43063912	37637	46193	rs397507242	NC_000017.11:43063911:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5112del (p.Phe1704_Leu1705insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055404	17	41215931	17	43063914	55404	70071	rs397509228	NC_000017.11:43063913:AAAA:AAA	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5109T>G (p.Tyr1703Ter)	BRCA1	Y1703*, Y599*, Y1656*, Y1724*, Y1576*, Y1613*, Y1614*, Y1615*, Y1633*, Y1655*, Y1659*, Y1661*, Y1662*, Y1677*, Y1684*, Y1701*, Y291*, Y512*, Y520*, Y1406*, Y1574*, Y1575*, Y1654*, Y1675*, Y1683*, Y487*, Y490*, Y511*, Y529*, Y555*, Y561*, Y574*, Y597*, Y598*, Y532*, Y558*, Y560*, Y596*, Y600*, Y834*, Y1549*, Y1591*, Y1632*, Y1634*, Y1636*, Y1660*, Y1676*, Y1700*, Y1725*, Y432*, Y472*, Y473*, Y486*, Y491*, Y510*, Y518*, Y533*, Y557*, Y559*, Y573*, Y575*, Y621*, Y622*, Y835*, Y1407*, Y1534*, Y1590*, Y1592*, Y1631*, Y1698*, Y1699*, Y1702*, Y1723*, Y423*, Y528*, Y530*, Y551*, Y552*, Y553*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055403	17	41215934	17	43063917	55403	70070	rs80356974	NC_000017.11:43063916:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5106del (p.Lys1702fs)	BRCA1	K1655fs, K1702fs, K598fs, K1723fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055402	17	41215937	17	43063920	55402	70069	rs80357553	NC_000017.11:43063919:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5102_5103del (p.Leu1701fs)	BRCA1	L1654fs, L597fs, L1701fs, L1722fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055401	17	41215940 - 41215941	17	43063923 - 43063924	55401	70068	rs80357608	NC_000017.11:43063922:CA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5102del (p.Leu1701fs)	BRCA1	L1701fs, L1722fs, L597fs, L1654fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548191	17	41215941	17	43063924	548191	538773	rs1555578613	NC_000017.11:43063923:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5098del (p.Thr1700fs)	BRCA1	T1653fs, T1700fs, T596fs, T1721fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125763	17	41215945	17	43063928	125763	131301	rs483353099	NC_000017.11:43063927:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	BRCA1	R1699Q, R1652Q, R595Q, R1720Q, R1572Q, R1611Q, R1627Q, R1657Q, R1671Q, R1672Q, R1698Q, R1721Q, R287Q, R469Q, R516Q, R529Q, R547Q, R548Q, R555Q, R556Q, R557Q, R569Q, R592Q, R593Q, R617Q, R1402Q, R1571Q, R1587Q, R1651Q, R1656Q, R1680Q, R1697Q, R506Q, R525Q, R528Q, R549Q, R553Q, R570Q, R618Q, R830Q, R1530Q, R1570Q, R1586Q, R1588Q, R1610Q, R1629Q, R1630Q, R1650Q, R1658Q, R1679Q, R1695Q, R1719Q, R419Q, R428Q, R468Q, R482Q, R486Q, R514Q, R524Q, R554Q, R596Q, R831Q, R1403Q, R1545Q, R1609Q, R1628Q, R1632Q, R1655Q, R1673Q, R1694Q, R1696Q, R483Q, R487Q, R507Q, R508Q, R526Q, R551Q, R571Q, R594Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037636	17	41215947	17	43063930	37636	46192	rs41293459	NC_000017.11:43063929:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 10, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5095C>T (p.Arg1699Trp)	BRCA1	R1699W, R595W, R1720W, R1652W, R1572W, R1630W, R1651W, R1655W, R1673W, R1694W, R1719W, R287W, R487W, R506W, R524W, R526W, R529W, R547W, R551W, R553W, R592W, R594W, R830W, R1570W, R1627W, R1658W, R1680W, R1696W, R1721W, R469W, R482W, R483W, R486W, R514W, R516W, R528W, R556W, R596W, R617W, R525W, R549W, R554W, R555W, R557W, R570W, R593W, R1402W, R1403W, R1545W, R1586W, R1588W, R1611W, R1629W, R1650W, R1657W, R1672W, R1697W, R1698W, R428W, R1530W, R1571W, R1587W, R1609W, R1610W, R1628W, R1632W, R1656W, R1671W, R1679W, R1695W, R419W, R468W, R507W, R508W, R548W, R569W, R571W, R618W, R831W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055396	17	41215948	17	43063931	55396	70063	rs55770810	NC_000017.11:43063930:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5091_5092dup (p.Glu1698fs)	BRCA1	E594fs, E1698fs, E1719fs, E1651fs	Hereditary cancer-predisposing syndrome	VCV001745277	17	41215950 - 41215951	17	43063933 - 43063934	1745277	1802330	rs80357710	NC_000017.11:43063933:CACACACA:CACACACACA	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Feb 27, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5089_5092del (p.Cys1697fs)	BRCA1	C1650fs, C1697fs, C1718fs, C593fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001331488	17	41215951 - 41215954	17	43063934 - 43063937	1331488	1322209	rs80357710	NC_000017.11:43063933:CACACACA:CACA	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5091_5092del (p.Cys1697_Glu1698delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055394	17	41215951 - 41215952	17	43063934 - 43063935	55394	70061	rs80357710	NC_000017.11:43063933:CACACACA:CACACA	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5091del (p.Cys1697fs)	BRCA1	C1718fs, C1697fs, C593fs, C1650fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431272	17	41215952	17	43063935	431272	424791	rs1135401882	NC_000017.11:43063934:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5089T>C (p.Cys1697Arg)	BRCA1	C1697R, C1650R, C593R, C1718R, C1401R, C1586R, C1607R, C1608R, C1609R, C1649R, C1653R, C1656R, C1670R, C1677R, C1695R, C1696R, C285R, C504R, C512R, C555R, C590R, C592R, C1568R, C1570R, C1626R, C1693R, C1694R, C1719R, C426R, C467R, C506R, C522R, C523R, C524R, C527R, C547R, C549R, C552R, C553R, C567R, C591R, C1400R, C1543R, C1584R, C1585R, C1628R, C1648R, C1654R, C1692R, C480R, C484R, C485R, C505R, C546R, C551R, C554R, C568R, C569R, C594R, C828R, C829R, C1528R, C1569R, C1625R, C1627R, C1630R, C1655R, C1669R, C1671R, C1678R, C1717R, C417R, C466R, C481R, C514R, C526R, C545R, C615R, C616R	BRCA1-related cancer predisposition	VCV000055392	17	41215954	17	43063937	55392	70059	rs80356993	NC_000017.11:43063936:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.5084_5087del (p.Phe1695fs)	BRCA1	F1398fs, F1566fs, F1653fs, F1668fs, F1676fs, F1691fs, F1693fs, F415fs, F520fs, F522fs, F524fs, F547fs, F549fs, F553fs, F567fs, F589fs, F1399fs, F1526fs, F1583fs, F1584fs, F1606fs, F1623fs, F1628fs, F1646fs, F1648fs, F1652fs, F1690fs, F1692fs, F1716fs, F464fs, F479fs, F510fs, F521fs, F525fs, F566fs, F614fs, F826fs, F592fs, F613fs, F827fs, F1541fs, F1568fs, F1605fs, F1625fs, F1626fs, F1651fs, F1667fs, F1694fs, F1695fs, F424fs, F502fs, F503fs, F543fs, F545fs, F550fs, F588fs, F1567fs, F1582fs, F1607fs, F1624fs, F1647fs, F1654fs, F1669fs, F1675fs, F1715fs, F1717fs, F283fs, F465fs, F478fs, F482fs, F483fs, F504fs, F512fs, F544fs, F551fs, F552fs, F565fs, F590fs, F591fs	Hereditary breast ovarian cancer syndrome	VCV002824269	17	41215956 - 41215959	17	43063939 - 43063942	2824269	2978943	rs2549560021	NC_000017.11:43063938:ACAAAC:AC	Deletion	frameshift variant|intron variant	Pathogenic	Jul 20, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5085dup (p.Val1696fs)	BRCA1	V1649fs, V1696fs, V1717fs, V592fs	Hereditary cancer-predisposing syndrome	VCV004215118	17	41215957 - 41215958	17	43063940 - 43063941	4215118	1245698		NC_000017.11:43063940:AAA:AAAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Aug 20, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5084_5085insG (p.Phe1695fs)	BRCA1	F1695fs, F1716fs, F591fs, F1648fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548238	17	41215958 - 41215959	17	43063941 - 43063942	548238	538774	rs1555578648	NC_000017.11:43063941::C	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5084_5085del (p.Phe1695fs)	BRCA1	F591fs, F1648fs, F1695fs, F1716fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055388	17	41215958 - 41215959	17	43063941 - 43063942	55388	70055	rs80357760	NC_000017.11:43063940:AAA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5083_5084insG (p.Phe1695fs)	BRCA1	F1648fs, F1716fs, F591fs, F1695fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266523	17	41215959 - 41215960	17	43063942 - 43063943	266523	261602	rs886040270	NC_000017.11:43063942::C	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5080del (p.Glu1694fs)	BRCA1	E590fs, E1715fs, E1647fs, E1694fs	Hereditary cancer-predisposing syndrome	VCV000479233	17	41215963	17	43063946	479233	478567	rs1555578650	NC_000017.11:43063945:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Nov 2, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5077_5080delinsTTGATTCTGC (p.Ala1693_Glu1694delinsLeuIleLeuGln)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267576	17	41215963 - 41215966	17	43063946 - 43063949	267576	262939	rs397509224	NC_000017.11:43063945:CAGC:GCAGAATCAA	Indel	inframe_indel|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5080G>T (p.Glu1694Ter)	BRCA1	E1694*, E1715*, E590*, E1647*, E1525*, E1566*, E1567*, E1627*, E1650*, E1652*, E1689*, E1714*, E1716*, E282*, E482*, E502*, E509*, E544*, E566*, E1581*, E1622*, E1623*, E1624*, E1645*, E1653*, E1668*, E1674*, E1675*, E1692*, E414*, E423*, E464*, E477*, E481*, E503*, E521*, E542*, E548*, E564*, E588*, E826*, E1582*, E1605*, E1646*, E1667*, E1690*, E1691*, E511*, E519*, E543*, E546*, E550*, E551*, E587*, E589*, E613*, E825*, E1397*, E1398*, E1540*, E1565*, E1583*, E1604*, E1606*, E1625*, E1651*, E1666*, E1693*, E463*, E478*, E501*, E520*, E523*, E524*, E549*, E552*, E565*, E591*, E612*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055387	17	41215963	17	43063946	55387	70054	rs80356896	NC_000017.11:43063945:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5078_5080del (p.Ala1693del)	BRCA1	A1693del, A1714del, A589del, A1646del, A1396del, A1565del, A1580del, A1581del, A1603del, A1623del, A1644del, A1666del, A1667del, A422del, A462del, A463del, A502del, A542del, A547del, A565del, A611del, A612del, A520del, A564del, A1397del, A1539del, A1604del, A1621del, A1622del, A1645del, A1650del, A1690del, A476del, A480del, A510del, A519del, A1524del, A1564del, A1566del, A1582del, A1624del, A1626del, A1649del, A1652del, A1665del, A1673del, A1688del, A1689del, A1691del, A1713del, A413del, A481del, A500del, A518del, A523del, A545del, A548del, A549del, A551del, A586del, A587del, A590del, A824del, A825del, A1605del, A1651del, A1674del, A1692del, A1715del, A281del, A477del, A501del, A508del, A522del, A541del, A543del, A550del, A563del, A588del	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055386	17	41215963 - 41215965	17	43063946 - 43063948	55386	70053	rs80358345	NC_000017.11:43063945:CAGCA:CA	Deletion	inframe_indel|inframe_deletion|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075_5078del (p.Asp1692fs)	BRCA1	D1645fs, D1692fs, D1713fs, D588fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055384	17	41215965 - 41215968	17	43063948 - 43063951	55384	70051	rs397509223	NC_000017.11:43063947:GCAT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5076del (p.Asp1692fs)	BRCA1	D1645fs, D588fs, D1692fs, D1713fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266522	17	41215967	17	43063950	266522	261603	rs886040269	NC_000017.11:43063949:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NG_005905.2:g.(?_92501)_(150377_154032)del	LOC126862571|BRCA1|LOC110485084|LOC111589215|LOC111589216		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373882	17	41215969 - 41277500	17	43063952 - 43125483	373882	360757			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5075-1G>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125759	17	41215969	17	43063952	125759	131297	rs1800747	NC_000017.11:43063951:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075-1G>T	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055378	17	41215969	17	43063952	55378	70045	rs1800747	NC_000017.11:43063951:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jan 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075-1G>A	BRCA1		Breast neoplasm|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000055377	17	41215969	17	43063952	55377	70044	rs1800747	NC_000017.11:43063951:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075-2del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000267575	17	41215970	17	43063953	267575	262940	rs886040913	NC_000017.11:43063952:T:	Deletion	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Nov 9, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075-2A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000252381	17	41215970	17	43063953	252381	246810	rs80358066	NC_000017.11:43063952:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075-2A>C	BRCA1		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055379	17	41215970	17	43063953	55379	70046	rs80358066	NC_000017.11:43063952:T:G	single nucleotide variant	intron variant|splice acceptor variant	Pathogenic/Likely pathogenic	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075-8T>G	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055382	17	41215976	17	43063959	55382	70049	rs397509221	NC_000017.11:43063958:A:C	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Nov 24, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4986+892_5075-981del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267566	17	41216949 - 41222053	17	43064932 - 43070036	267566	262941			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4986+890_5075-984del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373849	17	41216952 - 41222055	17	43064935 - 43070038	373849	360731			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4986+955_5074+751del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373852	17	41218874 - 41221990	17	43066857 - 43069973	373852	360732			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-577_5074+343del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267729	17	41219282 - 41220289	17	43067265 - 43068272	267729	262999			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4986+725_5074+84del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267567	17	41219541 - 41222220	17	43067524 - 43070203	267567	262942			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(?_43067588)_(43125483_?)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000650186	17	41219605 - 41277500	17	43067588 - 43125483	650186	653113			Deletion		Pathogenic	Sep 4, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41219605)_(41219732_?)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000645354	17	41219605 - 41219732	17	43067588 - 43067715	645354	652644			Duplication		Pathogenic	Dec 6, 2023	criteria provided, single submitter							
NC_000017.11:g.(?_43067602)_(43124102_?)del	LOC111589216|LOC126862571|LOC110485084|BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462194	17	41219619 - 41276119	17	43067602 - 43124102	462194	467105			Deletion		Pathogenic	Aug 16, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5074+3A>G	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055375	17	41219622	17	43067605	55375	70042	rs80358181	NC_000017.11:43067604:T:C	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5074+2T>A	BRCA1		Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000644935	17	41219623	17	43067606	644935	652960	rs80358089	NC_000017.11:43067605:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5074+2T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037631	17	41219623	17	43067606	37631	46187	rs80358089	NC_000017.11:43067605:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000267570	17	41219624	17	43067607	267570	262943	rs80358053	NC_000017.11:43067606:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 4, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5074+1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037630	17	41219624	17	43067607	37630	46186	rs80358053	NC_000017.11:43067606:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037629	17	41219624	17	43067607	37629	46185	rs80358053	NC_000017.11:43067606:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987_5074del (p.Val1665Serfs)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266506	17	41219625 - 41219712	17	43067608 - 43067695	266506	261604			Deletion	intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.3(BRCA1):c.4676-?_5074+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216106	17	41219625 - 41223255	17	43067608 - 43071238	216106	213237			Deletion		Pathogenic	Nov 29, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.(?_-1)_5074+?del	BRCA1|LOC110485084|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000216100	17	41219625 - 41276114	17	43067608 - 43124097	216100	213238			Deletion		Pathogenic	Feb 11, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4987-?_5074+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000089067	17	41219625 - 41219712	17	43067608 - 43067695	89067	94610			Deletion		Pathogenic	Nov 20, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5074G>T (p.Asp1692Tyr)	BRCA1	D1692Y, D1645Y, D1713Y, D588Y, D1396Y, D1538Y, D1602Y, D1604Y, D1621Y, D1622Y, D1650Y, D1651Y, D1664Y, D1666Y, D1673Y, D1689Y, D421Y, D476Y, D499Y, D501Y, D518Y, D519Y, D522Y, D542Y, D546Y, D548Y, D549Y, D610Y, D1564Y, D1603Y, D1620Y, D1643Y, D1648Y, D1665Y, D1688Y, D461Y, D462Y, D500Y, D509Y, D521Y, D547Y, D550Y, D563Y, D586Y, D824Y, G1692W, D1579Y, D1623Y, D1625Y, D1672Y, D1690Y, D1714Y, D412Y, D540Y, D562Y, D564Y, D589Y, D611Y, D823Y, D1395Y, D1523Y, D1563Y, D1565Y, D1580Y, D1581Y, D1644Y, D1649Y, D1687Y, D1691Y, D1712Y, D475Y, D479Y, D480Y, D507Y, D517Y, D541Y, D544Y, D585Y, D587Y, G1650W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055376	17	41219625	17	43067608	55376	70043	rs80187739	NC_000017.11:43067607:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5074G>C (p.Asp1692His)	BRCA1	D1692H, D1713H, D588H, D1645H, D1620H, D1621H, D1625H, D1664H, D1672H, D1688H, D1690H, D1712H, D412H, D479H, D500H, D501H, D507H, D521H, D542H, D546H, D610H, D611H, D824H, D1395H, D1563H, D1565H, D1579H, D1581H, D1648H, D1666H, D462H, D1564H, D1580H, D1622H, D1644H, D1651H, D1687H, D421H, D461H, D480H, D499H, D517H, D540H, D562H, D587H, D589H, D1538H, D1602H, D1603H, D1604H, D1623H, D1643H, D1649H, D1650H, D1665H, D1673H, D1689H, D1691H, D1714H, D475H, D549H, D564H, D585H, D586H, D823H, D1396H, D1523H, D476H, D509H, D518H, D519H, D522H, D541H, D544H, D547H, D548H, D550H, D563H, G1650R, G1692R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037633	17	41219625	17	43067608	37633	46189	rs80187739	NC_000017.11:43067607:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074G>A (p.Asp1692Asn)	BRCA1	D1692N, D1645N, D1713N, D588N, D1620N, D1648N, D1649N, D1650N, D1665N, D412N, D421N, D462N, D479N, D521N, D541N, D542N, D544N, D546N, D547N, D563N, D586N, D611N, D1523N, D1564N, D1565N, D1581N, D1603N, D1623N, D1673N, D1689N, D1691N, D500N, D519N, D540N, D549N, D550N, D562N, D564N, D587N, D823N, G1692R, D1395N, D1563N, D1579N, D1602N, D1622N, D1651N, D1664N, D1666N, D1687N, D1712N, D475N, D499N, D509N, D517N, D548N, D585N, G1650R, D1396N, D1538N, D1580N, D1604N, D1621N, D1625N, D1643N, D1644N, D1672N, D1688N, D1690N, D1714N, D461N, D476N, D480N, D501N, D507N, D518N, D522N, D589N, D610N, D824N	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037632	17	41219625	17	43067608	37632	46188	rs80187739	NC_000017.11:43067607:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5073A>T (p.Thr1691=)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000599302	17	41219626	17	43067609	599302	590564	rs80356853	NC_000017.11:43067608:T:A	single nucleotide variant	synonymous variant|intron variant	Pathogenic	Dec 13, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5071dup (p.Thr1691fs)	BRCA1	T1691fs, T1712fs, T587fs, T1644fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055372	17	41219627 - 41219628	17	43067610 - 43067611	55372	70039	rs80357672	NC_000017.11:43067610:TTTT:TTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5072C>T (p.Thr1691Ile)	BRCA1	T1691I, T1712I, T1644I, T587I, T1395I, T1619I, T1620I, T1649I, T1650I, T1664I, T1672I, T1686I, T1688I, T1689I, T1711I, T1713I, T420I, T506I, T508I, T541I, T545I, T547I, T585I, T588I, T1522I, T1563I, T1602I, T1624I, T411I, T500I, T540I, T609I, T610I, T1394I, T1579I, T1601I, T1603I, T1621I, T1643I, T1647I, T1648I, T1663I, T1665I, T1690I, T460I, T474I, T475I, T478I, T499I, T517I, T518I, T521I, T543I, T548I, T586I, T823I, T1537I, T1562I, T1564I, T1578I, T1580I, T1622I, T1642I, T1671I, T1687I, T461I, T479I, T498I, T516I, T520I, T539I, T546I, T549I, T561I, T562I, T563I, T584I, T822I	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000037628	17	41219627	17	43067610	37628	46184	rs80357034	NC_000017.11:43067609:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5072C>A (p.Thr1691Lys)	BRCA1	T1691K, T1644K, T1712K, T587K, T1394K, T1537K, T1563K, T1579K, T1601K, T1621K, T1643K, T1648K, T1650K, T1671K, T1672K, T1711K, T420K, T478K, T518K, T521K, T543K, T548K, T584K, T585K, T822K, T1562K, T1564K, T1578K, T1602K, T1642K, T1647K, T1664K, T1687K, T1688K, T1689K, T1690K, T474K, T499K, T517K, T520K, T547K, T562K, T586K, T823K, T1395K, T1522K, T1580K, T1622K, T1663K, T1713K, T475K, T479K, T498K, T539K, T545K, T546K, T549K, T609K, T1603K, T1619K, T1620K, T1624K, T1649K, T1665K, T1686K, T411K, T460K, T461K, T500K, T506K, T508K, T516K, T540K, T541K, T561K, T563K, T588K, T610K	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037627	17	41219627	17	43067610	37627	46183	rs80357034	NC_000017.11:43067609:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5068A>T (p.Lys1690Ter)	BRCA1	K1690*, K1643*, K586*, K1711*, K1393*, K1536*, K1561*, K1578*, K1601*, K1602*, K1685*, K1710*, K460*, K478*, K497*, K505*, K516*, K517*, K542*, K584*, K822*, K1562*, K1579*, K1642*, K1646*, K1649*, K1664*, K1686*, K1712*, K410*, K473*, K474*, K520*, K538*, K540*, K546*, K562*, K583*, K585*, K587*, K608*, K1521*, K1563*, K1621*, K1647*, K1663*, K1671*, K1688*, K1689*, K477*, K499*, K507*, K519*, K539*, K544*, K545*, K548*, K1394*, K1577*, K1600*, K1618*, K1619*, K1620*, K1623*, K1641*, K1648*, K1662*, K1670*, K1687*, K419*, K459*, K498*, K515*, K547*, K560*, K561*, K609*, K821*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037626	17	41219631	17	43067614	37626	46182	rs397507239	NC_000017.11:43067613:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5065dup (p.Met1689fs)	BRCA1	M585fs, M1689fs, M1642fs, M1710fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266521	17	41219633 - 41219634	17	43067616 - 43067617	266521	261605	rs886040268	NC_000017.11:43067616:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5066T>G (p.Met1689Arg)	BRCA1	M1689R, M1642R, M585R, M1710R, M1393R, M1560R, M1562R, M1576R, M1599R, M1619R, M1646R, M1648R, M1663R, M1669R, M1670R, M1709R, M418R, M473R, M504R, M541R, M559R, M560R, M586R, M1600R, M1620R, M1661R, M1711R, M409R, M458R, M459R, M476R, M498R, M506R, M516R, M538R, M543R, M546R, M607R, M821R, M1392R, M1535R, M1561R, M1577R, M1640R, M1641R, M1645R, M1662R, M1687R, M1688R, M472R, M477R, M497R, M514R, M537R, M539R, M545R, M584R, M608R, M820R, M1520R, M1578R, M1601R, M1617R, M1618R, M1622R, M1647R, M1684R, M1685R, M1686R, M496R, M515R, M518R, M519R, M544R, M547R, M561R, M582R, M583R	BRCA1-related disorder|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037625	17	41219633	17	43067616	37625	46181	rs80357061	NC_000017.11:43067615:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5059GTT[1] (p.Val1688del)	BRCA1	V1688del, V1709del, V1641del, V584del, V1392del, V1575del, V1598del, V1599del, V1618del, V1639del, V1644del, V1647del, V1661del, V1686del, V417del, V472del, V517del, V536del, V537del, V581del, V585del, V606del, V1621del, V1640del, V1662del, V1669del, V1708del, V1710del, V496del, V497del, V513del, V514del, V543del, V544del, V559del, V583del, V819del, V1391del, V1519del, V1559del, V1560del, V1561del, V1600del, V1619del, V1645del, V1683del, V1684del, V1687del, V408del, V471del, V476del, V495del, V505del, V515del, V518del, V538del, V545del, V546del, V558del, V560del, V582del, V820del, V1534del, V1576del, V1577del, V1616del, V1617del, V1646del, V1660del, V1668del, V1685del, V457del, V458del, V475del, V503del, V540del, V542del, V607del	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055368	17	41219635 - 41219637	17	43067618 - 43067620	55368	70035	rs80358344	NC_000017.11:43067617:AACAACA:AACA	Microsatellite	inframe_indel|inframe_deletion|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5059_5060insCAAC (p.Val1687fs)	BRCA1	V1687fs, V1708fs, V583fs, V1640fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548270	17	41219639 - 41219640	17	43067622 - 43067623	548270	538775	rs1555579630	NC_000017.11:43067622::GTTG	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5059del (p.Val1687fs)	BRCA1	V1708fs, V583fs, V1640fs, V1687fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482909	17	41219640	17	43067623	482909	479280	rs1555579633	NC_000017.11:43067622:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5058_5059insCAAC (p.Val1687fs)	BRCA1	V1687fs, V1640fs, V1708fs, V583fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266520	17	41219640 - 41219641	17	43067623 - 43067624	266520	261606	rs886040267	NC_000017.11:43067623::GTTG	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5054_5057dup (p.Val1687fs)	BRCA1	V1640fs, V1708fs, V1687fs, V583fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000246021	17	41219641 - 41219642	17	43067624 - 43067625	246021	245023	rs879254050	NC_000017.11:43067624:TGAGT:TGAGTGAGT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5058T>A (p.His1686Gln)	BRCA1	H1686Q, H1639Q, H582Q, H1707Q, H511Q, H512Q, H515Q, H534Q, H535Q, H542Q, H581Q, H817Q, H818Q, H1390Q, H1532Q, H1557Q, H1574Q, H1614Q, H1616Q, H1642Q, H1644Q, H1645Q, H1682Q, H1684Q, H1708Q, H406Q, H473Q, H474Q, H493Q, H516Q, H541Q, H543Q, H556Q, H583Q, H1597Q, H1598Q, H1617Q, H1637Q, H1643Q, H1658Q, H1659Q, H1667Q, H1683Q, H456Q, H470Q, H503Q, H536Q, H538Q, H544Q, H558Q, H1596Q, H1619Q, H1638Q, H1666Q, H1681Q, H1706Q, H415Q, H455Q, H469Q, H495Q, H1389Q, H1517Q, H1558Q, H1559Q, H1573Q, H1575Q, H1615Q, H1660Q, H1685Q, H494Q, H501Q, H513Q, H540Q, H557Q, H579Q, H580Q, H604Q, H605Q	Hereditary breast ovarian cancer syndrome	VCV000055366	17	41219641	17	43067624	55366	70033	rs397509218	NC_000017.11:43067623:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	May 3, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5057A>G (p.His1686Arg)	BRCA1	H1686R, H582R, H1707R, H1639R, H1684R, H406R, H455R, H474R, H495R, H511R, H512R, H513R, H516R, H535R, H604R, H817R, H1575R, H1597R, H1598R, H1615R, H1638R, H1642R, H1644R, H1389R, H1559R, H1614R, H1645R, H1658R, H1681R, H1708R, H503R, H540R, H541R, H556R, H557R, H579R, H580R, H818R, H1390R, H1517R, H1558R, H1573R, H1574R, H1596R, H1617R, H1643R, H1659R, H1660R, H1682R, H1685R, H1706R, H493R, H501R, H536R, H538R, H542R, H543R, H558R, H583R, H1532R, H1557R, H1616R, H1619R, H1637R, H1666R, H1667R, H1683R, H415R, H456R, H469R, H470R, H473R, H494R, H515R, H534R, H544R, H581R, H605R	Inherited ovarian cancer (without breast cancer)|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000183179	17	41219642	17	43067625	183179	181314	rs730882166	NC_000017.11:43067624:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5056dup (p.His1686fs)	BRCA1	H582fs, H1707fs, H1686fs, H1639fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125756	17	41219642 - 41219643	17	43067625 - 43067626	125756	131294	rs80357974	NC_000017.11:43067625:G:GG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5052_5053dup (p.Thr1685fs)	BRCA1	T581fs, T1638fs, T1685fs, T1706fs	Hereditary cancer-predisposing syndrome	VCV000825405	17	41219645 - 41219646	17	43067628 - 43067629	825405	813666	rs1597825743	NC_000017.11:43067628:TA:TATA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	May 30, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	BRCA1	T1685I, T1638I, T1706I, T581I, T1531I, T1557I, T1574I, T1595I, T1613I, T1659I, T1684I, T1705I, T405I, T493I, T494I, T533I, T556I, T579I, T1558I, T1572I, T1596I, T1597I, T1616I, T1618I, T1641I, T1643I, T1657I, T1658I, T1666I, T1680I, T1707I, T455I, T468I, T472I, T500I, T510I, T514I, T515I, T534I, T543I, T555I, T557I, T1516I, T1614I, T1636I, T1642I, T1665I, T1682I, T1683I, T454I, T511I, T512I, T535I, T539I, T578I, T582I, T603I, T604I, T816I, T1389I, T1388I, T1556I, T1573I, T1615I, T1637I, T1644I, T1681I, T414I, T469I, T473I, T492I, T502I, T537I, T540I, T541I, T542I, T580I, T817I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055365	17	41219645	17	43067628	55365	70032	rs80357043	NC_000017.11:43067627:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5051_5052dup (p.Thr1685fs)	BRCA1	T1685fs, T1706fs, T1638fs, T581fs	Hereditary cancer-predisposing syndrome	VCV001745035	17	41219646 - 41219647	17	43067629 - 43067630	1745035	1805881	rs2550221031	NC_000017.11:43067629:AG:AGAG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 18, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala)	BRCA1	T1685A, T1638A, T581A, T1706A, T1558A, T1574A, T1615A, T1618A, T1642A, T1657A, T1658A, T1682A, T1684A, T493A, T502A, T556A, T816A, T1531A, T1572A, T1597A, T1616A, T1636A, T1644A, T1665A, T1681A, T1683A, T405A, T454A, T469A, T511A, T537A, T540A, T541A, T578A, T579A, T582A, T603A, T604A, T1388A, T1389A, T1556A, T1573A, T1596A, T1613A, T1637A, T1641A, T1659A, T1680A, T1707A, T414A, T455A, T468A, T492A, T494A, T514A, T515A, T533A, T534A, T543A, T555A, T557A, T1516A, T1557A, T1595A, T1614A, T1643A, T1666A, T1705A, T472A, T473A, T500A, T510A, T512A, T535A, T539A, T542A, T580A, T817A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055364	17	41219646	17	43067629	55364	70031	rs80356890	NC_000017.11:43067628:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5049_5050dup (p.Thr1684fs)	BRCA1	T1637fs, T1684fs, T1705fs, T580fs	Familial cancer of breast	VCV001685579	17	41219648 - 41219649	17	43067631 - 43067632	1685579	1677595	rs2153700736	NC_000017.11:43067631:TCTCT:TCTCTCT	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	May 4, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5051del (p.Thr1684fs)	BRCA1	T1637fs, T1684fs, T1705fs, T580fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431271	17	41219648	17	43067631	431271	424792	rs1135401881	NC_000017.11:43067630:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5050_5051del (p.Thr1684fs)	BRCA1	T1637fs, T1684fs, T1705fs, T580fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252385	17	41219648 - 41219649	17	43067631 - 43067632	252385	246811	rs879255283	NC_000017.11:43067630:GT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5044_5048delinsT (p.Thr1681_Glu1682insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266519	17	41219651 - 41219655	17	43067634 - 43067638	266519	261607	rs886040266	NC_000017.11:43067633:TCTTC:A	Indel	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5047G>T (p.Glu1683Ter)	BRCA1	E1683*, E1704*, E579*, E1636*, E1555*, E1593*, E1595*, E1635*, E1656*, E452*, E491*, E533*, E538*, E555*, E576*, E602*, E1386*, E1387*, E1514*, E1572*, E1634*, E1639*, E1642*, E1663*, E1680*, E1681*, E1703*, E1705*, E403*, E412*, E453*, E470*, E471*, E490*, E492*, E498*, E500*, E509*, E510*, E540*, E553*, E578*, E1529*, E1570*, E1571*, E1611*, E1613*, E1614*, E1616*, E1641*, E1664*, E508*, E513*, E535*, E539*, E541*, E580*, E814*, E1554*, E1556*, E1594*, E1612*, E1640*, E1655*, E1657*, E1678*, E1679*, E1682*, E466*, E467*, E512*, E531*, E532*, E537*, E554*, E577*, E601*, E815*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055363	17	41219652	17	43067635	55363	70030	rs80356879	NC_000017.11:43067634:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5044del (p.Glu1682fs)	BRCA1	E1555fs, E1592fs, E1633fs, E1639fs, E1641fs, E1682fs, E1702fs, E402fs, E469fs, E499fs, E534fs, E538fs, E553fs, E554fs, E577fs, E579fs, E601fs, E813fs, E1662fs, E1679fs, E1681fs, E411fs, E491fs, E508fs, E509fs, E512fs, E539fs, E540fs, E578fs, E1553fs, E1571fs, E1593fs, E1610fs, E1612fs, E1638fs, E1654fs, E1655fs, E1513fs, E1528fs, E1554fs, E1569fs, E1570fs, E1611fs, E1615fs, E1634fs, E1656fs, E1663fs, E1677fs, E1680fs, E451fs, E452fs, E466fs, E470fs, E489fs, E497fs, E530fs, E531fs, E536fs, E537fs, E576fs, E600fs, E814fs, E1385fs, E1386fs, E1594fs, E1613fs, E1635fs, E1640fs, E1678fs, E1703fs, E1704fs, E465fs, E490fs, E507fs, E511fs, E532fs, E552fs, E575fs	Hereditary cancer-predisposing syndrome	VCV003481811	17	41219655	17	43067638	3481811	3640022		NC_000017.11:43067637:C:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 26, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5043_5044insTAAT (p.Glu1682Ter)	BRCA1	E578*, E1703*, E1635*, E1682*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548318	17	41219655 - 41219656	17	43067638 - 43067639	548318	538776	rs1555579675	NC_000017.11:43067638:A:ATTAA	Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5035_5042del (p.Asn1678_Leu1679insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003711669	17	41219657 - 41219664	17	43067640 - 43067647	3711669	3837351		NC_000017.11:43067639:GTAATTAG:	Deletion	nonsense|intron variant	Pathogenic	Dec 19, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5042del (p.Thr1681fs)	BRCA1	T1634fs, T1681fs, T577fs, T1702fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266518	17	41219657	17	43067640	266518	261609	rs886040265	NC_000017.11:43067639:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5041_5042insTTAA (p.Thr1681fs)	BRCA1	T1634fs, T577fs, T1702fs, T1681fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266517	17	41219657 - 41219658	17	43067640 - 43067641	266517	261608	rs886040264	NC_000017.11:43067640:T:TTAAT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5038_5041dup (p.Thr1681fs)	BRCA1	T1702fs, T1681fs, T1634fs, T577fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266516	17	41219657 - 41219658	17	43067640 - 43067641	266516	261610	rs1555579686	NC_000017.11:43067640:TAATTA:TAATTAATTA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5039_5040del (p.Ile1680fs)	BRCA1	I1633fs, I1701fs, I576fs, I1680fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431358	17	41219659 - 41219660	17	43067642 - 43067643	431358	424883	rs1135401935	NC_000017.11:43067641:AA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.5040del (p.Thr1681fs)	BRCA1	T1681fs, T1702fs, T1634fs, T577fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055360	17	41219659	17	43067642	55360	70027	rs80357673	NC_000017.11:43067641:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5035_5039del (p.Leu1679fs)	BRCA1	L1632fs, L1679fs, L575fs, L1700fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037624	17	41219660 - 41219664	17	43067643 - 43067647	37624	46180	rs80357623	NC_000017.11:43067642:ATTAGATTAG:ATTAG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5036_5037del (p.Leu1679fs)	BRCA1	L1382fs, L1383fs, L1589fs, L1590fs, L1610fs, L1632fs, L1635fs, L1660fs, L1678fs, L1701fs, L462fs, L463fs, L488fs, L494fs, L505fs, L509fs, L536fs, L598fs, L810fs, L1510fs, L1525fs, L1552fs, L1567fs, L1591fs, L1608fs, L1609fs, L1636fs, L1637fs, L1659fs, L1674fs, L1700fs, L399fs, L466fs, L504fs, L527fs, L533fs, L537fs, L550fs, L574fs, L1550fs, L1566fs, L1612fs, L1631fs, L1651fs, L1652fs, L1653fs, L1676fs, L1699fs, L408fs, L449fs, L467fs, L486fs, L496fs, L506fs, L508fs, L529fs, L534fs, L551fs, L572fs, L575fs, L811fs, L1551fs, L1568fs, L1607fs, L1630fs, L1638fs, L1675fs, L1677fs, L1679fs, L448fs, L487fs, L528fs, L531fs, L535fs, L549fs, L573fs, L576fs, L597fs	Hereditary breast ovarian cancer syndrome	VCV002739034	17	41219662 - 41219663	17	43067645 - 43067646	2739034	2902398	rs2550264308	NC_000017.11:43067644:TA:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 12, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5026_5036del (p.Leu1676fs)	BRCA1	L1629fs, L1676fs, L1697fs, L572fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055356	17	41219663 - 41219673	17	43067646 - 43067656	55356	70023	rs80357894	NC_000017.11:43067645:AGATTAGTTAAAG:AG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5035del (p.Asn1678_Leu1679insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055358	17	41219664	17	43067647	55358	70025	rs80357896	NC_000017.11:43067646:G:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5034del (p.Asn1678_Leu1679insTer)	BRCA1		not provided	VCV000988413	17	41219665	17	43067648	988413	976423	rs2052173011	NC_000017.11:43067647:A:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 25, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5030_5033dup (p.Asn1678_Leu1679insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266515	17	41219665 - 41219666	17	43067648 - 43067649	266515	261611	rs80357580	NC_000017.11:43067648:TTAGTTA:TTAGTTAGTTA	Duplication	frameshift variant|nonsense|inframe_insertion|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.3(BRCA1):c.5033_5034ins4	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125755	17	41219665 - 41219666	17	43067648 - 43067649	125755	131293			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5030_5033del (p.Thr1677fs)	BRCA1	T1677fs, T1630fs, T1698fs, T573fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037623	17	41219666 - 41219669	17	43067649 - 43067652	37623	46179	rs80357580	NC_000017.11:43067648:TTAGTTA:TTA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5027_5031del (p.Thr1675_Leu1676insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254461	17	41219668 - 41219672	17	43067651 - 43067655	254461	249082	rs431825410	NC_000017.11:43067650:AGTTAA:A	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5027_5028insCTTTTTCTTTTTTTTCTTTTNNNNNNNNNNGATCTCCTGACCTCGTGATCCGCCCGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGCGCCCGGCCCACCACATCACTTT (p.Leu1676delinsPhePhePhePhePhePhePheXaaXaaXaaXaaIleSerTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001072881	17	41219671 - 41219672	17	43067654 - 43067655	1072881	1064182	rs2153707696		Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Jan 6, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5027dup (p.Leu1676fs)	BRCA1	L1676fs, L1697fs, L1629fs, L572fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055357	17	41219671 - 41219672	17	43067654 - 43067655	55357	70024	rs397509217	NC_000017.11:43067654:AAA:AAAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5027T>A (p.Leu1676Ter)	BRCA1	L1676*, L1629*, L1697*, L572*, L1380*, L1547*, L1563*, L1565*, L1609*, L1633*, L1648*, L1673*, L1674*, L446*, L464*, L483*, L484*, L501*, L502*, L530*, L531*, L547*, L571*, L1379*, L1507*, L1607*, L1627*, L1635*, L1649*, L1650*, L1657*, L1675*, L1696*, L405*, L445*, L460*, L525*, L528*, L533*, L594*, L808*, L1564*, L1604*, L1605*, L1606*, L1628*, L1656*, L1672*, L1698*, L459*, L485*, L505*, L524*, L534*, L569*, L573*, L595*, L1522*, L1548*, L1549*, L1586*, L1587*, L1588*, L1632*, L1634*, L1671*, L396*, L463*, L491*, L493*, L503*, L506*, L526*, L532*, L546*, L548*, L570*, L807*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266513	17	41219672	17	43067655	266513	261612	rs786203754	NC_000017.11:43067654:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5027del (p.Thr1675_Leu1676insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266512	17	41219672	17	43067655	266512	261614	rs397509217	NC_000017.11:43067654:AAA:AA	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5026_5027del (p.Leu1676fs)	BRCA1	L1676fs, L572fs, L1629fs, L1697fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266511	17	41219672 - 41219673	17	43067655 - 43067656	266511	261613	rs397509217	NC_000017.11:43067654:AAA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5027T>G (p.Leu1676Ter)	BRCA1	L1676*, L572*, L1629*, L1697*, L1522*, L1627*, L1635*, L1675*, L446*, L525*, L530*, L570*, L595*, L1547*, L1549*, L1563*, L1564*, L1586*, L1604*, L1606*, L1650*, L1673*, L1674*, L1696*, L1698*, L463*, L483*, L485*, L491*, L493*, L501*, L569*, L571*, L573*, L594*, L1380*, L1507*, L1548*, L1565*, L1587*, L1588*, L1605*, L1633*, L1634*, L1648*, L396*, L460*, L505*, L531*, L533*, L546*, L547*, L807*, L808*, L1379*, L1607*, L1609*, L1628*, L1632*, L1649*, L1656*, L1657*, L1671*, L1672*, L405*, L445*, L459*, L464*, L484*, L502*, L503*, L506*, L524*, L526*, L528*, L532*, L534*, L548*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187466	17	41219672	17	43067655	187466	184889	rs786203754	NC_000017.11:43067654:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5024_5025insGAGCCGAATTGGTATATAGTTTAAACAAAACGAATGATTTC (p.Thr1675_Leu1676insSerArgIleGlyIleTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003379247	17	41219674 - 41219675	17	43067657 - 43067658	3379247	3538426		NC_000017.11:43067657:G:GAAATCATTCGTTTTGTTTAAACTATATACCAATTCGGCTCG	Insertion	nonsense|intron variant	Pathogenic	Jul 18, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5021dup (p.Thr1675fs)	BRCA1	T1675fs, T571fs, T1696fs, T1628fs	Hereditary breast ovarian cancer syndrome|not provided	VCV000545802	17	41219677 - 41219678	17	43067660 - 43067661	545802	536489	rs1555579721	NC_000017.11:43067660:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	May 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5019del (p.His1673fs)	BRCA1	H1626fs, H1673fs, H569fs, H1694fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266510	17	41219680	17	43067663	266510	261615	rs886040260	NC_000017.11:43067662:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5014CAC[1] (p.His1673del)	BRCA1	H1673del, H1694del, H569del, H1626del, H1377del, H1545del, H1560del, H1561del, H1583del, H1602del, H1603del, H1629del, H1631del, H1645del, H1647del, H442del, H461del, H498del, H499del, H527del, H529del, H530del, H543del, H570del, H1562del, H1585del, H1601del, H1604del, H1625del, H1632del, H1653del, H1654del, H1668del, H1670del, H402del, H460del, H490del, H500del, H521del, H522del, H531del, H544del, H545del, H567del, H592del, H804del, H1376del, H1544del, H1624del, H1630del, H1646del, H1669del, H1672del, H1695del, H393del, H456del, H457del, H488del, H502del, H525del, H528del, H566del, H568del, H591del, H1504del, H1519del, H1546del, H1584del, H1606del, H1671del, H1693del, H443del, H480del, H481del, H482del, H503del, H523del, H805del	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055355	17	41219680 - 41219682	17	43067663 - 43067665	55355	70022	rs80358343	NC_000017.11:43067662:GTGGTG:GTG	Microsatellite	inframe_indel|inframe_deletion|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5013dup (p.His1672fs)	BRCA1	H1672fs, H568fs, H1625fs, H1693fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266509	17	41219685 - 41219686	17	43067668 - 43067669	266509	261616	rs886040259	NC_000017.11:43067668:TTTT:TTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5009del (p.Arg1670fs)	BRCA1	R1373fs, R1374fs, R1501fs, R1516fs, R1541fs, R1542fs, R1543fs, R1557fs, R1558fs, R1559fs, R1580fs, R1581fs, R1582fs, R1598fs, R1599fs, R1600fs, R1601fs, R1603fs, R1621fs, R1622fs, R1623fs, R1626fs, R1627fs, R1628fs, R1629fs, R1642fs, R1643fs, R1644fs, R1650fs, R1651fs, R1665fs, R1666fs, R1667fs, R1668fs, R1669fs, R1670fs, R1690fs, R1691fs, R1692fs, R390fs, R399fs, R439fs, R440fs, R453fs, R454fs, R457fs, R458fs, R477fs, R478fs, R479fs, R485fs, R487fs, R495fs, R496fs, R497fs, R499fs, R500fs, R518fs, R519fs, R520fs, R522fs, R524fs, R525fs, R526fs, R527fs, R528fs, R540fs, R541fs, R542fs, R563fs, R564fs, R565fs, R566fs, R567fs, R588fs, R589fs, R801fs, R802fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003367190	17	41219690	17	43067673	3367190	3526389		NC_000017.11:43067672:C:	Deletion	frameshift variant|intron variant	Pathogenic		criteria provided, single submitter							
NM_007294.4(BRCA1):c.5008_5009insC (p.Arg1670fs)	BRCA1	R1691fs, R1623fs, R1670fs, R566fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548322	17	41219690 - 41219691	17	43067673 - 43067674	548322	538777	rs1555579738	NC_000017.11:43067673::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4995_5007dup (p.Arg1670fs)	BRCA1	R1670fs, R1623fs, R1691fs, R566fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266507	17	41219691 - 41219692	17	43067674 - 43067675	266507	261617	rs1555579747	NC_000017.11:43067674:GGCAAACTTGTAC:GGCAAACTTGTACGGCAAACTTGTAC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5005del (p.Ala1669fs)	BRCA1	A1622fs, A1669fs, A1690fs, A565fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055354	17	41219694	17	43067677	55354	70021	rs80357938	NC_000017.11:43067676:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4999A>T (p.Lys1667Ter)	BRCA1	K1667*, K563*, K1688*, K1620*, K1554*, K1598*, K1619*, K1640*, K1647*, K1663*, K1664*, K1665*, K1689*, K436*, K451*, K476*, K497*, K515*, K517*, K537*, K564*, K585*, K798*, K1513*, K1577*, K1579*, K1618*, K1624*, K1625*, K1639*, K1641*, K1662*, K396*, K455*, K475*, K494*, K519*, K521*, K586*, K1538*, K1539*, K1555*, K1556*, K1595*, K1600*, K1648*, K1666*, K437*, K450*, K474*, K482*, K484*, K492*, K516*, K523*, K525*, K538*, K560*, K561*, K799*, K1370*, K1371*, K1498*, K1540*, K1578*, K1596*, K1597*, K1623*, K1626*, K1687*, K387*, K454*, K493*, K496*, K522*, K524*, K539*, K562*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055353	17	41219700	17	43067683	55353	70020	rs80357204	NC_000017.11:43067682:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4996_4997dup (p.Lys1667fs)	BRCA1	K1688fs, K563fs, K1620fs, K1667fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409305	17	41219701 - 41219702	17	43067684 - 43067685	409305	402044	rs1555579782	NC_000017.11:43067684:TA:TATA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4997dup (p.Tyr1666Ter)	BRCA1	Y1687*, Y1619*, Y1666*, Y562*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231083	17	41219701 - 41219702	17	43067684 - 43067685	231083	235949	rs876658947	NC_000017.11:43067684:T:TT	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4998C>A (p.Tyr1666Ter)	BRCA1	Y1666*, Y1619*, Y1687*, Y562*, Y1512*, Y1538*, Y1553*, Y1578*, Y1596*, Y1597*, Y1618*, Y1625*, Y1647*, Y1661*, Y1662*, Y1686*, Y483*, Y491*, Y496*, Y514*, Y518*, Y523*, Y538*, Y584*, Y1497*, Y1554*, Y1555*, Y1623*, Y1665*, Y1688*, Y395*, Y450*, Y473*, Y481*, Y495*, Y515*, Y522*, Y524*, Y561*, Y798*, Y1369*, Y1576*, Y1577*, Y1599*, Y1622*, Y1624*, Y1640*, Y386*, Y436*, Y453*, Y454*, Y474*, Y475*, Y493*, Y520*, Y537*, Y563*, Y585*, Y797*, Y1370*, Y1537*, Y1539*, Y1594*, Y1595*, Y1617*, Y1638*, Y1639*, Y1646*, Y1663*, Y1664*, Y435*, Y449*, Y492*, Y516*, Y521*, Y536*, Y559*, Y560*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183178	17	41219701	17	43067684	183178	181315	rs730882165	NC_000017.11:43067683:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4996del (p.Tyr1666fs)	BRCA1	Y450fs, Y483fs, Y491fs, Y492fs, Y496fs, Y515fs, Y521fs, Y538fs, Y562fs, Y797fs, Y798fs, Y1537fs, Y1553fs, Y1554fs, Y1555fs, Y1576fs, Y1595fs, Y1597fs, Y1599fs, Y1618fs, Y395fs, Y449fs, Y453fs, Y474fs, Y495fs, Y516fs, Y518fs, Y523fs, Y559fs, Y560fs, Y563fs, Y584fs, Y585fs, Y1370fs, Y1577fs, Y1594fs, Y1619fs, Y1625fs, Y1638fs, Y1639fs, Y1662fs, Y1664fs, Y1686fs, Y1687fs, Y454fs, Y475fs, Y481fs, Y493fs, Y520fs, Y522fs, Y536fs, Y561fs, Y1369fs, Y1538fs, Y1539fs, Y1596fs, Y1617fs, Y1623fs, Y1624fs, Y1646fs, Y1661fs, Y1666fs, Y1688fs, Y436fs, Y473fs, Y514fs, Y524fs, Y537fs, Y1497fs, Y1512fs, Y1578fs, Y1622fs, Y1640fs, Y1647fs, Y1663fs, Y1665fs, Y386fs, Y435fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004056151	17	41219703	17	43067686	4056151	4170091		NC_000017.11:43067685:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 11, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4992dup (p.Val1665fs)	BRCA1	V1665fs, V1686fs, V1618fs, V561fs	Hereditary cancer-predisposing syndrome	VCV001744611	17	41219706 - 41219707	17	43067689 - 43067690	1744611	1809391	rs2550384637	NC_000017.11:43067689:G:GG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 19, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987del (p.Met1663fs)	BRCA1	M1616fs, M1663fs, M1684fs, M559fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267569	17	41219712	17	43067695	267569	262944	rs886040912	NC_000017.11:43067694:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-1G>C	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000481445	17	41219713	17	43067696	481445	478523	rs730881495	NC_000017.11:43067695:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NC_000017.10:g.(41219713_41222944)_(41267797_41276033)del	LOC110485084|LOC111589216|LOC126862571|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440439	17	41219713 - 41276033	17	43067696 - 43124016	440439	434069			Deletion		Pathogenic	Jan 16, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267565	17	41219713	17	43067696	267565	262945	rs730881495	NC_000017.11:43067695:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182165	17	41219713	17	43067696	182165	180825	rs730881495	NC_000017.11:43067695:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Apr 3, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-2A>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000240810	17	41219714	17	43067697	240810	242768	rs397509212	NC_000017.11:43067696:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Feb 7, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4987-2A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055345	17	41219714	17	43067697	55345	70012	rs397509212	NC_000017.11:43067696:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-3C>G	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055346	17	41219715	17	43067698	55346	70013	rs397509213	NC_000017.11:43067697:G:C	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4987-5T>A	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055347	17	41219717	17	43067700	55347	70014	rs397509214	NC_000017.11:43067699:A:T	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4987-1352A>G	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001383644	17	41221064	17	43069047	1383644	1354784	rs2153749819	NC_000017.11:43069046:T:C	single nucleotide variant	intron variant	Pathogenic	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4676-1420_4986+900del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267559	17	41222045 - 41224675	17	43070028 - 43072658	267559	262947			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4358-1746_4986+736dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001739969	17	41222208 - 41222209	17	43070191 - 43070192	1739969	1794415			Duplication	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Jun 14, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4358-1729_4986+736dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373850	17	41222208 - 41222209	17	43070191 - 43070192	373850	360733			Duplication	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(?_43070908)_(43125483_?)del	LOC111589216|LOC126862571|BRCA1|LOC110485084|LOC111589215		Hereditary breast ovarian cancer syndrome	VCV000666230	17	41222925 - 41277500	17	43070908 - 43125483	666230	652646			Deletion		Pathogenic	Oct 2, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43070922)_(43076620_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462188	17	41222939 - 41228637	17	43070922 - 43076620	462188	467115			Deletion		Pathogenic	Mar 10, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4986+6T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055344	17	41222939	17	43070922	55344	70011	rs80358086	NC_000017.11:43070921:A:C	single nucleotide variant	intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4986+6T>C	BRCA1		Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Breast and/or ovarian cancer|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037620	17	41222939	17	43070922	37620	46176	rs80358086	NC_000017.11:43070921:A:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Jul 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4986+5G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267562	17	41222940	17	43070923	267562	262948	rs397509211	NC_000017.11:43070922:C:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4986+5G>A	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000096936	17	41222940	17	43070923	96936	102839	rs397509211	NC_000017.11:43070922:C:T	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Oct 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4986+4A>T	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055342	17	41222941	17	43070924	55342	70009	rs80358087	NC_000017.11:43070923:T:A	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Mar 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4986+4A>C	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037619	17	41222941	17	43070924	37619	46175	rs80358087	NC_000017.11:43070923:T:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4986+3G>C	BRCA1		BRCA1-related cancer predisposition|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055341	17	41222942	17	43070925	55341	70008	rs80358023	NC_000017.11:43070924:C:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Aug 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4986+2T>A	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000868086	17	41222943	17	43070926	868086	855662	rs397509210	NC_000017.11:43070925:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Feb 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.4986+1_4986+2ins65	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267561	17	41222943 - 41222944	17	43070926 - 43070927	267561	262949			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4986+2T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055340	17	41222943	17	43070926	55340	70007	rs397509210	NC_000017.11:43070925:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4986dup (p.Met1663fs)	BRCA1	M559fs, M1684fs, M1616fs, M1663fs	Hereditary cancer-predisposing syndrome	VCV000491092	17	41222944 - 41222945	17	43070927 - 43070928	491092	485316	rs1555580601	NC_000017.11:43070927:AAA:AAAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Mar 31, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4986+1G>A	BRCA1		not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000125738	17	41222944	17	43070927	125738	131276	rs80358162	NC_000017.11:43070926:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4986+1G>T	BRCA1		not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037618	17	41222944	17	43070927	37618	46174	rs80358162	NC_000017.11:43070926:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.4676-?_4986+?del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000417597	17	41222945 - 41223255	17	43070928 - 43071238	417597	401984			Deletion		Pathogenic	Dec 5, 2016	criteria provided, single submitter							
NM_007294.3(BRCA1):c.81-?_4986+?del	LOC126862571|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000254043	17	41222945 - 41267796	17	43070928 - 43115779	254043	248523			Deletion		Pathogenic	May 5, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.4485-?_4986+?del	BRCA1		Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000089066	17	41222945 - 41226538	17	43070928 - 43074521	89066	94609			Deletion		Pathogenic	Jan 12, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4966_4984del (p.Gly1656fs)	BRCA1	G1609fs, G1677fs, G552fs, G1656fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017679	17	41222947 - 41222965	17	43070930 - 43070948	17679	32718	rs80359884	NC_000017.11:43070929:ATTCTTCTGGGGTCAGGCCA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4964_4982del (p.Ser1655fs)	BRCA1	S551fs, S1655fs, S1608fs, S1676fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037616	17	41222949 - 41222967	17	43070932 - 43070950	37616	46172	rs80359876	NC_000017.11:43070931:TCTTCTGGGGTCAGGCCAG:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4981G>T (p.Glu1661Ter)	BRCA1	E1661*, E1682*, E1614*, E557*, E1364*, E1492*, E1532*, E1533*, E1534*, E1572*, E1591*, E1594*, E1612*, E1618*, E1619*, E1656*, E1683*, E431*, E486*, E491*, E510*, E511*, E533*, E554*, E556*, E792*, E1592*, E1634*, E1657*, E381*, E448*, E478*, E509*, E515*, E519*, E531*, E579*, E580*, E1365*, E1507*, E1571*, E1589*, E1590*, E1613*, E1620*, E1633*, E1642*, E1660*, E390*, E430*, E469*, E476*, E487*, E488*, E490*, E513*, E516*, E555*, E558*, E1548*, E1549*, E1550*, E1573*, E1617*, E1635*, E1641*, E1658*, E1659*, E1681*, E444*, E445*, E449*, E468*, E470*, E517*, E518*, E532*, E793*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055338	17	41222950	17	43070933	55338	70005	rs80357401	NC_000017.11:43070932:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4964_4979del (p.Val1654_Ser1655insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055334	17	41222952 - 41222967	17	43070935 - 43070950	55334	70001	rs397509209	NC_000017.11:43070934:TCTGGGGTCAGGCCAG:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4976del (p.Pro1659fs)	BRCA1	P1659fs, P555fs, P1612fs, P1680fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252399	17	41222955	17	43070938	252399	246812	rs879255295	NC_000017.11:43070937:GGGG:GGG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4972del (p.Thr1658fs)	BRCA1	T554fs, T1658fs, T1679fs, T1611fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417822	17	41222959	17	43070942	417822	404711	rs1060505044	NC_000017.11:43070941:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4969del (p.Gly1656_Leu1657insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254460	17	41222962	17	43070945	254460	249083	rs886038038	NC_000017.11:43070944:GG:G	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4964C>T (p.Ser1655Phe)	BRCA1	S1655F, S1676F, S551F, S1608F, S1358F, S1526F, S1567F, S1654F, S384F, S439F, S463F, S481F, S482F, S485F, S507F, S509F, S512F, S525F, S550F, S574F, S442F, S443F, S462F, S470F, S472F, S484F, S504F, S526F, S549F, S552F, S1501F, S1542F, S1566F, S1583F, S1584F, S1607F, S1635F, S1636F, S1652F, S1675F, S438F, S1359F, S1527F, S1528F, S1585F, S1586F, S1588F, S1606F, S1613F, S1614F, S1628F, S1653F, S425F, S464F, S480F, S511F, S787F, S1486F, S1543F, S1544F, S1565F, S1611F, S1612F, S1627F, S1629F, S1650F, S1651F, S1677F, S375F, S424F, S503F, S505F, S510F, S513F, S527F, S548F, S573F, S786F	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055333	17	41222967	17	43070950	55333	70000	rs80357390	NC_000017.11:43070949:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4958_4959del (p.Val1653fs)	BRCA1	V1484fs, V1526fs, V1540fs, V1541fs, V1564fs, V1565fs, V1584fs, V1604fs, V1610fs, V1626fs, V1633fs, V1634fs, V1648fs, V1652fs, V1675fs, V373fs, V440fs, V441fs, V479fs, V480fs, V483fs, V503fs, V524fs, V1357fs, V1524fs, V1525fs, V1586fs, V1625fs, V1627fs, V1650fs, V1673fs, V422fs, V423fs, V437fs, V460fs, V461fs, V468fs, V482fs, V549fs, V550fs, V571fs, V784fs, V785fs, V1499fs, V1542fs, V1563fs, V1581fs, V1611fs, V1612fs, V1651fs, V1653fs, V382fs, V470fs, V501fs, V505fs, V509fs, V510fs, V511fs, V523fs, V548fs, V572fs, V1356fs, V1582fs, V1583fs, V1605fs, V1606fs, V1609fs, V1649fs, V1674fs, V436fs, V462fs, V478fs, V502fs, V507fs, V508fs, V525fs, V546fs, V547fs	Hereditary breast ovarian cancer syndrome	VCV002738785	17	41222972 - 41222973	17	43070955 - 43070956	2738785	2902150	rs2550820203	NC_000017.11:43070954:CAC:C	Deletion	frameshift variant|intron variant	Pathogenic	Jul 8, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4948_4951del (p.Met1650fs)	BRCA1	M1537fs, M1583fs, M1601fs, M1607fs, M1630fs, M1671fs, M433fs, M459fs, M500fs, M504fs, M520fs, M547fs, M1353fs, M1481fs, M1496fs, M1521fs, M1522fs, M1579fs, M1580fs, M1603fs, M1623fs, M1648fs, M1649fs, M1650fs, M1670fs, M1672fs, M370fs, M379fs, M420fs, M438fs, M465fs, M467fs, M477fs, M543fs, M544fs, M1538fs, M1560fs, M1561fs, M1562fs, M1622fs, M1624fs, M1631fs, M1645fs, M437fs, M479fs, M480fs, M505fs, M506fs, M508fs, M545fs, M546fs, M568fs, M569fs, M782fs, M1354fs, M1523fs, M1539fs, M1578fs, M1581fs, M1602fs, M1606fs, M1608fs, M1609fs, M1646fs, M1647fs, M419fs, M434fs, M457fs, M458fs, M475fs, M476fs, M498fs, M499fs, M502fs, M507fs, M521fs, M522fs, M781fs	Hereditary breast ovarian cancer syndrome	VCV002809998	17	41222980 - 41222983	17	43070963 - 43070966	2809998	2968527	rs2550829388	NC_000017.11:43070962:ACAT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4947_4948insT (p.Met1650fs)	BRCA1	M1603fs, M1650fs, M1671fs, M546fs	Hereditary breast ovarian cancer syndrome	VCV001076914	17	41222983 - 41222984	17	43070966 - 43070967	1076914	1064183	rs2153811844	NC_000017.11:43070966::A	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 5, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4946_4948del (p.Arg1649del)	BRCA1	R1602del, R1649del, R1670del, R545del, R1520del, R1538del, R1561del, R1580del, R1600del, R1606del, R1630del, R1647del, R1648del, R1671del, R418del, R433del, R466del, R497del, R543del, R544del, R567del, R1480del, R1495del, R1560del, R1601del, R1605del, R1608del, R1622del, R1623del, R1645del, R1646del, R475del, R478del, R499del, R501del, R506del, R520del, R521del, R542del, R780del, R1353del, R1521del, R1522del, R1537del, R1577del, R1621del, R419del, R432del, R437del, R457del, R458del, R476del, R479del, R503del, R504del, R507del, R546del, R781del, R1352del, R1536del, R1559del, R1578del, R1579del, R1582del, R1607del, R1629del, R1644del, R1669del, R369del, R378del, R436del, R456del, R464del, R474del, R498del, R505del, R519del, R568del	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803408	17	41222983 - 41222985	17	43070966 - 43070968	803408	791762	rs1597830403	NC_000017.11:43070965:TTCTT:TT	Deletion	inframe_indel|inframe_deletion|non-coding transcript variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4945_4947delinsTTTT (p.Arg1649fs)	BRCA1	R1602fs, R1670fs, R1649fs, R545fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055327	17	41222984 - 41222986	17	43070967 - 43070969	55327	69994	rs397509207	NC_000017.11:43070966:TCT:AAAA	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4945A>T (p.Arg1649Ter)	BRCA1	R1602*, R1649*, R545*, R1670*, R1605*, R1623*, R1669*, R369*, R418*, R433*, R456*, R458*, R501*, R504*, R507*, R521*, R543*, R544*, R780*, R1560*, R1579*, R1600*, R1352*, R1480*, R1495*, R1521*, R1522*, R1536*, R1537*, R1538*, R1577*, R1601*, R1607*, R1608*, R1621*, R1646*, R419*, R436*, R475*, R479*, R497*, R503*, R542*, R546*, R567*, R568*, R1578*, R1582*, R1606*, R1630*, R1644*, R1645*, R1647*, R478*, R498*, R499*, R505*, R519*, R781*, R1353*, R1520*, R1559*, R1561*, R1580*, R1622*, R1629*, R1648*, R1671*, R378*, R432*, R437*, R457*, R464*, R466*, R474*, R476*, R506*, R520*	not provided	VCV000868864	17	41222986	17	43070969	868864	854293	rs1312537519	NC_000017.11:43070968:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4944_4945insTTTT (p.Arg1649delinsPheTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803409	17	41222986 - 41222987	17	43070969 - 43070970	803409	791763	rs1597830446	NC_000017.11:43070969::AAAA	Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4944_4945del (p.Arg1649fs)	BRCA1	R1649fs, R1602fs, R1670fs, R545fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125737	17	41222986 - 41222987	17	43070969 - 43070970	125737	131275	rs80357655	NC_000017.11:43070968:TTTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4945del (p.Arg1649fs)	BRCA1	R1670fs, R545fs, R1602fs, R1649fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055328	17	41222986	17	43070969	55328	69995	rs80357655	NC_000017.11:43070968:TTTT:TTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4942A>T (p.Lys1648Ter)	BRCA1	K1648*, K1669*, K1601*, K544*, K1479*, K1519*, K1520*, K1558*, K1599*, K1605*, K1606*, K1629*, K1643*, K1647*, K417*, K455*, K456*, K473*, K478*, K504*, K520*, K543*, K779*, K780*, K1352*, K1559*, K1578*, K1604*, K1607*, K1620*, K1622*, K1628*, K1646*, K1668*, K368*, K418*, K475*, K498*, K506*, K519*, K541*, K545*, K566*, K1351*, K1535*, K1536*, K1576*, K1577*, K1581*, K1621*, K1644*, K1645*, K431*, K432*, K435*, K436*, K465*, K496*, K502*, K505*, K542*, K567*, K1494*, K1521*, K1537*, K1560*, K1579*, K1600*, K1670*, K377*, K457*, K463*, K474*, K477*, K497*, K500*, K503*, K518*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000650624	17	41222989	17	43070972	650624	645933	rs747694453	NC_000017.11:43070971:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jan 23, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4860_4941del (p.Asp1621fs)	BRCA1	D1621fs, D517fs, D1574fs, D1642fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266498	17	41222990 - 41223071	17	43070973 - 43071054	266498	261618	rs1555580648		Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4941del (p.Asn1647fs)	BRCA1	N1647fs, N1600fs, N543fs, N1668fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055326	17	41222990	17	43070973	55326	69993	rs80357905	NC_000017.11:43070972:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4935_4936insAA (p.Val1646fs)	BRCA1	V1599fs, V1667fs, V1646fs, V542fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548310	17	41222995 - 41222996	17	43070978 - 43070979	548310	538778	rs1555580653	NC_000017.11:43070978::TT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4936del (p.Val1646fs)	BRCA1	V542fs, V1599fs, V1667fs, V1646fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055322	17	41222995	17	43070978	55322	69989	rs80357653	NC_000017.11:43070977:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4932_4933dup (p.Arg1645fs)	BRCA1	R1598fs, R541fs, R1645fs, R1666fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254459	17	41222997 - 41222998	17	43070980 - 43070981	254459	249084	rs80357833	NC_000017.11:43070980:TTT:TTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4933del (p.Arg1645fs)	BRCA1	R1598fs, R1645fs, R1666fs, R541fs	not provided|Hereditary breast ovarian cancer syndrome	VCV001330057	17	41222998	17	43070981	1330057	1320740	rs80357833	NC_000017.11:43070980:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Feb 4, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4930G>T (p.Glu1644Ter)	BRCA1	E1644*, E1597*, E1665*, E540*, E1515*, E1517*, E1575*, E1577*, E1596*, E413*, E414*, E431*, E470*, E474*, E493*, E498*, E500*, E501*, E514*, E516*, E541*, E562*, E1347*, E1348*, E1572*, E1573*, E1600*, E1601*, E1617*, E1624*, E1625*, E1641*, E1666*, E427*, E428*, E432*, E451*, E453*, E459*, E473*, E496*, E539*, E775*, E1490*, E1516*, E1554*, E1555*, E1556*, E1574*, E1595*, E1603*, E1639*, E1642*, E1664*, E373*, E452*, E469*, E492*, E494*, E499*, E502*, E538*, E563*, E1475*, E1531*, E1532*, E1533*, E1602*, E1616*, E1618*, E1640*, E1643*, E364*, E461*, E471*, E515*, E537*, E776*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055317	17	41223001	17	43070984	55317	69984	rs397509205	NC_000017.11:43070983:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4929del (p.Glu1644fs)	BRCA1	E1597fs, E540fs, E1665fs, E1644fs	Hereditary cancer-predisposing syndrome	VCV001744168	17	41223002	17	43070985	1744168	1799064	rs2550863830	NC_000017.11:43070984:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Mar 22, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4925C>A (p.Ser1642Ter)	BRCA1	S1642*, S1663*, S538*, S1595*, S560*, S561*, S1638*, S1639*, S1641*, S449*, S450*, S471*, S490*, S498*, S499*, S500*, S514*, S537*, S1488*, S1513*, S1515*, S1554*, S1598*, S1623*, S1346*, S1529*, S1593*, S1614*, S1615*, S1622*, S1640*, S362*, S411*, S426*, S457*, S467*, S491*, S539*, S774*, S1530*, S1531*, S1552*, S1571*, S1572*, S1573*, S1575*, S1594*, S1599*, S371*, S425*, S430*, S451*, S459*, S468*, S469*, S472*, S496*, S497*, S512*, S536*, S429*, S492*, S494*, S513*, S535*, S773*, S1345*, S1473*, S1514*, S1553*, S1570*, S1600*, S1601*, S1616*, S1637*, S1662*, S1664*, S412*	Hereditary breast ovarian cancer syndrome	VCV000868851	17	41223006	17	43070989	868851	854344	rs2052376303	NC_000017.11:43070988:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Nov 1, 2021	criteria provided, single submitter							
NC_000017.11:g.(?_43070991)_(43082575_?)del	BRCA1		not specified	VCV000431354	17	41223008 - 41234592	17	43070991 - 43082575	431354	424881			Deletion		Pathogenic	Apr 20, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4921del (p.Ala1641fs)	BRCA1	A1594fs, A1641fs, A1662fs, A537fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266505	17	41223010	17	43070993	266505	261619	rs886040257	NC_000017.11:43070992:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4901_4919del (p.Arg1634fs)	BRCA1	R1587fs, R1655fs, R530fs, R1634fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431357	17	41223012 - 41223030	17	43070995 - 43071013	431357	424884	rs1555580678	NC_000017.11:43070994:GTCAATTCTGGCTTCTCCC:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4916del (p.Glu1638_Leu1639insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003717866	17	41223015	17	43070998	3717866	3852840		NC_000017.11:43070997:AA:A	Deletion	nonsense|intron variant	Pathogenic	Sep 18, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4911_4913delinsG (p.Glu1638fs)	BRCA1	E1469fs, E1548fs, E1549fs, E1550fs, E1571fs, E1619fs, E1637fs, E1659fs, E421fs, E446fs, E468fs, E487fs, E493fs, E557fs, E1341fs, E1342fs, E1509fs, E1510fs, E1511fs, E1569fs, E1591fs, E1610fs, E1638fs, E1658fs, E367fs, E408fs, E425fs, E426fs, E445fs, E447fs, E453fs, E455fs, E465fs, E467fs, E486fs, E494fs, E495fs, E509fs, E531fs, E556fs, E769fs, E770fs, E1484fs, E1526fs, E1594fs, E1595fs, E1611fs, E1612fs, E1633fs, E1634fs, E1635fs, E1636fs, E1660fs, E422fs, E463fs, E488fs, E492fs, E496fs, E508fs, E510fs, E532fs, E1525fs, E1527fs, E1566fs, E1567fs, E1568fs, E1589fs, E1590fs, E1596fs, E1597fs, E1618fs, E358fs, E407fs, E464fs, E490fs, E533fs, E534fs, E535fs	Hereditary cancer-predisposing syndrome	VCV004215071	17	41223018 - 41223020	17	43071001 - 43071003	4215071	4331984		NC_000017.11:43071000:TCT:C	Indel	frameshift variant|intron variant	Pathogenic	Jul 1, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4912G>T (p.Glu1638Ter)	BRCA1	E1591*, E1638*, E1659*, E534*, E1509*, E1526*, E1527*, E1550*, E1567*, E1568*, E1595*, E1610*, E1612*, E1636*, E1637*, E1658*, E358*, E453*, E464*, E494*, E495*, E531*, E535*, E557*, E770*, E367*, E421*, E422*, E425*, E445*, E468*, E488*, E496*, E509*, E1469*, E1549*, E1569*, E1590*, E1594*, E1596*, E1633*, E407*, E408*, E426*, E446*, E447*, E455*, E465*, E493*, E508*, E532*, E533*, E556*, E769*, E1341*, E1342*, E1511*, E1548*, E1566*, E1571*, E1589*, E1597*, E1635*, E1660*, E1484*, E1510*, E1525*, E1611*, E1618*, E1619*, E1634*, E463*, E467*, E486*, E487*, E490*, E492*, E510*	Hereditary cancer-predisposing syndrome	VCV000868400	17	41223019	17	43071002	868400	854373	rs2052380758	NC_000017.11:43071001:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Aug 19, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4910del (p.Pro1637fs)	BRCA1	P1590fs, P1658fs, P1637fs, P533fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055315	17	41223021	17	43071004	55315	69982	rs397509204	NC_000017.11:43071003:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4905_4906del (p.Lys1636fs)	BRCA1	K1636fs, K1657fs, K532fs, K1589fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055312	17	41223025 - 41223026	17	43071008 - 43071009	55312	69979	rs397509203	NC_000017.11:43071007:TCTC:TC	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4903dup (p.Glu1635fs)	BRCA1	E1588fs, E1635fs, E531fs, E1656fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000825276	17	41223027 - 41223028	17	43071010 - 43071011	825276	813675	rs1555580697	NC_000017.11:43071010:CCC:CCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	May 4, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4903del (p.Glu1635fs)	BRCA1	E531fs, E1588fs, E1635fs, E1656fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433718	17	41223028	17	43071011	433718	427539	rs1555580697	NC_000017.11:43071010:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4903G>T (p.Glu1635Ter)	BRCA1	E1635*, E1656*, E531*, E1588*, E1339*, E1481*, E1522*, E1545*, E1566*, E1592*, E1608*, E1609*, E1616*, E1632*, E1655*, E355*, E405*, E422*, E444*, E450*, E460*, E461*, E484*, E492*, E553*, E767*, E1546*, E1547*, E1565*, E1587*, E1630*, E1633*, E423*, E485*, E491*, E507*, E529*, E532*, E554*, E1338*, E1466*, E1507*, E1523*, E1524*, E1564*, E1568*, E1591*, E1634*, E1657*, E364*, E404*, E419*, E462*, E483*, E489*, E493*, E506*, E528*, E766*, E464*, E465*, E487*, E490*, E505*, E530*, E1506*, E1508*, E1563*, E1586*, E1593*, E1594*, E1607*, E1615*, E1631*, E418*, E442*, E443*, E452*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055311	17	41223028	17	43071011	55311	69978	rs200432771	NC_000017.11:43071010:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4895_4896del (p.Val1632fs)	BRCA1	V1632fs, V528fs, V1585fs, V1653fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254458	17	41223035 - 41223036	17	43071018 - 43071019	254458	249085	rs886038037	NC_000017.11:43071017:CACAC:CAC	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4887_4893del (p.Glu1629_Glu1630insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266503	17	41223038 - 41223044	17	43071021 - 43071027	266503	261620	rs886040255	NC_000017.11:43071020:ACTTTCT:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4891dup (p.Ser1631fs)	BRCA1	S1652fs, S1584fs, S527fs, S1631fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125733	17	41223039 - 41223040	17	43071022 - 43071023	125733	131271	rs80357656	NC_000017.11:43071022:TTT:TTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4891del (p.Ser1631fs)	BRCA1	S1652fs, S1631fs, S527fs, S1584fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266504	17	41223040	17	43071023	266504	261621	rs80357656	NC_000017.11:43071022:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4883_4890del (p.Met1628fs)	BRCA1	M1331fs, M1332fs, M1459fs, M1474fs, M1499fs, M1500fs, M1501fs, M1515fs, M1516fs, M1517fs, M1538fs, M1539fs, M1540fs, M1556fs, M1557fs, M1558fs, M1559fs, M1561fs, M1579fs, M1580fs, M1581fs, M1584fs, M1585fs, M1586fs, M1587fs, M1600fs, M1601fs, M1602fs, M1608fs, M1609fs, M1623fs, M1624fs, M1625fs, M1626fs, M1627fs, M1628fs, M1648fs, M1649fs, M1650fs, M348fs, M357fs, M397fs, M398fs, M411fs, M412fs, M415fs, M416fs, M435fs, M436fs, M437fs, M443fs, M445fs, M453fs, M454fs, M455fs, M457fs, M458fs, M476fs, M477fs, M478fs, M480fs, M482fs, M483fs, M484fs, M485fs, M486fs, M498fs, M499fs, M500fs, M521fs, M522fs, M523fs, M524fs, M525fs, M546fs, M547fs, M759fs, M760fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002583816	17	41223041 - 41223048	17	43071024 - 43071031	2583816	2751386	rs2550905546	NC_000017.11:43071023:TTCTTCCATT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Jun 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4888_4889del (p.Glu1630fs)	BRCA1	E1630fs, E526fs, E1583fs, E1651fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252882	17	41223042 - 41223043	17	43071025 - 43071026	252882	247283	rs879255490	NC_000017.11:43071024:TCT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4888G>T (p.Glu1630Ter)	BRCA1	E1630*, E526*, E1583*, E1651*, E1334*, E1461*, E1476*, E1518*, E1561*, E1563*, E1629*, E1652*, E350*, E413*, E418*, E438*, E456*, E459*, E482*, E484*, E486*, E487*, E488*, E523*, E524*, E527*, E548*, E1333*, E1502*, E1503*, E1519*, E1540*, E1589*, E1603*, E1627*, E1628*, E1650*, E414*, E437*, E455*, E479*, E500*, E501*, E549*, E761*, E1517*, E1542*, E1559*, E1581*, E1582*, E1587*, E1602*, E1625*, E359*, E400*, E417*, E439*, E445*, E447*, E478*, E502*, E762*, E1501*, E1541*, E1558*, E1560*, E1586*, E1588*, E1604*, E1610*, E1611*, E1626*, E399*, E457*, E460*, E480*, E485*, E525*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000487415	17	41223043	17	43071026	487415	480482	rs1173155015	NC_000017.11:43071025:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Feb 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4885dup (p.Glu1629fs)	BRCA1	E1582fs, E1629fs, E1650fs, E525fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266502	17	41223045 - 41223046	17	43071028 - 43071029	266502	261622	rs886040254	NC_000017.11:43071028:CC:CCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4885del (p.Glu1629fs)	BRCA1	E1582fs, E1629fs, E525fs, E1650fs	not provided	VCV000545864	17	41223046	17	43071029	545864	536490	rs886040254	NC_000017.11:43071028:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 10, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4873_4885del (p.Tyr1625fs)	BRCA1	Y1578fs, Y1646fs, Y1625fs, Y521fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055305	17	41223046 - 41223058	17	43071029 - 43071041	55305	69972	rs397509201	NC_000017.11:43071028:CCATTGCATTATACC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4883del (p.Met1628fs)	BRCA1	M1331fs, M1332fs, M1459fs, M1474fs, M1499fs, M1500fs, M1501fs, M1515fs, M1516fs, M1517fs, M1538fs, M1539fs, M1540fs, M1556fs, M1557fs, M1558fs, M1559fs, M1561fs, M1579fs, M1580fs, M1581fs, M1584fs, M1585fs, M1586fs, M1587fs, M1600fs, M1601fs, M1602fs, M1608fs, M1609fs, M1623fs, M1624fs, M1625fs, M1626fs, M1627fs, M1628fs, M1648fs, M1649fs, M1650fs, M348fs, M357fs, M397fs, M398fs, M411fs, M412fs, M415fs, M416fs, M435fs, M436fs, M437fs, M443fs, M445fs, M453fs, M454fs, M455fs, M457fs, M458fs, M476fs, M477fs, M478fs, M480fs, M482fs, M483fs, M484fs, M485fs, M486fs, M498fs, M499fs, M500fs, M521fs, M522fs, M523fs, M524fs, M525fs, M546fs, M547fs, M759fs, M760fs	not provided	VCV002681815	17	41223048	17	43071031	2681815	2842854	rs2550910145	NC_000017.11:43071030:A:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 7, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4878dup (p.Ala1627fs)	BRCA1	A1580fs, A523fs, A1648fs, A1627fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266501	17	41223052 - 41223053	17	43071035 - 43071036	266501	261623	rs886040253	NC_000017.11:43071035:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4878del (p.Asn1626fs)	BRCA1	N1626fs, N1579fs, N1647fs, N522fs	Hereditary breast ovarian cancer syndrome	VCV001409786	17	41223053	17	43071036	1409786	1435042	rs2153826963	NC_000017.11:43071035:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 23, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4873_4876dup (p.Asn1626delinsIleTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003724295	17	41223054 - 41223055	17	43071037 - 43071038	3724295	3857502		NC_000017.11:43071037:TATA:TATATATA	Microsatellite	nonsense|intron variant	Pathogenic	Nov 11, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4877del (p.Asn1626fs)	BRCA1	N1626fs, N1647fs, N1579fs, N522fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266500	17	41223054	17	43071037	266500	261624	rs886040252	NC_000017.11:43071036:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4875T>G (p.Tyr1625Ter)	BRCA1	Y1456*, Y1496*, Y1498*, Y1536*, Y1554*, Y1583*, Y1623*, Y1625*, Y1646*, Y345*, Y408*, Y409*, Y434*, Y442*, Y450*, Y455*, Y479*, Y497*, Y518*, Y521*, Y544*, Y1329*, Y1513*, Y1577*, Y1578*, Y1598*, Y1599*, Y1605*, Y1622*, Y394*, Y412*, Y432*, Y433*, Y454*, Y474*, Y475*, Y477*, Y482*, Y543*, Y1471*, Y1497*, Y1514*, Y1553*, Y1558*, Y1582*, Y1584*, Y1606*, Y1620*, Y1621*, Y1647*, Y395*, Y413*, Y440*, Y452*, Y473*, Y480*, Y481*, Y483*, Y519*, Y520*, Y756*, Y1328*, Y1512*, Y1535*, Y1537*, Y1555*, Y1556*, Y1576*, Y1581*, Y1597*, Y1624*, Y1645*, Y354*, Y451*, Y495*, Y496*, Y522*, Y757*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001743748	17	41223056	17	43071039	1743748	1802092	rs886040251	NC_000017.11:43071038:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4875T>A (p.Tyr1625Ter)	BRCA1	Y1625*, Y1646*, Y1578*, Y521*, Y1471*, Y1496*, Y1497*, Y1514*, Y1553*, Y1555*, Y1576*, Y1582*, Y1584*, Y1598*, Y1599*, Y1605*, Y1620*, Y1645*, Y412*, Y433*, Y434*, Y452*, Y473*, Y474*, Y479*, Y480*, Y481*, Y483*, Y496*, Y519*, Y544*, Y757*, Y409*, Y413*, Y432*, Y454*, Y482*, Y497*, Y520*, Y543*, Y1328*, Y1329*, Y1537*, Y1554*, Y1556*, Y1583*, Y1621*, Y1622*, Y408*, Y440*, Y451*, Y475*, Y477*, Y518*, Y1512*, Y1536*, Y1581*, Y1624*, Y345*, Y394*, Y395*, Y442*, Y450*, Y455*, Y495*, Y522*, Y756*, Y1456*, Y1498*, Y1513*, Y1535*, Y1558*, Y1577*, Y1597*, Y1606*, Y1623*, Y1647*, Y354*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266499	17	41223056	17	43071039	266499	261625	rs886040251	NC_000017.11:43071038:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4872del (p.Tyr1625fs)	BRCA1	Y1578fs, Y1625fs, Y1646fs, Y521fs	not provided|Hereditary breast ovarian cancer syndrome	VCV001319804	17	41223059	17	43071042	1319804	1310053	rs2153828150	NC_000017.11:43071041:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Nov 3, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4862_4871del (p.Asp1621fs)	BRCA1	D1621fs, D517fs, D1642fs, D1574fs	not provided|Hereditary cancer-predisposing syndrome	VCV000479248	17	41223060 - 41223069	17	43071043 - 43071052	479248	478573	rs1555580773	NC_000017.11:43071042:CCAGCAGTATC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 24, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4868C>G (p.Ala1623Gly)	BRCA1	A1623G, A519G, A1576G, A1644G, A1512G, A1534G, A1535G, A1556G, A1580G, A1582G, A1597G, A1603G, A1643G, A392G, A411G, A432G, A475G, A494G, A495G, A517G, A520G, A755G, A1496G, A1510G, A1511G, A1575G, A1579G, A1581G, A406G, A410G, A431G, A438G, A448G, A471G, A472G, A479G, A493G, A1326G, A1327G, A1469G, A1533G, A1552G, A1595G, A1596G, A1619G, A1621G, A343G, A352G, A393G, A449G, A450G, A453G, A477G, A478G, A480G, A481G, A516G, A518G, A542G, A1494G, A1495G, A1551G, A1553G, A1554G, A1574G, A1604G, A1618G, A1620G, A1622G, A1645G, A407G, A430G, A440G, A452G, A473G, A541G, A754G, A1454G	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037614	17	41223063	17	43071046	37614	46170	rs80356862	NC_000017.11:43071045:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4862_4863insG (p.Asp1621fs)	BRCA1	D1574fs, D1621fs, D1642fs, D517fs	Hereditary breast ovarian cancer syndrome	VCV001072912	17	41223068 - 41223069	17	43071051 - 43071052	1072912	1064184	rs2153829891	NC_000017.11:43071051::C	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Mar 24, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4859del (p.Thr1620fs)	BRCA1	T1323fs, T1324fs, T1451fs, T1466fs, T1491fs, T1492fs, T1493fs, T1507fs, T1508fs, T1509fs, T1530fs, T1531fs, T1532fs, T1548fs, T1549fs, T1550fs, T1551fs, T1553fs, T1571fs, T1572fs, T1573fs, T1576fs, T1577fs, T1578fs, T1579fs, T1592fs, T1593fs, T1594fs, T1600fs, T1601fs, T1615fs, T1616fs, T1617fs, T1618fs, T1619fs, T1620fs, T1640fs, T1641fs, T1642fs, T340fs, T349fs, T389fs, T390fs, T403fs, T404fs, T407fs, T408fs, T427fs, T428fs, T429fs, T435fs, T437fs, T445fs, T446fs, T447fs, T449fs, T450fs, T468fs, T469fs, T470fs, T472fs, T474fs, T475fs, T476fs, T477fs, T478fs, T490fs, T491fs, T492fs, T513fs, T514fs, T515fs, T516fs, T517fs, T538fs, T539fs, T751fs, T752fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004071363	17	41223072	17	43071055	4071363	4185211		NC_000017.11:43071054:G:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4852del (p.His1618fs)	BRCA1	H1464fs, H1491fs, H1505fs, H1528fs, H1529fs, H1549fs, H1575fs, H1576fs, H1598fs, H1615fs, H1617fs, H1618fs, H1640fs, H406fs, H427fs, H433fs, H447fs, H474fs, H1490fs, H1546fs, H1548fs, H1570fs, H1571fs, H1591fs, H1592fs, H1599fs, H1613fs, H1639fs, H338fs, H347fs, H401fs, H444fs, H470fs, H473fs, H476fs, H489fs, H513fs, H515fs, H750fs, H1489fs, H1506fs, H1530fs, H1569fs, H1614fs, H1616fs, H402fs, H405fs, H435fs, H443fs, H466fs, H468fs, H475fs, H488fs, H536fs, H537fs, H749fs, H1321fs, H1322fs, H1449fs, H1507fs, H1547fs, H1551fs, H1574fs, H1577fs, H1590fs, H1638fs, H387fs, H388fs, H425fs, H426fs, H445fs, H448fs, H467fs, H472fs, H490fs, H511fs, H512fs, H514fs	Hereditary cancer-predisposing syndrome	VCV004215125	17	41223079	17	43071062	4215125	4332036		NC_000017.11:43071061:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4848del (p.Ala1617fs)	BRCA1	A1320fs, A1321fs, A1448fs, A1463fs, A1488fs, A1489fs, A1490fs, A1504fs, A1505fs, A1506fs, A1527fs, A1528fs, A1529fs, A1545fs, A1546fs, A1547fs, A1548fs, A1550fs, A1568fs, A1569fs, A1570fs, A1573fs, A1574fs, A1575fs, A1576fs, A1589fs, A1590fs, A1591fs, A1597fs, A1598fs, A1612fs, A1613fs, A1614fs, A1615fs, A1616fs, A1617fs, A1637fs, A1638fs, A1639fs, A337fs, A346fs, A386fs, A387fs, A400fs, A401fs, A404fs, A405fs, A424fs, A425fs, A426fs, A432fs, A434fs, A442fs, A443fs, A444fs, A446fs, A447fs, A465fs, A466fs, A467fs, A469fs, A471fs, A472fs, A473fs, A474fs, A475fs, A487fs, A488fs, A489fs, A510fs, A511fs, A512fs, A513fs, A514fs, A535fs, A536fs, A748fs, A749fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003904707	17	41223083	17	43071066	3904707	4020579		NC_000017.11:43071065:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 22, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4843dup (p.Ala1615fs)	BRCA1	A1568fs, A1615fs, A1636fs, A511fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125732	17	41223087 - 41223088	17	43071070 - 43071071	125732	131270	rs80357615	NC_000017.11:43071070:C:CC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4841dup (p.Ala1615fs)	BRCA1	A1636fs, A511fs, A1568fs, A1615fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548257	17	41223089 - 41223090	17	43071072 - 43071073	548257	538779	rs1555580813	NC_000017.11:43071072:GG:GGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4841del (p.Pro1614fs)	BRCA1	P1317fs, P1318fs, P1445fs, P1460fs, P1485fs, P1486fs, P1487fs, P1501fs, P1502fs, P1503fs, P1524fs, P1525fs, P1526fs, P1542fs, P1543fs, P1544fs, P1545fs, P1547fs, P1565fs, P1566fs, P1567fs, P1570fs, P1571fs, P1572fs, P1573fs, P1586fs, P1587fs, P1588fs, P1594fs, P1595fs, P1609fs, P1610fs, P1611fs, P1612fs, P1613fs, P1614fs, P1634fs, P1635fs, P1636fs, P334fs, P343fs, P383fs, P384fs, P397fs, P398fs, P401fs, P402fs, P421fs, P422fs, P423fs, P429fs, P431fs, P439fs, P440fs, P441fs, P443fs, P444fs, P462fs, P463fs, P464fs, P466fs, P468fs, P469fs, P470fs, P471fs, P472fs, P484fs, P485fs, P486fs, P507fs, P508fs, P509fs, P510fs, P511fs, P532fs, P533fs, P745fs, P746fs	Hereditary cancer-predisposing syndrome	VCV004082357	17	41223090	17	43071073	4082357	4195045		NC_000017.11:43071072:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Jul 8, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4838_4839insCC (p.Pro1614fs)	BRCA1	P1317fs, P1318fs, P1445fs, P1460fs, P1485fs, P1486fs, P1487fs, P1501fs, P1502fs, P1503fs, P1524fs, P1525fs, P1526fs, P1542fs, P1543fs, P1544fs, P1545fs, P1547fs, P1565fs, P1566fs, P1567fs, P1570fs, P1571fs, P1572fs, P1573fs, P1586fs, P1587fs, P1588fs, P1594fs, P1595fs, P1609fs, P1610fs, P1611fs, P1612fs, P1613fs, P1614fs, P1634fs, P1635fs, P1636fs, P334fs, P343fs, P383fs, P384fs, P397fs, P398fs, P401fs, P402fs, P421fs, P422fs, P423fs, P429fs, P431fs, P439fs, P440fs, P441fs, P443fs, P444fs, P462fs, P463fs, P464fs, P466fs, P468fs, P469fs, P470fs, P471fs, P472fs, P484fs, P485fs, P486fs, P507fs, P508fs, P509fs, P510fs, P511fs, P532fs, P533fs, P745fs, P746fs	Hereditary breast ovarian cancer syndrome	VCV003769476	17	41223092 - 41223093	17	43071075 - 43071076	3769476	3885629		NC_000017.11:43071075::GG	Insertion	frameshift variant|intron variant	Pathogenic	Jan 23, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4838_4839insC (p.Pro1614fs)	BRCA1	P1635fs, P1567fs, P1614fs, P510fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055300	17	41223092 - 41223093	17	43071075 - 43071076	55300	69967	rs397509200	NC_000017.11:43071075::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4837_4838delinsGCC (p.Ser1613fs)	BRCA1	S1613fs, S1634fs, S509fs, S1566fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000180697	17	41223093 - 41223094	17	43071076 - 43071077	180697	178862	rs730880287	NC_000017.11:43071075:CT:GGC	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4834_4837delinsAGG (p.Gln1612fs)	BRCA1	Q1458fs, Q1483fs, Q1485fs, Q1540fs, Q1542fs, Q1543fs, Q1564fs, Q1584fs, Q1592fs, Q1593fs, Q1607fs, Q1610fs, Q1632fs, Q421fs, Q441fs, Q460fs, Q464fs, Q467fs, Q468fs, Q482fs, Q506fs, Q509fs, Q1315fs, Q1484fs, Q1499fs, Q1501fs, Q1523fs, Q1541fs, Q1586fs, Q1612fs, Q381fs, Q400fs, Q420fs, Q437fs, Q439fs, Q442fs, Q461fs, Q462fs, Q483fs, Q1443fs, Q1524fs, Q1545fs, Q1568fs, Q1569fs, Q1571fs, Q1608fs, Q1634fs, Q332fs, Q341fs, Q382fs, Q396fs, Q399fs, Q419fs, Q427fs, Q438fs, Q469fs, Q484fs, Q505fs, Q508fs, Q530fs, Q531fs, Q743fs, Q744fs, Q1316fs, Q1500fs, Q1522fs, Q1563fs, Q1565fs, Q1570fs, Q1585fs, Q1609fs, Q1611fs, Q1633fs, Q395fs, Q429fs, Q466fs, Q470fs, Q507fs	Hereditary cancer-predisposing syndrome	VCV004215066	17	41223094 - 41223097	17	43071077 - 43071080	4215066	4335922		NC_000017.11:43071076:TCTG:CCT	Indel	frameshift variant|intron variant	Pathogenic	Jun 25, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4837del (p.Ser1613fs)	BRCA1	S1566fs, S1613fs, S509fs, S1634fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055299	17	41223094	17	43071077	55299	69966	rs397509199	NC_000017.11:43071076:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4836dup (p.Ser1613fs)	BRCA1	S1613fs, S1634fs, S509fs, S1566fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055298	17	41223094 - 41223095	17	43071077 - 43071078	55298	69965	rs397509198	NC_000017.11:43071077:C:CC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4834_4835del (p.Gln1612fs)	BRCA1	Q1565fs, Q1612fs, Q508fs, Q1633fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441347	17	41223096 - 41223097	17	43071079 - 43071080	441347	435108	rs1555580840	NC_000017.11:43071078:TG:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4834del (p.Gln1612fs)	BRCA1	Q1612fs, Q508fs, Q1633fs, Q1565fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266496	17	41223097	17	43071080	266496	261626	rs886040249	NC_000017.11:43071079:GGG:GG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4834C>T (p.Gln1612Ter)	BRCA1	Q1612*, Q1565*, Q1633*, Q508*, Q1458*, Q1541*, Q1542*, Q1586*, Q1608*, Q1611*, Q341*, Q382*, Q399*, Q420*, Q442*, Q467*, Q468*, Q470*, Q506*, Q507*, Q1316*, Q1485*, Q1540*, Q1563*, Q1568*, Q1569*, Q1570*, Q1571*, Q1584*, Q1592*, Q1632*, Q332*, Q381*, Q395*, Q419*, Q427*, Q429*, Q437*, Q461*, Q464*, Q509*, Q531*, Q744*, Q1315*, Q1443*, Q1483*, Q1500*, Q1501*, Q1523*, Q1524*, Q1564*, Q1585*, Q1593*, Q1607*, Q396*, Q438*, Q439*, Q460*, Q482*, Q743*, Q1484*, Q1499*, Q1522*, Q1543*, Q1545*, Q1609*, Q1610*, Q1634*, Q400*, Q421*, Q441*, Q462*, Q466*, Q469*, Q483*, Q484*, Q505*, Q530*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185295	17	41223097	17	43071080	185295	184902	rs786202064	NC_000017.11:43071079:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4829_4830del (p.Ser1610fs)	BRCA1	S1456fs, S1498fs, S1520fs, S1521fs, S1522fs, S1561fs, S1563fs, S1566fs, S1605fs, S1606fs, S1607fs, S1608fs, S1609fs, S1632fs, S393fs, S417fs, S458fs, S462fs, S466fs, S467fs, S482fs, S503fs, S506fs, S507fs, S528fs, S741fs, S1314fs, S1441fs, S1540fs, S1541fs, S1568fs, S1582fs, S1591fs, S1630fs, S330fs, S379fs, S439fs, S440fs, S464fs, S465fs, S505fs, S1313fs, S1482fs, S1539fs, S1543fs, S1562fs, S1567fs, S1584fs, S1590fs, S1610fs, S380fs, S397fs, S419fs, S435fs, S437fs, S459fs, S480fs, S504fs, S529fs, S742fs, S1481fs, S1483fs, S1497fs, S1499fs, S1538fs, S1569fs, S1583fs, S1631fs, S339fs, S394fs, S398fs, S418fs, S425fs, S427fs, S436fs, S460fs, S468fs, S481fs	Hereditary breast ovarian cancer syndrome	VCV002866739	17	41223101 - 41223102	17	43071084 - 43071085	2866739	3020347	rs2550948129	NC_000017.11:43071083:AGA:A	Deletion	frameshift variant|intron variant	Pathogenic	May 27, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4829del (p.Ser1610fs)	BRCA1	S1610fs, S1631fs, S1563fs, S506fs	Hereditary cancer-predisposing syndrome	VCV000919848	17	41223102	17	43071085	919848	913865	rs2052400799	NC_000017.11:43071084:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 9, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4828dup (p.Ser1610fs)	BRCA1	S1631fs, S1610fs, S1563fs, S506fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000485380	17	41223102 - 41223103	17	43071085 - 43071086	485380	478578	rs1555580854	NC_000017.11:43071085:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4825G>T (p.Glu1609Ter)	BRCA1	E1313*, E1481*, E1497*, E1542*, E1561*, E1562*, E1604*, E1607*, E338*, E416*, E426*, E434*, E435*, E467*, E481*, E503*, E527*, E741*, E1440*, E1480*, E1496*, E1498*, E1538*, E1540*, E1560*, E1590*, E1606*, E1609*, E1629*, E329*, E379*, E396*, E424*, E438*, E439*, E461*, E464*, E465*, E504*, E506*, E740*, E1519*, E1521*, E1539*, E1565*, E1566*, E1581*, E1582*, E1589*, E392*, E393*, E397*, E417*, E418*, E436*, E457*, E459*, E463*, E479*, E480*, E502*, E1312*, E1455*, E1482*, E1520*, E1537*, E1567*, E1568*, E1583*, E1605*, E1608*, E1630*, E1631*, E378*, E458*, E466*, E505*, E528*	Hereditary cancer-predisposing syndrome	VCV001743383	17	41223106	17	43071089	1743383	1805529	rs2153835962	NC_000017.11:43071088:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Aug 11, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4823_4824insG (p.Glu1609fs)	BRCA1	E1562fs, E505fs, E1609fs, E1630fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548218	17	41223107 - 41223108	17	43071090 - 43071091	548218	538780	rs1555580865	NC_000017.11:43071090::C	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4822dup (p.Ala1608fs)	BRCA1	A1629fs, A504fs, A1561fs, A1608fs	Hereditary breast ovarian cancer syndrome	VCV000431356	17	41223108 - 41223109	17	43071091 - 43071092	431356	424887	rs1135401933	NC_000017.11:43071091:C:CC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jul 17, 2018	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4821del (p.Ala1608fs)	BRCA1	A1561fs, A1608fs, A1629fs, A504fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV001174603	17	41223110	17	43071093	1174603	1163968	rs2153836342	NC_000017.11:43071092:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4818del (p.Val1607fs)	BRCA1	V1560fs, V503fs, V1607fs, V1628fs	Familial cancer of breast	VCV000495093	17	41223113	17	43071096	495093	486652	rs1555580883	NC_000017.11:43071095:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4814_4815insTATT (p.Leu1605fs)	BRCA1	L1626fs, L1605fs, L1558fs, L501fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000862183	17	41223116 - 41223117	17	43071099 - 43071100	862183	845374	rs2052403348	NC_000017.11:43071099:AAT:AATAAAT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4810del (p.Gln1604fs)	BRCA1	Q500fs, Q1557fs, Q1604fs, Q1625fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000548837	17	41223121	17	43071104	548837	539360	rs1555580900	NC_000017.11:43071103:GGGG:GGG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4810C>T (p.Gln1604Ter)	BRCA1	Q1604*, Q1625*, Q500*, Q1557*, Q1308*, Q1435*, Q1491*, Q1492*, Q1516*, Q1533*, Q1555*, Q1576*, Q1578*, Q1584*, Q1599*, Q1603*, Q373*, Q429*, Q453*, Q454*, Q1535*, Q1561*, Q1601*, Q1602*, Q324*, Q374*, Q387*, Q421*, Q433*, Q460*, Q461*, Q497*, Q499*, Q523*, Q735*, Q1477*, Q1532*, Q458*, Q459*, Q501*, Q1307*, Q1476*, Q1556*, Q1562*, Q1585*, Q1624*, Q333*, Q419*, Q430*, Q431*, Q456*, Q462*, Q474*, Q475*, Q476*, Q736*, Q1450*, Q1475*, Q1493*, Q1514*, Q1515*, Q1534*, Q1537*, Q1560*, Q1563*, Q1577*, Q1600*, Q1626*, Q388*, Q391*, Q392*, Q411*, Q412*, Q413*, Q434*, Q452*, Q498*, Q522*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055291	17	41223121	17	43071104	55291	69958	rs80357352	NC_000017.11:43071103:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4806_4807insTATTGCGGCATTATTCACAATAGCAAAGACTTGGAACCAACCCAAATGTCCAACAATGATAGACTGGATTAANNNNNNNNNNAAAAAAAAAAAAAAAAAAAAGAAAGTT (p.Pro1603delinsTyrCysGlyIleIleHisAsnSerLysAspLeuGluProThrGlnMetSerAsnAsnAspArgLeuAspTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002022810	17	41223124 - 41223125	17	43071107 - 43071108	2022810	2076873	rs2550983705		Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Aug 8, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4806del (p.Gln1604fs)	BRCA1	Q1625fs, Q1557fs, Q500fs, Q1604fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254457	17	41223125	17	43071108	254457	249086	rs886038036	NC_000017.11:43071107:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4803del (p.Val1602fs)	BRCA1	V1602fs, V498fs, V1623fs, V1555fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479212	17	41223128	17	43071111	479212	478580	rs1555580912	NC_000017.11:43071110:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4801A>T (p.Lys1601Ter)	BRCA1	K1601*, K1622*, K497*, K1554*, K1304*, K1432*, K1488*, K1511*, K1513*, K1557*, K1597*, K1623*, K330*, K416*, K428*, K431*, K450*, K455*, K456*, K472*, K473*, K732*, K733*, K1447*, K1512*, K1532*, K1558*, K1559*, K1573*, K1575*, K1582*, K1599*, K1600*, K370*, K385*, K449*, K457*, K471*, K495*, K1472*, K1489*, K1530*, K1531*, K1552*, K1560*, K1598*, K1621*, K321*, K389*, K409*, K410*, K418*, K426*, K430*, K451*, K453*, K459*, K494*, K1305*, K1473*, K1474*, K1490*, K1529*, K1534*, K1553*, K1574*, K1581*, K1596*, K371*, K384*, K388*, K408*, K427*, K458*, K496*, K498*, K519*, K520*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055290	17	41223130	17	43071113	55290	69957	rs80357303	NC_000017.11:43071112:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4799dup (p.Leu1600fs)	BRCA1	L496fs, L1600fs, L1553fs, L1621fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142334	17	41223131 - 41223132	17	43071114 - 43071115	142334	152048	rs587782392	NC_000017.11:43071114:AA:AAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4799del (p.Ala1599_Leu1600insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001070948	17	41223132	17	43071115	1070948	1064185	rs587782392	NC_000017.11:43071114:AA:A	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Jun 8, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4794del (p.Ala1599fs)	BRCA1	A1303fs, A1472fs, A1486fs, A1527fs, A1528fs, A1530fs, A1552fs, A1571fs, A1573fs, A1579fs, A1594fs, A1621fs, A319fs, A369fs, A382fs, A386fs, A387fs, A406fs, A416fs, A424fs, A426fs, A447fs, A455fs, A470fs, A471fs, A493fs, A730fs, A731fs, A1302fs, A1470fs, A1471fs, A1487fs, A1529fs, A1551fs, A1558fs, A1572fs, A1580fs, A1620fs, A328fs, A408fs, A414fs, A451fs, A454fs, A492fs, A494fs, A496fs, A517fs, A1445fs, A1488fs, A1510fs, A1532fs, A1557fs, A425fs, A449fs, A453fs, A456fs, A469fs, A495fs, A518fs, A1430fs, A1509fs, A1511fs, A1550fs, A1555fs, A1556fs, A1595fs, A1596fs, A1597fs, A1598fs, A1599fs, A1619fs, A368fs, A383fs, A407fs, A428fs, A429fs, A448fs, A457fs	Hereditary cancer-predisposing syndrome	VCV002774828	17	41223137	17	43071120	2774828	2935555	rs2551001473	NC_000017.11:43071119:A:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 8, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4791del (p.Ser1598fs)	BRCA1	S1598fs, S1619fs, S1551fs, S494fs	not provided	VCV000871416	17	41223140	17	43071123	871416	860389	rs2052407546	NC_000017.11:43071122:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	May 1, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4787C>A (p.Ser1596Ter)	BRCA1	S1596*, S492*, S1549*, S1617*, S1468*, S1485*, S1526*, S1552*, S1568*, S1570*, S1576*, S316*, S403*, S404*, S411*, S423*, S446*, S448*, S453*, S468*, S489*, S490*, S493*, S1299*, S1300*, S1483*, S1506*, S1508*, S1524*, S1569*, S365*, S379*, S383*, S405*, S413*, S450*, S452*, S727*, S1442*, S1547*, S1554*, S1592*, S1594*, S325*, S366*, S426*, S444*, S451*, S454*, S467*, S491*, S514*, S515*, S1427*, S1467*, S1469*, S1484*, S1507*, S1525*, S1527*, S1529*, S1548*, S1553*, S1555*, S1577*, S1591*, S1593*, S1595*, S1616*, S1618*, S380*, S384*, S421*, S422*, S425*, S445*, S466*, S728*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000420037	17	41223144	17	43071127	420037	409959	rs80357429	NC_000017.11:43071126:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4784del (p.Ser1595fs)	BRCA1	S491fs, S1548fs, S1595fs, S1616fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266495	17	41223147	17	43071130	266495	261627	rs886040248	NC_000017.11:43071129:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4782del (p.Ser1595fs)	BRCA1	S491fs, S1548fs, S1595fs, S1616fs	Hereditary breast ovarian cancer syndrome	VCV000645242	17	41223149	17	43071132	645242	645938	rs1597831440	NC_000017.11:43071131:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Feb 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4781del (p.Pro1594fs)	BRCA1	P1547fs, P1594fs, P1615fs, P490fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000993136	17	41223150	17	43071133	993136	981160	rs2052409873	NC_000017.11:43071132:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4775_4779delinsC (p.Asn1592fs)	BRCA1	N1613fs, N1592fs, N488fs, N1545fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037610	17	41223152 - 41223156	17	43071135 - 43071139	37610	46166	rs397507237	NC_000017.11:43071134:TATGT:G	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4768del (p.Val1590fs)	BRCA1	V1611fs, V486fs, V1543fs, V1590fs	Hereditary breast ovarian cancer syndrome	VCV001434125	17	41223163	17	43071146	1434125	1497823	rs2153864590	NC_000017.11:43071145:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	May 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4764_4765del (p.Arg1589fs)	BRCA1	R1589fs, R485fs, R1610fs, R1542fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125730	17	41223166 - 41223167	17	43071149 - 43071150	125730	131268	rs80357795	NC_000017.11:43071148:GAG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4764del (p.Arg1589fs)	BRCA1	R1589fs, R485fs, R1542fs, R1610fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055282	17	41223167	17	43071150	55282	69949	rs397509196	NC_000017.11:43071149:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4759_4760insA (p.Ser1587fs)	BRCA1	S1540fs, S1608fs, S483fs, S1587fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548258	17	41223171 - 41223172	17	43071154 - 43071155	548258	538781	rs1555580980	NC_000017.11:43071154::T	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4760C>G (p.Ser1587Ter)	BRCA1	S1587*, S483*, S1540*, S1608*, S1291*, S1418*, S1476*, S1499*, S1515*, S1518*, S1520*, S1560*, S1568*, S1586*, S371*, S374*, S394*, S439*, S457*, S458*, S459*, S480*, S505*, S1433*, S1458*, S1459*, S1460*, S1497*, S1539*, S1544*, S1559*, S1583*, S316*, S357*, S370*, S395*, S396*, S402*, S442*, S484*, S506*, S1475*, S1538*, S1543*, S1584*, S1609*, S356*, S375*, S413*, S417*, S435*, S436*, S441*, S445*, S481*, S718*, S719*, S1290*, S1474*, S1498*, S1516*, S1517*, S1545*, S1546*, S1561*, S1567*, S1582*, S1585*, S1607*, S307*, S404*, S412*, S414*, S416*, S437*, S443*, S444*, S482*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055281	17	41223171	17	43071154	55281	69948	rs397509195	NC_000017.11:43071153:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4758_4759insA (p.Ser1587fs)	BRCA1	S1587fs, S1540fs, S483fs, S1608fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266494	17	41223172 - 41223173	17	43071155 - 43071156	266494	261628	rs886040247	NC_000017.11:43071155::T	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4756G>T (p.Glu1586Ter)	BRCA1	E1607*, E482*, E1586*, E1539*, E1290*, E1417*, E1457*, E1459*, E1473*, E1537*, E1558*, E1582*, E1606*, E306*, E370*, E395*, E411*, E412*, E416*, E434*, E443*, E458*, E481*, E483*, E717*, E1498*, E1517*, E1543*, E1545*, E1581*, E1584*, E1608*, E355*, E369*, E436*, E457*, E480*, E504*, E1289*, E1458*, E1475*, E1496*, E1497*, E1514*, E1542*, E1544*, E1559*, E1560*, E1567*, E1583*, E1585*, E315*, E393*, E403*, E413*, E438*, E442*, E456*, E718*, E1432*, E1474*, E1515*, E1516*, E1519*, E1538*, E1566*, E356*, E373*, E374*, E394*, E401*, E415*, E435*, E440*, E441*, E444*, E479*, E505*	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000919813	17	41223175	17	43071158	919813	913866	rs2052414656	NC_000017.11:43071157:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Mar 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4753_4754dup (p.Glu1586fs)	BRCA1	E1289fs, E1290fs, E1417fs, E1432fs, E1457fs, E1458fs, E1459fs, E1473fs, E1474fs, E1475fs, E1496fs, E1497fs, E1498fs, E1514fs, E1515fs, E1516fs, E1517fs, E1519fs, E1537fs, E1538fs, E1539fs, E1542fs, E1543fs, E1544fs, E1545fs, E1558fs, E1559fs, E1560fs, E1566fs, E1567fs, E1581fs, E1582fs, E1583fs, E1584fs, E1585fs, E1586fs, E1606fs, E1607fs, E1608fs, E306fs, E315fs, E355fs, E356fs, E369fs, E370fs, E373fs, E374fs, E393fs, E394fs, E395fs, E401fs, E403fs, E411fs, E412fs, E413fs, E415fs, E416fs, E434fs, E435fs, E436fs, E438fs, E440fs, E441fs, E442fs, E443fs, E444fs, E456fs, E457fs, E458fs, E479fs, E480fs, E481fs, E482fs, E483fs, E504fs, E505fs, E717fs, E718fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773505	17	41223176 - 41223177	17	43071159 - 43071160	3773505	3889655		NC_000017.11:43071159:GGGG:GGGGGG	Duplication	frameshift variant|intron variant	Pathogenic	Oct 17, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4754dup (p.Glu1586fs)	BRCA1	E1539fs, E482fs, E1586fs, E1607fs	Hereditary breast ovarian cancer syndrome	VCV000644358	17	41223176 - 41223177	17	43071159 - 43071160	644358	645939	rs1597831578	NC_000017.11:43071159:GGGG:GGGGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Apr 5, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4755del (p.Glu1586fs)	BRCA1	E482fs, E1586fs, E1539fs, E1607fs	Breast neoplasm	VCV000224423	17	41223176	17	43071159	224423	226194	rs886037789	NC_000017.11:43071158:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Nov 1, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4754_4755del (p.Pro1585fs)	BRCA1	P1585fs, P481fs, P1538fs, P1606fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055280	17	41223176 - 41223177	17	43071159 - 43071160	55280	69947	rs80357837	NC_000017.11:43071158:TG:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4750del (p.Ala1584fs)	BRCA1	A1584fs, A1605fs, A480fs, A1537fs	Hereditary breast ovarian cancer syndrome	VCV000934769	17	41223181	17	43071164	934769	937941	rs2052416215	NC_000017.11:43071163:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 15, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4749_4750del (p.Arg1583fs)	BRCA1	R1583fs, R1536fs, R1604fs, R479fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037609	17	41223181 - 41223182	17	43071164 - 43071165	37609	46165	rs80357641	NC_000017.11:43071163:CTCT:CT	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4745del (p.Asp1582fs)	BRCA1	D1582fs, D1535fs, D1603fs, D478fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055278	17	41223186	17	43071169	55278	69945	rs80357907	NC_000017.11:43071168:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4744delinsCC (p.Asp1582fs)	BRCA1	D1535fs, D1582fs, D1603fs, D478fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002431250	17	41223187	17	43071170	2431250	2404755	rs2551045296	NC_000017.11:43071169:C:GG	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Jan 17, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4743del (p.Asp1582fs)	BRCA1	D1603fs, D1582fs, D1535fs, D478fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266493	17	41223188	17	43071171	266493	261629	rs886040246	NC_000017.11:43071170:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4710_4740dup (p.Glu1581delinsLeuLeuTer)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001410828	17	41223190 - 41223191	17	43071173 - 43071174	1410828	1510265	rs2153881466	NC_000017.11:43071173:AGAAGGATCAGATTCAGGGTCATCAGAGAAGAG:AGAAGGATCAGATTCAGGGTCATCAGAGAAGAGAAGGATCAGATTCAGGGTCATCAGAGAAGAG	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Jan 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4741G>T (p.Glu1581Ter)	BRCA1	E1581*, E1534*, E477*, E1602*, E1412*, E1454*, E1469*, E1492*, E1512*, E1514*, E1538*, E1540*, E1562*, E1578*, E350*, E368*, E396*, E408*, E430*, E433*, E438*, E452*, E1284*, E1470*, E1511*, E1554*, E1561*, E1579*, E1603*, E351*, E365*, E390*, E406*, E431*, E436*, E451*, E475*, E499*, E500*, E712*, E1532*, E1537*, E1555*, E1576*, E1577*, E1601*, E301*, E310*, E364*, E369*, E398*, E410*, E411*, E429*, E437*, E439*, E476*, E478*, E1452*, E1468*, E1493*, E1510*, E1533*, E1539*, E1553*, E1580*, E388*, E389*, E407*, E435*, E453*, E474*, E713*, E1285*, E1427*, E1453*, E1491*, E1509*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055276	17	41223190	17	43071173	55276	69943	rs397509193	NC_000017.11:43071172:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4736_4739del (p.Pro1579fs)	BRCA1	P1532fs, P1600fs, P1579fs, P475fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000491087	17	41223192 - 41223195	17	43071175 - 43071178	491087	485320	rs1555581017	NC_000017.11:43071174:GAAGGA:GA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4728dup (p.Ser1577fs)	BRCA1	S1280fs, S1281fs, S1408fs, S1423fs, S1448fs, S1449fs, S1450fs, S1464fs, S1465fs, S1466fs, S1487fs, S1488fs, S1489fs, S1505fs, S1506fs, S1507fs, S1508fs, S1510fs, S1528fs, S1529fs, S1530fs, S1533fs, S1534fs, S1535fs, S1536fs, S1549fs, S1550fs, S1551fs, S1557fs, S1558fs, S1572fs, S1573fs, S1574fs, S1575fs, S1576fs, S1577fs, S1597fs, S1598fs, S1599fs, S297fs, S306fs, S346fs, S347fs, S360fs, S361fs, S364fs, S365fs, S384fs, S385fs, S386fs, S392fs, S394fs, S402fs, S403fs, S404fs, S406fs, S407fs, S425fs, S426fs, S427fs, S429fs, S431fs, S432fs, S433fs, S434fs, S435fs, S447fs, S448fs, S449fs, S470fs, S471fs, S472fs, S473fs, S474fs, S495fs, S496fs, S708fs, S709fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003336625	17	41223202 - 41223203	17	43071185 - 43071186	3336625	3495299		NC_000017.11:43071185:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Jul 10, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4724del (p.Pro1575fs)	BRCA1	P1596fs, P471fs, P1528fs, P1575fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055271	17	41223207	17	43071190	55271	69938	rs397509191	NC_000017.11:43071189:GGG:GG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4717del (p.Asp1573fs)	BRCA1	D1526fs, D1573fs, D1594fs, D469fs	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000837970	17	41223214	17	43071197	837970	845377	rs2052422166	NC_000017.11:43071196:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4715_4716del (p.Phe1571_Ser1572insTer)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001384927	17	41223215 - 41223216	17	43071198 - 43071199	1384927	1345750	rs2153889881	NC_000017.11:43071197:AGAGA:AGA	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 6, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4712_4716del (p.Leu1570_Phe1571insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055269	17	41223215 - 41223219	17	43071198 - 43071202	55269	69936	rs80357718	NC_000017.11:43071197:AGAGAAGAG:AGAG	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4712del (p.Phe1571fs)	BRCA1	F1524fs, F1592fs, F467fs, F1571fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224424	17	41223219	17	43071202	224424	226195	rs886037790	NC_000017.11:43071201:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4700_4710delinsA (p.Gly1567fs)	BRCA1	G1520fs, G1588fs, G463fs, G1567fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266492	17	41223221 - 41223231	17	43071204 - 43071214	266492	261630	rs886040245	NC_000017.11:43071203:GAGGCTGATTC:T	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4709dup (p.Phe1571fs)	BRCA1	F1571fs, F1592fs, F1524fs, F467fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000219511	17	41223221 - 41223222	17	43071204 - 43071205	219511	222653	rs864622132	NC_000017.11:43071204:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4699_4708del (p.Gly1567fs)	BRCA1	G1588fs, G1520fs, G1567fs, G463fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266491	17	41223223 - 41223232	17	43071206 - 43071215	266491	261631	rs886040244	NC_000017.11:43071205:GGCTGATTCC:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4688_4706del (p.Tyr1563fs)	BRCA1	Y371fs, Y372fs, Y378fs, Y380fs, Y388fs, Y389fs, Y390fs, Y392fs, Y393fs, Y411fs, Y412fs, Y413fs, Y415fs, Y417fs, Y418fs, Y419fs, Y420fs, Y421fs, Y433fs, Y434fs, Y435fs, Y456fs, Y457fs, Y458fs, Y459fs, Y460fs, Y481fs, Y482fs, Y694fs, Y695fs, Y1266fs, Y1267fs, Y1394fs, Y1409fs, Y1434fs, Y1435fs, Y1436fs, Y1450fs, Y1451fs, Y1452fs, Y1473fs, Y1474fs, Y1475fs, Y1491fs, Y1492fs, Y1493fs, Y1494fs, Y1496fs, Y1514fs, Y1515fs, Y1516fs, Y1519fs, Y1520fs, Y1521fs, Y1522fs, Y1535fs, Y1536fs, Y1537fs, Y1543fs, Y1544fs, Y1558fs, Y1559fs, Y1560fs, Y1561fs, Y1562fs, Y1563fs, Y1583fs, Y1584fs, Y1585fs, Y283fs, Y292fs, Y332fs, Y333fs, Y346fs, Y347fs, Y350fs, Y351fs, Y370fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773503	17	41223225 - 41223243	17	43071208 - 43071226	3773503	3889653		NC_000017.11:43071207:CTGATTCCAGATTCCAGGT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 17, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4698_4704dup (p.Ser1569fs)	BRCA1	S465fs, S1522fs, S1590fs, S1569fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252434	17	41223226 - 41223227	17	43071209 - 43071210	252434	246846	rs879255318	NC_000017.11:43071209:GATTCCAGATTCCAG:GATTCCAGATTCCAGATTCCAG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4699_4700dup (p.Ile1568fs)	BRCA1	I1589fs, I1568fs, I1521fs, I464fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000661222	17	41223230 - 41223231	17	43071213 - 43071214	661222	645940	rs1597831850	NC_000017.11:43071213:CC:CCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jul 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4697_4698insA (p.Gly1567fs)	BRCA1	G1588fs, G1520fs, G1567fs, G463fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548276	17	41223233 - 41223234	17	43071216 - 43071217	548276	538782	rs1555581078	NC_000017.11:43071216::T	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4696_4697insA (p.Ser1566fs)	BRCA1	S1519fs, S1566fs, S1587fs, S462fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125728	17	41223234 - 41223235	17	43071217 - 43071218	125728	131266	rs483353095	NC_000017.11:43071217::T	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4695dup (p.Ser1566fs)	BRCA1	S1566fs, S1519fs, S462fs, S1587fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055263	17	41223235 - 41223236	17	43071218 - 43071219	55263	69930	rs397509189	NC_000017.11:43071218:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4688_4694delinsG (p.Tyr1563_Glu1565delinsTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV000491085	17	41223237 - 41223243	17	43071220 - 43071226	491085	485068	rs1555581087	NC_000017.11:43071219:TCCAGGT:C	Indel	inframe_indel|nonsense|non-coding transcript variant	Pathogenic	Apr 12, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4690del (p.Leu1564fs)	BRCA1	L1267fs, L1268fs, L1395fs, L1410fs, L1435fs, L1436fs, L1437fs, L1451fs, L1452fs, L1453fs, L1474fs, L1475fs, L1476fs, L1492fs, L1493fs, L1494fs, L1495fs, L1497fs, L1515fs, L1516fs, L1517fs, L1520fs, L1521fs, L1522fs, L1523fs, L1536fs, L1537fs, L1538fs, L1544fs, L1545fs, L1559fs, L1560fs, L1561fs, L1562fs, L1563fs, L1564fs, L1584fs, L1585fs, L1586fs, L284fs, L293fs, L333fs, L334fs, L347fs, L348fs, L351fs, L352fs, L371fs, L372fs, L373fs, L379fs, L381fs, L389fs, L390fs, L391fs, L393fs, L394fs, L412fs, L413fs, L414fs, L416fs, L418fs, L419fs, L420fs, L421fs, L422fs, L434fs, L435fs, L436fs, L457fs, L458fs, L459fs, L460fs, L461fs, L482fs, L483fs, L695fs, L696fs	Hereditary cancer-predisposing syndrome	VCV003226161	17	41223241	17	43071224	3226161	3387225	rs2551081507	NC_000017.11:43071223:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 19, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4688dup (p.Tyr1563Ter)	BRCA1	Y1584*, Y459*, Y1563*, Y1516*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266490	17	41223242 - 41223243	17	43071225 - 43071226	266490	261632	rs886040243	NC_000017.11:43071225:T:TT	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4689C>G (p.Tyr1563Ter)	BRCA1	Y1563*, Y1584*, Y1516*, Y459*, Y1267*, Y1434*, Y1450*, Y1451*, Y1514*, Y1519*, Y1537*, Y1543*, Y1559*, Y1583*, Y333*, Y388*, Y389*, Y390*, Y392*, Y411*, Y415*, Y460*, Y283*, Y292*, Y346*, Y351*, Y371*, Y418*, Y420*, Y421*, Y482*, Y1266*, Y1394*, Y1409*, Y1436*, Y1492*, Y1493*, Y1515*, Y1522*, Y1536*, Y1544*, Y1585*, Y332*, Y347*, Y370*, Y372*, Y380*, Y393*, Y433*, Y434*, Y456*, Y458*, Y694*, Y1474*, Y1475*, Y1494*, Y1520*, Y1535*, Y1558*, Y1560*, Y1562*, Y1435*, Y1452*, Y1473*, Y1491*, Y1496*, Y1521*, Y1561*, Y350*, Y378*, Y412*, Y413*, Y417*, Y419*, Y435*, Y457*, Y481*, Y695*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037607	17	41223242	17	43071225	37607	46163	rs80357433	NC_000017.11:43071224:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4685del (p.Pro1562fs)	BRCA1	P1408fs, P1451fs, P1474fs, P1495fs, P1513fs, P1520fs, P1560fs, P350fs, P369fs, P377fs, P387fs, P391fs, P411fs, P412fs, P419fs, P433fs, P434fs, P458fs, P459fs, P481fs, P1433fs, P1434fs, P1449fs, P1472fs, P1491fs, P1492fs, P1514fs, P1518fs, P1535fs, P1543fs, P1557fs, P1558fs, P1559fs, P1562fs, P1582fs, P331fs, P332fs, P345fs, P370fs, P388fs, P414fs, P418fs, P457fs, P693fs, P1266fs, P1435fs, P1450fs, P1473fs, P1542fs, P1561fs, P346fs, P349fs, P379fs, P416fs, P420fs, P455fs, P480fs, P694fs, P1265fs, P1393fs, P1490fs, P1493fs, P1515fs, P1519fs, P1521fs, P1534fs, P1536fs, P1583fs, P1584fs, P282fs, P291fs, P371fs, P389fs, P392fs, P410fs, P417fs, P432fs, P456fs	Hereditary cancer-predisposing syndrome	VCV003825270	17	41223246	17	43071229	3825270	3942542		NC_000017.11:43071228:GGGG:GGG	Deletion	frameshift variant|intron variant	Pathogenic	Jan 17, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4684_4685del (p.Pro1562fs)	BRCA1	P1515fs, P458fs, P1562fs, P1583fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055260	17	41223246 - 41223247	17	43071229 - 43071230	55260	69927	rs397509188	NC_000017.11:43071228:GGGG:GG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4681del (p.Thr1561fs)	BRCA1	T1561fs, T1582fs, T1514fs, T457fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055258	17	41223250	17	43071233	55258	69925	rs397509187	NC_000017.11:43071232:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4679del (p.Gly1560fs)	BRCA1	G1513fs, G1560fs, G1581fs, G456fs	Hereditary breast ovarian cancer syndrome	VCV002029623	17	41223252	17	43071235	2029623	2078554	rs1555581104	NC_000017.11:43071234:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 9, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4678_4679del (p.Gly1560fs)	BRCA1	G1560fs, G456fs, G1513fs, G1581fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000430604	17	41223252 - 41223253	17	43071235 - 43071236	430604	423252	rs1555581104	NC_000017.11:43071234:CCC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4678G>T (p.Gly1560Ter)	BRCA1	G1560*, G1513*, G1581*, G456*, G1433*, G1447*, G1471*, G1472*, G1489*, G1493*, G1511*, G1512*, G1517*, G1541*, G1555*, G1556*, G348*, G385*, G386*, G416*, G432*, G453*, G1432*, G1491*, G1516*, G1518*, G1519*, G1557*, G289*, G343*, G347*, G387*, G408*, G409*, G417*, G418*, G457*, G691*, G1263*, G1264*, G1391*, G1406*, G1431*, G1449*, G1488*, G1534*, G1559*, G1580*, G280*, G330*, G367*, G368*, G369*, G375*, G410*, G412*, G414*, G415*, G430*, G454*, G455*, G692*, G1448*, G1470*, G1490*, G1532*, G1533*, G1540*, G1558*, G1582*, G329*, G344*, G377*, G389*, G390*, G431*, G478*, G479*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055257	17	41223253	17	43071236	55257	69924	rs80357349	NC_000017.11:43071235:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4676-1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000267560	17	41223256	17	43071239	267560	262950	rs80358008	NC_000017.11:43071238:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4676-1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125725	17	41223256	17	43071239	125725	131263	rs80358008	NC_000017.11:43071238:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4676-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000125726	17	41223257	17	43071240	125726	131264	rs80358096	NC_000017.11:43071239:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Apr 21, 2025	criteria provided, multiple submitters, no conflicts							
NC_000017.11:g.(?_43074311)_(43115799_?)del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000640454	17	41226328 - 41267816	17	43074311 - 43115799	640454	652820			Deletion		Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NC_000017.11:g.(?_43074325)_(43115785_?)del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000531551	17	41226342 - 41267802	17	43074325 - 43115785	531551	530482			Deletion		Pathogenic	Aug 15, 2017	criteria provided, single submitter							
NC_000017.11:g.(?_43074325)_(43094866_?)del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000462197	17	41226342 - 41246883	17	43074325 - 43094866	462197	467128			Deletion		Pathogenic	Jul 27, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4675+3A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125722	17	41226345	17	43074328	125722	131260	rs80358082	NC_000017.11:43074327:T:A	single nucleotide variant	intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4487_4675+2del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000433739	17	41226346 - 41226536	17	43074329 - 43074519	433739	427540	rs1555581778		Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic		criteria provided, single submitter							
NM_007294.4(BRCA1):c.4675+2T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267555	17	41226346	17	43074329	267555	262951	rs879255293	NC_000017.11:43074328:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jan 16, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4675+2T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267554	17	41226346	17	43074329	267554	262952	rs879255293	NC_000017.11:43074328:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4675+2T>G	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000252396	17	41226346	17	43074329	252396	246813	rs879255293	NC_000017.11:43074328:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4675+1del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003904743	17	41226347	17	43074330	3904743	4020615		NC_000017.11:43074329:CC:C	Deletion	splice donor variant|intron variant	Pathogenic	Mar 18, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4675+1G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267553	17	41226347	17	43074330	267553	262953	rs80358044	NC_000017.11:43074329:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4675+1G>T	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast	VCV000185411	17	41226347	17	43074330	185411	184911	rs80358044	NC_000017.11:43074329:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4675+1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055256	17	41226347	17	43074330	55256	69923	rs80358044	NC_000017.11:43074329:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675G>T (p.Glu1559Ter)	BRCA1	E1447*, E1471*, E1487*, E1490*, E1510*, E1531*, E1532*, E1539*, E1555*, E1559*, E1579*, E329*, E366*, E367*, E368*, E386*, E389*, E409*, E413*, E415*, E431*, E690*, E1430*, E1446*, E1489*, E1515*, E1517*, E1518*, E1533*, E1540*, E1557*, E1581*, E376*, E414*, E416*, E429*, E452*, E453*, E454*, E1262*, E1263*, E1431*, E1448*, E1469*, E1488*, E1511*, E1516*, E1554*, E1580*, E288*, E342*, E343*, E347*, E388*, E407*, E408*, E411*, E417*, E455*, E1390*, E1432*, E1470*, E1492*, E1512*, E1556*, E1558*, E328*, E346*, E374*, E384*, E385*, E430*, E456*, E477*, E478*, E691*	Hereditary cancer-predisposing syndrome	VCV004215086	17	41226348	17	43074331	4215086	4331999		NC_000017.11:43074330:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 28, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4674dup (p.Glu1559fs)	BRCA1	E1580fs, E1512fs, E1559fs, E455fs	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000838793	17	41226348 - 41226349	17	43074331 - 43074332	838793	845378	rs2052585246	NC_000017.11:43074331:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Aug 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.4186-?_4675+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000089061	17	41226348 - 41234592	17	43074331 - 43082575	89061	94604			Deletion		Pathogenic	Dec 12, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4675G>C (p.Glu1559Gln)	BRCA1	E1559Q, E455Q, E1580Q, E1512Q, E1447Q, E1516Q, E1554Q, E1556Q, E346Q, E384Q, E388Q, E407Q, E409Q, E413Q, E415Q, E417Q, E453Q, E477Q, E1262Q, E1263Q, E1390Q, E1469Q, E1487Q, E1510Q, E1517Q, E1518Q, E1540Q, E1581Q, E366Q, E367Q, E385Q, E411Q, E454Q, E478Q, E1430Q, E1446Q, E1488Q, E1489Q, E1490Q, E1511Q, E1515Q, E1531Q, E1539Q, E1555Q, E1557Q, E1579Q, E288Q, E342Q, E343Q, E376Q, E386Q, E408Q, E414Q, E416Q, E429Q, E452Q, E456Q, E690Q, E1431Q, E1432Q, E1448Q, E1470Q, E1471Q, E1492Q, E1532Q, E1533Q, E1558Q, E328Q, E329Q, E347Q, E368Q, E374Q, E389Q, E430Q, E431Q, E691Q	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037605	17	41226348	17	43074331	37605	46161	rs80356988	NC_000017.11:43074330:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4675G>A (p.Glu1559Lys)	BRCA1	E1559K, E1580K, E1512K, E455K, E1431K, E1515K, E1517K, E1532K, E1539K, E1540K, E386K, E388K, E407K, E409K, E691K, E1262K, E1432K, E1446K, E1447K, E1469K, E1489K, E1490K, E1492K, E1510K, E1518K, E1533K, E288K, E347K, E366K, E368K, E384K, E385K, E415K, E430K, E452K, E478K, E690K, E1263K, E1487K, E1488K, E1516K, E1531K, E1555K, E1556K, E1557K, E1558K, E329K, E342K, E343K, E374K, E376K, E389K, E411K, E414K, E417K, E454K, E1390K, E1430K, E1448K, E1470K, E1471K, E1511K, E1554K, E1579K, E1581K, E328K, E346K, E367K, E408K, E413K, E416K, E429K, E431K, E453K, E456K, E477K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037604	17	41226348	17	43074331	37604	46160	rs80356988	NC_000017.11:43074330:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4674del (p.Glu1559fs)	BRCA1	E1512fs, E1580fs, E455fs, E1559fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267552	17	41226349	17	43074332	267552	262954	rs886040911	NC_000017.11:43074331:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4654_4673del (p.Tyr1552fs)	BRCA1	Y1552fs, Y1573fs, Y448fs, Y1505fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231678	17	41226350 - 41226369	17	43074333 - 43074352	231678	235959	rs876659293	NC_000017.11:43074332:AGATCTTGCCTTGGCAAGTAAGAT:AGAT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4672del (p.Asp1557_Leu1558insTer)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000646336	17	41226351	17	43074334	646336	645942	rs1597835688	NC_000017.11:43074333:G:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Mar 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4659_4671del (p.Leu1553fs)	BRCA1	L449fs, L1506fs, L1553fs, L1574fs	Hereditary breast ovarian cancer syndrome	VCV002028077	17	41226352 - 41226364	17	43074335 - 43074347	2028077	2088552	rs2551395033	NC_000017.11:43074334:ATCTTGCCTTGGCA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 31, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4669del (p.Asp1557fs)	BRCA1	D1557fs, D1510fs, D453fs, D1578fs	Hereditary breast ovarian cancer syndrome	VCV001454000	17	41226354	17	43074337	1454000	1366609	rs2153987675	NC_000017.11:43074336:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 9, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4668dup (p.Asp1557fs)	BRCA1	D453fs, D1557fs, D1578fs, D1510fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266489	17	41226354 - 41226355	17	43074337 - 43074338	266489	261633	rs886040242	NC_000017.11:43074337:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4666C>T (p.Gln1556Ter)	BRCA1	Q1556*, Q1509*, Q452*, Q1577*, Q1429*, Q1443*, Q1468*, Q1484*, Q1529*, Q1553*, Q1554*, Q1576*, Q343*, Q364*, Q371*, Q404*, Q428*, Q451*, Q475*, Q1259*, Q1427*, Q1445*, Q1489*, Q1508*, Q1530*, Q1551*, Q285*, Q326*, Q340*, Q365*, Q373*, Q381*, Q383*, Q408*, Q426*, Q453*, Q688*, Q1260*, Q1387*, Q1444*, Q1485*, Q1486*, Q1507*, Q1515*, Q1528*, Q1536*, Q1537*, Q1552*, Q1555*, Q339*, Q344*, Q385*, Q386*, Q405*, Q406*, Q410*, Q411*, Q412*, Q413*, Q449*, Q450*, Q687*, Q1428*, Q1466*, Q1467*, Q1487*, Q1512*, Q1513*, Q1514*, Q1578*, Q325*, Q363*, Q382*, Q414*, Q427*, Q474*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433717	17	41226357	17	43074340	433717	427541	rs1555581812	NC_000017.11:43074339:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4646_4665del (p.Glu1549fs)	BRCA1	E445fs, E1570fs, E1502fs, E1549fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055250	17	41226358 - 41226377	17	43074341 - 43074360	55250	69917	rs397509186	NC_000017.11:43074340:CCTTGGCAAGTAAGATGTTTCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4663del (p.Arg1555fs)	BRCA1	R1508fs, R1555fs, R1576fs, R451fs	Hereditary breast ovarian cancer syndrome	VCV000949796	17	41226360	17	43074343	949796	928272	rs2052588365	NC_000017.11:43074342:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 8, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4658del (p.Leu1553fs)	BRCA1	L1506fs, L1553fs, L1574fs, L449fs	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000839374	17	41226365	17	43074348	839374	845379	rs2052588740	NC_000017.11:43074347:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4655_4658del (p.Tyr1552fs)	BRCA1	Y448fs, Y1552fs, Y1505fs, Y1573fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055252	17	41226365 - 41226368	17	43074348 - 43074351	55252	69919	rs80357561	NC_000017.11:43074347:AAGTAAG:AAG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4656C>A (p.Tyr1552Ter)	BRCA1	Y1505*, Y1552*, Y1573*, Y448*, Y1383*, Y1440*, Y1441*, Y1482*, Y1508*, Y1511*, Y335*, Y367*, Y381*, Y423*, Y446*, Y1464*, Y1480*, Y1481*, Y1485*, Y1525*, Y1532*, Y1548*, Y1550*, Y339*, Y340*, Y400*, Y409*, Y410*, Y445*, Y470*, Y471*, Y1255*, Y1256*, Y1425*, Y1462*, Y1463*, Y1483*, Y1503*, Y1510*, Y1533*, Y1547*, Y1549*, Y281*, Y321*, Y359*, Y369*, Y377*, Y378*, Y382*, Y401*, Y402*, Y407*, Y447*, Y683*, Y684*, Y1423*, Y1424*, Y1439*, Y1504*, Y1509*, Y1524*, Y1526*, Y1551*, Y1572*, Y1574*, Y322*, Y336*, Y360*, Y361*, Y379*, Y404*, Y406*, Y408*, Y422*, Y424*, Y449*	Hereditary breast ovarian cancer syndrome	VCV002910428	17	41226367	17	43074350	2910428	1245745	rs80357151	NC_000017.11:43074349:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 1, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4656del (p.Leu1553fs)	BRCA1	L1506fs, L1574fs, L1553fs, L449fs	Hereditary cancer-predisposing syndrome	VCV000918371	17	41226367	17	43074350	918371	913869	rs2052589590	NC_000017.11:43074349:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 15, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4655dup (p.Tyr1552Ter)	BRCA1	Y1505*, Y1552*, Y448*, Y1573*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000141960	17	41226367 - 41226368	17	43074350 - 43074351	141960	151674	rs587782143	NC_000017.11:43074350:T:TT	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4656C>G (p.Tyr1552Ter)	BRCA1	Y1552*, Y1505*, Y1573*, Y448*, Y1255*, Y1441*, Y1480*, Y1483*, Y1509*, Y1510*, Y1511*, Y1524*, Y1548*, Y1572*, Y335*, Y378*, Y382*, Y401*, Y407*, Y445*, Y470*, Y1256*, Y1383*, Y1462*, Y1503*, Y1504*, Y1508*, Y1526*, Y1550*, Y1551*, Y321*, Y340*, Y360*, Y1425*, Y1440*, Y1463*, Y1481*, Y1485*, Y1532*, Y1549*, Y1574*, Y322*, Y336*, Y367*, Y379*, Y404*, Y423*, Y471*, Y361*, Y377*, Y402*, Y406*, Y449*, Y1423*, Y1424*, Y1439*, Y1464*, Y1482*, Y1525*, Y1533*, Y1547*, Y281*, Y339*, Y359*, Y369*, Y381*, Y400*, Y408*, Y409*, Y410*, Y422*, Y424*, Y446*, Y447*, Y683*, Y684*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055253	17	41226367	17	43074350	55253	69920	rs80357151	NC_000017.11:43074349:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4654_4655insG (p.Tyr1552Ter)	BRCA1	Y1552*, Y1573*, Y1505*, Y448*	Hereditary breast ovarian cancer syndrome	VCV000858687	17	41226368 - 41226369	17	43074351 - 43074352	858687	845380	rs1555581824	NC_000017.11:43074351::C	Insertion	nonsense|frameshift variant|non-coding transcript variant	Pathogenic	May 1, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4654_4655insC (p.Tyr1552fs)	BRCA1	Y1552fs, Y1573fs, Y448fs, Y1505fs	Hereditary breast ovarian cancer syndrome	VCV000531389	17	41226368 - 41226369	17	43074351 - 43074352	531389	531197	rs1555581824	NC_000017.11:43074351::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 3, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4654del (p.Tyr1552fs)	BRCA1	Y1505fs, Y1552fs, Y1573fs, Y448fs	Hereditary cancer-predisposing syndrome|Inherited ovarian cancer (without breast cancer)|Hereditary breast ovarian cancer syndrome	VCV001437343	17	41226369	17	43074352	1437343	1513959	rs2153991069	NC_000017.11:43074351:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4650del (p.Ser1551fs)	BRCA1	S1255fs, S1424fs, S1461fs, S1480fs, S1502fs, S1508fs, S1532fs, S280fs, S358fs, S360fs, S368fs, S380fs, S405fs, S408fs, S409fs, S421fs, S444fs, S469fs, S682fs, S1422fs, S1440fs, S1479fs, S1482fs, S1503fs, S1509fs, S1510fs, S1524fs, S1525fs, S1531fs, S1548fs, S1571fs, S321fs, S334fs, S377fs, S400fs, S403fs, S407fs, S448fs, S1254fs, S1382fs, S1423fs, S1439fs, S1462fs, S1463fs, S1481fs, S1546fs, S1550fs, S1551fs, S1573fs, S320fs, S339fs, S359fs, S366fs, S378fs, S399fs, S422fs, S423fs, S445fs, S447fs, S1438fs, S1484fs, S1504fs, S1507fs, S1523fs, S1547fs, S1549fs, S1572fs, S335fs, S338fs, S376fs, S381fs, S401fs, S406fs, S446fs, S470fs, S683fs	Hereditary cancer-predisposing syndrome	VCV002774831	17	41226373	17	43074356	2774831	2935558	rs2551418406	NC_000017.11:43074355:T:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4645_4646dup (p.Thr1550fs)	BRCA1	T1503fs, T1550fs, T1571fs, T446fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001174602	17	41226376 - 41226377	17	43074359 - 43074360	1174602	1163969	rs2153992821	NC_000017.11:43074359:TC:TCTC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4645dup (p.Glu1549fs)	BRCA1	E1252fs, E1380fs, E1421fs, E1461fs, E1478fs, E1479fs, E1482fs, E1502fs, E1505fs, E319fs, E336fs, E337fs, E358fs, E366fs, E397fs, E407fs, E443fs, E1438fs, E1459fs, E1460fs, E1477fs, E1500fs, E1501fs, E1506fs, E1508fs, E1521fs, E1529fs, E1546fs, E1547fs, E1571fs, E375fs, E378fs, E379fs, E401fs, E404fs, E420fs, E444fs, E467fs, E1253fs, E1437fs, E1530fs, E1548fs, E1569fs, E1570fs, E278fs, E332fs, E374fs, E376fs, E398fs, E403fs, E421fs, E442fs, E446fs, E468fs, E680fs, E1420fs, E1422fs, E1436fs, E1480fs, E1507fs, E1522fs, E1523fs, E1544fs, E1545fs, E1549fs, E318fs, E333fs, E356fs, E357fs, E364fs, E399fs, E405fs, E406fs, E419fs, E445fs, E681fs	Hereditary cancer-predisposing syndrome	VCV003992586	17	41226377 - 41226378	17	43074360 - 43074361	3992586	4104837		NC_000017.11:43074360:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Mar 25, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4635del (p.His1545fs)	BRCA1	H441fs, H1545fs, H1498fs, H1566fs	Hereditary cancer-predisposing syndrome	VCV000928315	17	41226388	17	43074371	928315	913870	rs2052594151	NC_000017.11:43074370:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 15, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4623_4632del (p.Glu1541fs)	BRCA1	E1562fs, E1541fs, E1494fs, E437fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000633099	17	41226391 - 41226400	17	43074374 - 43074383	633099	621571	rs1567777811	NC_000017.11:43074373:TGGCCCAGACT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4631del (p.Pro1544fs)	BRCA1	P1544fs, P1497fs, P440fs, P1565fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001453130	17	41226392	17	43074375	1453130	1428416	rs2153996908	NC_000017.11:43074374:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4625_4626del (p.Ser1542fs)	BRCA1	S1495fs, S1542fs, S438fs, S1563fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055243	17	41226397 - 41226398	17	43074380 - 43074381	55243	69910	rs80357542	NC_000017.11:43074379:AGA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4622_4623del (p.Glu1541fs)	BRCA1	E437fs, E1494fs, E1541fs, E1562fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266488	17	41226400 - 41226401	17	43074383 - 43074384	266488	261634	rs886040241	NC_000017.11:43074382:CTCT:CT	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4621del (p.Glu1541fs)	BRCA1	E1494fs, E1541fs, E1562fs, E437fs	Hereditary breast ovarian cancer syndrome	VCV002769498	17	41226402	17	43074385	2769498	1064186	rs2551453077	NC_000017.11:43074384:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4618_4621delinsAAA (p.Glu1540fs)	BRCA1	E1540fs, E1493fs, E1561fs, E436fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266487	17	41226402 - 41226405	17	43074385 - 43074388	266487	261635	rs886040240	NC_000017.11:43074384:CTTC:TTT	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4621G>T (p.Glu1541Ter)	BRCA1	E1541*, E1562*, E437*, E1494*, E1244*, E1245*, E1451*, E1469*, E1471*, E1472*, E1492*, E1522*, E1536*, E1561*, E311*, E325*, E389*, E391*, E395*, E396*, E397*, E411*, E435*, E459*, E1414*, E1493*, E1497*, E1498*, E1537*, E1539*, E1540*, E1563*, E324*, E348*, E349*, E350*, E358*, E366*, E368*, E398*, E413*, E438*, E1413*, E1429*, E1430*, E1453*, E1470*, E1474*, E1499*, E1500*, E1513*, E1521*, E1538*, E328*, E329*, E356*, E370*, E393*, E412*, E436*, E460*, E673*, E1372*, E1412*, E1428*, E1452*, E1514*, E1515*, E270*, E310*, E367*, E371*, E390*, E399*, E434*, E672*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055241	17	41226402	17	43074385	55241	69908	rs80357248	NC_000017.11:43074384:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4616_4617dup (p.Glu1540fs)	BRCA1	E1243fs, E1244fs, E1371fs, E1411fs, E1412fs, E1413fs, E1427fs, E1428fs, E1429fs, E1450fs, E1451fs, E1452fs, E1468fs, E1469fs, E1470fs, E1471fs, E1473fs, E1491fs, E1492fs, E1493fs, E1496fs, E1497fs, E1498fs, E1499fs, E1512fs, E1513fs, E1514fs, E1520fs, E1521fs, E1535fs, E1536fs, E1537fs, E1538fs, E1539fs, E1540fs, E1560fs, E1561fs, E1562fs, E269fs, E309fs, E310fs, E323fs, E324fs, E327fs, E328fs, E347fs, E348fs, E349fs, E355fs, E357fs, E365fs, E366fs, E367fs, E369fs, E370fs, E388fs, E389fs, E390fs, E392fs, E394fs, E395fs, E396fs, E397fs, E398fs, E410fs, E411fs, E412fs, E433fs, E434fs, E435fs, E436fs, E437fs, E458fs, E459fs, E671fs, E672fs	Inherited breast cancer and ovarian cancer	VCV003387792	17	41226405 - 41226406	17	43074388 - 43074389	3387792	3546921		NC_000017.11:43074388:CA:CACA	Duplication	frameshift variant|intron variant	Pathogenic	Jul 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4618G>T (p.Glu1540Ter)	BRCA1	E1540*, E1493*, E436*, E1561*, E1428*, E1452*, E1471*, E1492*, E1498*, E1514*, E1535*, E269*, E309*, E324*, E348*, E349*, E365*, E370*, E398*, E411*, E435*, E1427*, E1429*, E1451*, E1468*, E1469*, E1499*, E1512*, E1520*, E1536*, E1537*, E1562*, E310*, E323*, E328*, E395*, E397*, E434*, E1243*, E1413*, E1450*, E1470*, E1473*, E1496*, E1497*, E1521*, E355*, E388*, E390*, E392*, E410*, E412*, E433*, E459*, E1244*, E1371*, E1411*, E1412*, E1491*, E1513*, E1538*, E1539*, E1560*, E327*, E347*, E357*, E366*, E367*, E369*, E389*, E394*, E396*, E437*, E458*, E671*, E672*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055240	17	41226405	17	43074388	55240	69907	rs80357277	NC_000017.11:43074387:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4616dup (p.Glu1540fs)	BRCA1	E1540fs, E436fs, E1561fs, E1493fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462654	17	41226406 - 41226407	17	43074389 - 43074390	462654	467684	rs1555581874	NC_000017.11:43074389:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4612_4613insG (p.Gln1538fs)	BRCA1	Q434fs, Q1491fs, Q1538fs, Q1559fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548250	17	41226410 - 41226411	17	43074393 - 43074394	548250	538784	rs1555581879	NC_000017.11:43074393::C	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4612C>T (p.Gln1538Ter)	BRCA1	Q1538*, Q1491*, Q1559*, Q434*, Q1241*, Q1242*, Q1449*, Q1466*, Q1495*, Q1496*, Q1512*, Q1534*, Q1537*, Q321*, Q325*, Q326*, Q364*, Q367*, Q388*, Q395*, Q1410*, Q1468*, Q1469*, Q1471*, Q1497*, Q1511*, Q1560*, Q345*, Q355*, Q387*, Q392*, Q394*, Q409*, Q431*, Q456*, Q1369*, Q1409*, Q1425*, Q1448*, Q1489*, Q1490*, Q1494*, Q1510*, Q1533*, Q1535*, Q267*, Q347*, Q353*, Q363*, Q365*, Q368*, Q386*, Q393*, Q432*, Q435*, Q457*, Q669*, Q670*, Q1411*, Q1426*, Q1427*, Q1450*, Q1467*, Q1518*, Q1519*, Q1536*, Q1558*, Q307*, Q308*, Q322*, Q346*, Q390*, Q396*, Q408*, Q410*, Q433*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055239	17	41226411	17	43074394	55239	69906	rs80356992	NC_000017.11:43074393:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4611_4612insG (p.Gln1538fs)	BRCA1	Q1538fs, Q1559fs, Q434fs, Q1491fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055238	17	41226411 - 41226412	17	43074394 - 43074395	55238	69905	rs80357915	NC_000017.11:43074394::C	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4610_4611insCC (p.Gln1537fs)	BRCA1	Q1558fs, Q1537fs, Q1490fs, Q433fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548194	17	41226412 - 41226413	17	43074395 - 43074396	548194	538785	rs1555581882	NC_000017.11:43074395::GG	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4609_4610insCC (p.Gln1537fs)	BRCA1	Q1558fs, Q433fs, Q1490fs, Q1537fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254456	17	41226413 - 41226414	17	43074396 - 43074397	254456	249087	rs886038035	NC_000017.11:43074396:G:GGG	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4609C>T (p.Gln1537Ter)	BRCA1	Q1537*, Q1490*, Q433*, Q1558*, Q1368*, Q1425*, Q1447*, Q1467*, Q1494*, Q1495*, Q1510*, Q1518*, Q1533*, Q1535*, Q1557*, Q1559*, Q266*, Q321*, Q325*, Q345*, Q352*, Q354*, Q386*, Q392*, Q409*, Q456*, Q668*, Q1240*, Q1408*, Q1466*, Q1468*, Q1488*, Q1532*, Q306*, Q307*, Q364*, Q366*, Q367*, Q385*, Q395*, Q407*, Q431*, Q432*, Q455*, Q1409*, Q1426*, Q1448*, Q1449*, Q1465*, Q1470*, Q1511*, Q1534*, Q320*, Q344*, Q362*, Q387*, Q389*, Q391*, Q394*, Q434*, Q1241*, Q1410*, Q1424*, Q1489*, Q1493*, Q1496*, Q1509*, Q1517*, Q1536*, Q324*, Q346*, Q363*, Q393*, Q408*, Q430*, Q669*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055237	17	41226414	17	43074397	55237	69904	rs80357229	NC_000017.11:43074396:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4608del (p.Glu1536fs)	BRCA1	E1489fs, E1557fs, E432fs, E1536fs	Hereditary cancer-predisposing syndrome	VCV001741855	17	41226415	17	43074398	1741855	1801499	rs2551464938	NC_000017.11:43074397:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	May 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4607del (p.Glu1536fs)	BRCA1	E1367fs, E1423fs, E1424fs, E1446fs, E1448fs, E1469fs, E1509fs, E1517fs, E1531fs, E1536fs, E265fs, E323fs, E345fs, E351fs, E361fs, E365fs, E366fs, E394fs, E408fs, E454fs, E1466fs, E1487fs, E1488fs, E1489fs, E1494fs, E1508fs, E1532fs, E1534fs, E1535fs, E1556fs, E343fs, E344fs, E385fs, E386fs, E388fs, E390fs, E406fs, E432fs, E433fs, E1447fs, E1464fs, E1467fs, E1492fs, E1493fs, E1495fs, E1516fs, E1533fs, E306fs, E319fs, E320fs, E353fs, E362fs, E363fs, E393fs, E667fs, E1239fs, E1240fs, E1407fs, E1408fs, E1409fs, E1425fs, E1465fs, E1510fs, E1557fs, E1558fs, E305fs, E324fs, E384fs, E391fs, E392fs, E407fs, E429fs, E430fs, E431fs, E455fs, E668fs	Hereditary breast ovarian cancer syndrome	VCV003655667	17	41226416	17	43074399	3655667	3786383		NC_000017.11:43074398:T:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 10, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4606G>T (p.Glu1536Ter)	BRCA1	E1489*, E1536*, E1557*, E432*, E1239*, E1367*, E1425*, E1487*, E1488*, E1494*, E1517*, E1556*, E365*, E366*, E384*, E386*, E388*, E394*, E407*, E431*, E1240*, E1407*, E1424*, E1448*, E1464*, E1508*, E1509*, E1516*, E1533*, E1535*, E265*, E305*, E306*, E324*, E362*, E363*, E392*, E393*, E406*, E408*, E455*, E667*, E1408*, E1409*, E1446*, E1447*, E1467*, E1492*, E1493*, E1495*, E1532*, E319*, E320*, E323*, E343*, E344*, E361*, E391*, E429*, E430*, E433*, E668*, E1423*, E1465*, E1466*, E1469*, E1510*, E1531*, E1534*, E1558*, E345*, E351*, E353*, E385*, E390*, E454*	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000935901	17	41226417	17	43074400	935901	937943	rs876660460	NC_000017.11:43074399:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Aug 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4603G>T (p.Glu1535Ter)	BRCA1	E1535*, E1488*, E1556*, E431*, E1366*, E1406*, E1422*, E1424*, E1465*, E1468*, E1491*, E1532*, E1555*, E318*, E360*, E364*, E392*, E406*, E407*, E429*, E667*, E1407*, E1423*, E1445*, E1464*, E1486*, E1507*, E1515*, E1530*, E1534*, E319*, E322*, E343*, E361*, E385*, E389*, E393*, E432*, E666*, E428*, E430*, E1238*, E1408*, E1446*, E1447*, E1463*, E1494*, E1508*, E1516*, E1557*, E305*, E323*, E350*, E352*, E362*, E387*, E390*, E391*, E405*, E453*, E454*, E1239*, E1466*, E1487*, E1492*, E1493*, E1509*, E1531*, E1533*, E264*, E304*, E342*, E344*, E365*, E383*, E384*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055236	17	41226420	17	43074403	55236	69903	rs80357366	NC_000017.11:43074402:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4599del (p.Asp1533fs)	BRCA1	D1486fs, D1533fs, D1554fs, D429fs	Hereditary breast ovarian cancer syndrome	VCV002012064	17	41226424	17	43074407	2012064	2067441	rs2551470484	NC_000017.11:43074406:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jun 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4596_4597insCT (p.Asp1533fs)	BRCA1	D1533fs, D1554fs, D1486fs, D429fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548312	17	41226426 - 41226427	17	43074409 - 43074410	548312	538786	rs1555581894	NC_000017.11:43074409:A:AGA	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4596del (p.Asp1533fs)	BRCA1	D1236fs, D1237fs, D1364fs, D1404fs, D1405fs, D1406fs, D1420fs, D1421fs, D1422fs, D1443fs, D1444fs, D1445fs, D1461fs, D1462fs, D1463fs, D1464fs, D1466fs, D1484fs, D1485fs, D1486fs, D1489fs, D1490fs, D1491fs, D1492fs, D1505fs, D1506fs, D1507fs, D1513fs, D1514fs, D1528fs, D1529fs, D1530fs, D1531fs, D1532fs, D1533fs, D1553fs, D1554fs, D1555fs, D262fs, D302fs, D303fs, D316fs, D317fs, D320fs, D321fs, D340fs, D341fs, D342fs, D348fs, D350fs, D358fs, D359fs, D360fs, D362fs, D363fs, D381fs, D382fs, D383fs, D385fs, D387fs, D388fs, D389fs, D390fs, D391fs, D403fs, D404fs, D405fs, D426fs, D427fs, D428fs, D429fs, D430fs, D451fs, D452fs, D664fs, D665fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003066084	17	41226427	17	43074410	3066084	3226097	rs2551473219	NC_000017.11:43074409:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Apr 3, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4595_4596insCT (p.Asp1533fs)	BRCA1	D1486fs, D429fs, D1533fs, D1554fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055234	17	41226427 - 41226428	17	43074410 - 43074411	55234	69901	rs80357699	NC_000017.11:43074410:A:AGA	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4593dup (p.Val1532fs)	BRCA1	V1485fs, V1532fs, V428fs, V1553fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266486	17	41226429 - 41226430	17	43074412 - 43074413	266486	261636	rs886040239	NC_000017.11:43074412:AA:AAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4591del (p.Val1531fs)	BRCA1	V1552fs, V427fs, V1484fs, V1531fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266485	17	41226432	17	43074415	266485	261637	rs886040238	NC_000017.11:43074414:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4583_4589dup (p.Lys1530delinsAsnHisTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001071926	17	41226433 - 41226434	17	43074416 - 43074417	1071926	1064187	rs2154006279	NC_000017.11:43074416:TTAATGA:TTAATGATTAATGA	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Nov 16, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4587_4590del (p.Ile1529fs)	BRCA1	I1550fs, I1529fs, I1482fs, I425fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096935	17	41226433 - 41226436	17	43074416 - 43074419	96935	102838	rs431825409	NC_000017.11:43074415:CTTA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4588A>T (p.Lys1530Ter)	BRCA1	K1551*, K1530*, K426*, K1483*, K1234*, K1361*, K1401*, K1441*, K1463*, K1511*, K1525*, K259*, K313*, K317*, K318*, K347*, K355*, K385*, K400*, K402*, K423*, K425*, K662*, K1461*, K1488*, K1504*, K1528*, K1529*, K299*, K337*, K345*, K360*, K378*, K379*, K401*, K424*, K427*, K661*, K1402*, K1417*, K1418*, K1440*, K1459*, K1460*, K1481*, K1486*, K1503*, K1527*, K1552*, K300*, K338*, K380*, K1233*, K1403*, K1419*, K1442*, K1458*, K1482*, K1487*, K1489*, K1502*, K1510*, K1526*, K1550*, K314*, K339*, K356*, K357*, K359*, K382*, K384*, K386*, K387*, K388*, K448*, K449*	Hereditary breast ovarian cancer syndrome	VCV001451288	17	41226435	17	43074418	1451288	1429542	rs764016240	NC_000017.11:43074417:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Nov 8, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4587del (p.Lys1530fs)	BRCA1	K1483fs, K1530fs, K1551fs, K426fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV001526271	17	41226436	17	43074419	1526271	1517675	rs2154006573	NC_000017.11:43074418:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Mar 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4575_4585del (p.Gln1525fs)	BRCA1	Q1546fs, Q1478fs, Q1525fs, Q421fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055230	17	41226438 - 41226448	17	43074421 - 43074431	55230	69897	rs397509184	NC_000017.11:43074420:TGAGCTCCTCTTGAG:TGAG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4579G>T (p.Glu1527Ter)	BRCA1	E1230*, E1231*, E1358*, E1398*, E1399*, E1400*, E1414*, E1415*, E1416*, E1437*, E1438*, E1439*, E1455*, E1456*, E1457*, E1458*, E1460*, E1478*, E1479*, E1480*, E1483*, E1484*, E1485*, E1486*, E1499*, E1500*, E1501*, E1507*, E1508*, E1522*, E1523*, E1524*, E1525*, E1526*, E1527*, E1547*, E1548*, E1549*, E256*, E296*, E297*, E310*, E311*, E314*, E315*, E334*, E335*, E336*, E342*, E344*, E352*, E353*, E354*, E356*, E357*, E375*, E376*, E377*, E379*, E381*, E382*, E383*, E384*, E385*, E397*, E398*, E399*, E420*, E421*, E422*, E423*, E424*, E445*, E446*, E658*, E659*	Gastric cancer|Neoplasm	VCV001801551	17	41226444	17	43074427	1801551	1858749	rs80357237	NC_000017.11:43074426:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jul 1, 2021	no assertion criteria provided				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_007294.4(BRCA1):c.4576G>T (p.Glu1526Ter)	BRCA1	E1526*, E422*, E1547*, E1479*, E1399*, E1414*, E1457*, E1459*, E1482*, E1499*, E1500*, E1506*, E1507*, E1522*, E1548*, E314*, E334*, E335*, E378*, E397*, E398*, E657*, E1229*, E1230*, E1397*, E1455*, E1484*, E1498*, E1523*, E343*, E353*, E383*, E396*, E423*, E1438*, E1454*, E1456*, E1485*, E1546*, E295*, E309*, E313*, E333*, E341*, E352*, E356*, E376*, E381*, E420*, E444*, E658*, E1483*, E1521*, E1524*, E1525*, E255*, E296*, E310*, E351*, E355*, E374*, E375*, E380*, E382*, E384*, E419*, E421*, E445*, E1357*, E1398*, E1413*, E1415*, E1436*, E1437*, E1477*, E1478*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236272	17	41226447	17	43074430	236272	237831	rs878853294	NC_000017.11:43074429:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4574_4575del (p.Gln1525fs)	BRCA1	Q1546fs, Q1478fs, Q1525fs, Q421fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055229	17	41226448 - 41226449	17	43074431 - 43074432	55229	69896	rs80357813	NC_000017.11:43074430:TT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4573C>T (p.Gln1525Ter)	BRCA1	Q1525*, Q1478*, Q1546*, Q421*, Q1229*, Q1396*, Q1413*, Q1414*, Q1453*, Q1455*, Q1458*, Q1505*, Q1520*, Q1547*, Q254*, Q295*, Q332*, Q355*, Q422*, Q443*, Q656*, Q1228*, Q1398*, Q1435*, Q1436*, Q1476*, Q1477*, Q1523*, Q294*, Q313*, Q342*, Q380*, Q383*, Q395*, Q418*, Q419*, Q444*, Q657*, Q1397*, Q1412*, Q1437*, Q1456*, Q1483*, Q1499*, Q1521*, Q1522*, Q1545*, Q333*, Q350*, Q351*, Q354*, Q373*, Q374*, Q375*, Q382*, Q1356*, Q1454*, Q1481*, Q1482*, Q1484*, Q1497*, Q1498*, Q1506*, Q1524*, Q308*, Q309*, Q312*, Q334*, Q340*, Q352*, Q377*, Q379*, Q381*, Q396*, Q397*, Q420*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266484	17	41226450	17	43074433	266484	261638	rs886040237	NC_000017.11:43074432:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4571_4572insCC (p.Gln1525fs)	BRCA1	Q1478fs, Q1525fs, Q421fs, Q1546fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548185	17	41226451 - 41226452	17	43074434 - 43074435	548185	538787	rs1555581948	NC_000017.11:43074434:G:GGG	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4569_4572del (p.Ser1524fs)	BRCA1	S1524fs, S420fs, S1477fs, S1545fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266483	17	41226451 - 41226454	17	43074434 - 43074437	266483	261639	rs886040236	NC_000017.11:43074433:AGAT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4569_4570insCC (p.Ser1524fs)	BRCA1	S1477fs, S1545fs, S420fs, S1524fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266482	17	41226453 - 41226454	17	43074436 - 43074437	266482	261640	rs886040235	NC_000017.11:43074436::GG	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4570del (p.Ser1524fs)	BRCA1	S420fs, S1524fs, S1477fs, S1545fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236271	17	41226453	17	43074436	236271	237832	rs878853293	NC_000017.11:43074435:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4566C>G (p.Tyr1522Ter)	BRCA1	Y1522*, Y418*, Y1475*, Y1543*, Y1226*, Y1393*, Y1409*, Y1411*, Y1450*, Y1473*, Y1474*, Y1478*, Y1503*, Y306*, Y329*, Y372*, Y376*, Y378*, Y394*, Y416*, Y419*, Y441*, Y1432*, Y1452*, Y1453*, Y1455*, Y1479*, Y1502*, Y1517*, Y1544*, Y291*, Y292*, Y310*, Y331*, Y339*, Y348*, Y351*, Y379*, Y417*, Y1225*, Y1353*, Y1394*, Y1395*, Y1451*, Y1481*, Y1494*, Y1496*, Y1520*, Y1521*, Y1542*, Y251*, Y337*, Y347*, Y349*, Y352*, Y370*, Y377*, Y653*, Y1410*, Y1433*, Y1434*, Y1480*, Y1495*, Y1518*, Y1519*, Y305*, Y309*, Y330*, Y371*, Y374*, Y380*, Y392*, Y393*, Y415*, Y440*, Y654*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266481	17	41226457	17	43074440	266481	261641	rs886040234	NC_000017.11:43074439:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4566C>A (p.Tyr1522Ter)	BRCA1	Y1522*, Y1475*, Y1543*, Y418*, Y1225*, Y1433*, Y1451*, Y1480*, Y1481*, Y1518*, Y1542*, Y310*, Y329*, Y331*, Y370*, Y380*, Y415*, Y417*, Y1353*, Y1395*, Y1409*, Y1410*, Y1432*, Y1473*, Y1479*, Y1496*, Y1519*, Y1520*, Y1521*, Y292*, Y306*, Y309*, Y348*, Y351*, Y371*, Y372*, Y379*, Y393*, Y394*, Y416*, Y441*, Y1226*, Y1394*, Y1494*, Y1544*, Y1393*, Y1411*, Y1434*, Y1450*, Y1452*, Y1453*, Y1455*, Y1474*, Y1478*, Y1495*, Y1502*, Y1503*, Y1517*, Y330*, Y337*, Y339*, Y347*, Y349*, Y376*, Y377*, Y392*, Y654*, Y251*, Y291*, Y305*, Y352*, Y374*, Y378*, Y419*, Y440*, Y653*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266480	17	41226457	17	43074440	266480	261642	rs886040234	NC_000017.11:43074439:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4562del (p.Asn1521fs)	BRCA1	N1474fs, N1542fs, N1521fs, N417fs	Hereditary cancer-predisposing syndrome	VCV001741502	17	41226461	17	43074444	1741502	1804946	rs2551485477	NC_000017.11:43074443:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jul 31, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4554del (p.Asn1519fs)	BRCA1	N1222fs, N1223fs, N1350fs, N1390fs, N1391fs, N1392fs, N1406fs, N1407fs, N1408fs, N1429fs, N1430fs, N1431fs, N1447fs, N1448fs, N1449fs, N1450fs, N1452fs, N1470fs, N1471fs, N1472fs, N1475fs, N1476fs, N1477fs, N1478fs, N1491fs, N1492fs, N1493fs, N1499fs, N1500fs, N1514fs, N1515fs, N1516fs, N1517fs, N1518fs, N1519fs, N1539fs, N1540fs, N1541fs, N248fs, N288fs, N289fs, N302fs, N303fs, N306fs, N307fs, N326fs, N327fs, N328fs, N334fs, N336fs, N344fs, N345fs, N346fs, N348fs, N349fs, N367fs, N368fs, N369fs, N371fs, N373fs, N374fs, N375fs, N376fs, N377fs, N389fs, N390fs, N391fs, N412fs, N413fs, N414fs, N415fs, N416fs, N437fs, N438fs, N650fs, N651fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573323	17	41226469	17	43074452	2573323	2738271	rs2551487239	NC_000017.11:43074451:C:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 13, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4552C>T (p.Gln1518Ter)	BRCA1	Q1518*, Q1539*, Q1471*, Q414*, Q247*, Q333*, Q366*, Q373*, Q374*, Q376*, Q415*, Q437*, Q1390*, Q1407*, Q1428*, Q1449*, Q1474*, Q1476*, Q1491*, Q1514*, Q1517*, Q1540*, Q1391*, Q1406*, Q1429*, Q1430*, Q1451*, Q1470*, Q1475*, Q1515*, Q1516*, Q302*, Q305*, Q325*, Q343*, Q347*, Q348*, Q368*, Q375*, Q388*, Q412*, Q649*, Q1222*, Q1405*, Q1447*, Q1448*, Q1492*, Q1498*, Q1513*, Q287*, Q288*, Q306*, Q335*, Q344*, Q367*, Q370*, Q389*, Q436*, Q650*, Q1221*, Q1349*, Q1389*, Q1446*, Q1469*, Q1477*, Q1490*, Q1499*, Q1538*, Q301*, Q326*, Q327*, Q345*, Q372*, Q390*, Q411*, Q413*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055226	17	41226471	17	43074454	55226	69893	rs80356881	NC_000017.11:43074453:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4544_4545dup (p.Ser1516fs)	BRCA1	S1469fs, S1516fs, S1537fs, S412fs	Hereditary breast ovarian cancer syndrome	VCV001074789	17	41226477 - 41226478	17	43074460 - 43074461	1074789	1064188	rs2154015072	NC_000017.11:43074460:CCC:CCCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 22, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4538dup (p.Cys1513fs)	BRCA1	C1344fs, C1386fs, C1423fs, C1466fs, C1216fs, C1402fs, C1424fs, C1441fs, C1464fs, C1465fs, C1486fs, C1510fs, C1512fs, C1513fs, C1534fs, C296fs, C301fs, C321fs, C330fs, C342fs, C363fs, C367fs, C369fs, C383fs, C385fs, C408fs, C431fs, C1470fs, C1487fs, C1493fs, C1535fs, C297fs, C300fs, C320fs, C362fs, C370fs, C384fs, C406fs, C407fs, C1400fs, C1442fs, C1443fs, C1444fs, C1508fs, C1533fs, C282fs, C322fs, C343fs, C365fs, C371fs, C410fs, C645fs, C1217fs, C1384fs, C1385fs, C1401fs, C1425fs, C1446fs, C1469fs, C1471fs, C1472fs, C1485fs, C1494fs, C1509fs, C1511fs, C242fs, C283fs, C328fs, C338fs, C339fs, C340fs, C361fs, C368fs, C409fs, C432fs, C644fs	Hereditary breast ovarian cancer syndrome	VCV002693388	17	41226484 - 41226485	17	43074467 - 43074468	2693388	2857372	rs2551490627	NC_000017.11:43074467:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Jan 24, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4539C>A (p.Cys1513Ter)	BRCA1	C1534*, C1466*, C409*, C1513*, C1217*, C1402*, C1508*, C1512*, C242*, C300*, C320*, C322*, C328*, C342*, C343*, C362*, C367*, C385*, C431*, C365*, C369*, C410*, C644*, C1469*, C1470*, C1471*, C1509*, C1535*, C283*, C297*, C330*, C339*, C340*, C383*, C384*, C407*, C408*, C432*, C645*, C1344*, C1384*, C1424*, C1442*, C1464*, C1216*, C1401*, C1425*, C1441*, C1444*, C1465*, C1472*, C1486*, C1494*, C1511*, C282*, C301*, C361*, C363*, C1385*, C1386*, C1400*, C1423*, C1443*, C1446*, C1485*, C1487*, C1493*, C1510*, C1533*, C296*, C321*, C338*, C368*, C370*, C371*, C406*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000924702	17	41226484	17	43074467	924702	913872	rs2052610048	NC_000017.11:43074466:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Aug 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4534_4535del (p.Ser1512fs)	BRCA1	S1512fs, S1465fs, S1533fs, S408fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055225	17	41226488 - 41226489	17	43074471 - 43074472	55225	69892	rs397509183	NC_000017.11:43074470:CT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4534del (p.Ser1512fs)	BRCA1	S1465fs, S408fs, S1512fs, S1533fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000633100	17	41226489	17	43074472	633100	621572	rs1567778176	NC_000017.11:43074471:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4533_4534del (p.His1511fs)	BRCA1	H1464fs, H1511fs, H1532fs, H407fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055223	17	41226489 - 41226490	17	43074472 - 43074473	55223	69890	rs80357534	NC_000017.11:43074471:TGTG:TG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4532dup (p.His1511fs)	BRCA1	H1511fs, H1464fs, H1532fs, H407fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440477	17	41226490 - 41226491	17	43074473 - 43074474	440477	432897	rs1555582009	NC_000017.11:43074473:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4528del (p.Met1510fs)	BRCA1	M1531fs, M1463fs, M1510fs, M406fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055222	17	41226495	17	43074478	55222	69889	rs397509182	NC_000017.11:43074477:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4527C>G (p.Tyr1509Ter)	BRCA1	Y1340*, Y1381*, Y1382*, Y1396*, Y1397*, Y1419*, Y1437*, Y1440*, Y1442*, Y1461*, Y1505*, Y1506*, Y1531*, Y293*, Y317*, Y335*, Y359*, Y364*, Y381*, Y406*, Y427*, Y1213*, Y1380*, Y1421*, Y1439*, Y1467*, Y1468*, Y1481*, Y1482*, Y1507*, Y1508*, Y279*, Y316*, Y326*, Y336*, Y357*, Y363*, Y367*, Y379*, Y404*, Y405*, Y1420*, Y1438*, Y1460*, Y1462*, Y1466*, Y1490*, Y1504*, Y1530*, Y238*, Y296*, Y318*, Y324*, Y334*, Y339*, Y365*, Y380*, Y403*, Y641*, Y1212*, Y1398*, Y1465*, Y1483*, Y1489*, Y1509*, Y1529*, Y278*, Y292*, Y297*, Y338*, Y358*, Y361*, Y366*, Y402*, Y428*, Y640*	Hereditary cancer-predisposing syndrome	VCV002585829	17	41226496	17	43074479	2585829	2753389	rs886040233	NC_000017.11:43074478:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4527C>A (p.Tyr1509Ter)	BRCA1	Y1509*, Y1462*, Y405*, Y1530*, Y1213*, Y1419*, Y1465*, Y1468*, Y1489*, Y1505*, Y279*, Y293*, Y296*, Y316*, Y338*, Y357*, Y358*, Y363*, Y365*, Y427*, Y641*, Y1380*, Y1396*, Y1398*, Y1420*, Y1437*, Y1460*, Y1461*, Y1466*, Y1481*, Y1490*, Y1506*, Y1531*, Y292*, Y324*, Y334*, Y335*, Y359*, Y366*, Y379*, Y404*, Y428*, Y640*, Y1212*, Y1340*, Y1381*, Y1382*, Y1421*, Y1438*, Y1483*, Y1508*, Y1529*, Y238*, Y278*, Y317*, Y318*, Y336*, Y361*, Y364*, Y381*, Y402*, Y406*, Y1397*, Y1439*, Y1440*, Y1442*, Y1467*, Y1482*, Y1504*, Y1507*, Y297*, Y326*, Y339*, Y367*, Y380*, Y403*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266479	17	41226496	17	43074479	266479	261643	rs886040233	NC_000017.11:43074478:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4525dup (p.Tyr1509fs)	BRCA1	Y1462fs, Y1509fs, Y405fs, Y1530fs	Hereditary breast ovarian cancer syndrome	VCV002045740	17	41226497 - 41226498	17	43074480 - 43074481	2045740	2099748	rs2551495416	NC_000017.11:43074480:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 17, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4523_4526delinsTGCCCATCATTAGATGAG (p.Trp1508_Tyr1509delinsLeuProIleIleArgTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000419633	17	41226497 - 41226500	17	43074480 - 43074483	419633	409964	rs1064794004	NC_000017.11:43074479:TACC:CTCATCTAATGATGGGCA	Indel	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4524del (p.Trp1508fs)	BRCA1	W1211fs, W1212fs, W1339fs, W1379fs, W1380fs, W1381fs, W1395fs, W1396fs, W1397fs, W1418fs, W1419fs, W1420fs, W1436fs, W1437fs, W1438fs, W1439fs, W1441fs, W1459fs, W1460fs, W1461fs, W1464fs, W1465fs, W1466fs, W1467fs, W1480fs, W1481fs, W1482fs, W1488fs, W1489fs, W1503fs, W1504fs, W1505fs, W1506fs, W1507fs, W1508fs, W1528fs, W1529fs, W1530fs, W237fs, W277fs, W278fs, W291fs, W292fs, W295fs, W296fs, W315fs, W316fs, W317fs, W323fs, W325fs, W333fs, W334fs, W335fs, W337fs, W338fs, W356fs, W357fs, W358fs, W360fs, W362fs, W363fs, W364fs, W365fs, W366fs, W378fs, W379fs, W380fs, W401fs, W402fs, W403fs, W404fs, W405fs, W426fs, W427fs, W639fs, W640fs	not provided|Hereditary breast ovarian cancer syndrome	VCV003381161	17	41226499	17	43074482	3381161	3540331		NC_000017.11:43074481:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4524G>A (p.Trp1508Ter)	BRCA1	W1508*, W1529*, W1461*, W404*, W1381*, W1460*, W1465*, W1480*, W1506*, W1507*, W1530*, W277*, W292*, W325*, W333*, W362*, W364*, W366*, W379*, W401*, W402*, W405*, W1211*, W1379*, W1397*, W1420*, W1438*, W1459*, W1464*, W1467*, W1482*, W1489*, W1503*, W295*, W315*, W357*, W358*, W365*, W427*, W639*, W1395*, W1396*, W1419*, W1437*, W1439*, W1441*, W1488*, W1505*, W1528*, W237*, W291*, W296*, W335*, W337*, W338*, W363*, W380*, W640*, W1212*, W1339*, W1380*, W1418*, W1436*, W1466*, W1481*, W1504*, W278*, W316*, W317*, W323*, W334*, W356*, W360*, W378*, W403*, W426*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055221	17	41226499	17	43074482	55221	69888	rs80356885	NC_000017.11:43074481:C:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4523G>A (p.Trp1508Ter)	BRCA1	W1508*, W1461*, W404*, W1529*, W1395*, W1436*, W1441*, W1467*, W1481*, W1489*, W1507*, W1528*, W292*, W295*, W315*, W364*, W378*, W401*, W402*, W1211*, W1379*, W1380*, W1381*, W1438*, W1460*, W1466*, W1504*, W1530*, W323*, W325*, W337*, W338*, W360*, W366*, W1339*, W1397*, W1418*, W1439*, W1459*, W1464*, W1465*, W1503*, W1505*, W1506*, W278*, W296*, W317*, W333*, W357*, W363*, W365*, W405*, W640*, W1212*, W1396*, W1419*, W1420*, W1437*, W1480*, W1482*, W1488*, W237*, W277*, W291*, W316*, W334*, W335*, W356*, W358*, W362*, W379*, W380*, W403*, W426*, W427*, W639*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186016	17	41226500	17	43074483	186016	184919	rs786202631	NC_000017.11:43074482:C:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4516del (p.Asp1506fs)	BRCA1	D1459fs, D1506fs, D402fs, D1527fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055220	17	41226507	17	43074490	55220	69887	rs273900736	NC_000017.11:43074489:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4515del (p.Asp1505fs)	BRCA1	D401fs, D1458fs, D1505fs, D1526fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001452692	17	41226508	17	43074491	1452692	1364411	rs2154021596	NC_000017.11:43074490:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jul 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4513del (p.Asp1505fs)	BRCA1	D1458fs, D1505fs, D1526fs, D401fs	Hereditary breast ovarian cancer syndrome	VCV001073249	17	41226510	17	43074493	1073249	1064189	rs2154021907	NC_000017.11:43074492:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 7, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4507_4511del (p.Ser1503fs)	BRCA1	S1503fs, S1456fs, S1524fs, S399fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431264	17	41226512 - 41226516	17	43074495 - 43074499	431264	424799	rs1135401877	NC_000017.11:43074494:AATGA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4508C>G (p.Ser1503Ter)	BRCA1	S1503*, S399*, S1456*, S1524*, S1206*, S1374*, S1391*, S1433*, S1436*, S1459*, S1477*, S1484*, S1501*, S1525*, S272*, S286*, S312*, S357*, S397*, S635*, S1375*, S1390*, S1414*, S1434*, S1460*, S1462*, S1476*, S290*, S328*, S330*, S332*, S351*, S352*, S355*, S359*, S373*, S396*, S400*, S421*, S1207*, S1413*, S1431*, S1461*, S1483*, S1500*, S273*, S287*, S320*, S333*, S353*, S358*, S361*, S374*, S422*, S634*, S1334*, S1376*, S1392*, S1415*, S1432*, S1454*, S1455*, S1475*, S1498*, S1499*, S1502*, S1523*, S232*, S291*, S310*, S311*, S318*, S329*, S360*, S375*, S398*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440476	17	41226515	17	43074498	440476	432898	rs80357437	NC_000017.11:43074497:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4508C>A (p.Ser1503Ter)	BRCA1	S1503*, S1456*, S1524*, S399*, S1206*, S1374*, S1375*, S1432*, S1433*, S1459*, S1483*, S1501*, S1502*, S1523*, S290*, S310*, S311*, S333*, S358*, S361*, S373*, S375*, S400*, S1376*, S1392*, S1415*, S1454*, S1460*, S1462*, S1476*, S1477*, S1525*, S287*, S320*, S330*, S360*, S396*, S422*, S635*, S1207*, S1391*, S1414*, S1431*, S1434*, S1455*, S1461*, S1484*, S1498*, S1500*, S273*, S286*, S291*, S318*, S329*, S351*, S352*, S355*, S357*, S421*, S1334*, S1390*, S1413*, S1436*, S1475*, S1499*, S232*, S272*, S312*, S328*, S332*, S353*, S359*, S374*, S397*, S398*, S634*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055219	17	41226515	17	43074498	55219	69886	rs80357437	NC_000017.11:43074497:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4505del (p.Pro1502fs)	BRCA1	P1523fs, P1502fs, P398fs, P1455fs	Hereditary cancer-predisposing syndrome	VCV000482901	17	41226518	17	43074501	482901	478534	rs1555582069	NC_000017.11:43074500:GGG:GG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 1, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4503C>A (p.Cys1501Ter)	BRCA1	C1501*, C397*, C1522*, C1454*, C270*, C288*, C326*, C327*, C349*, C355*, C356*, C371*, C394*, C420*, C1388*, C1413*, C1429*, C1434*, C1452*, C1453*, C1460*, C1500*, C1521*, C1205*, C1372*, C1389*, C1411*, C1432*, C1459*, C1473*, C1474*, C1498*, C271*, C330*, C331*, C353*, C373*, C395*, C632*, C1332*, C1373*, C1390*, C1412*, C1430*, C1431*, C1457*, C1481*, C1499*, C284*, C310*, C316*, C318*, C358*, C359*, C372*, C419*, C1204*, C1374*, C1458*, C1475*, C1482*, C1496*, C1497*, C1523*, C230*, C285*, C289*, C308*, C309*, C328*, C350*, C351*, C357*, C396*, C398*, C633*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266478	17	41226520	17	43074503	266478	261644	rs747539984	NC_000017.11:43074502:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4493del (p.Pro1498fs)	BRCA1	P1519fs, P1498fs, P1451fs, P394fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091631	17	41226530	17	43074513	91631	97108	rs398122687	NC_000017.11:43074512:GGGG:GGG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4489del (p.Ser1497fs)	BRCA1	S1200fs, S1201fs, S1328fs, S1368fs, S1369fs, S1370fs, S1384fs, S1385fs, S1386fs, S1407fs, S1408fs, S1409fs, S1425fs, S1426fs, S1427fs, S1428fs, S1430fs, S1448fs, S1449fs, S1450fs, S1453fs, S1454fs, S1455fs, S1456fs, S1469fs, S1470fs, S1471fs, S1477fs, S1478fs, S1492fs, S1493fs, S1494fs, S1495fs, S1496fs, S1497fs, S1517fs, S1518fs, S1519fs, S226fs, S266fs, S267fs, S280fs, S281fs, S284fs, S285fs, S304fs, S305fs, S306fs, S312fs, S314fs, S322fs, S323fs, S324fs, S326fs, S327fs, S345fs, S346fs, S347fs, S349fs, S351fs, S352fs, S353fs, S354fs, S355fs, S367fs, S368fs, S369fs, S390fs, S391fs, S392fs, S393fs, S394fs, S415fs, S416fs, S628fs, S629fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003379249	17	41226534	17	43074517	3379249	3538428		NC_000017.11:43074516:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 22, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4487C>G (p.Ser1496Ter)	BRCA1	S1496*, S1517*, S1449*, S392*, S1199*, S1367*, S1368*, S1369*, S1408*, S1425*, S1427*, S1448*, S1454*, S1493*, S1495*, S321*, S348*, S351*, S390*, S414*, S393*, S627*, S1327*, S1384*, S1406*, S1407*, S1447*, S1470*, S1491*, S1518*, S266*, S280*, S303*, S313*, S322*, S325*, S344*, S345*, S350*, S352*, S354*, S368*, S391*, S1426*, S1429*, S1452*, S1469*, S1477*, S1516*, S284*, S305*, S311*, S326*, S353*, S367*, S1200*, S1383*, S1385*, S1424*, S1453*, S1455*, S1468*, S1476*, S1492*, S1494*, S225*, S265*, S279*, S283*, S304*, S323*, S346*, S366*, S389*, S415*, S628*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055216	17	41226536	17	43074519	55216	69883	rs80356953	NC_000017.11:43074518:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4487C>A (p.Ser1496Ter)	BRCA1	S1496*, S1449*, S1517*, S392*, S1327*, S1369*, S1384*, S1407*, S1425*, S1427*, S1448*, S1452*, S1469*, S1470*, S1477*, S1491*, S1494*, S225*, S266*, S304*, S305*, S321*, S323*, S325*, S344*, S348*, S354*, S367*, S390*, S414*, S1199*, S1368*, S1385*, S1406*, S1424*, S1426*, S1495*, S1518*, S322*, S346*, S352*, S368*, S391*, S628*, S1200*, S1383*, S1408*, S1447*, S1453*, S1493*, S1516*, S303*, S311*, S326*, S345*, S353*, S366*, S393*, S1367*, S1429*, S1454*, S1455*, S1468*, S1476*, S1492*, S265*, S279*, S280*, S283*, S284*, S313*, S350*, S351*, S389*, S415*, S627*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055215	17	41226536	17	43074519	55215	69882	rs80356953	NC_000017.11:43074518:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4486del (p.Ser1496fs)	BRCA1	S1449fs, S392fs, S1517fs, S1496fs	Hereditary cancer-predisposing syndrome	VCV000479209	17	41226537	17	43074520	479209	478628	rs1555582082	NC_000017.11:43074519:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Mar 25, 2016	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(141497_143462)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373874	17	41226539 - 41277500	17	43074522 - 43125483	373874	360758			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4485-1G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267551	17	41226539	17	43074522	267551	262955	rs80358189	NC_000017.11:43074521:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4485-1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000246501	17	41226539	17	43074522	246501	245028	rs80358189	NC_000017.11:43074521:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4485-1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055213	17	41226539	17	43074522	55213	69880	rs80358189	NC_000017.11:43074521:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Sep 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4485-2A>C	BRCA1		Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000567954	17	41226540	17	43074523	567954	571419	rs80358054	NC_000017.11:43074522:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4485-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000055214	17	41226540	17	43074523	55214	69881	rs80358054	NC_000017.11:43074522:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Oct 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4186-1676_4484+839dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001738529	17	41227665 - 41227666	17	43075648 - 43075649	1738529	1790862			Duplication	splice acceptor variant|splice donor variant	Pathogenic	May 1, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4357+1514_4484+547del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373853	17	41227958 - 41232907	17	43075941 - 43080890	373853	360745			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4484+2T>G	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000993049	17	41228503	17	43076486	993049	981161	rs1555582520	NC_000017.11:43076485:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Feb 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4484+2T>C	BRCA1		Breast neoplasm	VCV000559970	17	41228503	17	43076486	559970	550689	rs1555582520	NC_000017.11:43076485:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Mar 20, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4484+1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267547	17	41228504	17	43076487	267547	262957	rs80358063	NC_000017.11:43076486:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Mar 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4484+1del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055211	17	41228504	17	43076487	55211	69878	rs397509181	NC_000017.11:43076486:CC:C	Deletion	splice donor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4484+1G>A	BRCA1		BRCA1-related cancer predisposition|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000037596	17	41228504	17	43076487	37596	46152	rs80358063	NC_000017.11:43076486:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jul 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4484G>C (p.Arg1495Thr)	BRCA1	R1495T, R391T, R1516T, R1448T, R1199T, R1326T, R1367T, R1423T, R1425T, R1426T, R1428T, R1446T, R1452T, R1453T, R1467T, R1475T, R1515T, R1517T, R265T, R303T, R304T, R312T, R321T, R325T, R347T, R349T, R365T, R414T, R627T, R1366T, R1368T, R1382T, R1468T, R1494T, R224T, R279T, R282T, R310T, R353T, R366T, R1383T, R1406T, R1447T, R1451T, R1469T, R1476T, R1490T, R1491T, R1493T, R264T, R278T, R302T, R320T, R322T, R324T, R345T, R352T, R388T, R390T, R392T, R413T, R626T, R389T, R1198T, R1384T, R1405T, R1407T, R1424T, R1454T, R1492T, R283T, R343T, R344T, R350T, R351T, R367T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000245697	17	41228505	17	43076488	245697	245029	rs80357389	NC_000017.11:43076487:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.3(BRCA1):c.4358-?_4484+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216104	17	41228505 - 41228631	17	43076488 - 43076614	216104	213239			Deletion		Pathogenic	Jan 7, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.4358_4484del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188413	17	41228505 - 41228631	17	43076488 - 43076614	188413	186541			Deletion	splice acceptor variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	BRCA1	R1495M, R1516M, R1448M, R391M, R1198M, R1326M, R1368M, R1383M, R1384M, R1469M, R1491M, R1493M, R283M, R303M, R310M, R320M, R321M, R324M, R352M, R365M, R366M, R389M, R626M, R1406M, R1407M, R1423M, R1424M, R1454M, R1476M, R1515M, R224M, R279M, R325M, R343M, R344M, R347M, R353M, R367M, R392M, R414M, R1199M, R1382M, R1405M, R1425M, R1428M, R1447M, R1453M, R1468M, R1490M, R1494M, R282M, R302M, R304M, R322M, R350M, R388M, R390M, R627M, R1366M, R1367M, R1426M, R1446M, R1451M, R1452M, R1467M, R1475M, R1492M, R1517M, R264M, R265M, R278M, R312M, R345M, R349M, R351M, R413M	Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000037598	17	41228505	17	43076488	37598	46154	rs80357389	NC_000017.11:43076487:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jul 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4484G>A (p.Arg1495Lys)	BRCA1	R1495K, R1448K, R391K, R1516K, R1198K, R1382K, R1453K, R1469K, R265K, R278K, R303K, R321K, R345K, R347K, R367K, R392K, R1199K, R1367K, R1383K, R1407K, R1423K, R1447K, R1454K, R1468K, R1476K, R1490K, R224K, R282K, R302K, R310K, R325K, R365K, R366K, R1326K, R1424K, R1426K, R1446K, R1452K, R1467K, R1493K, R1494K, R283K, R304K, R312K, R322K, R324K, R350K, R388K, R414K, R626K, R1366K, R1368K, R1384K, R1405K, R1406K, R1425K, R1428K, R1451K, R1475K, R1491K, R1492K, R1515K, R1517K, R264K, R279K, R320K, R343K, R344K, R349K, R351K, R352K, R353K, R389K, R390K, R413K, R627K	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037597	17	41228505	17	43076488	37597	46153	rs80357389	NC_000017.11:43076487:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4483del (p.Arg1495fs)	BRCA1	R1448fs, R1495fs, R1516fs, R391fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254455	17	41228506	17	43076489	254455	249088	rs80357854	NC_000017.11:43076488:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4482_4483del (p.Arg1495fs)	BRCA1	R1516fs, R391fs, R1448fs, R1495fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037595	17	41228506 - 41228507	17	43076489 - 43076490	37595	46151	rs80357854	NC_000017.11:43076488:TTT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4480G>T (p.Glu1494Ter)	BRCA1	E1494*, E1515*, E1447*, E390*, E1365*, E1381*, E1405*, E1427*, E1445*, E1452*, E1466*, E1468*, E1490*, E1514*, E1516*, E263*, E302*, E324*, E342*, E1197*, E1382*, E1406*, E1423*, E1424*, E1451*, E1453*, E1467*, E1474*, E223*, E364*, E388*, E412*, E1325*, E1366*, E1383*, E1404*, E1425*, E1446*, E1475*, E1493*, E264*, E277*, E282*, E301*, E311*, E319*, E321*, E323*, E351*, E366*, E389*, E391*, E626*, E343*, E346*, E352*, E387*, E1198*, E1367*, E1422*, E1450*, E1489*, E1491*, E1492*, E278*, E281*, E303*, E309*, E320*, E344*, E348*, E349*, E350*, E365*, E413*, E625*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055209	17	41228509	17	43076492	55209	69876	rs80357148	NC_000017.11:43076491:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4479delinsTT (p.Val1493_Glu1494insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003148692	17	41228510	17	43076493	3148692	3307940	rs2551620475	NC_000017.11:43076492:C:AA	Indel	frameshift variant|nonsense|intron variant	Pathogenic	Feb 1, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4475_4476insGGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCATGAGGTCAGGAGATCGAGACCATCCTGGCTAACAAGGTGAAACCNNNNNNNNNNAAAAAAAAAAAAAAAAAAAATAAAGAACCAGG (p.Gly1492_Val1493insAlaGlyArgGlyGlySerArgLeuTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069116	17	41228513 - 41228514	17	43076496 - 43076497	1069116	1064190	rs2154058114		Insertion	frameshift variant|nonsense|inframe_insertion|non-coding transcript variant	Pathogenic	Jan 26, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4453_4474del (p.Thr1485fs)	BRCA1	T1438fs, T1485fs, T1506fs, T381fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266477	17	41228515 - 41228536	17	43076498 - 43076519	266477	261645	rs886040232	NC_000017.11:43076497:CTGGTTCTTTATTTTTACTGGT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4474G>T (p.Gly1492Ter)	BRCA1	G1492*, G1513*, G1445*, G388*, G1363*, G1420*, G1444*, G1450*, G1451*, G1466*, G1490*, G1491*, G275*, G279*, G280*, G317*, G344*, G347*, G364*, G387*, G1195*, G1421*, G1425*, G1443*, G1448*, G1449*, G1473*, G1489*, G221*, G276*, G322*, G342*, G346*, G348*, G350*, G411*, G623*, G1364*, G1380*, G1381*, G1402*, G1487*, G1488*, G1512*, G262*, G301*, G309*, G321*, G341*, G349*, G362*, G363*, G385*, G386*, G1196*, G1323*, G1365*, G1379*, G1403*, G1404*, G1422*, G1423*, G1464*, G1465*, G1472*, G1514*, G261*, G299*, G300*, G307*, G318*, G319*, G340*, G389*, G410*, G624*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216105	17	41228515	17	43076498	216105	213312	rs863224511	NC_000017.11:43076497:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4470_4473del (p.Pro1491fs)	BRCA1	P1444fs, P1491fs, P1512fs, P387fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002431294	17	41228516 - 41228519	17	43076499 - 43076502	2431294	2404799	rs2551625320	NC_000017.11:43076498:TGGTT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 6, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4467_4470del (p.Lys1489fs)	BRCA1	K1442fs, K1510fs, K385fs, K1489fs	Hereditary breast ovarian cancer syndrome	VCV002059457	17	41228519 - 41228522	17	43076502 - 43076505	2059457	2117316	rs2551628076	NC_000017.11:43076501:TTCTTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	May 6, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4468del (p.Glu1490fs)	BRCA1	E1193fs, E1194fs, E1321fs, E1361fs, E1362fs, E1363fs, E1377fs, E1378fs, E1379fs, E1400fs, E1401fs, E1402fs, E1418fs, E1419fs, E1420fs, E1421fs, E1423fs, E1441fs, E1442fs, E1443fs, E1446fs, E1447fs, E1448fs, E1449fs, E1462fs, E1463fs, E1464fs, E1470fs, E1471fs, E1485fs, E1486fs, E1487fs, E1488fs, E1489fs, E1490fs, E1510fs, E1511fs, E1512fs, E219fs, E259fs, E260fs, E273fs, E274fs, E277fs, E278fs, E297fs, E298fs, E299fs, E305fs, E307fs, E315fs, E316fs, E317fs, E319fs, E320fs, E338fs, E339fs, E340fs, E342fs, E344fs, E345fs, E346fs, E347fs, E348fs, E360fs, E361fs, E362fs, E383fs, E384fs, E385fs, E386fs, E387fs, E408fs, E409fs, E621fs, E622fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773527	17	41228521	17	43076504	3773527	3889677		NC_000017.11:43076503:C:	Deletion	frameshift variant|intron variant	Pathogenic	Nov 21, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4467dup (p.Glu1490fs)	BRCA1	E305fs, E307fs, E316fs, E320fs, E339fs, E348fs, E1193fs, E1361fs, E1378fs, E1401fs, E1470fs, E1471fs, E1512fs, E274fs, E278fs, E340fs, E342fs, E345fs, E361fs, E385fs, E386fs, E409fs, E622fs, E1194fs, E1321fs, E1418fs, E1420fs, E1421fs, E1441fs, E1448fs, E1462fs, E1464fs, E1485fs, E1486fs, E1487fs, E1489fs, E1490fs, E219fs, E260fs, E277fs, E297fs, E317fs, E319fs, E338fs, E344fs, E346fs, E360fs, E383fs, E384fs, E621fs, E1362fs, E1363fs, E1379fs, E1400fs, E1402fs, E1419fs, E1443fs, E1446fs, E1449fs, E1463fs, E259fs, E299fs, E315fs, E347fs, E362fs, E387fs, E408fs, E1377fs, E1423fs, E1442fs, E1447fs, E1488fs, E1510fs, E1511fs, E273fs, E298fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002822262	17	41228521 - 41228522	17	43076504 - 43076505	2822262	2982065	rs2154059325	NC_000017.11:43076504:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4463_4467dup (p.Glu1490fs)	BRCA1	E1443fs, E1490fs, E1511fs, E386fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001071944	17	41228521 - 41228522	17	43076504 - 43076505	1071944	1064191	rs2154059426	NC_000017.11:43076504:TTTATTTT:TTTATTTTATTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4468G>T (p.Glu1490Ter)	BRCA1	E1443*, E1490*, E1511*, E386*, E1361*, E1377*, E1400*, E1419*, E1420*, E1446*, E1462*, E1485*, E1489*, E260*, E297*, E307*, E315*, E320*, E387*, E621*, E622*, E1362*, E1423*, E1441*, E1464*, E1470*, E274*, E299*, E305*, E338*, E345*, E384*, E342*, E346*, E348*, E360*, E362*, E1193*, E1363*, E1378*, E1402*, E1418*, E1421*, E1447*, E1471*, E1488*, E1512*, E259*, E273*, E277*, E316*, E319*, E340*, E1194*, E1321*, E1379*, E1401*, E1442*, E1448*, E1449*, E1463*, E1486*, E1487*, E1510*, E219*, E278*, E298*, E317*, E339*, E344*, E347*, E361*, E383*, E385*, E408*, E409*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000162502	17	41228521	17	43076504	162502	172180	rs138608489	NC_000017.11:43076503:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4467del (p.Glu1490fs)	BRCA1	E1443fs, E1490fs, E1511fs, E386fs	Hereditary breast ovarian cancer syndrome	VCV001687131	17	41228522	17	43076505	1687131	1679425	rs2154059325	NC_000017.11:43076504:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 22, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4463dup (p.Asn1488fs)	BRCA1	N1441fs, N384fs, N1488fs, N1509fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125712	17	41228525 - 41228526	17	43076508 - 43076509	125712	131250	rs80357620	NC_000017.11:43076508:TTTTT:TTTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4459A>T (p.Lys1487Ter)	BRCA1	K1360*, K1397*, K1398*, K1438*, K1444*, K1483*, K1507*, K274*, K296*, K339*, K341*, K359*, K1190*, K1318*, K1358*, K1375*, K1399*, K1416*, K1418*, K1443*, K1467*, K1468*, K1482*, K1484*, K1508*, K216*, K256*, K302*, K317*, K335*, K336*, K343*, K344*, K380*, K384*, K1359*, K1417*, K1439*, K1440*, K1459*, K1461*, K1486*, K1487*, K270*, K271*, K312*, K314*, K337*, K357*, K358*, K381*, K619*, K1191*, K1374*, K1376*, K1415*, K1420*, K1445*, K1446*, K1460*, K1485*, K1509*, K257*, K275*, K294*, K295*, K304*, K313*, K316*, K342*, K345*, K382*, K383*, K405*, K406*, K618*	Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4	VCV003582082	17	41228530	17	43076513	3582082	3709139		NC_000017.11:43076512:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 18, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4457del (p.Ser1486fs)	BRCA1	S1439fs, S1507fs, S1486fs, S382fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055205	17	41228532	17	43076515	55205	69872	rs397509180	NC_000017.11:43076514:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4456del (p.Ser1486fs)	BRCA1	S1439fs, S1507fs, S382fs, S1486fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055204	17	41228533	17	43076516	55204	69871	rs397509179	NC_000017.11:43076515:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4452_4455del (p.Thr1485fs)	BRCA1	T1438fs, T1485fs, T1506fs, T381fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055202	17	41228534 - 41228537	17	43076517 - 43076520	55202	69869	rs397509178	NC_000017.11:43076516:GGTAG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4447_4450dup (p.Ser1484Ter)	BRCA1	S1437*, S380*, S1484*, S1505*	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001388173	17	41228538 - 41228539	17	43076521 - 43076522	1388173	1370914	rs2154062615	NC_000017.11:43076521:AACTA:AACTAACTA	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic/Likely pathogenic	May 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4447del (p.Ser1483fs)	BRCA1	S1504fs, S379fs, S1436fs, S1483fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055200	17	41228542	17	43076525	55200	69867	rs397509177	NC_000017.11:43076524:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4438dup (p.Ser1480fs)	BRCA1	S1433fs, S1480fs, S1501fs, S376fs	Hereditary cancer-predisposing syndrome	VCV000922196	17	41228550 - 41228551	17	43076533 - 43076534	922196	913873	rs2052727486	NC_000017.11:43076533:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jan 15, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4435del (p.Val1479fs)	BRCA1	V375fs, V1500fs, V1432fs, V1479fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055199	17	41228554	17	43076537	55199	69866	rs397509176	NC_000017.11:43076536:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4432G>T (p.Glu1478Ter)	BRCA1	E1478*, E1499*, E1431*, E374*, E1309*, E1388*, E1390*, E1435*, E1437*, E1451*, E1458*, E1500*, E330*, E335*, E350*, E610*, E1365*, E1367*, E1407*, E1429*, E1430*, E1450*, E1452*, E1459*, E1498*, E261*, E265*, E266*, E285*, E286*, E303*, E305*, E307*, E308*, E334*, E348*, E396*, E397*, E1351*, E1366*, E1406*, E1408*, E1477*, E248*, E293*, E304*, E327*, E336*, E349*, E371*, E372*, E375*, E609*, E1181*, E1182*, E1349*, E1350*, E1389*, E1409*, E1411*, E1434*, E1436*, E1473*, E1474*, E1475*, E1476*, E207*, E247*, E262*, E287*, E295*, E326*, E328*, E332*, E333*, E373*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232619	17	41228557	17	43076540	232619	235966	rs876659878	NC_000017.11:43076539:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4427dup (p.Phe1477fs)	BRCA1	F1477fs, F1430fs, F373fs, F1498fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037592	17	41228561 - 41228562	17	43076544 - 43076545	37592	46148	rs397507231	NC_000017.11:43076544:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4400_4418delinsTTT (p.Gln1467fs)	BRCA1	Q363fs, Q1420fs, Q1467fs, Q1488fs	not provided|Hereditary cancer-predisposing syndrome	VCV000231705	17	41228571 - 41228589	17	43076554 - 43076572	231705	235969	rs876659310	NC_000017.11:43076553:GAAAGGCCTTCTGGATTCT:AAA	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Feb 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4415_4417delinsGG (p.Leu1472fs)	BRCA1	L1175fs, L1176fs, L1303fs, L1343fs, L1344fs, L1345fs, L1359fs, L1360fs, L1361fs, L1382fs, L1383fs, L1384fs, L1400fs, L1401fs, L1402fs, L1403fs, L1405fs, L1423fs, L1424fs, L1425fs, L1428fs, L1429fs, L1430fs, L1431fs, L1444fs, L1445fs, L1446fs, L1452fs, L1453fs, L1467fs, L1468fs, L1469fs, L1470fs, L1471fs, L1472fs, L1492fs, L1493fs, L1494fs, L201fs, L241fs, L242fs, L255fs, L256fs, L259fs, L260fs, L279fs, L280fs, L281fs, L287fs, L289fs, L297fs, L298fs, L299fs, L301fs, L302fs, L320fs, L321fs, L322fs, L324fs, L326fs, L327fs, L328fs, L329fs, L330fs, L342fs, L343fs, L344fs, L365fs, L366fs, L367fs, L368fs, L369fs, L390fs, L391fs, L603fs, L604fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002583854	17	41228572 - 41228574	17	43076555 - 43076557	2583854	2751423	rs886040231	NC_000017.11:43076554:AAA:CC	Indel	frameshift variant|intron variant	Pathogenic	Jun 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4417del (p.Ser1473fs)	BRCA1	S1473fs, S369fs, S1426fs, S1494fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266476	17	41228572	17	43076555	266476	261646	rs886040231	NC_000017.11:43076554:AAA:AA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4416_4417delinsG (p.Ser1473fs)	BRCA1	S1473fs, S1426fs, S1494fs, S369fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055197	17	41228572 - 41228573	17	43076555 - 43076556	55197	69864	rs397509174	NC_000017.11:43076554:AA:C	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4414del (p.Leu1472fs)	BRCA1	L1472fs, L368fs, L1493fs, L1425fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000631389	17	41228575	17	43076558	631389	618582	rs1567779686	NC_000017.11:43076557:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 25, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4412del (p.Gly1471fs)	BRCA1	G1471fs, G1492fs, G367fs, G1424fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000419556	17	41228577	17	43076560	419556	409966	rs1064793951	NC_000017.11:43076559:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4410dup (p.Gly1471fs)	BRCA1	G1471fs, G1492fs, G367fs, G1424fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000824872	17	41228578 - 41228579	17	43076561 - 43076562	824872	813690	rs1597839379	NC_000017.11:43076561:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Apr 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4408G>T (p.Glu1470Ter)	BRCA1	E1470*, E366*, E1423*, E1491*, E1341*, E1358*, E1380*, E1382*, E1399*, E1400*, E1429*, E1443*, E1450*, E1465*, E1490*, E199*, E240*, E253*, E299*, E300*, E325*, E326*, E365*, E1174*, E1343*, E1421*, E1422*, E1426*, E1428*, E1444*, E1467*, E1468*, E257*, E278*, E279*, E287*, E297*, E327*, E328*, E340*, E342*, E363*, E601*, E1359*, E1381*, E1427*, E1469*, E277*, E318*, E320*, E322*, E324*, E341*, E389*, E1173*, E1301*, E1342*, E1357*, E1398*, E1401*, E1403*, E1442*, E1451*, E1466*, E1492*, E239*, E254*, E258*, E285*, E295*, E296*, E319*, E364*, E367*, E388*, E602*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266475	17	41228581	17	43076564	266475	261647	rs886040230	NC_000017.11:43076563:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4406dup (p.Glu1470fs)	BRCA1	E1491fs, E366fs, E1423fs, E1470fs	Familial cancer of breast	VCV000870639	17	41228582 - 41228583	17	43076565 - 43076566	870639	858810	rs2052734372	NC_000017.11:43076565:GG:GGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic		criteria provided, single submitter							
NM_007294.4(BRCA1):c.4406del (p.Pro1469fs)	BRCA1	P278fs, P294fs, P298fs, P318fs, P323fs, P326fs, P362fs, P365fs, P601fs, P1356fs, P1380fs, P1381fs, P1399fs, P1422fs, P1426fs, P1441fs, P1443fs, P1468fs, P1490fs, P238fs, P252fs, P277fs, P284fs, P321fs, P324fs, P364fs, P1300fs, P1340fs, P1402fs, P1420fs, P1421fs, P1428fs, P1464fs, P1489fs, P198fs, P295fs, P296fs, P319fs, P327fs, P339fs, P341fs, P363fs, P387fs, P388fs, P600fs, P1172fs, P1341fs, P1342fs, P1357fs, P1397fs, P1398fs, P1400fs, P1425fs, P1427fs, P1442fs, P1450fs, P1465fs, P1466fs, P1467fs, P1469fs, P239fs, P256fs, P257fs, P276fs, P286fs, P299fs, P317fs, P325fs, P340fs, P366fs, P1173fs, P1358fs, P1379fs, P1449fs, P1491fs, P253fs	Hereditary breast ovarian cancer syndrome	VCV002824938	17	41228583	17	43076566	2824938	2989440	rs2052734372	NC_000017.11:43076565:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 30, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4400_4403dup (p.Asn1468fs)	BRCA1	N1171fs, N1172fs, N1299fs, N1339fs, N1340fs, N1341fs, N1355fs, N1356fs, N1357fs, N1378fs, N1379fs, N1380fs, N1396fs, N1397fs, N1398fs, N1399fs, N1401fs, N1419fs, N1420fs, N1421fs, N1424fs, N1425fs, N1426fs, N1427fs, N1440fs, N1441fs, N1442fs, N1448fs, N1449fs, N1463fs, N1464fs, N1465fs, N1466fs, N1467fs, N1468fs, N1488fs, N1489fs, N1490fs, N197fs, N237fs, N238fs, N251fs, N252fs, N255fs, N256fs, N275fs, N276fs, N277fs, N283fs, N285fs, N293fs, N294fs, N295fs, N297fs, N298fs, N316fs, N317fs, N318fs, N320fs, N322fs, N323fs, N324fs, N325fs, N326fs, N338fs, N339fs, N340fs, N361fs, N362fs, N363fs, N364fs, N365fs, N386fs, N387fs, N599fs, N600fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004071368	17	41228585 - 41228586	17	43076568 - 43076569	4071368	4185216		NC_000017.11:43076568:TTCT:TTCTTTCT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 10, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4391_4403delinsTT (p.Pro1464fs)	BRCA1	P1485fs, P360fs, P1417fs, P1464fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055188	17	41228586 - 41228598	17	43076569 - 43076581	55188	69855	rs273900731	NC_000017.11:43076568:TTCTGGCTTATAG:AA	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4401del (p.Asn1468fs)	BRCA1	N1421fs, N364fs, N1468fs, N1489fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000141260	17	41228588	17	43076571	141260	150974	rs587781611	NC_000017.11:43076570:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4398_4399insA (p.Gln1467fs)	BRCA1	Q1488fs, Q1467fs, Q1420fs, Q363fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548299	17	41228590 - 41228591	17	43076573 - 43076574	548299	538788	rs1555582663	NC_000017.11:43076573::T	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4399C>T (p.Gln1467Ter)	BRCA1	Q1467*, Q1420*, Q363*, Q1488*, Q1170*, Q1171*, Q1298*, Q1338*, Q1356*, Q1396*, Q1400*, Q1423*, Q1425*, Q1426*, Q1439*, Q1440*, Q1441*, Q1447*, Q1487*, Q196*, Q250*, Q255*, Q274*, Q296*, Q323*, Q325*, Q339*, Q360*, Q362*, Q385*, Q1339*, Q1354*, Q1355*, Q1379*, Q1397*, Q1489*, Q236*, Q254*, Q276*, Q292*, Q294*, Q297*, Q315*, Q337*, Q361*, Q1340*, Q1378*, Q1462*, Q1463*, Q1464*, Q282*, Q293*, Q316*, Q319*, Q322*, Q324*, Q386*, Q598*, Q1377*, Q1395*, Q1398*, Q1418*, Q1419*, Q1424*, Q1448*, Q1465*, Q1466*, Q237*, Q251*, Q275*, Q284*, Q317*, Q321*, Q338*, Q364*, Q599*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055191	17	41228590	17	43076573	55191	69858	rs397509171	NC_000017.11:43076572:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4397_4398insA (p.Ser1466fs)	BRCA1	S362fs, S1419fs, S1466fs, S1487fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266474	17	41228591 - 41228592	17	43076574 - 43076575	266474	261648	rs886040229	NC_000017.11:43076574::T	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4396dup (p.Ser1466fs)	BRCA1	S1487fs, S362fs, S1419fs, S1466fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000496380	17	41228592 - 41228593	17	43076575 - 43076576	496380	487933	rs397509170	NC_000017.11:43076575:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4394dup (p.Ser1466fs)	BRCA1	S1466fs, S362fs, S1419fs, S1487fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548269	17	41228594 - 41228595	17	43076577 - 43076578	548269	538789	rs1555582670	NC_000017.11:43076577:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4389_4392dup (p.Ile1465fs)	BRCA1	I1418fs, I361fs, I1486fs, I1465fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252380	17	41228596 - 41228597	17	43076579 - 43076580	252380	246817	rs879255282	NC_000017.11:43076579:AGGG:AGGGAGGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4393del (p.Pro1464_Ile1465insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037590	17	41228596	17	43076579	37590	46146	rs397507230	NC_000017.11:43076578:T:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4391_4393delinsTT (p.Pro1464fs)	BRCA1	P360fs, P1417fs, P1464fs, P1485fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037588	17	41228596 - 41228598	17	43076579 - 43076581	37588	46144	rs273900730	NC_000017.11:43076578:TAG:AA	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4392del (p.Pro1464_Ile1465insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000418999	17	41228597	17	43076580	418999	409968	rs1064793577	NC_000017.11:43076579:A:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4391dup (p.Ile1465fs)	BRCA1	I1418fs, I1465fs, I361fs, I1486fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055189	17	41228597 - 41228598	17	43076580 - 43076581	55189	69856	rs80357916	NC_000017.11:43076580:GGG:GGGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4391del (p.Pro1464fs)	BRCA1	P1417fs, P1464fs, P1485fs, P360fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037589	17	41228598	17	43076581	37589	46145	rs80357916	NC_000017.11:43076580:GGG:GG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4382_4388dup (p.Tyr1463Ter)	BRCA1	Y1484*, Y359*, Y1416*, Y1463*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000573344	17	41228600 - 41228601	17	43076583 - 43076584	573344	571426	rs1567779838	NC_000017.11:43076583:TATTCACTA:TATTCACTATTCACTA	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4389C>G (p.Tyr1463Ter)	BRCA1	Y1463*, Y1484*, Y359*, Y1416*, Y1334*, Y1336*, Y1396*, Y1414*, Y1419*, Y1422*, Y1460*, Y1461*, Y1462*, Y278*, Y289*, Y292*, Y312*, Y317*, Y356*, Y1166*, Y1350*, Y1352*, Y1373*, Y1374*, Y1375*, Y1459*, Y1485*, Y232*, Y250*, Y311*, Y319*, Y595*, Y1335*, Y1391*, Y1392*, Y1393*, Y1394*, Y1415*, Y1435*, Y1436*, Y1444*, Y1458*, Y1483*, Y192*, Y247*, Y270*, Y272*, Y280*, Y290*, Y313*, Y315*, Y320*, Y335*, Y357*, Y381*, Y594*, Y1167*, Y1294*, Y1351*, Y1420*, Y1421*, Y1437*, Y1443*, Y233*, Y246*, Y251*, Y271*, Y288*, Y293*, Y318*, Y321*, Y333*, Y334*, Y358*, Y360*, Y382*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142836	17	41228600	17	43076583	142836	152550	rs80356997	NC_000017.11:43076582:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4389C>A (p.Tyr1463Ter)	BRCA1	Y1463*, Y1416*, Y1484*, Y359*, Y1336*, Y1392*, Y1396*, Y1414*, Y1421*, Y1443*, Y1458*, Y1462*, Y1483*, Y233*, Y251*, Y270*, Y278*, Y288*, Y313*, Y315*, Y317*, Y321*, Y356*, Y595*, Y1394*, Y1435*, Y1436*, Y1437*, Y1444*, Y247*, Y250*, Y271*, Y289*, Y290*, Y311*, Y318*, Y320*, Y382*, Y594*, Y1334*, Y1352*, Y1373*, Y1374*, Y1375*, Y1420*, Y1422*, Y1460*, Y1461*, Y192*, Y232*, Y292*, Y312*, Y333*, Y335*, Y357*, Y358*, Y381*, Y1166*, Y1167*, Y1294*, Y1335*, Y1351*, Y1350*, Y1391*, Y1393*, Y1415*, Y1419*, Y1459*, Y1485*, Y246*, Y272*, Y280*, Y293*, Y319*, Y334*, Y360*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055187	17	41228600	17	43076583	55187	69854	rs80356997	NC_000017.11:43076582:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4373_4389del (p.Gln1458fs)	BRCA1	Q1458fs, Q354fs, Q1479fs, Q1411fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055184	17	41228600 - 41228616	17	43076583 - 43076599	55184	69851	rs80359885	NC_000017.11:43076582:GTATTCACTACTTTTCTGT:GT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4387dup (p.Tyr1463fs)	BRCA1	Y1167fs, Y1294fs, Y1335fs, Y1336fs, Y1392fs, Y1415fs, Y1416fs, Y1419fs, Y1444fs, Y1460fs, Y1462fs, Y1483fs, Y1485fs, Y233fs, Y251fs, Y278fs, Y288fs, Y289fs, Y293fs, Y1394fs, Y1420fs, Y1422fs, Y1435fs, Y1458fs, Y1459fs, Y1461fs, Y192fs, Y232fs, Y246fs, Y247fs, Y270fs, Y290fs, Y292fs, Y313fs, Y315fs, Y320fs, Y333fs, Y357fs, Y594fs, Y595fs, Y1334fs, Y1350fs, Y1351fs, Y1374fs, Y1396fs, Y1414fs, Y250fs, Y272fs, Y312fs, Y317fs, Y319fs, Y358fs, Y1166fs, Y1352fs, Y1373fs, Y1375fs, Y1391fs, Y1393fs, Y1421fs, Y1436fs, Y1437fs, Y1443fs, Y1463fs, Y1484fs, Y271fs, Y280fs, Y311fs, Y318fs, Y321fs, Y334fs, Y335fs, Y356fs, Y359fs, Y360fs, Y381fs, Y382fs	Hereditary cancer-predisposing syndrome	VCV003261486	17	41228601 - 41228602	17	43076584 - 43076585	3261486	3424254		NC_000017.11:43076584:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	May 31, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4386dup (p.Tyr1463fs)	BRCA1	Y359fs, Y1463fs, Y1484fs, Y1416fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188414	17	41228602 - 41228603	17	43076585 - 43076586	188414	186542	rs786204267	NC_000017.11:43076585:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4387del (p.Tyr1463fs)	BRCA1	Y1416fs, Y359fs, Y1463fs, Y1484fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037586	17	41228602	17	43076585	37586	46142	rs397507229	NC_000017.11:43076584:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4386del (p.Glu1462fs)	BRCA1	E1335fs, E1350fs, E1373fs, E1419fs, E1442fs, E1457fs, E1484fs, E231fs, E249fs, E287fs, E291fs, E292fs, E314fs, E320fs, E333fs, E356fs, E358fs, E359fs, E1372fs, E1395fs, E1415fs, E1435fs, E1458fs, E1459fs, E1460fs, E1462fs, E232fs, E271fs, E288fs, E289fs, E319fs, E334fs, E380fs, E381fs, E593fs, E594fs, E1166fs, E1293fs, E1334fs, E1351fs, E1374fs, E1391fs, E1393fs, E1413fs, E1420fs, E1421fs, E1434fs, E1436fs, E1483fs, E245fs, E269fs, E270fs, E279fs, E311fs, E316fs, E317fs, E357fs, E1165fs, E1333fs, E1349fs, E1390fs, E1392fs, E1414fs, E1418fs, E1443fs, E1461fs, E1482fs, E191fs, E246fs, E250fs, E277fs, E310fs, E312fs, E318fs, E332fs, E355fs	Hereditary breast ovarian cancer syndrome	VCV003677163	17	41228603	17	43076586	3677163	3817364		NC_000017.11:43076585:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	May 21, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4381dup (p.Ser1461fs)	BRCA1	S1164fs, S1165fs, S1292fs, S1332fs, S1333fs, S1334fs, S1348fs, S1349fs, S1350fs, S1371fs, S1372fs, S1373fs, S1389fs, S1390fs, S1391fs, S1392fs, S1394fs, S1412fs, S1413fs, S1414fs, S1417fs, S1418fs, S1419fs, S1420fs, S1433fs, S1434fs, S1435fs, S1441fs, S1442fs, S1456fs, S1457fs, S1458fs, S1459fs, S1460fs, S1461fs, S1481fs, S1482fs, S1483fs, S190fs, S230fs, S231fs, S244fs, S245fs, S248fs, S249fs, S268fs, S269fs, S270fs, S276fs, S278fs, S286fs, S287fs, S288fs, S290fs, S291fs, S309fs, S310fs, S311fs, S313fs, S315fs, S316fs, S317fs, S318fs, S319fs, S331fs, S332fs, S333fs, S354fs, S355fs, S356fs, S357fs, S358fs, S379fs, S380fs, S592fs, S593fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002673987	17	41228607 - 41228608	17	43076590 - 43076591	2673987	2841479	rs2551689269	NC_000017.11:43076590:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 19, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4379del (p.Ser1460fs)	BRCA1	S356fs, S1413fs, S1460fs, S1481fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186693	17	41228610	17	43076593	186693	184924	rs786203149	NC_000017.11:43076592:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4375A>T (p.Lys1459Ter)	BRCA1	K1459*, K1412*, K355*, K1480*, K1330*, K1370*, K1416*, K1433*, K1440*, K1479*, K188*, K229*, K267*, K268*, K276*, K285*, K308*, K311*, K315*, K330*, K331*, K1163*, K1347*, K1387*, K1389*, K1390*, K1417*, K242*, K243*, K286*, K288*, K313*, K316*, K317*, K591*, K1290*, K1346*, K1371*, K1410*, K1411*, K1418*, K1432*, K1456*, K1457*, K1481*, K247*, K266*, K284*, K314*, K352*, K353*, K354*, K356*, K378*, K1162*, K1331*, K1332*, K1348*, K1369*, K1388*, K1392*, K1415*, K1431*, K1439*, K1454*, K1455*, K1458*, K228*, K246*, K274*, K289*, K307*, K309*, K329*, K377*, K590*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266473	17	41228614	17	43076597	266473	261649	rs886040228	NC_000017.11:43076596:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4372_4373del (p.Gln1458fs)	BRCA1	Q1479fs, Q1411fs, Q1458fs, Q354fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252433	17	41228616 - 41228617	17	43076599 - 43076600	252433	246847	rs879255317	NC_000017.11:43076598:TGTG:TG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4372C>T (p.Gln1458Ter)	BRCA1	Q1458*, Q1411*, Q1479*, Q354*, Q1415*, Q1430*, Q1431*, Q1453*, Q265*, Q267*, Q313*, Q315*, Q316*, Q376*, Q590*, Q1289*, Q1369*, Q1386*, Q1387*, Q1409*, Q1410*, Q1414*, Q1161*, Q1162*, Q1388*, Q1391*, Q1432*, Q1457*, Q1478*, Q1480*, Q245*, Q273*, Q285*, Q306*, Q329*, Q330*, Q353*, Q355*, Q1331*, Q1346*, Q1347*, Q1370*, Q1389*, Q1417*, Q1455*, Q227*, Q241*, Q266*, Q275*, Q284*, Q308*, Q310*, Q312*, Q352*, Q589*, Q1329*, Q1330*, Q1345*, Q1368*, Q1416*, Q1438*, Q1439*, Q1454*, Q1456*, Q187*, Q228*, Q242*, Q246*, Q283*, Q287*, Q288*, Q307*, Q314*, Q328*, Q351*, Q377*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055183	17	41228617	17	43076600	55183	69850	rs80356932	NC_000017.11:43076599:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4370C>A (p.Ser1457Ter)	BRCA1	S1457*, S1478*, S1410*, S353*, S1161*, S1330*, S1346*, S1385*, S1409*, S1413*, S1416*, S1430*, S1431*, S1455*, S1479*, S186*, S244*, S265*, S284*, S313*, S588*, S589*, S1367*, S1386*, S1408*, S1415*, S1452*, S1453*, S1454*, S226*, S245*, S266*, S282*, S286*, S306*, S309*, S311*, S314*, S315*, S329*, S350*, S354*, S1160*, S1288*, S1369*, S1387*, S1414*, S1437*, S227*, S241*, S264*, S272*, S274*, S283*, S287*, S327*, S375*, S1328*, S1329*, S1344*, S1345*, S1368*, S1388*, S1390*, S1429*, S1438*, S1456*, S1477*, S240*, S305*, S307*, S312*, S328*, S351*, S352*, S376*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240803	17	41228619	17	43076602	240803	242775	rs80357130	NC_000017.11:43076601:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4370C>G (p.Ser1457Ter)	BRCA1	S1457*, S1410*, S1478*, S353*, S1160*, S1345*, S1367*, S1368*, S1386*, S1408*, S1430*, S1438*, S1456*, S240*, S244*, S265*, S274*, S282*, S286*, S313*, S327*, S589*, S1344*, S1388*, S1414*, S1453*, S1455*, S1479*, S186*, S227*, S264*, S283*, S305*, S306*, S351*, S354*, S376*, S1288*, S1346*, S1369*, S1385*, S1387*, S1413*, S1416*, S1429*, S1431*, S1452*, S226*, S241*, S266*, S287*, S307*, S309*, S311*, S315*, S329*, S352*, S588*, S1161*, S1328*, S1329*, S1330*, S1390*, S1409*, S1415*, S1437*, S1454*, S1477*, S245*, S272*, S284*, S312*, S314*, S328*, S350*, S375*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055182	17	41228619	17	43076602	55182	69849	rs80357130	NC_000017.11:43076601:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4365_4369del (p.Leu1455fs)	BRCA1	L351fs, L1476fs, L1408fs, L1455fs	Hereditary cancer-predisposing syndrome	VCV001740044	17	41228620 - 41228624	17	43076603 - 43076607	1740044	1794490	rs2551692654	NC_000017.11:43076602:AAGTTAA:AA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jun 10, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4364del (p.Val1454_Leu1455insTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV001740043	17	41228625	17	43076608	1740043	1794489	rs2551693911	NC_000017.11:43076607:AA:A	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Nov 2, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4364T>G (p.Leu1455Ter)	BRCA1	L1455*, L1476*, L351*, L1408*, L1327*, L1366*, L1388*, L1414*, L1428*, L1436*, L1475*, L242*, L282*, L304*, L313*, L348*, L350*, L373*, L587*, L1158*, L1286*, L1326*, L1365*, L1367*, L1384*, L1407*, L1412*, L1429*, L1452*, L1454*, L1477*, L184*, L239*, L243*, L262*, L263*, L272*, L280*, L285*, L305*, L310*, L327*, L374*, L1413*, L224*, L270*, L281*, L307*, L309*, L311*, L325*, L352*, L1159*, L1328*, L1342*, L1343*, L1344*, L1383*, L1385*, L1386*, L1406*, L1411*, L1427*, L1435*, L1450*, L1451*, L1453*, L225*, L238*, L264*, L284*, L303*, L312*, L326*, L349*, L586*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266472	17	41228625	17	43076608	266472	261650	rs886040227	NC_000017.11:43076607:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4359del (p.Val1454fs)	BRCA1	V1407fs, V1454fs, V1365fs, V1383fs, V1406fs, V1413fs, V1427fs, V1428fs, V280fs, V281fs, V283fs, V303fs, V311fs, V312fs, V347fs, V349fs, V585fs, V1326fs, V1327fs, V1342fs, V1382fs, V1387fs, V1426fs, V1450fs, V1476fs, V224fs, V242fs, V284fs, V324fs, V351fs, V373fs, V1285fs, V1364fs, V1411fs, V1434fs, V1452fs, V183fs, V223fs, V263fs, V304fs, V326fs, V372fs, V1158fs, V1341fs, V1343fs, V1366fs, V1384fs, V1405fs, V1412fs, V1435fs, V1453fs, V1475fs, V238fs, V241fs, V262fs, V271fs, V302fs, V306fs, V309fs, V310fs, V325fs, V348fs, V350fs, V586fs	Hereditary cancer-predisposing syndrome	VCV001739978	17	41228630	17	43076613	1739978	1794424	rs2551694878	NC_000017.11:43076612:T:	Deletion	frameshift variant|splice acceptor variant|intron variant	Pathogenic	Sep 13, 2019	criteria provided, single submitter							
NC_000017.10:g.(41228632_41234420)_(41276114_?)del	BRCA1|LOC110485084|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440442	17	41228632 - 41276114	17	43076615 - 43124097	440442	434072			Deletion		Pathogenic	May 23, 2016	criteria provided, single submitter							
NC_000017.10:g.(41228632_41234420)_(41251898_41256138)del	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440441	17	41228632 - 41256138	17	43076615 - 43104121	440441	434071			Deletion		Pathogenic	Apr 18, 2016	criteria provided, single submitter							
NC_000017.10:g.(41228632_41234420)_(41234593_41242960)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000440436	17	41228632 - 41242960	17	43076615 - 43090943	440436	434070			Duplication		Pathogenic	Mar 7, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4186-1783_4358-1665dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373832	17	41230295 - 41230296	17	43078278 - 43078279	373832	360741			Duplication	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4186-1787_4358-1667dup	BRCA1		not provided	VCV003337565	17	41230297 - 41230298	17	43078280 - 43078281	3337565	3496226			Duplication	splice acceptor variant|splice donor variant	Pathogenic	Mar 19, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4186-1787_4358-1668dup	BRCA1		BRCA1-related cancer predisposition	VCV000267530	17	41230298 - 41230299	17	43078281 - 43078282	267530	262958			Duplication	splice acceptor variant|splice donor variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-1643_4357+2020del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267529	17	41232401 - 41236235	17	43080384 - 43084218	267529	262959			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4186-832_4357+1955del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267531	17	41232466 - 41235424	17	43080449 - 43083407	267531	262960			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
Single allele	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373848	17	41233218 - 41243627	17	43081201 - 43091610	373848	360734			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(?_43082330)_(43082599_?)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001679085			17	43082330 - 43082599	1679085	1670879			Duplication		Pathogenic	Apr 19, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43082384)_(43082595_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000583795	17	41234401 - 41234612	17	43082384 - 43082595	583795	568616			Deletion		Pathogenic	Sep 24, 2018	criteria provided, single submitter							
NC_000017.10:g.(?_41234401)_(41234612_?)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000583774	17	41234401 - 41234612	17	43082384 - 43082595	583774	568618			Duplication		Pathogenic	Oct 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4357+1_4357+10del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267532	17	41234411 - 41234420	17	43082394 - 43082403	267532	262961	rs886040907	NC_000017.11:43082393:CAATACACACC:C	Deletion	splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4357+2T>A	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001076429	17	41234419	17	43082402	1076429	1064192	rs80358152	NC_000017.11:43082401:A:T	single nucleotide variant	splice donor variant	Pathogenic	Sep 17, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4357+2T>G	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000091629	17	41234419	17	43082402	91629	97106	rs80358152	NC_000017.11:43082401:A:C	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	May 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4357+2T>C	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000055180	17	41234419	17	43082402	55180	69847	rs80358152	NC_000017.11:43082401:A:G	single nucleotide variant	splice donor variant	Pathogenic	Jun 6, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4357+1del	BRCA1		not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055179	17	41234420	17	43082403	55179	69846	rs397509165	NC_000017.11:43082402:CC:C	Deletion	splice donor variant	Pathogenic/Likely pathogenic	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4357+1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055178	17	41234420	17	43082403	55178	69845	rs80358027	NC_000017.11:43082402:C:A	single nucleotide variant	splice donor variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+1G>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000055177	17	41234420	17	43082403	55177	69844	rs80358027	NC_000017.11:43082402:C:G	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Oct 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4357+1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037584	17	41234420	17	43082403	37584	46140	rs80358027	NC_000017.11:43082402:C:T	single nucleotide variant	splice donor variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NC_000017.11:g.(?_43082404)_(43124115_?)del	BRCA1|LOC110485084|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000417596	17	41234421 - 41276132	17	43082404 - 43124115	417596	402248			Deletion		Pathogenic	Dec 30, 2016	criteria provided, single submitter							
NM_007294.3(BRCA1):c.442-?_4357+?del	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000254055	17	41234421 - 41251897	17	43082404 - 43099880	254055	248534			Deletion		Pathogenic	Aug 12, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.4186-?_4357+?dup172	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188222	17	41234421 - 41234592	17	43082404 - 43082575	188222	186239			Duplication		Pathogenic	Apr 20, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4356del (p.Ala1453fs)	BRCA1	A1406fs, A1453fs, V350fs, D1453fs	Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000617480	17	41234422	17	43082405	617480	608842	rs1567782959	NC_000017.11:43082404:TTTTT:TTTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 1, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4354A>T (p.Lys1452Ter)	BRCA1	K1452*, K1405*, K349*, K1364*, K1403*, K260*, K268*, K282*, K302*, K308*, K309*, K347*, K348*, K1339*, K1380*, K1381*, K1404*, K1409*, K1425*, K1426*, K1448*, K236*, K269*, K301*, K307*, K346*, K583*, K1340*, K1362*, K1384*, K1411*, K1424*, K1450*, K1451*, K181*, K221*, K261*, K279*, K281*, K300*, K322*, K323*, K1156*, K1283*, K1324*, K1325*, K1341*, K1363*, K1382*, K1385*, K1410*, K222*, K238*, K239*, K240*, K278*, K304*, K310*, K584*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091628	17	41234424	17	43082407	91628	97105	rs398122685	NC_000017.11:43082406:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4351del (p.Glu1451fs)	BRCA1	E1339fs, E1340fs, E1379fs, E1384fs, E1402fs, E1410fs, E180fs, E237fs, E268fs, E277fs, E301fs, E308fs, E345fs, E347fs, E1323fs, E1362fs, E1403fs, E1424fs, E1451fs, E221fs, E259fs, E260fs, E267fs, E278fs, E281fs, E303fs, E306fs, E322fs, E346fs, E582fs, E1361fs, E1363fs, E1380fs, E1408fs, E1423fs, E1447fs, E1449fs, E1450fs, E235fs, E238fs, E299fs, E300fs, E583fs, E1155fs, E1282fs, E1324fs, E1338fs, E1381fs, E1383fs, E1404fs, E1409fs, E1425fs, E220fs, E239fs, E280fs, E307fs, E309fs, E321fs, E348fs	Hereditary cancer-predisposing syndrome	VCV003992598	17	41234427	17	43082410	3992598	4104849		NC_000017.11:43082409:C:	Deletion	frameshift variant	Pathogenic	Apr 14, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4349C>G (p.Ser1450Ter)	BRCA1	S1450*, S347*, S1403*, S1281*, S1408*, S220*, S234*, S258*, S277*, S306*, S267*, S298*, S305*, S320*, S1154*, S1322*, S1361*, S1424*, S1449*, S179*, S259*, S1323*, S1337*, S1338*, S1339*, S1362*, S1378*, S1379*, S1380*, S1402*, S1407*, S1422*, S1446*, S236*, S276*, S302*, S307*, S321*, S581*, S582*, S1360*, S1382*, S1383*, S1401*, S1409*, S1423*, S1448*, S219*, S237*, S238*, S266*, S279*, S280*, S299*, S300*, S308*, S344*, S345*, S346*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266471	17	41234429	17	43082412	266471	261651	rs886040226	NC_000017.11:43082411:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4348dup (p.Ser1450fs)	BRCA1	S1403fs, S1450fs, S347fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096930	17	41234429 - 41234430	17	43082412 - 43082413	96930	102833	rs80357548	NC_000017.11:43082412:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4348del (p.Ser1450fs)	BRCA1	S1403fs, S1450fs, S347fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431355	17	41234430	17	43082413	431355	424885	rs1135401932	NC_000017.11:43082412:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4342dup (p.Ser1448fs)	BRCA1	S1448fs, S1401fs, S345fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266470	17	41234435 - 41234436	17	43082418 - 43082419	266470	261652	rs886040225	NC_000017.11:43082418:TTT:TTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4339C>T (p.Gln1447Ter)	BRCA1	Q1447*, Q344*, Q1400*, Q1278*, Q1336*, Q1399*, Q1419*, Q1421*, Q295*, Q297*, Q299*, Q302*, Q303*, Q304*, Q341*, Q579*, Q1151*, Q1357*, Q1377*, Q1379*, Q1398*, Q1404*, Q1420*, Q176*, Q217*, Q235*, Q255*, Q263*, Q273*, Q317*, Q342*, Q1319*, Q1320*, Q1358*, Q1359*, Q1375*, Q1405*, Q1406*, Q1446*, Q231*, Q264*, Q274*, Q277*, Q296*, Q318*, Q343*, Q1334*, Q1335*, Q1376*, Q1380*, Q1443*, Q1445*, Q216*, Q233*, Q234*, Q256*, Q276*, Q305*, Q578*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055173	17	41234439	17	43082422	55173	69840	rs80357067	NC_000017.11:43082421:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4335_4338dup (p.Gln1447fs)	BRCA1	Q1400fs, Q1447fs, Q344fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055172	17	41234439 - 41234440	17	43082422 - 43082423	55172	69839	rs397509164	NC_000017.11:43082422:TTCT:TTCTTTCT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4331_4338del (p.Asn1444fs)	BRCA1	N341fs, N1444fs, N1397fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055171	17	41234440 - 41234447	17	43082423 - 43082430	55171	69838	rs80357825	NC_000017.11:43082422:TTCTGGATTTC:TTC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4336G>T (p.Glu1446Ter)	BRCA1	E1150*, E1277*, E1318*, E1319*, E1333*, E1334*, E1335*, E1356*, E1357*, E1358*, E1374*, E1375*, E1376*, E1378*, E1379*, E1397*, E1398*, E1399*, E1403*, E1404*, E1405*, E1418*, E1419*, E1420*, E1442*, E1444*, E1445*, E1446*, E175*, E215*, E216*, E230*, E232*, E233*, E234*, E254*, E255*, E262*, E263*, E272*, E273*, E275*, E276*, E294*, E295*, E296*, E298*, E301*, E302*, E303*, E304*, E316*, E317*, E340*, E341*, E342*, E343*, E577*, E578*	not provided	VCV002691994	17	41234442	17	43082425	2691994	2852997	rs2154146336	NC_000017.11:43082424:C:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4331_4332del (p.Asn1444fs)	BRCA1	N341fs, N1397fs, N1444fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055170	17	41234446 - 41234447	17	43082429 - 43082430	55170	69837	rs397509163	NC_000017.11:43082428:AT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4327C>T (p.Arg1443Ter)	BRCA1	R1443*, R340*, R1396*, R1147*, R1315*, R1316*, R1330*, R1355*, R1372*, R1395*, R1416*, R1442*, R213*, R227*, R295*, R300*, R314*, R339*, R574*, R1331*, R1332*, R1371*, R1375*, R1417*, R230*, R272*, R273*, R293*, R301*, R313*, R1354*, R1400*, R1401*, R1402*, R1415*, R1439*, R1441*, R172*, R229*, R251*, R260*, R269*, R291*, R292*, R298*, R337*, R338*, R575*, R1274*, R1353*, R1373*, R1376*, R1394*, R212*, R231*, R252*, R259*, R270*, R299*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017675	17	41234451	17	43082434	17675	32714	rs41293455	NC_000017.11:43082433:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4321_4324del (p.Asp1441fs)	BRCA1	D1145fs, D1272fs, D1313fs, D1314fs, D1328fs, D1329fs, D1330fs, D1351fs, D1352fs, D1353fs, D1369fs, D1370fs, D1371fs, D1373fs, D1374fs, D1392fs, D1393fs, D1394fs, D1398fs, D1399fs, D1400fs, D1413fs, D1414fs, D1415fs, D1437fs, D1439fs, D1440fs, D1441fs, D170fs, D210fs, D211fs, D225fs, D227fs, D228fs, D229fs, D249fs, D250fs, D257fs, D258fs, D267fs, D268fs, D270fs, D271fs, D289fs, D290fs, D291fs, D293fs, D296fs, D297fs, D298fs, D299fs, D311fs, D312fs, D335fs, D336fs, D337fs, D338fs, D572fs, D573fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003236918	17	41234454 - 41234457	17	43082437 - 43082440	3236918	3396044	rs2551898316	NC_000017.11:43082436:GGTC:	Deletion	frameshift variant	Pathogenic	May 27, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4321dup (p.Asp1441fs)	BRCA1	D1441fs, D338fs, D1394fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055168	17	41234456 - 41234457	17	43082439 - 43082440	55168	69835	rs80357748	NC_000017.11:43082439:CC:CCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4321del (p.Asp1441fs)	BRCA1	D1394fs, D1441fs, D338fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000824792	17	41234457	17	43082440	824792	813695	rs80357748	NC_000017.11:43082439:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4317dup (p.Glu1440Ter)	BRCA1	E1144*, E1271*, E1312*, E1313*, E1327*, E1328*, E1329*, E1350*, E1351*, E1352*, E1368*, E1369*, E1370*, E1372*, E1373*, E1391*, E1392*, E1393*, E1397*, E1398*, E1399*, E1412*, E1413*, E1414*, E1436*, E1438*, E1439*, E1440*, E169*, E209*, E210*, E224*, E226*, E227*, E228*, E248*, E249*, E256*, E257*, E266*, E267*, E269*, E270*, E288*, E289*, E290*, E292*, E295*, E296*, E297*, E298*, E310*, E311*, E334*, E335*, E336*, E337*, E571*, E572*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573280	17	41234460 - 41234461	17	43082443 - 43082444	2573280	2738228	rs2551899288	NC_000017.11:43082443:AA:AAA	Duplication	nonsense|frameshift variant	Pathogenic	Apr 18, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4309dup (p.Ser1437fs)	BRCA1	S334fs, S1437fs, S1390fs	Hereditary breast ovarian cancer syndrome	VCV002129863	17	41234468 - 41234469	17	43082451 - 43082452	2129863	2189140	rs886040223	NC_000017.11:43082451:AA:AAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Apr 24, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4310del (p.Ser1437fs)	BRCA1	S1390fs, S1437fs, S334fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431261	17	41234468	17	43082451	431261	424802	rs1135401874	NC_000017.11:43082450:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4308_4309del (p.Ser1437fs)	BRCA1	S1390fs, S1437fs, S334fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001325658	17	41234469 - 41234470	17	43082452 - 43082453	1325658	1315923	rs2154149764	NC_000017.11:43082451:AA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4309del (p.Ser1437fs)	BRCA1	S1390fs, S1437fs, S334fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266468	17	41234469	17	43082452	266468	261653	rs886040223	NC_000017.11:43082451:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4307_4308del (p.Ser1436fs)	BRCA1	S1389fs, S1436fs, S333fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055165	17	41234470 - 41234471	17	43082453 - 43082454	55165	69832	rs397509161	NC_000017.11:43082452:AGAG:AG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4301del (p.Ser1434fs)	BRCA1	S1387fs, S1434fs, S331fs	Hereditary breast ovarian cancer syndrome	VCV002982381	17	41234477	17	43082460	2982381	1245850	rs2551900916	NC_000017.11:43082459:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4300dup (p.Ser1434fs)	BRCA1	S1434fs, S1387fs, S331fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055164	17	41234477 - 41234478	17	43082460 - 43082461	55164	69831	rs80357790	NC_000017.11:43082460:TT:TTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4297del (p.Ile1432_Ile1433insTer)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001074622	17	41234481	17	43082464	1074622	1064193	rs2154151012	NC_000017.11:43082463:T:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic/Likely pathogenic	Sep 14, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4290_4296del (p.Pro1430_Ser1431insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266467	17	41234482 - 41234488	17	43082465 - 43082471	266467	261654	rs886040222	NC_000017.11:43082464:GATGGAAG:G	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4271_4295del (p.Gln1424fs)	BRCA1	Q1377fs, Q1424fs, Q321fs	Hereditary breast ovarian cancer syndrome|not provided	VCV000993204	17	41234483 - 41234507	17	43082466 - 43082490	993204	981162	rs2053050323	NC_000017.11:43082465:ATGGAAGGGTAGCTGTTAGAAGGCT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4289dup (p.Ser1431fs)	BRCA1	S1384fs, S1431fs, S328fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125701	17	41234488 - 41234489	17	43082471 - 43082472	125701	131239	rs80357556	NC_000017.11:43082471:GGG:GGGG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4289del (p.Pro1430fs)	BRCA1	P1302fs, P1318fs, P1340fs, P1359fs, P1363fs, P1404fs, P1426fs, P199fs, P218fs, P238fs, P256fs, P259fs, P301fs, P1303fs, P1317fs, P1341fs, P1383fs, P1387fs, P1428fs, P214fs, P260fs, P278fs, P279fs, P282fs, P561fs, P1261fs, P1358fs, P1360fs, P1381fs, P1402fs, P1403fs, P1429fs, P159fs, P200fs, P217fs, P239fs, P246fs, P247fs, P285fs, P287fs, P288fs, P324fs, P325fs, P326fs, P562fs, P1134fs, P1319fs, P1342fs, P1362fs, P1382fs, P1388fs, P1389fs, P1430fs, P216fs, P257fs, P280fs, P286fs, P300fs, P327fs	Hereditary cancer-predisposing syndrome	VCV002774837	17	41234489	17	43082472	2774837	2935564	rs80357556	NC_000017.11:43082471:GGG:GG	Deletion	frameshift variant	Pathogenic	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4286_4287insG (p.Tyr1429Ter)	BRCA1	Y326*, Y1429*, Y1382*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548254	17	41234491 - 41234492	17	43082474 - 43082475	548254	538790	rs1555584110	NC_000017.11:43082474::C	Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4287C>A (p.Tyr1429Ter)	BRCA1	Y1429*, Y1382*, Y326*, Y1260*, Y1302*, Y1359*, Y1380*, Y1387*, Y1388*, Y1427*, Y158*, Y198*, Y199*, Y255*, Y256*, Y284*, Y285*, Y324*, Y325*, Y1133*, Y1301*, Y1316*, Y1317*, Y1318*, Y1340*, Y1341*, Y1362*, Y1381*, Y1386*, Y1403*, Y1428*, Y216*, Y238*, Y245*, Y259*, Y277*, Y279*, Y560*, Y561*, Y1357*, Y1358*, Y1361*, Y1402*, Y1425*, Y246*, Y323*, Y1339*, Y1401*, Y213*, Y215*, Y217*, Y237*, Y258*, Y278*, Y281*, Y286*, Y287*, Y299*, Y300*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055161	17	41234491	17	43082474	55161	69828	rs397509160	NC_000017.11:43082473:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4285dup (p.Tyr1429fs)	BRCA1	Y1382fs, Y1429fs, Y326fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266466	17	41234492 - 41234493	17	43082475 - 43082476	266466	261656	rs1555584118	NC_000017.11:43082475:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4285_4286insG (p.Tyr1429Ter)	BRCA1	Y1382*, Y1429*, Y326*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125700	17	41234492 - 41234493	17	43082475 - 43082476	125700	131238	rs80357716	NC_000017.11:43082475::C	Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4284_4285insG (p.Tyr1429fs)	BRCA1	Y1382fs, Y1429fs, Y326fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548285	17	41234493 - 41234494	17	43082476 - 43082477	548285	538791	rs1555584122	NC_000017.11:43082476::C	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4284_4285delinsG (p.Ser1428fs)	BRCA1	S1428fs, S1381fs, S325fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266465	17	41234493 - 41234494	17	43082476 - 43082477	266465	261655	rs886040221	NC_000017.11:43082475:AG:C	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4282_4283del (p.Ser1428fs)	BRCA1	S1428fs, S325fs, S1381fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055160	17	41234495 - 41234496	17	43082478 - 43082479	55160	69827	rs397509159	NC_000017.11:43082477:CT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4282del (p.Ser1428fs)	BRCA1	S325fs, S1381fs, S1428fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000481454	17	41234496	17	43082479	481454	478550	rs1555584125	NC_000017.11:43082478:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4281_4282insTAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAAC (p.Ser1428Ter)	BRCA1	S1428*, S325*, S1381*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267495	17	41234496 - 41234497	17	43082479 - 43082480	267495	262962	rs886040896	NC_000017.11:43082479:GTTAGAAGGCTGGCTCCCATGCTGTTCTAACACAGCTT:GTTAGAAGGCTGGCTCCCATGCTGTTCTAACACAGCTTAGTTAGAAGGCTGGCTCCCATGCTGTTCTAACACAGCTT	Insertion	nonsense|inframe_indel|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4276del (p.Ser1426fs)	BRCA1	S1379fs, S1426fs, S323fs	Hereditary breast ovarian cancer syndrome	VCV000961620	17	41234502	17	43082485	961620	949932	rs2053054217	NC_000017.11:43082484:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Feb 25, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4270C>T (p.Gln1424Ter)	BRCA1	Q1424*, Q1377*, Q321*, Q1128*, Q1311*, Q1335*, Q1383*, Q1398*, Q153*, Q241*, Q250*, Q251*, Q295*, Q555*, Q1312*, Q1352*, Q1422*, Q208*, Q211*, Q233*, Q240*, Q254*, Q272*, Q273*, Q280*, Q282*, Q294*, Q320*, Q556*, Q1255*, Q1336*, Q1353*, Q1376*, Q1381*, Q1382*, Q1396*, Q1423*, Q253*, Q281*, Q1296*, Q1297*, Q1313*, Q1334*, Q1354*, Q1356*, Q1357*, Q1375*, Q1397*, Q1420*, Q193*, Q194*, Q210*, Q212*, Q232*, Q274*, Q276*, Q279*, Q318*, Q319*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266464	17	41234508	17	43082491	266464	261657	rs886040220	NC_000017.11:43082490:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4194_4267del (p.Asp1398fs)	BRCA1	D1351fs, D1398fs, D295fs	Hereditary breast ovarian cancer syndrome	VCV000644050	17	41234511 - 41234584	17	43082494 - 43082567	644050	645954	rs1597848148		Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 19, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4266dup (p.Ser1423fs)	BRCA1	S320fs, S1423fs, S1376fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055159	17	41234511 - 41234512	17	43082494 - 43082495	55159	69826	rs397509158	NC_000017.11:43082494:CCC:CCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4266del (p.Ser1423fs)	BRCA1	S1376fs, S1423fs, S320fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548196	17	41234512	17	43082495	548196	538792	rs397509158	NC_000017.11:43082494:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4258del (p.Gln1420fs)	BRCA1	Q1251fs, Q1293fs, Q1308fs, Q1309fs, Q1331fs, Q1348fs, Q1352fs, Q1372fs, Q1418fs, Q149fs, Q204fs, Q208fs, Q237fs, Q246fs, Q247fs, Q249fs, Q268fs, Q314fs, Q551fs, Q1124fs, Q1350fs, Q1371fs, Q1378fs, Q1392fs, Q190fs, Q228fs, Q229fs, Q278fs, Q291fs, Q316fs, Q317fs, Q552fs, Q1307fs, Q1330fs, Q1332fs, Q1353fs, Q1393fs, Q1419fs, Q189fs, Q207fs, Q236fs, Q270fs, Q277fs, Q290fs, Q315fs, Q1292fs, Q1349fs, Q1373fs, Q1377fs, Q1379fs, Q1394fs, Q1416fs, Q1420fs, Q206fs, Q250fs, Q269fs, Q272fs, Q275fs, Q276fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	VCV002710584	17	41234520	17	43082503	2710584	2867725	rs2551915138	NC_000017.11:43082502:G:	Deletion	frameshift variant	Pathogenic	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4258C>T (p.Gln1420Ter)	BRCA1	Q1420*, Q317*, Q1373*, Q1251*, Q1308*, Q1330*, Q1379*, Q1418*, Q1419*, Q189*, Q207*, Q208*, Q276*, Q291*, Q1124*, Q1309*, Q1331*, Q1350*, Q1371*, Q149*, Q229*, Q236*, Q247*, Q249*, Q250*, Q268*, Q269*, Q277*, Q278*, Q290*, Q314*, Q315*, Q1292*, Q1293*, Q1307*, Q1348*, Q1353*, Q1392*, Q1393*, Q1394*, Q1416*, Q190*, Q1332*, Q1349*, Q1352*, Q1372*, Q1377*, Q1378*, Q204*, Q206*, Q228*, Q237*, Q246*, Q270*, Q272*, Q275*, Q316*, Q551*, Q552*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055155	17	41234520	17	43082503	55155	69822	rs80357305	NC_000017.11:43082502:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4255G>T (p.Glu1419Ter)	BRCA1	E1419*, E1372*, E316*, E1123*, E1291*, E1329*, E1348*, E1349*, E1370*, E1376*, E1391*, E1415*, E188*, E235*, E248*, E267*, E289*, E1250*, E1292*, E1330*, E1331*, E1347*, E1352*, E1377*, E1378*, E1392*, E1393*, E148*, E189*, E203*, E207*, E228*, E246*, E268*, E269*, E271*, E277*, E290*, E313*, E315*, E550*, E1306*, E1307*, E1308*, E1371*, E1418*, E206*, E245*, E275*, E314*, E551*, E1351*, E1417*, E205*, E227*, E236*, E249*, E274*, E276*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266463	17	41234523	17	43082506	266463	261658	rs80357309	NC_000017.11:43082505:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4253dup (p.Leu1418fs)	BRCA1	L1418fs, L1371fs, L315fs	Hereditary breast ovarian cancer syndrome	VCV002026298	17	41234524 - 41234525	17	43082507 - 43082508	2026298	2077789	rs2154155295	NC_000017.11:43082507:AA:AAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Aug 22, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4253del (p.Val1417_Leu1418insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001098805	17	41234525	17	43082508	1098805	1087553	rs2154155295	NC_000017.11:43082507:AA:A	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Apr 18, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4253T>G (p.Leu1418Ter)	BRCA1	L1418*, L315*, L1371*, L1291*, L1330*, L1369*, L1392*, L1417*, L188*, L206*, L234*, L235*, L245*, L248*, L289*, L1122*, L1307*, L1351*, L1416*, L147*, L187*, L226*, L244*, L274*, L275*, L288*, L1305*, L1306*, L1329*, L1346*, L1348*, L1350*, L1370*, L1375*, L1377*, L205*, L227*, L247*, L270*, L276*, L314*, L1249*, L1290*, L1328*, L1347*, L1376*, L1390*, L1391*, L1414*, L202*, L204*, L266*, L267*, L268*, L273*, L312*, L313*, L549*, L550*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055153	17	41234525	17	43082508	55153	69820	rs397509157	NC_000017.11:43082507:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4251_4252del (p.Leu1418fs)	BRCA1	L1418fs, L315fs, L1371fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037579	17	41234526 - 41234527	17	43082509 - 43082510	37579	46135	rs80357977	NC_000017.11:43082508:ACACA:ACA	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4250del (p.Val1417fs)	BRCA1	V314fs, V1417fs, V1370fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142996	17	41234528	17	43082511	142996	152710	rs587782879	NC_000017.11:43082510:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4242_4244delinsG (p.Glu1415fs)	BRCA1	E1288fs, E1326fs, E1368fs, E1373fs, E1388fs, E1411fs, E144fs, E185fs, E201fs, E241fs, E245fs, E263fs, E273fs, E286fs, E546fs, E1302fs, E1304fs, E1343fs, E1348fs, E1389fs, E1415fs, E203fs, E224fs, E232fs, E264fs, E271fs, E272fs, E311fs, E312fs, E547fs, E1246fs, E1287fs, E1327fs, E1372fs, E1374fs, E1387fs, E184fs, E199fs, E202fs, E242fs, E244fs, E310fs, E1119fs, E1303fs, E1325fs, E1344fs, E1345fs, E1347fs, E1366fs, E1367fs, E1413fs, E1414fs, E223fs, E231fs, E265fs, E267fs, E270fs, E285fs, E309fs	Hereditary cancer-predisposing syndrome	VCV003825301	17	41234534 - 41234536	17	43082517 - 43082519	3825301	3942572		NC_000017.11:43082516:TCT:C	Indel	frameshift variant	Pathogenic	Jan 31, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4243_4244insT (p.Glu1415fs)	BRCA1	E312fs, E1368fs, E1415fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548281	17	41234534 - 41234535	17	43082517 - 43082518	548281	538793	rs1555584178	NC_000017.11:43082517::A	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4242dup (p.Glu1415fs)	BRCA1	E1119fs, E1246fs, E1287fs, E1288fs, E1302fs, E1303fs, E1304fs, E1325fs, E1326fs, E1327fs, E1343fs, E1344fs, E1345fs, E1347fs, E1348fs, E1366fs, E1367fs, E1368fs, E1372fs, E1373fs, E1374fs, E1387fs, E1388fs, E1389fs, E1411fs, E1413fs, E1414fs, E1415fs, E144fs, E184fs, E185fs, E199fs, E201fs, E202fs, E203fs, E223fs, E224fs, E231fs, E232fs, E241fs, E242fs, E244fs, E245fs, E263fs, E264fs, E265fs, E267fs, E270fs, E271fs, E272fs, E273fs, E285fs, E286fs, E309fs, E310fs, E311fs, E312fs, E546fs, E547fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002673991	17	41234535 - 41234536	17	43082518 - 43082519	2673991	2841483	rs2551920618	NC_000017.11:43082518:T:TT	Duplication	frameshift variant	Pathogenic	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4243G>T (p.Glu1415Ter)	BRCA1	E1415*, E1368*, E312*, E1246*, E1287*, E1326*, E1343*, E1367*, E1374*, E184*, E203*, E232*, E242*, E265*, E270*, E272*, E285*, E310*, E311*, E1302*, E1347*, E1387*, E144*, E264*, E546*, E1288*, E1303*, E1304*, E1327*, E1344*, E1345*, E1348*, E1366*, E1373*, E1388*, E1414*, E185*, E199*, E201*, E223*, E231*, E241*, E244*, E267*, E286*, E1119*, E1325*, E1372*, E1389*, E1411*, E1413*, E202*, E224*, E245*, E263*, E271*, E273*, E309*, E547*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000375546	17	41234535	17	43082518	375546	362357	rs1057519558	NC_000017.11:43082517:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4243del (p.Glu1415fs)	BRCA1	E312fs, E1368fs, E1415fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037578	17	41234535	17	43082518	37578	46134	rs80357981	NC_000017.11:43082517:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4240dup (p.Leu1414fs)	BRCA1	L1414fs, L311fs, L1367fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055149	17	41234537 - 41234538	17	43082520 - 43082521	55149	69816	rs397509154	NC_000017.11:43082520:G:GG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4239del (p.Glu1413fs)	BRCA1	E1366fs, E310fs, E1413fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266462	17	41234539	17	43082522	266462	261659	rs886040219	NC_000017.11:43082521:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4237G>T (p.Glu1413Ter)	BRCA1	E1413*, E1366*, E310*, E1286*, E1325*, E1345*, E1365*, E183*, E197*, E200*, E201*, E229*, E239*, E262*, E268*, E269*, E308*, E544*, E1300*, E1324*, E1342*, E1343*, E1346*, E1370*, E1371*, E1409*, E1411*, E199*, E221*, E222*, E242*, E243*, E265*, E307*, E1117*, E1285*, E1323*, E1372*, E1385*, E1386*, E1387*, E182*, E240*, E261*, E309*, E545*, E1244*, E1301*, E1302*, E1341*, E1364*, E1412*, E142*, E230*, E263*, E270*, E271*, E283*, E284*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055148	17	41234541	17	43082524	55148	69815	rs397509153	NC_000017.11:43082523:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4231del (p.Met1411fs)	BRCA1	M1115fs, M1242fs, M1283fs, M1284fs, M1298fs, M1299fs, M1300fs, M1321fs, M1322fs, M1323fs, M1339fs, M1340fs, M1341fs, M1343fs, M1344fs, M1362fs, M1363fs, M1364fs, M1368fs, M1369fs, M1370fs, M1383fs, M1384fs, M1385fs, M1407fs, M1409fs, M140fs, M1410fs, M1411fs, M180fs, M181fs, M195fs, M197fs, M198fs, M199fs, M219fs, M220fs, M227fs, M228fs, M237fs, M238fs, M240fs, M241fs, M259fs, M260fs, M261fs, M263fs, M266fs, M267fs, M268fs, M269fs, M281fs, M282fs, M305fs, M306fs, M307fs, M308fs, M542fs, M543fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573305	17	41234547	17	43082530	2573305	2738253	rs2551926903	NC_000017.11:43082529:TTT:TT	Deletion	frameshift variant	Pathogenic	Mar 1, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4228G>T (p.Glu1410Ter)	BRCA1	E1410*, E307*, E1363*, E1283*, E1338*, E1361*, E1384*, E139*, E179*, E180*, E194*, E236*, E258*, E260*, E262*, E265*, E281*, E306*, E1114*, E1297*, E1298*, E1320*, E1339*, E1340*, E1342*, E1343*, E1362*, E1368*, E1409*, E196*, E198*, E226*, E227*, E239*, E304*, E219*, E237*, E259*, E268*, E305*, E541*, E542*, E1241*, E1282*, E1321*, E1382*, E1406*, E1408*, E240*, E266*, E267*, E280*, E1299*, E1322*, E1367*, E1369*, E1383*, E197*, E218*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055146	17	41234550	17	43082533	55146	69813	rs397509152	NC_000017.11:43082532:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4225C>T (p.Gln1409Ter)	BRCA1	Q1409*, Q1362*, Q306*, Q1298*, Q1320*, Q1339*, Q1367*, Q138*, Q1382*, Q1383*, Q1407*, Q195*, Q196*, Q197*, Q217*, Q258*, Q266*, Q305*, Q540*, Q1319*, Q1321*, Q1342*, Q1361*, Q1381*, Q179*, Q218*, Q225*, Q236*, Q238*, Q257*, Q267*, Q304*, Q541*, Q1240*, Q1281*, Q1337*, Q1338*, Q1341*, Q1360*, Q1368*, Q1405*, Q193*, Q235*, Q239*, Q261*, Q264*, Q265*, Q279*, Q1113*, Q1282*, Q1296*, Q1297*, Q1366*, Q1408*, Q178*, Q226*, Q259*, Q280*, Q303*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266461	17	41234553	17	43082536	266461	261660	rs886040218	NC_000017.11:43082535:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4222C>T (p.Gln1408Ter)	BRCA1	Q1408*, Q305*, Q1361*, Q1239*, Q1365*, Q1382*, Q178*, Q217*, Q234*, Q237*, Q265*, Q279*, Q302*, Q304*, Q1280*, Q1319*, Q1336*, Q196*, Q256*, Q258*, Q260*, Q264*, Q303*, Q1295*, Q1296*, Q1297*, Q1320*, Q1338*, Q1340*, Q1341*, Q1360*, Q1366*, Q137*, Q1380*, Q1404*, Q1406*, Q192*, Q195*, Q216*, Q225*, Q263*, Q278*, Q539*, Q1112*, Q1281*, Q1318*, Q1337*, Q1359*, Q1367*, Q1381*, Q1407*, Q177*, Q194*, Q224*, Q235*, Q238*, Q257*, Q266*, Q540*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055145	17	41234556	17	43082539	55145	69812	rs80356989	NC_000017.11:43082538:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4217dup (p.Leu1407fs)	BRCA1	L1407fs, L304fs, L1360fs	Hereditary breast ovarian cancer syndrome	VCV001364632	17	41234560 - 41234561	17	43082543 - 43082544	1364632	1409113	rs2154159696	NC_000017.11:43082543:TTT:TTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 31, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4218del (p.Lys1406fs)	BRCA1	K1359fs, K303fs, K1406fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266460	17	41234560	17	43082543	266460	261661	rs886040217	NC_000017.11:43082542:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4216A>T (p.Lys1406Ter)	BRCA1	K1406*, K1359*, K303*, K1110*, K1317*, K1339*, K175*, K190*, K193*, K215*, K222*, K233*, K261*, K277*, K538*, K1278*, K1293*, K1334*, K1338*, K135*, K1357*, K1358*, K1363*, K1365*, K1379*, K192*, K214*, K232*, K235*, K255*, K262*, K264*, K276*, K537*, K194*, K236*, K256*, K300*, K301*, K302*, K1237*, K1294*, K1295*, K1316*, K1318*, K1402*, K1405*, K176*, K1279*, K1335*, K1336*, K1364*, K1378*, K1380*, K1404*, K223*, K254*, K258*, K263*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266459	17	41234562	17	43082545	266459	261662	rs886040216	NC_000017.11:43082544:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4214dup (p.Leu1407fs)	BRCA1	L1360fs, L304fs, L1407fs	Hereditary breast ovarian cancer syndrome	VCV000651892	17	41234563 - 41234564	17	43082546 - 43082547	651892	645956	rs1597848491	NC_000017.11:43082546:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jul 14, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4191_4213dup (p.Ile1405delinsArgIleProCysAsnIleThrTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV001738572	17	41234564 - 41234565	17	43082547 - 43082548	1738572	1790905	rs2551932759	NC_000017.11:43082547:TCAGGTTATGTTGCATGGTATCC:TCAGGTTATGTTGCATGGTATCCTCAGGTTATGTTGCATGGTATCC	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Aug 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4214del (p.Ile1405fs)	BRCA1	I1405fs, I302fs, I1358fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125698	17	41234564	17	43082547	125698	131236	rs273900728	NC_000017.11:43082546:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4210del (p.Asn1403_Leu1404insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055142	17	41234568	17	43082551	55142	69809	rs80357765	NC_000017.11:43082550:GG:G	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4206_4207del (p.His1402fs)	BRCA1	H1355fs, H1402fs, H299fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266458	17	41234571 - 41234572	17	43082554 - 43082555	266458	261663	rs886040215	NC_000017.11:43082553:TAT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4205del (p.His1402fs)	BRCA1	H1355fs, H1402fs, H299fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266457	17	41234573	17	43082556	266457	261664	rs886040214	NC_000017.11:43082555:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4203del (p.Gln1401fs)	BRCA1	Q1273fs, Q1274fs, Q1290fs, Q130fs, Q1312fs, Q1330fs, Q1333fs, Q1334fs, Q1359fs, Q1397fs, Q209fs, Q228fs, Q298fs, Q1311fs, Q1313fs, Q1353fs, Q1354fs, Q230fs, Q250fs, Q253fs, Q256fs, Q271fs, Q295fs, Q296fs, Q532fs, Q533fs, Q1105fs, Q1232fs, Q1288fs, Q1329fs, Q1331fs, Q1352fs, Q1375fs, Q1399fs, Q1401fs, Q170fs, Q188fs, Q189fs, Q227fs, Q251fs, Q257fs, Q272fs, Q297fs, Q171fs, Q185fs, Q187fs, Q210fs, Q217fs, Q218fs, Q231fs, Q249fs, Q258fs, Q259fs, Q1289fs, Q1358fs, Q1360fs, Q1373fs, Q1374fs, Q1400fs	Hereditary breast ovarian cancer syndrome	VCV002752483	17	41234575	17	43082558	2752483	2916249	rs2551935515	NC_000017.11:43082557:TT:T	Deletion	frameshift variant	Pathogenic	Aug 14, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4202_4203del (p.Gln1401fs)	BRCA1	Q1354fs, Q1401fs, Q298fs	Hereditary breast ovarian cancer syndrome	VCV002025101	17	41234575 - 41234576	17	43082558 - 43082559	2025101	2084304	rs2551935635	NC_000017.11:43082557:TT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 20, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4201C>T (p.Gln1401Ter)	BRCA1	Q1401*, Q298*, Q1354*, Q1105*, Q1232*, Q1273*, Q1373*, Q1374*, Q171*, Q227*, Q250*, Q253*, Q533*, Q1288*, Q1330*, Q1333*, Q1359*, Q217*, Q228*, Q231*, Q249*, Q257*, Q272*, Q296*, Q297*, Q1289*, Q130*, Q1312*, Q1313*, Q1329*, Q1352*, Q1360*, Q1400*, Q187*, Q188*, Q189*, Q209*, Q210*, Q218*, Q251*, Q256*, Q259*, Q271*, Q295*, Q1274*, Q1290*, Q1311*, Q1331*, Q1334*, Q1353*, Q1358*, Q1375*, Q1397*, Q1399*, Q170*, Q185*, Q230*, Q258*, Q532*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055139	17	41234577	17	43082560	55139	69806	rs397509151	NC_000017.11:43082559:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4196_4197delinsT (p.Thr1399fs)	BRCA1	T296fs, T1352fs, T1399fs	Hereditary breast ovarian cancer syndrome	VCV000580402	17	41234581 - 41234582	17	43082564 - 43082565	580402	569107	rs886040213	NC_000017.11:43082563:GG:A	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Jun 18, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4197del (p.Met1400fs)	BRCA1	M297fs, M1353fs, M1400fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266456	17	41234581	17	43082564	266456	261665	rs886040213	NC_000017.11:43082563:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4195_4196del (p.Thr1399fs)	BRCA1	T1352fs, T1399fs, T296fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055136	17	41234582 - 41234583	17	43082565 - 43082566	55136	69803	rs80357649	NC_000017.11:43082564:GT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4195del (p.Thr1399fs)	BRCA1	T1399fs, T296fs, T1352fs	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000578874	17	41234583	17	43082566	578874	571146	rs1567783654	NC_000017.11:43082565:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4194_4195insGG (p.Thr1399fs)	BRCA1	T1352fs, T1399fs, T296fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548305	17	41234583 - 41234584	17	43082566 - 43082567	548305	538794	rs1555584262	NC_000017.11:43082566::CC	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4193_4194insGG (p.Asp1398fs)	BRCA1	D1351fs, D1398fs, D295fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254454	17	41234584 - 41234585	17	43082567 - 43082568	254454	249089	rs886038033	NC_000017.11:43082567::CC	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4192del (p.Asp1398fs)	BRCA1	D1102fs, D1229fs, D1270fs, D1271fs, D127fs, D1285fs, D1286fs, D1287fs, D1308fs, D1309fs, D1310fs, D1326fs, D1327fs, D1328fs, D1330fs, D1331fs, D1349fs, D1350fs, D1351fs, D1355fs, D1356fs, D1357fs, D1370fs, D1371fs, D1372fs, D1394fs, D1396fs, D1397fs, D1398fs, D167fs, D168fs, D182fs, D184fs, D185fs, D186fs, D206fs, D207fs, D214fs, D215fs, D224fs, D225fs, D227fs, D228fs, D246fs, D247fs, D248fs, D250fs, D253fs, D254fs, D255fs, D256fs, D268fs, D269fs, D292fs, D293fs, D294fs, D295fs, D529fs, D530fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002680233	17	41234586	17	43082569	2680233	2833960	rs2551938740	NC_000017.11:43082568:CCC:CC	Deletion	frameshift variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4186C>T (p.Gln1396Ter)	BRCA1	Q1396*, Q1349*, Q293*, Q125*, Q1284*, Q1348*, Q1355*, Q1395*, Q166*, Q184*, Q248*, Q254*, Q292*, Q1268*, Q1307*, Q1328*, Q1370*, Q205*, Q223*, Q225*, Q251*, Q266*, Q290*, Q528*, Q1269*, Q1285*, Q1325*, Q1326*, Q165*, Q222*, Q226*, Q246*, Q253*, Q1100*, Q1308*, Q1329*, Q1354*, Q1369*, Q182*, Q204*, Q212*, Q213*, Q245*, Q252*, Q267*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055135	17	41234592	17	43082575	55135	69802	rs80357011	NC_000017.11:43082574:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NG_005905.2:g.(?_92501)_(127041_135408)del	BRCA1|LOC110485084|LOC111589215|LOC111589216|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373887	17	41234593 - 41277500	17	43082576 - 43125483	373887	360759			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1385_4186-2276del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000429036	17	41236868 - 41246163	17	43084851 - 43094146	429036	420998			Deletion	splice acceptor variant|splice donor variant	Pathogenic	Dec 19, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4097-78_4185+69del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267524	17	41242892 - 41243127	17	43090875 - 43091110	267524	262963	rs1555586010		Deletion	splice acceptor variant|splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4185+2_4185+22delinsA	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037574	17	41242939 - 41242959	17	43090922 - 43090942	37574	46130	rs273900724	NC_000017.11:43090921:CACACACACACACGCTTTTTA:T	Indel	splice donor variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NC_000017.11:g.(?_43090924)_(43106553_?)del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000583942	17	41242941 - 41258570	17	43090924 - 43106553	583942	568622			Deletion		Pathogenic	Sep 29, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43090924)_(43125483_?)del	LOC111589216|BRCA1|LOC110485084|LOC111589215|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000583429	17	41242941 - 41277500	17	43090924 - 43125483	583429	568623			Deletion		Pathogenic	Nov 25, 2023	criteria provided, single submitter							
NC_000017.11:g.(?_43090938)_(43106539_?)del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000462203	17	41242955 - 41258556	17	43090938 - 43106539	462203	467369			Deletion		Pathogenic	Jul 17, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4185_4185+3del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055132	17	41242958 - 41242961	17	43090941 - 43090944	55132	69799	rs397509149	NC_000017.11:43090940:TACCT:T	Deletion	splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4185+2T>G	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002152286	17	41242959	17	43090942	2152286	1245754	rs431825406	NC_000017.11:43090941:A:C	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Apr 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4185+2T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267525	17	41242959	17	43090942	267525	262964	rs431825406	NC_000017.11:43090941:A:G	single nucleotide variant	splice donor variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.703_4185+1del	BRCA1|LOC126862571		Fanconi anemia, complementation group S	VCV003778923	17	41242960 - 41246845	17	43090943 - 43094828	3778923	3894910			Deletion	splice acceptor variant|splice donor variant|initiator_codon_variant	Pathogenic	Sep 16, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4185+1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000186395	17	41242960	17	43090943	186395	184933	rs80358076	NC_000017.11:43090942:C:T	single nucleotide variant	splice donor variant	Pathogenic	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4185+1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 2|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055128	17	41242960	17	43090943	55128	69795	rs80358076	NC_000017.11:43090942:C:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.-19-?_4185+?del	BRCA1|LOC110485084|LOC111589216|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000254034	17	41242961 - 41276132	17	43090944 - 43124115	254034	248520			Deletion		Pathogenic	Jan 25, 2017	criteria provided, single submitter							
NM_007294.3(BRCA1):c.548-?_4185+?del	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000219772	17	41242961 - 41249306	17	43090944 - 43097289	219772	222547			Deletion		Pathogenic	Jan 10, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4185G>A (p.Gln1395=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055131	17	41242961	17	43090944	55131	69798	rs80356857	NC_000017.11:43090943:C:T	single nucleotide variant	synonymous variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4182_4183dup (p.Gln1395fs)	BRCA1	Q1348fs, Q1395fs, Q292fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055124	17	41242962 - 41242963	17	43090945 - 43090946	55124	69791	rs80357742	NC_000017.11:43090945:GAG:GAGAG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4182_4183del (p.Gln1395fs)	BRCA1	Q292fs, Q1348fs, Q1395fs	Hereditary breast ovarian cancer syndrome	VCV000855804	17	41242963 - 41242964	17	43090946 - 43090947	855804	845388	rs80357742	NC_000017.11:43090945:GAG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 1, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4183C>T (p.Gln1395Ter)	BRCA1	Q1395*, Q292*, Q1348*, Q1099*, Q1284*, Q1328*, Q165*, Q181*, Q204*, Q211*, Q244*, Q245*, Q250*, Q266*, Q289*, Q1283*, Q1324*, Q1327*, Q1368*, Q164*, Q183*, Q221*, Q225*, Q247*, Q252*, Q253*, Q290*, Q1227*, Q1268*, Q1306*, Q1325*, Q1353*, Q1354*, Q1369*, Q1392*, Q203*, Q527*, Q124*, Q1267*, Q1307*, Q1347*, Q1394*, Q180*, Q212*, Q222*, Q224*, Q251*, Q265*, Q291*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055125	17	41242963	17	43090946	55125	69792	rs80357260	NC_000017.11:43090945:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4175del (p.Ile1391_Leu1392insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266454	17	41242971	17	43090954	266454	261666	rs886040211	NC_000017.11:43090953:AAAA:AAA	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4171del (p.Ile1391fs)	BRCA1	I1344fs, I1391fs, I288fs	not provided	VCV001319805	17	41242975	17	43090958	1319805	1310054	rs2154251360	NC_000017.11:43090957:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Nov 3, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4168_4169dup (p.Asp1390fs)	BRCA1	D1343fs, D287fs, D1390fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548209	17	41242976 - 41242977	17	43090959 - 43090960	548209	538796	rs1555586100	NC_000017.11:43090959:TC:TCTC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4167_4170del (p.Ser1389fs)	BRCA1	S1342fs, S1389fs, S286fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055121	17	41242976 - 41242979	17	43090959 - 43090962	55121	69788	rs80357538	NC_000017.11:43090958:GTCA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4168_4169del (p.Asp1390fs)	BRCA1	D1390fs, D287fs, D1343fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548304	17	41242977 - 41242978	17	43090960 - 43090961	548304	538795	rs1555586103	NC_000017.11:43090959:TC:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4167_4168insAG (p.Asp1390fs)	BRCA1	D1343fs, D1390fs, D287fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125683	17	41242978 - 41242979	17	43090961 - 43090962	125683	131221	rs80357847	NC_000017.11:43090961::CT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4167_4168del (p.Ser1389fs)	BRCA1	S1389fs, S286fs, S1342fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055120	17	41242978 - 41242979	17	43090961 - 43090962	55120	69787	rs397509144	NC_000017.11:43090960:CAC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4167del (p.Ser1389fs)	BRCA1	S1342fs, S1389fs, S286fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055122	17	41242979	17	43090962	55122	69789	rs397509145	NC_000017.11:43090961:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4165_4166dup (p.Ser1389fs)	BRCA1	S1389fs, S286fs, S1342fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055118	17	41242979 - 41242980	17	43090962 - 43090963	55118	69785	rs80357572	NC_000017.11:43090962:CTCT:CTCTCT	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4165_4166del (p.Gln1388_Ser1389insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055117	17	41242980 - 41242981	17	43090963 - 43090964	55117	69784	rs80357572	NC_000017.11:43090962:CTCT:CT	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4163_4166del (p.Gln1388fs)	BRCA1	Q1388fs, Q285fs, Q1341fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055116	17	41242980 - 41242983	17	43090963 - 43090966	55116	69783	rs80357532	NC_000017.11:43090962:CTCT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4165del (p.Ser1389fs)	BRCA1	S1342fs, S1389fs, S286fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000631227	17	41242981	17	43090964	631227	618590	rs1567788282	NC_000017.11:43090963:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4162_4163dup (p.Gln1388fs)	BRCA1	Q1260fs, Q1261fs, Q1299fs, Q1340fs, Q1361fs, Q1385fs, Q1388fs, Q157fs, Q205fs, Q214fs, Q217fs, Q283fs, Q284fs, Q1092fs, Q1300fs, Q1318fs, Q1321fs, Q1362fs, Q1387fs, Q158fs, Q176fs, Q196fs, Q218fs, Q245fs, Q246fs, Q1220fs, Q1277fs, Q1317fs, Q1320fs, Q1346fs, Q1347fs, Q173fs, Q174fs, Q204fs, Q237fs, Q243fs, Q258fs, Q259fs, Q285fs, Q117fs, Q1276fs, Q1341fs, Q197fs, Q215fs, Q238fs, Q240fs, Q244fs, Q282fs, Q520fs	Hereditary cancer-predisposing syndrome	VCV004215112	17	41242982 - 41242983	17	43090965 - 43090966	4215112	4332024		NC_000017.11:43090965:TG:TGTG	Duplication	frameshift variant	Pathogenic	Aug 12, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4161_4164del (p.Gln1388fs)	BRCA1	Q1341fs, Q285fs, Q1388fs	Hereditary breast ovarian cancer syndrome	VCV000654657	17	41242982 - 41242985	17	43090965 - 43090968	654657	645960	rs1597858204	NC_000017.11:43090964:CTGA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4163dup (p.Ser1389fs)	BRCA1	S1389fs, S286fs, S1342fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125682	17	41242982 - 41242983	17	43090965 - 43090966	125682	131220	rs80357788	NC_000017.11:43090965:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4161_4162dup (p.Gln1388fs)	BRCA1	Q285fs, Q1341fs, Q1388fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000824643	17	41242983 - 41242984	17	43090966 - 43090967	824643	813702	rs80357565	NC_000017.11:43090966:GAGAG:GAGAGAG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Jul 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4162_4163del (p.Gln1388fs)	BRCA1	Q1388fs, Q285fs, Q1341fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266453	17	41242983 - 41242984	17	43090966 - 43090967	266453	261667	rs886040210	NC_000017.11:43090965:TG:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4162C>T (p.Gln1388Ter)	BRCA1	Q1388*, Q285*, Q1341*, Q1092*, Q1260*, Q1276*, Q1299*, Q1346*, Q1362*, Q1385*, Q1387*, Q157*, Q174*, Q176*, Q204*, Q214*, Q215*, Q237*, Q245*, Q246*, Q283*, Q284*, Q1317*, Q1318*, Q1347*, Q158*, Q217*, Q240*, Q259*, Q282*, Q117*, Q1261*, Q1300*, Q1320*, Q1321*, Q1361*, Q258*, Q1220*, Q1277*, Q1340*, Q173*, Q196*, Q197*, Q205*, Q218*, Q238*, Q243*, Q244*, Q520*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233727	17	41242984	17	43090967	233727	235981	rs876660601	NC_000017.11:43090966:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4161_4162del (p.Gln1388fs)	BRCA1	Q1341fs, Q1388fs, Q285fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055115	17	41242984 - 41242985	17	43090967 - 43090968	55115	69782	rs80357565	NC_000017.11:43090966:GAGAG:GAG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4158_4162del (p.Ser1387fs)	BRCA1	S284fs, S1387fs, S1340fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055113	17	41242984 - 41242988	17	43090967 - 43090971	55113	69780	rs397509142	NC_000017.11:43090966:GAGAGGA:GA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4146_4155dup (p.Ser1386fs)	BRCA1	S1339fs, S1386fs, S283fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266452	17	41242990 - 41242991	17	43090973 - 43090974	266452	261668	rs483353079	NC_000017.11:43090973:TAGCCCTGAG:TAGCCCTGAGTAGCCCTGAG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4152_4153del (p.Leu1385fs)	BRCA1	L1385fs, L1338fs, L282fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000584947	17	41242993 - 41242994	17	43090976 - 43090977	584947	575996	rs1567788338	NC_000017.11:43090975:GC:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4152del (p.Leu1385fs)	BRCA1	L1273fs, L1296fs, L1314fs, L1315fs, L1382fs, L1385fs, L155fs, L202fs, L212fs, L214fs, L241fs, L242fs, L281fs, L1217fs, L1317fs, L1337fs, L1343fs, L1358fs, L171fs, L201fs, L215fs, L243fs, L256fs, L279fs, L1257fs, L1274fs, L1344fs, L1359fs, L1384fs, L211fs, L234fs, L237fs, L280fs, L517fs, L1089fs, L114fs, L1258fs, L1297fs, L1318fs, L1338fs, L154fs, L170fs, L173fs, L193fs, L194fs, L235fs, L240fs, L255fs, L282fs	Hereditary cancer-predisposing syndrome	VCV003481824	17	41242994	17	43090977	3481824	3640035		NC_000017.11:43090976:CCC:CC	Deletion	frameshift variant	Pathogenic	Jul 10, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4148C>G (p.Ser1383Ter)	BRCA1	S1383*, S1336*, S280*, S1087*, S1356*, S1357*, S171*, S210*, S212*, S239*, S241*, S1215*, S1272*, S1312*, S1335*, S1382*, S152*, S169*, S191*, S200*, S213*, S233*, S254*, S277*, S515*, S1295*, S1316*, S168*, S199*, S209*, S232*, S235*, S238*, S240*, S278*, S1256*, S1294*, S112*, S1255*, S1271*, S1313*, S1315*, S1341*, S1342*, S1380*, S153*, S192*, S253*, S279*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037572	17	41242998	17	43090981	37572	46128	rs80357071	NC_000017.11:43090980:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4146C>A (p.Cys1382Ter)	BRCA1	C1382*, C279*, C1335*, C1271*, C1312*, C1340*, C1379*, C198*, C234*, C253*, C1270*, C1315*, C1334*, C167*, C168*, C190*, C209*, C231*, C252*, C1086*, C1293*, C1314*, C1341*, C1355*, C151*, C152*, C199*, C211*, C212*, C237*, C239*, C240*, C277*, C514*, C111*, C1214*, C1254*, C1255*, C1294*, C1311*, C1356*, C1381*, C170*, C191*, C208*, C232*, C238*, C276*, C278*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000371879	17	41243000	17	43090983	371879	358940	rs1057517574	NC_000017.11:43090982:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4139_4140del (p.Glu1380fs)	BRCA1	E277fs, E1333fs, E1380fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254453	17	41243006 - 41243007	17	43090989 - 43090990	254453	249090	rs886038032	NC_000017.11:43090988:TT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4138dup (p.Glu1380fs)	BRCA1	E1291fs, E1310fs, E1313fs, E1354fs, E1380fs, E149fs, E166fs, E189fs, E197fs, E207fs, E235fs, E1084fs, E109fs, E1253fs, E1268fs, E1312fs, E1353fs, E1377fs, E168fs, E250fs, E251fs, E277fs, E512fs, E1252fs, E1269fs, E1292fs, E1332fs, E1338fs, E165fs, E229fs, E230fs, E236fs, E237fs, E275fs, E1212fs, E1309fs, E1333fs, E1339fs, E1379fs, E150fs, E188fs, E196fs, E206fs, E209fs, E210fs, E232fs, E238fs, E274fs, E276fs	Hereditary cancer-predisposing syndrome	VCV002774840	17	41243007 - 41243008	17	43090990 - 43090991	2774840	2935567	rs2552093415	NC_000017.11:43090990:C:CC	Duplication	frameshift variant	Pathogenic	Oct 30, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4137_4138del (p.Glu1380fs)	BRCA1	E1333fs, E277fs, E1380fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266451	17	41243008 - 41243009	17	43090991 - 43090992	266451	261669	rs886040209	NC_000017.11:43090990:CA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4137del (p.Glu1380fs)	BRCA1	E1380fs, E277fs, E1333fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000419246	17	41243009	17	43090992	419246	409970	rs1064793746	NC_000017.11:43090991:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4136_4137del (p.Val1378_Ser1379insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055112	17	41243009 - 41243010	17	43090992 - 43090993	55112	69779	rs397509141	NC_000017.11:43090991:AGAGA:AGA	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4132del (p.Val1378fs)	BRCA1	V107fs, V1082fs, V1308fs, V1352fs, V227fs, V235fs, V236fs, V248fs, V1250fs, V1251fs, V1267fs, V1331fs, V1336fs, V1377fs, V1378fs, V164fs, V166fs, V186fs, V187fs, V205fs, V228fs, V274fs, V275fs, V1266fs, V1290fs, V1307fs, V1311fs, V1375fs, V230fs, V233fs, V234fs, V249fs, V273fs, V1210fs, V1289fs, V1310fs, V1330fs, V1337fs, V1351fs, V147fs, V148fs, V163fs, V194fs, V195fs, V204fs, V207fs, V208fs, V272fs, V510fs	Hereditary cancer-predisposing syndrome	VCV003261485	17	41243014	17	43090997	3261485	3424253		NC_000017.11:43090996:C:	Deletion	frameshift variant	Pathogenic	May 30, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4129del (p.Ser1377fs)	BRCA1	S1330fs, S1377fs, S274fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266450	17	41243017	17	43091000	266450	261671	rs886040208	NC_000017.11:43090999:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4126_4129del (p.Thr1376fs)	BRCA1	T1329fs, T273fs, T1376fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266448	17	41243017 - 41243020	17	43091000 - 43091003	266448	261670	rs886040206	NC_000017.11:43090999:TTGTTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4128_4129del (p.Ser1377fs)	BRCA1	S1330fs, S1377fs, S274fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125681	17	41243017 - 41243018	17	43091000 - 43091001	125681	131219	rs80357921	NC_000017.11:43090999:TT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4127del (p.Thr1376fs)	BRCA1	T273fs, T1376fs, T1329fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266449	17	41243019	17	43091002	266449	261672	rs886040207	NC_000017.11:43091001:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4123G>T (p.Glu1375Ter)	BRCA1	E1375*, E272*, E1328*, E191*, E204*, E205*, E227*, E246*, E271*, E1247*, E1327*, E1374*, E144*, E163*, E183*, E232*, E269*, E270*, E1248*, E1263*, E1287*, E1304*, E1334*, E145*, E160*, E104*, E1264*, E1333*, E1349*, E161*, E184*, E201*, E224*, E233*, E507*, E1079*, E1207*, E1286*, E1305*, E1307*, E1308*, E1348*, E1372*, E192*, E202*, E225*, E230*, E231*, E245*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055108	17	41243023	17	43091006	55108	69775	rs80357397	NC_000017.11:43091005:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4122_4123del (p.Ser1374fs)	BRCA1	S1327fs, S1374fs, S271fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055107	17	41243023 - 41243024	17	43091006 - 43091007	55107	69774	rs80357691	NC_000017.11:43091005:CAC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4120_4121del (p.Glu1373_Ser1374insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037570	17	41243025 - 41243026	17	43091008 - 43091009	37570	46126	rs80357787	NC_000017.11:43091007:CTCTC:CTC	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4119del (p.Ser1374fs)	BRCA1	S103fs, S1078fs, S1206fs, S1246fs, S1247fs, S1262fs, S1263fs, S1285fs, S1286fs, S1303fs, S1304fs, S1306fs, S1307fs, S1326fs, S1327fs, S1332fs, S1333fs, S1347fs, S1348fs, S1371fs, S1373fs, S1374fs, S143fs, S144fs, S159fs, S160fs, S162fs, S182fs, S183fs, S190fs, S191fs, S200fs, S201fs, S203fs, S204fs, S223fs, S224fs, S226fs, S229fs, S230fs, S231fs, S232fs, S244fs, S245fs, S268fs, S269fs, S270fs, S271fs, S506fs	Hereditary cancer-predisposing syndrome	VCV003226151	17	41243027	17	43091010	3226151	3387215	rs2552094742	NC_000017.11:43091009:C:	Deletion	frameshift variant	Pathogenic	Jan 22, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4117_4118insTT (p.Glu1373fs)	BRCA1	E1326fs, E1373fs, E270fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548190	17	41243028 - 41243029	17	43091011 - 43091012	548190	538797	rs1555586212	NC_000017.11:43091011::AA	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4116dup (p.Glu1373Ter)	BRCA1	E1326*, E1373*, E270*	Hereditary breast ovarian cancer syndrome	VCV002102633	17	41243029 - 41243030	17	43091012 - 43091013	2102633	2151352	rs398122682	NC_000017.11:43091012:A:AA	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Feb 23, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4116_4117insTT (p.Glu1373fs)	BRCA1	E1373fs, E270fs, E1326fs	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000091624	17	41243029 - 41243030	17	43091012 - 43091013	91624	97101	rs398122682	NC_000017.11:43091012:A:AAA	Insertion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4117G>T (p.Glu1373Ter)	BRCA1	E1373*, E270*, E1326*, E102*, E1077*, E1261*, E1303*, E1332*, E161*, E181*, E202*, E230*, E267*, E269*, E1246*, E1285*, E1331*, E158*, E199*, E229*, E243*, E505*, E1245*, E1284*, E1302*, E1306*, E1347*, E1370*, E1372*, E143*, E159*, E182*, E190*, E200*, E203*, E223*, E228*, E231*, E244*, E1205*, E1262*, E1305*, E1325*, E1346*, E142*, E189*, E222*, E225*, E268*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037569	17	41243029	17	43091012	37569	46125	rs80357259	NC_000017.11:43091011:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4116_4117del (p.Cys1372_Glu1373delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037568	17	41243029 - 41243030	17	43091012 - 43091013	37568	46124	rs80357804	NC_000017.11:43091011:CACAC:CAC	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4116del (p.Cys1372fs)	BRCA1	C1325fs, C269fs, C1372fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266446	17	41243030	17	43091013	266446	261673	rs886040204	NC_000017.11:43091012:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4116T>A (p.Cys1372Ter)	BRCA1	C1372*, C269*, C1325*, C1302*, C141*, C142*, C160*, C199*, C202*, C224*, C229*, C230*, C1244*, C1245*, C1260*, C1261*, C1283*, C1284*, C1301*, C1305*, C1324*, C1371*, C180*, C201*, C222*, C1330*, C1345*, C1346*, C1369*, C157*, C181*, C188*, C189*, C198*, C228*, C242*, C101*, C1076*, C1204*, C1304*, C1331*, C158*, C221*, C227*, C243*, C266*, C267*, C268*, C504*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055106	17	41243030	17	43091013	55106	69773	rs397509140	NC_000017.11:43091012:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4112_4113insATCT (p.Cys1372fs)	BRCA1	C1325fs, C1372fs, C269fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548282	17	41243033 - 41243034	17	43091016 - 43091017	548282	538798	rs1555586240	NC_000017.11:43091016::AGAT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4113del (p.Cys1372fs)	BRCA1	C1372fs, C269fs, C1325fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125680	17	41243033	17	43091016	125680	131218	rs80357861	NC_000017.11:43091015:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4111_4112insATCT (p.Gly1371fs)	BRCA1	G268fs, G1324fs, G1371fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125679	17	41243034 - 41243035	17	43091017 - 43091018	125679	131217	rs80357935	NC_000017.11:43091017::AGAT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4110_4111del (p.Gly1371fs)	BRCA1	G268fs, G1324fs, G1371fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125678	17	41243035 - 41243036	17	43091018 - 43091019	125678	131216	rs80357529	NC_000017.11:43091017:CA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4107_4110dup (p.Gly1371fs)	BRCA1	G1371fs, G268fs, G1324fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055104	17	41243035 - 41243036	17	43091018 - 43091019	55104	69771	rs397509139	NC_000017.11:43091018:AGAT:AGATAGAT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4108_4109insATCT (p.Ser1370fs)	BRCA1	S1323fs, S1370fs, S267fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548184	17	41243037 - 41243038	17	43091020 - 43091021	548184	538799	rs1555586260	NC_000017.11:43091020:A:AGATA	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4107_4108insATCT (p.Ser1370fs)	BRCA1	S267fs, S1323fs, S1370fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266444	17	41243038 - 41243039	17	43091021 - 43091022	266444	261674	rs886040202	NC_000017.11:43091021::AGAT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4099G>T (p.Glu1367Ter)	BRCA1	E1367*, E264*, E1320*, E1071*, E1255*, E1296*, E1297*, E1366*, E152*, E194*, E196*, E219*, E237*, E499*, E1199*, E1240*, E1256*, E1299*, E1319*, E1326*, E1341*, E136*, E137*, E155*, E193*, E197*, E216*, E217*, E225*, E96*, E1239*, E1278*, E1279*, E1300*, E1325*, E153*, E175*, E176*, E224*, E238*, E261*, E1340*, E1364*, E183*, E184*, E222*, E223*, E263*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186497	17	41243047	17	43091030	186497	184938	rs786202998	NC_000017.11:43091029:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NG_005905.2:g.(?_92501)_(126550_126951)del	LOC111589215|LOC111589216|LOC126862571|BRCA1|LOC110485084		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373885	17	41243050 - 41277500	17	43091033 - 43125483	373885	360761			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(122139_123344)_(126550_126951)dup	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373881	17	41243050 - 41247862	17	43091033 - 43095845	373881	360760			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4097-1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037567	17	41243050	17	43091033	37567	46123	rs80358070	NC_000017.11:43091032:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4097-2A>C	BRCA1		not provided	VCV000182158	17	41243051	17	43091034	182158	180836	rs80358019	NC_000017.11:43091033:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Apr 11, 2014	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4097-2A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055103	17	41243051	17	43091034	55103	69770	rs80358019	NC_000017.11:43091033:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4093_4094del (p.Leu1365fs)	BRCA1|LOC126862571	L1365fs, L1318fs, L1069fs, L1276fs, L1295fs, L497fs, L1237fs, L1254fs, L1277fs, L1297fs, L1324fs, L1338fs, L1339fs, L1362fs, L1238fs, L1253fs, L1294fs, L1364fs, L1197fs, L1298fs, L1317fs, L1323fs	Hereditary breast ovarian cancer syndrome	VCV002120181	17	41243454 - 41243455	17	43091437 - 43091438	2120181	2176677	rs2552106061	NC_000017.11:43091436:AA:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4094T>G (p.Leu1365Ter)	BRCA1|LOC126862571	L1365*, L1318*, L1197*, L1253*, L1294*, L1295*, L1338*, L1254*, L1277*, L1297*, L1317*, L1237*, L1238*, L1276*, L1298*, L1324*, L1339*, L1364*, L1069*, L1323*, L1362*, L497*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091623	17	41243454	17	43091437	91623	97100	rs398122681	NC_000017.11:43091436:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4094del (p.Asn1364_Leu1365insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055102	17	41243454	17	43091437	55102	69769	rs397509138	NC_000017.11:43091436:AA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4092_4093del (p.Leu1365fs)	BRCA1|LOC126862571	L1318fs, L1365fs, L1237fs, L1253fs, L1276fs, L1298fs, L1323fs, L1339fs, L1362fs, L497fs, L1197fs, L1294fs, L1364fs, L1069fs, L1238fs, L1254fs, L1277fs, L1295fs, L1297fs, L1317fs, L1324fs, L1338fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055101	17	41243455 - 41243456	17	43091438 - 43091439	55101	69768	rs397509137	NC_000017.11:43091437:AG:	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4074_4090del (p.Gln1359fs)	BRCA1|LOC126862571	Q1312fs, Q1359fs, Q1289fs, Q1333fs, Q1063fs, Q1231fs, Q1270fs, Q1271fs, Q1291fs, Q1356fs, Q1191fs, Q1248fs, Q1292fs, Q1311fs, Q1317fs, Q1332fs, Q1358fs, Q1232fs, Q1247fs, Q1288fs, Q1318fs, Q491fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266440	17	41243458 - 41243474	17	43091441 - 43091457	266440	261675	rs886040198	NC_000017.11:43091440:TTGAATCCATGCTTTGCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4086_4088delinsATA (p.Asp1362_Ser1363delinsGluTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003148649	17	41243460 - 41243462	17	43091443 - 43091445	3148649	3307897	rs2552106549	NC_000017.11:43091442:GAA:TAT	Indel	nonsense|intron variant	Pathogenic	Dec 13, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4088C>A (p.Ser1363Ter)	BRCA1|LOC126862571	S1363*, S1316*, S1067*, S1251*, S1293*, S1321*, S495*, S1236*, S1252*, S1274*, S1275*, S1322*, S1360*, S1235*, S1295*, S1315*, S1362*, S1195*, S1292*, S1296*, S1336*, S1337*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441374	17	41243460	17	43091443	441374	435124	rs398122680	NC_000017.11:43091442:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4088C>G (p.Ser1363Ter)	BRCA1|LOC126862571	S1363*, S1316*, S1252*, S1292*, S1322*, S1362*, S1195*, S1235*, S1251*, S1275*, S1293*, S1315*, S1337*, S1067*, S1295*, S1296*, S1336*, S495*, S1236*, S1274*, S1321*, S1360*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254452	17	41243460	17	43091443	254452	249091	rs398122680	NC_000017.11:43091442:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4075_4085dup (p.Ser1363fs)	BRCA1|LOC126862571	S1316fs, S1363fs, S1235fs, S1337fs, S1362fs, S495fs, S1251fs, S1292fs, S1295fs, S1296fs, S1315fs, S1321fs, S1322fs, S1067fs, S1252fs, S1274fs, S1293fs, S1195fs, S1236fs, S1275fs, S1336fs, S1360fs	Hereditary cancer-predisposing syndrome	VCV001737576	17	41243462 - 41243463	17	43091445 - 43091446	1737576	1787440	rs2552106937	NC_000017.11:43091445:TCCATGCTTTG:TCCATGCTTTGTCCATGCTTTG	Duplication	frameshift variant|intron variant	Pathogenic	Mar 26, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4085dup (p.Asp1362fs)	LOC126862571|BRCA1	D1362fs, D1315fs, D1066fs, D1235fs, D1251fs, D1274fs, D1320fs, D1194fs, D1234fs, D1291fs, D1294fs, D1359fs, D1250fs, D1273fs, D1292fs, D1314fs, D1336fs, D1361fs, D1295fs, D1321fs, D1335fs, D494fs	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Familial pancreatic carcinoma	VCV000915632	17	41243462 - 41243463	17	43091445 - 43091446	915632	904018	rs2053470202	NC_000017.11:43091445:T:TT	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Jan 15, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4085del (p.Asp1362fs)	BRCA1|LOC126862571	D1315fs, D1362fs, D1066fs, D1194fs, D1291fs, D1295fs, D1361fs, D1250fs, D1314fs, D1320fs, D1335fs, D1234fs, D1273fs, D1274fs, D1292fs, D1321fs, D1336fs, D1235fs, D1251fs, D1294fs, D1359fs, D494fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055100	17	41243463	17	43091446	55100	69767	rs80357737	NC_000017.11:43091445:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4079del (p.Ser1360fs)	BRCA1|LOC126862571	S1360fs, S1313fs, S1064fs, S1192fs, S1289fs, S1312fs, S1319fs, S1334fs, S1249fs, S1271fs, S1290fs, S1318fs, S1333fs, S1357fs, S1359fs, S492fs, S1248fs, S1293fs, S1232fs, S1233fs, S1272fs, S1292fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266441	17	41243469	17	43091452	266441	261676	rs886040199	NC_000017.11:43091451:C:	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4075del (p.Gln1359fs)	BRCA1|LOC126862571	Q1312fs, Q1359fs, Q1288fs, Q1311fs, Q1356fs, Q1063fs, Q1191fs, Q1231fs, Q1270fs, Q1271fs, Q1292fs, Q1318fs, Q1358fs, Q1232fs, Q1247fs, Q1317fs, Q1332fs, Q1248fs, Q1289fs, Q1291fs, Q1333fs, Q491fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002014269	17	41243473	17	43091456	2014269	2064482	rs2536299835	NC_000017.11:43091455:G:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4074dup (p.Gln1359fs)	BRCA1|LOC126862571	Q1312fs, Q1359fs, Q1063fs, Q1191fs, Q1232fs, Q1270fs, Q1289fs, Q1292fs, Q1317fs, Q1358fs, Q491fs, Q1248fs, Q1311fs, Q1318fs, Q1231fs, Q1288fs, Q1356fs, Q1247fs, Q1271fs, Q1291fs, Q1332fs, Q1333fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000862120	17	41243473 - 41243474	17	43091456 - 43091457	862120	845389	rs2053472498	NC_000017.11:43091456:C:CC	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Aug 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4075C>T (p.Gln1359Ter)	LOC126862571|BRCA1	Q1359*, Q1312*, Q1191*, Q1247*, Q1270*, Q1332*, Q1333*, Q1063*, Q1289*, Q1291*, Q1317*, Q1232*, Q1271*, Q1292*, Q1311*, Q1356*, Q491*, Q1231*, Q1248*, Q1288*, Q1318*, Q1358*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055098	17	41243473	17	43091456	55098	69765	rs80357456	NC_000017.11:43091455:G:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4072G>T (p.Glu1358Ter)	BRCA1|LOC126862571	E1358*, E1311*, E1310*, E1190*, E1230*, E1246*, E1288*, E1290*, E1291*, E490*, E1062*, E1247*, E1269*, E1270*, E1332*, E1357*, E1231*, E1287*, E1316*, E1317*, E1331*, E1355*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096924	17	41243476	17	43091459	96924	102827	rs397509136	NC_000017.11:43091458:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4067_4071del (p.Gln1356fs)	BRCA1|LOC126862571	Q1356fs, Q1309fs, Q1188fs, Q1267fs, Q1268fs, Q1285fs, Q1286fs, Q1315fs, Q1329fs, Q1228fs, Q1314fs, Q1330fs, Q1060fs, Q1229fs, Q1244fs, Q1289fs, Q1355fs, Q1245fs, Q1288fs, Q1308fs, Q1353fs, Q488fs	Hereditary breast ovarian cancer syndrome	VCV001385826	17	41243477 - 41243481	17	43091460 - 43091464	1385826	1460974	rs2154266021	NC_000017.11:43091459:TTCTT:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 14, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4070_4071insTTGA (p.Glu1357delinsAspTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548293	17	41243477 - 41243478	17	43091460 - 43091461	548293	538800	rs1555586517	NC_000017.11:43091460:TC:TCAATC	Insertion	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4071del (p.Glu1358fs)	LOC126862571|BRCA1	E1311fs, E1358fs, E1062fs, E1247fs, E1310fs, E1230fs, E1270fs, E1316fs, E1332fs, E1357fs, E1190fs, E1246fs, E1269fs, E1290fs, E1355fs, E1231fs, E1287fs, E1288fs, E1291fs, E1317fs, E1331fs, E490fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266439	17	41243477	17	43091460	266439	261677	rs886040197	NC_000017.11:43091459:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4069_4070insTTGA (p.Glu1357fs)	BRCA1|LOC126862571	E1310fs, E1357fs, E1246fs, E1268fs, E1309fs, E1331fs, E1061fs, E1230fs, E1269fs, E1316fs, E1229fs, E1287fs, E1315fs, E1330fs, E1189fs, E1245fs, E1286fs, E1289fs, E1290fs, E1354fs, E1356fs, E489fs	Breast neoplasm	VCV000224422	17	41243478 - 41243479	17	43091461 - 43091462	224422	226199	rs886037788	NC_000017.11:43091461::TCAA	Insertion	frameshift variant|intron variant	Pathogenic	Nov 1, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4068_4069delinsT (p.Gln1356fs)	BRCA1|LOC126862571	Q1309fs, Q1356fs, Q1060fs, Q1329fs, Q1355fs, Q1229fs, Q1268fs, Q1285fs, Q1315fs, Q1353fs, Q1245fs, Q1286fs, Q1288fs, Q1314fs, Q488fs, Q1188fs, Q1228fs, Q1244fs, Q1267fs, Q1289fs, Q1308fs, Q1330fs	Hereditary breast ovarian cancer syndrome	VCV000970661	17	41243479 - 41243480	17	43091462 - 43091463	970661	958120	rs2053473970	NC_000017.11:43091461:CT:A	Indel	frameshift variant|intron variant	Pathogenic	Sep 23, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4069G>T (p.Glu1357Ter)	BRCA1|LOC126862571	E1357*, E1310*, E1230*, E1269*, E1289*, E1309*, E1229*, E1246*, E1268*, E1290*, E1061*, E1245*, E1286*, E1287*, E1315*, E1316*, E1330*, E1331*, E1189*, E1354*, E1356*, E489*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266437	17	41243479	17	43091462	266437	261678	rs886040195	NC_000017.11:43091461:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4066_4069del (p.Gln1356fs)	BRCA1|LOC126862571	Q1309fs, Q1356fs, Q1188fs, Q1244fs, Q1268fs, Q1353fs, Q488fs, Q1229fs, Q1245fs, Q1267fs, Q1288fs, Q1060fs, Q1308fs, Q1315fs, Q1228fs, Q1285fs, Q1286fs, Q1289fs, Q1314fs, Q1329fs, Q1330fs, Q1355fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055094	17	41243479 - 41243482	17	43091462 - 43091465	55094	69761	rs397509135	NC_000017.11:43091461:CTTG:	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4062_4068del (p.Asn1354fs)	BRCA1|LOC126862571	N1307fs, N1354fs, N1227fs, N1242fs, N1266fs, N1284fs, N1286fs, N1312fs, N1327fs, N486fs, N1186fs, N1226fs, N1351fs, N1243fs, N1265fs, N1283fs, N1353fs, N1058fs, N1287fs, N1306fs, N1313fs, N1328fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055092	17	41243480 - 41243486	17	43091463 - 43091469	55092	69759	rs397509134	NC_000017.11:43091462:TTGATTATT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4065_4068del (p.Asn1355fs)	BRCA1|LOC126862571	N1355fs, N1308fs, N1059fs, N1227fs, N1284fs, N1288fs, N1307fs, N1314fs, N1187fs, N1243fs, N1267fs, N1313fs, N1244fs, N1285fs, N1287fs, N1328fs, N1329fs, N1352fs, N487fs, N1228fs, N1266fs, N1354fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017674	17	41243480 - 41243483	17	43091463 - 43091466	17674	32713	rs80357508	NC_000017.11:43091462:TTGATT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4064_4066delinsT (p.Asn1355fs)	BRCA1|LOC126862571	N1308fs, N1355fs, N1228fs, N1244fs, N1288fs, N1352fs, N1059fs, N1267fs, N1287fs, N1313fs, N1187fs, N1227fs, N1243fs, N1285fs, N1307fs, N1329fs, N1354fs, N1266fs, N1284fs, N1314fs, N1328fs, N487fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409338	17	41243482 - 41243484	17	43091465 - 43091467	409338	402053	rs1060502345	NC_000017.11:43091464:GAT:A	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4066del (p.Gln1356fs)	BRCA1|LOC126862571	Q1356fs, Q1309fs, Q1188fs, Q1228fs, Q1245fs, Q1315fs, Q1268fs, Q1285fs, Q1289fs, Q1308fs, Q1353fs, Q488fs, Q1288fs, Q1314fs, Q1330fs, Q1060fs, Q1229fs, Q1244fs, Q1267fs, Q1286fs, Q1329fs, Q1355fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266436	17	41243482	17	43091465	266436	261681	rs886040194	NC_000017.11:43091464:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4066C>T (p.Gln1356Ter)	BRCA1|LOC126862571	Q1356*, Q1309*, Q1285*, Q1329*, Q1188*, Q1228*, Q1244*, Q1245*, Q1267*, Q1289*, Q1308*, Q1315*, Q488*, Q1229*, Q1268*, Q1314*, Q1330*, Q1060*, Q1286*, Q1288*, Q1353*, Q1355*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266435	17	41243482	17	43091465	266435	261679	rs886040193	NC_000017.11:43091464:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4062_4066del (p.Asn1354fs)	BRCA1|LOC126862571	N1354fs, N1307fs, N1243fs, N1266fs, N1327fs, N1353fs, N486fs, N1186fs, N1242fs, N1283fs, N1312fs, N1328fs, N1058fs, N1227fs, N1284fs, N1306fs, N1226fs, N1265fs, N1286fs, N1287fs, N1313fs, N1351fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266434	17	41243482 - 41243486	17	43091465 - 43091469	266434	261680	rs886040192	NC_000017.11:43091464:GATTA:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4064dup (p.Asn1355fs)	BRCA1|LOC126862571	N1308fs, N1355fs, N1228fs, N1243fs, N1244fs, N1284fs, N1329fs, N1354fs, N487fs, N1187fs, N1266fs, N1267fs, N1288fs, N1227fs, N1307fs, N1314fs, N1352fs, N1059fs, N1285fs, N1287fs, N1313fs, N1328fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000975865	17	41243483 - 41243484	17	43091466 - 43091467	975865	964481	rs2053475644	NC_000017.11:43091466:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Jan 9, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4062_4065del (p.Asn1355fs)	BRCA1|LOC126862571	N1308fs, N1355fs, N1059fs, N1227fs, N1228fs, N1285fs, N1287fs, N1313fs, N1352fs, N1243fs, N1266fs, N1284fs, N1328fs, N487fs, N1187fs, N1307fs, N1314fs, N1329fs, N1354fs, N1244fs, N1267fs, N1288fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091621	17	41243483 - 41243486	17	43091466 - 43091469	91621	97098	rs398122679	NC_000017.11:43091465:ATTA:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4061_4064del (p.Asn1354fs)	BRCA1|LOC126862571	N1307fs, N1354fs, N1186fs, N1226fs, N1313fs, N1353fs, N1242fs, N1265fs, N1328fs, N1351fs, N1058fs, N1227fs, N1243fs, N1266fs, N1284fs, N1312fs, N1327fs, N486fs, N1283fs, N1286fs, N1287fs, N1306fs	Hereditary cancer-predisposing syndrome	VCV000824552	17	41243484 - 41243487	17	43091467 - 43091470	824552	813707	rs1597859595	NC_000017.11:43091466:TTATTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 26, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4061dup (p.Asn1354fs)	BRCA1|LOC126862571	N1186fs, N1242fs, N1243fs, N1286fs, N1312fs, N1313fs, N1354fs, N1227fs, N1265fs, N1284fs, N1287fs, N1306fs, N486fs, N1058fs, N1283fs, N1327fs, N1328fs, N1351fs, N1226fs, N1266fs, N1307fs, N1353fs	Hereditary cancer-predisposing syndrome	VCV003481866	17	41243486 - 41243487	17	43091469 - 43091470	3481866	3640077		NC_000017.11:43091469:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 15, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4057_4061del (p.Glu1352_Glu1353insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055091	17	41243487 - 41243491	17	43091470 - 43091474	55091	69758	rs397509133	NC_000017.11:43091469:TTTTCTT:TT	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4057G>T (p.Glu1353Ter)	BRCA1|LOC126862571	E1353*, E1306*, E1185*, E1241*, E1283*, E1285*, E1286*, E1326*, E1225*, E1226*, E1242*, E1265*, E1327*, E485*, E1305*, E1311*, E1312*, E1352*, E1057*, E1264*, E1282*, E1350*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055090	17	41243491	17	43091474	55090	69757	rs80357178	NC_000017.11:43091473:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4054del (p.Glu1352fs)	BRCA1|LOC126862571	E1305fs, E1352fs, E1184fs, E1310fs, E1326fs, E1056fs, E1224fs, E1284fs, E1304fs, E1311fs, E1349fs, E1351fs, E484fs, E1225fs, E1241fs, E1281fs, E1282fs, E1325fs, E1240fs, E1263fs, E1264fs, E1285fs	Hereditary cancer-predisposing syndrome	VCV001737403	17	41243494	17	43091477	1737403	1790602	rs2552108651	NC_000017.11:43091476:CC:C	Deletion	intron variant|frameshift variant	Pathogenic	Dec 18, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4054G>T (p.Glu1352Ter)	LOC126862571|BRCA1	E1352*, E1305*, E1241*, E1285*, E1304*, E1311*, E1351*, E1224*, E1225*, E1263*, E1284*, E1325*, E1184*, E1240*, E1264*, E1281*, E1282*, E1326*, E1349*, E1056*, E1310*, E484*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091620	17	41243494	17	43091477	91620	97097	rs80357202	NC_000017.11:43091476:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4052_4053insA (p.Glu1352fs)	LOC126862571|BRCA1	E1225fs, E1240fs, E1264fs, E1282fs, E1285fs, E1326fs, E1351fs, E1224fs, E1305fs, E1310fs, E1349fs, E1056fs, E1284fs, E1304fs, E1311fs, E1184fs, E1241fs, E1263fs, E1281fs, E1325fs, E1352fs, E484fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002565350	17	41243495 - 41243496	17	43091478 - 43091479	2565350	2732323	rs2552108732	NC_000017.11:43091478::T	Insertion	frameshift variant|intron variant	Pathogenic	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4052dup (p.Leu1351fs)	BRCA1|LOC126862571	L1351fs, L1304fs, L1223fs, L1239fs, L1240fs, L1283fs, L1284fs, L1310fs, L1325fs, L1183fs, L1281fs, L1224fs, L1262fs, L1263fs, L1324fs, L1350fs, L483fs, L1055fs, L1280fs, L1303fs, L1309fs, L1348fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055088	17	41243495 - 41243496	17	43091478 - 43091479	55088	69755	rs80357779	NC_000017.11:43091478:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4051_4052insG (p.Leu1351fs)	BRCA1|LOC126862571	L1351fs, L1304fs, L1183fs, L1263fs, L1280fs, L1309fs, L1310fs, L1325fs, L1348fs, L1262fs, L1283fs, L1303fs, L483fs, L1224fs, L1239fs, L1240fs, L1281fs, L1055fs, L1223fs, L1284fs, L1324fs, L1350fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548195	17	41243496 - 41243497	17	43091479 - 43091480	548195	538801	rs1555586564	NC_000017.11:43091479::C	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4052T>A (p.Leu1351Ter)	BRCA1|LOC126862571	L1351*, L1304*, L1240*, L1280*, L1283*, L1309*, L1310*, L1055*, L1239*, L1263*, L1284*, L1325*, L1348*, L1223*, L1224*, L1281*, L1350*, L483*, L1183*, L1262*, L1303*, L1324*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055087	17	41243496	17	43091479	55087	69754	rs397509132	NC_000017.11:43091478:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4050_4051insG (p.Leu1351fs)	LOC126862571|BRCA1	L1304fs, L1351fs, L1223fs, L1239fs, L1262fs, L1263fs, L1280fs, L1309fs, L1224fs, L1281fs, L1284fs, L1324fs, L1350fs, L483fs, L1055fs, L1183fs, L1283fs, L1303fs, L1310fs, L1325fs, L1240fs, L1348fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125661	17	41243497 - 41243498	17	43091480 - 43091481	125661	131199	rs483353092	NC_000017.11:43091480::C	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4049_4050insGAACGGA (p.Leu1351fs)	BRCA1|LOC126862571	L1055fs, L1183fs, L1223fs, L1224fs, L1239fs, L1240fs, L1262fs, L1263fs, L1280fs, L1281fs, L1283fs, L1284fs, L1303fs, L1304fs, L1309fs, L1310fs, L1324fs, L1325fs, L1348fs, L1350fs, L1351fs, L483fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773521	17	41243498 - 41243499	17	43091481 - 43091482	3773521	3889671		NC_000017.11:43091481::TCCGTTC	Insertion	frameshift variant|intron variant	Pathogenic	Nov 12, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4049dup (p.Glu1352fs)	BRCA1|LOC126862571	E1352fs, E1305fs, E1263fs, E1264fs, E1304fs, E484fs, E1224fs, E1225fs, E1241fs, E1284fs, E1285fs, E1311fs, E1325fs, E1281fs, E1282fs, E1326fs, E1056fs, E1184fs, E1240fs, E1310fs, E1349fs, E1351fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055086	17	41243498 - 41243499	17	43091481 - 43091482	55086	69753	rs397509131	NC_000017.11:43091481:CCC:CCCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4045_4046insTA (p.Thr1349fs)	BRCA1|LOC126862571	T1349fs, T1302fs, T1053fs, T1278fs, T1282fs, T1322fs, T1221fs, T1222fs, T1237fs, T1238fs, T1279fs, T1301fs, T1307fs, T1261fs, T1308fs, T1181fs, T1260fs, T1281fs, T1323fs, T1346fs, T1348fs, T481fs	Hereditary breast ovarian cancer syndrome	VCV000662073	17	41243502 - 41243503	17	43091485 - 43091486	662073	645964	rs1597859750	NC_000017.11:43091485:T:TAT	Insertion	frameshift variant|intron variant	Pathogenic	Jul 10, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4043del (p.Gly1348fs)	BRCA1|LOC126862571	G1348fs, G1301fs, G1180fs, G1259fs, G1281fs, G1300fs, G1347fs, G1052fs, G1236fs, G1278fs, G1306fs, G1345fs, G1220fs, G1221fs, G1277fs, G1322fs, G1237fs, G1260fs, G1280fs, G1307fs, G1321fs, G480fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055083	17	41243505	17	43091488	55083	69750	rs397509130	NC_000017.11:43091487:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4042G>T (p.Gly1348Ter)	BRCA1|LOC126862571	G1348*, G1301*, G1221*, G1237*, G1277*, G1300*, G1307*, G1321*, G1345*, G480*, G1259*, G1260*, G1220*, G1236*, G1280*, G1306*, G1347*, G1052*, G1180*, G1278*, G1281*, G1322*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266433	17	41243506	17	43091489	266433	261682	rs886040191	NC_000017.11:43091488:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4041_4042del (p.Gly1348fs)	BRCA1|LOC126862571	G1348fs, G1301fs, G1052fs, G1180fs, G1220fs, G1221fs, G1280fs, G1307fs, G1322fs, G480fs, G1259fs, G1278fs, G1306fs, G1321fs, G1236fs, G1277fs, G1300fs, G1345fs, G1237fs, G1260fs, G1281fs, G1347fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055082	17	41243506 - 41243507	17	43091489 - 43091490	55082	69749	rs80357727	NC_000017.11:43091488:CTCT:CT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4038_4041del (p.Arg1347fs)	BRCA1|LOC126862571	R1347fs, R1300fs, R1051fs, R1179fs, R1219fs, R1259fs, R1279fs, R1321fs, R1344fs, R1235fs, R1276fs, R1277fs, R1299fs, R1320fs, R1258fs, R1305fs, R479fs, R1220fs, R1236fs, R1280fs, R1306fs, R1346fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096923	17	41243507 - 41243510	17	43091490 - 43091493	96923	102826	rs431825404	NC_000017.11:43091489:TCTTTCTT:TCTT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4039dup (p.Arg1347fs)	BRCA1|LOC126862571	R1300fs, R1347fs, R1220fs, R1235fs, R479fs, R1051fs, R1259fs, R1277fs, R1305fs, R1321fs, R1179fs, R1258fs, R1276fs, R1279fs, R1280fs, R1299fs, R1306fs, R1219fs, R1236fs, R1320fs, R1344fs, R1346fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266432	17	41243508 - 41243509	17	43091491 - 43091492	266432	261683	rs273900721	NC_000017.11:43091491:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4039A>T (p.Arg1347Ter)	BRCA1|LOC126862571	R1347*, R1300*, R1235*, R1236*, R1279*, R1280*, R1320*, R1321*, R1179*, R1220*, R1277*, R1344*, R1346*, R1219*, R1299*, R1305*, R1306*, R1051*, R1258*, R1259*, R1276*, R479*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000531295	17	41243509	17	43091492	531295	531245	rs28897689	NC_000017.11:43091491:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4038_4039del (p.Gly1348fs)	BRCA1|LOC126862571	G1348fs, G1301fs, G1306fs, G1345fs, G1220fs, G1221fs, G1236fs, G1278fs, G1281fs, G480fs, G1052fs, G1237fs, G1277fs, G1280fs, G1300fs, G1322fs, G1180fs, G1259fs, G1260fs, G1307fs, G1321fs, G1347fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254451	17	41243509 - 41243510	17	43091492 - 43091493	254451	249092	rs273900721	NC_000017.11:43091491:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4036G>T (p.Glu1346Ter)	BRCA1|LOC126862571	E1050*, E1219*, E1234*, E1258*, E1298*, E1299*, E1304*, E1305*, E1345*, E478*, E1178*, E1257*, E1275*, E1279*, E1343*, E1276*, E1278*, E1319*, E1320*, E1218*, E1235*, E1346*	Hereditary cancer-predisposing syndrome	VCV002774841	17	41243512	17	43091495	2774841	2935568	rs80357407	NC_000017.11:43091494:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4036del (p.Glu1346fs)	BRCA1|LOC126862571	E1299fs, E1346fs, E1235fs, E1257fs, E1298fs, E1305fs, E1319fs, E1343fs, E1050fs, E1218fs, E1279fs, E1320fs, E1345fs, E478fs, E1178fs, E1258fs, E1219fs, E1234fs, E1275fs, E1276fs, E1278fs, E1304fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266431	17	41243512	17	43091495	266431	261684	rs886040189	NC_000017.11:43091494:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4035del (p.Glu1346fs)	BRCA1|LOC126862571	E1299fs, E1346fs, E1219fs, E1234fs, E1276fs, E1278fs, E1298fs, E1319fs, E478fs, E1178fs, E1258fs, E1275fs, E1304fs, E1320fs, E1343fs, E1050fs, E1218fs, E1235fs, E1257fs, E1279fs, E1305fs, E1345fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037560	17	41243513	17	43091496	37560	46116	rs80357711	NC_000017.11:43091495:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4033G>T (p.Glu1345Ter)	LOC126862571|BRCA1	E1345*, E1298*, E1217*, E1274*, E1275*, E1278*, E1297*, E1344*, E1257*, E1304*, E1049*, E1218*, E1233*, E1234*, E1256*, E1277*, E1319*, E1342*, E477*, E1177*, E1303*, E1318*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266430	17	41243515	17	43091498	266430	261685	rs886040188	NC_000017.11:43091497:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4022delinsGGACC (p.Val1341fs)	BRCA1|LOC126862571	V1294fs, V1341fs, V1173fs, V1213fs, V1214fs, V1270fs, V1338fs, V1340fs, V1230fs, V1299fs, V1300fs, V1252fs, V1271fs, V1273fs, V1274fs, V1293fs, V1315fs, V1045fs, V1229fs, V1253fs, V1314fs, V473fs	Hereditary cancer-predisposing syndrome	VCV000923630	17	41243526	17	43091509	923630	913882	rs2053483189	NC_000017.11:43091508:A:GGTCC	Indel	frameshift variant|intron variant	Pathogenic	Mar 12, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4018_4019dup (p.Leu1340fs)	BRCA1|LOC126862571	L1293fs, L1340fs, L1229fs, L1252fs, L1270fs, L1339fs, L1044fs, L1228fs, L1251fs, L1273fs, L1292fs, L1298fs, L1299fs, L1313fs, L1337fs, L472fs, L1172fs, L1212fs, L1213fs, L1272fs, L1269fs, L1314fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548162	17	41243528 - 41243529	17	43091511 - 43091512	548162	538802	rs1555586639	NC_000017.11:43091511:AA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4019T>A (p.Leu1340Ter)	BRCA1|LOC126862571	L1293*, L1340*, L1213*, L1228*, L1251*, L1273*, L472*, L1212*, L1252*, L1269*, L1298*, L1337*, L1270*, L1272*, L1292*, L1299*, L1313*, L1339*, L1044*, L1172*, L1229*, L1314*	not provided|Hereditary cancer-predisposing syndrome	VCV000993165	17	41243529	17	43091512	993165	981164	rs2053483708	NC_000017.11:43091511:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic/Likely pathogenic	Jan 8, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4016_4017insTT (p.Glu1339fs)	BRCA1|LOC126862571	E1339fs, E1292fs, E1228fs, E1251fs, E1313fs, E1336fs, E1043fs, E1211fs, E1269fs, E1271fs, E1272fs, E1298fs, E1312fs, E1338fs, E471fs, E1268fs, E1291fs, E1171fs, E1212fs, E1227fs, E1250fs, E1297fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266429	17	41243531 - 41243532	17	43091514 - 43091515	266429	261686	rs886040187	NC_000017.11:43091514::AA	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4015dup (p.Glu1339fs)	BRCA1|LOC126862571	E1292fs, E1339fs, E1291fs, E1297fs, E1336fs, E1228fs, E1269fs, E1271fs, E1298fs, E1312fs, E1313fs, E1338fs, E471fs, E1171fs, E1211fs, E1227fs, E1250fs, E1251fs, E1268fs, E1043fs, E1212fs, E1272fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254450	17	41243532 - 41243533	17	43091515 - 43091516	254450	249093	rs886038030	NC_000017.11:43091515:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4015G>T (p.Glu1339Ter)	LOC126862571|BRCA1	E1339*, E1292*, E1043*, E1211*, E1251*, E1268*, E1271*, E1171*, E1228*, E1291*, E1298*, E1312*, E1227*, E1250*, E1269*, E1297*, E1336*, E1338*, E1212*, E1272*, E1313*, E471*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037559	17	41243533	17	43091516	37559	46115	rs80357021	NC_000017.11:43091515:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4013del (p.Lys1338fs)	BRCA1|LOC126862571	K1291fs, K1338fs, K1227fs, K1270fs, K1249fs, K1267fs, K1271fs, K1296fs, K1311fs, K1337fs, K470fs, K1042fs, K1210fs, K1226fs, K1250fs, K1297fs, K1312fs, K1335fs, K1170fs, K1211fs, K1268fs, K1290fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254449	17	41243535	17	43091518	254449	249094	rs886038029	NC_000017.11:43091517:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4012A>T (p.Lys1338Ter)	BRCA1|LOC126862571	K1170*, K1249*, K1250*, K1270*, K1271*, K1335*, K1210*, K1211*, K1226*, K1268*, K1296*, K1312*, K1227*, K1267*, K1291*, K1311*, K470*, K1042*, K1290*, K1297*, K1337*, K1338*	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002450680	17	41243536	17	43091519	2450680	2423166	rs12946486	NC_000017.11:43091518:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic/Likely pathogenic	Feb 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4008dup (p.Asp1337Ter)	BRCA1|LOC126862571	D1290*, D1337*, D1169*, D1209*, D1210*, D1225*, D1269*, D1270*, D1310*, D1249*, D1289*, D1296*, D1226*, D1266*, D1311*, D1334*, D1041*, D1248*, D1267*, D1295*, D1336*, D469*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000992269	17	41243539 - 41243540	17	43091522 - 43091523	992269	980196	rs2053486046	NC_000017.11:43091522:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic/Likely pathogenic	Dec 27, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3999_4008del (p.Gly1334fs)	BRCA1|LOC126862571	G1287fs, G1334fs, G1038fs, G1245fs, G1267fs, G1293fs, G1307fs, G1166fs, G1206fs, G1207fs, G1222fs, G1264fs, G1308fs, G1331fs, G1223fs, G1292fs, G1333fs, G466fs, G1246fs, G1263fs, G1266fs, G1286fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254448	17	41243540 - 41243549	17	43091523 - 43091532	254448	249095	rs754792932	NC_000017.11:43091522:ACTCAGACCAACTC:ACTC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3994_4007del (p.Gln1331_Gly1332insTer)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV002009017	17	41243541 - 41243554	17	43091524 - 43091537	2009017	2063090	rs2552113740	NC_000017.11:43091523:CTCAGACCAACTCCCT:CT	Deletion	nonsense|intron variant	Pathogenic	Jun 23, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4002_4005del (p.Leu1335fs)	BRCA1|LOC126862571	L1335fs, L1288fs, L1223fs, L1224fs, L1247fs, L1268fs, L1294fs, L1039fs, L1246fs, L1265fs, L1309fs, L1332fs, L1167fs, L1208fs, L1267fs, L1287fs, L1334fs, L1207fs, L1264fs, L1293fs, L1308fs, L467fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055074	17	41243543 - 41243546	17	43091526 - 43091529	55074	69741	rs397509128	NC_000017.11:43091525:CAGAC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4002_4004delinsGC (p.Leu1335fs)	BRCA1|LOC126862571	L1335fs, L1288fs, L1267fs, L1293fs, L1332fs, L1207fs, L1246fs, L1268fs, L1294fs, L1308fs, L1334fs, L1039fs, L1167fs, L1208fs, L1224fs, L1247fs, L1265fs, L1287fs, L1223fs, L1264fs, L1309fs, L467fs	Hereditary cancer-predisposing syndrome	VCV001736940	17	41243544 - 41243546	17	43091527 - 43091529	1736940	1793982	rs2552114118	NC_000017.11:43091526:AGA:GC	Indel	frameshift variant|intron variant	Pathogenic	Jul 23, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3995_4001del (p.Gly1332fs)	BRCA1|LOC126862571	G1332fs, G1285fs, G1220fs, G1221fs, G1243fs, G1244fs, G1261fs, G1291fs, G1329fs, G1036fs, G1265fs, G1290fs, G1204fs, G1262fs, G1164fs, G1205fs, G1264fs, G1284fs, G1305fs, G1306fs, G1331fs, G464fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266427	17	41243547 - 41243553	17	43091530 - 43091536	266427	261687	rs886040185	NC_000017.11:43091529:CCAACTCCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4001del (p.Gly1334fs)	BRCA1|LOC126862571	G1287fs, G1334fs, G1207fs, G1222fs, G1266fs, G1267fs, G1307fs, G1038fs, G1166fs, G1292fs, G1308fs, G466fs, G1206fs, G1245fs, G1246fs, G1264fs, G1293fs, G1223fs, G1263fs, G1286fs, G1331fs, G1333fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055073	17	41243547	17	43091530	55073	69740	rs397509127	NC_000017.11:43091529:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3999del (p.Gly1334fs)	BRCA1|LOC126862571	G1287fs, G1334fs, G1038fs, G1207fs, G1222fs, G1245fs, G1293fs, G1331fs, G466fs, G1206fs, G1223fs, G1246fs, G1263fs, G1264fs, G1267fs, G1166fs, G1266fs, G1308fs, G1333fs, G1286fs, G1292fs, G1307fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055070	17	41243549	17	43091532	55070	69737	rs397509125	NC_000017.11:43091531:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3997dup (p.Val1333fs)	BRCA1|LOC126862571	V1286fs, V1333fs, V1037fs, V1165fs, V1206fs, V1222fs, V1265fs, V1306fs, V1332fs, V1244fs, V1266fs, V1285fs, V1307fs, V1330fs, V1291fs, V1205fs, V1221fs, V1245fs, V1262fs, V1263fs, V1292fs, V465fs	Hereditary breast ovarian cancer syndrome	VCV002091963	17	41243550 - 41243551	17	43091533 - 43091534	2091963	2152461	rs2552114596	NC_000017.11:43091533:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Feb 2, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3997del (p.Val1333fs)	BRCA1|LOC126862571	V1286fs, V1333fs, V1165fs, V1262fs, V1265fs, V1292fs, V1206fs, V1244fs, V1291fs, V1221fs, V1222fs, V1263fs, V1266fs, V1307fs, V1332fs, V1037fs, V1205fs, V1245fs, V1285fs, V1306fs, V1330fs, V465fs	Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer	VCV002133968	17	41243551	17	43091534	2133968	2188514	rs2552114625	NC_000017.11:43091533:C:	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Apr 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3990_3993del (p.Ser1330fs)	BRCA1|LOC126862571	S1283fs, S1330fs, S1202fs, S1259fs, S1282fs, S1303fs, S1304fs, S1162fs, S1260fs, S1289fs, S1034fs, S1218fs, S1242fs, S1262fs, S1263fs, S1288fs, S1327fs, S462fs, S1203fs, S1219fs, S1241fs, S1329fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266426	17	41243555 - 41243558	17	43091538 - 43091541	266426	261688	rs886040184	NC_000017.11:43091537:CTGGCT:CT	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3991C>T (p.Gln1331Ter)	BRCA1|LOC126862571	Q1331*, Q1284*, Q1263*, Q1264*, Q1290*, Q1328*, Q463*, Q1035*, Q1163*, Q1243*, Q1260*, Q1242*, Q1261*, Q1289*, Q1203*, Q1204*, Q1219*, Q1220*, Q1283*, Q1304*, Q1305*, Q1330*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037558	17	41243557	17	43091540	37558	46114	rs397507224	NC_000017.11:43091539:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3985_3987delinsTTTC (p.Glu1329fs)	BRCA1|LOC126862571	E1282fs, E1329fs, E1218fs, E1240fs, E1302fs, E1161fs, E1201fs, E1259fs, E1262fs, E1326fs, E1328fs, E461fs, E1217fs, E1241fs, E1258fs, E1033fs, E1202fs, E1261fs, E1281fs, E1287fs, E1288fs, E1303fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266425	17	41243561 - 41243563	17	43091544 - 43091546	266425	261689	rs886040183	NC_000017.11:43091543:TTC:GAAA	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3982dup (p.Ser1328fs)	LOC126862571|BRCA1	S1328fs, S1281fs, S1160fs, S1217fs, S1280fs, S1286fs, S460fs, S1200fs, S1261fs, S1287fs, S1301fs, S1032fs, S1201fs, S1216fs, S1258fs, S1325fs, S1239fs, S1240fs, S1257fs, S1260fs, S1302fs, S1327fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055069	17	41243565 - 41243566	17	43091548 - 43091549	55069	69736	rs397509124	NC_000017.11:43091548:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3981del (p.Gln1327fs)	BRCA1|LOC126862571	Q1280fs, Q1327fs, Q1239fs, Q1285fs, Q1301fs, Q1200fs, Q1216fs, Q1238fs, Q1259fs, Q1260fs, Q1279fs, Q1300fs, Q1031fs, Q1199fs, Q1286fs, Q1324fs, Q459fs, Q1159fs, Q1215fs, Q1256fs, Q1257fs, Q1326fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055068	17	41243567	17	43091550	55068	69735	rs397509123	NC_000017.11:43091549:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3980del (p.Gln1327fs)	BRCA1|LOC126862571	Q1280fs, Q1327fs, Q1199fs, Q1215fs, Q1257fs, Q1286fs, Q1301fs, Q1326fs, Q1031fs, Q1159fs, Q1200fs, Q1216fs, Q1239fs, Q1279fs, Q1285fs, Q1324fs, Q1256fs, Q1259fs, Q1300fs, Q459fs, Q1238fs, Q1260fs	Hereditary cancer-predisposing syndrome	VCV003261481	17	41243568	17	43091551	3261481	1245838		NC_000017.11:43091550:T:	Deletion	frameshift variant|intron variant	Pathogenic	May 21, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3979del (p.Gln1327fs)	BRCA1|LOC126862571	Q1327fs, Q1280fs, Q1216fs, Q1286fs, Q459fs, Q1199fs, Q1238fs, Q1239fs, Q1259fs, Q1285fs, Q1301fs, Q1324fs, Q1031fs, Q1159fs, Q1215fs, Q1257fs, Q1279fs, Q1200fs, Q1256fs, Q1260fs, Q1300fs, Q1326fs	Hereditary cancer-predisposing syndrome	VCV001736671	17	41243569	17	43091552	1736671	1793714	rs2552115803	NC_000017.11:43091551:G:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 18, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3979C>T (p.Gln1327Ter)	BRCA1|LOC126862571	Q1327*, Q1280*, Q1216*, Q1238*, Q1199*, Q1200*, Q1215*, Q1259*, Q1260*, Q1300*, Q1324*, Q1326*, Q459*, Q1257*, Q1279*, Q1285*, Q1031*, Q1159*, Q1239*, Q1256*, Q1286*, Q1301*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232360	17	41243569	17	43091552	232360	235987	rs876659720	NC_000017.11:43091551:G:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3977_3978del (p.His1326fs)	BRCA1|LOC126862571	H1030fs, H1158fs, H1198fs, H1199fs, H1214fs, H1215fs, H1237fs, H1238fs, H1255fs, H1256fs, H1258fs, H1259fs, H1278fs, H1279fs, H1284fs, H1285fs, H1299fs, H1300fs, H1323fs, H1325fs, H1326fs, H458fs	Hereditary cancer-predisposing syndrome	VCV003893909	17	41243570 - 41243571	17	43091553 - 43091554	3893909	4009790		NC_000017.11:43091552:AT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 10, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3949_3976dup (p.His1326fs)	BRCA1|LOC126862571	H1279fs, H1326fs, H1158fs, H1214fs, H1258fs, H1278fs, H1284fs, H1237fs, H1300fs, H1325fs, H458fs, H1030fs, H1198fs, H1199fs, H1238fs, H1255fs, H1299fs, H1323fs, H1215fs, H1256fs, H1259fs, H1285fs	Hereditary breast ovarian cancer syndrome	VCV000660515	17	41243571 - 41243572	17	43091554 - 43091555	660515	645965	rs1597860092	NC_000017.11:43091554:GCCTCATTTGTTTGGAAGAACCAATCAAG:GCCTCATTTGTTTGGAAGAACCAATCAAGCCTCATTTGTTTGGAAGAACCAATCAAG	Duplication	frameshift variant|intron variant	Pathogenic	Sep 24, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3975del (p.Arg1325fs)	BRCA1|LOC126862571	R1278fs, R1325fs, R1157fs, R1197fs, R1236fs, R1299fs, R1324fs, R1029fs, R1198fs, R1254fs, R1257fs, R1298fs, R1322fs, R457fs, R1213fs, R1214fs, R1255fs, R1277fs, R1284fs, R1237fs, R1258fs, R1283fs	Hereditary breast ovarian cancer syndrome	VCV001070111	17	41243573	17	43091556	1070111	1064198	rs2154271816	NC_000017.11:43091555:CC:C	Deletion	intron variant|frameshift variant	Pathogenic	Sep 30, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3972_3974delinsAA (p.Met1324fs)	BRCA1|LOC126862571	M1277fs, M1324fs, M1156fs, M1254fs, M1283fs, M456fs, M1196fs, M1213fs, M1235fs, M1253fs, M1282fs, M1297fs, M1323fs, M1028fs, M1212fs, M1236fs, M1257fs, M1197fs, M1256fs, M1276fs, M1298fs, M1321fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266424	17	41243574 - 41243576	17	43091557 - 43091559	266424	261690	rs886040182	NC_000017.11:43091556:CTC:TT	Indel	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3973del (p.Arg1325fs)	LOC126862571|BRCA1	R1325fs, R1278fs, R1237fs, R1255fs, R1258fs, R1299fs, R1322fs, R1157fs, R1197fs, R1257fs, R1283fs, R1284fs, R457fs, R1029fs, R1198fs, R1213fs, R1236fs, R1298fs, R1214fs, R1254fs, R1277fs, R1324fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055066	17	41243575	17	43091558	55066	69733	rs80357904	NC_000017.11:43091557:T:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3972del (p.Met1324fs)	BRCA1|LOC126862571	M1324fs, M1277fs, M1254fs, M1028fs, M1235fs, M1236fs, M1256fs, M1276fs, M1283fs, M1297fs, M1321fs, M1156fs, M1196fs, M1213fs, M1253fs, M456fs, M1197fs, M1212fs, M1257fs, M1282fs, M1298fs, M1323fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055065	17	41243576	17	43091559	55065	69732	rs80357987	NC_000017.11:43091558:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3968_3971del (p.Gln1323fs)	BRCA1|LOC126862571	Q1276fs, Q1323fs, Q1027fs, Q1155fs, Q1195fs, Q1256fs, Q1297fs, Q1320fs, Q1211fs, Q1212fs, Q1235fs, Q1252fs, Q1281fs, Q1282fs, Q1296fs, Q1322fs, Q1234fs, Q1255fs, Q1196fs, Q1253fs, Q1275fs, Q455fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266423	17	41243577 - 41243580	17	43091560 - 43091563	266423	261691	rs886040181	NC_000017.11:43091559:ATTT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3967_3970del (p.Lys1322_Gln1323insTer)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000659249	17	41243578 - 41243581	17	43091561 - 43091564	659249	645966	rs1597860167	NC_000017.11:43091560:TTTGTTTG:TTTG	Microsatellite	frameshift variant|nonsense|intron variant	Pathogenic	Dec 5, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3969_3970del (p.Gln1323fs)	BRCA1|LOC126862571	Q1323fs, Q1276fs, Q1027fs, Q1155fs, Q1211fs, Q1234fs, Q1255fs, Q1296fs, Q1235fs, Q1252fs, Q1281fs, Q1297fs, Q1322fs, Q1195fs, Q1196fs, Q1212fs, Q1275fs, Q1282fs, Q1320fs, Q455fs, Q1253fs, Q1256fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142938	17	41243578 - 41243579	17	43091561 - 43091562	142938	152652	rs587782834	NC_000017.11:43091560:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3967del (p.Gln1323fs)	BRCA1|LOC126862571	Q1323fs, Q1276fs, Q1211fs, Q1235fs, Q1255fs, Q1297fs, Q1320fs, Q455fs, Q1195fs, Q1234fs, Q1253fs, Q1256fs, Q1275fs, Q1322fs, Q1281fs, Q1296fs, Q1027fs, Q1155fs, Q1196fs, Q1282fs, Q1212fs, Q1252fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055063	17	41243581	17	43091564	55063	69730	rs397509122	NC_000017.11:43091563:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3967C>T (p.Gln1323Ter)	BRCA1|LOC126862571	Q1323*, Q1276*, Q1253*, Q1281*, Q1320*, Q1027*, Q1235*, Q1322*, Q1155*, Q1195*, Q1211*, Q1212*, Q1234*, Q1252*, Q1255*, Q1256*, Q1296*, Q455*, Q1196*, Q1275*, Q1282*, Q1297*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055062	17	41243581	17	43091564	55062	69729	rs80357262	NC_000017.11:43091563:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3966del (p.Lys1322fs)	BRCA1|LOC126862571	K1275fs, K1322fs, K1154fs, K1251fs, K1252fs, K1274fs, K1280fs, K1296fs, K1321fs, K1026fs, K1233fs, K1254fs, K1255fs, K1281fs, K1319fs, K1194fs, K1211fs, K1234fs, K1295fs, K1195fs, K1210fs, K454fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055061	17	41243582	17	43091565	55061	69728	rs80357979	NC_000017.11:43091564:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3964A>T (p.Lys1322Ter)	BRCA1|LOC126862571	K1322*, K1275*, K1194*, K1233*, K1251*, K1255*, K1274*, K1295*, K1195*, K1254*, K1210*, K1252*, K1281*, K1321*, K454*, K1026*, K1154*, K1211*, K1234*, K1280*, K1296*, K1319*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055059	17	41243584	17	43091567	55059	69726	rs80357343	NC_000017.11:43091566:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3961del (p.Ser1321fs)	BRCA1|LOC126862571	S1274fs, S1321fs, S1250fs, S1251fs, S1254fs, S1279fs, S1318fs, S1153fs, S1209fs, S1210fs, S1232fs, S1320fs, S453fs, S1193fs, S1194fs, S1233fs, S1253fs, S1295fs, S1025fs, S1273fs, S1280fs, S1294fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266422	17	41243587	17	43091570	266422	261692	rs886040180	NC_000017.11:43091569:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3959del (p.Ser1320fs)	BRCA1|LOC126862571	S1320fs, S1273fs, S1192fs, S1193fs, S1250fs, S1252fs, S1278fs, S1319fs, S1208fs, S1231fs, S1293fs, S1209fs, S1249fs, S1253fs, S1272fs, S1279fs, S1024fs, S1152fs, S1232fs, S1294fs, S1317fs, S452fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266421	17	41243589	17	43091572	266421	261693	rs886040179	NC_000017.11:43091571:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3956_3957del (p.Gly1319fs)	BRCA1|LOC126862571	G1272fs, G1319fs, G1230fs, G1277fs, G1316fs, G451fs, G1191fs, G1192fs, G1207fs, G1249fs, G1251fs, G1318fs, G1023fs, G1208fs, G1231fs, G1248fs, G1293fs, G1151fs, G1252fs, G1271fs, G1278fs, G1292fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431257	17	41243591 - 41243592	17	43091574 - 43091575	431257	424806	rs1135401871	NC_000017.11:43091573:AC:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3954dup (p.Gly1319fs)	BRCA1|LOC126862571	G1272fs, G1319fs, G1023fs, G1207fs, G1208fs, G1249fs, G1278fs, G1318fs, G1192fs, G1230fs, G1292fs, G1316fs, G1191fs, G1251fs, G1271fs, G451fs, G1151fs, G1231fs, G1248fs, G1252fs, G1277fs, G1293fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462626	17	41243593 - 41243594	17	43091576 - 43091577	462626	467710	rs1135401870	NC_000017.11:43091576:AA:AAA	Duplication	intron variant|frameshift variant	Pathogenic	Jun 16, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3952_3955del (p.Ile1318fs)	BRCA1|LOC126862571	I1271fs, I1318fs, I1022fs, I1190fs, I1206fs, I1207fs, I1248fs, I1251fs, I1270fs, I1277fs, I1291fs, I1315fs, I1250fs, I1292fs, I450fs, I1150fs, I1191fs, I1317fs, I1229fs, I1230fs, I1247fs, I1276fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266420	17	41243593 - 41243596	17	43091576 - 43091579	266420	261694	rs886040178	NC_000017.11:43091575:CAATCAA:CAA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3954del (p.Ile1318fs)	BRCA1|LOC126862571	I1271fs, I1318fs, I1150fs, I1190fs, I1191fs, I1206fs, I1250fs, I450fs, I1022fs, I1207fs, I1229fs, I1248fs, I1251fs, I1276fs, I1291fs, I1270fs, I1317fs, I1230fs, I1247fs, I1277fs, I1292fs, I1315fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431256	17	41243594	17	43091577	431256	424807	rs1135401870	NC_000017.11:43091576:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3947_3950del (p.Pro1315_Phe1316insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266419	17	41243598 - 41243601	17	43091581 - 43091584	266419	261695	rs886040177	NC_000017.11:43091580:AAGAAAG:AAG	Deletion	nonsense|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3935_3938del (p.Thr1312fs)	BRCA1|LOC126862571	T1016fs, T1144fs, T1184fs, T1185fs, T1200fs, T1201fs, T1223fs, T1224fs, T1241fs, T1242fs, T1244fs, T1245fs, T1264fs, T1265fs, T1270fs, T1271fs, T1285fs, T1286fs, T1309fs, T1311fs, T1312fs, T444fs	Hereditary cancer-predisposing syndrome	VCV003226148	17	41243610 - 41243613	17	43091593 - 43091596	3226148	3387212	rs2552119120	NC_000017.11:43091592:TGGGTG:TG	Deletion	intron variant|frameshift variant	Pathogenic	Feb 22, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3937C>T (p.Gln1313Ter)	BRCA1|LOC126862571	Q1313*, Q1266*, Q1145*, Q1224*, Q1242*, Q1245*, Q1265*, Q1272*, Q1186*, Q1243*, Q1286*, Q1287*, Q1201*, Q1225*, Q1271*, Q1310*, Q1312*, Q1017*, Q1185*, Q1202*, Q1246*, Q445*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037556	17	41243611	17	43091594	37556	46112	rs80357318	NC_000017.11:43091593:G:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3931_3934dup (p.Thr1312fs)	LOC126862571|BRCA1	T1265fs, T1312fs, T1200fs, T1201fs, T1241fs, T1242fs, T1271fs, T1286fs, T1144fs, T1185fs, T1223fs, T1245fs, T1270fs, T1309fs, T1016fs, T1184fs, T1224fs, T1244fs, T444fs, T1264fs, T1285fs, T1311fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232602	17	41243613 - 41243614	17	43091596 - 43091597	232602	235991	rs80357864	NC_000017.11:43091596:TGTTTGT:TGTTTGTTTGT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3931_3934del (p.Asn1311fs)	BRCA1|LOC126862571	N1311fs, N1264fs, N1199fs, N1263fs, N1269fs, N1284fs, N1183fs, N1200fs, N1184fs, N1222fs, N1241fs, N1243fs, N1244fs, N1285fs, N443fs, N1015fs, N1143fs, N1223fs, N1240fs, N1270fs, N1308fs, N1310fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055054	17	41243614 - 41243617	17	43091597 - 43091600	55054	69721	rs80357864	NC_000017.11:43091596:TGTTTGT:TGT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3932del (p.Asn1311fs)	BRCA1|LOC126862571	N1264fs, N1311fs, N1015fs, N1143fs, N1184fs, N1199fs, N1200fs, N1241fs, N1263fs, N1269fs, N1270fs, N1243fs, N1308fs, N1222fs, N1223fs, N1240fs, N1244fs, N1285fs, N443fs, N1183fs, N1284fs, N1310fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055055	17	41243616	17	43091599	55055	69722	rs80357504	NC_000017.11:43091598:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3927_3930del (p.Asn1309fs)	LOC126862571|BRCA1	N1309fs, N1262fs, N1238fs, N1239fs, N1241fs, N1242fs, N1182fs, N1197fs, N1198fs, N1261fs, N1267fs, N1306fs, N1308fs, N441fs, N1013fs, N1141fs, N1181fs, N1220fs, N1221fs, N1268fs, N1282fs, N1283fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055052	17	41243618 - 41243621	17	43091601 - 43091604	55052	69719	rs397509120	NC_000017.11:43091600:TGTAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3928dup (p.Thr1310fs)	BRCA1|LOC126862571	T1263fs, T1310fs, T1142fs, T1183fs, T1262fs, T1014fs, T1182fs, T1198fs, T1199fs, T1240fs, T1242fs, T1283fs, T1284fs, T1307fs, T1239fs, T1243fs, T1269fs, T1309fs, T1221fs, T1222fs, T1268fs, T442fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266418	17	41243619 - 41243620	17	43091602 - 43091603	266418	261696	rs886040176	NC_000017.11:43091602:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3926del (p.Asn1309fs)	BRCA1|LOC126862571	N1262fs, N1309fs, N1181fs, N1198fs, N1220fs, N1267fs, N1221fs, N1239fs, N1242fs, N1283fs, N1308fs, N1013fs, N1182fs, N1197fs, N1282fs, N1306fs, N441fs, N1141fs, N1238fs, N1241fs, N1261fs, N1268fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055051	17	41243622	17	43091605	55051	69718	rs397509119	NC_000017.11:43091604:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3917dup (p.Leu1306fs)	LOC126862571|BRCA1	L1259fs, L1306fs, L1179fs, L1195fs, L1178fs, L1194fs, L1217fs, L1258fs, L1264fs, L1279fs, L1280fs, L1303fs, L1010fs, L1138fs, L1218fs, L1235fs, L1238fs, L1239fs, L1305fs, L1236fs, L1265fs, L438fs	Hereditary breast ovarian cancer syndrome	VCV003722783	17	41243630 - 41243631	17	43091613 - 43091614	3722783	1245686		NC_000017.11:43091613:AA:AAA	Duplication	intron variant|frameshift variant	Pathogenic	Oct 9, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3917del (p.Asp1305_Leu1306insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266417	17	41243631	17	43091614	266417	261697	rs886040175	NC_000017.11:43091613:AA:A	Deletion	nonsense|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3916_3917del (p.Leu1306fs)	BRCA1|LOC126862571	L1306fs, L1259fs, L1138fs, L1238fs, L1305fs, L438fs, L1178fs, L1179fs, L1218fs, L1265fs, L1195fs, L1217fs, L1239fs, L1258fs, L1264fs, L1279fs, L1280fs, L1010fs, L1194fs, L1235fs, L1236fs, L1303fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055049	17	41243631 - 41243632	17	43091614 - 43091615	55049	69716	rs80357678	NC_000017.11:43091613:AA:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3914del (p.Asp1305fs)	BRCA1|LOC126862571	D1305fs, D1258fs, D1137fs, D1178fs, D1216fs, D1217fs, D1235fs, D1278fs, D1302fs, D1194fs, D1237fs, D1177fs, D1238fs, D1257fs, D1263fs, D1279fs, D437fs, D1009fs, D1193fs, D1234fs, D1264fs, D1304fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055048	17	41243634	17	43091617	55048	69715	rs397509118	NC_000017.11:43091616:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3908_3909dup (p.Glu1304fs)	BRCA1|LOC126862571	E1257fs, E1304fs, E1215fs, E1216fs, E1234fs, E1236fs, E1263fs, E1277fs, E1278fs, E1176fs, E1192fs, E1136fs, E1177fs, E1233fs, E1256fs, E1301fs, E1303fs, E1008fs, E1193fs, E1237fs, E1262fs, E436fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266416	17	41243638 - 41243639	17	43091621 - 43091622	266416	261698	rs886040174	NC_000017.11:43091621:CA:CACA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3910G>T (p.Glu1304Ter)	BRCA1|LOC126862571	E1304*, E1257*, E1233*, E1277*, E1303*, E1136*, E1192*, E1215*, E1236*, E1262*, E1278*, E1008*, E1193*, E1216*, E1237*, E1263*, E1176*, E1177*, E1234*, E1256*, E1301*, E436*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254447	17	41243638	17	43091621	254447	249096	rs886038028	NC_000017.11:43091620:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3910del (p.Glu1304fs)	LOC126862571|BRCA1	E1257fs, E1304fs, E1136fs, E1263fs, E1278fs, E1303fs, E436fs, E1215fs, E1233fs, E1236fs, E1237fs, E1177fs, E1216fs, E1262fs, E1277fs, E1008fs, E1176fs, E1192fs, E1193fs, E1234fs, E1256fs, E1301fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055047	17	41243638	17	43091621	55047	69714	rs397509117	NC_000017.11:43091620:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3908dup (p.Leu1303fs)	BRCA1|LOC126862571	L1256fs, L1303fs, L1176fs, L1192fs, L1214fs, L1236fs, L1261fs, L1277fs, L1302fs, L1007fs, L1135fs, L1233fs, L1235fs, L1255fs, L1215fs, L1232fs, L1262fs, L1276fs, L1300fs, L1175fs, L1191fs, L435fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125658	17	41243639 - 41243640	17	43091622 - 43091623	125658	131196	rs80357634	NC_000017.11:43091622:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3907_3908delinsGGA (p.Leu1303fs)	BRCA1|LOC126862571	L1303fs, L1256fs, L1191fs, L1233fs, L1276fs, L1300fs, L1135fs, L1175fs, L1176fs, L1214fs, L1232fs, L1261fs, L1302fs, L1007fs, L1235fs, L1236fs, L1255fs, L1262fs, L1192fs, L1215fs, L1277fs, L435fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266415	17	41243640 - 41243641	17	43091623 - 43091624	266415	261699	rs80357634	NC_000017.11:43091622:AA:TCC	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3904G>T (p.Glu1302Ter)	BRCA1|LOC126862571	E1302*, E1255*, E1175*, E1190*, E1231*, E1301*, E1006*, E1174*, E1214*, E1232*, E1261*, E1299*, E434*, E1134*, E1191*, E1254*, E1260*, E1275*, E1213*, E1234*, E1235*, E1276*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055045	17	41243644	17	43091627	55045	69712	rs80357461	NC_000017.11:43091626:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3901_3902del (p.Cys1300_Ser1301insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055043	17	41243646 - 41243647	17	43091629 - 43091630	55043	69710	rs80357646	NC_000017.11:43091628:CT:	Deletion	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3900C>A (p.Cys1300Ter)	BRCA1|LOC126862571	C1172*, C1188*, C1258*, C1300*, C432*, C1132*, C1173*, C1229*, C1230*, C1232*, C1253*, C1004*, C1189*, C1212*, C1259*, C1274*, C1211*, C1233*, C1252*, C1273*, C1297*, C1299*	Hereditary cancer-predisposing syndrome	VCV001736019	17	41243648	17	43091631	1736019	1787178	rs730881454	NC_000017.11:43091630:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 8, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3895C>T (p.Gln1299Ter)	BRCA1|LOC126862571	Q1299*, Q1252*, Q1210*, Q1231*, Q1298*, Q1003*, Q1171*, Q1187*, Q1211*, Q1229*, Q1232*, Q1251*, Q1258*, Q1172*, Q1228*, Q1257*, Q1272*, Q1273*, Q1296*, Q431*, Q1131*, Q1188*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055040	17	41243653	17	43091636	55040	69707	rs80357038	NC_000017.11:43091635:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3893C>G (p.Ser1298Ter)	BRCA1|LOC126862571	S1298*, S1251*, S1171*, S1210*, S1227*, S1228*, S1250*, S1170*, S1231*, S1271*, S1272*, S430*, S1002*, S1130*, S1186*, S1209*, S1230*, S1256*, S1257*, S1295*, S1297*, S1187*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240798	17	41243655	17	43091638	240798	242780	rs80357440	NC_000017.11:43091637:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3893C>A (p.Ser1298Ter)	BRCA1|LOC126862571	S1298*, S1251*, S1171*, S1187*, S1250*, S1271*, S1272*, S430*, S1130*, S1170*, S1228*, S1256*, S1257*, S1209*, S1230*, S1297*, S1002*, S1186*, S1210*, S1227*, S1231*, S1295*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055039	17	41243655	17	43091638	55039	69706	rs80357440	NC_000017.11:43091637:G:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3888_3889del (p.Ser1297fs)	BRCA1|LOC126862571	S1250fs, S1297fs, S1169fs, S1185fs, S1230fs, S1249fs, S1001fs, S1129fs, S1186fs, S1226fs, S1227fs, S1271fs, S1294fs, S1296fs, S429fs, S1209fs, S1255fs, S1256fs, S1270fs, S1170fs, S1208fs, S1229fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001692967	17	41243659 - 41243660	17	43091642 - 43091643	1692967	1685407	rs886038027	NC_000017.11:43091641:AAAA:AA	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3889del (p.Ser1297fs)	BRCA1|LOC126862571	S1250fs, S1297fs, S1129fs, S1255fs, S1256fs, S429fs, S1169fs, S1185fs, S1186fs, S1208fs, S1209fs, S1226fs, S1229fs, S1249fs, S1270fs, S1294fs, S1296fs, S1001fs, S1170fs, S1230fs, S1271fs, S1227fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254446	17	41243659	17	43091642	254446	249097	rs886038027	NC_000017.11:43091641:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3885del (p.Leu1295fs)	BRCA1|LOC126862571	L1248fs, L1295fs, L1127fs, L1167fs, L1184fs, L1206fs, L1183fs, L1207fs, L1254fs, L1292fs, L427fs, L1168fs, L1224fs, L1225fs, L1227fs, L1268fs, L1294fs, L1228fs, L1247fs, L1253fs, L1269fs, L999fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266414	17	41243663	17	43091646	266414	261700	rs886040172	NC_000017.11:43091645:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3880_3883del (p.Ser1294fs)	BRCA1|LOC126862571	S1247fs, S1294fs, S1183fs, S1223fs, S1246fs, S1267fs, S1126fs, S1205fs, S1206fs, S1252fs, S1291fs, S1166fs, S1224fs, S1226fs, S1227fs, S1253fs, S1268fs, S1293fs, S426fs, S1167fs, S1182fs, S998fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055037	17	41243665 - 41243668	17	43091648 - 43091651	55037	69704	rs397509116	NC_000017.11:43091647:AGCTAGC:AGC	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3882del (p.Leu1295fs)	BRCA1|LOC126862571	L1248fs, L1295fs, L1206fs, L1207fs, L1228fs, L1247fs, L1254fs, L1292fs, L999fs, L1167fs, L1225fs, L1253fs, L1269fs, L1294fs, L427fs, L1183fs, L1224fs, L1268fs, L1127fs, L1168fs, L1184fs, L1227fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000947848	17	41243666	17	43091649	947848	928288	rs2053505662	NC_000017.11:43091648:G:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3876_3877del (p.Ser1292_Ala1293insTer)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000642924	17	41243671 - 41243672	17	43091654 - 43091655	642924	645968	rs1597860714	NC_000017.11:43091653:CA:	Deletion	intron variant|frameshift variant	Pathogenic	Oct 20, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3870_3877del (p.Lys1290fs)	BRCA1|LOC126862571	K1290fs, K1243fs, K1178fs, K1202fs, K1223fs, K1249fs, K1289fs, K994fs, K1122fs, K1201fs, K1220fs, K1222fs, K1248fs, K1264fs, K422fs, K1163fs, K1179fs, K1219fs, K1287fs, K1162fs, K1242fs, K1263fs	Hereditary cancer-predisposing syndrome	VCV000482914	17	41243671 - 41243678	17	43091654 - 43091661	482914	478702	rs1555586879	NC_000017.11:43091653:CAGAACAT:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 13, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3876del (p.Ala1293fs)	BRCA1|LOC126862571	A1293fs, A1246fs, A1181fs, A1182fs, A1204fs, A1222fs, A1245fs, A1266fs, A1125fs, A1165fs, A1226fs, A1251fs, A1267fs, A997fs, A1223fs, A1225fs, A1290fs, A425fs, A1166fs, A1205fs, A1252fs, A1292fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055034	17	41243672	17	43091655	55034	69701	rs397509115	NC_000017.11:43091654:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3874del (p.Ser1292fs)	BRCA1|LOC126862571	S1245fs, S1292fs, S1165fs, S1181fs, S1244fs, S1251fs, S996fs, S1124fs, S1221fs, S1225fs, S1265fs, S1164fs, S1204fs, S1222fs, S1250fs, S1266fs, S1289fs, S1291fs, S1180fs, S1203fs, S1224fs, S424fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136086	17	41243674	17	43091657	136086	139798	rs587780802	NC_000017.11:43091656:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3873T>A (p.Cys1291Ter)	BRCA1|LOC126862571	C1123*, C1221*, C1264*, C1290*, C423*, C995*, C1164*, C1180*, C1223*, C1291*, C1202*, C1220*, C1249*, C1250*, C1288*, C1163*, C1179*, C1203*, C1224*, C1243*, C1244*, C1265*	Hereditary breast ovarian cancer syndrome	VCV001929513	17	41243675	17	43091658	1929513	1984521	rs1245187485	NC_000017.11:43091657:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 22, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3872_3873insC (p.Ser1292fs)	BRCA1|LOC126862571	S1292fs, S1245fs, S1203fs, S1221fs, S1251fs, S1265fs, S1291fs, S996fs, S1181fs, S1250fs, S424fs, S1124fs, S1165fs, S1204fs, S1224fs, S1244fs, S1266fs, S1164fs, S1180fs, S1222fs, S1225fs, S1289fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548287	17	41243675 - 41243676	17	43091658 - 43091659	548287	538803	rs1555586891	NC_000017.11:43091658::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3872del (p.Cys1291fs)	BRCA1|LOC126862571	C1291fs, C1244fs, C1221fs, C1249fs, C1265fs, C1288fs, C423fs, C1123fs, C1179fs, C1243fs, C1163fs, C1180fs, C1203fs, C1224fs, C1264fs, C995fs, C1164fs, C1202fs, C1220fs, C1223fs, C1250fs, C1290fs	Hereditary breast ovarian cancer syndrome	VCV000969791	17	41243676	17	43091659	969791	958121	rs2053508051	NC_000017.11:43091658:C:	Deletion	frameshift variant|intron variant	Pathogenic	Nov 8, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3871_3872insC (p.Cys1291fs)	BRCA1|LOC126862571	C1244fs, C1291fs, C1163fs, C1202fs, C1223fs, C1250fs, C1290fs, C1203fs, C1264fs, C1265fs, C423fs, C1123fs, C1224fs, C1243fs, C1288fs, C1164fs, C1179fs, C1180fs, C1220fs, C1221fs, C1249fs, C995fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055033	17	41243676 - 41243677	17	43091659 - 43091660	55033	69700	rs397509114	NC_000017.11:43091659::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3870dup (p.Cys1291fs)	BRCA1|LOC126862571	C1180fs, C1250fs, C1163fs, C1179fs, C1224fs, C1243fs, C1244fs, C1291fs, C1123fs, C1164fs, C1202fs, C1220fs, C1221fs, C1265fs, C1288fs, C423fs, C1203fs, C1223fs, C1249fs, C1264fs, C1290fs, C995fs	Hereditary breast ovarian cancer syndrome	VCV002847355	17	41243677 - 41243678	17	43091660 - 43091661	2847355	3012276	rs80357918	NC_000017.11:43091660:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Mar 19, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3867_3871del (p.Lys1290fs)	BRCA1|LOC126862571	K1290fs, K1243fs, K1201fs, K1219fs, K1220fs, K1222fs, K1287fs, K1122fs, K1163fs, K1178fs, K1263fs, K1264fs, K1289fs, K994fs, K1162fs, K1179fs, K1202fs, K1223fs, K1242fs, K1248fs, K1249fs, K422fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125657	17	41243677 - 41243681	17	43091660 - 43091664	125657	131195	rs80357560	NC_000017.11:43091659:ATTTT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3870del (p.Lys1290fs)	BRCA1|LOC126862571	K1243fs, K1290fs, K1163fs, K1220fs, K1242fs, K1289fs, K994fs, K1122fs, K1162fs, K1179fs, K1249fs, K1263fs, K422fs, K1201fs, K1222fs, K1248fs, K1264fs, K1287fs, K1178fs, K1202fs, K1219fs, K1223fs	Hereditary cancer-predisposing syndrome	VCV001735711	17	41243678	17	43091661	1735711	1790205	rs80357918	NC_000017.11:43091660:TTTT:TTT	Deletion	intron variant|frameshift variant	Pathogenic	Jun 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3869_3870del (p.Lys1290fs)	BRCA1|LOC126862571	K1290fs, K1243fs, K1162fs, K1178fs, K1248fs, K1263fs, K1289fs, K1201fs, K1202fs, K1220fs, K1264fs, K1287fs, K1122fs, K1179fs, K1222fs, K1223fs, K1242fs, K1249fs, K422fs, K994fs, K1163fs, K1219fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055032	17	41243678 - 41243679	17	43091661 - 43091662	55032	69699	rs80357918	NC_000017.11:43091660:TTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3868A>T (p.Lys1290Ter)	BRCA1|LOC126862571	K1290*, K1243*, K1122*, K1178*, K1201*, K1222*, K1223*, K1242*, K1287*, K994*, K1162*, K1163*, K1219*, K1248*, K1263*, K1264*, K422*, K1179*, K1202*, K1220*, K1249*, K1289*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037554	17	41243680	17	43091663	37554	46110	rs80357254	NC_000017.11:43091662:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3866del (p.Thr1289fs)	BRCA1|LOC126862571	T1162fs, T1178fs, T1201fs, T1218fs, T1219fs, T1222fs, T1262fs, T1263fs, T421fs, T993fs, T1177fs, T1286fs, T1289fs, T1161fs, T1200fs, T1247fs, T1121fs, T1221fs, T1241fs, T1242fs, T1248fs, T1288fs	Hereditary cancer-predisposing syndrome	VCV003825308	17	41243682	17	43091665	3825308	3942578		NC_000017.11:43091664:G:	Deletion	intron variant|frameshift variant	Pathogenic	Jan 23, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3865del (p.Thr1289fs)	LOC126862571|BRCA1	T1242fs, T1289fs, T1178fs, T1200fs, T1218fs, T1247fs, T1262fs, T993fs, T1161fs, T1219fs, T1248fs, T1263fs, T1288fs, T1162fs, T1177fs, T1222fs, T1241fs, T1286fs, T421fs, T1121fs, T1201fs, T1221fs	Hereditary breast ovarian cancer syndrome	VCV000928522	17	41243683	17	43091666	928522	917252	rs2053509532	NC_000017.11:43091665:TTT:TT	Deletion	intron variant|frameshift variant	Pathogenic/Likely pathogenic	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3862G>T (p.Glu1288Ter)	LOC126862571|BRCA1	E1288*, E1241*, E1160*, E1161*, E1177*, E1217*, E1246*, E1285*, E1120*, E1200*, E1220*, E1240*, E1261*, E1262*, E1221*, E1247*, E992*, E1176*, E1199*, E1218*, E1287*, E420*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266413	17	41243686	17	43091669	266413	261701	rs876659708	NC_000017.11:43091668:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3862del (p.Glu1288fs)	BRCA1|LOC126862571	E1241fs, E1288fs, E1120fs, E1200fs, E1240fs, E1287fs, E420fs, E1160fs, E1199fs, E1218fs, E1220fs, E1247fs, E1285fs, E992fs, E1176fs, E1221fs, E1262fs, E1161fs, E1177fs, E1217fs, E1246fs, E1261fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055031	17	41243686	17	43091669	55031	69698	rs273900718	NC_000017.11:43091668:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3858_3861del (p.Ser1286fs)	BRCA1|LOC126862571	S1239fs, S1286fs, S1118fs, S1218fs, S1238fs, S1158fs, S1174fs, S1175fs, S1219fs, S1283fs, S1285fs, S1159fs, S1197fs, S1198fs, S1260fs, S990fs, S1215fs, S1216fs, S1244fs, S1245fs, S1259fs, S418fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037553	17	41243687 - 41243690	17	43091670 - 43091673	37553	46109	rs80357842	NC_000017.11:43091669:CTCACT:CT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3856del (p.Ser1286fs)	BRCA1|LOC126862571	S1239fs, S1286fs, S1118fs, S1174fs, S1197fs, S1215fs, S1238fs, S1244fs, S1283fs, S1285fs, S1216fs, S1219fs, S1245fs, S1259fs, S1260fs, S418fs, S1158fs, S1159fs, S1175fs, S1198fs, S1218fs, S990fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055030	17	41243692	17	43091675	55030	69697	rs80357855	NC_000017.11:43091674:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3851_3852dup (p.Leu1285fs)	BRCA1|LOC126862571	L1238fs, L1285fs, L1158fs, L1258fs, L1284fs, L1117fs, L1157fs, L1173fs, L1174fs, L1214fs, L1243fs, L1259fs, L1282fs, L417fs, L1196fs, L1217fs, L1244fs, L989fs, L1197fs, L1215fs, L1218fs, L1237fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266412	17	41243695 - 41243696	17	43091678 - 43091679	266412	261702	rs397507221	NC_000017.11:43091678:GTG:GTGTG	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3853del (p.Ser1286fs)	BRCA1|LOC126862571	S1239fs, S1286fs, S1159fs, S1175fs, S1216fs, S1244fs, S1245fs, S1259fs, S1260fs, S1283fs, S418fs, S1118fs, S1218fs, S1285fs, S990fs, S1158fs, S1174fs, S1197fs, S1198fs, S1215fs, S1219fs, S1238fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254445	17	41243695	17	43091678	254445	249098	rs397507222	NC_000017.11:43091677:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3840_3850del (p.Gln1281fs)	BRCA1|LOC126862571	Q1234fs, Q1281fs, Q1170fs, Q1239fs, Q1280fs, Q1153fs, Q1169fs, Q1192fs, Q1211fs, Q1214fs, Q1278fs, Q413fs, Q1113fs, Q1154fs, Q1193fs, Q1240fs, Q1255fs, Q1210fs, Q1213fs, Q1233fs, Q1254fs, Q985fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266410	17	41243698 - 41243708	17	43091681 - 43091691	266410	261703	rs886040170	NC_000017.11:43091680:GATGTTCCTGAGATG:GATG	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3844G>T (p.Glu1282Ter)	BRCA1|LOC126862571	E1170*, E1171*, E1215*, E1241*, E1279*, E1155*, E1212*, E1235*, E1240*, E1281*, E986*, E1114*, E1154*, E1193*, E1211*, E1234*, E1255*, E414*, E1194*, E1214*, E1256*, E1282*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001735457	17	41243704	17	43091687	1735457	1789952	rs2154281717	NC_000017.11:43091686:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	May 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3844del (p.Glu1282fs)	BRCA1|LOC126862571	E1235fs, E1282fs, E1114fs, E1211fs, E1256fs, E1154fs, E1214fs, E1255fs, E1279fs, E1281fs, E1155fs, E1194fs, E1212fs, E1234fs, E1240fs, E414fs, E986fs, E1170fs, E1171fs, E1193fs, E1215fs, E1241fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055026	17	41243704	17	43091687	55026	69693	rs397509113	NC_000017.11:43091686:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3839_3843delinsAAGC (p.Ser1280_Gln1281delinsTer)	BRCA1|LOC126862571		Hereditary cancer-predisposing syndrome	VCV004082359	17	41243705 - 41243709	17	43091688 - 43091692	4082359	4195047		NC_000017.11:43091687:CTGAG:GCTT	Indel	nonsense|intron variant	Pathogenic	Jul 27, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3839_3843del (p.Ala1279_Ser1280insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266409	17	41243705 - 41243709	17	43091688 - 43091692	266409	261704	rs886040169	NC_000017.11:43091687:CTGAG:	Deletion	nonsense|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3839_3843delinsAGGC (p.Ser1280_Gln1281delinsTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055021	17	41243705 - 41243709	17	43091688 - 43091692	55021	69688	rs273900717	NC_000017.11:43091687:CTGAG:GCCT	Indel	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3841_3842del (p.Gln1281fs)	BRCA1|LOC126862571	Q1281fs, Q1234fs, Q1193fs, Q1210fs, Q1233fs, Q1240fs, Q1254fs, Q1153fs, Q1192fs, Q1255fs, Q985fs, Q1113fs, Q1154fs, Q1170fs, Q1213fs, Q1214fs, Q1280fs, Q413fs, Q1169fs, Q1211fs, Q1239fs, Q1278fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055023	17	41243706 - 41243707	17	43091689 - 43091690	55023	69690	rs80357584	NC_000017.11:43091688:TG:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3841C>T (p.Gln1281Ter)	BRCA1|LOC126862571	Q1281*, Q1234*, Q1113*, Q1211*, Q1255*, Q1153*, Q1169*, Q1210*, Q1233*, Q1239*, Q1240*, Q1254*, Q1170*, Q1192*, Q413*, Q1154*, Q1193*, Q1213*, Q1214*, Q1278*, Q1280*, Q985*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055022	17	41243707	17	43091690	55022	69689	rs80356866	NC_000017.11:43091689:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3837_3840del (p.Ser1280fs)	BRCA1|LOC126862571	S1233fs, S1280fs, S1153fs, S1191fs, S1212fs, S1238fs, S1239fs, S412fs, S1168fs, S1152fs, S1169fs, S1210fs, S1213fs, S1232fs, S1253fs, S1112fs, S1192fs, S1209fs, S1254fs, S1277fs, S1279fs, S984fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266408	17	41243708 - 41243711	17	43091691 - 43091694	266408	261705	rs886040168	NC_000017.11:43091690:AGAT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3835del (p.Ala1279fs)	BRCA1|LOC126862571	A1232fs, A1279fs, A1191fs, A1212fs, A1252fs, A1278fs, A983fs, A1111fs, A1152fs, A1168fs, A1190fs, A1209fs, A1211fs, A1231fs, A1253fs, A411fs, A1151fs, A1276fs, A1167fs, A1208fs, A1237fs, A1238fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417826	17	41243713	17	43091696	417826	404712	rs1060505047	NC_000017.11:43091695:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3833del (p.Lys1278fs)	BRCA1|LOC126862571	K1231fs, K1278fs, K1110fs, K1208fs, K1210fs, K1190fs, K1211fs, K1277fs, K410fs, K1166fs, K1230fs, K1236fs, K1275fs, K982fs, K1150fs, K1151fs, K1167fs, K1189fs, K1207fs, K1237fs, K1251fs, K1252fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431254	17	41243715	17	43091698	431254	424809	rs1135401868	NC_000017.11:43091697:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3831_3832insT (p.Lys1278Ter)	BRCA1|LOC126862571	K1110*, K1150*, K1166*, K1208*, K1230*, K1251*, K1252*, K410*, K1151*, K1167*, K1237*, K1189*, K1190*, K1207*, K1211*, K1275*, K982*, K1210*, K1231*, K1236*, K1277*, K1278*	Hereditary cancer-predisposing syndrome	VCV003992625	17	41243716 - 41243717	17	43091699 - 43091700	3992625	4104876		NC_000017.11:43091699::A	Insertion	nonsense|intron variant	Pathogenic	May 25, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3830dup (p.Ala1279fs)	BRCA1|LOC126862571	A1232fs, A1279fs, A1151fs, A1167fs, A1191fs, A1208fs, A1211fs, A1237fs, A1212fs, A1252fs, A1278fs, A1152fs, A1168fs, A1190fs, A1209fs, A1238fs, A1253fs, A1276fs, A1111fs, A1231fs, A411fs, A983fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125655	17	41243717 - 41243718	17	43091700 - 43091701	125655	131193	rs80357878	NC_000017.11:43091700:G:GG	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3825_3826del (p.Leu1276fs)	BRCA1|LOC126862571	L1205fs, L1206fs, L1273fs, L1275fs, L408fs, L1187fs, L1188fs, L1208fs, L1228fs, L1148fs, L1149fs, L1164fs, L1209fs, L1234fs, L1249fs, L1250fs, L1108fs, L1165fs, L1229fs, L1235fs, L1276fs, L980fs	Hereditary breast ovarian cancer syndrome	VCV003648763	17	41243722 - 41243723	17	43091705 - 43091706	3648763	3784620		NC_000017.11:43091704:ATAT:AT	Microsatellite	frameshift variant|intron variant	Pathogenic	Apr 4, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3825dup (p.Leu1276fs)	BRCA1|LOC126862571	L1229fs, L1276fs, L1188fs, L1209fs, L1235fs, L1249fs, L1250fs, L980fs, L1164fs, L1205fs, L1208fs, L1234fs, L408fs, L1148fs, L1206fs, L1108fs, L1149fs, L1165fs, L1187fs, L1228fs, L1273fs, L1275fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037550	17	41243722 - 41243723	17	43091705 - 43091706	37550	46106	rs397507220	NC_000017.11:43091705:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3824dup (p.Leu1276fs)	BRCA1|LOC126862571	L1276fs, L1229fs, L1108fs, L1188fs, L1205fs, L1228fs, L1249fs, L408fs, L1149fs, L980fs, L1164fs, L1187fs, L1206fs, L1209fs, L1234fs, L1235fs, L1250fs, L1273fs, L1148fs, L1165fs, L1208fs, L1275fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548295	17	41243723 - 41243724	17	43091706 - 43091707	548295	538804	rs1555586989	NC_000017.11:43091706:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3825del (p.Leu1276fs)	BRCA1|LOC126862571	L1229fs, L1276fs, L1165fs, L1187fs, L1208fs, L1209fs, L1234fs, L1275fs, L408fs, L1108fs, L1250fs, L1273fs, L1148fs, L1149fs, L1228fs, L980fs, L1164fs, L1188fs, L1205fs, L1206fs, L1235fs, L1249fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462622	17	41243723	17	43091706	462622	466860	rs1555586983	NC_000017.11:43091705:T:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3819_3823del (p.Gln1273fs)	BRCA1|LOC126862571	Q1226fs, Q1273fs, Q1145fs, Q1162fs, Q1206fs, Q1231fs, Q1247fs, Q1105fs, Q1161fs, Q1205fs, Q405fs, Q1146fs, Q1184fs, Q1185fs, Q1225fs, Q1232fs, Q977fs, Q1202fs, Q1203fs, Q1246fs, Q1270fs, Q1272fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224418	17	41243725 - 41243729	17	43091708 - 43091712	224418	226200	rs886037785	NC_000017.11:43091707:TTACCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3822_3823insT (p.Ile1275fs)	BRCA1|LOC126862571	I1275fs, I1228fs, I1107fs, I1186fs, I1204fs, I1205fs, I979fs, I1164fs, I1227fs, I1234fs, I1248fs, I1272fs, I1274fs, I407fs, I1147fs, I1163fs, I1187fs, I1207fs, I1208fs, I1148fs, I1233fs, I1249fs	not provided	VCV000055018	17	41243725 - 41243726	17	43091708 - 43091709	55018	69685	rs397509111	NC_000017.11:43091708::A	Insertion	frameshift variant|intron variant	Pathogenic	Aug 20, 2014	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3821dup (p.Ile1275fs)	BRCA1|LOC126862571	I1228fs, I1275fs, I1164fs, I1186fs, I1207fs, I1234fs, I979fs, I1148fs, I1187fs, I1227fs, I1233fs, I1272fs, I1147fs, I1163fs, I1204fs, I1205fs, I1248fs, I407fs, I1107fs, I1208fs, I1249fs, I1274fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266407	17	41243726 - 41243727	17	43091709 - 43091710	266407	261706	rs886040167	NC_000017.11:43091709:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3820dup (p.Val1274fs)	BRCA1|LOC126862571	V1274fs, V1227fs, V1146fs, V1203fs, V1204fs, V1247fs, V1248fs, V406fs, V1106fs, V1162fs, V1185fs, V1186fs, V1232fs, V1147fs, V1206fs, V1233fs, V1271fs, V1273fs, V978fs, V1163fs, V1207fs, V1226fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055017	17	41243727 - 41243728	17	43091710 - 43091711	55017	69684	rs80357616	NC_000017.11:43091710:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3820del (p.Gln1273_Val1274insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055016	17	41243728	17	43091711	55016	69683	rs80357616	NC_000017.11:43091710:CC:C	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3813_3819del (p.Ser1271fs)	BRCA1|LOC126862571	S1103fs, S1143fs, S1144fs, S1159fs, S1160fs, S1182fs, S1183fs, S1200fs, S1201fs, S1203fs, S1204fs, S1223fs, S1224fs, S1229fs, S1230fs, S1244fs, S1245fs, S1268fs, S1270fs, S1271fs, S403fs, S975fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003904691	17	41243729 - 41243735	17	43091712 - 43091718	3904691	4020563		NC_000017.11:43091711:CTGGTTACTG:CTG	Deletion	intron variant|frameshift variant	Pathogenic	Dec 27, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3817C>T (p.Gln1273Ter)	BRCA1|LOC126862571	Q1273*, Q1226*, Q1184*, Q1203*, Q1225*, Q977*, Q1145*, Q1202*, Q1205*, Q1247*, Q1270*, Q1105*, Q1161*, Q1162*, Q1232*, Q1246*, Q1272*, Q1146*, Q1185*, Q1206*, Q1231*, Q405*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055015	17	41243731	17	43091714	55015	69682	rs80357208	NC_000017.11:43091713:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3812_3816delinsATATTGGTAATATTGGCAAATGACTG (p.Ser1271_Asn1272delinsAsnIleGlyAsnIleGlyLysTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV004294278	17	41243732 - 41243736	17	43091715 - 43091719	4294278	4406801		NC_000017.11:43091714:GTTAC:CAGTCATTTGCCAATATTACCAATAT	Indel	nonsense|intron variant	Pathogenic	Sep 29, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3815dup (p.Asn1272fs)	BRCA1|LOC126862571	N1144fs, N1224fs, N1225fs, N1230fs, N1246fs, N1271fs, N1272fs, N1104fs, N1160fs, N1183fs, N1205fs, N1145fs, N1202fs, N976fs, N1245fs, N1269fs, N1161fs, N1184fs, N1201fs, N1204fs, N1231fs, N404fs	Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast	VCV003893007	17	41243732 - 41243733	17	43091715 - 43091716	3893007	4008891		NC_000017.11:43091715:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Jun 26, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3815_3816insT (p.Gln1273fs)	BRCA1|LOC126862571	Q1226fs, Q1273fs, Q1145fs, Q1162fs, Q1185fs, Q1246fs, Q1247fs, Q1270fs, Q1272fs, Q1206fs, Q1231fs, Q405fs, Q1146fs, Q1203fs, Q1225fs, Q1232fs, Q1105fs, Q1161fs, Q1184fs, Q1202fs, Q1205fs, Q977fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548165	17	41243732 - 41243733	17	43091715 - 43091716	548165	538805	rs1555587013	NC_000017.11:43091715::A	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3814_3815insT (p.Asn1272fs)	BRCA1|LOC126862571	N1225fs, N1272fs, N1160fs, N1183fs, N1184fs, N1204fs, N1205fs, N1245fs, N1246fs, N404fs, N1145fs, N1201fs, N1224fs, N976fs, N1202fs, N1230fs, N1231fs, N1269fs, N1271fs, N1104fs, N1144fs, N1161fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055014	17	41243733 - 41243734	17	43091716 - 43091717	55014	69681	rs397509109	NC_000017.11:43091716::A	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3813dup (p.Asn1272Ter)	BRCA1|LOC126862571	N1272*, N1225*, N1104*, N1183*, N1184*, N1201*, N1269*, N404*, N1144*, N1161*, N1202*, N1245*, N1145*, N1160*, N1224*, N1246*, N1271*, N1204*, N1205*, N1230*, N1231*, N976*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055013	17	41243734 - 41243735	17	43091717 - 43091718	55013	69680	rs397509108	NC_000017.11:43091717:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3810C>A (p.Cys1270Ter)	BRCA1|LOC126862571	C1270*, C1223*, C1142*, C1159*, C1200*, C1228*, C1102*, C1143*, C1158*, C1181*, C1182*, C1199*, C1267*, C402*, C1203*, C1222*, C974*, C1202*, C1229*, C1243*, C1244*, C1269*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266406	17	41243738	17	43091721	266406	261707	rs886040166	NC_000017.11:43091720:G:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3800T>A (p.Leu1267Ter)	BRCA1|LOC126862571	L1099*, L1139*, L1140*, L1155*, L1156*, L1178*, L1179*, L1196*, L1197*, L1199*, L1200*, L1219*, L1220*, L1225*, L1226*, L1240*, L1241*, L1264*, L1266*, L1267*, L399*, L971*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004071201	17	41243748	17	43091731	4071201	4185049		NC_000017.11:43091730:A:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Jun 11, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3800T>G (p.Leu1267Ter)	BRCA1|LOC126862571	L1267*, L1220*, L1140*, L1156*, L1219*, L1225*, L1264*, L399*, L1139*, L1178*, L1199*, L971*, L1179*, L1240*, L1241*, L1099*, L1155*, L1196*, L1197*, L1200*, L1226*, L1266*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531441	17	41243748	17	43091731	531441	531071	rs587782190	NC_000017.11:43091730:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3798del (p.Ser1266_Leu1267insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV002580983	17	41243750	17	43091733	2580983	2748568	rs2552136662	NC_000017.11:43091732:G:	Deletion	intron variant|frameshift variant	Pathogenic	Mar 25, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3794del (p.Asn1265fs)	BRCA1|LOC126862571	N1218fs, N1265fs, N1153fs, N1154fs, N1197fs, N1239fs, N1262fs, N397fs, N1097fs, N1138fs, N1194fs, N1195fs, N1223fs, N1224fs, N1137fs, N1176fs, N1198fs, N1238fs, N1264fs, N969fs, N1177fs, N1217fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055008	17	41243754	17	43091737	55008	69675	rs80357767	NC_000017.11:43091736:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3792dup (p.Asn1265fs)	BRCA1|LOC126862571	N1154fs, N1176fs, N1194fs, N1198fs, N1218fs, N1223fs, N1264fs, N1138fs, N1153fs, N1195fs, N1238fs, N397fs, N1137fs, N1177fs, N1197fs, N1224fs, N1265fs, N1097fs, N1217fs, N1239fs, N1262fs, N969fs	Hereditary cancer-predisposing syndrome	VCV003481837	17	41243755 - 41243756	17	43091738 - 43091739	3481837	3640048		NC_000017.11:43091738:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Aug 23, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3791del (p.Lys1264fs)	BRCA1|LOC126862571	K1217fs, K1264fs, K1096fs, K1152fs, K1194fs, K1196fs, K1136fs, K1137fs, K1175fs, K1176fs, K396fs, K1153fs, K1193fs, K1197fs, K1216fs, K1222fs, K1223fs, K1237fs, K1238fs, K1261fs, K1263fs, K968fs	not provided|Hereditary cancer-predisposing syndrome	VCV000619793	17	41243757	17	43091740	619793	611233	rs1567790067	NC_000017.11:43091739:TT:T	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3785C>A (p.Ser1262Ter)	BRCA1|LOC126862571	S1262*, S1215*, S1173*, S1195*, S1214*, S1259*, S394*, S1094*, S1134*, S1135*, S1150*, S1151*, S1192*, S1194*, S966*, S1191*, S1221*, S1236*, S1261*, S1174*, S1220*, S1235*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055006	17	41243763	17	43091746	55006	69673	rs80357269	NC_000017.11:43091745:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3782delinsATA (p.Leu1261fs)	BRCA1|LOC126862571	L1193fs, L1150fs, L1173fs, L1214fs, L1258fs, L1134fs, L1149fs, L1190fs, L1191fs, L1194fs, L1213fs, L1220fs, L1234fs, L1261fs, L393fs, L1093fs, L1133fs, L1172fs, L1219fs, L1235fs, L1260fs, L965fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003148667	17	41243766	17	43091749	3148667	3307915	rs2552137089	NC_000017.11:43091748:A:TAT	Indel	frameshift variant|intron variant	Pathogenic	Jan 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3773_3781dup (p.Leu1261Ter)	BRCA1|LOC126862571	L1093*, L1191*, L1213*, L1260*, L1261*, L1133*, L1134*, L1149*, L1172*, L1190*, L1219*, L1220*, L1234*, L1150*, L1173*, L1194*, L1214*, L393*, L965*, L1193*, L1235*, L1258*	Hereditary breast ovarian cancer syndrome	VCV002824395	17	41243766 - 41243767	17	43091749 - 43091750	2824395	2979069	rs2552137126	NC_000017.11:43091749:ATAAATTCT:ATAAATTCTATAAATTCT	Duplication	intron variant|nonsense	Pathogenic	Jan 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3782T>A (p.Leu1261Ter)	BRCA1|LOC126862571	L1214*, L1261*, L1093*, L1172*, L1220*, L1258*, L1173*, L1190*, L1194*, L1213*, L1234*, L1133*, L1134*, L1191*, L1193*, L1235*, L393*, L965*, L1149*, L1150*, L1219*, L1260*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000824201	17	41243766	17	43091749	824201	813721	rs397507219	NC_000017.11:43091748:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 8, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3782del (p.Leu1261fs)	BRCA1|LOC126862571	L1214fs, L1261fs, L1172fs, L1190fs, L1194fs, L1235fs, L1149fs, L1173fs, L1191fs, L1219fs, L1220fs, L1093fs, L1133fs, L1234fs, L1258fs, L393fs, L1134fs, L1150fs, L1193fs, L1213fs, L1260fs, L965fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055004	17	41243766	17	43091749	55004	69671	rs80357545	NC_000017.11:43091748:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3782T>G (p.Leu1261Ter)	BRCA1|LOC126862571	L1261*, L1214*, L1191*, L1258*, L1133*, L1134*, L1150*, L1194*, L1213*, L1219*, L1172*, L1190*, L1193*, L1234*, L1235*, L1260*, L393*, L965*, L1093*, L1149*, L1173*, L1220*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055003	17	41243766	17	43091749	55003	69670	rs397507219	NC_000017.11:43091748:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3780dup (p.Leu1261fs)	BRCA1|LOC126862571	L1214fs, L1261fs, L1172fs, L1191fs, L1213fs, L1219fs, L1220fs, L1260fs, L393fs, L965fs, L1133fs, L1134fs, L1150fs, L1190fs, L1193fs, L1194fs, L1234fs, L1149fs, L1235fs, L1258fs, L1093fs, L1173fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548291	17	41243767 - 41243768	17	43091750 - 43091751	548291	538806	rs1555587063	NC_000017.11:43091750:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3779T>G (p.Leu1260Ter)	BRCA1|LOC126862571	L1260*, L1213*, L1133*, L1189*, L392*, L964*, L1132*, L1149*, L1192*, L1193*, L1212*, L1148*, L1190*, L1233*, L1234*, L1257*, L1092*, L1171*, L1172*, L1218*, L1219*, L1259*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254444	17	41243769	17	43091752	254444	249099	rs886038025	NC_000017.11:43091751:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3778_3779insA (p.Leu1260fs)	BRCA1|LOC126862571	L1213fs, L1260fs, L1171fs, L1189fs, L1219fs, L392fs, L1092fs, L1133fs, L1192fs, L1218fs, L964fs, L1148fs, L1172fs, L1190fs, L1193fs, L1233fs, L1259fs, L1132fs, L1149fs, L1212fs, L1234fs, L1257fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125653	17	41243769 - 41243770	17	43091752 - 43091753	125653	131191	rs80357849	NC_000017.11:43091752::T	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3779del (p.Leu1260fs)	BRCA1|LOC126862571	L1213fs, L1260fs, L1148fs, L1149fs, L1212fs, L1233fs, L1171fs, L1172fs, L1190fs, L1192fs, L1193fs, L1218fs, L1234fs, L1092fs, L1189fs, L1219fs, L1257fs, L392fs, L964fs, L1132fs, L1133fs, L1259fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055002	17	41243769	17	43091752	55002	69669	rs80357798	NC_000017.11:43091751:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3771_3778del (p.Glu1257fs)	BRCA1|LOC126862571	E1210fs, E1257fs, E1089fs, E1129fs, E1130fs, E1145fs, E1186fs, E1187fs, E389fs, E1189fs, E1216fs, E1256fs, E1146fs, E1168fs, E1169fs, E1209fs, E1190fs, E1215fs, E1230fs, E1231fs, E1254fs, E961fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054999	17	41243770 - 41243777	17	43091753 - 43091760	54999	69666	rs397509104	NC_000017.11:43091752:AATTCTCC:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3770_3777del (p.Glu1257fs)	BRCA1|LOC126862571	E1210fs, E1257fs, E1146fs, E1190fs, E1230fs, E1256fs, E1130fs, E1215fs, E1231fs, E1089fs, E1145fs, E1169fs, E1187fs, E1189fs, E1216fs, E389fs, E961fs, E1129fs, E1168fs, E1186fs, E1209fs, E1254fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254443	17	41243771 - 41243778	17	43091754 - 43091761	254443	249100	rs886038024	NC_000017.11:43091753:ATTCTCCT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3772_3776del (p.Glu1258fs)	BRCA1|LOC126862571	E1258fs, E1211fs, E1130fs, E1190fs, E1216fs, E1217fs, E1231fs, E1090fs, E1170fs, E1191fs, E1232fs, E962fs, E1146fs, E1187fs, E1188fs, E390fs, E1131fs, E1147fs, E1169fs, E1210fs, E1255fs, E1257fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431253	17	41243772 - 41243776	17	43091755 - 43091759	431253	424810	rs1135401867	NC_000017.11:43091754:TTCTC:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3771_3775del (p.Glu1258fs)	BRCA1|LOC126862571	E1090fs, E1130fs, E1131fs, E1146fs, E1147fs, E1169fs, E1170fs, E1187fs, E1188fs, E1190fs, E1191fs, E1210fs, E1211fs, E1216fs, E1217fs, E1231fs, E1232fs, E1255fs, E1257fs, E1258fs, E390fs, E962fs	not provided	VCV003337554	17	41243773 - 41243777	17	43091756 - 43091760	3337554	3496215		NC_000017.11:43091755:TCTCCTCT:TCT	Deletion	frameshift variant|intron variant	Pathogenic	May 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3774_3775del (p.Asn1259fs)	BRCA1|LOC126862571	N1212fs, N1259fs, N1091fs, N1170fs, N1211fs, N1232fs, N391fs, N1188fs, N1192fs, N1256fs, N1131fs, N1132fs, N1147fs, N1189fs, N1218fs, N1233fs, N1148fs, N1171fs, N1191fs, N1217fs, N1258fs, N963fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055001	17	41243773 - 41243774	17	43091756 - 43091757	55001	69668	rs397509106	NC_000017.11:43091755:TCTC:TC	Microsatellite	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3771_3772del (p.Asn1259fs)	BRCA1|LOC126862571	N1212fs, N1259fs, N1147fs, N1170fs, N1256fs, N1188fs, N1211fs, N1218fs, N1232fs, N1091fs, N1189fs, N1192fs, N1217fs, N1131fs, N1132fs, N1148fs, N1171fs, N1191fs, N1233fs, N1258fs, N391fs, N963fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125650	17	41243776 - 41243777	17	43091759 - 43091760	125650	131188	rs80357810	NC_000017.11:43091758:CC:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3772G>T (p.Glu1258Ter)	BRCA1|LOC126862571	E1258*, E1211*, E1090*, E1131*, E1216*, E1231*, E390*, E962*, E1146*, E1147*, E1187*, E1190*, E1255*, E1130*, E1170*, E1188*, E1210*, E1257*, E1169*, E1191*, E1217*, E1232*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055000	17	41243776	17	43091759	55000	69667	rs397509105	NC_000017.11:43091758:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3771_3772delinsC (p.Glu1257fs)	BRCA1|LOC126862571	E1210fs, E1257fs, E1130fs, E1146fs, E1168fs, E1186fs, E1187fs, E389fs, E1089fs, E1190fs, E1209fs, E1215fs, E1230fs, E1254fs, E1129fs, E1145fs, E1169fs, E1231fs, E1256fs, E961fs, E1189fs, E1216fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037547	17	41243776 - 41243777	17	43091759 - 43091760	37547	46103	rs397507218	NC_000017.11:43091758:CC:G	Indel	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3770_3771del (p.Glu1257fs)	BRCA1|LOC126862571	E1257fs, E1210fs, E1089fs, E1130fs, E1145fs, E1209fs, E1216fs, E1231fs, E1129fs, E1146fs, E1186fs, E1215fs, E1254fs, E1168fs, E1187fs, E1189fs, E961fs, E1169fs, E1190fs, E1230fs, E1256fs, E389fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037546	17	41243777 - 41243778	17	43091760 - 43091761	37546	46102	rs80357579	NC_000017.11:43091759:CTCT:CT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3768_3769insAGGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAAGAACACA (p.Thr1256_Glu1257insArgProGlyAlaValAlaHisAlaCysAsnProSerThrLeuGlyGlyArgGlyGlyArgIleThrXaaXaaXaaXaaLysLysLysLysLysLysLysAsnThr)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV001450577	17	41243779 - 41243780	17	43091762 - 43091763	1450577	1351098			Microsatellite	intron variant|inframe_insertion	Pathogenic	May 14, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3767_3768del (p.Thr1256fs)	BRCA1|LOC126862571	T1209fs, T1256fs, T1088fs, T1129fs, T1144fs, T1145fs, T1189fs, T1255fs, T1128fs, T1168fs, T1185fs, T1186fs, T1215fs, T960fs, T1188fs, T1214fs, T1230fs, T1167fs, T1208fs, T1229fs, T1253fs, T388fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182074	17	41243780 - 41243781	17	43091763 - 43091764	182074	180842	rs730881440	NC_000017.11:43091762:TGTGT:TGT	Microsatellite	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3766dup (p.Thr1256fs)	BRCA1|LOC126862571	T1256fs, T1209fs, T1185fs, T1189fs, T1229fs, T1253fs, T388fs, T1088fs, T1144fs, T1145fs, T1186fs, T1188fs, T1208fs, T1167fs, T1214fs, T1230fs, T1255fs, T960fs, T1128fs, T1129fs, T1168fs, T1215fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125649	17	41243781 - 41243782	17	43091764 - 43091765	125649	131187	rs80357704	NC_000017.11:43091764:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3766del (p.Thr1256fs)	BRCA1|LOC126862571	T1088fs, T1128fs, T1129fs, T1144fs, T1145fs, T1167fs, T1168fs, T1185fs, T1186fs, T1188fs, T1189fs, T1208fs, T1209fs, T1214fs, T1215fs, T1229fs, T1230fs, T1253fs, T1255fs, T1256fs, T388fs, T960fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573259	17	41243782	17	43091765	2573259	2738207	rs2552138123	NC_000017.11:43091764:T:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 4, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3765del (p.Asn1255fs)	BRCA1|LOC126862571	N1255fs, N1208fs, N1087fs, N1127fs, N1187fs, N1207fs, N1252fs, N1128fs, N1166fs, N1184fs, N1185fs, N1188fs, N1213fs, N1229fs, N1143fs, N1167fs, N1214fs, N1228fs, N1254fs, N387fs, N1144fs, N959fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266405	17	41243783	17	43091766	266405	261708	rs886040165	NC_000017.11:43091765:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3764dup (p.Asn1255fs)	BRCA1|LOC126862571	N1208fs, N1255fs, N1166fs, N1167fs, N1188fs, N1207fs, N1252fs, N387fs, N1087fs, N1143fs, N1187fs, N1228fs, N1254fs, N1127fs, N1128fs, N1214fs, N1229fs, N959fs, N1144fs, N1184fs, N1185fs, N1213fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037545	17	41243783 - 41243784	17	43091766 - 43091767	37545	46101	rs80357848	NC_000017.11:43091766:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3763_3764del (p.Asn1255fs)	BRCA1|LOC126862571	N1255fs, N1208fs, N1143fs, N1087fs, N1167fs, N1228fs, N959fs, N1184fs, N1185fs, N1207fs, N1229fs, N1127fs, N1144fs, N1166fs, N1188fs, N1213fs, N1128fs, N1187fs, N1214fs, N1252fs, N1254fs, N387fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054997	17	41243784 - 41243785	17	43091767 - 43091768	54997	69664	rs397509103	NC_000017.11:43091766:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3762_3763insTT (p.Asn1255fs)	BRCA1|LOC126862571	N1208fs, N1255fs, N1144fs, N1167fs, N1184fs, N1252fs, N959fs, N1087fs, N1128fs, N1187fs, N1213fs, N1185fs, N1188fs, N1207fs, N1229fs, N1127fs, N1143fs, N1166fs, N1214fs, N1228fs, N1254fs, N387fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548244	17	41243785 - 41243786	17	43091768 - 43091769	548244	538807	rs1555587113	NC_000017.11:43091768::AA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3762_3763del (p.Asn1255fs)	BRCA1|LOC126862571	N1208fs, N1255fs, N1187fs, N1188fs, N1207fs, N1214fs, N1229fs, N387fs, N1144fs, N1166fs, N1252fs, N1087fs, N1143fs, N1184fs, N1228fs, N1254fs, N959fs, N1127fs, N1128fs, N1167fs, N1185fs, N1213fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054996	17	41243785 - 41243786	17	43091768 - 43091769	54996	69663	rs80357645	NC_000017.11:43091767:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3761_3762insT (p.Lys1254fs)	BRCA1|LOC126862571	K1254fs, K1207fs, K1143fs, K1165fs, K1166fs, K1183fs, K1184fs, K1213fs, K958fs, K1127fs, K1186fs, K1206fs, K1212fs, K1227fs, K1251fs, K386fs, K1126fs, K1187fs, K1253fs, K1086fs, K1142fs, K1228fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548207	17	41243786 - 41243787	17	43091769 - 43091770	548207	538808	rs80357928	NC_000017.11:43091769::A	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3761_3762insTT (p.Lys1254fs)	BRCA1|LOC126862571	K1207fs, K1254fs, K1086fs, K1126fs, K1127fs, K1165fs, K1183fs, K1184fs, K386fs, K1143fs, K1186fs, K1187fs, K1251fs, K1253fs, K1166fs, K1206fs, K1212fs, K1228fs, K958fs, K1142fs, K1213fs, K1227fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091614	17	41243786 - 41243787	17	43091769 - 43091770	91614	97091	rs80357928	NC_000017.11:43091769::AA	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3760_3761insT (p.Lys1254fs)	BRCA1|LOC126862571	K1207fs, K1254fs, K1086fs, K1127fs, K1143fs, K1166fs, K1213fs, K1227fs, K1142fs, K1187fs, K1165fs, K1184fs, K1186fs, K1206fs, K1228fs, K1251fs, K958fs, K1126fs, K1183fs, K1212fs, K1253fs, K386fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054995	17	41243787 - 41243788	17	43091770 - 43091771	54995	69662	rs80357986	NC_000017.11:43091770::A	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3760A>T (p.Lys1254Ter)	BRCA1|LOC126862571	K1183*, K1227*, K386*, K958*, K1142*, K1166*, K1184*, K1187*, K1207*, K1228*, K1253*, K1127*, K1165*, K1186*, K1212*, K1086*, K1126*, K1143*, K1206*, K1213*, K1251*, K1254*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002884071	17	41243788	17	43091771	2884071	3043373	rs80357362	NC_000017.11:43091770:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3759_3760insTT (p.Lys1254fs)	BRCA1|LOC126862571	K1207fs, K1254fs, K1142fs, K1143fs, K1165fs, K1213fs, K1228fs, K1251fs, K958fs, K1086fs, K1166fs, K1126fs, K1183fs, K1212fs, K1186fs, K1227fs, K1253fs, K1127fs, K1184fs, K1187fs, K1206fs, K386fs	Hereditary breast ovarian cancer syndrome	VCV001075602	17	41243788 - 41243789	17	43091771 - 43091772	1075602	1064200	rs80357687	NC_000017.11:43091771:A:AAA	Insertion	frameshift variant|intron variant	Pathogenic	Feb 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3756_3760del (p.Ser1253fs)	BRCA1|LOC126862571	S1206fs, S1253fs, S1186fs, S1226fs, S1126fs, S1183fs, S1185fs, S1252fs, S385fs, S1085fs, S1142fs, S1165fs, S1182fs, S1211fs, S1227fs, S1125fs, S1141fs, S1164fs, S1205fs, S1212fs, S1250fs, S957fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266404	17	41243788 - 41243792	17	43091771 - 43091775	266404	261709	rs886040164	NC_000017.11:43091770:TAGAC:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3759dup (p.Lys1254Ter)	BRCA1|LOC126862571	K1254*, K1207*, K1184*, K1187*, K1213*, K1127*, K1142*, K1165*, K1253*, K1086*, K1143*, K1186*, K1206*, K1212*, K1228*, K1251*, K386*, K1126*, K1166*, K1183*, K1227*, K958*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054992	17	41243788 - 41243789	17	43091771 - 43091772	54992	69659	rs80357687	NC_000017.11:43091771:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3759_3760del (p.Lys1254fs)	BRCA1|LOC126862571	K1207fs, K1254fs, K1126fs, K1127fs, K1166fs, K1184fs, K1206fs, K1227fs, K1251fs, K386fs, K1183fs, K1212fs, K958fs, K1086fs, K1143fs, K1165fs, K1186fs, K1228fs, K1253fs, K1142fs, K1187fs, K1213fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037544	17	41243788 - 41243789	17	43091771 - 43091772	37544	46100	rs80357520	NC_000017.11:43091770:TA:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3758_3759del (p.Leu1252_Ser1253insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548311	17	41243789 - 41243790	17	43091772 - 43091773	548311	538809	rs1555587135	NC_000017.11:43091771:AGA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3759del (p.Lys1254fs)	LOC126862571|BRCA1	K1254fs, K1207fs, K1126fs, K1143fs, K1183fs, K1127fs, K1187fs, K1228fs, K1251fs, K1253fs, K1086fs, K1165fs, K1166fs, K1212fs, K1213fs, K1227fs, K386fs, K958fs, K1142fs, K1184fs, K1186fs, K1206fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096915	17	41243789	17	43091772	96915	102818	rs431825398	NC_000017.11:43091771:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3756_3759del (p.Ser1253fs)	BRCA1|LOC126862571	S1253fs, S1206fs, S1141fs, S1205fs, S1212fs, S385fs, S1125fs, S1126fs, S1164fs, S1165fs, S1182fs, S1186fs, S1085fs, S1183fs, S1185fs, S1211fs, S1227fs, S1252fs, S957fs, S1142fs, S1226fs, S1250fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017673	17	41243789 - 41243792	17	43091772 - 43091775	17673	32712	rs80357868	NC_000017.11:43091771:AGACAGACA:AGACA	Microsatellite	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3756_3757del (p.Leu1252_Ser1253insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054989	17	41243791 - 41243792	17	43091774 - 43091775	54989	69656	rs397509099	NC_000017.11:43091773:ACA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3755dup (p.Ser1253fs)	LOC126862571|BRCA1	S1125fs, S1164fs, S1165fs, S1183fs, S1206fs, S1226fs, S1085fs, S1205fs, S1211fs, S1212fs, S1250fs, S1253fs, S1126fs, S1141fs, S1182fs, S1186fs, S1252fs, S957fs, S1142fs, S1185fs, S1227fs, S385fs	Hereditary breast ovarian cancer syndrome	VCV003645421	17	41243792 - 41243793	17	43091775 - 43091776	3645421	3783836		NC_000017.11:43091775:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Mar 12, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3755del (p.Leu1252fs)	BRCA1|LOC126862571	L1084fs, L1124fs, L1141fs, L1185fs, L1210fs, L1251fs, L1252fs, L1125fs, L1163fs, L1211fs, L1140fs, L1164fs, L1184fs, L1205fs, L956fs, L1181fs, L1182fs, L1204fs, L1225fs, L1226fs, L1249fs, L384fs	Hereditary breast ovarian cancer syndrome	VCV002708101	17	41243793	17	43091776	2708101	2874266	rs2552138619	NC_000017.11:43091775:A:	Deletion	intron variant|frameshift variant	Pathogenic	Jan 7, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3754_3755del (p.Leu1252fs)	BRCA1|LOC126862571	L1252fs, L1205fs, L1124fs, L1164fs, L1210fs, L1163fs, L1185fs, L1204fs, L1251fs, L956fs, L1084fs, L1125fs, L1181fs, L1184fs, L1225fs, L1140fs, L1141fs, L1182fs, L1211fs, L1226fs, L1249fs, L384fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431252	17	41243793 - 41243794	17	43091776 - 43091777	431252	424811	rs1135401866	NC_000017.11:43091775:AGA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3752_3753del (p.Cys1251fs)	BRCA1|LOC126862571	C1204fs, C1251fs, C1203fs, C1124fs, C1162fs, C1184fs, C1209fs, C1123fs, C1140fs, C1210fs, C1248fs, C1250fs, C955fs, C1083fs, C1139fs, C1163fs, C1180fs, C1181fs, C1183fs, C1224fs, C1225fs, C383fs	Hereditary cancer-predisposing syndrome	VCV003825327	17	41243795 - 41243796	17	43091778 - 43091779	3825327	1245827		NC_000017.11:43091777:ACAC:AC	Microsatellite	frameshift variant|intron variant	Pathogenic	Mar 13, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3753T>A (p.Cys1251Ter)	BRCA1|LOC126862571	C1251*, C1204*, C1203*, C1140*, C1163*, C1180*, C1181*, C1183*, C1225*, C1250*, C1083*, C1124*, C1139*, C1162*, C1224*, C1248*, C955*, C1123*, C1184*, C1209*, C1210*, C383*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054988	17	41243795	17	43091778	54988	69655	rs397509098	NC_000017.11:43091777:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3749_3752del (p.Glu1250fs)	BRCA1|LOC126862571	E1250fs, E1203fs, E1161fs, E1180fs, E1208fs, E1209fs, E1224fs, E1247fs, E382fs, E954fs, E1179fs, E1182fs, E1249fs, E1082fs, E1122fs, E1138fs, E1139fs, E1162fs, E1202fs, E1123fs, E1183fs, E1223fs	Hereditary breast ovarian cancer syndrome	VCV000941075	17	41243796 - 41243799	17	43091779 - 43091782	941075	937950	rs2053531990	NC_000017.11:43091778:CACTC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 13, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3750del (p.Glu1250fs)	BRCA1|LOC126862571	E1203fs, E1250fs, E1182fs, E1209fs, E1247fs, E1082fs, E1122fs, E1161fs, E1202fs, E954fs, E1139fs, E1180fs, E1208fs, E1223fs, E1224fs, E1123fs, E1138fs, E1162fs, E1179fs, E1183fs, E1249fs, E382fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266403	17	41243798	17	43091781	266403	261710	rs886040163	NC_000017.11:43091780:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3748_3749insC (p.Glu1250fs)	BRCA1|LOC126862571	E1250fs, E1203fs, E1138fs, E1161fs, E1182fs, E1208fs, E1209fs, E1223fs, E1224fs, E382fs, E1123fs, E1162fs, E1202fs, E1247fs, E1179fs, E1180fs, E1183fs, E1082fs, E1122fs, E1139fs, E1249fs, E954fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548228	17	41243799 - 41243800	17	43091782 - 43091783	548228	538810	rs1555587165	NC_000017.11:43091782::G	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3705_3747dup (p.Glu1250delinsGlnTyrThrPheSerValTyrTer)	LOC126862571|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440468	17	41243800 - 41243801	17	43091783 - 43091784	440468	432905	rs797044631	NC_000017.11:43091783:GGTAGCAACGGTGCTATGCCTAGTAGACTGAGAAGGTATATTG:GGTAGCAACGGTGCTATGCCTAGTAGACTGAGAAGGTATATTGGGTAGCAACGGTGCTATGCCTAGTAGACTGAGAAGGTATATTG	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3747dup (p.Glu1250fs)	BRCA1|LOC126862571	E1250fs, E1203fs, E1139fs, E1161fs, E1162fs, E1179fs, E1202fs, E1223fs, E1224fs, E1249fs, E1122fs, E1138fs, E1182fs, E382fs, E1123fs, E1180fs, E1183fs, E1247fs, E954fs, E1082fs, E1208fs, E1209fs	Hereditary cancer-predisposing syndrome	VCV000431251	17	41243800 - 41243801	17	43091783 - 43091784	431251	424812	rs1555587185	NC_000017.11:43091783:GG:GGG	Duplication	frameshift variant|intron variant	Pathogenic	Jan 12, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3748G>T (p.Glu1250Ter)	BRCA1|LOC126862571	E1250*, E1203*, E1123*, E1138*, E1161*, E1208*, E1223*, E954*, E1162*, E1179*, E1182*, E382*, E1082*, E1180*, E1202*, E1209*, E1122*, E1139*, E1183*, E1224*, E1247*, E1249*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017672	17	41243800	17	43091783	17672	32711	rs28897686	NC_000017.11:43091782:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3714_3747del (p.Gln1240fs)	BRCA1|LOC126862571	Q1193fs, Q1240fs, Q1129fs, Q1173fs, Q1213fs, Q1112fs, Q1128fs, Q1151fs, Q1192fs, Q1199fs, Q1237fs, Q1239fs, Q372fs, Q1152fs, Q1072fs, Q1113fs, Q1169fs, Q1170fs, Q1172fs, Q1198fs, Q1214fs, Q944fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125646	17	41243801 - 41243834	17	43091784 - 43091817	125646	131184	rs886038023	NC_000017.11:43091783:GGTAGCAACGGTGCTATGCCTAGTAGACTGAGAAGGTA:GGTA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3731_3743del (p.His1244fs)	LOC126862571|BRCA1	H1197fs, H1244fs, H1117fs, H1174fs, H1196fs, H1217fs, H1218fs, H1241fs, H376fs, H1116fs, H1155fs, H1156fs, H1173fs, H1177fs, H1203fs, H1243fs, H1076fs, H1132fs, H1133fs, H1176fs, H1202fs, H948fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266402	17	41243805 - 41243817	17	43091788 - 43091800	266402	261711	rs886040162	NC_000017.11:43091787:GCAACGGTGCTATGC:GC	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3722_3740del (p.Ser1241fs)	BRCA1|LOC126862571	S1194fs, S1241fs, S1114fs, S1130fs, S1193fs, S1200fs, S1073fs, S1171fs, S1174fs, S1113fs, S1129fs, S1199fs, S1215fs, S1238fs, S373fs, S1152fs, S1153fs, S1170fs, S1173fs, S1214fs, S1240fs, S945fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054981	17	41243808 - 41243826	17	43091791 - 43091809	54981	69648	rs80359882	NC_000017.11:43091790:ACGGTGCTATGCCTAGTAGAC:AC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3731_3738del (p.His1244fs)	BRCA1|LOC126862571	H1197fs, H1244fs, H1203fs, H1217fs, H1218fs, H1243fs, H1116fs, H1155fs, H1156fs, H1173fs, H1174fs, H1177fs, H1196fs, H1076fs, H1133fs, H1202fs, H1241fs, H376fs, H948fs, H1117fs, H1132fs, H1176fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266401	17	41243810 - 41243817	17	43091793 - 43091800	266401	261712	rs886040161	NC_000017.11:43091792:GGTGCTATG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3736del (p.Thr1246fs)	LOC126862571|BRCA1	T1199fs, T1246fs, T1219fs, T1220fs, T378fs, T950fs, T1078fs, T1135fs, T1157fs, T1158fs, T1176fs, T1204fs, T1205fs, T1118fs, T1134fs, T1179fs, T1198fs, T1243fs, T1119fs, T1175fs, T1178fs, T1245fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054984	17	41243812	17	43091795	54984	69651	rs80357578	NC_000017.11:43091794:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3734del (p.Ser1245fs)	BRCA1|LOC126862571	S1198fs, S1245fs, S1133fs, S1178fs, S1242fs, S1244fs, S1117fs, S1156fs, S1204fs, S377fs, S1118fs, S1134fs, S1157fs, S1175fs, S1177fs, S1219fs, S1077fs, S1174fs, S1197fs, S1203fs, S1218fs, S949fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000824142	17	41243814	17	43091797	824142	813724	rs1597861739	NC_000017.11:43091796:C:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3730_3731insGACACTTGTTATTTGGTAAAGTAAACAATATACCTTCTCAGTCTACTAGG (p.His1244fs)	BRCA1|LOC126862571	H1244fs, H1197fs, H1116fs, H1117fs, H1132fs, H1177fs, H1196fs, H948fs, H1174fs, H1202fs, H1203fs, H1243fs, H1076fs, H1133fs, H1173fs, H1176fs, H1217fs, H1218fs, H376fs, H1155fs, H1156fs, H1241fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548248	17	41243817 - 41243818	17	43091800 - 43091801	548248	538811	rs1555587210	NC_000017.11:43091800::CCTAGTAGACTGAGAAGGTATATTGTTTACTTTACCAAATAACAAGTGTC	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3729_3730insGACACTTGTTATTTGGTAAAGTAAACAATATACCTTCTCAGTCTACTAGG (p.His1244delinsAspThrCysTyrLeuValLysTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267494	17	41243818 - 41243819	17	43091801 - 43091802	267494	262965	rs886040895	NC_000017.11:43091801:CCTAGTAGACTGAGAAGGTATATTGTTTACTTTACCAAATAACAAGTGT:CCTAGTAGACTGAGAAGGTATATTGTTTACTTTACCAAATAACAAGTGTCCCTAGTAGACTGAGAAGGTATATTGTTTACTTTACCAAATAACAAGTGT	Insertion	frameshift variant|intron variant|nonsense	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3729del (p.Arg1243fs)	BRCA1|LOC126862571	R1115fs, R1116fs, R1176fs, R1202fs, R375fs, R1131fs, R1132fs, R1240fs, R1075fs, R1155fs, R1172fs, R1173fs, R1175fs, R1195fs, R1216fs, R1242fs, R1243fs, R1154fs, R1196fs, R1201fs, R1217fs, R947fs	Hereditary breast ovarian cancer syndrome	VCV003648964	17	41243819	17	43091802	3648964	3780973		NC_000017.11:43091801:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Apr 6, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3726dup (p.Arg1243Ter)	BRCA1|LOC126862571	R1196*, R1243*, R1132*, R1173*, R1202*, R1240*, R1175*, R1176*, R1116*, R1131*, R1154*, R1195*, R1216*, R375*, R1075*, R1115*, R1155*, R1172*, R1201*, R1217*, R1242*, R947*	Hereditary breast ovarian cancer syndrome	VCV000567094	17	41243821 - 41243822	17	43091804 - 43091805	567094	574470	rs1567790420	NC_000017.11:43091804:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	May 6, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3717_3718del (p.Gln1240fs)	BRCA1|LOC126862571	Q1072fs, Q1112fs, Q1113fs, Q1128fs, Q1129fs, Q1151fs, Q1152fs, Q1169fs, Q1170fs, Q1172fs, Q1173fs, Q1192fs, Q1193fs, Q1198fs, Q1199fs, Q1213fs, Q1214fs, Q1237fs, Q1239fs, Q1240fs, Q372fs, Q944fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004294238	17	41243830 - 41243831	17	43091813 - 43091814	4294238	4406763		NC_000017.11:43091812:GAGA:GA	Microsatellite	frameshift variant|intron variant	Pathogenic	Jul 21, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3718C>T (p.Gln1240Ter)	BRCA1|LOC126862571	Q1240*, Q1193*, Q1128*, Q1152*, Q1172*, Q1192*, Q1213*, Q1239*, Q1113*, Q1169*, Q1170*, Q1198*, Q1199*, Q1151*, Q1173*, Q1237*, Q372*, Q1072*, Q1112*, Q1129*, Q1214*, Q944*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054978	17	41243830	17	43091813	54978	69645	rs80356903	NC_000017.11:43091812:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3717del (p.Gln1240fs)	BRCA1|LOC126862571	Q1072fs, Q1112fs, Q1113fs, Q1128fs, Q1129fs, Q1151fs, Q1152fs, Q1169fs, Q1170fs, Q1172fs, Q1173fs, Q1192fs, Q1193fs, Q1198fs, Q1199fs, Q1213fs, Q1214fs, Q1237fs, Q1239fs, Q1240fs, Q372fs, Q944fs	Hereditary breast ovarian cancer syndrome	VCV002573560	17	41243831	17	43091814	2573560	2738504	rs2552139389	NC_000017.11:43091813:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 30, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3716dup (p.Gln1240fs)	BRCA1|LOC126862571	Q1240fs, Q1193fs, Q1112fs, Q1113fs, Q1172fs, Q1173fs, Q1192fs, Q1239fs, Q372fs, Q1128fs, Q1129fs, Q1152fs, Q1170fs, Q1213fs, Q1072fs, Q1198fs, Q1237fs, Q944fs, Q1151fs, Q1169fs, Q1199fs, Q1214fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054977	17	41243831 - 41243832	17	43091814 - 43091815	54977	69644	rs397509097	NC_000017.11:43091814:G:GG	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3715_3717delinsC (p.Ser1239fs)	BRCA1|LOC126862571	S1192fs, S1239fs, S1071fs, S1111fs, S1127fs, S1150fs, S1168fs, S1169fs, S1172fs, S1236fs, S1238fs, S1112fs, S1128fs, S1171fs, S1198fs, S1197fs, S1212fs, S371fs, S943fs, S1151fs, S1191fs, S1213fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054975	17	41243831 - 41243833	17	43091814 - 43091816	54975	69642	rs273900714	NC_000017.11:43091813:AGA:G	Indel	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3713_3716del (p.Pro1238fs)	BRCA1|LOC126862571	P1070fs, P1110fs, P1111fs, P1126fs, P1127fs, P1149fs, P1150fs, P1167fs, P1168fs, P1170fs, P1171fs, P1190fs, P1191fs, P1196fs, P1197fs, P1211fs, P1212fs, P1235fs, P1237fs, P1238fs, P370fs, P942fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003254360	17	41243832 - 41243835	17	43091815 - 43091818	3254360	3413139	rs2552139439	NC_000017.11:43091814:GAAGG:G	Deletion	frameshift variant|intron variant	Pathogenic	Apr 1, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3702_3715delinsCTATGC (p.Asn1235fs)	BRCA1|LOC126862571	N1067fs, N1107fs, N1108fs, N1123fs, N1124fs, N1146fs, N1147fs, N1164fs, N1165fs, N1167fs, N1168fs, N1187fs, N1188fs, N1193fs, N1194fs, N1208fs, N1209fs, N1232fs, N1234fs, N1235fs, N367fs, N939fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003254361	17	41243833 - 41243846	17	43091816 - 43091829	3254361	3413140	rs2552139489	NC_000017.11:43091815:AAGGTATATTGTTT:GCATAG	Indel	intron variant|frameshift variant	Pathogenic	Apr 2, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3711_3715del (p.Pro1238fs)	BRCA1|LOC126862571	P1191fs, P1238fs, P370fs, P1070fs, P1111fs, P1168fs, P1170fs, P1190fs, P1196fs, P1235fs, P1110fs, P1126fs, P1197fs, P1211fs, P1127fs, P1149fs, P1150fs, P1167fs, P1171fs, P1212fs, P1237fs, P942fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431250	17	41243833 - 41243837	17	43091816 - 43091820	431250	424813	rs1135401865	NC_000017.11:43091815:AAGGTA:A	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3715del (p.Ser1239fs)	BRCA1|LOC126862571	S1239fs, S1192fs, S1128fs, S1150fs, S1171fs, S1191fs, S1198fs, S1236fs, S943fs, S1071fs, S1111fs, S1112fs, S1127fs, S1168fs, S1172fs, S1213fs, S1238fs, S371fs, S1151fs, S1169fs, S1197fs, S1212fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054976	17	41243833	17	43091816	54976	69643	rs397509096	NC_000017.11:43091815:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3713del (p.Pro1238fs)	BRCA1|LOC126862571	P1191fs, P1238fs, P1111fs, P1171fs, P1237fs, P1070fs, P1149fs, P1150fs, P1168fs, P1170fs, P1190fs, P942fs, P1110fs, P1126fs, P1127fs, P1167fs, P1196fs, P1197fs, P1211fs, P1212fs, P1235fs, P370fs	Hereditary cancer-predisposing syndrome	VCV001734222	17	41243835	17	43091818	1734222	1786641	rs2552139542	NC_000017.11:43091817:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	May 14, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3706_3713del (p.Asn1236fs)	BRCA1|LOC126862571	N1236fs, N1189fs, N1108fs, N1125fs, N1148fs, N1165fs, N1194fs, N1233fs, N940fs, N1109fs, N1147fs, N1168fs, N1195fs, N368fs, N1124fs, N1169fs, N1188fs, N1209fs, N1210fs, N1068fs, N1166fs, N1235fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054969	17	41243835 - 41243842	17	43091818 - 43091825	54969	69636	rs80357552	NC_000017.11:43091817:GGTATATTG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3711_3712del (p.Pro1238fs)	BRCA1|LOC126862571	P1191fs, P1238fs, P1070fs, P1110fs, P1149fs, P1190fs, P942fs, P1126fs, P1150fs, P1167fs, P1170fs, P1197fs, P1212fs, P370fs, P1111fs, P1127fs, P1168fs, P1171fs, P1211fs, P1196fs, P1235fs, P1237fs	Hereditary cancer-predisposing syndrome	VCV000824110	17	41243836 - 41243837	17	43091819 - 43091820	824110	813727	rs1597861891	NC_000017.11:43091818:GT:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3710_3711dup (p.Pro1238fs)	BRCA1|LOC126862571	P1191fs, P1238fs, P1127fs, P1167fs, P1171fs, P1190fs, P1237fs, P942fs, P1070fs, P1149fs, P1211fs, P1235fs, P1110fs, P1126fs, P1168fs, P1170fs, P370fs, P1111fs, P1150fs, P1196fs, P1197fs, P1212fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254441	17	41243836 - 41243837	17	43091819 - 43091820	254441	249102	rs777371832	NC_000017.11:43091819:TATAT:TATATAT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3710del (p.Ile1237fs)	LOC126862571|BRCA1	I1237fs, I1190fs, I1110fs, I1169fs, I1211fs, I1236fs, I941fs, I1109fs, I1125fs, I1149fs, I1195fs, I1069fs, I1167fs, I1170fs, I1196fs, I1234fs, I1126fs, I1148fs, I1166fs, I1189fs, I1210fs, I369fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054972	17	41243838	17	43091821	54972	69639	rs80357564	NC_000017.11:43091820:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3706_3707del (p.Asn1236fs)	BRCA1|LOC126862571	N1189fs, N1236fs, N1125fs, N1165fs, N1194fs, N1195fs, N1233fs, N1068fs, N1108fs, N1124fs, N1169fs, N368fs, N1147fs, N1166fs, N1235fs, N1109fs, N1148fs, N1168fs, N1188fs, N1209fs, N1210fs, N940fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054968	17	41243841 - 41243842	17	43091824 - 43091825	54968	69635	rs80357666	NC_000017.11:43091823:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3704_3707del (p.Asn1235fs)	BRCA1|LOC126862571	N1188fs, N1235fs, N1067fs, N1193fs, N1194fs, N1208fs, N1234fs, N1107fs, N1108fs, N1124fs, N1147fs, N1165fs, N1168fs, N1187fs, N1209fs, N1232fs, N1123fs, N1164fs, N1146fs, N1167fs, N367fs, N939fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054966	17	41243841 - 41243844	17	43091824 - 43091827	54966	69633	rs397509094	NC_000017.11:43091823:TTGTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3704del (p.Asn1235fs)	BRCA1|LOC126862571	N1235fs, N1188fs, N1146fs, N1193fs, N1209fs, N1232fs, N1234fs, N1124fs, N1165fs, N1194fs, N1208fs, N1067fs, N1107fs, N1123fs, N1164fs, N1168fs, N1187fs, N367fs, N1108fs, N1147fs, N1167fs, N939fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054967	17	41243844	17	43091827	54967	69634	rs397509095	NC_000017.11:43091826:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3700_3704del (p.Val1234fs)	BRCA1|LOC126862571	V1234fs, V1187fs, V1122fs, V1145fs, V1186fs, V1207fs, V1231fs, V1066fs, V1166fs, V1233fs, V1106fs, V1123fs, V1163fs, V1193fs, V366fs, V1107fs, V1146fs, V1164fs, V1167fs, V1192fs, V1208fs, V938fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037542	17	41243844 - 41243848	17	43091827 - 43091831	37542	46098	rs80357609	NC_000017.11:43091826:TTTACTTTAC:TTTAC	Microsatellite	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3695_3698del (p.Gly1232fs)	BRCA1|LOC126862571	G1232fs, G1185fs, G1144fs, G1164fs, G1206fs, G1064fs, G1105fs, G1143fs, G1161fs, G1184fs, G1205fs, G364fs, G1120fs, G1121fs, G1190fs, G1191fs, G1229fs, G1231fs, G1104fs, G1162fs, G1165fs, G936fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054963	17	41243850 - 41243853	17	43091833 - 43091836	54963	69630	rs397509093	NC_000017.11:43091832:TTAC:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3697A>T (p.Lys1233Ter)	BRCA1|LOC126862571	K1233*, K1186*, K1106*, K1122*, K1162*, K1166*, K1207*, K1144*, K1163*, K1206*, K365*, K1065*, K1105*, K1121*, K1165*, K1192*, K1230*, K937*, K1145*, K1185*, K1191*, K1232*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254440	17	41243851	17	43091834	254440	249103	rs774679104	NC_000017.11:43091833:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3695del (p.Gly1232fs)	BRCA1|LOC126862571	G1185fs, G1232fs, G1120fs, G1161fs, G1164fs, G1184fs, G1206fs, G364fs, G1121fs, G1143fs, G1165fs, G1064fs, G1104fs, G1144fs, G1162fs, G936fs, G1105fs, G1190fs, G1191fs, G1205fs, G1229fs, G1231fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254439	17	41243853	17	43091836	254439	249104	rs886038022	NC_000017.11:43091835:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3693dup (p.Gly1232fs)	BRCA1|LOC126862571	G1185fs, G1232fs, G1104fs, G1143fs, G1164fs, G1165fs, G1206fs, G1229fs, G1105fs, G1121fs, G1144fs, G1162fs, G1190fs, G1231fs, G364fs, G1120fs, G1161fs, G936fs, G1064fs, G1184fs, G1191fs, G1205fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054962	17	41243854 - 41243855	17	43091837 - 43091838	54962	69629	rs397509092	NC_000017.11:43091837:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3689T>A (p.Leu1230Ter)	LOC126862571|BRCA1	L1062*, L1102*, L1159*, L1162*, L1163*, L1183*, L1188*, L1189*, L1203*, L1229*, L1103*, L1119*, L1227*, L362*, L934*, L1118*, L1141*, L1142*, L1160*, L1182*, L1204*, L1230*	Hereditary cancer-predisposing syndrome	VCV002450679	17	41243859	17	43091842	2450679	2423165	rs80357162	NC_000017.11:43091841:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 23, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3689T>G (p.Leu1230Ter)	BRCA1|LOC126862571	L1230*, L1183*, L1102*, L1141*, L1160*, L1189*, L1103*, L1119*, L1162*, L1188*, L1203*, L362*, L1062*, L1142*, L1159*, L1204*, L1227*, L934*, L1118*, L1163*, L1182*, L1229*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037540	17	41243859	17	43091842	37540	46096	rs80357162	NC_000017.11:43091841:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3686T>A (p.Leu1229Ter)	BRCA1|LOC126862571	L1229*, L1182*, L1102*, L1140*, L1159*, L1161*, L1181*, L1187*, L1061*, L1117*, L1202*, L1203*, L1101*, L1188*, L1226*, L1228*, L361*, L1118*, L1141*, L1158*, L1162*, L933*	Hereditary breast ovarian cancer syndrome	VCV000843569	17	41243862	17	43091845	843569	845398	rs2053543910	NC_000017.11:43091844:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3683del (p.His1228fs)	BRCA1|LOC126862571	H1181fs, H1228fs, H1100fs, H1117fs, H1158fs, H1160fs, H1202fs, H1225fs, H932fs, H1116fs, H1139fs, H1187fs, H1227fs, H1157fs, H1161fs, H1060fs, H1101fs, H1140fs, H1180fs, H1186fs, H1201fs, H360fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037539	17	41243865	17	43091848	37539	46095	rs397507217	NC_000017.11:43091847:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3679del (p.Gln1227fs)	BRCA1|LOC126862571	Q1180fs, Q1227fs, Q1226fs, Q1115fs, Q1116fs, Q1138fs, Q1159fs, Q359fs, Q1157fs, Q1186fs, Q1100fs, Q1139fs, Q1160fs, Q1200fs, Q1059fs, Q1099fs, Q1156fs, Q1179fs, Q1185fs, Q1201fs, Q1224fs, Q931fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001073669	17	41243869	17	43091852	1073669	1064201	rs2154295200	NC_000017.11:43091851:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Feb 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3679C>T (p.Gln1227Ter)	BRCA1|LOC126862571	Q1227*, Q1180*, Q1159*, Q1179*, Q1201*, Q1100*, Q1115*, Q1116*, Q1139*, Q1160*, Q1200*, Q1156*, Q1157*, Q1186*, Q1226*, Q359*, Q1185*, Q1224*, Q931*, Q1059*, Q1099*, Q1138*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266399	17	41243869	17	43091852	266399	261713	rs886040159	NC_000017.11:43091851:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3676_3679del (p.Phe1226fs)	BRCA1|LOC126862571	F1226fs, F1179fs, F1098fs, F1138fs, F1159fs, F1185fs, F1223fs, F358fs, F1058fs, F1114fs, F1178fs, F1200fs, F1225fs, F930fs, F1099fs, F1155fs, F1158fs, F1115fs, F1137fs, F1156fs, F1184fs, F1199fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054961	17	41243869 - 41243872	17	43091852 - 43091855	54961	69628	rs80357671	NC_000017.11:43091851:GGAAG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3675C>A (p.Cys1225Ter)	BRCA1|LOC126862571	C1225*, C1178*, C1097*, C1136*, C1154*, C1199*, C1155*, C1158*, C1183*, C1198*, C1057*, C1113*, C1114*, C1137*, C1157*, C1177*, C1184*, C929*, C1098*, C1222*, C1224*, C357*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000245968	17	41243873	17	43091856	245968	245036	rs879254023	NC_000017.11:43091855:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3672del (p.Cys1225fs)	BRCA1|LOC126862571	C1178fs, C1225fs, C1113fs, C1136fs, C1154fs, C1155fs, C1177fs, C1183fs, C1097fs, C1114fs, C1137fs, C1158fs, C1198fs, C357fs, C1184fs, C1224fs, C929fs, C1057fs, C1098fs, C1157fs, C1199fs, C1222fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091612	17	41243876	17	43091859	91612	97089	rs398122677	NC_000017.11:43091858:GGG:GG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3668_3671dup (p.Cys1225fs)	BRCA1|LOC126862571	C1178fs, C1225fs, C1114fs, C1158fs, C1177fs, C1183fs, C1057fs, C1157fs, C1198fs, C357fs, C1137fs, C1199fs, C1224fs, C929fs, C1097fs, C1098fs, C1113fs, C1136fs, C1154fs, C1155fs, C1184fs, C1222fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054960	17	41243876 - 41243877	17	43091859 - 43091860	54960	69627	rs80357797	NC_000017.11:43091859:GGAAG:GGAAGGAAG	Duplication	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3669del (p.Cys1225fs)	BRCA1|LOC126862571	C1225fs, C1178fs, C1097fs, C1114fs, C1157fs, C1057fs, C1113fs, C1137fs, C1183fs, C1224fs, C1158fs, C1098fs, C1155fs, C1177fs, C1184fs, C1198fs, C1222fs, C929fs, C1136fs, C1154fs, C1199fs, C357fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266398	17	41243879	17	43091862	266398	261714	rs886040158	NC_000017.11:43091861:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3665_3666del (p.Glu1222fs)	BRCA1|LOC126862571	E1222fs, E1175fs, E1110fs, E1133fs, E1134fs, E1152fs, E1174fs, E1196fs, E1221fs, E1054fs, E1111fs, E1151fs, E1195fs, E1219fs, E1094fs, E1095fs, E1180fs, E1181fs, E354fs, E1154fs, E1155fs, E926fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548246	17	41243882 - 41243883	17	43091865 - 43091866	548246	538813	rs1555587316	NC_000017.11:43091864:CTCT:CT	Microsatellite	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3665del (p.Glu1222fs)	LOC126862571|BRCA1	E1175fs, E1222fs, E1054fs, E1110fs, E1133fs, E1151fs, E1154fs, E1174fs, E354fs, E926fs, E1111fs, E1134fs, E1152fs, E1196fs, E1221fs, E1094fs, E1180fs, E1181fs, E1219fs, E1095fs, E1155fs, E1195fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000628180	17	41243883	17	43091866	628180	618601	rs1567790674	NC_000017.11:43091865:T:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3664G>T (p.Glu1222Ter)	BRCA1|LOC126862571	E1222*, E1175*, E1095*, E1111*, E1152*, E1155*, E1174*, E1094*, E1154*, E926*, E1110*, E1133*, E1221*, E354*, E1054*, E1134*, E1151*, E1180*, E1181*, E1195*, E1196*, E1219*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054959	17	41243884	17	43091867	54959	69626	rs80357356	NC_000017.11:43091866:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3661G>T (p.Glu1221Ter)	BRCA1|LOC126862571	E1221*, E1174*, E1053*, E1093*, E1109*, E1132*, E1151*, E1194*, E1218*, E1220*, E1110*, E1153*, E1180*, E1150*, E1154*, E1173*, E1179*, E1195*, E1094*, E1133*, E353*, E925*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054957	17	41243887	17	43091870	54957	69624	rs80357310	NC_000017.11:43091869:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3658del (p.Asp1220fs)	BRCA1|LOC126862571	D1173fs, D1220fs, D1092fs, D1149fs, D1150fs, D352fs, D1052fs, D1132fs, D1153fs, D1172fs, D1178fs, D924fs, D1093fs, D1109fs, D1152fs, D1179fs, D1193fs, D1108fs, D1131fs, D1194fs, D1217fs, D1219fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186452	17	41243890	17	43091873	186452	184958	rs786202963	NC_000017.11:43091872:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3648_3652del (p.Leu1216_Ser1217insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000531283	17	41243896 - 41243900	17	43091879 - 43091883	531283	531333	rs1555587333	NC_000017.11:43091878:TAGAT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3651dup (p.Ser1218Ter)	BRCA1|LOC126862571	S1171*, S1218*, S1129*, S1148*, S1176*, S1192*, S1217*, S1090*, S1091*, S1106*, S1130*, S1150*, S1170*, S1191*, S1215*, S1050*, S1107*, S1147*, S350*, S922*, S1151*, S1177*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266397	17	41243896 - 41243897	17	43091879 - 43091880	266397	261715	rs886040157	NC_000017.11:43091879:A:AA	Duplication	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3650_3651insA (p.Ser1217_Ser1218insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548286	17	41243897 - 41243898	17	43091880 - 43091881	548286	538814	rs1555587337	NC_000017.11:43091880::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3649_3650insA (p.Ser1217fs)	LOC126862571|BRCA1	S1217fs, S1170fs, S1089fs, S1090fs, S1150fs, S1175fs, S1176fs, S1216fs, S1106fs, S1129fs, S1149fs, S1214fs, S921fs, S1049fs, S1105fs, S1146fs, S1147fs, S1169fs, S349fs, S1128fs, S1190fs, S1191fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125644	17	41243898 - 41243899	17	43091881 - 43091882	125644	131182	rs80357831	NC_000017.11:43091881::T	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3649dup (p.Ser1217fs)	BRCA1|LOC126862571	S1217fs, S1170fs, S1106fs, S1128fs, S1129fs, S1147fs, S1176fs, S1190fs, S1214fs, S921fs, S1090fs, S1105fs, S1089fs, S1146fs, S1175fs, S1191fs, S349fs, S1049fs, S1149fs, S1150fs, S1169fs, S1216fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054954	17	41243898 - 41243899	17	43091881 - 43091882	54954	69621	rs1555587345	NC_000017.11:43091881:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3649del (p.Ser1217fs)	BRCA1|LOC126862571	S1049fs, S1089fs, S1090fs, S1105fs, S1106fs, S1128fs, S1129fs, S1146fs, S1147fs, S1149fs, S1150fs, S1169fs, S1170fs, S1175fs, S1176fs, S1190fs, S1191fs, S1214fs, S1216fs, S1217fs, S349fs, S921fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004526509	17	41243899	17	43091882	4526509	4638906		NC_000017.11:43091881:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 16, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3648dup (p.Ser1217fs)	BRCA1|LOC126862571	S1170fs, S1217fs, S1089fs, S1128fs, S1147fs, S1214fs, S1129fs, S1169fs, S1106fs, S1149fs, S1150fs, S1175fs, S1176fs, S1191fs, S1216fs, S349fs, S921fs, S1049fs, S1090fs, S1105fs, S1146fs, S1190fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037535	17	41243900	17	43091882 - 43091883	37535	46091	rs80357902	NC_000017.11:43091882:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3644_3648del (p.Asn1215fs)	BRCA1|LOC126862571	N1215fs, N1168fs, N1104fs, N1188fs, N1189fs, N1214fs, N919fs, N1088fs, N1212fs, N1047fs, N1145fs, N1147fs, N1148fs, N1174fs, N1087fs, N1103fs, N1126fs, N1127fs, N1144fs, N1167fs, N1173fs, N347fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417831	17	41243900 - 41243904	17	43091883 - 43091887	417831	404713	rs1060505051	NC_000017.11:43091882:TAAGTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3647T>A (p.Leu1216Ter)	BRCA1|LOC126862571	L1216*, L1169*, L1089*, L1145*, L1175*, L1088*, L1146*, L1168*, L1189*, L348*, L1128*, L1149*, L1213*, L920*, L1048*, L1104*, L1105*, L1127*, L1148*, L1174*, L1190*, L1215*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431249	17	41243901	17	43091884	431249	424814	rs397509091	NC_000017.11:43091883:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3647T>G (p.Leu1216Ter)	BRCA1|LOC126862571	L1216*, L1169*, L1088*, L1175*, L1189*, L1127*, L1128*, L1148*, L1168*, L1215*, L348*, L1048*, L1089*, L1104*, L1174*, L1190*, L1105*, L1145*, L1146*, L1149*, L1213*, L920*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054951	17	41243901	17	43091884	54951	69618	rs397509091	NC_000017.11:43091883:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3642_3643dup (p.Asn1215fs)	BRCA1|LOC126862571	N1215fs, N1168fs, N1103fs, N1104fs, N1147fs, N1188fs, N347fs, N1087fs, N1088fs, N1127fs, N1145fs, N1148fs, N1189fs, N1212fs, N1214fs, N919fs, N1047fs, N1126fs, N1144fs, N1167fs, N1173fs, N1174fs	not provided	VCV000801072	17	41243904 - 41243905	17	43091887 - 43091888	801072	789621	rs80357805	NC_000017.11:43091887:TCTCT:TCTCTCT	Microsatellite	frameshift variant|intron variant	Pathogenic	Dec 21, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3640_3644del (p.Glu1214fs)	BRCA1|LOC126862571	E1214fs, E1167fs, E1126fs, E1188fs, E1213fs, E1087fs, E1125fs, E1146fs, E1172fs, E1211fs, E346fs, E918fs, E1102fs, E1103fs, E1144fs, E1166fs, E1173fs, E1187fs, E1046fs, E1086fs, E1143fs, E1147fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479239	17	41243904 - 41243908	17	43091887 - 43091891	479239	478593	rs1555587356	NC_000017.11:43091886:TTCTCTTCT:TTCT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3642_3643del (p.Asn1215fs)	BRCA1|LOC126862571	N1215fs, N1168fs, N1047fs, N1104fs, N1145fs, N1214fs, N919fs, N1103fs, N1127fs, N1147fs, N1174fs, N1189fs, N1212fs, N1087fs, N1088fs, N1144fs, N1148fs, N1167fs, N1126fs, N1173fs, N1188fs, N347fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054950	17	41243905 - 41243906	17	43091888 - 43091889	54950	69617	rs80357805	NC_000017.11:43091887:TCTCT:TCT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3641del (p.Glu1214fs)	BRCA1|LOC126862571	E1167fs, E1214fs, E1087fs, E1172fs, E1188fs, E1102fs, E1125fs, E1166fs, E1211fs, E1213fs, E1046fs, E1103fs, E1126fs, E1144fs, E1147fs, E1173fs, E1187fs, E1086fs, E1143fs, E1146fs, E346fs, E918fs	Hereditary breast ovarian cancer syndrome	VCV000575828	17	41243907	17	43091890	575828	571158	rs1567790791	NC_000017.11:43091889:T:	Deletion	frameshift variant|intron variant	Pathogenic	May 13, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3640G>T (p.Glu1214Ter)	BRCA1|LOC126862571	E1214*, E1167*, E1046*, E1086*, E1102*, E1103*, E1143*, E1146*, E1173*, E1188*, E1211*, E1213*, E1087*, E1125*, E1126*, E346*, E918*, E1187*, E1144*, E1147*, E1166*, E1172*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054949	17	41243908	17	43091891	54949	69616	rs80356923	NC_000017.11:43091890:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3637_3638del (p.Glu1213fs)	BRCA1|LOC126862571	E1085fs, E1125fs, E1142fs, E1145fs, E1165fs, E1171fs, E1187fs, E1101fs, E1146fs, E1186fs, E1213fs, E917fs, E1045fs, E1102fs, E1124fs, E1166fs, E1172fs, E1210fs, E345fs, E1086fs, E1143fs, E1212fs	Hereditary breast ovarian cancer syndrome	VCV003724296	17	41243910 - 41243911	17	43091893 - 43091894	3724296	3857503		NC_000017.11:43091892:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jan 26, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3637del (p.Glu1213fs)	BRCA1|LOC126862571	E1166fs, E1213fs, E1101fs, E345fs, E917fs, E1045fs, E1102fs, E1142fs, E1143fs, E1146fs, E1172fs, E1085fs, E1124fs, E1187fs, E1212fs, E1086fs, E1125fs, E1145fs, E1165fs, E1171fs, E1186fs, E1210fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441386	17	41243911	17	43091894	441386	435129	rs1555587365	NC_000017.11:43091893:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3637G>T (p.Glu1213Ter)	BRCA1|LOC126862571	E1213*, E1166*, E1045*, E1101*, E1143*, E1165*, E1171*, E1187*, E1102*, E1146*, E1172*, E1210*, E1085*, E1086*, E1124*, E1145*, E1186*, E1212*, E345*, E917*, E1125*, E1142*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431248	17	41243911	17	43091894	431248	424815	rs1135401864	NC_000017.11:43091893:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3635C>G (p.Ser1212Ter)	BRCA1|LOC126862571	S1212*, S1165*, S1084*, S1100*, S1101*, S1211*, S344*, S1170*, S1185*, S1085*, S1142*, S1144*, S1145*, S1171*, S1044*, S1123*, S1124*, S1141*, S1164*, S1186*, S1209*, S916*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254438	17	41243913	17	43091896	254438	249105	rs886038021	NC_000017.11:43091895:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3631_3634del (p.Ser1211fs)	BRCA1|LOC126862571	S1164fs, S1211fs, S1084fs, S1099fs, S1100fs, S1141fs, S1143fs, S1184fs, S1210fs, S1140fs, S1169fs, S1170fs, S1185fs, S1208fs, S1043fs, S1083fs, S1122fs, S1123fs, S1144fs, S1163fs, S343fs, S915fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266396	17	41243914 - 41243917	17	43091897 - 43091900	266396	261716	rs886040156	NC_000017.11:43091896:AGGA:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3633del (p.Ser1212fs)	BRCA1|LOC126862571	S1165fs, S1212fs, S1123fs, S1124fs, S1141fs, S1209fs, S1144fs, S1171fs, S1185fs, S916fs, S1084fs, S1085fs, S1101fs, S1145fs, S1170fs, S1211fs, S344fs, S1044fs, S1100fs, S1142fs, S1164fs, S1186fs	Hereditary cancer-predisposing syndrome	VCV001733428	17	41243915	17	43091898	1733428	1245824	rs2552141139	NC_000017.11:43091897:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Feb 25, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3629dup (p.Ser1211fs)	BRCA1|LOC126862571	S1164fs, S1211fs, S1084fs, S1141fs, S1170fs, S343fs, S1043fs, S1083fs, S1144fs, S1185fs, S915fs, S1100fs, S1122fs, S1163fs, S1169fs, S1184fs, S1208fs, S1210fs, S1099fs, S1123fs, S1140fs, S1143fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000225306	17	41243918 - 41243919	17	43091901 - 43091902	225306	227390	rs886040154	NC_000017.11:43091901:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3629_3630del (p.Glu1210fs)	BRCA1|LOC126862571	E1210fs, E1163fs, E1142fs, E1169fs, E1082fs, E1122fs, E1139fs, E1184fs, E1209fs, E1042fs, E1083fs, E1143fs, E1162fs, E1168fs, E1183fs, E1207fs, E914fs, E1099fs, E1121fs, E1140fs, E342fs, E1098fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054947	17	41243918 - 41243919	17	43091901 - 43091902	54947	69614	rs80357589	NC_000017.11:43091900:CTCT:CT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3627_3628insAA (p.Glu1210fs)	BRCA1|LOC126862571	E1142fs, E1143fs, E1162fs, E1169fs, E1140fs, E1184fs, E342fs, E914fs, E1042fs, E1082fs, E1083fs, E1122fs, E1168fs, E1210fs, E1098fs, E1099fs, E1121fs, E1139fs, E1163fs, E1183fs, E1207fs, E1209fs	Hereditary breast ovarian cancer syndrome	VCV003657706	17	41243920 - 41243921	17	43091903 - 43091904	3657706	3779661		NC_000017.11:43091903:T:TTT	Insertion	frameshift variant|intron variant	Pathogenic	Sep 9, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3628del (p.Glu1210fs)	BRCA1|LOC126862571	E1210fs, E1163fs, E1082fs, E1099fs, E1168fs, E1169fs, E914fs, E1042fs, E1083fs, E1121fs, E1139fs, E1142fs, E1183fs, E1207fs, E1098fs, E1122fs, E1143fs, E342fs, E1140fs, E1162fs, E1184fs, E1209fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054946	17	41243920	17	43091903	54946	69613	rs397509090	NC_000017.11:43091902:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3627dup (p.Glu1210fs)	BRCA1|LOC126862571	E1163fs, E1210fs, E1099fs, E1139fs, E1209fs, E1082fs, E1098fs, E1184fs, E1207fs, E1083fs, E1140fs, E1143fs, E1162fs, E1168fs, E342fs, E914fs, E1042fs, E1121fs, E1122fs, E1142fs, E1169fs, E1183fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037534	17	41243920 - 41243921	17	43091903 - 43091904	37534	46090	rs80357729	NC_000017.11:43091903:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3626_3627del (p.Lys1208_Leu1209insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV002444500	17	41243921 - 41243922	17	43091904 - 43091905	2444500	2418230	rs2552141220	NC_000017.11:43091903:TA:	Deletion	nonsense|intron variant	Pathogenic	Feb 6, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3626dup (p.Leu1209fs)	BRCA1|LOC126862571	L1162fs, L1209fs, L1098fs, L1121fs, L1138fs, L1161fs, L1208fs, L1139fs, L1141fs, L1142fs, L341fs, L1041fs, L1168fs, L1182fs, L1081fs, L1082fs, L1097fs, L1120fs, L1167fs, L1183fs, L1206fs, L913fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054944	17	41243921 - 41243922	17	43091904 - 43091905	54944	69611	rs80357571	NC_000017.11:43091904:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3625_3626insA (p.Leu1209fs)	BRCA1|LOC126862571	L1162fs, L1209fs, L1139fs, L1141fs, L341fs, L1121fs, L1142fs, L1167fs, L913fs, L1041fs, L1081fs, L1082fs, L1097fs, L1168fs, L1182fs, L1183fs, L1098fs, L1120fs, L1138fs, L1161fs, L1206fs, L1208fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266394	17	41243922 - 41243923	17	43091905 - 43091906	266394	261717	rs886040153	NC_000017.11:43091905::T	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3626T>G (p.Leu1209Ter)	BRCA1|LOC126862571	L1209*, L1162*, L1206*, L1041*, L1098*, L1120*, L1141*, L1182*, L1183*, L1208*, L341*, L1082*, L1161*, L1167*, L1097*, L1121*, L1168*, L1081*, L1138*, L1139*, L1142*, L913*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187637	17	41243922	17	43091905	187637	184960	rs786203884	NC_000017.11:43091904:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3626del (p.Lys1208_Leu1209insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054943	17	41243922	17	43091905	54943	69610	rs80357571	NC_000017.11:43091904:AA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3621_3626delinsAA (p.Leu1209fs)	BRCA1|LOC126862571	L1162fs, L1209fs, L1121fs, L1183fs, L1206fs, L1081fs, L1097fs, L1120fs, L1138fs, L1141fs, L1142fs, L1161fs, L1208fs, L341fs, L1182fs, L913fs, L1041fs, L1082fs, L1098fs, L1139fs, L1167fs, L1168fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054939	17	41243922 - 41243927	17	43091905 - 43091910	54939	69606	rs397509087	NC_000017.11:43091904:AATTTC:TT	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3624dup (p.Leu1209fs)	BRCA1|LOC126862571	L1162fs, L1209fs, L1081fs, L1141fs, L1142fs, L1206fs, L1208fs, L1120fs, L1139fs, L1161fs, L1167fs, L1168fs, L913fs, L1097fs, L1098fs, L1138fs, L341fs, L1041fs, L1082fs, L1121fs, L1182fs, L1183fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054941	17	41243923 - 41243924	17	43091906 - 43091907	54941	69608	rs80357512	NC_000017.11:43091906:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3624del (p.Lys1208fs)	BRCA1|LOC126862571	K1161fs, K1208fs, K1137fs, K1160fs, K1166fs, K1182fs, K1081fs, K1097fs, K1119fs, K1138fs, K1140fs, K1141fs, K1207fs, K912fs, K1167fs, K1181fs, K340fs, K1040fs, K1080fs, K1096fs, K1120fs, K1205fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254437	17	41243924	17	43091907	254437	249106	rs80357512	NC_000017.11:43091906:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3621del (p.Lys1208fs)	BRCA1|LOC126862571	K1161fs, K1208fs, K1119fs, K1140fs, K1141fs, K1181fs, K912fs, K1080fs, K1081fs, K1097fs, K1137fs, K1138fs, K1160fs, K1207fs, K1096fs, K1182fs, K1040fs, K1120fs, K1166fs, K1167fs, K1205fs, K340fs	Ovarian cancer	VCV000559979	17	41243927	17	43091910	559979	550698	rs1555587401	NC_000017.11:43091909:C:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 22, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3620dup (p.Lys1208fs)	BRCA1|LOC126862571	K1208fs, K1161fs, K1138fs, K1166fs, K340fs, K1080fs, K1207fs, K912fs, K1120fs, K1167fs, K1181fs, K1096fs, K1097fs, K1119fs, K1137fs, K1040fs, K1081fs, K1140fs, K1141fs, K1160fs, K1182fs, K1205fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125642	17	41243927 - 41243928	17	43091910 - 43091911	125642	131180	rs80357926	NC_000017.11:43091910:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3619A>T (p.Lys1207Ter)	BRCA1|LOC126862571	K1207*, K1160*, K1118*, K1140*, K1206*, K1095*, K1119*, K1139*, K1181*, K339*, K1039*, K1079*, K1165*, K1204*, K911*, K1080*, K1096*, K1136*, K1137*, K1159*, K1166*, K1180*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054938	17	41243929	17	43091912	54938	69605	rs80357455	NC_000017.11:43091911:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3616dup (p.Ala1206fs)	BRCA1|LOC126862571	A1159fs, A1206fs, A1117fs, A1165fs, A1180fs, A1078fs, A1136fs, A1203fs, A910fs, A1139fs, A1158fs, A1038fs, A1079fs, A1094fs, A1095fs, A1118fs, A1135fs, A1138fs, A1164fs, A1179fs, A1205fs, A338fs	Hereditary breast ovarian cancer syndrome	VCV001075564	17	41243931 - 41243932	17	43091914 - 43091915	1075564	1064202	rs886038019	NC_000017.11:43091914:CCCC:CCCCC	Duplication	frameshift variant|intron variant	Pathogenic	Apr 29, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3616del (p.Ala1206fs)	BRCA1|LOC126862571	A1159fs, A1206fs, A1038fs, A1094fs, A1158fs, A1179fs, A1180fs, A1203fs, A910fs, A1138fs, A1139fs, A1078fs, A1079fs, A1136fs, A338fs, A1095fs, A1117fs, A1118fs, A1135fs, A1164fs, A1165fs, A1205fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254436	17	41243932	17	43091915	254436	249107	rs886038019	NC_000017.11:43091914:CCCC:CCC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3612del (p.Ala1206fs)	BRCA1|LOC126862571	A1159fs, A1206fs, A1117fs, A1136fs, A1164fs, A1165fs, A1203fs, A338fs, A1078fs, A1079fs, A1118fs, A1139fs, A1179fs, A1180fs, A910fs, A1038fs, A1095fs, A1205fs, A1094fs, A1135fs, A1138fs, A1158fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037533	17	41243936	17	43091919	37533	46089	rs80357980	NC_000017.11:43091918:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3610del (p.Arg1204fs)	BRCA1|LOC126862571	R1077fs, R1115fs, R1162fs, R336fs, R1093fs, R1133fs, R1203fs, R1136fs, R1137fs, R1157fs, R1178fs, R908fs, R1036fs, R1076fs, R1092fs, R1116fs, R1134fs, R1156fs, R1163fs, R1177fs, R1201fs, R1204fs	Hereditary breast ovarian cancer syndrome	VCV003727291	17	41243938	17	43091921	3727291	3861516		NC_000017.11:43091920:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3607C>T (p.Arg1203Ter)	BRCA1|LOC126862571	R1203*, R1156*, R1075*, R1092*, R1155*, R1162*, R1177*, R1202*, R1132*, R1136*, R1176*, R1091*, R1115*, R1161*, R1200*, R1035*, R1076*, R1114*, R1133*, R1135*, R335*, R907*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017671	17	41243941	17	43091924	17671	32710	rs62625308	NC_000017.11:43091923:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3605dup (p.Tyr1202Ter)	LOC126862571|BRCA1	Y1155*, Y1202*, Y1075*, Y1154*, Y1090*, Y1091*, Y1114*, Y1135*, Y1161*, Y1176*, Y1199*, Y1074*, Y1132*, Y1134*, Y1201*, Y1034*, Y1113*, Y1131*, Y1160*, Y1175*, Y334*, Y906*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266392	17	41243942 - 41243943	17	43091925 - 43091926	266392	261718	rs886040151	NC_000017.11:43091925:T:TT	Duplication	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3604del (p.Tyr1202fs)	BRCA1|LOC126862571	Y1155fs, Y1202fs, Y1034fs, Y1132fs, Y1135fs, Y1175fs, Y1074fs, Y1075fs, Y1091fs, Y1113fs, Y1131fs, Y1134fs, Y1161fs, Y1201fs, Y1090fs, Y1114fs, Y1154fs, Y1160fs, Y1176fs, Y1199fs, Y334fs, Y906fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266391	17	41243944	17	43091927	266391	261719	rs886040150	NC_000017.11:43091926:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3596_3602del (p.Ala1199fs)	BRCA1|LOC126862571	A1152fs, A1199fs, A1031fs, A1071fs, A1173fs, A1088fs, A1110fs, A1128fs, A1151fs, A1157fs, A1196fs, A1198fs, A1129fs, A1132fs, A1158fs, A1172fs, A331fs, A1072fs, A1087fs, A1111fs, A1131fs, A903fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054928	17	41243946 - 41243952	17	43091929 - 43091935	54928	69595	rs397509086	NC_000017.11:43091928:CCCTGAGCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3599_3600del (p.Gln1200fs)	BRCA1|LOC126862571	Q1153fs, Q1200fs, Q1032fs, Q1072fs, Q1088fs, Q1158fs, Q1174fs, Q1073fs, Q1112fs, Q1129fs, Q1132fs, Q1133fs, Q1199fs, Q332fs, Q1111fs, Q1130fs, Q1159fs, Q1173fs, Q1197fs, Q1089fs, Q1152fs, Q904fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091609	17	41243948 - 41243949	17	43091931 - 43091932	91609	97086	rs398122674	NC_000017.11:43091930:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3598C>T (p.Gln1200Ter)	BRCA1|LOC126862571	Q1200*, Q1153*, Q1032*, Q1088*, Q1089*, Q1111*, Q1112*, Q1152*, Q1159*, Q904*, Q1072*, Q1073*, Q1130*, Q1132*, Q1174*, Q1197*, Q1199*, Q1129*, Q1133*, Q1158*, Q1173*, Q332*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054929	17	41243950	17	43091933	54929	69596	rs62625307	NC_000017.11:43091932:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3593dup (p.Leu1198fs)	BRCA1|LOC126862571	L1127fs, L1128fs, L1151fs, L1157fs, L1195fs, L1030fs, L1071fs, L1109fs, L1110fs, L1150fs, L1171fs, L1197fs, L1198fs, L1070fs, L1087fs, L1172fs, L330fs, L902fs, L1086fs, L1130fs, L1131fs, L1156fs	Hereditary breast ovarian cancer syndrome	VCV002709217	17	41243954 - 41243955	17	43091937 - 43091938	2709217	2867626	rs80357562	NC_000017.11:43091937:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Jan 13, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3592_3593dup (p.Leu1198fs)	BRCA1|LOC126862571	L1151fs, L1198fs, L1087fs, L1110fs, L1130fs, L1157fs, L1171fs, L1195fs, L1030fs, L1071fs, L1128fs, L1131fs, L902fs, L1070fs, L1109fs, L1156fs, L1172fs, L1086fs, L1127fs, L1150fs, L1197fs, L330fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254435	17	41243954 - 41243955	17	43091937 - 43091938	254435	249108	rs80357562	NC_000017.11:43091937:AAA:AAAAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3593del (p.Leu1198fs)	BRCA1|LOC126862571	L1151fs, L1198fs, L1070fs, L1087fs, L1128fs, L1150fs, L1195fs, L1157fs, L1171fs, L1172fs, L1071fs, L1110fs, L1130fs, L1131fs, L902fs, L1030fs, L1086fs, L1109fs, L1127fs, L1156fs, L1197fs, L330fs	Hereditary breast ovarian cancer syndrome	VCV000861112	17	41243955	17	43091938	861112	845399	rs80357562	NC_000017.11:43091937:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 2, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3593T>A (p.Leu1198Ter)	BRCA1|LOC126862571	L1198*, L1151*, L1110*, L1171*, L330*, L902*, L1030*, L1071*, L1087*, L1128*, L1131*, L1070*, L1109*, L1130*, L1156*, L1157*, L1172*, L1197*, L1086*, L1127*, L1150*, L1195*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054927	17	41243955	17	43091938	54927	69594	rs397509085	NC_000017.11:43091937:A:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3590_3591dup (p.Leu1198fs)	BRCA1|LOC126862571	L1198fs, L1151fs, L1071fs, L1110fs, L1127fs, L1128fs, L1130fs, L1150fs, L1171fs, L1195fs, L1030fs, L1109fs, L1070fs, L1087fs, L1131fs, L1172fs, L1197fs, L330fs, L1086fs, L1156fs, L1157fs, L902fs	Hereditary cancer-predisposing syndrome	VCV001732988	17	41243956 - 41243957	17	43091939 - 43091940	1732988	1796062	rs2552141801	NC_000017.11:43091939:AT:ATAT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3583_3590del (p.His1195fs)	BRCA1|LOC126862571	H1148fs, H1195fs, H1068fs, H1084fs, H1107fs, H1128fs, H1154fs, H1169fs, H1067fs, H1106fs, H1124fs, H1147fs, H1192fs, H1194fs, H1027fs, H1127fs, H327fs, H899fs, H1083fs, H1125fs, H1153fs, H1168fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266388	17	41243958 - 41243965	17	43091941 - 43091948	266388	261720	rs886040147	NC_000017.11:43091940:TGTGTATG:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3582_3589del (p.His1195fs)	BRCA1|LOC126862571	H1148fs, H1195fs, H1027fs, H1067fs, H1083fs, H1106fs, H1127fs, H1154fs, H1128fs, H1169fs, H1194fs, H1068fs, H1107fs, H1124fs, H1147fs, H1168fs, H327fs, H1084fs, H1125fs, H1153fs, H1192fs, H899fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266387	17	41243959 - 41243966	17	43091942 - 43091949	266387	261721	rs886040146	NC_000017.11:43091941:GTGTATGGGTG:GTG	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3587dup (p.His1197fs)	BRCA1|LOC126862571	H1150fs, H1197fs, H1085fs, H1086fs, H1109fs, H1127fs, H1194fs, H329fs, H1155fs, H1156fs, H1196fs, H901fs, H1029fs, H1070fs, H1171fs, H1069fs, H1108fs, H1126fs, H1129fs, H1130fs, H1149fs, H1170fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266389	17	41243960 - 41243961	17	43091943 - 43091944	266389	261722	rs886040148	NC_000017.11:43091943:G:GG	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3586dup (p.Thr1196fs)	BRCA1|LOC126862571	T1149fs, T1196fs, T1085fs, T1108fs, T1155fs, T328fs, T900fs, T1028fs, T1126fs, T1129fs, T1068fs, T1125fs, T1128fs, T1148fs, T1170fs, T1193fs, T1195fs, T1069fs, T1084fs, T1107fs, T1154fs, T1169fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054924	17	41243961 - 41243962	17	43091944 - 43091945	54924	69591	rs80357531	NC_000017.11:43091944:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3583del (p.His1195fs)	BRCA1|LOC126862571	H1148fs, H1195fs, H1027fs, H1083fs, H1084fs, H1124fs, H1127fs, H1154fs, H1169fs, H327fs, H1106fs, H1125fs, H1168fs, H899fs, H1067fs, H1107fs, H1128fs, H1147fs, H1153fs, H1192fs, H1194fs, H1068fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054923	17	41243965	17	43091948	54923	69590	rs273900710	NC_000017.11:43091947:GGG:GG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3578_3581del (p.Phe1193fs)	BRCA1|LOC126862571	F1146fs, F1193fs, F1025fs, F1066fs, F1126fs, F1151fs, F1166fs, F1167fs, F1192fs, F897fs, F1081fs, F1105fs, F1145fs, F1152fs, F1065fs, F1082fs, F1122fs, F1125fs, F325fs, F1104fs, F1123fs, F1190fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002431297	17	41243967 - 41243970	17	43091950 - 43091953	2431297	2404802	rs2552142008	NC_000017.11:43091949:GTGA:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3580_3581insT (p.Thr1194fs)	BRCA1|LOC126862571	T1194fs, T1147fs, T1067fs, T1167fs, T1066fs, T1123fs, T1124fs, T1146fs, T1193fs, T326fs, T898fs, T1126fs, T1152fs, T1153fs, T1168fs, T1191fs, T1026fs, T1082fs, T1083fs, T1105fs, T1106fs, T1127fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548232	17	41243967 - 41243968	17	43091950 - 43091951	548232	538815	rs1555587464	NC_000017.11:43091950::A	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3579_3580insT (p.Thr1194fs)	BRCA1|LOC126862571	T1147fs, T1194fs, T1067fs, T1124fs, T1127fs, T1152fs, T1168fs, T1066fs, T1105fs, T1106fs, T1146fs, T1167fs, T1082fs, T1123fs, T1153fs, T1193fs, T1026fs, T1083fs, T1126fs, T1191fs, T326fs, T898fs	Hereditary cancer-predisposing syndrome	VCV000142925	17	41243968 - 41243969	17	43091951 - 43091952	142925	152639	rs587782824	NC_000017.11:43091951::A	Insertion	frameshift variant|intron variant	Pathogenic	Sep 6, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3580del (p.Thr1194fs)	BRCA1|LOC126862571	T1147fs, T1194fs, T1106fs, T1124fs, T1126fs, T1146fs, T1153fs, T1193fs, T326fs, T1127fs, T1152fs, T1191fs, T1026fs, T1067fs, T1123fs, T898fs, T1066fs, T1082fs, T1083fs, T1105fs, T1167fs, T1168fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054921	17	41243968	17	43091951	54921	69588	rs80357663	NC_000017.11:43091950:T:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3578dup (p.Thr1194fs)	BRCA1|LOC126862571	T1147fs, T1194fs, T1026fs, T1082fs, T1083fs, T1105fs, T1127fs, T1167fs, T1066fs, T1106fs, T1152fs, T1168fs, T1191fs, T326fs, T1067fs, T1123fs, T1124fs, T1126fs, T1146fs, T1153fs, T1193fs, T898fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054920	17	41243969 - 41243970	17	43091952 - 43091953	54920	69587	rs397509083	NC_000017.11:43091952:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3576_3577insAA (p.Phe1193fs)	BRCA1|LOC126862571	F1146fs, F1193fs, F1082fs, F1151fs, F1152fs, F897fs, F1065fs, F1066fs, F1123fs, F1145fs, F1025fs, F1081fs, F1105fs, F1192fs, F325fs, F1104fs, F1122fs, F1125fs, F1126fs, F1166fs, F1167fs, F1190fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548182	17	41243971 - 41243972	17	43091954 - 43091955	548182	538816	rs1555587476	NC_000017.11:43091954::TT	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3571del (p.Ser1191fs)	BRCA1|LOC126862571	S1191fs, S1144fs, S1064fs, S1102fs, S1164fs, S1188fs, S1023fs, S1063fs, S1103fs, S1121fs, S1123fs, S1149fs, S1150fs, S1190fs, S1080fs, S1143fs, S895fs, S1079fs, S1120fs, S1124fs, S1165fs, S323fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266386	17	41243977	17	43091960	266386	261723	rs886040145	NC_000017.11:43091959:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3568_3569dup (p.Ser1191fs)	BRCA1|LOC126862571	S1144fs, S1149fs, S1164fs, S1079fs, S1063fs, S1080fs, S1120fs, S1121fs, S1124fs, S1143fs, S1150fs, S1165fs, S1190fs, S1191fs, S895fs, S1023fs, S1064fs, S1102fs, S1103fs, S1123fs, S1188fs, S323fs	Hereditary breast ovarian cancer syndrome	VCV003637946	17	41243978 - 41243979	17	43091961 - 43091962	3637946	3764575		NC_000017.11:43091961:GG:GGGG	Duplication	frameshift variant|intron variant	Pathogenic	Feb 1, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3570del (p.Ser1191fs)	BRCA1|LOC126862571	S1144fs, S1191fs, S1023fs, S1120fs, S1121fs, S1124fs, S1165fs, S1190fs, S1102fs, S1143fs, S1188fs, S323fs, S1079fs, S895fs, S1063fs, S1064fs, S1080fs, S1103fs, S1123fs, S1149fs, S1150fs, S1164fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254434	17	41243978	17	43091961	254434	249109	rs886038018	NC_000017.11:43091960:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3569_3570del (p.Pro1190fs)	BRCA1|LOC126862571	P1143fs, P1190fs, P1119fs, P1142fs, P1189fs, P894fs, P1022fs, P1062fs, P1079fs, P1123fs, P1163fs, P1101fs, P1148fs, P322fs, P1063fs, P1078fs, P1102fs, P1120fs, P1122fs, P1149fs, P1164fs, P1187fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054918	17	41243978 - 41243979	17	43091961 - 43091962	54918	69585	rs80357845	NC_000017.11:43091960:AG:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3569del (p.Pro1190fs)	BRCA1|LOC126862571	P1143fs, P1190fs, P1102fs, P1120fs, P322fs, P894fs, P1079fs, P1149fs, P1063fs, P1101fs, P1119fs, P1122fs, P1142fs, P1148fs, P1022fs, P1062fs, P1078fs, P1123fs, P1163fs, P1164fs, P1187fs, P1189fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000485381	17	41243979	17	43091962	485381	479358	rs1555587497	NC_000017.11:43091961:GG:G	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Apr 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3564dup (p.Ser1189fs)	BRCA1|LOC126862571	S1142fs, S1189fs, S1061fs, S1119fs, S1121fs, S1162fs, S1186fs, S1078fs, S1118fs, S1122fs, S321fs, S1062fs, S1077fs, S1147fs, S1148fs, S1188fs, S893fs, S1021fs, S1100fs, S1101fs, S1141fs, S1163fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266384	17	41243983 - 41243984	17	43091966 - 43091967	266384	261724	rs886040143	NC_000017.11:43091966:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3547_3560del (p.Lys1183fs)	BRCA1|LOC126862571	K1055fs, K1156fs, K1116fs, K1182fs, K887fs, K1015fs, K1071fs, K1094fs, K1115fs, K1141fs, K1157fs, K1180fs, K1056fs, K1072fs, K1112fs, K1113fs, K1095fs, K1135fs, K1136fs, K1142fs, K1183fs, K315fs	Hereditary breast ovarian cancer syndrome	VCV002812748	17	41243988 - 41244001	17	43091971 - 43091984	2812748	2975980	rs2552144790	NC_000017.11:43091970:CTAAGCTCTCCTTTCT:CT	Deletion	frameshift variant|intron variant	Pathogenic	Jun 7, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3558dup (p.Ser1187Ter)	BRCA1|LOC126862571	S1019*, S1060*, S1099*, S1119*, S1120*, S1140*, S1145*, S1187*, S319*, S1075*, S1076*, S1116*, S1139*, S1160*, S1161*, S1184*, S1098*, S891*, S1059*, S1117*, S1146*, S1186*	Hereditary breast ovarian cancer syndrome	VCV002707429	17	41243989 - 41243990	17	43091972 - 43091973	2707429	2867119	rs2552144940	NC_000017.11:43091972:AA:AAA	Duplication	nonsense|intron variant	Pathogenic	Jan 4, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3553G>T (p.Glu1185Ter)	BRCA1|LOC126862571	E1185*, E1138*, E1017*, E1096*, E1097*, E1114*, E1117*, E1118*, E317*, E1058*, E1143*, E1159*, E1182*, E889*, E1073*, E1074*, E1115*, E1137*, E1144*, E1184*, E1057*, E1158*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054916	17	41243995	17	43091978	54916	69583	rs397509081	NC_000017.11:43091977:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3548_3552del (p.Lys1183fs)	BRCA1|LOC126862571	K1136fs, K1183fs, K1015fs, K1056fs, K1095fs, K1113fs, K1157fs, K1180fs, K887fs, K1071fs, K1072fs, K1141fs, K1142fs, K1182fs, K315fs, K1112fs, K1116fs, K1135fs, K1156fs, K1055fs, K1094fs, K1115fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001392086	17	41243996 - 41244000	17	43091979 - 43091983	1392086	1409427	rs2154303812	NC_000017.11:43091978:TCCTTTC:TC	Deletion	frameshift variant|intron variant	Pathogenic	Jun 26, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3550G>T (p.Gly1184Ter)	BRCA1|LOC126862571	G1073*, G1114*, G1137*, G1183*, G1016*, G1095*, G1117*, G1142*, G1157*, G1057*, G1113*, G1116*, G1143*, G1181*, G316*, G888*, G1056*, G1072*, G1096*, G1136*, G1158*, G1184*	Hereditary cancer-predisposing syndrome	VCV001732595	17	41243998	17	43091981	1732595	1786282	rs1472194405	NC_000017.11:43091980:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	May 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3547_3550delinsGAT (p.Lys1183fs)	BRCA1|LOC126862571	K1183fs, K1136fs, K1055fs, K1094fs, K1015fs, K1056fs, K1112fs, K1135fs, K1142fs, K1182fs, K315fs, K1072fs, K1095fs, K1113fs, K1115fs, K1141fs, K1156fs, K1180fs, K887fs, K1071fs, K1116fs, K1157fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254433	17	41243998 - 41244001	17	43091981 - 43091984	254433	249110	rs886038017	NC_000017.11:43091980:CTTT:ATC	Indel	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3549_3550delinsT (p.Lys1183fs)	BRCA1|LOC126862571	K1136fs, K1183fs, K1056fs, K1095fs, K1113fs, K1156fs, K1157fs, K1180fs, K315fs, K1015fs, K1071fs, K1094fs, K1116fs, K887fs, K1135fs, K1142fs, K1055fs, K1072fs, K1112fs, K1115fs, K1141fs, K1182fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054915	17	41243998 - 41243999	17	43091981 - 43091982	54915	69582	rs273899709	NC_000017.11:43091980:CT:A	Indel	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3549_3550del (p.Gly1184fs)	BRCA1|LOC126862571	G1137fs, G1184fs, G1057fs, G1095fs, G1117fs, G1143fs, G1157fs, G1158fs, G1073fs, G1096fs, G1114fs, G1142fs, G1181fs, G1016fs, G1072fs, G1113fs, G1183fs, G316fs, G888fs, G1056fs, G1116fs, G1136fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054914	17	41243998 - 41243999	17	43091981 - 43091982	54914	69581	rs730882057	NC_000017.11:43091980:CT:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3548_3549del (p.Lys1183fs)	BRCA1|LOC126862571	K1136fs, K1183fs, K1015fs, K1071fs, K1135fs, K1094fs, K1156fs, K887fs, K1141fs, K1157fs, K1180fs, K1182fs, K1055fs, K1072fs, K1115fs, K1116fs, K1142fs, K1056fs, K1095fs, K1112fs, K1113fs, K315fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125636	17	41243999 - 41244000	17	43091982 - 43091983	125636	131174	rs80357956	NC_000017.11:43091981:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3543_3544insGA (p.Gln1182fs)	LOC126862571|BRCA1	Q1135fs, Q1182fs, Q1055fs, Q1094fs, Q1115fs, Q1140fs, Q1155fs, Q1156fs, Q314fs, Q1014fs, Q1114fs, Q1141fs, Q1179fs, Q1181fs, Q1054fs, Q1071fs, Q1111fs, Q1112fs, Q1134fs, Q1070fs, Q1093fs, Q886fs	Hereditary breast ovarian cancer syndrome	VCV000462612	17	41244004 - 41244005	17	43091987 - 43091988	462612	466866	rs1555587537	NC_000017.11:43091987::TC	Insertion	frameshift variant|intron variant	Pathogenic	Apr 5, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3544C>T (p.Gln1182Ter)	BRCA1|LOC126862571	Q1182*, Q1135*, Q1054*, Q1055*, Q1093*, Q1115*, Q1155*, Q1014*, Q1071*, Q1111*, Q1114*, Q1134*, Q1140*, Q1141*, Q1156*, Q1179*, Q1181*, Q1070*, Q1094*, Q886*, Q1112*, Q314*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054913	17	41244004	17	43091987	54913	69580	rs80357296	NC_000017.11:43091986:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3541_3542del (p.Val1181fs)	BRCA1|LOC126862571	V1134fs, V1181fs, V1070fs, V1093fs, V1110fs, V1111fs, V1114fs, V313fs, V885fs, V1113fs, V1178fs, V1180fs, V1140fs, V1154fs, V1013fs, V1053fs, V1054fs, V1069fs, V1092fs, V1133fs, V1139fs, V1155fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266382	17	41244006 - 41244007	17	43091989 - 43091990	266382	261725	rs886040141	NC_000017.11:43091988:AC:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3541del (p.Val1181fs)	BRCA1|LOC126862571	V1181fs, V1134fs, V1070fs, V1114fs, V1139fs, V1053fs, V1110fs, V1140fs, V1054fs, V1069fs, V1092fs, V1111fs, V1133fs, V1155fs, V1178fs, V885fs, V1013fs, V1093fs, V1113fs, V1154fs, V1180fs, V313fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254432	17	41244007	17	43091990	254432	249111	rs886038016	NC_000017.11:43091989:C:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3540_3541del (p.Val1181fs)	BRCA1|LOC126862571	V1134fs, V1181fs, V1092fs, V1111fs, V1140fs, V1053fs, V1054fs, V1069fs, V1154fs, V1178fs, V1180fs, V885fs, V1070fs, V1093fs, V1114fs, V1155fs, V1013fs, V1110fs, V1113fs, V1133fs, V1139fs, V313fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054910	17	41244007 - 41244008	17	43091990 - 43091991	54910	69577	rs397509080	NC_000017.11:43091989:CGC:C	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3538del (p.Ser1180fs)	BRCA1|LOC126862571	S1012fs, S1052fs, S1053fs, S1068fs, S1069fs, S1091fs, S1092fs, S1109fs, S1110fs, S1112fs, S1113fs, S1132fs, S1133fs, S1138fs, S1139fs, S1153fs, S1154fs, S1177fs, S1179fs, S1180fs, S312fs, S884fs	Hereditary cancer-predisposing syndrome	VCV003226139	17	41244010	17	43091993	3226139	3387203	rs1567791274	NC_000017.11:43091992:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 13, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3535A>T (p.Lys1179Ter)	BRCA1|LOC126862571	K1179*, K1132*, K1051*, K1068*, K1090*, K1111*, K1112*, K1137*, K1176*, K1052*, K1067*, K1138*, K311*, K1011*, K1091*, K1108*, K1109*, K1131*, K1152*, K1153*, K1178*, K883*	not provided	VCV000495091	17	41244013	17	43091996	495091	486654	rs587782188	NC_000017.11:43091995:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3534del (p.Ser1178fs)	BRCA1|LOC126862571	S1178fs, S1131fs, S1111fs, S1151fs, S1152fs, S1177fs, S882fs, S1066fs, S1067fs, S1090fs, S1107fs, S1130fs, S1136fs, S1110fs, S1175fs, S310fs, S1010fs, S1050fs, S1051fs, S1089fs, S1108fs, S1137fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266381	17	41244014	17	43091997	266381	261726	rs886040140	NC_000017.11:43091996:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3531_3533delinsAA (p.Phe1177fs)	BRCA1|LOC126862571	F1130fs, F1177fs, F1135fs, F1151fs, F1066fs, F1150fs, F1174fs, F1009fs, F1088fs, F1089fs, F1106fs, F1109fs, F881fs, F1049fs, F1050fs, F1065fs, F1107fs, F1110fs, F1129fs, F1136fs, F1176fs, F309fs	Hereditary breast ovarian cancer syndrome	VCV000967660	17	41244015 - 41244017	17	43091998 - 43092000	967660	958126	rs2053570708	NC_000017.11:43091997:CTA:TT	Indel	frameshift variant|intron variant	Pathogenic	May 3, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3531dup (p.Ser1178Ter)	BRCA1|LOC126862571	S1131*, S1178*, S1090*, S1110*, S1111*, S1137*, S310*, S1050*, S1051*, S1010*, S1066*, S1067*, S1107*, S1108*, S1151*, S1177*, S882*, S1089*, S1130*, S1136*, S1152*, S1175*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254431	17	41244016 - 41244017	17	43091999 - 43092000	254431	249112	rs80357621	NC_000017.11:43091999:AAAAA:AAAAAA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3531del (p.Phe1177fs)	BRCA1|LOC126862571	F1177fs, F1130fs, F1049fs, F1088fs, F1089fs, F1106fs, F1109fs, F1110fs, F1050fs, F1066fs, F1129fs, F309fs, F1107fs, F1136fs, F1150fs, F1174fs, F1009fs, F1065fs, F1135fs, F1151fs, F1176fs, F881fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054909	17	41244017	17	43092000	54909	69576	rs80357621	NC_000017.11:43091999:AAAAA:AAAA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3526del (p.Val1176fs)	BRCA1|LOC126862571	V1129fs, V1176fs, V1049fs, V1064fs, V1065fs, V1108fs, V1134fs, V1149fs, V1150fs, V1087fs, V1106fs, V1128fs, V1048fs, V1088fs, V1173fs, V1175fs, V308fs, V880fs, V1008fs, V1105fs, V1109fs, V1135fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000419648	17	41244022	17	43092005	419648	409979	rs1064794016	NC_000017.11:43092004:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3514_3518del (p.Glu1172fs)	BRCA1|LOC126862571	E1172fs, E1125fs, E1004fs, E1060fs, E1104fs, E1105fs, E1131fs, E1145fs, E1146fs, E1169fs, E1061fs, E1083fs, E1101fs, E1130fs, E1171fs, E1084fs, E1102fs, E304fs, E876fs, E1044fs, E1045fs, E1124fs	Hereditary breast ovarian cancer syndrome	VCV001455774	17	41244030 - 41244034	17	43092013 - 43092017	1455774	1380034	rs2154306646	NC_000017.11:43092012:CTTTCCTT:CTT	Deletion	intron variant|frameshift variant	Pathogenic	Jun 11, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3514G>T (p.Glu1172Ter)	BRCA1|LOC126862571	E1172*, E1125*, E1044*, E1045*, E1061*, E1083*, E1130*, E1145*, E1146*, E1171*, E1084*, E1124*, E876*, E1004*, E1101*, E1102*, E1060*, E1104*, E1105*, E1131*, E1169*, E304*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054906	17	41244034	17	43092017	54906	69573	rs397509079	NC_000017.11:43092016:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3512del (p.Lys1171fs)	BRCA1|LOC126862571	K1171fs, K1124fs, K1043fs, K1060fs, K1100fs, K1129fs, K1144fs, K1082fs, K1083fs, K1168fs, K1003fs, K1044fs, K1101fs, K1103fs, K1104fs, K1145fs, K1170fs, K303fs, K1059fs, K1123fs, K1130fs, K875fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266380	17	41244036	17	43092019	266380	261727	rs886040139	NC_000017.11:43092018:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3511A>T (p.Lys1171Ter)	BRCA1|LOC126862571	K1171*, K1124*, K1100*, K1103*, K1144*, K875*, K1043*, K1044*, K1059*, K1060*, K1101*, K1104*, K1123*, K1145*, K1083*, K1170*, K1003*, K1082*, K1129*, K1130*, K1168*, K303*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183177	17	41244037	17	43092020	183177	181316	rs730882164	NC_000017.11:43092019:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3505_3509del (p.Asn1168_Asp1169insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054904	17	41244039 - 41244043	17	43092022 - 43092026	54904	69571	rs397509078	NC_000017.11:43092021:ATGTCAT:AT	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3506dup (p.Asp1169fs)	BRCA1|LOC126862571	D1169fs, D1122fs, D1042fs, D1080fs, D1081fs, D1143fs, D1057fs, D1099fs, D1102fs, D1128fs, D301fs, D1041fs, D1098fs, D1127fs, D1142fs, D1168fs, D873fs, D1001fs, D1058fs, D1101fs, D1121fs, D1166fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548160	17	41244041 - 41244042	17	43092024 - 43092025	548160	538817	rs1555587573	NC_000017.11:43092024:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3504_3505insA (p.Asp1169fs)	BRCA1|LOC126862571	D1122fs, D1169fs, D1001fs, D1057fs, D1142fs, D1166fs, D1042fs, D1058fs, D1081fs, D1099fs, D1101fs, D1128fs, D1143fs, D873fs, D1041fs, D301fs, D1080fs, D1098fs, D1102fs, D1121fs, D1127fs, D1168fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266379	17	41244043 - 41244044	17	43092026 - 43092027	266379	261728	rs886040138	NC_000017.11:43092026::T	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3503dup (p.Asn1168fs)	LOC126862571|BRCA1	N1121fs, N1168fs, N1040fs, N1041fs, N1141fs, N1167fs, N1079fs, N1126fs, N300fs, N872fs, N1000fs, N1056fs, N1057fs, N1080fs, N1101fs, N1127fs, N1097fs, N1098fs, N1100fs, N1120fs, N1142fs, N1165fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054903	17	41244044 - 41244045	17	43092027 - 43092028	54903	69570	rs397507216	NC_000017.11:43092027:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3503del (p.Asn1168fs)	BRCA1|LOC126862571	N1121fs, N1168fs, N1040fs, N1041fs, N1056fs, N1057fs, N1080fs, N1141fs, N1000fs, N1079fs, N1100fs, N1120fs, N1126fs, N300fs, N872fs, N1097fs, N1098fs, N1142fs, N1165fs, N1101fs, N1127fs, N1167fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037532	17	41244045	17	43092028	37532	46088	rs397507216	NC_000017.11:43092027:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3499del (p.Glu1167fs)	BRCA1|LOC126862571	E1039fs, E1096fs, E1120fs, E1126fs, E1140fs, E1167fs, E999fs, E1040fs, E1079fs, E1099fs, E1100fs, E1141fs, E1166fs, E299fs, E1056fs, E1078fs, E1097fs, E1125fs, E871fs, E1055fs, E1119fs, E1164fs	Hereditary breast ovarian cancer syndrome	VCV002832857	17	41244049	17	43092032	2832857	2991401	rs2552147230	NC_000017.11:43092031:C:	Deletion	intron variant|frameshift variant	Pathogenic	Jul 19, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3489_3499del (p.Ser1164fs)	BRCA1|LOC126862571	S1164fs, S1117fs, S1093fs, S1122fs, S1138fs, S1161fs, S296fs, S868fs, S996fs, S1037fs, S1075fs, S1076fs, S1096fs, S1123fs, S1137fs, S1053fs, S1097fs, S1163fs, S1036fs, S1052fs, S1094fs, S1116fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266377	17	41244049 - 41244059	17	43092032 - 43092042	266377	261729	rs886040136	NC_000017.11:43092031:CAGCAAAACTA:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3498del (p.Glu1167fs)	BRCA1|LOC126862571	E1120fs, E1167fs, E1126fs, E1140fs, E1141fs, E1164fs, E1040fs, E1119fs, E871fs, E1078fs, E1079fs, E1099fs, E1100fs, E1166fs, E299fs, E1039fs, E1055fs, E1056fs, E1096fs, E1097fs, E1125fs, E999fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266378	17	41244050	17	43092033	266378	261730	rs886040137	NC_000017.11:43092032:A:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3496del (p.Ala1166fs)	BRCA1|LOC126862571	A1166fs, A1119fs, A1038fs, A1039fs, A1095fs, A1118fs, A1165fs, A870fs, A1054fs, A1096fs, A1098fs, A1125fs, A1139fs, A298fs, A1055fs, A1078fs, A1099fs, A1124fs, A1140fs, A1077fs, A1163fs, A998fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254430	17	41244052	17	43092035	254430	249113	rs886038015	NC_000017.11:43092034:C:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3494_3495del (p.Phe1165fs)	BRCA1|LOC126862571	F1118fs, F1165fs, F1053fs, F1054fs, F1098fs, F1138fs, F1124fs, F1139fs, F297fs, F1038fs, F1077fs, F1094fs, F1095fs, F1117fs, F1123fs, F1164fs, F997fs, F1037fs, F1076fs, F1097fs, F1162fs, F869fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054901	17	41244053 - 41244054	17	43092036 - 43092037	54901	69568	rs397509076	NC_000017.11:43092035:AAAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3481_3493del (p.Glu1161fs)	BRCA1|LOC126862571	E1114fs, E1161fs, E1033fs, E1050fs, E1073fs, E1093fs, E1119fs, E293fs, E1094fs, E1113fs, E1120fs, E1160fs, E1034fs, E1072fs, E1090fs, E1091fs, E993fs, E1049fs, E1134fs, E1135fs, E1158fs, E865fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431245	17	41244055 - 41244067	17	43092038 - 43092050	431245	424816	rs1555587588	NC_000017.11:43092037:AACTAGTATCTTC:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3482_3492del (p.Glu1161fs)	BRCA1|LOC126862571	E1161fs, E1114fs, E1034fs, E1073fs, E1093fs, E1094fs, E1120fs, E1134fs, E1160fs, E293fs, E1033fs, E1050fs, E1158fs, E865fs, E993fs, E1049fs, E1090fs, E1119fs, E1072fs, E1091fs, E1113fs, E1135fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266374	17	41244056 - 41244066	17	43092039 - 43092049	266374	261731	rs886040133	NC_000017.11:43092038:ACTAGTATCTT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3485_3491del (p.Asp1162fs)	BRCA1|LOC126862571	D1162fs, D1115fs, D1034fs, D1114fs, D1135fs, D1159fs, D1035fs, D1050fs, D1051fs, D1120fs, D1121fs, D1136fs, D294fs, D866fs, D1092fs, D1095fs, D1161fs, D994fs, D1073fs, D1074fs, D1091fs, D1094fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266376	17	41244057 - 41244063	17	43092040 - 43092046	266376	261732	rs886040135	NC_000017.11:43092039:CTAGTATCT:CT	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3481_3491del (p.Glu1161fs)	BRCA1|LOC126862571	E1114fs, E1161fs, E1033fs, E1050fs, E1090fs, E1120fs, E1049fs, E1072fs, E1113fs, E1135fs, E1160fs, E993fs, E1091fs, E1119fs, E1158fs, E1034fs, E1073fs, E1093fs, E1094fs, E1134fs, E293fs, E865fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017684	17	41244057 - 41244067	17	43092040 - 43092050	17684	32723	rs80357877	NC_000017.11:43092039:CTAGTATCTTCCT:CT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3487dup (p.Thr1163fs)	BRCA1|LOC126862571	T1116fs, T1163fs, T1035fs, T1075fs, T1096fs, T1115fs, T1121fs, T995fs, T1052fs, T1092fs, T1093fs, T1095fs, T1122fs, T1136fs, T1162fs, T1036fs, T1051fs, T867fs, T1074fs, T1137fs, T1160fs, T295fs	Hereditary breast ovarian cancer syndrome	VCV003768922	17	41244060 - 41244061	17	43092043 - 43092044	3768922	1245678		NC_000017.11:43092043:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Feb 20, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3485_3488del (p.Asp1162fs)	BRCA1|LOC126862571	D1162fs, D1115fs, D1074fs, D1091fs, D1092fs, D1094fs, D1095fs, D1121fs, D1136fs, D1161fs, D294fs, D866fs, D1114fs, D1120fs, D994fs, D1034fs, D1035fs, D1050fs, D1051fs, D1135fs, D1159fs, D1073fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266375	17	41244060 - 41244063	17	43092043 - 43092046	266375	261733	rs886040134	NC_000017.11:43092042:GTAT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3479_3488del (p.Lys1160fs)	BRCA1|LOC126862571	K1160fs, K1113fs, K1032fs, K1071fs, K1133fs, K292fs, K1048fs, K1072fs, K1093fs, K1112fs, K1134fs, K864fs, K1049fs, K1089fs, K1090fs, K1157fs, K1159fs, K1033fs, K1092fs, K1118fs, K1119fs, K992fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054897	17	41244060 - 41244069	17	43092043 - 43092052	54897	69564	rs397509073	NC_000017.11:43092042:GTATCTTCCT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3478_3487del (p.Lys1160fs)	LOC126862571|BRCA1	K1160fs, K1113fs, K1033fs, K1092fs, K1118fs, K1032fs, K1072fs, K1089fs, K1093fs, K1133fs, K1157fs, K1049fs, K1071fs, K1112fs, K1119fs, K1048fs, K1090fs, K1134fs, K1159fs, K292fs, K864fs, K992fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187386	17	41244061 - 41244070	17	43092044 - 43092053	187386	184964	rs786203694	NC_000017.11:43092043:TATCTTCCTTTAT:TAT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3485del (p.Asp1162fs)	BRCA1|LOC126862571	D1115fs, D1162fs, D1092fs, D1095fs, D1114fs, D1120fs, D1121fs, D1135fs, D294fs, D1074fs, D1094fs, D1136fs, D1161fs, D866fs, D1034fs, D1035fs, D1050fs, D1051fs, D1073fs, D1091fs, D1159fs, D994fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037531	17	41244063	17	43092046	37531	46087	rs80357509	NC_000017.11:43092045:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3484del (p.Asp1162fs)	BRCA1|LOC126862571	D1162fs, D1115fs, D1051fs, D1092fs, D1135fs, D1159fs, D294fs, D1136fs, D1050fs, D1074fs, D1095fs, D1114fs, D866fs, D1035fs, D1073fs, D1091fs, D1034fs, D1094fs, D1120fs, D1121fs, D1161fs, D994fs	Hereditary cancer-predisposing syndrome	VCV001731867	17	41244064	17	43092047	1731867	1792770	rs2552147761	NC_000017.11:43092046:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 8, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3479_3483del (p.Lys1160fs)	BRCA1|LOC126862571	K1113fs, K1160fs, K1089fs, K1112fs, K864fs, K992fs, K1032fs, K1048fs, K1049fs, K1090fs, K1092fs, K1093fs, K1119fs, K1133fs, K1157fs, K1072fs, K292fs, K1033fs, K1071fs, K1118fs, K1134fs, K1159fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266373	17	41244065 - 41244069	17	43092048 - 43092052	266373	261734	rs886040132	NC_000017.11:43092047:TTCCTTT:TT	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3481G>T (p.Glu1161Ter)	BRCA1|LOC126862571	E1161*, E1114*, E1050*, E1091*, E1113*, E1119*, E293*, E1049*, E1093*, E1120*, E1160*, E993*, E1033*, E1034*, E1072*, E1090*, E1134*, E1135*, E1158*, E865*, E1073*, E1094*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187055	17	41244067	17	43092050	187055	184965	rs786203438	NC_000017.11:43092049:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3481del (p.Glu1161fs)	BRCA1|LOC126862571	E1114fs, E1161fs, E1034fs, E1050fs, E1073fs, E1090fs, E1093fs, E1120fs, E865fs, E1049fs, E1113fs, E1119fs, E1134fs, E1160fs, E293fs, E1033fs, E1072fs, E1094fs, E1135fs, E1158fs, E1091fs, E993fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054898	17	41244067	17	43092050	54898	69565	rs397509074	NC_000017.11:43092049:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3479dup (p.Glu1161fs)	BRCA1|LOC126862571	E1161fs, E1114fs, E1034fs, E1049fs, E1072fs, E1091fs, E1158fs, E1160fs, E1090fs, E1093fs, E1094fs, E1134fs, E293fs, E1033fs, E1073fs, E1113fs, E865fs, E1050fs, E1119fs, E1120fs, E1135fs, E993fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000949797	17	41244068 - 41244069	17	43092051 - 43092052	949797	928294	rs273899707	NC_000017.11:43092051:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3477_3480del (p.Ile1159fs)	BRCA1|LOC126862571	I1112fs, I1159fs, I1048fs, I1071fs, I1111fs, I1132fs, I1156fs, I1158fs, I291fs, I1031fs, I1032fs, I1091fs, I1117fs, I863fs, I1047fs, I1070fs, I1092fs, I991fs, I1088fs, I1089fs, I1118fs, I1133fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054896	17	41244068 - 41244071	17	43092051 - 43092054	54896	69563	rs80357781	NC_000017.11:43092050:CTTT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3479del (p.Lys1160fs)	BRCA1|LOC126862571	K1160fs, K1113fs, K1032fs, K1093fs, K1119fs, K1159fs, K292fs, K1049fs, K1071fs, K1048fs, K1090fs, K1092fs, K1112fs, K1118fs, K1133fs, K1157fs, K1033fs, K1072fs, K1089fs, K1134fs, K864fs, K992fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431244	17	41244069	17	43092052	431244	424818	rs273899707	NC_000017.11:43092051:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3478_3479del (p.Lys1160fs)	LOC126862571|BRCA1	K1113fs, K1160fs, K1048fs, K1072fs, K1118fs, K292fs, K1032fs, K1033fs, K1092fs, K1093fs, K1119fs, K1157fs, K864fs, K1089fs, K1090fs, K1112fs, K992fs, K1049fs, K1071fs, K1133fs, K1134fs, K1159fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266372	17	41244069 - 41244070	17	43092052 - 43092053	266372	261735	rs273899707	NC_000017.11:43092051:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3477_3479delinsC (p.Lys1160fs)	BRCA1|LOC126862571	K1113fs, K1160fs, K1049fs, K1071fs, K1072fs, K1112fs, K1118fs, K1157fs, K864fs, K1033fs, K1092fs, K1119fs, K992fs, K1032fs, K1090fs, K1134fs, K1159fs, K292fs, K1048fs, K1089fs, K1093fs, K1133fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054895	17	41244069 - 41244071	17	43092052 - 43092054	54895	69562	rs273899707	NC_000017.11:43092051:TTT:G	Indel	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3475dup (p.Ile1159fs)	BRCA1|LOC126862571	I1112fs, I1159fs, I1070fs, I1088fs, I1117fs, I1133fs, I991fs, I1031fs, I1032fs, I1071fs, I1118fs, I291fs, I863fs, I1089fs, I1111fs, I1132fs, I1156fs, I1047fs, I1048fs, I1091fs, I1092fs, I1158fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000496368	17	41244072 - 41244073	17	43092055 - 43092056	496368	487963	rs1555587638	NC_000017.11:43092055:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3456_3475delinsTGTT (p.Leu1153fs)	BRCA1|LOC126862571	L1025fs, L1065fs, L1105fs, L1127fs, L1150fs, L857fs, L1064fs, L1083fs, L1085fs, L1106fs, L1112fs, L1126fs, L1152fs, L1041fs, L1026fs, L1042fs, L1082fs, L1086fs, L1111fs, L1153fs, L285fs, L985fs	Hereditary cancer-predisposing syndrome	VCV003481816	17	41244073 - 41244092	17	43092056 - 43092075	3481816	3640027		NC_000017.11:43092055:TTTCACCATCATCTAACAGG:AACA	Indel	frameshift variant|intron variant	Pathogenic	Jul 1, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3475del (p.Glu1158_Ile1159insTer)	LOC126862571|BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000823814	17	41244073	17	43092056	823814	813738	rs1555587638	NC_000017.11:43092055:TTT:TT	Deletion	nonsense|intron variant|frameshift variant	Pathogenic/Likely pathogenic	Oct 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3472G>T (p.Glu1158Ter)	BRCA1|LOC126862571	E1158*, E1111*, E1046*, E1070*, E1117*, E1030*, E1110*, E1116*, E1157*, E290*, E1069*, E1087*, E1088*, E1132*, E1155*, E862*, E990*, E1031*, E1047*, E1090*, E1091*, E1131*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054894	17	41244076	17	43092059	54894	69561	rs397509072	NC_000017.11:43092058:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3468del (p.Asp1156fs)	BRCA1|LOC126862571	D1156fs, D1109fs, D1029fs, D1085fs, D1108fs, D1130fs, D1155fs, D288fs, D1045fs, D1067fs, D860fs, D988fs, D1068fs, D1089fs, D1115fs, D1129fs, D1028fs, D1044fs, D1086fs, D1088fs, D1114fs, D1153fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054892	17	41244080	17	43092063	54892	69559	rs397509070	NC_000017.11:43092062:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3462dup (p.Asp1155fs)	BRCA1|LOC126862571	D1108fs, D1155fs, D1027fs, D1129fs, D1028fs, D1043fs, D1067fs, D1084fs, D1085fs, D1087fs, D1107fs, D1114fs, D859fs, D1088fs, D1113fs, D1128fs, D1152fs, D1154fs, D1044fs, D1066fs, D287fs, D987fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125632	17	41244085 - 41244086	17	43092068 - 43092069	125632	131170	rs80357857	NC_000017.11:43092068:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3458_3462del (p.Leu1153fs)	BRCA1|LOC126862571	L1153fs, L1106fs, L1025fs, L1065fs, L285fs, L1041fs, L1083fs, L1086fs, L1111fs, L985fs, L1085fs, L1127fs, L1150fs, L1026fs, L1042fs, L1064fs, L1082fs, L1105fs, L1112fs, L1126fs, L1152fs, L857fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254429	17	41244086 - 41244090	17	43092069 - 43092073	254429	249114	rs886038014	NC_000017.11:43092068:TAACA:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3461T>G (p.Leu1154Ter)	BRCA1|LOC126862571	L1154*, L1107*, L1065*, L1086*, L1127*, L1128*, L1151*, L1153*, L286*, L1043*, L1066*, L1083*, L1084*, L1106*, L1027*, L1112*, L1113*, L858*, L986*, L1026*, L1042*, L1087*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266371	17	41244087	17	43092070	266371	261736	rs886040130	NC_000017.11:43092069:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3459_3460del (p.Leu1154fs)	BRCA1|LOC126862571	L1107fs, L1154fs, L1026fs, L1042fs, L1043fs, L1066fs, L1086fs, L1106fs, L1127fs, L1153fs, L1151fs, L1027fs, L1065fs, L1084fs, L1113fs, L1128fs, L286fs, L986fs, L1083fs, L1087fs, L1112fs, L858fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254428	17	41244088 - 41244089	17	43092071 - 43092072	254428	249115	rs886038013	NC_000017.11:43092070:ACA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3458del (p.Leu1153fs)	BRCA1|LOC126862571	L1106fs, L1153fs, L1026fs, L1065fs, L1083fs, L1086fs, L985fs, L1085fs, L1111fs, L285fs, L1025fs, L1041fs, L1064fs, L1105fs, L1112fs, L1126fs, L1150fs, L1042fs, L1082fs, L1127fs, L1152fs, L857fs	Hereditary breast ovarian cancer syndrome	VCV000948960	17	41244090	17	43092073	948960	928295	rs1567791573	NC_000017.11:43092072:A:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 20, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3455del (p.Asp1152fs)	BRCA1|LOC126862571	D1105fs, D1152fs, D1025fs, D1041fs, D1063fs, D1084fs, D1110fs, D1151fs, D1064fs, D1085fs, D1104fs, D1111fs, D1126fs, D284fs, D1024fs, D1040fs, D1081fs, D1125fs, D1149fs, D984fs, D1082fs, D856fs	Hereditary cancer-predisposing syndrome	VCV000823791	17	41244093	17	43092076	823791	813740	rs1597863566	NC_000017.11:43092075:T:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3450dup (p.Asp1151Ter)	BRCA1|LOC126862571	D1104*, D1151*, D1023*, D1040*, D1081*, D1083*, D1084*, D1109*, D283*, D1080*, D1124*, D1148*, D1150*, D855*, D983*, D1024*, D1039*, D1062*, D1063*, D1103*, D1110*, D1125*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054889	17	41244097 - 41244098	17	43092080 - 43092081	54889	69556	rs397509069	NC_000017.11:43092080:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3450del (p.Asp1151fs)	BRCA1|LOC126862571	D1151fs, D1104fs, D1023fs, D1039fs, D1081fs, D1124fs, D855fs, D1062fs, D1083fs, D1109fs, D1148fs, D1150fs, D1024fs, D1040fs, D1063fs, D1080fs, D1110fs, D1125fs, D1084fs, D1103fs, D283fs, D983fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054888	17	41244098	17	43092081	54888	69555	rs397509068	NC_000017.11:43092080:A:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3449del (p.Pro1150fs)	BRCA1|LOC126862571	P1022fs, P1062fs, P1080fs, P1123fs, P1147fs, P1149fs, P1023fs, P1038fs, P1082fs, P1103fs, P1061fs, P1079fs, P1083fs, P1102fs, P1150fs, P282fs, P982fs, P1109fs, P1124fs, P854fs, P1039fs, P1108fs	Hereditary cancer-predisposing syndrome	VCV003825280	17	41244099	17	43092082	3825280	3942552		NC_000017.11:43092081:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 16, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3447_3448del (p.Thr1149_Pro1150insTer)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV000937832	17	41244100 - 41244101	17	43092083 - 43092084	937832	937954	rs2053585404	NC_000017.11:43092082:GTGT:GT	Microsatellite	frameshift variant|nonsense|intron variant	Pathogenic	Nov 13, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3446del (p.Thr1149fs)	BRCA1|LOC126862571	T1102fs, T1149fs, T1021fs, T1037fs, T1038fs, T1060fs, T1107fs, T1146fs, T1148fs, T281fs, T981fs, T1061fs, T1079fs, T853fs, T1022fs, T1078fs, T1082fs, T1122fs, T1081fs, T1101fs, T1108fs, T1123fs	Hereditary breast ovarian cancer syndrome	VCV001452332	17	41244102	17	43092085	1452332	1364053	rs2154315058	NC_000017.11:43092084:G:	Deletion	frameshift variant|intron variant	Pathogenic	May 15, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3442G>T (p.Glu1148Ter)	BRCA1|LOC126862571	E1148*, E1101*, E1036*, E1060*, E1081*, E1122*, E852*, E1020*, E1077*, E1106*, E1121*, E1147*, E980*, E1021*, E280*, E1037*, E1059*, E1078*, E1080*, E1100*, E1107*, E1145*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254427	17	41244106	17	43092089	254427	249116	rs886038012	NC_000017.11:43092088:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3442del (p.Glu1148fs)	BRCA1|LOC126862571	E1101fs, E1148fs, E1059fs, E1121fs, E1145fs, E280fs, E980fs, E1021fs, E1107fs, E1037fs, E1078fs, E1080fs, E1100fs, E1122fs, E1020fs, E1036fs, E1060fs, E1077fs, E1081fs, E1106fs, E1147fs, E852fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037530	17	41244106	17	43092089	37530	46086	rs80357808	NC_000017.11:43092088:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3440_3441del (p.Cys1146_Ser1147insTer)	LOC126862571|BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000823774	17	41244107 - 41244108	17	43092090 - 43092091	823774	813741	rs1597863644	NC_000017.11:43092089:AGA:A	Deletion	nonsense|intron variant|frameshift variant	Pathogenic	Nov 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3109_3439del (p.Lys1037fs)	BRCA1|LOC126862571	K1010fs, K1011fs, K1034fs, K1036fs, K1037fs, K741fs, K869fs, K909fs, K910fs, K925fs, K926fs, K948fs, K949fs, K966fs, K967fs, K969fs, K970fs, K989fs, K990fs, K995fs, K996fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004294281	17	41244109 - 41244439	17	43092092 - 43092422	4294281	4406804			Deletion	frameshift variant|intron variant|splice acceptor variant	Pathogenic	Sep 24, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3436_3439del (p.Cys1146fs)	BRCA1|LOC126862571	C1146fs, C1099fs, C1019fs, C1075fs, C1078fs, C1104fs, C1105fs, C1120fs, C1034fs, C1076fs, C1079fs, C850fs, C1098fs, C1119fs, C278fs, C1018fs, C1035fs, C1057fs, C1058fs, C1143fs, C1145fs, C978fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054885	17	41244109 - 41244112	17	43092092 - 43092095	54885	69552	rs397509067	NC_000017.11:43092091:AACAAAC:AAC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3433del (p.Val1145fs)	BRCA1|LOC126862571	V1098fs, V1145fs, V1033fs, V277fs, V1074fs, V1075fs, V1097fs, V1103fs, V1104fs, V849fs, V1034fs, V1056fs, V1057fs, V1118fs, V1119fs, V1144fs, V977fs, V1017fs, V1018fs, V1077fs, V1078fs, V1142fs	Hereditary breast ovarian cancer syndrome	VCV000655970	17	41244115	17	43092098	655970	645976	rs1567791626	NC_000017.11:43092097:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 10, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3430C>T (p.Gln1144Ter)	BRCA1|LOC126862571	Q1144*, Q1097*, Q1077*, Q276*, Q976*, Q1032*, Q1073*, Q1074*, Q1096*, Q1118*, Q1141*, Q1143*, Q1055*, Q1076*, Q1102*, Q1117*, Q1016*, Q1017*, Q1033*, Q1056*, Q1103*, Q848*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054883	17	41244118	17	43092101	54883	69550	rs80357369	NC_000017.11:43092100:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3428delinsTA (p.Ser1143fs)	BRCA1|LOC126862571	S1096fs, S1143fs, S1015fs, S1076fs, S1101fs, S1140fs, S275fs, S1016fs, S1054fs, S1073fs, S1102fs, S1116fs, S1117fs, S1055fs, S1072fs, S1075fs, S1142fs, S847fs, S975fs, S1031fs, S1032fs, S1095fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054881	17	41244120	17	43092103	54881	69548	rs397509066	NC_000017.11:43092102:G:TA	Indel	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3416_3427delinsC (p.Ser1139fs)	BRCA1|LOC126862571	S1092fs, S1139fs, S1012fs, S1091fs, S843fs, S1027fs, S1069fs, S1136fs, S1011fs, S1072fs, S1097fs, S1112fs, S1113fs, S1138fs, S971fs, S1028fs, S1050fs, S1051fs, S1068fs, S1071fs, S1098fs, S271fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266369	17	41244121 - 41244132	17	43092104 - 43092115	266369	261737	rs886040128	NC_000017.11:43092103:ATGCATGACTAC:G	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3424del (p.Ala1142fs)	BRCA1|LOC126862571	A1142fs, A1095fs, A1014fs, A1031fs, A1115fs, A1116fs, A274fs, A1072fs, A1075fs, A1094fs, A1100fs, A1141fs, A1015fs, A1030fs, A1101fs, A846fs, A1053fs, A1054fs, A1071fs, A1074fs, A1139fs, A974fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000438924	17	41244124	17	43092107	438924	432906	rs1555587718	NC_000017.11:43092106:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3420dup (p.His1141fs)	BRCA1|LOC126862571	H1094fs, H1141fs, H1070fs, H1100fs, H1115fs, H845fs, H1030fs, H1053fs, H1071fs, H1099fs, H1114fs, H1140fs, H973fs, H1013fs, H1029fs, H1052fs, H1074fs, H273fs, H1014fs, H1073fs, H1093fs, H1138fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054877	17	41244127 - 41244128	17	43092110 - 43092111	54877	69544	rs397509065	NC_000017.11:43092110:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3416dup (p.Ser1139fs)	BRCA1|LOC126862571	S1092fs, S1139fs, S1027fs, S1050fs, S1072fs, S1091fs, S1113fs, S1136fs, S1138fs, S271fs, S1028fs, S1051fs, S1068fs, S1069fs, S1097fs, S1098fs, S1112fs, S1011fs, S1012fs, S1071fs, S843fs, S971fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548192	17	41244131 - 41244132	17	43092114 - 43092115	548192	538818	rs1555587739	NC_000017.11:43092114:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3417del (p.Ser1139fs)	BRCA1|LOC126862571	S1092fs, S1139fs, S1012fs, S1051fs, S1071fs, S1112fs, S1027fs, S1069fs, S1091fs, S1098fs, S1138fs, S1011fs, S1028fs, S1068fs, S1072fs, S1097fs, S1113fs, S1136fs, S843fs, S971fs, S1050fs, S271fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054875	17	41244131	17	43092114	54875	69542	rs273899706	NC_000017.11:43092113:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3415dup (p.Ser1139fs)	BRCA1|LOC126862571	S1011fs, S1028fs, S1051fs, S1068fs, S1071fs, S1092fs, S1139fs, S271fs, S1050fs, S1098fs, S1113fs, S1136fs, S1027fs, S1069fs, S1072fs, S1091fs, S1097fs, S1112fs, S843fs, S971fs, S1012fs, S1138fs	Hereditary breast ovarian cancer syndrome	VCV002827172	17	41244132 - 41244133	17	43092115 - 43092116	2827172	2983124	rs2552150484	NC_000017.11:43092115:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Jan 31, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3416del (p.Ser1139fs)	BRCA1|LOC126862571	S1139fs, S1092fs, S1011fs, S1050fs, S1072fs, S1097fs, S843fs, S1027fs, S1091fs, S1098fs, S1113fs, S971fs, S1012fs, S1051fs, S1071fs, S1136fs, S271fs, S1028fs, S1068fs, S1069fs, S1112fs, S1138fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054874	17	41244132	17	43092115	54874	69541	rs397509064	NC_000017.11:43092114:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3413dup (p.Ser1139fs)	BRCA1|LOC126862571	S1092fs, S1139fs, S1012fs, S1112fs, S971fs, S1011fs, S1027fs, S1068fs, S1071fs, S1091fs, S1097fs, S1098fs, S1113fs, S1136fs, S843fs, S1072fs, S1138fs, S271fs, S1028fs, S1050fs, S1051fs, S1069fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266368	17	41244134 - 41244135	17	43092117 - 43092118	266368	261738	rs397509063	NC_000017.11:43092117:CCC:CCCC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3413del (p.Gly1138fs)	BRCA1|LOC126862571	G1091fs, G1138fs, G1010fs, G1011fs, G1026fs, G1068fs, G1090fs, G1137fs, G1049fs, G1050fs, G1070fs, G1071fs, G1097fs, G842fs, G1027fs, G1067fs, G1135fs, G270fs, G1096fs, G1111fs, G1112fs, G970fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054872	17	41244135	17	43092118	54872	69539	rs397509063	NC_000017.11:43092117:CCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3412G>T (p.Gly1138Ter)	BRCA1|LOC126862571	G1138*, G1091*, G1049*, G1067*, G1070*, G1111*, G1135*, G842*, G1010*, G1027*, G1050*, G1097*, G270*, G970*, G1011*, G1026*, G1071*, G1096*, G1137*, G1068*, G1090*, G1112*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266367	17	41244136	17	43092119	266367	261739	rs886040126	NC_000017.11:43092118:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.3(BRCA1):c.3388_3408del21ins16 (p.?)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267522	17	41244140 - 41244160	17	43092123 - 43092143	267522	262966			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3401_3405del (p.Glu1134fs)	BRCA1|LOC126862571	E1087fs, E1134fs, E1006fs, E1022fs, E1064fs, E1067fs, E1086fs, E966fs, E1007fs, E1092fs, E1023fs, E1045fs, E1046fs, E1066fs, E1093fs, E1107fs, E1131fs, E1133fs, E266fs, E1063fs, E1108fs, E838fs	Hereditary breast ovarian cancer syndrome	VCV000462609	17	41244143 - 41244147	17	43092126 - 43092130	462609	466868	rs1555587781	NC_000017.11:43092125:CTGTTCT:CT	Deletion	frameshift variant|intron variant	Pathogenic	Feb 1, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3403C>T (p.Gln1135Ter)	BRCA1|LOC126862571	Q1135*, Q1088*, Q1008*, Q1024*, Q1065*, Q1067*, Q1093*, Q1108*, Q1047*, Q1064*, Q1109*, Q1134*, Q967*, Q1007*, Q1087*, Q1023*, Q1046*, Q1068*, Q1094*, Q1132*, Q267*, Q839*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054868	17	41244145	17	43092128	54868	69535	rs80357136	NC_000017.11:43092127:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3399_3400delinsGGGCTGGGGAAGACAGACCTACCCTTAATCTGGTGGGCACAATCTAGTCAGCTGCCAGTGAACATAATGCAGGCAGAAAAACCTGAAAAGGTGAGACTGGCCTAGGCTCCCAGCCTCCATCTTTCTCCCATGCTGGATGTTTCCTGCTCAAACATCAGACTCCAAGTTCTTCAGTTTTGAGACTCGGACTGACTCTCCTTGCTCCTTAAGCTTGCAGACAGCCTATTGTGGGACCTTCTGATCATGTAAGTTAATACTTAATAAACTCCCCTTTATATATATT (p.Glu1134delinsGlyTrpGlyArgGlnThrTyrProTer)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV002077675	17	41244148 - 41244149	17	43092131 - 43092132	2077675	2142059	rs2552150904		Indel	nonsense|intron variant	Pathogenic	May 23, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3400G>T (p.Glu1134Ter)	BRCA1|LOC126862571	E1134*, E1087*, E1022*, E1063*, E1086*, E1092*, E1093*, E1007*, E1023*, E1045*, E1046*, E1066*, E1108*, E1131*, E266*, E838*, E966*, E1006*, E1067*, E1107*, E1064*, E1133*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037529	17	41244148	17	43092131	37529	46085	rs80357018	NC_000017.11:43092130:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3398T>G (p.Leu1133Ter)	BRCA1|LOC126862571	L1133*, L1086*, L1006*, L1045*, L1063*, L1066*, L1091*, L1107*, L965*, L1062*, L1085*, L265*, L1021*, L1022*, L1092*, L1130*, L1132*, L837*, L1005*, L1044*, L1065*, L1106*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054867	17	41244150	17	43092133	54867	69534	rs80356971	NC_000017.11:43092132:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3398T>A (p.Leu1133Ter)	BRCA1|LOC126862571	L1133*, L1086*, L1021*, L1044*, L1062*, L1005*, L1006*, L1022*, L1063*, L1065*, L1092*, L1132*, L837*, L965*, L1045*, L1066*, L1085*, L1091*, L1106*, L1107*, L1130*, L265*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054866	17	41244150	17	43092133	54866	69533	rs80356971	NC_000017.11:43092132:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3397_3398del (p.Leu1133fs)	BRCA1|LOC126862571	L1086fs, L1133fs, L1022fs, L1066fs, L1107fs, L1006fs, L1044fs, L1045fs, L1063fs, L1065fs, L1085fs, L1092fs, L265fs, L965fs, L1005fs, L1021fs, L1062fs, L1130fs, L1132fs, L1091fs, L1106fs, L837fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054865	17	41244150 - 41244151	17	43092133 - 43092134	54865	69532	rs80357577	NC_000017.11:43092132:AA:	Deletion	intron variant|frameshift variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3396del (p.Asn1132_Leu1133insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266366	17	41244152	17	43092135	266366	261740	rs886040125	NC_000017.11:43092134:G:	Deletion	intron variant|frameshift variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3395del (p.Asn1132fs)	BRCA1|LOC126862571	N1085fs, N1132fs, N1020fs, N1044fs, N1064fs, N1105fs, N1131fs, N1062fs, N1084fs, N264fs, N1004fs, N1005fs, N1021fs, N1043fs, N1061fs, N1091fs, N1106fs, N836fs, N1065fs, N1090fs, N1129fs, N964fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266365	17	41244153	17	43092136	266365	261741	rs886040124	NC_000017.11:43092135:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3384_3391del (p.Leu1128_Ile1129insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266363	17	41244157 - 41244164	17	43092140 - 43092147	266363	261742	rs886040122	NC_000017.11:43092139:CTGAAATC:	Deletion	frameshift variant|intron variant|splice acceptor variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3390del (p.Asp1131fs)	BRCA1|LOC126862571	D1131fs, D1084fs, D1042fs, D1043fs, D1060fs, D1083fs, D1089fs, D1105fs, D1128fs, D835fs, D1019fs, D1064fs, D1104fs, D1130fs, D963fs, D1003fs, D1061fs, D1063fs, D1004fs, D1020fs, D1090fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054864	17	41244158	17	43092141	54864	69531	rs80357900	NC_000017.11:43092140:T:	Deletion	intron variant|frameshift variant|splice acceptor variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3389C>G (p.Ser1130Ter)	BRCA1|LOC126862571	S1130*, S1083*, S1103*, S1127*, S1018*, S1041*, S1042*, S1060*, S1088*, S1089*, S1104*, S1129*, S962*, S1002*, S1062*, S834*, S1003*, S1019*, S1059*, S1063*, S1082*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037528	17	41244159	17	43092142	37528	46084	rs80357405	NC_000017.11:43092141:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3388del (p.Ser1130fs)	BRCA1|LOC126862571	S1083fs, S1130fs, S1042fs, S1059fs, S1104fs, S1003fs, S1018fs, S1041fs, S1062fs, S1088fs, S1127fs, S1129fs, S834fs, S1002fs, S1019fs, S1060fs, S962fs, S1063fs, S1082fs, S1089fs, S1103fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266364	17	41244160	17	43092143	266364	261743	rs886040123	NC_000017.11:43092142:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3376_3386dup (p.Ile1129_Ser1130insHisIleTer)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV001999191	17	41244161 - 41244162	17	43092144 - 43092145	1999191	2060984	rs2552151333	NC_000017.11:43092144:ATCAGATATGGA:ATCAGATATGGATCAGATATGGA	Duplication	nonsense|inframe_insertion|intron variant	Pathogenic	May 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3381T>A (p.Tyr1127Ter)	BRCA1|LOC126862571	Y1080*, Y1127*, Y1039*, Y1059*, Y1086*, Y999*, Y1056*, Y1060*, Y1124*, Y1015*, Y1016*, Y1057*, Y1079*, Y1085*, Y1101*, Y1126*, Y831*, Y959*, Y1000*, Y1038*, Y1100*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001071282	17	41244167	17	43092150	1071282	1064204	rs781319410	NC_000017.11:43092149:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3381T>G (p.Tyr1127Ter)	BRCA1|LOC126862571	Y1127*, Y1080*, Y1000*, Y1038*, Y1039*, Y1126*, Y959*, Y1016*, Y1101*, Y831*, Y1015*, Y1057*, Y1059*, Y1079*, Y1086*, Y1124*, Y999*, Y1056*, Y1060*, Y1085*, Y1100*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266362	17	41244167	17	43092150	266362	261744	rs781319410	NC_000017.11:43092149:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3377del (p.Pro1126fs)	BRCA1|LOC126862571	P1079fs, P1126fs, P1015fs, P1055fs, P1059fs, P1037fs, P1099fs, P1123fs, P1125fs, P1056fs, P1058fs, P1078fs, P1085fs, P958fs, P1014fs, P1038fs, P1084fs, P1100fs, P830fs, P998fs, P999fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054863	17	41244171	17	43092154	54863	69530	rs397509061	NC_000017.11:43092153:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3375_3376del (p.Pro1126fs)	BRCA1|LOC126862571	P1126fs, P1079fs, P1037fs, P1055fs, P1056fs, P1058fs, P1085fs, P998fs, P1014fs, P1015fs, P1123fs, P1125fs, P830fs, P999fs, P1078fs, P1099fs, P958fs, P1038fs, P1059fs, P1084fs, P1100fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054861	17	41244172 - 41244173	17	43092155 - 43092156	54861	69528	rs80357828	NC_000017.11:43092154:GAGAGA:GAGA	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3373dup (p.Ser1125fs)	LOC126862571|BRCA1	S1078fs, S1125fs, S1014fs, S1058fs, S829fs, S957fs, S1054fs, S1055fs, S1057fs, S1077fs, S997fs, S1083fs, S1084fs, S1099fs, S1122fs, S1124fs, S1013fs, S1036fs, S1037fs, S1098fs, S998fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266361	17	41244174 - 41244175	17	43092157 - 43092158	266361	261745	rs886040121	NC_000017.11:43092157:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3358_3368del (p.Val1120fs)	BRCA1|LOC126862571	V1073fs, V1120fs, V1008fs, V1053fs, V1072fs, V1117fs, V1119fs, V824fs, V992fs, V1032fs, V1049fs, V1079fs, V993fs, V1031fs, V1078fs, V1094fs, V1009fs, V1050fs, V1052fs, V1093fs, V952fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266358	17	41244180 - 41244190	17	43092163 - 43092173	266358	261746	rs886040118	NC_000017.11:43092162:TCTGTATTAAC:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3365_3366del (p.Thr1122fs)	BRCA1|LOC126862571	T1075fs, T1122fs, T1055fs, T1096fs, T994fs, T1033fs, T1052fs, T1054fs, T1074fs, T1119fs, T954fs, T1034fs, T1080fs, T1081fs, T1095fs, T1121fs, T826fs, T1010fs, T1011fs, T1051fs, T995fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054859	17	41244182 - 41244183	17	43092165 - 43092166	54859	69526	rs80357892	NC_000017.11:43092164:TGT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3359_3363del (p.Val1120fs)	BRCA1|LOC126862571	V1073fs, V1120fs, V1008fs, V1032fs, V1078fs, V824fs, V993fs, V1050fs, V1053fs, V1093fs, V1117fs, V1009fs, V1049fs, V1052fs, V1079fs, V1094fs, V1119fs, V952fs, V1031fs, V1072fs, V992fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054857	17	41244185 - 41244189	17	43092168 - 43092172	54857	69524	rs397509060	NC_000017.11:43092167:ATTAA:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3362del (p.Asn1121fs)	BRCA1|LOC126862571	N1074fs, N1121fs, N1050fs, N1073fs, N1079fs, N1120fs, N953fs, N1032fs, N1051fs, N1053fs, N994fs, N1010fs, N1033fs, N1095fs, N1118fs, N993fs, N1009fs, N1054fs, N1080fs, N1094fs, N825fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054858	17	41244186	17	43092169	54858	69525	rs80357865	NC_000017.11:43092168:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3360dup (p.Asn1121Ter)	BRCA1|LOC126862571	N1074*, N1121*, N1051*, N1053*, N1080*, N1095*, N1118*, N993*, N1033*, N1050*, N1073*, N1010*, N1032*, N1079*, N1120*, N953*, N994*, N1009*, N1054*, N1094*, N825*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266360	17	41244187 - 41244188	17	43092170 - 43092171	266360	261747	rs886040120	NC_000017.11:43092170:AA:AAA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3359_3360insG (p.Val1120_Asn1121insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001174600	17	41244188 - 41244189	17	43092171 - 43092172	1174600	1163970	rs2154323689	NC_000017.11:43092171::C	Insertion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Apr 9, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3359_3360del (p.Val1120fs)	BRCA1|LOC126862571	V1120fs, V1073fs, V1009fs, V1053fs, V1072fs, V1078fs, V1079fs, V1119fs, V1008fs, V1117fs, V824fs, V993fs, V1049fs, V1050fs, V1093fs, V1094fs, V1031fs, V1032fs, V1052fs, V952fs, V992fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054856	17	41244188 - 41244189	17	43092171 - 43092172	54856	69523	rs80357843	NC_000017.11:43092170:AA:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3358_3359del (p.Thr1119_Val1120insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037526	17	41244189 - 41244190	17	43092172 - 43092173	37526	46082	rs80357945	NC_000017.11:43092171:ACA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3357del (p.Val1120fs)	BRCA1|LOC126862571	V1120fs, V1073fs, V1009fs, V1032fs, V1093fs, V1119fs, V992fs, V1053fs, V1072fs, V1078fs, V1008fs, V1052fs, V1079fs, V824fs, V952fs, V1031fs, V1049fs, V1050fs, V1094fs, V1117fs, V993fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125631	17	41244191	17	43092174	125631	131169	rs80357827	NC_000017.11:43092173:A:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3354_3355del (p.Gln1118fs)	BRCA1|LOC126862571	Q1071fs, Q1118fs, Q1007fs, Q1030fs, Q1050fs, Q1051fs, Q1076fs, Q1048fs, Q990fs, Q991fs, Q1006fs, Q1070fs, Q1091fs, Q1092fs, Q822fs, Q1029fs, Q1047fs, Q1077fs, Q1115fs, Q1117fs, Q950fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054854	17	41244193 - 41244194	17	43092176 - 43092177	54854	69521	rs397509059	NC_000017.11:43092175:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3351dup (p.Gln1118fs)	BRCA1|LOC126862571	Q1071fs, Q1118fs, Q1048fs, Q1076fs, Q1091fs, Q990fs, Q1030fs, Q1006fs, Q1029fs, Q1047fs, Q1051fs, Q1070fs, Q1115fs, Q1117fs, Q1007fs, Q1050fs, Q1077fs, Q1092fs, Q822fs, Q950fs, Q991fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125630	17	41244196 - 41244197	17	43092179 - 43092180	125630	131168	rs80357785	NC_000017.11:43092179:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3352C>T (p.Gln1118Ter)	BRCA1|LOC126862571	Q1118*, Q1071*, Q1029*, Q1047*, Q1050*, Q1076*, Q1115*, Q1117*, Q1006*, Q1007*, Q1048*, Q1091*, Q950*, Q990*, Q991*, Q1030*, Q1077*, Q1092*, Q822*, Q1051*, Q1070*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037524	17	41244196	17	43092179	37524	46080	rs397507215	NC_000017.11:43092178:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3342_3345del (p.Glu1114_Glu1115insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054850	17	41244203 - 41244206	17	43092186 - 43092189	54850	69517	rs397509058	NC_000017.11:43092185:TTCTT:T	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3343del (p.Glu1115fs)	BRCA1|LOC126862571	E1068fs, E1115fs, E1026fs, E1027fs, E1047fs, E1088fs, E1089fs, E947fs, E1044fs, E1048fs, E1073fs, E1114fs, E1004fs, E1045fs, E1067fs, E1112fs, E988fs, E1003fs, E1074fs, E819fs, E987fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054851	17	41244205	17	43092188	54851	69518	rs273899705	NC_000017.11:43092187:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3339_3341del (p.Tyr1113_Glu1114delinsTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266357	17	41244207 - 41244209	17	43092190 - 43092192	266357	261748	rs886040117	NC_000017.11:43092189:TCAT:T	Deletion	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3340G>T (p.Glu1114Ter)	BRCA1|LOC126862571	E1114*, E1067*, E1025*, E1047*, E1072*, E1087*, E1088*, E1003*, E1043*, E1111*, E1113*, E818*, E1026*, E1046*, E986*, E1002*, E1044*, E1066*, E1073*, E946*, E987*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054849	17	41244208	17	43092191	54849	69516	rs80357278	NC_000017.11:43092190:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3339T>G (p.Tyr1113Ter)	BRCA1|LOC126862571	Y1113*, Y1066*, Y1001*, Y1046*, Y1086*, Y1112*, Y1024*, Y1042*, Y1045*, Y1071*, Y1025*, Y1043*, Y1087*, Y1002*, Y1065*, Y1072*, Y1110*, Y817*, Y945*, Y985*, Y986*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054848	17	41244209	17	43092192	54848	69515	rs80357421	NC_000017.11:43092191:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3337dup (p.Tyr1113fs)	BRCA1|LOC126862571	Y1066fs, Y1113fs, Y1001fs, Y1025fs, Y1042fs, Y1043fs, Y1045fs, Y1065fs, Y1087fs, Y985fs, Y1072fs, Y1086fs, Y1112fs, Y817fs, Y1110fs, Y945fs, Y1002fs, Y1024fs, Y1046fs, Y1071fs, Y986fs	not provided|Hereditary cancer-predisposing syndrome	VCV000619790	17	41244210 - 41244211	17	43092193 - 43092194	619790	611237	rs1567792067	NC_000017.11:43092193:A:AA	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Dec 4, 2018	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3333_3336del (p.Gln1111fs)	LOC126862571|BRCA1	Q1064fs, Q1111fs, Q1069fs, Q1084fs, Q1110fs, Q984fs, Q1000fs, Q1023fs, Q1044fs, Q1063fs, Q815fs, Q983fs, Q1040fs, Q1070fs, Q1085fs, Q943fs, Q1022fs, Q1041fs, Q1043fs, Q1108fs, Q999fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054846	17	41244212 - 41244215	17	43092195 - 43092198	54846	69513	rs397509057	NC_000017.11:43092194:TTCTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3331_3335del (p.Gln1111fs)	BRCA1|LOC126862571	Q1111fs, Q1064fs, Q1000fs, Q1043fs, Q1069fs, Q1040fs, Q1041fs, Q1110fs, Q943fs, Q1022fs, Q1044fs, Q1085fs, Q815fs, Q1023fs, Q1063fs, Q1070fs, Q1084fs, Q1108fs, Q983fs, Q984fs, Q999fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266355	17	41244213 - 41244217	17	43092196 - 43092200	266355	261749	rs886040115	NC_000017.11:43092195:TCTTG:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3333dup (p.Glu1112fs)	BRCA1|LOC126862571	E1112fs, E1065fs, E1001fs, E1023fs, E1085fs, E1086fs, E985fs, E1070fs, E1071fs, E944fs, E984fs, E1000fs, E1042fs, E1044fs, E1109fs, E1111fs, E1024fs, E1041fs, E1045fs, E1064fs, E816fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548236	17	41244214 - 41244215	17	43092197 - 43092198	548236	538819	rs80357966	NC_000017.11:43092197:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3334del (p.Glu1112fs)	BRCA1|LOC126862571	E1065fs, E1112fs, E1024fs, E1064fs, E1085fs, E1086fs, E985fs, E1042fs, E1044fs, E1071fs, E1111fs, E1041fs, E1045fs, E816fs, E984fs, E1000fs, E1001fs, E1023fs, E1070fs, E1109fs, E944fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433705	17	41244214	17	43092197	433705	427553	rs1555587944	NC_000017.11:43092196:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3331_3334del (p.Gln1111fs)	LOC126862571|BRCA1	Q1064fs, Q1111fs, Q1000fs, Q1069fs, Q1108fs, Q1110fs, Q983fs, Q1022fs, Q1023fs, Q1063fs, Q1084fs, Q984fs, Q999fs, Q1040fs, Q1041fs, Q1043fs, Q1044fs, Q1070fs, Q1085fs, Q815fs, Q943fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037523	17	41244214 - 41244217	17	43092197 - 43092200	37523	46079	rs80357701	NC_000017.11:43092196:CTTGCTT:CTT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3333del (p.Glu1112fs)	BRCA1|LOC126862571	E1065fs, E1112fs, E1041fs, E1085fs, E1086fs, E1111fs, E1024fs, E1042fs, E1044fs, E1064fs, E1109fs, E985fs, E1000fs, E1001fs, E1070fs, E816fs, E944fs, E1023fs, E1045fs, E1071fs, E984fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054847	17	41244215	17	43092198	54847	69514	rs80357966	NC_000017.11:43092197:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3331del (p.Gln1111fs)	LOC126862571|BRCA1	Q1111fs, Q1064fs, Q1023fs, Q1108fs, Q1110fs, Q999fs, Q1022fs, Q1044fs, Q1069fs, Q983fs, Q1000fs, Q1040fs, Q1070fs, Q1085fs, Q815fs, Q943fs, Q1041fs, Q1043fs, Q1063fs, Q1084fs, Q984fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266356	17	41244217	17	43092200	266356	261750	rs886040116	NC_000017.11:43092199:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3330_3331insA (p.Gln1111fs)	BRCA1|LOC126862571	Q1111fs, Q1064fs, Q1043fs, Q1069fs, Q815fs, Q1000fs, Q1023fs, Q1070fs, Q1084fs, Q943fs, Q1040fs, Q1041fs, Q1085fs, Q1110fs, Q983fs, Q984fs, Q1022fs, Q1044fs, Q1063fs, Q1108fs, Q999fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125629	17	41244217 - 41244218	17	43092200 - 43092201	125629	131167	rs80357996	NC_000017.11:43092200::T	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3331C>T (p.Gln1111Ter)	BRCA1|LOC126862571	Q1111*, Q1064*, Q1000*, Q1022*, Q1085*, Q943*, Q1041*, Q1043*, Q1070*, Q1110*, Q983*, Q984*, Q1023*, Q1069*, Q1108*, Q999*, Q1040*, Q1044*, Q1063*, Q1084*, Q815*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054845	17	41244217	17	43092200	54845	69512	rs80357089	NC_000017.11:43092199:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3327_3330del (p.Lys1109fs)	BRCA1|LOC126862571	K1062fs, K1109fs, K1042fs, K1061fs, K941fs, K982fs, K998fs, K1020fs, K1041fs, K1106fs, K1108fs, K1067fs, K1082fs, K1021fs, K1038fs, K1039fs, K1068fs, K1083fs, K813fs, K981fs, K997fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV002565346	17	41244218 - 41244221	17	43092201 - 43092204	2565346	1245809	rs2552153510	NC_000017.11:43092200:CTTT:	Deletion	intron variant|frameshift variant	Pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3328_3329dup (p.Gln1111fs)	BRCA1|LOC126862571	Q1111fs, Q1064fs, Q1023fs, Q1108fs, Q999fs, Q1022fs, Q1069fs, Q1085fs, Q815fs, Q983fs, Q1000fs, Q1041fs, Q1043fs, Q1063fs, Q984fs, Q1040fs, Q1044fs, Q1070fs, Q1084fs, Q1110fs, Q943fs	Hereditary breast ovarian cancer syndrome	VCV001412697	17	41244218 - 41244219	17	43092201 - 43092202	1412697	1356295	rs80357575	NC_000017.11:43092201:TTTTTT:TTTTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Aug 11, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3330del (p.Lys1110fs)	BRCA1|LOC126862571	K1063fs, K1110fs, K1022fs, K1039fs, K1109fs, K814fs, K999fs, K1083fs, K1107fs, K983fs, K1040fs, K1042fs, K1068fs, K1069fs, K1084fs, K982fs, K998fs, K1021fs, K1043fs, K1062fs, K942fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254426	17	41244218	17	43092201	254426	249117	rs886038011	NC_000017.11:43092200:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3329dup (p.Gln1111fs)	BRCA1|LOC126862571	Q1064fs, Q1111fs, Q1000fs, Q1022fs, Q1041fs, Q1063fs, Q1044fs, Q1085fs, Q1108fs, Q999fs, Q1023fs, Q1043fs, Q815fs, Q983fs, Q1070fs, Q1110fs, Q984fs, Q1040fs, Q1069fs, Q1084fs, Q943fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054843	17	41244218 - 41244219	17	43092201 - 43092202	54843	69510	rs80357575	NC_000017.11:43092201:TTTTTT:TTTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3329_3330del (p.Lys1110fs)	BRCA1|LOC126862571	K1063fs, K1110fs, K1039fs, K1043fs, K1107fs, K1109fs, K1022fs, K1042fs, K1068fs, K1069fs, K814fs, K998fs, K999fs, K1040fs, K1084fs, K982fs, K1021fs, K1062fs, K1083fs, K942fs, K983fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054841	17	41244218 - 41244219	17	43092201 - 43092202	54841	69508	rs80357525	NC_000017.11:43092200:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3328_3329del (p.Lys1110fs)	BRCA1|LOC126862571	K1063fs, K1110fs, K1021fs, K1022fs, K1043fs, K1062fs, K1109fs, K814fs, K999fs, K1040fs, K1068fs, K942fs, K983fs, K998fs, K1042fs, K1069fs, K1083fs, K1107fs, K1039fs, K1084fs, K982fs	Hereditary breast ovarian cancer syndrome	VCV002910430	17	41244219 - 41244220	17	43092202 - 43092203	2910430	1245808	rs80357575	NC_000017.11:43092201:TTTTTT:TTTT	Deletion	frameshift variant|intron variant	Pathogenic	Jan 5, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3329del (p.Lys1110fs)	BRCA1|LOC126862571	K1063fs, K1110fs, K1039fs, K1068fs, K1069fs, K982fs, K1022fs, K1043fs, K1107fs, K814fs, K942fs, K998fs, K999fs, K1021fs, K1062fs, K1109fs, K1040fs, K1042fs, K1083fs, K1084fs, K983fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054842	17	41244219	17	43092202	54842	69509	rs80357575	NC_000017.11:43092201:TTTTTT:TTTTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3326_3329del (p.Lys1109fs)	BRCA1|LOC126862571	K1062fs, K1109fs, K1039fs, K1041fs, K1067fs, K1083fs, K981fs, K1038fs, K1061fs, K1106fs, K1020fs, K1021fs, K1108fs, K813fs, K982fs, K998fs, K1042fs, K1068fs, K1082fs, K941fs, K997fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054839	17	41244219 - 41244222	17	43092202 - 43092205	54839	69506	rs80357575	NC_000017.11:43092201:TTTTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3325_3329del (p.Lys1109fs)	BRCA1|LOC126862571	K1062fs, K1109fs, K1041fs, K1067fs, K1068fs, K813fs, K998fs, K1021fs, K1042fs, K1061fs, K941fs, K1020fs, K1038fs, K1039fs, K1082fs, K1083fs, K997fs, K1106fs, K1108fs, K981fs, K982fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054838	17	41244219 - 41244223	17	43092202 - 43092206	54838	69505	rs80357575	NC_000017.11:43092201:TTTTTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3323_3326del (p.Ile1108fs)	BRCA1|LOC126862571	I1061fs, I1108fs, I1037fs, I1040fs, I1041fs, I1066fs, I1067fs, I1081fs, I1105fs, I940fs, I981fs, I997fs, I1019fs, I1038fs, I1107fs, I980fs, I1020fs, I1060fs, I1082fs, I812fs, I996fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054837	17	41244222 - 41244225	17	43092205 - 43092208	54837	69504	rs80357763	NC_000017.11:43092204:TTTATTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3323_3324del (p.Ile1108fs)	BRCA1|LOC126862571	I1108fs, I1061fs, I1019fs, I1041fs, I980fs, I1020fs, I1060fs, I1067fs, I1082fs, I1105fs, I1107fs, I981fs, I1037fs, I1040fs, I812fs, I940fs, I1038fs, I1066fs, I1081fs, I996fs, I997fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186225	17	41244224 - 41244225	17	43092207 - 43092208	186225	184975	rs786202791	NC_000017.11:43092206:TAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3319G>T (p.Glu1107Ter)	BRCA1|LOC126862571	E1107*, E1060*, E1019*, E1036*, E1037*, E1066*, E996*, E1040*, E1059*, E1080*, E1106*, E811*, E1018*, E1065*, E1039*, E1104*, E939*, E979*, E980*, E1081*, E995*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054836	17	41244229	17	43092212	54836	69503	rs80357106	NC_000017.11:43092211:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3317del (p.Pro1106fs)	BRCA1|LOC126862571	P1106fs, P1059fs, P1018fs, P1035fs, P1064fs, P1080fs, P1103fs, P1017fs, P1036fs, P1038fs, P1039fs, P995fs, P1058fs, P1065fs, P1079fs, P810fs, P938fs, P978fs, P979fs, P994fs, P1105fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548261	17	41244231	17	43092214	548261	538820	rs1555587972	NC_000017.11:43092213:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3311_3314dup (p.His1105fs)	BRCA1|LOC126862571	H1017fs, H1035fs, H1057fs, H1063fs, H1079fs, H977fs, H993fs, H1038fs, H1058fs, H1078fs, H1102fs, H994fs, H1016fs, H1037fs, H1105fs, H1034fs, H1064fs, H1104fs, H809fs, H937fs, H978fs	Hereditary breast ovarian cancer syndrome	VCV002742822	17	41244233 - 41244234	17	43092216 - 43092217	2742822	2900585	rs2552154610	NC_000017.11:43092216:TGCTT:TGCTTGCTT	Duplication	frameshift variant|intron variant	Pathogenic	Jul 14, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3314del (p.His1105fs)	BRCA1|LOC126862571	H1058fs, H1105fs, H1017fs, H1035fs, H1057fs, H1064fs, H1078fs, H809fs, H978fs, H1016fs, H1037fs, H1063fs, H993fs, H1038fs, H1102fs, H937fs, H977fs, H1034fs, H1079fs, H1104fs, H994fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054835	17	41244234	17	43092217	54835	69502	rs397509054	NC_000017.11:43092216:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3311del (p.Lys1104fs)	BRCA1|LOC126862571	K1057fs, K1104fs, K1033fs, K1034fs, K1056fs, K1062fs, K936fs, K977fs, K1016fs, K1036fs, K1077fs, K1103fs, K992fs, K993fs, K1015fs, K1037fs, K1101fs, K1063fs, K1078fs, K808fs, K976fs	Hereditary breast ovarian cancer syndrome	VCV001405119	17	41244237	17	43092220	1405119	1483916	rs2154329862	NC_000017.11:43092219:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Feb 4, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3309_3310insC (p.Lys1104fs)	BRCA1|LOC126862571	K1057fs, K1104fs, K1015fs, K1016fs, K1103fs, K808fs, K1033fs, K1036fs, K1056fs, K1078fs, K1101fs, K976fs, K992fs, K1062fs, K1063fs, K1077fs, K977fs, K1034fs, K1037fs, K936fs, K993fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548200	17	41244238 - 41244239	17	43092221 - 43092222	548200	538821	rs1555587980	NC_000017.11:43092221::G	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3308_3309del (p.Asn1102_Cys1103insTer)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome	VCV003659054	17	41244239 - 41244240	17	43092222 - 43092223	3659054	3794051		NC_000017.11:43092221:ACA:A	Deletion	nonsense|intron variant	Pathogenic	Jul 9, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3308_3309insC (p.Cys1103_Lys1104insTer)	LOC126862571|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266353	17	41244239 - 41244240	17	43092222 - 43092223	266353	261751	rs886040113	NC_000017.11:43092222::G	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3309T>A (p.Cys1103Ter)	BRCA1|LOC126862571	C1103*, C1056*, C1032*, C1015*, C1033*, C1035*, C1061*, C1076*, C1077*, C1102*, C975*, C976*, C1014*, C935*, C991*, C1036*, C1055*, C1062*, C1100*, C807*, C992*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054833	17	41244239	17	43092222	54833	69500	rs80357317	NC_000017.11:43092221:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3307_3308insC (p.Cys1103fs)	BRCA1|LOC126862571	C1056fs, C1103fs, C1014fs, C1033fs, C1061fs, C1076fs, C1102fs, C1032fs, C1036fs, C992fs, C1062fs, C1100fs, C991fs, C1015fs, C1035fs, C1055fs, C1077fs, C807fs, C935fs, C975fs, C976fs	not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000545805	17	41244240 - 41244241	17	43092223 - 43092224	545805	536491	rs1555587988	NC_000017.11:43092223::G	Insertion	intron variant|frameshift variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3304_3307del (p.Asn1102fs)	BRCA1|LOC126862571	N1055fs, N1102fs, N1032fs, N1075fs, N990fs, N991fs, N1013fs, N1014fs, N1054fs, N1099fs, N1035fs, N1060fs, N806fs, N974fs, N1031fs, N1034fs, N1061fs, N1076fs, N1101fs, N934fs, N975fs	Hereditary cancer-predisposing syndrome	VCV000823517	17	41244241 - 41244244	17	43092224 - 43092227	823517	813748	rs1597864491	NC_000017.11:43092223:AATTA:A	Deletion	frameshift variant|intron variant	Pathogenic	May 25, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3302_3305del (p.Ser1101fs)	LOC126862571|BRCA1	S1054fs, S1101fs, S1074fs, S1100fs, S973fs, S1012fs, S1031fs, S1053fs, S1059fs, S1060fs, S1075fs, S933fs, S974fs, S1013fs, S1030fs, S1033fs, S1098fs, S990fs, S1034fs, S805fs, S989fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000479253	17	41244243 - 41244246	17	43092226 - 43092229	479253	479367	rs1555587992	NC_000017.11:43092225:TTACTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3301dup (p.Ser1101fs)	BRCA1|LOC126862571	S1031fs, S1053fs, S1101fs, S805fs, S973fs, S1030fs, S1059fs, S933fs, S990fs, S1012fs, S1033fs, S1034fs, S1054fs, S1060fs, S1074fs, S1075fs, S1098fs, S974fs, S989fs, S1013fs, S1100fs	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV002565335	17	41244246 - 41244247	17	43092229 - 43092230	2565335	2732309	rs2552155255	NC_000017.11:43092229:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	May 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3296del (p.Pro1099fs)	BRCA1|LOC126862571	P1099fs, P1052fs, P1031fs, P1072fs, P1096fs, P1098fs, P931fs, P972fs, P1032fs, P1058fs, P803fs, P1028fs, P987fs, P1010fs, P1011fs, P1029fs, P1051fs, P1057fs, P1073fs, P971fs, P988fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054824	17	41244252	17	43092235	54824	69491	rs80357815	NC_000017.11:43092234:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3294del (p.Pro1099fs)	BRCA1|LOC126862571	P1099fs, P1052fs, P1010fs, P1031fs, P1032fs, P1098fs, P987fs, P1028fs, P1051fs, P1057fs, P931fs, P971fs, P972fs, P1029fs, P1072fs, P1096fs, P1011fs, P1058fs, P1073fs, P803fs, P988fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230548	17	41244254	17	43092237	230548	236021	rs876658626	NC_000017.11:43092236:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3292_3293del (p.Leu1098fs)	BRCA1|LOC126862571	L1098fs, L1051fs, L1056fs, L1071fs, L930fs, L971fs, L987fs, L1009fs, L1028fs, L1057fs, L1095fs, L1097fs, L802fs, L970fs, L1010fs, L1027fs, L1030fs, L1072fs, L986fs, L1031fs, L1050fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054823	17	41244255 - 41244256	17	43092238 - 43092239	54823	69490	rs80357992	NC_000017.11:43092237:AGA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3289dup (p.Ser1097fs)	BRCA1|LOC126862571	S1050fs, S1097fs, S1049fs, S1070fs, S1071fs, S1096fs, S969fs, S1009fs, S1027fs, S1029fs, S1055fs, S1094fs, S970fs, S1008fs, S1026fs, S929fs, S1030fs, S1056fs, S801fs, S985fs, S986fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233101	17	41244258 - 41244259	17	43092241 - 43092242	233101	236022	rs80357686	NC_000017.11:43092241:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3286_3289del (p.Gln1096fs)	BRCA1|LOC126862571	Q1096fs, Q1049fs, Q1025fs, Q1069fs, Q928fs, Q984fs, Q1007fs, Q1055fs, Q1093fs, Q800fs, Q968fs, Q1026fs, Q1048fs, Q1054fs, Q1070fs, Q1095fs, Q969fs, Q1008fs, Q1028fs, Q1029fs, Q985fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001383435	17	41244259 - 41244262	17	43092242 - 43092245	1383435	1354576	rs2154331547	NC_000017.11:43092241:TTTGTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Aug 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3243_3288dup (p.Ser1097delinsCysTyrAlaTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266346	17	41244259 - 41244260	17	43092242 - 43092243	266346	261752	rs1555588016	NC_000017.11:43092242:TTGTTTATAGACCTCAGGTTGCAAAACCCCTAATCTAAGCATAGCATT:TTGTTTATAGACCTCAGGTTGCAAAACCCCTAATCTAAGCATAGCATTGTTTATAGACCTCAGGTTGCAAAACCCCTAATCTAAGCATAGCATT	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3289del (p.Ser1097fs)	BRCA1|LOC126862571	S1097fs, S1050fs, S1026fs, S1030fs, S1096fs, S929fs, S1029fs, S1071fs, S1094fs, S1008fs, S1009fs, S1027fs, S1049fs, S1056fs, S1070fs, S801fs, S969fs, S970fs, S1055fs, S985fs, S986fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054822	17	41244259	17	43092242	54822	69489	rs80357686	NC_000017.11:43092241:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3288_3289del (p.Leu1098fs)	BRCA1|LOC126862571	L1098fs, L1051fs, L1009fs, L971fs, L987fs, L1010fs, L1027fs, L1050fs, L1057fs, L1071fs, L930fs, L970fs, L986fs, L1028fs, L1031fs, L1056fs, L1072fs, L1030fs, L1095fs, L1097fs, L802fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054821	17	41244259 - 41244260	17	43092242 - 43092243	54821	69488	rs80357686	NC_000017.11:43092241:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3286del (p.Gln1096fs)	BRCA1|LOC126862571	Q1096fs, Q1049fs, Q1025fs, Q1028fs, Q1054fs, Q1095fs, Q800fs, Q1029fs, Q1093fs, Q928fs, Q968fs, Q985fs, Q1026fs, Q1069fs, Q1070fs, Q1007fs, Q1008fs, Q1048fs, Q1055fs, Q969fs, Q984fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054819	17	41244262	17	43092245	54819	69486	rs80357533	NC_000017.11:43092244:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3286C>T (p.Gln1096Ter)	BRCA1|LOC126862571	Q1096*, Q1049*, Q1055*, Q1007*, Q1070*, Q1093*, Q928*, Q968*, Q984*, Q985*, Q1008*, Q1025*, Q1029*, Q1069*, Q1095*, Q800*, Q1026*, Q1028*, Q1048*, Q1054*, Q969*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054818	17	41244262	17	43092245	54818	69485	rs80357485	NC_000017.11:43092244:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3285del (p.Lys1095fs)	BRCA1|LOC126862571	K1095fs, K1048fs, K1054fs, K927fs, K968fs, K1024fs, K1025fs, K1053fs, K1068fs, K1094fs, K967fs, K984fs, K1007fs, K1027fs, K1028fs, K1069fs, K799fs, K983fs, K1006fs, K1047fs, K1092fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054817	17	41244263	17	43092246	54817	69484	rs397509051	NC_000017.11:43092245:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3282T>G (p.Tyr1094Ter)	BRCA1|LOC126862571	Y1094*, Y1047*, Y1005*, Y1026*, Y1091*, Y1093*, Y1006*, Y1027*, Y1052*, Y1053*, Y926*, Y983*, Y1024*, Y1067*, Y798*, Y966*, Y967*, Y1023*, Y1046*, Y1068*, Y982*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266351	17	41244266	17	43092249	266351	261753	rs886040111	NC_000017.11:43092248:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3279_3280del (p.Val1093_Tyr1094insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254425	17	41244268 - 41244269	17	43092251 - 43092252	254425	249118	rs886038010	NC_000017.11:43092250:AGA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3147_3279del (p.Ser1050fs)	BRCA1|LOC126862571	S1002fs, S1003fs, S1008fs, S1009fs, S1023fs, S1024fs, S1047fs, S1049fs, S1050fs, S754fs, S882fs, S922fs, S923fs, S938fs, S939fs, S961fs, S962fs, S979fs, S980fs, S982fs, S983fs	Hereditary cancer-predisposing syndrome	VCV003226134	17	41244269 - 41244401	17	43092252 - 43092384	3226134	3387198	rs2552157869		Deletion	intron variant|frameshift variant	Pathogenic	Jan 23, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3279del (p.Tyr1094fs)	BRCA1|LOC126862571	Y1047fs, Y1094fs, Y1052fs, Y1053fs, Y1091fs, Y967fs, Y982fs, Y983fs, Y1024fs, Y798fs, Y926fs, Y1005fs, Y1027fs, Y1093fs, Y966fs, Y1006fs, Y1023fs, Y1026fs, Y1046fs, Y1067fs, Y1068fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054816	17	41244269	17	43092252	54816	69483	rs397509050	NC_000017.11:43092251:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3262_3277del (p.Val1088fs)	BRCA1|LOC126862571	V1041fs, V1088fs, V1000fs, V1021fs, V1018fs, V1047fs, V1087fs, V960fs, V976fs, V977fs, V999fs, V1017fs, V1040fs, V1046fs, V1085fs, V920fs, V961fs, V1020fs, V1061fs, V1062fs, V792fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266348	17	41244271 - 41244286	17	43092254 - 43092269	266348	261754	rs886040108	NC_000017.11:43092253:CCTCAGGTTGCAAAACCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3275_3276delinsT (p.Glu1092fs)	LOC126862571|BRCA1	E1022fs, E964fs, E1004fs, E1044fs, E1045fs, E1065fs, E1089fs, E981fs, E1003fs, E1024fs, E1025fs, E1092fs, E796fs, E924fs, E965fs, E980fs, E1021fs, E1050fs, E1051fs, E1066fs, E1091fs	Hereditary cancer-predisposing syndrome	VCV003481845	17	41244272 - 41244273	17	43092255 - 43092256	3481845	3640056		NC_000017.11:43092254:CT:A	Indel	intron variant|frameshift variant	Pathogenic	Aug 26, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3274G>T (p.Glu1092Ter)	BRCA1|LOC126862571	E1045*, E1092*, E1044*, E980*, E981*, E1003*, E1024*, E1051*, E1065*, E796*, E1021*, E1050*, E1089*, E924*, E964*, E1004*, E1022*, E1025*, E1066*, E1091*, E965*	Hereditary breast ovarian cancer syndrome	VCV001452574	17	41244274	17	43092257	1452574	1364293	rs876658360	NC_000017.11:43092256:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Feb 1, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3268C>T (p.Gln1090Ter)	BRCA1|LOC126862571	Q1090*, Q1043*, Q1023*, Q1049*, Q1064*, Q794*, Q962*, Q963*, Q978*, Q1042*, Q922*, Q1020*, Q1048*, Q1063*, Q979*, Q1001*, Q1002*, Q1019*, Q1022*, Q1087*, Q1089*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054815	17	41244280	17	43092263	54815	69482	rs80357402	NC_000017.11:43092262:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3266T>A (p.Leu1089Ter)	BRCA1|LOC126862571	L1089*, L1042*, L1021*, L1022*, L1041*, L1088*, L793*, L1018*, L1048*, L1062*, L1063*, L977*, L978*, L1000*, L921*, L1001*, L1019*, L1047*, L1086*, L961*, L962*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266350	17	41244282	17	43092265	266350	261755	rs886040110	NC_000017.11:43092264:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3266del (p.Leu1089fs)	BRCA1|LOC126862571	L1042fs, L1089fs, L1001fs, L1041fs, L1062fs, L1088fs, L793fs, L961fs, L977fs, L1021fs, L1048fs, L1086fs, L921fs, L1018fs, L1019fs, L1047fs, L978fs, L1000fs, L1022fs, L1063fs, L962fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266349	17	41244282	17	43092265	266349	261756	rs886040109	NC_000017.11:43092264:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3262dup (p.Val1088fs)	BRCA1|LOC126862571	V1041fs, V1088fs, V1018fs, V1021fs, V1040fs, V1061fs, V1062fs, V977fs, V999fs, V1000fs, V1017fs, V1020fs, V1085fs, V1087fs, V792fs, V920fs, V1046fs, V1047fs, V961fs, V960fs, V976fs	not provided	VCV001697605	17	41244285 - 41244286	17	43092268 - 43092269	1697605	1689989	rs397509049	NC_000017.11:43092268:CCCC:CCCCC	Duplication	frameshift variant|intron variant	Pathogenic	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3262del (p.Val1088fs)	BRCA1|LOC126862571	V1041fs, V1088fs, V1000fs, V1017fs, V1021fs, V1087fs, V976fs, V1018fs, V1046fs, V1061fs, V1047fs, V1062fs, V1085fs, V792fs, V920fs, V960fs, V1020fs, V1040fs, V961fs, V977fs, V999fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054813	17	41244286	17	43092269	54813	69480	rs397509049	NC_000017.11:43092268:CCCC:CCC	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3260_3261insCTA (p.Gly1087_Val1088insTer)	BRCA1|LOC126862571		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000823335	17	41244287 - 41244288	17	43092270 - 43092271	823335	813750	rs1597864731	NC_000017.11:43092270::TAG	Insertion	nonsense|inframe_insertion|intron variant	Pathogenic	Oct 18, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3255_3259del (p.Leu1086fs)	BRCA1|LOC126862571	L1015fs, L1044fs, L1059fs, L1085fs, L958fs, L998fs, L1018fs, L1045fs, L1086fs, L790fs, L959fs, L1038fs, L1060fs, L918fs, L975fs, L997fs, L1016fs, L1019fs, L1039fs, L1083fs, L974fs	Hereditary breast ovarian cancer syndrome	VCV003647539	17	41244289 - 41244293	17	43092272 - 43092276	3647539	3780832		NC_000017.11:43092271:CTAATCTAA:CTAA	Deletion	frameshift variant|intron variant	Pathogenic	Mar 25, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3257_3258insTTGC (p.Leu1086fs)	BRCA1|LOC126862571	L1039fs, L1086fs, L1038fs, L1044fs, L1045fs, L1085fs, L974fs, L1015fs, L1083fs, L790fs, L918fs, L1016fs, L1060fs, L997fs, L998fs, L1018fs, L1019fs, L1059fs, L958fs, L959fs, L975fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001071122	17	41244290 - 41244291	17	43092273 - 43092274	1071122	1064205	rs1555588074	NC_000017.11:43092273::GCAA	Insertion	frameshift variant|intron variant	Pathogenic	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3257_3258insGA (p.Gly1087fs)	BRCA1|LOC126862571	G1087fs, G1040fs, G1045fs, G1046fs, G960fs, G1019fs, G1039fs, G919fs, G975fs, G999fs, G1016fs, G1017fs, G1086fs, G791fs, G959fs, G998fs, G1020fs, G1060fs, G1061fs, G1084fs, G976fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548173	17	41244290 - 41244291	17	43092273 - 43092274	548173	538822	rs1555588074	NC_000017.11:43092273::TC	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3258del (p.Val1088fs)	BRCA1|LOC126862571	V1088fs, V1041fs, V1017fs, V1046fs, V1085fs, V1040fs, V1047fs, V1061fs, V1062fs, V792fs, V920fs, V1000fs, V1021fs, V960fs, V961fs, V976fs, V999fs, V1018fs, V1020fs, V1087fs, V977fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266347	17	41244290	17	43092273	266347	261757	rs886040107	NC_000017.11:43092272:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3257dup (p.Leu1086fs)	BRCA1|LOC126862571	L1039fs, L1086fs, L1016fs, L1060fs, L790fs, L958fs, L998fs, L1015fs, L1018fs, L1044fs, L1059fs, L1083fs, L1085fs, L974fs, L1045fs, L959fs, L975fs, L997fs, L1019fs, L1038fs, L918fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054811	17	41244290 - 41244291	17	43092273 - 43092274	54811	69478	rs80357858	NC_000017.11:43092273:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3257del (p.Arg1085_Leu1086insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252873	17	41244291	17	43092274	252873	247274	rs80357858	NC_000017.11:43092273:AA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3256_3257insGA (p.Leu1086Ter)	BRCA1|LOC126862571	L1086*, L1039*, L1015*, L1016*, L1038*, L1045*, L1085*, L918*, L974*, L998*, L1059*, L1060*, L958*, L1019*, L1083*, L959*, L1018*, L1044*, L790*, L975*, L997*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125620	17	41244291 - 41244292	17	43092274 - 43092275	125620	131158	rs80357764	NC_000017.11:43092274::TC	Insertion	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3257T>G (p.Leu1086Ter)	BRCA1|LOC126862571	L1086*, L1039*, L1015*, L1016*, L1019*, L1045*, L959*, L974*, L997*, L1038*, L1060*, L1083*, L1085*, L958*, L1044*, L918*, L975*, L1018*, L1059*, L790*, L998*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054810	17	41244291	17	43092274	54810	69477	rs80357006	NC_000017.11:43092273:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3257T>A (p.Leu1086Ter)	BRCA1|LOC126862571	L1086*, L1039*, L1018*, L975*, L959*, L974*, L997*, L1019*, L1044*, L790*, L1038*, L1045*, L1059*, L958*, L1015*, L1016*, L1060*, L1083*, L1085*, L918*, L998*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054808	17	41244291	17	43092274	54808	69475	rs80357006	NC_000017.11:43092273:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3255dup (p.Leu1086fs)	BRCA1|LOC126862571	L1039fs, L1086fs, L1085fs, L790fs, L998fs, L1015fs, L1016fs, L1045fs, L1060fs, L1083fs, L958fs, L959fs, L974fs, L1018fs, L1019fs, L1044fs, L1059fs, L997fs, L1038fs, L918fs, L975fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054807	17	41244292 - 41244293	17	43092275 - 43092276	54807	69474	rs1555588090	NC_000017.11:43092275:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3254_3255dup (p.Leu1086fs)	BRCA1|LOC126862571	L1086fs, L1039fs, L1015fs, L1018fs, L1038fs, L1083fs, L974fs, L997fs, L1016fs, L1059fs, L998fs, L1019fs, L1045fs, L1060fs, L918fs, L958fs, L959fs, L975fs, L1044fs, L1085fs, L790fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054806	17	41244292 - 41244293	17	43092275 - 43092276	54806	69473	rs80357624	NC_000017.11:43092275:TCT:TCTCT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3255del (p.Arg1085fs)	BRCA1|LOC126862571	R1038fs, R1085fs, R1015fs, R1084fs, R917fs, R973fs, R997fs, R1017fs, R1044fs, R974fs, R1018fs, R1037fs, R1082fs, R789fs, R957fs, R996fs, R1014fs, R1043fs, R1058fs, R1059fs, R958fs	not provided|Hereditary cancer-predisposing syndrome	VCV000928279	17	41244293	17	43092276	928279	913901	rs2053619372	NC_000017.11:43092275:T:	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3253dup (p.Arg1085fs)	BRCA1|LOC126862571	R1038fs, R1085fs, R1015fs, R1017fs, R1037fs, R1058fs, R1082fs, R1084fs, R789fs, R1014fs, R1018fs, R1044fs, R1059fs, R957fs, R974fs, R997fs, R917fs, R973fs, R1043fs, R958fs, R996fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054805	17	41244294 - 41244295	17	43092277 - 43092278	54805	69472	rs80357517	NC_000017.11:43092277:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3253A>T (p.Arg1085Ter)	BRCA1|LOC126862571	R1085*, R1038*, R1014*, R1043*, R1059*, R957*, R1015*, R1037*, R1082*, R789*, R1084*, R958*, R996*, R997*, R1017*, R1018*, R1044*, R1058*, R917*, R973*, R974*	Hereditary cancer-predisposing syndrome	VCV000491060	17	41244295	17	43092278	491060	485147	rs1432504119	NC_000017.11:43092277:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Apr 27, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3247_3251del (p.Ala1082_Met1083insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431241	17	41244297 - 41244301	17	43092280 - 43092284	431241	424821	rs1135401859	NC_000017.11:43092279:AGCATAGCAT:AGCAT	Microsatellite	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3244_3247del (p.Ala1082fs)	BRCA1|LOC126862571	A1014fs, A1079fs, A994fs, A1015fs, A1034fs, A1056fs, A1081fs, A1082fs, A993fs, A1011fs, A1040fs, A1041fs, A1055fs, A954fs, A955fs, A971fs, A1012fs, A1035fs, A786fs, A914fs, A970fs	Hereditary breast ovarian cancer syndrome	VCV002755843	17	41244301 - 41244304	17	43092284 - 43092287	2755843	2917015	rs2552160093	NC_000017.11:43092283:TAGC:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 28, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3239dup (p.Leu1080fs)	BRCA1|LOC126862571	L1012fs, L1032fs, L1077fs, L969fs, L992fs, L1010fs, L1054fs, L1079fs, L784fs, L968fs, L1009fs, L1033fs, L1038fs, L1039fs, L1080fs, L991fs, L1013fs, L1053fs, L912fs, L952fs, L953fs	Hereditary breast ovarian cancer syndrome	VCV002769319	17	41244308 - 41244309	17	43092291 - 43092292	2769319	2923594	rs2552160328	NC_000017.11:43092291:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 17, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3239T>A (p.Leu1080Ter)	BRCA1|LOC126862571	L1080*, L1033*, L1038*, L784*, L952*, L1009*, L1010*, L1013*, L1039*, L1077*, L1012*, L1053*, L1054*, L912*, L953*, L1032*, L1079*, L968*, L969*, L991*, L992*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054804	17	41244309	17	43092292	54804	69471	rs80357145	NC_000017.11:43092291:A:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3231_3238del (p.Pro1078fs)	BRCA1|LOC126862571	P1078fs, P1031fs, P1030fs, P1037fs, P782fs, P910fs, P950fs, P1010fs, P1011fs, P1051fs, P1075fs, P1077fs, P951fs, P990fs, P1052fs, P966fs, P967fs, P1007fs, P1008fs, P1036fs, P989fs	Hereditary breast ovarian cancer syndrome	VCV000860123	17	41244310 - 41244317	17	43092293 - 43092300	860123	845406	rs2053622241	NC_000017.11:43092292:ATTTTGGC:	Deletion	intron variant|frameshift variant	Pathogenic	Mar 6, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3235A>T (p.Lys1079Ter)	BRCA1|LOC126862571	K1012*, K1031*, K1037*, K1053*, K1079*, K967*, K991*, K1038*, K951*, K952*, K990*, K1008*, K1009*, K1078*, K783*, K968*, K1011*, K1032*, K1052*, K1076*, K911*	Hereditary cancer-predisposing syndrome	VCV001729232	17	41244313	17	43092296	1729232	1785521	rs2154335427	NC_000017.11:43092295:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Aug 26, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3231del (p.Pro1078fs)	BRCA1|LOC126862571	P1011fs, P1075fs, P782fs, P1007fs, P1052fs, P1078fs, P950fs, P989fs, P990fs, P1008fs, P1010fs, P1036fs, P1037fs, P1051fs, P951fs, P966fs, P1030fs, P1031fs, P1077fs, P910fs, P967fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002749950	17	41244317	17	43092300	2749950	2908547	rs2552160592	NC_000017.11:43092299:CCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3226_3229del (p.Arg1076fs)	BRCA1|LOC126862571	R1029fs, R1076fs, R1009fs, R1049fs, R908fs, R948fs, R1006fs, R1073fs, R780fs, R965fs, R988fs, R1008fs, R1034fs, R1075fs, R964fs, R1005fs, R1028fs, R1035fs, R1050fs, R949fs, R987fs	Hereditary cancer-predisposing syndrome	VCV000928179	17	41244319 - 41244322	17	43092302 - 43092305	928179	913902	rs2053623304	NC_000017.11:43092301:CTCT:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 15, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3228_3229del (p.Gly1077fs)	BRCA1|LOC126862571	G1077fs, G1030fs, G1006fs, G1007fs, G1051fs, G1076fs, G988fs, G1074fs, G781fs, G949fs, G966fs, G1009fs, G1010fs, G1035fs, G1036fs, G989fs, G1029fs, G1050fs, G909fs, G950fs, G965fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037516	17	41244319 - 41244320	17	43092302 - 43092303	37516	46072	rs80357635	NC_000017.11:43092301:CTCT:CT	Microsatellite	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3226A>T (p.Arg1076Ter)	BRCA1|LOC126862571	R1076*, R1029*, R1009*, R1028*, R1035*, R1050*, R780*, R965*, R988*, R1008*, R1049*, R1075*, R1034*, R1005*, R908*, R948*, R949*, R964*, R987*, R1006*, R1073*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254424	17	41244322	17	43092305	254424	249119	rs886038009	NC_000017.11:43092304:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3226del (p.Arg1076fs)	BRCA1|LOC126862571	R1029fs, R1076fs, R1006fs, R1008fs, R1035fs, R1049fs, R780fs, R908fs, R948fs, R964fs, R1075fs, R1028fs, R1073fs, R949fs, R988fs, R1005fs, R1009fs, R1034fs, R1050fs, R965fs, R987fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054801	17	41244322	17	43092305	54801	69468	rs273899703	NC_000017.11:43092304:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3224dup (p.Asn1075fs)	BRCA1|LOC126862571	N1075fs, N1028fs, N1004fs, N1007fs, N1048fs, N1049fs, N947fs, N1033fs, N1074fs, N779fs, N948fs, N964fs, N1005fs, N1008fs, N1027fs, N1072fs, N907fs, N987fs, N1034fs, N963fs, N986fs	Hereditary breast ovarian cancer syndrome	VCV000654295	17	41244323 - 41244324	17	43092306 - 43092307	654295	645983	rs1597865013	NC_000017.11:43092306:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Jan 3, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3220A>T (p.Arg1074Ter)	BRCA1|LOC126862571	R1027*, R1048*, R946*, R962*, R985*, R1033*, R1047*, R1074*, R986*, R1003*, R1006*, R1026*, R1071*, R947*, R963*, R1004*, R1007*, R1032*, R1073*, R778*, R906*	Hereditary breast ovarian cancer syndrome	VCV002032848	17	41244328	17	43092311	2032848	2079209	rs80357263	NC_000017.11:43092310:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3217_3218del (p.Leu1072_Gly1073insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266345	17	41244330 - 41244331	17	43092313 - 43092314	266345	261758	rs886040106	NC_000017.11:43092312:CC:	Deletion	nonsense|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3214del (p.Glu1071_Leu1072insTer)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054798	17	41244334	17	43092317	54798	69465	rs80357923	NC_000017.11:43092316:G:	Deletion	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3211_3212dup (p.Leu1072fs)	LOC126862571|BRCA1	L1025fs, L1072fs, L1005fs, L1045fs, L776fs, L904fs, L945fs, L983fs, L984fs, L1001fs, L1046fs, L1071fs, L960fs, L1004fs, L1024fs, L1031fs, L1069fs, L944fs, L961fs, L1002fs, L1030fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266344	17	41244335 - 41244336	17	43092318 - 43092319	266344	261759	rs886040105	NC_000017.11:43092318:TCT:TCTCT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3211dup (p.Glu1071fs)	BRCA1	E1024fs, E1071fs, E1000fs, E1004fs, E1070fs, E903fs, E959fs, E1003fs, E1023fs, E1030fs, E1044fs, E1045fs, E775fs, E944fs, E960fs, E983fs, E1001fs, E1029fs, E1068fs, E943fs, E982fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054797	17	41244336 - 41244337	17	43092319 - 43092320	54797	69464	rs397509047	NC_000017.11:43092319:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3211G>T (p.Glu1071Ter)	BRCA1	E1024*, E1071*, E1004*, E1023*, E1044*, E960*, E1000*, E1030*, E1045*, E775*, E982*, E1001*, E1003*, E1029*, E959*, E1068*, E1070*, E903*, E943*, E944*, E983*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000971124	17	41244337	17	43092320	971124	958127	rs41293445	NC_000017.11:43092319:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3210dup (p.Glu1071fs)	BRCA1	E1024fs, E1071fs, E1030fs, E1068fs, E959fs, E1000fs, E1004fs, E903fs, E943fs, E944fs, E983fs, E1001fs, E1045fs, E1070fs, E960fs, E982fs, E1044fs, E775fs, E1003fs, E1023fs, E1029fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266343	17	41244337 - 41244338	17	43092320 - 43092321	266343	261760	rs886040104	NC_000017.11:43092320:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3210del (p.Glu1071fs)	BRCA1	E1024fs, E1071fs, E1000fs, E1045fs, E775fs, E903fs, E959fs, E1003fs, E1029fs, E1030fs, E1044fs, E1068fs, E1070fs, E943fs, E1004fs, E1023fs, E944fs, E960fs, E983fs, E1001fs, E982fs	Hereditary cancer-predisposing syndrome	VCV001728930	17	41244338	17	43092321	1728930	1785220	rs2552161519	NC_000017.11:43092320:T:	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3150_3208dup (p.Ala1070delinsValLeuMetLysTrpAlaProValLeuMetLysTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266339	17	41244339 - 41244340	17	43092322 - 43092323	266339	261761	rs1555588199		Duplication	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3203_3206del (p.Ile1068fs)	BRCA1	I1021fs, I1068fs, I1027fs, I956fs, I957fs, I979fs, I1042fs, I1065fs, I941fs, I998fs, I1041fs, I1067fs, I772fs, I997fs, I1000fs, I1001fs, I1020fs, I1026fs, I900fs, I940fs, I980fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266341	17	41244342 - 41244345	17	43092325 - 43092328	266341	261762	rs886040102	NC_000017.11:43092324:TGAATG:TG	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3205C>T (p.Gln1069Ter)	BRCA1	Q1022*, Q1069*, Q1027*, Q901*, Q957*, Q998*, Q1002*, Q1042*, Q1043*, Q1068*, Q981*, Q1021*, Q941*, Q999*, Q1001*, Q1028*, Q1066*, Q773*, Q942*, Q958*, Q980*	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000923489	17	41244343	17	43092326	923489	913903	rs2053627043	NC_000017.11:43092325:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3205del (p.Gln1069fs)	BRCA1	Q1022fs, Q1069fs, Q1002fs, Q1043fs, Q957fs, Q980fs, Q1001fs, Q1066fs, Q941fs, Q998fs, Q1027fs, Q1028fs, Q1068fs, Q773fs, Q901fs, Q999fs, Q1021fs, Q1042fs, Q942fs, Q958fs, Q981fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266342	17	41244343	17	43092326	266342	261763	rs886040103	NC_000017.11:43092325:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3204del (p.Gln1069fs)	BRCA1	Q1069fs, Q1022fs, Q1021fs, Q1028fs, Q901fs, Q980fs, Q1002fs, Q1068fs, Q942fs, Q958fs, Q999fs, Q1001fs, Q1042fs, Q1043fs, Q957fs, Q981fs, Q998fs, Q1027fs, Q1066fs, Q773fs, Q941fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091607	17	41244344	17	43092327	91607	97084	rs398122673	NC_000017.11:43092326:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3196dup (p.Glu1066fs)	BRCA1	E1019fs, E1066fs, E1025fs, E1039fs, E1065fs, E898fs, E955fs, E977fs, E1040fs, E1063fs, E938fs, E978fs, E995fs, E996fs, E999fs, E1018fs, E1024fs, E770fs, E939fs, E954fs, E998fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548283	17	41244351 - 41244352	17	43092334 - 43092335	548283	538823	rs1555588222	NC_000017.11:43092334:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3196G>T (p.Glu1066Ter)	BRCA1	E1066*, E1019*, E1024*, E1039*, E1065*, E955*, E977*, E1040*, E1063*, E939*, E978*, E996*, E998*, E999*, E1018*, E1025*, E770*, E898*, E995*, E938*, E954*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441438	17	41244352	17	43092335	441438	435139	rs1555588220	NC_000017.11:43092334:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3194_3195insG (p.Asp1065fs)	BRCA1	D1018fs, D1065fs, D1017fs, D897fs, D937fs, D938fs, D995fs, D1023fs, D1062fs, D1064fs, D1038fs, D1039fs, D953fs, D954fs, D994fs, D998fs, D1024fs, D769fs, D976fs, D977fs, D997fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125613	17	41244353 - 41244354	17	43092336 - 43092337	125613	131151	rs80357883	NC_000017.11:43092336::C	Insertion	frameshift variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3193dup (p.Asp1065fs)	BRCA1	D1065fs, D1018fs, D1024fs, D769fs, D953fs, D954fs, D994fs, D995fs, D998fs, D1017fs, D976fs, D1039fs, D1062fs, D1064fs, D937fs, D938fs, D997fs, D1023fs, D1038fs, D897fs, D977fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054796	17	41244354 - 41244355	17	43092337 - 43092338	54796	69463	rs80357511	NC_000017.11:43092337:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3190del (p.Ser1064fs)	BRCA1	S1037fs, S1063fs, S768fs, S936fs, S953fs, S1061fs, S937fs, S976fs, S993fs, S994fs, S1016fs, S1022fs, S1038fs, S1064fs, S996fs, S997fs, S1017fs, S1023fs, S896fs, S952fs, S975fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV003481851	17	41244358	17	43092341	3481851	3640062		NC_000017.11:43092340:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3188_3189delinsG (p.Gly1062_Ser1063insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054794	17	41244359 - 41244360	17	43092342 - 43092343	54794	69461	rs273899701	NC_000017.11:43092341:GG:C	Indel	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3186_3187del (p.Ser1063fs)	BRCA1	S1015fs, S1062fs, S935fs, S1016fs, S1036fs, S1037fs, S1063fs, S952fs, S993fs, S1021fs, S1060fs, S936fs, S951fs, S975fs, S992fs, S995fs, S996fs, S1022fs, S767fs, S895fs, S974fs	Hereditary breast ovarian cancer syndrome	VCV002858159	17	41244361 - 41244362	17	43092344 - 43092345	2858159	3018205	rs2552163301	NC_000017.11:43092343:AA:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3183del (p.Ile1061fs)	BRCA1	I1061fs, I1014fs, I1013fs, I1034fs, I1035fs, I1058fs, I1060fs, I973fs, I991fs, I972fs, I990fs, I1019fs, I1020fs, I765fs, I893fs, I933fs, I934fs, I949fs, I950fs, I993fs, I994fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054793	17	41244365	17	43092348	54793	69460	rs397509046	NC_000017.11:43092347:T:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3182del (p.Ile1061fs)	BRCA1	I1061fs, I1014fs, I1013fs, I1019fs, I765fs, I933fs, I973fs, I1034fs, I1035fs, I1058fs, I990fs, I993fs, I1020fs, I1060fs, I893fs, I950fs, I972fs, I991fs, I994fs, I934fs, I949fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266340	17	41244366	17	43092349	266340	261764	rs886040101	NC_000017.11:43092348:A:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3181del (p.Glu1060_Ile1061insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054792	17	41244367	17	43092350	54792	69459	rs80357702	NC_000017.11:43092349:TTT:TT	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3178G>T (p.Glu1060Ter)	BRCA1	E1060*, E1013*, E1057*, E764*, E892*, E933*, E948*, E992*, E1012*, E1018*, E971*, E989*, E993*, E1033*, E949*, E1019*, E1034*, E1059*, E932*, E972*, E990*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054789	17	41244370	17	43092353	54789	69456	rs80357424	NC_000017.11:43092352:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3176_3177del (p.Asn1059fs)	BRCA1	N1059fs, N1012fs, N1017fs, N1058fs, N970fs, N988fs, N991fs, N947fs, N948fs, N989fs, N1011fs, N1033fs, N1056fs, N1018fs, N1032fs, N763fs, N891fs, N931fs, N932fs, N971fs, N992fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001459729	17	41244371 - 41244372	17	43092354 - 43092355	1459729	1484917	rs2154338498	NC_000017.11:43092353:AT:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3174del (p.Asn1059fs)	BRCA1	N1059fs, N1012fs, N1011fs, N1017fs, N763fs, N970fs, N971fs, N891fs, N931fs, N932fs, N947fs, N1032fs, N1056fs, N1058fs, N948fs, N989fs, N991fs, N992fs, N1018fs, N1033fs, N988fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037512	17	41244374	17	43092357	37512	46068	rs397507210	NC_000017.11:43092356:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3169_3172del (p.Ser1057fs)	BRCA1	S1010fs, S1057fs, S1054fs, S1056fs, S945fs, S969fs, S987fs, S1015fs, S1030fs, S990fs, S1016fs, S889fs, S929fs, S986fs, S1009fs, S1031fs, S761fs, S930fs, S946fs, S968fs, S989fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054788	17	41244376 - 41244379	17	43092359 - 43092362	54788	69455	rs397509045	NC_000017.11:43092358:TACT:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3168del (p.Ser1057fs)	BRCA1	S1010fs, S1057fs, S1016fs, S986fs, S987fs, S1031fs, S930fs, S945fs, S968fs, S989fs, S990fs, S1009fs, S1015fs, S1030fs, S761fs, S946fs, S969fs, S1054fs, S1056fs, S889fs, S929fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054786	17	41244380	17	43092363	54786	69453	rs397509044	NC_000017.11:43092362:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3166del (p.Ser1056fs)	BRCA1	S1056fs, S1009fs, S1053fs, S760fs, S944fs, S967fs, S986fs, S988fs, S1008fs, S1014fs, S1029fs, S929fs, S945fs, S968fs, S1030fs, S1055fs, S888fs, S928fs, S985fs, S1015fs, S989fs	Hereditary cancer-predisposing syndrome	VCV001728373	17	41244382	17	43092365	1728373	1791773	rs2552164686	NC_000017.11:43092364:A:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 24, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3161_3164dup (p.Ser1056fs)	BRCA1	S1056fs, S1009fs, S1008fs, S1015fs, S1030fs, S1053fs, S1055fs, S986fs, S760fs, S944fs, S968fs, S1014fs, S1029fs, S888fs, S928fs, S929fs, S945fs, S967fs, S985fs, S988fs, S989fs	Hereditary breast ovarian cancer syndrome	VCV000572059	17	41244383 - 41244384	17	43092366 - 43092367	572059	574474	rs1567792675	NC_000017.11:43092366:CCCAC:CCCACCCAC	Duplication	frameshift variant|intron variant	Pathogenic	Mar 28, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3164del (p.Gly1055fs)	BRCA1	G1008fs, G1055fs, G943fs, G1007fs, G1028fs, G1029fs, G1054fs, G887fs, G927fs, G944fs, G987fs, G1013fs, G1014fs, G1052fs, G966fs, G967fs, G985fs, G988fs, G759fs, G928fs, G984fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054785	17	41244384	17	43092367	54785	69452	rs397509043	NC_000017.11:43092366:CCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3158_3159insG (p.Val1054fs)	BRCA1	V1007fs, V1054fs, V1027fs, V1051fs, V986fs, V1012fs, V1053fs, V926fs, V984fs, V1006fs, V758fs, V927fs, V943fs, V965fs, V966fs, V1013fs, V1028fs, V886fs, V942fs, V983fs, V987fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125609	17	41244389 - 41244390	17	43092372 - 43092373	125609	131147	rs80357769	NC_000017.11:43092372::C	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3157dup (p.Glu1053fs)	BRCA1	E1053fs, E1006fs, E1027fs, E757fs, E941fs, E965fs, E986fs, E1005fs, E1026fs, E1050fs, E983fs, E1052fs, E885fs, E985fs, E1011fs, E1012fs, E925fs, E926fs, E942fs, E964fs, E982fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054784	17	41244390 - 41244391	17	43092373 - 43092374	54784	69451	rs397509042	NC_000017.11:43092373:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3157G>T (p.Glu1053Ter)	BRCA1	E1053*, E1006*, E1026*, E1027*, E1050*, E757*, E964*, E1012*, E1052*, E941*, E983*, E1005*, E925*, E942*, E982*, E985*, E986*, E1011*, E885*, E926*, E965*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187251	17	41244391	17	43092374	187251	184982	rs786203587	NC_000017.11:43092373:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3157del (p.Glu1053fs)	BRCA1	E1006fs, E1053fs, E1011fs, E1012fs, E757fs, E885fs, E925fs, E941fs, E964fs, E985fs, E1005fs, E1026fs, E1050fs, E965fs, E1027fs, E982fs, E983fs, E1052fs, E926fs, E942fs, E986fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054783	17	41244391	17	43092374	54783	69450	rs397509041	NC_000017.11:43092373:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3155del (p.Asn1052fs)	BRCA1	N1005fs, N1052fs, N1011fs, N756fs, N925fs, N1004fs, N1010fs, N924fs, N940fs, N963fs, N984fs, N985fs, N1026fs, N1049fs, N884fs, N941fs, N964fs, N981fs, N1025fs, N1051fs, N982fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054782	17	41244393	17	43092376	54782	69449	rs397509040	NC_000017.11:43092375:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3145del (p.Ser1049fs)	BRCA1	S1002fs, S1049fs, S1008fs, S922fs, S937fs, S960fs, S978fs, S981fs, S982fs, S1001fs, S1046fs, S1048fs, S921fs, S1007fs, S1022fs, S1023fs, S753fs, S881fs, S938fs, S961fs, S979fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054779	17	41244403	17	43092386	54779	69446	rs397509038	NC_000017.11:43092385:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3143del (p.Gly1048fs)	BRCA1	G1001fs, G1048fs, G1007fs, G752fs, G880fs, G936fs, G937fs, G980fs, G1000fs, G1006fs, G1045fs, G920fs, G1047fs, G959fs, G978fs, G1021fs, G1022fs, G921fs, G960fs, G977fs, G981fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266338	17	41244405	17	43092388	266338	261765	rs886040100	NC_000017.11:43092387:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3138_3141del (p.Gly1048fs)	BRCA1	G1001fs, G1048fs, G1000fs, G880fs, G920fs, G960fs, G977fs, G980fs, G1006fs, G1007fs, G1021fs, G1047fs, G752fs, G936fs, G959fs, G1022fs, G1045fs, G937fs, G921fs, G978fs, G981fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000419901	17	41244407 - 41244410	17	43092390 - 43092393	419901	409983	rs1064794177	NC_000017.11:43092389:TACTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3135_3138del (p.Asn1045fs)	BRCA1	N1045fs, N998fs, N917fs, N918fs, N956fs, N978fs, N1019fs, N977fs, N1003fs, N1004fs, N1042fs, N749fs, N877fs, N933fs, N975fs, N997fs, N1018fs, N1044fs, N934fs, N957fs, N974fs	Hereditary breast ovarian cancer syndrome	VCV000573193	17	41244410 - 41244413	17	43092393 - 43092396	573193	574475	rs1567792767	NC_000017.11:43092392:TTCATT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Jul 9, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3129_3138del (p.Asn1043fs)	BRCA1	N1043fs, N996fs, N1002fs, N1016fs, N1017fs, N1040fs, N931fs, N972fs, N975fs, N995fs, N1001fs, N1042fs, N955fs, N976fs, N747fs, N875fs, N915fs, N932fs, N954fs, N916fs, N973fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182111	17	41244410 - 41244419	17	43092393 - 43092402	182111	180846	rs730881462	NC_000017.11:43092392:TTCATTAATATT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3136del (p.Glu1046fs)	BRCA1	E1046fs, E999fs, E750fs, E975fs, E976fs, E1005fs, E1019fs, E878fs, E919fs, E935fs, E979fs, E1004fs, E1020fs, E1043fs, E1045fs, E934fs, E958fs, E978fs, E998fs, E918fs, E957fs	Hereditary cancer-predisposing syndrome	VCV001728014	17	41244412	17	43092395	1728014	1794882	rs2552167747	NC_000017.11:43092394:C:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3135_3136insAACTACTG (p.Glu1046fs)	BRCA1	E999fs, E1046fs, E1043fs, E750fs, E919fs, E958fs, E1005fs, E1045fs, E878fs, E934fs, E957fs, E975fs, E1019fs, E918fs, E976fs, E979fs, E998fs, E1004fs, E1020fs, E935fs, E978fs	Hereditary breast ovarian cancer syndrome	VCV001457027	17	41244412 - 41244413	17	43092395 - 43092396	1457027	1477766	rs2154340752	NC_000017.11:43092395::CAGTAGTT	Insertion	frameshift variant|intron variant	Pathogenic	Aug 16, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3136G>T (p.Glu1046Ter)	BRCA1	E1046*, E999*, E1004*, E750*, E878*, E935*, E976*, E1019*, E934*, E958*, E975*, E978*, E1043*, E1045*, E919*, E998*, E1005*, E1020*, E918*, E957*, E979*	Hereditary breast ovarian cancer syndrome|not provided	VCV001330044	17	41244412	17	43092395	1330044	1320727	rs1555588329	NC_000017.11:43092394:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3125_3134del (p.Ser1042fs)	BRCA1	S995fs, S1042fs, S1015fs, S1041fs, S914fs, S915fs, S975fs, S1000fs, S1001fs, S746fs, S931fs, S953fs, S954fs, S974fs, S874fs, S930fs, S971fs, S994fs, S1016fs, S1039fs, S972fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054774	17	41244414 - 41244423	17	43092397 - 43092406	54774	69441	rs397509036	NC_000017.11:43092396:TTAATATTGCTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3132del (p.Asn1045fs)	BRCA1	N998fs, N1045fs, N1019fs, N1042fs, N877fs, N934fs, N974fs, N977fs, N1018fs, N1044fs, N933fs, N997fs, N1003fs, N1004fs, N749fs, N917fs, N918fs, N956fs, N957fs, N975fs, N978fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252432	17	41244416	17	43092399	252432	246848	rs879255316	NC_000017.11:43092398:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3122C>G (p.Ser1041Ter)	BRCA1	S1041*, S994*, S1015*, S913*, S953*, S993*, S1038*, S745*, S914*, S970*, S1040*, S873*, S929*, S971*, S973*, S1000*, S1014*, S930*, S952*, S974*, S999*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054773	17	41244426	17	43092409	54773	69440	rs397509035	NC_000017.11:43092408:G:C	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3117_3120del (p.Ser1040fs)	BRCA1	S993fs, S1040fs, S1037fs, S872fs, S912fs, S913fs, S973fs, S999fs, S1013fs, S1014fs, S744fs, S929fs, S952fs, S928fs, S998fs, S1039fs, S951fs, S969fs, S970fs, S972fs, S992fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266337	17	41244428 - 41244431	17	43092411 - 43092414	266337	261766	rs886040099	NC_000017.11:43092410:GCTGGCT:GCT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3111_3118del (p.Glu1038fs)	BRCA1	E1038fs, E991fs, E742fs, E870fs, E926fs, E949fs, E967fs, E968fs, E970fs, E996fs, E997fs, E1011fs, E1012fs, E950fs, E927fs, E971fs, E1035fs, E1037fs, E910fs, E911fs, E990fs	Fanconi anemia, complementation group S	VCV003779416	17	41244430 - 41244437	17	43092413 - 43092420	3779416	1245803		NC_000017.11:43092412:TGGCTTCTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Nov 5, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3117del (p.Ser1040fs)	BRCA1	S993fs, S1040fs, S969fs, S992fs, S1014fs, S872fs, S913fs, S951fs, S998fs, S1013fs, S1039fs, S912fs, S952fs, S970fs, S972fs, S1037fs, S744fs, S928fs, S929fs, S973fs, S999fs	Hereditary breast ovarian cancer syndrome	VCV000462602	17	41244431	17	43092414	462602	466876	rs1555588361	NC_000017.11:43092413:GG:G	Deletion	intron variant|frameshift variant	Pathogenic	Jan 26, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3114_3117delinsGA (p.Ala1039fs)	BRCA1	A992fs, A1039fs, A1036fs, A912fs, A928fs, A951fs, A991fs, A911fs, A968fs, A971fs, A1012fs, A1038fs, A871fs, A972fs, A998fs, A1013fs, A743fs, A927fs, A950fs, A969fs, A997fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125607	17	41244431 - 41244434	17	43092414 - 43092417	125607	131145	rs273899700	NC_000017.11:43092413:GGCT:TC	Indel	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3113_3115delinsGA (p.Glu1038fs)	BRCA1	E1038fs, E991fs, E1012fs, E1035fs, E1037fs, E926fs, E970fs, E742fs, E911fs, E949fs, E968fs, E997fs, E870fs, E910fs, E927fs, E950fs, E990fs, E1011fs, E967fs, E971fs, E996fs	Hereditary cancer-predisposing syndrome	VCV000822914	17	41244433 - 41244435	17	43092416 - 43092418	822914	813758	rs1597865625	NC_000017.11:43092415:CTT:TC	Indel	frameshift variant|intron variant	Pathogenic	Jun 12, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3115del (p.Ala1039fs)	BRCA1	A992fs, A1039fs, A871fs, A969fs, A971fs, A972fs, A991fs, A998fs, A1013fs, A1038fs, A912fs, A928fs, A951fs, A968fs, A1012fs, A1036fs, A911fs, A950fs, A997fs, A743fs, A927fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266336	17	41244433	17	43092416	266336	261767	rs886040098	NC_000017.11:43092415:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3113_3114del (p.Glu1038fs)	BRCA1	E991fs, E1038fs, E870fs, E910fs, E911fs, E927fs, E967fs, E970fs, E990fs, E997fs, E1011fs, E1012fs, E926fs, E949fs, E971fs, E996fs, E1035fs, E742fs, E950fs, E968fs, E1037fs	not provided	VCV000619625	17	41244434 - 41244435	17	43092417 - 43092418	619625	611238	rs1567792876	NC_000017.11:43092416:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 1, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3112del (p.Glu1038fs)	BRCA1	E1011fs, E1012fs, E1035fs, E1037fs, E1038fs, E742fs, E870fs, E910fs, E911fs, E926fs, E927fs, E949fs, E950fs, E967fs, E968fs, E970fs, E971fs, E990fs, E991fs, E996fs, E997fs	not provided	VCV002691995	17	41244436	17	43092419	2691995	2852998	rs2552170356	NC_000017.11:43092418:C:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3107_3112del (p.Phe1036_Glu1038delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054770	17	41244436 - 41244441	17	43092419 - 43092424	54770	69437	rs80357920	NC_000017.11:43092418:CTTTAA:	Deletion	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3112G>T (p.Glu1038Ter)	BRCA1	E1038*, E991*, E1012*, E1037*, E926*, E949*, E996*, E1035*, E910*, E911*, E967*, E970*, E927*, E950*, E971*, E990*, E997*, E1011*, E742*, E870*, E968*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037509	17	41244436	17	43092419	37509	46065	rs80357161	NC_000017.11:43092418:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3110_3111insT (p.Lys1037fs)	BRCA1	K1037fs, K990fs, K741fs, K869fs, K969fs, K995fs, K1034fs, K910fs, K970fs, K996fs, K1010fs, K1036fs, K925fs, K948fs, K966fs, K967fs, K989fs, K1011fs, K909fs, K926fs, K949fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548193	17	41244437 - 41244438	17	43092420 - 43092421	548193	538824	rs1555588381	NC_000017.11:43092420::A	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3109_3110insT (p.Lys1037fs)	BRCA1	K990fs, K1037fs, K967fs, K970fs, K989fs, K996fs, K1011fs, K1034fs, K741fs, K869fs, K909fs, K925fs, K969fs, K1010fs, K1036fs, K910fs, K926fs, K948fs, K949fs, K966fs, K995fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266334	17	41244438 - 41244439	17	43092421 - 43092422	266334	261768	rs886040096	NC_000017.11:43092421::A	Insertion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.3(BRCA1):c.3108_3109insSVAelement	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000639676	17	41244439 - 41244440	17	43092422 - 43092423	639676	645988			Insertion		Pathogenic	Sep 18, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3106_3109del (p.Phe1036fs)	BRCA1	F989fs, F1036fs, F947fs, F969fs, F994fs, F1033fs, F868fs, F965fs, F968fs, F1009fs, F1010fs, F1035fs, F908fs, F909fs, F924fs, F948fs, F966fs, F988fs, F995fs, F740fs, F925fs	not provided	VCV000545848	17	41244439 - 41244442	17	43092422 - 43092425	545848	536492	rs1555588385	NC_000017.11:43092421:TAAA:	Deletion	frameshift variant|intron variant	Pathogenic	Nov 30, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3108dup (p.Lys1037Ter)	BRCA1	K1037*, K990*, K910*, K925*, K966*, K967*, K996*, K1010*, K1011*, K1036*, K869*, K948*, K969*, K741*, K909*, K989*, K995*, K1034*, K926*, K949*, K970*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054772	17	41244439 - 41244440	17	43092422 - 43092423	54772	69439	rs80357841	NC_000017.11:43092422:AAAAA:AAAAAA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3108del (p.Phe1036fs)	BRCA1	F1036fs, F989fs, F1010fs, F1035fs, F924fs, F988fs, F994fs, F740fs, F908fs, F947fs, F965fs, F968fs, F969fs, F1009fs, F1033fs, F909fs, F948fs, F966fs, F995fs, F868fs, F925fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054771	17	41244440	17	43092423	54771	69438	rs80357841	NC_000017.11:43092422:AAAAA:AAAA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3103_3104del (p.Val1035fs)	BRCA1	V988fs, V1035fs, V867fs, V1009fs, V1032fs, V908fs, V924fs, V964fs, V965fs, V907fs, V967fs, V987fs, V947fs, V968fs, V1008fs, V1034fs, V739fs, V923fs, V946fs, V993fs, V994fs	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000462601	17	41244444 - 41244445	17	43092427 - 43092428	462601	467954	rs1555588392	NC_000017.11:43092426:ACA:A	Deletion	frameshift variant|intron variant	Pathogenic	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3087_3100dup (p.Asn1034fs)	BRCA1	N987fs, N1034fs, N1031fs, N866fs, N946fs, N1033fs, N738fs, N906fs, N922fs, N963fs, N966fs, N967fs, N986fs, N993fs, N1007fs, N945fs, N992fs, N1008fs, N907fs, N923fs, N964fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266333	17	41244447 - 41244448	17	43092430 - 43092431	266333	261769	rs80357967	NC_000017.11:43092430:TTTCTCTAATGTTATT:TTTCTCTAATGTTATTTCTCTAATGTTATT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3096_3098delinsGT (p.Arg1032_Glu1033insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001192218	17	41244450 - 41244452	17	43092433 - 43092435	1192218	1182277	rs2154342721	NC_000017.11:43092432:TCT:AC	Indel	frameshift variant|nonsense|intron variant	Pathogenic	Jul 7, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3097G>T (p.Glu1033Ter)	BRCA1	E1033*, E986*, E1006*, E905*, E906*, E945*, E962*, E966*, E985*, E1007*, E1030*, E737*, E922*, E963*, E992*, E865*, E944*, E991*, E1032*, E921*, E965*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054769	17	41244451	17	43092434	54769	69436	rs273899698	NC_000017.11:43092433:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3084_3094del (p.Asn1029fs)	BRCA1	N1029fs, N982fs, N1002fs, N733fs, N861fs, N901fs, N902fs, N917fs, N918fs, N959fs, N961fs, N962fs, N1003fs, N940fs, N981fs, N988fs, N941fs, N958fs, N1026fs, N1028fs, N987fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054768	17	41244454 - 41244464	17	43092437 - 43092447	54768	69435	rs80357647	NC_000017.11:43092436:TAATGTTATTA:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3091dup (p.Ile1031fs)	BRCA1	I1031fs, I984fs, I863fs, I903fs, I920fs, I989fs, I990fs, I1004fs, I1005fs, I904fs, I943fs, I983fs, I1030fs, I960fs, I1028fs, I735fs, I919fs, I942fs, I961fs, I963fs, I964fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000421801	17	41244456 - 41244457	17	43092439 - 43092440	421801	409985	rs1555588399	NC_000017.11:43092439:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3083del (p.Arg1028fs)	BRCA1	R1028fs, R981fs, R1027fs, R860fs, R901fs, R917fs, R940fs, R960fs, R1002fs, R916fs, R957fs, R986fs, R732fs, R958fs, R961fs, R1001fs, R1025fs, R900fs, R939fs, R980fs, R987fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481038	17	41244465	17	43092448	481038	478689	rs1484076591	NC_000017.11:43092447:C:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3076_3077insGGAAAACTTTGAGGAACATTCAATGTCACCTGAAAGAGAAATGGGAAATGAGATCATTCCAAGTACAGTGAGCACA (p.Ile1026delinsArgLysThrLeuArgAsnIleGlnCysHisLeuLysGluLysTrpGluMetArgSerPheGlnValGlnTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548316	17	41244471 - 41244472	17	43092454 - 43092455	548316	538825	rs1555588427		Microsatellite	inframe_indel|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.3(BRCA1):c.3076_3077ins76 (p.?)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267521	17	41244471 - 41244472	17	43092454 - 43092455	267521	262967			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3000_3075dup (p.Ile1026delinsGlyLysLeuTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002848722	17	41244472 - 41244473	17	43092455 - 43092456	2848722	3015619	rs2552171891		Duplication	nonsense|intron variant	Pathogenic	Sep 5, 2023	criteria provided, single submitter							
NM_007294.3(BRCA1):c.3075_3076ins76 (p.?)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267520	17	41244472 - 41244473	17	43092455 - 43092456	267520	262968			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3075_3076insGGAAAACTTTGAGGAACATTCAATGTCACCTGAAAGAGAAATGGGAAATGAGATCATTCCAAGTACAGTGAGCACA (p.Ile1026delinsGlyLysLeuTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266332	17	41244472 - 41244473	17	43092455 - 43092456	266332	261770	rs886040095		Microsatellite	inframe_indel|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3068del (p.Val1023fs)	BRCA1	V1023fs, V976fs, V1022fs, V912fs, V1020fs, V855fs, V911fs, V935fs, V953fs, V955fs, V956fs, V996fs, V997fs, V727fs, V895fs, V934fs, V982fs, V896fs, V952fs, V975fs, V981fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000584949	17	41244480	17	43092463	584949	575998	rs1567793053	NC_000017.11:43092462:A:	Deletion	frameshift variant|intron variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3066del (p.Thr1022_Val1023insTer)	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186381	17	41244482	17	43092465	186381	184987	rs786202906	NC_000017.11:43092464:T:	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3064dup (p.Thr1022fs)	BRCA1	T1022fs, T975fs, T1021fs, T911fs, T951fs, T952fs, T954fs, T995fs, T726fs, T910fs, T934fs, T974fs, T894fs, T981fs, T1019fs, T854fs, T895fs, T933fs, T955fs, T980fs, T996fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000431240	17	41244483 - 41244484	17	43092466 - 43092467	431240	424822	rs1135401858	NC_000017.11:43092466:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3062del (p.Ser1021fs)	BRCA1	S1021fs, S974fs, S1020fs, S932fs, S980fs, S994fs, S995fs, S893fs, S933fs, S979fs, S1018fs, S894fs, S909fs, S953fs, S725fs, S853fs, S910fs, S950fs, S951fs, S954fs, S973fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431239	17	41244486	17	43092469	431239	424823	rs1135401857	NC_000017.11:43092468:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3059del (p.Pro1020fs)	BRCA1	P1020fs, P973fs, P852fs, P932fs, P953fs, P993fs, P724fs, P892fs, P893fs, P931fs, P949fs, P978fs, P979fs, P994fs, P1017fs, P1019fs, P908fs, P909fs, P950fs, P952fs, P972fs	Ovarian cancer	VCV000559976	17	41244489	17	43092472	559976	550695	rs1555588460	NC_000017.11:43092471:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Jul 3, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3056_3059del (p.Ile1019fs)	BRCA1	I1019fs, I972fs, I1018fs, I851fs, I930fs, I951fs, I952fs, I948fs, I977fs, I1016fs, I723fs, I891fs, I892fs, I908fs, I931fs, I971fs, I907fs, I949fs, I978fs, I992fs, I993fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431238	17	41244489 - 41244492	17	43092472 - 43092475	431238	424824	rs1135401856	NC_000017.11:43092471:GGAA:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3021_3058del (p.Met1008fs)	BRCA1	M880fs, M919fs, M938fs, M940fs, M967fs, M982fs, M1007fs, M1008fs, M881fs, M941fs, M961fs, M966fs, M1005fs, M712fs, M840fs, M920fs, M937fs, M896fs, M897fs, M960fs, M981fs	Hereditary breast ovarian cancer syndrome	VCV002859980	17	41244490 - 41244527	17	43092473 - 43092510	2859980	3028617	rs2552173068	NC_000017.11:43092472:GAATGTTCTCATTTCCCATTTCTCTTTCAGGTGACATTGAATGTTC:GAATGTTC	Deletion	frameshift variant|intron variant	Pathogenic	May 5, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3054_3055insTGAGA (p.Ile1019Ter)	BRCA1	I1019*, I972*, I1016*, I891*, I907*, I908*, I949*, I977*, I992*, I1018*, I931*, I978*, I993*, I723*, I892*, I951*, I952*, I971*, I851*, I930*, I948*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548264	17	41244493 - 41244494	17	43092476 - 43092477	548264	538826	rs1555588469	NC_000017.11:43092476::TCTCA	Insertion	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3054del (p.Asn1018fs)	BRCA1	N1018fs, N971fs, N850fs, N977fs, N1017fs, N722fs, N929fs, N930fs, N948fs, N951fs, N976fs, N890fs, N907fs, N947fs, N950fs, N992fs, N1015fs, N891fs, N906fs, N970fs, N991fs	Hereditary breast ovarian cancer syndrome|not provided	VCV001809519	17	41244494	17	43092477	1809519	1866523	rs2552173275	NC_000017.11:43092476:G:	Deletion	intron variant|frameshift variant	Pathogenic/Likely pathogenic	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3053_3054insTGAGA (p.Ile1019fs)	BRCA1	I1019fs, I972fs, I907fs, I930fs, I951fs, I851fs, I949fs, I952fs, I978fs, I993fs, I892fs, I908fs, I948fs, I971fs, I977fs, I992fs, I1016fs, I1018fs, I723fs, I891fs, I931fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125603	17	41244494 - 41244495	17	43092477 - 43092478	125603	131141	rs80357547	NC_000017.11:43092477:T:TCTCAT	Microsatellite	inframe_indel|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3048_3052dup (p.Asn1018fs)	BRCA1	N1018fs, N971fs, N890fs, N906fs, N907fs, N929fs, N948fs, N970fs, N977fs, N930fs, N947fs, N950fs, N991fs, N1015fs, N1017fs, N722fs, N976fs, N850fs, N891fs, N951fs, N992fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054763	17	41244495 - 41244496	17	43092478 - 43092479	54763	69430	rs80357856	NC_000017.11:43092478:TCTCAT:TCTCATCTCAT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.3(BRCA1):c.3052_3053ins5	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037503	17	41244495 - 41244496	17	43092478 - 43092479	37503	46059			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3048_3052del (p.Asn1016fs)	BRCA1	N1016fs, N969fs, N905fs, N975fs, N989fs, N990fs, N720fs, N904fs, N945fs, N946fs, N949fs, N1013fs, N1015fs, N848fs, N948fs, N974fs, N888fs, N889fs, N927fs, N928fs, N968fs	not provided	VCV000988332	17	41244496 - 41244500	17	43092479 - 43092483	988332	976424	rs80357856	NC_000017.11:43092478:TCTCAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jan 3, 2019	criteria provided, single submitter							
NM_007294.3:c.3049_3050ins7	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267519	17	41244498 - 41244499	17	43092481 - 43092482	267519	262969			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3049G>T (p.Glu1017Ter)	BRCA1	E1017*, E970*, E849*, E950*, E976*, E1016*, E890*, E928*, E949*, E969*, E889*, E905*, E946*, E947*, E975*, E1014*, E721*, E906*, E929*, E990*, E991*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054764	17	41244499	17	43092482	54764	69431	rs80357004	NC_000017.11:43092481:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3044dup (p.Asn1016fs)	BRCA1	N969fs, N1016fs, N1013fs, N1015fs, N904fs, N905fs, N927fs, N928fs, N948fs, N949fs, N975fs, N946fs, N888fs, N889fs, N990fs, N848fs, N945fs, N968fs, N974fs, N989fs, N720fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125601	17	41244503 - 41244504	17	43092486 - 43092487	125601	131139	rs80357746	NC_000017.11:43092486:CCC:CCCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3043G>T (p.Gly1015Ter)	BRCA1	G1012*, G1014*, G1015*, G719*, G847*, G887*, G888*, G903*, G904*, G926*, G927*, G944*, G945*, G947*, G948*, G967*, G968*, G973*, G974*, G988*, G989*	Hereditary cancer-predisposing syndrome	VCV003226129	17	41244505	17	43092488	3226129	3387193	rs2154345642	NC_000017.11:43092487:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 17, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3037_3038del (p.Glu1013fs)	BRCA1	E1013fs, E966fs, E1010fs, E717fs, E886fs, E925fs, E965fs, E972fs, E986fs, E901fs, E987fs, E1012fs, E845fs, E943fs, E945fs, E971fs, E885fs, E902fs, E924fs, E942fs, E946fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037502	17	41244510 - 41244511	17	43092493 - 43092494	37502	46058	rs397507208	NC_000017.11:43092492:TCTCT:TCT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3037G>T (p.Glu1013Ter)	BRCA1	E1013*, E966*, E1012*, E885*, E942*, E971*, E1010*, E717*, E901*, E924*, E946*, E965*, E986*, E987*, E845*, E902*, E943*, E886*, E925*, E945*, E972*	not provided|Hereditary breast ovarian cancer syndrome	VCV000986981	17	41244511	17	43092494	986981	975475	rs1555588500	NC_000017.11:43092493:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3033_3034del (p.Glu1013fs)	BRCA1	E1013fs, E966fs, E885fs, E942fs, E1010fs, E845fs, E902fs, E945fs, E986fs, E717fs, E924fs, E925fs, E972fs, E987fs, E1012fs, E886fs, E901fs, E943fs, E946fs, E965fs, E971fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000580620	17	41244514 - 41244515	17	43092497 - 43092498	580620	571447	rs1567793163	NC_000017.11:43092496:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jul 11, 2018	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3031G>T (p.Glu1011Ter)	BRCA1	E1011*, E964*, E944*, E963*, E969*, E984*, E899*, E900*, E923*, E941*, E985*, E715*, E1008*, E1010*, E843*, E943*, E970*, E883*, E884*, E922*, E940*	Hereditary breast ovarian cancer syndrome	VCV001452453	17	41244517	17	43092500	1452453	1364173	rs876659974	NC_000017.11:43092499:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 9, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3029_3030del (p.Pro1010fs)	BRCA1	P963fs, P1010fs, P1007fs, P882fs, P883fs, P922fs, P939fs, P940fs, P962fs, P899fs, P1009fs, P714fs, P921fs, P968fs, P969fs, P983fs, P984fs, P842fs, P898fs, P942fs, P943fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054757	17	41244518 - 41244519	17	43092501 - 43092502	54757	69424	rs80357510	NC_000017.11:43092500:AG:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3026C>A (p.Ser1009Ter)	BRCA1	S1009*, S962*, S1006*, S713*, S897*, S942*, S961*, S1008*, S921*, S938*, S982*, S983*, S841*, S898*, S939*, S941*, S881*, S882*, S920*, S967*, S968*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054756	17	41244522	17	43092505	54756	69423	rs273899696	NC_000017.11:43092504:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3024dup (p.Ser1009fs)	BRCA1	S962fs, S1009fs, S841fs, S882fs, S939fs, S968fs, S897fs, S1008fs, S941fs, S942fs, S1006fs, S713fs, S881fs, S898fs, S938fs, S967fs, S982fs, S920fs, S921fs, S961fs, S983fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266330	17	41244523 - 41244524	17	43092506 - 43092507	266330	261771	rs886040094	NC_000017.11:43092506:C:CC	Duplication	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3020_3023del (p.Ser1007fs)	BRCA1	S960fs, S1007fs, S1004fs, S839fs, S879fs, S980fs, S919fs, S936fs, S940fs, S1006fs, S711fs, S895fs, S896fs, S918fs, S937fs, S939fs, S959fs, S965fs, S981fs, S880fs, S966fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266329	17	41244525 - 41244528	17	43092508 - 43092511	266329	261772	rs886040093	NC_000017.11:43092507:ATTGA:A	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3018_3021del (p.His1006fs)	BRCA1	H959fs, H1006fs, H710fs, H838fs, H936fs, H958fs, H965fs, H1005fs, H1003fs, H878fs, H879fs, H895fs, H918fs, H935fs, H939fs, H980fs, H894fs, H917fs, H938fs, H964fs, H979fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054749	17	41244527 - 41244530	17	43092510 - 43092513	54749	69416	rs80357749	NC_000017.11:43092509:TGAATG:TG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3020C>A (p.Ser1007Ter)	BRCA1	S1007*, S960*, S1006*, S895*, S896*, S919*, S937*, S981*, S880*, S918*, S939*, S966*, S980*, S711*, S936*, S959*, S1004*, S839*, S879*, S940*, S965*	not provided|Hereditary breast ovarian cancer syndrome	VCV000955754	17	41244528	17	43092511	955754	949942	rs80357168	NC_000017.11:43092510:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3016_3020del (p.His1006fs)	BRCA1	H1006fs, H959fs, H1003fs, H1005fs, H935fs, H936fs, H980fs, H710fs, H939fs, H958fs, H964fs, H979fs, H838fs, H894fs, H918fs, H965fs, H878fs, H879fs, H895fs, H917fs, H938fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431237	17	41244528 - 41244532	17	43092511 - 43092515	431237	424825	rs1135401855	NC_000017.11:43092510:GAATG:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3020C>G (p.Ser1007Ter)	BRCA1	S1007*, S960*, S1006*, S918*, S936*, S937*, S939*, S966*, S1004*, S711*, S879*, S880*, S895*, S896*, S980*, S981*, S919*, S839*, S940*, S959*, S965*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054754	17	41244528	17	43092511	54754	69421	rs80357168	NC_000017.11:43092510:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3016del (p.His1006fs)	BRCA1	H1006fs, H959fs, H1005fs, H980fs, H1003fs, H878fs, H935fs, H939fs, H979fs, H838fs, H879fs, H918fs, H938fs, H965fs, H710fs, H894fs, H895fs, H917fs, H936fs, H958fs, H964fs	Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000995891	17	41244532	17	43092515	995891	983608	rs2154347100	NC_000017.11:43092514:G:	Deletion	frameshift variant|intron variant	Pathogenic	May 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3015dup (p.His1006fs)	BRCA1	H959fs, H1006fs, H878fs, H935fs, H936fs, H939fs, H980fs, H894fs, H918fs, H710fs, H838fs, H895fs, H917fs, H938fs, H965fs, H1003fs, H1005fs, H879fs, H958fs, H964fs, H979fs	Hereditary breast ovarian cancer syndrome	VCV000936488	17	41244532 - 41244533	17	43092515 - 43092516	936488	937958	rs886038008	NC_000017.11:43092515:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Aug 23, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3015del (p.Glu1005fs)	BRCA1	E958fs, E1005fs, E1002fs, E1004fs, E877fs, E964fs, E878fs, E916fs, E937fs, E978fs, E893fs, E894fs, E934fs, E957fs, E979fs, E709fs, E837fs, E917fs, E935fs, E938fs, E963fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254423	17	41244533	17	43092516	254423	249120	rs886038008	NC_000017.11:43092515:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3013G>T (p.Glu1005Ter)	BRCA1	E1005*, E709*, E893*, E935*, E938*, E957*, E963*, E877*, E878*, E917*, E964*, E1002*, E837*, E894*, E916*, E934*, E937*, E978*, E979*, E1004*, E958*	Hereditary breast ovarian cancer syndrome	VCV002982228	17	41244535	17	43092518	2982228	3138662	rs2154347293	NC_000017.11:43092517:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3013del (p.Glu1005fs)	BRCA1	E1005fs, E958fs, E837fs, E979fs, E709fs, E963fs, E964fs, E877fs, E878fs, E916fs, E1002fs, E1004fs, E893fs, E894fs, E917fs, E934fs, E935fs, E937fs, E938fs, E957fs, E978fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054748	17	41244535	17	43092518	54748	69415	rs80357937	NC_000017.11:43092517:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3011_3012del (p.Glu1004fs)	BRCA1	E1004fs, E957fs, E877fs, E892fs, E1003fs, E876fs, E934fs, E936fs, E962fs, E836fs, E893fs, E916fs, E937fs, E956fs, E1001fs, E708fs, E915fs, E933fs, E963fs, E977fs, E978fs	Hereditary breast ovarian cancer syndrome	VCV000960838	17	41244536 - 41244537	17	43092519 - 43092520	960838	949943	rs2053656452	NC_000017.11:43092518:CTC:C	Deletion	frameshift variant|intron variant	Pathogenic	Aug 14, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3009dup (p.Glu1004Ter)	BRCA1	E957*, E1004*, E1003*, E836*, E893*, E936*, E977*, E876*, E877*, E934*, E962*, E963*, E1001*, E892*, E915*, E916*, E956*, E978*, E708*, E933*, E937*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001798774	17	41244538 - 41244539	17	43092521 - 43092522	1798774	1856043	rs80357617	NC_000017.11:43092521:AAA:AAAA	Duplication	nonsense|intron variant|frameshift variant	Pathogenic	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3010G>T (p.Glu1004Ter)	BRCA1	E1004*, E957*, E1001*, E1003*, E963*, E836*, E916*, E936*, E956*, E978*, E708*, E876*, E893*, E915*, E933*, E934*, E977*, E877*, E892*, E937*, E962*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266328	17	41244538	17	43092521	266328	261773	rs786202534	NC_000017.11:43092520:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3006_3009del (p.Asn1002fs)	BRCA1	N1002fs, N955fs, N1001fs, N706fs, N874fs, N891fs, N914fs, N931fs, N934fs, N935fs, N999fs, N834fs, N890fs, N913fs, N960fs, N976fs, N875fs, N932fs, N954fs, N961fs, N975fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266327	17	41244539 - 41244542	17	43092522 - 43092525	266327	261774	rs886040092	NC_000017.11:43092521:AAAG:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3008_3009del (p.Asn1002_Phe1003insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054747	17	41244539 - 41244540	17	43092522 - 43092523	54747	69414	rs80357617	NC_000017.11:43092521:AAA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3005del (p.Asn1002fs)	BRCA1	N1002fs, N955fs, N834fs, N913fs, N1001fs, N874fs, N890fs, N934fs, N954fs, N961fs, N976fs, N914fs, N935fs, N975fs, N999fs, N706fs, N875fs, N891fs, N931fs, N932fs, N960fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017669	17	41244543	17	43092526	17669	32708	rs80357601	NC_000017.11:43092525:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.3001G>T (p.Glu1001Ter)	BRCA1	E1001*, E954*, E874*, E912*, E930*, E933*, E934*, E974*, E998*, E705*, E873*, E890*, E959*, E960*, E975*, E1000*, E833*, E913*, E953*, E889*, E931*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254422	17	41244547	17	43092530	254422	249121	rs886038007	NC_000017.11:43092529:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2999del (p.Glu1000fs)	BRCA1	E1000fs, E953fs, E832fs, E873fs, E911fs, E932fs, E933fs, E959fs, E704fs, E888fs, E889fs, E973fs, E912fs, E929fs, E930fs, E958fs, E872fs, E952fs, E974fs, E997fs, E999fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054744	17	41244549	17	43092532	54744	69411	rs80357991	NC_000017.11:43092531:T:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2995_2996delinsTA (p.Leu999Ter)	BRCA1	L999*, L952*, L871*, L928*, L932*, L972*, L998*, L703*, L872*, L957*, L973*, L831*, L910*, L911*, L929*, L951*, L958*, L996*, L887*, L888*, L931*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125597	17	41244552 - 41244553	17	43092535 - 43092536	125597	131135	rs273899692	NC_000017.11:43092534:AG:TA	Indel	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2989_2990dup (p.Asn997fs)	BRCA1	N997fs, N950fs, N869fs, N926fs, N929fs, N970fs, N885fs, N886fs, N927fs, N949fs, N956fs, N994fs, N701fs, N829fs, N909fs, N930fs, N870fs, N908fs, N955fs, N971fs, N996fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054738	17	41244557 - 41244558	17	43092540 - 43092541	54738	69405	rs80357829	NC_000017.11:43092540:TTTTT:TTTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2990del (p.Asn997fs)	BRCA1	N997fs, N950fs, N886fs, N908fs, N909fs, N926fs, N927fs, N971fs, N701fs, N869fs, N930fs, N970fs, N994fs, N870fs, N885fs, N929fs, N996fs, N829fs, N949fs, N955fs, N956fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054739	17	41244558	17	43092541	54739	69406	rs80357829	NC_000017.11:43092540:TTTTT:TTTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2974_2990del (p.Thr992fs)	BRCA1	T945fs, T992fs, T865fs, T881fs, T903fs, T904fs, T925fs, T989fs, T696fs, T864fs, T966fs, T991fs, T824fs, T922fs, T950fs, T951fs, T965fs, T880fs, T921fs, T924fs, T944fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054736	17	41244558 - 41244574	17	43092541 - 43092557	54736	69403	rs397509031	NC_000017.11:43092540:TTTTTCTTACATTTAGTTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2984del (p.Lys995fs)	BRCA1	K948fs, K995fs, K699fs, K867fs, K927fs, K947fs, K968fs, K969fs, K883fs, K884fs, K953fs, K868fs, K906fs, K907fs, K928fs, K827fs, K924fs, K925fs, K954fs, K992fs, K994fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000654333	17	41244564	17	43092547	654333	645992	rs1597866339	NC_000017.11:43092546:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jan 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2982_2983insGGTCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGAGGTCAGGNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAAAACTAAATGT (p.Lys995delinsGlyArgAlaArgTrpLeuThrProValIleProAlaLeuTrpGluAlaGluAlaGlyGlySerArgGlyGlnXaaXaaXaaXaaLysLysLysLysLysLysLysAsnTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002825624	17	41244565 - 41244566	17	43092548 - 43092549	2825624	2982857	rs2552178649		Insertion	nonsense|intron variant	Pathogenic	Jan 6, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2982dup (p.Lys995Ter)	BRCA1	K948*, K995*, K883*, K906*, K927*, K947*, K953*, K954*, K907*, K969*, K992*, K699*, K827*, K867*, K928*, K968*, K994*, K868*, K884*, K924*, K925*	Hereditary breast ovarian cancer syndrome	VCV001713247	17	41244565 - 41244566	17	43092548 - 43092549	1713247	1770760	rs2552178623	NC_000017.11:43092548:A:AA	Duplication	nonsense|intron variant	Pathogenic	Aug 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2983A>T (p.Lys995Ter)	BRCA1	K995*, K948*, K883*, K924*, K699*, K827*, K884*, K906*, K928*, K954*, K968*, K992*, K994*, K867*, K925*, K927*, K947*, K953*, K969*, K868*, K907*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252431	17	41244565	17	43092548	252431	246849	rs879255315	NC_000017.11:43092547:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2982T>A (p.Cys994Ter)	BRCA1	C698*, C906*, C924*, C927*, C947*, C952*, C953*, C967*, C994*, C867*, C882*, C905*, C926*, C968*, C993*, C826*, C866*, C883*, C923*, C946*, C991*	Hereditary cancer-predisposing syndrome	VCV001798415	17	41244566	17	43092549	1798415	1856555	rs2154349081	NC_000017.11:43092548:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 19, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2981_2982del (p.Lys993_Cys994insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037495	17	41244566 - 41244567	17	43092549 - 43092550	37495	46051	rs397507207	NC_000017.11:43092548:ACA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2981del (p.Cys994fs)	BRCA1	C994fs, C947fs, C924fs, C953fs, C993fs, C826fs, C923fs, C698fs, C882fs, C906fs, C952fs, C968fs, C866fs, C867fs, C883fs, C905fs, C926fs, C927fs, C946fs, C967fs, C991fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266326	17	41244567	17	43092550	266326	261775	rs886040091	NC_000017.11:43092549:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2980del (p.Cys994fs)	BRCA1	C994fs, C947fs, C698fs, C866fs, C883fs, C906fs, C923fs, C926fs, C946fs, C968fs, C991fs, C867fs, C882fs, C967fs, C905fs, C924fs, C927fs, C952fs, C953fs, C993fs, C826fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054737	17	41244568	17	43092551	54737	69404	rs80357502	NC_000017.11:43092550:A:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2979del (p.Lys993fs)	BRCA1	K923fs, K951fs, K866fs, K881fs, K925fs, K945fs, K946fs, K966fs, K990fs, K825fs, K905fs, K697fs, K865fs, K882fs, K904fs, K926fs, K952fs, K922fs, K967fs, K992fs, K993fs	Hereditary breast ovarian cancer syndrome	VCV002783313	17	41244569	17	43092552	2783313	2947912	rs34725869	NC_000017.11:43092551:TTT:TT	Deletion	intron variant|frameshift variant	Pathogenic	Jan 18, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2973_2979del (p.Lys991fs)	BRCA1	K991fs, K944fs, K823fs, K863fs, K902fs, K965fs, K988fs, K903fs, K920fs, K923fs, K949fs, K864fs, K880fs, K943fs, K990fs, K695fs, K879fs, K921fs, K924fs, K950fs, K964fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054735	17	41244569 - 41244575	17	43092552 - 43092558	54735	69402	rs397509030	NC_000017.11:43092551:TTTAGTTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2977A>T (p.Lys993Ter)	BRCA1	K866*, K881*, K882*, K904*, K926*, K992*, K865*, K905*, K922*, K946*, K966*, K967*, K990*, K993*, K925*, K697*, K825*, K923*, K945*, K951*, K952*	Hereditary breast ovarian cancer syndrome	VCV003663152	17	41244571	17	43092554	3663152	3801549		NC_000017.11:43092553:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 21, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2974del (p.Thr992fs)	BRCA1	T945fs, T992fs, T865fs, T880fs, T904fs, T922fs, T965fs, T696fs, T921fs, T966fs, T864fs, T903fs, T925fs, T944fs, T950fs, T989fs, T824fs, T881fs, T924fs, T951fs, T991fs	Hereditary breast ovarian cancer syndrome	VCV000853416	17	41244574	17	43092557	853416	845411	rs2053663370	NC_000017.11:43092556:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Jan 28, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2971A>T (p.Lys991Ter)	BRCA1	K991*, K944*, K823*, K864*, K879*, K921*, K924*, K863*, K880*, K903*, K965*, K695*, K920*, K923*, K950*, K964*, K990*, K902*, K943*, K949*, K988*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266325	17	41244577	17	43092560	266325	261776	rs886040090	NC_000017.11:43092559:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2967_2970del (p.Phe989fs)	BRCA1	F693fs, F821fs, F861fs, F862fs, F877fs, F878fs, F900fs, F901fs, F918fs, F919fs, F921fs, F922fs, F941fs, F942fs, F947fs, F948fs, F962fs, F963fs, F986fs, F988fs, F989fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002674418	17	41244578 - 41244581	17	43092561 - 43092564	2674418	2841904	rs2552179147	NC_000017.11:43092560:AACAAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Jul 6, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2970del (p.Thr992fs)	BRCA1	T945fs, T992fs, T865fs, T903fs, T904fs, T922fs, T989fs, T696fs, T824fs, T864fs, T880fs, T924fs, T925fs, T944fs, T881fs, T921fs, T950fs, T965fs, T951fs, T966fs, T991fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266324	17	41244578	17	43092561	266324	261777	rs886040089	NC_000017.11:43092560:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2964_2967del (p.Phe989fs)	BRCA1	F821fs, F862fs, F878fs, F918fs, F922fs, F941fs, F921fs, F942fs, F948fs, F988fs, F861fs, F900fs, F919fs, F693fs, F877fs, F901fs, F947fs, F962fs, F963fs, F986fs, F989fs	Hereditary breast ovarian cancer syndrome	VCV003685963	17	41244581 - 41244584	17	43092564 - 43092567	3685963	3816255		NC_000017.11:43092563:AAAT:	Deletion	intron variant|frameshift variant	Pathogenic	Nov 15, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2967del (p.Phe989fs)	BRCA1	F942fs, F989fs, F862fs, F900fs, F901fs, F693fs, F878fs, F918fs, F921fs, F922fs, F947fs, F962fs, F861fs, F877fs, F948fs, F821fs, F919fs, F941fs, F963fs, F988fs, F986fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054733	17	41244581	17	43092564	54733	69400	rs397509028	NC_000017.11:43092563:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2960_2964del (p.Lys987fs)	BRCA1	K940fs, K987fs, K876fs, K898fs, K919fs, K945fs, K946fs, K691fs, K819fs, K917fs, K920fs, K939fs, K960fs, K984fs, K875fs, K961fs, K986fs, K859fs, K860fs, K899fs, K916fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441377	17	41244584 - 41244588	17	43092567 - 43092571	441377	435143	rs1555588625	NC_000017.11:43092566:TGACTTGA:TGA	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2963C>G (p.Ser988Ter)	BRCA1	S860*, S861*, S917*, S920*, S940*, S941*, S962*, S985*, S988*, S820*, S876*, S877*, S899*, S900*, S918*, S692*, S921*, S987*, S946*, S947*, S961*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002565331	17	41244585	17	43092568	2565331	2732305	rs397507206	NC_000017.11:43092567:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2963C>A (p.Ser988Ter)	BRCA1	S988*, S941*, S876*, S899*, S900*, S961*, S692*, S860*, S861*, S940*, S985*, S820*, S877*, S917*, S918*, S920*, S921*, S946*, S947*, S962*, S987*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054732	17	41244585	17	43092568	54732	69399	rs397507206	NC_000017.11:43092567:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2961del (p.Lys987fs)	BRCA1	K940fs, K987fs, K860fs, K899fs, K917fs, K919fs, K946fs, K984fs, K691fs, K945fs, K986fs, K819fs, K859fs, K875fs, K898fs, K916fs, K920fs, K960fs, K961fs, K876fs, K939fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001798175	17	41244587	17	43092570	1798175	1853793	rs2552179573	NC_000017.11:43092569:C:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2960dup (p.Ser988fs)	BRCA1	S941fs, S988fs, S860fs, S861fs, S917fs, S921fs, S987fs, S899fs, S900fs, S918fs, S962fs, S877fs, S920fs, S961fs, S692fs, S820fs, S876fs, S940fs, S946fs, S947fs, S985fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266323	17	41244587 - 41244588	17	43092570 - 43092571	266323	261778	rs886040088	NC_000017.11:43092570:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2959A>T (p.Lys987Ter)	BRCA1	K987*, K940*, K691*, K919*, K920*, K939*, K945*, K946*, K860*, K819*, K875*, K898*, K916*, K917*, K961*, K986*, K859*, K876*, K899*, K960*, K984*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266322	17	41244589	17	43092572	266322	261779	rs878854941	NC_000017.11:43092571:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.3:c.2954_2958delins3	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267516	17	41244590 - 41244594	17	43092573 - 43092577	267516	262970			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2955dup (p.Ile986fs)	BRCA1	I818fs, I875fs, I897fs, I916fs, I919fs, I986fs, I858fs, I859fs, I918fs, I939fs, I915fs, I938fs, I945fs, I959fs, I983fs, I985fs, I690fs, I874fs, I898fs, I944fs, I960fs	Hereditary cancer-predisposing syndrome	VCV003992606	17	41244592 - 41244593	17	43092575 - 43092576	3992606	4104857		NC_000017.11:43092575:GGG:GGGG	Duplication	frameshift variant|intron variant	Pathogenic	Apr 21, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2955del (p.Ile986fs)	BRCA1	I939fs, I986fs, I874fs, I898fs, I944fs, I959fs, I690fs, I818fs, I915fs, I916fs, I938fs, I960fs, I985fs, I858fs, I859fs, I875fs, I897fs, I918fs, I919fs, I945fs, I983fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054731	17	41244593	17	43092576	54731	69398	rs397509027	NC_000017.11:43092575:GGG:GG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2952dup (p.Pro985fs)	BRCA1	P938fs, P985fs, P874fs, P918fs, P937fs, P944fs, P982fs, P817fs, P896fs, P914fs, P915fs, P958fs, P959fs, P689fs, P873fs, P943fs, P984fs, P857fs, P858fs, P897fs, P917fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054730	17	41244595 - 41244596	17	43092578 - 43092579	54730	69397	rs80357627	NC_000017.11:43092578:AAAAA:AAAAAA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2951_2952del (p.Phe984fs)	BRCA1	F937fs, F984fs, F688fs, F816fs, F873fs, F895fs, F914fs, F958fs, F983fs, F896fs, F913fs, F916fs, F936fs, F942fs, F857fs, F957fs, F856fs, F872fs, F917fs, F943fs, F981fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266321	17	41244596 - 41244597	17	43092579 - 43092580	266321	261780	rs80357627	NC_000017.11:43092578:AAAAA:AAA	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2952del (p.Ile986fs)	BRCA1	I939fs, I986fs, I858fs, I859fs, I916fs, I944fs, I945fs, I960fs, I875fs, I918fs, I919fs, I690fs, I818fs, I874fs, I897fs, I915fs, I959fs, I898fs, I938fs, I983fs, I985fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054729	17	41244596	17	43092579	54729	69396	rs80357627	NC_000017.11:43092578:AAAAA:AAAA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2947del (p.Leu983fs)	BRCA1	L936fs, L983fs, L687fs, L815fs, L871fs, L941fs, L980fs, L856fs, L894fs, L912fs, L935fs, L942fs, L855fs, L895fs, L916fs, L957fs, L982fs, L872fs, L913fs, L915fs, L956fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231349	17	41244601	17	43092584	231349	236045	rs876659108	NC_000017.11:43092583:G:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2945del (p.Pro982fs)	BRCA1	P982fs, P935fs, P854fs, P894fs, P855fs, P870fs, P871fs, P912fs, P934fs, P941fs, P955fs, P893fs, P911fs, P914fs, P915fs, P940fs, P979fs, P981fs, P686fs, P814fs, P956fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182109	17	41244603	17	43092586	182109	180848	rs730881461	NC_000017.11:43092585:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2938_2944del (p.Ile980fs)	BRCA1	I684fs, I812fs, I852fs, I853fs, I868fs, I869fs, I891fs, I892fs, I909fs, I910fs, I912fs, I913fs, I932fs, I933fs, I938fs, I939fs, I953fs, I954fs, I977fs, I979fs, I980fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573297	17	41244604 - 41244610	17	43092587 - 43092593	2573297	2738245	rs2552180314	NC_000017.11:43092586:GTGGTAT:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 23, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2943del (p.Pro982fs)	BRCA1	P870fs, P915fs, P934fs, P935fs, P955fs, P981fs, P686fs, P854fs, P941fs, P893fs, P894fs, P956fs, P979fs, P814fs, P855fs, P871fs, P911fs, P912fs, P914fs, P940fs, P982fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV003481855	17	41244605	17	43092588	3481855	3640066		NC_000017.11:43092587:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2940_2941insNNNNNNNNNNNNNNNN (p.Pro981fs)	BRCA1	P854fs, P870fs, P910fs, P913fs, P934fs, P853fs, P914fs, P933fs, P939fs, P954fs, P685fs, P892fs, P893fs, P911fs, P955fs, P978fs, P980fs, P813fs, P869fs, P940fs, P981fs	Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast	VCV003893006	17	41244607 - 41244608	17	43092590 - 43092591	3893006	4008890		NC_000017.11:43092590::NNNNNNNNNNNNNNNN	Insertion	intron variant|frameshift variant	Pathogenic	Jun 2, 2014	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2940del (p.Pro981fs)	BRCA1	P934fs, P981fs, P813fs, P892fs, P685fs, P854fs, P869fs, P853fs, P893fs, P910fs, P933fs, P940fs, P954fs, P978fs, P980fs, P870fs, P911fs, P913fs, P914fs, P939fs, P955fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091603	17	41244608	17	43092591	91603	97080	rs80357876	NC_000017.11:43092590:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2907_2938delinsCATGGAC (p.Lys970fs)	BRCA1	K923fs, K970fs, K802fs, K858fs, K859fs, K944fs, K881fs, K882fs, K899fs, K900fs, K943fs, K969fs, K674fs, K842fs, K903fs, K922fs, K843fs, K902fs, K928fs, K929fs, K967fs	Hereditary cancer-predisposing syndrome	VCV001797519	17	41244610 - 41244641	17	43092593 - 43092624	1797519	1854437	rs2552180629	NC_000017.11:43092592:TACGATATGGGTTTTGTAAAAGTCCATGTTTA:GTCCATG	Indel	frameshift variant|intron variant	Pathogenic	Mar 19, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2938del (p.Ile980fs)	BRCA1	I980fs, I933fs, I684fs, I853fs, I932fs, I939fs, I954fs, I979fs, I868fs, I869fs, I938fs, I977fs, I812fs, I891fs, I912fs, I953fs, I852fs, I892fs, I909fs, I910fs, I913fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182073	17	41244610	17	43092593	182073	180849	rs730881439	NC_000017.11:43092592:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2936del (p.Arg979fs)	BRCA1	R932fs, R979fs, R811fs, R852fs, R890fs, R911fs, R851fs, R867fs, R931fs, R938fs, R978fs, R683fs, R868fs, R937fs, R952fs, R891fs, R908fs, R909fs, R912fs, R953fs, R976fs	Hereditary breast ovarian cancer syndrome	VCV001362105	17	41244612	17	43092595	1362105	1376730	rs2154351661	NC_000017.11:43092594:C:	Deletion	frameshift variant|intron variant	Pathogenic	Nov 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2933_2934del (p.Tyr978fs)	BRCA1	Y682fs, Y810fs, Y850fs, Y851fs, Y866fs, Y867fs, Y889fs, Y890fs, Y907fs, Y908fs, Y910fs, Y911fs, Y930fs, Y931fs, Y936fs, Y937fs, Y951fs, Y952fs, Y975fs, Y977fs, Y978fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002573295	17	41244614 - 41244615	17	43092597 - 43092598	2573295	2738243	rs2552180801	NC_000017.11:43092596:ATAT:AT	Microsatellite	frameshift variant|intron variant	Pathogenic	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2934T>A (p.Tyr978Ter)	BRCA1	Y978*, Y931*, Y850*, Y889*, Y908*, Y930*, Y936*, Y952*, Y682*, Y810*, Y910*, Y975*, Y951*, Y851*, Y866*, Y867*, Y890*, Y907*, Y911*, Y937*, Y977*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431234	17	41244614	17	43092597	431234	424828	rs80357115	NC_000017.11:43092596:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2933dup (p.Tyr978Ter)	BRCA1	Y931*, Y978*, Y866*, Y810*, Y910*, Y930*, Y975*, Y682*, Y851*, Y867*, Y890*, Y907*, Y908*, Y911*, Y937*, Y951*, Y952*, Y977*, Y850*, Y889*, Y936*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236270	17	41244614 - 41244615	17	43092597 - 43092598	236270	237833	rs878853292	NC_000017.11:43092597:T:TT	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2934del (p.Arg979fs)	BRCA1	R979fs, R932fs, R811fs, R851fs, R909fs, R953fs, R683fs, R867fs, R908fs, R912fs, R952fs, R852fs, R891fs, R911fs, R931fs, R938fs, R976fs, R868fs, R890fs, R937fs, R978fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054726	17	41244614	17	43092597	54726	69393	rs80357741	NC_000017.11:43092596:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2934T>G (p.Tyr978Ter)	BRCA1	Y978*, Y931*, Y682*, Y911*, Y930*, Y937*, Y850*, Y867*, Y936*, Y951*, Y975*, Y851*, Y907*, Y910*, Y977*, Y810*, Y866*, Y889*, Y890*, Y908*, Y952*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037493	17	41244614	17	43092597	37493	46049	rs80357115	NC_000017.11:43092596:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2932dup (p.Tyr978fs)	BRCA1	Y682fs, Y810fs, Y850fs, Y910fs, Y931fs, Y951fs, Y851fs, Y867fs, Y889fs, Y911fs, Y930fs, Y978fs, Y866fs, Y907fs, Y977fs, Y890fs, Y908fs, Y936fs, Y937fs, Y952fs, Y975fs	Hereditary cancer-predisposing syndrome	VCV003825297	17	41244615 - 41244616	17	43092598 - 43092599	3825297	3942568		NC_000017.11:43092598:A:AA	Duplication	intron variant|frameshift variant	Pathogenic	Jan 23, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2929_2930dup (p.Tyr978fs)	BRCA1	Y978fs, Y931fs, Y682fs, Y810fs, Y867fs, Y910fs, Y911fs, Y937fs, Y975fs, Y890fs, Y907fs, Y930fs, Y866fs, Y936fs, Y952fs, Y977fs, Y850fs, Y851fs, Y889fs, Y908fs, Y951fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054723	17	41244617 - 41244618	17	43092600 - 43092601	54723	69390	rs397509025	NC_000017.11:43092600:GGG:GGGGG	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2930del (p.Pro977fs)	BRCA1	P977fs, P930fs, P866fs, P907fs, P929fs, P935fs, P976fs, P809fs, P849fs, P889fs, P906fs, P909fs, P951fs, P974fs, P888fs, P681fs, P850fs, P865fs, P910fs, P936fs, P950fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001797810	17	41244618	17	43092601	1797810	1853429	rs397509025	NC_000017.11:43092600:GGG:GG	Deletion	intron variant|frameshift variant	Pathogenic/Likely pathogenic	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2927del (p.Asn976fs)	BRCA1	N976fs, N929fs, N808fs, N888fs, N905fs, N908fs, N934fs, N935fs, N849fs, N864fs, N887fs, N909fs, N949fs, N950fs, N680fs, N848fs, N906fs, N975fs, N865fs, N928fs, N973fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254421	17	41244621	17	43092604	254421	249122	rs886038006	NC_000017.11:43092603:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2923C>T (p.Gln975Ter)	BRCA1	Q975*, Q928*, Q807*, Q887*, Q949*, Q974*, Q886*, Q904*, Q907*, Q679*, Q847*, Q848*, Q863*, Q864*, Q908*, Q927*, Q933*, Q934*, Q948*, Q972*, Q905*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054722	17	41244625	17	43092608	54722	69389	rs80357497	NC_000017.11:43092607:G:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2921dup (p.Leu974fs)	BRCA1	L974fs, L927fs, L847fs, L885fs, L903fs, L933fs, L948fs, L678fs, L862fs, L886fs, L904fs, L947fs, L971fs, L846fs, L926fs, L932fs, L806fs, L863fs, L906fs, L907fs, L973fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054721	17	41244626 - 41244627	17	43092609 - 43092610	54721	69388	rs80357611	NC_000017.11:43092609:AAAA:AAAAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2921del (p.Leu974fs)	BRCA1	L974fs, L927fs, L678fs, L846fs, L863fs, L885fs, L886fs, L933fs, L948fs, L971fs, L806fs, L906fs, L973fs, L903fs, L847fs, L862fs, L904fs, L907fs, L926fs, L932fs, L947fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000923350	17	41244627	17	43092610	923350	913908	rs80357611	NC_000017.11:43092609:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Apr 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2921T>A (p.Leu974Ter)	BRCA1	L974*, L927*, L678*, L903*, L971*, L886*, L932*, L973*, L847*, L863*, L906*, L926*, L947*, L948*, L806*, L846*, L862*, L885*, L904*, L907*, L933*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054719	17	41244627	17	43092610	54719	69386	rs80356872	NC_000017.11:43092609:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2920_2921del (p.Leu974fs)	BRCA1	L974fs, L927fs, L846fs, L907fs, L933fs, L947fs, L948fs, L971fs, L806fs, L862fs, L886fs, L903fs, L904fs, L885fs, L906fs, L973fs, L678fs, L847fs, L863fs, L926fs, L932fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054718	17	41244627 - 41244628	17	43092610 - 43092611	54718	69385	rs80357611	NC_000017.11:43092609:AAAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2917_2920del (p.Leu973fs)	BRCA1	L926fs, L973fs, L846fs, L972fs, L845fs, L885fs, L902fs, L905fs, L946fs, L805fs, L884fs, L906fs, L925fs, L931fs, L970fs, L677fs, L861fs, L862fs, L903fs, L932fs, L947fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266320	17	41244628 - 41244631	17	43092611 - 43092614	266320	261781	rs886040086	NC_000017.11:43092610:AAAG:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2915del (p.Gly972fs)	BRCA1	G972fs, G925fs, G676fs, G804fs, G883fs, G884fs, G860fs, G861fs, G905fs, G971fs, G845fs, G924fs, G930fs, G931fs, G945fs, G844fs, G901fs, G902fs, G904fs, G946fs, G969fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054716	17	41244633	17	43092616	54716	69383	rs80357573	NC_000017.11:43092615:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2914G>T (p.Gly972Ter)	BRCA1	G972*, G925*, G804*, G844*, G861*, G883*, G905*, G931*, G946*, G971*, G845*, G860*, G901*, G924*, G969*, G676*, G884*, G902*, G904*, G930*, G945*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054715	17	41244634	17	43092617	54715	69382	rs397509023	NC_000017.11:43092616:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2912_2913del (p.His971fs)	BRCA1	H924fs, H971fs, H904fs, H882fs, H883fs, H923fs, H929fs, H930fs, H970fs, H675fs, H859fs, H860fs, H900fs, H901fs, H945fs, H803fs, H843fs, H844fs, H903fs, H944fs, H968fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240783	17	41244635 - 41244636	17	43092618 - 43092619	240783	242790	rs878854940	NC_000017.11:43092617:AT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2905_2912del (p.Asn969fs)	BRCA1	N673fs, N801fs, N841fs, N842fs, N857fs, N858fs, N880fs, N881fs, N898fs, N899fs, N901fs, N902fs, N921fs, N922fs, N927fs, N928fs, N942fs, N943fs, N966fs, N968fs, N969fs	Hereditary breast ovarian cancer syndrome|not provided	VCV002690553	17	41244636 - 41244643	17	43092619 - 43092626	2690553	2851586	rs2552181197	NC_000017.11:43092618:TGTTTATTTG:TG	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	May 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2910dup (p.His971fs)	BRCA1	H924fs, H971fs, H675fs, H882fs, H900fs, H901fs, H904fs, H860fs, H903fs, H923fs, H930fs, H944fs, H970fs, H803fs, H844fs, H859fs, H929fs, H968fs, H843fs, H883fs, H945fs	Hereditary breast ovarian cancer syndrome	VCV001420054	17	41244637 - 41244638	17	43092620 - 43092621	1420054	1245667	rs80357893	NC_000017.11:43092620:TTT:TTTT	Duplication	intron variant|frameshift variant	Pathogenic	Oct 23, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2907_2910del (p.Lys970fs)	BRCA1	K843fs, K902fs, K922fs, K969fs, K802fs, K858fs, K903fs, K928fs, K929fs, K842fs, K859fs, K881fs, K882fs, K900fs, K923fs, K943fs, K674fs, K899fs, K944fs, K967fs, K970fs	Hereditary breast ovarian cancer syndrome	VCV003656677	17	41244638 - 41244641	17	43092621 - 43092624	3656677	3789533		NC_000017.11:43092620:TTTATTT:TTT	Deletion	intron variant|frameshift variant	Pathogenic	Jun 17, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2910del (p.Lys970fs)	BRCA1	K923fs, K970fs, K944fs, K967fs, K843fs, K859fs, K881fs, K969fs, K802fs, K882fs, K899fs, K900fs, K674fs, K842fs, K858fs, K902fs, K903fs, K922fs, K928fs, K929fs, K943fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054713	17	41244638	17	43092621	54713	69380	rs80357893	NC_000017.11:43092620:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2906_2908delinsCT (p.Asn969fs)	BRCA1	N922fs, N969fs, N857fs, N880fs, N943fs, N858fs, N901fs, N902fs, N928fs, N673fs, N842fs, N881fs, N899fs, N921fs, N966fs, N968fs, N801fs, N841fs, N898fs, N927fs, N942fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266318	17	41244640 - 41244642	17	43092623 - 43092625	266318	261782	rs886040084	NC_000017.11:43092622:TAT:AG	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2907del (p.Asn969fs)	BRCA1	N922fs, N969fs, N858fs, N880fs, N901fs, N927fs, N928fs, N942fs, N673fs, N921fs, N801fs, N857fs, N898fs, N943fs, N966fs, N968fs, N841fs, N842fs, N881fs, N899fs, N902fs	Hereditary cancer-predisposing syndrome	VCV000821961	17	41244641	17	43092624	821961	813768	rs1597866816	NC_000017.11:43092623:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 22, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2906del (p.Asn969fs)	BRCA1	N969fs, N922fs, N801fs, N858fs, N899fs, N921fs, N881fs, N943fs, N966fs, N968fs, N841fs, N842fs, N902fs, N927fs, N942fs, N673fs, N857fs, N880fs, N898fs, N901fs, N928fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266319	17	41244642	17	43092625	266319	261783	rs886040085	NC_000017.11:43092624:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2904_2905insTC (p.Asn969fs)	BRCA1	N969fs, N922fs, N841fs, N842fs, N880fs, N881fs, N898fs, N942fs, N943fs, N857fs, N858fs, N901fs, N902fs, N927fs, N966fs, N968fs, N673fs, N801fs, N899fs, N921fs, N928fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548247	17	41244643 - 41244644	17	43092626 - 43092627	548247	538827	rs1555588752	NC_000017.11:43092626::GA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2903dup (p.Asn969fs)	BRCA1	N969fs, N922fs, N898fs, N968fs, N673fs, N801fs, N841fs, N899fs, N943fs, N857fs, N880fs, N902fs, N921fs, N928fs, N942fs, N966fs, N842fs, N858fs, N881fs, N901fs, N927fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548203	17	41244644 - 41244645	17	43092627 - 43092628	548203	538828	rs1555588756	NC_000017.11:43092627:GG:GGG	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2903_2904insTC (p.Asn969fs)	BRCA1	N922fs, N969fs, N880fs, N943fs, N966fs, N673fs, N857fs, N858fs, N921fs, N928fs, N942fs, N801fs, N841fs, N842fs, N901fs, N902fs, N927fs, N881fs, N898fs, N899fs, N968fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266317	17	41244644 - 41244645	17	43092627 - 43092628	266317	261784	rs886040083	NC_000017.11:43092627:G:GAG	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2901_2902dup (p.Pro968fs)	BRCA1	P921fs, P968fs, P856fs, P857fs, P879fs, P897fs, P920fs, P967fs, P672fs, P900fs, P941fs, P840fs, P841fs, P880fs, P926fs, P965fs, P800fs, P898fs, P901fs, P927fs, P942fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091602	17	41244645 - 41244646	17	43092628 - 43092629	91602	97079	rs398122670	NC_000017.11:43092628:GAG:GAGAG	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2899dup (p.Thr967fs)	BRCA1	T920fs, T967fs, T799fs, T839fs, T840fs, T879fs, T899fs, T940fs, T964fs, T856fs, T896fs, T897fs, T900fs, T919fs, T671fs, T878fs, T925fs, T926fs, T855fs, T941fs, T966fs	Hereditary breast ovarian cancer syndrome	VCV001072656	17	41244648 - 41244649	17	43092631 - 43092632	1072656	1064206	rs2154353615	NC_000017.11:43092631:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Jun 28, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2898del (p.Thr967fs)	BRCA1	T967fs, T920fs, T941fs, T966fs, T799fs, T855fs, T897fs, T925fs, T926fs, T940fs, T671fs, T878fs, T879fs, T896fs, T900fs, T919fs, T839fs, T840fs, T856fs, T899fs, T964fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254420	17	41244650	17	43092633	254420	249123	rs886038005	NC_000017.11:43092632:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2896_2897del (p.Ile966fs)	BRCA1	I919fs, I966fs, I670fs, I855fs, I924fs, I925fs, I878fs, I896fs, I854fs, I895fs, I898fs, I939fs, I940fs, I798fs, I838fs, I839fs, I877fs, I899fs, I918fs, I963fs, I965fs	Hereditary breast ovarian cancer syndrome	VCV001367224	17	41244651 - 41244652	17	43092634 - 43092635	1367224	1245794	rs1567793812	NC_000017.11:43092633:AT:	Deletion	frameshift variant|intron variant	Pathogenic	May 12, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2890G>T (p.Gly964Ter)	BRCA1	G964*, G917*, G836*, G852*, G893*, G937*, G796*, G916*, G961*, G963*, G837*, G853*, G875*, G876*, G894*, G938*, G668*, G896*, G897*, G922*, G923*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266316	17	41244658	17	43092641	266316	261785	rs879254027	NC_000017.11:43092640:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2889_2890del (p.Gly964fs)	BRCA1	G964fs, G917fs, G668fs, G853fs, G896fs, G897fs, G963fs, G852fs, G875fs, G876fs, G893fs, G937fs, G796fs, G894fs, G916fs, G922fs, G836fs, G837fs, G923fs, G938fs, G961fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125595	17	41244658 - 41244659	17	43092641 - 43092642	125595	131133	rs80357890	NC_000017.11:43092640:CA:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2884_2888del (p.Glu962fs)	BRCA1	E666fs, E794fs, E834fs, E835fs, E850fs, E851fs, E873fs, E874fs, E891fs, E892fs, E894fs, E895fs, E914fs, E915fs, E920fs, E921fs, E935fs, E936fs, E959fs, E961fs, E962fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573247	17	41244660 - 41244664	17	43092643 - 43092647	2573247	2738195	rs2552181746	NC_000017.11:43092642:GTTTCGTT:GTT	Deletion	frameshift variant|intron variant	Pathogenic	Mar 23, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2887del (p.Thr963fs)	BRCA1	T916fs, T963fs, T835fs, T852fs, T896fs, T936fs, T851fs, T893fs, T922fs, T960fs, T836fs, T875fs, T895fs, T937fs, T962fs, T667fs, T795fs, T874fs, T892fs, T915fs, T921fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054710	17	41244661	17	43092644	54710	69377	rs80357559	NC_000017.11:43092643:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2880_2884del (p.Glu962fs)	BRCA1	E851fs, E873fs, E874fs, E891fs, E892fs, E894fs, E895fs, E914fs, E915fs, E920fs, E921fs, E935fs, E936fs, E959fs, E961fs, E962fs, E666fs, E794fs, E834fs, E835fs, E850fs	Hereditary breast ovarian cancer syndrome	VCV003902402	17	41244664 - 41244668	17	43092647 - 43092651	3902402	4018272		NC_000017.11:43092646:CGTTGC:C	Deletion	frameshift variant|intron variant	Pathogenic	May 29, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2882del (p.Asn961fs)	BRCA1	N914fs, N961fs, N834fs, N894fs, N919fs, N665fs, N793fs, N850fs, N872fs, N920fs, N935fs, N960fs, N833fs, N873fs, N890fs, N891fs, N913fs, N934fs, N958fs, N849fs, N893fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266315	17	41244666	17	43092649	266315	261786	rs886040082	NC_000017.11:43092648:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2880dup (p.Asn961fs)	BRCA1	N665fs, N793fs, N833fs, N834fs, N849fs, N850fs, N872fs, N873fs, N890fs, N891fs, N893fs, N894fs, N913fs, N914fs, N919fs, N920fs, N934fs, N935fs, N958fs, N960fs, N961fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003379245	17	41244667 - 41244668	17	43092650 - 43092651	3379245	3538424		NC_000017.11:43092650:G:GG	Duplication	frameshift variant|intron variant	Pathogenic	Jul 18, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2879del (p.Gly960fs)	BRCA1	G664fs, G792fs, G832fs, G833fs, G848fs, G849fs, G871fs, G872fs, G889fs, G890fs, G892fs, G893fs, G912fs, G913fs, G918fs, G919fs, G933fs, G934fs, G957fs, G959fs, G960fs	Hereditary cancer-predisposing syndrome	VCV003226124	17	41244669	17	43092652	3226124	3387188	rs2552181944	NC_000017.11:43092651:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 5, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2878_2879del (p.Gly960fs)	BRCA1	G960fs, G913fs, G849fs, G664fs, G792fs, G833fs, G848fs, G890fs, G893fs, G918fs, G959fs, G871fs, G889fs, G892fs, G912fs, G933fs, G832fs, G872fs, G919fs, G934fs, G957fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266314	17	41244669 - 41244670	17	43092652 - 43092653	266314	261787	rs886040081	NC_000017.11:43092651:CC:	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2872_2876del (p.Phe958fs)	BRCA1	F911fs, F958fs, F790fs, F831fs, F887fs, F916fs, F917fs, F957fs, F662fs, F910fs, F846fs, F869fs, F888fs, F890fs, F955fs, F830fs, F847fs, F870fs, F891fs, F931fs, F932fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054707	17	41244672 - 41244676	17	43092655 - 43092659	54707	69374	rs397509021	NC_000017.11:43092654:CTGAACTGA:CTGA	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2875A>T (p.Arg959Ter)	BRCA1	R959*, R912*, R791*, R831*, R888*, R918*, R933*, R958*, R848*, R891*, R892*, R956*, R832*, R889*, R917*, R932*, R663*, R847*, R870*, R871*, R911*	not provided	VCV000545978	17	41244673	17	43092656	545978	536493	rs1401324575	NC_000017.11:43092655:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 15, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2875del (p.Arg959fs)	BRCA1	R959fs, R912fs, R791fs, R832fs, R889fs, R933fs, R870fs, R891fs, R892fs, R932fs, R958fs, R888fs, R917fs, R918fs, R956fs, R663fs, R831fs, R847fs, R848fs, R871fs, R911fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266313	17	41244673	17	43092656	266313	261788	rs886040080	NC_000017.11:43092655:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2872_2873insA (p.Phe958fs)	BRCA1	F911fs, F958fs, F662fs, F831fs, F910fs, F932fs, F887fs, F916fs, F955fs, F957fs, F790fs, F846fs, F870fs, F890fs, F891fs, F917fs, F830fs, F847fs, F869fs, F888fs, F931fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548231	17	41244675 - 41244676	17	43092658 - 43092659	548231	538829	rs1555588803	NC_000017.11:43092658::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2871_2872insA (p.Phe958fs)	BRCA1	F911fs, F958fs, F662fs, F846fs, F910fs, F830fs, F847fs, F887fs, F917fs, F931fs, F790fs, F869fs, F888fs, F890fs, F891fs, F932fs, F831fs, F870fs, F916fs, F955fs, F957fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125594	17	41244676 - 41244677	17	43092659 - 43092660	125594	131132	rs80357693	NC_000017.11:43092659::T	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2870dup (p.Phe958fs)	BRCA1	F958fs, F911fs, F662fs, F831fs, F869fs, F910fs, F932fs, F957fs, F830fs, F891fs, F931fs, F846fs, F847fs, F887fs, F890fs, F916fs, F790fs, F870fs, F888fs, F917fs, F955fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054705	17	41244677 - 41244678	17	43092660 - 43092661	54705	69372	rs397509020	NC_000017.11:43092660:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2866_2870del (p.Ser956fs)	BRCA1	S956fs, S909fs, S828fs, S888fs, S914fs, S953fs, S660fs, S844fs, S845fs, S867fs, S908fs, S930fs, S868fs, S885fs, S915fs, S788fs, S829fs, S886fs, S889fs, S929fs, S955fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054702	17	41244678 - 41244682	17	43092661 - 43092665	54702	69369	rs80357819	NC_000017.11:43092660:TGAGATGA:TGA	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2868_2869del (p.Gln957fs)	BRCA1	Q661fs, Q789fs, Q829fs, Q830fs, Q845fs, Q846fs, Q868fs, Q869fs, Q886fs, Q887fs, Q889fs, Q890fs, Q909fs, Q910fs, Q915fs, Q916fs, Q930fs, Q931fs, Q954fs, Q956fs, Q957fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573288	17	41244679 - 41244680	17	43092662 - 43092663	2573288	2738236	rs2552182200	NC_000017.11:43092661:GAGA:GA	Microsatellite	frameshift variant|intron variant	Pathogenic	Feb 8, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2869C>T (p.Gln957Ter)	BRCA1	Q957*, Q910*, Q789*, Q886*, Q830*, Q846*, Q868*, Q915*, Q916*, Q956*, Q829*, Q869*, Q889*, Q930*, Q931*, Q954*, Q661*, Q845*, Q887*, Q890*, Q909*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054703	17	41244679	17	43092662	54703	69370	rs80356973	NC_000017.11:43092661:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2868del (p.Gln957fs)	BRCA1	Q910fs, Q957fs, Q830fs, Q868fs, Q890fs, Q931fs, Q829fs, Q845fs, Q846fs, Q869fs, Q886fs, Q915fs, Q916fs, Q954fs, Q789fs, Q889fs, Q661fs, Q887fs, Q909fs, Q930fs, Q956fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125593	17	41244680	17	43092663	125593	131131	rs80357929	NC_000017.11:43092662:A:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2866dup (p.Ser956fs)	BRCA1	S956fs, S909fs, S829fs, S867fs, S868fs, S885fs, S888fs, S929fs, S788fs, S660fs, S845fs, S886fs, S915fs, S828fs, S955fs, S844fs, S889fs, S908fs, S914fs, S930fs, S953fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548249	17	41244681 - 41244682	17	43092664 - 43092665	548249	538830	rs1555588822	NC_000017.11:43092664:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2865del (p.Ser956fs)	BRCA1	S909fs, S956fs, S868fs, S955fs, S660fs, S829fs, S845fs, S886fs, S888fs, S930fs, S788fs, S828fs, S867fs, S915fs, S929fs, S844fs, S885fs, S889fs, S908fs, S914fs, S953fs	Hereditary breast ovarian cancer syndrome	VCV000649129	17	41244683	17	43092666	649129	645997	rs1597867163	NC_000017.11:43092665:T:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 15, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2864_2865insT (p.Ser956fs)	BRCA1	S909fs, S956fs, S788fs, S868fs, S886fs, S914fs, S660fs, S867fs, S885fs, S908fs, S915fs, S953fs, S828fs, S829fs, S844fs, S845fs, S888fs, S889fs, S929fs, S955fs, S930fs	Hereditary breast ovarian cancer syndrome	VCV000037492	17	41244683 - 41244684	17	43092666 - 43092667	37492	46048	rs397507205	NC_000017.11:43092666::A	Insertion	frameshift variant|intron variant	Pathogenic	Aug 11, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2860_2864del (p.Leu954fs)	BRCA1	L907fs, L954fs, L826fs, L827fs, L842fs, L865fs, L912fs, L951fs, L843fs, L866fs, L883fs, L884fs, L887fs, L906fs, L658fs, L786fs, L913fs, L928fs, L886fs, L927fs, L953fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000801067	17	41244684 - 41244688	17	43092667 - 43092671	801067	789625	rs1597867185	NC_000017.11:43092666:GATAG:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2864C>G (p.Ser955Ter)	BRCA1	S955*, S908*, S659*, S827*, S866*, S884*, S928*, S929*, S787*, S828*, S954*, S843*, S844*, S867*, S885*, S887*, S888*, S914*, S907*, S913*, S952*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266312	17	41244684	17	43092667	266312	261789	rs80357295	NC_000017.11:43092666:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2861_2864del (p.Leu954fs)	BRCA1	L907fs, L954fs, L883fs, L884fs, L886fs, L887fs, L927fs, L906fs, L912fs, L928fs, L953fs, L658fs, L786fs, L842fs, L843fs, L866fs, L913fs, L951fs, L826fs, L827fs, L865fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266310	17	41244684 - 41244687	17	43092667 - 43092670	266310	261790	rs886040078	NC_000017.11:43092666:GATAGA:GA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2864C>A (p.Ser955Ter)	BRCA1	S955*, S908*, S827*, S866*, S884*, S787*, S844*, S907*, S914*, S928*, S659*, S828*, S929*, S952*, S843*, S867*, S885*, S887*, S888*, S913*, S954*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054701	17	41244684	17	43092667	54701	69368	rs80357295	NC_000017.11:43092666:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2861dup (p.Ser955fs)	BRCA1	S908fs, S955fs, S659fs, S843fs, S867fs, S914fs, S787fs, S827fs, S828fs, S866fs, S884fs, S887fs, S907fs, S952fs, S954fs, S888fs, S928fs, S929fs, S844fs, S885fs, S913fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266311	17	41244686 - 41244687	17	43092669 - 43092670	266311	261791	rs886040079	NC_000017.11:43092669:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2861del (p.Leu954fs)	BRCA1	L907fs, L954fs, L843fs, L865fs, L887fs, L913fs, L927fs, L928fs, L953fs, L658fs, L826fs, L827fs, L886fs, L786fs, L842fs, L866fs, L883fs, L884fs, L906fs, L912fs, L951fs	Hereditary cancer-predisposing syndrome	VCV000821916	17	41244687	17	43092670	821916	813773	rs1597867214	NC_000017.11:43092669:A:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 5, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2857dup (p.Cys953fs)	BRCA1	C842fs, C865fs, C952fs, C953fs, C785fs, C883fs, C905fs, C911fs, C912fs, C926fs, C657fs, C826fs, C841fs, C864fs, C886fs, C825fs, C882fs, C885fs, C906fs, C927fs, C950fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV003656797	17	41244690 - 41244691	17	43092673 - 43092674	3656797	3789653		NC_000017.11:43092673:AAAA:AAAAA	Duplication	frameshift variant|intron variant	Pathogenic	May 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2857del (p.Cys953fs)	BRCA1	C906fs, C953fs, C842fs, C885fs, C952fs, C826fs, C864fs, C911fs, C657fs, C785fs, C825fs, C882fs, C886fs, C912fs, C926fs, C927fs, C841fs, C865fs, C883fs, C905fs, C950fs	not provided|Hereditary cancer-predisposing syndrome	VCV001696794	17	41244691	17	43092674	1696794	1689192	rs397509019	NC_000017.11:43092673:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2856_2857del (p.Phe952fs)	BRCA1	F952fs, F905fs, F825fs, F863fs, F864fs, F911fs, F656fs, F840fs, F881fs, F884fs, F885fs, F904fs, F949fs, F910fs, F926fs, F784fs, F824fs, F841fs, F882fs, F925fs, F951fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054700	17	41244691 - 41244692	17	43092674 - 43092675	54700	69367	rs397509019	NC_000017.11:43092673:AAAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2853_2854insA (p.Phe952fs)	BRCA1	F784fs, F840fs, F841fs, F864fs, F882fs, F885fs, F905fs, F925fs, F952fs, F656fs, F904fs, F911fs, F926fs, F949fs, F824fs, F825fs, F863fs, F881fs, F884fs, F910fs, F951fs	Hereditary breast ovarian cancer syndrome	VCV003661517	17	41244694 - 41244695	17	43092677 - 43092678	3661517	3801196		NC_000017.11:43092677::T	Insertion	frameshift variant|intron variant	Pathogenic	Aug 6, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2853del (p.Arg951fs)	BRCA1	R655fs, R783fs, R823fs, R824fs, R839fs, R840fs, R862fs, R863fs, R880fs, R881fs, R883fs, R884fs, R903fs, R904fs, R909fs, R910fs, R924fs, R925fs, R948fs, R950fs, R951fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003338381	17	41244695	17	43092678	3338381	3497042		NC_000017.11:43092677:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Jul 17, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2844_2853del (p.Gly949fs)	BRCA1	G902fs, G949fs, G821fs, G837fs, G838fs, G860fs, G879fs, G901fs, G861fs, G878fs, G908fs, G923fs, G881fs, G882fs, G907fs, G922fs, G946fs, G653fs, G781fs, G822fs, G948fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054698	17	41244695 - 41244704	17	43092678 - 43092687	54698	69365	rs397509017	NC_000017.11:43092677:CCTAGAGCCTCCT:CCT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2851_2852insC (p.Arg951fs)	BRCA1	R951fs, R904fs, R824fs, R840fs, R863fs, R883fs, R910fs, R948fs, R783fs, R903fs, R924fs, R925fs, R655fs, R823fs, R839fs, R880fs, R884fs, R950fs, R862fs, R881fs, R909fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548166	17	41244696 - 41244697	17	43092679 - 43092680	548166	538831	rs1555588844	NC_000017.11:43092679::G	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2850dup (p.Arg951Ter)	BRCA1	R904*, R951*, R783*, R824*, R903*, R948*, R655*, R839*, R840*, R862*, R863*, R881*, R884*, R910*, R924*, R883*, R925*, R950*, R823*, R880*, R909*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266309	17	41244697 - 41244698	17	43092680 - 43092681	266309	261793	rs1555588846	NC_000017.11:43092680:A:AA	Duplication	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2850_2851insC (p.Arg951fs)	BRCA1	R904fs, R951fs, R862fs, R909fs, R783fs, R823fs, R839fs, R863fs, R880fs, R884fs, R924fs, R925fs, R948fs, R950fs, R655fs, R824fs, R903fs, R910fs, R840fs, R881fs, R883fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266308	17	41244697 - 41244698	17	43092680 - 43092681	266308	261792	rs886040077	NC_000017.11:43092680::G	Insertion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2845_2849del (p.Gly948_Gly949insTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV002585824	17	41244699 - 41244703	17	43092682 - 43092686	2585824	2753384	rs2552182707	NC_000017.11:43092681:GAGCC:	Deletion	nonsense|intron variant	Pathogenic	Jul 20, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2848dup (p.Ser950fs)	BRCA1	S903fs, S950fs, S924fs, S822fs, S861fs, S862fs, S879fs, S883fs, S909fs, S654fs, S782fs, S838fs, S880fs, S882fs, S947fs, S823fs, S839fs, S902fs, S908fs, S923fs, S949fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054699	17	41244699 - 41244700	17	43092682 - 43092683	54699	69366	rs397509018	NC_000017.11:43092682:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2844_2845del (p.Gly949fs)	BRCA1	G653fs, G781fs, G821fs, G822fs, G837fs, G838fs, G860fs, G861fs, G878fs, G879fs, G881fs, G882fs, G901fs, G902fs, G907fs, G908fs, G922fs, G923fs, G946fs, G948fs, G949fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002680225	17	41244703 - 41244704	17	43092686 - 43092687	2680225	2833953	rs2552182764	NC_000017.11:43092685:CTC:C	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2843del (p.Gly948fs)	BRCA1	G901fs, G948fs, G780fs, G820fs, G836fs, G652fs, G821fs, G837fs, G859fs, G900fs, G945fs, G860fs, G878fs, G906fs, G907fs, G921fs, G947fs, G877fs, G880fs, G881fs, G922fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266307	17	41244705	17	43092688	266307	261794	rs886040076	NC_000017.11:43092687:CC:C	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2840_2841del (p.Lys947fs)	BRCA1	K900fs, K947fs, K858fs, K877fs, K899fs, K651fs, K819fs, K835fs, K836fs, K876fs, K920fs, K921fs, K946fs, K779fs, K820fs, K859fs, K879fs, K880fs, K905fs, K944fs, K906fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054697	17	41244707 - 41244708	17	43092690 - 43092691	54697	69364	rs80357984	NC_000017.11:43092689:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2839A>T (p.Lys947Ter)	BRCA1	K947*, K900*, K779*, K820*, K877*, K879*, K899*, K944*, K651*, K836*, K858*, K859*, K906*, K920*, K946*, K876*, K921*, K819*, K835*, K880*, K905*	Hereditary cancer-predisposing syndrome	VCV000821794	17	41244709	17	43092692	821794	813774	rs1597867344	NC_000017.11:43092691:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Apr 9, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2837_2838delinsA (p.Ile946fs)	BRCA1	I899fs, I946fs, I819fs, I857fs, I878fs, I898fs, I905fs, I945fs, I650fs, I834fs, I835fs, I858fs, I904fs, I919fs, I875fs, I879fs, I920fs, I943fs, I778fs, I818fs, I876fs	Hereditary cancer-predisposing syndrome	VCV001796650	17	41244710 - 41244711	17	43092693 - 43092694	1796650	1855225	rs2552182879	NC_000017.11:43092692:GA:T	Indel	frameshift variant|intron variant	Pathogenic	Apr 23, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2831_2837del (p.Cys944fs)	BRCA1	C897fs, C944fs, C816fs, C832fs, C877fs, C903fs, C917fs, C941fs, C648fs, C817fs, C856fs, C874fs, C918fs, C776fs, C855fs, C873fs, C876fs, C902fs, C943fs, C833fs, C896fs	Hereditary breast ovarian cancer syndrome	VCV001432534	17	41244711 - 41244717	17	43092694 - 43092700	1432534	1480789	rs2154356972	NC_000017.11:43092693:ATACTACAT:AT	Deletion	frameshift variant|intron variant	Pathogenic	Nov 25, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2836_2837del (p.Ile946fs)	BRCA1	I946fs, I899fs, I778fs, I818fs, I819fs, I834fs, I879fs, I920fs, I650fs, I835fs, I875fs, I876fs, I878fs, I904fs, I857fs, I858fs, I905fs, I919fs, I898fs, I943fs, I945fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054696	17	41244711 - 41244712	17	43092694 - 43092695	54696	69363	rs397509016	NC_000017.11:43092693:ATA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2835_2836insCC (p.Ile946fs)	BRCA1	I946fs, I899fs, I819fs, I835fs, I858fs, I875fs, I876fs, I879fs, I778fs, I857fs, I878fs, I898fs, I919fs, I945fs, I650fs, I920fs, I943fs, I818fs, I834fs, I904fs, I905fs	Hereditary breast ovarian cancer syndrome	VCV000645289	17	41244712 - 41244713	17	43092695 - 43092696	645289	645999	rs1597867385	NC_000017.11:43092695::GG	Insertion	frameshift variant|intron variant	Pathogenic	Nov 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2835dup (p.Ile946fs)	BRCA1	I899fs, I946fs, I819fs, I835fs, I875fs, I818fs, I876fs, I905fs, I919fs, I920fs, I945fs, I834fs, I858fs, I878fs, I879fs, I898fs, I650fs, I778fs, I857fs, I904fs, I943fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054695	17	41244712 - 41244713	17	43092695 - 43092696	54695	69362	rs80357519	NC_000017.11:43092695:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2834_2836delinsC (p.Ser945fs)	BRCA1	S898fs, S945fs, S817fs, S818fs, S857fs, S875fs, S897fs, S919fs, S942fs, S874fs, S877fs, S903fs, S918fs, S649fs, S834fs, S856fs, S944fs, S777fs, S833fs, S878fs, S904fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054694	17	41244712 - 41244714	17	43092695 - 43092697	54694	69361	rs386134270	NC_000017.11:43092694:TAC:G	Indel	intron variant|frameshift variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2831_2835del (p.Cys944fs)	BRCA1	C897fs, C944fs, C816fs, C903fs, C917fs, C943fs, C776fs, C817fs, C832fs, C874fs, C876fs, C902fs, C918fs, C648fs, C833fs, C855fs, C856fs, C873fs, C896fs, C941fs, C877fs	Hereditary cancer-predisposing syndrome	VCV001796594	17	41244713 - 41244717	17	43092696 - 43092700	1796594	1855169	rs2552182964	NC_000017.11:43092695:ACTACA:A	Deletion	frameshift variant|intron variant	Pathogenic	Nov 14, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2834_2835del (p.Ser945fs)	BRCA1	S945fs, S898fs, S777fs, S875fs, S897fs, S942fs, S834fs, S856fs, S874fs, S878fs, S904fs, S649fs, S817fs, S818fs, S833fs, S857fs, S877fs, S944fs, S903fs, S918fs, S919fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054692	17	41244713 - 41244714	17	43092696 - 43092697	54692	69359	rs397509015	NC_000017.11:43092695:AC:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2832_2833dup (p.Ser945fs)	BRCA1	S777fs, S817fs, S818fs, S857fs, S833fs, S856fs, S878fs, S897fs, S942fs, S944fs, S649fs, S834fs, S898fs, S903fs, S919fs, S874fs, S875fs, S877fs, S904fs, S918fs, S945fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003148677	17	41244714 - 41244715	17	43092697 - 43092698	3148677	3307925	rs2552182990	NC_000017.11:43092697:TA:TATA	Duplication	intron variant|frameshift variant	Pathogenic	Jan 16, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2833del (p.Ser945fs)	BRCA1	S898fs, S945fs, S649fs, S833fs, S856fs, S875fs, S877fs, S919fs, S944fs, S817fs, S818fs, S857fs, S903fs, S942fs, S777fs, S874fs, S878fs, S904fs, S918fs, S834fs, S897fs	Hereditary cancer-predisposing syndrome	VCV001796615	17	41244715	17	43092698	1796615	1855190	rs2552182985	NC_000017.11:43092697:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 9, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2832T>A (p.Cys944Ter)	BRCA1	C944*, C897*, C832*, C873*, C917*, C941*, C833*, C874*, C918*, C943*, C648*, C855*, C856*, C876*, C877*, C896*, C903*, C776*, C816*, C817*, C902*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054691	17	41244716	17	43092699	54691	69358	rs80357458	NC_000017.11:43092698:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2820_2830delinsAAGATAAGCCAGTTTGATAA (p.Asp940_Cys944delinsGluArgTer)	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000479217	17	41244718 - 41244728	17	43092701 - 43092711	479217	478616	rs1555588883	NC_000017.11:43092700:ATTTGGCATTA:TTATCAAACTGGCTTATCTT	Indel	nonsense|intron variant	Pathogenic	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2830del (p.Cys944fs)	BRCA1	C944fs, C897fs, C648fs, C856fs, C917fs, C833fs, C874fs, C943fs, C776fs, C816fs, C817fs, C855fs, C873fs, C877fs, C902fs, C918fs, C941fs, C832fs, C876fs, C896fs, C903fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054690	17	41244718	17	43092701	54690	69357	rs397509014	NC_000017.11:43092700:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2829del (p.Lys943fs)	BRCA1	K647fs, K816fs, K854fs, K875fs, K895fs, K940fs, K943fs, K855fs, K896fs, K832fs, K872fs, K873fs, K901fs, K902fs, K916fs, K917fs, K942fs, K775fs, K815fs, K831fs, K876fs	Hereditary cancer-predisposing syndrome	VCV003825281	17	41244719	17	43092702	3825281	3942553		NC_000017.11:43092701:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 18, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2815_2827del (p.Val939fs)	BRCA1	V892fs, V939fs, V828fs, V872fs, V936fs, V643fs, V771fs, V811fs, V827fs, V851fs, V891fs, V812fs, V869fs, V897fs, V912fs, V913fs, V938fs, V850fs, V868fs, V871fs, V898fs	Hereditary cancer-predisposing syndrome	VCV000927262	17	41244721 - 41244733	17	43092704 - 43092716	927262	913912	rs2053690127	NC_000017.11:43092703:TGGCATTATCAACTGGC:TGGC	Deletion	frameshift variant|intron variant	Pathogenic	Feb 18, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2823del (p.Asn941fs)	BRCA1	N894fs, N941fs, N645fs, N773fs, N871fs, N873fs, N830fs, N853fs, N893fs, N900fs, N940fs, N813fs, N814fs, N852fs, N874fs, N899fs, N915fs, N829fs, N870fs, N914fs, N938fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266306	17	41244725	17	43092708	266306	261795	rs886040075	NC_000017.11:43092707:A:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2817del (p.Asp940fs)	BRCA1	D644fs, D772fs, D812fs, D813fs, D828fs, D829fs, D851fs, D852fs, D869fs, D870fs, D872fs, D873fs, D892fs, D893fs, D898fs, D899fs, D913fs, D914fs, D937fs, D939fs, D940fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002680221	17	41244731	17	43092714	2680221	2833949	rs2552183224	NC_000017.11:43092713:AA:A	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Sep 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2814del (p.Val939fs)	BRCA1	V892fs, V939fs, V812fs, V828fs, V851fs, V898fs, V936fs, V643fs, V811fs, V868fs, V869fs, V912fs, V827fs, V850fs, V871fs, V872fs, V891fs, V771fs, V897fs, V913fs, V938fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266305	17	41244734	17	43092717	266305	261796	rs886040074	NC_000017.11:43092716:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2812_2813delinsG (p.Pro938fs)	BRCA1	P891fs, P938fs, P811fs, P867fs, P890fs, P935fs, P827fs, P849fs, P912fs, P642fs, P868fs, P896fs, P897fs, P911fs, P937fs, P770fs, P810fs, P826fs, P850fs, P870fs, P871fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054687	17	41244735 - 41244736	17	43092718 - 43092719	54687	69354	rs273899689	NC_000017.11:43092717:GG:C	Indel	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2812_2813del (p.Pro938fs)	BRCA1	P891fs, P938fs, P826fs, P849fs, P896fs, P912fs, P937fs, P642fs, P850fs, P867fs, P870fs, P811fs, P827fs, P871fs, P890fs, P770fs, P810fs, P868fs, P897fs, P911fs, P935fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054686	17	41244735 - 41244736	17	43092718 - 43092719	54686	69353	rs730882056	NC_000017.11:43092717:GG:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2808_2812del (p.Lys937fs)	BRCA1	K890fs, K937fs, K848fs, K866fs, K911fs, K936fs, K641fs, K826fs, K869fs, K870fs, K895fs, K809fs, K810fs, K849fs, K889fs, K896fs, K934fs, K769fs, K825fs, K867fs, K910fs	Hereditary breast ovarian cancer syndrome	VCV002078457	17	41244736 - 41244740	17	43092719 - 43092723	2078457	2134987	rs2552183398	NC_000017.11:43092718:GCTTA:	Deletion	intron variant|frameshift variant	Pathogenic	Jan 11, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2808_2811del (p.Lys937fs)	BRCA1	K890fs, K937fs, K641fs, K867fs, K869fs, K889fs, K934fs, K849fs, K866fs, K911fs, K936fs, K769fs, K825fs, K848fs, K870fs, K809fs, K810fs, K826fs, K895fs, K896fs, K910fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054685	17	41244737 - 41244740	17	43092720 - 43092723	54685	69352	rs397509013	NC_000017.11:43092719:CTTA:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2809A>T (p.Lys937Ter)	BRCA1	K937*, K890*, K810*, K848*, K870*, K896*, K934*, K641*, K849*, K825*, K866*, K889*, K910*, K911*, K769*, K809*, K826*, K867*, K869*, K895*, K936*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000438921	17	41244739	17	43092722	438921	432908	rs1555588915	NC_000017.11:43092721:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2806_2809del (p.Asp936fs)	BRCA1	D936fs, D889fs, D847fs, D866fs, D868fs, D808fs, D809fs, D825fs, D865fs, D894fs, D909fs, D935fs, D768fs, D895fs, D910fs, D640fs, D824fs, D848fs, D869fs, D888fs, D933fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037491	17	41244739 - 41244742	17	43092722 - 43092725	37491	46047	rs80357832	NC_000017.11:43092721:TATCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2806_2807del (p.Lys935_Asp936insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254419	17	41244741 - 41244742	17	43092724 - 43092725	254419	249124	rs886038004	NC_000017.11:43092723:TCT:T	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2805dup (p.Asp936fs)	BRCA1	D889fs, D936fs, D808fs, D825fs, D869fs, D888fs, D640fs, D848fs, D866fs, D868fs, D910fs, D933fs, D768fs, D824fs, D909fs, D935fs, D809fs, D847fs, D865fs, D894fs, D895fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236269	17	41244742 - 41244743	17	43092725 - 43092726	236269	237834	rs397509012	NC_000017.11:43092725:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2805del (p.Asp936fs)	BRCA1	D889fs, D936fs, D808fs, D809fs, D825fs, D888fs, D895fs, D768fs, D847fs, D848fs, D865fs, D910fs, D640fs, D824fs, D869fs, D894fs, D909fs, D933fs, D935fs, D866fs, D868fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054684	17	41244743	17	43092726	54684	69351	rs397509012	NC_000017.11:43092725:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2802del (p.Asp936fs)	BRCA1	D936fs, D889fs, D768fs, D847fs, D888fs, D895fs, D824fs, D825fs, D865fs, D868fs, D869fs, D909fs, D910fs, D640fs, D808fs, D809fs, D848fs, D894fs, D935fs, D866fs, D933fs	Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000837250	17	41244746	17	43092729	837250	845414	rs2053694038	NC_000017.11:43092728:C:	Deletion	frameshift variant|intron variant	Pathogenic	May 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2800C>T (p.Gln934Ter)	BRCA1	Q934*, Q887*, Q807*, Q822*, Q864*, Q867*, Q907*, Q638*, Q823*, Q863*, Q892*, Q766*, Q846*, Q866*, Q893*, Q931*, Q933*, Q806*, Q845*, Q886*, Q908*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054683	17	41244748	17	43092731	54683	69350	rs80357223	NC_000017.11:43092730:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2799del (p.Gln934fs)	BRCA1	Q887fs, Q934fs, Q638fs, Q807fs, Q823fs, Q846fs, Q886fs, Q931fs, Q766fs, Q845fs, Q867fs, Q908fs, Q806fs, Q822fs, Q866fs, Q907fs, Q863fs, Q864fs, Q892fs, Q893fs, Q933fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125590	17	41244749	17	43092732	125590	131128	rs80357998	NC_000017.11:43092731:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2798_2799del (p.Gly933fs)	BRCA1	G933fs, G886fs, G805fs, G806fs, G822fs, G845fs, G863fs, G885fs, G765fs, G821fs, G930fs, G637fs, G844fs, G862fs, G892fs, G865fs, G866fs, G891fs, G906fs, G907fs, G932fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054682	17	41244749 - 41244750	17	43092732 - 43092733	54682	69349	rs397509011	NC_000017.11:43092731:AC:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2796_2799del (p.Gly933fs)	BRCA1	G886fs, G933fs, G765fs, G805fs, G822fs, G863fs, G865fs, G637fs, G845fs, G862fs, G866fs, G885fs, G892fs, G806fs, G907fs, G930fs, G932fs, G821fs, G844fs, G891fs, G906fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054681	17	41244749 - 41244752	17	43092732 - 43092735	54681	69348	rs80357840	NC_000017.11:43092731:ACCAACCA:ACCA	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2796del (p.Gly933fs)	BRCA1	G933fs, G886fs, G822fs, G891fs, G906fs, G932fs, G765fs, G845fs, G862fs, G865fs, G866fs, G892fs, G637fs, G805fs, G806fs, G844fs, G863fs, G907fs, G821fs, G885fs, G930fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441384	17	41244752	17	43092735	441384	435144	rs1555588942	NC_000017.11:43092734:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2794del (p.Val932fs)	BRCA1	V821fs, V884fs, V932fs, V636fs, V764fs, V820fs, V843fs, V885fs, V891fs, V929fs, V931fs, V804fs, V844fs, V865fs, V890fs, V906fs, V805fs, V861fs, V862fs, V864fs, V905fs	Hereditary breast ovarian cancer syndrome	VCV002836879	17	41244754	17	43092737	2836879	2999258	rs2552183662	NC_000017.11:43092736:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Feb 14, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2770_2792del (p.Asn924fs)	BRCA1	N877fs, N924fs, N812fs, N813fs, N856fs, N857fs, N923fs, N628fs, N835fs, N853fs, N876fs, N882fs, N796fs, N897fs, N898fs, N756fs, N797fs, N836fs, N854fs, N883fs, N921fs	Hereditary cancer-predisposing syndrome	VCV001795804	17	41244756 - 41244778	17	43092739 - 43092761	1795804	1853163	rs2552183680	NC_000017.11:43092738:ACAGGAAAGCCTGCAGTGATATTA:A	Deletion	frameshift variant|intron variant	Pathogenic	Aug 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2788_2789insTTATCACTGCAGGCTTT (p.Pro930fs)	BRCA1	P883fs, P930fs, P803fs, P842fs, P859fs, P863fs, P904fs, P841fs, P860fs, P862fs, P889fs, P927fs, P762fs, P802fs, P818fs, P634fs, P819fs, P882fs, P888fs, P903fs, P929fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548241	17	41244759 - 41244760	17	43092742 - 43092743	548241	538832	rs1555588952	NC_000017.11:43092742::AAAGCCTGCAGTGATAA	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2785_2788del (p.Phe929fs)	BRCA1	F761fs, F858fs, F861fs, F887fs, F818fs, F840fs, F888fs, F902fs, F926fs, F633fs, F802fs, F841fs, F881fs, F882fs, F928fs, F801fs, F817fs, F859fs, F862fs, F903fs, F929fs	Hereditary breast ovarian cancer syndrome	VCV003641635	17	41244760 - 41244763	17	43092743 - 43092746	3641635	3775792		NC_000017.11:43092742:GAAAG:G	Deletion	frameshift variant|intron variant	Pathogenic	Feb 17, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2787_2788insTTATCACTGCAGGCTTT (p.Pro930fs)	BRCA1	P883fs, P930fs, P634fs, P802fs, P842fs, P860fs, P862fs, P889fs, P904fs, P818fs, P819fs, P841fs, P882fs, P929fs, P803fs, P859fs, P863fs, P888fs, P903fs, P762fs, P927fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266304	17	41244760 - 41244761	17	43092743 - 43092744	266304	261797	rs886040073	NC_000017.11:43092743:AAAGCCTGCAGTGATA:AAAGCCTGCAGTGATAAAAAGCCTGCAGTGATA	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2787del (p.Pro930fs)	BRCA1	P883fs, P930fs, P803fs, P842fs, P634fs, P818fs, P860fs, P863fs, P882fs, P904fs, P762fs, P841fs, P859fs, P903fs, P929fs, P802fs, P819fs, P862fs, P888fs, P889fs, P927fs	Hereditary breast ovarian cancer syndrome	VCV001075264	17	41244761	17	43092744	1075264	1064207	rs2154359567	NC_000017.11:43092743:AAA:AA	Deletion	intron variant|frameshift variant	Pathogenic	Jan 21, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2783del (p.Gly928fs)	BRCA1	G881fs, G928fs, G817fs, G840fs, G858fs, G860fs, G880fs, G632fs, G800fs, G886fs, G887fs, G927fs, G760fs, G839fs, G857fs, G861fs, G902fs, G925fs, G801fs, G816fs, G901fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000422164	17	41244765	17	43092748	422164	409990	rs1064795600	NC_000017.11:43092747:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2778_2779insAT (p.Ala927fs)	BRCA1	A927fs, A880fs, A759fs, A839fs, A885fs, A631fs, A799fs, A815fs, A857fs, A926fs, A886fs, A800fs, A838fs, A856fs, A859fs, A879fs, A924fs, A816fs, A860fs, A900fs, A901fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548208	17	41244769 - 41244770	17	43092752 - 43092753	548208	538833	rs886040072	NC_000017.11:43092752:A:ATA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2778dup (p.Ala927fs)	BRCA1	A927fs, A880fs, A799fs, A815fs, A838fs, A860fs, A885fs, A886fs, A926fs, A631fs, A800fs, A759fs, A839fs, A879fs, A900fs, A816fs, A856fs, A857fs, A859fs, A901fs, A924fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266303	17	41244769 - 41244770	17	43092752 - 43092753	266303	261798	rs886040072	NC_000017.11:43092752:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2776_2777insTA (p.Thr926fs)	BRCA1	T879fs, T926fs, T798fs, T799fs, T859fs, T884fs, T815fs, T837fs, T856fs, T858fs, T885fs, T899fs, T900fs, T925fs, T814fs, T838fs, T630fs, T758fs, T855fs, T878fs, T923fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266302	17	41244771 - 41244772	17	43092754 - 43092755	266302	261800	rs886040071	NC_000017.11:43092754:T:TAT	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2776_2777del (p.Thr926fs)	BRCA1	T879fs, T926fs, T814fs, T855fs, T885fs, T630fs, T758fs, T837fs, T856fs, T878fs, T798fs, T799fs, T859fs, T925fs, T815fs, T838fs, T858fs, T884fs, T899fs, T900fs, T923fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266301	17	41244771 - 41244772	17	43092754 - 43092755	266301	261799	rs886040070	NC_000017.11:43092753:GTG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2773_2774del (p.Ile925fs)	BRCA1	I797fs, I837fs, I854fs, I857fs, I898fs, I757fs, I798fs, I813fs, I877fs, I884fs, I629fs, I855fs, I878fs, I899fs, I922fs, I924fs, I814fs, I836fs, I858fs, I883fs, I925fs	Hereditary breast ovarian cancer syndrome	VCV002763690	17	41244774 - 41244775	17	43092757 - 43092758	2763690	2925729	rs2552183886	NC_000017.11:43092756:ATAT:AT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 27, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2774del (p.Ile925fs)	BRCA1	I878fs, I925fs, I836fs, I855fs, I857fs, I899fs, I757fs, I837fs, I883fs, I884fs, I922fs, I797fs, I813fs, I854fs, I858fs, I629fs, I798fs, I814fs, I877fs, I898fs, I924fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091601	17	41244774	17	43092757	91601	97078	rs398122669	NC_000017.11:43092756:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2771_2772insC (p.Ile925fs)	BRCA1	I878fs, I925fs, I798fs, I813fs, I814fs, I858fs, I899fs, I757fs, I877fs, I883fs, I898fs, I924fs, I836fs, I854fs, I855fs, I629fs, I797fs, I837fs, I857fs, I884fs, I922fs	Hereditary cancer-predisposing syndrome	VCV001795812	17	41244776 - 41244777	17	43092759 - 43092760	1795812	1853171	rs2552183902	NC_000017.11:43092759::G	Insertion	frameshift variant|intron variant	Pathogenic	Jul 28, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2767_2770del (p.Val923fs)	BRCA1	V876fs, V923fs, V811fs, V812fs, V875fs, V896fs, V897fs, V755fs, V835fs, V853fs, V627fs, V795fs, V852fs, V855fs, V856fs, V881fs, V922fs, V796fs, V834fs, V882fs, V920fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054678	17	41244778 - 41244781	17	43092761 - 43092764	54678	69345	rs80357661	NC_000017.11:43092760:TAACT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2764_2767del (p.Thr922fs)	BRCA1	T922fs, T875fs, T754fs, T851fs, T880fs, T881fs, T919fs, T794fs, T852fs, T854fs, T874fs, T921fs, T626fs, T795fs, T810fs, T811fs, T834fs, T855fs, T833fs, T895fs, T896fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054675	17	41244781 - 41244784	17	43092764 - 43092767	54675	69342	rs80357822	NC_000017.11:43092763:CTGTCTGT:CTGT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2766del (p.Val923fs)	BRCA1	V876fs, V923fs, V755fs, V795fs, V834fs, V835fs, V875fs, V882fs, V897fs, V920fs, V922fs, V853fs, V627fs, V796fs, V812fs, V852fs, V855fs, V881fs, V811fs, V856fs, V896fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054677	17	41244782	17	43092765	54677	69344	rs80357812	NC_000017.11:43092764:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2762del (p.Gln921fs)	BRCA1	Q921fs, Q874fs, Q793fs, Q809fs, Q832fs, Q853fs, Q854fs, Q873fs, Q918fs, Q753fs, Q794fs, Q851fs, Q880fs, Q895fs, Q625fs, Q850fs, Q879fs, Q920fs, Q810fs, Q833fs, Q894fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054674	17	41244786	17	43092769	54674	69341	rs80357703	NC_000017.11:43092768:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2761C>T (p.Gln921Ter)	BRCA1	Q921*, Q874*, Q810*, Q854*, Q873*, Q880*, Q753*, Q809*, Q851*, Q853*, Q625*, Q832*, Q894*, Q895*, Q918*, Q793*, Q794*, Q833*, Q850*, Q879*, Q920*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054673	17	41244787	17	43092770	54673	69340	rs80357377	NC_000017.11:43092769:G:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2760del (p.Gln921fs)	BRCA1	Q921fs, Q874fs, Q793fs, Q850fs, Q854fs, Q753fs, Q853fs, Q879fs, Q918fs, Q794fs, Q832fs, Q833fs, Q873fs, Q880fs, Q920fs, Q625fs, Q809fs, Q810fs, Q851fs, Q894fs, Q895fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000422417	17	41244788	17	43092771	422417	409991	rs1064795769	NC_000017.11:43092770:T:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2755_2756insGGGTG (p.Pro919fs)	BRCA1	P919fs, P872fs, P830fs, P848fs, P849fs, P851fs, P918fs, P623fs, P751fs, P791fs, P808fs, P831fs, P852fs, P871fs, P893fs, P792fs, P807fs, P877fs, P878fs, P892fs, P916fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548274	17	41244792 - 41244793	17	43092775 - 43092776	548274	538834	rs1555589008	NC_000017.11:43092775::CACCC	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2754_2755insGGGTG (p.Pro919fs)	BRCA1	P919fs, P872fs, P623fs, P751fs, P807fs, P808fs, P831fs, P852fs, P892fs, P791fs, P830fs, P848fs, P851fs, P877fs, P878fs, P893fs, P792fs, P871fs, P916fs, P918fs, P849fs	not provided	VCV000418838	17	41244793 - 41244794	17	43092776 - 43092777	418838	409992	rs1064793468	NC_000017.11:43092776:C:CACCCC	Insertion	frameshift variant|intron variant	Pathogenic	Nov 26, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2753_2755delinsCA (p.Lys918fs)	BRCA1	K871fs, K918fs, K791fs, K806fs, K848fs, K876fs, K917fs, K622fs, K847fs, K850fs, K877fs, K915fs, K830fs, K870fs, K891fs, K892fs, K750fs, K790fs, K807fs, K829fs, K851fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266300	17	41244793 - 41244795	17	43092776 - 43092778	266300	261801	rs886040069	NC_000017.11:43092775:GCT:TG	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2749_2752delinsTC (p.Ile917fs)	BRCA1	I805fs, I828fs, I829fs, I847fs, I849fs, I850fs, I875fs, I917fs, I789fs, I790fs, I846fs, I876fs, I914fs, I916fs, I749fs, I806fs, I870fs, I890fs, I891fs, I621fs, I869fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003148655	17	41244796 - 41244799	17	43092779 - 43092782	3148655	3307903	rs2552184121	NC_000017.11:43092778:TGAT:GA	Indel	frameshift variant|intron variant	Pathogenic	Dec 21, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2745_2751dup (p.Lys918Ter)	BRCA1	K750*, K790*, K806*, K829*, K870*, K891*, K622*, K791*, K847*, K876*, K918*, K848*, K850*, K851*, K915*, K807*, K830*, K871*, K877*, K892*, K917*	Hereditary cancer-predisposing syndrome	VCV002565330	17	41244796 - 41244797	17	43092779 - 43092780	2565330	2732304	rs2552184147	NC_000017.11:43092779:GATATTAGA:GATATTAGATATTAGA	Duplication	nonsense|intron variant|frameshift variant	Pathogenic	Mar 27, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2751del (p.Lys918fs)	BRCA1	K918fs, K871fs, K790fs, K877fs, K915fs, K917fs, K791fs, K829fs, K847fs, K848fs, K870fs, K622fs, K750fs, K806fs, K807fs, K830fs, K850fs, K851fs, K876fs, K891fs, K892fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266299	17	41244797	17	43092780	266299	261802	rs886040068	NC_000017.11:43092779:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2740_2750del (p.Glu914fs)	BRCA1	E867fs, E914fs, E825fs, E826fs, E888fs, E786fs, E802fs, E803fs, E844fs, E846fs, E872fs, E887fs, E911fs, E618fs, E746fs, E843fs, E847fs, E866fs, E787fs, E873fs, E913fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000630808	17	41244798 - 41244808	17	43092781 - 43092791	630808	618630	rs1567794393	NC_000017.11:43092780:ATATTAGACTCAT:AT	Deletion	frameshift variant|intron variant	Pathogenic	Feb 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2750del (p.Ile917fs)	BRCA1	I870fs, I917fs, I789fs, I790fs, I805fs, I846fs, I849fs, I890fs, I891fs, I621fs, I806fs, I847fs, I869fs, I876fs, I916fs, I749fs, I828fs, I829fs, I850fs, I875fs, I914fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266298	17	41244798	17	43092781	266298	261803	rs886040067	NC_000017.11:43092780:A:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2749dup (p.Ile917fs)	BRCA1	I870fs, I917fs, I805fs, I828fs, I847fs, I849fs, I869fs, I621fs, I829fs, I846fs, I876fs, I749fs, I789fs, I806fs, I890fs, I916fs, I790fs, I850fs, I875fs, I891fs, I914fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054670	17	41244798 - 41244799	17	43092781 - 43092782	54670	69337	rs80357942	NC_000017.11:43092781:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2748del (p.Asn916fs)	BRCA1	N869fs, N916fs, N804fs, N828fs, N846fs, N874fs, N748fs, N788fs, N789fs, N827fs, N889fs, N890fs, N913fs, N845fs, N848fs, N849fs, N868fs, N620fs, N805fs, N875fs, N915fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091599	17	41244800	17	43092783	91599	97076	rs398122667	NC_000017.11:43092782:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2745dup (p.Asn916Ter)	BRCA1	N869*, N916*, N804*, N805*, N875*, N889*, N846*, N868*, N890*, N789*, N827*, N845*, N913*, N620*, N748*, N788*, N828*, N848*, N849*, N874*, N915*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054669	17	41244802 - 41244803	17	43092785 - 43092786	54669	69336	rs397509008	NC_000017.11:43092785:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2744_2745del (p.Glu914_Ser915insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054668	17	41244803 - 41244804	17	43092786 - 43092787	54668	69335	rs80357540	NC_000017.11:43092785:AGA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2740G>T (p.Glu914Ter)	BRCA1	E914*, E867*, E786*, E803*, E826*, E846*, E866*, E887*, E618*, E746*, E787*, E825*, E872*, E873*, E844*, E847*, E888*, E911*, E802*, E843*, E913*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054667	17	41244808	17	43092791	54667	69334	rs80357419	NC_000017.11:43092790:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2735_2738del (p.Lys912fs)	BRCA1	K865fs, K912fs, K616fs, K784fs, K823fs, K841fs, K845fs, K800fs, K824fs, K842fs, K864fs, K871fs, K870fs, K885fs, K744fs, K785fs, K801fs, K844fs, K886fs, K909fs, K911fs	Hereditary breast ovarian cancer syndrome	VCV001074746	17	41244810 - 41244813	17	43092793 - 43092796	1074746	1064208	rs2154362073	NC_000017.11:43092792:TTCTTTC:TTC	Deletion	frameshift variant|intron variant	Pathogenic	Dec 5, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2727_2730del (p.Asn909fs)	BRCA1	N862fs, N909fs, N781fs, N798fs, N839fs, N842fs, N906fs, N908fs, N820fs, N838fs, N861fs, N867fs, N868fs, N613fs, N797fs, N821fs, N883fs, N741fs, N782fs, N841fs, N882fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054661	17	41244818 - 41244821	17	43092801 - 43092804	54661	69328	rs80357605	NC_000017.11:43092800:TTGATT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2726_2730del (p.Asn909fs)	BRCA1	N909fs, N862fs, N781fs, N782fs, N798fs, N820fs, N867fs, N821fs, N908fs, N741fs, N797fs, N838fs, N842fs, N882fs, N906fs, N613fs, N839fs, N841fs, N861fs, N868fs, N883fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054658	17	41244818 - 41244822	17	43092801 - 43092805	54658	69325	rs80357712	NC_000017.11:43092800:TTGATTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2728del (p.Gln910fs)	BRCA1	Q910fs, Q863fs, Q614fs, Q821fs, Q868fs, Q884fs, Q742fs, Q798fs, Q799fs, Q842fs, Q862fs, Q907fs, Q782fs, Q783fs, Q822fs, Q869fs, Q909fs, Q839fs, Q840fs, Q843fs, Q883fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054663	17	41244820	17	43092803	54663	69330	rs397509005	NC_000017.11:43092802:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2728C>T (p.Gln910Ter)	BRCA1	Q910*, Q863*, Q840*, Q862*, Q868*, Q783*, Q842*, Q883*, Q909*, Q798*, Q799*, Q614*, Q821*, Q822*, Q843*, Q907*, Q742*, Q782*, Q839*, Q869*, Q884*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054662	17	41244820	17	43092803	54662	69329	rs397509004	NC_000017.11:43092802:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2726dup (p.Asn909fs)	BRCA1	N862fs, N909fs, N613fs, N782fs, N798fs, N820fs, N821fs, N883fs, N741fs, N838fs, N867fs, N882fs, N839fs, N842fs, N906fs, N908fs, N781fs, N797fs, N841fs, N861fs, N868fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054660	17	41244821 - 41244822	17	43092804 - 43092805	54660	69327	rs80357614	NC_000017.11:43092804:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2726del (p.Asn909fs)	BRCA1	N909fs, N862fs, N613fs, N782fs, N797fs, N839fs, N842fs, N867fs, N741fs, N821fs, N838fs, N883fs, N906fs, N882fs, N781fs, N798fs, N820fs, N841fs, N861fs, N868fs, N908fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054659	17	41244822	17	43092805	54659	69326	rs80357614	NC_000017.11:43092804:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2722G>T (p.Glu908Ter)	BRCA1	E908*, E861*, E740*, E781*, E837*, E840*, E907*, E796*, E819*, E820*, E866*, E867*, E882*, E905*, E780*, E797*, E841*, E860*, E612*, E838*, E881*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054657	17	41244826	17	43092809	54657	69324	rs80356978	NC_000017.11:43092808:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2719_2722del (p.Glu907fs)	BRCA1	E860fs, E907fs, E880fs, E780fs, E795fs, E837fs, E904fs, E611fs, E840fs, E865fs, E866fs, E906fs, E739fs, E779fs, E796fs, E818fs, E819fs, E836fs, E839fs, E859fs, E881fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054656	17	41244826 - 41244829	17	43092809 - 43092812	54656	69323	rs80357731	NC_000017.11:43092808:CTTCCTT:CTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2719del (p.Glu907fs)	BRCA1	E860fs, E907fs, E739fs, E779fs, E880fs, E906fs, E611fs, E780fs, E818fs, E836fs, E840fs, E881fs, E795fs, E796fs, E837fs, E859fs, E865fs, E904fs, E819fs, E839fs, E866fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252870	17	41244829	17	43092812	252870	247271	rs879255481	NC_000017.11:43092811:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2719G>T (p.Glu907Ter)	BRCA1	E907*, E860*, E611*, E739*, E795*, E839*, E865*, E906*, E780*, E796*, E818*, E819*, E836*, E837*, E859*, E779*, E840*, E866*, E880*, E881*, E904*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230485	17	41244829	17	43092812	230485	236061	rs876658593	NC_000017.11:43092811:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2717_2718del (p.Lys906fs)	BRCA1	K859fs, K906fs, K610fs, K794fs, K817fs, K836fs, K838fs, K864fs, K865fs, K903fs, K738fs, K835fs, K839fs, K905fs, K778fs, K818fs, K858fs, K879fs, K880fs, K779fs, K795fs	Hereditary breast ovarian cancer syndrome	VCV001455805	17	41244830 - 41244831	17	43092813 - 43092814	1455805	1380065	rs2154363046	NC_000017.11:43092812:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 12, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2717del (p.Lys906fs)	BRCA1	K859fs, K906fs, K794fs, K839fs, K864fs, K905fs, K795fs, K817fs, K818fs, K879fs, K610fs, K738fs, K779fs, K835fs, K865fs, K880fs, K903fs, K778fs, K836fs, K838fs, K858fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231289	17	41244831	17	43092814	231289	236062	rs876659072	NC_000017.11:43092813:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2713C>T (p.Gln905Ter)	BRCA1	Q905*, Q858*, Q793*, Q794*, Q837*, Q878*, Q609*, Q778*, Q817*, Q838*, Q902*, Q835*, Q857*, Q864*, Q879*, Q737*, Q777*, Q816*, Q834*, Q863*, Q904*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054655	17	41244835	17	43092818	54655	69322	rs397509002	NC_000017.11:43092817:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2710del (p.Glu904fs)	BRCA1	E904fs, E857fs, E792fs, E833fs, E834fs, E856fs, E608fs, E793fs, E815fs, E837fs, E736fs, E862fs, E901fs, E903fs, E776fs, E777fs, E816fs, E836fs, E863fs, E877fs, E878fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266297	17	41244838	17	43092821	266297	261805	rs886040066	NC_000017.11:43092820:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2709_2710del (p.Cys903_Glu904delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266296	17	41244838 - 41244839	17	43092821 - 43092822	266296	261804	rs886040065	NC_000017.11:43092820:CACA:CA	Microsatellite	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2710G>T (p.Glu904Ter)	BRCA1	E904*, E857*, E736*, E776*, E836*, E862*, E901*, E903*, E792*, E793*, E816*, E856*, E863*, E877*, E833*, E878*, E608*, E777*, E815*, E834*, E837*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037484	17	41244838	17	43092821	37484	46040	rs80357035	NC_000017.11:43092820:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2709T>A (p.Cys903Ter)	BRCA1	C903*, C856*, C607*, C735*, C814*, C815*, C862*, C877*, C900*, C776*, C861*, C876*, C775*, C791*, C792*, C833*, C902*, C832*, C835*, C836*, C855*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000495221	17	41244839	17	43092822	495221	486720	rs1555589094	NC_000017.11:43092821:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2709del (p.Cys903fs)	BRCA1	C903fs, C856fs, C792fs, C833fs, C862fs, C607fs, C776fs, C832fs, C836fs, C877fs, C902fs, C775fs, C814fs, C815fs, C861fs, C876fs, C900fs, C735fs, C791fs, C835fs, C855fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054654	17	41244839	17	43092822	54654	69321	rs80357594	NC_000017.11:43092821:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2706_2707dup (p.Cys903fs)	BRCA1	C856fs, C903fs, C832fs, C835fs, C877fs, C792fs, C833fs, C836fs, C876fs, C607fs, C735fs, C791fs, C814fs, C855fs, C861fs, C900fs, C775fs, C776fs, C815fs, C862fs, C902fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037483	17	41244840 - 41244841	17	43092823 - 43092824	37483	46039	rs80357717	NC_000017.11:43092823:AT:ATAT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2707del (p.Cys903fs)	BRCA1	C856fs, C903fs, C776fs, C792fs, C815fs, C902fs, C832fs, C861fs, C862fs, C877fs, C900fs, C607fs, C735fs, C775fs, C791fs, C814fs, C833fs, C835fs, C836fs, C855fs, C876fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000421037	17	41244841	17	43092824	421037	409994	rs1064794864	NC_000017.11:43092823:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2706del (p.Glu902fs)	BRCA1	E902fs, E855fs, E791fs, E813fs, E814fs, E606fs, E790fs, E860fs, E861fs, E774fs, E775fs, E831fs, E899fs, E734fs, E832fs, E834fs, E835fs, E854fs, E875fs, E876fs, E901fs	Hereditary breast ovarian cancer syndrome	VCV000667415	17	41244842	17	43092825	667415	654832	rs1597868211	NC_000017.11:43092824:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 13, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2704del (p.Glu902fs)	BRCA1	E902fs, E855fs, E791fs, E813fs, E814fs, E832fs, E834fs, E854fs, E860fs, E861fs, E875fs, E606fs, E775fs, E876fs, E899fs, E774fs, E831fs, E901fs, E734fs, E790fs, E835fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266295	17	41244844	17	43092827	266295	261806	rs886040064	NC_000017.11:43092826:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2702_2703del (p.Thr900_Phe901insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054653	17	41244845 - 41244846	17	43092828 - 43092829	54653	69320	rs80357899	NC_000017.11:43092827:AAAA:AA	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2697del (p.Thr900fs)	BRCA1	T812fs, T853fs, T897fs, T899fs, T732fs, T773fs, T788fs, T811fs, T873fs, T604fs, T789fs, T832fs, T852fs, T859fs, T900fs, T772fs, T829fs, T830fs, T833fs, T858fs, T874fs	Hereditary breast ovarian cancer syndrome	VCV003659872	17	41244851	17	43092834	3659872	3800820		NC_000017.11:43092833:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 11, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2695del (p.Val899fs)	BRCA1	V852fs, V899fs, V772fs, V832fs, V857fs, V896fs, V898fs, V731fs, V787fs, V788fs, V811fs, V829fs, V831fs, V858fs, V872fs, V873fs, V771fs, V828fs, V851fs, V603fs, V810fs	Hereditary cancer-predisposing syndrome	VCV000920348	17	41244853	17	43092836	920348	913916	rs1567794603	NC_000017.11:43092835:C:	Deletion	intron variant|frameshift variant	Pathogenic	Feb 9, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2693_2694dup (p.Val899fs)	BRCA1	V852fs, V899fs, V831fs, V832fs, V858fs, V873fs, V731fs, V788fs, V811fs, V898fs, V810fs, V829fs, V857fs, V872fs, V603fs, V771fs, V772fs, V787fs, V828fs, V851fs, V896fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000245696	17	41244853 - 41244854	17	43092836 - 43092837	245696	245043	rs80357549	NC_000017.11:43092836:TTTT:TTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2694dup (p.Val899fs)	BRCA1	V852fs, V899fs, V771fs, V787fs, V788fs, V896fs, V731fs, V828fs, V829fs, V857fs, V873fs, V811fs, V831fs, V851fs, V858fs, V872fs, V603fs, V772fs, V810fs, V832fs, V898fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054650	17	41244853 - 41244854	17	43092836 - 43092837	54650	69317	rs80357549	NC_000017.11:43092836:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2694del (p.Val899fs)	BRCA1	V852fs, V899fs, V772fs, V811fs, V851fs, V873fs, V898fs, V731fs, V831fs, V896fs, V603fs, V810fs, V832fs, V857fs, V858fs, V872fs, V771fs, V787fs, V788fs, V828fs, V829fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266294	17	41244854	17	43092837	266294	261807	rs80357549	NC_000017.11:43092836:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2687_2693del (p.Ser896fs)	BRCA1	S849fs, S896fs, S807fs, S808fs, S825fs, S826fs, S848fs, S829fs, S600fs, S768fs, S769fs, S784fs, S854fs, S855fs, S895fs, S728fs, S785fs, S828fs, S869fs, S870fs, S893fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266293	17	41244855 - 41244861	17	43092838 - 43092844	266293	261808	rs886040062	NC_000017.11:43092837:TTTGGACTTTG:TTTG	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2683_2693del (p.Gln895fs)	BRCA1	Q848fs, Q895fs, Q727fs, Q784fs, Q853fs, Q854fs, Q599fs, Q768fs, Q806fs, Q827fs, Q894fs, Q783fs, Q824fs, Q825fs, Q828fs, Q847fs, Q868fs, Q869fs, Q767fs, Q807fs, Q892fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266292	17	41244855 - 41244865	17	43092838 - 43092848	266292	261809	rs886040061	NC_000017.11:43092837:TTTGGACTTTGTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2691_2692insSVAelement	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000870239	17	41244856 - 41244857	17	43092839 - 43092840	870239	858417			Insertion		Pathogenic	Dec 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2690_2691dup (p.Lys898fs)	BRCA1	K898fs, K851fs, K787fs, K809fs, K810fs, K850fs, K871fs, K602fs, K770fs, K856fs, K897fs, K730fs, K771fs, K828fs, K830fs, K857fs, K872fs, K786fs, K827fs, K831fs, K895fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548268	17	41244856 - 41244857	17	43092839 - 43092840	548268	538835	rs1555589128	NC_000017.11:43092839:TG:TGTG	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2689_2690insAC (p.Pro897fs)	BRCA1	P897fs, P850fs, P729fs, P770fs, P808fs, P849fs, P896fs, P786fs, P809fs, P826fs, P829fs, P870fs, P601fs, P855fs, P856fs, P871fs, P894fs, P769fs, P785fs, P827fs, P830fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254418	17	41244858 - 41244859	17	43092841 - 43092842	254418	249125	rs1555589138	NC_000017.11:43092841:G:GTG	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2688_2689insA (p.Pro897fs)	BRCA1	P897fs, P850fs, P770fs, P808fs, P809fs, P827fs, P849fs, P870fs, P786fs, P830fs, P855fs, P894fs, P896fs, P769fs, P829fs, P601fs, P729fs, P785fs, P826fs, P856fs, P871fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548253	17	41244859 - 41244860	17	43092842 - 43092843	548253	538836	rs1555589140	NC_000017.11:43092842::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2680_2687del (p.Lys894fs)	BRCA1	K847fs, K894fs, K766fs, K767fs, K827fs, K598fs, K782fs, K805fs, K806fs, K853fs, K867fs, K868fs, K852fs, K726fs, K823fs, K891fs, K893fs, K783fs, K824fs, K826fs, K846fs	Hereditary breast ovarian cancer syndrome	VCV000462592	17	41244861 - 41244868	17	43092844 - 43092851	462592	468170	rs1555589143	NC_000017.11:43092843:CTTTGTTTCTTT:CTTT	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2686dup (p.Ser896fs)	BRCA1	S849fs, S896fs, S728fs, S808fs, S829fs, S893fs, S825fs, S854fs, S855fs, S869fs, S895fs, S784fs, S807fs, S826fs, S848fs, S600fs, S768fs, S769fs, S785fs, S828fs, S870fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091596	17	41244861 - 41244862	17	43092844 - 43092845	91596	97073	rs80357636	NC_000017.11:43092844:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2686del (p.Ser896fs)	BRCA1	S896fs, S849fs, S785fs, S807fs, S826fs, S600fs, S728fs, S768fs, S769fs, S825fs, S854fs, S855fs, S895fs, S808fs, S828fs, S848fs, S870fs, S893fs, S784fs, S829fs, S869fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125581	17	41244862	17	43092845	125581	131119	rs80357636	NC_000017.11:43092844:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2685_2686del (p.Pro897fs)	BRCA1	P850fs, P897fs, P770fs, P829fs, P849fs, P870fs, P871fs, P894fs, P729fs, P769fs, P855fs, P601fs, P785fs, P827fs, P856fs, P896fs, P786fs, P808fs, P809fs, P826fs, P830fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054646	17	41244862 - 41244863	17	43092845 - 43092846	54646	69313	rs80357636	NC_000017.11:43092844:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2683_2686del (p.Gln895fs)	BRCA1	Q895fs, Q848fs, Q783fs, Q807fs, Q824fs, Q853fs, Q825fs, Q847fs, Q868fs, Q894fs, Q727fs, Q768fs, Q784fs, Q827fs, Q828fs, Q854fs, Q599fs, Q767fs, Q806fs, Q869fs, Q892fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054645	17	41244862 - 41244865	17	43092845 - 43092848	54645	69312	rs397508998	NC_000017.11:43092844:TTTGTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2682_2683insG (p.Gln895fs)	BRCA1	Q599fs, Q767fs, Q784fs, Q825fs, Q854fs, Q895fs, Q727fs, Q768fs, Q827fs, Q828fs, Q894fs, Q783fs, Q807fs, Q847fs, Q848fs, Q868fs, Q806fs, Q824fs, Q853fs, Q869fs, Q892fs	Hereditary breast ovarian cancer syndrome	VCV003726840	17	41244865 - 41244866	17	43092848 - 43092849	3726840	3851461		NC_000017.11:43092848::C	Insertion	frameshift variant|intron variant	Pathogenic	Dec 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2683del (p.Gln895fs)	BRCA1	Q848fs, Q895fs, Q727fs, Q768fs, Q807fs, Q806fs, Q828fs, Q869fs, Q767fs, Q784fs, Q824fs, Q827fs, Q847fs, Q853fs, Q854fs, Q868fs, Q892fs, Q599fs, Q783fs, Q825fs, Q894fs	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV001685580	17	41244865	17	43092848	1685580	1677596	rs2154364983	NC_000017.11:43092847:G:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2683C>T (p.Gln895Ter)	BRCA1	Q895*, Q848*, Q727*, Q825*, Q828*, Q894*, Q784*, Q806*, Q824*, Q827*, Q599*, Q853*, Q868*, Q892*, Q767*, Q768*, Q783*, Q807*, Q847*, Q854*, Q869*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054644	17	41244865	17	43092848	54644	69311	rs397508997	NC_000017.11:43092847:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2682del (p.Lys894fs)	BRCA1	K847fs, K894fs, K767fs, K782fs, K783fs, K824fs, K826fs, K766fs, K827fs, K846fs, K853fs, K805fs, K823fs, K867fs, K893fs, K598fs, K726fs, K806fs, K852fs, K868fs, K891fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054643	17	41244866	17	43092849	54643	69310	rs80357971	NC_000017.11:43092848:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2679_2682del (p.Lys893fs)	BRCA1	K893fs, K846fs, K766fs, K822fs, K823fs, K825fs, K826fs, K805fs, K852fs, K866fs, K890fs, K597fs, K725fs, K804fs, K851fs, K867fs, K892fs, K765fs, K781fs, K782fs, K845fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037481	17	41244866 - 41244869	17	43092849 - 43092852	37481	46037	rs80357596	NC_000017.11:43092848:TTTCTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2681_2682del (p.Lys894fs)	BRCA1	K894fs, K847fs, K598fs, K766fs, K783fs, K805fs, K824fs, K891fs, K767fs, K782fs, K852fs, K806fs, K846fs, K867fs, K893fs, K726fs, K823fs, K826fs, K827fs, K853fs, K868fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017667	17	41244866 - 41244867	17	43092849 - 43092850	17667	32706	rs80357971	NC_000017.11:43092848:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2680A>T (p.Lys894Ter)	BRCA1	K894*, K847*, K782*, K783*, K805*, K806*, K823*, K853*, K867*, K868*, K726*, K826*, K891*, K893*, K766*, K824*, K827*, K852*, K598*, K767*, K846*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231951	17	41244868	17	43092851	231951	236063	rs876659457	NC_000017.11:43092850:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2679_2680del (p.Lys894fs)	BRCA1	K847fs, K894fs, K726fs, K766fs, K824fs, K853fs, K867fs, K782fs, K783fs, K826fs, K827fs, K852fs, K891fs, K598fs, K846fs, K893fs, K767fs, K805fs, K806fs, K823fs, K868fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054641	17	41244868 - 41244869	17	43092851 - 43092852	54641	69308	rs397508995	NC_000017.11:43092850:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2678dup (p.Lys894fs)	BRCA1	K894fs, K847fs, K726fs, K767fs, K783fs, K805fs, K826fs, K846fs, K853fs, K893fs, K598fs, K852fs, K806fs, K867fs, K766fs, K782fs, K823fs, K824fs, K827fs, K868fs, K891fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266291	17	41244869 - 41244870	17	43092852 - 43092853	266291	261810	rs886040060	NC_000017.11:43092852:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2675_2678del (p.Ser891_Leu892insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054639	17	41244870 - 41244873	17	43092853 - 43092856	54639	69306	rs80357518	NC_000017.11:43092852:TTTA:	Deletion	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2677A>T (p.Lys893Ter)	BRCA1	K893*, K846*, K765*, K823*, K826*, K766*, K781*, K804*, K845*, K851*, K866*, K867*, K597*, K725*, K825*, K852*, K892*, K782*, K805*, K822*, K890*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037480	17	41244871	17	43092854	37480	46036	rs80357170	NC_000017.11:43092853:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2675T>G (p.Leu892Ter)	BRCA1	L892*, L845*, L724*, L780*, L781*, L822*, L803*, L821*, L825*, L851*, L596*, L764*, L765*, L804*, L844*, L850*, L866*, L889*, L891*, L824*, L865*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266290	17	41244873	17	43092856	266290	261811	rs397508994	NC_000017.11:43092855:A:C	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2669_2670dup (p.Ser891fs)	BRCA1	S595fs, S723fs, S763fs, S764fs, S779fs, S780fs, S802fs, S803fs, S820fs, S821fs, S823fs, S824fs, S843fs, S844fs, S849fs, S850fs, S864fs, S865fs, S888fs, S890fs, S891fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773497	17	41244877 - 41244878	17	43092860 - 43092861	3773497	3889647		NC_000017.11:43092860:CCC:CCCCC	Duplication	intron variant|frameshift variant	Pathogenic	Oct 1, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2671del (p.Ser891fs)	BRCA1	S844fs, S891fs, S763fs, S779fs, S821fs, S890fs, S595fs, S764fs, S802fs, S823fs, S824fs, S843fs, S723fs, S780fs, S849fs, S864fs, S888fs, S803fs, S820fs, S850fs, S865fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054637	17	41244877	17	43092860	54637	69304	rs397508993	NC_000017.11:43092859:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2670del (p.Ser891fs)	BRCA1	S891fs, S844fs, S595fs, S723fs, S764fs, S779fs, S803fs, S821fs, S849fs, S850fs, S820fs, S824fs, S864fs, S888fs, S890fs, S763fs, S802fs, S865fs, S780fs, S823fs, S843fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054636	17	41244878	17	43092861	54636	69303	rs80357659	NC_000017.11:43092860:CCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2666_2667del (p.Ser889fs)	BRCA1	S593fs, S721fs, S761fs, S762fs, S777fs, S778fs, S800fs, S801fs, S818fs, S819fs, S821fs, S822fs, S841fs, S842fs, S847fs, S848fs, S862fs, S863fs, S886fs, S888fs, S889fs	Fanconi anemia, complementation group S	VCV003778927	17	41244881 - 41244882	17	43092864 - 43092865	3778927	3894914		NC_000017.11:43092863:AGAG:AG	Microsatellite	intron variant|frameshift variant	Pathogenic	Dec 10, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2666dup (p.Gly890fs)	BRCA1	G890fs, G843fs, G802fs, G822fs, G823fs, G594fs, G762fs, G763fs, G778fs, G722fs, G779fs, G820fs, G889fs, G848fs, G849fs, G863fs, G864fs, G887fs, G801fs, G819fs, G842fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233462	17	41244881 - 41244882	17	43092864 - 43092865	233462	236065	rs876660425	NC_000017.11:43092864:G:GG	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2665dup (p.Ser889fs)	BRCA1	S889fs, S842fs, S593fs, S778fs, S862fs, S888fs, S761fs, S800fs, S801fs, S818fs, S886fs, S721fs, S777fs, S819fs, S821fs, S841fs, S848fs, S863fs, S762fs, S822fs, S847fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054633	17	41244882 - 41244883	17	43092865 - 43092866	54633	69300	rs397508992	NC_000017.11:43092865:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2660_2661insA (p.His888fs)	BRCA1	H888fs, H841fs, H760fs, H777fs, H817fs, H820fs, H761fs, H800fs, H821fs, H846fs, H847fs, H592fs, H720fs, H776fs, H799fs, H818fs, H861fs, H862fs, H840fs, H885fs, H887fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548216	17	41244887 - 41244888	17	43092870 - 43092871	548216	538837	rs1555589195	NC_000017.11:43092870::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2659dup (p.Ala887fs)	BRCA1	A887fs, A840fs, A719fs, A760fs, A798fs, A839fs, A775fs, A776fs, A799fs, A816fs, A817fs, A884fs, A759fs, A819fs, A820fs, A860fs, A861fs, A886fs, A591fs, A845fs, A846fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054631	17	41244888 - 41244889	17	43092871 - 43092872	54631	69298	rs1555589203	NC_000017.11:43092871:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2659_2660insA (p.Ala887fs)	BRCA1	A840fs, A887fs, A719fs, A775fs, A819fs, A820fs, A884fs, A591fs, A759fs, A839fs, A860fs, A886fs, A760fs, A799fs, A816fs, A845fs, A776fs, A798fs, A817fs, A846fs, A861fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054630	17	41244888 - 41244889	17	43092871 - 43092872	54630	69297	rs397508991	NC_000017.11:43092871::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2658_2659insA (p.Ala887fs)	BRCA1	A840fs, A887fs, A591fs, A776fs, A819fs, A839fs, A861fs, A775fs, A820fs, A845fs, A759fs, A816fs, A817fs, A846fs, A860fs, A719fs, A760fs, A798fs, A799fs, A884fs, A886fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125579	17	41244889 - 41244890	17	43092872 - 43092873	125579	131117	rs80357541	NC_000017.11:43092872::T	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2657_2658del (p.Ser886fs)	BRCA1	S886fs, S839fs, S718fs, S759fs, S774fs, S797fs, S815fs, S844fs, S885fs, S775fs, S845fs, S860fs, S816fs, S818fs, S819fs, S590fs, S758fs, S798fs, S838fs, S859fs, S883fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054629	17	41244890 - 41244891	17	43092873 - 43092874	54629	69296	rs397508990	NC_000017.11:43092872:AGAGA:AGA	Microsatellite	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2654dup (p.Ser886fs)	BRCA1	S839fs, S886fs, S758fs, S774fs, S797fs, S860fs, S590fs, S759fs, S775fs, S798fs, S815fs, S816fs, S838fs, S718fs, S845fs, S859fs, S883fs, S818fs, S819fs, S844fs, S885fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187257	17	41244893 - 41244894	17	43092876 - 43092877	187257	185010	rs398122663	NC_000017.11:43092876:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2606_2654del (p.Phe869fs)	BRCA1	F822fs, F869fs, F573fs, F757fs, F758fs, F780fs, F798fs, F802fs, F827fs, F843fs, F742fs, F801fs, F828fs, F868fs, F741fs, F799fs, F842fs, F701fs, F781fs, F821fs, F866fs	Hereditary cancer-predisposing syndrome	VCV001793724	17	41244894 - 41244942	17	43092877 - 43092925	1793724	1845849	rs2552185674	NC_000017.11:43092876:AATGTTGCACATTCCTCTTCTGCATTTCCTGGATTTGAAAACGGAGCAAA:A	Deletion	frameshift variant|intron variant	Pathogenic	May 31, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2654del (p.Phe885fs)	BRCA1	F838fs, F885fs, F757fs, F773fs, F843fs, F858fs, F758fs, F774fs, F797fs, F815fs, F837fs, F589fs, F717fs, F796fs, F818fs, F882fs, F884fs, F814fs, F817fs, F844fs, F859fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091595	17	41244894	17	43092877	91595	97072	rs398122663	NC_000017.11:43092876:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2652dup (p.Phe885fs)	BRCA1	F838fs, F885fs, F757fs, F817fs, F818fs, F843fs, F882fs, F717fs, F773fs, F774fs, F797fs, F815fs, F844fs, F884fs, F758fs, F796fs, F858fs, F589fs, F814fs, F837fs, F859fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266289	17	41244895 - 41244896	17	43092878 - 43092879	266289	261812	rs886040059	NC_000017.11:43092878:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2650_2651insGGCA (p.Thr884fs)	BRCA1	T884fs, T837fs, T814fs, T588fs, T716fs, T757fs, T773fs, T795fs, T796fs, T813fs, T842fs, T816fs, T883fs, T756fs, T772fs, T817fs, T836fs, T843fs, T857fs, T858fs, T881fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548262	17	41244897 - 41244898	17	43092880 - 43092881	548262	538838	rs1555589228	NC_000017.11:43092880:T:TGCCT	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2649_2650insGGCT (p.Thr884fs)	BRCA1	T837fs, T884fs, T756fs, T772fs, T773fs, T813fs, T842fs, T883fs, T836fs, T843fs, T588fs, T757fs, T814fs, T816fs, T817fs, T881fs, T716fs, T795fs, T796fs, T857fs, T858fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000915315	17	41244898 - 41244899	17	43092881 - 43092882	915315	903619	rs2053722405	NC_000017.11:43092881::AGCC	Insertion	frameshift variant|intron variant	Pathogenic	May 3, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2649_2650del (p.Thr884fs)	BRCA1	T837fs, T884fs, T773fs, T817fs, T857fs, T858fs, T588fs, T756fs, T757fs, T795fs, T796fs, T883fs, T772fs, T813fs, T816fs, T842fs, T881fs, T716fs, T814fs, T836fs, T843fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266288	17	41244898 - 41244899	17	43092881 - 43092882	266288	261813	rs886040058	NC_000017.11:43092880:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2649_2650insGGCA (p.Thr884fs)	BRCA1	T837fs, T884fs, T772fs, T795fs, T796fs, T813fs, T817fs, T843fs, T857fs, T881fs, T883fs, T588fs, T756fs, T757fs, T816fs, T858fs, T842fs, T716fs, T773fs, T814fs, T836fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254417	17	41244898 - 41244899	17	43092881 - 43092882	254417	249126	rs886038003	NC_000017.11:43092881:TGC:TGCCTGC	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2648_2649insGGCA (p.Thr884fs)	BRCA1	T837fs, T884fs, T756fs, T772fs, T773fs, T813fs, T814fs, T843fs, T858fs, T796fs, T881fs, T588fs, T716fs, T795fs, T883fs, T757fs, T816fs, T817fs, T836fs, T842fs, T857fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266287	17	41244899 - 41244900	17	43092882 - 43092883	266287	261814	rs886040057	NC_000017.11:43092882::TGCC	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2647_2648insGGCA (p.Ala883fs)	BRCA1	A883fs, A836fs, A715fs, A755fs, A880fs, A587fs, A756fs, A815fs, A816fs, A835fs, A841fs, A856fs, A882fs, A772fs, A813fs, A771fs, A794fs, A795fs, A812fs, A842fs, A857fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548234	17	41244900 - 41244901	17	43092883 - 43092884	548234	538839	rs1555589236	NC_000017.11:43092883::TGCC	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2646_2648del (p.Cys882_Ala883delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054627	17	41244900 - 41244902	17	43092883 - 43092885	54627	69294	rs80357513	NC_000017.11:43092882:GCA:	Deletion	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2646T>A (p.Cys882Ter)	BRCA1	C586*, C714*, C754*, C755*, C770*, C771*, C793*, C794*, C811*, C812*, C814*, C815*, C834*, C835*, C840*, C841*, C855*, C856*, C879*, C881*, C882*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573266	17	41244902	17	43092885	2573266	2738214	rs2053723557	NC_000017.11:43092884:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 10, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2643dup (p.Cys882fs)	BRCA1	C882fs, C835fs, C834fs, C855fs, C586fs, C714fs, C770fs, C793fs, C794fs, C812fs, C881fs, C755fs, C811fs, C815fs, C840fs, C754fs, C771fs, C814fs, C841fs, C856fs, C879fs	Hereditary breast ovarian cancer syndrome	VCV000574879	17	41244904 - 41244905	17	43092887 - 43092888	574879	574479	rs397508989	NC_000017.11:43092887:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2643del (p.Glu881fs)	BRCA1	E881fs, E834fs, E585fs, E770fs, E840fs, E855fs, E793fs, E810fs, E833fs, E839fs, E878fs, E753fs, E769fs, E811fs, E814fs, E880fs, E713fs, E754fs, E792fs, E813fs, E854fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054626	17	41244905	17	43092888	54626	69293	rs397508989	NC_000017.11:43092887:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2641G>T (p.Glu881Ter)	BRCA1	E881*, E834*, E585*, E713*, E753*, E754*, E770*, E792*, E793*, E810*, E833*, E880*, E769*, E811*, E855*, E878*, E813*, E814*, E839*, E854*, E840*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054625	17	41244907	17	43092890	54625	69292	rs397508988	NC_000017.11:43092889:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2638G>T (p.Glu880Ter)	BRCA1	E753*, E791*, E838*, E839*, E853*, E712*, E809*, E810*, E813*, E584*, E768*, E769*, E833*, E854*, E880*, E752*, E792*, E812*, E832*, E877*, E879*	Hereditary cancer-predisposing syndrome	VCV003261455	17	41244910	17	43092893	3261455	3424224		NC_000017.11:43092892:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 26, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2636_2637del (p.Glu879fs)	BRCA1	E583fs, E711fs, E751fs, E752fs, E767fs, E768fs, E790fs, E791fs, E808fs, E809fs, E811fs, E812fs, E831fs, E832fs, E837fs, E838fs, E852fs, E853fs, E876fs, E878fs, E879fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003234089	17	41244911 - 41244912	17	43092894 - 43092895	3234089	3393212	rs2552185858	NC_000017.11:43092893:TT:	Deletion	intron variant|frameshift variant	Pathogenic	Apr 17, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2637del (p.Glu880fs)	BRCA1	E833fs, E880fs, E584fs, E810fs, E877fs, E879fs, E712fs, E752fs, E769fs, E791fs, E792fs, E812fs, E813fs, E839fs, E853fs, E854fs, E753fs, E832fs, E838fs, E768fs, E809fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266286	17	41244911	17	43092894	266286	261815	rs886040056	NC_000017.11:43092893:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2635del (p.Glu879fs)	BRCA1	E832fs, E879fs, E808fs, E809fs, E837fs, E853fs, E752fs, E790fs, E791fs, E812fs, E711fs, E767fs, E838fs, E852fs, E876fs, E583fs, E751fs, E768fs, E811fs, E831fs, E878fs	Hereditary breast ovarian cancer syndrome	VCV001074407	17	41244913	17	43092896	1074407	1064209	rs2154367532	NC_000017.11:43092895:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 19, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2635G>T (p.Glu879Ter)	BRCA1	E879*, E832*, E583*, E767*, E791*, E808*, E837*, E838*, E852*, E711*, E752*, E809*, E831*, E853*, E876*, E878*, E751*, E768*, E790*, E811*, E812*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037478	17	41244913	17	43092896	37478	46034	rs80357251	NC_000017.11:43092895:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2630del (p.Asn877fs)	BRCA1	N877fs, N830fs, N581fs, N765fs, N789fs, N829fs, N876fs, N807fs, N810fs, N850fs, N749fs, N750fs, N766fs, N788fs, N806fs, N835fs, N836fs, N709fs, N809fs, N851fs, N874fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254416	17	41244918	17	43092901	254416	249127	rs886038002	NC_000017.11:43092900:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2599_2626del (p.Gln867fs)	BRCA1	Q820fs, Q867fs, Q739fs, Q796fs, Q819fs, Q825fs, Q571fs, Q740fs, Q778fs, Q799fs, Q840fs, Q699fs, Q755fs, Q797fs, Q841fs, Q864fs, Q866fs, Q756fs, Q779fs, Q800fs, Q826fs	Hereditary cancer-predisposing syndrome	VCV001793596	17	41244922 - 41244949	17	43092905 - 43092932	1793596	1845721	rs2552185996	NC_000017.11:43092904:CTGGATTTGAAAACGGAGCAAATGACTG:	Deletion	frameshift variant|intron variant	Pathogenic	Nov 13, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2624del (p.Pro875fs)	BRCA1	P828fs, P875fs, P579fs, P707fs, P827fs, P833fs, P874fs, P747fs, P748fs, P786fs, P804fs, P805fs, P834fs, P872fs, P763fs, P787fs, P807fs, P808fs, P764fs, P848fs, P849fs	Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001192261	17	41244924	17	43092907	1192261	1182278	rs2154368003	NC_000017.11:43092906:GG:G	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2621dup (p.Asn874fs)	BRCA1	N874fs, N827fs, N706fs, N746fs, N747fs, N803fs, N826fs, N833fs, N871fs, N578fs, N832fs, N848fs, N762fs, N785fs, N804fs, N807fs, N847fs, N873fs, N763fs, N786fs, N806fs	Hereditary breast ovarian cancer syndrome	VCV001408952	17	41244926 - 41244927	17	43092909 - 43092910	1408952	1496741	rs587781423	NC_000017.11:43092909:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Jun 28, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2621del (p.Asn874fs)	BRCA1	N827fs, N874fs, N785fs, N786fs, N807fs, N832fs, N873fs, N746fs, N806fs, N848fs, N871fs, N706fs, N747fs, N763fs, N803fs, N804fs, N578fs, N762fs, N826fs, N833fs, N847fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000140993	17	41244927	17	43092910	140993	150707	rs587781423	NC_000017.11:43092909:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2617dup (p.Ser873fs)	BRCA1	S873fs, S826fs, S577fs, S705fs, S784fs, S785fs, S806fs, S832fs, S745fs, S803fs, S846fs, S872fs, S761fs, S762fs, S805fs, S831fs, S746fs, S802fs, S825fs, S847fs, S870fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054622	17	41244930 - 41244931	17	43092913 - 43092914	54622	69289	rs80357912	NC_000017.11:43092913:AAAA:AAAAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2617del (p.Ser873fs)	BRCA1	S826fs, S873fs, S832fs, S847fs, S785fs, S805fs, S831fs, S872fs, S577fs, S705fs, S745fs, S762fs, S802fs, S803fs, S870fs, S746fs, S761fs, S784fs, S806fs, S825fs, S846fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266285	17	41244931	17	43092914	266285	261816	rs80357912	NC_000017.11:43092913:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2612dup (p.Phe872fs)	BRCA1	F825fs, F872fs, F784fs, F804fs, F831fs, F576fs, F704fs, F760fs, F761fs, F783fs, F824fs, F744fs, F745fs, F830fs, F846fs, F869fs, F871fs, F801fs, F802fs, F805fs, F845fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054621	17	41244935 - 41244936	17	43092918 - 43092919	54621	69288	rs1555589289	NC_000017.11:43092918:GG:GGG	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2612_2613insT (p.Phe872fs)	BRCA1	F825fs, F872fs, F744fs, F745fs, F831fs, F846fs, F704fs, F845fs, F576fs, F760fs, F784fs, F801fs, F802fs, F804fs, F830fs, F761fs, F783fs, F805fs, F824fs, F869fs, F871fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054619	17	41244935 - 41244936	17	43092918 - 43092919	54619	69286	rs80357948	NC_000017.11:43092918::A	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2612delinsTT (p.Pro871fs)	BRCA1	P824fs, P871fs, P782fs, P804fs, P830fs, P744fs, P759fs, P783fs, P803fs, P703fs, P760fs, P800fs, P823fs, P868fs, P829fs, P844fs, P845fs, P870fs, P575fs, P743fs, P801fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054620	17	41244936	17	43092919	54620	69287	rs397508986	NC_000017.11:43092918:G:AA	Indel	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2611_2612del (p.Pro871fs)	BRCA1	P824fs, P871fs, P759fs, P783fs, P801fs, P868fs, P703fs, P743fs, P744fs, P760fs, P804fs, P829fs, P870fs, P575fs, P782fs, P800fs, P823fs, P830fs, P803fs, P844fs, P845fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054617	17	41244936 - 41244937	17	43092919 - 43092920	54617	69284	rs80357962	NC_000017.11:43092918:GG:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2607dup (p.Ala870fs)	BRCA1	A574fs, A702fs, A742fs, A743fs, A758fs, A759fs, A781fs, A782fs, A799fs, A800fs, A802fs, A803fs, A822fs, A823fs, A828fs, A829fs, A843fs, A844fs, A867fs, A869fs, A870fs	Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV002674457	17	41244940 - 41244941	17	43092923 - 43092924	2674457	2841943	rs2552186265	NC_000017.11:43092923:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2601_2604dup (p.Phe869fs)	BRCA1	F869fs, F822fs, F742fs, F758fs, F798fs, F828fs, F866fs, F701fs, F799fs, F802fs, F842fs, F868fs, F781fs, F821fs, F843fs, F573fs, F741fs, F757fs, F780fs, F801fs, F827fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254415	17	41244943 - 41244944	17	43092926 - 43092927	254415	249128	rs80357603	NC_000017.11:43092926:TGACTG:TGACTGACTG	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2603C>A (p.Ser868Ter)	BRCA1	S868*, S821*, S741*, S780*, S801*, S827*, S841*, S867*, S700*, S779*, S798*, S826*, S756*, S757*, S800*, S820*, S572*, S797*, S842*, S865*, S740*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054616	17	41244945	17	43092928	54616	69283	rs80356925	NC_000017.11:43092927:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2603C>G (p.Ser868Ter)	BRCA1	S868*, S821*, S740*, S757*, S797*, S801*, S865*, S741*, S798*, S867*, S572*, S826*, S827*, S841*, S700*, S756*, S779*, S780*, S800*, S820*, S842*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037477	17	41244945	17	43092928	37477	46033	rs80356925	NC_000017.11:43092927:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2598_2601dup (p.Ser868fs)	BRCA1	S572fs, S700fs, S741fs, S756fs, S780fs, S797fs, S801fs, S821fs, S865fs, S867fs, S740fs, S798fs, S826fs, S868fs, S827fs, S757fs, S779fs, S800fs, S820fs, S841fs, S842fs	Hereditary cancer-predisposing syndrome	VCV003481813	17	41244946 - 41244947	17	43092929 - 43092930	3481813	3640024		NC_000017.11:43092929:CTGGC:CTGGCTGGC	Duplication	frameshift variant|intron variant	Pathogenic	Jun 26, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2599C>T (p.Gln867Ter)	BRCA1	Q867*, Q820*, Q699*, Q739*, Q796*, Q864*, Q866*, Q755*, Q778*, Q797*, Q799*, Q819*, Q841*, Q756*, Q825*, Q571*, Q740*, Q779*, Q800*, Q826*, Q840*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254414	17	41244949	17	43092932	254414	249129	rs886038001	NC_000017.11:43092931:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2589_2594delinsATTCTTTT (p.Ser864fs)	BRCA1	S817fs, S864fs, S568fs, S736fs, S753fs, S775fs, S793fs, S823fs, S863fs, S797fs, S837fs, S861fs, S696fs, S737fs, S752fs, S776fs, S794fs, S796fs, S816fs, S822fs, S838fs	Hereditary breast ovarian cancer syndrome	VCV000579868	17	41244954 - 41244959	17	43092937 - 43092942	579868	571162	rs1567795017	NC_000017.11:43092936:TTTGAA:AAAAGAAT	Indel	frameshift variant|intron variant	Pathogenic	Mar 21, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2594del (p.Lys865fs)	BRCA1	K818fs, K865fs, K569fs, K738fs, K798fs, K817fs, K823fs, K754fs, K777fs, K794fs, K797fs, K839fs, K697fs, K795fs, K864fs, K737fs, K753fs, K776fs, K824fs, K838fs, K862fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054612	17	41244954	17	43092937	54612	69279	rs80357756	NC_000017.11:43092936:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2593A>T (p.Lys865Ter)	BRCA1	K865*, K818*, K697*, K738*, K795*, K798*, K838*, K569*, K753*, K776*, K777*, K817*, K862*, K864*, K754*, K797*, K737*, K794*, K823*, K824*, K839*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142666	17	41244955	17	43092938	142666	152380	rs587782628	NC_000017.11:43092937:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2586_2593del (p.Val863fs)	BRCA1	V816fs, V863fs, V567fs, V751fs, V796fs, V836fs, V736fs, V793fs, V862fs, V735fs, V795fs, V815fs, V695fs, V752fs, V774fs, V775fs, V792fs, V821fs, V822fs, V837fs, V860fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125575	17	41244955 - 41244962	17	43092938 - 43092945	125575	131113	rs80357675	NC_000017.11:43092937:TTGAAACCTTGAA:TTGAA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2590dup (p.Ser864fs)	BRCA1	S817fs, S864fs, S568fs, S737fs, S816fs, S823fs, S775fs, S776fs, S796fs, S861fs, S696fs, S752fs, S753fs, S794fs, S822fs, S838fs, S863fs, S736fs, S793fs, S797fs, S837fs	Hereditary cancer-predisposing syndrome	VCV000821534	17	41244957 - 41244958	17	43092940 - 43092941	821534	813784	rs1597868983	NC_000017.11:43092940:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Apr 29, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2591C>G (p.Ser864Ter)	BRCA1	S864*, S817*, S568*, S752*, S796*, S822*, S696*, S775*, S823*, S837*, S838*, S861*, S736*, S776*, S797*, S816*, S863*, S737*, S753*, S793*, S794*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054610	17	41244957	17	43092940	54610	69277	rs80357003	NC_000017.11:43092939:G:C	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2590del (p.Ser864fs)	BRCA1	S817fs, S864fs, S568fs, S752fs, S776fs, S822fs, S863fs, S696fs, S793fs, S797fs, S736fs, S775fs, S796fs, S823fs, S837fs, S737fs, S753fs, S794fs, S816fs, S838fs, S861fs	Hereditary cancer-predisposing syndrome	VCV001793519	17	41244958	17	43092941	1793519	1845645	rs1597868983	NC_000017.11:43092940:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2579_2588del (p.Thr860fs)	BRCA1	T564fs, T733fs, T748fs, T771fs, T789fs, T790fs, T793fs, T813fs, T818fs, T749fs, T792fs, T812fs, T819fs, T859fs, T692fs, T833fs, T834fs, T732fs, T772fs, T857fs, T860fs	Hereditary cancer-predisposing syndrome	VCV003481832	17	41244960 - 41244969	17	43092943 - 43092952	3481832	3640043		NC_000017.11:43092942:ACCTTGAATG:	Deletion	intron variant|frameshift variant	Pathogenic	Aug 19, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2587del (p.Val863fs)	BRCA1	V816fs, V863fs, V735fs, V751fs, V774fs, V795fs, V796fs, V860fs, V567fs, V695fs, V815fs, V836fs, V862fs, V736fs, V792fs, V793fs, V752fs, V775fs, V821fs, V822fs, V837fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266283	17	41244961	17	43092944	266283	261817	rs886040053	NC_000017.11:43092943:CC:C	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2578_2579insTT (p.Thr860fs)	BRCA1	T860fs, T813fs, T733fs, T789fs, T790fs, T818fs, T859fs, T692fs, T749fs, T564fs, T732fs, T771fs, T772fs, T793fs, T819fs, T857fs, T748fs, T792fs, T812fs, T833fs, T834fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548227	17	41244969 - 41244970	17	43092952 - 43092953	548227	538840	rs1555589340	NC_000017.11:43092952::AA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2578del (p.Thr860fs)	BRCA1	T860fs, T813fs, T564fs, T749fs, T792fs, T819fs, T857fs, T748fs, T790fs, T833fs, T834fs, T692fs, T733fs, T772fs, T789fs, T812fs, T732fs, T771fs, T793fs, T818fs, T859fs	Hereditary breast ovarian cancer syndrome	VCV002113391	17	41244970	17	43092953	2113391	2160926	rs2552186766	NC_000017.11:43092952:T:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 18, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2577_2578insTT (p.Thr860fs)	BRCA1	T813fs, T860fs, T692fs, T792fs, T812fs, T818fs, T857fs, T733fs, T749fs, T793fs, T819fs, T833fs, T859fs, T732fs, T748fs, T771fs, T790fs, T564fs, T772fs, T789fs, T834fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266282	17	41244970 - 41244971	17	43092953 - 43092954	266282	261818	rs886040052	NC_000017.11:43092953:A:AAA	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2576del (p.Asn859fs)	BRCA1	N812fs, N859fs, N732fs, N771fs, N788fs, N833fs, N856fs, N770fs, N792fs, N832fs, N691fs, N747fs, N817fs, N858fs, N563fs, N731fs, N748fs, N789fs, N791fs, N811fs, N818fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548256	17	41244972	17	43092955	548256	538841	rs1555589351	NC_000017.11:43092954:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2572C>T (p.Gln858Ter)	BRCA1	Q858*, Q811*, Q769*, Q690*, Q746*, Q788*, Q791*, Q562*, Q747*, Q787*, Q816*, Q817*, Q831*, Q730*, Q731*, Q770*, Q790*, Q810*, Q832*, Q855*, Q857*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054607	17	41244976	17	43092959	54607	69274	rs397508983	NC_000017.11:43092958:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2569_2570insA (p.Leu857fs)	BRCA1	L810fs, L857fs, L689fs, L730fs, L745fs, L561fs, L729fs, L746fs, L769fs, L787fs, L790fs, L816fs, L830fs, L854fs, L789fs, L831fs, L856fs, L768fs, L786fs, L809fs, L815fs	Hereditary breast ovarian cancer syndrome	VCV002122351	17	41244978 - 41244979	17	43092961 - 43092962	2122351	2173776	rs2552186870	NC_000017.11:43092961::T	Insertion	frameshift variant|intron variant	Pathogenic	Apr 7, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2570T>A (p.Leu857Ter)	BRCA1	L857*, L810*, L561*, L746*, L786*, L856*, L730*, L745*, L789*, L830*, L729*, L768*, L787*, L790*, L815*, L831*, L854*, L689*, L769*, L809*, L816*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224421	17	41244978	17	43092961	224421	226202	rs886037787	NC_000017.11:43092960:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2568T>G (p.Tyr856Ter)	BRCA1	Y856*, Y809*, Y688*, Y728*, Y744*, Y815*, Y829*, Y830*, Y853*, Y855*, Y745*, Y788*, Y808*, Y560*, Y729*, Y785*, Y786*, Y814*, Y767*, Y768*, Y789*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054606	17	41244980	17	43092963	54606	69273	rs80356832	NC_000017.11:43092962:A:C	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2567del (p.Tyr856fs)	BRCA1	Y856fs, Y809fs, Y688fs, Y728fs, Y729fs, Y768fs, Y789fs, Y829fs, Y853fs, Y560fs, Y785fs, Y786fs, Y815fs, Y830fs, Y767fs, Y788fs, Y855fs, Y744fs, Y745fs, Y808fs, Y814fs	Hereditary cancer-predisposing syndrome	VCV000821496	17	41244981	17	43092964	821496	813788	rs1597869157	NC_000017.11:43092963:T:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 14, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2566_2567insTGATT (p.Tyr856fs)	BRCA1	Y809fs, Y856fs, Y788fs, Y808fs, Y814fs, Y815fs, Y729fs, Y744fs, Y745fs, Y830fs, Y853fs, Y560fs, Y688fs, Y767fs, Y768fs, Y785fs, Y789fs, Y829fs, Y728fs, Y786fs, Y855fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548156	17	41244981 - 41244982	17	43092964 - 43092965	548156	538842	rs1555589385	NC_000017.11:43092964:A:AATCAA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2561_2565del (p.Ala854fs)	BRCA1	A854fs, A807fs, A686fs, A784fs, A786fs, A827fs, A742fs, A765fs, A783fs, A806fs, A853fs, A726fs, A743fs, A812fs, A813fs, A828fs, A851fs, A558fs, A727fs, A766fs, A787fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054602	17	41244983 - 41244987	17	43092966 - 43092970	54602	69269	rs397508981	NC_000017.11:43092965:CTGAGC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2563_2564insGC (p.Gln855fs)	BRCA1	Q808fs, Q855fs, Q559fs, Q727fs, Q728fs, Q744fs, Q788fs, Q807fs, Q766fs, Q814fs, Q828fs, Q854fs, Q687fs, Q767fs, Q784fs, Q785fs, Q743fs, Q787fs, Q813fs, Q829fs, Q852fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548172	17	41244984 - 41244985	17	43092967 - 43092968	548172	538843	rs1555589397	NC_000017.11:43092967:G:GCG	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2562_2563insGC (p.Gln855fs)	BRCA1	Q808fs, Q855fs, Q559fs, Q687fs, Q727fs, Q744fs, Q784fs, Q788fs, Q828fs, Q829fs, Q854fs, Q767fs, Q785fs, Q766fs, Q787fs, Q813fs, Q852fs, Q728fs, Q743fs, Q807fs, Q814fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236268	17	41244985 - 41244986	17	43092968 - 43092969	236268	237835	rs878853290	NC_000017.11:43092968::GC	Insertion	intron variant|frameshift variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2563C>T (p.Gln855Ter)	BRCA1	Q855*, Q808*, Q743*, Q744*, Q785*, Q787*, Q829*, Q854*, Q766*, Q784*, Q807*, Q814*, Q852*, Q559*, Q687*, Q727*, Q767*, Q788*, Q813*, Q728*, Q828*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037475	17	41244985	17	43092968	37475	46031	rs80357131	NC_000017.11:43092967:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2560_2561dup (p.Gln855fs)	BRCA1	Q855fs, Q808fs, Q559fs, Q744fs, Q767fs, Q785fs, Q788fs, Q828fs, Q727fs, Q743fs, Q807fs, Q852fs, Q854fs, Q728fs, Q766fs, Q814fs, Q829fs, Q687fs, Q784fs, Q787fs, Q813fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054600	17	41244986 - 41244987	17	43092969 - 43092970	54600	69267	rs80357968	NC_000017.11:43092969:GC:GCGC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2558dup (p.Asp853fs)	BRCA1	D853fs, D806fs, D557fs, D725fs, D764fs, D765fs, D783fs, D811fs, D812fs, D850fs, D726fs, D785fs, D805fs, D827fs, D782fs, D826fs, D685fs, D741fs, D742fs, D786fs, D852fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054599	17	41244989 - 41244990	17	43092972 - 43092973	54599	69266	rs80357835	NC_000017.11:43092972:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2557_2558insTTCACTTTTC (p.Asp853fs)	BRCA1	D806fs, D853fs, D764fs, D765fs, D785fs, D805fs, D812fs, D741fs, D786fs, D852fs, D557fs, D685fs, D725fs, D783fs, D827fs, D850fs, D726fs, D742fs, D782fs, D811fs, D826fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548157	17	41244990 - 41244991	17	43092973 - 43092974	548157	538844	rs1555589410	NC_000017.11:43092973::GAAAAGTGAA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2556_2557insTTCACTTTTC (p.Asp853fs)	BRCA1	D853fs, D806fs, D557fs, D741fs, D786fs, D811fs, D826fs, D827fs, D685fs, D725fs, D742fs, D765fs, D852fs, D726fs, D764fs, D783fs, D850fs, D782fs, D785fs, D805fs, D812fs	Breast neoplasm	VCV000224420	17	41244991 - 41244992	17	43092974 - 43092975	224420	226203	rs397508979	NC_000017.11:43092974::GAAAAGTGAA	Insertion	frameshift variant|intron variant	Pathogenic	Nov 1, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2556dup (p.Asp853Ter)	BRCA1	D853*, D806*, D726*, D764*, D765*, D783*, D850*, D741*, D782*, D785*, D805*, D826*, D827*, D557*, D685*, D725*, D786*, D811*, D852*, D742*, D812*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054598	17	41244991 - 41244992	17	43092974 - 43092975	54598	69265	rs397508978	NC_000017.11:43092974:AA:AAA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2556del (p.Asp853fs)	BRCA1	D806fs, D853fs, D783fs, D805fs, D685fs, D764fs, D782fs, D785fs, D812fs, D725fs, D786fs, D826fs, D827fs, D557fs, D741fs, D742fs, D765fs, D726fs, D811fs, D850fs, D852fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054597	17	41244992	17	43092975	54597	69264	rs397508978	NC_000017.11:43092974:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2552_2553dup (p.Leu852fs)	BRCA1	L805fs, L852fs, L740fs, L804fs, L851fs, L556fs, L684fs, L741fs, L764fs, L781fs, L825fs, L724fs, L725fs, L782fs, L785fs, L811fs, L826fs, L849fs, L763fs, L784fs, L810fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266281	17	41244994 - 41244995	17	43092977 - 43092978	266281	261820	rs886040051	NC_000017.11:43092977:TT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2552_2553del (p.Glu851fs)	BRCA1	E804fs, E851fs, E739fs, E724fs, E740fs, E781fs, E783fs, E683fs, E780fs, E784fs, E803fs, E848fs, E555fs, E723fs, E762fs, E763fs, E809fs, E810fs, E824fs, E825fs, E850fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266280	17	41244995 - 41244996	17	43092978 - 43092979	266280	261819	rs886040050	NC_000017.11:43092977:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2550dup (p.Glu851Ter)	BRCA1	E740*, E783*, E784*, E804*, E555*, E724*, E763*, E781*, E723*, E762*, E780*, E809*, E810*, E850*, E683*, E739*, E803*, E824*, E825*, E848*, E851*	Hereditary breast ovarian cancer syndrome	VCV003726453	17	41244997 - 41244998	17	43092980 - 43092981	3726453	3854943		NC_000017.11:43092980:A:AA	Duplication	nonsense|intron variant	Pathogenic	Dec 2, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2550_2551del (p.Ser850fs)	BRCA1	S803fs, S850fs, S723fs, S738fs, S782fs, S823fs, S849fs, S682fs, S739fs, S761fs, S779fs, S554fs, S762fs, S783fs, S808fs, S824fs, S722fs, S780fs, S802fs, S809fs, S847fs	Hereditary cancer-predisposing syndrome	VCV000821473	17	41244997 - 41244998	17	43092980 - 43092981	821473	813790	rs1597869317	NC_000017.11:43092979:CAC:C	Deletion	frameshift variant|intron variant	Pathogenic	May 6, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2551G>T (p.Glu851Ter)	BRCA1	E851*, E804*, E683*, E740*, E780*, E824*, E850*, E724*, E739*, E763*, E803*, E723*, E809*, E810*, E555*, E762*, E781*, E783*, E784*, E825*, E848*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266279	17	41244997	17	43092980	266279	261821	rs398122662	NC_000017.11:43092979:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2551del (p.Glu851fs)	BRCA1	E804fs, E851fs, E723fs, E724fs, E739fs, E781fs, E824fs, E848fs, E683fs, E780fs, E784fs, E803fs, E850fs, E555fs, E809fs, E825fs, E740fs, E762fs, E763fs, E783fs, E810fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054596	17	41244997	17	43092980	54596	69263	rs397508977	NC_000017.11:43092979:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2548del (p.Ser850fs)	BRCA1	S850fs, S803fs, S722fs, S739fs, S783fs, S824fs, S723fs, S782fs, S808fs, S809fs, S823fs, S554fs, S762fs, S780fs, S802fs, S847fs, S682fs, S738fs, S761fs, S779fs, S849fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441315	17	41245000	17	43092983	441315	435150	rs1555589434	NC_000017.11:43092982:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2545_2546del (p.Glu849fs)	BRCA1	E553fs, E681fs, E721fs, E722fs, E737fs, E738fs, E760fs, E761fs, E778fs, E779fs, E781fs, E782fs, E801fs, E802fs, E807fs, E808fs, E822fs, E823fs, E846fs, E848fs, E849fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004071387	17	41245002 - 41245003	17	43092985 - 43092986	4071387	4185235		NC_000017.11:43092984:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	May 7, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2542_2545del (p.Glu848fs)	BRCA1	E801fs, E848fs, E680fs, E806fs, E845fs, E737fs, E778fs, E780fs, E552fs, E736fs, E781fs, E800fs, E821fs, E720fs, E721fs, E759fs, E760fs, E777fs, E807fs, E822fs, E847fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266278	17	41245003 - 41245006	17	43092986 - 43092989	266278	261822	rs886040049	NC_000017.11:43092985:CTTCC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2545G>T (p.Glu849Ter)	BRCA1	E849*, E802*, E681*, E823*, E553*, E721*, E778*, E782*, E807*, E846*, E848*, E760*, E761*, E779*, E781*, E808*, E822*, E722*, E737*, E738*, E801*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054595	17	41245003	17	43092986	54595	69262	rs80356951	NC_000017.11:43092985:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2538_2540delinsG (p.Met847fs)	BRCA1	M847fs, M800fs, M551fs, M719fs, M736fs, M759fs, M777fs, M799fs, M820fs, M844fs, M735fs, M776fs, M806fs, M821fs, M720fs, M780fs, M805fs, M846fs, M679fs, M758fs, M779fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266277	17	41245008 - 41245010	17	43092991 - 43092993	266277	261823	rs886040048	NC_000017.11:43092990:ATT:C	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2539del (p.Met847fs)	BRCA1	M800fs, M847fs, M551fs, M679fs, M719fs, M758fs, M759fs, M780fs, M735fs, M736fs, M777fs, M779fs, M805fs, M844fs, M720fs, M776fs, M799fs, M820fs, M806fs, M821fs, M846fs	Hereditary cancer-predisposing syndrome	VCV001792790	17	41245009	17	43092992	1792790	1851839	rs2552187485	NC_000017.11:43092991:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 18, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2536G>T (p.Glu846Ter)	BRCA1	E846*, E799*, E678*, E718*, E719*, E757*, E778*, E779*, E798*, E735*, E775*, E805*, E845*, E550*, E819*, E734*, E758*, E776*, E804*, E820*, E843*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266276	17	41245012	17	43092995	266276	261824	rs786203523	NC_000017.11:43092994:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2532_2536del (p.Ser844fs)	BRCA1	S844fs, S797fs, S717fs, S777fs, S841fs, S548fs, S676fs, S755fs, S803fs, S817fs, S843fs, S716fs, S773fs, S774fs, S776fs, S796fs, S818fs, S732fs, S733fs, S756fs, S802fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266275	17	41245012 - 41245016	17	43092995 - 43092999	266275	261825	rs886040047	NC_000017.11:43092994:CTATGCT:CT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2530del (p.Ser844fs)	BRCA1	S797fs, S844fs, S676fs, S716fs, S755fs, S776fs, S777fs, S818fs, S548fs, S733fs, S773fs, S774fs, S717fs, S756fs, S796fs, S802fs, S841fs, S732fs, S803fs, S817fs, S843fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001792697	17	41245018	17	43093001	1792697	1245787	rs2552187612	NC_000017.11:43093000:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jan 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2529_2530del (p.Ser844fs)	BRCA1	S797fs, S844fs, S716fs, S756fs, S776fs, S796fs, S817fs, S843fs, S548fs, S733fs, S755fs, S773fs, S818fs, S841fs, S732fs, S803fs, S676fs, S717fs, S774fs, S777fs, S802fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266274	17	41245018 - 41245019	17	43093001 - 43093002	266274	261826	rs886040046	NC_000017.11:43093000:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2527del (p.Thr843fs)	BRCA1	T843fs, T796fs, T716fs, T731fs, T775fs, T776fs, T795fs, T842fs, T817fs, T840fs, T547fs, T675fs, T754fs, T755fs, T715fs, T732fs, T772fs, T773fs, T801fs, T802fs, T816fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000427237	17	41245021	17	43093004	427237	416228	rs1085308034	NC_000017.11:43093003:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2524dup (p.Glu842fs)	BRCA1	E795fs, E842fs, E714fs, E731fs, E754fs, E800fs, E801fs, E815fs, E546fs, E730fs, E753fs, E794fs, E816fs, E715fs, E771fs, E772fs, E774fs, E775fs, E839fs, E841fs, E674fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266272	17	41245023 - 41245024	17	43093006 - 43093007	266272	261828	rs886040045	NC_000017.11:43093006:CCC:CCCC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2524G>T (p.Glu842Ter)	BRCA1	E842*, E795*, E546*, E816*, E715*, E754*, E774*, E794*, E801*, E839*, E674*, E714*, E730*, E731*, E771*, E800*, E815*, E753*, E772*, E775*, E841*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266273	17	41245024	17	43093007	266273	261827	rs876658552	NC_000017.11:43093006:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2518_2521del (p.Ser840fs)	BRCA1	S840fs, S793fs, S672fs, S772fs, S773fs, S814fs, S728fs, S799fs, S813fs, S544fs, S712fs, S752fs, S769fs, S798fs, S837fs, S713fs, S729fs, S751fs, S770fs, S792fs, S839fs	Hereditary breast ovarian cancer syndrome	VCV000850892	17	41245027 - 41245030	17	43093010 - 43093013	850892	845419	rs2053746603	NC_000017.11:43093009:GACTG:G	Deletion	intron variant|frameshift variant	Pathogenic	Apr 16, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2518del (p.Ser840fs)	BRCA1	S793fs, S840fs, S544fs, S672fs, S752fs, S770fs, S814fs, S773fs, S792fs, S798fs, S813fs, S712fs, S713fs, S729fs, S751fs, S772fs, S799fs, S837fs, S839fs, S728fs, S769fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054590	17	41245030	17	43093013	54590	69257	rs397508975	NC_000017.11:43093012:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2517_2518del (p.His839fs)	BRCA1	H792fs, H839fs, H543fs, H711fs, H812fs, H671fs, H728fs, H836fs, H750fs, H751fs, H769fs, H771fs, H772fs, H791fs, H838fs, H712fs, H727fs, H768fs, H797fs, H798fs, H813fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054589	17	41245030 - 41245031	17	43093013 - 43093014	54589	69256	rs397508974	NC_000017.11:43093012:TGTG:TG	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2515del (p.His839fs)	BRCA1	H839fs, H792fs, H543fs, H727fs, H750fs, H797fs, H836fs, H671fs, H728fs, H798fs, H812fs, H751fs, H768fs, H769fs, H791fs, H838fs, H711fs, H712fs, H771fs, H772fs, H813fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037474	17	41245033	17	43093016	37474	46030	rs80357607	NC_000017.11:43093015:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2513del (p.Asn838fs)	BRCA1	N791fs, N838fs, N749fs, N768fs, N797fs, N811fs, N750fs, N767fs, N812fs, N711fs, N770fs, N790fs, N835fs, N542fs, N670fs, N710fs, N726fs, N727fs, N771fs, N796fs, N837fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054588	17	41245035	17	43093018	54588	69255	rs80357863	NC_000017.11:43093017:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2511del (p.Asn838fs)	BRCA1	N791fs, N838fs, N670fs, N710fs, N727fs, N811fs, N835fs, N726fs, N750fs, N771fs, N837fs, N542fs, N767fs, N796fs, N711fs, N749fs, N768fs, N770fs, N790fs, N797fs, N812fs	not provided	VCV000495090	17	41245037	17	43093020	495090	486655	rs1555589501	NC_000017.11:43093019:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2507_2508del (p.Glu836fs)	BRCA1	E789fs, E836fs, E668fs, E810fs, E833fs, E835fs, E709fs, E725fs, E766fs, E809fs, E708fs, E724fs, E747fs, E748fs, E768fs, E788fs, E794fs, E795fs, E540fs, E765fs, E769fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054587	17	41245040 - 41245041	17	43093023 - 43093024	54587	69254	rs273899686	NC_000017.11:43093022:TT:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2506del (p.Glu836fs)	BRCA1	E789fs, E836fs, E708fs, E724fs, E725fs, E769fs, E795fs, E833fs, E709fs, E766fs, E768fs, E810fs, E835fs, E668fs, E748fs, E765fs, E788fs, E794fs, E809fs, E540fs, E747fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136082	17	41245042	17	43093025	136082	139794	rs587780798	NC_000017.11:43093024:C:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2504dup (p.His835fs)	BRCA1	H835fs, H788fs, H539fs, H708fs, H767fs, H787fs, H793fs, H834fs, H746fs, H765fs, H667fs, H707fs, H723fs, H747fs, H768fs, H809fs, H832fs, H724fs, H764fs, H794fs, H808fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000431228	17	41245043 - 41245044	17	43093026 - 43093027	431228	424834	rs1555589513	NC_000017.11:43093026:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Jul 20, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2488_2504dup (p.His835fs)	BRCA1	H835fs, H788fs, H707fs, H724fs, H747fs, H794fs, H809fs, H832fs, H667fs, H723fs, H787fs, H793fs, H808fs, H834fs, H539fs, H708fs, H764fs, H746fs, H765fs, H767fs, H768fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000280050	17	41245043 - 41245044	17	43093026 - 43093027	280050	264769	rs483353078	NC_000017.11:43093026:TGTCCCAATGGATACTT:TGTCCCAATGGATACTTTGTCCCAATGGATACTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.3(BRCA1):c.2504_2505ins17 (p.?)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091590	17	41245043 - 41245044	17	43093026 - 43093027	91590	97067			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2501del (p.Gly834fs)	BRCA1	G787fs, G834fs, G666fs, G706fs, G766fs, G786fs, G792fs, G807fs, G808fs, G831fs, G707fs, G722fs, G745fs, G833fs, G538fs, G764fs, G723fs, G746fs, G763fs, G767fs, G793fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266271	17	41245047	17	43093030	266271	261829	rs886040044	NC_000017.11:43093029:CCC:CC	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2500G>T (p.Gly834Ter)	BRCA1	G787*, G834*, G538*, G723*, G766*, G767*, G807*, G831*, G833*, G666*, G745*, G808*, G706*, G746*, G763*, G764*, G793*, G707*, G722*, G786*, G792*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001076402	17	41245048	17	43093031	1076402	1064211	rs786202215	NC_000017.11:43093030:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2498dup (p.Leu833fs)	BRCA1	L833fs, L786fs, L665fs, L744fs, L762fs, L806fs, L830fs, L537fs, L706fs, L722fs, L832fs, L705fs, L766fs, L791fs, L792fs, L807fs, L721fs, L745fs, L763fs, L765fs, L785fs	Hereditary breast ovarian cancer syndrome	VCV000940268	17	41245049 - 41245050	17	43093032 - 43093033	940268	937961	rs2053749959	NC_000017.11:43093032:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Jul 30, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2498T>A (p.Leu833Ter)	BRCA1	L833*, L786*, L705*, L763*, L791*, L830*, L832*, L706*, L722*, L765*, L766*, L665*, L721*, L744*, L792*, L806*, L537*, L745*, L762*, L785*, L807*	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000838543	17	41245050	17	43093033	838543	845420	rs2053749811	NC_000017.11:43093032:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2490_2497dup (p.Leu833fs)	BRCA1	L786fs, L833fs, L665fs, L705fs, L706fs, L744fs, L745fs, L765fs, L785fs, L792fs, L830fs, L832fs, L537fs, L721fs, L806fs, L763fs, L766fs, L807fs, L722fs, L762fs, L791fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266270	17	41245050 - 41245051	17	43093033 - 43093034	266270	261830	rs1555589539	NC_000017.11:43093033:ATGGATAC:ATGGATACATGGATAC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2488_2497dup (p.Leu833Ter)	BRCA1	L786*, L833*, L537*, L706*, L721*, L745*, L766*, L792*, L807*, L832*, L722*, L763*, L806*, L744*, L765*, L791*, L665*, L705*, L762*, L785*, L830*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054586	17	41245050 - 41245051	17	43093033 - 43093034	54586	69253	rs397508973	NC_000017.11:43093033:ATGGATACTTA:ATGGATACTTATGGATACTTA	Duplication	nonsense|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2493_2494insGT (p.Pro832fs)	BRCA1	P832fs, P785fs, P743fs, P761fs, P764fs, P784fs, P791fs, P831fs, P720fs, P829fs, P721fs, P762fs, P765fs, P536fs, P705fs, P744fs, P790fs, P805fs, P806fs, P664fs, P704fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548319	17	41245054 - 41245055	17	43093037 - 43093038	548319	538845	rs1555589547	NC_000017.11:43093037:A:ACA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2489_2492del (p.Lys830fs)	BRCA1	K830fs, K783fs, K703fs, K741fs, K763fs, K782fs, K803fs, K702fs, K718fs, K759fs, K760fs, K827fs, K662fs, K719fs, K742fs, K788fs, K789fs, K534fs, K762fs, K804fs, K829fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266269	17	41245056 - 41245059	17	43093039 - 43093042	266269	261831	rs886040043	NC_000017.11:43093038:TACTTA:TA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2477_2492delinsTG (p.Thr826fs)	BRCA1	T826fs, T779fs, T715fs, T758fs, T799fs, T530fs, T658fs, T699fs, T714fs, T737fs, T784fs, T785fs, T823fs, T738fs, T755fs, T756fs, T698fs, T759fs, T778fs, T800fs, T825fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266266	17	41245056 - 41245071	17	43093039 - 43093054	266266	261832	rs886040041	NC_000017.11:43093038:TACTTAAAGCCTTCTG:CA	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2489_2490insAAGTATCCAT (p.Tyr831fs)	BRCA1	Y831fs, Y784fs, Y719fs, Y703fs, Y704fs, Y720fs, Y783fs, Y790fs, Y535fs, Y742fs, Y743fs, Y760fs, Y764fs, Y805fs, Y828fs, Y830fs, Y663fs, Y761fs, Y763fs, Y789fs, Y804fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548298	17	41245058 - 41245059	17	43093041 - 43093042	548298	538846	rs1555589559	NC_000017.11:43093041::ATGGATACTT	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2488_2489insCCCCT (p.Lys830fs)	BRCA1	K830fs, K783fs, K719fs, K741fs, K759fs, K763fs, K804fs, K827fs, K702fs, K718fs, K742fs, K760fs, K762fs, K789fs, K803fs, K782fs, K788fs, K534fs, K662fs, K703fs, K829fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548206	17	41245059 - 41245060	17	43093042 - 43093043	548206	538847	rs1555589565	NC_000017.11:43093042::AGGGG	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2486_2487dup (p.Lys830fs)	BRCA1	K534fs, K662fs, K719fs, K759fs, K760fs, K763fs, K803fs, K804fs, K783fs, K788fs, K827fs, K703fs, K741fs, K702fs, K718fs, K742fs, K762fs, K782fs, K789fs, K829fs, K830fs	not provided|Hereditary breast ovarian cancer syndrome	VCV002751478	17	41245060 - 41245061	17	43093043 - 43093044	2751478	2908774	rs80357658	NC_000017.11:43093043:AAA:AAAAA	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Nov 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2488A>T (p.Lys830Ter)	BRCA1	K830*, K783*, K702*, K703*, K763*, K788*, K804*, K534*, K742*, K782*, K718*, K719*, K741*, K762*, K789*, K803*, K829*, K662*, K759*, K760*, K827*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000481451	17	41245060	17	43093043	481451	479401	rs1555589569	NC_000017.11:43093042:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2487_2488insCCCCT (p.Lys830fs)	BRCA1	K783fs, K830fs, K741fs, K788fs, K829fs, K662fs, K702fs, K703fs, K718fs, K759fs, K763fs, K782fs, K534fs, K742fs, K760fs, K789fs, K803fs, K804fs, K719fs, K762fs, K827fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266268	17	41245060 - 41245061	17	43093043 - 43093044	266268	261833	rs397508972	NC_000017.11:43093043:A:AGGGGA	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2487dup (p.Lys830Ter)	BRCA1	K830*, K783*, K718*, K741*, K763*, K760*, K789*, K829*, K702*, K703*, K762*, K788*, K804*, K827*, K759*, K782*, K803*, K534*, K662*, K719*, K742*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054585	17	41245060 - 41245061	17	43093043 - 43093044	54585	69252	rs80357658	NC_000017.11:43093043:AAA:AAAA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2487del (p.Phe829fs)	BRCA1	F829fs, F782fs, F533fs, F661fs, F702fs, F718fs, F761fs, F762fs, F788fs, F701fs, F758fs, F759fs, F826fs, F803fs, F828fs, F717fs, F740fs, F741fs, F781fs, F787fs, F802fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054584	17	41245061	17	43093044	54584	69251	rs80357658	NC_000017.11:43093043:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2486_2487del (p.Gly828_Phe829insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054583	17	41245061 - 41245062	17	43093044 - 43093045	54583	69250	rs80357658	NC_000017.11:43093043:AAA:A	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2485_2486insAA (p.Phe829Ter)	BRCA1	F533*, F661*, F701*, F702*, F717*, F718*, F740*, F741*, F758*, F759*, F761*, F762*, F781*, F782*, F787*, F788*, F802*, F803*, F826*, F828*, F829*	Hereditary cancer-predisposing syndrome	VCV003226118	17	41245062 - 41245063	17	43093045 - 43093046	3226118	3387182	rs2552188102	NC_000017.11:43093045::TT	Insertion	nonsense|intron variant	Pathogenic	Jan 2, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2481del (p.Gly828fs)	BRCA1	G828fs, G781fs, G660fs, G701fs, G739fs, G758fs, G760fs, G761fs, G780fs, G801fs, G802fs, G825fs, G700fs, G757fs, G786fs, G532fs, G716fs, G787fs, G717fs, G740fs, G827fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266267	17	41245067	17	43093050	266267	261834	rs886040042	NC_000017.11:43093049:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2479_2480del (p.Glu827fs)	BRCA1	E780fs, E827fs, E715fs, E786fs, E826fs, E659fs, E738fs, E756fs, E757fs, E759fs, E801fs, E824fs, E700fs, E739fs, E779fs, E800fs, E716fs, E760fs, E785fs, E531fs, E699fs	Hereditary breast ovarian cancer syndrome	VCV001068565	17	41245068 - 41245069	17	43093051 - 43093052	1068565	1064212	rs2154375290	NC_000017.11:43093050:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Aug 10, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2477_2478insT (p.Glu827fs)	BRCA1	E780fs, E827fs, E659fs, E699fs, E716fs, E801fs, E826fs, E715fs, E757fs, E759fs, E824fs, E531fs, E700fs, E738fs, E760fs, E785fs, E786fs, E800fs, E739fs, E756fs, E779fs	Hereditary cancer-predisposing syndrome	VCV001791842	17	41245070 - 41245071	17	43093053 - 43093054	1791842	1845275	rs2552188174	NC_000017.11:43093053::A	Insertion	frameshift variant|intron variant	Pathogenic	Aug 18, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2477_2478del (p.Thr826fs)	BRCA1	T826fs, T779fs, T530fs, T699fs, T799fs, T800fs, T715fs, T737fs, T825fs, T738fs, T778fs, T785fs, T658fs, T698fs, T714fs, T755fs, T756fs, T758fs, T759fs, T784fs, T823fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054578	17	41245070 - 41245071	17	43093053 - 43093054	54578	69245	rs80357800	NC_000017.11:43093052:TGTGT:TGT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2477del (p.Thr826fs)	BRCA1	T779fs, T826fs, T530fs, T738fs, T778fs, T785fs, T699fs, T756fs, T758fs, T784fs, T800fs, T698fs, T714fs, T737fs, T755fs, T823fs, T658fs, T715fs, T759fs, T799fs, T825fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054579	17	41245071	17	43093054	54579	69246	rs80357740	NC_000017.11:43093053:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2476del (p.Thr826fs)	BRCA1	T779fs, T826fs, T737fs, T759fs, T784fs, T785fs, T823fs, T530fs, T658fs, T699fs, T714fs, T738fs, T755fs, T758fs, T799fs, T825fs, T698fs, T715fs, T800fs, T756fs, T778fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054577	17	41245072	17	43093055	54577	69244	rs80357631	NC_000017.11:43093054:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2473_2475delinsTAA (p.Asp825Ter)	BRCA1	D778*, D825*, D529*, D698*, D737*, D798*, D824*, D697*, D713*, D754*, D777*, D784*, D755*, D783*, D799*, D822*, D657*, D714*, D736*, D757*, D758*	Hereditary cancer-predisposing syndrome	VCV001171638	17	41245073 - 41245075	17	43093056 - 43093058	1171638	1161361	rs2154375606	NC_000017.11:43093055:GTC:TTA	Indel	nonsense|intron variant	Pathogenic	Dec 21, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2474dup (p.Asp825fs)	BRCA1	D825fs, D778fs, D736fs, D737fs, D755fs, D758fs, D697fs, D714fs, D754fs, D777fs, D798fs, D799fs, D529fs, D657fs, D698fs, D783fs, D822fs, D824fs, D713fs, D757fs, D784fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125571	17	41245073 - 41245074	17	43093056 - 43093057	125571	131109	rs80357830	NC_000017.11:43093056:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2475del (p.Asp825fs)	BRCA1	D778fs, D825fs, D529fs, D657fs, D698fs, D755fs, D697fs, D713fs, D714fs, D757fs, D758fs, D822fs, D736fs, D737fs, D783fs, D784fs, D798fs, D824fs, D754fs, D777fs, D799fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037472	17	41245073	17	43093056	37472	46028	rs80357970	NC_000017.11:43093055:G:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2473del (p.Asp825fs)	BRCA1	D825fs, D778fs, D713fs, D714fs, D737fs, D757fs, D777fs, D822fs, D529fs, D698fs, D754fs, D758fs, D798fs, D799fs, D657fs, D697fs, D736fs, D755fs, D783fs, D784fs, D824fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266265	17	41245075	17	43093058	266265	261835	rs886040040	NC_000017.11:43093057:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2471del (p.Asn824fs)	BRCA1	N777fs, N824fs, N528fs, N697fs, N735fs, N798fs, N823fs, N712fs, N736fs, N797fs, N821fs, N696fs, N713fs, N753fs, N754fs, N756fs, N782fs, N656fs, N757fs, N776fs, N783fs	Hereditary breast ovarian cancer syndrome	VCV000951341	17	41245077	17	43093060	951341	928304	rs1567795563	NC_000017.11:43093059:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	May 1, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2468del (p.Arg823fs)	BRCA1	R776fs, R823fs, R696fs, R711fs, R735fs, R752fs, R753fs, R756fs, R782fs, R797fs, R822fs, R527fs, R695fs, R712fs, R734fs, R755fs, R781fs, R655fs, R775fs, R796fs, R820fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054574	17	41245080	17	43093063	54574	69241	rs80357799	NC_000017.11:43093062:C:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2467del (p.Arg823fs)	BRCA1	R776fs, R823fs, R696fs, R734fs, R752fs, R695fs, R711fs, R712fs, R735fs, R753fs, R755fs, R775fs, R781fs, R822fs, R527fs, R782fs, R796fs, R797fs, R655fs, R756fs, R820fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000421918	17	41245081	17	43093064	421918	410000	rs1064795446	NC_000017.11:43093063:T:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2457del (p.Asp821fs)	BRCA1	D821fs, D774fs, D525fs, D709fs, D733fs, D794fs, D653fs, D693fs, D753fs, D795fs, D754fs, D779fs, D780fs, D818fs, D820fs, D694fs, D710fs, D732fs, D750fs, D751fs, D773fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037471	17	41245091	17	43093074	37471	46027	rs80357669	NC_000017.11:43093073:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2450dup (p.Cys818fs)	BRCA1	C771fs, C818fs, C522fs, C730fs, C770fs, C776fs, C791fs, C729fs, C751fs, C815fs, C691fs, C706fs, C707fs, C750fs, C777fs, C650fs, C690fs, C747fs, C748fs, C792fs, C817fs	Hereditary cancer-predisposing syndrome	VCV001791482	17	41245097 - 41245098	17	43093080 - 43093081	1791482	1848301	rs80357679	NC_000017.11:43093080:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 1, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2437_2450del (p.Gly813fs)	BRCA1	G766fs, G813fs, G685fs, G701fs, G743fs, G771fs, G772fs, G810fs, G702fs, G724fs, G746fs, G645fs, G686fs, G742fs, G745fs, G765fs, G812fs, G517fs, G725fs, G786fs, G787fs	Hereditary breast ovarian cancer syndrome	VCV000842645	17	41245098 - 41245111	17	43093081 - 43093094	842645	845422	rs2053758543	NC_000017.11:43093080:CCATGAATTAGTCCC:C	Deletion	intron variant|frameshift variant	Pathogenic	Jan 25, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2450del (p.Gly817fs)	BRCA1	G817fs, G770fs, G689fs, G728fs, G746fs, G790fs, G816fs, G521fs, G690fs, G705fs, G706fs, G729fs, G747fs, G769fs, G776fs, G750fs, G814fs, G649fs, G749fs, G775fs, G791fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054573	17	41245098	17	43093081	54573	69240	rs80357679	NC_000017.11:43093080:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2445_2448del (p.Ile815fs)	BRCA1	I815fs, I768fs, I647fs, I687fs, I773fs, I789fs, I726fs, I767fs, I519fs, I688fs, I727fs, I745fs, I747fs, I812fs, I814fs, I703fs, I704fs, I744fs, I748fs, I774fs, I788fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254413	17	41245100 - 41245103	17	43093083 - 43093086	254413	249130	rs886038000	NC_000017.11:43093082:ATGAAT:AT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2445dup (p.His816fs)	BRCA1	H769fs, H816fs, H648fs, H688fs, H689fs, H745fs, H746fs, H748fs, H790fs, H704fs, H705fs, H728fs, H768fs, H789fs, H815fs, H520fs, H749fs, H775fs, H727fs, H774fs, H813fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548226	17	41245102 - 41245103	17	43093085 - 43093086	548226	538848	rs1555589652	NC_000017.11:43093085:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2443dup (p.Ile815fs)	BRCA1	I768fs, I815fs, I727fs, I748fs, I773fs, I788fs, I519fs, I745fs, I747fs, I767fs, I774fs, I814fs, I647fs, I688fs, I726fs, I744fs, I789fs, I687fs, I703fs, I704fs, I812fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548313	17	41245104 - 41245105	17	43093087 - 43093088	548313	538849	rs80357598	NC_000017.11:43093087:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2442_2443insT (p.Ile815fs)	BRCA1	I815fs, I768fs, I687fs, I726fs, I788fs, I519fs, I704fs, I727fs, I747fs, I767fs, I774fs, I647fs, I688fs, I703fs, I744fs, I748fs, I814fs, I745fs, I773fs, I789fs, I812fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266263	17	41245105 - 41245106	17	43093088 - 43093089	266263	261836	rs886040038	NC_000017.11:43093088::A	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2443del (p.Ile815fs)	BRCA1	I815fs, I768fs, I703fs, I726fs, I745fs, I774fs, I789fs, I812fs, I647fs, I688fs, I704fs, I744fs, I748fs, I788fs, I747fs, I773fs, I814fs, I519fs, I687fs, I727fs, I767fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054572	17	41245105	17	43093088	54572	69239	rs80357598	NC_000017.11:43093087:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2438_2439dup (p.Leu814fs)	BRCA1	L814fs, L767fs, L518fs, L686fs, L687fs, L725fs, L744fs, L813fs, L646fs, L703fs, L746fs, L772fs, L773fs, L788fs, L726fs, L743fs, L747fs, L787fs, L811fs, L702fs, L766fs	Hereditary breast ovarian cancer syndrome	VCV002108902	17	41245108 - 41245109	17	43093091 - 43093092	2108902	2170660	rs2552188577	NC_000017.11:43093091:TC:TCTC	Duplication	intron variant|frameshift variant	Pathogenic	Jun 8, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2436_2439del (p.Lys812fs)	BRCA1	K516fs, K644fs, K684fs, K685fs, K700fs, K701fs, K723fs, K724fs, K741fs, K742fs, K744fs, K745fs, K764fs, K765fs, K770fs, K771fs, K785fs, K786fs, K809fs, K811fs, K812fs	Fanconi anemia, complementation group S	VCV003778928	17	41245109 - 41245112	17	43093092 - 43093095	3778928	3894915		NC_000017.11:43093091:TCCCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Feb 3, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2438dup (p.Leu814fs)	BRCA1	L767fs, L814fs, L702fs, L725fs, L726fs, L772fs, L773fs, L813fs, L687fs, L703fs, L788fs, L811fs, L518fs, L743fs, L746fs, L766fs, L646fs, L686fs, L744fs, L747fs, L787fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125568	17	41245109 - 41245110	17	43093092 - 43093093	125568	131106	rs80357503	NC_000017.11:43093092:CCC:CCCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2437G>T (p.Gly813Ter)	BRCA1	G813*, G766*, G517*, G685*, G742*, G771*, G810*, G686*, G786*, G812*, G645*, G724*, G743*, G745*, G765*, G772*, G787*, G701*, G702*, G725*, G746*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054570	17	41245111	17	43093094	54570	69237	rs80357186	NC_000017.11:43093093:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2433dup (p.Lys812fs)	BRCA1	K765fs, K812fs, K811fs, K644fs, K701fs, K724fs, K764fs, K685fs, K723fs, K744fs, K770fs, K786fs, K809fs, K516fs, K684fs, K700fs, K785fs, K741fs, K742fs, K745fs, K771fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230060	17	41245114 - 41245115	17	43093097 - 43093098	230060	236075	rs80357524	NC_000017.11:43093097:GGGG:GGGGG	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2434A>T (p.Lys812Ter)	BRCA1	K812*, K765*, K516*, K644*, K724*, K764*, K771*, K811*, K723*, K741*, K745*, K770*, K701*, K742*, K785*, K786*, K684*, K685*, K700*, K744*, K809*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054569	17	41245114	17	43093097	54569	69236	rs397508968	NC_000017.11:43093096:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2433del (p.Lys812fs)	BRCA1	K812fs, K765fs, K516fs, K684fs, K764fs, K771fs, K644fs, K701fs, K723fs, K786fs, K811fs, K700fs, K741fs, K742fs, K770fs, K785fs, K809fs, K685fs, K724fs, K744fs, K745fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037469	17	41245115	17	43093098	37469	46025	rs80357524	NC_000017.11:43093097:GGGG:GGG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2429dup (p.Asn810fs)	BRCA1	N763fs, N810fs, N698fs, N739fs, N783fs, N784fs, N514fs, N682fs, N740fs, N742fs, N743fs, N768fs, N807fs, N809fs, N762fs, N642fs, N683fs, N699fs, N721fs, N722fs, N769fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266262	17	41245118 - 41245119	17	43093101 - 43093102	266262	261837	rs397508967	NC_000017.11:43093101:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2429del (p.Asn810fs)	BRCA1	N810fs, N763fs, N514fs, N722fs, N742fs, N743fs, N762fs, N768fs, N642fs, N683fs, N698fs, N699fs, N739fs, N783fs, N784fs, N682fs, N721fs, N740fs, N769fs, N807fs, N809fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054568	17	41245119	17	43093102	54568	69235	rs397508967	NC_000017.11:43093101:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2424del (p.Phe808fs)	BRCA1	F761fs, F808fs, F640fs, F680fs, F719fs, F720fs, F738fs, F760fs, F766fs, F782fs, F807fs, F696fs, F740fs, F741fs, F767fs, F512fs, F681fs, F697fs, F737fs, F781fs, F805fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037467	17	41245124	17	43093107	37467	46023	rs397507200	NC_000017.11:43093106:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2416_2422del (p.Ala806fs)	BRCA1	A510fs, A638fs, A678fs, A679fs, A694fs, A695fs, A717fs, A718fs, A735fs, A736fs, A738fs, A739fs, A758fs, A759fs, A764fs, A765fs, A779fs, A780fs, A803fs, A805fs, A806fs	not provided	VCV003337516	17	41245126 - 41245132	17	43093109 - 43093115	3337516	3496177		NC_000017.11:43093108:ATGCTGCA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 18, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2418dup (p.Ala807fs)	BRCA1	A760fs, A807fs, A739fs, A740fs, A806fs, A680fs, A696fs, A718fs, A719fs, A736fs, A765fs, A639fs, A695fs, A737fs, A781fs, A511fs, A679fs, A759fs, A766fs, A780fs, A804fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266261	17	41245129 - 41245130	17	43093112 - 43093113	266261	261838	rs886040036	NC_000017.11:43093112:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2418del (p.Ala807fs)	BRCA1	A807fs, A760fs, A759fs, A639fs, A696fs, A739fs, A780fs, A804fs, A695fs, A718fs, A719fs, A737fs, A740fs, A766fs, A806fs, A511fs, A679fs, A680fs, A736fs, A765fs, A781fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252379	17	41245130	17	43093113	252379	246820	rs879255281	NC_000017.11:43093112:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2416_2417del (p.Ala806fs)	BRCA1	A806fs, A759fs, A678fs, A779fs, A679fs, A694fs, A718fs, A738fs, A739fs, A764fs, A695fs, A717fs, A735fs, A736fs, A765fs, A780fs, A510fs, A638fs, A758fs, A803fs, A805fs	Hereditary cancer-predisposing syndrome	VCV000491045	17	41245131 - 41245132	17	43093114 - 43093115	491045	485171	rs1555589706	NC_000017.11:43093113:GC:	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2415_2416del (p.Ala806fs)	BRCA1	A759fs, A806fs, A510fs, A638fs, A718fs, A738fs, A805fs, A679fs, A717fs, A736fs, A739fs, A765fs, A780fs, A695fs, A764fs, A779fs, A678fs, A694fs, A735fs, A758fs, A803fs	Hereditary cancer-predisposing syndrome	VCV001790927	17	41245132 - 41245133	17	43093115 - 43093116	1790927	1851288	rs2552188800	NC_000017.11:43093114:CACAC:CAC	Microsatellite	intron variant|frameshift variant	Pathogenic	Mar 17, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2415T>A (p.Cys805Ter)	BRCA1	C758*, C805*, C637*, C678*, C716*, C509*, C735*, C738*, C694*, C737*, C757*, C763*, C778*, C779*, C804*, C677*, C693*, C717*, C734*, C764*, C802*	Hereditary cancer-predisposing syndrome	VCV000821145	17	41245133	17	43093116	821145	813798	rs1597870104	NC_000017.11:43093115:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 17, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2410_2413del (p.Gln804fs)	BRCA1	Q508fs, Q636fs, Q676fs, Q677fs, Q692fs, Q693fs, Q715fs, Q716fs, Q733fs, Q734fs, Q736fs, Q737fs, Q756fs, Q757fs, Q762fs, Q763fs, Q777fs, Q778fs, Q801fs, Q803fs, Q804fs	not provided	VCV004076606	17	41245135 - 41245138	17	43093118 - 43093121	4076606	4189288		NC_000017.11:43093117:ACTGACT:ACT	Deletion	frameshift variant|intron variant	Pathogenic	Feb 20, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2412dup (p.Cys805fs)	BRCA1	C758fs, C805fs, C637fs, C693fs, C694fs, C734fs, C757fs, C764fs, C677fs, C735fs, C737fs, C738fs, C779fs, C802fs, C716fs, C717fs, C509fs, C678fs, C763fs, C778fs, C804fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002431293	17	41245135 - 41245136	17	43093118 - 43093119	2431293	2404798	rs2552188875	NC_000017.11:43093118:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2411_2412del (p.Gln804fs)	BRCA1	Q757fs, Q804fs, Q692fs, Q716fs, Q736fs, Q508fs, Q676fs, Q734fs, Q762fs, Q763fs, Q777fs, Q636fs, Q677fs, Q693fs, Q803fs, Q715fs, Q733fs, Q737fs, Q756fs, Q778fs, Q801fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037466	17	41245136 - 41245137	17	43093119 - 43093120	37466	46022	rs80357664	NC_000017.11:43093118:CT:	Deletion	intron variant|frameshift variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2411del (p.Gln804fs)	BRCA1	Q757fs, Q804fs, Q508fs, Q676fs, Q677fs, Q734fs, Q762fs, Q777fs, Q803fs, Q693fs, Q715fs, Q716fs, Q763fs, Q801fs, Q636fs, Q737fs, Q692fs, Q733fs, Q736fs, Q756fs, Q778fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266260	17	41245137	17	43093120	266260	261840	rs886040035	NC_000017.11:43093119:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2398_2411del (p.Lys800fs)	BRCA1	K753fs, K800fs, K504fs, K672fs, K711fs, K712fs, K759fs, K774fs, K673fs, K730fs, K733fs, K689fs, K773fs, K797fs, K632fs, K688fs, K729fs, K732fs, K752fs, K758fs, K799fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266259	17	41245137 - 41245150	17	43093120 - 43093133	266259	261839	rs886040034	NC_000017.11:43093119:TGACTCACACATTT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2410C>T (p.Gln804Ter)	BRCA1	Q804*, Q757*, Q508*, Q692*, Q716*, Q756*, Q762*, Q763*, Q803*, Q636*, Q715*, Q733*, Q777*, Q801*, Q677*, Q693*, Q736*, Q737*, Q778*, Q676*, Q734*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054560	17	41245138	17	43093121	54560	69227	rs80356982	NC_000017.11:43093120:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2409del (p.Gln804fs)	BRCA1	Q804fs, Q757fs, Q734fs, Q763fs, Q801fs, Q677fs, Q693fs, Q715fs, Q733fs, Q777fs, Q508fs, Q636fs, Q716fs, Q736fs, Q762fs, Q676fs, Q692fs, Q737fs, Q756fs, Q778fs, Q803fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254412	17	41245139	17	43093122	254412	249131	rs770460699	NC_000017.11:43093121:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2406_2409del (p.Gln804fs)	BRCA1	Q757fs, Q804fs, Q693fs, Q716fs, Q508fs, Q636fs, Q676fs, Q736fs, Q737fs, Q762fs, Q763fs, Q801fs, Q715fs, Q733fs, Q777fs, Q803fs, Q677fs, Q692fs, Q734fs, Q756fs, Q778fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054559	17	41245139 - 41245142	17	43093122 - 43093125	54559	69226	rs80357674	NC_000017.11:43093121:ACTCAC:AC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2407_2408del (p.Gln804fs)	BRCA1	Q804fs, Q757fs, Q692fs, Q715fs, Q733fs, Q777fs, Q778fs, Q803fs, Q734fs, Q737fs, Q762fs, Q763fs, Q508fs, Q636fs, Q677fs, Q756fs, Q801fs, Q676fs, Q693fs, Q716fs, Q736fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186397	17	41245140 - 41245141	17	43093123 - 43093124	186397	185023	rs786202919	NC_000017.11:43093122:CTC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2405dup (p.Ser803fs)	BRCA1	S676fs, S691fs, S733fs, S755fs, S756fs, S762fs, S803fs, S635fs, S692fs, S714fs, S761fs, S802fs, S507fs, S715fs, S735fs, S736fs, S800fs, S675fs, S732fs, S776fs, S777fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002450681	17	41245142 - 41245143	17	43093125 - 43093126	2450681	2423167	rs2552189026	NC_000017.11:43093125:A:AA	Duplication	intron variant|frameshift variant	Pathogenic/Likely pathogenic	Feb 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2405_2406del (p.Val802fs)	BRCA1	V802fs, V755fs, V675fs, V690fs, V691fs, V731fs, V735fs, V776fs, V674fs, V713fs, V734fs, V775fs, V801fs, V714fs, V754fs, V760fs, V761fs, V799fs, V506fs, V634fs, V732fs	Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Breast neoplasm|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054558	17	41245142 - 41245143	17	43093125 - 43093126	54558	69225	rs80357706	NC_000017.11:43093124:CACACA:CACA	Microsatellite	frameshift variant|intron variant	Pathogenic	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2402_2404delinsCATTTCCCCTATAGCAAAAACATGACGGCACTTACTGTATCAA (p.Cys801_Val802delinsSerPheProLeuTer)	BRCA1		Hereditary breast ovarian cancer syndrome|not provided	VCV000619788	17	41245144 - 41245146	17	43093127 - 43093129	619788	611241	rs1567795809	NC_000017.11:43093126:CAC:TTGATACAGTAAGTGCCGTCATGTTTTTGCTATAGGGGAAATG	Indel	nonsense|intron variant	Pathogenic/Likely pathogenic	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2403T>A (p.Cys801Ter)	BRCA1	C801*, C754*, C689*, C731*, C753*, C759*, C760*, C798*, C633*, C690*, C730*, C775*, C800*, C673*, C712*, C734*, C505*, C674*, C713*, C733*, C774*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054557	17	41245145	17	43093128	54557	69224	rs80357381	NC_000017.11:43093127:A:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2402del (p.Cys801fs)	BRCA1	C801fs, C754fs, C633fs, C674fs, C713fs, C731fs, C753fs, C760fs, C775fs, C798fs, C505fs, C673fs, C734fs, C712fs, C733fs, C774fs, C689fs, C690fs, C730fs, C759fs, C800fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231926	17	41245146	17	43093129	231926	236077	rs876659447	NC_000017.11:43093128:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2398_2401del (p.Lys800fs)	BRCA1	K753fs, K800fs, K632fs, K672fs, K688fs, K729fs, K759fs, K774fs, K504fs, K673fs, K711fs, K712fs, K730fs, K752fs, K758fs, K799fs, K733fs, K773fs, K797fs, K689fs, K732fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186090	17	41245147 - 41245150	17	43093130 - 43093133	186090	185024	rs786202684	NC_000017.11:43093129:ATTTATTT:ATTT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2396del (p.Asn799fs)	BRCA1	N752fs, N799fs, N503fs, N687fs, N688fs, N710fs, N711fs, N757fs, N772fs, N773fs, N631fs, N729fs, N732fs, N798fs, N671fs, N731fs, N751fs, N758fs, N672fs, N728fs, N796fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266258	17	41245152	17	43093135	266258	261841	rs886040033	NC_000017.11:43093134:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2340_2394dup (p.Asn799delinsGlyLysTyrLeuValThrGlySerTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV000821125	17	41245153 - 41245154	17	43093136 - 43093137	821125	813799	rs1597870272		Duplication	nonsense|intron variant|frameshift variant	Pathogenic	Jan 11, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2392_2393delinsA (p.Pro798fs)	BRCA1	P798fs, P751fs, P686fs, P709fs, P730fs, P771fs, P630fs, P671fs, P731fs, P756fs, P772fs, P502fs, P687fs, P728fs, P757fs, P797fs, P670fs, P710fs, P727fs, P750fs, P795fs	Hereditary cancer-predisposing syndrome	VCV000482912	17	41245155 - 41245156	17	43093138 - 43093139	482912	478639	rs80357850	NC_000017.11:43093137:GG:T	Indel	frameshift variant|intron variant	Pathogenic	Jun 15, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2393del (p.Pro798fs)	BRCA1	P798fs, P751fs, P502fs, P686fs, P710fs, P731fs, P771fs, P772fs, P671fs, P687fs, P727fs, P728fs, P750fs, P756fs, P630fs, P709fs, P730fs, P797fs, P670fs, P757fs, P795fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054555	17	41245155	17	43093138	54555	69222	rs80357850	NC_000017.11:43093137:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2390_2391del (p.Glu797fs)	BRCA1	E750fs, E797fs, E501fs, E629fs, E669fs, E729fs, E749fs, E685fs, E686fs, E726fs, E770fs, E730fs, E756fs, E670fs, E708fs, E709fs, E727fs, E755fs, E771fs, E794fs, E796fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054554	17	41245157 - 41245158	17	43093140 - 43093141	54554	69221	rs80357546	NC_000017.11:43093139:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2389_2390del (p.Glu797fs)	BRCA1	E750fs, E797fs, E730fs, E755fs, E756fs, E771fs, E796fs, E686fs, E727fs, E770fs, E794fs, E501fs, E629fs, E669fs, E670fs, E685fs, E708fs, E709fs, E726fs, E729fs, E749fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054552	17	41245158 - 41245159	17	43093141 - 43093142	54552	69219	rs80357695	NC_000017.11:43093140:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2389del (p.Glu797fs)	BRCA1	E750fs, E797fs, E629fs, E670fs, E685fs, E730fs, E771fs, E796fs, E501fs, E708fs, E686fs, E727fs, E755fs, E756fs, E669fs, E709fs, E726fs, E729fs, E749fs, E770fs, E794fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054553	17	41245159	17	43093142	54553	69220	rs397508965	NC_000017.11:43093141:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2389G>T (p.Glu797Ter)	BRCA1	E797*, E750*, E685*, E729*, E749*, E629*, E686*, E708*, E709*, E726*, E770*, E796*, E501*, E669*, E756*, E771*, E670*, E727*, E730*, E755*, E794*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017682	17	41245159	17	43093142	17682	32721	rs62625306	NC_000017.11:43093141:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2387dup (p.Glu797fs)	BRCA1	E750fs, E797fs, E727fs, E729fs, E629fs, E669fs, E670fs, E709fs, E726fs, E749fs, E755fs, E501fs, E708fs, E770fs, E794fs, E796fs, E685fs, E686fs, E730fs, E756fs, E771fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266256	17	41245160 - 41245161	17	43093143 - 43093144	266256	261842	rs886040031	NC_000017.11:43093143:G:GG	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2386_2387delinsT (p.Lys795_Thr796insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233279	17	41245161 - 41245162	17	43093144 - 43093145	233279	236079	rs876660305	NC_000017.11:43093143:GT:A	Indel	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2386dup (p.Thr796fs)	BRCA1	T749fs, T796fs, T628fs, T707fs, T748fs, T769fs, T685fs, T708fs, T725fs, T728fs, T770fs, T793fs, T668fs, T684fs, T754fs, T755fs, T795fs, T500fs, T669fs, T726fs, T729fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091585	17	41245161 - 41245162	17	43093144 - 43093145	91585	97062	rs398122657	NC_000017.11:43093144:TTTTT:TTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2386del (p.Thr796fs)	BRCA1	T796fs, T749fs, T628fs, T668fs, T685fs, T707fs, T725fs, T728fs, T754fs, T769fs, T770fs, T708fs, T795fs, T500fs, T684fs, T729fs, T755fs, T793fs, T669fs, T726fs, T748fs	Hereditary breast ovarian cancer syndrome	VCV000662411	17	41245162	17	43093145	662411	646004	rs398122657	NC_000017.11:43093144:TTTTT:TTTT	Deletion	frameshift variant|intron variant	Pathogenic	Jan 5, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2380dup (p.Ala794fs)	BRCA1	A747fs, A794fs, A682fs, A706fs, A626fs, A666fs, A667fs, A683fs, A723fs, A726fs, A746fs, A768fs, A793fs, A498fs, A724fs, A727fs, A791fs, A705fs, A752fs, A753fs, A767fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254411	17	41245167 - 41245168	17	43093150 - 43093151	254411	249132	rs886037999	NC_000017.11:43093150:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2378dup (p.Ala794fs)	BRCA1	A794fs, A747fs, A683fs, A726fs, A753fs, A768fs, A791fs, A498fs, A626fs, A666fs, A723fs, A724fs, A682fs, A706fs, A727fs, A767fs, A667fs, A705fs, A746fs, A752fs, A793fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000220464	17	41245169 - 41245170	17	43093152 - 43093153	220464	222669	rs864622536	NC_000017.11:43093152:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2376del (p.Lys793fs)	BRCA1	K793fs, K746fs, K625fs, K745fs, K752fs, K665fs, K704fs, K722fs, K766fs, K767fs, K792fs, K497fs, K666fs, K723fs, K725fs, K681fs, K682fs, K705fs, K726fs, K751fs, K790fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125560	17	41245172	17	43093155	125560	131098	rs80357913	NC_000017.11:43093154:CCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2368_2369del (p.Thr790fs)	BRCA1	T790fs, T743fs, T719fs, T723fs, T763fs, T494fs, T622fs, T679fs, T701fs, T742fs, T749fs, T662fs, T678fs, T722fs, T748fs, T663fs, T702fs, T720fs, T764fs, T787fs, T789fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266254	17	41245179 - 41245180	17	43093162 - 43093163	266254	261843	rs886040029	NC_000017.11:43093161:GTG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2362del (p.Val788fs)	BRCA1	V741fs, V788fs, V661fs, V720fs, V740fs, V787fs, V660fs, V717fs, V718fs, V747fs, V785fs, V492fs, V676fs, V699fs, V746fs, V761fs, V762fs, V620fs, V677fs, V700fs, V721fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231402	17	41245186	17	43093169	231402	236081	rs876659136	NC_000017.11:43093168:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2361del (p.Val788fs)	BRCA1	V741fs, V788fs, V720fs, V740fs, V761fs, V785fs, V718fs, V746fs, V787fs, V661fs, V747fs, V762fs, V492fs, V620fs, V660fs, V676fs, V677fs, V699fs, V700fs, V717fs, V721fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266253	17	41245187	17	43093170	266253	261844	rs886040028	NC_000017.11:43093169:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2359dup (p.Glu787fs)	BRCA1	E787fs, E740fs, E659fs, E698fs, E719fs, E745fs, E746fs, E784fs, E619fs, E716fs, E720fs, E760fs, E675fs, E786fs, E491fs, E660fs, E676fs, E699fs, E717fs, E739fs, E761fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054549	17	41245188 - 41245189	17	43093171 - 43093172	54549	69216	rs80357739	NC_000017.11:43093171:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2359del (p.Glu787fs)	BRCA1	E740fs, E787fs, E491fs, E698fs, E720fs, E745fs, E619fs, E675fs, E676fs, E719fs, E739fs, E784fs, E660fs, E659fs, E699fs, E716fs, E746fs, E786fs, E717fs, E760fs, E761fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054548	17	41245189	17	43093172	54548	69215	rs80357739	NC_000017.11:43093171:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2357del (p.Leu786fs)	BRCA1	L786fs, L739fs, L490fs, L618fs, L658fs, L674fs, L718fs, L719fs, L783fs, L785fs, L659fs, L698fs, L716fs, L697fs, L715fs, L744fs, L745fs, L675fs, L738fs, L759fs, L760fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054547	17	41245191	17	43093174	54547	69214	rs397508963	NC_000017.11:43093173:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2351_2357del (p.Ser784fs)	BRCA1	S737fs, S784fs, S616fs, S656fs, S657fs, S672fs, S696fs, S757fs, S673fs, S714fs, S716fs, S736fs, S742fs, S758fs, S783fs, S488fs, S717fs, S743fs, S695fs, S713fs, S781fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054544	17	41245191 - 41245197	17	43093174 - 43093180	54544	69211	rs80357820	NC_000017.11:43093173:AGTAACGAG:AG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2355dup (p.Leu786fs)	BRCA1	L739fs, L786fs, L697fs, L698fs, L490fs, L659fs, L738fs, L744fs, L658fs, L674fs, L715fs, L618fs, L675fs, L716fs, L745fs, L783fs, L718fs, L719fs, L759fs, L760fs, L785fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125556	17	41245192 - 41245193	17	43093175 - 43093176	125556	131094	rs80357990	NC_000017.11:43093175:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2356del (p.Leu786fs)	BRCA1	L786fs, L739fs, L675fs, L716fs, L738fs, L659fs, L674fs, L719fs, L745fs, L785fs, L618fs, L658fs, L698fs, L715fs, L759fs, L760fs, L783fs, L490fs, L697fs, L718fs, L744fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054546	17	41245192	17	43093175	54546	69213	rs397508962	NC_000017.11:43093174:G:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2354T>A (p.Leu785Ter)	BRCA1	L785*, L738*, L658*, L673*, L674*, L717*, L718*, L737*, L758*, L489*, L617*, L784*, L657*, L715*, L759*, L696*, L697*, L714*, L743*, L744*, L782*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054545	17	41245194	17	43093177	54545	69212	rs397508961	NC_000017.11:43093176:A:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2347_2350dup (p.Ser784fs)	BRCA1	S488fs, S616fs, S656fs, S657fs, S672fs, S673fs, S695fs, S696fs, S713fs, S714fs, S716fs, S717fs, S736fs, S737fs, S742fs, S743fs, S757fs, S758fs, S781fs, S783fs, S784fs	Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003779417	17	41245197 - 41245198	17	43093180 - 43093181	3779417	3895400		NC_000017.11:43093180:AGATA:AGATAGATA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 5, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2351C>A (p.Ser784Ter)	BRCA1	S784*, S737*, S672*, S695*, S716*, S742*, S757*, S758*, S781*, S656*, S657*, S673*, S714*, S743*, S783*, S488*, S616*, S696*, S713*, S717*, S736*	Hereditary cancer-predisposing syndrome|not provided	VCV000487430	17	41245197	17	43093180	487430	480483	rs55914168	NC_000017.11:43093179:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic/Likely pathogenic	Jul 11, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2350_2351del (p.Ser784fs)	BRCA1	S784fs, S737fs, S695fs, S713fs, S714fs, S758fs, S616fs, S656fs, S657fs, S742fs, S743fs, S488fs, S673fs, S716fs, S736fs, S757fs, S672fs, S696fs, S717fs, S781fs, S783fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054543	17	41245197 - 41245198	17	43093180 - 43093181	54543	69210	rs397508960	NC_000017.11:43093179:GAGA:GA	Microsatellite	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2347_2348del (p.Ile783fs)	BRCA1	I736fs, I783fs, I672fs, I694fs, I741fs, I757fs, I780fs, I487fs, I656fs, I713fs, I715fs, I742fs, I756fs, I671fs, I716fs, I615fs, I655fs, I695fs, I712fs, I735fs, I782fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000821131	17	41245200 - 41245201	17	43093183 - 43093184	821131	813801	rs1597870555	NC_000017.11:43093182:ATA:A	Deletion	frameshift variant|intron variant	Pathogenic	Feb 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2346dup (p.Ile783fs)	BRCA1	I736fs, I783fs, I694fs, I715fs, I716fs, I735fs, I742fs, I487fs, I695fs, I757fs, I615fs, I655fs, I656fs, I713fs, I756fs, I782fs, I671fs, I672fs, I712fs, I741fs, I780fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266252	17	41245201 - 41245202	17	43093184 - 43093185	266252	261845	rs886040027	NC_000017.11:43093184:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2344dup (p.Ser782fs)	BRCA1	S782fs, S735fs, S655fs, S693fs, S755fs, S781fs, S670fs, S694fs, S715fs, S614fs, S671fs, S712fs, S714fs, S734fs, S741fs, S486fs, S654fs, S711fs, S740fs, S756fs, S779fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000856990	17	41245203 - 41245204	17	43093186 - 43093187	856990	845427	rs2053777729	NC_000017.11:43093186:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2345del (p.Ser782fs)	BRCA1	S735fs, S782fs, S655fs, S711fs, S712fs, S614fs, S671fs, S694fs, S714fs, S734fs, S755fs, S781fs, S654fs, S670fs, S693fs, S715fs, S741fs, S756fs, S486fs, S740fs, S779fs	Hereditary cancer-predisposing syndrome	VCV000821129	17	41245203	17	43093186	821129	813802	rs1597870583	NC_000017.11:43093185:C:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 5, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2342_2343insCT (p.Glu781fs)	BRCA1	E734fs, E781fs, E669fs, E692fs, E713fs, E739fs, E780fs, E485fs, E653fs, E654fs, E693fs, E710fs, E733fs, E613fs, E711fs, E714fs, E740fs, E754fs, E755fs, E778fs, E670fs	Hereditary cancer-predisposing syndrome	VCV001789880	17	41245205 - 41245206	17	43093188 - 43093189	1789880	1848010	rs2552189867	NC_000017.11:43093188::AG	Insertion	intron variant|frameshift variant	Pathogenic	Feb 25, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2340_2343del (p.Glu781fs)	BRCA1	E734fs, E781fs, E613fs, E653fs, E693fs, E733fs, E780fs, E485fs, E711fs, E714fs, E739fs, E754fs, E654fs, E670fs, E710fs, E713fs, E669fs, E692fs, E740fs, E755fs, E778fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266251	17	41245205 - 41245208	17	43093188 - 43093191	266251	261846	rs886040026	NC_000017.11:43093187:TTCCT:T	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2341G>T (p.Glu781Ter)	BRCA1	E613*, E654*, E714*, E781*, E670*, E692*, E739*, E740*, E754*, E755*, E485*, E653*, E669*, E710*, E711*, E713*, E778*, E693*, E733*, E734*, E780*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001789877	17	41245207	17	43093190	1789877	1848007	rs757933953	NC_000017.11:43093189:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2329_2339del (p.Tyr777fs)	BRCA1	Y688fs, Y706fs, Y707fs, Y736fs, Y774fs, Y776fs, Y481fs, Y649fs, Y689fs, Y650fs, Y665fs, Y710fs, Y730fs, Y750fs, Y751fs, Y777fs, Y609fs, Y666fs, Y709fs, Y729fs, Y735fs	Hereditary breast ovarian cancer syndrome	VCV003722357	17	41245209 - 41245219	17	43093192 - 43093202	3722357	3856870		NC_000017.11:43093191:TGAGTGCCATA:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 17, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2337_2338del (p.Gln780fs)	BRCA1	Q733fs, Q780fs, Q691fs, Q713fs, Q709fs, Q710fs, Q712fs, Q754fs, Q777fs, Q612fs, Q653fs, Q692fs, Q739fs, Q484fs, Q652fs, Q668fs, Q669fs, Q732fs, Q738fs, Q753fs, Q779fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125555	17	41245210 - 41245211	17	43093193 - 43093194	125555	131093	rs80357515	NC_000017.11:43093192:GAG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2338C>T (p.Gln780Ter)	BRCA1	Q780*, Q733*, Q612*, Q669*, Q712*, Q713*, Q732*, Q738*, Q777*, Q779*, Q653*, Q668*, Q691*, Q753*, Q754*, Q652*, Q709*, Q739*, Q484*, Q692*, Q710*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054540	17	41245210	17	43093193	54540	69207	rs80356945	NC_000017.11:43093192:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2331_2332dup (p.Gly778fs)	BRCA1	G731fs, G778fs, G650fs, G666fs, G689fs, G708fs, G710fs, G711fs, G730fs, G751fs, G651fs, G667fs, G777fs, G482fs, G610fs, G690fs, G707fs, G737fs, G736fs, G752fs, G775fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252382	17	41245215 - 41245216	17	43093198 - 43093199	252382	246821	rs431825390	NC_000017.11:43093198:CA:CACA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2331T>G (p.Tyr777Ter)	BRCA1	Y777*, Y730*, Y481*, Y649*, Y688*, Y689*, Y706*, Y707*, Y736*, Y750*, Y609*, Y709*, Y710*, Y751*, Y774*, Y665*, Y666*, Y735*, Y650*, Y729*, Y776*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266250	17	41245217	17	43093200	266250	261847	rs80357444	NC_000017.11:43093199:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2331T>A (p.Tyr777Ter)	BRCA1	Y777*, Y730*, Y666*, Y688*, Y689*, Y706*, Y650*, Y751*, Y776*, Y481*, Y665*, Y709*, Y710*, Y729*, Y750*, Y609*, Y649*, Y707*, Y735*, Y736*, Y774*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054538	17	41245217	17	43093200	54538	69205	rs80357444	NC_000017.11:43093199:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2329del (p.Tyr777fs)	BRCA1	Y730fs, Y777fs, Y649fs, Y666fs, Y709fs, Y735fs, Y736fs, Y774fs, Y481fs, Y688fs, Y729fs, Y750fs, Y689fs, Y706fs, Y707fs, Y609fs, Y650fs, Y665fs, Y710fs, Y751fs, Y776fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054536	17	41245219	17	43093202	54536	69203	rs80357725	NC_000017.11:43093201:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2327dup (p.Asp776fs)	BRCA1	D776fs, D729fs, D648fs, D706fs, D708fs, D735fs, D480fs, D664fs, D665fs, D687fs, D705fs, D734fs, D749fs, D688fs, D728fs, D775fs, D608fs, D649fs, D709fs, D750fs, D773fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548187	17	41245220 - 41245221	17	43093203 - 43093204	548187	538850	rs1555589901	NC_000017.11:43093203:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2325_2326insAA (p.Asp776fs)	BRCA1	D664fs, D728fs, D776fs, D648fs, D687fs, D706fs, D708fs, D735fs, D608fs, D688fs, D705fs, D709fs, D734fs, D750fs, D773fs, D480fs, D649fs, D665fs, D729fs, D749fs, D775fs	Hereditary cancer-predisposing syndrome	VCV004215091	17	41245222 - 41245223	17	43093205 - 43093206	4215091	4332003		NC_000017.11:43093205::TT	Insertion	frameshift variant|intron variant	Pathogenic	Jul 22, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2311_2323del (p.Val772fs)	BRCA1	V772fs, V725fs, V604fs, V701fs, V724fs, V731fs, V476fs, V645fs, V704fs, V745fs, V746fs, V644fs, V660fs, V661fs, V705fs, V730fs, V683fs, V684fs, V702fs, V769fs, V771fs	Hereditary breast ovarian cancer syndrome	VCV000952915	17	41245225 - 41245237	17	43093208 - 43093220	952915	928308	rs2053780973	NC_000017.11:43093207:TACCAGGTACCAAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jun 8, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2322del (p.Thr775fs)	BRCA1	T728fs, T775fs, T479fs, T607fs, T648fs, T686fs, T772fs, T663fs, T687fs, T705fs, T708fs, T733fs, T734fs, T748fs, T749fs, T774fs, T704fs, T707fs, T647fs, T664fs, T727fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266249	17	41245226	17	43093209	266249	261848	rs886040025	NC_000017.11:43093208:A:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2311_2317del (p.Pro773fs)	BRCA1	P726fs, P773fs, P661fs, P684fs, P605fs, P646fs, P702fs, P705fs, P706fs, P732fs, P747fs, P772fs, P685fs, P703fs, P725fs, P731fs, P770fs, P477fs, P645fs, P662fs, P746fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409354	17	41245231 - 41245237	17	43093214 - 43093220	409354	402512	rs1060502354	NC_000017.11:43093213:GTACCAA:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2314_2315del (p.Val772fs)	BRCA1	V725fs, V772fs, V476fs, V683fs, V701fs, V704fs, V745fs, V746fs, V769fs, V661fs, V702fs, V724fs, V730fs, V731fs, V771fs, V644fs, V645fs, V684fs, V604fs, V660fs, V705fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266248	17	41245233 - 41245234	17	43093216 - 43093217	266248	261849	rs886040024	NC_000017.11:43093215:AC:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2314del (p.Val772fs)	BRCA1	V725fs, V772fs, V701fs, V704fs, V769fs, V644fs, V660fs, V684fs, V724fs, V476fs, V604fs, V645fs, V745fs, V771fs, V661fs, V683fs, V702fs, V705fs, V730fs, V731fs, V746fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054532	17	41245234	17	43093217	54532	69199	rs80357957	NC_000017.11:43093216:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2312_2313insC (p.Leu771fs)	BRCA1	L771fs, L724fs, L475fs, L644fs, L703fs, L768fs, L683fs, L700fs, L704fs, L729fs, L770fs, L643fs, L659fs, L660fs, L701fs, L723fs, L730fs, L745fs, L603fs, L682fs, L744fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548229	17	41245235 - 41245236	17	43093218 - 43093219	548229	538851	rs1555589935	NC_000017.11:43093218::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2307_2313del (p.Ile769fs)	BRCA1	I722fs, I769fs, I601fs, I698fs, I699fs, I702fs, I728fs, I743fs, I766fs, I768fs, I641fs, I658fs, I680fs, I681fs, I721fs, I727fs, I742fs, I642fs, I701fs, I473fs, I657fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266245	17	41245235 - 41245241	17	43093218 - 43093224	266245	261850	rs886040022	NC_000017.11:43093217:CAATGAA:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2312T>A (p.Leu771Ter)	BRCA1	L603*, L659*, L682*, L701*, L703*, L704*, L744*, L770*, L771*, L643*, L660*, L683*, L723*, L729*, L475*, L730*, L745*, L768*, L644*, L700*, L724*	Hereditary breast ovarian cancer syndrome	VCV002826597	17	41245236	17	43093219	2826597	2989818	rs730881481	NC_000017.11:43093218:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2311_2312insC (p.Leu771fs)	BRCA1	L724fs, L771fs, L644fs, L703fs, L729fs, L768fs, L475fs, L659fs, L682fs, L700fs, L704fs, L730fs, L744fs, L603fs, L683fs, L770fs, L643fs, L660fs, L701fs, L723fs, L745fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266247	17	41245236 - 41245237	17	43093219 - 43093220	266247	261851	rs886040023	NC_000017.11:43093219::G	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2309_2311delinsGAC (p.Ser770_Leu771delinsTer)	BRCA1	S770*	Hereditary breast ovarian cancer syndrome	VCV003896107	17	41245237 - 41245239	17	43093220 - 43093222	3896107	4011979		NC_000017.11:43093219:ATG:GTC	Indel	nonsense|intron variant	Pathogenic	Mar 19, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2292_2310dup (p.Leu771delinsArgGluTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054523	17	41245237 - 41245238	17	43093220 - 43093221	54523	69190	rs397508955	NC_000017.11:43093220:TGAAATACTGCTACTCTCT:TGAAATACTGCTACTCTCTTGAAATACTGCTACTCTCT	Duplication	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2308dup (p.Ser770fs)	BRCA1	S474fs, S602fs, S642fs, S643fs, S658fs, S659fs, S681fs, S682fs, S699fs, S700fs, S702fs, S703fs, S722fs, S723fs, S728fs, S729fs, S743fs, S744fs, S767fs, S769fs, S770fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004294252	17	41245239 - 41245240	17	43093222 - 43093223	4294252	4406777		NC_000017.11:43093222:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Aug 12, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2309C>G (p.Ser770Ter)	BRCA1	S770*, S723*, S474*, S602*, S682*, S699*, S658*, S703*, S729*, S767*, S769*, S642*, S643*, S659*, S681*, S728*, S744*, S700*, S702*, S722*, S743*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266246	17	41245239	17	43093222	266246	261852	rs80357063	NC_000017.11:43093221:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2309C>A (p.Ser770Ter)	BRCA1	S770*, S723*, S602*, S642*, S700*, S722*, S643*, S659*, S699*, S703*, S743*, S767*, S769*, S474*, S681*, S682*, S744*, S658*, S702*, S728*, S729*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054527	17	41245239	17	43093222	54527	69194	rs80357063	NC_000017.11:43093221:G:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2308del (p.Ser770fs)	BRCA1	S770fs, S723fs, S658fs, S681fs, S682fs, S743fs, S744fs, S767fs, S659fs, S699fs, S703fs, S728fs, S729fs, S602fs, S643fs, S700fs, S722fs, S769fs, S474fs, S642fs, S702fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054526	17	41245240	17	43093223	54526	69193	rs397508956	NC_000017.11:43093222:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2305_2306del (p.Ile769fs)	BRCA1	I722fs, I769fs, I641fs, I681fs, I768fs, I642fs, I658fs, I698fs, I743fs, I766fs, I657fs, I680fs, I702fs, I727fs, I742fs, I473fs, I601fs, I699fs, I701fs, I721fs, I728fs	Hereditary breast ovarian cancer syndrome	VCV001417831	17	41245242 - 41245243	17	43093225 - 43093226	1417831	1374317	rs2154384493	NC_000017.11:43093224:ATA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 29, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2302del (p.Ser768fs)	BRCA1	S768fs, S721fs, S742fs, S640fs, S720fs, S726fs, S727fs, S600fs, S656fs, S679fs, S680fs, S701fs, S765fs, S767fs, S472fs, S641fs, S657fs, S697fs, S698fs, S700fs, S741fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441331	17	41245246	17	43093229	441331	435154	rs1555589953	NC_000017.11:43093228:T:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2294_2300del (p.Glu765fs)	BRCA1	E469fs, E597fs, E637fs, E638fs, E653fs, E654fs, E676fs, E677fs, E694fs, E695fs, E697fs, E698fs, E717fs, E718fs, E723fs, E724fs, E738fs, E739fs, E762fs, E764fs, E765fs	Hereditary cancer-predisposing syndrome	VCV003893732	17	41245248 - 41245254	17	43093231 - 43093237	3893732	4009613		NC_000017.11:43093230:CTACTCTCTAC:CTAC	Deletion	intron variant|frameshift variant	Pathogenic	Apr 29, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2298dup (p.Ser767Ter)	BRCA1	S767*, S720*, S696*, S699*, S700*, S741*, S639*, S678*, S697*, S725*, S764*, S655*, S656*, S679*, S719*, S726*, S471*, S599*, S640*, S740*, S766*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188409	17	41245250	17	43093232 - 43093233	188409	186546	rs786204264	NC_000017.11:43093232:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2299del (p.Ser767fs)	BRCA1	S767fs, S720fs, S656fs, S697fs, S699fs, S725fs, S726fs, S766fs, S471fs, S640fs, S679fs, S719fs, S655fs, S696fs, S599fs, S639fs, S678fs, S700fs, S740fs, S741fs, S764fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037462	17	41245249	17	43093232	37462	46018	rs80357786	NC_000017.11:43093231:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2298del (p.Ser766fs)	BRCA1	S719fs, S766fs, S598fs, S638fs, S655fs, S696fs, S724fs, S725fs, S763fs, S765fs, S740fs, S470fs, S654fs, S695fs, S698fs, S699fs, S639fs, S677fs, S678fs, S718fs, S739fs	Hereditary breast ovarian cancer syndrome	VCV002122950	17	41245250	17	43093233	2122950	2180844	rs2552190424	NC_000017.11:43093232:A:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 31, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2297_2298del (p.Ser766fs)	BRCA1	S766fs, S719fs, S639fs, S655fs, S695fs, S724fs, S739fs, S763fs, S698fs, S740fs, S598fs, S654fs, S677fs, S699fs, S470fs, S638fs, S678fs, S696fs, S718fs, S725fs, S765fs	Hereditary cancer-predisposing syndrome	VCV000821021	17	41245250 - 41245251	17	43093233 - 43093234	821021	813806	rs1597870909	NC_000017.11:43093232:AC:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 26, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2296_2297del (p.Glu765_Ser766insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017666	17	41245251 - 41245252	17	43093234 - 43093235	17666	32705	rs80357780	NC_000017.11:43093233:CTCTCT:CTCT	Microsatellite	nonsense|intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2295del (p.Ser766fs)	BRCA1	S719fs, S766fs, S470fs, S698fs, S724fs, S739fs, S740fs, S598fs, S654fs, S655fs, S677fs, S725fs, S638fs, S678fs, S695fs, S696fs, S699fs, S639fs, S718fs, S763fs, S765fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000632678	17	41245253	17	43093236	632678	621584	rs1567796243	NC_000017.11:43093235:C:	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2293G>T (p.Glu765Ter)	BRCA1	E765*, E718*, E676*, E677*, E698*, E717*, E724*, E638*, E697*, E738*, E739*, E637*, E694*, E695*, E762*, E469*, E597*, E653*, E654*, E723*, E764*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054524	17	41245255	17	43093238	54524	69191	rs80357449	NC_000017.11:43093237:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2289del (p.Ser763_Val764insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230816	17	41245259	17	43093242	230816	236083	rs876658791	NC_000017.11:43093241:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2285_2286del (p.Arg762fs)	BRCA1	R715fs, R762fs, R651fs, R691fs, R714fs, R736fs, R635fs, R673fs, R721fs, R759fs, R761fs, R594fs, R674fs, R694fs, R720fs, R735fs, R466fs, R634fs, R650fs, R692fs, R695fs	Hereditary breast ovarian cancer syndrome	VCV001409413	17	41245262 - 41245263	17	43093245 - 43093246	1409413	1245779	rs2154385474	NC_000017.11:43093244:TCT:T	Deletion	intron variant|frameshift variant	Pathogenic	Mar 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2283_2284del (p.Arg762fs)	BRCA1	R762fs, R715fs, R650fs, R651fs, R691fs, R692fs, R720fs, R735fs, R759fs, R634fs, R635fs, R466fs, R695fs, R721fs, R736fs, R674fs, R694fs, R714fs, R761fs, R594fs, R673fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054521	17	41245264 - 41245265	17	43093247 - 43093248	54521	69188	rs80357657	NC_000017.11:43093246:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2281G>T (p.Glu761Ter)	BRCA1	E714*, E761*, E633*, E673*, E693*, E694*, E734*, E593*, E634*, E690*, E719*, E720*, E758*, E649*, E650*, E691*, E465*, E672*, E713*, E735*, E760*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001788951	17	41245267	17	43093250	1788951	1245735	rs397507198	NC_000017.11:43093249:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2246_2280del (p.Asp749fs)	BRCA1	D749fs, D702fs, D581fs, D621fs, D637fs, D746fs, D453fs, D638fs, D681fs, D682fs, D707fs, D748fs, D661fs, D723fs, D708fs, D722fs, D622fs, D660fs, D678fs, D679fs, D701fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254410	17	41245268 - 41245302	17	43093251 - 43093285	254410	249133	rs886037998	NC_000017.11:43093250:AGTTTGCAAAACCCTTTCTCCACTTAACATGAGAT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2278del (p.Thr760fs)	BRCA1	T713fs, T760fs, T592fs, T632fs, T633fs, T672fs, T712fs, T757fs, T693fs, T464fs, T649fs, T671fs, T689fs, T692fs, T733fs, T734fs, T759fs, T648fs, T690fs, T718fs, T719fs	Hereditary breast ovarian cancer syndrome	VCV000965907	17	41245270	17	43093253	965907	958133	rs2053790230	NC_000017.11:43093252:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Nov 11, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2275C>T (p.Gln759Ter)	BRCA1	Q759*, Q712*, Q631*, Q688*, Q689*, Q711*, Q756*, Q648*, Q691*, Q591*, Q632*, Q647*, Q670*, Q671*, Q717*, Q733*, Q463*, Q692*, Q718*, Q732*, Q758*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054519	17	41245273	17	43093256	54519	69186	rs80356999	NC_000017.11:43093255:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2273dup (p.Leu758fs)	BRCA1	L711fs, L758fs, L462fs, L687fs, L731fs, L631fs, L646fs, L647fs, L688fs, L717fs, L732fs, L590fs, L670fs, L690fs, L710fs, L716fs, L630fs, L669fs, L691fs, L755fs, L757fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125552	17	41245274 - 41245275	17	43093257 - 43093258	125552	131090	rs80357681	NC_000017.11:43093257:AAAA:AAAAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2273T>A (p.Leu758Ter)	BRCA1	L758*, L711*, L462*, L688*, L691*, L731*, L757*, L630*, L646*, L669*, L716*, L717*, L670*, L710*, L590*, L631*, L647*, L687*, L690*, L732*, L755*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409317	17	41245275	17	43093258	409317	402018	rs1060502334	NC_000017.11:43093257:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2273del (p.Leu758fs)	BRCA1	L758fs, L711fs, L630fs, L647fs, L710fs, L757fs, L590fs, L691fs, L731fs, L462fs, L631fs, L670fs, L690fs, L717fs, L732fs, L755fs, L646fs, L669fs, L687fs, L688fs, L716fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266244	17	41245275	17	43093258	266244	261853	rs80357681	NC_000017.11:43093257:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2269del (p.Val757fs)	BRCA1	V757fs, V710fs, V686fs, V690fs, V754fs, V461fs, V630fs, V669fs, V689fs, V730fs, V646fs, V668fs, V687fs, V715fs, V716fs, V756fs, V589fs, V629fs, V645fs, V709fs, V731fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037459	17	41245279	17	43093262	37459	46015	rs80357583	NC_000017.11:43093261:CCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2266_2267del (p.Arg756fs)	BRCA1	R460fs, R588fs, R628fs, R629fs, R644fs, R645fs, R667fs, R668fs, R685fs, R686fs, R688fs, R689fs, R708fs, R709fs, R714fs, R715fs, R729fs, R730fs, R753fs, R755fs, R756fs	not provided	VCV002576278	17	41245281 - 41245282	17	43093264 - 43093265	2576278	2741174	rs2552190792	NC_000017.11:43093263:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2263del (p.Glu755fs)	BRCA1	E708fs, E755fs, E459fs, E644fs, E707fs, E713fs, E754fs, E687fs, E729fs, E627fs, E643fs, E666fs, E685fs, E688fs, E752fs, E587fs, E628fs, E667fs, E684fs, E714fs, E728fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054517	17	41245285	17	43093268	54517	69184	rs80357960	NC_000017.11:43093267:C:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2263G>T (p.Glu755Ter)	BRCA1	E755*, E708*, E627*, E666*, E684*, E687*, E728*, E754*, E644*, E714*, E729*, E459*, E685*, E752*, E587*, E628*, E643*, E667*, E688*, E707*, E713*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054516	17	41245285	17	43093268	54516	69183	rs41286296	NC_000017.11:43093267:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2262del (p.Glu755fs)	BRCA1	E708fs, E755fs, E628fs, E643fs, E667fs, E687fs, E707fs, E713fs, E587fs, E644fs, E666fs, E684fs, E714fs, E752fs, E459fs, E627fs, E685fs, E688fs, E728fs, E729fs, E754fs	Hereditary breast ovarian cancer syndrome	VCV001365174	17	41245286	17	43093269	1365174	1502218	rs2154386642	NC_000017.11:43093268:T:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 3, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2256_2260del (p.Ser753fs)	BRCA1	S753fs, S706fs, S585fs, S625fs, S683fs, S705fs, S727fs, S457fs, S642fs, S664fs, S711fs, S641fs, S665fs, S712fs, S726fs, S626fs, S682fs, S685fs, S686fs, S750fs, S752fs	Hereditary breast ovarian cancer syndrome	VCV000965126	17	41245288 - 41245292	17	43093271 - 43093275	965126	958135	rs2053792576	NC_000017.11:43093270:CACTT:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 3, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2260G>T (p.Gly754Ter)	BRCA1	G707*, G754*, G586*, G642*, G683*, G687*, G712*, G627*, G643*, G666*, G686*, G706*, G713*, G665*, G684*, G727*, G751*, G753*, G458*, G626*, G728*	Hereditary cancer-predisposing syndrome	VCV000919467	17	41245288	17	43093271	919467	913928	rs2053792392	NC_000017.11:43093270:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	May 1, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2257dup (p.Ser753fs)	BRCA1	S706fs, S753fs, S585fs, S625fs, S705fs, S727fs, S457fs, S641fs, S642fs, S664fs, S685fs, S750fs, S626fs, S665fs, S682fs, S683fs, S712fs, S752fs, S686fs, S711fs, S726fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417829	17	41245290 - 41245291	17	43093273 - 43093274	417829	404714	rs1555590033	NC_000017.11:43093273:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2174_2256dup (p.Ser753delinsAlaPheGlnGluLysLysLysLysArgAsnTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV001787143	17	41245291 - 41245292	17	43093274 - 43093275	1787143	1840664	rs2552190906		Duplication	nonsense|intron variant|frameshift variant	Pathogenic	Feb 26, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2255_2256dup (p.Ser753Ter)	BRCA1	S753*, S706*, S641*, S682*, S686*, S457*, S625*, S642*, S705*, S711*, S712*, S585*, S664*, S665*, S683*, S685*, S726*, S752*, S626*, S727*, S750*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254409	17	41245291 - 41245292	17	43093274 - 43093275	254409	249134	rs80357557	NC_000017.11:43093274:TA:TATA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2255T>A (p.Leu752Ter)	BRCA1	L752*, L705*, L682*, L685*, L751*, L456*, L584*, L663*, L681*, L710*, L641*, L684*, L725*, L726*, L749*, L624*, L625*, L640*, L664*, L704*, L711*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431225	17	41245293	17	43093276	431225	424837	rs1135401852	NC_000017.11:43093275:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2253_2254del (p.Met751fs)	BRCA1	M751fs, M704fs, M455fs, M583fs, M639fs, M640fs, M662fs, M683fs, M709fs, M710fs, M663fs, M703fs, M725fs, M748fs, M623fs, M624fs, M724fs, M680fs, M681fs, M684fs, M750fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054515	17	41245294 - 41245295	17	43093277 - 43093278	54515	69182	rs80357602	NC_000017.11:43093276:ACA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2248_2252del (p.Leu750fs)	BRCA1	L703fs, L750fs, L623fs, L639fs, L662fs, L724fs, L454fs, L661fs, L683fs, L708fs, L622fs, L679fs, L680fs, L682fs, L702fs, L709fs, L747fs, L749fs, L582fs, L638fs, L723fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054513	17	41245296 - 41245300	17	43093279 - 43093283	54513	69180	rs397508954	NC_000017.11:43093278:ATGAGAT:AT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2242_2251del (p.Lys748fs)	BRCA1	K701fs, K748fs, K452fs, K636fs, K678fs, K681fs, K580fs, K677fs, K700fs, K620fs, K621fs, K680fs, K722fs, K745fs, K637fs, K659fs, K660fs, K706fs, K707fs, K721fs, K747fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254408	17	41245297 - 41245306	17	43093280 - 43093289	254408	249135	rs886037997	NC_000017.11:43093279:TGAGATCTTT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2247_2248insGA (p.Leu750fs)	BRCA1	L703fs, L750fs, L454fs, L582fs, L622fs, L679fs, L747fs, L749fs, L623fs, L638fs, L661fs, L680fs, L723fs, L639fs, L662fs, L683fs, L702fs, L708fs, L724fs, L682fs, L709fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548213	17	41245300 - 41245301	17	43093283 - 43093284	548213	538852	rs1555590055	NC_000017.11:43093283::TC	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2245del (p.Asp749fs)	BRCA1	D702fs, D749fs, D622fs, D678fs, D681fs, D722fs, D723fs, D746fs, D748fs, D581fs, D660fs, D661fs, D701fs, D707fs, D708fs, D621fs, D638fs, D682fs, D453fs, D637fs, D679fs	Hereditary cancer-predisposing syndrome	VCV000920249	17	41245303	17	43093286	920249	913929	rs2053796108	NC_000017.11:43093285:C:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 15, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2244dup (p.Asp749fs)	BRCA1	D702fs, D749fs, D621fs, D637fs, D707fs, D708fs, D748fs, D622fs, D678fs, D682fs, D722fs, D660fs, D661fs, D681fs, D723fs, D746fs, D453fs, D581fs, D638fs, D679fs, D701fs	Hereditary breast ovarian cancer syndrome	VCV000856461	17	41245303 - 41245304	17	43093286 - 43093287	856461	845429	rs2053796291	NC_000017.11:43093286:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Mar 13, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2244del (p.Asp749fs)	BRCA1	D702fs, D749fs, D581fs, D621fs, D638fs, D682fs, D746fs, D748fs, D453fs, D660fs, D661fs, D701fs, D707fs, D708fs, D622fs, D637fs, D678fs, D679fs, D723fs, D681fs, D722fs	Hereditary cancer-predisposing syndrome	VCV001788321	17	41245304	17	43093287	1788321	1844383	rs2053796291	NC_000017.11:43093286:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2241dup (p.Lys748fs)	BRCA1	K748fs, K701fs, K580fs, K621fs, K637fs, K678fs, K680fs, K681fs, K706fs, K745fs, K747fs, K636fs, K707fs, K721fs, K452fs, K659fs, K660fs, K722fs, K620fs, K677fs, K700fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054511	17	41245306 - 41245307	17	43093289 - 43093290	54511	69178	rs80357650	NC_000017.11:43093289:GGGG:GGGGG	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2241del (p.Asp749fs)	BRCA1	D702fs, D749fs, D621fs, D637fs, D707fs, D723fs, D660fs, D661fs, D678fs, D681fs, D581fs, D622fs, D679fs, D701fs, D746fs, D748fs, D453fs, D638fs, D682fs, D708fs, D722fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054510	17	41245307	17	43093290	54510	69177	rs80357650	NC_000017.11:43093289:GGGG:GGG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2236dup (p.Asp746fs)	BRCA1	D699fs, D746fs, D450fs, D578fs, D618fs, D657fs, D676fs, D678fs, D635fs, D675fs, D704fs, D719fs, D745fs, D619fs, D634fs, D698fs, D743fs, D658fs, D679fs, D705fs, D720fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054509	17	41245311 - 41245312	17	43093294 - 43093295	54509	69176	rs80357909	NC_000017.11:43093294:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2233G>T (p.Glu745Ter)	BRCA1	E698*, E745*, E577*, E633*, E656*, E675*, E678*, E742*, E449*, E657*, E674*, E697*, E704*, E719*, E744*, E617*, E634*, E703*, E618*, E677*, E718*	Hereditary breast ovarian cancer syndrome	VCV001434918	17	41245315	17	43093298	1434918	1507122	rs2154389241	NC_000017.11:43093297:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 26, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2228del (p.Asn743fs)	BRCA1	N696fs, N743fs, N616fs, N676fs, N695fs, N701fs, N716fs, N717fs, N740fs, N615fs, N673fs, N702fs, N447fs, N575fs, N631fs, N654fs, N655fs, N672fs, N632fs, N675fs, N742fs	Hereditary breast ovarian cancer syndrome	VCV000462578	17	41245320	17	43093303	462578	467730	rs1555590121	NC_000017.11:43093302:TT:T	Deletion	intron variant|frameshift variant	Pathogenic	May 4, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2226_2227del (p.Asn742fs)	BRCA1	N695fs, N742fs, N446fs, N631fs, N694fs, N715fs, N716fs, N614fs, N630fs, N653fs, N741fs, N654fs, N671fs, N700fs, N701fs, N739fs, N574fs, N615fs, N672fs, N674fs, N675fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240780	17	41245321 - 41245322	17	43093304 - 43093305	240780	242793	rs878854938	NC_000017.11:43093303:TAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2223dup (p.Asn742Ter)	BRCA1	N695*, N742*, N446*, N614*, N675*, N741*, N574*, N615*, N672*, N674*, N700*, N715*, N739*, N630*, N653*, N654*, N701*, N631*, N671*, N694*, N716*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266243	17	41245324 - 41245325	17	43093307 - 43093308	266243	261855	rs886040020	NC_000017.11:43093307:A:AA	Duplication	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2222_2223del (p.Val740_Ser741insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266242	17	41245325 - 41245326	17	43093308 - 43093309	266242	261854	rs886040019	NC_000017.11:43093307:AGA:A	Deletion	nonsense|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2155_2221dup (p.Ser741Ter)	BRCA1	S741*, S694*, S699*, S700*, S715*, S445*, S614*, S630*, S653*, S674*, S714*, S573*, S629*, S670*, S671*, S673*, S613*, S652*, S693*, S738*, S740*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266227	17	41245326 - 41245327	17	43093309 - 43093310	266227	261856	rs1555590136		Duplication	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2220del (p.Ser741fs)	BRCA1	S741fs, S694fs, S629fs, S693fs, S700fs, S740fs, S445fs, S573fs, S652fs, S653fs, S670fs, S674fs, S613fs, S699fs, S714fs, S715fs, S614fs, S630fs, S671fs, S673fs, S738fs	Hereditary breast ovarian cancer syndrome	VCV001382980	17	41245328	17	43093311	1382980	1509576	rs2154391486	NC_000017.11:43093310:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 18, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2219_2220insTAAT (p.Ser741fs)	BRCA1	S694fs, S741fs, S630fs, S673fs, S700fs, S738fs, S740fs, S445fs, S614fs, S671fs, S674fs, S699fs, S715fs, S573fs, S613fs, S653fs, S670fs, S714fs, S629fs, S652fs, S693fs	Hereditary breast ovarian cancer syndrome	VCV001076672	17	41245328 - 41245329	17	43093311 - 43093312	1076672	1064214	rs2154391568	NC_000017.11:43093311:A:ATTAA	Insertion	frameshift variant|intron variant	Pathogenic	Mar 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2218del (p.Val740fs)	BRCA1	V693fs, V740fs, V628fs, V652fs, V670fs, V613fs, V572fs, V651fs, V673fs, V699fs, V737fs, V739fs, V669fs, V672fs, V713fs, V444fs, V612fs, V629fs, V692fs, V698fs, V714fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266241	17	41245330	17	43093313	266241	261858	rs886040018	NC_000017.11:43093312:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2214_2218delinsAAA (p.Lys739fs)	BRCA1	K692fs, K739fs, K612fs, K627fs, K628fs, K698fs, K443fs, K671fs, K712fs, K571fs, K650fs, K651fs, K668fs, K669fs, K691fs, K738fs, K611fs, K672fs, K697fs, K713fs, K736fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266240	17	41245330 - 41245334	17	43093313 - 43093317	266240	261857	rs886040017	NC_000017.11:43093312:CTTTA:TTT	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2217dup (p.Val740fs)	BRCA1	V740fs, V693fs, V444fs, V651fs, V669fs, V673fs, V713fs, V737fs, V739fs, V628fs, V629fs, V670fs, V692fs, V714fs, V612fs, V613fs, V652fs, V698fs, V699fs, V572fs, V672fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125548	17	41245330 - 41245331	17	43093313 - 43093314	125548	131086	rs80357802	NC_000017.11:43093313:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2216_2217insCT (p.Lys739fs)	BRCA1	K692fs, K739fs, K611fs, K627fs, K671fs, K628fs, K650fs, K669fs, K691fs, K712fs, K443fs, K651fs, K668fs, K697fs, K698fs, K713fs, K738fs, K571fs, K612fs, K672fs, K736fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548161	17	41245331 - 41245332	17	43093314 - 43093315	548161	538853	rs1555590163	NC_000017.11:43093314::AG	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2216_2217del (p.Lys739fs)	BRCA1	K692fs, K739fs, K650fs, K668fs, K672fs, K698fs, K443fs, K628fs, K669fs, K691fs, K736fs, K738fs, K571fs, K651fs, K697fs, K713fs, K611fs, K612fs, K627fs, K671fs, K712fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054504	17	41245331 - 41245332	17	43093314 - 43093315	54504	69171	rs80357802	NC_000017.11:43093313:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2215_2216insCT (p.Lys739fs)	BRCA1	K739fs, K692fs, K443fs, K669fs, K612fs, K671fs, K672fs, K713fs, K736fs, K571fs, K628fs, K651fs, K668fs, K691fs, K698fs, K611fs, K627fs, K650fs, K697fs, K712fs, K738fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125547	17	41245332 - 41245333	17	43093315 - 43093316	125547	131085	rs80357930	NC_000017.11:43093315::AG	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2214dup (p.Lys739Ter)	BRCA1	K739*, K692*, K627*, K650*, K672*, K736*, K571*, K611*, K628*, K668*, K671*, K443*, K669*, K738*, K612*, K651*, K691*, K697*, K698*, K712*, K713*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186881	17	41245333 - 41245334	17	43093316 - 43093317	186881	185031	rs80357574	NC_000017.11:43093316:AA:AAA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2215A>T (p.Lys739Ter)	BRCA1	K739*, K692*, K571*, K611*, K669*, K672*, K736*, K628*, K650*, K651*, K668*, K713*, K738*, K627*, K671*, K443*, K612*, K691*, K697*, K698*, K712*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054503	17	41245333	17	43093316	54503	69170	rs56329598	NC_000017.11:43093315:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2212_2215del (p.Val738fs)	BRCA1	V691fs, V738fs, V442fs, V570fs, V649fs, V668fs, V670fs, V712fs, V650fs, V667fs, V711fs, V610fs, V611fs, V697fs, V737fs, V626fs, V627fs, V671fs, V690fs, V696fs, V735fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054502	17	41245333 - 41245336	17	43093316 - 43093319	54502	69169	rs397508951	NC_000017.11:43093315:TAACT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2213_2214dup (p.Lys739fs)	BRCA1	K739fs, K692fs, K650fs, K651fs, K691fs, K611fs, K627fs, K628fs, K672fs, K698fs, K713fs, K443fs, K668fs, K671fs, K697fs, K736fs, K571fs, K612fs, K669fs, K712fs, K738fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037457	17	41245333 - 41245334	17	43093316 - 43093317	37457	46013	rs80357574	NC_000017.11:43093316:AA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2214del (p.Val740fs)	BRCA1	V693fs, V740fs, V572fs, V628fs, V672fs, V673fs, V699fs, V714fs, V713fs, V444fs, V612fs, V629fs, V651fs, V670fs, V737fs, V613fs, V652fs, V669fs, V692fs, V698fs, V739fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125546	17	41245334	17	43093317	125546	131084	rs80357574	NC_000017.11:43093316:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2211dup (p.Val738fs)	BRCA1	V738fs, V691fs, V442fs, V649fs, V667fs, V668fs, V670fs, V697fs, V671fs, V690fs, V696fs, V735fs, V611fs, V627fs, V712fs, V570fs, V610fs, V626fs, V650fs, V711fs, V737fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266239	17	41245336 - 41245337	17	43093319 - 43093320	266239	261859	rs886040016	NC_000017.11:43093319:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2211_2212del (p.Thr737_Val738insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054501	17	41245336 - 41245337	17	43093319 - 43093320	54501	69168	rs397508950	NC_000017.11:43093318:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2210_2211del (p.Thr737fs)	BRCA1	T690fs, T737fs, T609fs, T610fs, T649fs, T696fs, T710fs, T441fs, T669fs, T711fs, T736fs, T569fs, T626fs, T648fs, T670fs, T689fs, T625fs, T666fs, T667fs, T695fs, T734fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037456	17	41245337 - 41245338	17	43093320 - 43093321	37456	46012	rs80357654	NC_000017.11:43093319:TGT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2210del (p.Thr737fs)	BRCA1	T690fs, T737fs, T649fs, T669fs, T670fs, T689fs, T696fs, T711fs, T736fs, T569fs, T609fs, T610fs, T626fs, T667fs, T710fs, T441fs, T625fs, T648fs, T734fs, T666fs, T695fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054500	17	41245338	17	43093321	54500	69167	rs80357793	NC_000017.11:43093320:G:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2209del (p.Thr737fs)	BRCA1	T690fs, T737fs, T441fs, T609fs, T625fs, T666fs, T695fs, T710fs, T649fs, T670fs, T696fs, T711fs, T736fs, T648fs, T667fs, T669fs, T734fs, T569fs, T610fs, T626fs, T689fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409310	17	41245339	17	43093322	409310	402023	rs1060502333	NC_000017.11:43093321:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2206G>T (p.Glu736Ter)	BRCA1	E689*, E736*, E568*, E608*, E625*, E694*, E609*, E624*, E647*, E648*, E666*, E669*, E695*, E440*, E665*, E688*, E709*, E710*, E735*, E668*, E733*	not provided	VCV002682150	17	41245342	17	43093325	2682150	1245734	rs2154393441	NC_000017.11:43093324:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Feb 10, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2206del (p.Glu736fs)	BRCA1	E689fs, E736fs, E440fs, E624fs, E625fs, E648fs, E666fs, E695fs, E733fs, E568fs, E608fs, E609fs, E669fs, E694fs, E709fs, E710fs, E647fs, E688fs, E665fs, E668fs, E735fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054498	17	41245342	17	43093325	54498	69165	rs80357860	NC_000017.11:43093324:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2205del (p.Glu736fs)	BRCA1	E689fs, E736fs, E608fs, E624fs, E625fs, E648fs, E665fs, E688fs, E694fs, E647fs, E668fs, E695fs, E709fs, E735fs, E440fs, E568fs, E669fs, E710fs, E609fs, E666fs, E733fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266238	17	41245343	17	43093326	266238	261860	rs886040015	NC_000017.11:43093325:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2202dup (p.Leu735fs)	BRCA1	L688fs, L735fs, L608fs, L646fs, L665fs, L668fs, L567fs, L647fs, L693fs, L732fs, L439fs, L623fs, L664fs, L667fs, L708fs, L734fs, L607fs, L624fs, L687fs, L694fs, L709fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266237	17	41245345 - 41245346	17	43093328 - 43093329	266237	261861	rs80357982	NC_000017.11:43093328:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2203del (p.Lys734_Leu735insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054497	17	41245345	17	43093328	54497	69164	rs80357936	NC_000017.11:43093327:G:	Deletion	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2202del (p.Lys734fs)	BRCA1	K734fs, K687fs, K438fs, K607fs, K623fs, K645fs, K666fs, K667fs, K686fs, K692fs, K708fs, K646fs, K663fs, K664fs, K693fs, K707fs, K606fs, K622fs, K566fs, K731fs, K733fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054496	17	41245346	17	43093329	54496	69163	rs80357982	NC_000017.11:43093328:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2197_2201del (p.Glu733fs)	BRCA1	E686fs, E733fs, E621fs, E645fs, E691fs, E732fs, E644fs, E663fs, E665fs, E666fs, E730fs, E437fs, E662fs, E565fs, E605fs, E606fs, E622fs, E685fs, E692fs, E706fs, E707fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054495	17	41245347 - 41245351	17	43093330 - 43093334	54495	69162	rs80357507	NC_000017.11:43093329:TTCTCTTCT:TTCT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2188_2201del (p.Glu730fs)	BRCA1	E683fs, E730fs, E434fs, E662fs, E562fs, E602fs, E641fs, E642fs, E659fs, E682fs, E689fs, E703fs, E663fs, E688fs, E729fs, E603fs, E618fs, E619fs, E660fs, E704fs, E727fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054489	17	41245347 - 41245360	17	43093330 - 43093343	54489	69156	rs273898681	NC_000017.11:43093329:TTCTCTTCTTTTTCTTCTCTT:TTCTCTT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2197_2200del (p.Glu733fs)	BRCA1	E437fs, E565fs, E605fs, E606fs, E621fs, E622fs, E644fs, E645fs, E662fs, E663fs, E665fs, E666fs, E685fs, E686fs, E691fs, E692fs, E706fs, E707fs, E730fs, E732fs, E733fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002674454	17	41245348 - 41245351	17	43093331 - 43093334	2674454	2841940	rs2552192047	NC_000017.11:43093330:TCTCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Aug 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2198dup (p.Lys734fs)	BRCA1	K734fs, K687fs, K566fs, K606fs, K663fs, K692fs, K708fs, K731fs, K438fs, K607fs, K622fs, K667fs, K693fs, K707fs, K623fs, K646fs, K666fs, K733fs, K645fs, K664fs, K686fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266235	17	41245349 - 41245350	17	43093332 - 43093333	266235	261862	rs886040012	NC_000017.11:43093332:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2199del (p.Lys734fs)	BRCA1	K687fs, K734fs, K438fs, K622fs, K645fs, K663fs, K667fs, K731fs, K733fs, K566fs, K606fs, K664fs, K666fs, K686fs, K693fs, K607fs, K623fs, K708fs, K646fs, K692fs, K707fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091578	17	41245349	17	43093332	91578	97055	rs80357944	NC_000017.11:43093331:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2196dup (p.Glu733fs)	BRCA1	E605fs, E606fs, E665fs, E686fs, E691fs, E621fs, E644fs, E662fs, E663fs, E666fs, E685fs, E707fs, E730fs, E732fs, E622fs, E645fs, E692fs, E437fs, E565fs, E706fs, E733fs	Hereditary breast ovarian cancer syndrome	VCV003645930	17	41245351 - 41245352	17	43093334 - 43093335	3645930	3780505		NC_000017.11:43093334:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Jun 7, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2197G>T (p.Glu733Ter)	BRCA1	E733*, E686*, E437*, E606*, E663*, E730*, E732*, E644*, E685*, E706*, E707*, E565*, E621*, E622*, E645*, E665*, E691*, E605*, E662*, E666*, E692*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054494	17	41245351	17	43093334	54494	69161	rs397508949	NC_000017.11:43093333:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2195_2196delinsG (p.Glu732fs)	BRCA1	E732fs, E685fs, E436fs, E662fs, E729fs, E621fs, E643fs, E644fs, E664fs, E706fs, E731fs, E605fs, E684fs, E690fs, E691fs, E564fs, E604fs, E620fs, E661fs, E665fs, E705fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266234	17	41245352 - 41245353	17	43093335 - 43093336	266234	261863	rs397508948	NC_000017.11:43093334:TT:C	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2196del (p.Glu733fs)	BRCA1	E686fs, E733fs, E605fs, E622fs, E644fs, E645fs, E663fs, E691fs, E706fs, E707fs, E732fs, E437fs, E606fs, E662fs, E730fs, E565fs, E666fs, E621fs, E665fs, E685fs, E692fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054493	17	41245352	17	43093335	54493	69160	rs397508948	NC_000017.11:43093334:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2193_2196del (p.Glu732fs)	BRCA1	E732fs, E685fs, E621fs, E643fs, E661fs, E664fs, E691fs, E662fs, E665fs, E684fs, E690fs, E705fs, E729fs, E731fs, E436fs, E564fs, E620fs, E644fs, E706fs, E604fs, E605fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054491	17	41245352 - 41245355	17	43093335 - 43093338	54491	69158	rs397508947	NC_000017.11:43093334:TTCTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2192_2196del (p.Lys731fs)	BRCA1	K684fs, K731fs, K603fs, K619fs, K690fs, K705fs, K435fs, K660fs, K664fs, K683fs, K728fs, K620fs, K642fs, K661fs, K689fs, K563fs, K604fs, K643fs, K663fs, K704fs, K730fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054490	17	41245352 - 41245356	17	43093335 - 43093339	54490	69157	rs397508946	NC_000017.11:43093334:TTCTTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2194_2195del (p.Glu732fs)	BRCA1	E605fs, E621fs, E643fs, E661fs, E665fs, E684fs, E731fs, E436fs, E604fs, E620fs, E690fs, E729fs, E662fs, E685fs, E705fs, E732fs, E564fs, E644fs, E664fs, E691fs, E706fs	Hereditary cancer-predisposing syndrome	VCV003992596	17	41245353 - 41245354	17	43093336 - 43093337	3992596	4104847		NC_000017.11:43093335:TCT:T	Deletion	intron variant|frameshift variant	Pathogenic	Apr 15, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2188_2195delinsAAAAAGG (p.Glu730fs)	BRCA1	E683fs, E730fs, E562fs, E603fs, E659fs, E729fs, E619fs, E662fs, E663fs, E688fs, E689fs, E602fs, E642fs, E660fs, E703fs, E434fs, E618fs, E641fs, E682fs, E704fs, E727fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266231	17	41245353 - 41245360	17	43093336 - 43093343	266231	261864	rs886040008	NC_000017.11:43093335:TCTTTTTC:CCTTTTT	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2193dup (p.Glu732fs)	BRCA1	E604fs, E620fs, E621fs, E684fs, E685fs, E690fs, E732fs, E436fs, E644fs, E665fs, E691fs, E706fs, E729fs, E564fs, E605fs, E643fs, E661fs, E664fs, E731fs, E662fs, E705fs	Hereditary cancer-predisposing syndrome	VCV002565336	17	41245354 - 41245355	17	43093337 - 43093338	2565336	2732310	rs886040009	NC_000017.11:43093337:TTTTT:TTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 10, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2194delinsAA (p.Glu732fs)	BRCA1	E685fs, E732fs, E436fs, E621fs, E684fs, E691fs, E705fs, E564fs, E643fs, E664fs, E665fs, E706fs, E605fs, E644fs, E661fs, E729fs, E731fs, E604fs, E620fs, E662fs, E690fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266233	17	41245354	17	43093337	266233	261865	rs886040010	NC_000017.11:43093336:C:TT	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2194G>T (p.Glu732Ter)	BRCA1	E732*, E685*, E564*, E621*, E690*, E605*, E620*, E643*, E662*, E665*, E705*, E706*, E436*, E644*, E684*, E691*, E731*, E604*, E661*, E664*, E729*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054492	17	41245354	17	43093337	54492	69159	rs80357426	NC_000017.11:43093336:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2193del (p.Glu732fs)	BRCA1	E685fs, E732fs, E621fs, E643fs, E684fs, E691fs, E706fs, E436fs, E690fs, E729fs, E604fs, E620fs, E662fs, E705fs, E731fs, E564fs, E605fs, E644fs, E661fs, E664fs, E665fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266232	17	41245355	17	43093338	266232	261866	rs886040009	NC_000017.11:43093337:TTTTT:TTTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2188_2192del (p.Glu730fs)	BRCA1	E434fs, E562fs, E602fs, E603fs, E618fs, E619fs, E641fs, E642fs, E659fs, E660fs, E662fs, E663fs, E682fs, E683fs, E688fs, E689fs, E703fs, E704fs, E727fs, E729fs, E730fs	not provided	VCV002691997	17	41245356 - 41245360	17	43093339 - 43093343	2691997	2853000	rs2552192216	NC_000017.11:43093338:TTTTCTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2185_2189del (p.Glu729fs)	BRCA1	E729fs, E682fs, E602fs, E617fs, E659fs, E702fs, E703fs, E561fs, E640fs, E662fs, E681fs, E433fs, E618fs, E658fs, E687fs, E726fs, E601fs, E641fs, E661fs, E688fs, E728fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266230	17	41245359 - 41245363	17	43093342 - 43093346	266230	261867	rs886040007	NC_000017.11:43093341:TCTTCTCTT:TCTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2188dup (p.Glu730fs)	BRCA1	E683fs, E730fs, E602fs, E603fs, E704fs, E562fs, E618fs, E660fs, E727fs, E619fs, E641fs, E642fs, E663fs, E682fs, E688fs, E689fs, E659fs, E662fs, E703fs, E729fs, E434fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125542	17	41245359 - 41245360	17	43093342 - 43093343	125542	131080	rs80357566	NC_000017.11:43093342:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2188G>T (p.Glu730Ter)	BRCA1	E730*, E683*, E641*, E663*, E689*, E703*, E434*, E602*, E682*, E729*, E562*, E603*, E659*, E660*, E662*, E727*, E618*, E619*, E642*, E688*, E704*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054488	17	41245360	17	43093343	54488	69155	rs80357058	NC_000017.11:43093342:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2187del (p.Glu730fs)	BRCA1	E683fs, E730fs, E562fs, E641fs, E659fs, E703fs, E434fs, E603fs, E663fs, E727fs, E602fs, E619fs, E642fs, E682fs, E688fs, E704fs, E729fs, E618fs, E660fs, E662fs, E689fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001787347	17	41245361	17	43093344	1787347	1850329	rs2552192281	NC_000017.11:43093343:TT:T	Deletion	intron variant|frameshift variant	Pathogenic	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2185del (p.Glu729fs)	BRCA1	E682fs, E729fs, E433fs, E617fs, E640fs, E659fs, E662fs, E702fs, E561fs, E618fs, E641fs, E687fs, E726fs, E658fs, E703fs, E601fs, E602fs, E661fs, E681fs, E688fs, E728fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000422530	17	41245363	17	43093346	422530	410004	rs1064795840	NC_000017.11:43093345:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2185G>T (p.Glu729Ter)	BRCA1	E729*, E682*, E561*, E601*, E659*, E681*, E618*, E640*, E641*, E687*, E703*, E433*, E602*, E702*, E617*, E658*, E661*, E662*, E688*, E726*, E728*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417823	17	41245363	17	43093346	417823	404715	rs876659852	NC_000017.11:43093345:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2182A>T (p.Arg728Ter)	BRCA1	R661*, R701*, R702*, R432*, R560*, R600*, R616*, R617*, R639*, R686*, R687*, R640*, R657*, R658*, R680*, R725*, R727*, R728*, R601*, R660*, R681*	Hereditary breast ovarian cancer syndrome	VCV002811747	17	41245366	17	43093349	2811747	2968985	rs1555590265	NC_000017.11:43093348:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 3, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2178del (p.Pro727fs)	BRCA1	P680fs, P727fs, P431fs, P679fs, P701fs, P726fs, P600fs, P616fs, P656fs, P685fs, P686fs, P700fs, P724fs, P615fs, P638fs, P639fs, P659fs, P660fs, P559fs, P599fs, P657fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000872895	17	41245370	17	43093353	872895	861036	rs2053810963	NC_000017.11:43093352:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2176_2177del (p.Leu726fs)	BRCA1	L726fs, L679fs, L558fs, L599fs, L638fs, L655fs, L723fs, L598fs, L615fs, L637fs, L678fs, L684fs, L659fs, L685fs, L725fs, L430fs, L614fs, L656fs, L658fs, L699fs, L700fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054484	17	41245371 - 41245372	17	43093354 - 43093355	54484	69151	rs397508945	NC_000017.11:43093353:AG:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2176del (p.Leu726fs)	BRCA1	L679fs, L726fs, L558fs, L598fs, L637fs, L638fs, L658fs, L685fs, L430fs, L655fs, L678fs, L599fs, L614fs, L656fs, L659fs, L684fs, L699fs, L723fs, L615fs, L700fs, L725fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054485	17	41245372	17	43093355	54485	69152	rs80357668	NC_000017.11:43093354:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2174del (p.Ser725fs)	BRCA1	S678fs, S725fs, S557fs, S613fs, S657fs, S429fs, S598fs, S614fs, S655fs, S684fs, S699fs, S724fs, S597fs, S636fs, S658fs, S677fs, S683fs, S637fs, S654fs, S698fs, S722fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054482	17	41245374	17	43093357	54482	69149	rs397508944	NC_000017.11:43093356:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2071_2171del (p.Lys690_Arg691insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548170	17	41245377 - 41245477	17	43093360 - 43093460	548170	538854	rs1555590294		Deletion	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2155_2168del (p.Lys719fs)	BRCA1	K672fs, K719fs, K423fs, K631fs, K651fs, K607fs, K630fs, K649fs, K671fs, K678fs, K692fs, K716fs, K718fs, K551fs, K592fs, K608fs, K652fs, K693fs, K591fs, K648fs, K677fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054477	17	41245380 - 41245393	17	43093363 - 43093376	54477	69144	rs397508941	NC_000017.11:43093362:TTGACAAATTCTTT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2166del (p.Asn723fs)	BRCA1	N723fs, N676fs, N427fs, N595fs, N611fs, N675fs, N612fs, N655fs, N696fs, N596fs, N634fs, N635fs, N652fs, N653fs, N656fs, N697fs, N720fs, N722fs, N555fs, N681fs, N682fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054480	17	41245382	17	43093365	54480	69147	rs397508943	NC_000017.11:43093364:G:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2162_2165del (p.Phe721fs)	BRCA1	F674fs, F721fs, F633fs, F650fs, F673fs, F695fs, F720fs, F425fs, F553fs, F609fs, F680fs, F694fs, F594fs, F610fs, F632fs, F653fs, F654fs, F718fs, F593fs, F651fs, F679fs	Hereditary breast ovarian cancer syndrome	VCV001075630	17	41245383 - 41245386	17	43093366 - 43093369	1075630	1064215	rs2154395922	NC_000017.11:43093365:ACAAA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 31, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2156_2163dup (p.Val722fs)	BRCA1	V675fs, V722fs, V655fs, V426fs, V611fs, V634fs, V680fs, V681fs, V696fs, V721fs, V554fs, V651fs, V652fs, V654fs, V719fs, V594fs, V595fs, V610fs, V633fs, V674fs, V695fs	Hereditary cancer-predisposing syndrome	VCV000491039	17	41245384 - 41245385	17	43093367 - 43093368	491039	485102	rs1555590322	NC_000017.11:43093367:AAATTCTT:AAATTCTTAAATTCTT	Duplication	frameshift variant|intron variant	Pathogenic	May 4, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2164del (p.Val722fs)	BRCA1	V722fs, V675fs, V426fs, V633fs, V654fs, V674fs, V681fs, V721fs, V594fs, V595fs, V634fs, V695fs, V554fs, V610fs, V652fs, V655fs, V719fs, V611fs, V651fs, V680fs, V696fs	Hereditary cancer-predisposing syndrome	VCV000481441	17	41245384	17	43093367	481441	479425	rs1555590315	NC_000017.11:43093366:C:	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2163del (p.Phe721fs)	BRCA1	F674fs, F721fs, F609fs, F632fs, F650fs, F653fs, F694fs, F425fs, F680fs, F718fs, F720fs, F593fs, F594fs, F610fs, F633fs, F651fs, F654fs, F673fs, F695fs, F553fs, F679fs	Hereditary breast ovarian cancer syndrome	VCV001070603	17	41245385	17	43093368	1070603	1064216	rs1555590319	NC_000017.11:43093367:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 20, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2162_2163insG (p.Phe721fs)	BRCA1	F721fs, F674fs, F553fs, F633fs, F653fs, F654fs, F679fs, F694fs, F720fs, F594fs, F651fs, F680fs, F718fs, F609fs, F632fs, F695fs, F425fs, F593fs, F610fs, F650fs, F673fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548223	17	41245385 - 41245386	17	43093368 - 43093369	548223	538855	rs1555590332	NC_000017.11:43093368::C	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2162_2163del (p.Phe721fs)	BRCA1	F674fs, F721fs, F425fs, F553fs, F651fs, F673fs, F679fs, F695fs, F718fs, F720fs, F633fs, F694fs, F632fs, F593fs, F594fs, F609fs, F610fs, F650fs, F653fs, F654fs, F680fs	Hereditary breast ovarian cancer syndrome	VCV000462575	17	41245385 - 41245386	17	43093368 - 43093369	462575	467732	rs1555590319	NC_000017.11:43093367:AAA:A	Deletion	frameshift variant|intron variant	Pathogenic	Nov 18, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2161_2162insG (p.Phe721fs)	BRCA1	F674fs, F721fs, F553fs, F632fs, F651fs, F679fs, F718fs, F425fs, F594fs, F650fs, F673fs, F680fs, F695fs, F633fs, F654fs, F593fs, F609fs, F610fs, F653fs, F694fs, F720fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266229	17	41245386 - 41245387	17	43093369 - 43093370	266229	261868	rs886040006	NC_000017.11:43093369::C	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2155_2161del (p.Lys719fs)	BRCA1	K423fs, K551fs, K591fs, K592fs, K607fs, K608fs, K630fs, K631fs, K648fs, K649fs, K651fs, K652fs, K671fs, K672fs, K677fs, K678fs, K692fs, K693fs, K716fs, K718fs, K719fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002674451	17	41245387 - 41245393	17	43093370 - 43093376	2674451	2841937	rs2552192660	NC_000017.11:43093369:ATTCTTTA:A	Deletion	intron variant|frameshift variant	Pathogenic	Aug 18, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2160del (p.Glu720fs)	BRCA1	E673fs, E720fs, E552fs, E609fs, E652fs, E653fs, E678fs, E693fs, E717fs, E631fs, E650fs, E672fs, E679fs, E694fs, E719fs, E608fs, E632fs, E424fs, E592fs, E593fs, E649fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000654815	17	41245388	17	43093371	654815	646011	rs1567796774	NC_000017.11:43093370:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2157_2160del (p.Lys719fs)	BRCA1	K672fs, K719fs, K551fs, K591fs, K677fs, K607fs, K608fs, K630fs, K631fs, K648fs, K671fs, K678fs, K692fs, K423fs, K592fs, K693fs, K718fs, K649fs, K651fs, K652fs, K716fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266228	17	41245388 - 41245391	17	43093371 - 43093374	266228	261869	rs886040005	NC_000017.11:43093370:TTCTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2158_2159del (p.Glu720fs)	BRCA1	E673fs, E720fs, E649fs, E652fs, E693fs, E694fs, E592fs, E608fs, E631fs, E653fs, E672fs, E424fs, E650fs, E552fs, E593fs, E609fs, E632fs, E678fs, E679fs, E717fs, E719fs	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000619623	17	41245389 - 41245390	17	43093372 - 43093373	619623	611243	rs1567796780	NC_000017.11:43093371:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Apr 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2157dup (p.Glu720fs)	BRCA1	E720fs, E673fs, E592fs, E672fs, E694fs, E717fs, E424fs, E631fs, E678fs, E609fs, E632fs, E649fs, E693fs, E719fs, E552fs, E593fs, E608fs, E650fs, E652fs, E653fs, E679fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054478	17	41245390 - 41245391	17	43093373 - 43093374	54478	69145	rs80357715	NC_000017.11:43093373:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2158G>T (p.Glu720Ter)	BRCA1	E720*, E673*, E631*, E649*, E678*, E679*, E719*, E592*, E650*, E672*, E552*, E608*, E609*, E652*, E693*, E717*, E424*, E593*, E632*, E653*, E694*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037453	17	41245390	17	43093373	37453	46009	rs80356875	NC_000017.11:43093372:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2157del (p.Glu720fs)	BRCA1	E673fs, E720fs, E593fs, E608fs, E609fs, E672fs, E719fs, E424fs, E632fs, E649fs, E679fs, E552fs, E631fs, E653fs, E678fs, E693fs, E694fs, E717fs, E592fs, E650fs, E652fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001451304	17	41245391	17	43093374	1451304	1429558	rs80357715	NC_000017.11:43093373:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2143_2155delinsTCTTT (p.Thr715fs)	BRCA1	T668fs, T715fs, T547fs, T647fs, T673fs, T689fs, T714fs, T644fs, T674fs, T688fs, T603fs, T627fs, T645fs, T667fs, T712fs, T419fs, T587fs, T588fs, T604fs, T626fs, T648fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000570393	17	41245393 - 41245405	17	43093376 - 43093388	570393	571180	rs1567796807	NC_000017.11:43093375:TAAGTTCACTGGT:AAAGA	Indel	frameshift variant|intron variant	Pathogenic	Aug 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2155A>T (p.Lys719Ter)	BRCA1	K719*, K672*, K423*, K592*, K649*, K692*, K631*, K678*, K718*, K591*, K607*, K630*, K652*, K677*, K716*, K551*, K608*, K648*, K651*, K671*, K693*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054476	17	41245393	17	43093376	54476	69143	rs80357147	NC_000017.11:43093375:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2145_2152del (p.Thr715_Ser716insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001071268	17	41245396 - 41245403	17	43093379 - 43093386	1071268	1064217	rs2154396775	NC_000017.11:43093378:GTTCACTGGT:GT	Deletion	frameshift variant|intron variant	Pathogenic	Aug 30, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2149_2152del (p.Glu717fs)	BRCA1	E670fs, E717fs, E590fs, E606fs, E676fs, E716fs, E589fs, E649fs, E650fs, E714fs, E549fs, E646fs, E675fs, E421fs, E605fs, E628fs, E629fs, E647fs, E669fs, E690fs, E691fs	Hereditary cancer-predisposing syndrome	VCV000628267	17	41245396 - 41245399	17	43093379 - 43093382	628267	618649	rs1567796819	NC_000017.11:43093378:GTTC:	Deletion	frameshift variant|intron variant	Pathogenic	May 6, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2149G>T (p.Glu717Ter)	BRCA1	E717*, E670*, E590*, E646*, E647*, E650*, E691*, E714*, E421*, E606*, E669*, E675*, E676*, E628*, E629*, E649*, E716*, E549*, E589*, E605*, E690*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266226	17	41245399	17	43093382	266226	261870	rs886040004	NC_000017.11:43093381:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2146_2147del (p.Thr715_Ser716insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002700820	17	41245401 - 41245402	17	43093384 - 43093385	2700820	2865660	rs2552192943	NC_000017.11:43093383:CT:	Deletion	nonsense|intron variant	Pathogenic	Dec 4, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2145del (p.Ser716fs)	BRCA1	S669fs, S716fs, S588fs, S627fs, S646fs, S668fs, S674fs, S715fs, S420fs, S548fs, S604fs, S605fs, S628fs, S648fs, S675fs, S689fs, S589fs, S645fs, S649fs, S690fs, S713fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254407	17	41245403	17	43093386	254407	249136	rs886037996	NC_000017.11:43093385:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2143dup (p.Thr715fs)	BRCA1	T419fs, T547fs, T587fs, T588fs, T603fs, T604fs, T626fs, T627fs, T644fs, T645fs, T647fs, T648fs, T667fs, T668fs, T673fs, T674fs, T688fs, T689fs, T712fs, T714fs, T715fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003379261	17	41245404 - 41245405	17	43093387 - 43093388	3379261	3538439		NC_000017.11:43093387:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Aug 6, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2140_2144del (p.Asn714fs)	BRCA1	N667fs, N714fs, N546fs, N586fs, N626fs, N643fs, N646fs, N666fs, N688fs, N713fs, N418fs, N587fs, N625fs, N673fs, N602fs, N603fs, N644fs, N647fs, N672fs, N687fs, N711fs	Hereditary breast ovarian cancer syndrome	VCV000945653	17	41245404 - 41245408	17	43093387 - 43093391	945653	928311	rs2053817949	NC_000017.11:43093386:GTATT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 6, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2142_2144delinsAG (p.Asn714fs)	BRCA1	N667fs, N714fs, N644fs, N646fs, N672fs, N711fs, N713fs, N586fs, N643fs, N546fs, N587fs, N603fs, N625fs, N647fs, N687fs, N688fs, N418fs, N602fs, N626fs, N666fs, N673fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266225	17	41245404 - 41245406	17	43093387 - 43093389	266225	261871	rs886040003	NC_000017.11:43093386:GTA:CT	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2142del (p.Asn714fs)	BRCA1	N667fs, N714fs, N625fs, N688fs, N711fs, N713fs, N418fs, N626fs, N673fs, N586fs, N602fs, N603fs, N646fs, N666fs, N672fs, N687fs, N546fs, N587fs, N643fs, N644fs, N647fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054475	17	41245406	17	43093389	54475	69142	rs273898679	NC_000017.11:43093388:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2141del (p.Asn714fs)	BRCA1	N586fs, N603fs, N644fs, N666fs, N672fs, N711fs, N587fs, N667fs, N714fs, N418fs, N602fs, N626fs, N643fs, N646fs, N673fs, N546fs, N625fs, N647fs, N687fs, N688fs, N713fs	Hereditary breast ovarian cancer syndrome	VCV003638588	17	41245407	17	43093390	3638588	3774883		NC_000017.11:43093389:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Feb 4, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2136_2140del (p.Cys712_Asn714delinsTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001429911	17	41245408 - 41245412	17	43093391 - 43093395	1429911	1477644	rs2154397327	NC_000017.11:43093390:TTGAA:	Deletion	intron variant|nonsense	Pathogenic	Jun 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2138_2139dup (p.Asn714fs)	BRCA1	N714fs, N667fs, N587fs, N626fs, N666fs, N672fs, N687fs, N546fs, N625fs, N688fs, N711fs, N418fs, N602fs, N603fs, N643fs, N644fs, N646fs, N673fs, N586fs, N647fs, N713fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266224	17	41245408 - 41245409	17	43093391 - 43093392	266224	261872	rs886040002	NC_000017.11:43093391:TG:TGTG	Duplication	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2138C>A (p.Ser713Ter)	BRCA1	S713*, S666*, S417*, S602*, S642*, S645*, S671*, S672*, S601*, S646*, S712*, S624*, S625*, S643*, S665*, S687*, S710*, S545*, S585*, S586*, S686*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254406	17	41245410	17	43093393	254406	249137	rs80357233	NC_000017.11:43093392:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2138C>G (p.Ser713Ter)	BRCA1	S713*, S666*, S624*, S417*, S545*, S586*, S601*, S643*, S645*, S665*, S672*, S642*, S687*, S585*, S602*, S625*, S646*, S671*, S686*, S710*, S712*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037451	17	41245410	17	43093393	37451	46007	rs80357233	NC_000017.11:43093392:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2135_2136del (p.Cys712fs)	BRCA1	C712fs, C665fs, C623fs, C664fs, C670fs, C709fs, C601fs, C624fs, C645fs, C671fs, C711fs, C544fs, C584fs, C600fs, C641fs, C642fs, C416fs, C585fs, C644fs, C685fs, C686fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266223	17	41245412 - 41245413	17	43093395 - 43093396	266223	261873	rs886040001	NC_000017.11:43093394:ACAC:AC	Microsatellite	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2132del (p.Lys711fs)	BRCA1	K663fs, K670fs, K710fs, K584fs, K644fs, K664fs, K669fs, K685fs, K543fs, K583fs, K600fs, K623fs, K640fs, K643fs, K711fs, K415fs, K599fs, K622fs, K641fs, K684fs, K708fs	Hereditary cancer-predisposing syndrome	VCV004215111	17	41245416	17	43093399	4215111	4332023		NC_000017.11:43093398:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Aug 26, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2112_2131dup (p.Lys711fs)	BRCA1	K711fs, K664fs, K584fs, K415fs, K599fs, K670fs, K600fs, K622fs, K623fs, K644fs, K543fs, K583fs, K640fs, K643fs, K708fs, K641fs, K663fs, K669fs, K684fs, K685fs, K710fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266219	17	41245416 - 41245417	17	43093399 - 43093400	266219	261874	rs886039998	NC_000017.11:43093399:TAGTAAAAGAACCAGGTGCAT:TAGTAAAAGAACCAGGTGCATAGTAAAAGAACCAGGTGCAT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2131_2132del (p.Lys711fs)	BRCA1	K711fs, K664fs, K543fs, K599fs, K623fs, K640fs, K643fs, K415fs, K622fs, K669fs, K685fs, K710fs, K583fs, K584fs, K600fs, K641fs, K644fs, K663fs, K670fs, K684fs, K708fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091577	17	41245416 - 41245417	17	43093399 - 43093400	91577	97054	rs398122653	NC_000017.11:43093398:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2130delinsAA (p.Cys712fs)	BRCA1	C665fs, C712fs, C585fs, C600fs, C644fs, C645fs, C670fs, C685fs, C584fs, C623fs, C664fs, C544fs, C641fs, C642fs, C671fs, C416fs, C601fs, C624fs, C686fs, C709fs, C711fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409309	17	41245418	17	43093401	409309	402700	rs1060502332	NC_000017.11:43093400:A:TT	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2128dup (p.Thr710fs)	BRCA1	T663fs, T710fs, T621fs, T642fs, T668fs, T669fs, T707fs, T414fs, T599fs, T622fs, T639fs, T683fs, T684fs, T709fs, T542fs, T583fs, T640fs, T643fs, T662fs, T582fs, T598fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548263	17	41245419 - 41245420	17	43093402 - 43093403	548263	538857	rs1555590415	NC_000017.11:43093402:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2128_2129insGA (p.Thr710fs)	BRCA1	T710fs, T663fs, T414fs, T542fs, T643fs, T662fs, T582fs, T598fs, T668fs, T583fs, T622fs, T669fs, T683fs, T684fs, T709fs, T599fs, T621fs, T639fs, T640fs, T642fs, T707fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548251	17	41245419 - 41245420	17	43093402 - 43093403	548251	538856	rs1555590415	NC_000017.11:43093402:T:TCT	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2127_2128insGA (p.Thr710fs)	BRCA1	T710fs, T663fs, T599fs, T622fs, T640fs, T642fs, T709fs, T582fs, T621fs, T639fs, T683fs, T414fs, T542fs, T598fs, T662fs, T684fs, T707fs, T583fs, T643fs, T668fs, T669fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266221	17	41245420 - 41245421	17	43093403 - 43093404	266221	261875	rs886039999	NC_000017.11:43093403::TC	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2126_2127insA (p.Phe709fs)	BRCA1	F662fs, F709fs, F413fs, F541fs, F598fs, F620fs, F621fs, F639fs, F661fs, F667fs, F682fs, F683fs, F582fs, F638fs, F641fs, F708fs, F581fs, F668fs, F597fs, F642fs, F706fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431223	17	41245421 - 41245422	17	43093404 - 43093405	431223	424839	rs1135401851	NC_000017.11:43093404::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2127del (p.Phe709fs)	BRCA1	F662fs, F709fs, F641fs, F642fs, F706fs, F708fs, F541fs, F620fs, F661fs, F668fs, F682fs, F413fs, F597fs, F621fs, F638fs, F581fs, F582fs, F598fs, F683fs, F639fs, F667fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266222	17	41245421	17	43093404	266222	261876	rs397508939	NC_000017.11:43093403:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2126_2127del (p.Phe709fs)	BRCA1	F709fs, F662fs, F413fs, F598fs, F682fs, F683fs, F541fs, F581fs, F638fs, F642fs, F661fs, F708fs, F597fs, F620fs, F639fs, F667fs, F582fs, F621fs, F641fs, F668fs, F706fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054470	17	41245421 - 41245422	17	43093404 - 43093405	54470	69137	rs397508939	NC_000017.11:43093403:AAAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2125_2126insAG (p.Phe709Ter)	BRCA1	F621*, F638*, F639*, F582*, F598*, F662*, F668*, F682*, F709*, F413*, F581*, F597*, F641*, F642*, F706*, F708*, F541*, F620*, F661*, F667*, F683*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV002624675	17	41245422 - 41245423	17	43093405 - 43093406	2624675	2793764	rs80357871	NC_000017.11:43093405::CT	Insertion	intron variant|nonsense	Pathogenic	Feb 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2125_2126insAGT (p.Phe709Ter)	BRCA1	F662*, F709*, F582*, F620*, F621*, F706*, F581*, F598*, F641*, F661*, F667*, F413*, F541*, F597*, F642*, F668*, F683*, F708*, F638*, F639*, F682*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266220	17	41245422 - 41245423	17	43093405 - 43093406	266220	261877	rs1555590428	NC_000017.11:43093405:A:ACTA	Insertion	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2125_2126insA (p.Phe709fs)	BRCA1	F709fs, F662fs, F541fs, F661fs, F581fs, F639fs, F641fs, F668fs, F413fs, F598fs, F620fs, F682fs, F706fs, F582fs, F597fs, F621fs, F638fs, F642fs, F667fs, F683fs, F708fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054469	17	41245422 - 41245423	17	43093405 - 43093406	54469	69136	rs80357871	NC_000017.11:43093405::T	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2120del (p.Gly707fs)	BRCA1	G660fs, G707fs, G579fs, G639fs, G666fs, G704fs, G596fs, G618fs, G640fs, G680fs, G595fs, G637fs, G659fs, G665fs, G411fs, G539fs, G580fs, G619fs, G636fs, G681fs, G706fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548188	17	41245428	17	43093411	548188	538858	rs1555590441	NC_000017.11:43093410:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2109_2116del (p.Asn704fs)	BRCA1	N408fs, N536fs, N577fs, N615fs, N616fs, N657fs, N703fs, N593fs, N656fs, N678fs, N633fs, N634fs, N637fs, N663fs, N677fs, N576fs, N592fs, N636fs, N662fs, N701fs, N704fs	Hereditary breast ovarian cancer syndrome	VCV003631397	17	41245432 - 41245439	17	43093415 - 43093422	3631397	3772878		NC_000017.11:43093414:GTGCATTTGT:GT	Deletion	frameshift variant|intron variant	Pathogenic	Aug 17, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2114del (p.Ala705fs)	BRCA1	A409fs, A537fs, A577fs, A578fs, A593fs, A594fs, A616fs, A617fs, A634fs, A635fs, A637fs, A638fs, A657fs, A658fs, A663fs, A664fs, A678fs, A679fs, A702fs, A704fs, A705fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004294272	17	41245434	17	43093417	4294272	4406796		NC_000017.11:43093416:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 16, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2111_2112del (p.Asn704fs)	BRCA1	N657fs, N704fs, N662fs, N701fs, N634fs, N637fs, N677fs, N678fs, N633fs, N656fs, N663fs, N408fs, N536fs, N576fs, N577fs, N592fs, N593fs, N615fs, N616fs, N636fs, N703fs	Hereditary breast ovarian cancer syndrome	VCV000942992	17	41245436 - 41245437	17	43093419 - 43093420	942992	937963	rs2053824237	NC_000017.11:43093418:AT:	Deletion	intron variant|frameshift variant	Pathogenic	Aug 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2110_2111del (p.Asn704fs)	BRCA1	N657fs, N704fs, N616fs, N663fs, N678fs, N408fs, N536fs, N577fs, N656fs, N662fs, N701fs, N703fs, N576fs, N633fs, N634fs, N677fs, N592fs, N593fs, N615fs, N636fs, N637fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054462	17	41245437 - 41245438	17	43093420 - 43093421	54462	69129	rs80357814	NC_000017.11:43093419:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2105dup (p.Leu702fs)	BRCA1	L702fs, L655fs, L574fs, L613fs, L614fs, L632fs, L654fs, L661fs, L406fs, L590fs, L675fs, L676fs, L699fs, L701fs, L534fs, L631fs, L635fs, L575fs, L591fs, L634fs, L660fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037445	17	41245442 - 41245443	17	43093425 - 43093426	37445	46001	rs80357880	NC_000017.11:43093425:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2105del (p.Lys701_Leu702insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266218	17	41245443	17	43093426	266218	261878	rs80357880	NC_000017.11:43093425:AA:A	Deletion	intron variant|nonsense|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2105T>G (p.Leu702Ter)	BRCA1	L702*, L655*, L575*, L591*, L660*, L661*, L406*, L534*, L574*, L614*, L632*, L654*, L675*, L634*, L635*, L699*, L590*, L613*, L631*, L676*, L701*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054460	17	41245443	17	43093426	54460	69127	rs80357298	NC_000017.11:43093425:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2101_2102del (p.Lys701fs)	BRCA1	K701fs, K654fs, K405fs, K589fs, K631fs, K660fs, K674fs, K573fs, K630fs, K653fs, K612fs, K675fs, K700fs, K533fs, K574fs, K590fs, K613fs, K633fs, K634fs, K659fs, K698fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096905	17	41245446 - 41245447	17	43093429 - 43093430	96905	102808	rs431825389	NC_000017.11:43093428:TT:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2101A>T (p.Lys701Ter)	BRCA1	K701*, K654*, K589*, K612*, K630*, K674*, K675*, K700*, K533*, K631*, K634*, K659*, K698*, K405*, K574*, K660*, K590*, K613*, K573*, K633*, K653*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233241	17	41245447	17	43093430	233241	236096	rs876660282	NC_000017.11:43093429:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2099_2100insA (p.Lys701fs)	BRCA1	K654fs, K701fs, K405fs, K612fs, K634fs, K674fs, K700fs, K533fs, K590fs, K631fs, K653fs, K574fs, K613fs, K675fs, K698fs, K573fs, K589fs, K630fs, K633fs, K659fs, K660fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548158	17	41245448 - 41245449	17	43093431 - 43093432	548158	538859	rs1555590461	NC_000017.11:43093431::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2098_2099insA (p.Leu700fs)	BRCA1	L653fs, L700fs, L572fs, L589fs, L633fs, L674fs, L697fs, L573fs, L630fs, L632fs, L699fs, L588fs, L629fs, L652fs, L659fs, L673fs, L404fs, L532fs, L611fs, L612fs, L658fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125539	17	41245449 - 41245450	17	43093432 - 43093433	125539	131077	rs483353086	NC_000017.11:43093432::T	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2095G>T (p.Glu699Ter)	BRCA1	E699*, E652*, E587*, E588*, E610*, E628*, E403*, E629*, E673*, E696*, E531*, E631*, E632*, E657*, E672*, E571*, E572*, E611*, E651*, E658*, E698*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254405	17	41245453	17	43093436	254405	249138	rs876658306	NC_000017.11:43093435:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2090dup (p.Glu699fs)	BRCA1	E652fs, E699fs, E531fs, E610fs, E587fs, E588fs, E611fs, E629fs, E632fs, E651fs, E657fs, E672fs, E698fs, E571fs, E696fs, E403fs, E572fs, E628fs, E631fs, E658fs, E673fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266217	17	41245457 - 41245458	17	43093440 - 43093441	266217	261879	rs886039996	NC_000017.11:43093440:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2090del (p.Phe697fs)	BRCA1	F650fs, F697fs, F586fs, F609fs, F626fs, F627fs, F630fs, F671fs, F694fs, F401fs, F569fs, F629fs, F696fs, F529fs, F570fs, F649fs, F655fs, F670fs, F585fs, F608fs, F656fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440454	17	41245458	17	43093441	440454	434085	rs886039996	NC_000017.11:43093440:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2086_2089del (p.Thr696fs)	BRCA1	T696fs, T649fs, T607fs, T625fs, T629fs, T693fs, T568fs, T584fs, T628fs, T655fs, T669fs, T528fs, T585fs, T608fs, T670fs, T695fs, T400fs, T569fs, T626fs, T648fs, T654fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266215	17	41245459 - 41245462	17	43093442 - 43093445	266215	261880	rs886039994	NC_000017.11:43093441:AAGTA:A	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2086dup (p.Thr696fs)	BRCA1	T696fs, T649fs, T528fs, T568fs, T584fs, T648fs, T670fs, T569fs, T654fs, T585fs, T607fs, T695fs, T400fs, T608fs, T625fs, T626fs, T628fs, T629fs, T655fs, T669fs, T693fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266216	17	41245461 - 41245462	17	43093444 - 43093445	266216	261881	rs886039995	NC_000017.11:43093444:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2086del (p.Thr696fs)	BRCA1	T696fs, T649fs, T569fs, T584fs, T626fs, T654fs, T670fs, T693fs, T585fs, T400fs, T568fs, T608fs, T625fs, T628fs, T669fs, T695fs, T528fs, T607fs, T629fs, T648fs, T655fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054458	17	41245462	17	43093445	54458	69125	rs397508937	NC_000017.11:43093444:T:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2083del (p.Asp695fs)	BRCA1	D695fs, D648fs, D399fs, D606fs, D692fs, D624fs, D625fs, D653fs, D567fs, D568fs, D627fs, D628fs, D647fs, D654fs, D527fs, D583fs, D584fs, D607fs, D668fs, D669fs, D694fs	not provided	VCV000545776	17	41245465	17	43093448	545776	536494	rs1555590505	NC_000017.11:43093447:C:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 31, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2080_2082delinsT (p.Asp693_Ser694insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003148722	17	41245466 - 41245468	17	43093449 - 43093451	3148722	3307970	rs2552193952	NC_000017.11:43093448:GCT:A	Indel	nonsense|intron variant	Pathogenic	Mar 7, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2080dup (p.Ser694fs)	BRCA1	S647fs, S694fs, S526fs, S567fs, S646fs, S667fs, S668fs, S582fs, S605fs, S606fs, S623fs, S653fs, S691fs, S693fs, S398fs, S566fs, S583fs, S624fs, S626fs, S627fs, S652fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266214	17	41245467 - 41245468	17	43093450 - 43093451	266214	261882	rs886039993	NC_000017.11:43093450:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2079_2080insTA (p.Ser694Ter)	BRCA1	S694*, S647*, S398*, S566*, S583*, S605*, S606*, S627*, S691*, S653*, S667*, S526*, S567*, S624*, S646*, S668*, S693*, S582*, S652*, S623*, S626*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548215	17	41245468 - 41245469	17	43093451 - 43093452	548215	538860	rs1555590520	NC_000017.11:43093451::TA	Insertion	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2079_2080del (p.Asp693fs)	BRCA1	D693fs, D646fs, D565fs, D581fs, D626fs, D566fs, D604fs, D605fs, D622fs, D651fs, D690fs, D397fs, D525fs, D623fs, D625fs, D667fs, D582fs, D645fs, D652fs, D666fs, D692fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054454	17	41245468 - 41245469	17	43093451 - 43093452	54454	69121	rs80357773	NC_000017.11:43093450:TGT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2078_2079insTA (p.Ser694fs)	BRCA1	S694fs, S647fs, S398fs, S567fs, S583fs, S668fs, S693fs, S526fs, S566fs, S624fs, S646fs, S626fs, S653fs, S667fs, S691fs, S582fs, S605fs, S606fs, S623fs, S627fs, S652fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266213	17	41245469 - 41245470	17	43093452 - 43093453	266213	261883	rs886039992	NC_000017.11:43093452:T:TAT	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2077_2078insTA (p.Asp693fs)	BRCA1	D693fs, D646fs, D397fs, D566fs, D582fs, D651fs, D667fs, D690fs, D525fs, D604fs, D625fs, D652fs, D666fs, D692fs, D622fs, D623fs, D645fs, D565fs, D581fs, D605fs, D626fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125535	17	41245470 - 41245471	17	43093453 - 43093454	125535	131073	rs80357595	NC_000017.11:43093453::TA	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2076dup (p.Asp693Ter)	BRCA1	D397*, D525*, D565*, D566*, D581*, D582*, D604*, D605*, D622*, D623*, D625*, D626*, D645*, D646*, D651*, D652*, D666*, D667*, D690*, D692*, D693*	not provided	VCV002691998	17	41245471 - 41245472	17	43093454 - 43093455	2691998	2853001	rs2552194047	NC_000017.11:43093454:A:AA	Duplication	nonsense|intron variant	Pathogenic	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2077delinsATA (p.Asp693fs)	BRCA1	D646fs, D693fs, D565fs, D581fs, D625fs, D525fs, D622fs, D626fs, D566fs, D604fs, D623fs, D651fs, D652fs, D666fs, D397fs, D582fs, D605fs, D645fs, D667fs, D690fs, D692fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266212	17	41245471	17	43093454	266212	261884	rs886039991	NC_000017.11:43093453:C:TAT	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2075_2076del (p.His692fs)	BRCA1	H645fs, H692fs, H524fs, H564fs, H651fs, H665fs, H396fs, H581fs, H622fs, H624fs, H666fs, H565fs, H604fs, H621fs, H689fs, H580fs, H603fs, H625fs, H644fs, H650fs, H691fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054452	17	41245472 - 41245473	17	43093455 - 43093456	54452	69119	rs397508936	NC_000017.11:43093454:AT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2065_2075del (p.Thr688_Ser689insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002129025	17	41245473 - 41245483	17	43093456 - 43093466	2129025	2175274	rs2552194079	NC_000017.11:43093455:TGTCTTTTACTTGTCT:TGTCT	Deletion	nonsense|intron variant	Pathogenic	Apr 21, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2074_2075del (p.Arg691_His692insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254404	17	41245473 - 41245474	17	43093456 - 43093457	254404	249139	rs886037995	NC_000017.11:43093455:TGT:T	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2074del (p.His692fs)	BRCA1	H645fs, H692fs, H603fs, H625fs, H651fs, H689fs, H524fs, H604fs, H621fs, H624fs, H644fs, H650fs, H564fs, H565fs, H581fs, H666fs, H396fs, H580fs, H622fs, H665fs, H691fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054451	17	41245474	17	43093457	54451	69118	rs80357554	NC_000017.11:43093456:G:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2070_2071del (p.Arg691fs)	BRCA1	R691fs, R644fs, R395fs, R579fs, R623fs, R643fs, R523fs, R563fs, R580fs, R603fs, R621fs, R649fs, R665fs, R688fs, R620fs, R664fs, R564fs, R602fs, R624fs, R650fs, R690fs	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091574	17	41245477 - 41245478	17	43093460 - 43093461	91574	97051	rs80357688	NC_000017.11:43093459:TTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2071del (p.Arg691fs)	BRCA1	R691fs, R644fs, R580fs, R620fs, R624fs, R665fs, R395fs, R564fs, R603fs, R643fs, R664fs, R688fs, R690fs, R563fs, R602fs, R621fs, R623fs, R649fs, R523fs, R579fs, R650fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037444	17	41245477	17	43093460	37444	46000	rs80357688	NC_000017.11:43093459:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2066_2069del (p.Ser689fs)	BRCA1	S642fs, S689fs, S521fs, S578fs, S601fs, S663fs, S393fs, S561fs, S621fs, S647fs, S686fs, S688fs, S600fs, S619fs, S648fs, S662fs, S562fs, S577fs, S618fs, S622fs, S641fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254403	17	41245479 - 41245482	17	43093462 - 43093465	254403	249140	rs886037994	NC_000017.11:43093461:TTACTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2068A>T (p.Lys690Ter)	BRCA1	K690*, K643*, K563*, K578*, K601*, K649*, K562*, K579*, K602*, K620*, K663*, K522*, K619*, K623*, K642*, K648*, K664*, K687*, K689*, K394*, K622*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266211	17	41245480	17	43093463	266211	261885	rs587781448	NC_000017.11:43093462:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2066dup (p.Ser689fs)	BRCA1	S689fs, S642fs, S562fs, S577fs, S578fs, S600fs, S647fs, S648fs, S686fs, S561fs, S622fs, S663fs, S521fs, S621fs, S662fs, S393fs, S601fs, S618fs, S619fs, S641fs, S688fs	Hereditary breast ovarian cancer syndrome	VCV000570907	17	41245481 - 41245482	17	43093464 - 43093465	570907	571189	rs1567797130	NC_000017.11:43093464:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Mar 23, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2063_2066del (p.Thr688fs)	BRCA1	T688fs, T641fs, T392fs, T577fs, T600fs, T687fs, T561fs, T617fs, T646fs, T685fs, T560fs, T599fs, T620fs, T621fs, T640fs, T647fs, T520fs, T576fs, T618fs, T661fs, T662fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054449	17	41245482 - 41245485	17	43093465 - 43093468	54449	69116	rs397508935	NC_000017.11:43093464:CTTG:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2063_2064del (p.Thr688fs)	BRCA1	T641fs, T688fs, T560fs, T561fs, T647fs, T687fs, T599fs, T600fs, T617fs, T662fs, T685fs, T392fs, T520fs, T576fs, T577fs, T620fs, T640fs, T646fs, T618fs, T621fs, T661fs	Hereditary breast ovarian cancer syndrome	VCV002030561	17	41245484 - 41245485	17	43093467 - 43093468	2030561	2085908	rs2552194328	NC_000017.11:43093466:TGT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 15, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2061_2064del (p.Thr688fs)	BRCA1	T641fs, T688fs, T520fs, T560fs, T617fs, T618fs, T640fs, T662fs, T687fs, T392fs, T577fs, T561fs, T576fs, T599fs, T600fs, T620fs, T621fs, T646fs, T647fs, T661fs, T685fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000820627	17	41245484 - 41245487	17	43093467 - 43093470	820627	813817	rs1597872420	NC_000017.11:43093466:TGTCTGT:TGT	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2057_2060del (p.Glu686fs)	BRCA1	E639fs, E686fs, E390fs, E518fs, E558fs, E619fs, E638fs, E659fs, E574fs, E575fs, E598fs, E644fs, E615fs, E616fs, E618fs, E685fs, E559fs, E597fs, E645fs, E660fs, E683fs	Hereditary cancer-predisposing syndrome	VCV000820614	17	41245488 - 41245491	17	43093471 - 43093474	820614	813819	rs1597872456	NC_000017.11:43093470:TGTT:	Deletion	intron variant|frameshift variant	Pathogenic	Jun 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2059C>T (p.Gln687Ter)	BRCA1	Q687*, Q640*, Q575*, Q619*, Q684*, Q391*, Q616*, Q639*, Q661*, Q519*, Q559*, Q598*, Q617*, Q660*, Q560*, Q576*, Q599*, Q620*, Q645*, Q646*, Q686*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054448	17	41245489	17	43093472	54448	69115	rs273898674	NC_000017.11:43093471:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2056dup (p.Glu686fs)	BRCA1	E575fs, E615fs, E616fs, E618fs, E619fs, E644fs, E660fs, E685fs, E686fs, E518fs, E558fs, E598fs, E390fs, E559fs, E597fs, E639fs, E645fs, E659fs, E683fs, E574fs, E638fs	Hereditary cancer-predisposing syndrome	VCV002585825	17	41245491 - 41245492	17	43093474 - 43093475	2585825	2753385	rs2469569614	NC_000017.11:43093474:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Jul 11, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2055dup (p.Glu686Ter)	BRCA1	E639*, E686*, E558*, E615*, E518*, E559*, E597*, E645*, E659*, E390*, E598*, E638*, E644*, E660*, E683*, E574*, E575*, E616*, E618*, E619*, E685*	Hereditary cancer-predisposing syndrome	VCV001785125	17	41245492 - 41245493	17	43093475 - 43093476	1785125	1843770	rs2552194490	NC_000017.11:43093475:A:AA	Duplication	nonsense|intron variant|frameshift variant	Pathogenic	Dec 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2056G>T (p.Glu686Ter)	BRCA1	E686*, E639*, E558*, E574*, E598*, E616*, E638*, E660*, E390*, E518*, E615*, E683*, E559*, E575*, E645*, E597*, E618*, E619*, E644*, E659*, E685*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142776	17	41245492	17	43093475	142776	152490	rs587782709	NC_000017.11:43093474:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2048del (p.Lys683fs)	BRCA1	K683fs, K636fs, K612fs, K615fs, K635fs, K680fs, K387fs, K556fs, K571fs, K594fs, K595fs, K616fs, K642fs, K657fs, K515fs, K613fs, K682fs, K555fs, K572fs, K641fs, K656fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054446	17	41245500	17	43093483	54446	69113	rs397508933	NC_000017.11:43093482:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2046del (p.Asn682fs)	BRCA1	N635fs, N682fs, N514fs, N554fs, N615fs, N655fs, N681fs, N570fs, N571fs, N593fs, N611fs, N612fs, N641fs, N679fs, N386fs, N555fs, N594fs, N614fs, N634fs, N640fs, N656fs	Hereditary cancer-predisposing syndrome	VCV001784972	17	41245502	17	43093485	1784972	1843617	rs2552194667	NC_000017.11:43093484:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 22, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2043dup (p.Asn682Ter)	BRCA1	N635*, N682*, N554*, N681*, N555*, N641*, N655*, N571*, N593*, N611*, N634*, N656*, N386*, N514*, N570*, N594*, N612*, N614*, N615*, N640*, N679*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216102	17	41245504 - 41245505	17	43093487 - 43093488	216102	213325	rs863224510	NC_000017.11:43093487:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2039_2040insCC (p.Lys680fs)	BRCA1	K633fs, K680fs, K512fs, K552fs, K553fs, K613fs, K639fs, K654fs, K384fs, K569fs, K592fs, K609fs, K610fs, K638fs, K679fs, K568fs, K591fs, K612fs, K632fs, K653fs, K677fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548168	17	41245508 - 41245509	17	43093491 - 43093492	548168	538861	rs1555590620	NC_000017.11:43093491::GG	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2038_2039insCC (p.Lys680fs)	BRCA1	K633fs, K680fs, K591fs, K612fs, K654fs, K512fs, K568fs, K569fs, K639fs, K384fs, K552fs, K553fs, K592fs, K632fs, K638fs, K677fs, K609fs, K610fs, K613fs, K653fs, K679fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125532	17	41245509 - 41245510	17	43093492 - 43093493	125532	131070	rs80357940	NC_000017.11:43093492::GG	Insertion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2037_2038insC (p.Lys680fs)	BRCA1	K633fs, K680fs, K384fs, K609fs, K613fs, K638fs, K653fs, K679fs, K591fs, K592fs, K612fs, K632fs, K552fs, K553fs, K569fs, K610fs, K677fs, K512fs, K568fs, K639fs, K654fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803416	17	41245510 - 41245511	17	43093493 - 43093494	803416	791770	rs1597872557	NC_000017.11:43093493::G	Insertion	frameshift variant|intron variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2038A>T (p.Lys680Ter)	BRCA1	K680*, K633*, K552*, K569*, K592*, K613*, K632*, K639*, K679*, K512*, K609*, K610*, K612*, K677*, K568*, K638*, K654*, K384*, K553*, K591*, K653*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431222	17	41245510	17	43093493	431222	424840	rs1135401850	NC_000017.11:43093492:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2037delinsCC (p.Lys679fs)	BRCA1	K632fs, K679fs, K567fs, K591fs, K611fs, K511fs, K608fs, K631fs, K637fs, K551fs, K590fs, K638fs, K678fs, K383fs, K552fs, K568fs, K609fs, K612fs, K652fs, K653fs, K676fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054443	17	41245511	17	43093494	54443	69110	rs397508932	NC_000017.11:43093493:C:GG	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2035A>T (p.Lys679Ter)	BRCA1	K679*, K632*, K511*, K551*, K609*, K611*, K612*, K631*, K638*, K653*, K383*, K552*, K590*, K637*, K567*, K568*, K652*, K676*, K591*, K608*, K678*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054442	17	41245513	17	43093496	54442	69109	rs80357082	NC_000017.11:43093495:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2029G>T (p.Gly677Ter)	BRCA1	G630*, G677*, G549*, G607*, G636*, G381*, G606*, G610*, G650*, G550*, G565*, G566*, G635*, G674*, G509*, G588*, G589*, G609*, G629*, G651*, G676*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000820554	17	41245519	17	43093502	820554	813821	rs1597872603	NC_000017.11:43093501:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	May 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2028_2029del (p.Gly677fs)	BRCA1	G630fs, G677fs, G566fs, G589fs, G635fs, G674fs, G509fs, G607fs, G636fs, G651fs, G676fs, G565fs, G588fs, G650fs, G381fs, G549fs, G550fs, G606fs, G609fs, G610fs, G629fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054441	17	41245519 - 41245520	17	43093502 - 43093503	54441	69108	rs397508931	NC_000017.11:43093501:CA:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2022_2023dup (p.Ala675fs)	BRCA1	A628fs, A675fs, A379fs, A564fs, A633fs, A634fs, A649fs, A548fs, A605fs, A607fs, A608fs, A674fs, A547fs, A563fs, A587fs, A627fs, A672fs, A507fs, A586fs, A604fs, A648fs	Hereditary breast ovarian cancer syndrome	VCV000663305	17	41245524 - 41245525	17	43093507 - 43093508	663305	646015	rs1597872648	NC_000017.11:43093507:CA:CACA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 28, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.442-814_2022del	BRCA1		BRCA1-related cancer predisposition	VCV003386218	17	41245526 - 41252711	17	43093509 - 43100694	3386218	3545359			Deletion	splice acceptor variant|splice donor variant|initiator_codon_variant	Pathogenic	Sep 27, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1998_2022del (p.Met669fs)	BRCA1	M669fs, M622fs, M373fs, M558fs, M602fs, M666fs, M542fs, M581fs, M599fs, M601fs, M621fs, M627fs, M642fs, M668fs, M501fs, M557fs, M598fs, M541fs, M580fs, M628fs, M643fs	Hereditary cancer-predisposing syndrome	VCV001784081	17	41245526 - 41245550	17	43093509 - 43093533	1784081	1849640	rs2552195075	NC_000017.11:43093508:AGGTTCTTTACCTTCCATGAGTTGTAGGTT:AGGTT	Deletion	frameshift variant|intron variant	Pathogenic	Jun 23, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2021del (p.Pro674fs)	BRCA1	P674fs, P627fs, P378fs, P604fs, P606fs, P607fs, P671fs, P547fs, P586fs, P632fs, P633fs, P673fs, P506fs, P546fs, P562fs, P563fs, P603fs, P626fs, P648fs, P585fs, P647fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054440	17	41245527	17	43093510	54440	69107	rs397508930	NC_000017.11:43093509:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2019del (p.Glu673fs)	BRCA1	E673fs, E626fs, E545fs, E546fs, E606fs, E631fs, E647fs, E602fs, E625fs, E632fs, E670fs, E672fs, E561fs, E562fs, E377fs, E505fs, E584fs, E585fs, E605fs, E603fs, E646fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054438	17	41245529	17	43093512	54438	69105	rs80357626	NC_000017.11:43093511:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2016dup (p.Glu673fs)	BRCA1	E673fs, E626fs, E584fs, E585fs, E631fs, E647fs, E546fs, E606fs, E646fs, E672fs, E377fs, E505fs, E603fs, E670fs, E545fs, E561fs, E562fs, E602fs, E605fs, E625fs, E632fs	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001456613	17	41245531 - 41245532	17	43093514 - 43093515	1456613	1454715	rs2154403814	NC_000017.11:43093514:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2017del (p.Glu673fs)	BRCA1	E626fs, E673fs, E505fs, E584fs, E585fs, E603fs, E646fs, E546fs, E561fs, E631fs, E647fs, E670fs, E562fs, E602fs, E605fs, E606fs, E625fs, E632fs, E377fs, E545fs, E672fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054437	17	41245531	17	43093514	54437	69104	rs80357638	NC_000017.11:43093513:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2017G>T (p.Glu673Ter)	BRCA1	E673*, E626*, E505*, E546*, E605*, E625*, E632*, E646*, E670*, E585*, E606*, E631*, E672*, E545*, E584*, E602*, E377*, E561*, E562*, E603*, E647*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054436	17	41245531	17	43093514	54436	69103	rs80357391	NC_000017.11:43093513:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2014A>T (p.Lys672Ter)	BRCA1	K672*, K625*, K504*, K544*, K605*, K630*, K376*, K560*, K561*, K583*, K584*, K601*, K624*, K645*, K669*, K671*, K631*, K646*, K545*, K602*, K604*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054435	17	41245534	17	43093517	54435	69102	rs397508929	NC_000017.11:43093516:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2012_2013dup (p.Lys672fs)	BRCA1	K625fs, K672fs, K545fs, K646fs, K376fs, K504fs, K584fs, K669fs, K671fs, K544fs, K583fs, K602fs, K630fs, K645fs, K560fs, K561fs, K601fs, K604fs, K605fs, K624fs, K631fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054434	17	41245534 - 41245535	17	43093517 - 43093518	54434	69101	rs397508928	NC_000017.11:43093517:AC:ACAC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2012dup (p.Gly671_Lys672insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266209	17	41245535 - 41245536	17	43093518 - 43093519	266209	261886	rs886039989	NC_000017.11:43093518:CC:CCC	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.2008G>T (p.Glu670Ter)	BRCA1	E623*, E670*, E374*, E558*, E581*, E582*, E602*, E502*, E628*, E629*, E644*, E542*, E559*, E600*, E603*, E622*, E643*, E667*, E669*, E543*, E599*	Hereditary breast ovarian cancer syndrome	VCV001255800	17	41245540	17	43093523	1255800	1245732	rs80357029	NC_000017.11:43093522:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 16, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2001dup (p.Leu668fs)	BRCA1	L621fs, L668fs, L626fs, L641fs, L667fs, L556fs, L372fs, L540fs, L580fs, L598fs, L500fs, L557fs, L600fs, L601fs, L627fs, L642fs, L541fs, L579fs, L597fs, L620fs, L665fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096903	17	41245546 - 41245547	17	43093529 - 43093530	96903	102806	rs80357521	NC_000017.11:43093529:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1999C>T (p.Gln667Ter)	BRCA1	Q667*, Q620*, Q555*, Q556*, Q596*, Q640*, Q641*, Q371*, Q539*, Q579*, Q619*, Q597*, Q625*, Q626*, Q499*, Q540*, Q578*, Q599*, Q600*, Q664*, Q666*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054430	17	41245549	17	43093532	54430	69097	rs80356889	NC_000017.11:43093531:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1997_1998del (p.Leu666fs)	BRCA1	L619fs, L666fs, L538fs, L577fs, L595fs, L498fs, L554fs, L578fs, L618fs, L640fs, L599fs, L639fs, L663fs, L370fs, L539fs, L555fs, L596fs, L598fs, L624fs, L625fs, L665fs	Hereditary breast ovarian cancer syndrome	VCV001069423	17	41245550 - 41245551	17	43093533 - 43093534	1069423	1064220	rs2154404837	NC_000017.11:43093532:TA:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 28, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1997del (p.Leu666fs)	BRCA1	L370fs, L554fs, L596fs, L577fs, L595fs, L598fs, L618fs, L639fs, L539fs, L578fs, L599fs, L640fs, L665fs, L498fs, L538fs, L555fs, L619fs, L624fs, L625fs, L663fs, L666fs	Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast	VCV003893004	17	41245551	17	43093534	3893004	4008888		NC_000017.11:43093533:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 3, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1996del (p.Leu666fs)	BRCA1	L619fs, L666fs, L555fs, L577fs, L598fs, L618fs, L665fs, L498fs, L578fs, L599fs, L624fs, L640fs, L538fs, L554fs, L625fs, L370fs, L539fs, L595fs, L596fs, L639fs, L663fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054429	17	41245552	17	43093535	54429	69096	rs80357922	NC_000017.11:43093534:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1994del (p.Asn665fs)	BRCA1	N618fs, N665fs, N576fs, N595fs, N598fs, N537fs, N553fs, N597fs, N617fs, N624fs, N638fs, N369fs, N497fs, N577fs, N594fs, N623fs, N639fs, N662fs, N538fs, N554fs, N664fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433699	17	41245554	17	43093537	433699	427559	rs1555590714	NC_000017.11:43093536:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1915_1993del (p.Leu639fs)	BRCA1	L592fs, L639fs, L343fs, L471fs, L527fs, L597fs, L613fs, L572fs, L598fs, L528fs, L550fs, L569fs, L612fs, L511fs, L512fs, L551fs, L568fs, L571fs, L591fs, L636fs, L638fs	Hereditary cancer-predisposing syndrome	VCV001782566	17	41245555 - 41245633	17	43093538 - 43093616	1782566	1842950	rs2552195514		Deletion	frameshift variant|intron variant	Pathogenic	Jul 9, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1987del (p.Ser663fs)	BRCA1	S616fs, S663fs, S622fs, S495fs, S535fs, S552fs, S595fs, S596fs, S621fs, S367fs, S536fs, S574fs, S593fs, S636fs, S637fs, S551fs, S575fs, S592fs, S615fs, S660fs, S662fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001783887	17	41245561	17	43093544	1783887	1849446	rs2552195584	NC_000017.11:43093543:T:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1978del (p.Val660fs)	BRCA1	V613fs, V660fs, V364fs, V492fs, V593fs, V619fs, V634fs, V659fs, V532fs, V549fs, V592fs, V657fs, V533fs, V589fs, V612fs, V618fs, V548fs, V571fs, V572fs, V590fs, V633fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266208	17	41245570	17	43093553	266208	261887	rs886039988	NC_000017.11:43093552:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1977_1978del (p.Val660fs)	BRCA1	V660fs, V613fs, V571fs, V592fs, V593fs, V657fs, V532fs, V572fs, V618fs, V633fs, V364fs, V492fs, V533fs, V619fs, V659fs, V548fs, V549fs, V589fs, V590fs, V612fs, V634fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254402	17	41245570 - 41245571	17	43093553 - 43093554	254402	249141	rs773413634	NC_000017.11:43093552:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1974del (p.Met658fs)	BRCA1	M658fs, M611fs, M531fs, M570fs, M610fs, M617fs, M631fs, M632fs, M490fs, M547fs, M588fs, M590fs, M616fs, M546fs, M569fs, M587fs, M591fs, M657fs, M362fs, M530fs, M655fs	Hereditary cancer-predisposing syndrome	VCV001783675	17	41245574	17	43093557	1783675	1839771	rs2552195752	NC_000017.11:43093556:C:	Deletion	intron variant|frameshift variant	Pathogenic	Apr 9, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1972del (p.Met658fs)	BRCA1	M658fs, M611fs, M490fs, M530fs, M547fs, M569fs, M587fs, M546fs, M588fs, M590fs, M610fs, M632fs, M657fs, M362fs, M531fs, M570fs, M591fs, M631fs, M616fs, M617fs, M655fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037439	17	41245576	17	43093559	37439	45995	rs397507195	NC_000017.11:43093558:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1969C>T (p.Gln657Ter)	BRCA1	Q657*, Q610*, Q361*, Q545*, Q569*, Q586*, Q589*, Q615*, Q529*, Q546*, Q609*, Q630*, Q568*, Q587*, Q616*, Q631*, Q654*, Q656*, Q489*, Q530*, Q590*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054423	17	41245579	17	43093562	54423	69090	rs397508926	NC_000017.11:43093561:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1962_1968del (p.Lys654fs)	BRCA1	K607fs, K654fs, K358fs, K527fs, K543fs, K565fs, K586fs, K587fs, K606fs, K627fs, K486fs, K542fs, K584fs, K613fs, K566fs, K628fs, K651fs, K526fs, K583fs, K612fs, K653fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431221	17	41245580 - 41245586	17	43093563 - 43093569	431221	424841	rs1135401849	NC_000017.11:43093562:GTTGTAC:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1965C>G (p.Tyr655Ter)	BRCA1	Y655*, Y608*, Y528*, Y587*, Y588*, Y614*, Y652*, Y359*, Y527*, Y607*, Y613*, Y543*, Y544*, Y566*, Y567*, Y585*, Y628*, Y629*, Y654*, Y487*, Y584*	Hereditary cancer-predisposing syndrome	VCV000820435	17	41245583	17	43093566	820435	813825	rs886039987	NC_000017.11:43093565:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1964_1965insG (p.Tyr655Ter)	BRCA1	Y608*, Y655*, Y543*, Y588*, Y607*, Y629*, Y544*, Y567*, Y584*, Y613*, Y652*, Y487*, Y527*, Y528*, Y585*, Y628*, Y359*, Y566*, Y587*, Y614*, Y654*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548297	17	41245583 - 41245584	17	43093566 - 43093567	548297	538862	rs1555590775	NC_000017.11:43093566::C	Insertion	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1965C>A (p.Tyr655Ter)	BRCA1	Y655*, Y608*, Y629*, Y652*, Y527*, Y528*, Y584*, Y588*, Y614*, Y654*, Y487*, Y544*, Y567*, Y585*, Y587*, Y628*, Y359*, Y543*, Y566*, Y607*, Y613*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266207	17	41245583	17	43093566	266207	261888	rs886039987	NC_000017.11:43093565:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1964del (p.Tyr655fs)	BRCA1	Y655fs, Y608fs, Y543fs, Y584fs, Y588fs, Y607fs, Y613fs, Y359fs, Y527fs, Y528fs, Y614fs, Y629fs, Y566fs, Y567fs, Y585fs, Y628fs, Y652fs, Y487fs, Y544fs, Y587fs, Y654fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187259	17	41245584	17	43093567	187259	185037	rs786203594	NC_000017.11:43093566:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1963dup (p.Tyr655fs)	BRCA1	Y608fs, Y655fs, Y359fs, Y544fs, Y567fs, Y588fs, Y607fs, Y652fs, Y487fs, Y527fs, Y566fs, Y584fs, Y629fs, Y528fs, Y587fs, Y614fs, Y628fs, Y543fs, Y585fs, Y613fs, Y654fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054420	17	41245584 - 41245585	17	43093567 - 43093568	54420	69087	rs397508924	NC_000017.11:43093567:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1963_1964insG (p.Tyr655Ter)	BRCA1	Y608*, Y655*, Y652*, Y527*, Y543*, Y567*, Y585*, Y628*, Y629*, Y654*, Y528*, Y487*, Y544*, Y584*, Y607*, Y614*, Y359*, Y566*, Y587*, Y588*, Y613*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054419	17	41245584 - 41245585	17	43093567 - 43093568	54419	69086	rs1555590789	NC_000017.11:43093567::C	Insertion	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1962dup (p.Tyr655fs)	BRCA1	Y608fs, Y655fs, Y359fs, Y544fs, Y567fs, Y588fs, Y614fs, Y543fs, Y584fs, Y607fs, Y628fs, Y487fs, Y527fs, Y566fs, Y585fs, Y587fs, Y654fs, Y528fs, Y613fs, Y629fs, Y652fs	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000584953	17	41245585 - 41245586	17	43093568 - 43093569	584953	576002	rs1567797549	NC_000017.11:43093568:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	May 28, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1962del (p.Lys654fs)	BRCA1	K607fs, K654fs, K543fs, K566fs, K584fs, K653fs, K358fs, K527fs, K587fs, K628fs, K586fs, K613fs, K651fs, K486fs, K526fs, K542fs, K565fs, K583fs, K606fs, K612fs, K627fs	Hereditary cancer-predisposing syndrome	VCV001783465	17	41245586	17	43093569	1783465	1839561	rs2552195963	NC_000017.11:43093568:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 23, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1961_1962del (p.Lys654fs)	BRCA1	K607fs, K654fs, K486fs, K586fs, K627fs, K565fs, K606fs, K613fs, K653fs, K358fs, K542fs, K543fs, K583fs, K587fs, K612fs, K526fs, K527fs, K566fs, K584fs, K628fs, K651fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254401	17	41245586 - 41245587	17	43093569 - 43093570	254401	249142	rs886037993	NC_000017.11:43093568:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1961dup (p.Tyr655fs)	BRCA1	Y608fs, Y655fs, Y359fs, Y527fs, Y528fs, Y567fs, Y585fs, Y588fs, Y613fs, Y544fs, Y587fs, Y628fs, Y629fs, Y566fs, Y607fs, Y487fs, Y543fs, Y584fs, Y614fs, Y652fs, Y654fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054417	17	41245586 - 41245587	17	43093569 - 43093570	54417	69084	rs80357522	NC_000017.11:43093569:TTTTTTTT:TTTTTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1960_1961del (p.Lys654fs)	BRCA1	K607fs, K654fs, K542fs, K566fs, K583fs, K586fs, K651fs, K358fs, K486fs, K543fs, K606fs, K627fs, K584fs, K587fs, K613fs, K653fs, K526fs, K527fs, K565fs, K612fs, K628fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054416	17	41245587 - 41245588	17	43093570 - 43093571	54416	69083	rs80357522	NC_000017.11:43093569:TTTTTTTT:TTTTTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1958_1961del (p.Lys653fs)	BRCA1	K653fs, K606fs, K541fs, K542fs, K564fs, K582fs, K583fs, K586fs, K627fs, K357fs, K485fs, K525fs, K652fs, K526fs, K585fs, K605fs, K626fs, K650fs, K565fs, K611fs, K612fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054413	17	41245587 - 41245590	17	43093570 - 43093573	54413	69080	rs80357522	NC_000017.11:43093569:TTTTTTTT:TTTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1961del (p.Lys654fs)	BRCA1	K607fs, K654fs, K486fs, K543fs, K651fs, K565fs, K566fs, K583fs, K586fs, K606fs, K653fs, K526fs, K527fs, K542fs, K584fs, K612fs, K613fs, K627fs, K358fs, K587fs, K628fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037438	17	41245587	17	43093570	37438	45994	rs80357522	NC_000017.11:43093569:TTTTTTTT:TTTTTTT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1959_1960delinsG (p.Lys654fs)	BRCA1	K607fs, K654fs, K358fs, K486fs, K526fs, K542fs, K584fs, K612fs, K628fs, K606fs, K613fs, K651fs, K543fs, K565fs, K566fs, K583fs, K586fs, K627fs, K653fs, K527fs, K587fs	Hereditary breast ovarian cancer syndrome	VCV000974978	17	41245588 - 41245589	17	43093571 - 43093572	974978	963302	rs2053853194	NC_000017.11:43093570:TT:C	Indel	frameshift variant|intron variant	Pathogenic	Jul 26, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1960A>T (p.Lys654Ter)	BRCA1	K654*, K607*, K527*, K584*, K606*, K653*, K526*, K542*, K565*, K586*, K587*, K612*, K628*, K358*, K486*, K543*, K566*, K583*, K613*, K627*, K651*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037436	17	41245588	17	43093571	37436	45992	rs80357355	NC_000017.11:43093570:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1953_1956del (p.Lys653fs)	BRCA1	K606fs, K653fs, K542fs, K564fs, K565fs, K586fs, K357fs, K526fs, K541fs, K582fs, K583fs, K611fs, K626fs, K485fs, K585fs, K612fs, K627fs, K525fs, K605fs, K650fs, K652fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037435	17	41245592 - 41245595	17	43093575 - 43093578	37435	45991	rs80357526	NC_000017.11:43093574:TTTCTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1954A>T (p.Lys652Ter)	BRCA1	K356*, K484*, K524*, K525*, K540*, K541*, K563*, K564*, K581*, K582*, K584*, K585*, K604*, K605*, K610*, K611*, K625*, K626*, K649*, K651*, K652*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003903711	17	41245594	17	43093577	3903711	4019584		NC_000017.11:43093576:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 28, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1953dup (p.Lys652fs)	BRCA1	K605fs, K652fs, K484fs, K541fs, K563fs, K584fs, K649fs, K610fs, K626fs, K525fs, K564fs, K581fs, K604fs, K611fs, K540fs, K582fs, K625fs, K651fs, K356fs, K524fs, K585fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054412	17	41245594 - 41245595	17	43093577 - 43093578	54412	69079	rs80357753	NC_000017.11:43093577:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1953del (p.Lys654fs)	BRCA1	K607fs, K654fs, K358fs, K651fs, K486fs, K526fs, K543fs, K587fs, K627fs, K583fs, K584fs, K527fs, K542fs, K565fs, K566fs, K586fs, K606fs, K612fs, K613fs, K628fs, K653fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266206	17	41245595	17	43093578	266206	261889	rs886039986	NC_000017.11:43093577:C:	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1952dup (p.Lys652fs)	BRCA1	K605fs, K652fs, K610fs, K611fs, K484fs, K541fs, K563fs, K582fs, K584fs, K625fs, K356fs, K525fs, K540fs, K564fs, K581fs, K651fs, K524fs, K585fs, K604fs, K626fs, K649fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054411	17	41245595 - 41245596	17	43093578 - 43093579	54411	69078	rs80357885	NC_000017.11:43093578:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1949_1952del (p.Ile650fs)	BRCA1	I650fs, I603fs, I354fs, I482fs, I539fs, I561fs, I562fs, I538fs, I580fs, I582fs, I602fs, I583fs, I608fs, I623fs, I624fs, I647fs, I649fs, I522fs, I523fs, I579fs, I609fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266205	17	41245596 - 41245599	17	43093579 - 43093582	266205	261890	rs886039985	NC_000017.11:43093578:TTTAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1952del (p.Lys651fs)	BRCA1	K604fs, K651fs, K483fs, K562fs, K583fs, K648fs, K355fs, K523fs, K524fs, K539fs, K580fs, K584fs, K625fs, K540fs, K563fs, K624fs, K650fs, K581fs, K603fs, K609fs, K610fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054410	17	41245596	17	43093579	54410	69077	rs80357885	NC_000017.11:43093578:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1950_1951insCA (p.Lys651fs)	BRCA1	K604fs, K651fs, K355fs, K483fs, K523fs, K562fs, K581fs, K625fs, K648fs, K524fs, K580fs, K584fs, K610fs, K624fs, K539fs, K540fs, K563fs, K583fs, K603fs, K650fs, K609fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548211	17	41245597 - 41245598	17	43093580 - 43093581	548211	538863	rs1555590811	NC_000017.11:43093580:T:TGT	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1949dup (p.Lys652fs)	BRCA1	K605fs, K652fs, K541fs, K581fs, K524fs, K540fs, K563fs, K564fs, K582fs, K585fs, K604fs, K610fs, K649fs, K651fs, K525fs, K626fs, K356fs, K484fs, K584fs, K611fs, K625fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409311	17	41245598 - 41245599	17	43093581 - 43093582	409311	402520	rs879255480	NC_000017.11:43093581:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1949_1950del (p.Ile650fs)	BRCA1	I603fs, I650fs, I482fs, I579fs, I582fs, I583fs, I609fs, I624fs, I539fs, I580fs, I623fs, I647fs, I354fs, I562fs, I608fs, I522fs, I523fs, I538fs, I561fs, I602fs, I649fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054409	17	41245598 - 41245599	17	43093581 - 43093582	54409	69076	rs397508921	NC_000017.11:43093580:TAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1949del (p.Ile650fs)	BRCA1	I522fs, I539fs, I562fs, I583fs, I623fs, I647fs, I354fs, I538fs, I561fs, I579fs, I582fs, I602fs, I608fs, I523fs, I603fs, I609fs, I624fs, I649fs, I650fs, I482fs, I580fs	Hereditary cancer-predisposing syndrome	VCV004215074	17	41245599	17	43093582	4215074	4331987		NC_000017.11:43093581:A:	Deletion	intron variant|frameshift variant	Pathogenic	Jul 10, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1938_1947del (p.Ser646fs)	BRCA1	S599fs, S646fs, S518fs, S519fs, S575fs, S576fs, S598fs, S604fs, S578fs, S605fs, S619fs, S620fs, S350fs, S534fs, S558fs, S643fs, S478fs, S535fs, S557fs, S579fs, S645fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054406	17	41245601 - 41245610	17	43093584 - 43093593	54406	69073	rs397508920	NC_000017.11:43093583:CTCTTCACTGCT:CT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1938_1945del (p.Ser646fs)	BRCA1	S646fs, S599fs, S576fs, S598fs, S605fs, S620fs, S557fs, S558fs, S578fs, S604fs, S619fs, S643fs, S478fs, S518fs, S575fs, S645fs, S350fs, S519fs, S534fs, S535fs, S579fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266203	17	41245603 - 41245610	17	43093586 - 43093593	266203	261891	rs886039983	NC_000017.11:43093585:CTTCACTGCT:CT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1945G>T (p.Glu649Ter)	BRCA1	E649*, E602*, E353*, E522*, E578*, E581*, E607*, E623*, E537*, E560*, E579*, E608*, E622*, E481*, E646*, E521*, E538*, E561*, E582*, E601*, E648*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054408	17	41245603	17	43093586	54408	69075	rs80356907	NC_000017.11:43093585:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1942G>T (p.Glu648Ter)	BRCA1	E648*, E601*, E352*, E480*, E521*, E536*, E559*, E647*, E520*, E537*, E560*, E580*, E621*, E645*, E577*, E581*, E607*, E578*, E600*, E606*, E622*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266204	17	41245606	17	43093589	266204	261892	rs886039984	NC_000017.11:43093588:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1936del (p.Ser646fs)	BRCA1	S599fs, S646fs, S350fs, S575fs, S579fs, S604fs, S519fs, S534fs, S535fs, S576fs, S578fs, S619fs, S645fs, S478fs, S518fs, S558fs, S557fs, S598fs, S605fs, S620fs, S643fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054405	17	41245612	17	43093595	54405	69072	rs397508919	NC_000017.11:43093594:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1934del (p.Ser645fs)	BRCA1	S598fs, S645fs, S533fs, S556fs, S577fs, S604fs, S644fs, S349fs, S518fs, S557fs, S597fs, S534fs, S578fs, S642fs, S618fs, S619fs, S477fs, S517fs, S574fs, S575fs, S603fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001782933	17	41245614	17	43093597	1782933	1245769	rs2552196404	NC_000017.11:43093596:G:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1929_1930delinsA (p.Ser643fs)	BRCA1	S643fs, S596fs, S347fs, S572fs, S575fs, S595fs, S601fs, S475fs, S516fs, S531fs, S532fs, S573fs, S576fs, S602fs, S617fs, S642fs, S616fs, S515fs, S554fs, S555fs, S640fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000480996	17	41245618 - 41245619	17	43093601 - 43093602	480996	478788	rs886039982	NC_000017.11:43093600:AA:T	Indel	frameshift variant|intron variant	Pathogenic/Likely pathogenic	May 20, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1930del (p.Cys644fs)	BRCA1	C597fs, C644fs, C517fs, C602fs, C617fs, C618fs, C641fs, C643fs, C348fs, C532fs, C574fs, C577fs, C596fs, C476fs, C533fs, C573fs, C603fs, C516fs, C555fs, C556fs, C576fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266202	17	41245618	17	43093601	266202	261893	rs886039982	NC_000017.11:43093600:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1925_1929del (p.Asp642fs)	BRCA1	D346fs, D641fs, D642fs, D531fs, D553fs, D571fs, D574fs, D575fs, D601fs, D530fs, D554fs, D572fs, D594fs, D595fs, D600fs, D514fs, D515fs, D615fs, D616fs, D639fs, D474fs	Hereditary breast ovarian cancer syndrome	VCV003655420	17	41245619 - 41245623	17	43093602 - 43093606	3655420	3786136		NC_000017.11:43093601:ACTAT:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 4, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1923dup (p.Asp642Ter)	BRCA1	D595*, D642*, D515*, D554*, D615*, D641*, D474*, D514*, D531*, D571*, D574*, D594*, D601*, D530*, D553*, D572*, D575*, D346*, D600*, D616*, D639*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240777	17	41245624 - 41245625	17	43093607 - 43093608	240777	242795	rs878854935	NC_000017.11:43093607:AA:AAA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1921dup (p.Ile641fs)	BRCA1	I641fs, I594fs, I530fs, I573fs, I614fs, I615fs, I345fs, I473fs, I514fs, I529fs, I552fs, I570fs, I593fs, I638fs, I574fs, I599fs, I513fs, I553fs, I571fs, I600fs, I640fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037434	17	41245626 - 41245627	17	43093609 - 43093610	37434	45990	rs397507194	NC_000017.11:43093609:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1921del (p.Ile641fs)	BRCA1	I641fs, I594fs, I530fs, I553fs, I615fs, I640fs, I514fs, I529fs, I552fs, I574fs, I600fs, I570fs, I571fs, I638fs, I345fs, I473fs, I513fs, I573fs, I593fs, I599fs, I614fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091571	17	41245627	17	43093610	91571	97048	rs397507194	NC_000017.11:43093609:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1918C>T (p.Gln640Ter)	BRCA1	Q640*, Q593*, Q472*, Q592*, Q599*, Q614*, Q637*, Q528*, Q569*, Q570*, Q598*, Q344*, Q513*, Q572*, Q613*, Q512*, Q529*, Q551*, Q552*, Q573*, Q639*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266201	17	41245630	17	43093613	266201	261894	rs886039981	NC_000017.11:43093612:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1916T>A (p.Leu639Ter)	BRCA1	L639*, L592*, L343*, L471*, L568*, L571*, L612*, L636*, L551*, L572*, L591*, L598*, L613*, L511*, L527*, L550*, L638*, L512*, L528*, L569*, L597*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054399	17	41245632	17	43093615	54399	69066	rs80357267	NC_000017.11:43093614:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1912del (p.Glu638fs)	BRCA1	E638fs, E591fs, E527fs, E568fs, E611fs, E612fs, E635fs, E526fs, E567fs, E570fs, E596fs, E597fs, E637fs, E342fs, E510fs, E511fs, E549fs, E550fs, E470fs, E571fs, E590fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054398	17	41245636	17	43093619	54398	69065	rs80357933	NC_000017.11:43093618:C:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1912G>T (p.Glu638Ter)	BRCA1	E638*, E591*, E510*, E550*, E567*, E511*, E526*, E568*, E571*, E597*, E611*, E635*, E637*, E342*, E549*, E570*, E590*, E596*, E612*, E470*, E527*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054397	17	41245636	17	43093619	54397	69064	rs80357005	NC_000017.11:43093618:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1908_1911del (p.Cys636fs)	BRCA1	C589fs, C636fs, C525fs, C569fs, C594fs, C609fs, C633fs, C635fs, C340fs, C468fs, C509fs, C524fs, C565fs, C595fs, C610fs, C508fs, C547fs, C548fs, C566fs, C568fs, C588fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266200	17	41245637 - 41245640	17	43093620 - 43093623	266200	261895	rs886039980	NC_000017.11:43093619:AGTA:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1901_1910del (p.Pro634fs)	BRCA1	P587fs, P634fs, P506fs, P507fs, P631fs, P523fs, P592fs, P607fs, P522fs, P546fs, P563fs, P566fs, P567fs, P338fs, P466fs, P545fs, P564fs, P586fs, P593fs, P608fs, P633fs	Hereditary cancer-predisposing syndrome	VCV000628941	17	41245638 - 41245647	17	43093621 - 43093630	628941	618659	rs1567797748	NC_000017.11:43093620:GTACAATTAGGT:GT	Deletion	intron variant|frameshift variant	Pathogenic	Jan 15, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1905_1909del (p.Asn635_Cys636insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266199	17	41245639 - 41245643	17	43093622 - 43093626	266199	261896	rs886039979	NC_000017.11:43093621:TACAAT:T	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1908T>A (p.Cys636Ter)	BRCA1	C340*, C468*, C524*, C568*, C588*, C594*, C595*, C633*, C635*, C508*, C509*, C548*, C636*, C547*, C565*, C566*, C569*, C609*, C525*, C589*, C610*	Hereditary cancer-predisposing syndrome	VCV004215072	17	41245640	17	43093623	4215072	4331985		NC_000017.11:43093622:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 11, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1906del (p.Cys636fs)	BRCA1	C636fs, C589fs, C340fs, C588fs, C508fs, C548fs, C565fs, C569fs, C609fs, C635fs, C468fs, C509fs, C525fs, C566fs, C568fs, C594fs, C595fs, C524fs, C547fs, C610fs, C633fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054393	17	41245642	17	43093625	54393	69060	rs397508916	NC_000017.11:43093624:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1895_1904del (p.Ser632fs)	BRCA1	S504fs, S543fs, S561fs, S564fs, S590fs, S336fs, S606fs, S464fs, S520fs, S521fs, S544fs, S562fs, S585fs, S629fs, S631fs, S632fs, S505fs, S565fs, S584fs, S591fs, S605fs	Hereditary breast ovarian cancer syndrome	VCV002755026	17	41245644 - 41245653	17	43093627 - 43093636	2755026	2909725	rs2552196923	NC_000017.11:43093626:TTAGGTGGGCTTAG:TTAG	Deletion	frameshift variant|intron variant	Pathogenic	Aug 25, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1869_1902del (p.Glu624fs)	BRCA1	E624fs, E577fs, E456fs, E535fs, E553fs, E583fs, E497fs, E513fs, E556fs, E597fs, E512fs, E536fs, E582fs, E328fs, E496fs, E554fs, E557fs, E576fs, E598fs, E621fs, E623fs	Hereditary cancer-predisposing syndrome	VCV001781609	17	41245646 - 41245679	17	43093629 - 43093662	1781609	1838955	rs2552196960	NC_000017.11:43093628:AGGTGGGCTTAGATTTCTACTGACTACTAGTTCAAG:AG	Deletion	frameshift variant|intron variant	Pathogenic	Mar 26, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1887_1900dup (p.Pro634delinsGlnIleTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266197	17	41245647 - 41245648	17	43093630 - 43093631	266197	261897	rs886039977	NC_000017.11:43093630:GTGGGCTTAGATTT:GTGGGCTTAGATTTGTGGGCTTAGATTT	Duplication	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1898del (p.Pro633fs)	BRCA1	P586fs, P633fs, P505fs, P506fs, P585fs, P545fs, P566fs, P591fs, P607fs, P465fs, P521fs, P522fs, P544fs, P606fs, P632fs, P337fs, P562fs, P563fs, P565fs, P592fs, P630fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054388	17	41245650	17	43093633	54388	69055	rs80357851	NC_000017.11:43093632:GGG:GG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1894_1895insT (p.Ser632fs)	BRCA1	S585fs, S632fs, S336fs, S504fs, S520fs, S564fs, S631fs, S505fs, S521fs, S562fs, S590fs, S591fs, S605fs, S606fs, S629fs, S464fs, S584fs, S543fs, S544fs, S561fs, S565fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548259	17	41245653 - 41245654	17	43093636 - 43093637	548259	538864	rs1555590964	NC_000017.11:43093636::A	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1893_1894insT (p.Ser632Ter)	BRCA1	S632*, S585*, S336*, S520*, S521*, S544*, S584*, S504*, S590*, S605*, S606*, S629*, S464*, S543*, S561*, S591*, S631*, S505*, S562*, S564*, S565*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125528	17	41245654 - 41245655	17	43093637 - 43093638	125528	131066	rs80357768	NC_000017.11:43093637::A	Insertion	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1892dup (p.Ser632fs)	BRCA1	S632fs, S585fs, S504fs, S520fs, S565fs, S591fs, S605fs, S631fs, S464fs, S521fs, S562fs, S629fs, S505fs, S544fs, S561fs, S590fs, S336fs, S543fs, S564fs, S584fs, S606fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054383	17	41245655 - 41245656	17	43093638 - 43093639	54383	69050	rs80357932	NC_000017.11:43093638:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1890del (p.Asn630_Leu631insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002855789	17	41245658	17	43093641	2855789	3010870	rs2552197172	NC_000017.11:43093640:A:	Deletion	frameshift variant|intron variant	Pathogenic	Nov 21, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1889del (p.Asn630fs)	BRCA1	N583fs, N630fs, N462fs, N503fs, N541fs, N542fs, N559fs, N603fs, N627fs, N502fs, N604fs, N629fs, N334fs, N563fs, N589fs, N518fs, N519fs, N560fs, N562fs, N582fs, N588fs	Hereditary breast ovarian cancer syndrome	VCV000653179	17	41245659	17	43093642	653179	646019	rs1597873542	NC_000017.11:43093641:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 4, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1885A>T (p.Arg629Ter)	BRCA1	R629*, R582*, R501*, R502*, R518*, R581*, R517*, R541*, R559*, R562*, R626*, R461*, R558*, R587*, R603*, R628*, R333*, R540*, R561*, R588*, R602*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548273	17	41245663	17	43093646	548273	538865	rs1555590987	NC_000017.11:43093645:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1885del (p.Arg629fs)	BRCA1	R582fs, R629fs, R461fs, R501fs, R559fs, R561fs, R562fs, R518fs, R602fs, R333fs, R502fs, R517fs, R541fs, R581fs, R588fs, R626fs, R540fs, R558fs, R587fs, R603fs, R628fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266196	17	41245663	17	43093646	266196	261898	rs886039976	NC_000017.11:43093645:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1881_1884del (p.Ser628fs)	BRCA1	S581fs, S628fs, S500fs, S516fs, S517fs, S540fs, S560fs, S561fs, S587fs, S601fs, S539fs, S586fs, S602fs, S625fs, S501fs, S557fs, S627fs, S332fs, S460fs, S558fs, S580fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054379	17	41245664 - 41245667	17	43093647 - 43093650	54379	69046	rs80357567	NC_000017.11:43093646:ACTGACT:ACT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1882_1883insCC (p.Ser628fs)	BRCA1	S581fs, S628fs, S460fs, S516fs, S560fs, S602fs, S561fs, S601fs, S500fs, S501fs, S517fs, S539fs, S558fs, S580fs, S627fs, S332fs, S540fs, S557fs, S586fs, S587fs, S625fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548233	17	41245665 - 41245666	17	43093648 - 43093649	548233	538866	rs1555590997	NC_000017.11:43093648::GG	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1881_1882insCC (p.Ser628fs)	BRCA1	S581fs, S628fs, S539fs, S540fs, S557fs, S560fs, S601fs, S625fs, S332fs, S558fs, S586fs, S602fs, S460fs, S501fs, S516fs, S561fs, S500fs, S517fs, S580fs, S587fs, S627fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236267	17	41245666 - 41245667	17	43093649 - 43093650	236267	237836	rs878853289	NC_000017.11:43093649:G:GGG	Insertion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1880_1881insAGTT (p.Ser628fs)	BRCA1	S581fs, S628fs, S501fs, S561fs, S557fs, S601fs, S602fs, S625fs, S332fs, S460fs, S516fs, S517fs, S539fs, S540fs, S558fs, S560fs, S580fs, S586fs, S587fs, S627fs, S500fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548202	17	41245667 - 41245668	17	43093650 - 43093651	548202	538867	rs1555591019	NC_000017.11:43093650:A:AACTA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1878_1879insTAGT (p.Val627Ter)	BRCA1	V580*, V627*, V331*, V515*, V579*, V586*, V601*, V459*, V499*, V500*, V516*, V556*, V557*, V560*, V600*, V624*, V539*, V559*, V585*, V626*, V538*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266195	17	41245669 - 41245670	17	43093652 - 43093653	266195	261899	rs886039975	NC_000017.11:43093652::ACTA	Insertion	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1874_1877dup (p.Val627fs)	BRCA1	V627fs, V580fs, V624fs, V499fs, V538fs, V559fs, V579fs, V600fs, V601fs, V459fs, V500fs, V516fs, V586fs, V331fs, V515fs, V539fs, V556fs, V557fs, V560fs, V585fs, V626fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054376	17	41245670 - 41245671	17	43093653 - 43093654	54376	69043	rs80357516	NC_000017.11:43093653:ACTA:ACTAACTA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1875del (p.Leu625_Val626insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091567	17	41245673	17	43093656	91567	97044	rs398122646	NC_000017.11:43093655:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1874del (p.Leu625fs)	BRCA1	L329fs, L457fs, L497fs, L498fs, L513fs, L514fs, L536fs, L537fs, L554fs, L555fs, L557fs, L558fs, L577fs, L578fs, L583fs, L584fs, L598fs, L599fs, L622fs, L624fs, L625fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003072564	17	41245674	17	43093657	3072564	3231005	rs2552197446	NC_000017.11:43093656:A:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 14, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1871_1874delinsTTC (p.Glu624fs)	BRCA1	E624fs, E577fs, E456fs, E512fs, E553fs, E554fs, E556fs, E328fs, E496fs, E513fs, E576fs, E583fs, E598fs, E535fs, E582fs, E623fs, E497fs, E536fs, E557fs, E597fs, E621fs	Hereditary cancer-predisposing syndrome	VCV001781690	17	41245674 - 41245677	17	43093657 - 43093660	1781690	1839036	rs2552197452	NC_000017.11:43093656:AGTT:GAA	Indel	intron variant|frameshift variant	Pathogenic	Oct 15, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1870G>T (p.Glu624Ter)	BRCA1	E624*, E577*, E328*, E456*, E512*, E576*, E582*, E597*, E513*, E553*, E557*, E621*, E535*, E536*, E583*, E496*, E497*, E554*, E556*, E598*, E623*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054375	17	41245678	17	43093661	54375	69042	rs80356950	NC_000017.11:43093660:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1865del (p.Ala622fs)	BRCA1	A622fs, A575fs, A326fs, A533fs, A534fs, A580fs, A581fs, A596fs, A621fs, A551fs, A554fs, A454fs, A510fs, A511fs, A552fs, A555fs, A494fs, A495fs, A574fs, A595fs, A619fs	Hereditary breast ovarian cancer syndrome	VCV002056143	17	41245683	17	43093666	2056143	2112726	rs2552197578	NC_000017.11:43093665:G:	Deletion	frameshift variant|intron variant	Pathogenic	Nov 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1860del (p.His621fs)	BRCA1	H574fs, H621fs, H325fs, H509fs, H550fs, H573fs, H580fs, H618fs, H554fs, H595fs, H620fs, H453fs, H493fs, H510fs, H533fs, H553fs, H579fs, H494fs, H532fs, H551fs, H594fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182105	17	41245688	17	43093671	182105	180871	rs730881459	NC_000017.11:43093670:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1854del (p.Arg618fs)	BRCA1	R571fs, R618fs, R450fs, R490fs, R506fs, R548fs, R591fs, R615fs, R491fs, R507fs, R529fs, R550fs, R551fs, R577fs, R322fs, R547fs, R576fs, R530fs, R570fs, R592fs, R617fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037431	17	41245694	17	43093677	37431	45987	rs397507193	NC_000017.11:43093676:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1847del (p.Ser616fs)	BRCA1	S569fs, S616fs, S489fs, S545fs, S548fs, S589fs, S590fs, S613fs, S615fs, S320fs, S504fs, S505fs, S527fs, S568fs, S528fs, S549fs, S574fs, S575fs, S448fs, S488fs, S546fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266194	17	41245701	17	43093684	266194	261900	rs886039974	NC_000017.11:43093683:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1846dup (p.Ser616fs)	BRCA1	S569fs, S616fs, S448fs, S489fs, S505fs, S527fs, S574fs, S575fs, S488fs, S590fs, S613fs, S615fs, S504fs, S528fs, S545fs, S546fs, S548fs, S549fs, S589fs, S320fs, S568fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054370	17	41245701 - 41245702	17	43093684 - 43093685	54370	69037	rs397508914	NC_000017.11:43093684:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1845_1846del (p.Ser616fs)	BRCA1	S616fs, S569fs, S320fs, S489fs, S527fs, S528fs, S546fs, S548fs, S574fs, S575fs, S448fs, S568fs, S488fs, S590fs, S613fs, S615fs, S504fs, S505fs, S545fs, S549fs, S589fs	Hereditary breast ovarian cancer syndrome	VCV000953656	17	41245702 - 41245703	17	43093685 - 43093686	953656	949951	rs2053874117	NC_000017.11:43093684:AA:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 27, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1845_1846insG (p.Ser616fs)	BRCA1	S569fs, S616fs, S528fs, S546fs, S549fs, S568fs, S590fs, S613fs, S615fs, S489fs, S505fs, S545fs, S589fs, S320fs, S504fs, S527fs, S548fs, S574fs, S448fs, S488fs, S575fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548224	17	41245702 - 41245703	17	43093685 - 43093686	548224	538868	rs1555591112	NC_000017.11:43093685::C	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1844_1845insG (p.Ser616fs)	BRCA1	S569fs, S616fs, S504fs, S527fs, S546fs, S549fs, S568fs, S320fs, S574fs, S590fs, S548fs, S575fs, S613fs, S448fs, S488fs, S489fs, S505fs, S528fs, S545fs, S589fs, S615fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266193	17	41245703 - 41245704	17	43093686 - 43093687	266193	261901	rs886039973	NC_000017.11:43093686::C	Insertion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1842_1843dup (p.Ser615fs)	BRCA1	S615fs, S568fs, S527fs, S548fs, S614fs, S319fs, S447fs, S487fs, S504fs, S544fs, S545fs, S547fs, S567fs, S573fs, S488fs, S503fs, S526fs, S589fs, S574fs, S588fs, S612fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254400	17	41245704 - 41245705	17	43093687 - 43093688	254400	249143	rs767595162	NC_000017.11:43093687:AC:ACAC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1839_1840del (p.Lys614fs)	BRCA1	K567fs, K614fs, K543fs, K547fs, K587fs, K525fs, K566fs, K613fs, K486fs, K502fs, K446fs, K487fs, K526fs, K572fs, K573fs, K611fs, K318fs, K503fs, K544fs, K546fs, K588fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254399	17	41245708 - 41245709	17	43093691 - 43093692	254399	249144	rs752474843	NC_000017.11:43093690:TC:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1840A>T (p.Lys614Ter)	BRCA1	K614*, K567*, K502*, K503*, K543*, K544*, K587*, K573*, K318*, K446*, K487*, K546*, K572*, K611*, K613*, K486*, K525*, K526*, K547*, K566*, K588*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054369	17	41245708	17	43093691	54369	69036	rs80357282	NC_000017.11:43093690:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1837dup (p.Arg613fs)	BRCA1	R317fs, R445fs, R485fs, R486fs, R501fs, R502fs, R524fs, R525fs, R542fs, R543fs, R545fs, R546fs, R565fs, R566fs, R571fs, R572fs, R586fs, R587fs, R610fs, R612fs, R613fs	Hereditary cancer-predisposing syndrome	VCV003226110	17	41245710 - 41245711	17	43093693 - 43093694	3226110	3390615	rs2552198082	NC_000017.11:43093693:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 18, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1836dup (p.Arg613fs)	BRCA1	R566fs, R613fs, R445fs, R485fs, R524fs, R545fs, R571fs, R587fs, R610fs, R612fs, R565fs, R502fs, R542fs, R546fs, R586fs, R317fs, R486fs, R501fs, R525fs, R543fs, R572fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233617	17	41245711 - 41245712	17	43093694 - 43093695	233617	236110	rs876660523	NC_000017.11:43093694:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1837del (p.Arg613fs)	BRCA1	R566fs, R613fs, R485fs, R545fs, R565fs, R572fs, R610fs, R501fs, R524fs, R525fs, R587fs, R317fs, R445fs, R486fs, R543fs, R612fs, R502fs, R542fs, R546fs, R571fs, R586fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054368	17	41245711	17	43093694	54368	69035	rs80357652	NC_000017.11:43093693:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1833_1834insGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGAGGTCAGNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAAAAAGAATAGGCTG (p.Arg612delinsAlaGlyArgGlyGlySerArgLeuTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001452163	17	41245714 - 41245715	17	43093697 - 43093698	1452163	1438921	rs2154418702		Insertion	nonsense|intron variant	Pathogenic	Aug 4, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1832dup (p.Arg612fs)	BRCA1	R485fs, R524fs, R541fs, R565fs, R571fs, R612fs, R484fs, R500fs, R501fs, R545fs, R570fs, R609fs, R444fs, R523fs, R542fs, R585fs, R611fs, R316fs, R544fs, R564fs, R586fs	Hereditary breast ovarian cancer syndrome	VCV002811646	17	41245715 - 41245716	17	43093698 - 43093699	2811646	2972726	rs2552198126	NC_000017.11:43093698:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Feb 2, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1831del (p.Arg610_Leu611insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054366	17	41245717	17	43093700	54366	69033	rs397508913	NC_000017.11:43093699:G:	Deletion	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1826del (p.Asn609fs)	BRCA1	N609fs, N562fs, N313fs, N497fs, N520fs, N538fs, N561fs, N582fs, N606fs, N441fs, N481fs, N482fs, N567fs, N568fs, N498fs, N521fs, N542fs, N608fs, N539fs, N541fs, N583fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254398	17	41245722	17	43093705	254398	249145	rs80357736	NC_000017.11:43093704:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1823_1826del (p.Lys608fs)	BRCA1	K608fs, K561fs, K312fs, K496fs, K566fs, K567fs, K581fs, K480fs, K497fs, K537fs, K538fs, K440fs, K481fs, K519fs, K520fs, K540fs, K541fs, K605fs, K607fs, K560fs, K582fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054361	17	41245722 - 41245725	17	43093705 - 43093708	54361	69028	rs80357585	NC_000017.11:43093704:TTCTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1824_1825del (p.Lys608_Asn609insTer)	BRCA1		Hereditary breast ovarian cancer syndrome|not provided	VCV001330774	17	41245723 - 41245724	17	43093706 - 43093707	1330774	1321452	rs2154419366	NC_000017.11:43093705:TCT:T	Deletion	intron variant|frameshift variant	Pathogenic	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1823dup (p.Asn609fs)	BRCA1	N562fs, N609fs, N498fs, N520fs, N567fs, N583fs, N441fs, N481fs, N521fs, N539fs, N568fs, N497fs, N606fs, N608fs, N313fs, N482fs, N538fs, N541fs, N542fs, N561fs, N582fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001459329	17	41245724 - 41245725	17	43093707 - 43093708	1459329	1406456	rs397508911	NC_000017.11:43093707:TTTTT:TTTTTT	Duplication	intron variant|frameshift variant	Pathogenic	Jun 23, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1820_1823del (p.Lys607fs)	BRCA1	K560fs, K607fs, K439fs, K480fs, K518fs, K536fs, K540fs, K565fs, K580fs, K606fs, K479fs, K539fs, K311fs, K537fs, K566fs, K604fs, K495fs, K496fs, K519fs, K559fs, K581fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266192	17	41245725 - 41245728	17	43093708 - 43093711	266192	261902	rs397508911	NC_000017.11:43093707:TTTTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1823del (p.Lys608fs)	BRCA1	K608fs, K561fs, K519fs, K605fs, K607fs, K440fs, K537fs, K538fs, K540fs, K541fs, K566fs, K581fs, K312fs, K496fs, K497fs, K480fs, K481fs, K520fs, K560fs, K567fs, K582fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054362	17	41245725	17	43093708	54362	69029	rs397508911	NC_000017.11:43093707:TTTTT:TTTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1819A>T (p.Lys607Ter)	BRCA1	K607*, K560*, K495*, K536*, K559*, K479*, K539*, K566*, K311*, K480*, K518*, K537*, K540*, K580*, K581*, K604*, K439*, K496*, K519*, K565*, K606*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054358	17	41245729	17	43093712	54358	69025	rs80357220	NC_000017.11:43093711:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1817del (p.Pro606fs)	BRCA1	P559fs, P606fs, P310fs, P495fs, P517fs, P538fs, P603fs, P535fs, P536fs, P558fs, P564fs, P478fs, P539fs, P565fs, P580fs, P605fs, P438fs, P479fs, P494fs, P518fs, P579fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054357	17	41245731	17	43093714	54357	69024	rs397508910	NC_000017.11:43093713:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1812del (p.Ala605fs)	BRCA1	A605fs, A558fs, A477fs, A494fs, A535fs, A563fs, A602fs, A309fs, A478fs, A493fs, A516fs, A538fs, A564fs, A578fs, A604fs, A534fs, A437fs, A517fs, A537fs, A557fs, A579fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125513	17	41245736	17	43093719	125513	131051	rs80357927	NC_000017.11:43093718:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1807dup (p.Ser603fs)	BRCA1	S556fs, S603fs, S514fs, S536fs, S561fs, S576fs, S435fs, S475fs, S491fs, S515fs, S533fs, S600fs, S307fs, S535fs, S555fs, S476fs, S492fs, S532fs, S562fs, S577fs, S602fs	Hereditary breast ovarian cancer syndrome	VCV001444186	17	41245740 - 41245741	17	43093723 - 43093724	1444186	1388151	rs2154421251	NC_000017.11:43093723:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Nov 23, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1808C>G (p.Ser603Ter)	BRCA1	S603*, S556*, S491*, S561*, S600*, S602*, S475*, S492*, S536*, S562*, S577*, S435*, S576*, S307*, S476*, S514*, S515*, S532*, S533*, S535*, S555*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054356	17	41245740	17	43093723	54356	69023	rs397508909	NC_000017.11:43093722:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1805del (p.Asn602fs)	BRCA1	N602fs, N555fs, N490fs, N513fs, N560fs, N601fs, N475fs, N554fs, N561fs, N599fs, N474fs, N491fs, N514fs, N531fs, N534fs, N576fs, N306fs, N434fs, N532fs, N535fs, N575fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054355	17	41245743	17	43093726	54355	69022	rs397508908	NC_000017.11:43093725:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1803del (p.His601fs)	BRCA1	H554fs, H601fs, H473fs, H490fs, H305fs, H433fs, H534fs, H559fs, H574fs, H575fs, H474fs, H489fs, H512fs, H513fs, H533fs, H600fs, H530fs, H531fs, H553fs, H560fs, H598fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266190	17	41245745	17	43093728	266190	261903	rs886039970	NC_000017.11:43093727:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1801dup (p.His601fs)	BRCA1	H530fs, H531fs, H553fs, H560fs, H598fs, H433fs, H512fs, H305fs, H513fs, H533fs, H534fs, H554fs, H559fs, H574fs, H575fs, H473fs, H474fs, H489fs, H490fs, H600fs, H601fs	Hereditary cancer-predisposing syndrome	VCV003261451	17	41245746 - 41245747	17	43093729 - 43093730	3261451	3424220		NC_000017.11:43093729:GG:GGG	Duplication	intron variant|frameshift variant	Pathogenic	Mar 29, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1796_1799del (p.Asn599fs)	BRCA1	N552fs, N599fs, N488fs, N531fs, N558fs, N572fs, N431fs, N472fs, N510fs, N529fs, N532fs, N303fs, N557fs, N598fs, N471fs, N487fs, N511fs, N528fs, N551fs, N573fs, N596fs	Familial cancer of breast	VCV001685581	17	41245749 - 41245752	17	43093732 - 43093735	1685581	1677597	rs1380657206	NC_000017.11:43093731:ATAT:	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1799del (p.Ile600fs)	BRCA1	I553fs, I600fs, I304fs, I473fs, I511fs, I512fs, I432fs, I530fs, I532fs, I552fs, I558fs, I559fs, I472fs, I488fs, I489fs, I533fs, I573fs, I574fs, I597fs, I529fs, I599fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240776	17	41245749	17	43093732	240776	242796	rs878854934	NC_000017.11:43093731:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1795_1798del (p.Asn599fs)	BRCA1	N552fs, N599fs, N303fs, N511fs, N531fs, N532fs, N471fs, N472fs, N431fs, N488fs, N529fs, N551fs, N558fs, N573fs, N598fs, N487fs, N510fs, N528fs, N557fs, N572fs, N596fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266188	17	41245750 - 41245753	17	43093733 - 43093736	266188	261904	rs886039968	NC_000017.11:43093732:TATTTA:TA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1793T>G (p.Leu598Ter)	BRCA1	L598*, L551*, L531*, L572*, L486*, L487*, L510*, L527*, L530*, L550*, L430*, L470*, L509*, L471*, L556*, L557*, L571*, L595*, L302*, L528*, L597*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054352	17	41245755	17	43093738	54352	69019	rs80357118	NC_000017.11:43093737:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1793T>A (p.Leu598Ter)	BRCA1	L598*, L551*, L430*, L470*, L509*, L527*, L528*, L557*, L471*, L486*, L487*, L302*, L530*, L531*, L556*, L572*, L597*, L510*, L550*, L571*, L595*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054351	17	41245755	17	43093738	54351	69018	rs80357118	NC_000017.11:43093737:A:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1791del (p.Glu597fs)	BRCA1	E550fs, E597fs, E469fs, E485fs, E509fs, E301fs, E429fs, E530fs, E596fs, E508fs, E549fs, E555fs, E571fs, E594fs, E470fs, E486fs, E526fs, E527fs, E529fs, E556fs, E570fs	Hereditary cancer-predisposing syndrome	VCV001780196	17	41245757	17	43093740	1780196	1834897	rs2552198575	NC_000017.11:43093739:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Apr 23, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1789G>T (p.Glu597Ter)	BRCA1	E597*, E550*, E429*, E470*, E486*, E526*, E530*, E555*, E570*, E549*, E594*, E301*, E527*, E596*, E469*, E485*, E508*, E509*, E529*, E556*, E571*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054348	17	41245759	17	43093742	54348	69015	rs55650082	NC_000017.11:43093741:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1785del (p.Glu595fs)	BRCA1	E548fs, E595fs, E427fs, E524fs, E525fs, E547fs, E299fs, E467fs, E468fs, E527fs, E553fs, E554fs, E568fs, E483fs, E484fs, E507fs, E528fs, E569fs, E592fs, E506fs, E594fs	Hereditary breast ovarian cancer syndrome	VCV000573017	17	41245763	17	43093746	573017	571193	rs1567798263	NC_000017.11:43093745:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jan 6, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1779_1785del (p.Met594fs)	BRCA1	M594fs, M547fs, M483fs, M524fs, M526fs, M467fs, M482fs, M523fs, M552fs, M591fs, M298fs, M426fs, M505fs, M527fs, M593fs, M466fs, M506fs, M546fs, M553fs, M567fs, M568fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266187	17	41245763 - 41245769	17	43093746 - 43093752	266187	261905	rs886039967	NC_000017.11:43093745:TTCCATATT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.671-26_1781del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267616	17	41245767 - 41246903	17	43093750 - 43094886	267616	262971			Deletion	splice acceptor variant|splice donor variant|intron variant|initiator_codon_variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1780del (p.Met594fs)	BRCA1	M547fs, M594fs, M506fs, M546fs, M553fs, M426fs, M466fs, M467fs, M524fs, M567fs, M568fs, M591fs, M298fs, M482fs, M483fs, M505fs, M526fs, M552fs, M523fs, M527fs, M593fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431219	17	41245768	17	43093751	431219	424843	rs1135401848	NC_000017.11:43093750:T:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1772del (p.Ile591fs)	BRCA1	I544fs, I591fs, I479fs, I503fs, I521fs, I524fs, I543fs, I549fs, I550fs, I565fs, I590fs, I464fs, I502fs, I523fs, I588fs, I423fs, I520fs, I564fs, I295fs, I463fs, I480fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054346	17	41245776	17	43093759	54346	69013	rs80357901	NC_000017.11:43093758:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1768_1770delinsC (p.Ser590fs)	BRCA1	S590fs, S543fs, S463fs, S479fs, S522fs, S563fs, S587fs, S422fs, S462fs, S501fs, S548fs, S549fs, S564fs, S589fs, S478fs, S520fs, S523fs, S294fs, S502fs, S519fs, S542fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231505	17	41245778 - 41245780	17	43093761 - 43093763	231505	236115	rs876659196	NC_000017.11:43093760:ACT:G	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1765del (p.Ser589fs)	BRCA1	S589fs, S542fs, S421fs, S461fs, S478fs, S518fs, S563fs, S462fs, S477fs, S519fs, S541fs, S547fs, S548fs, S588fs, S293fs, S522fs, S562fs, S500fs, S501fs, S521fs, S586fs	Hereditary cancer-predisposing syndrome	VCV000491036	17	41245783	17	43093766	491036	485379	rs1555591273	NC_000017.11:43093765:T:	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1763_1764del (p.Ser588fs)	BRCA1	S541fs, S588fs, S476fs, S477fs, S521fs, S540fs, S547fs, S561fs, S292fs, S420fs, S518fs, S546fs, S587fs, S461fs, S499fs, S500fs, S460fs, S517fs, S520fs, S562fs, S585fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000246392	17	41245784 - 41245785	17	43093767 - 43093768	246392	245046	rs879254237	NC_000017.11:43093766:GC:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1762dup (p.Ser588fs)	BRCA1	S541fs, S588fs, S476fs, S499fs, S518fs, S561fs, S292fs, S420fs, S520fs, S562fs, S460fs, S500fs, S517fs, S540fs, S546fs, S547fs, S585fs, S587fs, S461fs, S477fs, S521fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266185	17	41245785 - 41245786	17	43093768 - 43093769	266185	261906	rs886039966	NC_000017.11:43093768:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1762del (p.Ser588fs)	BRCA1	S547fs, S420fs, S461fs, S476fs, S477fs, S520fs, S540fs, S561fs, S562fs, S588fs, S499fs, S500fs, S518fs, S546fs, S585fs, S587fs, S292fs, S460fs, S517fs, S521fs, S541fs	Hereditary breast ovarian cancer syndrome	VCV003664452	17	41245786	17	43093769	3664452	3791549		NC_000017.11:43093768:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 4, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1759_1762del (p.Ile587fs)	BRCA1	I587fs, I540fs, I476fs, I520fs, I539fs, I561fs, I460fs, I475fs, I499fs, I519fs, I545fs, I586fs, I459fs, I498fs, I516fs, I560fs, I584fs, I291fs, I419fs, I517fs, I546fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252868	17	41245786 - 41245789	17	43093769 - 43093772	252868	247269	rs879255479	NC_000017.11:43093768:TTAT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1760_1761del (p.Ile587fs)	BRCA1	I459fs, I460fs, I539fs, I540fs, I291fs, I475fs, I498fs, I520fs, I560fs, I516fs, I519fs, I561fs, I584fs, I587fs, I419fs, I476fs, I499fs, I517fs, I545fs, I546fs, I586fs	Hereditary breast ovarian cancer syndrome	VCV002700743	17	41245787 - 41245788	17	43093770 - 43093771	2700743	2865583	rs2552198877	NC_000017.11:43093769:TATA:TA	Microsatellite	intron variant|frameshift variant	Pathogenic	Dec 4, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1760dup (p.Ser588fs)	BRCA1	S588fs, S541fs, S460fs, S477fs, S520fs, S561fs, S562fs, S420fs, S461fs, S517fs, S518fs, S521fs, S540fs, S546fs, S585fs, S476fs, S500fs, S292fs, S499fs, S547fs, S587fs	not provided	VCV000545790	17	41245787 - 41245788	17	43093770 - 43093771	545790	536496	rs1555591286	NC_000017.11:43093770:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	May 16, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1758_1760delinsAA (p.Ile587fs)	BRCA1	I587fs, I540fs, I291fs, I476fs, I498fs, I539fs, I584fs, I419fs, I460fs, I475fs, I499fs, I519fs, I586fs, I459fs, I520fs, I545fs, I546fs, I561fs, I516fs, I517fs, I560fs	Hereditary cancer-predisposing syndrome	VCV001779498	17	41245788 - 41245790	17	43093771 - 43093773	1779498	1839065	rs2552198905	NC_000017.11:43093770:ATA:TT	Indel	intron variant|frameshift variant	Pathogenic	Jan 9, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1760del (p.Ile587fs)	BRCA1	I587fs, I540fs, I291fs, I419fs, I476fs, I519fs, I539fs, I561fs, I586fs, I475fs, I498fs, I545fs, I584fs, I499fs, I520fs, I546fs, I560fs, I459fs, I460fs, I516fs, I517fs	Hereditary breast ovarian cancer syndrome	VCV001448864	17	41245788	17	43093771	1448864	1338620	rs2154425630	NC_000017.11:43093770:A:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 4, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1757_1760delinsGA (p.Pro586fs)	BRCA1	P539fs, P586fs, P290fs, P475fs, P515fs, P545fs, P560fs, P474fs, P498fs, P518fs, P519fs, P583fs, P585fs, P418fs, P459fs, P497fs, P516fs, P538fs, P458fs, P544fs, P559fs	not provided	VCV000545752	17	41245788 - 41245791	17	43093771 - 43093774	545752	536495	rs1555591287	NC_000017.11:43093770:ATAG:TC	Indel	frameshift variant|intron variant	Pathogenic	Nov 23, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1758_1759insTT (p.Ile587fs)	BRCA1	I587fs, I540fs, I498fs, I560fs, I584fs, I499fs, I546fs, I586fs, I291fs, I419fs, I460fs, I476fs, I517fs, I520fs, I539fs, I545fs, I459fs, I475fs, I516fs, I519fs, I561fs	Hereditary breast ovarian cancer syndrome	VCV002027308	17	41245789 - 41245790	17	43093772 - 43093773	2027308	2081381	rs2552198952	NC_000017.11:43093772:A:AAA	Insertion	frameshift variant|intron variant	Pathogenic	Aug 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1759del (p.Pro586_Ile587insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091563	17	41245789	17	43093772	91563	97040	rs398122642	NC_000017.11:43093771:T:	Deletion	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1757del (p.Pro586fs)	BRCA1	P539fs, P586fs, P459fs, P474fs, P515fs, P544fs, P418fs, P497fs, P516fs, P519fs, P545fs, P585fs, P458fs, P498fs, P559fs, P560fs, P290fs, P475fs, P518fs, P538fs, P583fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054343	17	41245791	17	43093774	54343	69010	rs80357723	NC_000017.11:43093773:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1749_1755del (p.Lys583fs)	BRCA1	K583fs, K536fs, K456fs, K495fs, K535fs, K542fs, K557fs, K415fs, K455fs, K471fs, K513fs, K516fs, K580fs, K494fs, K512fs, K541fs, K582fs, K287fs, K472fs, K515fs, K556fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266184	17	41245793 - 41245799	17	43093776 - 43093782	266184	261907	rs886039965	NC_000017.11:43093775:TTCAGCTTTC:TTC	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1753G>T (p.Glu585Ter)	BRCA1	E289*, E417*, E457*, E458*, E473*, E474*, E496*, E497*, E514*, E515*, E517*, E518*, E537*, E538*, E543*, E544*, E558*, E559*, E582*, E584*, E585*	not provided	VCV003893340	17	41245795	17	43093778	3893340	4009221		NC_000017.11:43093777:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 22, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1752del (p.Glu585fs)	BRCA1	E289fs, E417fs, E457fs, E458fs, E473fs, E474fs, E496fs, E497fs, E514fs, E515fs, E517fs, E518fs, E537fs, E538fs, E543fs, E544fs, E558fs, E559fs, E582fs, E584fs, E585fs	not provided	VCV003337864	17	41245796	17	43093779	3337864	3496524		NC_000017.11:43093778:A:	Deletion	frameshift variant|intron variant	Pathogenic	May 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1749dup (p.Ala584fs)	BRCA1	A584fs, A537fs, A416fs, A456fs, A472fs, A495fs, A517fs, A581fs, A496fs, A457fs, A473fs, A514fs, A516fs, A542fs, A557fs, A558fs, A288fs, A513fs, A536fs, A543fs, A583fs	Hereditary breast ovarian cancer syndrome	VCV002035933	17	41245798 - 41245799	17	43093781 - 43093782	2035933	2093850	rs2552199118	NC_000017.11:43093781:TTT:TTTT	Duplication	intron variant|frameshift variant	Pathogenic	Oct 17, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1747A>T (p.Lys583Ter)	BRCA1	K583*, K536*, K287*, K471*, K494*, K512*, K582*, K455*, K516*, K542*, K580*, K456*, K472*, K515*, K535*, K541*, K556*, K557*, K415*, K495*, K513*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054341	17	41245801	17	43093784	54341	69008	rs80356928	NC_000017.11:43093783:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1744dup (p.Thr582fs)	BRCA1	T535fs, T582fs, T286fs, T555fs, T556fs, T579fs, T414fs, T454fs, T470fs, T493fs, T511fs, T534fs, T540fs, T455fs, T514fs, T471fs, T494fs, T512fs, T515fs, T541fs, T581fs	Hereditary breast ovarian cancer syndrome	VCV001456027	17	41245803 - 41245804	17	43093786 - 43093787	1456027	1380285	rs398122641	NC_000017.11:43093786:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Feb 6, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1745del (p.Thr582fs)	BRCA1	T535fs, T582fs, T286fs, T493fs, T515fs, T555fs, T455fs, T512fs, T514fs, T540fs, T556fs, T579fs, T414fs, T454fs, T470fs, T471fs, T494fs, T511fs, T534fs, T541fs, T581fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000819989	17	41245803	17	43093786	819989	813840	rs1597874447	NC_000017.11:43093785:G:	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Feb 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1744del (p.Thr582fs)	BRCA1	T582fs, T535fs, T286fs, T471fs, T515fs, T540fs, T455fs, T514fs, T534fs, T541fs, T579fs, T581fs, T414fs, T493fs, T555fs, T454fs, T470fs, T494fs, T511fs, T512fs, T556fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091561	17	41245804	17	43093787	91561	97038	rs398122641	NC_000017.11:43093786:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1740_1741insCCATCCTGGCTAACAAGGTGAAACCCCGTCTCTACTAAAAATACAAAAAATTAGCCGGGCGCGGTGGCGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAGAATCTGCTTTC (p.Lys581delinsProSerTrpLeuThrArgTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001451303	17	41245807 - 41245808	17	43093790 - 43093791	1451303	1429557	rs2154427068		Insertion	nonsense|intron variant	Pathogenic	Apr 19, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1741A>T (p.Lys581Ter)	BRCA1	K581*, K534*, K513*, K285*, K413*, K454*, K470*, K493*, K533*, K453*, K510*, K514*, K555*, K578*, K469*, K492*, K511*, K539*, K540*, K554*, K580*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054339	17	41245807	17	43093790	54339	69006	rs397508905	NC_000017.11:43093789:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1733_1734del (p.Ser578fs)	BRCA1	S531fs, S578fs, S410fs, S450fs, S451fs, S466fs, S490fs, S510fs, S511fs, S537fs, S467fs, S530fs, S536fs, S551fs, S575fs, S577fs, S282fs, S489fs, S552fs, S507fs, S508fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254397	17	41245814 - 41245815	17	43093797 - 43093798	254397	249146	rs886037991	NC_000017.11:43093796:AGA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1731dup (p.Ser578fs)	BRCA1	S531fs, S578fs, S410fs, S451fs, S466fs, S490fs, S508fs, S511fs, S552fs, S282fs, S450fs, S467fs, S489fs, S530fs, S551fs, S575fs, S507fs, S510fs, S536fs, S537fs, S577fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000425546	17	41245816 - 41245817	17	43093799 - 43093800	425546	413881	rs1064797381	NC_000017.11:43093799:TT:TTT	Duplication	intron variant|frameshift variant	Pathogenic	Aug 7, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1728_1731del (p.Lys576fs)	BRCA1	K529fs, K576fs, K408fs, K448fs, K449fs, K505fs, K573fs, K280fs, K464fs, K535fs, K506fs, K508fs, K509fs, K549fs, K575fs, K465fs, K487fs, K488fs, K528fs, K534fs, K550fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001072154	17	41245817 - 41245820	17	43093800 - 43093803	1072154	1064221	rs2154427544	NC_000017.11:43093799:TTCTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	May 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1729_1730insCTCTCCCTCTCCCTCTCCCTCTCCCTCTCCGTCTCCGTCGCCCTCCCCGGGCTCCGGGACGGGNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAGAATCACTCGAAAAAG (p.Glu577fs)	BRCA1	E577fs, E530fs, E450fs, E506fs, E510fs, E536fs, E409fs, E449fs, E465fs, E529fs, E535fs, E551fs, E281fs, E466fs, E488fs, E507fs, E550fs, E576fs, E489fs, E509fs, E574fs	Hereditary breast ovarian cancer syndrome	VCV001999770	17	41245818 - 41245819	17	43093801 - 43093802	1999770	2054263	rs2552199435		Insertion	frameshift variant|intron variant	Pathogenic	Jul 12, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1729_1730del (p.Glu577fs)	BRCA1	E530fs, E577fs, E489fs, E550fs, E574fs, E576fs, E281fs, E409fs, E506fs, E535fs, E449fs, E450fs, E466fs, E510fs, E536fs, E551fs, E465fs, E488fs, E507fs, E509fs, E529fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054336	17	41245818 - 41245819	17	43093801 - 43093802	54336	69003	rs80357834	NC_000017.11:43093800:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1729G>T (p.Glu577Ter)	BRCA1	E577*, E530*, E409*, E449*, E450*, E506*, E509*, E529*, E550*, E574*, E281*, E466*, E510*, E535*, E536*, E576*, E465*, E488*, E489*, E507*, E551*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054335	17	41245819	17	43093802	54335	69002	rs397508903	NC_000017.11:43093801:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1728dup (p.Glu577fs)	BRCA1	E577fs, E530fs, E281fs, E466fs, E488fs, E509fs, E550fs, E576fs, E450fs, E489fs, E536fs, E574fs, E409fs, E449fs, E465fs, E507fs, E529fs, E535fs, E551fs, E506fs, E510fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037428	17	41245819 - 41245820	17	43093802 - 43093803	37428	45984	rs397507192	NC_000017.11:43093802:TTTTT:TTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1726_1727insG (p.Lys576fs)	BRCA1	K576fs, K529fs, K487fs, K506fs, K534fs, K280fs, K464fs, K508fs, K535fs, K550fs, K449fs, K465fs, K505fs, K528fs, K549fs, K575fs, K408fs, K448fs, K488fs, K509fs, K573fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548225	17	41245821 - 41245822	17	43093804 - 43093805	548225	538869	rs1555591326	NC_000017.11:43093804::C	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1723dup (p.Glu575fs)	BRCA1	E528fs, E575fs, E279fs, E464fs, E486fs, E505fs, E548fs, E572fs, E447fs, E448fs, E504fs, E507fs, E508fs, E407fs, E463fs, E527fs, E533fs, E534fs, E549fs, E487fs, E574fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000438914	17	41245824 - 41245825	17	43093807 - 43093808	438914	432914	rs1555591335	NC_000017.11:43093807:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1723G>T (p.Glu575Ter)	BRCA1	E575*, E528*, E447*, E507*, E508*, E533*, E549*, E572*, E464*, E505*, E527*, E574*, E448*, E463*, E487*, E504*, E534*, E279*, E407*, E486*, E548*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266183	17	41245825	17	43093808	266183	261908	rs397508902	NC_000017.11:43093807:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1718C>G (p.Ser573Ter)	BRCA1	S405*, S505*, S446*, S526*, S531*, S532*, S277*, S461*, S462*, S484*, S485*, S506*, S546*, S572*, S445*, S502*, S503*, S525*, S547*, S570*, S573*	not provided|Hereditary breast ovarian cancer syndrome	VCV002842766	17	41245830	17	43093813	2842766	2997472	rs876660434	NC_000017.11:43093812:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1718del (p.Ser573fs)	BRCA1	S277fs, S405fs, S445fs, S446fs, S461fs, S462fs, S484fs, S485fs, S502fs, S503fs, S505fs, S506fs, S525fs, S526fs, S531fs, S532fs, S546fs, S547fs, S570fs, S572fs, S573fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002674434	17	41245830	17	43093813	2674434	2841920	rs2552199592	NC_000017.11:43093812:G:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 7, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1716dup (p.Ser573fs)	BRCA1	S526fs, S573fs, S485fs, S546fs, S405fs, S446fs, S505fs, S547fs, S277fs, S462fs, S503fs, S506fs, S572fs, S445fs, S461fs, S484fs, S502fs, S525fs, S531fs, S532fs, S570fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054333	17	41245831 - 41245832	17	43093814 - 43093815	54333	69000	rs397508900	NC_000017.11:43093814:TT:TTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1713_1717del (p.Glu572fs)	BRCA1	E572fs, E525fs, E276fs, E460fs, E461fs, E483fs, E505fs, E530fs, E501fs, E545fs, E546fs, E571fs, E404fs, E445fs, E484fs, E502fs, E524fs, E444fs, E504fs, E531fs, E569fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054331	17	41245831 - 41245835	17	43093814 - 43093818	54331	68998	rs80357640	NC_000017.11:43093813:ATTCTATT:ATT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1716del (p.Glu572fs)	BRCA1	E525fs, E572fs, E444fs, E445fs, E484fs, E501fs, E545fs, E571fs, E460fs, E461fs, E502fs, E505fs, E524fs, E530fs, E546fs, E276fs, E404fs, E483fs, E504fs, E531fs, E569fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054332	17	41245832	17	43093815	54332	68999	rs397508900	NC_000017.11:43093814:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1714G>T (p.Glu572Ter)	BRCA1	E572*, E525*, E444*, E460*, E461*, E545*, E276*, E483*, E484*, E502*, E505*, E404*, E504*, E530*, E445*, E501*, E524*, E531*, E546*, E569*, E571*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182135	17	41245834	17	43093817	182135	180873	rs730881473	NC_000017.11:43093816:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1709del (p.Pro570fs)	BRCA1	P523fs, P570fs, P402fs, P458fs, P481fs, P529fs, P442fs, P443fs, P482fs, P499fs, P543fs, P567fs, P274fs, P500fs, P544fs, P569fs, P459fs, P502fs, P503fs, P522fs, P528fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001074646	17	41245839	17	43093822	1074646	1064222	rs2154428779	NC_000017.11:43093821:GGG:GG	Deletion	frameshift variant|intron variant	Pathogenic	Nov 12, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1706del (p.Asn569fs)	BRCA1	N569fs, N522fs, N441fs, N458fs, N502fs, N528fs, N566fs, N401fs, N442fs, N480fs, N481fs, N521fs, N457fs, N498fs, N499fs, N543fs, N273fs, N501fs, N527fs, N542fs, N568fs	Hereditary breast ovarian cancer syndrome	VCV001423876	17	41245842	17	43093825	1423876	1415060	rs2154428923	NC_000017.11:43093824:TT:T	Deletion	intron variant|frameshift variant	Pathogenic	Mar 29, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1700_1701dup (p.Pro568fs)	BRCA1	P568fs, P521fs, P440fs, P457fs, P501fs, P520fs, P542fs, P272fs, P400fs, P441fs, P456fs, P480fs, P498fs, P526fs, P479fs, P500fs, P527fs, P565fs, P567fs, P497fs, P541fs	Hereditary cancer-predisposing syndrome	VCV001778339	17	41245846 - 41245847	17	43093829 - 43093830	1778339	1834312	rs2552199954	NC_000017.11:43093829:AT:ATAT	Duplication	intron variant|frameshift variant	Pathogenic	Dec 27, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1700dup (p.Asn567fs)	BRCA1	N567fs, N520fs, N399fs, N478fs, N499fs, N439fs, N497fs, N500fs, N526fs, N566fs, N440fs, N456fs, N496fs, N519fs, N541fs, N564fs, N271fs, N455fs, N479fs, N525fs, N540fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125508	17	41245847 - 41245848	17	43093830 - 43093831	125508	131046	rs80357784	NC_000017.11:43093830:TTTTT:TTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1700del (p.Asn567fs)	BRCA1	N520fs, N567fs, N479fs, N499fs, N540fs, N399fs, N439fs, N456fs, N478fs, N541fs, N566fs, N440fs, N455fs, N500fs, N519fs, N271fs, N496fs, N497fs, N525fs, N526fs, N564fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054327	17	41245848	17	43093831	54327	68994	rs80357784	NC_000017.11:43093830:TTTTT:TTTT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1695dup (p.Lys566fs)	BRCA1	K519fs, K566fs, K398fs, K495fs, K540fs, K439fs, K454fs, K496fs, K539fs, K565fs, K438fs, K455fs, K478fs, K498fs, K525fs, K270fs, K477fs, K499fs, K518fs, K524fs, K563fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125507	17	41245852 - 41245853	17	43093835 - 43093836	125507	131045	rs273897664	NC_000017.11:43093835:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1693G>T (p.Glu565Ter)	BRCA1	E565*, E518*, E437*, E453*, E494*, E495*, E517*, E538*, E269*, E397*, E438*, E454*, E476*, E477*, E498*, E564*, E523*, E562*, E497*, E524*, E539*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266181	17	41245855	17	43093838	266181	261909	rs886039963	NC_000017.11:43093837:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1691del (p.Asn564fs)	BRCA1	N564fs, N517fs, N437fs, N452fs, N476fs, N494fs, N522fs, N538fs, N561fs, N268fs, N453fs, N516fs, N537fs, N563fs, N436fs, N475fs, N493fs, N396fs, N496fs, N497fs, N523fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000951336	17	41245857	17	43093840	951336	928315	rs2053899411	NC_000017.11:43093839:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	May 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1644_1689dup (p.Asn564delinsTyrTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV001778064	17	41245858 - 41245859	17	43093841 - 43093842	1778064	1837996	rs2552200187	NC_000017.11:43093841:CTGAATAGAATCACCTTTTGTTTTATTCTCATGACCACTATTAGTA:CTGAATAGAATCACCTTTTGTTTTATTCTCATGACCACTATTAGTACTGAATAGAATCACCTTTTGTTTTATTCTCATGACCACTATTAGTA	Duplication	nonsense|intron variant|frameshift variant	Pathogenic	Nov 6, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1687C>T (p.Gln563Ter)	BRCA1	Q563*, Q516*, Q435*, Q536*, Q452*, Q493*, Q495*, Q496*, Q395*, Q436*, Q451*, Q474*, Q475*, Q521*, Q522*, Q537*, Q267*, Q492*, Q515*, Q560*, Q562*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037426	17	41245861	17	43093844	37426	45982	rs80356898	NC_000017.11:43093843:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1685_1686insGAAAG (p.Ile562fs)	BRCA1	I515fs, I562fs, I394fs, I435fs, I473fs, I494fs, I536fs, I559fs, I266fs, I434fs, I474fs, I492fs, I450fs, I451fs, I495fs, I521fs, I535fs, I491fs, I514fs, I520fs, I561fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548154	17	41245862 - 41245863	17	43093845 - 43093846	548154	538870	rs1555591372	NC_000017.11:43093845::CTTTC	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1684dup (p.Ile562fs)	BRCA1	I515fs, I562fs, I451fs, I474fs, I492fs, I559fs, I266fs, I435fs, I473fs, I495fs, I521fs, I491fs, I494fs, I514fs, I520fs, I535fs, I394fs, I434fs, I450fs, I536fs, I561fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000915401	17	41245863 - 41245864	17	43093846 - 43093847	915401	903620	rs2053901114	NC_000017.11:43093846:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	May 3, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1637_1685delinsGAAAG (p.Met546fs)	BRCA1	M499fs, M546fs, M418fs, M419fs, M543fs, M435fs, M457fs, M478fs, M479fs, M498fs, M504fs, M520fs, M545fs, M378fs, M475fs, M519fs, M250fs, M434fs, M458fs, M476fs, M505fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266177	17	41245863 - 41245911	17	43093846 - 43093894	266177	261910	rs483353085	NC_000017.11:43093845:ATAGAATCACCTTTTGTTTTATTCTCATGACCACTATTAGTAATATTCA:CTTTC	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1682del (p.Ser561fs)	BRCA1	S514fs, S561fs, S434fs, S473fs, S494fs, S520fs, S535fs, S560fs, S450fs, S513fs, S558fs, S449fs, S472fs, S490fs, S491fs, S493fs, S519fs, S265fs, S393fs, S433fs, S534fs	Hereditary breast ovarian cancer syndrome	VCV001074750	17	41245866	17	43093849	1074750	1064223	rs2154430392	NC_000017.11:43093848:G:	Deletion	frameshift variant|intron variant	Pathogenic	Feb 7, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1677_1678del (p.Asp560fs)	BRCA1	D513fs, D560fs, D448fs, D492fs, D512fs, D519fs, D533fs, D534fs, D392fs, D449fs, D432fs, D472fs, D489fs, D493fs, D557fs, D559fs, D264fs, D433fs, D471fs, D490fs, D518fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000834291	17	41245870 - 41245871	17	43093853 - 43093854	834291	845439	rs2053901700	NC_000017.11:43093852:CAC:C	Deletion	frameshift variant|intron variant	Pathogenic	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1677del (p.Asp560fs)	BRCA1	D513fs, D560fs, D432fs, D448fs, D449fs, D512fs, D519fs, D471fs, D490fs, D493fs, D264fs, D392fs, D433fs, D472fs, D489fs, D518fs, D534fs, D557fs, D559fs, D492fs, D533fs	not provided|Hereditary breast ovarian cancer syndrome	VCV001071595	17	41245871	17	43093854	1071595	1064224	rs2154430698	NC_000017.11:43093853:A:	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1676del (p.Gly559fs)	BRCA1	G512fs, G559fs, G431fs, G470fs, G491fs, G391fs, G432fs, G492fs, G518fs, G532fs, G263fs, G447fs, G448fs, G511fs, G533fs, G556fs, G558fs, G471fs, G488fs, G489fs, G517fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000480991	17	41245872	17	43093855	480991	478799	rs1555591383	NC_000017.11:43093854:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1674dup (p.Gly559fs)	BRCA1	G559fs, G512fs, G263fs, G432fs, G471fs, G488fs, G518fs, G558fs, G431fs, G448fs, G470fs, G489fs, G391fs, G447fs, G492fs, G532fs, G556fs, G491fs, G511fs, G517fs, G533fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417825	17	41245873 - 41245874	17	43093856 - 43093857	417825	404716	rs80357600	NC_000017.11:43093856:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1673_1674del (p.Lys558fs)	BRCA1	K511fs, K558fs, K446fs, K447fs, K470fs, K488fs, K490fs, K516fs, K555fs, K390fs, K430fs, K510fs, K517fs, K531fs, K262fs, K431fs, K469fs, K487fs, K491fs, K532fs, K557fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054322	17	41245874 - 41245875	17	43093857 - 43093858	54322	68989	rs80357600	NC_000017.11:43093856:TTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1674del (p.Gly559fs)	BRCA1	G559fs, G512fs, G432fs, G470fs, G489fs, G518fs, G558fs, G263fs, G491fs, G492fs, G532fs, G556fs, G448fs, G511fs, G391fs, G431fs, G447fs, G471fs, G488fs, G517fs, G533fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037425	17	41245874	17	43093857	37425	45981	rs80357600	NC_000017.11:43093856:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1670_1673del (p.Thr557fs)	BRCA1	T510fs, T557fs, T429fs, T531fs, T554fs, T261fs, T446fs, T469fs, T509fs, T515fs, T445fs, T487fs, T556fs, T389fs, T430fs, T468fs, T486fs, T489fs, T490fs, T516fs, T530fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548277	17	41245875 - 41245878	17	43093858 - 43093861	548277	538871	rs1555591390	NC_000017.11:43093857:TTTGTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1669_1670delinsT (p.Lys556_Thr557insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV002583830	17	41245878 - 41245879	17	43093861 - 43093862	2583830	2751400	rs2552200470	NC_000017.11:43093860:GT:A	Indel	intron variant|nonsense	Pathogenic	May 24, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1669del (p.Thr557fs)	BRCA1	T510fs, T557fs, T389fs, T490fs, T556fs, T429fs, T446fs, T486fs, T516fs, T530fs, T261fs, T430fs, T445fs, T469fs, T515fs, T468fs, T487fs, T489fs, T509fs, T531fs, T554fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266180	17	41245879	17	43093862	266180	261911	rs886039962	NC_000017.11:43093861:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1660G>T (p.Glu554Ter)	BRCA1	E554*, E507*, E258*, E426*, E512*, E527*, E551*, E427*, E442*, E466*, E483*, E486*, E506*, E513*, E553*, E443*, E487*, E528*, E386*, E465*, E484*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054320	17	41245888	17	43093871	54320	68987	rs397508894	NC_000017.11:43093870:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1658del (p.His553fs)	BRCA1	H464fs, H483fs, H505fs, H527fs, H425fs, H441fs, H465fs, H482fs, H485fs, H552fs, H257fs, H442fs, H506fs, H511fs, H512fs, H550fs, H385fs, H426fs, H486fs, H526fs, H553fs	Hereditary breast ovarian cancer syndrome	VCV003654597	17	41245890	17	43093873	3654597	3778692		NC_000017.11:43093872:T:	Deletion	frameshift variant|intron variant	Pathogenic	May 26, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1636_1654del (p.Met546fs)	BRCA1	M499fs, M546fs, M378fs, M434fs, M498fs, M520fs, M545fs, M458fs, M476fs, M478fs, M504fs, M505fs, M419fs, M435fs, M457fs, M479fs, M519fs, M543fs, M250fs, M418fs, M475fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054315	17	41245894 - 41245912	17	43093877 - 43093895	54315	68982	rs80359881	NC_000017.11:43093876:CACTATTAGTAATATTCATCACT:CACT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1652_1653insC (p.Gly552fs)	BRCA1	G505fs, G552fs, G464fs, G504fs, G424fs, G425fs, G440fs, G463fs, G484fs, G485fs, G384fs, G481fs, G510fs, G525fs, G526fs, G549fs, G256fs, G441fs, G482fs, G511fs, G551fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548265	17	41245895 - 41245896	17	43093878 - 43093879	548265	538872	rs1555591420	NC_000017.11:43093878::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1651_1652insC (p.Ser551fs)	BRCA1	S504fs, S551fs, S423fs, S439fs, S440fs, S503fs, S255fs, S383fs, S462fs, S480fs, S484fs, S509fs, S524fs, S525fs, S548fs, S483fs, S510fs, S550fs, S424fs, S463fs, S481fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266179	17	41245896 - 41245897	17	43093879 - 43093880	266179	261912	rs886039961	NC_000017.11:43093879::G	Insertion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1650dup (p.Ser551Ter)	BRCA1	S551*, S504*, S481*, S483*, S484*, S509*, S510*, S255*, S383*, S440*, S462*, S424*, S480*, S503*, S524*, S423*, S439*, S463*, S525*, S548*, S550*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254396	17	41245897 - 41245898	17	43093880 - 43093881	254396	249147	rs753524038	NC_000017.11:43093880:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1650del (p.Asn550fs)	BRCA1	N550fs, N503fs, N382fs, N438fs, N480fs, N483fs, N549fs, N254fs, N422fs, N479fs, N509fs, N547fs, N423fs, N439fs, N461fs, N462fs, N508fs, N482fs, N502fs, N523fs, N524fs	Hereditary breast ovarian cancer syndrome	VCV000962686	17	41245898	17	43093881	962686	949953	rs2053906428	NC_000017.11:43093880:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 25, 2019	criteria provided, single submitter							
NM_007294.3:c.1642_1650delins2	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267510	17	41245898 - 41245906	17	43093881 - 43093889	267510	262972			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1649del (p.Asn550fs)	BRCA1	N550fs, N503fs, N382fs, N422fs, N439fs, N479fs, N482fs, N483fs, N502fs, N423fs, N461fs, N462fs, N547fs, N549fs, N254fs, N438fs, N480fs, N508fs, N509fs, N523fs, N524fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054318	17	41245899	17	43093882	54318	68985	rs80357619	NC_000017.11:43093881:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1637_1647del (p.Met546fs)	BRCA1	M434fs, M458fs, M475fs, M498fs, M519fs, M520fs, M418fs, M499fs, M545fs, M419fs, M435fs, M457fs, M476fs, M546fs, M250fs, M378fs, M478fs, M479fs, M504fs, M505fs, M543fs	Hereditary breast ovarian cancer syndrome	VCV002828992	17	41245901 - 41245911	17	43093884 - 43093894	2828992	2983658	rs2552200713	NC_000017.11:43093883:AGTAATATTCA:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 28, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1638_1646delinsA (p.Met546fs)	BRCA1	M499fs, M546fs, M475fs, M476fs, M505fs, M543fs, M419fs, M478fs, M504fs, M545fs, M378fs, M418fs, M434fs, M457fs, M458fs, M479fs, M519fs, M250fs, M435fs, M498fs, M520fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431217	17	41245902 - 41245910	17	43093885 - 43093893	431217	424845	rs1135401846	NC_000017.11:43093884:GTAATATTC:T	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1642_1643del (p.Ile548fs)	BRCA1	I548fs, I501fs, I380fs, I420fs, I436fs, I500fs, I421fs, I478fs, I507fs, I252fs, I477fs, I480fs, I521fs, I545fs, I547fs, I437fs, I459fs, I460fs, I481fs, I506fs, I522fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266178	17	41245905 - 41245906	17	43093888 - 43093889	266178	261913	rs886039960	NC_000017.11:43093887:ATAT:AT	Microsatellite	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1641_1642insG (p.Ile548fs)	BRCA1	I501fs, I548fs, I436fs, I459fs, I477fs, I478fs, I522fs, I380fs, I421fs, I437fs, I460fs, I480fs, I481fs, I500fs, I507fs, I521fs, I547fs, I252fs, I545fs, I420fs, I506fs	Hereditary breast ovarian cancer syndrome|not provided	VCV000663277	17	41245906 - 41245907	17	43093889 - 43093890	663277	646027	rs1597874930	NC_000017.11:43093889::C	Insertion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Jul 29, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1630C>T (p.Gln544Ter)	BRCA1	Q544*, Q497*, Q376*, Q417*, Q473*, Q477*, Q496*, Q541*, Q248*, Q416*, Q432*, Q455*, Q503*, Q517*, Q476*, Q518*, Q433*, Q456*, Q474*, Q502*, Q543*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054313	17	41245918	17	43093901	54313	68980	rs80356952	NC_000017.11:43093900:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1628del (p.Gly543fs)	BRCA1	G496fs, G543fs, G472fs, G475fs, G495fs, G247fs, G415fs, G432fs, G454fs, G476fs, G516fs, G375fs, G416fs, G455fs, G502fs, G431fs, G473fs, G501fs, G517fs, G540fs, G542fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091560	17	41245920	17	43093903	91560	97037	rs398122640	NC_000017.11:43093902:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1622_1626del (p.Gln541fs)	BRCA1	Q494fs, Q541fs, Q245fs, Q413fs, Q429fs, Q499fs, Q500fs, Q414fs, Q470fs, Q493fs, Q514fs, Q474fs, Q515fs, Q538fs, Q540fs, Q373fs, Q430fs, Q452fs, Q453fs, Q471fs, Q473fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252430	17	41245922 - 41245926	17	43093905 - 43093909	252430	246850	rs879255314	NC_000017.11:43093904:ATTCT:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1616_1625del (p.Thr539fs)	BRCA1	T492fs, T539fs, T411fs, T468fs, T472fs, T513fs, T469fs, T498fs, T243fs, T371fs, T427fs, T428fs, T450fs, T451fs, T412fs, T471fs, T491fs, T538fs, T497fs, T512fs, T536fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266175	17	41245923 - 41245932	17	43093906 - 43093915	266175	261914	rs886039959	NC_000017.11:43093905:TTCTGCTCCGTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1623dup (p.Asn542fs)	BRCA1	N542fs, N495fs, N246fs, N414fs, N415fs, N430fs, N474fs, N516fs, N472fs, N475fs, N541fs, N374fs, N454fs, N471fs, N500fs, N501fs, N539fs, N431fs, N453fs, N494fs, N515fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054312	17	41245924 - 41245925	17	43093907 - 43093908	54312	68979	rs397508891	NC_000017.11:43093907:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1620_1621del (p.Gln541fs)	BRCA1	Q373fs, Q413fs, Q470fs, Q474fs, Q493fs, Q500fs, Q538fs, Q540fs, Q245fs, Q430fs, Q494fs, Q452fs, Q453fs, Q471fs, Q473fs, Q499fs, Q541fs, Q414fs, Q429fs, Q514fs, Q515fs	Hereditary breast ovarian cancer syndrome	VCV003653443	17	41245927 - 41245928	17	43093910 - 43093911	3653443	3788876		NC_000017.11:43093909:GC:	Deletion	frameshift variant|intron variant	Pathogenic	May 15, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1621C>T (p.Gln541Ter)	BRCA1	Q541*, Q494*, Q452*, Q245*, Q414*, Q430*, Q473*, Q474*, Q500*, Q514*, Q540*, Q453*, Q493*, Q515*, Q538*, Q373*, Q413*, Q429*, Q470*, Q471*, Q499*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054311	17	41245927	17	43093910	54311	68978	rs80356904	NC_000017.11:43093909:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1618del (p.Glu540fs)	BRCA1	E493fs, E540fs, E244fs, E451fs, E452fs, E472fs, E498fs, E499fs, E513fs, E537fs, E429fs, E514fs, E539fs, E412fs, E469fs, E473fs, E492fs, E372fs, E413fs, E428fs, E470fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441292	17	41245930	17	43093913	441292	435158	rs1555591470	NC_000017.11:43093912:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1618G>T (p.Glu540Ter)	BRCA1	E540*, E493*, E413*, E429*, E469*, E470*, E539*, E244*, E492*, E499*, E473*, E498*, E513*, E537*, E372*, E412*, E428*, E451*, E452*, E472*, E514*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266176	17	41245930	17	43093913	266176	261915	rs730881471	NC_000017.11:43093912:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1612_1616del (p.Gln538fs)	BRCA1	Q491fs, Q538fs, Q411fs, Q467fs, Q468fs, Q471fs, Q242fs, Q370fs, Q490fs, Q537fs, Q427fs, Q449fs, Q450fs, Q470fs, Q496fs, Q497fs, Q512fs, Q535fs, Q410fs, Q426fs, Q511fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000156184	17	41245932 - 41245936	17	43093915 - 43093919	156184	165983	rs587776480	NC_000017.11:43093914:GTTTGGTT:GTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.3(BRCA1):c.1604_1612delGAACTAACCins13 (p.?)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267509	17	41245936 - 41245944	17	43093919 - 43093927	267509	262973			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1612C>T (p.Gln538Ter)	BRCA1	Q538*, Q491*, Q242*, Q468*, Q471*, Q535*, Q426*, Q449*, Q450*, Q497*, Q410*, Q427*, Q496*, Q537*, Q370*, Q411*, Q467*, Q470*, Q490*, Q511*, Q512*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054309	17	41245936	17	43093919	54309	68976	rs80356893	NC_000017.11:43093918:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1608_1611del (p.Asn537fs)	BRCA1	N490fs, N537fs, N369fs, N410fs, N425fs, N448fs, N467fs, N469fs, N489fs, N496fs, N511fs, N536fs, N449fs, N466fs, N470fs, N495fs, N241fs, N409fs, N426fs, N510fs, N534fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054306	17	41245937 - 41245940	17	43093920 - 43093923	54306	68973	rs80357698	NC_000017.11:43093919:GTTAGTT:GTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1606del (p.Thr536fs)	BRCA1	T489fs, T536fs, T424fs, T447fs, T448fs, T465fs, T466fs, T468fs, T488fs, T495fs, T368fs, T409fs, T533fs, T535fs, T240fs, T408fs, T425fs, T469fs, T494fs, T509fs, T510fs	Hereditary cancer-predisposing syndrome	VCV001776293	17	41245942	17	43093925	1776293	1837523	rs2552201322	NC_000017.11:43093924:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1597_1606del (p.Asn533fs)	BRCA1	N486fs, N533fs, N530fs, N365fs, N445fs, N485fs, N491fs, N237fs, N405fs, N444fs, N463fs, N465fs, N492fs, N507fs, N406fs, N421fs, N422fs, N462fs, N466fs, N506fs, N532fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000968196	17	41245942 - 41245951	17	43093925 - 43093934	968196	958137	rs2053913899	NC_000017.11:43093924:TTCCCTGATTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jul 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1604del (p.Gly535fs)	BRCA1	G488fs, G535fs, G424fs, G493fs, G494fs, G509fs, G534fs, G367fs, G447fs, G239fs, G446fs, G464fs, G465fs, G467fs, G407fs, G408fs, G423fs, G468fs, G487fs, G508fs, G532fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001677030	17	41245944	17	43093927	1677030	1668662	rs2154434302	NC_000017.11:43093926:CCC:CC	Deletion	intron variant|frameshift variant	Pathogenic/Likely pathogenic	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1601_1602del (p.Gln534fs)	BRCA1	Q487fs, Q534fs, Q366fs, Q406fs, Q466fs, Q486fs, Q531fs, Q238fs, Q407fs, Q445fs, Q463fs, Q467fs, Q492fs, Q507fs, Q446fs, Q464fs, Q493fs, Q422fs, Q423fs, Q508fs, Q533fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240774	17	41245946 - 41245947	17	43093929 - 43093930	240774	242798	rs878854933	NC_000017.11:43093928:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1601dup (p.Thr536fs)	BRCA1	T536fs, T489fs, T368fs, T408fs, T409fs, T425fs, T469fs, T240fs, T424fs, T447fs, T468fs, T448fs, T466fs, T494fs, T509fs, T510fs, T533fs, T465fs, T488fs, T495fs, T535fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054305	17	41245946 - 41245947	17	43093929 - 43093930	54305	68972	rs397508889	NC_000017.11:43093929:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1595_1601del (p.Ile532fs)	BRCA1	I485fs, I532fs, I236fs, I404fs, I405fs, I462fs, I491fs, I505fs, I529fs, I420fs, I444fs, I464fs, I465fs, I421fs, I443fs, I490fs, I531fs, I364fs, I461fs, I484fs, I506fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054302	17	41245947 - 41245953	17	43093930 - 43093936	54302	68969	rs397508888	NC_000017.11:43093929:TGATTTAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1600del (p.Gln534fs)	BRCA1	Q487fs, Q534fs, Q422fs, Q466fs, Q467fs, Q423fs, Q507fs, Q531fs, Q445fs, Q464fs, Q486fs, Q492fs, Q508fs, Q238fs, Q366fs, Q406fs, Q407fs, Q446fs, Q463fs, Q493fs, Q533fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000225707	17	41245948	17	43093931	225707	227564	rs869320776	NC_000017.11:43093930:G:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1600C>T (p.Gln534Ter)	BRCA1	Q534*, Q487*, Q238*, Q423*, Q486*, Q533*, Q366*, Q422*, Q446*, Q467*, Q531*, Q407*, Q463*, Q466*, Q507*, Q406*, Q445*, Q464*, Q492*, Q493*, Q508*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054303	17	41245948	17	43093931	54303	68970	rs142074233	NC_000017.11:43093930:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1598del (p.Asn533fs)	BRCA1	N486fs, N533fs, N365fs, N465fs, N506fs, N532fs, N237fs, N445fs, N466fs, N485fs, N491fs, N421fs, N422fs, N463fs, N530fs, N405fs, N406fs, N444fs, N462fs, N492fs, N507fs	Hereditary cancer-predisposing syndrome	VCV001776041	17	41245950	17	43093933	1776041	1827840	rs2154434603	NC_000017.11:43093932:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 23, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1590_1594del (p.Glu530fs)	BRCA1	E403fs, E442fs, E459fs, E460fs, E489fs, E504fs, E402fs, E418fs, E419fs, E441fs, E482fs, E529fs, E362fs, E462fs, E483fs, E527fs, E234fs, E463fs, E488fs, E503fs, E530fs	Hereditary breast ovarian cancer syndrome	VCV002820095	17	41245954 - 41245958	17	43093937 - 43093941	2820095	2985026	rs2552201470	NC_000017.11:43093936:TCATTTCA:TCA	Deletion	intron variant|frameshift variant	Pathogenic	Dec 11, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1583_1589del (p.Thr528fs)	BRCA1	T481fs, T528fs, T458fs, T461fs, T487fs, T400fs, T416fs, T417fs, T440fs, T460fs, T480fs, T501fs, T232fs, T457fs, T525fs, T527fs, T360fs, T401fs, T439fs, T486fs, T502fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054301	17	41245959 - 41245965	17	43093942 - 43093948	54301	68968	rs80357613	NC_000017.11:43093941:TCAGGAGTC:TC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1586del (p.Pro529fs)	BRCA1	P482fs, P529fs, P233fs, P402fs, P417fs, P418fs, P459fs, P502fs, P361fs, P401fs, P458fs, P461fs, P487fs, P528fs, P440fs, P462fs, P481fs, P503fs, P526fs, P441fs, P488fs	Hereditary cancer-predisposing syndrome	VCV001775802	17	41245962	17	43093945	1775802	1827602	rs2552201554	NC_000017.11:43093944:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 2, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1576_1580delinsAAG (p.Gln526fs)	BRCA1	Q526fs, Q479fs, Q455fs, Q478fs, Q485fs, Q230fs, Q358fs, Q414fs, Q484fs, Q499fs, Q398fs, Q399fs, Q458fs, Q459fs, Q500fs, Q415fs, Q437fs, Q438fs, Q456fs, Q523fs, Q525fs	Hereditary cancer-predisposing syndrome	VCV001775589	17	41245968 - 41245972	17	43093951 - 43093955	1775589	1830786	rs2552201614	NC_000017.11:43093950:TTTTG:CTT	Indel	frameshift variant|intron variant	Pathogenic	May 27, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1579_1580del (p.Lys527fs)	BRCA1	K480fs, K527fs, K438fs, K399fs, K400fs, K416fs, K439fs, K456fs, K485fs, K524fs, K526fs, K231fs, K359fs, K415fs, K460fs, K486fs, K457fs, K459fs, K479fs, K500fs, K501fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096902	17	41245968 - 41245969	17	43093951 - 43093952	96902	102805	rs431825387	NC_000017.11:43093950:TTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1576_1577del (p.Gln526fs)	BRCA1	Q526fs, Q479fs, Q230fs, Q358fs, Q415fs, Q456fs, Q523fs, Q525fs, Q399fs, Q437fs, Q478fs, Q484fs, Q499fs, Q414fs, Q485fs, Q398fs, Q438fs, Q455fs, Q458fs, Q459fs, Q500fs	Hereditary breast ovarian cancer syndrome	VCV000575484	17	41245971 - 41245972	17	43093954 - 43093955	575484	569166	rs1567799078	NC_000017.11:43093953:TG:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 13, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1575dup (p.Gln526fs)	BRCA1	Q479fs, Q526fs, Q230fs, Q398fs, Q399fs, Q414fs, Q415fs, Q456fs, Q485fs, Q499fs, Q478fs, Q500fs, Q523fs, Q455fs, Q458fs, Q459fs, Q525fs, Q358fs, Q437fs, Q438fs, Q484fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252867	17	41245972 - 41245973	17	43093955 - 43093956	252867	247268	rs879255478	NC_000017.11:43093955:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1576C>T (p.Gln526Ter)	BRCA1	Q526*, Q479*, Q358*, Q398*, Q414*, Q415*, Q438*, Q478*, Q484*, Q437*, Q485*, Q399*, Q458*, Q523*, Q230*, Q455*, Q456*, Q459*, Q499*, Q500*, Q525*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054299	17	41245972	17	43093955	54299	68966	rs80356984	NC_000017.11:43093954:G:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1575del (p.Gln526fs)	BRCA1	Q526fs, Q479fs, Q358fs, Q398fs, Q484fs, Q499fs, Q525fs, Q230fs, Q399fs, Q414fs, Q478fs, Q500fs, Q523fs, Q415fs, Q437fs, Q438fs, Q455fs, Q456fs, Q458fs, Q459fs, Q485fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266174	17	41245973	17	43093956	266174	261916	rs879255478	NC_000017.11:43093955:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1570del (p.Ala524fs)	BRCA1	A477fs, A524fs, A397fs, A413fs, A435fs, A454fs, A476fs, A483fs, A523fs, A521fs, A356fs, A396fs, A436fs, A453fs, A482fs, A497fs, A228fs, A412fs, A456fs, A457fs, A498fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054296	17	41245978	17	43093961	54296	68963	rs397508886	NC_000017.11:43093960:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1568T>A (p.Leu523Ter)	BRCA1	L523*, L476*, L395*, L396*, L455*, L496*, L355*, L453*, L475*, L481*, L482*, L520*, L227*, L412*, L434*, L435*, L452*, L456*, L497*, L411*, L522*	Hereditary breast ovarian cancer syndrome	VCV000847303	17	41245980	17	43093963	847303	845440	rs397508885	NC_000017.11:43093962:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 5, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1568del (p.Leu523fs)	BRCA1	L476fs, L523fs, L227fs, L355fs, L395fs, L396fs, L411fs, L412fs, L452fs, L496fs, L434fs, L455fs, L481fs, L482fs, L497fs, L453fs, L456fs, L520fs, L522fs, L435fs, L475fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000522623	17	41245980	17	43093963	522623	513369	rs1555591543	NC_000017.11:43093962:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Aug 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1566_1567insC (p.Ala524fs)	BRCA1	A477fs, A524fs, A356fs, A396fs, A454fs, A483fs, A497fs, A412fs, A435fs, A456fs, A521fs, A228fs, A397fs, A436fs, A457fs, A413fs, A453fs, A476fs, A482fs, A498fs, A523fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548306	17	41245981 - 41245982	17	43093964 - 43093965	548306	538874	rs1555591551	NC_000017.11:43093964::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1561_1564delinsTAAA (p.Ala521_Asp522delinsTer)	BRCA1	A521*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054292	17	41245984 - 41245987	17	43093967 - 43093970	54292	68959	rs397508883	NC_000017.11:43093966:CTGC:TTTA	Indel	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1561_1562delinsTA (p.Ala521Ter)	BRCA1	A521X, A474*, A451*, A480*, A450*, A454*, A473*, A494*, A409*, A432*, A518*, A225*, A353*, A393*, A394*, A410*, A433*, A453*, A479*, A495*, A520*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125504	17	41245986 - 41245987	17	43093969 - 43093970	125504	131042	rs273897663	NC_000017.11:43093968:GC:TA	Indel	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1556del (p.Lys519fs)	BRCA1	K472fs, K519fs, K223fs, K452fs, K477fs, K516fs, K351fs, K391fs, K392fs, K407fs, K430fs, K448fs, K451fs, K478fs, K492fs, K493fs, K408fs, K431fs, K518fs, K449fs, K471fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017685	17	41245992	17	43093975	17685	32724	rs80357662	NC_000017.11:43093974:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1531_1555del (p.Gly511fs)	BRCA1	G511fs, G464fs, G215fs, G383fs, G444fs, G469fs, G470fs, G485fs, G510fs, G343fs, G422fs, G441fs, G484fs, G384fs, G400fs, G423fs, G440fs, G463fs, G399fs, G443fs, G508fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001774630	17	41245993 - 41246017	17	43093976 - 43094000	1774630	1837168	rs2552202280	NC_000017.11:43093975:TGATAAAATCCTCAGGATGAAGGCCTGAT:TGAT	Deletion	frameshift variant|intron variant	Pathogenic	Feb 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1551_1552insTTTTTTTTTTTTTTTTTTTTNNNNNNNNNNACCTCGTGATCCGCCCGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGCGCCCGGCCCATCCTGAGGATTTT (p.Ile518delinsPhePhePhePhePhePheXaaXaaXaaXaaThrSerTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002865905	17	41245996 - 41245997	17	43093979 - 43093980	2865905	3026978			Microsatellite	nonsense|intron variant	Pathogenic	Oct 23, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1551dup (p.Ile518fs)	BRCA1	I518fs, I471fs, I222fs, I429fs, I447fs, I476fs, I492fs, I350fs, I390fs, I406fs, I451fs, I470fs, I477fs, I407fs, I430fs, I450fs, I391fs, I448fs, I491fs, I515fs, I517fs	Hereditary cancer-predisposing syndrome	VCV001775071	17	41245996 - 41245997	17	43093979 - 43093980	1775071	1833656	rs80357630	NC_000017.11:43093979:AAAA:AAAAA	Duplication	frameshift variant|intron variant	Pathogenic	May 27, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1551del (p.Phe517fs)	BRCA1	F517fs, F470fs, F221fs, F390fs, F406fs, F429fs, F447fs, F449fs, F491fs, F469fs, F490fs, F514fs, F389fs, F428fs, F516fs, F349fs, F405fs, F446fs, F450fs, F475fs, F476fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054289	17	41245997	17	43093980	54289	68956	rs80357630	NC_000017.11:43093979:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1544_1550del (p.Glu515fs)	BRCA1	E515fs, E468fs, E426fs, E445fs, E448fs, E512fs, E514fs, E347fs, E387fs, E404fs, E488fs, E388fs, E403fs, E447fs, E489fs, E219fs, E427fs, E444fs, E467fs, E473fs, E474fs	Hereditary breast ovarian cancer syndrome	VCV002066155	17	41245998 - 41246004	17	43093981 - 43093987	2066155	2128840	rs2552202616	NC_000017.11:43093980:AAATCCT:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 24, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1542_1550delinsCG (p.Glu515fs)	BRCA1	E468fs, E515fs, E403fs, E404fs, E447fs, E473fs, E474fs, E488fs, E219fs, E347fs, E426fs, E427fs, E444fs, E448fs, E467fs, E512fs, E514fs, E445fs, E489fs, E387fs, E388fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232164	17	41245998 - 41246006	17	43093981 - 43093989	232164	236125	rs876659591	NC_000017.11:43093980:AAATCCTCA:CG	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1543G>T (p.Glu515Ter)	BRCA1	E515*, E468*, E387*, E403*, E404*, E445*, E448*, E219*, E426*, E427*, E444*, E447*, E467*, E474*, E514*, E347*, E388*, E473*, E488*, E489*, E512*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254395	17	41246005	17	43093988	254395	249148	rs886037990	NC_000017.11:43093987:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1535_1536insATGA (p.Leu512_His513insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003240938	17	41246012 - 41246013	17	43093995 - 43093996	3240938	3399921	rs2552203155	NC_000017.11:43093995::TCAT	Insertion	intron variant|nonsense|inframe_insertion	Pathogenic	Mar 24, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1534del (p.Leu512fs)	BRCA1	L465fs, L512fs, L401fs, L216fs, L385fs, L442fs, L464fs, L486fs, L511fs, L424fs, L441fs, L444fs, L470fs, L509fs, L423fs, L471fs, L344fs, L384fs, L400fs, L445fs, L485fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001774696	17	41246014	17	43093997	1774696	1245758	rs2552203224	NC_000017.11:43093996:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1532dup (p.Leu512fs)	BRCA1	L216fs, L344fs, L384fs, L385fs, L400fs, L401fs, L423fs, L424fs, L441fs, L442fs, L444fs, L445fs, L464fs, L465fs, L470fs, L471fs, L485fs, L486fs, L509fs, L511fs, L512fs	Hereditary cancer-predisposing syndrome	VCV003226104	17	41246015 - 41246016	17	43093998 - 43093999	3226104	3390609	rs2552203316	NC_000017.11:43093998:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Nov 27, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1532del (p.Gly511fs)	BRCA1	G464fs, G511fs, G399fs, G441fs, G469fs, G484fs, G343fs, G400fs, G422fs, G444fs, G470fs, G485fs, G510fs, G215fs, G383fs, G423fs, G440fs, G443fs, G384fs, G463fs, G508fs	Hereditary cancer-predisposing syndrome	VCV001774655	17	41246016	17	43093999	1774655	1245757	rs2552203316	NC_000017.11:43093998:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 16, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1521_1531del (p.Thr509fs)	BRCA1	T462fs, T509fs, T382fs, T421fs, T438fs, T439fs, T461fs, T508fs, T381fs, T420fs, T467fs, T483fs, T398fs, T442fs, T482fs, T213fs, T341fs, T397fs, T441fs, T468fs, T506fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548314	17	41246017 - 41246027	17	43094000 - 43094010	548314	538875	rs1555591596	NC_000017.11:43093999:CTGATGTAGGTCT:CT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1530del (p.Gly511fs)	BRCA1	G464fs, G511fs, G384fs, G399fs, G440fs, G400fs, G441fs, G469fs, G510fs, G383fs, G463fs, G215fs, G343fs, G422fs, G423fs, G443fs, G444fs, G470fs, G484fs, G485fs, G508fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054287	17	41246018	17	43094001	54287	68954	rs80357735	NC_000017.11:43094000:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1529C>A (p.Ser510Ter)	BRCA1	S510*, S463*, S398*, S469*, S509*, S382*, S421*, S422*, S462*, S214*, S342*, S399*, S439*, S442*, S483*, S383*, S440*, S443*, S468*, S484*, S507*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266173	17	41246019	17	43094002	266173	261917	rs80357427	NC_000017.11:43094001:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1529C>G (p.Ser510Ter)	BRCA1	S510*, S463*, S399*, S442*, S462*, S468*, S507*, S342*, S383*, S484*, S382*, S443*, S483*, S509*, S214*, S398*, S421*, S422*, S439*, S440*, S469*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054286	17	41246019	17	43094002	54286	68953	rs80357427	NC_000017.11:43094001:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1525dup (p.Thr509fs)	BRCA1	T381fs, T397fs, T421fs, T438fs, T461fs, T506fs, T508fs, T398fs, T462fs, T467fs, T468fs, T482fs, T420fs, T441fs, T442fs, T509fs, T213fs, T341fs, T382fs, T439fs, T483fs	Hereditary cancer-predisposing syndrome	VCV003992610	17	41246022 - 41246023	17	43094005 - 43094006	3992610	4104861		NC_000017.11:43094005:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 30, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1523del (p.Pro508fs)	BRCA1	P461fs, P508fs, P381fs, P397fs, P419fs, P441fs, P482fs, P505fs, P212fs, P380fs, P396fs, P438fs, P340fs, P420fs, P440fs, P467fs, P481fs, P507fs, P437fs, P460fs, P466fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054285	17	41246025	17	43094008	54285	68952	rs80357782	NC_000017.11:43094007:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1517_1521del (p.Arg506fs)	BRCA1	R459fs, R506fs, R394fs, R395fs, R458fs, R465fs, R505fs, R210fs, R378fs, R418fs, R439fs, R479fs, R379fs, R435fs, R436fs, R438fs, R480fs, R338fs, R417fs, R464fs, R503fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054282	17	41246027 - 41246031	17	43094010 - 43094014	54282	68949	rs397508879	NC_000017.11:43094009:TCTCCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1519A>T (p.Arg507Ter)	BRCA1	R507*, R460*, R396*, R418*, R459*, R504*, R380*, R395*, R437*, R440*, R481*, R211*, R419*, R439*, R480*, R339*, R379*, R436*, R465*, R466*, R506*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054283	17	41246029	17	43094012	54283	68950	rs397508880	NC_000017.11:43094011:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1518del (p.Arg507fs)	BRCA1	R460fs, R507fs, R395fs, R419fs, R440fs, R506fs, R211fs, R418fs, R439fs, R465fs, R339fs, R379fs, R380fs, R396fs, R437fs, R466fs, R481fs, R504fs, R436fs, R459fs, R480fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125503	17	41246030	17	43094013	125503	131041	rs80357947	NC_000017.11:43094012:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1514_1515insT (p.Lys505fs)	BRCA1	K458fs, K505fs, K209fs, K393fs, K394fs, K417fs, K479fs, K504fs, K337fs, K434fs, K464fs, K377fs, K378fs, K416fs, K437fs, K463fs, K435fs, K438fs, K457fs, K478fs, K502fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548280	17	41246033 - 41246034	17	43094016 - 43094017	548280	538876	rs1555591635	NC_000017.11:43094016::A	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1513_1514insT (p.Lys505fs)	BRCA1	K458fs, K505fs, K434fs, K457fs, K463fs, K504fs, K209fs, K394fs, K435fs, K478fs, K502fs, K337fs, K378fs, K416fs, K437fs, K479fs, K377fs, K393fs, K417fs, K438fs, K464fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054281	17	41246034 - 41246035	17	43094017 - 43094018	54281	68948	rs397508878	NC_000017.11:43094017::A	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1512dup (p.Lys505Ter)	BRCA1	K458*, K505*, K209*, K337*, K457*, K377*, K393*, K416*, K434*, K438*, K479*, K378*, K463*, K464*, K478*, K502*, K504*, K394*, K417*, K435*, K437*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091554	17	41246035 - 41246036	17	43094018 - 43094019	91554	97031	rs398122636	NC_000017.11:43094018:A:AA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1513A>T (p.Lys505Ter)	BRCA1	K505*, K458*, K377*, K434*, K435*, K437*, K463*, K502*, K209*, K378*, K479*, K394*, K416*, K457*, K464*, K478*, K337*, K393*, K417*, K438*, K504*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054280	17	41246035	17	43094018	54280	68947	rs397508877	NC_000017.11:43094017:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1511dup (p.Arg504_Lys505insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054279	17	41246036 - 41246037	17	43094019 - 43094020	54279	68946	rs80357817	NC_000017.11:43094019:C:CC	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1506_1510del (p.Leu502_Lys503insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054273	17	41246038 - 41246042	17	43094021 - 43094025	54273	68940	rs397508876	NC_000017.11:43094020:GCTTT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1510del (p.Arg504fs)	BRCA1	R457fs, R504fs, R376fs, R433fs, R436fs, R393fs, R462fs, R477fs, R208fs, R336fs, R437fs, R456fs, R463fs, R503fs, R377fs, R392fs, R415fs, R416fs, R434fs, R478fs, R501fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037418	17	41246038	17	43094021	37418	45974	rs80357908	NC_000017.11:43094020:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1497_1509del (p.Asn500fs)	BRCA1	N453fs, N500fs, N388fs, N412fs, N432fs, N373fs, N389fs, N411fs, N429fs, N433fs, N473fs, N204fs, N332fs, N452fs, N459fs, N497fs, N372fs, N430fs, N458fs, N474fs, N499fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266169	17	41246039 - 41246051	17	43094022 - 43094034	266169	261918	rs886039954	NC_000017.11:43094021:CTTTAATTTATTT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1505_1509del (p.Leu502fs)	BRCA1	L455fs, L502fs, L391fs, L434fs, L454fs, L460fs, L461fs, L501fs, L375fs, L432fs, L206fs, L374fs, L431fs, L435fs, L499fs, L334fs, L390fs, L413fs, L414fs, L475fs, L476fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231406	17	41246039 - 41246043	17	43094022 - 43094026	231406	236126	rs876659139	NC_000017.11:43094021:CTTTA:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1499_1508dup (p.Lys503_Arg504insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054270	17	41246039 - 41246040	17	43094022 - 43094023	54270	68937	rs397508873	NC_000017.11:43094022:TTTAATTTATTT:TTTAATTTATTTTAATTTATTT	Duplication	frameshift variant|nonsense|inframe_insertion|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1423_1508del (p.Ser475fs)	BRCA1	S428fs, S475fs, S347fs, S386fs, S472fs, S474fs, S307fs, S348fs, S363fs, S387fs, S404fs, S427fs, S434fs, S364fs, S408fs, S433fs, S449fs, S179fs, S405fs, S407fs, S448fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001074343	17	41246040 - 41246125	17	43094023 - 43094108	1074343	1064226	rs2154442124		Deletion	frameshift variant|intron variant	Pathogenic	Apr 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1508del (p.Lys503fs)	BRCA1	K503fs, K456fs, K207fs, K375fs, K392fs, K433fs, K455fs, K477fs, K500fs, K376fs, K391fs, K415fs, K461fs, K462fs, K476fs, K335fs, K414fs, K432fs, K435fs, K436fs, K502fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054275	17	41246040	17	43094023	54275	68942	rs80357506	NC_000017.11:43094022:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1504_1508del (p.Leu502fs)	BRCA1	L455fs, L502fs, L206fs, L334fs, L374fs, L413fs, L431fs, L391fs, L414fs, L435fs, L461fs, L475fs, L375fs, L432fs, L434fs, L454fs, L476fs, L501fs, L390fs, L460fs, L499fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037417	17	41246040 - 41246044	17	43094023 - 43094027	37417	45973	rs80357888	NC_000017.11:43094022:TTTAATTTA:TTTA	Deletion	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1504_1507del (p.Leu502fs)	BRCA1	L502fs, L455fs, L334fs, L413fs, L414fs, L431fs, L460fs, L475fs, L501fs, L375fs, L435fs, L454fs, L499fs, L206fs, L374fs, L390fs, L434fs, L461fs, L476fs, L391fs, L432fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266170	17	41246041 - 41246044	17	43094024 - 43094027	266170	261919	rs886039955	NC_000017.11:43094023:TTAATT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1505T>G (p.Leu502Ter)	BRCA1	L502*, L455*, L334*, L390*, L434*, L454*, L460*, L501*, L391*, L413*, L432*, L206*, L374*, L375*, L414*, L435*, L461*, L476*, L499*, L431*, L475*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266172	17	41246043	17	43094026	266172	261920	rs886039957	NC_000017.11:43094025:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1505del (p.Lys501_Leu502insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266171	17	41246043	17	43094026	266171	261921	rs886039956	NC_000017.11:43094025:AA:A	Deletion	nonsense|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1501_1504del (p.Asn500_Lys501insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254394	17	41246044 - 41246047	17	43094027 - 43094030	254394	249149	rs80357632	NC_000017.11:43094026:ATTTATTT:ATTT	Microsatellite	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1501A>T (p.Lys501Ter)	BRCA1	K390*, K413*, K431*, K453*, K498*, K501*, K373*, K412*, K434*, K460*, K205*, K459*, K475*, K333*, K374*, K389*, K430*, K433*, K454*, K474*, K500*	Hereditary breast ovarian cancer syndrome	VCV003646696	17	41246047	17	43094030	3646696	3787249		NC_000017.11:43094029:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 3, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1499del (p.Asn500fs)	BRCA1	N453fs, N500fs, N373fs, N388fs, N432fs, N459fs, N473fs, N474fs, N389fs, N452fs, N204fs, N332fs, N433fs, N499fs, N372fs, N411fs, N412fs, N429fs, N430fs, N458fs, N497fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054271	17	41246049	17	43094032	54271	68938	rs397508874	NC_000017.11:43094031:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1483_1498del (p.Glu495fs)	BRCA1	E495fs, E448fs, E368fs, E424fs, E447fs, E454fs, E494fs, E199fs, E367fs, E384fs, E425fs, E427fs, E406fs, E407fs, E469fs, E327fs, E383fs, E453fs, E492fs, E428fs, E468fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054266	17	41246050 - 41246065	17	43094033 - 43094048	54266	68933	rs397508872	NC_000017.11:43094032:TTGTGAGGGGACGCTCTTGT:TTGT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1492dup (p.Leu498fs)	BRCA1	L451fs, L498fs, L370fs, L456fs, L495fs, L202fs, L387fs, L427fs, L430fs, L431fs, L472fs, L497fs, L330fs, L371fs, L409fs, L410fs, L386fs, L428fs, L450fs, L457fs, L471fs	Hereditary breast ovarian cancer syndrome	VCV002736596	17	41246055 - 41246056	17	43094038 - 43094039	2736596	1245648	rs80357527	NC_000017.11:43094038:GGGG:GGGGG	Duplication	frameshift variant|intron variant	Pathogenic	Mar 16, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1492del (p.Leu498fs)	BRCA1	L498fs, L451fs, L370fs, L457fs, L471fs, L497fs, L330fs, L371fs, L387fs, L410fs, L430fs, L495fs, L202fs, L386fs, L431fs, L450fs, L456fs, L472fs, L409fs, L427fs, L428fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054268	17	41246056	17	43094039	54268	68935	rs80357527	NC_000017.11:43094038:GGGG:GGG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1488del (p.Leu498fs)	BRCA1	L451fs, L498fs, L387fs, L427fs, L431fs, L330fs, L370fs, L371fs, L409fs, L410fs, L430fs, L450fs, L456fs, L471fs, L202fs, L386fs, L428fs, L472fs, L457fs, L495fs, L497fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142122	17	41246060	17	43094043	142122	151836	rs587782251	NC_000017.11:43094042:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1483G>T (p.Glu495Ter)	BRCA1	E448*, E495*, E367*, E383*, E384*, E425*, E447*, E468*, E492*, E327*, E368*, E454*, E406*, E427*, E428*, E453*, E469*, E199*, E407*, E424*, E494*	Hereditary cancer-predisposing syndrome	VCV001687137	17	41246065	17	43094048	1687137	1679431	rs2053932763	NC_000017.11:43094047:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 26, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1480dup (p.Gln494fs)	BRCA1	Q447fs, Q494fs, Q382fs, Q424fs, Q426fs, Q452fs, Q453fs, Q366fs, Q383fs, Q446fs, Q493fs, Q198fs, Q326fs, Q367fs, Q405fs, Q427fs, Q468fs, Q406fs, Q423fs, Q467fs, Q491fs	Hereditary breast ovarian cancer syndrome	VCV000531258	17	41246067 - 41246068	17	43094050 - 43094051	531258	531367	rs1555591706	NC_000017.11:43094050:G:GG	Duplication	frameshift variant|intron variant	Pathogenic	Sep 16, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1480C>T (p.Gln494Ter)	BRCA1	Q494*, Q447*, Q326*, Q423*, Q426*, Q453*, Q198*, Q366*, Q383*, Q406*, Q452*, Q467*, Q491*, Q382*, Q405*, Q427*, Q468*, Q493*, Q367*, Q424*, Q446*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037415	17	41246068	17	43094051	37415	45971	rs80357010	NC_000017.11:43094050:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1477del (p.Ile493fs)	BRCA1	I493fs, I446fs, I422fs, I445fs, I197fs, I325fs, I423fs, I452fs, I466fs, I467fs, I381fs, I382fs, I404fs, I426fs, I492fs, I365fs, I366fs, I405fs, I425fs, I451fs, I490fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187763	17	41246071	17	43094054	187763	185063	rs786203982	NC_000017.11:43094053:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1475_1476del (p.Ile492fs)	BRCA1	I445fs, I492fs, I196fs, I381fs, I403fs, I444fs, I465fs, I364fs, I421fs, I422fs, I450fs, I466fs, I489fs, I380fs, I404fs, I425fs, I451fs, I491fs, I324fs, I365fs, I424fs	Hereditary cancer-predisposing syndrome	VCV001773447	17	41246072 - 41246073	17	43094055 - 43094056	1773447	1833341	rs2552207591	NC_000017.11:43094054:TAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jun 25, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1473_1474del (p.Gln491fs)	BRCA1	Q444fs, Q491fs, Q323fs, Q421fs, Q195fs, Q380fs, Q464fs, Q488fs, Q490fs, Q364fs, Q379fs, Q403fs, Q423fs, Q450fs, Q465fs, Q363fs, Q402fs, Q420fs, Q424fs, Q443fs, Q449fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002028059	17	41246074 - 41246075	17	43094057 - 43094058	2028059	2088534	rs2552207753	NC_000017.11:43094056:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1471C>T (p.Gln491Ter)	BRCA1	Q491*, Q444*, Q364*, Q402*, Q403*, Q421*, Q424*, Q449*, Q465*, Q323*, Q363*, Q423*, Q450*, Q488*, Q490*, Q195*, Q379*, Q380*, Q420*, Q443*, Q464*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054264	17	41246077	17	43094060	54264	68931	rs62625303	NC_000017.11:43094059:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1465G>T (p.Glu489Ter)	BRCA1	E489*, E442*, E377*, E418*, E422*, E441*, E447*, E463*, E321*, E361*, E362*, E401*, E419*, E421*, E448*, E462*, E400*, E486*, E193*, E378*, E488*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054262	17	41246083	17	43094066	54262	68929	rs80357167	NC_000017.11:43094065:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1462dup (p.Thr488fs)	BRCA1	T488fs, T441fs, T376fs, T400fs, T192fs, T320fs, T361fs, T399fs, T417fs, T421fs, T440fs, T446fs, T485fs, T360fs, T418fs, T447fs, T377fs, T420fs, T461fs, T462fs, T487fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125501	17	41246085 - 41246086	17	43094068 - 43094069	125501	131039	rs80357599	NC_000017.11:43094068:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1457_1461del (p.Phe486fs)	BRCA1	F439fs, F486fs, F358fs, F419fs, F190fs, F359fs, F375fs, F415fs, F459fs, F460fs, F374fs, F398fs, F438fs, F444fs, F483fs, F485fs, F318fs, F397fs, F416fs, F418fs, F445fs	Hereditary cancer-predisposing syndrome	VCV001773067	17	41246087 - 41246091	17	43094070 - 43094074	1773067	1832962	rs2552208265	NC_000017.11:43094069:AACAAA:A	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1454del (p.Ala485fs)	BRCA1	A358fs, A373fs, A414fs, A437fs, A444fs, A482fs, A317fs, A357fs, A374fs, A415fs, A418fs, A438fs, A484fs, A485fs, A189fs, A396fs, A397fs, A459fs, A417fs, A443fs, A458fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003148473	17	41246094	17	43094077	3148473	3307721	rs2552208532	NC_000017.11:43094076:G:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 30, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1399_1453dup (p.Ala485delinsGluGluGlyLysProProGlnLeuLysProCysAsnTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000945661	17	41246094 - 41246095	17	43094077 - 43094078	945661	928318	rs2053936273		Duplication	frameshift variant|nonsense|intron variant	Pathogenic/Likely pathogenic	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1451del (p.Gly484fs)	BRCA1	G356fs, G436fs, G442fs, G443fs, G484fs, G316fs, G357fs, G372fs, G413fs, G417fs, G437fs, G457fs, G458fs, G483fs, G373fs, G395fs, G414fs, G188fs, G396fs, G416fs, G481fs	Hereditary breast ovarian cancer syndrome	VCV003638075	17	41246097	17	43094080	3638075	3764704		NC_000017.11:43094079:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Feb 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1450G>T (p.Gly484Ter)	BRCA1	G484*, G437*, G357*, G457*, G481*, G356*, G373*, G395*, G414*, G416*, G436*, G458*, G396*, G442*, G188*, G316*, G372*, G413*, G417*, G443*, G483*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054257	17	41246098	17	43094081	54257	68924	rs80357304	NC_000017.11:43094080:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1444_1447dup (p.Ile483fs)	BRCA1	I436fs, I483fs, I355fs, I394fs, I412fs, I416fs, I480fs, I356fs, I372fs, I413fs, I435fs, I456fs, I482fs, I371fs, I395fs, I442fs, I457fs, I187fs, I315fs, I415fs, I441fs	Hereditary cancer-predisposing syndrome	VCV000819234	17	41246100 - 41246101	17	43094083 - 43094084	819234	813855	rs80357801	NC_000017.11:43094083:TAATTA:TAATTAATTA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1444_1447del (p.Leu481_Ile482insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037413	17	41246101 - 41246104	17	43094084 - 43094087	37413	45969	rs80357801	NC_000017.11:43094083:TAATTA:TA	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1444del (p.Ile482fs)	BRCA1	I482fs, I435fs, I393fs, I441fs, I481fs, I314fs, I371fs, I394fs, I411fs, I415fs, I455fs, I186fs, I355fs, I412fs, I440fs, I456fs, I479fs, I354fs, I370fs, I414fs, I434fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054253	17	41246104	17	43094087	54253	68920	rs80357648	NC_000017.11:43094086:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1432_1441dup (p.Leu481delinsHisTer)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002585850	17	41246106 - 41246107	17	43094089 - 43094090	2585850	2753410	rs2552209059	NC_000017.11:43094089:GATTTTCAGT:GATTTTCAGTGATTTTCAGT	Duplication	nonsense|intron variant|frameshift variant	Pathogenic	Sep 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1441_1442insA (p.Leu481fs)	BRCA1	L434fs, L481fs, L313fs, L411fs, L414fs, L433fs, L480fs, L354fs, L439fs, L440fs, L478fs, L413fs, L454fs, L455fs, L369fs, L392fs, L393fs, L185fs, L353fs, L370fs, L410fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548255	17	41246106 - 41246107	17	43094089 - 43094090	548255	538877	rs1555591749	NC_000017.11:43094089::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1441del (p.Asn480_Leu481insTer)	BRCA1		not provided	VCV001324845	17	41246107	17	43094090	1324845	1315109	rs2154445945	NC_000017.11:43094089:G:	Deletion	intron variant|nonsense|frameshift variant	Pathogenic	Oct 4, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1440_1441insA (p.Leu481fs)	BRCA1	L481fs, L434fs, L370fs, L410fs, L454fs, L478fs, L185fs, L313fs, L353fs, L354fs, L369fs, L411fs, L414fs, L433fs, L440fs, L480fs, L392fs, L393fs, L439fs, L455fs, L413fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125500	17	41246107 - 41246108	17	43094090 - 43094091	125500	131038	rs80357778	NC_000017.11:43094090::T	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1439dup (p.Asn480fs)	BRCA1	N433fs, N480fs, N413fs, N453fs, N479fs, N353fs, N438fs, N312fs, N368fs, N369fs, N391fs, N410fs, N184fs, N352fs, N392fs, N409fs, N412fs, N432fs, N439fs, N454fs, N477fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054252	17	41246108 - 41246109	17	43094091 - 43094092	54252	68919	rs80357505	NC_000017.11:43094091:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1428_1437del (p.His476fs)	BRCA1	H429fs, H476fs, H348fs, H349fs, H387fs, H449fs, H450fs, H473fs, H475fs, H180fs, H406fs, H428fs, H434fs, H308fs, H364fs, H388fs, H405fs, H408fs, H409fs, H365fs, H435fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266168	17	41246111 - 41246120	17	43094094 - 43094103	266168	261922	rs886039953	NC_000017.11:43094093:TTCAGTTACAT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1434_1435del (p.Glu479fs)	BRCA1	E432fs, E479fs, E183fs, E351fs, E368fs, E390fs, E412fs, E431fs, E391fs, E408fs, E409fs, E437fs, E352fs, E367fs, E452fs, E476fs, E478fs, E311fs, E411fs, E438fs, E453fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417830	17	41246113 - 41246114	17	43094096 - 43094097	417830	404717	rs1060505050	NC_000017.11:43094095:CA:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1434del (p.Glu479fs)	BRCA1	E432fs, E479fs, E311fs, E352fs, E368fs, E412fs, E453fs, E478fs, E351fs, E390fs, E431fs, E437fs, E183fs, E367fs, E408fs, E438fs, E391fs, E409fs, E411fs, E452fs, E476fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096900	17	41246114	17	43094097	96900	102803	rs431825386	NC_000017.11:43094096:A:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1426del (p.His476fs)	BRCA1	H429fs, H476fs, H308fs, H364fs, H388fs, H405fs, H434fs, H180fs, H365fs, H409fs, H349fs, H387fs, H406fs, H428fs, H449fs, H450fs, H475fs, H348fs, H408fs, H435fs, H473fs	Hereditary breast ovarian cancer syndrome	VCV003609771	17	41246122	17	43094105	3609771	1245750		NC_000017.11:43094104:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1419_1422del (p.Asn473fs)	BRCA1	N426fs, N473fs, N361fs, N403fs, N425fs, N432fs, N305fs, N362fs, N385fs, N405fs, N470fs, N346fs, N177fs, N345fs, N384fs, N402fs, N406fs, N431fs, N446fs, N447fs, N472fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266167	17	41246126 - 41246129	17	43094109 - 43094112	266167	261923	rs886039952	NC_000017.11:43094108:TAAGT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1421T>G (p.Leu474Ter)	BRCA1	L474*, L427*, L385*, L404*, L433*, L473*, L347*, L362*, L447*, L306*, L363*, L386*, L407*, L426*, L432*, L448*, L471*, L178*, L346*, L403*, L406*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054250	17	41246127	17	43094110	54250	68917	rs80357490	NC_000017.11:43094109:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1416dup (p.Asn473fs)	BRCA1	N177fs, N305fs, N345fs, N346fs, N361fs, N362fs, N384fs, N385fs, N402fs, N403fs, N405fs, N406fs, N425fs, N426fs, N431fs, N432fs, N446fs, N447fs, N470fs, N472fs, N473fs	Hereditary breast ovarian cancer syndrome	VCV003769170	17	41246131 - 41246132	17	43094114 - 43094115	3769170	3885324		NC_000017.11:43094114:GGGG:GGGGG	Duplication	intron variant|frameshift variant	Pathogenic	Jan 13, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1410_1416delinsTTGGGG (p.Leu471fs)	BRCA1	L175fs, L303fs, L343fs, L344fs, L359fs, L360fs, L382fs, L383fs, L400fs, L401fs, L403fs, L404fs, L423fs, L424fs, L429fs, L430fs, L444fs, L445fs, L468fs, L470fs, L471fs	Fanconi anemia, complementation group S	VCV003778930	17	41246132 - 41246138	17	43094115 - 43094121	3778930	3894917		NC_000017.11:43094114:GGGGAGG:CCCCAA	Indel	intron variant|frameshift variant	Pathogenic	Sep 24, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1416del (p.Asn473fs)	BRCA1	N426fs, N473fs, N305fs, N402fs, N177fs, N361fs, N384fs, N403fs, N405fs, N425fs, N432fs, N446fs, N345fs, N346fs, N385fs, N406fs, N431fs, N362fs, N447fs, N470fs, N472fs	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000491034	17	41246132	17	43094115	491034	484925	rs1555591774	NC_000017.11:43094114:GGGG:GGG	Deletion	frameshift variant|intron variant	Pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1412dup (p.Asn473fs)	BRCA1	N473fs, N426fs, N177fs, N305fs, N345fs, N362fs, N346fs, N384fs, N402fs, N403fs, N406fs, N432fs, N446fs, N447fs, N472fs, N361fs, N425fs, N470fs, N385fs, N405fs, N431fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266166	17	41246135 - 41246136	17	43094118 - 43094119	266166	261924	rs886039951	NC_000017.11:43094118:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1411_1412insA (p.Leu471fs)	BRCA1	L175fs, L303fs, L343fs, L344fs, L359fs, L360fs, L382fs, L383fs, L400fs, L401fs, L403fs, L404fs, L423fs, L424fs, L429fs, L430fs, L444fs, L445fs, L468fs, L470fs, L471fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003254387	17	41246136 - 41246137	17	43094119 - 43094120	3254387	3413166	rs2552210240	NC_000017.11:43094119::T	Insertion	frameshift variant|intron variant	Pathogenic	May 14, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1411del (p.Leu471fs)	BRCA1	L424fs, L471fs, L344fs, L383fs, L400fs, L401fs, L403fs, L430fs, L444fs, L468fs, L359fs, L445fs, L360fs, L175fs, L303fs, L343fs, L382fs, L404fs, L423fs, L429fs, L470fs	Hereditary breast ovarian cancer syndrome	VCV001352307	17	41246137	17	43094120	1352307	1482843	rs2154447439	NC_000017.11:43094119:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 10, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1407_1408del (p.Ser470fs)	BRCA1	S423fs, S470fs, S174fs, S382fs, S403fs, S469fs, S343fs, S399fs, S443fs, S302fs, S358fs, S381fs, S400fs, S422fs, S428fs, S429fs, S467fs, S342fs, S359fs, S402fs, S444fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252863	17	41246140 - 41246141	17	43094123 - 43094124	252863	247264	rs879255476	NC_000017.11:43094122:TT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1405del (p.Ala469fs)	BRCA1	A422fs, A469fs, A301fs, A381fs, A466fs, A341fs, A398fs, A401fs, A402fs, A428fs, A443fs, A342fs, A399fs, A468fs, A173fs, A357fs, A358fs, A380fs, A421fs, A427fs, A442fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054244	17	41246143	17	43094126	54244	68911	rs397508871	NC_000017.11:43094125:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1403del (p.Lys468fs)	BRCA1	K421fs, K468fs, K397fs, K398fs, K467fs, K340fs, K401fs, K426fs, K465fs, K172fs, K300fs, K341fs, K356fs, K420fs, K442fs, K357fs, K379fs, K380fs, K400fs, K427fs, K441fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054243	17	41246145	17	43094128	54243	68910	rs397508870	NC_000017.11:43094127:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1399A>T (p.Lys467Ter)	BRCA1	K467*, K420*, K378*, K379*, K425*, K464*, K171*, K339*, K397*, K419*, K426*, K340*, K400*, K440*, K299*, K355*, K356*, K396*, K399*, K441*, K466*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054241	17	41246149	17	43094132	54241	68908	rs80357279	NC_000017.11:43094131:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1398del (p.Lys467fs)	BRCA1	K467fs, K420fs, K379fs, K419fs, K425fs, K171fs, K355fs, K396fs, K400fs, K299fs, K339fs, K397fs, K399fs, K426fs, K440fs, K464fs, K466fs, K340fs, K356fs, K378fs, K441fs	Hereditary breast ovarian cancer syndrome	VCV000856569	17	41246150	17	43094133	856569	845445	rs2053943650	NC_000017.11:43094132:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Feb 24, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1395dup (p.Arg466fs)	BRCA1	R419fs, R466fs, R170fs, R338fs, R378fs, R298fs, R339fs, R354fs, R377fs, R395fs, R418fs, R439fs, R463fs, R355fs, R399fs, R424fs, R425fs, R465fs, R396fs, R398fs, R440fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548239	17	41246152 - 41246153	17	43094135 - 43094136	548239	538878	rs1555591796	NC_000017.11:43094135:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1395del (p.Arg466fs)	BRCA1	R466fs, R419fs, R354fs, R378fs, R440fs, R465fs, R339fs, R377fs, R170fs, R338fs, R355fs, R395fs, R398fs, R399fs, R425fs, R298fs, R396fs, R418fs, R424fs, R439fs, R463fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001771621	17	41246153	17	43094136	1771621	1832817	rs2552211365	NC_000017.11:43094135:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1395T>G (p.Tyr465Ter)	BRCA1	Y418*, Y465*, Y169*, Y354*, Y397*, Y417*, Y338*, Y353*, Y423*, Y438*, Y462*, Y337*, Y395*, Y424*, Y297*, Y376*, Y377*, Y394*, Y398*, Y439*, Y464*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV001203083	17	41246153	17	43094136	1203083	1195200	rs2154448397	NC_000017.11:43094135:A:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.1393_1394ins10 (p.?)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267507	17	41246154 - 41246155	17	43094137 - 43094138	267507	262974			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1384_1393dup (p.Tyr465fs)	BRCA1	Y418fs, Y465fs, Y394fs, Y398fs, Y417fs, Y423fs, Y438fs, Y297fs, Y338fs, Y353fs, Y424fs, Y376fs, Y377fs, Y395fs, Y397fs, Y439fs, Y462fs, Y169fs, Y337fs, Y354fs, Y464fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054231	17	41246154 - 41246155	17	43094137 - 43094138	54231	68898	rs397508864	NC_000017.11:43094137:AGGTTTTCCCA:AGGTTTTCCCAGGTTTTCCCA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1392_1393insG (p.Tyr465fs)	BRCA1	Y465fs, Y418fs, Y297fs, Y394fs, Y397fs, Y424fs, Y438fs, Y462fs, Y169fs, Y337fs, Y353fs, Y354fs, Y376fs, Y377fs, Y395fs, Y439fs, Y338fs, Y398fs, Y417fs, Y423fs, Y464fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548181	17	41246155 - 41246156	17	43094138 - 43094139	548181	538879	rs1555591814	NC_000017.11:43094138::C	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1392dup (p.Tyr465fs)	BRCA1	Y465fs, Y418fs, Y297fs, Y377fs, Y395fs, Y397fs, Y439fs, Y169fs, Y376fs, Y394fs, Y424fs, Y462fs, Y337fs, Y338fs, Y398fs, Y438fs, Y353fs, Y354fs, Y417fs, Y423fs, Y464fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125499	17	41246155 - 41246156	17	43094138 - 43094139	125499	131037	rs80357592	NC_000017.11:43094138:GG:GGG	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1391_1392insG (p.Tyr465fs)	BRCA1	Y418fs, Y465fs, Y297fs, Y338fs, Y354fs, Y377fs, Y398fs, Y464fs, Y169fs, Y394fs, Y462fs, Y397fs, Y417fs, Y438fs, Y439fs, Y337fs, Y353fs, Y376fs, Y395fs, Y423fs, Y424fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431212	17	41246156 - 41246157	17	43094139 - 43094140	431212	424850	rs1135401845	NC_000017.11:43094139::C	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1392del (p.Tyr465fs)	BRCA1	Y418fs, Y465fs, Y377fs, Y394fs, Y423fs, Y424fs, Y462fs, Y353fs, Y376fs, Y395fs, Y169fs, Y337fs, Y354fs, Y439fs, Y464fs, Y297fs, Y338fs, Y397fs, Y398fs, Y417fs, Y438fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054238	17	41246156	17	43094139	54238	68905	rs80357592	NC_000017.11:43094138:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1390dup (p.Thr464fs)	BRCA1	T464fs, T417fs, T296fs, T375fs, T393fs, T423fs, T336fs, T337fs, T394fs, T396fs, T168fs, T352fs, T376fs, T422fs, T438fs, T463fs, T353fs, T397fs, T416fs, T437fs, T461fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266164	17	41246157 - 41246158	17	43094140 - 43094141	266164	261925	rs80357770	NC_000017.11:43094140:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1390_1391insG (p.Thr464fs)	BRCA1	T417fs, T464fs, T168fs, T337fs, T393fs, T397fs, T416fs, T437fs, T463fs, T296fs, T336fs, T376fs, T422fs, T423fs, T396fs, T438fs, T461fs, T352fs, T353fs, T375fs, T394fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054235	17	41246157 - 41246158	17	43094140 - 43094141	54235	68902	rs397508867	NC_000017.11:43094140::C	Insertion	frameshift variant|intron variant	Pathogenic	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1390del (p.Thr464fs)	BRCA1	T417fs, T464fs, T336fs, T337fs, T396fs, T416fs, T463fs, T168fs, T375fs, T423fs, T438fs, T352fs, T353fs, T394fs, T422fs, T437fs, T296fs, T376fs, T393fs, T397fs, T461fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054236	17	41246158	17	43094141	54236	68903	rs80357770	NC_000017.11:43094140:TTTT:TTT	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1387_1390delinsGAAAG (p.Lys463fs)	BRCA1	K416fs, K463fs, K335fs, K374fs, K375fs, K422fs, K436fs, K395fs, K396fs, K437fs, K167fs, K295fs, K352fs, K393fs, K421fs, K462fs, K336fs, K351fs, K392fs, K415fs, K460fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054234	17	41246158 - 41246161	17	43094141 - 43094144	54234	68901	rs80357770	NC_000017.11:43094140:TTTT:CTTTC	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1389_1390delinsG (p.Thr464fs)	BRCA1	T417fs, T464fs, T352fs, T376fs, T422fs, T461fs, T168fs, T337fs, T353fs, T375fs, T437fs, T438fs, T296fs, T336fs, T397fs, T416fs, T423fs, T463fs, T393fs, T394fs, T396fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037409	17	41246158 - 41246159	17	43094141 - 43094142	37409	45965	rs273897659	NC_000017.11:43094140:TT:C	Indel	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1386dup (p.Lys463fs)	BRCA1	K463fs, K416fs, K336fs, K375fs, K392fs, K460fs, K374fs, K393fs, K421fs, K436fs, K167fs, K351fs, K352fs, K295fs, K335fs, K395fs, K396fs, K415fs, K422fs, K437fs, K462fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054233	17	41246161 - 41246162	17	43094144 - 43094145	54233	68900	rs80357722	NC_000017.11:43094144:CCC:CCCC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1386del (p.Thr464fs)	BRCA1	T417fs, T464fs, T168fs, T375fs, T393fs, T396fs, T422fs, T423fs, T463fs, T296fs, T336fs, T352fs, T394fs, T397fs, T437fs, T438fs, T461fs, T337fs, T376fs, T353fs, T416fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054232	17	41246162	17	43094145	54232	68899	rs80357722	NC_000017.11:43094144:CCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1383dup (p.Gly462fs)	BRCA1	G415fs, G462fs, G350fs, G373fs, G374fs, G420fs, G436fs, G166fs, G335fs, G392fs, G394fs, G421fs, G435fs, G461fs, G351fs, G395fs, G459fs, G294fs, G334fs, G391fs, G414fs	Hereditary breast ovarian cancer syndrome	VCV000584954	17	41246164 - 41246165	17	43094147 - 43094148	584954	576003	rs80357879	NC_000017.11:43094147:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Jul 2, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1383del (p.Phe461fs)	BRCA1	F414fs, F461fs, F293fs, F333fs, F413fs, F419fs, F434fs, F435fs, F460fs, F349fs, F373fs, F393fs, F420fs, F390fs, F391fs, F165fs, F334fs, F350fs, F372fs, F394fs, F458fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054229	17	41246165	17	43094148	54229	68896	rs80357879	NC_000017.11:43094147:AAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1380dup (p.Phe461fs)	BRCA1	F414fs, F461fs, F165fs, F349fs, F350fs, F393fs, F394fs, F419fs, F293fs, F391fs, F420fs, F333fs, F372fs, F390fs, F413fs, F435fs, F334fs, F373fs, F434fs, F458fs, F460fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054226	17	41246167 - 41246168	17	43094150 - 43094151	54226	68893	rs80357714	NC_000017.11:43094150:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1380del (p.Phe461fs)	BRCA1	F414fs, F461fs, F334fs, F372fs, F390fs, F435fs, F349fs, F373fs, F391fs, F394fs, F413fs, F165fs, F333fs, F350fs, F419fs, F420fs, F434fs, F293fs, F393fs, F458fs, F460fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054225	17	41246168	17	43094151	54225	68892	rs397508863	NC_000017.11:43094150:T:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1379del (p.Ile460fs)	BRCA1	I413fs, I460fs, I348fs, I389fs, I393fs, I434fs, I457fs, I349fs, I371fs, I372fs, I390fs, I392fs, I332fs, I412fs, I418fs, I419fs, I433fs, I459fs, I164fs, I292fs, I333fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266163	17	41246169	17	43094152	266163	261926	rs886039949	NC_000017.11:43094151:A:	Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1378dup (p.Ile460fs)	BRCA1	I413fs, I460fs, I389fs, I418fs, I433fs, I372fs, I392fs, I459fs, I333fs, I348fs, I390fs, I393fs, I434fs, I457fs, I164fs, I292fs, I332fs, I349fs, I371fs, I412fs, I419fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266162	17	41246169 - 41246170	17	43094152 - 43094153	266162	261927	rs398122633	NC_000017.11:43094152:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1377_1378del (p.Lys459fs)	BRCA1	K459fs, K412fs, K163fs, K348fs, K370fs, K388fs, K417fs, K332fs, K389fs, K391fs, K456fs, K418fs, K291fs, K331fs, K347fs, K371fs, K392fs, K411fs, K432fs, K433fs, K458fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091550	17	41246170 - 41246171	17	43094153 - 43094154	91550	97027	rs398122633	NC_000017.11:43094152:TTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1374_1375del (p.Asp458fs)	BRCA1	D162fs, D290fs, D330fs, D331fs, D346fs, D347fs, D369fs, D370fs, D387fs, D388fs, D390fs, D391fs, D410fs, D411fs, D416fs, D417fs, D431fs, D432fs, D455fs, D457fs, D458fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003904688	17	41246173 - 41246174	17	43094156 - 43094157	3904688	4020560		NC_000017.11:43094155:TGT:T	Deletion	frameshift variant|intron variant	Pathogenic	Feb 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1375A>T (p.Lys459Ter)	BRCA1	K459*, K412*, K332*, K388*, K411*, K458*, K331*, K348*, K371*, K391*, K392*, K418*, K456*, K291*, K347*, K389*, K433*, K163*, K370*, K417*, K432*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266161	17	41246173	17	43094156	266161	261928	rs886039947	NC_000017.11:43094155:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1374del (p.Asp458fs)	BRCA1	D411fs, D458fs, D290fs, D347fs, D387fs, D457fs, D390fs, D410fs, D455fs, D331fs, D346fs, D369fs, D370fs, D417fs, D162fs, D330fs, D388fs, D391fs, D416fs, D431fs, D432fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054224	17	41246174	17	43094157	54224	68891	rs397508862	NC_000017.11:43094156:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1371del (p.Asp458fs)	BRCA1	D411fs, D458fs, D162fs, D390fs, D455fs, D457fs, D290fs, D330fs, D331fs, D347fs, D370fs, D387fs, D416fs, D432fs, D346fs, D369fs, D410fs, D417fs, D388fs, D391fs, D431fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054223	17	41246177	17	43094160	54223	68890	rs397508861	NC_000017.11:43094159:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1369G>T (p.Glu457Ter)	BRCA1	E410*, E457*, E389*, E415*, E431*, E454*, E289*, E387*, E161*, E369*, E386*, E409*, E430*, E329*, E330*, E346*, E368*, E390*, E416*, E456*, E345*	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001255798	17	41246179	17	43094162	1255798	1245730	rs2154451153	NC_000017.11:43094161:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1364_1365insGA (p.Asn455fs)	BRCA1	N455fs, N408fs, N287fs, N327fs, N428fs, N452fs, N159fs, N366fs, N407fs, N454fs, N328fs, N344fs, N367fs, N385fs, N388fs, N413fs, N429fs, N343fs, N384fs, N387fs, N414fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548300	17	41246183 - 41246184	17	43094166 - 43094167	548300	538880	rs1555591846	NC_000017.11:43094166:T:TCT	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1363_1364insT (p.Asn455fs)	BRCA1	N408fs, N455fs, N287fs, N343fs, N344fs, N388fs, N407fs, N429fs, N452fs, N366fs, N367fs, N384fs, N387fs, N413fs, N328fs, N414fs, N159fs, N327fs, N385fs, N428fs, N454fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	VCV000481485	17	41246184 - 41246185	17	43094167 - 43094168	481485	426563	rs1555591850	NC_000017.11:43094167::A	Insertion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1361del (p.Ser454fs)	BRCA1	S407fs, S454fs, S326fs, S327fs, S365fs, S342fs, S383fs, S451fs, S286fs, S343fs, S366fs, S412fs, S427fs, S428fs, S453fs, S158fs, S384fs, S386fs, S387fs, S406fs, S413fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091549	17	41246187	17	43094170	91549	97026	rs398122632	NC_000017.11:43094169:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1360_1361del (p.Glu453_Ser454insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037406	17	41246187 - 41246188	17	43094170 - 43094171	37406	45962	rs80357969	NC_000017.11:43094169:CTCTCT:CTCT	Microsatellite	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1360del (p.Ser454fs)	BRCA1	S407fs, S454fs, S158fs, S286fs, S326fs, S365fs, S386fs, S387fs, S412fs, S366fs, S383fs, S451fs, S327fs, S342fs, S413fs, S427fs, S428fs, S343fs, S384fs, S406fs, S453fs	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001315516	17	41246188	17	43094171	1315516	1305776	rs2154453207	NC_000017.11:43094170:T:	Deletion	frameshift variant|intron variant	Pathogenic	Nov 13, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1357G>T (p.Glu453Ter)	BRCA1	E285*, E325*, E364*, E365*, E385*, E412*, E426*, E450*, E452*, E326*, E341*, E342*, E382*, E406*, E157*, E383*, E386*, E411*, E453*, E405*, E427*	Hereditary breast ovarian cancer syndrome	VCV002131509	17	41246191	17	43094174	2131509	2189497	rs768054411	NC_000017.11:43094173:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 28, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1356del (p.Glu453fs)	BRCA1	E453fs, E406fs, E157fs, E341fs, E382fs, E411fs, E450fs, E452fs, E342fs, E383fs, E412fs, E325fs, E326fs, E386fs, E405fs, E426fs, E427fs, E285fs, E364fs, E365fs, E385fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125495	17	41246192	17	43094175	125495	131033	rs80357939	NC_000017.11:43094174:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1354del (p.Ser451_Val452insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266160	17	41246194	17	43094177	266160	261929	rs886039946	NC_000017.11:43094176:C:	Deletion	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1352C>G (p.Ser451Ter)	BRCA1	S451*, S404*, S323*, S380*, S381*, S383*, S403*, S425*, S339*, S362*, S448*, S155*, S324*, S384*, S409*, S283*, S340*, S363*, S410*, S424*, S450*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054218	17	41246196	17	43094179	54218	68885	rs80356891	NC_000017.11:43094178:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1352C>A (p.Ser451Ter)	BRCA1	S451*, S404*, S283*, S323*, S363*, S380*, S424*, S155*, S339*, S403*, S448*, S362*, S381*, S383*, S409*, S410*, S324*, S340*, S384*, S425*, S450*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054217	17	41246196	17	43094179	54217	68884	rs80356891	NC_000017.11:43094178:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1350del (p.Lys450fs)	BRCA1	K403fs, K450fs, K154fs, K339fs, K383fs, K409fs, K322fs, K338fs, K380fs, K408fs, K423fs, K424fs, K282fs, K323fs, K379fs, K447fs, K361fs, K362fs, K382fs, K402fs, K449fs	Hereditary breast ovarian cancer syndrome	VCV001457522	17	41246198	17	43094181	1457522	1393463	rs2154456229	NC_000017.11:43094180:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Feb 5, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1348A>T (p.Lys450Ter)	BRCA1	K450*, K403*, K154*, K361*, K383*, K408*, K282*, K323*, K338*, K362*, K379*, K424*, K380*, K382*, K402*, K409*, K447*, K322*, K339*, K423*, K449*	Hereditary cancer-predisposing syndrome	VCV000924799	17	41246200	17	43094183	924799	913956	rs2053952990	NC_000017.11:43094182:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Mar 21, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1347del (p.Lys450fs)	BRCA1	K450fs, K403fs, K154fs, K322fs, K383fs, K402fs, K409fs, K423fs, K361fs, K382fs, K408fs, K447fs, K323fs, K362fs, K379fs, K380fs, K449fs, K282fs, K338fs, K339fs, K424fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266159	17	41246201	17	43094184	266159	261930	rs886039945	NC_000017.11:43094183:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1345del (p.Ser449fs)	BRCA1	S321fs, S337fs, S360fs, S381fs, S446fs, S153fs, S401fs, S423fs, S449fs, S322fs, S338fs, S361fs, S402fs, S408fs, S448fs, S281fs, S378fs, S379fs, S382fs, S407fs, S422fs	Hereditary breast ovarian cancer syndrome	VCV002824681	17	41246203	17	43094186	2824681	2989183	rs2552214973	NC_000017.11:43094185:A:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 9, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1327_1345del (p.Lys443fs)	BRCA1	K443fs, K396fs, K331fs, K442fs, K316fs, K373fs, K395fs, K416fs, K275fs, K332fs, K372fs, K375fs, K401fs, K417fs, K147fs, K315fs, K354fs, K355fs, K376fs, K402fs, K440fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266156	17	41246203 - 41246221	17	43094186 - 43094204	266156	261931	rs886039942	NC_000017.11:43094185:AGTGAACTCTTTCACTTTTA:A	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1341_1342insG (p.His448fs)	BRCA1	H448fs, H401fs, H320fs, H321fs, H378fs, H280fs, H337fs, H377fs, H380fs, H400fs, H407fs, H422fs, H445fs, H336fs, H359fs, H381fs, H152fs, H360fs, H406fs, H421fs, H447fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548290	17	41246206 - 41246207	17	43094189 - 43094190	548290	538881	rs1555591909	NC_000017.11:43094189::C	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1340_1341del (p.Val447fs)	BRCA1	V400fs, V447fs, V319fs, V336fs, V421fs, V320fs, V406fs, V151fs, V279fs, V335fs, V358fs, V359fs, V376fs, V379fs, V444fs, V377fs, V380fs, V399fs, V405fs, V420fs, V446fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182103	17	41246207 - 41246208	17	43094190 - 43094191	182103	180878	rs730881458	NC_000017.11:43094189:AA:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1340_1341insG (p.His448fs)	BRCA1	H401fs, H448fs, H336fs, H337fs, H377fs, H406fs, H407fs, H421fs, H445fs, H447fs, H152fs, H321fs, H378fs, H360fs, H400fs, H422fs, H280fs, H320fs, H359fs, H380fs, H381fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037401	17	41246207 - 41246208	17	43094190 - 43094191	37401	45957	rs80357597	NC_000017.11:43094190::C	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1339dup (p.Val447fs)	BRCA1	V447fs, V400fs, V320fs, V358fs, V359fs, V405fs, V420fs, V151fs, V319fs, V335fs, V336fs, V379fs, V421fs, V376fs, V406fs, V446fs, V279fs, V377fs, V380fs, V399fs, V444fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054206	17	41246208 - 41246209	17	43094191 - 43094192	54206	68873	rs397508855	NC_000017.11:43094191:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1338_1339del (p.Arg446fs)	BRCA1	R399fs, R446fs, R319fs, R375fs, R419fs, R150fs, R278fs, R376fs, R405fs, R443fs, R378fs, R379fs, R398fs, R404fs, R445fs, R318fs, R334fs, R335fs, R357fs, R358fs, R420fs	Hereditary breast ovarian cancer syndrome	VCV002982382	17	41246209 - 41246210	17	43094192 - 43094193	2982382	1245738	rs2552215665	NC_000017.11:43094191:CTCT:CT	Microsatellite	frameshift variant|intron variant	Pathogenic	Jan 3, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1336dup (p.Arg446fs)	BRCA1	R399fs, R446fs, R150fs, R278fs, R358fs, R376fs, R404fs, R318fs, R398fs, R445fs, R319fs, R378fs, R379fs, R419fs, R443fs, R334fs, R335fs, R357fs, R375fs, R405fs, R420fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091546	17	41246211 - 41246212	17	43094194 - 43094195	91546	97023	rs80357978	NC_000017.11:43094194:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1336del (p.Arg446fs)	BRCA1	R446fs, R399fs, R150fs, R334fs, R335fs, R376fs, R420fs, R357fs, R375fs, R378fs, R398fs, R404fs, R405fs, R419fs, R278fs, R319fs, R358fs, R379fs, R318fs, R443fs, R445fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266158	17	41246212	17	43094195	266158	261932	rs80357978	NC_000017.11:43094194:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1335_1336del (p.Arg446fs)	BRCA1	R399fs, R446fs, R278fs, R335fs, R357fs, R398fs, R318fs, R319fs, R420fs, R445fs, R334fs, R358fs, R376fs, R378fs, R404fs, R405fs, R443fs, R150fs, R375fs, R379fs, R419fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054205	17	41246212 - 41246213	17	43094195 - 43094196	54205	68872	rs80357978	NC_000017.11:43094194:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1333del (p.Glu445fs)	BRCA1	E398fs, E445fs, E149fs, E317fs, E334fs, E377fs, E418fs, E442fs, E444fs, E277fs, E333fs, E357fs, E378fs, E403fs, E404fs, E419fs, E318fs, E374fs, E375fs, E397fs, E356fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266157	17	41246215	17	43094198	266157	261933	rs886039943	NC_000017.11:43094197:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1333G>T (p.Glu445Ter)	BRCA1	E445*, E398*, E317*, E356*, E378*, E397*, E403*, E444*, E277*, E318*, E374*, E442*, E149*, E334*, E375*, E418*, E419*, E333*, E357*, E377*, E404*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054204	17	41246215	17	43094198	54204	68871	rs80356915	NC_000017.11:43094197:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1320_1330del (p.Leu440_Ile441insTer)	BRCA1		Familial cancer of breast	VCV001685582	17	41246218 - 41246228	17	43094201 - 43094211	1685582	1677598	rs2154458213	NC_000017.11:43094200:TTTTACATATT:	Deletion	frameshift variant|intron variant	Pathogenic	May 4, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1330del (p.Ser444fs)	BRCA1	S397fs, S444fs, S356fs, S377fs, S418fs, S441fs, S355fs, S373fs, S417fs, S148fs, S276fs, S317fs, S374fs, S402fs, S403fs, S316fs, S332fs, S333fs, S376fs, S396fs, S443fs	Hereditary breast ovarian cancer syndrome	VCV000941345	17	41246218	17	43094201	941345	937970	rs2053956161	NC_000017.11:43094200:TTTT:TTT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 1, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1327A>T (p.Lys443Ter)	BRCA1	K443*, K396*, K315*, K332*, K354*, K372*, K376*, K395*, K440*, K147*, K355*, K375*, K402*, K275*, K401*, K416*, K316*, K331*, K373*, K417*, K442*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091545	17	41246221	17	43094204	91545	97022	rs398122630	NC_000017.11:43094203:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1325_1326dup (p.Lys443fs)	BRCA1	K396fs, K443fs, K315fs, K332fs, K416fs, K417fs, K331fs, K372fs, K401fs, K316fs, K354fs, K147fs, K275fs, K355fs, K373fs, K375fs, K376fs, K395fs, K402fs, K440fs, K442fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091544	17	41246221 - 41246222	17	43094204 - 43094205	91544	97021	rs80357543	NC_000017.11:43094204:ACA:ACACA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1326T>A (p.Cys442Ter)	BRCA1	C442*, C395*, C146*, C330*, C354*, C371*, C394*, C401*, C274*, C353*, C400*, C415*, C439*, C314*, C331*, C375*, C416*, C315*, C372*, C374*, C441*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054202	17	41246222	17	43094205	54202	68869	rs397508854	NC_000017.11:43094204:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1325del (p.Cys442fs)	BRCA1	C395fs, C442fs, C330fs, C353fs, C372fs, C375fs, C416fs, C441fs, C146fs, C315fs, C394fs, C400fs, C274fs, C314fs, C331fs, C354fs, C371fs, C401fs, C415fs, C374fs, C439fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002431272	17	41246223	17	43094206	2431272	2404777	rs2485541223	NC_000017.11:43094205:C:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 10, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1323dup (p.Cys442fs)	BRCA1	C442fs, C395fs, C274fs, C314fs, C394fs, C400fs, C439fs, C330fs, C331fs, C374fs, C375fs, C401fs, C415fs, C146fs, C315fs, C353fs, C354fs, C372fs, C371fs, C416fs, C441fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548167	17	41246224 - 41246225	17	43094207 - 43094208	548167	538882	rs1555591939	NC_000017.11:43094207:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1323_1324del (p.Ile441fs)	BRCA1	I441fs, I394fs, I330fs, I352fs, I370fs, I399fs, I314fs, I329fs, I371fs, I373fs, I400fs, I440fs, I374fs, I145fs, I273fs, I313fs, I353fs, I393fs, I414fs, I415fs, I438fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054201	17	41246224 - 41246225	17	43094207 - 43094208	54201	68868	rs80357570	NC_000017.11:43094206:ATAT:AT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1312_1322del (p.Glu438fs)	BRCA1	E391fs, E438fs, E311fs, E349fs, E437fs, E310fs, E326fs, E327fs, E368fs, E371fs, E435fs, E270fs, E350fs, E370fs, E390fs, E397fs, E412fs, E142fs, E367fs, E396fs, E411fs	Hereditary cancer-predisposing syndrome	VCV001769686	17	41246226 - 41246236	17	43094209 - 43094219	1769686	1832172	rs2552216341	NC_000017.11:43094208:ATTAAAGCCTCAT:AT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 30, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1319dup (p.Leu440fs)	BRCA1	L393fs, L440fs, L144fs, L313fs, L370fs, L373fs, L413fs, L328fs, L369fs, L372fs, L398fs, L312fs, L329fs, L351fs, L392fs, L414fs, L437fs, L272fs, L352fs, L399fs, L439fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054198	17	41246228 - 41246229	17	43094211 - 43094212	54198	68865	rs80357683	NC_000017.11:43094211:AAA:AAAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1319T>G (p.Leu440Ter)	BRCA1	L440*, L393*, L351*, L370*, L399*, L439*, L313*, L329*, L398*, L413*, L414*, L272*, L312*, L328*, L369*, L372*, L437*, L144*, L352*, L373*, L392*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230733	17	41246229	17	43094212	230733	236135	rs273897656	NC_000017.11:43094211:A:C	single nucleotide variant	intron variant|nonsense	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1319del (p.Ala439_Leu440insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054197	17	41246229	17	43094212	54197	68864	rs80357683	NC_000017.11:43094211:AAA:AA	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1315dup (p.Ala439fs)	BRCA1	A439fs, A392fs, A271fs, A312fs, A368fs, A391fs, A397fs, A412fs, A311fs, A438fs, A350fs, A371fs, A372fs, A143fs, A327fs, A328fs, A351fs, A369fs, A398fs, A413fs, A436fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000482946	17	41246232 - 41246233	17	43094215 - 43094216	482946	479445	rs1555591956	NC_000017.11:43094215:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Jun 25, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1310_1313del (p.His437fs)	BRCA1	H437fs, H390fs, H269fs, H309fs, H366fs, H367fs, H389fs, H410fs, H434fs, H326fs, H349fs, H369fs, H370fs, H395fs, H396fs, H411fs, H436fs, H141fs, H310fs, H325fs, H348fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433697	17	41246235 - 41246238	17	43094218 - 43094221	433697	427561	rs1555591959	NC_000017.11:43094217:TCAT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1312G>T (p.Glu438Ter)	BRCA1	E270*, E367*, E327*, E368*, E371*, E142*, E310*, E349*, E350*, E390*, E391*, E396*, E438*, E311*, E326*, E370*, E397*, E411*, E412*, E435*, E437*	Hereditary cancer-predisposing syndrome|not provided	VCV001769706	17	41246236	17	43094219	1769706	1832192	rs2154459453	NC_000017.11:43094218:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic/Likely pathogenic	Oct 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1281_1312delinsATATGT (p.Lys428fs)	BRCA1	K381fs, K428fs, K316fs, K317fs, K340fs, K357fs, K300fs, K339fs, K358fs, K387fs, K427fs, K132fs, K360fs, K361fs, K386fs, K260fs, K301fs, K380fs, K401fs, K402fs, K425fs	Hereditary cancer-predisposing syndrome	VCV001332472	17	41246236 - 41246267	17	43094219 - 43094250	1332472	1323190	rs2154459525	NC_000017.11:43094218:CATGAGGATCACTGGCCAGTAAGTCTATTTTC:ACATAT	Indel	frameshift variant|intron variant	Pathogenic	Apr 30, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1303_1309del (p.Asp435fs)	BRCA1	D388fs, D435fs, D267fs, D307fs, D365fs, D432fs, D323fs, D346fs, D368fs, D434fs, D139fs, D308fs, D347fs, D324fs, D367fs, D387fs, D408fs, D364fs, D393fs, D394fs, D409fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001769454	17	41246239 - 41246245	17	43094222 - 43094228	1769454	1245733	rs2552217036	NC_000017.11:43094221:GAGGATC:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1303_1309delinsAAAGT (p.Asp435fs)	BRCA1	D388fs, D435fs, D307fs, D368fs, D393fs, D409fs, D432fs, D139fs, D267fs, D323fs, D347fs, D367fs, D387fs, D408fs, D434fs, D324fs, D308fs, D346fs, D364fs, D365fs, D394fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266155	17	41246239 - 41246245	17	43094222 - 43094228	266155	261934	rs886039941	NC_000017.11:43094221:GAGGATC:ACTTT	Indel	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1300_1307del (p.Ser434_Asp435insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV004294250	17	41246241 - 41246248	17	43094224 - 43094231	4294250	4406775		NC_000017.11:43094223:GGATCACTGG:GG	Deletion	frameshift variant|intron variant	Pathogenic	Aug 12, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1299dup (p.Ser434fs)	BRCA1	S434fs, S387fs, S138fs, S306fs, S366fs, S386fs, S393fs, S407fs, S431fs, S266fs, S345fs, S346fs, S367fs, S392fs, S307fs, S322fs, S363fs, S364fs, S408fs, S323fs, S433fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224419	17	41246248 - 41246249	17	43094231 - 43094232	224419	226206	rs886037786	NC_000017.11:43094231:GG:GGG	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1297del (p.Ala433fs)	BRCA1	A386fs, A433fs, A391fs, A406fs, A345fs, A363fs, A365fs, A392fs, A407fs, A432fs, A137fs, A265fs, A322fs, A344fs, A362fs, A366fs, A305fs, A306fs, A321fs, A385fs, A430fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054190	17	41246251	17	43094234	54190	68857	rs80357794	NC_000017.11:43094233:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1292_1295del (p.Leu431fs)	BRCA1	L384fs, L431fs, L319fs, L389fs, L390fs, L430fs, L135fs, L303fs, L364fs, L343fs, L360fs, L361fs, L363fs, L405fs, L428fs, L263fs, L304fs, L320fs, L342fs, L383fs, L404fs	not provided	VCV000495089	17	41246253 - 41246256	17	43094236 - 43094239	495089	486656	rs1555591984	NC_000017.11:43094235:AGTAAGT:AGT	Deletion	frameshift variant|intron variant	Pathogenic	Nov 3, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1293_1295delinsGA (p.Leu432fs)	BRCA1	L385fs, L432fs, L264fs, L321fs, L361fs, L405fs, L431fs, L136fs, L343fs, L364fs, L365fs, L406fs, L304fs, L320fs, L390fs, L391fs, L429fs, L305fs, L344fs, L362fs, L384fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054189	17	41246253 - 41246255	17	43094236 - 43094238	54189	68856	rs397508852	NC_000017.11:43094235:AGT:TC	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1293dup (p.Leu432fs)	BRCA1	L385fs, L432fs, L136fs, L264fs, L304fs, L343fs, L361fs, L390fs, L321fs, L305fs, L320fs, L364fs, L365fs, L362fs, L406fs, L431fs, L344fs, L391fs, L405fs, L429fs, L384fs	Hereditary breast ovarian cancer syndrome	VCV000645749	17	41246254 - 41246255	17	43094237 - 43094238	645749	646034	rs1597876950	NC_000017.11:43094237:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Nov 7, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1292dup (p.Leu431fs)	BRCA1	L384fs, L431fs, L263fs, L303fs, L319fs, L342fs, L343fs, L363fs, L405fs, L304fs, L320fs, L361fs, L383fs, L390fs, L404fs, L135fs, L360fs, L428fs, L364fs, L389fs, L430fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054188	17	41246255 - 41246256	17	43094238 - 43094239	54188	68855	rs80357528	NC_000017.11:43094238:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1277_1292del (p.Ser426fs)	BRCA1	S426fs, S379fs, S258fs, S298fs, S314fs, S356fs, S399fs, S423fs, S337fs, S355fs, S359fs, S378fs, S425fs, S130fs, S315fs, S338fs, S358fs, S299fs, S384fs, S385fs, S400fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000927208	17	41246256 - 41246271	17	43094239 - 43094254	927208	913958	rs2053962732	NC_000017.11:43094238:AAGTCTATTTTCTCTGAAG:AAG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1292del (p.Leu431fs)	BRCA1	L384fs, L431fs, L263fs, L303fs, L319fs, L320fs, L342fs, L390fs, L304fs, L361fs, L363fs, L364fs, L428fs, L135fs, L343fs, L383fs, L389fs, L360fs, L404fs, L405fs, L430fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091543	17	41246256	17	43094239	91543	97020	rs80357528	NC_000017.11:43094238:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1292T>G (p.Leu431Ter)	BRCA1	L431*, L384*, L303*, L320*, L363*, L135*, L342*, L360*, L390*, L404*, L364*, L383*, L389*, L405*, L428*, L263*, L304*, L319*, L343*, L361*, L430*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054187	17	41246256	17	43094239	54187	68854	rs80357346	NC_000017.11:43094238:A:C	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1288_1289insC (p.Asp430fs)	BRCA1	D383fs, D430fs, D360fs, D388fs, D389fs, D134fs, D342fs, D359fs, D362fs, D363fs, D404fs, D429fs, D262fs, D302fs, D319fs, D427fs, D303fs, D318fs, D341fs, D382fs, D403fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548177	17	41246259 - 41246260	17	43094242 - 43094243	548177	538883	rs1555591993	NC_000017.11:43094242::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1288dup (p.Asp430fs)	BRCA1	D430fs, D383fs, D262fs, D404fs, D134fs, D319fs, D341fs, D360fs, D362fs, D388fs, D389fs, D382fs, D427fs, D302fs, D303fs, D318fs, D342fs, D359fs, D363fs, D403fs, D429fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266154	17	41246259 - 41246260	17	43094242 - 43094243	266154	261935	rs886039940	NC_000017.11:43094242:C:CC	Duplication	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1287dup (p.Asp430fs)	BRCA1	D430fs, D383fs, D318fs, D359fs, D363fs, D302fs, D341fs, D389fs, D403fs, D134fs, D303fs, D360fs, D362fs, D404fs, D427fs, D262fs, D319fs, D342fs, D382fs, D388fs, D429fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054186	17	41246260 - 41246261	17	43094243 - 43094244	54186	68853	rs80357576	NC_000017.11:43094243:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1287del (p.Ile429fs)	BRCA1	I382fs, I429fs, I359fs, I362fs, I133fs, I302fs, I358fs, I361fs, I402fs, I403fs, I428fs, I261fs, I317fs, I318fs, I341fs, I381fs, I387fs, I426fs, I301fs, I340fs, I388fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417824	17	41246261	17	43094244	417824	404718	rs1060505045	NC_000017.11:43094243:T:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1285del (p.Lys428_Ile429insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000579869	17	41246263	17	43094246	579869	569169	rs1567800172	NC_000017.11:43094245:TTTT:TTT	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Mar 3, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1279G>T (p.Glu427Ter)	BRCA1	E427*, E380*, E339*, E357*, E401*, E424*, E259*, E315*, E316*, E299*, E300*, E356*, E379*, E385*, E386*, E400*, E426*, E131*, E338*, E359*, E360*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054185	17	41246269	17	43094252	54185	68852	rs397508851	NC_000017.11:43094251:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1277del (p.Ser425_Ser426insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000422431	17	41246271	17	43094254	422431	410017	rs1064795775	NC_000017.11:43094253:G:	Deletion	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1277C>G (p.Ser426Ter)	BRCA1	S426*, S379*, S298*, S299*, S338*, S355*, S356*, S400*, S314*, S358*, S384*, S130*, S258*, S315*, S359*, S399*, S425*, S337*, S378*, S385*, S423*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266153	17	41246271	17	43094254	266153	261936	rs886039939	NC_000017.11:43094253:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1277C>A (p.Ser426Ter)	BRCA1	S426*, S379*, S298*, S338*, S378*, S130*, S258*, S314*, S315*, S337*, S355*, S359*, S385*, S400*, S425*, S299*, S356*, S358*, S384*, S399*, S423*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266152	17	41246271	17	43094254	266152	261937	rs886039939	NC_000017.11:43094253:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1276del (p.Ser426fs)	BRCA1	S379fs, S426fs, S299fs, S314fs, S358fs, S384fs, S356fs, S359fs, S385fs, S399fs, S423fs, S258fs, S337fs, S355fs, S378fs, S400fs, S130fs, S298fs, S315fs, S338fs, S425fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054184	17	41246272	17	43094255	54184	68851	rs80357766	NC_000017.11:43094254:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1273dup (p.Ser425fs)	BRCA1	S378fs, S425fs, S297fs, S314fs, S358fs, S399fs, S422fs, S129fs, S257fs, S336fs, S337fs, S354fs, S355fs, S383fs, S398fs, S424fs, S298fs, S313fs, S357fs, S377fs, S384fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266151	17	41246274 - 41246275	17	43094257 - 43094258	266151	261938	rs886039938	NC_000017.11:43094257:AA:AAA	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1271del (p.Gly424fs)	BRCA1	G377fs, G424fs, G256fs, G357fs, G376fs, G398fs, G296fs, G313fs, G335fs, G356fs, G423fs, G128fs, G297fs, G383fs, G312fs, G336fs, G353fs, G354fs, G382fs, G397fs, G421fs	Hereditary cancer-predisposing syndrome	VCV001765579	17	41246277	17	43094260	1765579	1821219	rs2552218329	NC_000017.11:43094259:CC:C	Deletion	intron variant|frameshift variant	Pathogenic	Aug 22, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1265_1266dup (p.Ser423fs)	BRCA1	S376fs, S423fs, S255fs, S312fs, S352fs, S356fs, S127fs, S296fs, S397fs, S295fs, S311fs, S335fs, S353fs, S355fs, S375fs, S382fs, S396fs, S334fs, S381fs, S420fs, S422fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054181	17	41246281 - 41246282	17	43094264 - 43094265	54181	68848	rs397508850	NC_000017.11:43094264:ATAT:ATATAT	Microsatellite	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1266T>G (p.Tyr422Ter)	BRCA1	Y422*, Y375*, Y295*, Y354*, Y381*, Y254*, Y294*, Y334*, Y352*, Y310*, Y351*, Y374*, Y395*, Y421*, Y126*, Y311*, Y333*, Y355*, Y380*, Y396*, Y419*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054183	17	41246282	17	43094265	54183	68850	rs80357417	NC_000017.11:43094264:A:C	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1265dup (p.Tyr422Ter)	BRCA1	Y375*, Y422*, Y295*, Y334*, Y351*, Y352*, Y354*, Y380*, Y355*, Y374*, Y396*, Y294*, Y395*, Y421*, Y126*, Y254*, Y310*, Y311*, Y333*, Y381*, Y419*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054182	17	41246282 - 41246283	17	43094265 - 43094266	54182	68849	rs80357809	NC_000017.11:43094265:T:TT	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1258_1265del (p.Asp420fs)	BRCA1	D373fs, D420fs, D332fs, D349fs, D352fs, D393fs, D394fs, D417fs, D419fs, D292fs, D350fs, D372fs, D378fs, D308fs, D331fs, D353fs, D379fs, D124fs, D252fs, D293fs, D309fs	Hereditary breast ovarian cancer syndrome	VCV002101155	17	41246283 - 41246290	17	43094266 - 43094273	2101155	2151175	rs2552218418	NC_000017.11:43094265:TATTCATCTA:TA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 25, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1264dup (p.Tyr422fs)	BRCA1	Y375fs, Y422fs, Y126fs, Y355fs, Y381fs, Y395fs, Y334fs, Y380fs, Y396fs, Y419fs, Y295fs, Y310fs, Y333fs, Y351fs, Y374fs, Y421fs, Y254fs, Y294fs, Y311fs, Y352fs, Y354fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001763854	17	41246283 - 41246284	17	43094266 - 43094267	1763854	1820720	rs2552218440	NC_000017.11:43094266:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1261G>T (p.Glu421Ter)	BRCA1	E421*, E374*, E294*, E333*, E353*, E395*, E125*, E253*, E293*, E332*, E351*, E354*, E373*, E309*, E379*, E380*, E394*, E310*, E350*, E418*, E420*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266150	17	41246287	17	43094270	266150	261939	rs80357046	NC_000017.11:43094269:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1259del (p.Asp420fs)	BRCA1	D420fs, D373fs, D252fs, D308fs, D331fs, D353fs, D379fs, D417fs, D292fs, D332fs, D349fs, D352fs, D393fs, D394fs, D419fs, D124fs, D309fs, D372fs, D293fs, D350fs, D378fs	Hereditary cancer-predisposing syndrome	VCV001762558	17	41246289	17	43094272	1762558	1816956	rs2552218484	NC_000017.11:43094271:T:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 21, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1257del (p.Asp420fs)	BRCA1	D420fs, D373fs, D378fs, D419fs, D331fs, D349fs, D379fs, D394fs, D292fs, D309fs, D332fs, D352fs, D353fs, D124fs, D252fs, D293fs, D308fs, D350fs, D372fs, D417fs, D393fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254393	17	41246291	17	43094274	254393	249150	rs886037988	NC_000017.11:43094273:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1256dup (p.Asp420fs)	BRCA1	D373fs, D420fs, D293fs, D331fs, D394fs, D419fs, D252fs, D308fs, D353fs, D372fs, D379fs, D124fs, D309fs, D349fs, D350fs, D352fs, D378fs, D417fs, D292fs, D332fs, D393fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186634	17	41246291 - 41246292	17	43094274 - 43094275	186634	185072	rs786203103	NC_000017.11:43094274:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1255del (p.Glu418_Val419insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054177	17	41246293	17	43094276	54177	68844	rs80357535	NC_000017.11:43094275:CC:C	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1253del (p.Glu418fs)	BRCA1	E371fs, E418fs, E250fs, E291fs, E377fs, E392fs, E122fs, E306fs, E348fs, E351fs, E376fs, E391fs, E415fs, E330fs, E290fs, E307fs, E329fs, E347fs, E350fs, E370fs, E417fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266149	17	41246295	17	43094278	266149	261940	rs886039937	NC_000017.11:43094277:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1252dup (p.Glu418fs)	BRCA1	E418fs, E371fs, E290fs, E329fs, E330fs, E347fs, E376fs, E377fs, E392fs, E370fs, E122fs, E250fs, E291fs, E306fs, E307fs, E351fs, E391fs, E348fs, E350fs, E415fs, E417fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266148	17	41246295 - 41246296	17	43094278 - 43094279	266148	261941	rs886039936	NC_000017.11:43094278:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1251_1252delinsA (p.Asn417fs)	BRCA1	N417fs, N370fs, N289fs, N306fs, N376fs, N390fs, N414fs, N416fs, N121fs, N328fs, N329fs, N346fs, N305fs, N347fs, N369fs, N391fs, N249fs, N290fs, N349fs, N350fs, N375fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267498	17	41246296 - 41246297	17	43094279 - 43094280	267498	262975	rs886040899	NC_000017.11:43094278:CA:T	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1252del (p.Glu418fs)	BRCA1	E371fs, E418fs, E329fs, E330fs, E347fs, E350fs, E376fs, E122fs, E306fs, E391fs, E417fs, E291fs, E307fs, E348fs, E351fs, E370fs, E377fs, E415fs, E250fs, E290fs, E392fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233760	17	41246296	17	43094279	233760	236137	rs876660623	NC_000017.11:43094278:C:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1252G>T (p.Glu418Ter)	BRCA1	E418*, E371*, E122*, E290*, E391*, E291*, E329*, E350*, E351*, E370*, E377*, E250*, E347*, E376*, E392*, E306*, E307*, E330*, E348*, E415*, E417*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054176	17	41246296	17	43094279	54176	68843	rs80357083	NC_000017.11:43094278:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1240_1246del (p.Leu413_Asp414insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054170	17	41246302 - 41246308	17	43094285 - 43094291	54170	68837	rs80357964	NC_000017.11:43094284:GAACGTC:	Deletion	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1241dup (p.Asp414fs)	BRCA1	D414fs, D367fs, D287fs, D303fs, D366fs, D118fs, D326fs, D344fs, D346fs, D411fs, D246fs, D325fs, D413fs, D286fs, D302fs, D343fs, D347fs, D372fs, D373fs, D387fs, D388fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054171	17	41246306 - 41246307	17	43094289 - 43094290	54171	68838	rs80357514	NC_000017.11:43094289:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1240dup (p.Asp414fs)	BRCA1	D367fs, D414fs, D387fs, D246fs, D286fs, D347fs, D411fs, D118fs, D287fs, D302fs, D372fs, D388fs, D303fs, D325fs, D326fs, D343fs, D344fs, D346fs, D366fs, D373fs, D413fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188403	17	41246307 - 41246308	17	43094290 - 43094291	188403	186261	rs786204260	NC_000017.11:43094290:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1240del (p.Asp414fs)	BRCA1	D414fs, D367fs, D286fs, D343fs, D372fs, D413fs, D246fs, D303fs, D325fs, D388fs, D118fs, D287fs, D302fs, D326fs, D344fs, D347fs, D366fs, D373fs, D346fs, D387fs, D411fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548189	17	41246308	17	43094291	548189	538884	rs786204260	NC_000017.11:43094290:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1235_1238del (p.Val412fs)	BRCA1	V116fs, V244fs, V284fs, V285fs, V300fs, V301fs, V323fs, V324fs, V341fs, V342fs, V344fs, V345fs, V364fs, V365fs, V370fs, V371fs, V385fs, V386fs, V409fs, V411fs, V412fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002583827	17	41246310 - 41246313	17	43094293 - 43094296	2583827	2751397	rs2552218830	NC_000017.11:43094292:AATA:	Deletion	frameshift variant|intron variant	Pathogenic	May 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1232_1235delinsCA (p.Asp411fs)	BRCA1	D411fs, D364fs, D115fs, D370fs, D385fs, D408fs, D323fs, D340fs, D369fs, D243fs, D283fs, D284fs, D341fs, D344fs, D384fs, D299fs, D300fs, D322fs, D343fs, D363fs, D410fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231599	17	41246313 - 41246316	17	43094296 - 43094299	231599	236138	rs876659253	NC_000017.11:43094295:ACAT:TG	Indel	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1232_1233del (p.Asp411fs)	BRCA1	D364fs, D411fs, D115fs, D322fs, D341fs, D343fs, D384fs, D370fs, D385fs, D243fs, D283fs, D340fs, D363fs, D369fs, D284fs, D299fs, D300fs, D323fs, D344fs, D408fs, D410fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054169	17	41246315 - 41246316	17	43094298 - 43094299	54169	68836	rs397508848	NC_000017.11:43094297:AT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1227_1230dup (p.Asp411delinsSerTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266147	17	41246317 - 41246318	17	43094300 - 43094301	266147	261942	rs886039935	NC_000017.11:43094300:AGCTA:AGCTAGCTA	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1230del (p.Asp411fs)	BRCA1	D364fs, D411fs, D115fs, D299fs, D322fs, D323fs, D340fs, D343fs, D384fs, D385fs, D243fs, D369fs, D283fs, D300fs, D341fs, D284fs, D344fs, D363fs, D370fs, D408fs, D410fs	Hereditary breast ovarian cancer syndrome	VCV000531273	17	41246318	17	43094301	531273	531375	rs1555592108	NC_000017.11:43094300:A:	Deletion	intron variant|frameshift variant	Pathogenic	Oct 27, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1224del (p.Lys408_Val409insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252436	17	41246324	17	43094307	252436	246851	rs879255320	NC_000017.11:43094306:TTT:TT	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1222A>T (p.Lys408Ter)	BRCA1	K408*, K361*, K280*, K297*, K366*, K407*, K296*, K340*, K367*, K240*, K281*, K319*, K337*, K338*, K112*, K320*, K341*, K360*, K381*, K382*, K405*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266146	17	41246326	17	43094309	266146	261943	rs80357253	NC_000017.11:43094308:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1221del (p.Lys408_Val409insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003639212	17	41246327	17	43094310	3639212	3768209		NC_000017.11:43094309:GG:G	Deletion	intron variant|frameshift variant	Pathogenic	Feb 6, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1218_1219insA (p.Ala407fs)	BRCA1	A407fs, A360fs, A318fs, A319fs, A359fs, A365fs, A380fs, A239fs, A336fs, A366fs, A381fs, A406fs, A279fs, A280fs, A337fs, A339fs, A404fs, A111fs, A295fs, A296fs, A340fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548307	17	41246329 - 41246330	17	43094312 - 43094313	548307	538885	rs1555592129	NC_000017.11:43094312::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1177_1219del (p.Leu393fs)	BRCA1	L393fs, L346fs, L322fs, L325fs, L351fs, L366fs, L390fs, L392fs, L265fs, L305fs, L345fs, L352fs, L367fs, L97fs, L225fs, L281fs, L304fs, L323fs, L266fs, L282fs, L326fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037396	17	41246329 - 41246371	17	43094312 - 43094354	37396	45952	rs397507182	NC_000017.11:43094311:CATTTGATTCAGACTCCCCATCATGTGAGTCATCAGAACCTAACA:CA	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1217dup (p.Asn406fs)	BRCA1	N359fs, N406fs, N294fs, N318fs, N335fs, N339fs, N358fs, N380fs, N295fs, N317fs, N336fs, N338fs, N405fs, N364fs, N379fs, N110fs, N238fs, N278fs, N279fs, N365fs, N403fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431207	17	41246330 - 41246331	17	43094313 - 43094314	431207	424855	rs397508846	NC_000017.11:43094313:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 26, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1175_1218del (p.Leu392fs)	BRCA1	L392fs, L345fs, L264fs, L304fs, L325fs, L351fs, L281fs, L321fs, L350fs, L391fs, L96fs, L224fs, L280fs, L303fs, L322fs, L365fs, L265fs, L324fs, L344fs, L366fs, L389fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037397	17	41246330 - 41246373	17	43094313 - 43094356	37397	45953	rs397507183	NC_000017.11:43094312:ATTTGATTCAGACTCCCCATCATGTGAGTCATCAGAACCTAACA:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1216_1217del (p.Asn406fs)	BRCA1	N359fs, N406fs, N279fs, N317fs, N318fs, N338fs, N110fs, N295fs, N339fs, N358fs, N379fs, N380fs, N403fs, N405fs, N335fs, N336fs, N365fs, N238fs, N278fs, N294fs, N364fs	Hereditary breast ovarian cancer syndrome	VCV002101394	17	41246331 - 41246332	17	43094314 - 43094315	2101394	2147652	rs397508846	NC_000017.11:43094313:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Feb 22, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1217del (p.Asn406fs)	BRCA1	N406fs, N359fs, N110fs, N238fs, N335fs, N338fs, N339fs, N405fs, N294fs, N295fs, N317fs, N318fs, N358fs, N364fs, N365fs, N278fs, N279fs, N336fs, N379fs, N380fs, N403fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054165	17	41246331	17	43094314	54165	68832	rs397508846	NC_000017.11:43094313:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1175_1215del (p.Leu392fs)	BRCA1	L345fs, L392fs, L280fs, L322fs, L324fs, L391fs, L96fs, L304fs, L344fs, L351fs, L366fs, L264fs, L281fs, L303fs, L365fs, L224fs, L265fs, L321fs, L325fs, L350fs, L389fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037394	17	41246333 - 41246373	17	43094316 - 43094356	37394	45950	rs397507180	NC_000017.11:43094315:TGATTCAGACTCCCCATCATGTGAGTCATCAGAACCTAACA:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1214C>G (p.Ser405Ter)	BRCA1	S405*, S358*, S277*, S316*, S317*, S334*, S335*, S338*, S402*, S237*, S278*, S294*, S337*, S357*, S378*, S379*, S404*, S109*, S293*, S363*, S364*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096896	17	41246334	17	43094317	96896	102799	rs80357481	NC_000017.11:43094316:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1214C>A (p.Ser405Ter)	BRCA1	S405*, S358*, S293*, S357*, S363*, S404*, S316*, S317*, S334*, S335*, S402*, S109*, S277*, S294*, S338*, S364*, S378*, S237*, S278*, S337*, S379*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054164	17	41246334	17	43094317	54164	68831	rs80357481	NC_000017.11:43094316:G:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1175_1214del (p.Leu392fs)	BRCA1	L345fs, L392fs, L265fs, L322fs, L325fs, L351fs, L304fs, L321fs, L324fs, L365fs, L366fs, L389fs, L391fs, L224fs, L264fs, L280fs, L303fs, L350fs, L96fs, L281fs, L344fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017665	17	41246334 - 41246373	17	43094317 - 43094356	17665	32704	rs80359874	NC_000017.11:43094316:GATTCAGACTCCCCATCATGTGAGTCATCAGAACCTAACAG:G	Deletion	intron variant|frameshift variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1211_1212insCT (p.Glu404fs)	BRCA1	E357fs, E404fs, E108fs, E316fs, E236fs, E293fs, E276fs, E277fs, E333fs, E334fs, E377fs, E401fs, E403fs, E292fs, E315fs, E336fs, E337fs, E356fs, E362fs, E363fs, E378fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548221	17	41246336 - 41246337	17	43094319 - 43094320	548221	538889	rs1555592174	NC_000017.11:43094319::AG	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1210_1211insCT (p.Glu404fs)	BRCA1	E357fs, E404fs, E292fs, E293fs, E315fs, E337fs, E362fs, E377fs, E108fs, E276fs, E336fs, E356fs, E378fs, E316fs, E334fs, E363fs, E236fs, E277fs, E333fs, E401fs, E403fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266145	17	41246337 - 41246338	17	43094320 - 43094321	266145	261944	rs886039934	NC_000017.11:43094320::AG	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1209dup (p.Glu404Ter)	BRCA1	E357*, E404*, E333*, E293*, E316*, E356*, E276*, E292*, E315*, E334*, E362*, E401*, E403*, E108*, E236*, E277*, E336*, E337*, E363*, E377*, E378*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266144	17	41246338 - 41246339	17	43094321 - 43094322	266144	261946	rs886039933	NC_000017.11:43094321:A:AA	Duplication	intron variant|nonsense	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1209_1210del (p.Glu404fs)	BRCA1	E404fs, E357fs, E276fs, E293fs, E316fs, E336fs, E403fs, E292fs, E315fs, E337fs, E377fs, E401fs, E108fs, E333fs, E334fs, E362fs, E378fs, E236fs, E277fs, E356fs, E363fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266143	17	41246338 - 41246339	17	43094321 - 43094322	266143	261945	rs886039932	NC_000017.11:43094320:CA:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1209del (p.Glu404fs)	BRCA1	E404fs, E357fs, E292fs, E337fs, E401fs, E403fs, E293fs, E334fs, E336fs, E362fs, E108fs, E236fs, E315fs, E333fs, E363fs, E276fs, E277fs, E316fs, E356fs, E377fs, E378fs	Hereditary cancer-predisposing syndrome	VCV000630569	17	41246339	17	43094322	630569	618679	rs1567800523	NC_000017.11:43094321:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 15, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1205dup (p.Ser403fs)	BRCA1	S356fs, S403fs, S235fs, S275fs, S107fs, S276fs, S292fs, S333fs, S376fs, S315fs, S362fs, S377fs, S402fs, S291fs, S314fs, S332fs, S335fs, S336fs, S355fs, S361fs, S400fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000438910	17	41246342 - 41246343	17	43094325 - 43094326	438910	432919	rs1555592219	NC_000017.11:43094325:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1204del (p.Glu402fs)	BRCA1	E355fs, E402fs, E106fs, E290fs, E332fs, E354fs, E313fs, E335fs, E360fs, E375fs, E275fs, E291fs, E314fs, E234fs, E274fs, E331fs, E334fs, E361fs, E376fs, E399fs, E401fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054162	17	41246344	17	43094327	54162	68829	rs80357859	NC_000017.11:43094326:CCCC:CCC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1204G>T (p.Glu402Ter)	BRCA1	E402*, E355*, E274*, E291*, E376*, E314*, E331*, E334*, E360*, E401*, E106*, E234*, E290*, E313*, E332*, E335*, E354*, E399*, E275*, E361*, E375*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054161	17	41246344	17	43094327	54161	68828	rs273897655	NC_000017.11:43094326:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1194dup (p.His399fs)	BRCA1	H399fs, H352fs, H328fs, H357fs, H310fs, H332fs, H358fs, H373fs, H103fs, H271fs, H272fs, H311fs, H331fs, H351fs, H396fs, H398fs, H231fs, H287fs, H288fs, H329fs, H372fs	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000545825	17	41246353 - 41246354	17	43094336 - 43094337	545825	536497	rs1555592264	NC_000017.11:43094336:T:TT	Duplication	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Jan 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1193C>G (p.Ser398Ter)	BRCA1	S398*, S351*, S270*, S287*, S331*, S356*, S357*, S371*, S102*, S328*, S350*, S372*, S395*, S230*, S271*, S330*, S397*, S286*, S309*, S310*, S327*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054160	17	41246355	17	43094338	54160	68827	rs80357068	NC_000017.11:43094337:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1193C>A (p.Ser398Ter)	BRCA1	S398*, S351*, S102*, S230*, S287*, S310*, S357*, S397*, S327*, S331*, S356*, S371*, S270*, S271*, S286*, S309*, S372*, S328*, S330*, S350*, S395*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054159	17	41246355	17	43094338	54159	68826	rs80357068	NC_000017.11:43094337:G:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1190del (p.Asp397fs)	BRCA1	D350fs, D397fs, D229fs, D286fs, D270fs, D285fs, D308fs, D329fs, D330fs, D370fs, D371fs, D101fs, D309fs, D327fs, D394fs, D396fs, D269fs, D326fs, D349fs, D355fs, D356fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254392	17	41246358	17	43094341	254392	249151	rs748714307	NC_000017.11:43094340:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1188del (p.Asp396fs)	BRCA1	D349fs, D396fs, D284fs, D268fs, D307fs, D326fs, D393fs, D100fs, D285fs, D325fs, D328fs, D348fs, D369fs, D395fs, D228fs, D269fs, D308fs, D329fs, D354fs, D355fs, D370fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054158	17	41246360	17	43094343	54158	68825	rs397508845	NC_000017.11:43094342:A:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1180_1181insT (p.Gly394fs)	BRCA1	G347fs, G394fs, G266fs, G283fs, G306fs, G323fs, G346fs, G352fs, G393fs, G226fs, G282fs, G324fs, G327fs, G367fs, G391fs, G98fs, G353fs, G368fs, G267fs, G305fs, G326fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548245	17	41246367 - 41246368	17	43094350 - 43094351	548245	538890	rs1555592299	NC_000017.11:43094350::A	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1179_1180dup (p.Gly394fs)	BRCA1	G347fs, G394fs, G266fs, G283fs, G368fs, G267fs, G282fs, G323fs, G327fs, G353fs, G393fs, G324fs, G326fs, G346fs, G367fs, G226fs, G305fs, G306fs, G352fs, G391fs, G98fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000531380	17	41246367 - 41246368	17	43094350 - 43094351	531380	531308	rs1555592304	NC_000017.11:43094350:CT:CTCT	Duplication	frameshift variant|intron variant	Pathogenic	Apr 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1179_1180insT (p.Gly394fs)	BRCA1	G394fs, G347fs, G226fs, G267fs, G323fs, G346fs, G368fs, G305fs, G306fs, G352fs, G367fs, G266fs, G283fs, G324fs, G326fs, G353fs, G391fs, G393fs, G98fs, G282fs, G327fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266142	17	41246368 - 41246369	17	43094351 - 43094352	266142	261947	rs886039931	NC_000017.11:43094351::A	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1175_1178del (p.Leu392fs)	BRCA1	L345fs, L392fs, L265fs, L281fs, L350fs, L389fs, L391fs, L96fs, L224fs, L304fs, L366fs, L264fs, L280fs, L322fs, L325fs, L351fs, L303fs, L321fs, L324fs, L344fs, L365fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054156	17	41246370 - 41246373	17	43094353 - 43094356	54156	68823	rs397508844	NC_000017.11:43094352:AACA:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1174del (p.Leu392fs)	BRCA1	L345fs, L392fs, L224fs, L280fs, L321fs, L351fs, L391fs, L303fs, L304fs, L322fs, L344fs, L365fs, L389fs, L96fs, L265fs, L325fs, L264fs, L281fs, L324fs, L350fs, L366fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266141	17	41246374	17	43094357	266141	261948	rs886039930	NC_000017.11:43094356:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1171G>T (p.Glu391Ter)	BRCA1	E391*, E344*, E223*, E280*, E323*, E364*, E390*, E264*, E279*, E302*, E343*, E95*, E303*, E320*, E349*, E365*, E388*, E263*, E321*, E324*, E350*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266140	17	41246377	17	43094360	266140	261949	rs562553169	NC_000017.11:43094359:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1166del (p.Ser389fs)	BRCA1	S342fs, S389fs, S221fs, S277fs, S278fs, S319fs, S347fs, S348fs, S363fs, S388fs, S261fs, S262fs, S318fs, S321fs, S362fs, S386fs, S341fs, S300fs, S301fs, S322fs, S93fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054155	17	41246382	17	43094365	54155	68822	rs273897653	NC_000017.11:43094364:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1165del (p.Ser389fs)	BRCA1	S342fs, S389fs, S221fs, S277fs, S278fs, S319fs, S388fs, S261fs, S301fs, S321fs, S386fs, S300fs, S347fs, S362fs, S363fs, S262fs, S318fs, S322fs, S341fs, S348fs, S93fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054154	17	41246383	17	43094366	54154	68821	rs80357985	NC_000017.11:43094365:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1162A>T (p.Arg388Ter)	BRCA1	R388*, R341*, R260*, R276*, R318*, R340*, R261*, R317*, R321*, R362*, R220*, R277*, R299*, R320*, R347*, R385*, R387*, R92*, R300*, R346*, R361*	Hereditary cancer-predisposing syndrome	VCV000482924	17	41246386	17	43094369	482924	478834	rs111312760	NC_000017.11:43094368:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 30, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1160delinsTG (p.Ser387fs)	BRCA1	S219fs, S259fs, S260fs, S275fs, S276fs, S298fs, S299fs, S316fs, S317fs, S319fs, S320fs, S339fs, S340fs, S345fs, S346fs, S360fs, S361fs, S384fs, S386fs, S387fs, S91fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003904716	17	41246388	17	43094371	3904716	4020588		NC_000017.11:43094370:G:CA	Indel	frameshift variant|intron variant	Pathogenic	Feb 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1159dup (p.Ser387fs)	BRCA1	S340fs, S387fs, S384fs, S276fs, S319fs, S339fs, S345fs, S346fs, S219fs, S298fs, S316fs, S317fs, S360fs, S361fs, S386fs, S259fs, S260fs, S275fs, S299fs, S320fs, S91fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054150	17	41246388 - 41246389	17	43094371 - 43094372	54150	68817	rs397508842	NC_000017.11:43094371:AAAA:AAAAA	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1159del (p.Ser387fs)	BRCA1	S219fs, S259fs, S260fs, S275fs, S276fs, S298fs, S299fs, S316fs, S317fs, S319fs, S320fs, S339fs, S340fs, S345fs, S346fs, S360fs, S361fs, S384fs, S386fs, S387fs, S91fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002680214	17	41246389	17	43094372	2680214	2833942	rs397508842	NC_000017.11:43094371:AAAA:AAA	Deletion	frameshift variant|intron variant	Pathogenic	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1158_1159del (p.Ser387fs)	BRCA1	S387fs, S340fs, S219fs, S259fs, S299fs, S317fs, S276fs, S298fs, S91fs, S346fs, S384fs, S319fs, S320fs, S339fs, S360fs, S316fs, S345fs, S361fs, S386fs, S260fs, S275fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054149	17	41246389 - 41246390	17	43094372 - 43094373	54149	68816	rs397508842	NC_000017.11:43094371:AAAA:AA	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1155del (p.Trp385fs)	BRCA1	W385fs, W338fs, W314fs, W318fs, W337fs, W382fs, W384fs, W315fs, W317fs, W358fs, W89fs, W258fs, W274fs, W296fs, W359fs, W217fs, W257fs, W273fs, W297fs, W343fs, W344fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001454280	17	41246393	17	43094376	1454280	1366885	rs2154473109	NC_000017.11:43094375:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Feb 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1155G>A (p.Trp385Ter)	BRCA1	W385*, W338*, W257*, W258*, W273*, W315*, W318*, W343*, W274*, W296*, W344*, W358*, W359*, W382*, W384*, W217*, W314*, W317*, W337*, W89*, W297*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233665	17	41246393	17	43094376	233665	236140	rs876660558	NC_000017.11:43094375:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1154G>A (p.Trp385Ter)	BRCA1	W385*, W338*, W296*, W297*, W318*, W344*, W217*, W314*, W315*, W337*, W343*, W358*, W258*, W274*, W317*, W382*, W89*, W257*, W273*, W359*, W384*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479259	17	41246394	17	43094377	479259	478700	rs1555592354	NC_000017.11:43094376:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 4, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1152dup (p.Trp385fs)	BRCA1	W338fs, W385fs, W274fs, W296fs, W314fs, W382fs, W273fs, W315fs, W359fs, W384fs, W317fs, W318fs, W358fs, W89fs, W217fs, W257fs, W297fs, W337fs, W343fs, W344fs, W258fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054148	17	41246395 - 41246396	17	43094378 - 43094379	54148	68815	rs397508841	NC_000017.11:43094378:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1150G>T (p.Glu384Ter)	BRCA1	E384*, E337*, E216*, E257*, E295*, E313*, E317*, E343*, E357*, E381*, E256*, E296*, E314*, E342*, E358*, E272*, E273*, E336*, E383*, E88*, E316*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236266	17	41246398	17	43094381	236266	237837	rs878853288	NC_000017.11:43094380:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1148_1149del (p.Asn383fs)	BRCA1	N336fs, N383fs, N312fs, N316fs, N256fs, N272fs, N315fs, N335fs, N380fs, N255fs, N271fs, N341fs, N342fs, N356fs, N87fs, N215fs, N294fs, N295fs, N313fs, N357fs, N382fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096895	17	41246399 - 41246400	17	43094382 - 43094383	96895	102798	rs431825384	NC_000017.11:43094381:AT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1148del (p.Asn383fs)	BRCA1	N383fs, N336fs, N256fs, N272fs, N294fs, N313fs, N341fs, N342fs, N357fs, N382fs, N255fs, N271fs, N312fs, N315fs, N335fs, N215fs, N295fs, N316fs, N356fs, N380fs, N87fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240770	17	41246400	17	43094383	240770	242801	rs878854930	NC_000017.11:43094382:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1144del (p.Val382fs)	BRCA1	V254fs, V334fs, V335fs, V356fs, V381fs, V271fs, V311fs, V294fs, V314fs, V315fs, V341fs, V382fs, V214fs, V255fs, V270fs, V293fs, V312fs, V340fs, V355fs, V379fs, V86fs	Hereditary breast ovarian cancer syndrome	VCV002851937	17	41246404	17	43094387	2851937	3016265	rs2552220762	NC_000017.11:43094386:C:	Deletion	frameshift variant|intron variant	Pathogenic	Apr 4, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1142_1143del (p.Lys381fs)	BRCA1	K334fs, K381fs, K270fs, K314fs, K85fs, K213fs, K253fs, K269fs, K310fs, K313fs, K333fs, K339fs, K340fs, K355fs, K378fs, K254fs, K292fs, K293fs, K311fs, K380fs, K354fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252429	17	41246405 - 41246406	17	43094388 - 43094389	252429	246852	rs879255313	NC_000017.11:43094387:TTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1140dup (p.Lys381fs)	BRCA1	K334fs, K381fs, K254fs, K292fs, K310fs, K311fs, K355fs, K378fs, K253fs, K270fs, K339fs, K340fs, K213fs, K354fs, K380fs, K85fs, K269fs, K293fs, K313fs, K314fs, K333fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231732	17	41246407 - 41246408	17	43094390 - 43094391	231732	236141	rs876659327	NC_000017.11:43094390:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1086_1141del (p.Asn363fs)	BRCA1	N316fs, N363fs, N275fs, N292fs, N322fs, N251fs, N252fs, N274fs, N293fs, N337fs, N360fs, N362fs, N195fs, N235fs, N295fs, N296fs, N236fs, N315fs, N321fs, N336fs, N67fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091539	17	41246407 - 41246462	17	43094390 - 43094445	91539	97016	rs80359875		Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1141A>T (p.Lys381Ter)	BRCA1	K381*, K334*, K253*, K293*, K355*, K213*, K269*, K310*, K313*, K314*, K339*, K270*, K292*, K311*, K333*, K354*, K85*, K254*, K340*, K378*, K380*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054145	17	41246407	17	43094390	54145	68812	rs80357385	NC_000017.11:43094389:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1140del (p.Val382fs)	BRCA1	V382fs, V335fs, V270fs, V293fs, V312fs, V340fs, V356fs, V271fs, V379fs, V86fs, V255fs, V311fs, V334fs, V381fs, V214fs, V254fs, V294fs, V314fs, V315fs, V341fs, V355fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266139	17	41246408	17	43094391	266139	261950	rs886039929	NC_000017.11:43094390:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1138C>T (p.Gln380Ter)	BRCA1	Q380*, Q333*, Q312*, Q313*, Q379*, Q212*, Q268*, Q309*, Q339*, Q354*, Q253*, Q269*, Q310*, Q332*, Q338*, Q353*, Q377*, Q252*, Q291*, Q292*, Q84*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054144	17	41246410	17	43094393	54144	68811	rs397508840	NC_000017.11:43094392:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1132_1135del (p.Ser378fs)	BRCA1	S331fs, S378fs, S250fs, S251fs, S267fs, S289fs, S307fs, S351fs, S375fs, S210fs, S290fs, S308fs, S352fs, S82fs, S266fs, S336fs, S377fs, S310fs, S311fs, S330fs, S337fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431206	17	41246413 - 41246416	17	43094396 - 43094399	431206	424856	rs1135401841	NC_000017.11:43094395:TGCT:	Deletion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1133del (p.Ser378fs)	BRCA1	S378fs, S331fs, S250fs, S266fs, S308fs, S311fs, S375fs, S82fs, S210fs, S267fs, S289fs, S337fs, S251fs, S330fs, S351fs, S290fs, S307fs, S310fs, S336fs, S352fs, S377fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000818400	17	41246415	17	43094398	818400	813868	rs1597877892	NC_000017.11:43094397:C:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1125_1132del (p.Asn376fs)	BRCA1	N329fs, N376fs, N264fs, N288fs, N80fs, N249fs, N308fs, N309fs, N328fs, N334fs, N265fs, N305fs, N350fs, N375fs, N208fs, N248fs, N287fs, N306fs, N335fs, N349fs, N373fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266138	17	41246416 - 41246423	17	43094399 - 43094406	266138	261951	rs886039928	NC_000017.11:43094398:TGCTATTT:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1129dup (p.Ser377fs)	BRCA1	S330fs, S377fs, S288fs, S81fs, S209fs, S266fs, S329fs, S336fs, S350fs, S376fs, S249fs, S265fs, S289fs, S335fs, S374fs, S250fs, S306fs, S307fs, S309fs, S310fs, S351fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125488	17	41246418 - 41246419	17	43094401 - 43094402	125488	131026	rs80357776	NC_000017.11:43094401:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1126_1129del (p.Asn376fs)	BRCA1	N208fs, N248fs, N305fs, N309fs, N335fs, N350fs, N373fs, N249fs, N334fs, N264fs, N287fs, N288fs, N80fs, N375fs, N265fs, N306fs, N308fs, N328fs, N329fs, N349fs, N376fs	Hereditary breast ovarian cancer syndrome	VCV003722919	17	41246419 - 41246422	17	43094402 - 43094405	3722919	3854011		NC_000017.11:43094401:TATTTA:TA	Deletion	frameshift variant|intron variant	Pathogenic	Oct 15, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1129del (p.Ser377fs)	BRCA1	S330fs, S377fs, S250fs, S288fs, S306fs, S309fs, S350fs, S289fs, S307fs, S209fs, S249fs, S265fs, S310fs, S329fs, S335fs, S336fs, S351fs, S376fs, S81fs, S266fs, S374fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000946950	17	41246419	17	43094402	946950	928320	rs2053988613	NC_000017.11:43094401:T:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1127del (p.Asn376fs)	BRCA1	N329fs, N376fs, N208fs, N287fs, N305fs, N328fs, N349fs, N249fs, N264fs, N265fs, N306fs, N308fs, N335fs, N350fs, N248fs, N288fs, N309fs, N334fs, N373fs, N375fs, N80fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054140	17	41246421	17	43094404	54140	68807	rs80357821	NC_000017.11:43094403:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1124del (p.Leu375fs)	BRCA1	L247fs, L307fs, L334fs, L263fs, L304fs, L349fs, L375fs, L248fs, L287fs, L305fs, L308fs, L328fs, L333fs, L374fs, L286fs, L327fs, L348fs, L372fs, L79fs, L207fs, L264fs	Hereditary cancer-predisposing syndrome	VCV003481815	17	41246424	17	43094407	3481815	3640026		NC_000017.11:43094406:A:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 1, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1123_1124delinsA (p.Leu375fs)	BRCA1	L375fs, L328fs, L207fs, L263fs, L287fs, L304fs, L307fs, L334fs, L349fs, L264fs, L286fs, L308fs, L372fs, L305fs, L327fs, L348fs, L247fs, L248fs, L333fs, L374fs, L79fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000919767	17	41246424 - 41246425	17	43094407 - 43094408	919767	913960	rs2053989334	NC_000017.11:43094406:AG:T	Indel	frameshift variant|intron variant	Pathogenic	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1123del (p.Thr374_Leu375insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254391	17	41246425	17	43094408	254391	249152	rs886037987	NC_000017.11:43094407:G:	Deletion	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1122_1123del (p.Leu375fs)	BRCA1	L328fs, L375fs, L247fs, L248fs, L264fs, L305fs, L308fs, L79fs, L287fs, L307fs, L327fs, L349fs, L374fs, L348fs, L207fs, L263fs, L286fs, L304fs, L333fs, L334fs, L372fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054138	17	41246425 - 41246426	17	43094408 - 43094409	54138	68805	rs397508839	NC_000017.11:43094407:GTGT:GT	Microsatellite	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1121_1123delinsT (p.Thr374fs)	BRCA1	T374fs, T327fs, T285fs, T78fs, T247fs, T306fs, T332fs, T333fs, T348fs, T373fs, T246fs, T262fs, T263fs, T303fs, T326fs, T206fs, T286fs, T304fs, T307fs, T347fs, T371fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054137	17	41246425 - 41246427	17	43094408 - 43094410	54137	68804	rs273897652	NC_000017.11:43094407:GTG:A	Indel	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1121del (p.Thr374fs)	BRCA1	T374fs, T327fs, T263fs, T326fs, T348fs, T78fs, T206fs, T285fs, T304fs, T332fs, T262fs, T286fs, T303fs, T371fs, T246fs, T247fs, T306fs, T307fs, T333fs, T347fs, T373fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037391	17	41246427	17	43094410	37391	45947	rs80357612	NC_000017.11:43094409:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1120del (p.Thr374fs)	BRCA1	T327fs, T374fs, T262fs, T303fs, T333fs, T263fs, T304fs, T307fs, T371fs, T373fs, T206fs, T285fs, T306fs, T326fs, T347fs, T348fs, T78fs, T247fs, T286fs, T332fs, T246fs	Hereditary cancer-predisposing syndrome	VCV001797697	17	41246428	17	43094411	1797697	1245723	rs2552222026	NC_000017.11:43094410:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jan 28, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1116del (p.Pro371_Trp372insTer)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003075802	17	41246432	17	43094415	3075802	3235091	rs2552222387	NC_000017.11:43094414:CC:C	Deletion	nonsense|intron variant	Pathogenic	Jun 19, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1116G>A (p.Trp372Ter)	BRCA1	W372*, W325*, W305*, W331*, W345*, W244*, W245*, W260*, W284*, W369*, W371*, W76*, W204*, W261*, W301*, W302*, W304*, W346*, W283*, W324*, W330*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054135	17	41246432	17	43094415	54135	68802	rs80357468	NC_000017.11:43094414:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1115G>A (p.Trp372Ter)	BRCA1	W372*, W325*, W204*, W245*, W284*, W302*, W304*, W301*, W346*, W371*, W261*, W283*, W305*, W324*, W331*, W369*, W244*, W260*, W330*, W345*, W76*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054134	17	41246433	17	43094416	54134	68801	rs397508838	NC_000017.11:43094415:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1112del (p.Pro371fs)	BRCA1	P371fs, P324fs, P244fs, P300fs, P301fs, P304fs, P344fs, P370fs, P203fs, P303fs, P329fs, P330fs, P368fs, P259fs, P260fs, P283fs, P323fs, P75fs, P243fs, P282fs, P345fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054133	17	41246436	17	43094419	54133	68800	rs397508837	NC_000017.11:43094418:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1110del (p.Pro371fs)	BRCA1	P324fs, P371fs, P243fs, P304fs, P370fs, P203fs, P260fs, P282fs, P300fs, P323fs, P329fs, P75fs, P259fs, P301fs, P345fs, P244fs, P283fs, P303fs, P330fs, P344fs, P368fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000439442	17	41246438	17	43094421	439442	433273	rs1555592474	NC_000017.11:43094420:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1104_1108dup (p.Val370fs)	BRCA1	V370fs, V323fs, V243fs, V299fs, V322fs, V344fs, V369fs, V258fs, V303fs, V367fs, V300fs, V302fs, V328fs, V343fs, V202fs, V242fs, V259fs, V281fs, V282fs, V329fs, V74fs	Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome	VCV001353501	17	41246439 - 41246440	17	43094422 - 43094423	1353501	1499500	rs2154475632	NC_000017.11:43094422:CATCT:CATCTCATCT	Duplication	frameshift variant|intron variant	Pathogenic	Jan 27, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1107_1108insCT (p.Val370fs)	BRCA1	V323fs, V370fs, V242fs, V259fs, V300fs, V243fs, V282fs, V329fs, V202fs, V281fs, V299fs, V303fs, V322fs, V328fs, V343fs, V344fs, V367fs, V74fs, V258fs, V302fs, V369fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548288	17	41246440 - 41246441	17	43094423 - 43094424	548288	538891	rs1555592487	NC_000017.11:43094423:A:AGA	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1105dup (p.Asp369fs)	BRCA1	D322fs, D369fs, D280fs, D327fs, D328fs, D241fs, D281fs, D299fs, D321fs, D342fs, D73fs, D201fs, D242fs, D257fs, D298fs, D301fs, D302fs, D368fs, D258fs, D343fs, D366fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254390	17	41246442 - 41246443	17	43094425 - 43094426	254390	249153	rs1555592498	NC_000017.11:43094425:C:CC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1105_1106insTC (p.Asp369fs)	BRCA1	D322fs, D369fs, D201fs, D298fs, D301fs, D321fs, D327fs, D343fs, D366fs, D281fs, D368fs, D73fs, D241fs, D257fs, D299fs, D328fs, D242fs, D258fs, D280fs, D302fs, D342fs	Hereditary cancer-predisposing syndrome	VCV000231841	17	41246442 - 41246443	17	43094425 - 43094426	231841	236144	rs876659396	NC_000017.11:43094425::GA	Insertion	intron variant|frameshift variant	Pathogenic	Jul 28, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1104del (p.Asp369fs)	BRCA1	D322fs, D369fs, D343fs, D73fs, D201fs, D242fs, D257fs, D281fs, D327fs, D366fs, D368fs, D280fs, D298fs, D301fs, D241fs, D299fs, D328fs, D342fs, D258fs, D302fs, D321fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266137	17	41246444	17	43094427	266137	261952	rs886039927	NC_000017.11:43094426:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1102_1103insC (p.Glu368fs)	BRCA1	E368fs, E321fs, E297fs, E320fs, E327fs, E257fs, E300fs, E342fs, E72fs, E240fs, E241fs, E280fs, E326fs, E367fs, E200fs, E256fs, E279fs, E298fs, E301fs, E341fs, E365fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548183	17	41246445 - 41246446	17	43094428 - 43094429	548183	538892	rs1555592500	NC_000017.11:43094428::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1101_1102insC (p.Glu368fs)	BRCA1	E321fs, E368fs, E367fs, E72fs, E240fs, E241fs, E256fs, E297fs, E300fs, E320fs, E365fs, E200fs, E280fs, E298fs, E301fs, E326fs, E341fs, E342fs, E257fs, E279fs, E327fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125486	17	41246446 - 41246447	17	43094429 - 43094430	125486	131024	rs80357665	NC_000017.11:43094429::G	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1102G>T (p.Glu368Ter)	BRCA1	E368*, E321*, E200*, E240*, E257*, E280*, E365*, E298*, E241*, E297*, E301*, E320*, E327*, E342*, E72*, E256*, E279*, E300*, E326*, E341*, E367*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054128	17	41246446	17	43094429	54128	68795	rs80357139	NC_000017.11:43094428:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1100dup (p.Thr367_Glu368insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054127	17	41246447 - 41246448	17	43094430 - 43094431	54127	68794	rs397508836	NC_000017.11:43094430:G:GG	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1100del (p.Thr367fs)	BRCA1	T320fs, T367fs, T256fs, T278fs, T296fs, T366fs, T239fs, T279fs, T297fs, T299fs, T300fs, T319fs, T326fs, T340fs, T71fs, T199fs, T240fs, T255fs, T325fs, T341fs, T364fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV001049239	17	41246448	17	43094431	1049239	1038579	rs2154476126	NC_000017.11:43094430:G:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 16, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1099dup (p.Thr367fs)	BRCA1	T320fs, T367fs, T319fs, T326fs, T71fs, T325fs, T364fs, T256fs, T278fs, T296fs, T240fs, T279fs, T297fs, T300fs, T366fs, T199fs, T239fs, T255fs, T299fs, T340fs, T341fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054126	17	41246448 - 41246449	17	43094431 - 43094432	54126	68793	rs397508835	NC_000017.11:43094431:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1099del (p.Thr367fs)	BRCA1	T320fs, T367fs, T255fs, T296fs, T340fs, T240fs, T256fs, T297fs, T71fs, T199fs, T278fs, T279fs, T325fs, T326fs, T341fs, T364fs, T239fs, T299fs, T300fs, T319fs, T366fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001073703	17	41246449	17	43094432	1073703	1064227	rs2154476235	NC_000017.11:43094431:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 22, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1095del (p.Asp366fs)	BRCA1	D319fs, D366fs, D198fs, D238fs, D299fs, D318fs, D70fs, D277fs, D324fs, D339fs, D340fs, D363fs, D365fs, D239fs, D254fs, D255fs, D296fs, D278fs, D295fs, D298fs, D325fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001069112	17	41246453	17	43094436	1069112	1064228	rs2154476432	NC_000017.11:43094435:T:	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	Apr 4, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1093A>T (p.Arg365Ter)	BRCA1	R365*, R318*, R237*, R238*, R277*, R317*, R362*, R197*, R276*, R295*, R297*, R298*, R323*, R324*, R364*, R69*, R253*, R254*, R338*, R294*, R339*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091540	17	41246455	17	43094438	91540	97017	rs398122627	NC_000017.11:43094437:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1091_1092del (p.Pro364fs)	BRCA1	P364fs, P317fs, P236fs, P293fs, P316fs, P322fs, P237fs, P323fs, P361fs, P68fs, P196fs, P294fs, P296fs, P337fs, P252fs, P253fs, P275fs, P276fs, P297fs, P338fs, P363fs	Hereditary breast ovarian cancer syndrome	VCV000462548	17	41246456 - 41246457	17	43094439 - 43094440	462548	468002	rs1555592526	NC_000017.11:43094438:AG:	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	May 15, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1082_1092del (p.Cys360_Ser361insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054122	17	41246456 - 41246466	17	43094439 - 43094449	54122	68789	rs80359880	NC_000017.11:43094438:AGGATTCTCTGAG:AG	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1091del (p.Pro364fs)	BRCA1	P364fs, P317fs, P253fs, P363fs, P237fs, P252fs, P293fs, P296fs, P316fs, P337fs, P196fs, P294fs, P297fs, P323fs, P68fs, P236fs, P275fs, P276fs, P322fs, P338fs, P361fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054125	17	41246457	17	43094440	54125	68792	rs397508834	NC_000017.11:43094439:GG:G	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1088del (p.Asn363fs)	BRCA1	N363fs, N316fs, N295fs, N360fs, N235fs, N252fs, N321fs, N322fs, N336fs, N362fs, N195fs, N274fs, N292fs, N293fs, N296fs, N337fs, N236fs, N251fs, N275fs, N315fs, N67fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054124	17	41246460	17	43094443	54124	68791	rs80357954	NC_000017.11:43094442:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1086_1087del (p.Asn363fs)	BRCA1	N316fs, N363fs, N195fs, N292fs, N296fs, N337fs, N251fs, N252fs, N275fs, N360fs, N236fs, N293fs, N295fs, N321fs, N235fs, N274fs, N315fs, N322fs, N336fs, N362fs, N67fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054123	17	41246461 - 41246462	17	43094444 - 43094445	54123	68790	rs80357897	NC_000017.11:43094443:TCTCT:TCT	Microsatellite	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1085dup (p.Asn363fs)	BRCA1	N316fs, N363fs, N293fs, N322fs, N360fs, N67fs, N195fs, N235fs, N236fs, N251fs, N362fs, N275fs, N321fs, N252fs, N274fs, N292fs, N295fs, N296fs, N315fs, N336fs, N337fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548321	17	41246462 - 41246463	17	43094445 - 43094446	548321	538893	rs1555592537	NC_000017.11:43094445:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1081_1082insA (p.Ser361fs)	BRCA1	S314fs, S361fs, S193fs, S233fs, S250fs, S273fs, S313fs, S293fs, S358fs, S360fs, S234fs, S290fs, S294fs, S319fs, S65fs, S249fs, S272fs, S291fs, S320fs, S334fs, S335fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548292	17	41246466 - 41246467	17	43094449 - 43094450	548292	538894	rs1555592544	NC_000017.11:43094449::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1082C>G (p.Ser361Ter)	BRCA1	S361*, S314*, S293*, S319*, S334*, S249*, S250*, S273*, S294*, S335*, S360*, S272*, S291*, S313*, S65*, S193*, S233*, S234*, S290*, S320*, S358*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054121	17	41246466	17	43094449	54121	68788	rs397508833	NC_000017.11:43094448:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1080C>A (p.Cys360Ter)	BRCA1	C360*, C313*, C192*, C232*, C233*, C333*, C249*, C312*, C318*, C357*, C359*, C64*, C248*, C271*, C290*, C319*, C272*, C289*, C292*, C293*, C334*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254389	17	41246468	17	43094451	254389	249154	rs886037986	NC_000017.11:43094450:G:T	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1068_1077del (p.Gln356fs)	BRCA1	Q309fs, Q356fs, Q188fs, Q229fs, Q244fs, Q245fs, Q314fs, Q267fs, Q329fs, Q353fs, Q228fs, Q268fs, Q285fs, Q286fs, Q60fs, Q288fs, Q289fs, Q308fs, Q315fs, Q330fs, Q355fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054116	17	41246471 - 41246480	17	43094454 - 43094463	54116	68783	rs397508830	NC_000017.11:43094453:TGGCAGTTTCTG:TG	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1071dup (p.Leu358fs)	BRCA1	L311fs, L358fs, L246fs, L270fs, L355fs, L62fs, L190fs, L269fs, L288fs, L316fs, L331fs, L332fs, L357fs, L230fs, L247fs, L287fs, L317fs, L231fs, L290fs, L291fs, L310fs	Hereditary breast ovarian cancer syndrome	VCV000937899	17	41246476 - 41246477	17	43094459 - 43094460	937899	937971	rs2053998620	NC_000017.11:43094459:TTT:TTTT	Duplication	frameshift variant|intron variant	Pathogenic	Oct 6, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1072del (p.Leu358fs)	BRCA1	L358fs, L311fs, L246fs, L290fs, L310fs, L331fs, L357fs, L190fs, L231fs, L247fs, L269fs, L332fs, L288fs, L62fs, L230fs, L270fs, L287fs, L291fs, L316fs, L317fs, L355fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054117	17	41246476	17	43094459	54117	68784	rs80357836	NC_000017.11:43094458:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1071del (p.Lys357fs)	BRCA1	K230fs, K269fs, K287fs, K290fs, K315fs, K189fs, K309fs, K310fs, K316fs, K330fs, K331fs, K245fs, K356fs, K357fs, K229fs, K246fs, K268fs, K286fs, K289fs, K354fs, K61fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002746628	17	41246477	17	43094460	2746628	2897503	rs2053998620	NC_000017.11:43094459:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1069A>T (p.Lys357Ter)	BRCA1	K310*, K357*, K189*, K230*, K286*, K287*, K309*, K268*, K61*, K245*, K246*, K289*, K315*, K330*, K354*, K229*, K269*, K290*, K316*, K331*, K356*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000848630	17	41246479	17	43094462	848630	845453	rs2053998767	NC_000017.11:43094461:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1067del (p.Gln356fs)	BRCA1	Q309fs, Q356fs, Q285fs, Q286fs, Q308fs, Q314fs, Q267fs, Q315fs, Q353fs, Q188fs, Q229fs, Q268fs, Q289fs, Q329fs, Q330fs, Q355fs, Q228fs, Q244fs, Q245fs, Q288fs, Q60fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054115	17	41246481	17	43094464	54115	68782	rs80357796	NC_000017.11:43094463:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1066delinsGATGGAATAAGG (p.Gln356fs)	BRCA1	Q309fs, Q356fs, Q244fs, Q268fs, Q288fs, Q314fs, Q315fs, Q330fs, Q353fs, Q229fs, Q285fs, Q355fs, Q286fs, Q289fs, Q329fs, Q60fs, Q188fs, Q228fs, Q245fs, Q267fs, Q308fs	Hereditary cancer-predisposing syndrome	VCV001781934	17	41246482	17	43094465	1781934	1835330	rs2552224279	NC_000017.11:43094464:G:CCTTATTCCATC	Indel	frameshift variant|intron variant	Pathogenic	Jul 11, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1066C>T (p.Gln356Ter)	BRCA1	Q356*, Q309*, Q285*, Q289*, Q330*, Q188*, Q267*, Q288*, Q315*, Q329*, Q228*, Q229*, Q245*, Q268*, Q314*, Q60*, Q244*, Q286*, Q308*, Q353*, Q355*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054114	17	41246482	17	43094465	54114	68781	rs80357215	NC_000017.11:43094464:G:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1065del (p.Lys355fs)	BRCA1	K187fs, K227fs, K228fs, K243fs, K244fs, K266fs, K267fs, K284fs, K285fs, K287fs, K288fs, K307fs, K308fs, K313fs, K314fs, K328fs, K329fs, K352fs, K354fs, K355fs, K59fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV002674341	17	41246483	17	43094466	2674341	2841827	rs2552224311	NC_000017.11:43094465:C:	Deletion	intron variant|frameshift variant	Pathogenic	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1064del (p.Lys355fs)	BRCA1	K187fs, K227fs, K228fs, K243fs, K244fs, K266fs, K267fs, K284fs, K285fs, K287fs, K288fs, K307fs, K308fs, K313fs, K314fs, K328fs, K329fs, K352fs, K354fs, K355fs, K59fs	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV002674276	17	41246484	17	43094467	2674276	2841764	rs2552224333	NC_000017.11:43094466:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1063A>T (p.Lys355Ter)	BRCA1	K355*, K308*, K243*, K244*, K285*, K288*, K307*, K328*, K354*, K187*, K227*, K266*, K267*, K284*, K287*, K329*, K352*, K228*, K313*, K314*, K59*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054111	17	41246485	17	43094468	54111	68778	rs397508829	NC_000017.11:43094467:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1058_1062del (p.Glu352_Trp353insTer)	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000531224	17	41246486 - 41246490	17	43094469 - 43094473	531224	531325	rs1555592576	NC_000017.11:43094468:ATTCCATTC:ATTC	Deletion	nonsense|frameshift variant|intron variant	Pathogenic	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1059del (p.Glu352_Trp353insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003068404	17	41246489	17	43094472	3068404	3227738	rs2552224377	NC_000017.11:43094471:CC:C	Deletion	intron variant|nonsense	Pathogenic	Mar 9, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1059G>A (p.Trp353Ter)	BRCA1	W353*, W306*, W242*, W283*, W305*, W311*, W312*, W326*, W350*, W225*, W226*, W241*, W282*, W185*, W264*, W327*, W265*, W285*, W286*, W352*, W57*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054110	17	41246489	17	43094472	54110	68777	rs80356935	NC_000017.11:43094471:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1058G>A (p.Trp353Ter)	BRCA1	W353*, W306*, W226*, W242*, W264*, W265*, W282*, W305*, W312*, W283*, W350*, W185*, W326*, W327*, W352*, W57*, W225*, W241*, W285*, W286*, W311*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054109	17	41246490	17	43094473	54109	68776	rs80356908	NC_000017.11:43094472:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1054del (p.Glu352fs)	BRCA1	E352fs, E305fs, E184fs, E240fs, E264fs, E282fs, E284fs, E325fs, E326fs, E349fs, E351fs, E304fs, E225fs, E241fs, E285fs, E310fs, E224fs, E263fs, E281fs, E311fs, E56fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266136	17	41246494	17	43094477	266136	261953	rs886039926	NC_000017.11:43094476:C:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1054G>T (p.Glu352Ter)	BRCA1	E352*, E305*, E184*, E263*, E264*, E304*, E325*, E56*, E225*, E241*, E311*, E351*, E240*, E310*, E326*, E349*, E224*, E281*, E282*, E284*, E285*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054108	17	41246494	17	43094477	54108	68775	rs80357472	NC_000017.11:43094476:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1049_1050del (p.Arg350fs)	BRCA1	R350fs, R303fs, R222fs, R238fs, R261fs, R302fs, R309fs, R262fs, R283fs, R308fs, R323fs, R324fs, R54fs, R223fs, R279fs, R280fs, R282fs, R349fs, R182fs, R239fs, R347fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266135	17	41246498 - 41246499	17	43094481 - 43094482	266135	261954	rs886039925	NC_000017.11:43094480:TCTCTC:TCTC	Microsatellite	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1044_1047del (p.Leu347_Cys348insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266134	17	41246501 - 41246504	17	43094484 - 43094487	266134	261955	rs886039924	NC_000017.11:43094483:CTCAC:C	Deletion	nonsense|frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1044_1045dup (p.Glu349fs)	BRCA1	E302fs, E349fs, E221fs, E222fs, E238fs, E282fs, E322fs, E181fs, E260fs, E261fs, E278fs, E301fs, E307fs, E323fs, E279fs, E281fs, E346fs, E237fs, E308fs, E348fs, E53fs	Hereditary breast ovarian cancer syndrome	VCV001456441	17	41246502 - 41246503	17	43094485 - 43094486	1456441	1458380	rs1555592601	NC_000017.11:43094485:CACACA:CACACACA	Microsatellite	frameshift variant|intron variant	Pathogenic	Feb 25, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1045_1046insTCAC (p.Glu349fs)	BRCA1	E349fs, E302fs, E279fs, E307fs, E322fs, E346fs, E53fs, E181fs, E221fs, E237fs, E260fs, E282fs, E308fs, E348fs, E222fs, E238fs, E261fs, E278fs, E281fs, E301fs, E323fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548267	17	41246502 - 41246503	17	43094485 - 43094486	548267	538895	rs1555592590	NC_000017.11:43094485::GTGA	Insertion	intron variant|frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1044_1045del (p.Cys348_Glu349delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548315	17	41246503 - 41246504	17	43094486 - 43094487	548315	538896	rs1555592601	NC_000017.11:43094485:CACACA:CACA	Microsatellite	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1044_1045insTCAC (p.Glu349fs)	BRCA1	E302fs, E349fs, E221fs, E261fs, E308fs, E348fs, E181fs, E279fs, E281fs, E322fs, E346fs, E237fs, E260fs, E301fs, E307fs, E323fs, E222fs, E238fs, E278fs, E282fs, E53fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266133	17	41246503 - 41246504	17	43094486 - 43094487	266133	261956	rs886039923	NC_000017.11:43094486::GTGA	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1045G>T (p.Glu349Ter)	BRCA1	E349*, E302*, E323*, E346*, E261*, E281*, E301*, E181*, E222*, E237*, E278*, E279*, E308*, E307*, E348*, E53*, E238*, E322*, E221*, E260*, E282*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054107	17	41246503	17	43094486	54107	68774	rs80357338	NC_000017.11:43094485:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1044T>A (p.Cys348Ter)	BRCA1	C348*, C301*, C259*, C280*, C321*, C347*, C237*, C260*, C300*, C307*, C345*, C180*, C220*, C221*, C277*, C278*, C306*, C236*, C281*, C322*, C52*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254388	17	41246504	17	43094487	254388	249155	rs886037985	NC_000017.11:43094486:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1041del (p.Cys348fs)	BRCA1	C301fs, C348fs, C277fs, C278fs, C345fs, C52fs, C220fs, C307fs, C237fs, C259fs, C260fs, C306fs, C321fs, C322fs, C347fs, C180fs, C221fs, C236fs, C280fs, C281fs, C300fs	Hereditary cancer-predisposing syndrome	VCV000818303	17	41246507	17	43094490	818303	813870	rs1597878453	NC_000017.11:43094489:C:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 26, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1040del (p.Leu347fs)	BRCA1	L347fs, L300fs, L179fs, L219fs, L220fs, L235fs, L236fs, L258fs, L299fs, L321fs, L276fs, L277fs, L279fs, L346fs, L51fs, L305fs, L306fs, L320fs, L259fs, L280fs, L344fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054106	17	41246508	17	43094491	54106	68773	rs397508828	NC_000017.11:43094490:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1039_1040del (p.Leu347fs)	BRCA1	L300fs, L347fs, L258fs, L276fs, L277fs, L279fs, L220fs, L235fs, L236fs, L321fs, L179fs, L219fs, L280fs, L320fs, L346fs, L259fs, L299fs, L305fs, L306fs, L344fs, L51fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054105	17	41246508 - 41246509	17	43094491 - 43094492	54105	68772	rs397508827	NC_000017.11:43094490:AG:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1039del (p.Leu347fs)	BRCA1	L347fs, L300fs, L258fs, L259fs, L305fs, L321fs, L344fs, L235fs, L236fs, L277fs, L279fs, L346fs, L219fs, L276fs, L280fs, L299fs, L51fs, L179fs, L220fs, L306fs, L320fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254387	17	41246509	17	43094492	254387	249156	rs749508254	NC_000017.11:43094491:GGGG:GGG	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1031del (p.Ala344fs)	BRCA1	A297fs, A344fs, A176fs, A233fs, A273fs, A274fs, A303fs, A343fs, A255fs, A296fs, A302fs, A317fs, A318fs, A48fs, A217fs, A256fs, A277fs, A216fs, A232fs, A276fs, A341fs	Hereditary breast ovarian cancer syndrome	VCV000958386	17	41246517	17	43094500	958386	949958	rs2054005225	NC_000017.11:43094499:G:	Deletion	frameshift variant|intron variant	Pathogenic	Jul 23, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1018_1019insA (p.Val340fs)	BRCA1	V340fs, V293fs, V273fs, V292fs, V298fs, V313fs, V212fs, V228fs, V229fs, V270fs, V272fs, V299fs, V314fs, V337fs, V172fs, V213fs, V251fs, V44fs, V252fs, V269fs, V339fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548294	17	41246529 - 41246530	17	43094512 - 43094513	548294	538897	rs1555592640	NC_000017.11:43094512::T	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1018dup (p.Val340fs)	BRCA1	V340fs, V293fs, V213fs, V228fs, V229fs, V252fs, V298fs, V313fs, V269fs, V270fs, V273fs, V339fs, V44fs, V172fs, V212fs, V251fs, V292fs, V299fs, V314fs, V337fs, V272fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254386	17	41246529 - 41246530	17	43094512 - 43094513	254386	249157	rs80357774	NC_000017.11:43094512:CC:CCC	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1017_1018insC (p.Val340fs)	BRCA1	V293fs, V340fs, V292fs, V298fs, V313fs, V229fs, V251fs, V272fs, V299fs, V314fs, V339fs, V212fs, V270fs, V273fs, V172fs, V213fs, V228fs, V252fs, V269fs, V337fs, V44fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548176	17	41246530 - 41246531	17	43094513 - 43094514	548176	538898	rs886039921	NC_000017.11:43094513::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1017_1018insA (p.Val340fs)	BRCA1	V293fs, V340fs, V251fs, V212fs, V228fs, V272fs, V298fs, V172fs, V213fs, V252fs, V269fs, V299fs, V313fs, V314fs, V339fs, V44fs, V229fs, V270fs, V273fs, V292fs, V337fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266131	17	41246530 - 41246531	17	43094513 - 43094514	266131	261957	rs886039921	NC_000017.11:43094513::T	Insertion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1018del (p.Lys339_Val340insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037387	17	41246530	17	43094513	37387	45943	rs80357774	NC_000017.11:43094512:CC:C	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1016_1017insC (p.Lys339fs)	BRCA1	K339fs, K292fs, K251fs, K268fs, K269fs, K312fs, K212fs, K272fs, K291fs, K211fs, K298fs, K336fs, K338fs, K171fs, K227fs, K228fs, K250fs, K271fs, K297fs, K313fs, K43fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266130	17	41246531 - 41246532	17	43094514 - 43094515	266130	261958	rs1555592653	NC_000017.11:43094514::G	Insertion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1016dup (p.Val340fs)	BRCA1	V340fs, V293fs, V213fs, V228fs, V292fs, V299fs, V44fs, V172fs, V269fs, V270fs, V272fs, V273fs, V298fs, V313fs, V314fs, V229fs, V251fs, V212fs, V252fs, V337fs, V339fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054102	17	41246531 - 41246532	17	43094514 - 43094515	54102	68769	rs80357569	NC_000017.11:43094514:TTTTTTT:TTTTTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1016del (p.Lys339fs)	BRCA1	K292fs, K339fs, K211fs, K251fs, K272fs, K297fs, K312fs, K336fs, K228fs, K250fs, K269fs, K291fs, K43fs, K212fs, K268fs, K271fs, K298fs, K313fs, K171fs, K227fs, K338fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037386	17	41246532	17	43094515	37386	45942	rs80357569	NC_000017.11:43094514:TTTTTTT:TTTTTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.952_1015del (p.His318fs)	BRCA1	H318fs, H271fs, H22fs, H248fs, H250fs, H270fs, H317fs, H190fs, H191fs, H207fs, H292fs, H315fs, H150fs, H229fs, H230fs, H247fs, H276fs, H206fs, H251fs, H277fs, H291fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037710	17	41246533 - 41246596	17	43094516 - 43094579	37710	46266	rs80359872		Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1012A>T (p.Lys338Ter)	BRCA1	K338*, K291*, K210*, K227*, K250*, K297*, K312*, K335*, K211*, K271*, K296*, K42*, K170*, K249*, K311*, K226*, K267*, K268*, K270*, K290*, K337*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054101	17	41246536	17	43094519	54101	68768	rs397508826	NC_000017.11:43094518:T:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1009dup (p.Glu337fs)	BRCA1	E290fs, E337fs, E169fs, E249fs, E266fs, E269fs, E289fs, E41fs, E248fs, E267fs, E270fs, E295fs, E296fs, E310fs, E311fs, E209fs, E210fs, E226fs, E334fs, E336fs, E225fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV001794679	17	41246538 - 41246539	17	43094521 - 43094522	1794679	1852424	rs2552225185	NC_000017.11:43094521:C:CC	Duplication	intron variant|frameshift variant	Pathogenic	Mar 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1009_1010del (p.Glu337fs)	BRCA1	E290fs, E337fs, E296fs, E336fs, E41fs, E225fs, E289fs, E295fs, E310fs, E169fs, E209fs, E226fs, E248fs, E266fs, E311fs, E210fs, E249fs, E267fs, E269fs, E270fs, E334fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000545868	17	41246538 - 41246539	17	43094521 - 43094522	545868	536498	rs1555592671	NC_000017.11:43094520:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic/Likely pathogenic	May 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.998_1010del (p.Thr333fs)	BRCA1	T333fs, T286fs, T262fs, T266fs, T307fs, T332fs, T263fs, T265fs, T306fs, T221fs, T244fs, T245fs, T292fs, T330fs, T165fs, T205fs, T206fs, T222fs, T285fs, T291fs, T37fs	Hereditary cancer-predisposing syndrome	VCV000482945	17	41246538 - 41246550	17	43094521 - 43094533	482945	478709	rs1555592676	NC_000017.11:43094520:TCTGTGCTGGGAGTC:TC	Deletion	frameshift variant|intron variant	Pathogenic	Apr 27, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1009G>T (p.Glu337Ter)	BRCA1	E290*, E337*, E209*, E267*, E289*, E334*, E169*, E210*, E225*, E226*, E248*, E249*, E270*, E295*, E311*, E269*, E296*, E266*, E310*, E336*, E41*	Hereditary breast ovarian cancer syndrome	VCV001074684	17	41246539	17	43094522	1074684	1064229	rs2054008789	NC_000017.11:43094521:C:A	single nucleotide variant	intron variant|nonsense	Pathogenic	Apr 5, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1008dup (p.Glu337fs)	BRCA1	E337fs, E290fs, E226fs, E266fs, E267fs, E269fs, E336fs, E169fs, E295fs, E296fs, E209fs, E210fs, E249fs, E311fs, E334fs, E41fs, E225fs, E248fs, E270fs, E289fs, E310fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054100	17	41246539 - 41246540	17	43094522 - 43094523	54100	68767	rs67284603	NC_000017.11:43094522:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1008del (p.Glu337fs)	BRCA1	E290fs, E337fs, E169fs, E209fs, E225fs, E249fs, E311fs, E41fs, E210fs, E226fs, E267fs, E289fs, E296fs, E310fs, E334fs, E248fs, E266fs, E269fs, E270fs, E295fs, E336fs	Hereditary breast ovarian cancer syndrome	VCV001430439	17	41246540	17	43094523	1430439	1245718	rs2154480403	NC_000017.11:43094522:T:	Deletion	frameshift variant|intron variant	Pathogenic	Jan 11, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.944_1007del (p.Arg315fs)	BRCA1	R268fs, R315fs, R245fs, R247fs, R267fs, R188fs, R19fs, R203fs, R226fs, R273fs, R274fs, R147fs, R248fs, R187fs, R204fs, R227fs, R244fs, R288fs, R289fs, R312fs, R314fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266594	17	41246541 - 41246604	17	43094524 - 43094587	266594	261959	rs1555592683		Deletion	intron variant|frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.1003del (p.Ser335fs)	BRCA1	S288fs, S335fs, S207fs, S247fs, S264fs, S287fs, S294fs, S334fs, S167fs, S224fs, S293fs, S308fs, S223fs, S246fs, S265fs, S332fs, S208fs, S267fs, S268fs, S309fs, S39fs	Hereditary breast ovarian cancer syndrome	VCV001452362	17	41246545	17	43094528	1452362	1364083	rs2154480585	NC_000017.11:43094527:T:	Deletion	frameshift variant|intron variant	Pathogenic	Jun 23, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1002del (p.Ser335fs)	BRCA1	S335fs, S288fs, S208fs, S247fs, S264fs, S267fs, S287fs, S332fs, S39fs, S207fs, S268fs, S293fs, S334fs, S223fs, S308fs, S309fs, S167fs, S224fs, S246fs, S265fs, S294fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230126	17	41246546	17	43094529	230126	236151	rs876658404	NC_000017.11:43094528:GGG:GG	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.983_990dup (p.Arg331fs)	BRCA1	R284fs, R331fs, R203fs, R242fs, R264fs, R290fs, R163fs, R219fs, R260fs, R289fs, R304fs, R330fs, R243fs, R261fs, R283fs, R305fs, R35fs, R204fs, R220fs, R263fs, R328fs	Hereditary cancer-predisposing syndrome	VCV000923161	17	41246557 - 41246558	17	43094540 - 43094541	923161	913967	rs2054011546	NC_000017.11:43094540:ATCATTACAT:ATCATTACATCATTACAT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 9, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.984_988del (p.Cys328_Asp330delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188407	17	41246560 - 41246564	17	43094543 - 43094547	188407	186548	rs786204262	NC_000017.11:43094542:CATTACAT:CAT	Deletion	frameshift variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.985_986insC (p.Asn329fs)	BRCA1	N282fs, N329fs, N161fs, N201fs, N217fs, N240fs, N261fs, N302fs, N33fs, N202fs, N262fs, N287fs, N328fs, N218fs, N241fs, N259fs, N281fs, N258fs, N288fs, N303fs, N326fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548220	17	41246562 - 41246563	17	43094545 - 43094546	548220	538899	rs1555592723	NC_000017.11:43094545::G	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.985_986del (p.Cys328_Asn329insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055773	17	41246562 - 41246563	17	43094545 - 43094546	55773	70440	rs397509341	NC_000017.11:43094544:TT:	Deletion	nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.984_985insC (p.Asn329fs)	BRCA1	N282fs, N329fs, N161fs, N240fs, N241fs, N287fs, N326fs, N201fs, N302fs, N202fs, N217fs, N218fs, N258fs, N261fs, N262fs, N328fs, N259fs, N281fs, N288fs, N303fs, N33fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125481	17	41246563 - 41246564	17	43094546 - 43094547	125481	131019	rs80357775	NC_000017.11:43094546::G	Insertion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.982del (p.Cys328fs)	BRCA1	C281fs, C328fs, C261fs, C287fs, C325fs, C216fs, C257fs, C260fs, C286fs, C301fs, C302fs, C160fs, C239fs, C240fs, C258fs, C32fs, C200fs, C201fs, C217fs, C280fs, C327fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV002110661	17	41246566	17	43094549	2110661	2171125	rs2552225801	NC_000017.11:43094548:A:	Deletion	intron variant|frameshift variant	Pathogenic	May 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.981_982del (p.Thr327_Cys328insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055772	17	41246566 - 41246567	17	43094549 - 43094550	55772	70439	rs80357772	NC_000017.11:43094548:AT:	Deletion	intron variant|frameshift variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.959_981del (p.Arg320fs)	BRCA1	R273fs, R320fs, R193fs, R252fs, R272fs, R279fs, R293fs, R192fs, R209fs, R231fs, R249fs, R278fs, R294fs, R317fs, R152fs, R208fs, R232fs, R24fs, R250fs, R253fs, R319fs	Hereditary breast ovarian cancer syndrome	VCV001075200	17	41246567 - 41246589	17	43094550 - 43094572	1075200	1064230	rs2154481407	NC_000017.11:43094549:TGTTTCCTTACTTCCAGCCCATCTGTT:TGTT	Deletion	frameshift variant|intron variant	Pathogenic	Sep 18, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.980_981del (p.Thr327fs)	BRCA1	T327fs, T280fs, T216fs, T239fs, T260fs, T285fs, T31fs, T159fs, T199fs, T215fs, T238fs, T286fs, T324fs, T326fs, T200fs, T256fs, T257fs, T301fs, T259fs, T279fs, T300fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055770	17	41246567 - 41246568	17	43094550 - 43094551	55770	70437	rs80357610	NC_000017.11:43094549:TGT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.979del (p.Thr327fs)	BRCA1	T280fs, T327fs, T159fs, T199fs, T216fs, T260fs, T215fs, T300fs, T324fs, T326fs, T238fs, T256fs, T259fs, T285fs, T301fs, T200fs, T239fs, T257fs, T279fs, T286fs, T31fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266599	17	41246569	17	43094552	266599	261960	rs886040337	NC_000017.11:43094551:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-1235_976del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373836	17	41246572 - 41253132	17	43094555 - 43101115	373836	360735			Deletion	splice acceptor variant|splice donor variant|initiator_codon_variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.971del (p.Ser324fs)	BRCA1	S324fs, S277fs, S156fs, S254fs, S28fs, S298fs, S196fs, S256fs, S282fs, S197fs, S212fs, S235fs, S253fs, S276fs, S321fs, S323fs, S213fs, S236fs, S257fs, S283fs, S297fs	Hereditary breast ovarian cancer syndrome	VCV000946287	17	41246577	17	43094560	946287	928323	rs2054014288	NC_000017.11:43094559:C:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.964_968del (p.Ala322fs)	BRCA1	A275fs, A322fs, A233fs, A234fs, A255fs, A274fs, A280fs, A295fs, A194fs, A195fs, A251fs, A26fs, A296fs, A252fs, A319fs, A321fs, A154fs, A210fs, A211fs, A254fs, A281fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000438947	17	41246580 - 41246584	17	43094563 - 43094567	438947	432920	rs1555592744	NC_000017.11:43094562:CCAGCCCA:CCA	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.966del (p.Gly323fs)	BRCA1	G276fs, G323fs, G235fs, G256fs, G281fs, G211fs, G234fs, G252fs, G253fs, G275fs, G27fs, G282fs, G155fs, G196fs, G212fs, G255fs, G320fs, G195fs, G296fs, G297fs, G322fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266598	17	41246582	17	43094565	266598	261961	rs886040336	NC_000017.11:43094564:A:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.964del (p.Ala322fs)	BRCA1	A275fs, A322fs, A154fs, A194fs, A211fs, A233fs, A234fs, A251fs, A255fs, A321fs, A252fs, A26fs, A274fs, A280fs, A195fs, A210fs, A281fs, A319fs, A254fs, A295fs, A296fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055768	17	41246584	17	43094567	55768	70435	rs273903794	NC_000017.11:43094566:CCC:CC	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.963G>A (p.Trp321Ter)	BRCA1	W321*, W274*, W210*, W251*, W253*, W194*, W232*, W279*, W280*, W153*, W25*, W294*, W295*, W320*, W193*, W209*, W233*, W250*, W254*, W273*, W318*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266597	17	41246585	17	43094568	266597	261962	rs886040335	NC_000017.11:43094567:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.962G>A (p.Trp321Ter)	BRCA1	W321*, W274*, W209*, W210*, W232*, W233*, W254*, W279*, W320*, W194*, W250*, W253*, W280*, W295*, W153*, W193*, W25*, W251*, W294*, W273*, W318*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037712	17	41246586	17	43094569	37712	46268	rs80357292	NC_000017.11:43094568:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.961del (p.Trp321fs)	BRCA1	W321fs, W274fs, W194fs, W193fs, W25fs, W273fs, W153fs, W232fs, W251fs, W253fs, W279fs, W280fs, W209fs, W233fs, W320fs, W210fs, W250fs, W254fs, W294fs, W295fs, W318fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055765	17	41246587	17	43094570	55765	70432	rs397509340	NC_000017.11:43094569:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.959_960del (p.Arg320fs)	BRCA1	R320fs, R273fs, R24fs, R250fs, R279fs, R152fs, R208fs, R232fs, R317fs, R192fs, R193fs, R249fs, R272fs, R293fs, R294fs, R209fs, R231fs, R252fs, R253fs, R278fs, R319fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055764	17	41246588 - 41246589	17	43094571 - 43094572	55764	70431	rs397509339	NC_000017.11:43094570:TCT:T	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.958A>T (p.Arg320Ter)	BRCA1	R273*, R320*, R193*, R231*, R253*, R272*, R294*, R319*, R208*, R209*, R232*, R252*, R317*, R152*, R192*, R24*, R250*, R278*, R249*, R279*, R293*	not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803418	17	41246590	17	43094573	803418	791772	rs1131692065	NC_000017.11:43094572:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Feb 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.958del (p.Arg320fs)	BRCA1	R320fs, R273fs, R231fs, R250fs, R279fs, R293fs, R317fs, R192fs, R208fs, R209fs, R232fs, R249fs, R272fs, R319fs, R152fs, R193fs, R252fs, R278fs, R24fs, R253fs, R294fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266596	17	41246590	17	43094573	266596	261963	rs886040334	NC_000017.11:43094572:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.955_956insGT (p.Asn319fs)	BRCA1	N272fs, N319fs, N252fs, N292fs, N192fs, N207fs, N208fs, N230fs, N231fs, N277fs, N316fs, N191fs, N248fs, N249fs, N251fs, N293fs, N318fs, N151fs, N23fs, N271fs, N278fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548317	17	41246592 - 41246593	17	43094575 - 43094576	548317	538900	rs1555592770	NC_000017.11:43094575::AC	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.954dup (p.Asn319Ter)	BRCA1	N272*, N319*, N249*, N252*, N293*, N318*, N230*, N231*, N251*, N277*, N191*, N192*, N271*, N292*, N316*, N151*, N207*, N208*, N23*, N248*, N278*	Hereditary breast ovarian cancer syndrome	VCV001399584	17	41246593 - 41246594	17	43094576 - 43094577	1399584	1245914	rs80357690	NC_000017.11:43094576:A:AA	Duplication	nonsense|intron variant	Pathogenic	Apr 22, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.954_955insTT (p.Asn319fs)	BRCA1	N319fs, N272fs, N191fs, N192fs, N248fs, N251fs, N293fs, N318fs, N151fs, N207fs, N231fs, N252fs, N271fs, N277fs, N230fs, N249fs, N292fs, N316fs, N208fs, N23fs, N278fs	Hereditary breast ovarian cancer syndrome	VCV000855921	17	41246593 - 41246594	17	43094576 - 43094577	855921	845455	rs80357690	NC_000017.11:43094576:A:AAA	Insertion	frameshift variant|intron variant	Pathogenic	Apr 7, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.954_955insGT (p.Asn319fs)	BRCA1	N319fs, N272fs, N192fs, N231fs, N248fs, N251fs, N292fs, N293fs, N316fs, N318fs, N151fs, N191fs, N23fs, N252fs, N271fs, N277fs, N207fs, N208fs, N230fs, N249fs, N278fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254385	17	41246593 - 41246594	17	43094576 - 43094577	254385	249158	rs80357690	NC_000017.11:43094576:A:ACA	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.954del (p.His318fs)	BRCA1	H271fs, H318fs, H191fs, H229fs, H251fs, H270fs, H291fs, H206fs, H22fs, H230fs, H190fs, H207fs, H276fs, H315fs, H317fs, H150fs, H247fs, H248fs, H250fs, H277fs, H292fs	Hereditary breast ovarian cancer syndrome	VCV000567541	17	41246594	17	43094577	567541	571205	rs1567801398	NC_000017.11:43094576:A:	Deletion	frameshift variant|intron variant	Pathogenic	May 15, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.953delinsTGT (p.His318fs)	BRCA1	H318fs, H271fs, H190fs, H191fs, H206fs, H229fs, H292fs, H150fs, H247fs, H277fs, H315fs, H22fs, H230fs, H248fs, H251fs, H276fs, H291fs, H317fs, H207fs, H250fs, H270fs	Hereditary breast ovarian cancer syndrome	VCV000970429	17	41246595	17	43094578	970429	958138	rs2054018121	NC_000017.11:43094577:T:ACA	Indel	frameshift variant|intron variant	Pathogenic	Apr 14, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.953del (p.His318fs)	BRCA1	H271fs, H318fs, H229fs, H247fs, H276fs, H150fs, H191fs, H207fs, H230fs, H248fs, H250fs, H251fs, H317fs, H206fs, H270fs, H190fs, H22fs, H315fs, H277fs, H291fs, H292fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266595	17	41246595	17	43094578	266595	261964	rs886040333	NC_000017.11:43094577:T:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.949_953del (p.Ser316_Gln317insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055763	17	41246595 - 41246599	17	43094578 - 43094582	55763	70430	rs80357555	NC_000017.11:43094577:TGTTG:	Deletion	intron variant|nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.951del (p.Gln317fs)	BRCA1	Q270fs, Q317fs, Q189fs, Q190fs, Q205fs, Q21fs, Q249fs, Q290fs, Q291fs, Q316fs, Q228fs, Q275fs, Q276fs, Q314fs, Q246fs, Q250fs, Q149fs, Q206fs, Q229fs, Q247fs, Q269fs	Hereditary cancer-predisposing syndrome	VCV000480990	17	41246597	17	43094580	480990	479470	rs1555592776	NC_000017.11:43094579:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Apr 7, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.949C>T (p.Gln317Ter)	BRCA1	Q317*, Q270*, Q21*, Q228*, Q250*, Q275*, Q205*, Q247*, Q276*, Q290*, Q190*, Q206*, Q249*, Q269*, Q291*, Q314*, Q316*, Q149*, Q189*, Q229*, Q246*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055762	17	41246599	17	43094582	55762	70429	rs80357211	NC_000017.11:43094581:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.945del (p.Ser316fs)	BRCA1	S189fs, S228fs, S275fs, S188fs, S20fs, S248fs, S269fs, S274fs, S204fs, S205fs, S227fs, S246fs, S268fs, S289fs, S313fs, S316fs, S148fs, S245fs, S249fs, S290fs, S315fs	Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast	VCV003893008	17	41246603	17	43094586	3893008	4008892		NC_000017.11:43094585:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Nov 25, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.943del (p.Arg315fs)	BRCA1	R203fs, R244fs, R247fs, R267fs, R312fs, R188fs, R204fs, R248fs, R268fs, R289fs, R315fs, R227fs, R245fs, R288fs, R314fs, R147fs, R187fs, R19fs, R226fs, R273fs, R274fs	Hereditary cancer-predisposing syndrome	VCV003481862	17	41246605	17	43094588	3481862	3640073		NC_000017.11:43094587:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Oct 2, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.939delinsTTTGCTGGCTTTTTGCTGTTATGTTG (p.Leu313fs)	BRCA1	L287fs, L224fs, L243fs, L246fs, L272fs, L286fs, L312fs, L185fs, L271fs, L310fs, L313fs, L17fs, L201fs, L242fs, L265fs, L266fs, L145fs, L186fs, L202fs, L225fs, L245fs	Hereditary cancer-predisposing syndrome	VCV003992632	17	41246609	17	43094592	3992632	4104883		NC_000017.11:43094591:T:CAACATAACAGCAAAAAGCCAGCAAA	Indel	frameshift variant|intron variant	Pathogenic	May 29, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.934_937dup (p.Leu313fs)	BRCA1	L201fs, L186fs, L242fs, L271fs, L272fs, L312fs, L225fs, L245fs, L265fs, L287fs, L313fs, L145fs, L185fs, L224fs, L246fs, L310fs, L17fs, L202fs, L243fs, L266fs, L286fs	Hereditary breast ovarian cancer syndrome	VCV002855452	17	41246610 - 41246611	17	43094593 - 43094594	2855452	3013960	rs2552226620	NC_000017.11:43094593:AGCCAG:AGCCAGCCAG	Duplication	frameshift variant|intron variant	Pathogenic	Apr 23, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.936del (p.Gly312_Leu313insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091669	17	41246612	17	43094595	91669	97146	rs398122709	NC_000017.11:43094594:G:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.931_934dup (p.Gly312fs)	BRCA1	G265fs, G312fs, G185fs, G244fs, G270fs, G271fs, G144fs, G184fs, G223fs, G242fs, G16fs, G201fs, G224fs, G245fs, G285fs, G200fs, G241fs, G264fs, G286fs, G309fs, G311fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000654213	17	41246613 - 41246614	17	43094596 - 43094597	654213	646042	rs1597879048	NC_000017.11:43094596:CAGGC:CAGGCAGGC	Duplication	frameshift variant|intron variant	Pathogenic	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.933del (p.Gly312fs)	BRCA1	G265fs, G312fs, G244fs, G285fs, G311fs, G16fs, G185fs, G242fs, G270fs, G200fs, G201fs, G224fs, G241fs, G245fs, G271fs, G286fs, G144fs, G184fs, G223fs, G264fs, G309fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431204	17	41246615	17	43094598	431204	424858	rs1135401839	NC_000017.11:43094597:A:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.930del (p.Gln310fs)	BRCA1	Q263fs, Q310fs, Q142fs, Q182fs, Q239fs, Q268fs, Q283fs, Q183fs, Q198fs, Q199fs, Q242fs, Q269fs, Q307fs, Q221fs, Q222fs, Q262fs, Q284fs, Q14fs, Q240fs, Q243fs, Q309fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055759	17	41246618	17	43094601	55759	70426	rs80357689	NC_000017.11:43094600:C:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.929del (p.Gln310fs)	BRCA1	Q263fs, Q310fs, Q182fs, Q199fs, Q242fs, Q268fs, Q198fs, Q243fs, Q307fs, Q14fs, Q183fs, Q222fs, Q239fs, Q262fs, Q283fs, Q284fs, Q142fs, Q221fs, Q240fs, Q269fs, Q309fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037708	17	41246619	17	43094602	37708	46264	rs80357844	NC_000017.11:43094601:T:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.928C>T (p.Gln310Ter)	BRCA1	Q310*, Q263*, Q198*, Q221*, Q222*, Q14*, Q183*, Q268*, Q283*, Q142*, Q182*, Q239*, Q242*, Q243*, Q262*, Q284*, Q199*, Q240*, Q269*, Q307*, Q309*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055758	17	41246620	17	43094603	55758	70425	rs397509338	NC_000017.11:43094602:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.927del (p.Lys309fs)	BRCA1	K262fs, K309fs, K13fs, K197fs, K239fs, K267fs, K268fs, K220fs, K221fs, K238fs, K242fs, K181fs, K182fs, K198fs, K241fs, K261fs, K306fs, K308fs, K141fs, K282fs, K283fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055757	17	41246621	17	43094604	55757	70424	rs397509337	NC_000017.11:43094603:TTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.925A>T (p.Lys309Ter)	BRCA1	K309*, K262*, K13*, K261*, K267*, K282*, K306*, K220*, K239*, K242*, K181*, K182*, K198*, K221*, K268*, K308*, K141*, K197*, K238*, K241*, K283*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266592	17	41246623	17	43094606	266592	261965	rs879255498	NC_000017.11:43094605:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.923_924del (p.Ser308fs)	BRCA1	S261fs, S308fs, S140fs, S196fs, S197fs, S220fs, S266fs, S307fs, S219fs, S281fs, S305fs, S12fs, S180fs, S237fs, S240fs, S267fs, S181fs, S238fs, S241fs, S260fs, S282fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266591	17	41246624 - 41246625	17	43094607 - 43094608	266591	261966	rs886040331	NC_000017.11:43094606:GC:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.924del (p.Ser308fs)	BRCA1	S308fs, S261fs, S197fs, S220fs, S237fs, S281fs, S307fs, S12fs, S181fs, S238fs, S240fs, S241fs, S305fs, S219fs, S140fs, S180fs, S196fs, S260fs, S266fs, S267fs, S282fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055755	17	41246624	17	43094607	55755	70422	rs397509336	NC_000017.11:43094606:G:	Deletion	frameshift variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.922_924delinsT (p.Lys307_Ser308insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055753	17	41246624 - 41246626	17	43094607 - 43094609	55753	70420	rs397509335	NC_000017.11:43094606:GCT:A	Indel	nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.922_923insTAAAATAAAATAAAATAAAATAAAATAAAA (p.Ser308delinsIleLysTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003904748	17	41246625 - 41246626	17	43094608 - 43094609	3904748	4020620		NC_000017.11:43094608:TTTTATT:TTTTATTTTATTTTATTTTATTTTATTTTATTTTATT	Microsatellite	nonsense|intron variant	Pathogenic	Mar 18, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.922dup (p.Ser308fs)	BRCA1	S140fs, S180fs, S197fs, S238fs, S260fs, S267fs, S281fs, S282fs, S12fs, S219fs, S220fs, S241fs, S261fs, S305fs, S308fs, S181fs, S307fs, S196fs, S237fs, S240fs, S266fs	Hereditary cancer-predisposing syndrome	VCV002774864	17	41246625 - 41246626	17	43094608 - 43094609	2774864	2935590	rs2154485304	NC_000017.11:43094608:TTTT:TTTTT	Duplication	frameshift variant|intron variant	Pathogenic	Sep 10, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.923del (p.Ser308fs)	BRCA1	S308fs, S261fs, S197fs, S219fs, S237fs, S266fs, S12fs, S220fs, S240fs, S260fs, S305fs, S180fs, S181fs, S267fs, S281fs, S282fs, S140fs, S196fs, S238fs, S241fs, S307fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055754	17	41246625	17	43094608	55754	70421	rs80357953	NC_000017.11:43094607:C:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.922_923del (p.Ser308fs)	BRCA1	S308fs, S261fs, S140fs, S180fs, S220fs, S260fs, S12fs, S196fs, S219fs, S240fs, S241fs, S266fs, S181fs, S237fs, S267fs, S281fs, S282fs, S197fs, S238fs, S305fs, S307fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055752	17	41246625 - 41246626	17	43094608 - 43094609	55752	70419	rs80357644	NC_000017.11:43094607:CT:	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.915dup (p.Asn306Ter)	BRCA1	N259*, N306*, N179*, N195*, N10*, N178*, N236*, N265*, N303*, N305*, N138*, N238*, N239*, N258*, N194*, N217*, N218*, N235*, N264*, N279*, N280*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001072882	17	41246632 - 41246633	17	43094615 - 43094616	1072882	1064232	rs2154485546	NC_000017.11:43094615:A:AA	Duplication	nonsense|intron variant	Pathogenic/Likely pathogenic	Aug 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.911del (p.Phe304fs)	BRCA1	F304fs, F257fs, F136fs, F177fs, F256fs, F303fs, F8fs, F176fs, F234fs, F263fs, F193fs, F216fs, F233fs, F301fs, F192fs, F215fs, F236fs, F237fs, F262fs, F277fs, F278fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055751	17	41246637	17	43094620	55751	70418	rs80357622	NC_000017.11:43094619:AA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.909del (p.Glu303fs)	BRCA1	E256fs, E303fs, E135fs, E176fs, E215fs, E255fs, E175fs, E192fs, E232fs, E233fs, E235fs, E276fs, E191fs, E214fs, E277fs, E302fs, E236fs, E261fs, E262fs, E300fs, E7fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055750	17	41246639	17	43094622	55750	70417	rs397509334	NC_000017.11:43094621:TT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.905dup (p.Ala302_Glu303insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548159	17	41246642 - 41246643	17	43094625 - 43094626	548159	538901	rs1555592859	NC_000017.11:43094625:G:GG	Duplication	frameshift variant|nonsense|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.903_904insT (p.Ala302fs)	BRCA1	A302fs, A255fs, A175fs, A190fs, A191fs, A235fs, A254fs, A260fs, A6fs, A213fs, A232fs, A234fs, A275fs, A276fs, A299fs, A134fs, A174fs, A214fs, A261fs, A301fs, A231fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548272	17	41246644 - 41246645	17	43094627 - 43094628	548272	538902	rs397509333	NC_000017.11:43094627::A	Insertion	frameshift variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.904del (p.Ala302fs)	BRCA1	A255fs, A302fs, A134fs, A175fs, A232fs, A254fs, A276fs, A213fs, A299fs, A190fs, A191fs, A231fs, A234fs, A260fs, A261fs, A275fs, A301fs, A174fs, A214fs, A235fs, A6fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055749	17	41246644	17	43094627	55749	70416	rs273903793	NC_000017.11:43094626:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.902_903insT (p.Lys301fs)	BRCA1	K254fs, K301fs, K190fs, K213fs, K253fs, K260fs, K275fs, K173fs, K189fs, K274fs, K133fs, K231fs, K233fs, K300fs, K5fs, K174fs, K212fs, K230fs, K234fs, K259fs, K298fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125477	17	41246645 - 41246646	17	43094628 - 43094629	125477	131015	rs80357726	NC_000017.11:43094628::A	Insertion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.901_902del (p.Lys301fs)	BRCA1	K133fs, K173fs, K174fs, K189fs, K190fs, K212fs, K213fs, K230fs, K231fs, K233fs, K234fs, K253fs, K254fs, K259fs, K260fs, K274fs, K275fs, K298fs, K300fs, K301fs, K5fs	Hereditary cancer-predisposing syndrome	VCV003226180	17	41246646 - 41246647	17	43094629 - 43094630	3226180	3387243	rs2552227360	NC_000017.11:43094628:TTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Mar 11, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.671-215_901del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267615	17	41246647 - 41247092	17	43094630 - 43095075	267615	262976	rs1555592870		Deletion	splice acceptor variant|splice donor variant|intron variant|initiator_codon_variant	Pathogenic/Likely pathogenic	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.898G>T (p.Glu300Ter)	BRCA1	E300*, E253*, E132*, E172*, E173*, E188*, E232*, E273*, E212*, E230*, E258*, E297*, E211*, E229*, E233*, E252*, E259*, E189*, E274*, E299*, E4*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266590	17	41246650	17	43094633	266590	261967	rs886040330	NC_000017.11:43094632:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.897del (p.Glu300fs)	BRCA1	E253fs, E300fs, E188fs, E252fs, E273fs, E4fs, E132fs, E173fs, E212fs, E232fs, E259fs, E172fs, E189fs, E230fs, E233fs, E258fs, E274fs, E299fs, E211fs, E229fs, E297fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254384	17	41246651	17	43094634	254384	249159	rs886037982	NC_000017.11:43094633:T:	Deletion	intron variant|frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.891_896delinsTC (p.Met297fs)	BRCA1	M250fs, M297fs, M1fs, M226fs, M227fs, M230fs, M255fs, M208fs, M271fs, M294fs, M129fs, M185fs, M229fs, M249fs, M256fs, M270fs, M296fs, M169fs, M170fs, M186fs, M209fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000419578	17	41246652 - 41246657	17	43094635 - 43094640	419578	410021	rs1064793967	NC_000017.11:43094634:ACATTC:GA	Indel	frameshift variant|initiator_codon_variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.892_895dup (p.Val299fs)	BRCA1	V299fs, V252fs, V228fs, V257fs, V272fs, V273fs, V3fs, V211fs, V231fs, V258fs, V171fs, V187fs, V210fs, V251fs, V298fs, V131fs, V172fs, V188fs, V229fs, V232fs, V296fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188406	17	41246652 - 41246653	17	43094635 - 43094636	188406	186549	rs80357806	NC_000017.11:43094635:CATTCATTC:CATTCATTCATTC	Microsatellite	frameshift variant|initiator_codon_variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.895_896del (p.Val299fs)	BRCA1	V299fs, V252fs, V211fs, V257fs, V172fs, V210fs, V229fs, V258fs, V171fs, V188fs, V228fs, V231fs, V272fs, V273fs, V131fs, V187fs, V232fs, V251fs, V296fs, V298fs, V3fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055744	17	41246652 - 41246653	17	43094635 - 43094636	55744	70411	rs80357670	NC_000017.11:43094634:ACA:A	Deletion	frameshift variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.893_894del (p.Asn298fs)	BRCA1	N251fs, N298fs, N210fs, N227fs, N230fs, N250fs, N257fs, N130fs, N271fs, N297fs, N186fs, N187fs, N228fs, N231fs, N272fs, N170fs, N171fs, N209fs, N256fs, N295fs, N2fs	Hereditary breast ovarian cancer syndrome	VCV000531256	17	41246654 - 41246655	17	43094637 - 43094638	531256	531612	rs1555592891	NC_000017.11:43094636:AT:	Deletion	frameshift variant|intron variant	Pathogenic	Dec 1, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.885_888del (p.Asp295fs)	BRCA1	D248fs, D295fs, D167fs, D254fs, D269fs, D168fs, D183fs, D207fs, D227fs, D247fs, D253fs, D294fs, D184fs, D225fs, D228fs, D268fs, D292fs, D127fs, D206fs, D224fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409359	17	41246660 - 41246663	17	43094643 - 43094646	409359	402067	rs1060502359	NC_000017.11:43094642:TCTGTCT:TCT	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.886A>T (p.Arg296Ter)	BRCA1	R296*, R249*, R248*, R269*, R169*, R208*, R226*, R293*, R184*, R185*, R207*, R229*, R254*, R270*, R128*, R168*, R225*, R228*, R255*, R295*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431203	17	41246662	17	43094645	431203	424859	rs748675395	NC_000017.11:43094644:T:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.886del (p.Arg296fs)	BRCA1	R296fs, R249fs, R184fs, R225fs, R293fs, R208fs, R226fs, R229fs, R248fs, R254fs, R295fs, R128fs, R168fs, R169fs, R228fs, R255fs, R270fs, R185fs, R207fs, R269fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000225727	17	41246662	17	43094645	225727	227567	rs869320786	NC_000017.11:43094644:T:	Deletion	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.885_886del (p.Asp295fs)	BRCA1	D295fs, D248fs, D127fs, D183fs, D207fs, D224fs, D228fs, D253fs, D269fs, D294fs, D168fs, D184fs, D292fs, D225fs, D247fs, D268fs, D167fs, D206fs, D227fs, D254fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188405	17	41246662 - 41246663	17	43094645 - 43094646	188405	186550	rs786204261	NC_000017.11:43094644:TGT:T	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.881_884del (p.Lys294fs)	BRCA1	K126fs, K166fs, K167fs, K182fs, K183fs, K205fs, K206fs, K223fs, K224fs, K226fs, K227fs, K246fs, K247fs, K252fs, K253fs, K267fs, K268fs, K291fs, K293fs, K294fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003254367	17	41246664 - 41246667	17	43094647 - 43094650	3254367	3413146	rs2552227815	NC_000017.11:43094646:TCTTT:T	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Apr 15, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.880_884del (p.Lys294fs)	BRCA1	K247fs, K294fs, K126fs, K166fs, K167fs, K226fs, K206fs, K205fs, K224fs, K246fs, K253fs, K291fs, K182fs, K183fs, K223fs, K227fs, K252fs, K267fs, K268fs, K293fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431202	17	41246664 - 41246668	17	43094647 - 43094651	431202	424860	rs1135401838	NC_000017.11:43094646:TCTTT:	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.882del (p.Asp295fs)	BRCA1	D295fs, D248fs, D127fs, D247fs, D168fs, D183fs, D206fs, D224fs, D227fs, D253fs, D268fs, D292fs, D184fs, D207fs, D228fs, D254fs, D294fs, D167fs, D225fs, D269fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125465	17	41246666	17	43094649	125465	131003	rs80357587	NC_000017.11:43094648:TTT:TT	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.876_879del (p.Thr293fs)	BRCA1	T246fs, T293fs, T223fs, T181fs, T222fs, T292fs, T166fs, T225fs, T252fs, T267fs, T125fs, T165fs, T182fs, T204fs, T205fs, T226fs, T251fs, T245fs, T266fs, T290fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548186	17	41246669 - 41246672	17	43094652 - 43094655	548186	538903	rs1555592938	NC_000017.11:43094651:AGTGAGT:AGT	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.848_879del (p.Ser282_Leu283insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000265362	17	41246669 - 41246700	17	43094652 - 43094683	265362	260174	rs886039501	NC_000017.11:43094651:AGTGAGTAATAAACTGCTGTTCTCATGCTGTAA:A	Deletion	frameshift variant|nonsense|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.875del (p.Leu292fs)	BRCA1	L292fs, L245fs, L164fs, L180fs, L203fs, L221fs, L225fs, L244fs, L250fs, L289fs, L266fs, L124fs, L165fs, L222fs, L224fs, L291fs, L181fs, L204fs, L251fs, L265fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254383	17	41246673	17	43094656	254383	249160	rs886037981	NC_000017.11:43094655:A:	Deletion	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.874del (p.Leu292fs)	BRCA1	L292fs, L245fs, L181fs, L204fs, L221fs, L224fs, L251fs, L265fs, L165fs, L203fs, L222fs, L244fs, L266fs, L291fs, L124fs, L164fs, L180fs, L225fs, L250fs, L289fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266589	17	41246674	17	43094657	266589	261968	rs886040329	NC_000017.11:43094656:G:	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.873dup (p.Leu292fs)	BRCA1	L245fs, L292fs, L124fs, L164fs, L221fs, L251fs, L266fs, L181fs, L204fs, L265fs, L165fs, L203fs, L222fs, L224fs, L289fs, L180fs, L225fs, L244fs, L250fs, L291fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266588	17	41246674 - 41246675	17	43094657 - 43094658	266588	261969	rs886040328	NC_000017.11:43094657:T:TT	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.870_871insAC (p.Leu291fs)	BRCA1	L123fs, L163fs, L164fs, L179fs, L180fs, L202fs, L203fs, L220fs, L221fs, L223fs, L224fs, L243fs, L244fs, L249fs, L250fs, L264fs, L265fs, L288fs, L290fs, L291fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002573301	17	41246677 - 41246678	17	43094660 - 43094661	2573301	2738249	rs2552228129	NC_000017.11:43094660::GT	Insertion	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.869del (p.Leu290fs)	BRCA1	L290fs, L243fs, L122fs, L242fs, L248fs, L249fs, L201fs, L223fs, L162fs, L163fs, L178fs, L179fs, L220fs, L264fs, L289fs, L202fs, L219fs, L222fs, L263fs, L287fs	Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000548826	17	41246679	17	43094662	548826	539364	rs1555592956	NC_000017.11:43094661:AAA:AA	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Jun 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.869T>A (p.Leu290Ter)	BRCA1	L290*, L243*, L223*, L242*, L249*, L264*, L287*, L162*, L220*, L248*, L122*, L163*, L201*, L202*, L222*, L263*, L178*, L179*, L219*, L289*	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000371981	17	41246679	17	43094662	371981	358942	rs730881468	NC_000017.11:43094661:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.869T>G (p.Leu290Ter)	BRCA1	L290*, L243*, L162*, L220*, L248*, L163*, L201*, L202*, L219*, L179*, L223*, L249*, L263*, L264*, L287*, L122*, L178*, L222*, L242*, L289*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182128	17	41246679	17	43094662	182128	180883	rs730881468	NC_000017.11:43094661:A:C	single nucleotide variant	intron variant|nonsense|5 prime UTR variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.864_867del (p.Ser289fs)	BRCA1	S121fs, S161fs, S162fs, S177fs, S178fs, S200fs, S201fs, S218fs, S219fs, S221fs, S222fs, S241fs, S242fs, S247fs, S248fs, S262fs, S263fs, S286fs, S288fs, S289fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773500	17	41246681 - 41246684	17	43094664 - 43094667	3773500	3889650		NC_000017.11:43094663:ACTG:	Deletion	frameshift variant|intron variant|5 prime UTR variant	Pathogenic	Oct 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.861_862dup (p.Ser288fs)	BRCA1	S241fs, S288fs, S199fs, S200fs, S221fs, S246fs, S247fs, S261fs, S287fs, S120fs, S217fs, S285fs, S161fs, S177fs, S218fs, S220fs, S262fs, S160fs, S176fs, S240fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266586	17	41246685 - 41246686	17	43094668 - 43094669	266586	261970	rs886040326	NC_000017.11:43094668:TGT:TGTGT	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.862del (p.Ser288fs)	BRCA1	S241fs, S288fs, S221fs, S240fs, S247fs, S176fs, S200fs, S220fs, S177fs, S199fs, S217fs, S218fs, S246fs, S261fs, S262fs, S287fs, S120fs, S160fs, S161fs, S285fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266587	17	41246686	17	43094669	266587	261971	rs886040327	NC_000017.11:43094668:T:	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.856G>T (p.Glu286Ter)	BRCA1	E286*, E239*, E118*, E159*, E216*, E218*, E245*, E260*, E174*, E198*, E158*, E259*, E283*, E175*, E197*, E215*, E219*, E238*, E244*, E285*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254382	17	41246692	17	43094675	254382	249161	rs886037980	NC_000017.11:43094674:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.851dup (p.His285fs)	BRCA1	H117fs, H196fs, H197fs, H214fs, H217fs, H285fs, H157fs, H237fs, H238fs, H259fs, H282fs, H284fs, H158fs, H173fs, H174fs, H215fs, H218fs, H243fs, H244fs, H258fs	Hereditary cancer-predisposing syndrome	VCV003481888	17	41246696 - 41246697	17	43094679 - 43094680	3481888	3640099		NC_000017.11:43094679:T:TT	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Nov 9, 2024	criteria provided, single submitter							
NM_007294.3(BRCA1):c.851_852ins7	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125918	17	41246696 - 41246697	17	43094679 - 43094680	125918	131456			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.851_852del (p.Gln284fs)	BRCA1	Q237fs, Q284fs, Q157fs, Q195fs, Q196fs, Q213fs, Q217fs, Q236fs, Q242fs, Q243fs, Q116fs, Q172fs, Q258fs, Q281fs, Q216fs, Q257fs, Q283fs, Q156fs, Q173fs, Q214fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055740	17	41246696 - 41246697	17	43094679 - 43094680	55740	70407	rs80357719	NC_000017.11:43094678:CT:	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.844_850dup (p.Gln284fs)	BRCA1	Q237fs, Q284fs, Q156fs, Q172fs, Q242fs, Q243fs, Q257fs, Q281fs, Q213fs, Q214fs, Q217fs, Q258fs, Q116fs, Q195fs, Q216fs, Q236fs, Q157fs, Q173fs, Q196fs, Q283fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055735	17	41246697 - 41246698	17	43094680 - 43094681	55735	70402	rs80357989	NC_000017.11:43094680:GTAATGAG:GTAATGAGTAATGAG	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.850del (p.Gln284fs)	BRCA1	Q237fs, Q284fs, Q196fs, Q216fs, Q217fs, Q243fs, Q258fs, Q116fs, Q157fs, Q172fs, Q213fs, Q257fs, Q156fs, Q283fs, Q173fs, Q195fs, Q214fs, Q236fs, Q242fs, Q281fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV001315518	17	41246698	17	43094681	1315518	1305778	rs2154489566	NC_000017.11:43094680:G:	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic		criteria provided, single submitter							
NM_007294.4(BRCA1):c.849dup (p.Gln284fs)	BRCA1	Q237fs, Q284fs, Q257fs, Q283fs, Q157fs, Q213fs, Q214fs, Q216fs, Q243fs, Q116fs, Q156fs, Q172fs, Q196fs, Q173fs, Q195fs, Q217fs, Q236fs, Q242fs, Q258fs, Q281fs	not provided	VCV000495088	17	41246698 - 41246699	17	43094681 - 43094682	495088	486657	rs1555592986	NC_000017.11:43094681:T:TT	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.850C>T (p.Gln284Ter)	BRCA1	Q284*, Q237*, Q157*, Q196*, Q214*, Q216*, Q243*, Q257*, Q281*, Q156*, Q217*, Q236*, Q173*, Q283*, Q116*, Q172*, Q195*, Q213*, Q242*, Q258*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055738	17	41246698	17	43094681	55738	70405	rs397509330	NC_000017.11:43094680:G:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.848_849insCTCATTA (p.Leu283fs)	BRCA1	L115fs, L155fs, L156fs, L171fs, L172fs, L194fs, L195fs, L212fs, L213fs, L215fs, L216fs, L235fs, L236fs, L241fs, L242fs, L256fs, L257fs, L280fs, L282fs, L283fs	Hereditary cancer-predisposing syndrome	VCV003893678	17	41246699 - 41246700	17	43094682 - 43094683	3893678	4009559		NC_000017.11:43094682::TAATGAG	Insertion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Feb 12, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.848dup (p.Leu283fs)	BRCA1	L236fs, L283fs, L155fs, L156fs, L213fs, L215fs, L257fs, L282fs, L171fs, L172fs, L216fs, L235fs, L241fs, L242fs, L256fs, L115fs, L194fs, L195fs, L212fs, L280fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000971603	17	41246699 - 41246700	17	43094682 - 43094683	971603	958139	rs2054036520	NC_000017.11:43094682:AA:AAA	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic/Likely pathogenic	Nov 14, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.848delinsGGCAA (p.Leu283fs)	BRCA1	L194fs, L213fs, L215fs, L236fs, L195fs, L235fs, L242fs, L256fs, L257fs, L115fs, L171fs, L172fs, L282fs, L155fs, L156fs, L212fs, L216fs, L241fs, L280fs, L283fs	Hereditary cancer-predisposing syndrome	VCV003481894	17	41246700	17	43094683	3481894	3640105		NC_000017.11:43094682:A:TTGCC	Indel	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Nov 21, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.848T>G (p.Leu283Ter)	BRCA1	L283*, L236*, L195*, L215*, L115*, L155*, L171*, L212*, L213*, L216*, L241*, L256*, L257*, L282*, L156*, L172*, L194*, L235*, L242*, L280*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055737	17	41246700	17	43094683	55737	70404	rs273902792	NC_000017.11:43094682:A:C	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.848T>A (p.Leu283Ter)	BRCA1	L283*, L236*, L195*, L215*, L156*, L212*, L235*, L241*, L280*, L115*, L172*, L194*, L213*, L256*, L257*, L282*, L155*, L171*, L216*, L242*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055736	17	41246700	17	43094683	55736	70403	rs273902792	NC_000017.11:43094682:A:T	single nucleotide variant	intron variant|nonsense|5 prime UTR variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.846dup (p.Leu283fs)	BRCA1	L115fs, L155fs, L156fs, L171fs, L172fs, L194fs, L195fs, L212fs, L213fs, L215fs, L216fs, L235fs, L236fs, L241fs, L242fs, L256fs, L257fs, L280fs, L282fs, L283fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573268	17	41246701 - 41246702	17	43094684 - 43094685	2573268	2738216	rs2552228541	NC_000017.11:43094684:T:TT	Duplication	frameshift variant|intron variant|5 prime UTR variant	Pathogenic	Apr 10, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.843_846del (p.Ser282fs)	BRCA1	S282fs, S235fs, S114fs, S155fs, S171fs, S215fs, S234fs, S279fs, S170fs, S194fs, S212fs, S256fs, S281fs, S154fs, S193fs, S211fs, S214fs, S240fs, S241fs, S255fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017683	17	41246702 - 41246705	17	43094685 - 43094688	17683	32722	rs80357919	NC_000017.11:43094684:TGAG:	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.845C>A (p.Ser282Ter)	BRCA1	S282*, S235*, S154*, S171*, S211*, S214*, S255*, S279*, S281*, S194*, S215*, S234*, S241*, S114*, S155*, S170*, S212*, S240*, S193*, S256*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000427236	17	41246703	17	43094686	427236	416229	rs786203027	NC_000017.11:43094685:G:T	single nucleotide variant	intron variant|nonsense|5 prime UTR variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.841_842dup (p.Ser281fs)	BRCA1	S234fs, S281fs, S113fs, S153fs, S154fs, S170fs, S192fs, S213fs, S240fs, S254fs, S280fs, S169fs, S255fs, S193fs, S211fs, S214fs, S210fs, S233fs, S239fs, S278fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254381	17	41246705 - 41246706	17	43094688 - 43094689	254381	249162	rs80357792	NC_000017.11:43094688:CT:CTCT	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.838dup (p.Ala280fs)	BRCA1	A233fs, A280fs, A168fs, A191fs, A213fs, A232fs, A253fs, A277fs, A152fs, A209fs, A210fs, A212fs, A238fs, A239fs, A279fs, A153fs, A112fs, A169fs, A192fs, A254fs	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Familial cancer of breast	VCV000872255	17	41246709 - 41246710	17	43094692 - 43094693	872255	860392	rs2054038332	NC_000017.11:43094692:C:CC	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Mar 19, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.829_836del (p.Asn277fs)	BRCA1	N277fs, N230fs, N165fs, N188fs, N210fs, N229fs, N235fs, N109fs, N189fs, N209fs, N250fs, N150fs, N206fs, N236fs, N251fs, N276fs, N149fs, N166fs, N207fs, N274fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266584	17	41246712 - 41246719	17	43094695 - 43094702	266584	261972	rs886040324	NC_000017.11:43094694:TGAGTATTTG:TG	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.834_835insA (p.His279fs)	BRCA1	H232fs, H279fs, H151fs, H152fs, H167fs, H211fs, H231fs, H253fs, H278fs, H168fs, H208fs, H111fs, H209fs, H212fs, H252fs, H276fs, H190fs, H191fs, H237fs, H238fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548271	17	41246713 - 41246714	17	43094696 - 43094697	548271	538904	rs1555593007	NC_000017.11:43094696::T	Insertion	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.835del (p.His279fs)	BRCA1	H232fs, H279fs, H168fs, H211fs, H212fs, H253fs, H278fs, H152fs, H276fs, H111fs, H151fs, H167fs, H191fs, H238fs, H190fs, H208fs, H209fs, H231fs, H237fs, H252fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055729	17	41246713	17	43094696	55729	70396	rs80357523	NC_000017.11:43094695:G:	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.824_833dup (p.Ala280fs)	BRCA1	A233fs, A280fs, A153fs, A213fs, A169fs, A191fs, A210fs, A232fs, A279fs, A112fs, A152fs, A168fs, A212fs, A277fs, A192fs, A209fs, A238fs, A239fs, A253fs, A254fs	Hereditary cancer-predisposing syndrome	VCV001762594	17	41246714 - 41246715	17	43094697 - 43094698	1762594	1816992	rs2552228760	NC_000017.11:43094697:GTATTTGTGC:GTATTTGTGCGTATTTGTGC	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Mar 4, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.832dup (p.Thr278fs)	BRCA1	T231fs, T278fs, T166fs, T167fs, T230fs, T275fs, T110fs, T151fs, T208fs, T210fs, T211fs, T237fs, T251fs, T277fs, T189fs, T207fs, T252fs, T150fs, T190fs, T236fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266585	17	41246715 - 41246716	17	43094698 - 43094699	266585	261973	rs886040325	NC_000017.11:43094698:T:TT	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.829_830del (p.Asn277fs)	BRCA1	N230fs, N277fs, N109fs, N165fs, N166fs, N207fs, N210fs, N250fs, N251fs, N150fs, N188fs, N229fs, N235fs, N276fs, N189fs, N206fs, N209fs, N149fs, N236fs, N274fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266583	17	41246718 - 41246719	17	43094701 - 43094702	266583	261974	rs886040323	NC_000017.11:43094700:TTT:T	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.828_829insT (p.Asn277Ter)	BRCA1	N277*, N230*, N166*, N207*, N235*, N251*, N149*, N206*, N209*, N210*, N150*, N188*, N229*, N236*, N109*, N165*, N189*, N250*, N274*, N276*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548164	17	41246719 - 41246720	17	43094702 - 43094703	548164	538905	rs1555593017	NC_000017.11:43094702::A	Insertion	nonsense|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.825_828delinsAAT (p.Thr276fs)	BRCA1	T276fs, T229fs, T149fs, T165fs, T187fs, T188fs, T206fs, T209fs, T250fs, T148fs, T205fs, T208fs, T235fs, T249fs, T273fs, T275fs, T164fs, T228fs, T234fs, T108fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441387	17	41246720 - 41246723	17	43094703 - 43094706	441387	435168	rs1555593020	NC_000017.11:43094702:TGTG:ATT	Indel	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.815_824dup (p.Thr276fs)	BRCA1	T229fs, T276fs, T164fs, T165fs, T205fs, T206fs, T234fs, T250fs, T188fs, T209fs, T148fs, T149fs, T208fs, T249fs, T108fs, T187fs, T228fs, T235fs, T273fs, T275fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055723	17	41246723 - 41246724	17	43094706 - 43094707	55723	70390	rs387906563	NC_000017.11:43094706:CCACATGGCTCCACATG:CCACATGGCTCCACATGGCTCCACATG	Duplication	frameshift variant|intron variant|5 prime UTR variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.814_824dup (p.Thr276fs)	BRCA1	T276fs, T229fs, T165fs, T187fs, T188fs, T206fs, T234fs, T275fs, T164fs, T209fs, T228fs, T235fs, T108fs, T149fs, T208fs, T249fs, T273fs, T148fs, T205fs, T250fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055722	17	41246723 - 41246724	17	43094706 - 43094707	55722	70389	rs1555593031	NC_000017.11:43094706:CCACATGGCTCC:CCACATGGCTCCCACATGGCTCC	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.815_824del (p.Glu272fs)	BRCA1	E144fs, E161fs, E201fs, E204fs, E245fs, E272fs, E104fs, E183fs, E225fs, E269fs, E160fs, E205fs, E230fs, E231fs, E246fs, E271fs, E145fs, E184fs, E202fs, E224fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003148716	17	41246724 - 41246733	17	43094707 - 43094716	3148716	3307964	rs387906563	NC_000017.11:43094706:CCACATGGCTCCACATG:CCACATG	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Mar 4, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.822T>A (p.Cys274Ter)	BRCA1	C274*, C227*, C106*, C206*, C207*, C248*, C271*, C146*, C162*, C226*, C233*, C163*, C185*, C204*, C232*, C273*, C147*, C186*, C203*, C247*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055724	17	41246726	17	43094709	55724	70391	rs80357331	NC_000017.11:43094708:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.817_818insATGTGGAGCC (p.Pro273fs)	BRCA1	P105fs, P145fs, P146fs, P161fs, P162fs, P184fs, P185fs, P202fs, P203fs, P205fs, P206fs, P225fs, P226fs, P231fs, P232fs, P246fs, P247fs, P270fs, P272fs, P273fs	Hereditary cancer-predisposing syndrome	VCV004082360	17	41246730 - 41246731	17	43094713 - 43094714	4082360	4195048		NC_000017.11:43094713:G:GGCTCCACATG	Insertion	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Apr 13, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.807_817dup (p.Pro273fs)	BRCA1	P226fs, P273fs, P205fs, P231fs, P145fs, P225fs, P161fs, P162fs, P202fs, P232fs, P246fs, P270fs, P105fs, P146fs, P184fs, P185fs, P203fs, P206fs, P247fs, P272fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266580	17	41246730 - 41246731	17	43094713 - 43094714	266580	261975	rs886040320	NC_000017.11:43094713:GCTCCACATGC:GCTCCACATGCGCTCCACATGC	Duplication	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.816_817insTCCATGTGGA (p.Pro273fs)	BRCA1	P226fs, P273fs, P105fs, P145fs, P146fs, P162fs, P184fs, P202fs, P225fs, P232fs, P247fs, P272fs, P161fs, P185fs, P203fs, P205fs, P206fs, P231fs, P246fs, P270fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548169	17	41246731 - 41246732	17	43094714 - 43094715	548169	538906	rs1555593043	NC_000017.11:43094714::TCCACATGGA	Insertion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.815_816insTCCATGTGGA (p.Glu272fs)	BRCA1	E272fs, E225fs, E145fs, E183fs, E204fs, E205fs, E246fs, E104fs, E160fs, E184fs, E201fs, E245fs, E144fs, E161fs, E202fs, E224fs, E230fs, E231fs, E269fs, E271fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266582	17	41246732 - 41246733	17	43094715 - 43094716	266582	261976	rs886040322	NC_000017.11:43094715:TCCACATG:TCCACATGGATCCACATG	Insertion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.814G>T (p.Glu272Ter)	BRCA1	E272*, E225*, E205*, E224*, E269*, E271*, E144*, E160*, E183*, E201*, E204*, E145*, E161*, E202*, E231*, E104*, E184*, E230*, E245*, E246*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266581	17	41246734	17	43094717	266581	261977	rs886040321	NC_000017.11:43094716:C:A	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.809del (p.His270fs)	BRCA1	H223fs, H270fs, H143fs, H158fs, H181fs, H200fs, H228fs, H142fs, H182fs, H202fs, H222fs, H243fs, H244fs, H102fs, H159fs, H199fs, H203fs, H229fs, H267fs, H269fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055714	17	41246739	17	43094722	55714	70381	rs80357965	NC_000017.11:43094721:T:	Deletion	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.796_807delinsA (p.Val266fs)	BRCA1	V219fs, V266fs, V177fs, V198fs, V199fs, V224fs, V239fs, V154fs, V178fs, V195fs, V263fs, V138fs, V155fs, V218fs, V225fs, V240fs, V265fs, V98fs, V139fs, V196fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409314	17	41246741 - 41246752	17	43094724 - 43094735	409314	402719	rs1064792958	NC_000017.11:43094723:CAAGTTTGAAAC:T	Indel	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.806T>A (p.Leu269Ter)	BRCA1	L227*, L243*, L101*, L199*, L266*, L269*, L141*, L142*, L181*, L198*, L228*, L242*, L268*, L157*, L158*, L180*, L201*, L202*, L221*, L222*	Periventricular nodular heterotopia|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Inherited breast cancer and ovarian cancer	VCV001761872	17	41246742	17	43094725	1761872	1823814	rs2154492047	NC_000017.11:43094724:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.800C>A (p.Ser267Ter)	BRCA1	S267*, S220*, S139*, S178*, S179*, S196*, S225*, S264*, S199*, S200*, S219*, S226*, S240*, S266*, S99*, S140*, S156*, S241*, S155*, S197*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431201	17	41246748	17	43094731	431201	424861	rs80357392	NC_000017.11:43094730:G:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.800C>G (p.Ser267Ter)	BRCA1	S267*, S220*, S155*, S178*, S226*, S240*, S264*, S200*, S99*, S139*, S140*, S156*, S196*, S197*, S199*, S219*, S179*, S225*, S241*, S266*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055713	17	41246748	17	43094731	55713	70380	rs80357392	NC_000017.11:43094730:G:C	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.799dup (p.Ser267fs)	BRCA1	S220fs, S267fs, S139fs, S219fs, S225fs, S264fs, S266fs, S179fs, S226fs, S99fs, S140fs, S196fs, S200fs, S240fs, S155fs, S156fs, S178fs, S197fs, S199fs, S241fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055709	17	41246748 - 41246749	17	43094731 - 43094732	55709	70376	rs80357724	NC_000017.11:43094731:AAA:AAAA	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.799del (p.Ser267fs)	BRCA1	S220fs, S267fs, S139fs, S179fs, S199fs, S200fs, S266fs, S155fs, S226fs, S140fs, S156fs, S178fs, S196fs, S99fs, S197fs, S219fs, S225fs, S240fs, S241fs, S264fs	Hereditary cancer-predisposing syndrome	VCV000479251	17	41246749	17	43094732	479251	478786	rs80357724	NC_000017.11:43094731:AAA:AA	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Feb 13, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.798_799del (p.Ser267fs)	BRCA1	S220fs, S267fs, S155fs, S178fs, S179fs, S219fs, S226fs, S264fs, S266fs, S99fs, S139fs, S200fs, S140fs, S196fs, S225fs, S241fs, S156fs, S197fs, S199fs, S240fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037698	17	41246749 - 41246750	17	43094732 - 43094733	37698	46254	rs80357724	NC_000017.11:43094731:AAA:A	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.794_795del (p.Ser265fs)	BRCA1	S218fs, S265fs, S137fs, S153fs, S176fs, S217fs, S238fs, S264fs, S197fs, S239fs, S154fs, S177fs, S195fs, S198fs, S223fs, S262fs, S138fs, S194fs, S224fs, S97fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055707	17	41246753 - 41246754	17	43094736 - 43094737	55707	70374	rs80357955	NC_000017.11:43094735:AGA:A	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.791_794del (p.Ser264fs)	BRCA1	S217fs, S264fs, S176fs, S194fs, S222fs, S196fs, S263fs, S96fs, S136fs, S137fs, S153fs, S193fs, S216fs, S238fs, S261fs, S152fs, S175fs, S197fs, S223fs, S237fs	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055705	17	41246754 - 41246757	17	43094737 - 43094740	55705	70372	rs80357707	NC_000017.11:43094736:GAAC:	Deletion	frameshift variant|5 prime UTR variant|intron variant|splice donor variant	Pathogenic	Jul 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.791del (p.Ser264fs)	BRCA1	S217fs, S264fs, S136fs, S176fs, S194fs, S196fs, S261fs, S96fs, S153fs, S193fs, S222fs, S263fs, S152fs, S175fs, S197fs, S223fs, S238fs, S137fs, S216fs, S237fs	Hereditary breast ovarian cancer syndrome	VCV001413004	17	41246757	17	43094740	1413004	1356601	rs2154492556	NC_000017.11:43094739:C:	Deletion	frameshift variant|5 prime UTR variant|intron variant|splice donor variant	Pathogenic	Aug 30, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.788dup (p.Gly263_Ser264insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266579	17	41246759 - 41246760	17	43094742 - 43094743	266579	261978	rs886040319	NC_000017.11:43094742:CCC:CCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.788del (p.Gly263fs)	BRCA1	G216fs, G263fs, G136fs, G151fs, G260fs, G175fs, G193fs, G215fs, G236fs, G262fs, G174fs, G195fs, G196fs, G221fs, G222fs, G237fs, G135fs, G152fs, G192fs, G95fs	not provided|Hereditary breast ovarian cancer syndrome	VCV000935747	17	41246760	17	43094743	935747	937976	rs886040319	NC_000017.11:43094742:CCC:CC	Deletion	frameshift variant|splice donor variant|intron variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.784del (p.Gln262fs)	BRCA1	Q215fs, Q262fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266578	17	41246764	17	43094747	266578	261979	rs886040318	NC_000017.11:43094746:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.784C>T (p.Gln262Ter)	BRCA1	Q262*, Q215*, Q134*, Q135*, Q217*, Q220*, Q235*, Q150*, Q151*, Q191*, Q259*, Q173*, Q174*, Q195*, Q214*, Q261*, Q192*, Q194*, Q221*, Q236*, Q94*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254380	17	41246764	17	43094747	254380	249163	rs886037979	NC_000017.11:43094746:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.783T>G (p.Tyr261Ter)	BRCA1	Y261*, Y214*, Y134*, Y172*, Y173*, Y193*, Y194*, Y213*, Y258*, Y93*, Y133*, Y235*, Y260*, Y149*, Y150*, Y191*, Y216*, Y219*, Y220*, Y190*, Y234*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037697	17	41246765	17	43094748	37697	46253	rs80357321	NC_000017.11:43094747:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.779dup (p.Tyr261fs)	BRCA1	Y214fs, Y261fs	Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S	VCV000580680	17	41246768 - 41246769	17	43094751 - 43094752	580680	569173	rs886040317	NC_000017.11:43094751:TTTT:TTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Feb 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.778_779dup (p.Tyr261fs)	BRCA1	Y214fs, Y261fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266577	17	41246768 - 41246769	17	43094751 - 43094752	266577	261980	rs886040317	NC_000017.11:43094751:TTTT:TTTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.778A>T (p.Lys260Ter)	BRCA1	K213*, K260*, K133*, K212*, K259*, K92*, K148*, K149*, K172*, K192*, K257*, K132*, K171*, K190*, K193*, K215*, K233*, K189*, K218*, K219*, K234*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000850337	17	41246770	17	43094753	850337	845462	rs786202263	NC_000017.11:43094752:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Mar 19, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.775del (p.Glu259fs)	BRCA1	E212fs, E259fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055697	17	41246773	17	43094756	55697	70364	rs80357628	NC_000017.11:43094755:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.770_771insGA (p.His257fs)	BRCA1	H210fs, H257fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548242	17	41246777 - 41246778	17	43094760 - 43094761	548242	538907	rs1555593134	NC_000017.11:43094760:T:TCT	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.770dup (p.His257fs)	BRCA1	H257fs, H210fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548212	17	41246777 - 41246778	17	43094760 - 43094761	548212	538908	rs1555593134	NC_000017.11:43094760:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.763G>T (p.Glu255Ter)	BRCA1	E255*, E208*, E167*, E184*, E213*, E254*, E87*, E127*, E128*, E143*, E166*, E188*, E207*, E210*, E228*, E144*, E214*, E229*, E185*, E187*, E252*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055693	17	41246785	17	43094768	55693	70360	rs80357009	NC_000017.11:43094767:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.751_754dup (p.Arg252fs)	BRCA1	R124fs, R125fs, R140fs, R141fs, R163fs, R164fs, R181fs, R182fs, R184fs, R185fs, R204fs, R205fs, R207fs, R210fs, R211fs, R225fs, R226fs, R249fs, R251fs, R252fs, R84fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773511	17	41246793 - 41246794	17	43094776 - 43094777	3773511	3889661		NC_000017.11:43094776:GCTT:GCTTGCTT	Duplication	frameshift variant|intron variant|5 prime UTR variant	Pathogenic	Oct 30, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.754del (p.Arg252fs)	BRCA1	R252fs, R205fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000496401	17	41246794	17	43094777	496401	487732	rs1555593195	NC_000017.11:43094776:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.750_751del (p.Lys251fs)	BRCA1	K204fs, K251fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266576	17	41246797 - 41246798	17	43094780 - 43094781	266576	261981	rs886040316	NC_000017.11:43094779:TCTC:TC	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.746_749del (p.Thr249fs)	BRCA1	T121fs, T122fs, T137fs, T138fs, T160fs, T161fs, T178fs, T179fs, T181fs, T182fs, T201fs, T202fs, T204fs, T207fs, T208fs, T222fs, T223fs, T246fs, T248fs, T249fs, T81fs	Hereditary breast ovarian cancer syndrome	VCV003629507	17	41246799 - 41246802	17	43094782 - 43094785	3629507	3762188		NC_000017.11:43094781:TCAGT:T	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Nov 27, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.745dup (p.Thr249fs)	BRCA1	T249fs, T202fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548219	17	41246802 - 41246803	17	43094785 - 43094786	548219	538909	rs1555593207	NC_000017.11:43094785:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.745_746del (p.Thr248_Thr249insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254379	17	41246802 - 41246803	17	43094785 - 43094786	254379	249164	rs886037978	NC_000017.11:43094784:GTG:G	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.744del (p.Thr249fs)	BRCA1	T202fs, T249fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409361	17	41246804	17	43094787	409361	402543	rs1060502360	NC_000017.11:43094786:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.743_744insA (p.Thr249fs)	BRCA1	T249fs, T202fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266575	17	41246804 - 41246805	17	43094787 - 43094788	266575	261982	rs886040315	NC_000017.11:43094787::T	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.742_743del (p.Thr248fs)	BRCA1	T136fs, T177fs, T201fs, T203fs, T206fs, T137fs, T159fs, T178fs, T180fs, T200fs, T221fs, T245fs, T247fs, T248fs, T207fs, T80fs, T120fs, T121fs, T160fs, T181fs, T222fs	Hereditary breast ovarian cancer syndrome	VCV003662100	17	41246805 - 41246806	17	43094788 - 43094789	3662100	3797965		NC_000017.11:43094787:GTGT:GT	Microsatellite	frameshift variant|intron variant|5 prime UTR variant	Pathogenic	Aug 12, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.742dup (p.Thr248fs)	BRCA1	T248fs, T201fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055686	17	41246805 - 41246806	17	43094788 - 43094789	55686	70353	rs397509314	NC_000017.11:43094788:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.741del (p.Asn247fs)	BRCA1	N119fs, N120fs, N135fs, N136fs, N158fs, N159fs, N176fs, N177fs, N179fs, N180fs, N199fs, N200fs, N202fs, N205fs, N206fs, N220fs, N221fs, N244fs, N246fs, N247fs, N79fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003254408	17	41246807	17	43094790	3254408	3413187	rs2552230260	NC_000017.11:43094789:G:	Deletion	frameshift variant|intron variant|5 prime UTR variant	Pathogenic	Jun 19, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.738dup (p.Asn247fs)	BRCA1	N200fs, N247fs	Hereditary cancer-predisposing syndrome	VCV000827009	17	41246809 - 41246810	17	43094792 - 43094793	827009	813885	rs1597880292	NC_000017.11:43094792:C:CC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Mar 21, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.736_737del (p.Leu246fs)	BRCA1	L199fs, L246fs	Hereditary breast ovarian cancer syndrome	VCV002025419	17	41246811 - 41246812	17	43094794 - 43094795	2025419	2084621	rs397509312	NC_000017.11:43094793:AAA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 20, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.737T>A (p.Leu246Ter)	BRCA1	L246*, L199*, L119*, L204*, L157*, L158*, L198*, L205*, L245*, L78*, L134*, L175*, L178*, L179*, L219*, L118*, L135*, L176*, L201*, L220*, L243*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254378	17	41246811	17	43094794	254378	249165	rs886037977	NC_000017.11:43094793:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.737del (p.Asp245_Leu246insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055683	17	41246811	17	43094794	55683	70350	rs397509312	NC_000017.11:43094793:AAA:AA	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.730_731insGTAACAAATACTGAACATCATCAACCCAGTA (p.Asn244delinsSerAsnLysTyrTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548222	17	41246817 - 41246818	17	43094800 - 43094801	548222	538910	rs1555593246	NC_000017.11:43094800:TA:TACTGGGTTGATGATGTTCAGTATTTGTTACTA	Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.731del (p.Asn244fs)	BRCA1	N197fs, N244fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055681	17	41246817	17	43094800	55681	70348	rs80357700	NC_000017.11:43094799:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.729_730insGTAACAAATACTGAACATCATCAACCCAGTA (p.Asn244fs)	BRCA1	N197fs, N244fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266574	17	41246818 - 41246819	17	43094801 - 43094802	266574	261983	rs886040314	NC_000017.11:43094801::TACTGGGTTGATGATGTTCAGTATTTGTTAC	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.726del (p.Ser242fs)	BRCA1	S195fs, S242fs	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV002435173	17	41246822	17	43094805	2435173	1245896	rs2552230383	NC_000017.11:43094804:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.717_720del (p.Gln240fs)	BRCA1	Q193fs, Q240fs	Hereditary breast ovarian cancer syndrome	VCV002098771	17	41246828 - 41246831	17	43094811 - 43094814	2098771	2154086	rs2552230463	NC_000017.11:43094810:TTGAT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Feb 18, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.718C>T (p.Gln240Ter)	BRCA1	Q240*, Q193*, Q151*, Q169*, Q192*, Q237*, Q239*, Q172*, Q173*, Q199*, Q213*, Q112*, Q128*, Q170*, Q195*, Q198*, Q214*, Q72*, Q113*, Q129*, Q152*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266573	17	41246830	17	43094813	266573	261984	rs886040313	NC_000017.11:43094812:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.715del (p.His239fs)	BRCA1	H192fs, H239fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252397	17	41246833	17	43094816	252397	246826	rs879255294	NC_000017.11:43094815:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.709G>T (p.Glu237Ter)	BRCA1	E190*, E237*, E126*, E148*, E149*, E192*, E234*, E236*, E69*, E125*, E166*, E169*, E211*, E109*, E170*, E189*, E210*, E110*, E167*, E195*, E196*	Hereditary breast ovarian cancer syndrome	VCV001050371	17	41246839	17	43094822	1050371	1038582	rs2154496548	NC_000017.11:43094821:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Feb 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.706dup (p.Thr236fs)	BRCA1	T236fs, T189fs	Hereditary cancer-predisposing syndrome	VCV000479206	17	41246841 - 41246842	17	43094824 - 43094825	479206	478853	rs1555593279	NC_000017.11:43094824:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jan 2, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.707del (p.Thr236fs)	BRCA1	T189fs, T236fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266571	17	41246841	17	43094824	266571	261985	rs886040311	NC_000017.11:43094823:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.693_705delinsAAATC (p.Asp232fs)	BRCA1	D165fs, D187fs, D190fs, D229fs, D64fs, D105fs, D121fs, D144fs, D164fs, D143fs, D161fs, D185fs, D191fs, D205fs, D206fs, D231fs, D104fs, D120fs, D162fs, D184fs, D232fs	Hereditary breast ovarian cancer syndrome	VCV003895750	17	41246843 - 41246855	17	43094826 - 43094838	3895750	2882589		NC_000017.11:43094825:ATTTGTTACATCC:GATTT	Indel	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Mar 10, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.700_704del (p.Thr234fs)	BRCA1	T234fs, T187fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431200	17	41246844 - 41246848	17	43094827 - 43094831	431200	424862	rs1135401837	NC_000017.11:43094826:TTTGTT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.704del (p.Asn235fs)	BRCA1	N235fs, N188fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266570	17	41246844	17	43094827	266570	261986	rs886040310	NC_000017.11:43094826:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.701_702insTG (p.Asn235fs)	BRCA1	N108fs, N146fs, N147fs, N167fs, N193fs, N234fs, N164fs, N168fs, N123fs, N124fs, N187fs, N190fs, N208fs, N209fs, N107fs, N165fs, N188fs, N194fs, N232fs, N235fs, N67fs	Hereditary breast ovarian cancer syndrome	VCV002853069	17	41246846 - 41246847	17	43094829 - 43094830	2853069	3006887	rs2552230734	NC_000017.11:43094829::CA	Insertion	frameshift variant|intron variant|5 prime UTR variant	Pathogenic	May 29, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.700del (p.Thr234fs)	BRCA1	T187fs, T234fs	Hereditary cancer-predisposing syndrome	VCV001756673	17	41246848	17	43094831	1756673	1245889	rs2552230774	NC_000017.11:43094830:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jun 23, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.697_698del (p.Val233fs)	BRCA1	V186fs, V233fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037695	17	41246850 - 41246851	17	43094833 - 43094834	37695	46251	rs80357747	NC_000017.11:43094832:ACA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.697del (p.Asp232_Val233insTer)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000491186	17	41246851	17	43094834	491186	485389	rs1555593298	NC_000017.11:43094833:C:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Feb 26, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.695dup (p.Asp232fs)	BRCA1	D232fs, D185fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433694	17	41246852 - 41246853	17	43094835 - 43094836	433694	427564	rs1555593302	NC_000017.11:43094835:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.689_692del (p.Glu230fs)	BRCA1	E183fs, E230fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266567	17	41246856 - 41246859	17	43094839 - 43094842	266567	261987	rs886040308	NC_000017.11:43094838:GTCT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.690_691del (p.Glu230fs)	BRCA1	E102fs, E103fs, E118fs, E119fs, E141fs, E142fs, E159fs, E160fs, E162fs, E163fs, E182fs, E183fs, E185fs, E188fs, E189fs, E203fs, E204fs, E227fs, E229fs, E230fs, E62fs	not provided	VCV003337596	17	41246857 - 41246858	17	43094840 - 43094841	3337596	3496257		NC_000017.11:43094839:TCTC:TC	Microsatellite	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Aug 18, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.688G>T (p.Glu230Ter)	BRCA1	E230*, E183*, E102*, E103*, E163*, E188*, E118*, E162*, E229*, E62*, E119*, E141*, E159*, E160*, E185*, E142*, E182*, E189*, E203*, E204*, E227*	Hereditary cancer-predisposing syndrome|not provided	VCV000491185	17	41246860	17	43094843	491185	485108	rs1555593310	NC_000017.11:43094842:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 24, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.685del (p.Ser229fs)	BRCA1	S229fs, S182fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055666	17	41246863	17	43094846	55666	70333	rs80357824	NC_000017.11:43094845:AAAA:AAA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.673_680delinsCAGTAT (p.Ala225fs)	BRCA1	A113fs, A114fs, A136fs, A137fs, A154fs, A155fs, A157fs, A158fs, A177fs, A178fs, A180fs, A183fs, A184fs, A198fs, A199fs, A222fs, A224fs, A225fs, A57fs, A97fs, A98fs	Hereditary cancer-predisposing syndrome	VCV003774436	17	41246868 - 41246875	17	43094851 - 43094858	3774436	3890580		NC_000017.11:43094850:TCACAAGC:ATACTG	Indel	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 20, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.671-1_679dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773525	17	41246868 - 41246869	17	43094851 - 43094852	3773525	3889675		NC_000017.11:43094851:CACAAGCAGC:CACAAGCAGCCACAAGCAGC	Duplication	splice acceptor variant|intron variant	Pathogenic	Nov 13, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.678_679insC (p.Glu227fs)	BRCA1	E180fs, E227fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548296	17	41246869 - 41246870	17	43094852 - 43094853	548296	538911	rs1555593321	NC_000017.11:43094852::G	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.679G>T (p.Glu227Ter)	BRCA1	E227*, E180*, E139*, E160*, E179*, E200*, E59*, E157*, E185*, E186*, E226*, E100*, E115*, E138*, E159*, E116*, E156*, E182*, E201*, E224*, E99*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252435	17	41246869	17	43094852	252435	246853	rs879255319	NC_000017.11:43094851:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.678T>A (p.Cys226Ter)	BRCA1	C226*, C179*, C114*, C138*, C156*, C159*, C223*, C98*, C137*, C181*, C225*, C99*, C115*, C155*, C158*, C185*, C58*, C178*, C184*, C199*, C200*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055665	17	41246870	17	43094853	55665	70332	rs397509308	NC_000017.11:43094852:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.676del (p.Cys226fs)	BRCA1	C226fs, C179fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037693	17	41246872	17	43094855	37693	46249	rs80357941	NC_000017.11:43094854:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.672del (p.Ala225fs)	BRCA1	A178fs, A225fs	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001049208	17	41246876	17	43094859	1049208	1038583	rs2154500888	NC_000017.11:43094858:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.671-1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000055662	17	41246878	17	43094861	55662	70329	rs80358020	NC_000017.11:43094860:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Feb 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.671-8_671-2del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073509	17	41246879 - 41246885	17	43094862 - 43094868	1073509	1064236	rs2154501062	NC_000017.11:43094861:TGAAAAT:	Deletion	splice acceptor variant|intron variant	Pathogenic	Jul 12, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.671-2A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267618	17	41246879	17	43094862	267618	262977	rs80358108	NC_000017.11:43094861:T:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	May 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.671-2A>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055663	17	41246879	17	43094862	55663	70330	rs80358108	NC_000017.11:43094861:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NC_000017.11:g.(?_43095840)_(43106539_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000531562	17	41247857 - 41258556	17	43095840 - 43106539	531562	530638			Deletion		Pathogenic	Nov 9, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.667_668del (p.Lys223fs)	BRCA1	K176fs, K223fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055657	17	41247865 - 41247866	17	43095848 - 43095849	55657	70324	rs80357537	NC_000017.11:43095847:TTTTTT:TTTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.640del (p.Asp214fs)	BRCA1	D167fs, D214fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267610	17	41247893	17	43095876	267610	262980	rs886040921	NC_000017.11:43095875:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.594_597delTGTG	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209105	17	41247936 - 41247939	17	43095919 - 43095922	209105	205705	rs797045175	NC_000017.11:43095918:CACAC:C	Deletion	splice acceptor variant	Pathogenic/Likely pathogenic	Mar 7, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.442-822_593+506del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373844	17	41248755 - 41252719	17	43096738 - 43100702	373844	360736			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.442-?_593+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000254047	17	41249261 - 41251897	17	43097244 - 43099880	254047	248524			Deletion		Pathogenic	Jan 17, 2017	criteria provided, multiple submitters, no conflicts							
NC_000017.10:g.(41249307_41251791)_(41251898_41256138)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440437	17	41249307 - 41256138	17	43097290 - 43104121	440437	434073			Deletion		Pathogenic	Jul 1, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.441+1729_547+704dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001740399	17	41251087 - 41251088	17	43099070 - 43099071	1740399	1791430			Duplication	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Jan 26, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.442-1129_547+223del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267544	17	41251569 - 41253026	17	43099552 - 43101009	267544	262982			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.536_547+166delinsT	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000919622	17	41251626 - 41251803	17	43099609 - 43099786	919622	916735	rs2054281859		Indel	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.536_547+165del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000531432	17	41251627 - 41251803	17	43099610 - 43099786	531432	531334	rs1555594718		Deletion	splice donor variant|intron variant	Pathogenic	Sep 19, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43099755)_(43115799_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000660701	17	41251772 - 41267816	17	43099755 - 43115799	660701	653140			Deletion		Pathogenic	Oct 16, 2018	criteria provided, single submitter							
NC_000017.11:g.(?_43099769)_(43124102_?)del	BRCA1|LOC110485084|LOC111589216		Hereditary breast ovarian cancer syndrome	VCV000531547	17	41251786 - 41276119	17	43099769 - 43124102	531547	530660			Deletion		Pathogenic	Dec 3, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.547+3A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267607	17	41251789	17	43099772	267607	262983	rs886040919	NC_000017.11:43099771:T:A	single nucleotide variant	intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.547+2T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003904100	17	41251790	17	43099773	3904100	4019973		NC_000017.11:43099772:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Mar 11, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.547+2T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037674	17	41251790	17	43099773	37674	46230	rs80358047	NC_000017.11:43099772:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Apr 3, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+1G>C	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462674	17	41251791	17	43099774	462674	466911	rs80358030	NC_000017.11:43099773:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Oct 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.442-952_547dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267546	17	41251791 - 41251792	17	43099774 - 43099775	267546	262984			Duplication	splice acceptor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.547+1G>A	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	VCV000125881	17	41251791	17	43099774	125881	131419	rs80358030	NC_000017.11:43099773:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.547+1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055590	17	41251791	17	43099774	55590	70257	rs80358030	NC_000017.11:43099773:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.3(BRCA1):c.442-?_547+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000254075	17	41251792 - 41251897	17	43099775 - 43099880	254075	248529			Deletion		Pathogenic	Dec 5, 2016	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.543del (p.Glu181fs)	BRCA1	E134fs, E181fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV001709944	17	41251796	17	43099779	1709944	1708297	rs2552238958	NC_000017.11:43099778:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 3, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.541G>T (p.Glu181Ter)	BRCA1	E181*, E134*, E136*, E178*, E110*, E111*, E154*, E180*, E155*, E53*, E133*, E54*	Breast neoplasm|Hereditary breast ovarian cancer syndrome	VCV000430632	17	41251798	17	43099781	430632	423863	rs1131692162	NC_000017.11:43099780:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.536del (p.Tyr179fs)	BRCA1	Y132fs, Y179fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055555	17	41251803	17	43099786	55555	70222	rs397509273	NC_000017.11:43099785:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.532_533dup (p.Tyr179fs)	BRCA1	Y108fs, Y109fs, Y52fs, Y132fs, Y152fs, Y153fs, Y178fs, Y51fs, Y131fs, Y134fs, Y176fs, Y179fs	Hereditary breast ovarian cancer syndrome	VCV003660311	17	41251805 - 41251806	17	43099788 - 43099789	3660311	3797452		NC_000017.11:43099788:ACA:ACACA	Duplication	frameshift variant|intron variant	Pathogenic	Jul 23, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.531dup (p.Val178fs)	BRCA1	V131fs, V178fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000220026	17	41251807 - 41251808	17	43099790 - 43099791	220026	222676	rs864622350	NC_000017.11:43099790:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.531del (p.Val178fs)	BRCA1	V131fs, V178fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266546	17	41251808	17	43099791	266546	261988	rs886040290	NC_000017.11:43099790:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.529del (p.Ser177fs)	BRCA1	S177fs, S130fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055512	17	41251810	17	43099793	55512	70179	rs80357758	NC_000017.11:43099792:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.526dup (p.Thr176fs)	BRCA1	T105fs, T106fs, T128fs, T129fs, T131fs, T149fs, T150fs, T173fs, T175fs, T176fs, T48fs, T49fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003073505	17	41251812 - 41251813	17	43099795 - 43099796	3073505	3234461	rs2552239279	NC_000017.11:43099795:T:TT	Duplication	frameshift variant|intron variant	Pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.442-43_524del	BRCA1		Breast and/or ovarian cancer	VCV000267223	17	41251815 - 41251940	17	43099798 - 43099923	267223	262104	rs1555594841		Deletion	splice acceptor variant|intron variant	Pathogenic	Mar 15, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.520C>T (p.Gln174Ter)	BRCA1	Q174*, Q127*, Q129*, Q46*, Q104*, Q126*, Q148*, Q171*, Q47*, Q103*, Q147*, Q173*	Hereditary breast ovarian cancer syndrome	VCV000575899	17	41251819	17	43099802	575899	571211	rs1567806048	NC_000017.11:43099801:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jun 10, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.520del (p.Gln174fs)	BRCA1	Q174fs, Q127fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055460	17	41251819	17	43099802	55460	70127	rs80357639	NC_000017.11:43099801:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.519del (p.Gln174fs)	BRCA1	Q127fs, Q174fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224417	17	41251820	17	43099803	224417	226209	rs886037784	NC_000017.11:43099802:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.518del (p.Pro173fs)	BRCA1	P126fs, P173fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266531	17	41251821	17	43099804	266531	261989	rs886040276	NC_000017.11:43099803:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.516del (p.Gln172fs)	BRCA1	Q125fs, Q172fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000246360	17	41251823	17	43099806	246360	245053	rs879254223	NC_000017.11:43099805:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.513dup (p.Gln172fs)	BRCA1	Q125fs, Q172fs	Hereditary breast ovarian cancer syndrome	VCV000646923	17	41251825 - 41251826	17	43099808 - 43099809	646923	646053	rs1597887797	NC_000017.11:43099808:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 5, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.514del (p.Gln172fs)	BRCA1	Q172fs, Q125fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055421	17	41251825	17	43099808	55421	70088	rs80357872	NC_000017.11:43099807:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.514C>T (p.Gln172Ter)	BRCA1	Q172*, Q125*, Q146*, Q44*, Q45*, Q145*, Q171*, Q101*, Q102*, Q127*, Q124*, Q169*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055420	17	41251825	17	43099808	55420	70087	rs80356947	NC_000017.11:43099807:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.512dup (p.Gln172fs)	BRCA1	Q125fs, Q172fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000141091	17	41251826 - 41251827	17	43099809 - 43099810	141091	150805	rs587781487	NC_000017.11:43099809:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.510del (p.Ile171fs)	BRCA1	I171fs, I124fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417833	17	41251829	17	43099812	417833	404719	rs1060505052	NC_000017.11:43099811:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.502_506del (p.Lys168fs)	BRCA1	K121fs, K168fs	Hereditary breast ovarian cancer syndrome	VCV002018284	17	41251833 - 41251837	17	43099816 - 43099820	2018284	2072368	rs2552239689	NC_000017.11:43099815:TGCTTTG:TG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jul 20, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.505C>T (p.Gln169Ter)	BRCA1	Q169*, Q122*, Q121*, Q143*, Q41*, Q42*, Q99*, Q124*, Q166*, Q142*, Q168*, Q98*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055367	17	41251834	17	43099817	55367	70034	rs80357133	NC_000017.11:43099816:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.500_503del (p.Thr167fs)	BRCA1	T167fs, T120fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000642233	17	41251836 - 41251839	17	43099819 - 43099822	642233	646054	rs1597887869	NC_000017.11:43099818:TTTGT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.502A>T (p.Lys168Ter)	BRCA1	K168*, K121*, K97*, K120*, K123*, K141*, K142*, K167*, K41*, K98*, K165*, K40*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266514	17	41251837	17	43099820	266514	261990	rs886040263	NC_000017.11:43099819:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.500_501del (p.Thr167fs)	BRCA1	T120fs, T167fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266508	17	41251838 - 41251839	17	43099821 - 43099822	266508	261991	rs886040258	NC_000017.11:43099820:TGT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.496del (p.Arg166fs)	BRCA1	R119fs, R166fs	Hereditary cancer-predisposing syndrome	VCV003226170	17	41251843	17	43099826	3226170	1245854	rs2552239841	NC_000017.11:43099825:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Nov 16, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.494dup (p.Arg166fs)	BRCA1	R119fs, R166fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055329	17	41251844 - 41251845	17	43099827 - 43099828	55329	69996	rs80357762	NC_000017.11:43099827:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.474_493dup (p.Leu165delinsProLeuGluLeuTer)	BRCA1		Hereditary cancer-predisposing syndrome	VCV001742769	17	41251845 - 41251846	17	43099828 - 43099829	1742769	1808852	rs2552239924	NC_000017.11:43099828:GAGTTCTCACAGTTCCAAGG:GAGTTCTCACAGTTCCAAGGGAGTTCTCACAGTTCCAAGG	Duplication	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 22, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.493_494del (p.Leu165fs)	BRCA1	L118fs, L165fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055323	17	41251845 - 41251846	17	43099828 - 43099829	55323	69990	rs397509206	NC_000017.11:43099827:AGAG:AG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.493del (p.Thr164_Leu165insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055324	17	41251846	17	43099829	55324	69991	rs80357551	NC_000017.11:43099828:G:	Deletion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.490del (p.Thr164fs)	BRCA1	T117fs, T164fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216107	17	41251849	17	43099832	216107	213331	rs863224512	NC_000017.11:43099831:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.488del (p.Arg163fs)	BRCA1	R163fs, R116fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055308	17	41251851	17	43099834	55308	69975	rs397509202	NC_000017.11:43099833:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NC_000017.10:g.(41251852_41256215)_(41258551_41267742)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440443	17	41251852 - 41267742	17	43099835 - 43115725	440443	434074			Deletion		Pathogenic	Jan 19, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.485_486dup (p.Arg163Ter)	BRCA1	R163*, R116*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266497	17	41251852 - 41251853	17	43099835 - 43099836	266497	261992	rs80357708	NC_000017.11:43099835:CACA:CACACA	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.485dup (p.Arg163fs)	BRCA1	R163fs, R116fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000140998	17	41251853 - 41251854	17	43099836 - 43099837	140998	150712	rs587781427	NC_000017.11:43099836:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.485_486del (p.Val162fs)	BRCA1	V162fs, V115fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055304	17	41251853 - 41251854	17	43099836 - 43099837	55304	69971	rs80357708	NC_000017.11:43099835:CACA:CA	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.475_482dup (p.Val162fs)	BRCA1	V117fs, V135fs, V136fs, V34fs, V35fs, V91fs, V161fs, V162fs, V92fs, V114fs, V115fs, V159fs	Hereditary breast ovarian cancer syndrome	VCV002818336	17	41251856 - 41251857	17	43099839 - 43099840	2818336	2984551	rs2552240116	NC_000017.11:43099839:GTTCCAAGGTT:GTTCCAAGGTTCCAAGGTT	Duplication	frameshift variant|intron variant	Pathogenic	Dec 3, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.470_477del (p.Ser157fs)	BRCA1	S157fs, S110fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055267	17	41251862 - 41251869	17	43099845 - 43099852	55267	69934	rs397509190	NC_000017.11:43099844:AAGGTTAGA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.475del (p.Gly160fs)	BRCA1	G113fs, G160fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254377	17	41251864	17	43099847	254377	249166	rs886037976	NC_000017.11:43099846:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.470_471del (p.Leu156_Ser157insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037608	17	41251868 - 41251869	17	43099851 - 43099852	37608	46164	rs80357887	NC_000017.11:43099850:AGAGAG:AGAG	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.469_470insAT (p.Ser157fs)	BRCA1	S157fs, S110fs	Hereditary breast ovarian cancer syndrome	VCV000531392	17	41251869 - 41251870	17	43099852 - 43099853	531392	531385	rs1555594935	NC_000017.11:43099852:A:ATA	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 11, 2017	criteria provided, single submitter							
NM_007294.4(BRCA1):c.460_467del (p.Val154fs)	BRCA1	V154fs, V107fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409363	17	41251872 - 41251879	17	43099855 - 43099862	409363	402553	rs1060502362	NC_000017.11:43099854:AGTTGGACA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.466dup (p.Leu156fs)	BRCA1	L109fs, L156fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037602	17	41251872 - 41251873	17	43099855 - 43099856	37602	46158	rs397507236	NC_000017.11:43099855:G:GG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.465del (p.Gln155fs)	BRCA1	Q155fs, Q108fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254376	17	41251874	17	43099857	254376	249168	rs1555594954	NC_000017.11:43099856:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.464_465del (p.Gln155fs)	BRCA1	Q155fs, Q108fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254375	17	41251874 - 41251875	17	43099857 - 43099858	254375	249167	rs886037974	NC_000017.11:43099856:TT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.463dup (p.Gln155fs)	BRCA1	Q107fs, Q108fs, Q110fs, Q128fs, Q129fs, Q152fs, Q154fs, Q155fs, Q27fs, Q28fs, Q84fs, Q85fs	Hereditary cancer-predisposing syndrome	VCV003226160	17	41251875 - 41251876	17	43099858 - 43099859	3226160	3387224	rs2552240430	NC_000017.11:43099858:GG:GGG	Duplication	frameshift variant|intron variant	Pathogenic	Nov 22, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.463C>T (p.Gln155Ter)	BRCA1	Q155*, Q108*, Q110*, Q27*, Q128*, Q154*, Q85*, Q107*, Q129*, Q152*, Q84*, Q28*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055248	17	41251876	17	43099859	55248	69915	rs80357180	NC_000017.11:43099858:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.3(BRCA1):c.457_458ins21 (p.?)	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417834	17	41251881 - 41251882	17	43099864 - 43099865	417834	404720			Insertion		Pathogenic	Jan 1, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.457_458del (p.Ser153fs)	BRCA1	S153fs, S106fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055232	17	41251881 - 41251882	17	43099864 - 43099865	55232	69899	rs397509185	NC_000017.11:43099863:CT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.456_457del (p.Ser153fs)	BRCA1	S153fs, S106fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125874	17	41251882 - 41251883	17	43099865 - 43099866	125874	131412	rs80357882	NC_000017.11:43099864:TG:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.456del (p.Ser153fs)	BRCA1	S153fs, S106fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000232543	17	41251883	17	43099866	232543	236164	rs876659830	NC_000017.11:43099865:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.450del (p.Ser151fs)	BRCA1	S104fs, S151fs	Hereditary breast ovarian cancer syndrome	VCV003704479	17	41251889	17	43099872	3704479	1245834		NC_000017.11:43099871:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 23, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.445G>T (p.Glu149Ter)	BRCA1	E149*, E102*, E146*, E101*, E123*, E148*, E21*, E22*, E78*, E79*, E104*, E122*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000417828	17	41251894	17	43099877	417828	404721	rs876658381	NC_000017.11:43099876:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.445del (p.Glu149fs)	BRCA1	E149fs, E102fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000409302	17	41251894	17	43099877	409302	402143	rs1060502327	NC_000017.11:43099876:CC:C	Deletion	frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NG_005905.2:g.(?_92501)_(113863_118103)del	BRCA1|LOC110485084|LOC111589215|LOC111589216		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373861	17	41251898 - 41277500	17	43099881 - 43125483	373861	360762			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.442-7T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267545	17	41251904	17	43099887	267545	262985	rs886040909	NC_000017.11:43099886:A:T	single nucleotide variant	intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.442-22_442-13del	BRCA1		BRCA1-related cancer predisposition	VCV000246362	17	41251910 - 41251919	17	43099893 - 43099902	246362	245054	rs879254224	NC_000017.11:43099892:GTAAAGAACAGT:GT	Deletion	intron variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-1004_441+1609del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373841	17	41254530 - 41259554	17	43102513 - 43107537	373841	360737			Deletion	splice acceptor variant|splice donor variant|initiator_codon_variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.135-1206_441+1607del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373842	17	41254532 - 41259756	17	43102515 - 43107739	373842	360738			Deletion	splice acceptor variant|splice donor variant|initiator_codon_variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(?_43104102)_(43125483_?)del	BRCA1|LOC110485084|LOC111589215|LOC111589216		Hereditary breast ovarian cancer syndrome	VCV000662865	17	41256119 - 41277500	17	43104102 - 43125483	662865	652824			Deletion		Pathogenic	Oct 13, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43104102)_(43115799_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000659613	17	41256119 - 41267816	17	43104102 - 43115799	659613	653145			Deletion		Pathogenic	Oct 9, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43104116)_(43115785_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000584025	17	41256133 - 41267802	17	43104116 - 43115785	584025	568629			Deletion		Pathogenic	Jan 22, 2018	criteria provided, single submitter							
NC_000017.11:g.(?_43104116)_(43124102_?)del	LOC110485084|LOC111589216|BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462207	17	41256133 - 41276119	17	43104116 - 43124102	462207	467041			Deletion		Pathogenic	Jan 24, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.441+2T>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000481461	17	41256137	17	43104120	481461	479538	rs397509173	NC_000017.11:43104119:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.441+2T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236261	17	41256137	17	43104120	236261	237838	rs397509173	NC_000017.11:43104119:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Apr 3, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+2T>A	BRCA1		Breast and/or ovarian cancer|Breast neoplasm|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000055196	17	41256137	17	43104120	55196	69863	rs397509173	NC_000017.11:43104119:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Aug 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.441+1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055195	17	41256138	17	43104121	55195	69862	rs397509172	NC_000017.11:43104120:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.440del (p.Leu147fs)	BRCA1	L100fs, L147fs	Hereditary cancer-predisposing syndrome	VCV003825303	17	41256140	17	43104123	3825303	1245828		NC_000017.11:43104122:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Feb 3, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.437_440del (p.Ser146fs)	BRCA1	S146fs, S99fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055186	17	41256140 - 41256143	17	43104123 - 43104126	55186	69853	rs397509168	NC_000017.11:43104122:AAGGAAGGA:AAGGA	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.3(BRCA1):c.438_439ins25 (p.?)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267538	17	41256141 - 41256142	17	43104124 - 43104125	267538	262986			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.432_433del (p.Pro145fs)	BRCA1	P101fs, P119fs, P142fs, P145fs, P18fs, P75fs, P98fs	not provided	VCV002576281	17	41256147 - 41256148	17	43104130 - 43104131	2576281	2741177	rs2552250616	NC_000017.11:43104129:GA:	Deletion	frameshift variant|intron variant	Pathogenic	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.431dup (p.Asn144fs)	BRCA1	N144fs, N97fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266469	17	41256148 - 41256149	17	43104131 - 43104132	266469	261993	rs397509162	NC_000017.11:43104131:TTTT:TTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.424_431del (p.Pro142fs)	BRCA1	P142fs, P95fs	not provided|Hereditary cancer-predisposing syndrome	VCV000545837	17	41256149 - 41256156	17	43104132 - 43104139	545837	536499	rs1555596294	NC_000017.11:43104131:TTTTCGGGTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.431del (p.Asn144fs)	BRCA1	N97fs, N144fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055167	17	41256149	17	43104132	55167	69834	rs397509162	NC_000017.11:43104131:TTTT:TTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.427G>T (p.Glu143Ter)	BRCA1	E143*, E96*, E16*, E117*, E73*, E99*, E140*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037581	17	41256153	17	43104136	37581	46137	rs80356991	NC_000017.11:43104135:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.426del (p.Glu143fs)	BRCA1	E143fs, E96fs	Hereditary breast ovarian cancer syndrome	VCV002082968	17	41256154	17	43104137	2082968	2143480	rs2552250735	NC_000017.11:43104136:GGG:GG	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 14, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.421G>T (p.Glu141Ter)	BRCA1	E138*, E14*, E97*, E115*, E141*, E71*, E94*	Hereditary breast ovarian cancer syndrome	VCV002024556	17	41256159	17	43104142	2024556	2077333	rs2154548776	NC_000017.11:43104141:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Aug 18, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.418dup (p.Ser140fs)	BRCA1	S140fs, S93fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266455	17	41256161 - 41256162	17	43104144 - 43104145	266455	261994	rs886040212	NC_000017.11:43104144:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.412_418del (p.Leu138fs)	BRCA1	L91fs, L138fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055109	17	41256162 - 41256168	17	43104145 - 43104151	55109	69776	rs80357816	NC_000017.11:43104144:TCTGTAG:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.416dup (p.Ser140fs)	BRCA1	S140fs, S93fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187048	17	41256163 - 41256164	17	43104146 - 43104147	187048	185114	rs786203432	NC_000017.11:43104146:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.415_416del (p.Gln139fs)	BRCA1	Q136fs, Q12fs, Q69fs, Q92fs, Q95fs, Q113fs, Q139fs	Hereditary cancer-predisposing syndrome	VCV002450676	17	41256164 - 41256165	17	43104147 - 43104148	2450676	2423162	rs2552250848	NC_000017.11:43104146:TGT:T	Deletion	frameshift variant|intron variant	Pathogenic	Mar 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.414dup (p.Gln139fs)	BRCA1	Q136fs, Q95fs, Q113fs, Q69fs, Q12fs, Q139fs, Q92fs	Hereditary breast ovarian cancer syndrome	VCV003724891	17	41256165 - 41256166	17	43104148 - 43104149	3724891	3854670		NC_000017.11:43104148:T:TT	Duplication	intron variant|frameshift variant	Pathogenic	Nov 9, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.415del (p.Gln139fs)	BRCA1	Q139fs, Q92fs	Hereditary cancer-predisposing syndrome	VCV000491068	17	41256165	17	43104148	491068	485407	rs1555596315	NC_000017.11:43104147:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	May 1, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.415C>T (p.Gln139Ter)	BRCA1	Q139*, Q92*, Q95*, Q113*, Q69*, Q12*, Q136*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055114	17	41256165	17	43104148	55114	69781	rs80357372	NC_000017.11:43104147:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.411_414del (p.Leu138fs)	BRCA1	L91fs, L138fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266445	17	41256166 - 41256169	17	43104149 - 43104152	266445	261995	rs886040203	NC_000017.11:43104148:TAGA:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.411dup (p.Leu138fs)	BRCA1	L91fs, L138fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000441309	17	41256168 - 41256169	17	43104151 - 43104152	441309	435173	rs886040205	NC_000017.11:43104151:AA:AAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.411del (p.Leu138fs)	BRCA1	L91fs, L138fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266447	17	41256169	17	43104152	266447	261996	rs886040205	NC_000017.11:43104151:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.404_408del (p.Lys135fs)	BRCA1	K109fs, K132fs, K135fs, K65fs, K88fs, K8fs, K91fs	not provided	VCV003026904	17	41256172 - 41256176	17	43104155 - 43104159	3026904	3187213	rs2552250937	NC_000017.11:43104154:TCTTTT:T	Deletion	frameshift variant|intron variant	Pathogenic	Dec 1, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.407del (p.Arg136fs)	BRCA1	R136fs, R89fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266442	17	41256173	17	43104156	266442	261997	rs886040200	NC_000017.11:43104155:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.406dup (p.Arg136fs)	BRCA1	R136fs, R89fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055095	17	41256173 - 41256174	17	43104156 - 43104157	55095	69762	rs80357709	NC_000017.11:43104156:TTTT:TTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.406del (p.Arg136fs)	BRCA1	R136fs, R89fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266438	17	41256174	17	43104157	266438	261998	rs80357709	NC_000017.11:43104156:TTTT:TTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.403A>T (p.Lys135Ter)	BRCA1	K135X, K88*, K65*, K109*, K8*, K132*, K91*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252876	17	41256177	17	43104160	252876	247277	rs879255485	NC_000017.11:43104159:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.399_400del (p.Ala134fs)	BRCA1	A134fs, A87fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055071	17	41256180 - 41256181	17	43104163 - 43104164	55071	69738	rs80357568	NC_000017.11:43104162:CAC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.397del (p.Arg133fs)	BRCA1	R133fs, R86fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254374	17	41256183	17	43104166	254374	249169	rs886037973	NC_000017.11:43104165:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.391del (p.Arg131fs)	BRCA1	R61fs, R87fs, R105fs, R131fs, R84fs, R128fs, R4fs	Hereditary breast ovarian cancer syndrome	VCV003653032	17	41256189	17	43104172	3653032	3778421		NC_000017.11:43104171:T:	Deletion	frameshift variant|intron variant	Pathogenic	Aug 8, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.389_391delinsTCT (p.Tyr130_Arg131delinsPheTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000418066	17	41256189 - 41256191	17	43104172 - 43104174	418066	410030	rs1064793054	NC_000017.11:43104171:TGT:AGA	Indel	nonsense|non-coding transcript variant	Pathogenic	Dec 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.391A>T (p.Arg131Ter)	BRCA1	R131*, R84*, R105*, R61*, R128*, R87*, R4*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055050	17	41256189	17	43104172	55050	69717	rs80357207	NC_000017.11:43104171:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.390C>G (p.Tyr130Ter)	BRCA1	Y130*, Y83*, Y127*, Y60*, Y86*, Y104*, Y3*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254373	17	41256190	17	43104173	254373	249170	rs80356888	NC_000017.11:43104172:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.390C>A (p.Tyr130Ter)	BRCA1	Y130*, Y83*, Y127*, Y104*, Y60*, Y3*, Y86*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055046	17	41256190	17	43104173	55046	69713	rs80356888	NC_000017.11:43104172:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.386del (p.Gly129fs)	BRCA1	G82fs, G129fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431198	17	41256194	17	43104177	431198	424864	rs1135401836	NC_000017.11:43104176:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.385_386delinsC (p.Gly129fs)	BRCA1	G129fs, G82fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266411	17	41256194 - 41256195	17	43104177 - 43104178	266411	261999	rs886040171	NC_000017.11:43104176:CC:G	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.381dup (p.Met128fs)	BRCA1	M102fs, M125fs, M128fs, M1fs, M58fs, M81fs, M84fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573302	17	41256198 - 41256199	17	43104181 - 43104182	2573302	2738250	rs2552251454	NC_000017.11:43104181:A:AA	Duplication	frameshift variant|intron variant	Pathogenic	Feb 8, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.376_377insT (p.Gln126fs)	BRCA1	Q79fs, Q126fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548289	17	41256203 - 41256204	17	43104186 - 43104187	548289	538912	rs1555596382	NC_000017.11:43104186::A	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.376C>T (p.Gln126Ter)	BRCA1	Q126*, Q79*, Q82*, Q123*, Q56*, Q100*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000427022	17	41256204	17	43104187	427022	415562	rs1085307902	NC_000017.11:43104186:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.375_376insT (p.Gln126fs)	BRCA1	Q79fs, Q126fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054993	17	41256204 - 41256205	17	43104187 - 43104188	54993	69660	rs397509101	NC_000017.11:43104187::A	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.374dup (p.Gln126fs)	BRCA1	Q126fs, Q79fs	Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000545900	17	41256205 - 41256206	17	43104188 - 43104189	545900	536500	rs1555596392	NC_000017.11:43104188:A:AA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.372del (p.Ile125fs)	BRCA1	I78fs, I125fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266400	17	41256208	17	43104191	266400	262000	rs886040160	NC_000017.11:43104190:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.367dup (p.Ser123fs)	BRCA1	S120fs, S53fs, S123fs, S76fs, S79fs, S97fs	Hereditary breast ovarian cancer syndrome	VCV002694354	17	41256212 - 41256213	17	43104195 - 43104196	2694354	2860493	rs2552251752	NC_000017.11:43104195:AAA:AAAA	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Nov 8, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.368del (p.Ser123fs)	BRCA1	S76fs, S123fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096914	17	41256212	17	43104195	96914	102817	rs431825397	NC_000017.11:43104194:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.367del (p.Ser123fs)	BRCA1	S120fs, S123fs, S53fs, S76fs, S79fs, S97fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV003481893	17	41256213	17	43104196	3481893	3640104		NC_000017.11:43104195:AAA:AA	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.363_364del (p.Glu121fs)	BRCA1	E74fs, E121fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266395	17	41256216 - 41256217	17	43104199 - 43104200	266395	262001	rs886040155	NC_000017.11:43104198:CT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.361dup (p.Glu121fs)	BRCA1	E121fs, E74fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266393	17	41256218 - 41256219	17	43104201 - 43104202	266393	262002	rs886040152	NC_000017.11:43104201:C:CC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.357_358delinsT (p.Lys119fs)	BRCA1	K119fs, K72fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266385	17	41256222 - 41256223	17	43104205 - 43104206	266385	262003	rs886040144	NC_000017.11:43104204:CT:A	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.355A>T (p.Lys119Ter)	BRCA1	K119*, K72*, K75*, K116*, K49*, K93*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266383	17	41256225	17	43104208	266383	262004	rs886040142	NC_000017.11:43104207:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.349dup (p.His117fs)	BRCA1	H117fs, H70fs	Hereditary cancer-predisposing syndrome	VCV001732025	17	41256230 - 41256231	17	43104213 - 43104214	1732025	1789057	rs2552251957	NC_000017.11:43104213:G:GG	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.345dup (p.Glu116Ter)	BRCA1	E113*, E116*, E46*, E69*, E72*, E90*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002674461	17	41256234 - 41256235	17	43104217 - 43104218	2674461	2841947	rs2552252010	NC_000017.11:43104217:A:AA	Duplication	nonsense|5 prime UTR variant|frameshift variant|intron variant	Pathogenic	Sep 8, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.346G>T (p.Glu116Ter)	BRCA1	E116*, E69*, E46*, E72*, E90*, E113*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000634735	17	41256234	17	43104217	634735	622569	rs397509071	NC_000017.11:43104216:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Mar 6, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.346del (p.Glu116fs)	BRCA1	E69fs, E116fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252400	17	41256234	17	43104217	252400	246827	rs762635795	NC_000017.11:43104216:C:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.344del (p.Pro115fs)	BRCA1	P68fs, P71fs, P89fs, P112fs, P115fs, P45fs	Hereditary breast ovarian cancer syndrome	VCV002759632	17	41256236	17	43104219	2759632	2924685	rs2552252029	NC_000017.11:43104218:GG:G	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.342_343del (p.Ser114_Pro115insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054882	17	41256237 - 41256238	17	43104220 - 43104221	54882	69549	rs80357881	NC_000017.11:43104219:GAGAG:GAG	Microsatellite	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.342del (p.Pro115fs)	BRCA1	P68fs, P115fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266370	17	41256238	17	43104221	266370	262005	rs886040129	NC_000017.11:43104220:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.335_338del (p.Asn112fs)	BRCA1	N65fs, N112fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142716	17	41256242 - 41256245	17	43104225 - 43104228	142716	152430	rs587782666	NC_000017.11:43104224:TTATTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.335dup (p.Asn112fs)	BRCA1	N65fs, N112fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548240	17	41256244 - 41256245	17	43104227 - 43104228	548240	538913	rs886040119	NC_000017.11:43104227:TTTT:TTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.335del (p.Asn112fs)	BRCA1	N65fs, N112fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266359	17	41256245	17	43104228	266359	262006	rs886040119	NC_000017.11:43104227:TTTT:TTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.331G>T (p.Glu111Ter)	BRCA1	E67*, E85*, E64*, E108*, E41*, E111*	Hereditary cancer-predisposing syndrome	VCV001730189	17	41256249	17	43104232	1730189	1788524	rs1414264431	NC_000017.11:43104231:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 27, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.331del (p.Glu111fs)	BRCA1	E64fs, E111fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266354	17	41256249	17	43104232	266354	262008	rs886040114	NC_000017.11:43104231:CC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.330_331insA (p.Glu111fs)	BRCA1	E64fs, E111fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266352	17	41256249 - 41256250	17	43104232 - 43104233	266352	262007	rs886040112	NC_000017.11:43104232::T	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.329_330delinsT (p.Lys110fs)	BRCA1	K107fs, K110fs, K40fs, K63fs, K66fs, K84fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV003773533	17	41256250 - 41256251	17	43104233 - 43104234	3773533	3889683		NC_000017.11:43104232:CT:A	Indel	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Nov 25, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.329dup (p.Glu111fs)	BRCA1	E111fs, E64fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054827	17	41256250 - 41256251	17	43104233 - 43104234	54827	69494	rs80357604	NC_000017.11:43104233:TTTTTT:TTTTTTT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.329_330del (p.Lys110fs)	BRCA1	K110fs, K63fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054826	17	41256250 - 41256251	17	43104233 - 43104234	54826	69493	rs80357754	NC_000017.11:43104232:CT:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.328_329del (p.Lys110fs)	BRCA1	K110fs, K63fs	Hereditary cancer-predisposing syndrome	VCV000925654	17	41256251 - 41256252	17	43104234 - 43104235	925654	913982	rs80357604	NC_000017.11:43104233:TTTTTT:TTTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.329del (p.Lys110fs)	BRCA1	K63fs, K110fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037521	17	41256251	17	43104234	37521	46077	rs80357604	NC_000017.11:43104233:TTTTTT:TTTTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.328A>T (p.Lys110Ter)	BRCA1	K110*, K63*, K40*, K84*, K66*, K107*	Hereditary breast ovarian cancer syndrome	VCV000963052	17	41256252	17	43104235	963052	949965	rs878854946	NC_000017.11:43104234:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Aug 21, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.323delinsAA (p.Ala108fs)	BRCA1	A61fs, A64fs, A82fs, A38fs, A105fs, A108fs	Hereditary cancer-predisposing syndrome	VCV003481887	17	41256257	17	43104240	3481887	3640098		NC_000017.11:43104239:G:TT	Indel	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Nov 1, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.323del (p.Ala108fs)	BRCA1	A108fs, A61fs	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000823272	17	41256257	17	43104240	823272	813904	rs1597897136	NC_000017.11:43104239:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 11, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.321del (p.Phe107fs)	BRCA1	F60fs, F107fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054799	17	41256259	17	43104242	54799	69466	rs80357544	NC_000017.11:43104241:AAAA:AAA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.317del (p.Asn106fs)	BRCA1	N59fs, N106fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054791	17	41256263	17	43104246	54791	69458	rs80357950	NC_000017.11:43104245:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.315T>A (p.Tyr105Ter)	BRCA1	Y79*, Y102*, Y105*, Y58*, Y61*, Y35*	Hereditary cancer-predisposing syndrome	VCV003825315	17	41256265	17	43104248	3825315	3942585		NC_000017.11:43104247:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Feb 10, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.310dup (p.Ser104fs)	BRCA1	S57fs, S104fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000418681	17	41256269 - 41256270	17	43104252 - 43104253	418681	410032	rs1555596484	NC_000017.11:43104252:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.310del (p.Ser104fs)	BRCA1	S104fs, S57fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266335	17	41256270	17	43104253	266335	262009	rs886040097	NC_000017.11:43104252:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.305del (p.Ala102fs)	BRCA1	A102fs, A55fs	Hereditary breast ovarian cancer syndrome	VCV000845906	17	41256275	17	43104258	845906	845475	rs2054641544	NC_000017.11:43104257:G:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Jan 16, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.302_303delinsGA (p.Tyr101Ter)	BRCA1	Y101*, Y54*, D98G, Y57*, Y31*, Y75*	Hereditary breast ovarian cancer syndrome	VCV001679002	17	41256277 - 41256278	17	43104260 - 43104261	1679002	1670796	rs2154550229	NC_000017.11:43104259:AT:TC	Indel	nonsense|non-coding transcript variant|missense variant	Pathogenic	Apr 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.303T>A (p.Tyr101Ter)	BRCA1	Y101*, Y54*, D98E, Y31*, Y57*, Y75*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266331	17	41256277	17	43104260	266331	262010	rs80356936	NC_000017.11:43104259:A:T	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.303T>G (p.Tyr101Ter)	BRCA1	Y101*, Y54*, D98E, Y57*, Y75*, Y31*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054758	17	41256277	17	43104260	54758	69425	rs80356936	NC_000017.11:43104259:A:C	single nucleotide variant	nonsense|missense variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.302-1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000125667	17	41256279	17	43104262	125667	131205	rs80358116	NC_000017.11:43104261:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jan 19, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.302-1G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054751	17	41256279	17	43104262	54751	69418	rs80358116	NC_000017.11:43104261:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.302-1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054750	17	41256279	17	43104262	54750	69417	rs80358116	NC_000017.11:43104261:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.302-2del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054753	17	41256280	17	43104263	54753	69420	rs273899695	NC_000017.11:43104262:T:	Deletion	splice acceptor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.302-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054752	17	41256280	17	43104263	54752	69419	rs80358011	NC_000017.11:43104262:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jul 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.302-2A>C	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037500	17	41256280	17	43104263	37500	46056	rs80358011	NC_000017.11:43104262:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jun 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.302-3C>G	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037501	17	41256281	17	43104264	37501	46057	rs80358051	NC_000017.11:43104263:G:C	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NC_000017.11:g.(?_43104848)_(43106553_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000650726	17	41256865 - 41258570	17	43104848 - 43106553	650726	652657			Deletion		Pathogenic	Oct 16, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.297_300del (p.Leu99fs)	BRCA1	L52fs, L99fs	Hereditary cancer-predisposing syndrome	VCV001798281	17	41256886 - 41256889	17	43104869 - 43104872	1798281	1856423	rs2552254007	NC_000017.11:43104868:CTCC:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Apr 5, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.296del (p.Leu99fs)	BRCA1	L29fs, L55fs, L52fs, L73fs, L99fs	Hereditary breast ovarian cancer syndrome	VCV002961610	17	41256890	17	43104873	2961610	3116772	rs2552254053	NC_000017.11:43104872:AAA:AA	Deletion	frameshift variant|5 prime UTR variant|intron variant|splice donor variant	Pathogenic	Dec 11, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.292_293insT (p.Gly98fs)	BRCA1	G51fs, G98fs	Hereditary breast ovarian cancer syndrome	VCV001072718	17	41256893 - 41256894	17	43104876 - 43104877	1072718	1064238	rs2154551556	NC_000017.11:43104876::A	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Mar 14, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.288_292delinsAACCTGT (p.Asp96fs)	BRCA1	D96fs, D49fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary breast ovarian cancer syndrome	VCV000482947	17	41256894 - 41256898	17	43104877 - 43104881	482947	478813	rs483353091	NC_000017.11:43104876:CTGTG:ACAGGTT	Indel	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.288_292delCACAGins7	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125660	17	41256894 - 41256898	17	43104877 - 43104881	125660	131198			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.290_291del (p.Thr97fs)	BRCA1	T50fs, T97fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054712	17	41256895 - 41256896	17	43104878 - 43104879	54712	69379	rs80357738	NC_000017.11:43104877:TGTGT:TGT	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.287A>T (p.Asp96Val)	BRCA1	D49V, D96V, D26V, D70V, D52V	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868827	17	41256899	17	43104882	868827	854438	rs864622444	NC_000017.11:43104881:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.287A>G (p.Asp96Gly)	BRCA1	D96G, D49G, D52G, D26G, D70G	Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000220258	17	41256899	17	43104882	220258	222681	rs864622444	NC_000017.11:43104881:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.283_286del (p.Leu95fs)	BRCA1	L48fs, L95fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000573376	17	41256900 - 41256903	17	43104883 - 43104886	573376	574492	rs1567811070	NC_000017.11:43104882:CAAGC:C	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.269_281del (p.Ile90fs)	BRCA1	I43fs, I90fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054652	17	41256905 - 41256917	17	43104888 - 43104900	54652	69319	rs80359879	NC_000017.11:43104887:TGAAAAGCACAAATGA:TGA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.279_280delinsGAA (p.Phe93fs)	BRCA1	F93fs, F46fs	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462593	17	41256906 - 41256907	17	43104889 - 43104890	462593	468075	rs1555596663	NC_000017.11:43104888:GA:TTC	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Apr 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.280C>T (p.Gln94Ter)	BRCA1	Q94*, Q47*, Q68*, Q24*, Q50*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254372	17	41256906	17	43104889	254372	249171	rs886037972	NC_000017.11:43104888:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.279del (p.Gln94fs)	BRCA1	Q47fs, Q94fs	not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV001697609	17	41256907	17	43104890	1697609	1689993	rs2154551873	NC_000017.11:43104889:AAAA:AAA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.277_279delinsCC (p.Phe93fs)	BRCA1	F46fs, F93fs	Hereditary cancer-predisposing syndrome	VCV000918604	17	41256907 - 41256909	17	43104890 - 43104892	918604	913985	rs2054677202	NC_000017.11:43104889:AAA:GG	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Mar 31, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.273_274del (p.Ala92fs)	BRCA1	A45fs, A92fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000156189	17	41256912 - 41256913	17	43104895 - 43104896	156189	165988	rs587776485	NC_000017.11:43104894:CACA:CA	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.273del (p.Cys91fs)	BRCA1	C44fs, C91fs	Hereditary cancer-predisposing syndrome	VCV001795414	17	41256913	17	43104896	1795414	1245785	rs2552254394	NC_000017.11:43104895:A:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Aug 25, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.273T>A (p.Cys91Ter)	BRCA1	C44*, C91*, C47*, C21*, C65*	Hereditary breast ovarian cancer syndrome	VCV000868339	17	41256913	17	43104896	868339	854474	rs397509006	NC_000017.11:43104895:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 30, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.260dup (p.Leu87fs)	BRCA1	L43fs, L87fs, L17fs, L40fs, L61fs	Hereditary breast ovarian cancer syndrome	VCV002761838	17	41256925 - 41256926	17	43104908 - 43104909	2761838	2911367	rs2552254599	NC_000017.11:43104908:AA:AAA	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Sep 19, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.260T>A (p.Leu87Ter)	BRCA1	L87*, L40*, L43*, L61*, L17*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266284	17	41256926	17	43104909	266284	262011	rs886040054	NC_000017.11:43104908:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.250_257dup (p.Leu87fs)	BRCA1	L87fs, L40fs	Hereditary cancer-predisposing syndrome	VCV001792243	17	41256928 - 41256929	17	43104911 - 43104912	1792243	1841831	rs2552254639	NC_000017.11:43104911:AGCTCTTCA:AGCTCTTCAGCTCTTCA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Aug 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.241_251del (p.Gln81fs)	BRCA1	Q34fs, Q81fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091588	17	41256935 - 41256945	17	43104918 - 43104928	91588	97065	rs398122659	NC_000017.11:43104917:TCAACAAGTTG:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.250G>T (p.Glu84Ter)	BRCA1	E84*, E37*, E40*, E58*, E14*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091591	17	41256936	17	43104919	91591	97068	rs398122661	NC_000017.11:43104918:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.246del (p.Val83fs)	BRCA1	V36fs, V83fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266264	17	41256940	17	43104923	266264	262012	rs886040039	NC_000017.11:43104922:AA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.243del (p.Gln81fs)	BRCA1	Q81fs, Q34fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125634	17	41256943	17	43104926	125634	131172	rs273899684	NC_000017.11:43104925:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.239_241delinsTT (p.Ser80fs)	BRCA1	S33fs, S80fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266257	17	41256945 - 41256947	17	43104928 - 43104930	266257	262013	rs886040032	NC_000017.11:43104927:GAC:AA	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.241C>T (p.Gln81Ter)	BRCA1	Q81*, Q34*, Q11*, Q55*, Q37*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054565	17	41256945	17	43104928	54565	69232	rs80357350	NC_000017.11:43104927:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.3(BRCA1):c.238_239delAGins22 (p.?)	BRCA1		Hereditary cancer-predisposing syndrome	VCV000142825	17	41256947 - 41256948	17	43104930 - 43104931	142825	152539			Indel		Pathogenic	Mar 14, 2014	criteria provided, single submitter							
NM_007294.4(BRCA1):c.237del (p.Phe79fs)	BRCA1	F32fs, F79fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266255	17	41256949	17	43104932	266255	262014	rs886040030	NC_000017.11:43104931:AAA:AA	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.232del (p.Arg78fs)	BRCA1	R78fs, R31fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054537	17	41256954	17	43104937	54537	69204	rs80357884	NC_000017.11:43104936:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.230delinsGTCAACTTGTT (p.Thr77fs)	BRCA1	T77fs, T30fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054530	17	41256956	17	43104939	54530	69197	rs397508957	NC_000017.11:43104938:G:AACAAGTTGAC	Indel	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.227del (p.Ser76fs)	BRCA1	S29fs, S32fs, S50fs, S6fs, S76fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573249	17	41256959	17	43104942	2573249	2738197	rs2552255190	NC_000017.11:43104941:C:	Deletion	frameshift variant|intron variant|5 prime UTR variant	Pathogenic	Feb 14, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.224_227del (p.Glu75fs)	BRCA1	E28fs, E75fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054514	17	41256959 - 41256962	17	43104942 - 43104945	54514	69181	rs80357697	NC_000017.11:43104941:CTTTCTT:CTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.223G>T (p.Glu75Ter)	BRCA1	E28*, E75*, E31*, E5*, E49*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000867358	17	41256963	17	43104946	867358	854586	rs1567811244	NC_000017.11:43104945:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jul 7, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.220C>T (p.Gln74Ter)	BRCA1	Q74*, Q27*, Q30*, Q48*, Q4*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054499	17	41256966	17	43104949	54499	69166	rs80357234	NC_000017.11:43104948:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.213-1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267728	17	41256974	17	43104957	267728	263000	rs80358146	NC_000017.11:43104956:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.213-1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Breast neoplasm|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054472	17	41256974	17	43104957	54472	69139	rs80358146	NC_000017.11:43104956:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jul 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.213-2A>T	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000662713	17	41256975	17	43104958	662713	652805	rs397508940	NC_000017.11:43104957:T:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jan 30, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.213-2A>G	BRCA1		Breast neoplasm|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224426	17	41256975	17	43104958	224426	226210	rs397508940	NC_000017.11:43104957:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.213-2A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054473	17	41256975	17	43104958	54473	69140	rs397508940	NC_000017.11:43104957:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.213-5T>A	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000254639	17	41256978	17	43104961	254639	249184	rs886038196	NC_000017.11:43104960:A:T	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Sep 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.213-11T>G	BRCA1		Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|BRCA1-related cancer predisposition|Inherited breast cancer and ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000037449	17	41256984	17	43104967	37449	46005	rs80358061	NC_000017.11:43104966:A:C	single nucleotide variant	intron variant	Pathogenic	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.213-12A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037450	17	41256985	17	43104968	37450	46006	rs80358163	NC_000017.11:43104967:T:C	single nucleotide variant	intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.212+3A>G	BRCA1		BRCA1-related cancer predisposition	VCV000054467	17	41258470	17	43106453	54467	69134	rs80358083	NC_000017.11:43106452:T:C	single nucleotide variant	intron variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.212+2T>C	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054466	17	41258471	17	43106454	54466	69133	rs80358026	NC_000017.11:43106453:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.212+1G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054465	17	41258472	17	43106455	54465	69132	rs80358042	NC_000017.11:43106454:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.212+1G>C	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Neoplasm	VCV000054464	17	41258472	17	43106455	54464	69131	rs80358042	NC_000017.11:43106454:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Dec 15, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_007294.4(BRCA1):c.212+1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037446	17	41258472	17	43106455	37446	46002	rs80358042	NC_000017.11:43106454:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.212G>C (p.Arg71Thr)	BRCA1	R71T, R24T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267512	17	41258473	17	43106456	267512	262989	rs80356913	NC_000017.11:43106455:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.212G>T (p.Arg71Met)	BRCA1	R71M, R24M	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000185705	17	41258473	17	43106456	185705	185125	rs80356913	NC_000017.11:43106455:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	BRCA1	R71K, R24K	Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054471	17	41258473	17	43106456	54471	69138	rs80356913	NC_000017.11:43106455:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.211dup (p.Arg71fs)	BRCA1	R24fs, R71fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054463	17	41258473 - 41258474	17	43106456 - 43106457	54463	69130	rs397508938	NC_000017.11:43106456:TTTT:TTTTT	Duplication	frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.210_211del (p.Arg71fs)	BRCA1	R24fs, R71fs	Hereditary breast ovarian cancer syndrome	VCV002703032	17	41258474 - 41258475	17	43106457 - 43106458	2703032	2862728	rs397508938	NC_000017.11:43106456:TTTT:TT	Deletion	frameshift variant|intron variant	Pathogenic	Nov 5, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.190_211del (p.Cys64fs)	BRCA1	C64fs, C17fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266198	17	41258474 - 41258495	17	43106457 - 43106478	266198	262015	rs886039978	NC_000017.11:43106456:TTTTGGTTATATCATTCTTACAT:T	Deletion	frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.211del (p.Arg71fs)	BRCA1	R24fs, R71fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254371	17	41258474	17	43106457	254371	249172	rs397508938	NC_000017.11:43106456:TTTT:TTT	Deletion	frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	BRCA1	R71G, R24G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017693	17	41258474	17	43106457	17693	32732	rs80357382	NC_000017.11:43106456:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.207dup (p.Lys70fs)	BRCA1	K70fs, K23fs	Hereditary breast ovarian cancer syndrome	VCV002029059	17	41258477 - 41258478	17	43106460 - 43106461	2029059	2081852	rs2154554705	NC_000017.11:43106460:GG:GGG	Duplication	frameshift variant	Pathogenic	Sep 6, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.205dup (p.Thr69fs)	BRCA1	T69fs, T22fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254370	17	41258479 - 41258480	17	43106462 - 43106463	254370	249173	rs273898673	NC_000017.11:43106462:TT:TTT	Duplication	frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.196_204delinsGACATAAGGTATAT (p.Asn66fs)	BRCA1	N19fs, N66fs	Hereditary cancer-predisposing syndrome	VCV001783414	17	41258481 - 41258489	17	43106464 - 43106472	1783414	1843359	rs2552258074	NC_000017.11:43106463:TATATCATT:ATATACCTTATGTC	Indel	frameshift variant	Pathogenic	Oct 12, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.203_204del (p.Ile68fs)	BRCA1	I21fs, I68fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091573	17	41258481 - 41258482	17	43106464 - 43106465	91573	97050	rs398122651	NC_000017.11:43106463:TATAT:TAT	Microsatellite	frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.202dup (p.Ile68fs)	BRCA1	I68fs, I21fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266210	17	41258482 - 41258483	17	43106465 - 43106466	266210	262016	rs886039990	NC_000017.11:43106465:T:TT	Duplication	frameshift variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.195del (p.Asn66fs)	BRCA1	N66fs, N19fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054414	17	41258490	17	43106473	54414	69081	rs80357869	NC_000017.11:43106472:C:	Deletion	frameshift variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.190_193del (p.Cys64fs)	BRCA1	C64fs, C17fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054395	17	41258492 - 41258495	17	43106475 - 43106478	54395	69062	rs397508917	NC_000017.11:43106474:TACATA:TA	Deletion	frameshift variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.192T>G (p.Cys64Trp)	BRCA1	C64W, C17W	Breast neoplasm|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224427	17	41258493	17	43106476	224427	226211	rs587781632	NC_000017.11:43106475:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.192T>A (p.Cys64Ter)	BRCA1	C64*, C17*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000141286	17	41258493	17	43106476	141286	151000	rs587781632	NC_000017.11:43106475:A:T	single nucleotide variant	nonsense	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.190_191insAATGTAAGGATGATATAAA (p.Cys64Ter)	BRCA1	C64*, C17*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548178	17	41258494 - 41258495	17	43106477 - 43106478	548178	538914	rs1555597215	NC_000017.11:43106477::TTTATATCATCCTTACATT	Insertion	frameshift variant|nonsense|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser)	BRCA1	C64S, C17S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462571	17	41258494	17	43106477	462571	468251	rs55851803	NC_000017.11:43106476:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr)	BRCA1	C64Y, C17Y	BRCA1-related cancer predisposition	VCV000054400	17	41258494	17	43106477	54400	69067	rs55851803	NC_000017.11:43106476:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.190T>C (p.Cys64Arg)	BRCA1	C64R, C17R, M1T	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000054394	17	41258495	17	43106478	54394	69061	rs80357064	NC_000017.11:43106477:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jul 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.189dup (p.Cys64fs)	BRCA1	C17fs, C64fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054390	17	41258495 - 41258496	17	43106478 - 43106479	54390	69057	rs273897665	NC_000017.11:43106478:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.190T>G (p.Cys64Gly)	BRCA1	C64G, C17G, M1R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017660	17	41258495	17	43106478	17660	32699	rs80357064	NC_000017.11:43106477:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.187_188dup (p.Leu63fs)	BRCA1	L16fs, L63fs	Hereditary breast ovarian cancer syndrome	VCV001407446	17	41258496 - 41258497	17	43106479 - 43106480	1407446	1483655	rs1555597235	NC_000017.11:43106479:AAA:AAAAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Apr 12, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.187_188del (p.Leu63fs)	BRCA1	L63fs, L16fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548171	17	41258497 - 41258498	17	43106480 - 43106481	548171	538915	rs1555597235	NC_000017.11:43106479:AAA:A	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.188T>A (p.Leu63Ter)	BRCA1	L63*, L16*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054381	17	41258497	17	43106480	54381	69048	rs80357086	NC_000017.11:43106479:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.183_184insGCGC (p.Pro62fs)	BRCA1	P15fs, P62fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548199	17	41258501 - 41258502	17	43106484 - 43106485	548199	538916	rs1555597239	NC_000017.11:43106484::GCGC	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.182_183insGCGC (p.Cys61fs)	BRCA1	C14fs, C61fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266191	17	41258502 - 41258503	17	43106485 - 43106486	266191	262017	rs886039971	NC_000017.11:43106485::GCGC	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.182_183del (p.Cys61fs)	BRCA1	C14fs, C61fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054365	17	41258502 - 41258503	17	43106485 - 43106486	54365	69032	rs397508912	NC_000017.11:43106484:ACAC:AC	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.182G>A (p.Cys61Tyr)	BRCA1	C61Y, C14Y	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054364	17	41258503	17	43106486	54364	69031	rs80357093	NC_000017.11:43106485:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.181T>C (p.Cys61Arg)	BRCA1	C61R, C14R	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054360	17	41258504	17	43106487	54360	69027	rs28897672	NC_000017.11:43106486:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.181T>A (p.Cys61Ser)	BRCA1	C61S, C14S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054359	17	41258504	17	43106487	54359	69026	rs28897672	NC_000017.11:43106486:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 2, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	BRCA1	C61G, C14G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017661	17	41258504	17	43106487	17661	32700	rs28897672	NC_000017.11:43106486:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.179dup (p.Cys61fs)	BRCA1	C61fs, C14fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266189	17	41258505 - 41258506	17	43106488 - 43106489	266189	262018	rs886039969	NC_000017.11:43106488:T:TT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.179del (p.Gln60fs)	BRCA1	Q13fs, Q60fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054353	17	41258506	17	43106489	54353	69020	rs80357591	NC_000017.11:43106488:T:	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.178_179del (p.Gln60fs)	BRCA1	Q13fs, Q60fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054350	17	41258506 - 41258507	17	43106489 - 43106490	54350	69017	rs397508907	NC_000017.11:43106488:TGTG:TG	Microsatellite	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.178C>T (p.Gln60Ter)	BRCA1	Q60*, Q13*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054349	17	41258507	17	43106490	54349	69016	rs80357471	NC_000017.11:43106489:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.175dup (p.Ser59fs)	BRCA1	S12fs, S59fs	Hereditary breast ovarian cancer syndrome	VCV002011772	17	41258509 - 41258510	17	43106492 - 43106493	2011772	2067149	rs2552258479	NC_000017.11:43106492:AA:AAA	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Jun 28, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.176C>A (p.Ser59Ter)	BRCA1	S59*, S12*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266186	17	41258509	17	43106492	266186	262019	rs199522616	NC_000017.11:43106491:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.171dup (p.Pro58fs)	BRCA1	P58fs, P11fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266182	17	41258513 - 41258514	17	43106496 - 43106497	266182	262020	rs80357660	NC_000017.11:43106496:CCC:CCCC	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.171del (p.Pro58fs)	BRCA1	P58fs, P11fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125589	17	41258514	17	43106497	125589	131127	rs80357660	NC_000017.11:43106496:CCC:CC	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.166_169del (p.Lys56fs)	BRCA1	K56fs, K9fs	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV001068970	17	41258516 - 41258519	17	43106499 - 43106502	1068970	1064240	rs2154555258	NC_000017.11:43106498:CTTTCTT:CTT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Nov 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.165_166dup (p.Lys56fs)	BRCA1	K56fs, K9fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254369	17	41258518 - 41258519	17	43106501 - 43106502	254369	249174	rs80357550	NC_000017.11:43106501:TCT:TCTCT	Duplication	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.166A>T (p.Lys56Ter)	BRCA1	K56*, K9*	Hereditary cancer-predisposing syndrome	VCV000867295	17	41258519	17	43106502	867295	854695	rs2054785999	NC_000017.11:43106501:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jan 20, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.160del (p.Gln54fs)	BRCA1	Q7fs, Q54fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054308	17	41258525	17	43106508	54308	68975	rs397508890	NC_000017.11:43106507:GG:G	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.160C>T (p.Gln54Ter)	BRCA1	Q54*, Q7*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054307	17	41258525	17	43106508	54307	68974	rs80356864	NC_000017.11:43106507:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.158del (p.Asn53fs)	BRCA1	N53fs, N6fs	Hereditary breast ovarian cancer syndrome	VCV002024251	17	41258527	17	43106510	2024251	2077028	rs2552258664	NC_000017.11:43106509:TT:T	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Oct 7, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.150del (p.Lys50fs)	BRCA1	K3fs, K50fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054276	17	41258535	17	43106518	54276	68943	rs273897662	NC_000017.11:43106517:TTT:TT	Deletion	frameshift variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.144del (p.Met48fs)	BRCA1	M48fs, M1fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054256	17	41258541	17	43106524	54256	68923	rs80357682	NC_000017.11:43106523:C:	Deletion	frameshift variant|initiator_codon_variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.143del (p.Met48fs)	BRCA1	M48fs, M1fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037412	17	41258542	17	43106525	37412	45968	rs80357637	NC_000017.11:43106524:A:	Deletion	frameshift variant|initiator_codon_variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.141_142insT (p.Met48fs)	BRCA1	M48fs, M1fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548198	17	41258543 - 41258544	17	43106526 - 43106527	548198	538917	rs1555597309	NC_000017.11:43106526::A	Insertion	frameshift variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.137_141delinsAATTTATAGATTT (p.Phe46_Cys47delinsTer)	BRCA1		BRCA1-related cancer predisposition|Hereditary cancer-predisposing syndrome	VCV003226100	17	41258544 - 41258548	17	43106527 - 43106531	3226100	3390605	rs2552258916	NC_000017.11:43106526:GCAAA:AAATCTATAAATT	Indel	nonsense|5 prime UTR variant|frameshift variant|intron variant	Pathogenic	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.140_141insT (p.Met48fs)	BRCA1	M48fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266165	17	41258544 - 41258545	17	43106527 - 43106528	266165	262021	rs886039950	NC_000017.11:43106527::A	Insertion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.141C>A (p.Cys47Ter)	BRCA1	C47*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091553	17	41258544	17	43106527	91553	97030	rs398122635	NC_000017.11:43106526:G:T	single nucleotide variant	5 prime UTR variant|nonsense|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.139dup (p.Cys47fs)	BRCA1	C47fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125570	17	41258545 - 41258546	17	43106528 - 43106529	125570	131108	rs80357734	NC_000017.11:43106528:AAAA:AAAAA	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.140G>T (p.Cys47Phe)	BRCA1	C47F	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054247	17	41258545	17	43106528	54247	68914	rs80357150	NC_000017.11:43106527:C:A	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.140G>A (p.Cys47Tyr)	BRCA1	C47Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054246	17	41258545	17	43106528	54246	68913	rs80357150	NC_000017.11:43106527:C:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.139T>C (p.Cys47Arg)	BRCA1	C47R	Hereditary breast ovarian cancer syndrome	VCV000651975	17	41258546	17	43106529	651975	646060	rs80357370	NC_000017.11:43106528:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.139T>A (p.Cys47Ser)	BRCA1	C47S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267508	17	41258546	17	43106529	267508	262990	rs80357370	NC_000017.11:43106528:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.10:g.(41258551_41267742)_(41276114_?)del	BRCA1|LOC110485084|LOC111589216		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000440440	17	41258551 - 41276114	17	43106534 - 43124097	440440	434075			Deletion		Pathogenic	Mar 20, 2015	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(102259_111450)del	BRCA1|LOC110485084|LOC111589215|LOC111589216		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373864	17	41258551 - 41277500	17	43106534 - 43125483	373864	360763			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.135-1G>A	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000245755	17	41258551	17	43106534	245755	245056	rs80358158	NC_000017.11:43106533:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.135-1G>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054215	17	41258551	17	43106534	54215	68882	rs80358158	NC_000017.11:43106533:C:G	single nucleotide variant	intron variant|splice acceptor variant	Pathogenic	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.135-1G>T	BRCA1		BRCA1-related cancer predisposition	VCV000037404	17	41258551	17	43106534	37404	45960	rs80358158	NC_000017.11:43106533:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125567	17	41258552	17	43106535	125567	131105	rs80358065	NC_000017.11:43106534:T:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NC_000017.11:g.43110502_43125418del	BRCA1|LOC110485084|LOC111589215|LOC111589216		Familial cancer of breast	VCV001685583			17	43110502 - 43125418	1685583	1677599			Deletion		Pathogenic	May 4, 2022	criteria provided, single submitter							
Single allele	BRCA1|LOC110485084|LOC111589216		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373839	17	41263493 - 41273654	17	43111476 - 43121637	373839	360739			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.81-1588_134+1725del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267627	17	41266018 - 41269384	17	43114001 - 43117367	267627	262991			Deletion	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.115_134+1567del	BRCA1		Hereditary cancer-predisposing syndrome	VCV001733845	17	41266176 - 41267762	17	43114159 - 43115745	1733845	1789595			Deletion	splice donor variant|intron variant	Pathogenic	Aug 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.105_134+1007delinsTCCTTGAT	BRCA1		Hereditary cancer-predisposing syndrome	VCV001776759	17	41266736 - 41267772	17	43114719 - 43115755	1776759	1834033			Indel	splice donor variant|intron variant	Pathogenic	Jun 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.105_134+1007del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462546	17	41266736 - 41267772	17	43114719 - 43115755	462546	466927			Deletion	splice donor variant|intron variant	Pathogenic	Aug 24, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.81-1794_134+629dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001762060	17	41267113 - 41267114	17	43115096 - 43115097	1762060	1820196			Duplication	splice acceptor variant|splice donor variant|intron variant	Pathogenic	Aug 9, 2017	criteria provided, single submitter							
NC_000017.11:g.(?_43115706)_(43125483_?)del	BRCA1|LOC110485084|LOC111589215|LOC111589216		Hereditary breast ovarian cancer syndrome	VCV000584117	17	41267723 - 41277500	17	43115706 - 43125483	584117	568637			Deletion		Pathogenic	Aug 16, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43115720)_(43124102_?)del	LOC110485084|LOC111589216|BRCA1		Hereditary breast ovarian cancer syndrome	VCV000462212	17	41267737 - 41276119	17	43115720 - 43124102	462212	467373			Deletion		Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.134+3_134+6del	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054213	17	41267737 - 41267740	17	43115720 - 43115723	54213	68880	rs397508858	NC_000017.11:43115719:ACTTACTT:ACTT	Microsatellite	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Nov 5, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.134+5G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000091548	17	41267738	17	43115721	91548	97025	rs80358038	NC_000017.11:43115720:C:T	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	May 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.134+5G>C	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000037400	17	41267738	17	43115721	37400	45956	rs80358038	NC_000017.11:43115720:C:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.134+3_134+4insT	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267727	17	41267739 - 41267740	17	43115722 - 43115723	267727	263001	rs886041002	NC_000017.11:43115722::A	Insertion	intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.134+3A>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054212	17	41267740	17	43115723	54212	68879	rs80358064	NC_000017.11:43115722:T:G	single nucleotide variant	intron variant	Pathogenic	Dec 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.133_134+3delinsT	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054207	17	41267740 - 41267744	17	43115723 - 43115727	54207	68874	rs397508856	NC_000017.11:43115722:TACTT:A	Indel	splice donor variant|intron variant	Pathogenic	Jun 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.134+2T>A	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867519	17	41267741	17	43115724	867519	855795	rs80358131	NC_000017.11:43115723:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.134+2T>C	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091547	17	41267741	17	43115724	91547	97024	rs80358131	NC_000017.11:43115723:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.134+2del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054211	17	41267741	17	43115724	54211	68878	rs273897657	NC_000017.11:43115723:A:	Deletion	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.134+2T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054210	17	41267741	17	43115724	54210	68877	rs80358131	NC_000017.11:43115723:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.133_134+1del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073201	17	41267742 - 41267744	17	43115725 - 43115727	1073201	1064242	rs2154565302	NC_000017.11:43115724:CTT:	Deletion	splice donor variant|intron variant	Pathogenic	May 21, 2018	criteria provided, single submitter							
NM_007294.4(BRCA1):c.134+1G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000267499	17	41267742	17	43115725	267499	262992	rs80358043	NC_000017.11:43115724:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	May 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.134+1G>C	BRCA1		Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000125563	17	41267742	17	43115725	125563	131101	rs80358043	NC_000017.11:43115724:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.134+1G>T	BRCA1		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054209	17	41267742	17	43115725	54209	68876	rs80358043	NC_000017.11:43115724:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Jan 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.81-?_134+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224944	17	41267743 - 41267796	17	43115726 - 43115779	224944	226810			Deletion		Pathogenic/Likely pathogenic	Apr 20, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81_134del (p.Cys27_Lys45delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000224416	17	41267743 - 41267796	17	43115726 - 43115779	224416	226212	rs1555599208		Deletion	nonsense|inframe_indel|non-coding transcript variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.3(BRCA1):c.(?_-1)_134+?del	BRCA1|LOC110485084|LOC111589216		Hereditary breast ovarian cancer syndrome	VCV000218290	17	41267743 - 41276114	17	43115726 - 43124097	218290	214915			Deletion		Pathogenic	Nov 26, 2014	criteria provided, single submitter							
NM_007294.4(BRCA1):c.133_134delAA (p.Lys45fs)	BRCA1	K45fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054208	17	41267743 - 41267744	17	43115726 - 43115727	54208	68875	rs397508857	NC_000017.11:43115725:TT:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.131_132del (p.Phe43_Cys44insTer)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803420	17	41267745 - 41267746	17	43115728 - 43115729	803420	791774	rs1597911705	NC_000017.11:43115727:GC:	Deletion	frameshift variant|nonsense|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Mar 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.132C>T (p.Cys44=)	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000230061	17	41267745	17	43115728	230061	236178	rs876658362	NC_000017.11:43115727:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant|splice donor variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.131G>C (p.Cys44Ser)	BRCA1	C44S	Hereditary breast ovarian cancer syndrome	VCV000868170	17	41267746	17	43115729	868170	854771	rs80357446	NC_000017.11:43115728:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jul 25, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.130dup (p.Cys44fs)	BRCA1	C44fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096898	17	41267746 - 41267747	17	43115729 - 43115730	96898	102801	rs80357951	NC_000017.11:43115729:AAAA:AAAAA	Duplication	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.131G>T (p.Cys44Phe)	BRCA1	C44F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054200	17	41267746	17	43115729	54200	68867	rs80357446	NC_000017.11:43115728:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	BRCA1	C44Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054199	17	41267746	17	43115729	54199	68866	rs80357446	NC_000017.11:43115728:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.130del (p.Cys44fs)	BRCA1	C44fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054194	17	41267747	17	43115730	54194	68861	rs80357951	NC_000017.11:43115729:AAAA:AAA	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.130T>C (p.Cys44Arg)	BRCA1	C44R	Hereditary breast ovarian cancer syndrome	VCV000054192	17	41267747	17	43115730	54192	68859	rs80357327	NC_000017.11:43115729:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Mar 6, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.130T>A (p.Cys44Ser)	BRCA1	C44S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054191	17	41267747	17	43115730	54191	68858	rs80357327	NC_000017.11:43115729:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.125dup (p.Phe43fs)	BRCA1	F43fs	Hereditary breast ovarian cancer syndrome	VCV001679003	17	41267751 - 41267752	17	43115734 - 43115735	1679003	1670797	rs2154565438	NC_000017.11:43115734:A:AA	Duplication	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Apr 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.124del (p.Ile42fs)	BRCA1	I42fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054173	17	41267753	17	43115736	54173	68840	rs80357943	NC_000017.11:43115735:T:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.122del (p.His41fs)	BRCA1	H41fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054167	17	41267755	17	43115738	54167	68834	rs397508847	NC_000017.11:43115737:T:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.122A>G (p.His41Arg)	BRCA1	H41R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054166	17	41267755	17	43115738	54166	68833	rs80357276	NC_000017.11:43115737:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.117_121delinsGAG (p.Cys39fs)	BRCA1	C39fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002673993	17	41267756 - 41267760	17	43115739 - 43115743	2673993	2841485	rs2552269033	NC_000017.11:43115738:GGTCA:CTC	Indel	intron variant|frameshift variant|5 prime UTR variant	Pathogenic	Oct 25, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.121C>T (p.His41Tyr)	BRCA1	H41Y	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|BRCA1-related cancer predisposition	VCV000580736	17	41267756	17	43115739	580736	569193	rs1060502353	NC_000017.11:43115738:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.121del (p.His41fs)	BRCA1	H41fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548235	17	41267756	17	43115739	548235	538918	rs1555599226	NC_000017.11:43115738:GG:G	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.117_118del (p.Cys39_Asp40delinsTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054157	17	41267759 - 41267760	17	43115742 - 43115743	54157	68824	rs80357972	NC_000017.11:43115741:CACAC:CAC	Microsatellite	frameshift variant|nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.117T>A (p.Cys39Ter)	BRCA1	C39*	Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000479243	17	41267760	17	43115743	479243	478892	rs886040898	NC_000017.11:43115742:A:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Mar 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.117T>G (p.Cys39Trp)	BRCA1	C39W	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000267497	17	41267760	17	43115743	267497	262993	rs886040898	NC_000017.11:43115742:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Jan 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.116G>T (p.Cys39Phe)	BRCA1	C39F	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037393	17	41267761	17	43115744	37393	45949	rs80357498	NC_000017.11:43115743:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.116G>A (p.Cys39Tyr)	BRCA1	C39Y	Hereditary cancer-predisposing syndrome|Breast neoplasm|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037392	17	41267761	17	43115744	37392	45948	rs80357498	NC_000017.11:43115743:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.115T>G (p.Cys39Gly)	BRCA1	C39G	not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054153	17	41267762	17	43115745	54153	68820	rs80357164	NC_000017.11:43115744:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg)	BRCA1	C39R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054152	17	41267762	17	43115745	54152	68819	rs80357164	NC_000017.11:43115744:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.115T>A (p.Cys39Ser)	BRCA1	C39S	Inherited breast cancer and ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054151	17	41267762	17	43115745	54151	68818	rs80357164	NC_000017.11:43115744:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jul 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.112_113del (p.Lys38fs)	BRCA1	K38fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054141	17	41267764 - 41267765	17	43115747 - 43115748	54141	68808	rs80357949	NC_000017.11:43115746:TTT:T	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.110C>G (p.Thr37Arg)	BRCA1	T37R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054132	17	41267767	17	43115750	54132	68799	rs80356880	NC_000017.11:43115749:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys)	BRCA1	T37K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054131	17	41267767	17	43115750	54131	68798	rs80356880	NC_000017.11:43115749:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.105dup (p.Ser36fs)	BRCA1	S36fs	Hereditary cancer-predisposing syndrome	VCV000631234	17	41267771 - 41267772	17	43115754 - 43115755	631234	618704	rs1567817957	NC_000017.11:43115754:G:GG	Duplication	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Dec 28, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.98_105del (p.Glu33fs)	BRCA1	E33fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266600	17	41267772 - 41267779	17	43115755 - 43115762	266600	262023	rs886040338	NC_000017.11:43115754:GACAGGTT:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.101_105del (p.Pro34fs)	BRCA1	P34fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266129	17	41267772 - 41267776	17	43115755 - 43115759	266129	262022	rs886039920	NC_000017.11:43115754:GACAGG:G	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.104del (p.Val35fs)	BRCA1	V35fs	Hereditary breast ovarian cancer syndrome	VCV003726007	17	41267773	17	43115756	3726007	3857915		NC_000017.11:43115755:A:	Deletion	intron variant|5 prime UTR variant|frameshift variant	Pathogenic	Dec 24, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.102del (p.Val35fs)	BRCA1	V35fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266132	17	41267775	17	43115758	266132	262024	rs886039922	NC_000017.11:43115757:A:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.101del (p.Pro34fs)	BRCA1	P34fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054103	17	41267776	17	43115759	54103	68770	rs80357750	NC_000017.11:43115758:GG:G	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.97G>T (p.Glu33Ter)	BRCA1	E33*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000462693	17	41267780	17	43115763	462693	467784	rs80357066	NC_000017.11:43115762:C:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Nov 21, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.94A>T (p.Lys32Ter)	BRCA1	K32*	Hereditary breast ovarian cancer syndrome	VCV000867794	17	41267783	17	43115766	867794	854837	rs2055258887	NC_000017.11:43115765:T:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Oct 26, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.93del (p.Lys32fs)	BRCA1	K32fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266593	17	41267784	17	43115767	266593	262025	rs886040332	NC_000017.11:43115766:G:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.89T>A (p.Leu30Ter)	BRCA1	L30*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055745	17	41267788	17	43115771	55745	70412	rs397509331	NC_000017.11:43115770:A:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.85del (p.Glu29fs)	BRCA1	E29fs	not provided	VCV003337865	17	41267792	17	43115775	3337865	3496525		NC_000017.11:43115774:CC:C	Deletion	5 prime UTR variant|frameshift variant|intron variant	Pathogenic	May 27, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.85G>T (p.Glu29Ter)	BRCA1	E29*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037707	17	41267792	17	43115775	37707	46263	rs80357443	NC_000017.11:43115774:C:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.83_84del (p.Leu28fs)	BRCA1	L28fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055733	17	41267793 - 41267794	17	43115776 - 43115777	55733	70400	rs80357728	NC_000017.11:43115775:CA:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.83del (p.Leu28fs)	BRCA1	L28fs	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000482898	17	41267794	17	43115777	482898	478830	rs1555599281	NC_000017.11:43115776:A:	Deletion	frameshift variant|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-1G>T	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867461	17	41267797	17	43115780	867461	855796	rs80358018	NC_000017.11:43115779:C:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-5_81-1delinsACCTTGA	BRCA1		Hereditary cancer-predisposing syndrome	VCV000491192	17	41267797 - 41267801	17	43115780 - 43115784	491192	484971	rs1555599292	NC_000017.11:43115779:CTAGC:TCAAGGT	Indel	splice acceptor variant|intron variant	Pathogenic	Nov 17, 2020	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(93968_102204)dup	BRCA1|LOC110485084|LOC111589215|LOC111589216		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373886	17	41267797 - 41277500	17	43115780 - 43125483	373886	360765			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.(?_92501)_(93968_102204)del	BRCA1|LOC110485084|LOC111589215|LOC111589216		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373880	17	41267797 - 41277500	17	43115780 - 43125483	373880	360764			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.81-1G>A	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091668	17	41267797	17	43115780	91668	97145	rs80358018	NC_000017.11:43115779:C:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-1G>C	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055715	17	41267797	17	43115780	55715	70382	rs80358018	NC_000017.11:43115779:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-2A>C	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136092	17	41267798	17	43115781	136092	139804	rs397509326	NC_000017.11:43115780:T:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jun 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-2del	BRCA1		Inherited ovarian cancer (without breast cancer)|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055717	17	41267798	17	43115781	55717	70384	rs273902791	NC_000017.11:43115780:T:	Deletion	splice acceptor variant|intron variant	Pathogenic	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-2A>G	BRCA1		Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055716	17	41267798	17	43115781	55716	70383	rs397509326	NC_000017.11:43115780:T:C	single nucleotide variant	intron variant|splice acceptor variant	Pathogenic/Likely pathogenic	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-9C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055719	17	41267805	17	43115788	55719	70386	rs80358127	NC_000017.11:43115787:G:C	single nucleotide variant	intron variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.3(BRCA1):c.-7620_80+468delins8	NBR2|BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267619	17	41275566 - 41284888	17	43123549 - 43132871	267619	262994			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.-19-48_80+248delins[U77841.1:g.2145_2536]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373856	17	41275786 - 41276180	17	43123769 - 43124163	373856	360740			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(?_43123997)_(43125483_?)del	BRCA1|LOC111589215		Hereditary breast ovarian cancer syndrome	VCV000584147	17	41276014 - 41277500	17	43123997 - 43125483	584147	570705			Deletion		Pathogenic	Jan 8, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.70_80+9del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV004071381	17	41276025 - 41276044	17	43124008 - 43124027	4071381	4185229		NC_000017.11:43124007:CTGACTTACCAGATGGGACACT:CT	Deletion	splice donor variant|intron variant	Pathogenic	May 1, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.80+5G>T	BRCA1		Hereditary cancer-predisposing syndrome	VCV000479218	17	41276029	17	43124012	479218	479563	rs80358045	NC_000017.11:43124011:C:A	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Apr 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.80+4A>T	BRCA1		BRCA1-related cancer predisposition	VCV000125519	17	41276030	17	43124013	125519	131057	rs80358003	NC_000017.11:43124012:T:A	single nucleotide variant	intron variant	Pathogenic	May 23, 2025	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+3A>C	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000865069	17	41276031	17	43124014	865069	855841	rs1567823106	NC_000017.11:43124013:T:G	single nucleotide variant	intron variant	Pathogenic	Dec 9, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.80+2T>C	BRCA1		Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S	VCV000868761	17	41276032	17	43124015	868761	855842	rs80358128	NC_000017.11:43124014:A:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Sep 25, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.80+2T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267620	17	41276032	17	43124015	267620	262995	rs80358128	NC_000017.11:43124014:A:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.80+2T>G	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000125518	17	41276032	17	43124015	125518	131056	rs80358128	NC_000017.11:43124014:A:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.80+1G>T	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125517	17	41276033	17	43124016	125517	131055	rs80358010	NC_000017.11:43124015:C:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jan 21, 2020	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.80+1G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000125516	17	41276033	17	43124016	125516	131054	rs80358010	NC_000017.11:43124015:C:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Oct 9, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.80+1G>A	BRCA1		Hereditary cancer-predisposing syndrome|Ovarian cancer|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055710	17	41276033	17	43124016	55710	70377	rs80358010	NC_000017.11:43124015:C:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Sep 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.-19-?_80+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000254080	17	41276034 - 41276132	17	43124017 - 43124115	254080	248530			Deletion		Pathogenic	Jan 17, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.(?_-1)_80+?del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000218291	17	41276034 - 41276114	17	43124017 - 43124097	218291	214916			Deletion		Pathogenic	May 27, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.69_79delGTGTCCCATCT (p.Cys24fs)	BRCA1	C24fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055676	17	41276034 - 41276044	17	43124017 - 43124027	55676	70343	rs80357696	NC_000017.11:43124016:CAGATGGGACAC:C	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.75del (p.Ile26fs)	BRCA1	I26fs	Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000827148	17	41276039	17	43124022	827148	813920	rs80357633	NC_000017.11:43124021:GGG:GG	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.67_75del (p.Glu23_Pro25del)	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000496400	17	41276039 - 41276047	17	43124022 - 43124030	496400	487999	rs1555600865	NC_000017.11:43124021:GGGACACTC:	Deletion	inframe_indel|inframe_deletion|5 prime UTR variant|non-coding transcript variant	Pathogenic	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.74_75del (p.Pro25fs)	BRCA1	P25fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254368	17	41276039 - 41276040	17	43124022 - 43124023	254368	249175	rs80357633	NC_000017.11:43124021:GGG:G	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.70_73dup (p.Pro25fs)	BRCA1	P25fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055675	17	41276040 - 41276041	17	43124023 - 43124024	55675	70342	rs397509310	NC_000017.11:43124023:GACA:GACAGACA	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.72_73insGTCT (p.Pro25fs)	BRCA1	P25fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548230	17	41276041 - 41276042	17	43124024 - 43124025	548230	538919	rs1555600872	NC_000017.11:43124024:A:AGACA	Insertion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.72_73del (p.Pro25fs)	BRCA1	P25fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055680	17	41276041 - 41276042	17	43124024 - 43124025	55680	70347	rs397509311	NC_000017.11:43124023:GA:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.72T>A (p.Cys24Ter)	BRCA1	C24*	Hereditary breast ovarian cancer syndrome|not provided	VCV000868782	17	41276042	17	43124025	868782	854880	rs1597923232	NC_000017.11:43124024:A:T	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.72T>G (p.Cys24Trp)	BRCA1	C24W	Hereditary breast ovarian cancer syndrome	VCV000652430	17	41276042	17	43124025	652430	646062	rs1597923232	NC_000017.11:43124024:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 9, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.71_72insA (p.Cys24Ter)	BRCA1	C24*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548320	17	41276042 - 41276043	17	43124025 - 43124026	548320	538920	rs1555600873	NC_000017.11:43124025::T	Insertion	frameshift variant|nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.71_72del (p.Cys24fs)	BRCA1	C24fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266572	17	41276042 - 41276043	17	43124025 - 43124026	266572	262026	rs886040312	NC_000017.11:43124024:ACAC:AC	Microsatellite	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.70_71insTGTC (p.Cys24fs)	BRCA1	C24fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125512	17	41276043 - 41276044	17	43124026 - 43124027	125512	131050	rs80357536	NC_000017.11:43124026::GACA	Insertion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.70_71insA (p.Cys24Ter)	BRCA1	C24*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125511	17	41276043 - 41276044	17	43124026 - 43124027	125511	131049	rs80357536	NC_000017.11:43124026::T	Insertion	frameshift variant|nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.71G>A (p.Cys24Tyr)	BRCA1	C24Y	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055678	17	41276043	17	43124026	55678	70345	rs80357198	NC_000017.11:43124025:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.70T>G (p.Cys24Gly)	BRCA1	C24G	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000649351	17	41276044	17	43124027	649351	646063	rs80357410	NC_000017.11:43124026:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.70T>A (p.Cys24Ser)	BRCA1	C24S	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000638952	17	41276044	17	43124027	638952	646064	rs80357410	NC_000017.11:43124026:A:T	single nucleotide variant	missense variant|non-coding transcript variant|5 prime UTR variant	Pathogenic/Likely pathogenic	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.69dup (p.Cys24fs)	BRCA1	C24fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266569	17	41276044 - 41276045	17	43124027 - 43124028	266569	262027	rs1555600893	NC_000017.11:43124027:C:CC	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.70T>C (p.Cys24Arg)	BRCA1	C24R	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055674	17	41276044	17	43124027	55674	70341	rs80357410	NC_000017.11:43124026:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.68_69dup (p.Cys24fs)	BRCA1	C24fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055667	17	41276044 - 41276045	17	43124027 - 43124028	55667	70334	rs80357914	NC_000017.11:43124027:CTCT:CTCTCT	Microsatellite	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.68dup (p.Cys24fs)	BRCA1	C24fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055668	17	41276045 - 41276046	17	43124028 - 43124029	55668	70335	rs397509309	NC_000017.11:43124028:T:TT	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.68_69del (p.Glu23fs)	BRCA1	E23fs	BRCA1-related cancer predisposition	VCV000017662	17	41276045 - 41276046	17	43124028 - 43124029	17662	32701	rs80357914	NC_000017.11:43124027:CTCT:CT	Microsatellite	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.67_68insC (p.Glu23fs)	BRCA1	E23fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548217	17	41276046 - 41276047	17	43124029 - 43124030	548217	538921	rs1555600897	NC_000017.11:43124029::G	Insertion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.68del (p.Glu23fs)	BRCA1	E23fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266568	17	41276046	17	43124029	266568	262028	rs886040309	NC_000017.11:43124028:T:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.67del (p.Glu23fs)	BRCA1	E23fs	Hereditary cancer-predisposing syndrome	VCV001755509	17	41276047	17	43124030	1755509	1818799	rs2552278873	NC_000017.11:43124029:C:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Mar 29, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.66_67insTC (p.Glu23fs)	BRCA1	E23fs	Hereditary cancer-predisposing syndrome	VCV000920945	17	41276047 - 41276048	17	43124030 - 43124031	920945	913986	rs1555600909	NC_000017.11:43124030::GA	Insertion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Mar 16, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.67G>T (p.Glu23Ter)	BRCA1	E23*	Hereditary cancer-predisposing syndrome	VCV000868753	17	41276047	17	43124030	868753	854886	rs372047427	NC_000017.11:43124029:C:A	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 24, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.66dup (p.Glu23fs)	BRCA1	E23fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037691	17	41276047 - 41276048	17	43124030 - 43124031	37691	46247	rs80357783	NC_000017.11:43124030:T:TT	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.65_66insTA (p.Leu22fs)	BRCA1	L22fs	Hereditary breast ovarian cancer syndrome	VCV000568974	17	41276048 - 41276049	17	43124031 - 43124032	568974	574493	rs1567823254	NC_000017.11:43124031::TA	Insertion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jul 24, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.64_65dup (p.Leu22fs)	BRCA1	L22fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236275	17	41276048 - 41276049	17	43124031 - 43124032	236275	237839	rs80357642	NC_000017.11:43124031:AA:AAAA	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.65T>G (p.Leu22Ter)	BRCA1	L22*	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000867737	17	41276049	17	43124032	867737	854889	rs80357438	NC_000017.11:43124031:A:C	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.62_65del (p.Ile21fs)	BRCA1	I21fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266566	17	41276049 - 41276052	17	43124032 - 43124035	266566	262029	rs886040307	NC_000017.11:43124031:AAGA:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.65del (p.Ile21_Leu22insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254367	17	41276049	17	43124032	254367	249176	rs80357642	NC_000017.11:43124031:AA:A	Deletion	frameshift variant|nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.65T>A (p.Leu22Ter)	BRCA1	L22*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000252428	17	41276049	17	43124032	252428	246854	rs80357438	NC_000017.11:43124031:A:T	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.65T>C (p.Leu22Ser)	BRCA1	L22S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055656	17	41276049	17	43124032	55656	70323	rs80357438	NC_000017.11:43124031:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.64_65del (p.Leu22fs)	BRCA1	L22fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055653	17	41276049 - 41276050	17	43124032 - 43124033	55653	70320	rs397509304	NC_000017.11:43124031:AA:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.62dup (p.Glu23fs)	BRCA1	E23fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055651	17	41276051 - 41276052	17	43124034 - 43124035	55651	70318	rs397509303	NC_000017.11:43124034:A:AA	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.61dup (p.Ile21fs)	BRCA1	I21fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573315	17	41276052 - 41276053	17	43124035 - 43124036	2573315	2738263	rs273902778	NC_000017.11:43124035:TTTT:TTTTT	Duplication	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Feb 13, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.60_61dup (p.Ile21fs)	BRCA1	I21fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV002573277	17	41276052 - 41276053	17	43124035 - 43124036	2573277	2738225	rs273902778	NC_000017.11:43124035:TTTT:TTTTTT	Duplication	5 prime UTR variant|frameshift variant|intron variant	Pathogenic	Apr 17, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.61del (p.Ile21fs)	BRCA1	I21fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055649	17	41276053	17	43124036	55649	70316	rs273902778	NC_000017.11:43124035:TTTT:TTT	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.55C>T (p.Gln19Ter)	BRCA1	Q19*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055638	17	41276059	17	43124042	55638	70305	rs397509299	NC_000017.11:43124041:G:A	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.52dup (p.Met18fs)	BRCA1	M18fs	Hereditary breast ovarian cancer syndrome	VCV000857496	17	41276061 - 41276062	17	43124044 - 43124045	857496	845479	rs2055727310	NC_000017.11:43124044:T:TT	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Nov 26, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.53T>A (p.Met18Lys)	BRCA1	M18K	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome	VCV000055559	17	41276061	17	43124044	55559	70226	rs80356929	NC_000017.11:43124043:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.53T>C (p.Met18Thr)	BRCA1	M18T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037664	17	41276061	17	43124044	37664	46220	rs80356929	NC_000017.11:43124043:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.51del (p.Met18fs)	BRCA1	M18fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000254366	17	41276063	17	43124046	254366	249177	rs886037967	NC_000017.11:43124045:A:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.49_50insT (p.Ala17fs)	BRCA1	A17fs	Hereditary cancer-predisposing syndrome	VCV003226169	17	41276064 - 41276065	17	43124047 - 43124048	3226169	3387233	rs2552278937	NC_000017.11:43124047::A	Insertion	5 prime UTR variant|frameshift variant|intron variant	Pathogenic	Jan 22, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.22_50del (p.Val8fs)	BRCA1	V8fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266236	17	41276064 - 41276092	17	43124047 - 43124075	266236	262030	rs886040013	NC_000017.11:43124046:GCATTAATGACATTTTGTACTTCTTCAACGC:GC	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.19_47del (p.Arg7fs)	BRCA1	R7fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125491	17	41276067 - 41276095	17	43124050 - 43124078	125491	131029	rs80359871	NC_000017.11:43124049:TTAATGACATTTTGTACTTCTTCAACGCG:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.45dup (p.Asn16Ter)	BRCA1	N16*	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000570400	17	41276068 - 41276069	17	43124051 - 43124052	570400	574495	rs730881457	NC_000017.11:43124051:AA:AAA	Duplication	frameshift variant|nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.45del (p.Asn16fs)	BRCA1	N16fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000182100	17	41276069	17	43124052	182100	180896	rs730881457	NC_000017.11:43124051:AA:A	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.43_44del (p.Val14_Ile15insTer)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003379257	17	41276070 - 41276071	17	43124053 - 43124054	3379257	3538435		NC_000017.11:43124052:AT:	Deletion	nonsense|5 prime UTR variant|intron variant	Pathogenic	Jul 30, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.40_41del (p.Val14fs)	BRCA1	V14fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266428	17	41276073 - 41276074	17	43124056 - 43124057	266428	262031	rs886040186	NC_000017.11:43124055:ACA:A	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.40del (p.Val14fs)	BRCA1	V14fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266443	17	41276074	17	43124057	266443	262032	rs886040201	NC_000017.11:43124056:C:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.37_40del (p.Asn13fs)	BRCA1	N13fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055010	17	41276074 - 41276077	17	43124057 - 43124060	55010	69677	rs80357530	NC_000017.11:43124056:CATT:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.36_39del (p.Asn13fs)	BRCA1	N13fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000266390	17	41276075 - 41276078	17	43124058 - 43124061	266390	262033	rs886040149	NC_000017.11:43124057:ATTT:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 18, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.38del (p.Asn13fs)	BRCA1	N13fs	Hereditary cancer-predisposing syndrome	VCV002774866	17	41276076	17	43124059	2774866	2935592	rs2552278972	NC_000017.11:43124058:TTTT:TTT	Deletion	5 prime UTR variant|frameshift variant|intron variant	Pathogenic	Aug 29, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.32_35del (p.Val11fs)	BRCA1	V11fs	Hereditary breast ovarian cancer syndrome	VCV001993517	17	41276079 - 41276082	17	43124062 - 43124065	1993517	2049304	rs2552278982	NC_000017.11:43124061:TGTA:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	May 12, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.34dup (p.Gln12fs)	BRCA1	Q12fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548210	17	41276079 - 41276080	17	43124062 - 43124063	548210	538922	rs1555601009	NC_000017.11:43124062:G:GG	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.34C>T (p.Gln12Ter)	BRCA1	Q12*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054902	17	41276080	17	43124063	54902	69569	rs80357134	NC_000017.11:43124062:G:A	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 22, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.32_33insC (p.Gln12fs)	BRCA1	Q12fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054829	17	41276081 - 41276082	17	43124064 - 43124065	54829	69496	rs80357811	NC_000017.11:43124064::G	Insertion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 8, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.30del (p.Val11fs)	BRCA1	V11fs	Hereditary breast ovarian cancer syndrome	VCV002692290	17	41276084	17	43124067	2692290	2853292	rs2552278993	NC_000017.11:43124066:TT:T	Deletion	frameshift variant|5 prime UTR variant|intron variant	Pathogenic	Oct 16, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.21_28del (p.Val8fs)	BRCA1	V8fs	Hereditary breast ovarian cancer syndrome	VCV002764006	17	41276086 - 41276093	17	43124069 - 43124076	2764006	2922175	rs2552278999	NC_000017.11:43124068:CTTCAACGC:C	Deletion	5 prime UTR variant|frameshift variant|intron variant	Pathogenic	Sep 28, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.20dup (p.Val8fs)	BRCA1	V8fs	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000548163	17	41276093 - 41276094	17	43124076 - 43124077	548163	538923	rs1555601027	NC_000017.11:43124076:C:CC	Duplication	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.17_18del (p.Leu6fs)	BRCA1	L6fs	Hereditary cancer-predisposing syndrome	VCV003825289	17	41276096 - 41276097	17	43124079 - 43124080	3825289	1245644		NC_000017.11:43124078:AA:	Deletion	frameshift variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jan 16, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.8T>G (p.Leu3Ter)	BRCA1	L3*	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055746	17	41276106	17	43124089	55746	70413	rs397509332	NC_000017.11:43124088:A:C	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Dec 15, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3G>A (p.Met1Ile)	BRCA1	M1I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000431194	17	41276111	17	43124094	431194	424868	rs80357475	NC_000017.11:43124093:C:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3G>C (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267523	17	41276111	17	43124094	267523	262996	rs80357475	NC_000017.11:43124093:C:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	BRCA1	M1I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055072	17	41276111	17	43124094	55072	69739	rs80357475	NC_000017.11:43124093:C:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2T>A (p.Met1Lys)	BRCA1	M1K	not provided	VCV000801069	17	41276112	17	43124095	801069	789636	rs80357111	NC_000017.11:43124094:A:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Feb 27, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2T>G (p.Met1Arg)	BRCA1	M1R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000054746	17	41276112	17	43124095	54746	69413	rs80357111	NC_000017.11:43124094:A:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Apr 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	BRCA1	M1T	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054745	17	41276112	17	43124095	54745	69412	rs80357111	NC_000017.11:43124094:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1A>G (p.Met1Val)	BRCA1	M1V	Inherited breast cancer and ovarian cancer|Hereditary cancer-predisposing syndrome|Breast neoplasm|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054432	17	41276113	17	43124096	54432	69099	rs80357287	NC_000017.11:43124095:T:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NG_005905.2:g.(?_92501)_(92714_93868)del	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373865	17	41276133 - 41277500	17	43124116 - 43125483	373865	360766			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.-19-2A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S	VCV000267511	17	41276134	17	43124117	267511	262997	rs886040902	NC_000017.11:43124116:T:C	single nucleotide variant	5 prime UTR variant|intron variant|splice acceptor variant	Pathogenic/Likely pathogenic	Oct 2, 2015	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.-107A>T	BRCA1|LOC111589215		Familial cancer of breast	VCV001685584	17	41277375	17	43125358	1685584	1677600	rs2154580237	NC_000017.11:43125357:T:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Pathogenic	May 4, 2022	criteria provided, single submitter							
NC_000017.10:g.(41197820_41199659)_(41277382_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV004525940	17	41197820 - 41277382			4525940	4638339			Deletion		Pathogenic	Jul 14, 2025	criteria provided, single submitter							
GRCh37/hg19 17q21.31(chr17:41235799-41248470)x1	BRCA1		not specified	VCV004076018	17	41235799 - 41248470			4076018	4188704			copy number loss		Pathogenic		criteria provided, single submitter							
NC_000017.10:g.(?_41209140)_(41215974_?)del	BRCA1		Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1	VCV003780828	17	41209140 - 41215974			3780828	3896788			Deletion		Pathogenic	Jul 31, 2014	criteria provided, single submitter							
GRCh37/hg19 17q21.31(chr17:41209069-41215968)x3	BRCA1		not provided	VCV003390311	17	41209069 - 41215968			3390311	3549433			copy number gain		Pathogenic	Sep 1, 2024	criteria provided, single submitter							
NC_000017.10:g.(41209153_41215349)_(41277382_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003385107	17	41209153 - 41277382			3385107	3544250			Deletion		Pathogenic	Oct 24, 2024	criteria provided, single submitter							
NC_000017.10:g.(41251898_41256138)_(41277382_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003336051	17	41251898 - 41277382			3336051	3494732			Deletion		Pathogenic	May 10, 2024	criteria provided, single submitter							
NC_000017.10:g.(41234593_41242960)_(41277382_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003251452	17	41234593 - 41277382			3251452	3410251			Deletion		Pathogenic	Apr 8, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41245486)_(41260384_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243023	17	41245486 - 41260384			3243023	3401621			Deletion		Pathogenic	Feb 24, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41222963)_(41230954_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243021	17	41222963 - 41230954			3243021	3401619			Deletion		Pathogenic	Nov 9, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41211000)_(41243958_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243019	17	41211000 - 41243958			3243019	3401617			Deletion		Pathogenic	Apr 12, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41232561)_(41244132_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243018	17	41232561 - 41244132			3243018	3401616			Deletion		Pathogenic	Jun 26, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41242725)_(41243458_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243017	17	41242725 - 41243458			3243017	3401615			Deletion		Pathogenic	Sep 10, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41242664)_(41246581_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243016	17	41242664 - 41246581			3243016	3401614			Deletion		Pathogenic	Oct 15, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41236868)_(41246163_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243015	17	41236868 - 41246163			3243015	3401613			Deletion		Pathogenic	Nov 23, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41251627)_(41251803_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243014	17	41251627 - 41251803			3243014	3401612			Deletion		Pathogenic	Sep 6, 2019	criteria provided, single submitter							
NC_000017.10:g.(?_41266736)_(41267772_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243013	17	41266736 - 41267772			3243013	3401611			Deletion		Pathogenic	Jan 21, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41196280)_(41197785_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243012	17	41196280 - 41197785			3243012	3401610			Deletion		Pathogenic	Jul 24, 2019	criteria provided, single submitter							
NC_000017.10:g.(?_41196279)_(41197784_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243011	17	41196279 - 41197784			3243011	3401609			Deletion		Pathogenic	Nov 5, 2018	criteria provided, single submitter							
NC_000017.10:g.(?_41205887)_(41209133_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243010	17	41205887 - 41209133			3243010	3404721			Deletion		Pathogenic	Feb 17, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41222925)_(41228666_?)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003243003	17	41222925 - 41228666			3243003	3404714			Duplication		Pathogenic	Dec 31, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41197637)_(41247959_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242995	17	41197637 - 41247959			3242995	3404706			Deletion		Pathogenic	Jun 24, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41249326_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242994	17	41215330 - 41249326			3242994	3404705			Deletion		Pathogenic	Jan 7, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41238856)_(41249326_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242993	17	41238856 - 41249326			3242993	3404704			Deletion		Pathogenic	Jan 23, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41258453)_(41267816_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242992	17	41258453 - 41267816			3242992	3404703			Deletion		Pathogenic	Oct 27, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41197695)_(41199745_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242991	17	41197695 - 41199745			3242991	3404702			Deletion		Pathogenic	Jan 3, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41197695)_(41203154_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242990	17	41197695 - 41203154			3242990	3404701			Deletion		Pathogenic	Jan 29, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41215996_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242989	17	41215330 - 41215996			3242989	3404700			Deletion		Pathogenic	Jan 12, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41209048)_(41223340_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242988	17	41209048 - 41223340			3242988	1458235			Deletion		Pathogenic	Apr 11, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41196353)_(41228651_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242986	17	41196353 - 41228651			3242986	3404698			Deletion		Pathogenic	Feb 9, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41209049)_(41228666_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242985	17	41209049 - 41228666			3242985	3404697			Deletion		Pathogenic	Dec 15, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41238856_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242984	17	41215330 - 41238856			3242984	3404696			Deletion		Pathogenic	Jan 24, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41251772)_(41251917_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242983	17	41251772 - 41251917			3242983	3404695			Deletion		Pathogenic	Jan 10, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41219605)_(41221064_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242982	17	41219605 - 41221064			3242982	3404694			Deletion		Pathogenic	Dec 29, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41222925)_(41223275_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242981	17	41222925 - 41223275			3242981	3404693			Deletion		Pathogenic	Jan 5, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41228485)_(41228666_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242980	17	41228485 - 41228666			3242980	3404692			Deletion		Pathogenic	Jan 24, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41197695)_(41277500_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003242978	17	41197695 - 41277500			3242978	3404690			Deletion		Pathogenic	Jan 19, 2024	criteria provided, single submitter							
NC_000017.10:g.(41209153_41215349)_(41234593_41242960)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003233900	17	41209153 - 41242960			3233900	3393023			Deletion		Pathogenic	Mar 18, 2024	criteria provided, single submitter							
NC_000017.10:g.(41251898_41256138)_(41256279_41256884)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003233739	17	41251898 - 41256884			3233739	3392862			Deletion		Pathogenic	May 15, 2025	criteria provided, single submitter							
NC_000017.10:g.(41267797_41276033)_(41277382_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003069068	17	41267797 - 41277382			3069068	3228393			Deletion		Pathogenic	Feb 21, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41196311)_(41277382_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV003063784	17	41196311 - 41277382			3063784	3223993			Deletion		Pathogenic	Jan 5, 2024	criteria provided, single submitter							
GRCh37/hg19 17q21.31(chr17:41202962-41307101)x1	BRCA1|NBR2		not specified	VCV003063522	17	41202962 - 41307101			3063522	3223732			copy number loss		Pathogenic		criteria provided, single submitter							
NC_000017.10:g.(41215969_41219624)_(41226539_41228504)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002637636	17	41215969 - 41228504			2637636	2805115			Deletion		Pathogenic	Oct 9, 2023	criteria provided, single submitter							
NC_000017.10:g.(41209153_41215349)_(41219713_41222944)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002504041	17	41209153 - 41222944			2504041	2668947			Deletion		Pathogenic	Apr 17, 2023	criteria provided, single submitter							
NC_000017.10:g.(41201212_41203079)_(41203135_41209068)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002429230	17	41201212 - 41209068			2429230	2402663			Deletion		Pathogenic	Jan 18, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41242955)_(41246883_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425746	17	41242955 - 41246883			2425746	1939751			Deletion		Pathogenic	Nov 16, 2017	criteria provided, single submitter							
NC_000017.10:g.(?_41222945)_(41228631_?)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425745	17	41222945 - 41228631			2425745	1939750			Duplication		Pathogenic	Apr 11, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41242941)_(41249326_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425743	17	41242941 - 41249326			2425743	1939748			Deletion		Pathogenic	Oct 31, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41249241)_(41251917_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425742	17	41249241 - 41251917			2425742	1939747			Deletion		Pathogenic	Sep 5, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41197695)_(41251917_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425741	17	41197695 - 41251917			2425741	1939746			Deletion		Pathogenic	May 25, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41256119)_(41258570_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425740	17	41256119 - 41258570			2425740	1939745			Deletion		Pathogenic	Oct 23, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41196977)_(41199745_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425739	17	41196977 - 41199745			2425739	1939744			Deletion		Pathogenic	Oct 25, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41199654)_(41203140_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425738	17	41199654 - 41203140			2425738	1939743			Deletion		Pathogenic	Jun 4, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41196977)_(41209172_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425737	17	41196977 - 41209172			2425737	1939742			Deletion		Pathogenic	May 24, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41219605)_(41223275_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425735	17	41219605 - 41223275			2425735	1939741			Deletion		Pathogenic	Oct 31, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41209048)_(41226558_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425734	17	41209048 - 41226558			2425734	1939740			Deletion		Pathogenic	Jun 1, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41209049)_(41228651_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425733	17	41209049 - 41228651			2425733	1939739			Deletion		Pathogenic	Oct 22, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41226328)_(41246897_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425732	17	41226328 - 41246897			2425732	1939738			Deletion		Pathogenic	Aug 19, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41201118)_(41201231_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425731	17	41201118 - 41201231			2425731	1939737			Deletion		Pathogenic	May 3, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41226342)_(41226544_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425730	17	41226342 - 41226544			2425730	1939736			Deletion		Pathogenic	Jul 12, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41234401)_(41236614_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425729	17	41234401 - 41236614			2425729	1939735			Deletion		Pathogenic	Oct 12, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41267778)_(41280110_?)del	BRCA1|NBR2		Hereditary breast ovarian cancer syndrome	VCV002425726	17	41267778 - 41280110			2425726	1939733			Deletion		Pathogenic	Oct 19, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41258383)_(41258523_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425725	17	41258383 - 41258523			2425725	1939732			Deletion		Pathogenic	Nov 29, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41251772)_(41256993_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425717	17	41251772 - 41256993			2425717	1939724			Deletion		Pathogenic	Jan 19, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41199640)_(41201231_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425716	17	41199640 - 41201231			2425716	1939723			Deletion		Pathogenic	Mar 9, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41196353)_(41215988_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425715	17	41196353 - 41215988			2425715	1939722			Deletion		Pathogenic	Jul 5, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41197637)_(41234612_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425712	17	41197637 - 41234612			2425712	1939720			Deletion		Pathogenic	Jan 27, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41226328)_(41277500_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002425711	17	41226328 - 41277500			2425711	1939719			Deletion		Pathogenic	Jun 16, 2022	criteria provided, single submitter							
NC_000017.10:g.(41209153_41215349)_(41277501_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001878370	17	41209153 - 41277501			1878370	1935135			Deletion		Pathogenic	Dec 22, 2022	criteria provided, single submitter							
NC_000017.10:g.(41219713_41222944)_(41223256_41226347)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001878369	17	41219713 - 41226347			1878369	1935134			Deletion		Pathogenic	Dec 22, 2022	criteria provided, single submitter							
NC_000017.10:g.(41256974_41258472)_(41267797_41276033)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001722423	17	41256974 - 41276033			1722423	1779933			Deletion		Pathogenic	Sep 2, 2022	criteria provided, single submitter							
NC_000017.10:g.(41267797_41276033)_(41277501_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001696294	17	41267797 - 41277501			1696294	1688700			Deletion		Pathogenic	May 6, 2022	criteria provided, single submitter							
NC_000017.10:g.(41256974_41258472)_(41258551_41267742)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001683333	17	41256974 - 41267742			1683333	1675231			Deletion		Pathogenic	Apr 25, 2022	criteria provided, single submitter							
GRCh37/hg19 17q21.31(chr17:41235798-41248470)	BRCA1		not specified	VCV001526578	17	41235798 - 41248470			1526578	1518067			copy number loss		Pathogenic	Mar 1, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41239343)_(41245904_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001460451	17	41239343 - 41245904			1460451	1504501			Deletion		Pathogenic	Sep 13, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41196353)_(41249326_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001460091	17	41196353 - 41249326			1460091	1481448			Deletion		Pathogenic	Aug 3, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41203060)_(41277500_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001459038	17	41203060 - 41277500			1459038	1406167			Deletion		Pathogenic	Aug 6, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41219605)_(41251921_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001456305	17	41219605 - 41251921			1456305	1458245			Deletion		Pathogenic	Feb 19, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41228651_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001456294	17	41215330 - 41228651			1456294	1458234			Deletion		Pathogenic	Jan 26, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41222925)_(41228651_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001456293	17	41222925 - 41228651			1456293	1458233			Deletion		Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41228485)_(41277500_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001456291	17	41228485 - 41277500			1456291	1458231			Deletion		Pathogenic	Apr 6, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41236869)_(41246163_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001453787	17	41236869 - 41246163			1453787	1451313			Deletion		Pathogenic	Nov 7, 2018	criteria provided, single submitter							
NC_000017.10:g.(?_41206281)_(41209103_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001420683	17	41206281 - 41209103			1420683	1403289			Deletion		Pathogenic	Mar 1, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41226558_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001420319	17	41215330 - 41226558			1420319	1503098			Deletion		Pathogenic	Sep 13, 2022	criteria provided, single submitter							
NC_000017.10:g.(41199721_41201137)_(41203135_41209068)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001339762	17	41199721 - 41209068			1339762	1330972			Deletion		Pathogenic	Jan 5, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41196311)_(41199721_41201137)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001339722	17	41196311 - 41201137			1339722	1330932			Deletion		Pathogenic	Jan 19, 2022	criteria provided, single submitter							
NC_000017.10:g.(41215391_41215890)_(41215969_41219624)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001217296	17	41215391 - 41219624			1217296	1207275			Deletion		Pathogenic	Aug 9, 2021	criteria provided, single submitter							
NC_000017.10:g.(41197820_41199659)_(41277501_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001217257	17	41197820 - 41277501			1217257	1207237			Deletion		Pathogenic	Aug 18, 2021	criteria provided, single submitter							
NC_000017.10:g.(41197820_41199659)_(41276133_41277287)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001217237	17	41197820 - 41277287			1217237	1207217			Deletion		Pathogenic	Aug 11, 2021	criteria provided, single submitter							
NC_000017.10:g.(41219713_41222944)_(41226539_41228504)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001098832	17	41219713 - 41228504			1098832	1087477			Deletion		Pathogenic	May 12, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41251772)_(41251921_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001076991	17	41251772 - 41251921			1076991	1057963			Deletion		Pathogenic	Oct 13, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41267723)_(41267816_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001076990	17	41267723 - 41267816			1076990	1057967			Deletion		Pathogenic	Oct 16, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41199640)_(41199745_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001076989	17	41199640 - 41199745			1076989	1057924			Deletion		Pathogenic	Jul 19, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41201105)_(41201221_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001076988	17	41201105 - 41201221			1076988	1057927			Deletion		Pathogenic	Sep 10, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41276014)_(41276152_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001076987	17	41276014 - 41276152			1076987	1057968			Deletion		Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41203060)_(41203154_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001076464	17	41203060 - 41203154			1076464	1057929			Deletion		Pathogenic	Dec 11, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41199654)_(41276119_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001075234	17	41199654 - 41276119			1075234	1057926			Deletion		Pathogenic	Jan 29, 2018	criteria provided, single submitter							
NC_000017.10:g.(?_41215344)_(41276119_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001075233	17	41215344 - 41276119			1075233	1057940			Deletion		Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41234415)_(41276119_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001075232	17	41234415 - 41276119			1075232	1057953			Deletion		Pathogenic	Feb 15, 2017	criteria provided, single submitter							
NC_000017.10:g.(?_41242955)_(41276119_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001075231	17	41242955 - 41276119			1075231	1057959			Deletion		Pathogenic	Apr 27, 2017	criteria provided, single submitter							
NC_000017.10:g.(?_41249241)_(41251921_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073300	17	41249241 - 41251921			1073300	1057961			Deletion		Pathogenic	Aug 31, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41197637)_(41251921_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073299	17	41197637 - 41251921			1073299	1057922			Deletion		Pathogenic	Apr 2, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41234401)_(41251921_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073298	17	41234401 - 41251921			1073298	1057951			Deletion		Pathogenic	Aug 22, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41256129)_(41258568_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073297	17	41256129 - 41258568			1073297	1057964			Deletion		Pathogenic	Mar 5, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41219605)_(41223340_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073080	17	41219605 - 41223340			1073080	1057942			Deletion		Pathogenic	Oct 15, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41222925)_(41226558_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073079	17	41222925 - 41226558			1073079	1057944			Deletion		Pathogenic	Sep 27, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41209048)_(41228651_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073078	17	41209048 - 41228651			1073078	1057933			Deletion		Pathogenic	Oct 19, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41234612_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001073077	17	41215330 - 41234612			1073077	1057939			Deletion		Pathogenic	Sep 25, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41234401)_(41277500_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001072983	17	41234401 - 41277500			1072983	1057952			Deletion		Pathogenic	Jan 14, 2024	criteria provided, single submitter							
NC_000017.10:g.(?_41215238)_(41258921_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001071391	17	41215238 - 41258921			1071391	1057935			Deletion		Pathogenic	Feb 20, 2015	criteria provided, single submitter							
NC_000017.10:g.(?_41226328)_(41258570_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001071390	17	41226328 - 41258570			1071390	1057949			Deletion		Pathogenic	Dec 3, 2023	criteria provided, single submitter							
NC_000017.10:g.(?_41226328)_(41234612_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001071182	17	41226328 - 41234612			1071182	1057948			Deletion		Pathogenic	Oct 19, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41256865)_(41277500_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001071180	17	41256865 - 41277500			1071180	1057965			Deletion		Pathogenic	Jul 17, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41222925)_(41267816_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069353	17	41222925 - 41267816			1069353	1057945			Deletion		Pathogenic	Jul 1, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41242941)_(41267816_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069352	17	41242941 - 41267816			1069352	1057958			Deletion		Pathogenic	Dec 7, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41199640)_(41203154_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069351	17	41199640 - 41203154			1069351	1057925			Deletion		Pathogenic	Mar 15, 2019	criteria provided, single submitter							
NC_000017.10:g.(?_41201118)_(41203154_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069350	17	41201118 - 41203154			1069350	1057928			Deletion		Pathogenic	Oct 24, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41197689)_(41209158_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069180	17	41197689 - 41209158			1069180	1057923			Deletion		Pathogenic	Jul 25, 2016	criteria provided, single submitter							
NC_000017.10:g.(?_41209048)_(41215988_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069179	17	41209048 - 41215988			1069179	1057931			Deletion		Pathogenic	Aug 14, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41215988_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069178	17	41215330 - 41215988			1069178	1057936			Deletion		Pathogenic	Nov 1, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41209048)_(41219732_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069177	17	41209048 - 41219732			1069177	1057932			Deletion		Pathogenic	Oct 4, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41219732_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069176	17	41215330 - 41219732			1069176	1057937			Deletion		Pathogenic	Oct 20, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41215330)_(41223340_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001069175	17	41215330 - 41223340			1069175	1057938			Deletion		Pathogenic	Mar 27, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41219605)_(41219732_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001068886	17	41219605 - 41219732			1068886	1057941			Deletion		Pathogenic	Sep 26, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41222925)_(41223340_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001068885	17	41222925 - 41223340			1068885	1057943			Deletion		Pathogenic	Sep 14, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41226328)_(41226558_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001068884	17	41226328 - 41226558			1068884	1057947			Deletion		Pathogenic	Jun 30, 2020	criteria provided, single submitter							
NC_000017.10:g.(?_41228485)_(41228651_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001068883	17	41228485 - 41228651			1068883	1057950			Deletion		Pathogenic	Oct 24, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41242941)_(41243069_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001068882	17	41242941 - 41243069			1068882	1057957			Deletion		Pathogenic	Mar 26, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41196977)_(41277500_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001068881	17	41196977 - 41277500			1068881	1057921			Deletion		Pathogenic	Oct 26, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41234401)_(41249326_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001066580	17	41234401 - 41249326			1066580	1054627			Deletion		Pathogenic	Jul 5, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41228485)_(41258570_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001066374	17	41228485 - 41258570			1066374	1054626			Deletion		Pathogenic	Sep 4, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41219605)_(41228651_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001066373	17	41219605 - 41228651			1066373	1054625			Deletion		Pathogenic	Sep 24, 2022	criteria provided, single submitter							
NC_000017.10:g.(?_41258453)_(41258570_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001066372	17	41258453 - 41258570			1066372	1054632			Deletion		Pathogenic	Aug 16, 2022	criteria provided, single submitter							
NC_000017.10:g.(41197820_41199659)_(41199721_41201137)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001065138	17	41197820 - 41201137			1065138	1053444			Deletion		Pathogenic	Apr 2, 2021	criteria provided, single submitter							
NC_000017.10:g.(41203135_41209068)_(41209153_41215349)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001027624	17	41203135 - 41215349			1027624	1015344			Deletion		Pathogenic	Mar 9, 2021	criteria provided, single submitter							
NC_000017.10:g.(?_41196311)_(41203135_41209068)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001027595	17	41196311 - 41209068			1027595	1015345			Deletion		Pathogenic	May 22, 2023	criteria provided, single submitter							
NC_000017.10:g.(41251898_41256138)_(41258551_41267742)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000997866	17	41251898 - 41267742			997866	985578			Deletion		Pathogenic	Feb 3, 2021	criteria provided, single submitter							
NC_000017.10:g.(41228632_41234420)_(41234593_41242960)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000987816	17	41228632 - 41242960			987816	975758			Deletion		Pathogenic	Nov 9, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.(5193+1_5194-1)_(5277+1_5278-1)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000983561	17	41203135 - 41215349			983561	971628			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NC_000017.11:g.(43074522_43076487)_(43076615_43082403)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000982003	17	41226539 - 41234420			982003	970089			Deletion		Pathogenic	Sep 30, 2020	criteria provided, single submitter							
NC_000017.11:g.(43106534_43115725)_(43115780_43124016)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000982001	17	41258551 - 41276033			982001	970093			Duplication		Pathogenic	Mar 27, 2020	criteria provided, single submitter							
NC_000017.11:g.(43063952_43067607)_(43076615_43082403)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000982000	17	41215969 - 41234420			982000	970086			Deletion		Pathogenic	Dec 17, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43044294)_(43125484_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981999	17	41196311 - 41277501			981999	970098			Deletion		Pathogenic	Apr 7, 2020	criteria provided, single submitter							
NC_000017.11:g.(43063952_43067607)_(43071239_43074330)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981998	17	41215969 - 41226347			981998	970085			Deletion		Pathogenic	Oct 11, 2021	criteria provided, single submitter							
NC_000017.11:g.(43063952_43067607)_(43067696_43070927)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981997	17	41215969 - 41222944			981997	970084			Deletion		Pathogenic	Mar 6, 2025	criteria provided, single submitter							
NC_000017.11:g.(43099881_43104121)_(43125484_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981996	17	41251898 - 41277501			981996	970091			Deletion		Pathogenic	Jul 8, 2019	criteria provided, single submitter							
NC_000017.11:g.(43106534_43115725)_(43115780_43124016)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981987	17	41258551 - 41276033			981987	970092			Deletion		Pathogenic	May 15, 2019	criteria provided, single submitter							
NC_000017.11:g.(43057136_43063332)_(43063952_43067607)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981986	17	41209153 - 41219624			981986	970083			Duplication		Pathogenic	May 2, 2019	criteria provided, single submitter							
NC_000017.11:g.(43082576_43090943)_(43097290_43099774)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981985	17	41234593 - 41251791			981985	970090			Deletion		Pathogenic	Aug 28, 2019	criteria provided, single submitter							
NC_000017.11:g.(43051118_43057051)_(43076615_43082403)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981984	17	41203135 - 41234420			981984	970081			Deletion		Pathogenic	Apr 6, 2020	criteria provided, single submitter							
NC_000017.11:g.(43071239_43074330)_(43082576_43090943)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981970	17	41223256 - 41242960			981970	970087			Deletion		Pathogenic	Jul 21, 2020	criteria provided, single submitter							
NC_000017.11:g.(?_43044294)_(43045803_43047642)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981969	17	41196311 - 41199659			981969	970095			Deletion		Pathogenic	Mar 18, 2022	criteria provided, single submitter							
NC_000017.11:g.(43071239_43074330)_(43115780_43124016)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981968	17	41223256 - 41276033			981968	970088			Deletion		Pathogenic	Jul 21, 2020	criteria provided, single submitter							
NC_000017.11:g.(43115780_43124016)_(43124116_43125270)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981967	17	41267797 - 41277287			981967	970094			Deletion		Pathogenic	Aug 5, 2020	criteria provided, single submitter							
NC_000017.11:g.(43057136_43063332)_(43063952_43067607)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981966	17	41209153 - 41219624			981966	970082			Deletion		Pathogenic	Mar 10, 2020	criteria provided, single submitter							
NC_000017.11:g.(?_43044294)_(43124116_43125270)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981965	17	41196311 - 41277287			981965	970096			Deletion		Pathogenic	Apr 6, 2020	criteria provided, single submitter							
NC_000017.11:g.(43051118_43057051)_(43063952_43067607)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000981964	17	41203135 - 41219624			981964	970080			Duplication		Pathogenic	Mar 7, 2025	criteria provided, single submitter							
NC_000017.11:g.(?_43070908)_(43076634_?)dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000833284	17	41222925 - 41228651			833284	821075			Duplication		Pathogenic	Oct 12, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43067588)_(43074541_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000833281	17	41219605 - 41226558			833281	821071			Deletion		Pathogenic	Nov 18, 2023	criteria provided, single submitter							
NC_000017.11:g.(?_43099755)_(43106553_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000832902	17	41251772 - 41258570			832902	821091			Deletion		Pathogenic	Sep 1, 2023	criteria provided, single submitter							
NC_000017.11:g.(?_43099755)_(43125483_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000832729	17	41251772 - 41277500			832729	821092			Deletion		Pathogenic	Dec 29, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43044336)_(43045822_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000832503	17	41196353 - 41197839			832503	821045			Deletion		Pathogenic	Dec 20, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43044336)_(43099904_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000832385	17	41196353 - 41251921			832385	821048			Deletion		Pathogenic	Nov 27, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43044336)_(43051137_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000832373	17	41196353 - 41203154			832373	821047			Deletion		Pathogenic	Dec 11, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045620)_(43047728_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000832372	17	41197637 - 41199745			832372	821054			Deletion		Pathogenic	Dec 4, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43104102)_(43104281_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000832234	17	41256119 - 41256298			832234	821093			Deletion		Pathogenic	May 12, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045658)_(43067715_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000832145	17	41197675 - 41219732			832145	821055			Deletion		Pathogenic	Apr 23, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43057032)_(43074541_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831969	17	41209049 - 41226558			831969	821067			Deletion		Pathogenic	Apr 29, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43115614)_(43125483_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831951	17	41267631 - 41277500			831951	821095			Deletion		Pathogenic	Oct 29, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045658)_(43097309_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831915	17	41197675 - 41249326			831915	821056			Deletion		Pathogenic	Mar 3, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43044336)_(43047728_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831890	17	41196353 - 41199745			831890	821046			Deletion		Pathogenic	Sep 18, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43095826)_(43106553_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831801	17	41247843 - 41258570			831801	821087			Deletion		Pathogenic	Aug 21, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045658)_(43106553_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831782	17	41197675 - 41258570			831782	821058			Deletion		Pathogenic	Aug 2, 2021	criteria provided, single submitter							
NC_000017.11:g.(?_43044878)_(43045822_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831723	17	41196895 - 41197839			831723	821051			Deletion		Pathogenic	Oct 28, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43090924)_(43094880_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831221	17	41242941 - 41246897			831221	821083			Deletion		Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NC_000017.11:g.(?_43047633)_(43126360_?)del	BRCA1|NBR2		Hereditary breast ovarian cancer syndrome	VCV000831192	17	41199650 - 41278377			831192	821059			Deletion		Pathogenic	Nov 15, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43045658)_(43099900_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831128	17	41197675 - 41251917			831128	821057			Deletion		Pathogenic	Apr 15, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43057031)_(43057155_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831095	17	41209048 - 41209172			831095	821063			Deletion		Pathogenic	Dec 20, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43057032)_(43063971_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000831049	17	41209049 - 41215988			831049	821066			Deletion		Pathogenic	Sep 6, 2022	criteria provided, single submitter							
NC_000017.11:g.(?_43044336)_(43125483_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000830640	17	41196353 - 41277500			830640	821049			Deletion		Pathogenic	Dec 8, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43044960)_(43071323_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000830606	17	41196977 - 41223340			830606	821053			Deletion		Pathogenic	Oct 13, 2023	criteria provided, single submitter							
NC_000017.11:g.(?_43044960)_(43045822_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000830601	17	41196977 - 41197839			830601	821052			Deletion		Pathogenic	Dec 20, 2019	criteria provided, single submitter							
NC_000017.11:g.(?_43049101)_(43082595_?)del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000830417	17	41201118 - 41234612			830417	821061			Deletion		Pathogenic	Jul 6, 2022	criteria provided, single submitter							
Single allele	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000433576	17	41197694 - 41197818			433576	427588			Deletion		Pathogenic	Oct 14, 2016	criteria provided, single submitter							
NM_007294.3(BRCA1):c.548-?_593+?dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000433574	17	41249261 - 41249306			433574	427517			Duplication		Pathogenic		criteria provided, single submitter							
Single allele	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000433573	17	41276034 - 41276113			433573	427586			Deletion		Pathogenic	Jul 10, 2012	criteria provided, single submitter							
Single allele	BRCA1		Breast neoplasm	VCV000430589	17	41215969 - 41277341			430589	423237			Deletion		Pathogenic		criteria provided, single submitter							
NM_007294.3(BRCA1):c.4186-?_5193+?del	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216103	17	41215350 - 41234592			216103	213235			Deletion		Pathogenic	Oct 2, 2015	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.?-232_4484+?del	BRCA1		Familial cancer of breast	VCV000089068	17	41228505 - 41277500			89068	94611			Deletion		Pathogenic		criteria provided, single submitter							
NM_007294.3(BRCA1):c.4186-?_4986+?del	BRCA1		Familial cancer of breast	VCV000089062	17	41222945 - 41234592			89062	94605			Deletion		Pathogenic		criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_441+?del	BRCA1		Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000089055	17	41256139 - 41258550			89055	94598			Deletion		Pathogenic	Jan 3, 2017	criteria provided, multiple submitters, no conflicts							
NM_007294.4:c.(80+1_81-1)_(4986+1_4987-1)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003236920					3236920	3396046			Deletion		Pathogenic	May 27, 2024	criteria provided, single submitter							
NM_007294.4:c.(5152-1_5153+1)_(5193+1_5194-1)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003236919					3236919	3396045			Deletion		Pathogenic	May 27, 2024	criteria provided, single submitter							
NM_007294.4:c.(4096+1_4097-1)_(4185+1_4186-1)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003236917					3236917	3396043			Deletion		Pathogenic	May 27, 2024	criteria provided, single submitter							
NM_007294.4:c.(80+1_81-1)_(134+1_135-1)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV003236916					3236916	3396042			Deletion		Pathogenic	May 27, 2024	criteria provided, single submitter							
NM_007294.3:c.-76154_4890del	BRCA1		Hereditary cancer-predisposing syndrome	VCV003226178					3226178	3387241			Deletion		Pathogenic	Oct 10, 2023	criteria provided, single submitter							
NM_007294.3:c.-232_80del	BRCA1		not provided	VCV001809531					1809531	1866535			Deletion		Pathogenic	Sep 30, 2021	criteria provided, single submitter							
NM_007294.3:c.5075_5193del	BRCA1		not provided	VCV001809530					1809530	1866534			Deletion		Pathogenic	Jun 11, 2021	criteria provided, single submitter							
NM_007294.3:c.442_593del	BRCA1		not provided	VCV001809529					1809529	1866533			Deletion		Pathogenic	Jun 11, 2021	criteria provided, single submitter							
NM_007294.3:c.548_4185del	BRCA1		not provided	VCV001809528					1809528	1866532			Deletion		Pathogenic	Jun 26, 2019	criteria provided, single submitter							
NM_007294.3:c.134+2513_4357+2438dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001770346					1770346	1829451			Duplication		Pathogenic	Jul 11, 2017	criteria provided, single submitter							
NM_007294.3:c.134+2460_4357+2437dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001770345					1770345	1829450			Duplication		Pathogenic	Feb 23, 2018	criteria provided, single submitter							
NM_007294.3:c.5074+925_5277+2098dup	BRCA1		Hereditary cancer-predisposing syndrome	VCV001745174					1745174	1806020			Duplication		Pathogenic	Feb 21, 2017	criteria provided, single submitter							
NM_007294.4:c.(441+1_442-1)_(547+1_548-1)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV001707505					1707505	1705810			Deletion		Pathogenic	Jul 25, 2022	criteria provided, single submitter							
NM_007294.4:c.(19_?80_?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV001344536					1344536	1336239			Deletion		Pathogenic		criteria provided, single submitter							
NM_007294.4:c.(4676-?_4986-?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV001344534					1344534	1336237			Deletion		Pathogenic		criteria provided, single submitter							
NM_007294.4:c.(442_?547_?)del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV001344525					1344525	1336228			Deletion		Pathogenic		criteria provided, single submitter							
NC_000017.10:g.(?_41276015)_41277500del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001072984					1072984	1057969			Deletion		Pathogenic	Aug 7, 2018	criteria provided, single submitter							
NM_007294.4:c.4186_4357dup	BRCA1		not provided	VCV000993170					993170	980983			Duplication		Pathogenic	Sep 21, 2019	criteria provided, single submitter							
NM_007294.3:c.-232_*1383del	BRCA1		not provided	VCV000993168					993168	980982			Deletion		Pathogenic	Nov 14, 2019	criteria provided, single submitter							
NM_007294.4:c.445_650del	BRCA1		not provided	VCV000993139					993139	980985			Deletion		Pathogenic	Oct 29, 2019	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5075-?_5193+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000984417					984417	972484			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4485-?_4675+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000984416					984416	972483			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.-19-?_80+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000984415					984415	972482			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5333-?_5406+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000984414					984414	972481			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_441+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000984413					984413	972480			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
Single allele	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000870298					870298	858467			Insertion		Pathogenic	Oct 7, 2019	criteria provided, single submitter							
NM_007294.3(BRCA1):c.(80+1_81-1)_(134+1_135-1)del	BRCA1		Hereditary cancer-predisposing syndrome	VCV000584574					584574	575631			Deletion		Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.3(BRCA1):c.(5467+1_5468-1)_(*1_?)del	BRCA1		Hereditary cancer-predisposing syndrome	VCV000584573					584573	575630			Deletion		Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.3(BRCA1):c.(5074+1-5075-1)_(5193+1_5194-1)del	BRCA1		Hereditary cancer-predisposing syndrome	VCV000584572					584572	575629			Deletion		Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.3(BRCA1):c.(441+1_442-1)_(547+1_548-1)del	BRCA1		Hereditary cancer-predisposing syndrome	VCV000584571					584571	575628			Deletion		Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.3(BRCA1):c.(?_-1)_(80+1_81-1)del	BRCA1		Hereditary cancer-predisposing syndrome	VCV000584570					584570	575627			Deletion		Pathogenic	Jan 1, 2020	criteria provided, single submitter							
NM_007294.3:c.(671_4096)ins(300)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373890					373890	360778			Insertion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.61068_98138del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373857					373857	360746			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.118449_154829del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373851					373851	360744			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.116321_140085del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373838					373838	360743			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NG_005905.2:g.110966_142550del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000373835					373835	360742			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.81-?_547+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267626					267626	262910			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.81-?_5193+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267625					267625	262883			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.81-?_5152+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267624					267624	262886			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.81-?_441+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267623					267623	262912			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.81-?_4185+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267622					267622	262903			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.81-?_134+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267621					267621	262915			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.671-?_4675+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267614					267614	262893			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.671-?_4484+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267613					267613	262896			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.671-?_4185+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267612					267612	262900			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.594-?_4484+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267608					267608	262897			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5407-?_5467+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267603					267603	262865			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5407-?_5467+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267602					267602	262864			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5278-?_5467+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267592					267592	262866			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5278-?_5406+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267591					267591	262870			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5278-?_5406+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267590					267590	262869			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5278-?_5332+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267589					267589	262871			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5194-?_5277+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267581					267581	262873			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5194-?_5277+?delinsG	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267580					267580	262872			Indel		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5153-?_5193+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267578					267578	262878			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5075-?_5277+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267574					267574	262874			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5075-?_5193+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267573					267573	262880			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5075-?_5193+?del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000267572					267572	262879			Deletion		Pathogenic	May 29, 2013	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5075-?_5152+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267571					267571	262884			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4987-?_5277+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267564					267564	262875			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4987-?_5152+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267563					267563	262885			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4676-?_5467+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267558					267558	262867			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4676-?_5193+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267557					267557	262881			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4676-?_4986+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267556					267556	262889			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4485-?_5074+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267550					267550	262887			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4485-?_4675+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267549					267549	262892			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.442-?_670+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267543					267543	262904			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.442-?_547+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267542					267542	262907			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.442-?_5467+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267541					267541	262868			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.442-?_5277+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267540					267540	262877			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.442-?_4185+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267539					267539	262901			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4358-?_5193+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267537					267537	262882			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4358-?_5074+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267536					267536	262888			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4358-?_4986+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267535					267535	262891			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4358-?_4986+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267534					267534	262890			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4358-?_4484+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267533					267533	262894			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4186-?_5277+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267528					267528	262876			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4186-?_4484+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267527					267527	262895			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4186-?_4357+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267526					267526	262899			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.302-?_593+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267518					267518	262906			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.213-?_441+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267513					267513	262911			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_670+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267506					267506	262905			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_547+?dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267505					267505	262909			Duplication		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_547+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267504					267504	262908			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_4484+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267503					267503	262898			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_4185+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267502					267502	262902			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_301+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267501					267501	262913			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_212+?del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000267500					267500	262914			Deletion		Pathogenic	Oct 2, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.5333-?_5406+?del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000254068					254068	248516			Deletion		Pathogenic	Feb 5, 2016	criteria provided, single submitter							
NM_007294.3(BRCA1):c.4485-?_4675+?del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000254041					254041	248527			Deletion		Pathogenic	Dec 22, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4677_5075del (p.Glu1559_Thr1691del)	BRCA1		Breast neoplasm	VCV000224425					224425	226213			Deletion		Pathogenic	Nov 1, 2015	criteria provided, single submitter							
NM_007294.3(BRCA1):c.135-?_5193+?del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000216101					216101	213236			Deletion		Pathogenic	Feb 20, 2015	criteria provided, single submitter							
NM_007294.3:c.3764insA	BRCA1		Familial cancer of breast	VCV000182114					182114	181139			Insertion		Pathogenic	Oct 1, 2014	criteria provided, single submitter							
NM_007294.3:c.1363insT	BRCA1		Familial cancer of breast	VCV000182104					182104	181133			Insertion		Pathogenic	May 20, 2014	criteria provided, single submitter							
